<SEC-DOCUMENT>0001601830-26-000078.txt : 20260506
<SEC-HEADER>0001601830-26-000078.hdr.sgml : 20260506
<ACCEPTANCE-DATETIME>20260506063240
ACCESSION NUMBER:		0001601830-26-000078
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		74
CONFORMED PERIOD OF REPORT:	20260331
FILED AS OF DATE:		20260506
DATE AS OF CHANGE:		20260506

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			RECURSION PHARMACEUTICALS, INC.
		CENTRAL INDEX KEY:			0001601830
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				464099738
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40323
		FILM NUMBER:		26945687

	BUSINESS ADDRESS:	
		STREET 1:		41S RIO GRANDE STREET
		CITY:			SALT LAKE CITY
		STATE:			UT
		ZIP:			84101
		BUSINESS PHONE:		(385) 269-0203

	MAIL ADDRESS:	
		STREET 1:		41S RIO GRANDE STREET
		CITY:			SALT LAKE CITY
		STATE:			UT
		ZIP:			84101

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Recursion Pharmaceuticals, LLC
		DATE OF NAME CHANGE:	20140305
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>rxrx-20260331.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019c9ac1-acf5-79ea-ae98-b958c721a179,g:9f615d00-f48b-491d-8614-00e244a2e814,d:cf34ee3be70a44349aaa73f1b5df5e08-->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ecd="http://xbrl.sec.gov/ecd/2025" xmlns:rxrx="http://www.recursion.com/20260331" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>rxrx-20260331</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-26">0001601830</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" format="ixt:fixed-false" id="f-27">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalYearFocus" id="f-28">2026</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalPeriodFocus" id="f-29">Q1</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:CurrentFiscalYearEndDate" format="ixt:date-month-day" id="f-30">12/31</ix:nonNumeric><ix:nonNumeric contextRef="c-43" name="rxrx:LicenseAgreementTradingPeriodUsedForEquityValueDetermination" id="f-283">P7D</ix:nonNumeric><ix:nonNumeric contextRef="c-43" name="rxrx:LicenseAgreementAmountOfTimePriorToThePaymentDate" id="f-284">P5D</ix:nonNumeric><ix:nonFraction unitRef="segment" contextRef="c-1" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="f-547">one</ix:nonFraction><ix:nonFraction unitRef="segment" contextRef="c-1" decimals="INF" name="us-gaap:NumberOfOperatingSegments" format="ixt-sec:numwordsen" scale="0" id="f-548">one</ix:nonFraction><ix:nonNumeric contextRef="c-129" name="ecd:TrdArrDuration" format="ixt-sec:durday" id="f-559">456</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="rxrx-20260331.xsd"/></ix:references><ix:resources><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="vote"><xbrli:measure>rxrx:vote</xbrli:measure></xbrli:unit><xbrli:unit id="class"><xbrli:measure>rxrx:class</xbrli:measure></xbrli:unit><xbrli:unit id="candidate"><xbrli:measure>rxrx:candidate</xbrli:measure></xbrli:unit><xbrli:unit id="performance_obligation"><xbrli:measure>rxrx:performance_obligation</xbrli:measure></xbrli:unit><xbrli:unit id="phenomap"><xbrli:measure>rxrx:phenomap</xbrli:measure></xbrli:unit><xbrli:unit id="program"><xbrli:measure>rxrx:program</xbrli:measure></xbrli:unit><xbrli:unit id="segment"><xbrli:measure>rxrx:segment</xbrli:measure></xbrli:unit><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-05-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-05-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-10"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">rxrx:ExchangeableStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-11"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">rxrx:ExchangeableStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-12"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-13"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-14"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-15"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-16"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-17"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-18"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-19"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-20"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-21"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-22"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-23"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-24"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-25"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-26"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-27"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-28"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-29"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-30"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-32"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-33"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-34"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-35"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-36"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-37"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-38"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-39"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-40"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-41"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-42"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-43"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxrx:TempusLabsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-11-01</xbrli:startDate><xbrli:endDate>2023-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-44"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxrx:TempusLabsIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-45"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxrx:TempusLabsIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-46"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">rxrx:REVenturesIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-47"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">rxrx:REVenturesIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-07-01</xbrli:startDate><xbrli:endDate>2025-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-48"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">rxrx:REVenturesIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-08-01</xbrli:startDate><xbrli:endDate>2025-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-49"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rxrx:AlphaBiotechnologyGmbHAlphaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-50"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">rxrx:ExscientiaGmbHMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-51"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rxrx:AlphaBiotechnologyGmbHAlphaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-52"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-53"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-54"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-55"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-56"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-57"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-58"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-59"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">rxrx:AtTheMarketOfferingProgramTDCowenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-02-01</xbrli:startDate><xbrli:endDate>2026-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-60"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">rxrx:AtTheMarketOfferingProgramTDCowenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-61"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rxrx:ValenceDiscoveryIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">rxrx:ExchangeableStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-01</xbrli:startDate><xbrli:endDate>2023-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-62"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">rxrx:ExchangeableStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-63"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rxrx:ValenceDiscoveryIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-01</xbrli:startDate><xbrli:endDate>2023-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-64"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-65"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxrx:SanofiMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-66"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxrx:SanofiMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-67"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxrx:SanofiMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-68"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxrx:SanofiMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rxrx:MilestoneTypeAxis">rxrx:ResearchMilestonesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-69"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxrx:SanofiMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rxrx:MilestoneTypeAxis">rxrx:DevelopmentAndRegulatoryMilestonesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-70"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxrx:MerckKGaAMerckMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-71"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxrx:MerckKGaAMerckMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rxrx:MilestoneTypeAxis">rxrx:DiscoveryDevelopmentAndSalesMilestonesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-72"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxrx:MerckKGaAMerckMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-09-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-73"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxrx:RocheAndGenentechMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-74"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxrx:RocheAndGenentechMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-09-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-75"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxrx:RocheAndGenentechMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-10-01</xbrli:startDate><xbrli:endDate>2025-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-76"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxrx:RocheAndGenentechMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rxrx:RevenueRemainingPerformanceObligationAxis">rxrx:PhenomapsCreationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-77"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxrx:RocheAndGenentechMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rxrx:RevenueRemainingPerformanceObligationAxis">rxrx:PhenomapsRawImagesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-78"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxrx:RocheAndGenentechMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rxrx:RevenueRemainingPerformanceObligationAxis">rxrx:DevelopedAndCommercializedProgramsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-79"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxrx:RocheAndGenentechMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-80"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxrx:RocheAndGenentechMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rxrx:RevenueRemainingPerformanceObligationAxis">rxrx:GastrointestinalCancerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-81"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxrx:RocheAndGenentechMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rxrx:RevenueRemainingPerformanceObligationAxis">rxrx:NeuroscienceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-82"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rxrx:A2021EquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-83"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rxrx:A2024InducementEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-84"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-85"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-86"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-87"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-88"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-89"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-90"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-91"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-92"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-93"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-94"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-95"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">rxrx:TempusAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-96"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">rxrx:TempusAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-97"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-98"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-99"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-100"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-102"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-103"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-105"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-107"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-108"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-109"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-110"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-111"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-113"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-114"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-115"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-116"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-117"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-118"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-119"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:PortionAtOtherThanFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:PortionAtOtherThanFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-122"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-123"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:PortionAtOtherThanFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-124"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:PortionAtOtherThanFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-125"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-126"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rxrx:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-128"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rxrx:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">rxrx:NamandjeBumpusMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601830</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">rxrx:NamandjeBumpusMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="icf34ee3be70a44349aaa73f1b5df5e08_1"></div><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:513.00pt"><tr><td style="width:1.0pt"/><td style="width:511.00pt"/><td style="width:1.0pt"/></tr><tr style="height:314pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;text-align:center"><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">UNITED STATES </span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION </span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">10-Q</ix:nonNumeric></span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Mark One)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentQuarterlyReport" format="ixt:fixed-true" id="f-2">&#9746;</ix:nonNumeric></span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">  </span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></div><div><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-3">March&#160;31, 2026</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">or</span></div><div style="text-align:center"><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="f-4">&#9744;</ix:nonNumeric></span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">For the transition period from  </span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline">            </span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> to </span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline">            </span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">        </span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:130%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="text-align:center"><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Commission File Number: <ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">001-40323</ix:nonNumeric></span></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:130%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-6">RECURSION PHARMACEUTICALS, INC.</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-7">Delaware</ix:nonNumeric>                                                                                             </span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-8">46-4099738</ix:nonNumeric></span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">                </span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:130%">(State or other jurisdiction of incorporation or organization)                                 (I.R.S. Employer Identification No.)</span></div><div style="padding-left:18pt;padding-right:18pt;text-align:center;text-indent:36pt"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-9">41 S Rio Grande Street</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-10">Salt Lake City,</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" id="f-11">UT</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-12">84101</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Address of principal executive offices) (Zip code)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-13">385</ix:nonNumeric>) <ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-14">269 - 0203</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Registrant&#8217;s telephone number, including area code)</span></div></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:513.00pt"><tr><td style="width:1.0pt"/><td style="width:201.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:97.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:208.00pt"/><td style="width:1.0pt"/></tr><tr style="height:14pt"><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Securities registered pursuant to Section 12(b) of the Act:</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Trading symbol(s)</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-15">Class A Common Stock, par value $0.00001</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-16">RXRX</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-17">Nasdaq Global Select Market</ix:nonNumeric> </span></div></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:513.00pt"><tr><td style="width:1.0pt"/><td style="width:511.00pt"/><td style="width:1.0pt"/></tr><tr style="height:126pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;         <ix:nonNumeric contextRef="c-1" name="dei:EntityCurrentReportingStatus" id="f-18">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%">x</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">    No &#9744;</span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). </span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;          <ix:nonNumeric contextRef="c-1" name="dei:EntityInteractiveDataCurrent" id="f-19">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%">x</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">   No &#9744;</span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and "emerging growth company" in Rule 12b-2 of the Exchange Act.</span></div></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:513.00pt"><tr><td style="width:1.0pt"/><td style="width:103.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:22.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:223.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:132.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:22.00pt"/><td style="width:1.0pt"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="f-20">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntitySmallBusiness" format="ixt:fixed-false" id="f-21">&#9744;</ix:nonNumeric></span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="f-22">&#9744;</ix:nonNumeric></span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:513.00pt"><tr><td style="width:1.0pt"/><td style="width:511.00pt"/><td style="width:1.0pt"/></tr><tr style="height:92pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.       </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).   Yes </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityShellCompany" format="ixt:fixed-false" id="f-23">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">   No </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9746;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">As of May&#160;1, 2026, there were <ix:nonFraction unitRef="shares" contextRef="c-2" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-24">524,677,865</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-25">5,227,334</ix:nonFraction> of the registrant&#8217;s Class A and B common stock outstanding, respectively.</span></div></td></tr></table></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.234%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div></div></div><div id="icf34ee3be70a44349aaa73f1b5df5e08_7"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf34ee3be70a44349aaa73f1b5df5e08_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:79.309%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.772%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline">Page</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ee;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ee;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#icf34ee3be70a44349aaa73f1b5df5e08_13">Part I </a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#icf34ee3be70a44349aaa73f1b5df5e08_13">Financial Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ee;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ee;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icf34ee3be70a44349aaa73f1b5df5e08_13">1</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1. </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icf34ee3be70a44349aaa73f1b5df5e08_16">Financial Statements (unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ee;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ee;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icf34ee3be70a44349aaa73f1b5df5e08_16">1</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 2. </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icf34ee3be70a44349aaa73f1b5df5e08_82">Management's Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ee;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ee;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icf34ee3be70a44349aaa73f1b5df5e08_82">19</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 3. </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ee;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ee;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icf34ee3be70a44349aaa73f1b5df5e08_112">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ee;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ee;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icf34ee3be70a44349aaa73f1b5df5e08_112">27</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ee;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ee;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icf34ee3be70a44349aaa73f1b5df5e08_115">Controls and Procedures </a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ee;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ee;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icf34ee3be70a44349aaa73f1b5df5e08_115">27</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ee;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ee;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#icf34ee3be70a44349aaa73f1b5df5e08_118">Part II </a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#icf34ee3be70a44349aaa73f1b5df5e08_118">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ee;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ee;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icf34ee3be70a44349aaa73f1b5df5e08_118">29</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icf34ee3be70a44349aaa73f1b5df5e08_121">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ee;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ee;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icf34ee3be70a44349aaa73f1b5df5e08_121">29</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1A. </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icf34ee3be70a44349aaa73f1b5df5e08_124">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ee;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ee;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icf34ee3be70a44349aaa73f1b5df5e08_124">29</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icf34ee3be70a44349aaa73f1b5df5e08_127">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ee;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ee;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icf34ee3be70a44349aaa73f1b5df5e08_127">29</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 6. </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icf34ee3be70a44349aaa73f1b5df5e08_136">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ee;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ee;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icf34ee3be70a44349aaa73f1b5df5e08_136">29</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ee;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ee;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icf34ee3be70a44349aaa73f1b5df5e08_139">Signatures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ee;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ee;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icf34ee3be70a44349aaa73f1b5df5e08_139">31</a></span></div></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf34ee3be70a44349aaa73f1b5df5e08_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span><br/></span></div><div id="icf34ee3be70a44349aaa73f1b5df5e08_10"></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cautionary Note Regarding Forward-Looking Statements</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">This Quarterly Report on Form 10-Q contains &#8220;forward-looking statements&#8221; about us and our industry within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical facts are forward-looking statements. In some cases, you can identify forward-looking statements by terms such as &#8220;may,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;would,&#8221; &#8220;expect,&#8221; &#8220;plan,&#8221; &#8220;anticipate,&#8221; &#8220;could,&#8221; &#8220;intend,&#8221; &#8220;target,&#8221; &#8220;project,&#8221; &#8220;contemplate,&#8221; &#8220;believe,&#8221; &#8220;estimate,&#8221; &#8220;predict,&#8221; &#8220;potential,&#8221; or &#8220;continue&#8221; or the negative of these terms or other similar expressions. Forward-looking statements contained in this report may include without limitation those regarding: </span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> </span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">our research and development programs;</span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">the initiation, timing, progress, results, and cost of our current and future preclinical and clinical studies, including statements regarding the design of, and the timing of initiation and completion of, studies and related preparatory work, as well as the period during which the results of the studies will become available and key milestones will be met; </span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">our continued ability to achieve milestones and receive associated milestone payments and royalties from current and future collaborations;</span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">our ability to use our combined assets from our business combination to create a fully integrated, technology-first drug discovery platform;</span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">our ability to reduce our cash burn;</span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">the timing and likelihood of our ability to shift our wet-lab from a source of data generation to a model for validating data from AI-generated results and the projected impact of our ClinTech platform on our business; </span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">the ability and willingness of our collaborators to continue research and development activities relating to our development candidates and investigational medicines; </span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">future agreements with third parties in connection with the commercialization of our investigational medicines and any other approved product; </span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">the timing, scope, and likelihood of regulatory filings and approvals, including the timing of Investigational New Drug applications and final approval by the U.S. Food and Drug Administration, or FDA, of our current drug candidates and any other future drug candidates, as well as our ability to maintain any such approvals; </span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">the timing, scope, or likelihood of foreign regulatory filings and approvals, including our ability to maintain any such approvals; </span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">the size of the potential market opportunity for TechBio companies, including the expected impact of AI-enabled technologies;</span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">the size of the potential market opportunity for our drug candidates, including our estimates of the number of patients who suffer from the diseases we are targeting; </span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">our ability to identify viable new drug candidates for clinical development and the rate at which we expect to identify such candidates, whether through an inferential approach or otherwise; </span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">our expectation that the assets that will drive the most value for us are those that we will identify in the future using our datasets and tools; </span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">our ability to develop and advance our current drug candidates and programs into, and successfully complete, clinical studies; </span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">our ability to reduce the time or cost or increase the likelihood of success of our research and development relative to the traditional drug discovery paradigm, including the use of data sets from our partners to accelerate the development of our AI-enabled technologies; </span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">our ability to improve, and the rate of improvement in, our infrastructure, datasets, biology, technology tools, and drug discovery platform, and our ability to realize benefits from such improvements; </span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">our ability to effectively use machine learning and artificial intelligence in our drug development process;</span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">our ability to leverage our collaborations and partnerships to develop our products and grow our business;</span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">our expectations related to the performance and benefits of our BioHive-2 supercomputer, Recursion OS, and our digital chemistry platform;</span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">our ability to realize a return on our investment of resources and cash in our drug discovery collaborations; </span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">our ability to sell or license assets and re-invest proceeds into funding our long-term strategy;</span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">our ability to scale like a technology company and to add more programs to our pipeline each year; </span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">our ability to acquire and generate datasets to train and develop our AI-enabled technologies;</span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">our ability to successfully compete in a highly competitive market; </span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">our manufacturing, commercialization, and marketing capabilities and strategies; </span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">our plans relating to commercializing our drug candidates, if approved, including the geographic areas of focus and sales strategy; </span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">our expectations regarding the approval and use of our drug candidates in combination with other drugs; </span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">the rate and degree of market acceptance and clinical utility of our current drug candidates, if approved, and other drug candidates we may develop; </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf34ee3be70a44349aaa73f1b5df5e08_7">Table of Contents</a></span></div></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">our competitive position and the success of competing approaches that are or may become available, including with respect to our AI-enabled technologies; </span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">our estimates of the number of patients that we will enroll in our clinical trials and the timing of their enrollment; </span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">the beneficial characteristics, safety, efficacy, and therapeutic effects of our drug candidates; </span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">our plans for further development of our drug candidates, including additional indications we may pursue; </span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">our ability to adequately protect and enforce our intellectual property and proprietary technology, including the scope of protection we are able to establish and maintain for intellectual property rights covering our current drug candidates and other drug candidates we may develop, receipt of patent protection, the extensions of existing patent terms where available, the validity of intellectual property rights held by third parties, the protection of our trade secrets, and our ability not to infringe, misappropriate or otherwise violate any third-party intellectual property rights; </span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">the impact of any intellectual property disputes and our ability to defend against claims of infringement, misappropriation, or other violations of intellectual property rights; </span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">our ability to keep pace with new technological developments, including with respect to AI; </span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">our ability to utilize third-party open source software and cloud-based infrastructure, on which we are dependent; </span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">the adequacy of our insurance policies and the scope of their coverage; </span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">the potential impact of a pandemic, epidemic, or outbreak of an infectious disease, such as COVID-19, or natural disaster, global political instability, or warfare, and the effect of such outbreak or natural disaster, global political instability, or warfare on our business and financial results; </span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">our ability to maintain our technical operations infrastructure to avoid errors, delays, or cybersecurity breaches; </span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">our continued reliance on third parties to conduct additional clinical trials of our drug candidates, and for the manufacture of our drug candidates for preclinical studies and clinical trials; </span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">our ability to obtain, and negotiate favorable terms of, any collaboration, licensing or other arrangements that may be necessary or desirable to research, develop, manufacture, or commercialize our platform and drug candidates; </span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">the pricing and reimbursement of our current drug candidates and other drug candidates we may develop, if approved; </span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">our estimates regarding expenses, future revenue, capital requirements, and need for additional financing;</span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">our financial performance; </span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">the period over which we estimate our existing cash and cash equivalents will be sufficient to fund our future operating expenses and capital expenditure requirements; </span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">our ability to raise substantial additional funding; </span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">the impact of current and future laws and regulations, and our ability to comply with all regulations that we are, or may become, subject to; </span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">the need to hire additional personnel and our ability to attract and retain such personnel; </span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">the impact of any current or future litigation, which may arise during the ordinary course of business and be costly to defend; </span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">our ability to maintain effective internal control over financial reporting and disclosure controls and procedures, including our ability to remediate the material weaknesses in internal control over financial reporting;</span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">our anticipated use of our existing resources and the net proceeds from our public offerings; and </span></div><div style="padding-left:18pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:10.18pt">other risks and uncertainties, including those listed in the section titled &#8220;Risk Factors.&#8221; </span></div><div style="text-indent:4.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">We have based these forward-looking statements largely on our current expectations and projections about our business, the industry in which we operate, and financial trends that we believe may affect our business, financial condition, results of operations, and prospects. These forward-looking statements are not guarantees of future performance or development. These statements speak only as of the date of this report and are subject to a number of risks, uncertainties and assumptions described in the section titled &#8220;Risk Factors&#8221; and elsewhere in this report. Because forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified, you should not rely on these forward-looking statements as predictions of future events. The events and circumstances reflected in our forward-looking statements may not be achieved or occur and actual results could differ materially from those projected in the forward-looking statements. Except as required by applicable law, we undertake no obligation to update or revise any forward-looking statements contained herein, whether as a result of any new information, future events, or otherwise.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">In addition, statements that &#8220;we believe&#8221; and similar statements reflect our beliefs and opinions on the relevant subject. These statements are based upon information available to us as of the date of this report. While we believe such information forms a reasonable basis for such statements, the information may be limited or incomplete, and our statements should not be read to indicate that we have conducted an exhaustive inquiry into, or review of, all potentially available relevant information. These statements are inherently uncertain and you are cautioned not to unduly rely upon them.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">iii</span></div></div></div><div id="icf34ee3be70a44349aaa73f1b5df5e08_13"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf34ee3be70a44349aaa73f1b5df5e08_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I - FINANCIAL INFORMATION</span></div><div><span><br/></span></div><div id="icf34ee3be70a44349aaa73f1b5df5e08_16"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1. Financial Statements.</span></div><div><span><br/></span></div><div id="icf34ee3be70a44349aaa73f1b5df5e08_19"></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recursion Pharmaceuticals, Inc. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Balance Sheets (unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except share and per share amounts)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"><tr><td style="width:1.0%"/><td style="width:71.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.657%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.658%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">March 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2025</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current assets</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-31">654,473</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-32">743,294</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:RestrictedCashCurrent" format="ixt:num-dot-decimal" scale="3" id="f-33">5,511</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:RestrictedCashCurrent" format="ixt:num-dot-decimal" scale="3" id="f-34">4,594</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="3" id="f-35">13,585</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OtherReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="3" id="f-36">24,649</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid data assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PrepaidExpenseCurrent" format="ixt:num-dot-decimal" scale="3" id="f-37">11,742</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:PrepaidExpenseCurrent" format="ixt:num-dot-decimal" scale="3" id="f-38">11,742</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-39">24,246</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-40">28,566</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-41">709,557</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-42">812,845</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted cash, non-current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:RestrictedCashNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-43">5,196</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:RestrictedCashNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-44">6,033</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-45">95,811</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-46">103,931</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-47">42,816</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-48">45,339</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Financing lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-49">18,694</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-50">20,210</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-51">294,073</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-52">309,903</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-53">160,170</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-54">162,158</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="3" id="f-55">957</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="3" id="f-56">957</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets, non-current</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-57">12,248</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-58">12,754</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-59">1,339,522</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-60">1,474,130</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liabilities and stockholders&#8217; equity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-61">20,348</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-62">18,118</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses and other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-63">54,205</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-64">70,230</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unearned revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-65">32,794</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-66">37,605</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-67">13,087</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-68">12,663</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Notes payable and financing lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-69">9,265</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-70">9,091</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-71">129,699</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-72">147,707</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unearned revenue, non-current</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-73">114,723</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-74">114,012</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease liabilities, non-current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-75">42,842</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-76">46,647</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Notes payable and financing lease liabilities, non-current</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="3" id="f-77">7,181</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="3" id="f-78">9,564</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="f-79">18,283</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="f-80">23,255</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other liabilities, non-current</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-81">2,025</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-82">2,080</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-83">314,753</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-84">343,265</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commitments and contingencies (Note&#160;7)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-4" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-85"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-5" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-86"></ix:nonFraction></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Stockholders&#8217; equity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-87"><ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-88">0.00001</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-89"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-90">2,000,000,000</ix:nonFraction></ix:nonFraction> shares (Class A <ix:nonFraction unitRef="shares" contextRef="c-6" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-91"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-92">1,989,032,117</ix:nonFraction></ix:nonFraction> and Class B <ix:nonFraction unitRef="shares" contextRef="c-8" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-93"><ix:nonFraction unitRef="shares" contextRef="c-9" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-94">10,967,883</ix:nonFraction></ix:nonFraction>) authorized as of March&#160;31, 2026 and December&#160;31, 2025; <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-95"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-96">530,628,653</ix:nonFraction></ix:nonFraction> shares (Class A <ix:nonFraction unitRef="shares" contextRef="c-6" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-97"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-98">524,464,320</ix:nonFraction></ix:nonFraction>, Class B <ix:nonFraction unitRef="shares" contextRef="c-9" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-99"><ix:nonFraction unitRef="shares" contextRef="c-9" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-100">5,307,334</ix:nonFraction></ix:nonFraction> and Exchangeable <ix:nonFraction unitRef="shares" contextRef="c-10" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-101"><ix:nonFraction unitRef="shares" contextRef="c-10" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-102">856,999</ix:nonFraction></ix:nonFraction>) and <ix:nonFraction unitRef="shares" contextRef="c-5" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-103"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-104">528,182,693</ix:nonFraction></ix:nonFraction> shares (Class A <ix:nonFraction unitRef="shares" contextRef="c-7" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-105"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-106">521,831,046</ix:nonFraction></ix:nonFraction>, Class B <ix:nonFraction unitRef="shares" contextRef="c-8" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-107"><ix:nonFraction unitRef="shares" contextRef="c-8" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-108">5,547,334</ix:nonFraction></ix:nonFraction> and Exchangeable <ix:nonFraction unitRef="shares" contextRef="c-11" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-109"><ix:nonFraction unitRef="shares" contextRef="c-11" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-110">804,313</ix:nonFraction></ix:nonFraction>) issued and outstanding as of March&#160;31, 2026 and December&#160;31, 2025, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="f-111">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="f-112">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="f-113">3,191,608</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="f-114">3,170,145</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-115">2,193,506</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-116">2,076,002</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-117">26,662</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-118">36,717</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-119">1,024,769</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-120">1,130,865</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total liabilities and stockholders&#8217; equity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-121">1,339,522</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-122">1,474,130</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See the accompanying notes to these c</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ondensed </span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><div id="icf34ee3be70a44349aaa73f1b5df5e08_22"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf34ee3be70a44349aaa73f1b5df5e08_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recursion Pharmaceuticals, Inc. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Operations (unaudited)</span></div><div style="text-align:center"><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">in thousands, except share and per share amounts)</span></div><div style="text-align:center"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.215%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.743%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Three months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2025</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenue</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating revenue</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-123">6,301</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-124">14,818</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grant revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="f-125">171</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="f-126">73</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total revenue</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-127">6,472</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-128">14,745</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating costs and expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="f-129">12,490</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="f-130">21,829</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-131">87,896</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-132">129,634</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-133">34,591</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-134">54,650</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total operating costs and expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-135">134,977</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-136">206,113</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Loss from operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-137">128,505</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-138">191,368</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (loss), net</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-139">6,397</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-140">11,277</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Loss before income tax benefit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-141">122,108</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-142">202,645</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-143">4,604</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="f-144">158</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-145">117,504</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-146">202,487</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Per share data</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net loss per share of Class A, B and Exchangeable common stock, basic and diluted</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-147"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-148">0.22</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-16" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-149"><ix:nonFraction unitRef="usdPerShare" contextRef="c-16" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-150">0.50</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:3pt double #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-average shares (Class A, B and Exchangeable) outstanding, basic and diluted</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-151"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-152">529,303,984</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-16" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-153"><ix:nonFraction unitRef="shares" contextRef="c-16" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-154">402,771,972</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See the accompanying notes to these c</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ondensed</span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="icf34ee3be70a44349aaa73f1b5df5e08_25"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recursion Pharmaceuticals, Inc. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Comprehensive Loss (unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands) </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.707%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.497%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Three months ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">March 31,</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2026</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2025</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-155">117,504</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-156">202,487</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other comprehensive income (loss):</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="f-157">10,055</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="f-158">21,782</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other comprehensive income (loss)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="f-159">10,055</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="f-160">21,782</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Comprehensive loss</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-161">127,559</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-162">180,705</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See the accompanying notes to these condensed consolidated financial statements</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="icf34ee3be70a44349aaa73f1b5df5e08_28"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf34ee3be70a44349aaa73f1b5df5e08_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recursion Pharmaceuticals, Inc. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Stockholders&#8217; Equity (unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except share amounts)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:34.246%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.945%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.945%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.945%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.712%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.538%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Common Stock </span></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional Paid-in-Capital</span></div></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Accumulated</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Deficit</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span></div></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Accumulated other comprehensive income (loss)</span></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Stockholders&#8217;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Equity</span></div></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Class A, B and Exchangeable)</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Shares </span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amount </span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance as of December 31, 2025</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-17" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-163">528,182,693</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-164">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-165">3,170,145</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-166">2,076,002</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-167">36,717</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-168">1,130,865</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-169">117,504</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-170">117,504</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="f-171">10,055</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="f-172">10,055</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock option exercises and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-23" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="f-173">2,613,410</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-24" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="f-174">752</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="f-175">752</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-24" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-176">22,215</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-177">22,215</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance as of March 31, 2026</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-25" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-178">530,796,103</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-179">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-180">3,191,608</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-181">2,193,506</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-182">26,662</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-183">1,024,769</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:34.246%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.945%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.945%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.945%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.712%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.538%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Common Stock </span></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional Paid-in-Capital</span></div></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Accumulated</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Deficit</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span></div></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Accumulated other comprehensive income (loss)</span></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Stockholders&#8217;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Equity</span></div></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Class A, B and Exchangeable)</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Shares </span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amount </span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance as of December 31, 2024</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-29" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-184">396,802,394</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-29" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-185">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-30" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-186">2,473,698</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-187">1,431,283</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-188">7,637</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-189">1,034,782</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-190">202,487</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-191">202,487</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-35" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="f-192">21,782</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="f-193">21,782</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock option exercises and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-36" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="f-194">4,108,659</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-195">2,712</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="f-196">76</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-197">2,788</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-198">36,058</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-199">36,058</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock sales issuances, net of issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-36" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-200">5,499,680</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-201">41,024</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-202">41,024</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance as of March 31, 2025</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-38" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-203">406,410,733</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-204">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-39" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-205">2,553,492</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-40" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-206">1,633,694</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-41" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-207">14,145</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-42" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-208">933,947</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See the accompanying notes to these c</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ondensed </span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">consolidated financial statements</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="icf34ee3be70a44349aaa73f1b5df5e08_31"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf34ee3be70a44349aaa73f1b5df5e08_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recursion Pharmaceuticals, Inc. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Cash Flows (unaudited) (in thousands) </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.953%"><tr><td style="width:1.0%"/><td style="width:65.019%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.870%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.811%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from operating activities</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-209">117,504</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-210">202,487</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net loss to net cash used in operating activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-211">19,673</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-212">19,331</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-213">22,215</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-214">36,058</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:TangibleAssetImpairmentCharges" format="ixt:fixed-zero" scale="3" id="f-215">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" name="us-gaap:TangibleAssetImpairmentCharges" format="ixt:num-dot-decimal" scale="3" id="f-216">5,956</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OperatingLeaseExpense" format="ixt:num-dot-decimal" scale="3" id="f-217">5,243</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" name="us-gaap:OperatingLeaseExpense" format="ixt:num-dot-decimal" scale="3" id="f-218">6,130</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on disposal of a business</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:fixed-zero" scale="3" id="f-219">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" sign="-" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:num-dot-decimal" scale="3" id="f-220">4,502</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-221">4,597</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="f-222">419</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:OtherNoncashIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-223">1,674</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" sign="-" name="us-gaap:OtherNoncashIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-224">4,824</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other receivables and assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" format="ixt:num-dot-decimal" scale="3" id="f-225">14,746</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" format="ixt:num-dot-decimal" scale="3" id="f-226">4,839</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid data assets</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="rxrx:IncreaseDecreaseInPrepaidDataAssets" format="ixt:fixed-zero" scale="3" id="f-227">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" sign="-" name="rxrx:IncreaseDecreaseInPrepaidDataAssets" format="ixt:num-dot-decimal" scale="3" id="f-228">27,131</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unearned revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="f-229">2,248</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="f-230">9,762</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="f-231">2,070</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="f-232">3,692</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued development expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="rxrx:IncreaseDecreaseInAccruedDevelopmentExpense" scale="3" id="f-233">730</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" name="rxrx:IncreaseDecreaseInAccruedDevelopmentExpense" scale="3" id="f-234">599</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-235">18,451</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-236">26,591</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="rxrx:IncreaseDecreaseInLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-237">4,652</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" sign="-" name="rxrx:IncreaseDecreaseInLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-238">5,760</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash used in operating activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-239">81,101</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-240">131,957</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:3pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from investing activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="f-241">258</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-242">1,832</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of an intangible asset</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsToAcquireIntangibleAssets" scale="3" id="f-243">80</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" name="us-gaap:PaymentsToAcquireIntangibleAssets" format="ixt:fixed-zero" scale="3" id="f-244">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease in cash related to disposal of a business</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested" format="ixt:fixed-zero" scale="3" id="f-245">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" sign="-" name="us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested" format="ixt:num-dot-decimal" scale="3" id="f-246">4,438</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsToAcquireInvestments" format="ixt:fixed-zero" scale="3" id="f-247">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" name="us-gaap:PaymentsToAcquireInvestments" format="ixt:num-dot-decimal" scale="3" id="f-248">1,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="f-249">338</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="f-250">7,270</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from financing activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from issuance of common shares, net of issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:fixed-zero" scale="3" id="f-251">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-252">41,024</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity incentive plans</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="rxrx:ProceedsFromPaymentForShareBasedPaymentArrangement" format="ixt:num-dot-decimal" scale="3" id="f-253">1,262</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" name="rxrx:ProceedsFromPaymentForShareBasedPaymentArrangement" format="ixt:num-dot-decimal" scale="3" id="f-254">1,550</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repayment of long-term debt and finance lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RepaymentsOfLongTermDebtAndCapitalSecurities" format="ixt:num-dot-decimal" scale="3" id="f-255">2,208</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" name="us-gaap:RepaymentsOfLongTermDebtAndCapitalSecurities" format="ixt:num-dot-decimal" scale="3" id="f-256">2,047</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash provided by (used in) financing activities</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-257">3,470</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-258">40,527</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Effect of exchange rate changes on cash, cash equivalents and restricted cash</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-259">3,832</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-260">4,833</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net change in cash, cash equivalents and restricted cash</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="f-261">88,741</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="f-262">93,867</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash, beginning of period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-263">753,921</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-264">603,024</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash, cash equivalents and restricted cash, end of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-265">665,180</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-42" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-266">509,157</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Supplemental schedule of non-cash investing and financing activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of an intangible asset</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1" format="ixt:num-dot-decimal" scale="3" id="f-267">1,915</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" name="us-gaap:NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1" format="ixt:fixed-zero" scale="3" id="f-268">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" format="ixt:fixed-zero" scale="3" id="f-269">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" format="ixt:num-dot-decimal" scale="3" id="f-270">1,146</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of an equity investment</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="rxrx:PurchaseOfAnEquityInvestmentNonCash" format="ixt:fixed-zero" scale="3" id="f-271">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" name="rxrx:PurchaseOfAnEquityInvestmentNonCash" format="ixt:num-dot-decimal" scale="3" id="f-272">4,438</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See the accompanying notes to these condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="icf34ee3be70a44349aaa73f1b5df5e08_34"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf34ee3be70a44349aaa73f1b5df5e08_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recursion Pharmaceuticals, Inc. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (unaudited)</span></div><div style="text-align:center"><span><br/></span></div><div id="icf34ee3be70a44349aaa73f1b5df5e08_37"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 1.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:NatureOfOperations" id="f-273" continuedAt="f-273-1" escape="true">Description of the Business </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="f-273-1"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Recursion Pharmaceuticals, Inc. (Recursion, the Company, we or our) is a clinical stage TechBio company decoding biology and chemistry to industrialize drug discovery. The Recursion Operating System (Recursion OS), a platform built across diverse technologies, enables the Company to map and navigate trillions of biological and chemical relationships within the Recursion Data Universe, one of the world&#8217;s largest proprietary biological and chemical datasets. The Company integrates physical and digital components as iterative loops of atoms and bits scaling wet lab biology and chemistry data organized into virtuous cycles with computational tools to rapidly translate </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in silico </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">hypotheses into validated insights and novel chemistry.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2026, the Company had an accumulated deficit of $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-8" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="9" id="f-274">2.2</ix:nonFraction> billion. The Company expects to incur substantial operating losses in future periods and will require additional capital to advance its drug candidates. The Company does not expect to generate significant revenue until the Company successfully completes significant drug development milestones or in collaboration&#160;with third parties, which the Company expects will take a number of years. In order to commercialize its drug candidates, the Company or its partners need to complete clinical development and comply with comprehensive regulatory requirements. The Company is subject to a number of risks and uncertainties similar to those of other companies of the same size within the biotechnology industry, such as the uncertainty of clinical trial outcomes, uncertainty of additional funding and a history of operating losses. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has funded its operations to date primarily through the issuance of Class A common stock (see Note 8, &#8220;Common Stock&#8221; for additional details). Additionally, the Company has received payments from its strategic partnerships (see Note 9, &#8220;Collaborative Development Contracts&#8221; for additional details). Recursion will likely be required to raise additional capital. As of March&#160;31, 2026, the Company did not have any unconditional outstanding commitments for additional funding. If the Company is unable to access additional funds when needed, it may not be able to continue the development of its products or the Company could be required to delay, scale back or abandon some or all of its development programs and other operations. The Company&#8217;s ability to access capital when needed is not assured and, if not achieved on a timely basis, could materially harm its business, financial condition and results of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Recursion believes that the Company&#8217;s existing cash and cash equivalents will be sufficient to fund the Company&#8217;s operating expenses and capital expenditures for at least the next 12 months from the issuance date of these financial statements.</span></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div id="icf34ee3be70a44349aaa73f1b5df5e08_40"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 2. <ix:nonNumeric contextRef="c-1" name="us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" id="f-275" continuedAt="f-275-1" escape="true">Basis of Presentation</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="f-275-1" continuedAt="f-275-2"><ix:nonNumeric contextRef="c-1" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="f-276" escape="true"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited interim condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (SEC). Accordingly, certain information and footnote disclosures normally included in annual financial statements prepared in accordance with generally accepted accounting principles in the United States (U.S. GAAP) have been condensed or omitted. These unaudited interim condensed consolidated financial statements should be read in conjunction with the Company&#8217;s audited consolidated financial statements and notes for the year ended December&#160;31, 2025. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is management&#8217;s opinion that these condensed consolidated financial statements include all normal and recurring adjustments necessary for a fair statement of the financial position, results of operations and cash flows for the periods presented. Revenue and net loss for any interim period are not necessarily indicative of future or annual results.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="f-277" continuedAt="f-277-1" escape="true"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Pronouncements </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2025, the FASB issued ASU No. 2025-10, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Government Grants (Topic 832). </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The new standard adds guidance to ASC 832 on the recognition, measurement and presentation of government grants. This standard will be effective for Recursion starting the annual period of 2029 and for interim reporting periods within that annual </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf34ee3be70a44349aaa73f1b5df5e08_7">Table of Contents</a></span></div></div><ix:continuation id="f-277-1"><ix:continuation id="f-275-2"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">reporting period. Early adoption is permitted. The amendments can be applied on a prospective, modified prospective or retrospective basis. Recursion is currently assessing the impact of adopting this guidance on its consolidated financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2025, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2025-07, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives and Hedging (Topic 350) and Revenue from Contracts with Customers (Topic 606).</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The new standard refines the scope of the guidance on derivatives in Topic 815 and clarifies the guidance on shared-based payments from a customer in ASC 606. This standard will be effective for Recursion starting the annual period of 2027 and for interim reporting periods within that annual reporting period. Early adoption is permitted. Recursion is currently assessing the impact of adopting this guidance on its consolidated financial statements. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2025, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2025-06, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounting for internal-use software costs (Topic 350)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The new standard amends specific aspects of the accounting for internal-use software costs including the criteria for capitalizing software costs. It also amends the related disclosure requirements. This standard will be effective for Recursion starting the annual period ending 2028 and for interim reporting periods within that annual reporting period. Early adoption is permitted. The amendments can be applied on a prospective, modified prospective or retrospective basis. Recursion is currently assessing the impact of adopting this guidance on its consolidated financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2024, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2024-03, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disaggregation of Income Statement Expenses (Topic 220)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The standard requires new disclosures in the notes to the financial statements about certain caption expenses presented on the face of the Income Statement including information on: purchases of inventory; employee compensation; depreciation and intangible asset amortization. Recursion must also disclose a qualitative description of the amounts remaining in expense captions that are not separately disaggregated. This standard will be effective for Recursion starting the annual period of 2027. Early adoption is permitted. The amendments can be applied on a prospective or retrospective basis. Recursion is currently assessing the impact of adopting this guidance on its consolidated financial statements.</span></div></ix:continuation></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div id="icf34ee3be70a44349aaa73f1b5df5e08_43"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 3.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="rxrx:SupplementalBalanceSheetAndIncomeStatementInformationTextBlock" id="f-278" continuedAt="f-278-1" escape="true">Supplemental Financial Information </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="f-278-1" continuedAt="f-278-2"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Tempus agreement</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2023, Recursion entered into a <ix:nonNumeric contextRef="c-43" name="rxrx:LicenseAgreementTerm" format="ixt-sec:durwordsen" id="f-279">five-year</ix:nonNumeric> agreement (the Tempus Agreement) with Tempus AI, Inc. (Tempus) to purchase access to their records of patient-centric multimodal oncology data and use rights for therapeutic development purposes. This data will be used to improve the training of Recursion&#8217;s artificial intelligence and machine learning models and is expected to accelerate Recursion&#8217;s drug discovery process. Recursion is making annual payments, ranging between $<ix:nonFraction unitRef="usd" contextRef="c-44" decimals="-5" name="rxrx:LicenseAgreementAnnualPayments" scale="6" id="f-280">22.0</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-45" decimals="-5" name="rxrx:LicenseAgreementAnnualPayments" scale="6" id="f-281">42.0</ix:nonFraction>&#160;million, up to $<ix:nonFraction unitRef="usd" contextRef="c-45" decimals="-5" name="rxrx:LicenseAgreementAggregatePayments" scale="6" id="f-282">160.0</ix:nonFraction>&#160;million in aggregate, to Tempus in cash or equity at the Company&#8217;s option. The equity value is determined by using the <span style="-sec-ix-hidden:f-283">seven</span>-trading day period dollar volume-weighted average price (VWAP) for Recursion Class A common stock ending on the day immediately preceding the date that is <span style="-sec-ix-hidden:f-284">five</span> business days prior to the payment date.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Recursion is expensing the record purchases based on a contractually agreed price as &#8220;Research and Development&#8221; expenses in the Condensed Consolidated Statements of Operations as the records are downloaded. To the extent that the Recursion payments to Tempus are greater than or less than the records purchased amount, Recursion records the applicable amount to &#8220;Prepaid data assets&#8221; or &#8220;Accrued data liability&#8221; on the Condensed Consolidated Balance Sheet, respectively. Recursion did <ix:nonFraction unitRef="usd" contextRef="c-1" decimals="INF" name="rxrx:LicenseAgreementIncreaseDecreaseAccruedLiabilities" format="ixt:fixed-zero" scale="0" id="f-285">not</ix:nonFraction> purchase any records for the three months ended March 31, 2026. For the three months ended March 31, 2025, record purchases were $<ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-5" name="rxrx:LicenseAgreementIncreaseDecreaseAccruedLiabilities" scale="6" id="f-286">27.1</ix:nonFraction> million. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf34ee3be70a44349aaa73f1b5df5e08_7">Table of Contents</a></span></div></div><div><span><br/></span></div><ix:continuation id="f-278-2"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" id="f-287" escape="true"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accrued Expenses and Other Liabilities</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.660%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.521%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-288">14,566</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-289">31,771</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compute liabilities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="rxrx:AccruedComputeLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-290">7,535</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="rxrx:AccruedComputeLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-291">8,278</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued development expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="rxrx:AccruedDevelopmentCostsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-292">4,214</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="rxrx:AccruedDevelopmentCostsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-293">2,693</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued early discovery expenses</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="rxrx:AccruedEarlyDiscoveryExpensesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-294">7,535</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="rxrx:AccruedEarlyDiscoveryExpensesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-295">4,581</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional fees</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccruedProfessionalFeesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-296">1,875</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AccruedProfessionalFeesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-297">1,232</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Materials received not invoiced</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="rxrx:MaterialsReceivedNotInvoiced" format="ixt:num-dot-decimal" scale="3" id="f-298">1,010</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="rxrx:MaterialsReceivedNotInvoiced" scale="3" id="f-299">703</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued license fees</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="rxrx:AccruedLicenseFeeCurrent" format="ixt:num-dot-decimal" scale="3" id="f-300">4,915</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="rxrx:AccruedLicenseFeeCurrent" format="ixt:num-dot-decimal" scale="3" id="f-301">3,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued other expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-302">12,555</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-303">17,972</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expense and other liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-304">54,205</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-305">70,230</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock" id="f-306" escape="true"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Income, Net</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.461%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:InvestmentIncomeNonoperating" format="ixt:num-dot-decimal" scale="3" id="f-307">5,963</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" name="us-gaap:InvestmentIncomeNonoperating" format="ixt:num-dot-decimal" scale="3" id="f-308">5,558</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:InterestExpenseNonoperating" scale="3" id="f-309">350</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" name="us-gaap:InterestExpenseNonoperating" scale="3" id="f-310">508</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:InterestIncomeExpenseNonoperatingNet" format="ixt:num-dot-decimal" scale="3" id="f-311">5,613</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" name="us-gaap:InterestIncomeExpenseNonoperatingNet" format="ixt:num-dot-decimal" scale="3" id="f-312">5,050</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March 31, 2026 and 2025, interest income primarily related to earnings on cash and cash equivalents in money market funds. Interest expense primarily related to the Company&#8217;s supercomputer financing lease. Interest income, net was included in &#8220;Other income (loss), net&#8221; on the Condensed Consolidated Statements of Operations.</span></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div id="icf34ee3be70a44349aaa73f1b5df5e08_46"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 4. <ix:nonNumeric contextRef="c-1" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="f-313" continuedAt="f-313-1" escape="true">Acquisitions</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="f-313-1" continuedAt="f-313-2"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">RE Ventures I</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2025, Recursion acquired Rallybio&#8217;s interest in the joint venture, RE Ventures I, such that Recursion now owns <ix:nonFraction unitRef="number" contextRef="c-46" decimals="2" name="rxrx:AssetAcquisitionEquityOwnershipPercentage" scale="-2" id="f-314">100</ix:nonFraction>% of the interest in RE Ventures I for total consideration of $<ix:nonFraction unitRef="usd" contextRef="c-47" decimals="-5" name="us-gaap:AssetAcquisitionConsiderationTransferred" scale="6" id="f-315">20.2</ix:nonFraction> million. Recursion determined that this transaction met the criteria for as an asset acquisition since the lead asset, ENPP1 (Rec-102), an inhibitor program for the treatment of hypophosphatasia (HPP), represented substantially all of the fair value of the gross assets acquired. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to closing, in August 2025, Recursion issued additional consideration as part of a required milestone payment. As a result, Recursion recorded an additional expense of $<ix:nonFraction unitRef="usd" contextRef="c-48" decimals="-5" name="us-gaap:PaymentsToAcquireInProcessResearchAndDevelopment" scale="6" id="f-316">2.4</ix:nonFraction> million </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the agreement, Rallybio is eligible to receive additional milestone payments under certain conditions. Milestone payment obligations that are incurred prior to regulatory approval of the compound will be expensed as acquired IPR&amp;D when recognized.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sale of Exscientia GmbH</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2025, Recursion completed the sale of its Austrian operations (Exscientia GmbH) to Alpha Biotechnology GmbH (Alpha). As part of the sale, Recursion obtained a <ix:nonFraction unitRef="number" contextRef="c-49" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="f-317">49</ix:nonFraction>% equity interest in Alpha. For the year ended December 31, 2025, Recursion recorded a loss on the disposal of Exscientia GmbH of $<ix:nonFraction unitRef="usd" contextRef="c-50" decimals="-5" sign="-" name="us-gaap:GainLossOnSaleOfBusiness" scale="6" id="f-318">4.5</ix:nonFraction> million, which was classified as &#8220;Other income (loss), net&#8221; on the Condensed Consolidated Statement of Operations. Recursion also </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf34ee3be70a44349aaa73f1b5df5e08_7">Table of Contents</a></span></div></div><ix:continuation id="f-313-2"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">recorded a $<ix:nonFraction unitRef="usd" contextRef="c-51" decimals="-5" name="us-gaap:EquityMethodInvestments" scale="6" id="f-319">4.4</ix:nonFraction> million investment on the Condensed Consolidated Balance Sheet within &#8220;Other assets, non-current&#8221; related to its <ix:nonFraction unitRef="number" contextRef="c-49" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="f-320">49</ix:nonFraction>% equity interest in Alpha, which was determined to be an equity method investment.</span></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div id="icf34ee3be70a44349aaa73f1b5df5e08_49"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 5.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeOperatingLeasesTextBlock" id="f-322" continuedAt="f-322-1" escape="true"><ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeFinanceLeasesTextBlock" id="f-321" continuedAt="f-321-1" escape="true">Leases </ix:nonNumeric></ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="f-322-1"><ix:continuation id="f-321-1"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has entered into various long-term real estate operating leases primarily related to office, research and development and operating activities and an equipment financing lease related to the supercomputer. The Company&#8217;s leases have remaining terms from under <ix:nonNumeric contextRef="c-52" name="us-gaap:LesseeOperatingLeaseRemainingLeaseTerm" format="ixt-sec:durwordsen" id="f-323">one year</ix:nonNumeric> to <ix:nonNumeric contextRef="c-53" name="us-gaap:LesseeOperatingLeaseRemainingLeaseTerm" format="ixt-sec:durwordsen" id="f-324">seven years</ix:nonNumeric> and some of those leases include options that provide Recursion with the ability to extend the lease term, generally for <ix:nonNumeric contextRef="c-4" name="us-gaap:LesseeOperatingLeaseRenewalTerm" format="ixt-sec:durwordsen" id="f-325">five years</ix:nonNumeric>. The options are included in the lease term when it is reasonably certain that the option will be exercised. </span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three months ended March 31, 2025,</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Recursion entered into operating lease modifications and terminations resulting in a decrease to the right-of-use asset and lease liability of $<ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-5" sign="-" name="rxrx:IncreaseDecreaseInOperatingLeaseRightOfUseAssets" scale="6" id="f-326"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-5" sign="-" name="rxrx:LesseeOperatingLeaseIncreaseDecreaseInOperatingLeaseLiabilityDueToLeaseModifications" scale="6" id="f-327">10.1</ix:nonFraction></ix:nonFraction>&#160;million. The modifications had no impact to the Condensed Consolidated Statements of Operations.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:LeaseCostTableTextBlock" id="f-328" escape="true"><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to leases were:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.028%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.837%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amount included in the measurement of lease liabilities: </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="f-329">4,316</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="f-330">5,265</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from financing leases</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="3" id="f-331">336</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="3" id="f-332">495</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash flows from financing leases</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" format="ixt:num-dot-decimal" scale="3" id="f-333">2,178</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" format="ixt:num-dot-decimal" scale="3" id="f-334">2,019</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets additions, modifications and termination:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="rxrx:IncreaseDecreaseInOperatingLeaseRightOfUseAssets" format="ixt:fixed-zero" scale="3" id="f-335">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" sign="-" name="rxrx:IncreaseDecreaseInOperatingLeaseRightOfUseAssets" format="ixt:num-dot-decimal" scale="3" id="f-336">10,084</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div id="icf34ee3be70a44349aaa73f1b5df5e08_52"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 6.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="f-337" continuedAt="f-337-1" escape="true">Goodwill and Intangible Assets </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="f-337-1" continuedAt="f-337-2"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfGoodwillTextBlock" id="f-338" escape="true"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes in the carrying amount of goodwill: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:82.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.836%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2025</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-339">162,158</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" format="ixt:num-dot-decimal" scale="3" id="f-340">1,988</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2026</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-341">160,170</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="INF" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="0" id="f-342"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="INF" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="0" id="f-343">No</ix:nonFraction></ix:nonFraction> goodwill impairment was recorded during the three months ended March 31, 2026 and 2025.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf34ee3be70a44349aaa73f1b5df5e08_7">Table of Contents</a></span></div></div><ix:continuation id="f-337-2"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible Assets, Net</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" id="f-345" escape="true"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="f-344" escape="true"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes intangible assets:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:21.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.888%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.350%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2026</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2025</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross carrying amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net carrying amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross carrying amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net carrying amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Definite-lived technology intangible assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-54" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-346">233,086</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-54" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="f-347">79,725</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-54" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="f-348">153,361</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-55" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-349">236,497</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-55" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="f-350">69,156</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-55" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="f-351">167,341</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Definite-lived licensed intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-56" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-352">13,072</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-56" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="f-353">7,908</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-56" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="f-354">5,164</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-57" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-355">11,158</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-57" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="f-356">6,619</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-57" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="f-357">4,539</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite-lived intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-358">135,548</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-359">135,548</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-360">138,023</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-361">138,023</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-362">381,706</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="f-363">87,633</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-364">294,073</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-365">385,678</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="f-366">75,775</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-367">309,903</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense was $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="f-368">12.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="f-369">11.7</ix:nonFraction> million during the three months ended March 31, 2026 and 2025, respectively. Amortization expense was included in &#8220;Research and Development&#8221; in the Condensed Consolidated Statements of Operations. Intangible assets, net decreased by $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="rxrx:IntangibleAssetsForeignCurrencyTranslationGainLoss" scale="6" id="f-370">5.2</ix:nonFraction> million during the three months ended March 31, 2026 due to foreign currency translation adjustments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="INF" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" format="ixt:fixed-zero" scale="0" id="f-371"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="INF" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" format="ixt:fixed-zero" scale="0" id="f-372">No</ix:nonFraction></ix:nonFraction> indefinite-lived intangible asset impairment charges were recorded during the three months ended March 31, 2026 and 2025.</span></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div id="icf34ee3be70a44349aaa73f1b5df5e08_55"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 7. <ix:nonNumeric contextRef="c-1" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="f-373" continuedAt="f-373-1" escape="true">Commitments and Contingencies</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="f-373-1" continuedAt="f-373-2"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contract Obligations</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, the Company enters into contracts with clinical research organizations, drug manufacturers and other vendors&#160;for preclinical and clinical research studies, research and development supplies and other services and products for operating purposes. These contracts generally provide for termination on notice and are cancellable contracts.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Indemnification</span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has agreed to indemnify its officers and directors for certain events or occurrences, while the officer or director is or was serving at the Company&#8217;s request in such capacity. The Company purchases directors and officers liability insurance coverage that provides for reimbursement to the Company for covered obligations and this is intended to limit the Company&#8217;s exposure and enable it to recover a portion of any amount it pays under its indemnification obligations. The Company had <ix:nonFraction unitRef="usd" contextRef="c-4" decimals="INF" name="us-gaap:LossContingencyAccrualAtCarryingValue" format="ixt:fixed-zero" scale="0" id="f-374"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="INF" name="us-gaap:LossContingencyAccrualAtCarryingValue" format="ixt:fixed-zero" scale="0" id="f-375">no</ix:nonFraction></ix:nonFraction> liabilities recorded for these agreements as of March&#160;31, 2026 and December&#160;31, 2025, as no amounts were probable. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employee Agreements </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has signed employment agreements with certain key employees pursuant to which, if their employment is terminated following a change of control of the Company, the employees are entitled to receive certain benefits, including accelerated vesting of equity incentives. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Legal Matters</span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may, from time to time, be involved in various legal proceedings arising in the normal course of business. An unfavorable resolution of any such matter could materially affect the Company&#8217;s future financial position, results of operations or cash flows. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2021, the Company entered into a lease agreement for laboratory and office space (the Industry Lease) with Industry Office SLC, LLC (the landlord). In March 2023, the Company sent a letter to the landlord detailing numerous construction delays and irregularities, deficiencies and deviations from applicable structural drawings and/or non-conforming conditions with applicable building codes (collectively, the Claims). On June&#160;23, 2023, the </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf34ee3be70a44349aaa73f1b5df5e08_7">Table of Contents</a></span></div></div><ix:continuation id="f-373-2"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">landlord filed a lawsuit against the Company (Industry Office SLC, LLC v. Recursion Pharmaceuticals, Inc., Case No. 230904627) amended in October 2023, in the Third District Court for Salt Lake County, State of Utah (the Court), alleging anticipatory repudiation, breach of contract and breach of the implied covenant of good faith and fair dealing and seeks monetary damages and attorney&#8217;s fees. As of March&#160;31, 2026, the Company had <ix:nonFraction unitRef="usd" contextRef="c-4" decimals="INF" name="us-gaap:LossContingencyAccrualAtCarryingValue" format="ixt:fixed-zero" scale="0" id="f-376">no</ix:nonFraction> liability recorded for these events as an unfavorable outcome was not probable. In September 2023, the Company filed claims in the Court against the landlord alleging, among other things, breach of contract and fraudulent misrepresentation (the Counterclaims). In October 2023, the landlord filed an answer and denied the Company&#8217;s allegations asserted in the Counterclaims. The Company and the landlord are currently engaged in discovery. The Company is unable to estimate the possible amount or range of damages associated with the Counterclaims.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pledged Assets</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2026, assets pledged as collateral against finance leases totaled $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="rxrx:FinanceLeasesAssetsPledgedAsCollateral" scale="6" id="f-377">15.2</ix:nonFraction> million. Assets pledged as collateral are Lab Equipment reported in &#8220;Property and Equipment, net&#8221; on the Condensed Consolidated Balance Sheet. As of March&#160;31, 2026, the liabilities associated with collateral pledged were solely comprised of a finance lease and had a carrying value of $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:FinanceLeaseLiability" scale="6" id="f-378">16.2</ix:nonFraction> million. The collateral pledged under the lease agreement may only be operated by the Company within the continental United States and must maintain a good title. The assets cannot be sold, disposed of or repledged by the Company.</span></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div id="icf34ee3be70a44349aaa73f1b5df5e08_58"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 8. <ix:nonNumeric contextRef="c-1" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="f-379" continuedAt="f-379-1" escape="true">Common Stock </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="f-379-1" continuedAt="f-379-2"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each share of Class A common stock entitles the holder to <ix:nonFraction unitRef="vote" contextRef="c-6" decimals="INF" name="rxrx:CommonStockVotePerShare" format="ixt-sec:numwordsen" scale="0" id="f-380">one</ix:nonFraction> vote per share and each share of Class B common stock entitles the holder to <ix:nonFraction unitRef="vote" contextRef="c-9" decimals="INF" name="rxrx:CommonStockVotePerShare" scale="0" id="f-381">10</ix:nonFraction> votes per share on all matters submitted to a vote of the Company&#8217;s stockholders. Common stockholders are entitled to receive dividends, as may be declared by the Company&#8217;s Board of Directors. As of March&#160;31, 2026 and December&#160;31, 2025, <ix:nonFraction unitRef="usd" contextRef="c-58" decimals="INF" name="us-gaap:DividendsStock" format="ixt:fixed-zero" scale="0" id="f-382"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="INF" name="us-gaap:DividendsStock" format="ixt:fixed-zero" scale="0" id="f-383">no</ix:nonFraction></ix:nonFraction> dividends had been declared. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">At-The-Market Offerings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In </span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February 2026</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company entered into a Sales Agreement (the TD Cowen Sales Agreement) with TD Securities (USA), LLC (the TD Cowen Sales Agent), to provide for the offering, issuance and sale of up to an aggregate amount of $<ix:nonFraction unitRef="usd" contextRef="c-59" decimals="-6" name="rxrx:SaleOfStockValueAuthorized" scale="6" id="f-384">300</ix:nonFraction> million of its Class A common stock from time to time in at-the-market offerings (the TD Cowen ATM Offering). The TD Cowen ATM Offering was made under a prospectus supplement dated February&#160;24, 2026 and related prospectus filed with the Securities and Exchange Commission pursuant to the Company&#8217;s automatically effective shelf registration statement on Form S-3 (Registration No. 333-284878). </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March 31, 2026, the Company sold no</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">shares. As of&#160;March&#160;31, 2026, an amount of $<ix:nonFraction unitRef="usd" contextRef="c-60" decimals="-5" name="rxrx:SaleOfStockValueRemainingAuthorized" scale="6" id="f-385">300.0</ix:nonFraction> million remained available for future sales under the Sales Agreement.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to </span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February 2026, Recursion had entered into sales agreements with Citigroup Capital Markets Inc. and Jefferies LLC. See Note 8, &#8220;Common Stock,&#8221; in the Company&#8217;s Annual Report on Form 10-K for the year ended </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2025</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Valence Acquisition Exchangeable Shares</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In </span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">May 2023</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, in connection with the acquisition of Valence Discovery Inc. (Valence), the Company entered into an agreement to issue up to <ix:nonFraction unitRef="shares" contextRef="c-61" decimals="-5" name="rxrx:BusinessAcquisitionContingentConsiderationEquityInterestsIssuableNumberOfShares" scale="6" id="f-386">5.9</ix:nonFraction>&#160;million shares of Class A common stock (the Exchangeable Shares), that may be issued upon exchange of exchangeable shares of a subsidiary of Recursion. The Exchangeable Shares are substantially the economic equivalent of the Class A shares and classified as common stock within the Company&#8217;s stockholders&#8217; equity. The Company&#8217;s calculation of weighted-average shares outstanding includes the exchangeable shares. As of March&#160;31, 2026, <ix:nonFraction unitRef="shares" contextRef="c-62" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" scale="6" id="f-387">4.9</ix:nonFraction>&#160;million Exchangeable Shares have been redeemed for Class A shares.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Registration Rights Agreements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Tempus agreement</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In </span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">November 2023</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, in connection with the Tempus Agreement, the Company filed a registration statement for resale of the shares of Class A common stock issued or issuable under the Tempus Agreement. A new registration </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf34ee3be70a44349aaa73f1b5df5e08_7">Table of Contents</a></span></div></div><ix:continuation id="f-379-2"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">statement (333-284878) was filed in February 2025 and a prospectus supplement covering all shares that have been issued under the Tempus Agreement and remained held by Tempus was filed in May 2025 and in November 2025, a prospectus supplement was filed to register shares issued to Tempus in payment for the 2025 annual fee.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After registration of any shares issued to Tempus under the Tempus Agreement, the Company has agreed to use commercially reasonable efforts to keep such registration statement effective until such date that all shares issued to Tempus covered by such registration statement have been sold. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Acquisitions</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2024, in connection with the acquisition of Exscientia plc (Exscientia), the Company filed a Registration Agreement providing for the resale of the shares of Class A common stock issued for Recursion stock options and RSUs. A registration statement on Form S-8 (File No. 333-283347) was filed to register the shares for resale by the holders. The registration statement must remain effective as long as such Recursion stock options and RSUs remain outstanding.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2023, in connection with the acquisition of Valence, the Company filed a Registration Agreement providing for the resale of the shares of Class A common stock and Exchange Shares issued or issuable in such transaction. A registration statement on Form S-3ASR (File No. 333-272281) was filed to register the shares for resale by the holders. The registration statement must remain effective for a period of not less than <ix:nonNumeric contextRef="c-63" name="rxrx:RegistrationRightsAgreementTerm" format="ixt-sec:durwordsen" id="f-388">three years</ix:nonNumeric>. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Class A and B Common Shares Authorization</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2021, the Company&#8217;s Board of Directors authorized <ix:nonFraction unitRef="class" contextRef="c-64" decimals="INF" name="rxrx:NumberOfClassesOfCommonStockAuthorized" format="ixt-sec:numwordsen" scale="0" id="f-389">two</ix:nonFraction> classes of common stock, Class A and Class B. The rights of the holders of Class A and B common stock are identical, except with respect to voting and conversion. Each share of Class A common stock is entitled to <ix:nonFraction unitRef="vote" contextRef="c-6" decimals="INF" name="rxrx:CommonStockVotePerShare" format="ixt-sec:numwordsen" scale="0" id="f-390">one</ix:nonFraction> vote per share. Each share of Class B common stock is entitled to <ix:nonFraction unitRef="vote" contextRef="c-9" decimals="INF" name="rxrx:CommonStockVotePerShare" scale="0" id="f-391">10</ix:nonFraction> votes per share and is convertible at any time into <ix:nonFraction unitRef="number" contextRef="c-6" decimals="INF" name="rxrx:CommonStockConversionRatio" format="ixt-sec:numwordsen" scale="0" id="f-392">one</ix:nonFraction> share of Class A common stock.</span></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div id="icf34ee3be70a44349aaa73f1b5df5e08_61"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note&#160;9. <ix:nonNumeric contextRef="c-1" name="us-gaap:CollaborativeArrangementDisclosureTextBlock" id="f-393" continuedAt="f-393-1" escape="true">Collaborative Development Contracts </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="f-393-1" continuedAt="f-393-2"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sanofi</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Description</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In </span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">January 2022</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company and Sanofi entered into a collaboration agreement to develop an AI-driven pipeline of precision-engineered medicines. The research is focused on up to <ix:nonFraction unitRef="candidate" contextRef="c-65" decimals="INF" name="rxrx:ContractWithCustomerNumberOfNovelSmallMoleculeCandidates" scale="0" id="f-394">15</ix:nonFraction> novel small molecule candidates across oncology and immunology and utilizes the Company&#8217;s AI platform. The Company is leading small molecule drug design and lead optimization activities with Sanofi assuming responsibility for preclinical and clinical development, manufacturing and commercialization.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Pricing</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company received a $<ix:nonFraction unitRef="usd" contextRef="c-66" decimals="-5" name="us-gaap:ContractWithCustomerLiability" scale="6" id="f-395">100.0</ix:nonFraction> million non-refundable upfront payment. The Company has received multiple milestone payments related to this agreement totaling approximately $<ix:nonFraction unitRef="usd" contextRef="c-67" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="f-396">34.0</ix:nonFraction> million. These related to the advancement of several of the discovery programs within the collaboration and the addition of an existing Company program into the collaboration. Recursion is eligible for additional milestone payments based on performance progress of the collaboration and tiered royalties ranging from high-single-digits to mid-teens. Recursion could earn a maximum of $<ix:nonFraction unitRef="usd" contextRef="c-68" decimals="-5" name="us-gaap:ContractWithCustomerLiability" scale="6" id="f-397">555.0</ix:nonFraction> million from all research milestones and $<ix:nonFraction unitRef="usd" contextRef="c-69" decimals="-8" name="us-gaap:ContractWithCustomerLiability" scale="9" id="f-398">1.8</ix:nonFraction> billion from all development and regulatory milestones.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Accounting</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Recursion has determined that it has at least <ix:nonFraction unitRef="performance_obligation" contextRef="c-65" decimals="INF" name="rxrx:RevenuePerformanceObligationNumberOfObligations" format="ixt-sec:numwordsen" scale="0" id="f-399">eight</ix:nonFraction> performance obligations related to the small molecule projects. These performance obligations are for performing research and development services for Sanofi to design small molecules and perform lead optimization activities. The performance obligations also include potential licenses related to the intellectual property. The Company concluded that licenses within the contract are not distinct from the research and development services as they are interrelated due to the fact that the research and development services significantly impact the potential licenses. Any additional services are considered customer options and will be considered as separate contracts for accounting purposes.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf34ee3be70a44349aaa73f1b5df5e08_7">Table of Contents</a></span></div></div><ix:continuation id="f-393-2" continuedAt="f-393-3"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has determined the transaction price to be $<ix:nonFraction unitRef="usd" contextRef="c-66" decimals="-5" name="us-gaap:RevenueRemainingPerformanceObligation" scale="6" id="f-400">154.5</ix:nonFraction> million, for the initial performance obligations, comprised of the upfront payment, several milestones that have been achieved and estimated additional target exercises. Recursion has fully constrained the amounts of remaining variable consideration to be received from potential milestones considering the stage of development and the risks associated with the remaining development required to achieve each milestone. Recursion will re-evaluate the transaction price each reporting period. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue over time based on costs incurred relative to total expected costs to perform the research and development services. Recursion was unable to estimate the completion date of the performance obligations due to the current stage of work.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Merck KGaA (Merck)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Description</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In </span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">September 2023</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company and Merck entered into a collaboration agreement to discover novel small molecule drug candidates across oncology, neuroinflammation and immunology. The collaboration utilizes the Company&#8217;s AI platform and the Company is performing drug design and discovery while Merck will be assuming responsibility for the preclinical and clinical development.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Pricing</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company received a $<ix:nonFraction unitRef="usd" contextRef="c-70" decimals="-5" name="us-gaap:ContractWithCustomerLiability" scale="6" id="f-401">20.1</ix:nonFraction> million non-refundable upfront payment. Recursion is eligible for additional milestone payments based on performance progress of the collaboration and tiered royalties from the mid-single-digits to low-double-digits. The Company could earn a maximum of $<ix:nonFraction unitRef="usd" contextRef="c-71" decimals="-5" name="us-gaap:ContractWithCustomerLiability" scale="6" id="f-402">73.0</ix:nonFraction> million for discovery, development and sales milestones per project.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Accounting</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Recursion has determined that it has <ix:nonFraction unitRef="performance_obligation" contextRef="c-72" decimals="INF" name="rxrx:RevenuePerformanceObligationNumberOfObligations" format="ixt-sec:numwordsen" scale="0" id="f-403">three</ix:nonFraction> performance obligations related to the small molecule projects and the transaction price to be $<ix:nonFraction unitRef="usd" contextRef="c-70" decimals="-5" name="us-gaap:RevenueRemainingPerformanceObligation" scale="6" id="f-404">20.1</ix:nonFraction> million. Recursion has fully constrained the amounts of remaining variable consideration to be received from potential milestones. Recursion will re-evaluate the transaction price each reporting period. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue over time based on costs incurred relative to total expected costs to perform the research and development services. Recursion was unable to estimate the completion date of the performance obligations due to the current stage of work.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Roche and Genentech</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Description</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2021, Recursion entered into a collaboration and license agreement with Roche and Genentech (collectively referred to as Roche). Recursion is constructing, using the Company&#8217;s imaging technology and proprietary machine-learning algorithms, unique maps of the inferred relationships amongst perturbation phenotypes in a given cellular context with the goal to discover and develop therapeutic small molecule programs in a gastrointestinal cancer indication and in key areas of neuroscience. Roche and Recursion will collaborate to select certain novel inferences with respect to small molecules or targets generated from the Phenomaps for further validation and optimization as collaboration programs. Roche and Recursion may also combine sequencing datasets from Roche with Recursion&#8217;s Phenomaps and collaborate to generate new algorithms to produce multi-modal maps from which additional collaboration programs may be initiated. For every collaboration program that successfully identifies potential therapeutic small molecules or validates a target, Roche will have an option to obtain an exclusive license to develop and commercialize such potential therapeutic small molecules or to exploit such target in the applicable exclusive field.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Pricing</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In January 2022, Recursion received a $<ix:nonFraction unitRef="usd" contextRef="c-73" decimals="-5" name="us-gaap:ContractWithCustomerLiability" scale="6" id="f-405">150.0</ix:nonFraction> million non-refundable upfront payment from the Company&#8217;s collaboration with Roche. In September 2024, Recursion received a $<ix:nonFraction unitRef="usd" contextRef="c-74" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="f-406">30.0</ix:nonFraction> million milestone payment ( &#8220;acceptance fee 1&#8221;), which was an acceptance fee related to the first accepted neuroscience Phenomap. In October 2025, Recursion received another $<ix:nonFraction unitRef="usd" contextRef="c-75" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="f-407">30.0</ix:nonFraction> million milestone payment (&#8220;acceptance fee 2&#8221;), which was an acceptance fee related to the second accepted neuroscience Phenomap. Recursion is eligible for additional milestone payments based on performance progress of the collaboration. Each of the Phenomaps requested by Roche and created by Recursion may be subject to either an initiation fee, acceptance fee or both. Such fees could exceed $<ix:nonFraction unitRef="usd" contextRef="c-76" decimals="-5" name="rxrx:RevenueRemainingPerformanceObligationVariableConsiderationAmount" scale="6" id="f-408">250.0</ix:nonFraction> million for <ix:nonFraction unitRef="phenomap" contextRef="c-76" decimals="INF" name="rxrx:ContractWithCustomerMaximumAcceptedProduct" scale="0" id="f-409">16</ix:nonFraction> accepted Phenomaps. In addition, for a period of time after Roche&#8217;s acceptance of certain Phenomaps, </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf34ee3be70a44349aaa73f1b5df5e08_7">Table of Contents</a></span></div></div><ix:continuation id="f-393-3" continuedAt="f-393-4"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Roche will have the option to obtain, subject to payment of an exercise fee, rights to use outside the collaboration the raw images generated in the course of creating those Phenomaps. If Roche exercises its external use option for all <ix:nonFraction unitRef="phenomap" contextRef="c-77" decimals="INF" name="rxrx:ContractWithCustomerMaximumAcceptedProduct" scale="0" id="f-410">12</ix:nonFraction> eligible Phenomaps, Roche&#8217;s associated exercise fee payments to Recursion could exceed $<ix:nonFraction unitRef="usd" contextRef="c-77" decimals="-5" name="rxrx:RevenueRemainingPerformanceObligationVariableConsiderationAmount" scale="6" id="f-411">250.0</ix:nonFraction> million. Under the collaboration, Roche may initiate up to <ix:nonFraction unitRef="program" contextRef="c-78" decimals="INF" name="rxrx:RevenueRemainingPerformanceObligationNumberOfProjectsThatMayBeInitiated" scale="0" id="f-412">40</ix:nonFraction> programs, each of which, if successfully developed and commercialized, could yield more than $<ix:nonFraction unitRef="usd" contextRef="c-78" decimals="-5" name="rxrx:RevenueRemainingPerformanceObligationVariableConsiderationAmount" scale="6" id="f-413">300.0</ix:nonFraction>&#160;million in development, commercialization and net revenue milestones for Recursion, as well as tiered royalties on net revenue.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Accounting</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Recursion has determined that it has <ix:nonFraction unitRef="performance_obligation" contextRef="c-79" decimals="INF" name="rxrx:RevenuePerformanceObligationNumberOfObligations" format="ixt-sec:numwordsen" scale="0" id="f-414">three</ix:nonFraction> performance obligations, <ix:nonFraction unitRef="performance_obligation" contextRef="c-80" decimals="INF" name="rxrx:RevenuePerformanceObligationNumberOfObligations" format="ixt-sec:numwordsen" scale="0" id="f-415">one</ix:nonFraction> related to gastrointestinal cancer and <ix:nonFraction unitRef="performance_obligation" contextRef="c-81" decimals="INF" name="rxrx:RevenuePerformanceObligationNumberOfObligations" format="ixt-sec:numwordsen" scale="0" id="f-416">two</ix:nonFraction> in neuroscience. These performance obligations are for performing research and development services for Roche to identify targets and medicines. The performance obligations also include potential licenses related to the intellectual property. The Company concluded that licenses within the contract are not distinct from the research and development services as they are interrelated due to the fact that the research and development services significantly impact the potential licenses. Any additional services are considered customer options and will be considered as separate contracts for accounting purposes.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company has determined the transaction price to be $<ix:nonFraction unitRef="usd" contextRef="c-73" decimals="-5" name="us-gaap:RevenueRemainingPerformanceObligation" scale="6" id="f-417">210.0</ix:nonFraction> million, comprised of the upfront payment and the acceptance fees. The consideration did not include the $<ix:nonFraction unitRef="usd" contextRef="c-74" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="f-418">30.0</ix:nonFraction> million variable consideration for the first acceptance fee until the map was accepted, which was during the third quarter of 2024. As a result of Roche&#8217;s acceptance of the neuroscience Phenomap, Recursion is now recognizing the acceptance fee as part of the transaction price over the completion period of one of the neuroscience performance obligations. The consideration did not include the $<ix:nonFraction unitRef="usd" contextRef="c-74" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="f-419">30.0</ix:nonFraction> million variable consideration for the second acceptance fee until the map was accepted, which was during the fourth quarter of 2025. As a result of Roche&#8217;s acceptance of the neuroscience Phenomap, Recursion is now recognizing the acceptance fees as part of the transaction price over the completion period of one of the neuroscience performance obligations. Recursion has fully constrained the remaining amounts of variable consideration to be received from potential milestones considering the stage of development and the risks associated with the remaining development required to achieve each milestone. Recursion will re-evaluate the transaction price each reporting period.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue over time based on costs incurred relative to total expected costs to perform the research and development services. Recursion has estimated the completion of the performance obligations by 2028.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Additional Revenue Disclosures</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Of the revenue recognized during the three months ended March 31, 2026 and 2025, $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="f-420">4.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="f-421">14.7</ix:nonFraction> million was included in the unearned revenue balance as of December&#160;31, 2025 and December&#160;31, 2024, respectively. Revenue recognized was from the upfront and variable consideration payments received from the related contracts, which decreased the aggregate unearned revenue recognized. As of March&#160;31, 2026, the Company had $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:ContractWithCustomerAssetNetCurrent" scale="6" id="f-422">5.2</ix:nonFraction> million of costs incurred to fulfill a contract on its Condensed Consolidated Balance Sheet within &#8220;Other Current Assets.&#8221;</span></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-393-4">Unearned revenue was classified as short-term and long-term on the Condensed Consolidated Balance Sheets based on the Company&#8217;s estimate of revenue that will be recognized during the next twelve months.</ix:continuation> </span></div><div><span><br/></span></div><div><span><br/></span></div><div id="icf34ee3be70a44349aaa73f1b5df5e08_64"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 10. <ix:nonNumeric contextRef="c-1" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="f-423" continuedAt="f-423-1" escape="true">Stock-Based Compensation </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="f-423-1" continuedAt="f-423-2"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2021, the Board of Directors and the stockholders of the Company adopted the 2021 Equity Incentive Plan (the 2021 Plan). The Company may grant stock options, restricted stock units (RSUs), stock appreciation rights, restricted stock awards and other forms of stock-based compensation. As of March&#160;31, 2026, <ix:nonFraction unitRef="shares" contextRef="c-82" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" scale="6" id="f-424">27.1</ix:nonFraction>&#160;million shares of Class A common stock were available for grant in the 2021 plan. In November 2024, the Board of Directors and the stockholders of the Company adopted the 2024 Inducement Equity Incentive Plan (the 2024 Plan) as part of the Exscientia acquisition. As of March&#160;31, 2026, <ix:nonFraction unitRef="shares" contextRef="c-83" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" scale="6" id="f-425">11.3</ix:nonFraction>&#160;million shares of Class A common stock were available for grant in the 2024 plan.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf34ee3be70a44349aaa73f1b5df5e08_7">Table of Contents</a></span></div></div><ix:continuation id="f-423-2"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" id="f-426" escape="true"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the classification of stock-based compensation expense for employees and non-employees within the Condensed Consolidated Statements of Operations: </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:76.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.012%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-84" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="f-427">900</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-85" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-428">2,950</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-86" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-429">11,876</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-87" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-430">17,800</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-88" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-431">9,219</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-89" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-432">14,839</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-433">21,995</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-434">35,589</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">RSUs</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity awards granted to employees primarily consist of RSUs and generally vest over <ix:nonNumeric contextRef="c-90" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="f-435">four years</ix:nonNumeric>. The weighted-average grant-date fair value of RSUs generally is determined based on the number of units granted and the quoted price of Recursion&#8217;s common stock on the date of grant.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock" id="f-436" escape="true"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes Recursion&#8217;s RSU activity during the three months ended March 31, 2026: </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.784%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stock units</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-average grant date fair value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding as of December 31, 2025</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-91" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="f-437">27,489,925</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-91" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-438">6.55</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-90" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-439">6,154,778</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-90" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-440">3.98</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-90" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-441">2,703,740</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-90" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-442">6.69</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-90" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-443">2,375,565</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-90" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="f-444">6.46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding as of March 31, 2026</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-92" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="f-445">28,565,398</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-92" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-446">5.99</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair market value of RSUs vested was $<ix:nonFraction unitRef="usd" contextRef="c-90" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="f-447">18.1</ix:nonFraction> million during the three months ended March 31, 2026. As of March&#160;31, 2026, $<ix:nonFraction unitRef="usd" contextRef="c-92" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" scale="6" id="f-448">159.1</ix:nonFraction> million of unrecognized compensation cost related to RSUs is expected to be recognized as expense over approximately the next <ix:nonNumeric contextRef="c-90" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:durwordsen" id="f-449">three years</ix:nonNumeric>.</span></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div id="icf34ee3be70a44349aaa73f1b5df5e08_67"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 11. <ix:nonNumeric contextRef="c-1" name="us-gaap:IncomeTaxDisclosureTextBlock" id="f-450" continuedAt="f-450-1" escape="true">Income Taxes </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="f-450-1"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company did not incur a significant amount of U.S. income tax expense during the three months ended March 31, 2026 and 2025. The Company has historically incurred operating losses and continues to maintain a full valuation allowance against most of its U.S. net deferred tax assets. Foreign income tax benefits were $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:ForeignIncomeTaxExpenseBenefitContinuingOperations" scale="6" id="f-451">5.5</ix:nonFraction> million</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for the three months ended March 31, 2026 and the Company did <ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-5" name="us-gaap:ForeignIncomeTaxExpenseBenefitContinuingOperations" format="ixt:fixed-zero" scale="0" id="f-452">not</ix:nonFraction> incur a significant amount for 2025. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s U.S. net operating loss (&#8220;NOL&#8221;) and tax credit carryforwards are subject to review and adjustment by the Internal Revenue Service (&#8220;IRS&#8221;) and may be subject to annual limitations under Section 382 of the Internal Revenue Code, as amended and similar state provisions in the event of certain ownership changes. These ownership changes may limit the amount of NOLs and other tax attributes that can be utilized annually to offset future taxable income. In general, an ownership change, as defined by Section 382, occurs when the ownership of certain shareholders or public groups increases by more than 50% over a rolling three-year period. As of March&#160;31, 2026, the Company completed a Section 382 study covering the period through January&#160;31, 2025 and concluded that a deemed ownership change occurred on September&#160;25, 2017. As a result, the Company&#8217;s ability to utilize its NOLs and other tax attributes may be subject to annual limitations. The Company will continue to monitor ownership changes that could result in additional limitations on the utilization of its tax attributes. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company files income tax returns in the United States (federal and various state jurisdictions), Canada and the United Kingdom and is subject to examination by taxing authorities in these jurisdictions. The Company is not currently under examination by any taxing authority. For U.S. federal income tax purposes, tax years beginning with 2016 remain open for examination.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf34ee3be70a44349aaa73f1b5df5e08_7">Table of Contents</a></span></div></div><div><span><br/></span></div><div id="icf34ee3be70a44349aaa73f1b5df5e08_70"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 12. <ix:nonNumeric contextRef="c-1" name="us-gaap:EarningsPerShareTextBlock" id="f-453" continuedAt="f-453-1" escape="true">Net Loss Per Share</ix:nonNumeric></span><ix:continuation id="f-453-1" continuedAt="f-453-2"><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></ix:continuation></div><div><span><br/></span></div><ix:continuation id="f-453-2"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March 31, 2026 and 2025, Recursion calculated net loss per share of Class A, Class B and the Exchangeable common stock. Basic net loss per share is computed using the weighted-average number of shares outstanding during the period. Diluted net loss per share is computed using the weighted-average number of shares and the effect of potentially dilutive securities outstanding during the period. Potentially dilutive securities consist of stock options and other contingently issuable shares. For periods presented in which the Company reports a net loss, all potentially dilutive shares are anti-dilutive and as such are excluded from the calculation. For the three months ended March 31, 2026 and 2025, the Company reported a net loss and therefore basic and diluted loss per share were the same.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The rights, including the liquidation and dividend rights, of the holders of the Company&#8217;s Class A, Class B and the Exchangeable common stock are identical, except with respect to voting. As a result, the undistributed earnings for each period are allocated based on the contractual participation rights of the Class A, Class B and the Exchangeable common stock as if the earnings for the period had been distributed. As the liquidation and dividend rights are identical, the undistributed earnings are allocated on a proportionate basis and the resulting amount per share for Class A, Class B and the Exchangeable common stock was the same during the three months ended March 31, 2026 and 2025.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="f-454" escape="true"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables set forth the computation of basic and diluted net loss per share of Class A, Class B and Exchangeable common stock:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.438%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.058%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands, except share and per share amounts)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-455">117,504</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-456">202,487</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-457"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-458">529,303,984</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-16" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-459"><ix:nonFraction unitRef="shares" contextRef="c-16" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-460">402,771,972</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per share, basic and diluted</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-461"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-462">0.22</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-16" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-463"><ix:nonFraction unitRef="usdPerShare" contextRef="c-16" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-464">0.50</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="f-465" escape="true"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company excluded the following potential common shares from the computation of diluted net loss per share for the periods indicated because including them would have had an anti-dilutive effect: </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.438%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.057%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.205%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Stock based compensation</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-93" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-466">5,504,219</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-94" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-467">11,896,288</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tempus agreement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-95" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="0" id="f-468">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-96" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-469">5,369,128</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-470">5,504,219</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-16" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-471">17,265,416</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div id="icf34ee3be70a44349aaa73f1b5df5e08_73"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 13. <ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueDisclosuresTextBlock" id="f-472" continuedAt="f-472-1" escape="true">Fair Value Measurements</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="f-472-1" continuedAt="f-472-2"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value hierarchy consists of the following three levels:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1 &#8212; Valuations based on unadjusted quoted prices in active markets for identical assets that the company has the ability to access;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2 &#8212; Valuations based on quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active and model-based valuations in which all significant inputs are observable in the market; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3 &#8212; Valuations using significant inputs that are unobservable in the market and include the use of judgment by the company's management about the assumptions market participants would use in pricing the asset or liability.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf34ee3be70a44349aaa73f1b5df5e08_7">Table of Contents</a></span></div></div><div><span><br/></span></div><ix:continuation id="f-472-2"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is required to maintain a cash balance in a collateralized account to secure the Company&#8217;s credit cards. Additionally, the Company holds restricted cash related to an outstanding letter of credit issued by J.P. Morgan, which was obtained to secure certain Company obligations relating to tenant improvements. Recursion also holds restricted cash as required by a lease agreement. The Company also holds restricted cash as required by several grant agreements.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="f-473" escape="true"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the Company&#8217;s assets and liabilities that are measured at fair value on a recurring basis:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.514%"><tr><td style="width:1.0%"/><td style="width:43.727%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.741%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.543%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.744%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.745%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2026</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basis of fair value measurement</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-97" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-474">45,442</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-98" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-475">45,442</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-99" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-476">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-100" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-477">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-101" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-478">609,031</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-102" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-479">609,031</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-103" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-480">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-104" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-481">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="rxrx:RestrictedCashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-482">10,707</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-105" decimals="-3" name="rxrx:RestrictedCashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-483">10,707</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-3" name="rxrx:RestrictedCashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-484">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-107" decimals="-3" name="rxrx:RestrictedCashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-485">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-486">665,180</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-105" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-487">665,180</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-488">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-107" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-489">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.098%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.452%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2025</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basis of fair value measurement</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-108" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-490">72,627</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-109" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-491">72,627</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-110" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-492">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-111" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-493">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-112" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-494">670,667</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-113" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-495">670,667</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-114" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-496">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-115" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-497">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="rxrx:RestrictedCashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-498">10,627</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-116" decimals="-3" name="rxrx:RestrictedCashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-499">10,627</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-117" decimals="-3" name="rxrx:RestrictedCashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-500">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-118" decimals="-3" name="rxrx:RestrictedCashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-501">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-502">753,921</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-116" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-503">753,921</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-117" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-504">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-118" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-505">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the financial instruments that are recognized at fair value on the Condensed Consolidated Balance Sheet, the Company has certain financial instruments that are recognized at amortized cost or some basis other than fair value. The carrying amount of these instruments are considered to be representative of their approximate fair values. </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock" id="f-506" escape="true"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the Company&#8217;s financial instruments that are not measured at fair value: </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:26.531%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.992%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.448%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Book values</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair values</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2025</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes payable and financing lease liabilities, current</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-119" decimals="-3" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-507">9,265</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-120" decimals="-3" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-508">9,091</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-121" decimals="-3" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-509">9,265</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-122" decimals="-3" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-510">9,091</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes payable and financing lease liabilities, non-current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-119" decimals="-3" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="3" id="f-511">7,181</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-120" decimals="-3" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="3" id="f-512">9,564</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-121" decimals="-3" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="3" id="f-513">7,181</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-122" decimals="-3" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="3" id="f-514">9,564</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-123" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-515">16,446</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-124" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-516">18,655</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-125" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-517">16,446</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-518">18,655</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><div id="icf34ee3be70a44349aaa73f1b5df5e08_76"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf34ee3be70a44349aaa73f1b5df5e08_7">Table of Contents</a></span></div></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 14. <ix:nonNumeric contextRef="c-1" name="us-gaap:SegmentReportingDisclosureTextBlock" id="f-519" continuedAt="f-519-1" escape="true">Segment Information</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="f-519-1"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Segment loss</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Recursion operates as a single operating segment that is managed on a consolidated basis. The Company&#8217;s chief operating decision maker (CODM) is its Chief Executive Officer. The CODM uses segment net loss to evaluate the performance of its segment, analyze financial trends, compare the budget to the actual operating results and make resource allocation decisions. Segment net loss represents the Company&#8217;s consolidated net loss. All corporate costs, global function support costs, overhead costs and other shared costs are included within this segment. Other segment items primarily include general and administrative expenses including facilities, information technology, professional fees (including auditing, tax and legal) and insurance.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="f-520" escape="true"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents Recursion&#8217;s segment revenue, significant segment expenses, and segment net loss: </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.484%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:112%">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-521">6,472</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-522">14,745</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Significant segment expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Salaries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-3" name="us-gaap:LaborAndRelatedExpense" format="ixt:num-dot-decimal" scale="3" id="f-523">74,298</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-3" name="us-gaap:LaborAndRelatedExpense" format="ixt:num-dot-decimal" scale="3" id="f-524">83,554</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Consumables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-3" name="rxrx:ConsumableExpense" format="ixt:num-dot-decimal" scale="3" id="f-525">7,146</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-3" name="rxrx:ConsumableExpense" format="ixt:num-dot-decimal" scale="3" id="f-526">54,677</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Platform</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-3" name="rxrx:PlatformFeeExpense" format="ixt:num-dot-decimal" scale="3" id="f-527">7,614</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-3" name="rxrx:PlatformFeeExpense" format="ixt:num-dot-decimal" scale="3" id="f-528">8,765</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Discovery</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-3" name="rxrx:DiscoveryExpense" format="ixt:num-dot-decimal" scale="3" id="f-529">6,332</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-3" name="rxrx:DiscoveryExpense" format="ixt:num-dot-decimal" scale="3" id="f-530">6,287</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Clinical development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-3" name="rxrx:ClinicalDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-531">6,569</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-3" name="rxrx:ClinicalDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-532">10,564</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSoldDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-533">19,673</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSoldDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-534">19,331</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Other segment items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-3" name="us-gaap:SegmentReportingOtherItemAmount" format="ixt:num-dot-decimal" scale="3" id="f-535">13,345</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-3" name="us-gaap:SegmentReportingOtherItemAmount" format="ixt:num-dot-decimal" scale="3" id="f-536">22,935</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Loss from operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-537">128,505</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-538">191,368</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Other non-operating income (loss), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-539">6,397</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-540">11,277</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Income tax benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-541">4,604</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="f-542">158</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Total segment loss</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-543">117,504</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-544">202,487</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Supplemental asset information</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Total expenditures for additions to long-lived assets</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-3" name="us-gaap:SegmentExpenditureAdditionToLongLivedAssets" scale="3" id="f-545">258</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-3" name="us-gaap:SegmentExpenditureAdditionToLongLivedAssets" format="ixt:num-dot-decimal" scale="3" id="f-546">2,978</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><div id="icf34ee3be70a44349aaa73f1b5df5e08_82"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf34ee3be70a44349aaa73f1b5df5e08_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The following is a discussion and analysis of the financial condition of Recursion Pharmaceuticals, Inc. (Recursion, the Company, we, us or our) and the results of our operations. This commentary should be read in conjunction with the unaudited Condensed Consolidated Financial Statements and accompanying notes appearing in Item 1, &#8220;Financial Statements&#8221; and the Company&#8217;s audited consolidated financial statements and accompanying notes and "Management's Discussion and Analysis of Financial Condition and Results of Operations" included in the Annual Report on Form 10-K for the year ended December 31, 2025 (the 2025 Annual Report). This discussion, particularly information with respect to our future results of operations or financial condition, business strategy and plans and objectives of management for future operations, includes forward-looking statements that involve risks and uncertainties as described under the heading "Note About Forward-Looking Statements" in this Quarterly Report on Form 10-Q. You should review the disclosure under the heading "Risk Factors" in the 2025 Annual Report and in our subsequent Quarterly Reports on Form 10-Q, including this Quarterly Report on Form 10-Q, for a discussion of important factors that could cause our actual results to differ materially from those anticipated in these forward-looking statements. We assume no obligation to revise or publicly release any revision to any forward-looking statements contained in this Quarterly Report on Form 10-Q, unless required by law.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investors and others should note that we announce material financial and other information to our investors using our investor relations website (https://ir.recursion.com/), SEC filings, press releases, public conference calls and webcasts. We use these channels as well as social media and blogs to communicate with our stakeholders and the public about our company, our services and other issues. It is possible that the information we post on social media and blogs could be deemed to be material information. Therefore, we encourage investors, the media and others interested in our company to review the information we post on the social media channels and blogs listed on our investor relations website. Information contained in, or that can be accessed through, our website is not a part of, and is not incorporated into, this report.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span></div><div id="icf34ee3be70a44349aaa73f1b5df5e08_85"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Recursion is a clinical-stage TechBio company with a mission to decode biology to radically improve lives. We have advanced a portfolio of differentiated internal programs and strategic partnerships powered by our integrated drug discovery and development platform, the Recursion Operating System (OS). This platform provides end-to-end, AI-native capabilities that span from novel biological ideas through the clinic, integrating multimodal biological data</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">generation, AI-powered small molecule synthesis, and AI-enabled clinical development. All of our technologies are designed to translate complex science into medicines that matter &#8212; faster, better, and at scale &#8212; for patients who are waiting. </span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> </span></div><div id="icf34ee3be70a44349aaa73f1b5df5e08_88"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Wholly Owned Pipeline Updates</span></div><div style="text-align:center"><img src="rxrx-20260331_g1.jpg" alt="earnings_pipeline (1).jpg" style="height:307px;margin-bottom:5pt;vertical-align:text-bottom;width:584px" id="i-1"/></div><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf34ee3be70a44349aaa73f1b5df5e08_7">Table of Contents</a></span></div></div><div><span style="background-color:#ffffff;color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Favorable Safety and PK Data for REC-1245 (RBM39):</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Preliminary safety and pharmacokinetic (PK) data from REC-1245, a potential first-in-class RBM39 degrader discovered and developed using Recursion&#8217;s platform, highlight early clinical progress for a novel approach to targeting cancer vulnerabilities linked to replication stress and DNA repair. </span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">REC-1245 advanced from biological discovery to development candidate in 18 months, more than twice as fast as the industry average, demonstrating Recursion&#8217;s ability to identify novel targets and design differentiated molecules using its integrated AI-enabled platform. </span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Early data from the ongoing Phase 1/2 DAHLIA study show:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">REC-1245 was well-tolerated across select solid tumors (n=16)</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">No dose-limiting toxicities (DLTs) have been observed to date, and the maximum tolerated dose has not yet been reached</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The majority of TRAEs were Grade 1 or 2, most common GI-related events were constipation, nausea, and vomiting </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Pharmacokinetic analysis demonstrates predictable, dose-dependent exposure across evaluated patients</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Pharmacodynamic assessments demonstrate target engagement</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Dose escalation is ongoing to determine the recommended Phase 2 dose for monotherapy expansion cohorts </span></div><div style="margin-bottom:3pt"><span><br/></span></div><div style="padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:53.508%"><tr><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/></tr><tr><td colspan="6" style="background-color:#026dce;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Treatment-Related Adverse Event (TRAE)</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patients  (n=16)</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Patients with any TRAE</span></td><td colspan="3" style="background-color:#dbdbdb;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10 (62.5%)</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grade 1-2</span></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 (56.3%)</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grade 3</span></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 (6.2%)</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grade 4-5</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0 (0.0%)</span></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Continued Momentum for REC-4881 (MEK1/2):</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">REC-4881 is an allosteric MEK1/2 inhibitor being developed for familial adenomatous polyposis (FAP), a genetically defined disease driven by APC loss. Based on platform insights into MAPK pathway modulation in APC-deficient systems, REC-4881 represents a targeted approach to addressing the underlying biology of disease progression:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Phase 2 positive proof-of-concept clinical data showed a median 43% reduction in polyp burden at Week 13, deepening to 53% at Week 25 following a treatment break, with 40% of patients demonstrating improvement in Spigelman stage, supporting a differentiated and durable profile in FAP. </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Safety was consistent with MEK1/2 inhibition, with mostly Grade 1&#8211;2 TRAEs, Grade 3 events in 15.8% of patients, no Grade &#8805;4 TRAEs, and commonly including dermatitis acneiform/rash and increased CPK.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Recursion has initiated FDA engagement to align on a potential registrational study design, with an update expected in the second half of 2026. Expansion of TUPELO to include patients aged 18+ to support a broader development strategy is also ongoing. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">First Patient Dosed in REC-4539 (LSD1 inhibitor):</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">REC-4539, an AI-designed, LSD1 inhibitor, highlights early progress for a differentiated approach to targeting epigenetic drivers in cancer. In April, the first patient was dosed in the ENLYGHT Phase 1 clinical study for solid tumors, including small cell lung cancer (SCLC).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">REC-4539 was precision designed to have a reversible mechanism and shorter predicted human half-life to address treatment-limiting platelet toxicity observed with other LSD1 inhibitors, enabling a potentially differentiated profile across solid tumors and hematologic malignancies.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf34ee3be70a44349aaa73f1b5df5e08_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The differentiated, CNS-penetrant development candidate was delivered in approximately 20 months through Recursion&#8217;s AI-native design platform, demonstrating the Company&#8217;s ability to rapidly translate platform insights into optimized clinical candidates.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the rest of the portfolio, programs continue to progress as planned. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Expected upcoming milestones across Recursion&#8217;s wholly-owned pipeline: </span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">REC-4881 (MEK1/2): </span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Regulatory update expected in 2H26</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Additional Phase 1b/2 clinical data expected in 1H27</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">REC-1245 (RBM39): Additional Phase 1 dose escalation data expected in 2H26 </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">REC-7735 (PI3K&#945; H1047R) and REC-102 (ENPP1): IND-enabling studies ongoing; data-driven go/no-go decision on Phase 1 initiation expected in 2H26 </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">REC-617 (CDK7): Early Phase 1 safety and PK combination data expected in 1H27</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">REC-3565 (MALT1): Early Phase 1 safety and PK monotherapy data expected in 1H27</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">REC-4539 (LSD1): Early Phase 1 safety and PK monotherapy data expected in 2H27</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Advancing partnered discovery, with over $500 million in milestone and upfront payments achieved to date:</span></div><div><span><br/></span></div><div style="text-align:center"><img src="rxrx-20260331_g2.jpg" alt="earnings_partners (1).jpg" style="height:282px;margin-bottom:5pt;vertical-align:text-bottom;width:576px" id="i-2"/></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Meaningful upcoming milestones across partnered discovery: </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Recursion continues to advance partnered programs that leverage complementary strengths of the Recursion OS. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In AI-enabled chemistry, Sanofi and Recursion joint programs continue progressing toward development candidate designation and earlier-stage milestones over the next 12 months, including programs designed against challenging targets in immunology and oncology. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In AI-enabled biology, Recursion expects to continue jointly translating insights from its large-scale maps of biology delivered to Roche and Genentech into potential target validation milestones over the next 12 months. The maps, jointly built by Recursion, Roche and Genentech are disease-relevant high-content maps built at large scale, including a Neuron map generated from a subset of 1 trillion internally manufactured iPSC-derived neuronal cells and a Microglia map generated from more than 100 billion internally manufactured iPSC-derived microglial cells. Additionally, we are combining our phenomics dataset with Roche and Genentech&#8217;s proprietary transcriptomics data to build multi-modal maps designed to explore potential novel targets and pathways by systematically linking gene perturbations to cellular phenotypes</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf34ee3be70a44349aaa73f1b5df5e08_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recursion OS Advances: Driving platform innovations, grounded in impact</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Full Stack AI-powered Platform:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Recursion Operating System (OS) is continuing to drive program development by integrating AI across multimodal biology, precision design, and next-generation clinical development&#8212;enabling faster, more efficient, and more innovative drug discovery and development from biology to insight, insight to molecule, and molecule to patient.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">State of the Art Transcriptomics Models:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Built to better connect Recursion&#8217;s proprietary perturbational biology with patient biology to find novel insights and medicines, the integration of these models help bridge the translation gap between what we see in the lab and what matters in disease:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">TxPert, recently featured in Nature Biotechnology, is a proof-of-principle model for predicting transcriptomic responses to perturbations. The model can generalize beyond its training data, including predicting responses to unseen single-gene perturbations, novel combinations, and known perturbations in new cell types&#8212;enabling more efficient hypothesis generation and experimental prioritization, and laying the foundation for Recursion's Virtual Cell.          </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">TxFM, presented at the ICLR Workshop on Foundation Models for Science, is a transcriptomics foundation model designed to connect lab perturbations with patient biology within the Recursion OS. Trained on a large, curated dataset of public and proprietary data, it outperforms 16 leading foundation models and baselines, including models trained on datasets 10&#8211;100x larger. Beyond enabling target identification, mechanistic understanding, and patient stratification, TxFM's superior batch correction and denoising drive operational efficiency&#8212;reducing experimental re-runs, enabling cross-experiment comparisons, and increasing the value of every sequencing dollar spent.</span></div><div><span><br/></span></div><div><span><br/></span></div><div id="icf34ee3be70a44349aaa73f1b5df5e08_91"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financing and Operations</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since </span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2024</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, our financing and operations activities include the following: In June 2024, we issued an aggregate of 35.4&#160;million shares of our Class A common stock at a purchase price of </span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$6.50</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> per share and received net proceeds of $216.4 million</span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, after deducting </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">transaction costs of $13.6 million. </span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2024, we received a Phenomap acceptance fee of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$30.0 million</span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> from our collaboration with Roche. In February 2025, the Company terminated the Sales Agreement with Jefferies LLC and entered into a Sales Agreement with Citigroup Capital Markets Inc., to provide for the offering, issuance and sale of up to an aggregate amount of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$500.0 million</span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of its Class A common stock. In </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2025</span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company sold </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">99.9 million</span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> shares and received net proceeds of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$491.7 million</span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> under the agreement. Pursuant to its terms, the Sales Agreement was completed and no amount remained available for future sales. In </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2025</span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we received multiple milestone payments related to our collaborative development contracts totaling </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$37.0 million, with aggregate milestone inflows in 2026 of $4.0 million.</span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In February 2026, the Company entered into a Sales Agreement with TD Securities (USA) LLC (TD Cowan), to provide for the offering, issuance and sale of up to an aggregate amount of $300.0 million of its Class A common stock. As of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March&#160;31, 2026</span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, no amounts have been sold under the Sales Agreement with TD Cowan.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use the capital we have raised to fund operating and investing activities across platform research operations, drug discovery, clinical development, digital and other infrastructure, creation of our portfolio of intellectual property and administrative support. We do not have any products approved for commercial sale and have not generated any revenues from product sales. Cash, cash equivalents and restricted cash totaled $665.2 million as of March&#160;31, 2026. Based on our current operating plan, we believe that our cash and cash equivalents will be sufficient to fund our operations for at least the next twelve months. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since inception, we have incurred significant operating losses. Our net losses were $117.5 million and $202.5 million during the three months ended March 31, 2026 and 2025, respectively. As of March&#160;31, 2026, our accumulated deficit was $2.2 billion. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2026, we did not have any unconditional outstanding commitments for additional funding. We anticipate that we will need to raise additional financing in the future to fund our operations, including the potential commercialization of any approved product candidates. Until such time, if ever, as we can generate significant product revenue, we expect to finance our operations with our existing cash and cash equivalents, any future equity or debt financings and upfront, milestone and royalty payments, if any, received under current or future license or collaboration agreements. We may not be able to raise additional capital on terms acceptable to us or at all. If we </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf34ee3be70a44349aaa73f1b5df5e08_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">are unable to raise additional capital when desired, our business, results of operations and financial condition may be adversely affected.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had a valuation allowance against all of our Canadian subsidiary deferred tax assets (DTAs) as of March&#160;31, 2026, and December&#160;31, 2025. We intend to continue maintaining a full valuation allowance on the Canadian DTAs until there is sufficient evidence to support the reversal of all or some portion of these allowances. However, given our current earnings and anticipated future earnings of our Canadian operations, we believe that there is a reasonable possibility that within the next 12 months, sufficient positive evidence may become available to allow us to reach a conclusion that a significant portion of the valuation allowance will no longer be needed. Release of the valuation allowance would result in the recognition of certain DTAs and a decrease to income tax expense for the period the release is recorded. However, the exact timing and amount of the valuation allowance release are subject to change on the basis of the level of profitability that we are able to actually achieve.</span></div><div><span><br/></span></div><div id="icf34ee3be70a44349aaa73f1b5df5e08_94"></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our results of operations: </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.157%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.888%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.651%"/><td style="width:0.1%"/></tr><tr style="height:24pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands, except percentages)</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Three months ended March 31,</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Change</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">%</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Revenue</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating revenue</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,301&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,818&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,517)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(57)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Grant revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(73)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">n/m</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total revenue</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,472&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,745&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,273)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating costs and expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,490&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,829&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,339)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">87,896&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">129,634&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(41,738)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,591&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54,650&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20,059)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total operating costs and expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">134,977&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">206,113&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(71,136)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Loss from operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(128,505)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(191,368)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62,863&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,397&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11,277)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,674&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&gt;100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Loss before income tax benefit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(122,108)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(202,645)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">80,537&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax benefit (expense)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,604&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,446&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">n/m</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(117,504)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(202,487)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84,983&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">n/m = Not meaningful </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our components of revenue: </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.067%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Three months ended March 31,</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands, except percentages)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$ </span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">% </span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenue</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating revenue</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,301&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,818&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,517)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(57)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Grant revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(73)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">n/m</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,472&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,745&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,273)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">n/m = Not meaningful </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating revenue is generated through research and development agreements derived from strategic alliances. We are entitled to receive variable consideration as certain milestones are achieved. The timing of revenue recognition is not directly correlated to the timing of cash receipts.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf34ee3be70a44349aaa73f1b5df5e08_7">Table of Contents</a></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March 31, 2026, the decrease in revenue compared to the prior period was due to a decrease in revenue recognized from Roche due to the successful completion of certain project phases in the prior period.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Revenue</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our cost of revenue: </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.090%"/><td style="width:0.1%"/></tr><tr style="height:24pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands, except percentages)</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Three months ended March 31,</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Change</span></td></tr><tr style="height:24pt"><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$ </span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">% </span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total cost of revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,490&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,829&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,339)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of revenue consists of the Company&#8217;s costs to provide services for drug discovery required under performance obligations with partnership customers. These primarily include materials costs, service hours performed by our employees and depreciation of property and equipment. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March 31, 2026, the change in cost of revenue compared to the prior period was due to a decrease in costs of revenue recognized from Roche, which was due to the shifting scope of work across our various performance obligations as certain phases of the projects reached completion. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our components of research and development expense: </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.543%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.549%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.549%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.772%"/><td style="width:0.1%"/></tr><tr style="height:24pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands, except percentages)</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Three months ended March 31,</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Change</span></td></tr><tr style="height:24pt"><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$ </span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">% </span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development expense</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Platform</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,154&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68,753&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(27,599)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Discovery</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,940&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,849&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,909)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Clinical</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,595&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,557&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,915&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,800&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,885)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">UK R&amp;D tax credit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,760)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,281)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">521&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,956&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,904)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(99)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total research and development expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">87,896&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">129,634&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(41,738)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses account for a significant portion of our operating expenses. We recognize research and development expenses as they are incurred. Research and development expenses consist of costs incurred in performing activities including: </span></div><div><span><br/></span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">costs to develop and operate our platform; </span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">costs of discovery efforts which may lead to development candidates, including research materials and external research; </span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">costs for clinical development of our investigational products; </span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">costs for materials and supplies associated with the manufacture of active pharmaceutical ingredients, investigational products for preclinical testing and clinical trials; </span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">personnel-related expenses, including salaries, benefits, bonuses and stock-based compensation for employees engaged in research and development functions; </span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">costs associated with operating our digital infrastructure;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">other direct and allocated expenses incurred as a result of research and development activities, including those for facilities, depreciation, amortization and insurance; and</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf34ee3be70a44349aaa73f1b5df5e08_7">Table of Contents</a></span></div></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">certain cash refundable research and development tax credits including the research and development expenditure credit (RDEC) in the United Kingdom. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize expenses associated with third-party contracted services as they are incurred. Upon termination of contracts with third parties, our financial obligations are generally limited to costs incurred or committed to date. Any advance payments for goods or services to be used or rendered in future research and product development activities pursuant to a contractual arrangement are classified as prepaid expenses until such goods or services are rendered. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant components of research and development expense include the following allocated by development phase: Platform, which refers primarily to expenses related to screening of product candidates through hit identification, this also includes expenses related to Tempus records purchased; Discovery, which refers primarily to expenses related to hit identification through development of candidates; and Clinical, which refers primarily to expenses related to development of candidates and beyond.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March 31, 2026, the decrease in research and development expenses compared to the prior period was primarily driven by platform expense. Platform expense decreased due to Tempus record purchases, which were $27.1 million for the three months ended March 31, 2025. There were no Tempus record purchases for the three months ended March 31, 2026.</span></div><div><span><br/></span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">General and Administrative Expense</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our general and administrative expense: </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.090%"/><td style="width:0.1%"/></tr><tr style="height:24pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands, except percentages)</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Three months ended March 31,</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Change</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$ </span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">% </span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total general and administrative expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,591&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54,650&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20,059)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expense general and administrative costs as incurred. General and administrative expenses consist primarily of salaries; including employee benefits and stock-based compensation. General and administrative expenses also include facilities, depreciation, information technology, professional fees for auditing and tax, legal fees for corporate and patent matters and insurance costs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March 31, 2026, the decrease relative to the three months ended March 31, 2025, was primarily driven by a decrease in salaries of $6.7 million as a result of headcount reductions in the year, in addition to one-time transaction costs in the prior year associated with the Exscientia acquisition including impairment charges of $6.0 million in relation to leasehold improvements. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Income (loss), Net </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our components of other income (loss), net: </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.666%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.235%"/><td style="width:0.1%"/></tr><tr style="height:24pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands, except percentages)</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Three months ended March 31,</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Change</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$ </span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">% </span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,963&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,558&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">405&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(350)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(508)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">784&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(16,327)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,111&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">n/m</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income (loss), net</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,397&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11,277)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,674&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">n/m</span></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">n/m = Not meaningful</span></div><div><span><br/></span></div><div><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">For the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">three months ended March 31, 2026, the</span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">decrease in other income (loss), net compared to the prior period related to our loss on disposal of Exscientia GmbH and our Vienna lease termination for the three months ended March 31, 2025.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><div id="icf34ee3be70a44349aaa73f1b5df5e08_97"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf34ee3be70a44349aaa73f1b5df5e08_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div id="icf34ee3be70a44349aaa73f1b5df5e08_100"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Sources of Liquidity </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have not yet commercialized any products and do not expect to generate revenue from the sales of any product candidates for at least several years. Cash, cash equivalents and restricted cash totaled $665.2 million and $753.9 million as of March&#160;31, 2026 and December&#160;31, 2025, respectively. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have incurred operating losses and experienced negative operating cash flows and we anticipate that the Company will continue to incur losses for at least the foreseeable future. Our net loss was $117.5 million and $202.5 million during the three months ended March 31, 2026 and 2025, respectively. As of March&#160;31, 2026, we had an accumulated deficit of $2.2 billion. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since </span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2024</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we have financed our operations primarily through Class A common stock issuances. As of March&#160;31, 2026, we have received net proceeds of $829.0 million from Class A common stock issuances. See Note 8, &#8220;Common Stock&#8221; to the Condensed Consolidated Financial Statements for additional details on Class A common stock issuances. Additionally, as of March&#160;31, 2026, we have received proceeds of $78.0 million from our strategic partnerships. See Note 9, &#8220;Collaborative Development Contracts&#8221; to the Condensed Consolidated Financial Statements for additional details on the strategic partnerships.</span></div><div><span><br/></span></div><div id="icf34ee3be70a44349aaa73f1b5df5e08_103"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash Flows</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the Condensed Consolidated Statements of Cash Flows for each of the periods presented below: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.274%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.275%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2026</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash used in operating activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81,101)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(131,957)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash used in investing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(338)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,270)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash provided by (used in) financing activities</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,470)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,527&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Operating Activities</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash used by operating activities decreased during the three months ended March 31, 2026 as a result of lower costs incurred for research and development and general and administrative primarily due to improved operating efficiency and the strategic reprioritization of our clinical portfolio.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash used by operating activities increased during the three months ended March 31, 2025 as a result of higher costs incurred for research and development and general and administrative primarily due to the Company&#8217;s acquisition of Exscientia. This included Exscientia GmbH disposal related payments of $9.7 million and severance payments of $6.5 million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Investing Activities</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash used by investing activities during the three months ended March 31, 2026 was not significant. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash used by investing activities during the three months ended March 31, 2025 consisted of the disposal of Exscientia GmbH of $4.4&#160;million and property and equipment purchases of $1.8&#160;million. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Financing Activities </span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash used by financing activities during the three months ended March 31, 2026 primarily included repayment of long-term debt and financing lease liabilities of $2.2&#160;million from common stock issuances. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash provided by financing activities during the three months ended March 31, 2025 primarily included proceeds of $41.0 million from common stock issuances. Financing outflows included a $1.6 million payment for the purchase of an intangible asset that was not soon after the purchase. </span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><div id="icf34ee3be70a44349aaa73f1b5df5e08_106"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf34ee3be70a44349aaa73f1b5df5e08_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Estimates and Policies </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the Company&#8217;s significant accounting estimates and policies is included in Note 2, &#8220;Summary of Significant Accounting Policies&#8221; in our 2025 Annual Report. There were no significant changes in the Company&#8217;s application of its critical accounting policies during the three months ended March 31, 2026.</span></div><div><span><br/></span></div><div id="icf34ee3be70a44349aaa73f1b5df5e08_109"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Issued and Adopted Accounting Pronouncements</span></div><div><span><br/></span></div><div><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 2, &#8220;Basis of Presentation</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; in Item 1 of this Quarterly Report on Form 10-Q</span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for information regarding recently issued and adopted accounting pronouncements. </span></div><div><span><br/></span></div><div id="icf34ee3be70a44349aaa73f1b5df5e08_112"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3. Quantitative and Qualitative Disclosures About Market Risk.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Risk</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to market risk related to changes in interest rates on our investment portfolio of cash and cash equivalents. As of March&#160;31, 2026, our cash and cash equivalents consisted of money market funds. Our primary exposure to market risk is interest income sensitivity, which is affected by changes in interest rates. A hypothetical 100 basis point decrease in interest rates as of</span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March&#160;31, 2026</span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">would have an insignificant effect on net loss in the ensuing year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Exchange Risk</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our employees and our operations are primarily located in the United States, United Kingdom and Canada and our expenses are primarily denominated in U.S. dollars, Great British pounds and Canadian dollars. We also have entered into a limited number of contracts with vendors for research and development services that have underlying payment obligations denominated in foreign currencies. We are subject to foreign currency transaction gains or losses on our contracts denominated in foreign currencies. To date, foreign currency transaction gains and losses have not been material to our financial statements and we do not have a formal hedging program with respect to foreign currency. A 10% increase or decrease in current exchange rates would have an insignificant effect on our financial results during the three and three months ended March 31, 2026 and 2025.</span></div><div><span><br/></span></div><div id="icf34ee3be70a44349aaa73f1b5df5e08_115"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4. Controls and Procedures.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has established disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the Exchange Act)) designed to provide reasonable assurance that information required to be disclosed in the reports that the Company files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC&#8217;s rules and forms and is accumulated and communicated to management, including the principal executive officer (our Chief Executive Officer) and principal financial officer (our Chief Financial Officer), to allow timely decisions regarding required disclosure. In addition, the design of disclosure controls and procedures must reflect the fact that there are resource constraints and that management is required to apply judgment in evaluating the benefits of possible controls and procedures relative to their costs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management has evaluated, with the participation of our Chief Executive Officer and Chief Financial Officer, the effectiveness of our disclosure controls and procedures as of the end of the period covered by this report. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives as management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Our disclosure controls and procedures have been designed to provide reasonable assurance of achieving their objectives. Based on that evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that, as of March&#160;31, 2026, our disclosure controls and procedures were ineffective due to the material weaknesses in internal control over financial reporting disclosed in Part II, Item 9A of our Annual Report on Form 10-K for the year ended December 31, 2025.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf34ee3be70a44349aaa73f1b5df5e08_7">Table of Contents</a></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Remediation of Material Weaknesses</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The following remediation actions have been taken as of March&#160;31, 2026 related to the material weaknesses for the acquired Exscientia business:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We have designed and implemented certain information technology general controls and are in the process of implementing additional information technology general controls within the Exscientia business, including controls over the maintenance of appropriate segregation of duties, controls over change management and controls over program development and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We have designed and implemented certain processes and controls to appropriately analyze, record and disclose accounting matters timely and accurately while maintaining appropriate segregation of duties and are in the process of implementing others.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We completed an implementation of a new enterprise resource planning ("ERP") system and a Purchase to Pay (P2P) system. In the process of deploying these new systems, we designed and implemented new, or otherwise enhanced existing, internal control activities to complement operational and administrative process changes required to support the functionality of our new ERP and P2P systems.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the remediation actions described above, we are in the process of integrating Exscientia&#8217;s operations into our overall system of internal control over financial reporting.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe the above actions will be effective in remediating the material weaknesses described above. However, the material weaknesses cannot be considered remediated until controls operate for a sufficient period of time and management has concluded, through testing, that these controls are operating effectively. As such, we were unable to conclude that the material weaknesses have been remediated as of March&#160;31, 2026.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in Internal Control Over Financial Reporting</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2026, management implemented  new ERP and P2P systems, replacing legacy systems that had supported a significant portion of our transaction origination, processing and recording. We updated our internal control over financial reporting to accommodate related changes in our financial management processes resulting from these implementations. While management believes that these new systems will ultimately enhance the effectiveness of its internal control over financial reporting, there are inherent risks in implementing new ERP and P2P systems. Accordingly, we will continue to evaluate the design and operating effectiveness of controls impacted by these system implementations. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, management is in the process of integrating the internal controls of the acquired business (Exscientia) into Recursion's existing operations as part of planned integration activities. There were no other changes in internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during the quarter ended March&#160;31, 2026 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><div id="icf34ee3be70a44349aaa73f1b5df5e08_118"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf34ee3be70a44349aaa73f1b5df5e08_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II - OTHER INFORMATION</span></div><div><span><br/></span></div><div id="icf34ee3be70a44349aaa73f1b5df5e08_121"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1. Legal Proceedings.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may, from time to time, be involved in various legal proceedings arising in the normal course of business. An unfavorable resolution of any such matter could materially affect the Company&#8217;s future financial position, results of operations or cash flows. For more information pertaining to legal proceedings, see Part I, Item 1, Note 7, &#8220;Commitments and Contingencies,&#8221; which is incorporated herein by reference.</span></div><div><span><br/></span></div><div id="icf34ee3be70a44349aaa73f1b5df5e08_124"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1A. Risk Factors.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investing in our common stock involves a high degree of risk. For a detailed discussion of the risks that affect our business. Please refer to the section titled Part I, Item 1A. &#8220;Risk Factors&#8221; of our 2025 Annual Report.</span></div><div><span><br/></span></div><div id="icf34ee3be70a44349aaa73f1b5df5e08_127"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(a) Sales of Unregistered Securities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Stock Option Exercises</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March 31, 2026, we issued 4,800 shares of our Class A common stock to our employees, directors, advisors and consultants upon the exercise of stock options under our Key Personnel Incentive Stock Plan for aggregate consideration of approximately $2 thousand, in reliance on the exemption provided by Rule 701(b)(2) promulgated under the Securities Act, or pursuant to Section 4(a)(2) under the Securities Act, relative to transactions by an issuer not involving any public offering, to the extent an exemption from such registration was required. All recipients either received adequate information about our company or had access, through employment or other relationships, to such information.</span></div><div><span><br/></span></div><div id="icf34ee3be70a44349aaa73f1b5df5e08_130"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5. <ix:nonNumeric contextRef="c-1" name="ecd:Rule10b51ArrTrmntdFlag" format="ixt:fixed-false" id="f-549"><ix:nonNumeric contextRef="c-1" name="ecd:NonRule10b51ArrTrmntdFlag" format="ixt:fixed-false" id="f-550"><ix:nonNumeric contextRef="c-1" name="ecd:NonRule10b51ArrAdoptedFlag" format="ixt:fixed-false" id="f-551">Other Information</ix:nonNumeric></ix:nonNumeric></ix:nonNumeric>.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="c-129" name="ecd:MtrlTermsOfTrdArrTextBlock" id="f-552" escape="true"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On <ix:nonNumeric contextRef="c-129" name="ecd:TrdArrAdoptionDate" id="f-553">March 3, 2026</ix:nonNumeric>, <ix:nonNumeric contextRef="c-129" name="ecd:TrdArrIndName" id="f-554">Namandj&#233; Bumpus</ix:nonNumeric>, <ix:nonNumeric contextRef="c-129" name="ecd:TrdArrIndTitle" id="f-555">a member of our Board of Directors</ix:nonNumeric>, <ix:nonNumeric contextRef="c-129" name="ecd:Rule10b51ArrAdoptedFlag" format="ixt:fixed-true" id="f-556">adopted</ix:nonNumeric> a Rule 10b5-1 trading arrangement that is intended to satisfy the affirmative defense of Rule 10b5-1(c) for the potential sale of up to <ix:nonFraction unitRef="shares" contextRef="c-130" decimals="INF" name="ecd:TrdArrSecuritiesAggAvailAmt" format="ixt:num-dot-decimal" scale="0" id="f-557">12,735</ix:nonFraction> shares of the Company&#8217;s Class A common stock until <ix:nonNumeric contextRef="c-129" name="ecd:TrdArrExpirationDate" id="f-558">June&#160;2, 2027</ix:nonNumeric></span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div></ix:nonNumeric><div><span><br/></span></div><div><span><br/></span></div><div id="icf34ee3be70a44349aaa73f1b5df5e08_136"></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6. Exhibits.</span></div><div><span><br/></span></div><div><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibit Index:</span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:40.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.356%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.332%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.259%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Incorporated by Reference</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit number</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Form</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">File No.</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit No. </span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Filing Date</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Filed / Furnished Herewith</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.1*</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1601830/000119312524196505/d856792dex21.htm">Transaction Agreement by and between Recursion Pharmaceuticals, Inc. and Exscientia plc dated as of August 8, 2024.</a></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-40323</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">August 8, 2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0001601830/000119312521123764/d149444dex31.htm">Amended and Restated Certificate of Incorporation of Recursion Pharmaceuticals, Inc.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-40323</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">April 21, 2021</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1601830/000160183024000009/a1-25x24amendedbylaws.htm">Amended and Restated Bylaws of Recursion Pharmaceuticals, Inc.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-40323</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">January 31, 2024</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0001601830/000119312521089610/d89478dex42.htm">Specimen Class A common stock certificate of the Registrant.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">S-1/A</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">333-254576</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">April 15, 2021</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1601830/000160183023000036/exhibit42-valencexexchange.htm">Exchangeable Share Support Agreement, dated May 8, 2023.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">S-3ASR</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">333-272281</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 30, 2023</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.3</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1601830/000119312522268003/d365090dex102.htm">Registration Rights Agreement, dated October 24, 2022, by and among the Company and the Purchasers.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-40323</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">October 25, 2022</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.4</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1601830/000160183023000036/exhibit43-valencexregistra.htm">Registration Agreement, dated May 16, 2023, by and among the Registrant, Valence Discovery, Inc., and certain shareholders of Valence Discovery, Inc.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">S-3ASR</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">333-272281</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.3</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 30, 2023</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.5</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1601830/000160183023000044/exhibit41registrationagree.htm">Registration Agreement, dated May 25, 2023, by and among the Registrant, Recursion Canada Inc., and certain shareholders of Cyclica Inc.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-40323</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">June 9, 2023</span></td><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf34ee3be70a44349aaa73f1b5df5e08_7">Table of Contents</a></span></div></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:40.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.356%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.332%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.259%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.6</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1601830/000160183023000050/ex102-rxrxxnvidiaregrights.htm">Registration Rights Agreement, dated July 11, 2023, by and among the Registrant and NVIDIA.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-40323</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">July 12. 2023</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.1&#x5E;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1601830/000160183026000039/exhibit1035-tdcowenagreeme.htm">Sales Agreement dated February 25, 2026 by and between the Registrant and TD Securities (USA), LLC</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1601830/000160183026000039/exhibit1035-tdcowenagreeme.htm">.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10-K</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-40323</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.35</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 25, 2026</span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit311-q0126.htm">Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit312-q0126.htm">Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32.1**</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit321-q0126.htm">Certification of Principal Executive Officer and Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XBRL Instance Document</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Schema Document</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Calculation Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Definition Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Label Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;101.PRE</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Presentation Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">X</span></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">+</span></td><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indicates a management contract or compensatory plan.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#x5E;</span></div></td><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Certain schedules and exhibits have been omitted pursuant to Item 601(a)(5) of Regulation S-K. A copy of any omitted schedule and/or exhibit will be furnished to the SEC upon request.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibits and/or schedules have been omitted pursuant to Item 601(a)(5) of Regulation S-K. The registrant hereby undertakes to furnish supplementally copies of any of the omitted exhibits and schedules upon request by the SEC; provided, however, that the registrant may request confidential treatment pursuant to Rule 24b-2 under the Exchange Act for any exhibits or schedules so furnished.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The certifications furnished in Exhibit 32.1 hereto are deemed to accompany this Quarterly Report on Form 10-Q and will not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended. Such certifications will not be deemed to be incorporated by reference into any filings under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, except to the extent that the Registrant specifically incorporates it by reference. </span></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="18" style="padding:0 1pt"/></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><div id="icf34ee3be70a44349aaa73f1b5df5e08_139"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#icf34ee3be70a44349aaa73f1b5df5e08_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized on May&#160;6, 2026. </span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.444%"><tr><td style="width:1.0%"/><td style="width:7.781%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:88.704%"/><td style="width:0.1%"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">RECURSION PHARMACEUTICALS, INC.</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">By:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">/s/ Najat Khan</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Najat Khan</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Chief Executive Officer</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(Principal Executive Officer)</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">/s/ Ben Taylor</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Ben Taylor</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Chief Financial Officer</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(Principal Financial and Accounting Officer)</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="margin-top:12pt;text-indent:30.6pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>exhibit311-q0126.htm
<DESCRIPTION>EX-31.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2026 Workiva -->
<title>Document</title></head><body><div id="i399bded994084588b5fc6b65ce9a2581_1"></div><div style="min-height:63pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification of Principal Executive Officer</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Rules 13a-14(a) and 15d-14(a) of the Securities Exchange Act of 1934, as amended</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Najat Khan, certify that&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.  I have reviewed this Quarterly Report on Form 10-Q of Recursion Pharmaceuticals, Inc.&#59;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4. The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5. The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:68.589%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Najat Khan</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Najat Khan, Chief Executive Officer (principal executive officer)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; May&#160;6, 2026</font></div></td></tr></table></div><div><font><br></font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>exhibit312-q0126.htm
<DESCRIPTION>EX-31.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2026 Workiva -->
<title>Document</title></head><body><div id="ic965fd066510460c9867c44141ab87f7_1"></div><div style="min-height:63pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification of Principal Financial Officer</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Rules 13a-14(a) and 15d-14(a) of the Securities Exchange Act of 1934, as amended</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Ben Taylor, certify that&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1. I have reviewed this Quarterly Report on Form 10-Q of Recursion Pharmaceuticals, Inc.&#59;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4. The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5. The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:58.173%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Ben Taylor</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ben Taylor, Chief Financial Officer (principal financial officer)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; May&#160;6, 2026</font></div></td></tr></table></div><div><font><br></font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>exhibit321-q0126.htm
<DESCRIPTION>EX-32.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2026 Workiva -->
<title>Document</title></head><body><div id="i81e1b1dfd97a4599b551a5dffa7d3410_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.1</font></div></div><div style="text-align:right"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certifications of Principal Executive Officer and Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Quarterly Report of Recursion Pharmaceuticals, Inc. (the &#8220;Company&#8221;) on Form 10-Q for the period ended March&#160;31, 2026 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), The undersigned certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended&#59; and</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:69.711%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Najat Khan</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Najat Khan, Chief Executive Officer (principal executive officer)</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Ben Taylor</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ben Taylor, Chief Financial Officer (principal financial officer)</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; May&#160;6, 2026</font></div></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>rxrx-20260331.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019c9ac1-acf5-79ea-ae98-b958c721a179,g:9f615d00-f48b-491d-8614-00e244a2e814-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:rxrx="http://www.recursion.com/20260331" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.recursion.com/20260331">
  <xs:import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2024-01-31" schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/ecd/2025" schemaLocation="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="rxrx-20260331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="rxrx-20260331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="rxrx-20260331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="rxrx-20260331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.recursion.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetsunaudited" roleURI="http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited">
        <link:definition>9952151 - Statement - Condensed Consolidated Balance Sheets (unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetsunauditedParenthetical" roleURI="http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunauditedParenthetical">
        <link:definition>9952152 - Statement - Condensed Consolidated Balance Sheets (unaudited) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofOperationsunaudited" roleURI="http://www.recursion.com/role/CondensedConsolidatedStatementsofOperationsunaudited">
        <link:definition>9952153 - Statement - Condensed Consolidated Statements of Operations (unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofComprehensiveLossunaudited" roleURI="http://www.recursion.com/role/CondensedConsolidatedStatementsofComprehensiveLossunaudited">
        <link:definition>9952154 - Statement - Condensed Consolidated Statements of Comprehensive Loss (unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofStockholdersEquityunaudited" roleURI="http://www.recursion.com/role/CondensedConsolidatedStatementsofStockholdersEquityunaudited">
        <link:definition>9952155 - Statement - Condensed Consolidated Statements of Stockholders&#8217; Equity (unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofCashFlowsunaudited" roleURI="http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited">
        <link:definition>9952156 - Statement - Condensed Consolidated Statements of Cash Flows (unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DescriptionoftheBusiness" roleURI="http://www.recursion.com/role/DescriptionoftheBusiness">
        <link:definition>9952157 - Disclosure - Description of the Business</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentation" roleURI="http://www.recursion.com/role/BasisofPresentation">
        <link:definition>9952158 - Disclosure - Basis of Presentation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalFinancialInformation" roleURI="http://www.recursion.com/role/SupplementalFinancialInformation">
        <link:definition>9952159 - Disclosure - Supplemental Financial Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Acquisitions" roleURI="http://www.recursion.com/role/Acquisitions">
        <link:definition>9952160 - Disclosure - Acquisitions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://www.recursion.com/role/Leases">
        <link:definition>9952161 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssets" roleURI="http://www.recursion.com/role/GoodwillandIntangibleAssets">
        <link:definition>9952162 - Disclosure - Goodwill and Intangible Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://www.recursion.com/role/CommitmentsandContingencies">
        <link:definition>9952163 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommonStock" roleURI="http://www.recursion.com/role/CommonStock">
        <link:definition>9952164 - Disclosure - Common Stock</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborativeDevelopmentContracts" roleURI="http://www.recursion.com/role/CollaborativeDevelopmentContracts">
        <link:definition>9952165 - Disclosure - Collaborative Development Contracts</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensation" roleURI="http://www.recursion.com/role/StockBasedCompensation">
        <link:definition>9952166 - Disclosure - Stock-Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.recursion.com/role/IncomeTaxes">
        <link:definition>9952167 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerShare" roleURI="http://www.recursion.com/role/NetLossPerShare">
        <link:definition>9952168 - Disclosure - Net Loss Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://www.recursion.com/role/FairValueMeasurements">
        <link:definition>9952169 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformation" roleURI="http://www.recursion.com/role/SegmentInformation">
        <link:definition>9952170 - Disclosure - Segment Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationPolicies" roleURI="http://www.recursion.com/role/BasisofPresentationPolicies">
        <link:definition>9955511 - Disclosure - Basis of Presentation (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalFinancialInformationTables" roleURI="http://www.recursion.com/role/SupplementalFinancialInformationTables">
        <link:definition>9955512 - Disclosure - Supplemental Financial Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://www.recursion.com/role/LeasesTables">
        <link:definition>9955513 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsTables" roleURI="http://www.recursion.com/role/GoodwillandIntangibleAssetsTables">
        <link:definition>9955514 - Disclosure - Goodwill and Intangible Assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationTables" roleURI="http://www.recursion.com/role/StockBasedCompensationTables">
        <link:definition>9955515 - Disclosure - Stock-Based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerShareTables" roleURI="http://www.recursion.com/role/NetLossPerShareTables">
        <link:definition>9955516 - Disclosure - Net Loss Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://www.recursion.com/role/FairValueMeasurementsTables">
        <link:definition>9955517 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationTables" roleURI="http://www.recursion.com/role/SegmentInformationTables">
        <link:definition>9955518 - Disclosure - Segment Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DescriptionoftheBusinessDetails" roleURI="http://www.recursion.com/role/DescriptionoftheBusinessDetails">
        <link:definition>9955519 - Disclosure - Description of the Business (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalFinancialInformationNarrativeDetails" roleURI="http://www.recursion.com/role/SupplementalFinancialInformationNarrativeDetails">
        <link:definition>9955520 - Disclosure - Supplemental Financial Information - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalFinancialInformationScheduleofAccruedExpensesandOtherLiabilitiesDetails" roleURI="http://www.recursion.com/role/SupplementalFinancialInformationScheduleofAccruedExpensesandOtherLiabilitiesDetails">
        <link:definition>9955521 - Disclosure - Supplemental Financial Information - Schedule of Accrued Expenses and Other Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalFinancialInformationScheduleofInterestIncomeNetDetails" roleURI="http://www.recursion.com/role/SupplementalFinancialInformationScheduleofInterestIncomeNetDetails">
        <link:definition>9955522 - Disclosure - Supplemental Financial Information - Schedule of Interest Income, Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsNarrativeDetails" roleURI="http://www.recursion.com/role/AcquisitionsNarrativeDetails">
        <link:definition>9955523 - Disclosure - Acquisitions - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesNarrativeDetails" roleURI="http://www.recursion.com/role/LeasesNarrativeDetails">
        <link:definition>9955524 - Disclosure - Leases - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesScheduleofSupplementalCashFlowInformationRelatedtoLeasesDetails" roleURI="http://www.recursion.com/role/LeasesScheduleofSupplementalCashFlowInformationRelatedtoLeasesDetails">
        <link:definition>9955525 - Disclosure - Leases - Schedule of Supplemental Cash Flow Information Related to Leases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsScheduleofChangesintheCarryingAmountofGoodwillDetails" roleURI="http://www.recursion.com/role/GoodwillandIntangibleAssetsScheduleofChangesintheCarryingAmountofGoodwillDetails">
        <link:definition>9955526 - Disclosure - Goodwill and Intangible Assets - Schedule of Changes in the Carrying Amount of Goodwill (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsNarrativeDetails" roleURI="http://www.recursion.com/role/GoodwillandIntangibleAssetsNarrativeDetails">
        <link:definition>9955527 - Disclosure - Goodwill and Intangible Assets - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsScheduleofIntangibleassetsDetails" roleURI="http://www.recursion.com/role/GoodwillandIntangibleAssetsScheduleofIntangibleassetsDetails">
        <link:definition>9955528 - Disclosure - Goodwill and Intangible Assets - Schedule of Intangible assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsScheduleofIntangibleassetsDetails_1" roleURI="http://www.recursion.com/role/GoodwillandIntangibleAssetsScheduleofIntangibleassetsDetails_1">
        <link:definition>9955528 - Disclosure - Goodwill and Intangible Assets - Schedule of Intangible assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesDetails" roleURI="http://www.recursion.com/role/CommitmentsandContingenciesDetails">
        <link:definition>9955529 - Disclosure - Commitments and Contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommonStockNarrativeDetails" roleURI="http://www.recursion.com/role/CommonStockNarrativeDetails">
        <link:definition>9955530 - Disclosure - Common Stock - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommonStockAtTheMarketOfferingNarrativeDetails" roleURI="http://www.recursion.com/role/CommonStockAtTheMarketOfferingNarrativeDetails">
        <link:definition>9955531 - Disclosure - Common Stock - At-The-Market Offering (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommonStockValenceAcquisitionExchangeableSharesNarrativeDetails" roleURI="http://www.recursion.com/role/CommonStockValenceAcquisitionExchangeableSharesNarrativeDetails">
        <link:definition>9955532 - Disclosure - Common Stock - Valence Acquisition Exchangeable Shares (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommonStockRegistrationRightsAgreementsNarrativeDetails" roleURI="http://www.recursion.com/role/CommonStockRegistrationRightsAgreementsNarrativeDetails">
        <link:definition>9955533 - Disclosure - Common Stock - Registration Rights Agreements (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommonStockClassAandBCommonSharesAuthorizationNarrativeDetails" roleURI="http://www.recursion.com/role/CommonStockClassAandBCommonSharesAuthorizationNarrativeDetails">
        <link:definition>9955534 - Disclosure - Common Stock - Class A and B Common Shares Authorization (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborativeDevelopmentContractsDetails" roleURI="http://www.recursion.com/role/CollaborativeDevelopmentContractsDetails">
        <link:definition>9955535 - Disclosure - Collaborative Development Contracts (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationNarrativeDetails" roleURI="http://www.recursion.com/role/StockBasedCompensationNarrativeDetails">
        <link:definition>9955536 - Disclosure - Stock-Based Compensation - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationScheduleofStockBasedCompensationExpenseDetails" roleURI="http://www.recursion.com/role/StockBasedCompensationScheduleofStockBasedCompensationExpenseDetails">
        <link:definition>9955537 - Disclosure - Stock-Based Compensation - Schedule of Stock-Based Compensation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationScheduleofRSUActivityDetails" roleURI="http://www.recursion.com/role/StockBasedCompensationScheduleofRSUActivityDetails">
        <link:definition>9955538 - Disclosure - Stock-Based Compensation - Schedule of RSU Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDetails" roleURI="http://www.recursion.com/role/IncomeTaxesDetails">
        <link:definition>9955539 - Disclosure - Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerShareScheduleofComputationofBasicandDilutedNetLossPerShareDetails" roleURI="http://www.recursion.com/role/NetLossPerShareScheduleofComputationofBasicandDilutedNetLossPerShareDetails">
        <link:definition>9955540 - Disclosure - Net Loss Per Share - Schedule of Computation of Basic and Diluted Net Loss Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofNetLossPerShareDetails" roleURI="http://www.recursion.com/role/NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofNetLossPerShareDetails">
        <link:definition>9955541 - Disclosure - Net Loss Per Share - Schedule of Antidilutive Securities Excluded from Computation of Net Loss Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" roleURI="http://www.recursion.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails">
        <link:definition>9955542 - Disclosure - Fair Value Measurements - Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsScheduleofFinancialInstrumentsNotMeasuredatFairValueDetails" roleURI="http://www.recursion.com/role/FairValueMeasurementsScheduleofFinancialInstrumentsNotMeasuredatFairValueDetails">
        <link:definition>9955543 - Disclosure - Fair Value Measurements - Schedule of Financial Instruments Not Measured at Fair Value (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationNarrativeDetails" roleURI="http://www.recursion.com/role/SegmentInformationNarrativeDetails">
        <link:definition>9955544 - Disclosure - Segment Information - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationScheduleofSegmentNetLossandReconciliationsofSegmentOperatingLosstoLossBeforeIncomeTaxBenefitDetails" roleURI="http://www.recursion.com/role/SegmentInformationScheduleofSegmentNetLossandReconciliationsofSegmentOperatingLosstoLossBeforeIncomeTaxBenefitDetails">
        <link:definition>9955545 - Disclosure - Segment Information - Schedule of Segment Net Loss and Reconciliations of Segment Operating Loss to Loss Before Income Tax Benefit (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="rxrx_ExchangeableStockMember" abstract="true" name="ExchangeableStockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rxrx_IncreaseDecreaseInPrepaidDataAssets" abstract="false" name="IncreaseDecreaseInPrepaidDataAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rxrx_IncreaseDecreaseInAccruedDevelopmentExpense" abstract="false" name="IncreaseDecreaseInAccruedDevelopmentExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rxrx_IncreaseDecreaseInLeaseLiability" abstract="false" name="IncreaseDecreaseInLeaseLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rxrx_ProceedsFromPaymentForShareBasedPaymentArrangement" abstract="false" name="ProceedsFromPaymentForShareBasedPaymentArrangement" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rxrx_PurchaseOfAnEquityInvestmentNonCash" abstract="false" name="PurchaseOfAnEquityInvestmentNonCash" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rxrx_SupplementalFinancialInformationAbstract" abstract="true" name="SupplementalFinancialInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="rxrx_SupplementalBalanceSheetAndIncomeStatementInformationTextBlock" abstract="false" name="SupplementalBalanceSheetAndIncomeStatementInformationTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="rxrx_TempusLabsIncMember" abstract="true" name="TempusLabsIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rxrx_LicenseAgreementTerm" abstract="false" name="LicenseAgreementTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="rxrx_LicenseAgreementAnnualPayments" abstract="false" name="LicenseAgreementAnnualPayments" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rxrx_LicenseAgreementAggregatePayments" abstract="false" name="LicenseAgreementAggregatePayments" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rxrx_LicenseAgreementTradingPeriodUsedForEquityValueDetermination" abstract="false" name="LicenseAgreementTradingPeriodUsedForEquityValueDetermination" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="rxrx_LicenseAgreementAmountOfTimePriorToThePaymentDate" abstract="false" name="LicenseAgreementAmountOfTimePriorToThePaymentDate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="rxrx_LicenseAgreementIncreaseDecreaseAccruedLiabilities" abstract="false" name="LicenseAgreementIncreaseDecreaseAccruedLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rxrx_AccruedComputeLiabilitiesCurrent" abstract="false" name="AccruedComputeLiabilitiesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rxrx_AccruedDevelopmentCostsCurrent" abstract="false" name="AccruedDevelopmentCostsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rxrx_AccruedEarlyDiscoveryExpensesCurrent" abstract="false" name="AccruedEarlyDiscoveryExpensesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rxrx_MaterialsReceivedNotInvoiced" abstract="false" name="MaterialsReceivedNotInvoiced" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rxrx_AccruedLicenseFeeCurrent" abstract="false" name="AccruedLicenseFeeCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rxrx_REVenturesIMember" abstract="true" name="REVenturesIMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rxrx_AlphaBiotechnologyGmbHAlphaMember" abstract="true" name="AlphaBiotechnologyGmbHAlphaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rxrx_ExscientiaGmbHMember" abstract="true" name="ExscientiaGmbHMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rxrx_AssetAcquisitionEquityOwnershipPercentage" abstract="false" name="AssetAcquisitionEquityOwnershipPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="rxrx_IncreaseDecreaseInOperatingLeaseRightOfUseAssets" abstract="false" name="IncreaseDecreaseInOperatingLeaseRightOfUseAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rxrx_LesseeOperatingLeaseIncreaseDecreaseInOperatingLeaseLiabilityDueToLeaseModifications" abstract="false" name="LesseeOperatingLeaseIncreaseDecreaseInOperatingLeaseLiabilityDueToLeaseModifications" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rxrx_CashPaidForAmountIncludedInTheMeasurementOfLeaseLiabilitiesAbstract" abstract="true" name="CashPaidForAmountIncludedInTheMeasurementOfLeaseLiabilitiesAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="rxrx_RightOfUseAssetsObtainedInExchangeForLeaseLiabilitiesAbstract" abstract="true" name="RightOfUseAssetsObtainedInExchangeForLeaseLiabilitiesAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="rxrx_IntangibleAssetsForeignCurrencyTranslationGainLoss" abstract="false" name="IntangibleAssetsForeignCurrencyTranslationGainLoss" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rxrx_FinanceLeasesAssetsPledgedAsCollateral" abstract="false" name="FinanceLeasesAssetsPledgedAsCollateral" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rxrx_CommonStockVotePerShare" abstract="false" name="CommonStockVotePerShare" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="rxrx_AtTheMarketOfferingProgramTDCowenMember" abstract="true" name="AtTheMarketOfferingProgramTDCowenMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rxrx_SaleOfStockValueAuthorized" abstract="false" name="SaleOfStockValueAuthorized" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rxrx_SaleOfStockValueRemainingAuthorized" abstract="false" name="SaleOfStockValueRemainingAuthorized" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rxrx_ValenceDiscoveryIncMember" abstract="true" name="ValenceDiscoveryIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rxrx_BusinessAcquisitionContingentConsiderationEquityInterestsIssuableNumberOfShares" abstract="false" name="BusinessAcquisitionContingentConsiderationEquityInterestsIssuableNumberOfShares" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="rxrx_RegistrationRightsAgreementTerm" abstract="false" name="RegistrationRightsAgreementTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="rxrx_NumberOfClassesOfCommonStockAuthorized" abstract="false" name="NumberOfClassesOfCommonStockAuthorized" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="rxrx_CommonStockConversionRatio" abstract="false" name="CommonStockConversionRatio" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="rxrx_SanofiMember" abstract="true" name="SanofiMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rxrx_MerckKGaAMerckMember" abstract="true" name="MerckKGaAMerckMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rxrx_RocheAndGenentechMember" abstract="true" name="RocheAndGenentechMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rxrx_MilestoneTypeAxis" abstract="true" name="MilestoneTypeAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="rxrx_MilestoneTypeDomain" abstract="true" name="MilestoneTypeDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rxrx_ResearchMilestonesMember" abstract="true" name="ResearchMilestonesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rxrx_DevelopmentAndRegulatoryMilestonesMember" abstract="true" name="DevelopmentAndRegulatoryMilestonesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rxrx_DiscoveryDevelopmentAndSalesMilestonesMember" abstract="true" name="DiscoveryDevelopmentAndSalesMilestonesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rxrx_RevenueRemainingPerformanceObligationAxis" abstract="true" name="RevenueRemainingPerformanceObligationAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="rxrx_RevenueRemainingPerformanceObligationDomain" abstract="true" name="RevenueRemainingPerformanceObligationDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rxrx_PhenomapsCreationMember" abstract="true" name="PhenomapsCreationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rxrx_PhenomapsRawImagesMember" abstract="true" name="PhenomapsRawImagesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rxrx_DevelopedAndCommercializedProgramsMember" abstract="true" name="DevelopedAndCommercializedProgramsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rxrx_GastrointestinalCancerMember" abstract="true" name="GastrointestinalCancerMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rxrx_NeuroscienceMember" abstract="true" name="NeuroscienceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rxrx_ContractWithCustomerNumberOfNovelSmallMoleculeCandidates" abstract="false" name="ContractWithCustomerNumberOfNovelSmallMoleculeCandidates" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="rxrx_RevenuePerformanceObligationNumberOfObligations" abstract="false" name="RevenuePerformanceObligationNumberOfObligations" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="rxrx_RevenueRemainingPerformanceObligationVariableConsiderationAmount" abstract="false" name="RevenueRemainingPerformanceObligationVariableConsiderationAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rxrx_ContractWithCustomerMaximumAcceptedProduct" abstract="false" name="ContractWithCustomerMaximumAcceptedProduct" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="rxrx_RevenueRemainingPerformanceObligationNumberOfProjectsThatMayBeInitiated" abstract="false" name="RevenueRemainingPerformanceObligationNumberOfProjectsThatMayBeInitiated" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="rxrx_A2021EquityIncentivePlanMember" abstract="true" name="A2021EquityIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rxrx_A2024InducementEquityIncentivePlanMember" abstract="true" name="A2024InducementEquityIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rxrx_TempusAgreementMember" abstract="true" name="TempusAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rxrx_RestrictedCashAndCashEquivalentsFairValueDisclosure" abstract="false" name="RestrictedCashAndCashEquivalentsFairValueDisclosure" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rxrx_ReportableSegmentMember" abstract="true" name="ReportableSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rxrx_SignificantSegmentExpensesAbstract" abstract="true" name="SignificantSegmentExpensesAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="rxrx_ConsumableExpense" abstract="false" name="ConsumableExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rxrx_PlatformFeeExpense" abstract="false" name="PlatformFeeExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rxrx_DiscoveryExpense" abstract="false" name="DiscoveryExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rxrx_ClinicalDevelopmentExpense" abstract="false" name="ClinicalDevelopmentExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rxrx_SupplementalAssetInformationAbstract" abstract="true" name="SupplementalAssetInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="rxrx_NamandjeBumpusMember" abstract="true" name="NamandjeBumpusMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>6
<FILENAME>rxrx-20260331_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019c9ac1-acf5-79ea-ae98-b958c721a179,g:9f615d00-f48b-491d-8614-00e244a2e814-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="https://xbrl.org/2023/arcrole/summation-item" xlink:type="simple" xlink:href="https://www.xbrl.org/2023/calculation-1.1.xsd#summation-item"/>
  <link:roleRef roleURI="http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited" xlink:type="simple" xlink:href="rxrx-20260331.xsd#CondensedConsolidatedBalanceSheetsunaudited"/>
  <link:calculationLink xlink:role="http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_019c9ac1-adb4-7c5a-8ac6-c2d5237298cd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_019c9ac1-adb4-75ea-8164-0e62f3c33919" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_019c9ac1-adb4-7c5a-8ac6-c2d5237298cd" xlink:to="loc_us-gaap_LiabilitiesCurrent_019c9ac1-adb4-75ea-8164-0e62f3c33919" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_019c9ac1-adb4-73e4-b82b-fe21111aeaba" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_019c9ac1-adb4-7c5a-8ac6-c2d5237298cd" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_019c9ac1-adb4-73e4-b82b-fe21111aeaba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_019c9ac1-adb4-7f1f-85af-adb0159ded20" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_019c9ac1-adb4-7c5a-8ac6-c2d5237298cd" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_019c9ac1-adb4-7f1f-85af-adb0159ded20" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_019c9ac1-adb4-7643-97a4-f8903c7802d8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_019c9ac1-adb4-7c5a-8ac6-c2d5237298cd" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_019c9ac1-adb4-7643-97a4-f8903c7802d8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_019c9ac1-adb4-7559-b8b5-6765d16f8061" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_019c9ac1-adb4-7c5a-8ac6-c2d5237298cd" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_019c9ac1-adb4-7559-b8b5-6765d16f8061" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_019c9ac1-adb4-7203-9810-54418d0bb75d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_019c9ac1-adb4-7c5a-8ac6-c2d5237298cd" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_019c9ac1-adb4-7203-9810-54418d0bb75d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_019c9ac1-adb4-79ea-9074-fec3f9d3802b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_019c9ac1-adb4-72e0-86b2-95d16cfb9835" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019c9ac1-adb4-79ea-9074-fec3f9d3802b" xlink:to="loc_us-gaap_AdditionalPaidInCapital_019c9ac1-adb4-72e0-86b2-95d16cfb9835" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_019c9ac1-adb4-74d4-8b53-95227443a5f7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019c9ac1-adb4-79ea-9074-fec3f9d3802b" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_019c9ac1-adb4-74d4-8b53-95227443a5f7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_019c9ac1-adb4-774c-b644-5f98ea8f2957" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019c9ac1-adb4-79ea-9074-fec3f9d3802b" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_019c9ac1-adb4-774c-b644-5f98ea8f2957" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_019c9ac1-adb4-7e72-a228-6c14f77d9b44" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019c9ac1-adb4-79ea-9074-fec3f9d3802b" xlink:to="loc_us-gaap_CommonStockValue_019c9ac1-adb4-7e72-a228-6c14f77d9b44" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_019c9ac1-adb4-73a0-b967-29cad941eab7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_019c9ac1-adb4-774c-b37c-1a7a8ff4e474" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_019c9ac1-adb4-73a0-b967-29cad941eab7" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_019c9ac1-adb4-774c-b37c-1a7a8ff4e474" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_019c9ac1-adb4-7ccc-865c-8f7513575c50" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_019c9ac1-adb4-73a0-b967-29cad941eab7" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_019c9ac1-adb4-7ccc-865c-8f7513575c50" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019c9ac1-adb4-722c-a6c0-72f2314adc54" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_019c9ac1-adb4-73a0-b967-29cad941eab7" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019c9ac1-adb4-722c-a6c0-72f2314adc54" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_019c9ac1-adb4-7f94-8374-657ad594c367" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_019c9ac1-adb4-73a0-b967-29cad941eab7" xlink:to="loc_us-gaap_RestrictedCashCurrent_019c9ac1-adb4-7f94-8374-657ad594c367" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_019c9ac1-adb4-7ee8-9923-225f50787e40" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_019c9ac1-adb4-73a0-b967-29cad941eab7" xlink:to="loc_us-gaap_OtherAssetsCurrent_019c9ac1-adb4-7ee8-9923-225f50787e40" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_019c9ac1-adb4-75ee-a1fd-ff17f5910b5f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_019c9ac1-adb4-78dd-a2d9-8274a1215c1d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019c9ac1-adb4-75ee-a1fd-ff17f5910b5f" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_019c9ac1-adb4-78dd-a2d9-8274a1215c1d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_019c9ac1-adb4-79d4-92db-a127483fcfe8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019c9ac1-adb4-75ee-a1fd-ff17f5910b5f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_019c9ac1-adb4-79d4-92db-a127483fcfe8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_019c9ac1-adb4-7fa2-903b-35fa26e77293" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019c9ac1-adb4-75ee-a1fd-ff17f5910b5f" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_019c9ac1-adb4-7fa2-903b-35fa26e77293" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_019c9ac1-adb4-7d5b-95d9-81f7ea2d26c3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019c9ac1-adb4-75ee-a1fd-ff17f5910b5f" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_019c9ac1-adb4-7d5b-95d9-81f7ea2d26c3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_019c9ac1-adb4-7523-850d-a0ac0e194109" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019c9ac1-adb4-75ee-a1fd-ff17f5910b5f" xlink:to="loc_us-gaap_Goodwill_019c9ac1-adb4-7523-850d-a0ac0e194109" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_019c9ac1-adb4-79c9-83bc-bca7942e0e00" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019c9ac1-adb4-75ee-a1fd-ff17f5910b5f" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_019c9ac1-adb4-79c9-83bc-bca7942e0e00" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_019c9ac1-adb4-7f12-aae9-df7347f0358b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019c9ac1-adb4-75ee-a1fd-ff17f5910b5f" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_019c9ac1-adb4-7f12-aae9-df7347f0358b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_019c9ac1-adb4-7012-ba56-b2d2c7a38038" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019c9ac1-adb4-75ee-a1fd-ff17f5910b5f" xlink:to="loc_us-gaap_AssetsCurrent_019c9ac1-adb4-7012-ba56-b2d2c7a38038" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_019c9ac1-adb4-7d31-bdf1-be9cce2a6831" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019c9ac1-adb4-75ee-a1fd-ff17f5910b5f" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_019c9ac1-adb4-7d31-bdf1-be9cce2a6831" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_019c9ac1-adb4-74e7-b34f-ed48e9ea7f2a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_019c9ac1-adb4-7486-9097-40ddfe25c0b5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_019c9ac1-adb4-74e7-b34f-ed48e9ea7f2a" xlink:to="loc_us-gaap_Liabilities_019c9ac1-adb4-7486-9097-40ddfe25c0b5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_019c9ac1-adb4-7d38-b1a2-7774398e1bae" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_019c9ac1-adb4-74e7-b34f-ed48e9ea7f2a" xlink:to="loc_us-gaap_CommitmentsAndContingencies_019c9ac1-adb4-7d38-b1a2-7774398e1bae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_019c9ac1-adb4-76bb-9b29-4c7b8543b466" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_019c9ac1-adb4-74e7-b34f-ed48e9ea7f2a" xlink:to="loc_us-gaap_StockholdersEquity_019c9ac1-adb4-76bb-9b29-4c7b8543b466" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_019c9ac1-adb4-7386-82dd-323e44331c3d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_019c9ac1-adb4-7250-b6f8-832fa6c0ab12" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_019c9ac1-adb4-7386-82dd-323e44331c3d" xlink:to="loc_us-gaap_AccountsPayableCurrent_019c9ac1-adb4-7250-b6f8-832fa6c0ab12" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_019c9ac1-adb4-7d0d-9af1-6606204ca515" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_019c9ac1-adb4-7386-82dd-323e44331c3d" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_019c9ac1-adb4-7d0d-9af1-6606204ca515" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_019c9ac1-adb4-743a-a707-a5d3e887be30" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_019c9ac1-adb4-7386-82dd-323e44331c3d" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_019c9ac1-adb4-743a-a707-a5d3e887be30" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_019c9ac1-adb4-7f93-aa57-0531b1c459f0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_019c9ac1-adb4-7386-82dd-323e44331c3d" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_019c9ac1-adb4-7f93-aa57-0531b1c459f0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_019c9ac1-adb4-72f3-a9b7-500323275a58" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_019c9ac1-adb4-7386-82dd-323e44331c3d" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_019c9ac1-adb4-72f3-a9b7-500323275a58" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/CondensedConsolidatedStatementsofOperationsunaudited" xlink:type="simple" xlink:href="rxrx-20260331.xsd#CondensedConsolidatedStatementsofOperationsunaudited"/>
  <link:calculationLink xlink:role="http://www.recursion.com/role/CondensedConsolidatedStatementsofOperationsunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019c9ac1-adb4-7a6f-9270-c670dd14fdd2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_019c9ac1-adb4-779f-886c-5e0685577d07" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_019c9ac1-adb4-7a6f-9270-c670dd14fdd2" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_019c9ac1-adb4-779f-886c-5e0685577d07" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_019c9ac1-adb4-7360-8508-4450c5b39d6f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_019c9ac1-adb4-7a6f-9270-c670dd14fdd2" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_019c9ac1-adb4-7360-8508-4450c5b39d6f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_019c9ac1-adb4-78a6-babc-19daf4644d54" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019c9ac1-adb4-7d3e-b78c-cadd27d31529" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_019c9ac1-adb4-78a6-babc-19daf4644d54" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019c9ac1-adb4-7d3e-b78c-cadd27d31529" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_019c9ac1-adb4-73e8-978d-6f29030df5bd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostsAndExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_019c9ac1-adb4-78a6-babc-19daf4644d54" xlink:to="loc_us-gaap_CostsAndExpenses_019c9ac1-adb4-73e8-978d-6f29030df5bd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_019c9ac1-adb4-7901-9193-5b3bd4e384d6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_019c9ac1-adb4-7857-9795-32046616cd03" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_019c9ac1-adb4-7901-9193-5b3bd4e384d6" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_019c9ac1-adb4-7857-9795-32046616cd03" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_019c9ac1-adb4-7b1c-8646-0117a1aab336" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_019c9ac1-adb4-7901-9193-5b3bd4e384d6" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_019c9ac1-adb4-7b1c-8646-0117a1aab336" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_019c9ac1-adb4-7439-a572-97fab16f1f4c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_019c9ac1-adb4-7901-9193-5b3bd4e384d6" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_019c9ac1-adb4-7439-a572-97fab16f1f4c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_019c9ac1-adb4-7511-bfce-6f237e239365" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_019c9ac1-adb4-7233-85fa-c9dca4de2c40" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_019c9ac1-adb4-7511-bfce-6f237e239365" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_019c9ac1-adb4-7233-85fa-c9dca4de2c40" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_019c9ac1-adb4-776a-961e-81061b1e6b21" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_019c9ac1-adb4-7511-bfce-6f237e239365" xlink:to="loc_us-gaap_OperatingIncomeLoss_019c9ac1-adb4-776a-961e-81061b1e6b21" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/CondensedConsolidatedStatementsofComprehensiveLossunaudited" xlink:type="simple" xlink:href="rxrx-20260331.xsd#CondensedConsolidatedStatementsofComprehensiveLossunaudited"/>
  <link:calculationLink xlink:role="http://www.recursion.com/role/CondensedConsolidatedStatementsofComprehensiveLossunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_019c9ac1-adb4-76d8-96de-92338d9a6f09" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_019c9ac1-adb4-7481-a418-4de9c0936740" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_019c9ac1-adb4-76d8-96de-92338d9a6f09" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_019c9ac1-adb4-7481-a418-4de9c0936740" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_019c9ac1-adb4-77bd-9af5-df8c47e7817c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019c9ac1-adb4-7130-bdb7-92bdec144f5e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_019c9ac1-adb4-77bd-9af5-df8c47e7817c" xlink:to="loc_us-gaap_NetIncomeLoss_019c9ac1-adb4-7130-bdb7-92bdec144f5e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_019c9ac1-adb4-714f-805a-40542c35cad4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_019c9ac1-adb4-77bd-9af5-df8c47e7817c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_019c9ac1-adb4-714f-805a-40542c35cad4" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited" xlink:type="simple" xlink:href="rxrx-20260331.xsd#CondensedConsolidatedStatementsofCashFlowsunaudited"/>
  <link:calculationLink xlink:role="http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019c9ac1-adb4-7677-b187-9ab7d37e9618" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019c9ac1-adb4-7fb8-beb5-56c9590cac36" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019c9ac1-adb4-7677-b187-9ab7d37e9618" xlink:to="loc_us-gaap_NetIncomeLoss_019c9ac1-adb4-7fb8-beb5-56c9590cac36" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_019c9ac1-adb4-7997-a872-3082e9f3f2ff" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019c9ac1-adb4-7677-b187-9ab7d37e9618" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_019c9ac1-adb4-7997-a872-3082e9f3f2ff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_019c9ac1-adb4-7736-bbef-0ee40a4dfe17" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019c9ac1-adb4-7677-b187-9ab7d37e9618" xlink:to="loc_us-gaap_ShareBasedCompensation_019c9ac1-adb4-7736-bbef-0ee40a4dfe17" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TangibleAssetImpairmentCharges_019c9ac1-adb4-7bd2-9d8f-32584843abbb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TangibleAssetImpairmentCharges"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019c9ac1-adb4-7677-b187-9ab7d37e9618" xlink:to="loc_us-gaap_TangibleAssetImpairmentCharges_019c9ac1-adb4-7bd2-9d8f-32584843abbb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_019c9ac1-adb4-73f7-a628-0a75bfdd5d99" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019c9ac1-adb4-7677-b187-9ab7d37e9618" xlink:to="loc_us-gaap_OperatingLeaseExpense_019c9ac1-adb4-73f7-a628-0a75bfdd5d99" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_019c9ac1-adb4-700c-8dd6-18d2e46a71f1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019c9ac1-adb4-7677-b187-9ab7d37e9618" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_019c9ac1-adb4-700c-8dd6-18d2e46a71f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_019c9ac1-adb4-7a53-9eec-840cf92cbb57" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019c9ac1-adb4-7677-b187-9ab7d37e9618" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_019c9ac1-adb4-7a53-9eec-840cf92cbb57" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_019c9ac1-adb4-7602-815a-baf2c25015c7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019c9ac1-adb4-7677-b187-9ab7d37e9618" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_019c9ac1-adb4-7602-815a-baf2c25015c7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_IncreaseDecreaseInPrepaidDataAssets_019c9ac1-adb4-7cd2-9253-2614b90d2b76" xlink:href="rxrx-20260331.xsd#rxrx_IncreaseDecreaseInPrepaidDataAssets"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019c9ac1-adb4-7677-b187-9ab7d37e9618" xlink:to="loc_rxrx_IncreaseDecreaseInPrepaidDataAssets_019c9ac1-adb4-7cd2-9253-2614b90d2b76" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_019c9ac1-adb4-7e79-a3ad-2d7a15a1768b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019c9ac1-adb4-7677-b187-9ab7d37e9618" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_019c9ac1-adb4-7e79-a3ad-2d7a15a1768b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_019c9ac1-adb4-701e-91d1-37bcf75c9244" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019c9ac1-adb4-7677-b187-9ab7d37e9618" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_019c9ac1-adb4-701e-91d1-37bcf75c9244" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_IncreaseDecreaseInAccruedDevelopmentExpense_019c9ac1-adb4-76a4-9140-0ccaa8263807" xlink:href="rxrx-20260331.xsd#rxrx_IncreaseDecreaseInAccruedDevelopmentExpense"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019c9ac1-adb4-7677-b187-9ab7d37e9618" xlink:to="loc_rxrx_IncreaseDecreaseInAccruedDevelopmentExpense_019c9ac1-adb4-76a4-9140-0ccaa8263807" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities_019c9ac1-adb4-7b64-8409-3d608c5b89e5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOtherAccruedLiabilities"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019c9ac1-adb4-7677-b187-9ab7d37e9618" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities_019c9ac1-adb4-7b64-8409-3d608c5b89e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_IncreaseDecreaseInLeaseLiability_019c9ac1-adb4-789d-8e50-8bae04551a6c" xlink:href="rxrx-20260331.xsd#rxrx_IncreaseDecreaseInLeaseLiability"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019c9ac1-adb4-7677-b187-9ab7d37e9618" xlink:to="loc_rxrx_IncreaseDecreaseInLeaseLiability_019c9ac1-adb4-789d-8e50-8bae04551a6c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_019dcd54-5fab-71d0-8451-64b45044efcc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019c9ac1-adb4-7677-b187-9ab7d37e9618" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_019dcd54-5fab-71d0-8451-64b45044efcc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019c9ac1-adb4-70dd-bae6-27fbe65a0486" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019c9ac1-adb4-7226-9074-196477681992" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019c9ac1-adb4-70dd-bae6-27fbe65a0486" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019c9ac1-adb4-7226-9074-196477681992" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019c9ac1-adb4-7ba4-a64a-0e809f91ba6d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019c9ac1-adb4-70dd-bae6-27fbe65a0486" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019c9ac1-adb4-7ba4-a64a-0e809f91ba6d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019c9ac1-adb4-7d0e-bb56-ae9db6ee4db4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019c9ac1-adb4-70dd-bae6-27fbe65a0486" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019c9ac1-adb4-7d0e-bb56-ae9db6ee4db4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019c9ac1-adb4-7b28-9c7e-95e44d336b56" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019c9ac1-adb4-70dd-bae6-27fbe65a0486" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019c9ac1-adb4-7b28-9c7e-95e44d336b56" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019c9ac1-adb4-74ad-aaea-8a391771f74a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_019c9ac1-adb4-79b1-81ea-1cb841243906" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019c9ac1-adb4-74ad-aaea-8a391771f74a" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_019c9ac1-adb4-79b1-81ea-1cb841243906" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_019c9ac1-adb4-7d41-be86-e767098f8766" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019c9ac1-adb4-74ad-aaea-8a391771f74a" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_019c9ac1-adb4-7d41-be86-e767098f8766" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_019c9ac1-adb4-703b-ae59-63046fcfd9fc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019c9ac1-adb4-74ad-aaea-8a391771f74a" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_019c9ac1-adb4-703b-ae59-63046fcfd9fc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments_019db0a6-9a9c-7d4a-824d-04cbf681af23" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019c9ac1-adb4-74ad-aaea-8a391771f74a" xlink:to="loc_us-gaap_PaymentsToAcquireInvestments_019db0a6-9a9c-7d4a-824d-04cbf681af23" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019c9ac1-adb4-7999-8c99-130856bf4552" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_019c9ac1-adb4-72fe-95d4-f79649504e02" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019c9ac1-adb4-7999-8c99-130856bf4552" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_019c9ac1-adb4-72fe-95d4-f79649504e02" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_ProceedsFromPaymentForShareBasedPaymentArrangement_019c9ac1-adb4-70c0-9535-41919d7a0540" xlink:href="rxrx-20260331.xsd#rxrx_ProceedsFromPaymentForShareBasedPaymentArrangement"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019c9ac1-adb4-7999-8c99-130856bf4552" xlink:to="loc_rxrx_ProceedsFromPaymentForShareBasedPaymentArrangement_019c9ac1-adb4-70c0-9535-41919d7a0540" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities_019c9ac1-adb4-728f-ad4f-38fda813ce69" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019c9ac1-adb4-7999-8c99-130856bf4552" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities_019c9ac1-adb4-728f-ad4f-38fda813ce69" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/SupplementalFinancialInformationScheduleofAccruedExpensesandOtherLiabilitiesDetails" xlink:type="simple" xlink:href="rxrx-20260331.xsd#SupplementalFinancialInformationScheduleofAccruedExpensesandOtherLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.recursion.com/role/SupplementalFinancialInformationScheduleofAccruedExpensesandOtherLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_019c9ac1-ae72-740b-939e-54623b967d3e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_019c9ac1-ae72-7279-ae9f-3baf3cfd6931" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_019c9ac1-ae72-740b-939e-54623b967d3e" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_019c9ac1-ae72-7279-ae9f-3baf3cfd6931" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_AccruedComputeLiabilitiesCurrent_019c9ac1-ae72-73c5-b996-ba8b43f520ce" xlink:href="rxrx-20260331.xsd#rxrx_AccruedComputeLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_019c9ac1-ae72-740b-939e-54623b967d3e" xlink:to="loc_rxrx_AccruedComputeLiabilitiesCurrent_019c9ac1-ae72-73c5-b996-ba8b43f520ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_AccruedDevelopmentCostsCurrent_019c9ac1-ae72-76af-95e8-37022e170635" xlink:href="rxrx-20260331.xsd#rxrx_AccruedDevelopmentCostsCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_019c9ac1-ae72-740b-939e-54623b967d3e" xlink:to="loc_rxrx_AccruedDevelopmentCostsCurrent_019c9ac1-ae72-76af-95e8-37022e170635" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_AccruedEarlyDiscoveryExpensesCurrent_019c9ac1-ae72-7e4e-8a09-acb00be593ee" xlink:href="rxrx-20260331.xsd#rxrx_AccruedEarlyDiscoveryExpensesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_019c9ac1-ae72-740b-939e-54623b967d3e" xlink:to="loc_rxrx_AccruedEarlyDiscoveryExpensesCurrent_019c9ac1-ae72-7e4e-8a09-acb00be593ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_019c9ac1-ae72-7bf5-86fd-00818fce6122" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_019c9ac1-ae72-740b-939e-54623b967d3e" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_019c9ac1-ae72-7bf5-86fd-00818fce6122" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_MaterialsReceivedNotInvoiced_019c9ac1-ae72-7b30-92ea-58bd48b0e31e" xlink:href="rxrx-20260331.xsd#rxrx_MaterialsReceivedNotInvoiced"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_019c9ac1-ae72-740b-939e-54623b967d3e" xlink:to="loc_rxrx_MaterialsReceivedNotInvoiced_019c9ac1-ae72-7b30-92ea-58bd48b0e31e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_AccruedLicenseFeeCurrent_019c9ac1-ae72-70b5-80c0-196695021f1d" xlink:href="rxrx-20260331.xsd#rxrx_AccruedLicenseFeeCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_019c9ac1-ae72-740b-939e-54623b967d3e" xlink:to="loc_rxrx_AccruedLicenseFeeCurrent_019c9ac1-ae72-70b5-80c0-196695021f1d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_019d8673-14e6-7c63-af36-40d0e3683d59" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_019c9ac1-ae72-740b-939e-54623b967d3e" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_019d8673-14e6-7c63-af36-40d0e3683d59" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/SupplementalFinancialInformationScheduleofInterestIncomeNetDetails" xlink:type="simple" xlink:href="rxrx-20260331.xsd#SupplementalFinancialInformationScheduleofInterestIncomeNetDetails"/>
  <link:calculationLink xlink:role="http://www.recursion.com/role/SupplementalFinancialInformationScheduleofInterestIncomeNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_019c9ac1-ae72-7cea-b5fb-589980f03013" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseNonoperating_019c9ac1-ae72-70ae-94c2-4db804c1c0ba" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestExpenseNonoperating"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_019c9ac1-ae72-7cea-b5fb-589980f03013" xlink:to="loc_us-gaap_InterestExpenseNonoperating_019c9ac1-ae72-70ae-94c2-4db804c1c0ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNonoperating_019c9ac1-ae72-7f7c-a745-5e994cf7f275" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentIncomeNonoperating"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_019c9ac1-ae72-7cea-b5fb-589980f03013" xlink:to="loc_us-gaap_InvestmentIncomeNonoperating_019c9ac1-ae72-7f7c-a745-5e994cf7f275" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/GoodwillandIntangibleAssetsScheduleofIntangibleassetsDetails" xlink:type="simple" xlink:href="rxrx-20260331.xsd#GoodwillandIntangibleAssetsScheduleofIntangibleassetsDetails"/>
  <link:calculationLink xlink:role="http://www.recursion.com/role/GoodwillandIntangibleAssetsScheduleofIntangibleassetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_019c9ac1-ae72-7416-8e18-6b0de4d209d4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_019c9ac1-ae72-7706-9d6f-4d3bba39fcc9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_019c9ac1-ae72-7416-8e18-6b0de4d209d4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_019c9ac1-ae72-7706-9d6f-4d3bba39fcc9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_019c9ac1-ae72-748a-98fa-9249aff72631" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_019c9ac1-ae72-7416-8e18-6b0de4d209d4" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_019c9ac1-ae72-748a-98fa-9249aff72631" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_019c9ac1-ae72-734f-8601-efa8f21a20c6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_019c9ac1-ae72-758e-8c87-7fd4398755d9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_019c9ac1-ae72-734f-8601-efa8f21a20c6" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_019c9ac1-ae72-758e-8c87-7fd4398755d9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_019c9ac1-ae72-74f3-8d65-9fbb5779beca" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_019c9ac1-ae72-734f-8601-efa8f21a20c6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_019c9ac1-ae72-74f3-8d65-9fbb5779beca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_019c9ac1-ae72-794b-bcb1-4e747b5fbe21" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_019c9ac1-ae72-7304-82e6-2931cdbb6be0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_019c9ac1-ae72-794b-bcb1-4e747b5fbe21" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_019c9ac1-ae72-7304-82e6-2931cdbb6be0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_019c9ac1-ae72-703b-b61c-42706a699ccd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_019c9ac1-ae72-794b-bcb1-4e747b5fbe21" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_019c9ac1-ae72-703b-b61c-42706a699ccd" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/GoodwillandIntangibleAssetsScheduleofIntangibleassetsDetails_1" xlink:type="simple" xlink:href="rxrx-20260331.xsd#GoodwillandIntangibleAssetsScheduleofIntangibleassetsDetails_1"/>
  <link:calculationLink xlink:role="http://www.recursion.com/role/GoodwillandIntangibleAssetsScheduleofIntangibleassetsDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_019c9ac1-ae72-7f5b-bd60-5d9c65d91c15" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_019c9ac1-ae72-70d6-88d4-cb36b3458142" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_019c9ac1-ae72-7f5b-bd60-5d9c65d91c15" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_019c9ac1-ae72-70d6-88d4-cb36b3458142" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_019c9ac1-ae72-7802-8896-2339020485c9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_019c9ac1-ae72-7f5b-bd60-5d9c65d91c15" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_019c9ac1-ae72-7802-8896-2339020485c9" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" xlink:type="simple" xlink:href="rxrx-20260331.xsd#FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"/>
  <link:calculationLink xlink:role="http://www.recursion.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_019c9ac1-ae73-7d04-a95a-f5df2c0e93b4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_019c9ac1-ae73-784b-bbba-630e132309c4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_019c9ac1-ae73-7d04-a95a-f5df2c0e93b4" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_019c9ac1-ae73-784b-bbba-630e132309c4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_RestrictedCashAndCashEquivalentsFairValueDisclosure_019c9ac1-ae73-7967-a927-ec8dee94a584" xlink:href="rxrx-20260331.xsd#rxrx_RestrictedCashAndCashEquivalentsFairValueDisclosure"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_019c9ac1-ae73-7d04-a95a-f5df2c0e93b4" xlink:to="loc_rxrx_RestrictedCashAndCashEquivalentsFairValueDisclosure_019c9ac1-ae73-7967-a927-ec8dee94a584" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/FairValueMeasurementsScheduleofFinancialInstrumentsNotMeasuredatFairValueDetails" xlink:type="simple" xlink:href="rxrx-20260331.xsd#FairValueMeasurementsScheduleofFinancialInstrumentsNotMeasuredatFairValueDetails"/>
  <link:calculationLink xlink:role="http://www.recursion.com/role/FairValueMeasurementsScheduleofFinancialInstrumentsNotMeasuredatFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_019c9ac1-ae73-7dc4-9f0d-80882cb11a4b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_019c9ac1-ae73-7a95-bc30-e5d181e2fb1b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_019c9ac1-ae73-7dc4-9f0d-80882cb11a4b" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_019c9ac1-ae73-7a95-bc30-e5d181e2fb1b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_019c9ac1-ae73-789c-ba41-44acc8be8a7a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_019c9ac1-ae73-7dc4-9f0d-80882cb11a4b" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_019c9ac1-ae73-789c-ba41-44acc8be8a7a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/SegmentInformationScheduleofSegmentNetLossandReconciliationsofSegmentOperatingLosstoLossBeforeIncomeTaxBenefitDetails" xlink:type="simple" xlink:href="rxrx-20260331.xsd#SegmentInformationScheduleofSegmentNetLossandReconciliationsofSegmentOperatingLosstoLossBeforeIncomeTaxBenefitDetails"/>
  <link:calculationLink xlink:role="http://www.recursion.com/role/SegmentInformationScheduleofSegmentNetLossandReconciliationsofSegmentOperatingLosstoLossBeforeIncomeTaxBenefitDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019c9ac1-ae73-732a-8f29-a06bbc729c71" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_019c9ac1-ae73-797b-8929-d626f794d954" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_019c9ac1-ae73-732a-8f29-a06bbc729c71" xlink:to="loc_us-gaap_OperatingIncomeLoss_019c9ac1-ae73-797b-8929-d626f794d954" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_019c9ac1-ae73-7288-87a3-07ff36f993b6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_019c9ac1-ae73-732a-8f29-a06bbc729c71" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_019c9ac1-ae73-7288-87a3-07ff36f993b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_019c9ac1-ae73-728c-9227-58b71feb3362" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_019c9ac1-ae73-732a-8f29-a06bbc729c71" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_019c9ac1-ae73-728c-9227-58b71feb3362" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_019c9ac1-ae73-7ea7-bea3-f056de4fa7e9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_PlatformFeeExpense_019c9ac1-ae73-7300-87ea-ed3c96340718" xlink:href="rxrx-20260331.xsd#rxrx_PlatformFeeExpense"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_019c9ac1-ae73-7ea7-bea3-f056de4fa7e9" xlink:to="loc_rxrx_PlatformFeeExpense_019c9ac1-ae73-7300-87ea-ed3c96340718" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingOtherItemAmount_019c9ac1-ae73-7beb-9a18-56926e450714" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingOtherItemAmount"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_019c9ac1-ae73-7ea7-bea3-f056de4fa7e9" xlink:to="loc_us-gaap_SegmentReportingOtherItemAmount_019c9ac1-ae73-7beb-9a18-56926e450714" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LaborAndRelatedExpense_019c9ac1-ae73-7b9d-aae0-fd799b59c98b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LaborAndRelatedExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_019c9ac1-ae73-7ea7-bea3-f056de4fa7e9" xlink:to="loc_us-gaap_LaborAndRelatedExpense_019c9ac1-ae73-7b9d-aae0-fd799b59c98b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_ClinicalDevelopmentExpense_019c9ac1-ae73-77d5-81ed-bfa5bebd008e" xlink:href="rxrx-20260331.xsd#rxrx_ClinicalDevelopmentExpense"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_019c9ac1-ae73-7ea7-bea3-f056de4fa7e9" xlink:to="loc_rxrx_ClinicalDevelopmentExpense_019c9ac1-ae73-77d5-81ed-bfa5bebd008e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_DiscoveryExpense_019c9ac1-ae73-752e-8605-05493b51158c" xlink:href="rxrx-20260331.xsd#rxrx_DiscoveryExpense"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_019c9ac1-ae73-7ea7-bea3-f056de4fa7e9" xlink:to="loc_rxrx_DiscoveryExpense_019c9ac1-ae73-752e-8605-05493b51158c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019c9ac1-ae73-7354-b113-4186126da979" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_019c9ac1-ae73-7ea7-bea3-f056de4fa7e9" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019c9ac1-ae73-7354-b113-4186126da979" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_ConsumableExpense_019c9ac1-ae73-740f-9fed-6731396250cc" xlink:href="rxrx-20260331.xsd#rxrx_ConsumableExpense"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_019c9ac1-ae73-7ea7-bea3-f056de4fa7e9" xlink:to="loc_rxrx_ConsumableExpense_019c9ac1-ae73-740f-9fed-6731396250cc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization_019c9ac1-ae73-7838-a8d6-b6289e07288d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_019c9ac1-ae73-7ea7-bea3-f056de4fa7e9" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization_019c9ac1-ae73-7838-a8d6-b6289e07288d" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>7
<FILENAME>rxrx-20260331_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019c9ac1-acf5-79ea-ae98-b958c721a179,g:9f615d00-f48b-491d-8614-00e244a2e814-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.recursion.com/role/Cover" xlink:type="simple" xlink:href="rxrx-20260331.xsd#Cover"/>
  <link:definitionLink xlink:role="http://www.recursion.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_019c9ac1-adb4-7434-b5b3-e0528cb3afbf" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_019c9ac1-adb4-7207-b5f6-388f9e1e792e" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentInformationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_DocumentInformationLineItems_019c9ac1-adb4-7434-b5b3-e0528cb3afbf" xlink:to="loc_dei_DocumentInformationTable_019c9ac1-adb4-7207-b5f6-388f9e1e792e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_019c9ac1-adb4-7f9b-bb9d-b89532cf4fba" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_DocumentInformationTable_019c9ac1-adb4-7207-b5f6-388f9e1e792e" xlink:to="loc_us-gaap_StatementClassOfStockAxis_019c9ac1-adb4-7f9b-bb9d-b89532cf4fba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_019c9ac1-adb4-7f9b-bb9d-b89532cf4fba_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_019c9ac1-adb4-7f9b-bb9d-b89532cf4fba" xlink:to="loc_us-gaap_ClassOfStockDomain_019c9ac1-adb4-7f9b-bb9d-b89532cf4fba_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_019c9ac1-adb4-76fa-8770-119ae2fb0f56" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_019c9ac1-adb4-7f9b-bb9d-b89532cf4fba" xlink:to="loc_us-gaap_ClassOfStockDomain_019c9ac1-adb4-76fa-8770-119ae2fb0f56" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_019c9ac1-adb4-7c08-8c8d-15051495ba10" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_019c9ac1-adb4-76fa-8770-119ae2fb0f56" xlink:to="loc_us-gaap_CommonClassAMember_019c9ac1-adb4-7c08-8c8d-15051495ba10" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_019c9ac1-adb4-7a22-b3ff-1377649fe90c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_019c9ac1-adb4-76fa-8770-119ae2fb0f56" xlink:to="loc_us-gaap_CommonClassBMember_019c9ac1-adb4-7a22-b3ff-1377649fe90c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_019c9ac1-adb4-7eea-b044-c3868fec5507" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019c9ac1-adb4-7434-b5b3-e0528cb3afbf" xlink:to="loc_dei_DocumentType_019c9ac1-adb4-7eea-b044-c3868fec5507" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_019c9ac1-adb4-776e-922f-a12c4228d1a8" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019c9ac1-adb4-7434-b5b3-e0528cb3afbf" xlink:to="loc_dei_DocumentQuarterlyReport_019c9ac1-adb4-776e-922f-a12c4228d1a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_019c9ac1-adb4-73c6-8686-5208b8a28d74" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019c9ac1-adb4-7434-b5b3-e0528cb3afbf" xlink:to="loc_dei_DocumentPeriodEndDate_019c9ac1-adb4-73c6-8686-5208b8a28d74" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_019c9ac1-adb4-7aee-9532-fa656e676b84" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019c9ac1-adb4-7434-b5b3-e0528cb3afbf" xlink:to="loc_dei_DocumentTransitionReport_019c9ac1-adb4-7aee-9532-fa656e676b84" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_019c9ac1-adb4-79f1-b135-5e77592e8faa" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019c9ac1-adb4-7434-b5b3-e0528cb3afbf" xlink:to="loc_dei_EntityFileNumber_019c9ac1-adb4-79f1-b135-5e77592e8faa" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_019c9ac1-adb4-7510-8f2d-bf5c604386f2" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019c9ac1-adb4-7434-b5b3-e0528cb3afbf" xlink:to="loc_dei_EntityRegistrantName_019c9ac1-adb4-7510-8f2d-bf5c604386f2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_019c9ac1-adb4-7f6e-9942-158ba99326f1" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019c9ac1-adb4-7434-b5b3-e0528cb3afbf" xlink:to="loc_dei_EntityIncorporationStateCountryCode_019c9ac1-adb4-7f6e-9942-158ba99326f1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_019c9ac1-adb4-79c3-9c19-6798e033ed24" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019c9ac1-adb4-7434-b5b3-e0528cb3afbf" xlink:to="loc_dei_EntityTaxIdentificationNumber_019c9ac1-adb4-79c3-9c19-6798e033ed24" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_019c9ac1-adb4-7d75-90c7-cd32d9a17aa1" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019c9ac1-adb4-7434-b5b3-e0528cb3afbf" xlink:to="loc_dei_EntityAddressAddressLine1_019c9ac1-adb4-7d75-90c7-cd32d9a17aa1" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_019c9ac1-adb4-7d28-a6fb-1ddff74834e9" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019c9ac1-adb4-7434-b5b3-e0528cb3afbf" xlink:to="loc_dei_EntityAddressCityOrTown_019c9ac1-adb4-7d28-a6fb-1ddff74834e9" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_019c9ac1-adb4-71a1-9432-dc879c0f9fd5" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019c9ac1-adb4-7434-b5b3-e0528cb3afbf" xlink:to="loc_dei_EntityAddressStateOrProvince_019c9ac1-adb4-71a1-9432-dc879c0f9fd5" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_019c9ac1-adb4-7c4e-b973-80b996e1432c" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019c9ac1-adb4-7434-b5b3-e0528cb3afbf" xlink:to="loc_dei_EntityAddressPostalZipCode_019c9ac1-adb4-7c4e-b973-80b996e1432c" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_019c9ac1-adb4-718a-91d3-4cd0cd8f8786" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019c9ac1-adb4-7434-b5b3-e0528cb3afbf" xlink:to="loc_dei_CityAreaCode_019c9ac1-adb4-718a-91d3-4cd0cd8f8786" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_019c9ac1-adb4-71d6-9f6c-c0adcfa206e5" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019c9ac1-adb4-7434-b5b3-e0528cb3afbf" xlink:to="loc_dei_LocalPhoneNumber_019c9ac1-adb4-71d6-9f6c-c0adcfa206e5" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_019c9ac1-adb4-7619-93d0-1888d9a43650" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019c9ac1-adb4-7434-b5b3-e0528cb3afbf" xlink:to="loc_dei_Security12bTitle_019c9ac1-adb4-7619-93d0-1888d9a43650" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_019c9ac1-adb4-7ccf-b830-a48f9839eb80" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019c9ac1-adb4-7434-b5b3-e0528cb3afbf" xlink:to="loc_dei_TradingSymbol_019c9ac1-adb4-7ccf-b830-a48f9839eb80" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_019c9ac1-adb4-7ff5-9803-4ca4efddd8cf" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019c9ac1-adb4-7434-b5b3-e0528cb3afbf" xlink:to="loc_dei_SecurityExchangeName_019c9ac1-adb4-7ff5-9803-4ca4efddd8cf" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_019c9ac1-adb4-7407-9a0a-ef39e5cbad60" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019c9ac1-adb4-7434-b5b3-e0528cb3afbf" xlink:to="loc_dei_EntityCurrentReportingStatus_019c9ac1-adb4-7407-9a0a-ef39e5cbad60" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_019c9ac1-adb4-74c4-b211-661f23d88d60" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019c9ac1-adb4-7434-b5b3-e0528cb3afbf" xlink:to="loc_dei_EntityInteractiveDataCurrent_019c9ac1-adb4-74c4-b211-661f23d88d60" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_019c9ac1-adb4-7a7d-9fe1-c33d10da02d1" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019c9ac1-adb4-7434-b5b3-e0528cb3afbf" xlink:to="loc_dei_EntityFilerCategory_019c9ac1-adb4-7a7d-9fe1-c33d10da02d1" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_019c9ac1-adb4-741c-98e1-3f393aa216a6" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019c9ac1-adb4-7434-b5b3-e0528cb3afbf" xlink:to="loc_dei_EntitySmallBusiness_019c9ac1-adb4-741c-98e1-3f393aa216a6" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_019c9ac1-adb4-7f77-8f72-159fb9e1d74e" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019c9ac1-adb4-7434-b5b3-e0528cb3afbf" xlink:to="loc_dei_EntityEmergingGrowthCompany_019c9ac1-adb4-7f77-8f72-159fb9e1d74e" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_019c9ac1-adb4-7f10-927e-4f1f9dc427ca" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019c9ac1-adb4-7434-b5b3-e0528cb3afbf" xlink:to="loc_dei_EntityShellCompany_019c9ac1-adb4-7f10-927e-4f1f9dc427ca" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_019c9ac1-adb4-7579-ae31-eef58a3b4f57" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019c9ac1-adb4-7434-b5b3-e0528cb3afbf" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_019c9ac1-adb4-7579-ae31-eef58a3b4f57" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_019c9ac1-adb4-7e33-94e0-060e654ff6b5" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019c9ac1-adb4-7434-b5b3-e0528cb3afbf" xlink:to="loc_dei_EntityCentralIndexKey_019c9ac1-adb4-7e33-94e0-060e654ff6b5" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_019c9ac1-adb4-707b-a536-8afc7cec11d0" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019c9ac1-adb4-7434-b5b3-e0528cb3afbf" xlink:to="loc_dei_AmendmentFlag_019c9ac1-adb4-707b-a536-8afc7cec11d0" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_019c9ac1-adb4-79c5-9faa-45a660b4f44d" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019c9ac1-adb4-7434-b5b3-e0528cb3afbf" xlink:to="loc_dei_DocumentFiscalYearFocus_019c9ac1-adb4-79c5-9faa-45a660b4f44d" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_019c9ac1-adb4-76a7-b53f-3c7c6d02a12e" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019c9ac1-adb4-7434-b5b3-e0528cb3afbf" xlink:to="loc_dei_DocumentFiscalPeriodFocus_019c9ac1-adb4-76a7-b53f-3c7c6d02a12e" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_019c9ac1-adb4-730e-a482-62cf712b2ce7" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019c9ac1-adb4-7434-b5b3-e0528cb3afbf" xlink:to="loc_dei_CurrentFiscalYearEndDate_019c9ac1-adb4-730e-a482-62cf712b2ce7" xlink:type="arc" order="28"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunauditedParenthetical" xlink:type="simple" xlink:href="rxrx-20260331.xsd#CondensedConsolidatedBalanceSheetsunauditedParenthetical"/>
  <link:definitionLink xlink:role="http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunauditedParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_019c9ac1-adb4-7bec-8072-2a991df753cb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_019c9ac1-adb4-7f72-8bb0-5e1901eab234" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_019c9ac1-adb4-7bec-8072-2a991df753cb" xlink:to="loc_us-gaap_StatementTable_019c9ac1-adb4-7f72-8bb0-5e1901eab234" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_019c9ac1-adb4-7f98-b5ea-34ed70b806b1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_019c9ac1-adb4-7f72-8bb0-5e1901eab234" xlink:to="loc_us-gaap_StatementClassOfStockAxis_019c9ac1-adb4-7f98-b5ea-34ed70b806b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_019c9ac1-adb4-7f98-b5ea-34ed70b806b1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_019c9ac1-adb4-7f98-b5ea-34ed70b806b1" xlink:to="loc_us-gaap_ClassOfStockDomain_019c9ac1-adb4-7f98-b5ea-34ed70b806b1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_019c9ac1-adb4-7907-951f-1d4b0dc1c314" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_019c9ac1-adb4-7f98-b5ea-34ed70b806b1" xlink:to="loc_us-gaap_ClassOfStockDomain_019c9ac1-adb4-7907-951f-1d4b0dc1c314" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_019c9ac1-adb4-7084-abe6-856623affe67" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_019c9ac1-adb4-7907-951f-1d4b0dc1c314" xlink:to="loc_us-gaap_CommonClassAMember_019c9ac1-adb4-7084-abe6-856623affe67" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_019c9ac1-adb4-72ce-a01b-1aa7cf80ce94" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_019c9ac1-adb4-7907-951f-1d4b0dc1c314" xlink:to="loc_us-gaap_CommonClassBMember_019c9ac1-adb4-72ce-a01b-1aa7cf80ce94" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_ExchangeableStockMember_019c9ac1-adb4-713e-a01f-f68aee158b6b" xlink:href="rxrx-20260331.xsd#rxrx_ExchangeableStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_019c9ac1-adb4-7907-951f-1d4b0dc1c314" xlink:to="loc_rxrx_ExchangeableStockMember_019c9ac1-adb4-713e-a01f-f68aee158b6b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_019c9ac1-adb4-7e9b-9d49-070eafc448e1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019c9ac1-adb4-7bec-8072-2a991df753cb" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_019c9ac1-adb4-7e9b-9d49-070eafc448e1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_019c9ac1-adb4-7fed-88da-f3cb3aa276c5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019c9ac1-adb4-7bec-8072-2a991df753cb" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_019c9ac1-adb4-7fed-88da-f3cb3aa276c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_019c9ac1-adb4-74dd-9600-c40b6bd294b5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019c9ac1-adb4-7bec-8072-2a991df753cb" xlink:to="loc_us-gaap_CommonStockSharesIssued_019c9ac1-adb4-74dd-9600-c40b6bd294b5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_019c9ac1-adb4-7011-a3dd-751716ce262e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019c9ac1-adb4-7bec-8072-2a991df753cb" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_019c9ac1-adb4-7011-a3dd-751716ce262e" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.recursion.com/role/CondensedConsolidatedStatementsofOperationsunaudited" xlink:type="simple" xlink:href="rxrx-20260331.xsd#CondensedConsolidatedStatementsofOperationsunaudited"/>
  <link:definitionLink xlink:role="http://www.recursion.com/role/CondensedConsolidatedStatementsofOperationsunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_019c9ac1-adb4-7590-a02c-e089fed6fc8b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_019c9ac1-adb4-7c1b-8d9f-dd373d44db00" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_019c9ac1-adb4-7590-a02c-e089fed6fc8b" xlink:to="loc_us-gaap_StatementTable_019c9ac1-adb4-7c1b-8d9f-dd373d44db00" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_019c9ac1-adb4-795e-a5fd-883c07890612" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_019c9ac1-adb4-7c1b-8d9f-dd373d44db00" xlink:to="loc_srt_ProductOrServiceAxis_019c9ac1-adb4-795e-a5fd-883c07890612" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_019c9ac1-adb4-795e-a5fd-883c07890612_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_019c9ac1-adb4-795e-a5fd-883c07890612" xlink:to="loc_srt_ProductsAndServicesDomain_019c9ac1-adb4-795e-a5fd-883c07890612_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_019c9ac1-adb4-7555-bef9-e7ead5c2cd5c" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_019c9ac1-adb4-795e-a5fd-883c07890612" xlink:to="loc_srt_ProductsAndServicesDomain_019c9ac1-adb4-7555-bef9-e7ead5c2cd5c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicenseAndServiceMember_019c9ac1-adb4-7a04-901c-78dac51816b7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LicenseAndServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_019c9ac1-adb4-7555-bef9-e7ead5c2cd5c" xlink:to="loc_us-gaap_LicenseAndServiceMember_019c9ac1-adb4-7a04-901c-78dac51816b7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrantMember_019c9ac1-adb4-734b-a567-1be763ed4d2f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_019c9ac1-adb4-7555-bef9-e7ead5c2cd5c" xlink:to="loc_us-gaap_GrantMember_019c9ac1-adb4-734b-a567-1be763ed4d2f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_019c9ac1-adb4-7bc8-bb7f-6a096a016641" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019c9ac1-adb4-7590-a02c-e089fed6fc8b" xlink:to="loc_us-gaap_RevenuesAbstract_019c9ac1-adb4-7bc8-bb7f-6a096a016641" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019c9ac1-adb4-74fe-8613-d94e0045ef32" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_019c9ac1-adb4-7bc8-bb7f-6a096a016641" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019c9ac1-adb4-74fe-8613-d94e0045ef32" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_019c9ac1-adb4-7f08-9370-44959c94bc83" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019c9ac1-adb4-7590-a02c-e089fed6fc8b" xlink:to="loc_us-gaap_OperatingExpensesAbstract_019c9ac1-adb4-7f08-9370-44959c94bc83" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_019c9ac1-adb4-7736-aa9b-4ce0d45f79ae" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_019c9ac1-adb4-7f08-9370-44959c94bc83" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_019c9ac1-adb4-7736-aa9b-4ce0d45f79ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_019c9ac1-adb4-70f1-9dec-c73ec06c34b1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_019c9ac1-adb4-7f08-9370-44959c94bc83" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_019c9ac1-adb4-70f1-9dec-c73ec06c34b1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_019c9ac1-adb4-7020-8e0a-36cdb572208c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_019c9ac1-adb4-7f08-9370-44959c94bc83" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_019c9ac1-adb4-7020-8e0a-36cdb572208c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_019c9ac1-adb4-73f6-a705-4d36ee56702a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostsAndExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_019c9ac1-adb4-7f08-9370-44959c94bc83" xlink:to="loc_us-gaap_CostsAndExpenses_019c9ac1-adb4-73f6-a705-4d36ee56702a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_019c9ac1-adb4-7a0a-8754-c57dc5cf4958" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019c9ac1-adb4-7590-a02c-e089fed6fc8b" xlink:to="loc_us-gaap_OperatingIncomeLoss_019c9ac1-adb4-7a0a-8754-c57dc5cf4958" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_019c9ac1-adb4-7c57-bfe0-3b5c66f193f5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019c9ac1-adb4-7590-a02c-e089fed6fc8b" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_019c9ac1-adb4-7c57-bfe0-3b5c66f193f5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_019c9ac1-adb4-7c29-8dfd-e0d9fff33d67" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019c9ac1-adb4-7590-a02c-e089fed6fc8b" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_019c9ac1-adb4-7c29-8dfd-e0d9fff33d67" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_019c9ac1-adb4-76cd-8c85-5510f82b443a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019c9ac1-adb4-7590-a02c-e089fed6fc8b" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_019c9ac1-adb4-76cd-8c85-5510f82b443a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019c9ac1-adb4-7504-a18a-5611bd004276" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019c9ac1-adb4-7590-a02c-e089fed6fc8b" xlink:to="loc_us-gaap_NetIncomeLoss_019c9ac1-adb4-7504-a18a-5611bd004276" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_019c9ac1-adb4-7391-a005-c83e4298cc1c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019c9ac1-adb4-7590-a02c-e089fed6fc8b" xlink:to="loc_us-gaap_EarningsPerShareAbstract_019c9ac1-adb4-7391-a005-c83e4298cc1c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_019c9ac1-adb4-7e44-a0ca-2c9640a4b709" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_019c9ac1-adb4-7391-a005-c83e4298cc1c" xlink:to="loc_us-gaap_EarningsPerShareBasic_019c9ac1-adb4-7e44-a0ca-2c9640a4b709" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_019c9ac1-adb4-75e3-88e4-abf511a977a1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_019c9ac1-adb4-7391-a005-c83e4298cc1c" xlink:to="loc_us-gaap_EarningsPerShareDiluted_019c9ac1-adb4-75e3-88e4-abf511a977a1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_019c9ac1-adb4-7677-9db5-b16f56788e27" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_019c9ac1-adb4-7391-a005-c83e4298cc1c" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_019c9ac1-adb4-7677-9db5-b16f56788e27" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_019c9ac1-adb4-7630-8a40-07f5087b6491" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_019c9ac1-adb4-7391-a005-c83e4298cc1c" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_019c9ac1-adb4-7630-8a40-07f5087b6491" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.recursion.com/role/CondensedConsolidatedStatementsofStockholdersEquityunaudited" xlink:type="simple" xlink:href="rxrx-20260331.xsd#CondensedConsolidatedStatementsofStockholdersEquityunaudited"/>
  <link:definitionLink xlink:role="http://www.recursion.com/role/CondensedConsolidatedStatementsofStockholdersEquityunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_019c9ac1-adb4-733f-b8e1-4a7da44d231e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_019c9ac1-adb4-7c5d-af46-6be86834a669" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_019c9ac1-adb4-733f-b8e1-4a7da44d231e" xlink:to="loc_us-gaap_StatementTable_019c9ac1-adb4-7c5d-af46-6be86834a669" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_019c9ac1-adb4-79f5-a941-71b68935d95c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_019c9ac1-adb4-7c5d-af46-6be86834a669" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_019c9ac1-adb4-79f5-a941-71b68935d95c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_019c9ac1-adb4-79f5-a941-71b68935d95c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_019c9ac1-adb4-79f5-a941-71b68935d95c" xlink:to="loc_us-gaap_EquityComponentDomain_019c9ac1-adb4-79f5-a941-71b68935d95c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_019c9ac1-adb4-7600-8bb2-f4fa1b9ddc5c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_019c9ac1-adb4-79f5-a941-71b68935d95c" xlink:to="loc_us-gaap_EquityComponentDomain_019c9ac1-adb4-7600-8bb2-f4fa1b9ddc5c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_019c9ac1-adb4-7f84-b991-73746db0a1f0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_019c9ac1-adb4-7600-8bb2-f4fa1b9ddc5c" xlink:to="loc_us-gaap_CommonStockMember_019c9ac1-adb4-7f84-b991-73746db0a1f0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_019c9ac1-adb4-7f4a-a50e-3c38f2d65f07" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_019c9ac1-adb4-7600-8bb2-f4fa1b9ddc5c" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_019c9ac1-adb4-7f4a-a50e-3c38f2d65f07" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_019c9ac1-adb4-7b59-aa5c-70c5f83fbf7c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_019c9ac1-adb4-7600-8bb2-f4fa1b9ddc5c" xlink:to="loc_us-gaap_RetainedEarningsMember_019c9ac1-adb4-7b59-aa5c-70c5f83fbf7c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_019c9ac1-adb4-7b31-b2b8-b223afb63b20" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_019c9ac1-adb4-7600-8bb2-f4fa1b9ddc5c" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_019c9ac1-adb4-7b31-b2b8-b223afb63b20" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019c9ac1-adb4-74b4-b632-ff7529637d97" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019c9ac1-adb4-733f-b8e1-4a7da44d231e" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019c9ac1-adb4-74b4-b632-ff7529637d97" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_019c9ac1-adb4-7706-ab22-46c94dd7db37" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019c9ac1-adb4-74b4-b632-ff7529637d97" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_019c9ac1-adb4-7706-ab22-46c94dd7db37" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_019c9ac1-adb4-73ec-a24d-fe0acf6a2a91" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019c9ac1-adb4-74b4-b632-ff7529637d97" xlink:to="loc_us-gaap_StockholdersEquity_019c9ac1-adb4-73ec-a24d-fe0acf6a2a91" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019c9ac1-adb4-7d91-af45-350617a8ca72" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019c9ac1-adb4-74b4-b632-ff7529637d97" xlink:to="loc_us-gaap_NetIncomeLoss_019c9ac1-adb4-7d91-af45-350617a8ca72" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_019c9ac1-adb4-79c9-9a2d-571c6378c401" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019c9ac1-adb4-74b4-b632-ff7529637d97" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_019c9ac1-adb4-79c9-9a2d-571c6378c401" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_019c9ac1-adb4-76fe-83ac-43a1747589dc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019c9ac1-adb4-74b4-b632-ff7529637d97" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_019c9ac1-adb4-76fe-83ac-43a1747589dc" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_019c9ac1-adb4-79cb-8ef7-b30a0bb9dbf2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019c9ac1-adb4-74b4-b632-ff7529637d97" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_019c9ac1-adb4-79cb-8ef7-b30a0bb9dbf2" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_019c9ac1-adb4-7af1-899d-92d270982691" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019c9ac1-adb4-74b4-b632-ff7529637d97" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_019c9ac1-adb4-7af1-899d-92d270982691" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_019d862f-75f6-76d0-b0c9-dd95433d73ea" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019c9ac1-adb4-74b4-b632-ff7529637d97" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_019d862f-75f6-76d0-b0c9-dd95433d73ea" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_019c9ac1-adb4-7826-b242-8d6149904f73" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019c9ac1-adb4-74b4-b632-ff7529637d97" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_019c9ac1-adb4-7826-b242-8d6149904f73" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_019c9ac1-adb4-7e3d-a36a-82d0ea46b585" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_019c9ac1-adb4-7e7f-b5c5-f619dfc053ab" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.recursion.com/role/SupplementalFinancialInformationNarrativeDetails" xlink:type="simple" xlink:href="rxrx-20260331.xsd#SupplementalFinancialInformationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.recursion.com/role/SupplementalFinancialInformationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_019c9ac1-ae72-7304-a243-fae2c193725f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_019c9ac1-ae72-7087-ab00-81db56fdbdfa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_019c9ac1-ae72-7304-a243-fae2c193725f" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_019c9ac1-ae72-7087-ab00-81db56fdbdfa" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_019c9ac1-ae72-7440-8461-cc4d20e94c3f" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_019c9ac1-ae72-7087-ab00-81db56fdbdfa" xlink:to="loc_srt_CounterpartyNameAxis_019c9ac1-ae72-7440-8461-cc4d20e94c3f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_019c9ac1-ae72-7440-8461-cc4d20e94c3f_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_019c9ac1-ae72-7440-8461-cc4d20e94c3f" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_019c9ac1-ae72-7440-8461-cc4d20e94c3f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_019c9ac1-ae72-743a-aa6e-b347f4d14ae5" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_019c9ac1-ae72-7440-8461-cc4d20e94c3f" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_019c9ac1-ae72-743a-aa6e-b347f4d14ae5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_TempusLabsIncMember_019c9ac1-ae72-706b-97ac-05992fa2107f" xlink:href="rxrx-20260331.xsd#rxrx_TempusLabsIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_019c9ac1-ae72-743a-aa6e-b347f4d14ae5" xlink:to="loc_rxrx_TempusLabsIncMember_019c9ac1-ae72-706b-97ac-05992fa2107f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_019c9ac1-ae72-7305-959d-ea4a56a76785" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_019c9ac1-ae72-7087-ab00-81db56fdbdfa" xlink:to="loc_srt_RangeAxis_019c9ac1-ae72-7305-959d-ea4a56a76785" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_019c9ac1-ae72-7305-959d-ea4a56a76785_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_019c9ac1-ae72-7305-959d-ea4a56a76785" xlink:to="loc_srt_RangeMember_019c9ac1-ae72-7305-959d-ea4a56a76785_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_019c9ac1-ae72-7ffe-b114-fcf51448781f" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_019c9ac1-ae72-7305-959d-ea4a56a76785" xlink:to="loc_srt_RangeMember_019c9ac1-ae72-7ffe-b114-fcf51448781f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_019c9ac1-ae72-7933-a972-b673730c02ee" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_019c9ac1-ae72-7ffe-b114-fcf51448781f" xlink:to="loc_srt_MinimumMember_019c9ac1-ae72-7933-a972-b673730c02ee" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_019c9ac1-ae72-7ebf-9b52-d19b60574333" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_019c9ac1-ae72-7ffe-b114-fcf51448781f" xlink:to="loc_srt_MaximumMember_019c9ac1-ae72-7ebf-9b52-d19b60574333" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_LicenseAgreementTerm_019c9ac1-ae72-71bc-bb95-97337792af6c" xlink:href="rxrx-20260331.xsd#rxrx_LicenseAgreementTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_019c9ac1-ae72-7304-a243-fae2c193725f" xlink:to="loc_rxrx_LicenseAgreementTerm_019c9ac1-ae72-71bc-bb95-97337792af6c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_LicenseAgreementAnnualPayments_019c9ac1-ae72-7c4d-9de3-6f60bad46fb6" xlink:href="rxrx-20260331.xsd#rxrx_LicenseAgreementAnnualPayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_019c9ac1-ae72-7304-a243-fae2c193725f" xlink:to="loc_rxrx_LicenseAgreementAnnualPayments_019c9ac1-ae72-7c4d-9de3-6f60bad46fb6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_LicenseAgreementAggregatePayments_019c9ac1-ae72-7fb4-b6cf-c75ab18c2392" xlink:href="rxrx-20260331.xsd#rxrx_LicenseAgreementAggregatePayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_019c9ac1-ae72-7304-a243-fae2c193725f" xlink:to="loc_rxrx_LicenseAgreementAggregatePayments_019c9ac1-ae72-7fb4-b6cf-c75ab18c2392" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_LicenseAgreementTradingPeriodUsedForEquityValueDetermination_019c9ac1-ae72-7503-95bd-37073ecfd4e6" xlink:href="rxrx-20260331.xsd#rxrx_LicenseAgreementTradingPeriodUsedForEquityValueDetermination"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_019c9ac1-ae72-7304-a243-fae2c193725f" xlink:to="loc_rxrx_LicenseAgreementTradingPeriodUsedForEquityValueDetermination_019c9ac1-ae72-7503-95bd-37073ecfd4e6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_LicenseAgreementAmountOfTimePriorToThePaymentDate_019c9ac1-ae72-7874-a3a8-88737541d1d8" xlink:href="rxrx-20260331.xsd#rxrx_LicenseAgreementAmountOfTimePriorToThePaymentDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_019c9ac1-ae72-7304-a243-fae2c193725f" xlink:to="loc_rxrx_LicenseAgreementAmountOfTimePriorToThePaymentDate_019c9ac1-ae72-7874-a3a8-88737541d1d8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_LicenseAgreementIncreaseDecreaseAccruedLiabilities_019c9ac1-ae72-79a6-992a-6ea7827fc84b" xlink:href="rxrx-20260331.xsd#rxrx_LicenseAgreementIncreaseDecreaseAccruedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_019c9ac1-ae72-7304-a243-fae2c193725f" xlink:to="loc_rxrx_LicenseAgreementIncreaseDecreaseAccruedLiabilities_019c9ac1-ae72-79a6-992a-6ea7827fc84b" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.recursion.com/role/AcquisitionsNarrativeDetails" xlink:type="simple" xlink:href="rxrx-20260331.xsd#AcquisitionsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.recursion.com/role/AcquisitionsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_019d8679-589d-7eae-abc4-aa3daaad7ff0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_019d8679-589d-742f-9fe1-c7367563e24b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_019d8679-589d-7eae-abc4-aa3daaad7ff0" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_019d8679-589d-742f-9fe1-c7367563e24b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis_019d8679-589d-7e85-ab52-061d916becc2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_019d8679-589d-742f-9fe1-c7367563e24b" xlink:to="loc_us-gaap_AssetAcquisitionAxis_019d8679-589d-7e85-ab52-061d916becc2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_019d8679-589d-7e85-ab52-061d916becc2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AssetAcquisitionAxis_019d8679-589d-7e85-ab52-061d916becc2" xlink:to="loc_us-gaap_AssetAcquisitionDomain_019d8679-589d-7e85-ab52-061d916becc2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_019d8679-589d-76e9-8662-5276f48b0d45" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AssetAcquisitionAxis_019d8679-589d-7e85-ab52-061d916becc2" xlink:to="loc_us-gaap_AssetAcquisitionDomain_019d8679-589d-76e9-8662-5276f48b0d45" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_REVenturesIMember_019d8679-589d-7a27-bb5e-4cebc19c24a8" xlink:href="rxrx-20260331.xsd#rxrx_REVenturesIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionDomain_019d8679-589d-76e9-8662-5276f48b0d45" xlink:to="loc_rxrx_REVenturesIMember_019d8679-589d-7a27-bb5e-4cebc19c24a8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_019d867a-ed43-76cf-afd8-12081860ac4f" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_019d8679-589d-742f-9fe1-c7367563e24b" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_019d867a-ed43-76cf-afd8-12081860ac4f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_019d867a-ed43-76cf-afd8-12081860ac4f_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_019d867a-ed43-76cf-afd8-12081860ac4f" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_019d867a-ed43-76cf-afd8-12081860ac4f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_019d867a-ed43-79f6-98c8-61c969bbfb19" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_019d867a-ed43-76cf-afd8-12081860ac4f" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_019d867a-ed43-79f6-98c8-61c969bbfb19" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_AlphaBiotechnologyGmbHAlphaMember_019d867a-ed43-7191-bc9e-ad4dc2390b19" xlink:href="rxrx-20260331.xsd#rxrx_AlphaBiotechnologyGmbHAlphaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_019d867a-ed43-79f6-98c8-61c969bbfb19" xlink:to="loc_rxrx_AlphaBiotechnologyGmbHAlphaMember_019d867a-ed43-7191-bc9e-ad4dc2390b19" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_019d867a-ed43-7b14-b9c3-d2c3c4f156d7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_019d8679-589d-742f-9fe1-c7367563e24b" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_019d867a-ed43-7b14-b9c3-d2c3c4f156d7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_019d867a-ed43-7b14-b9c3-d2c3c4f156d7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_019d867a-ed43-7b14-b9c3-d2c3c4f156d7" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_019d867a-ed43-7b14-b9c3-d2c3c4f156d7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_019d867a-ed43-76cd-a568-ede177bd89b5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_019d867a-ed43-7b14-b9c3-d2c3c4f156d7" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_019d867a-ed43-76cd-a568-ede177bd89b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_019d867a-ed43-717a-84c0-be28d3cc0035" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_019d867a-ed43-76cd-a568-ede177bd89b5" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_019d867a-ed43-717a-84c0-be28d3cc0035" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019d867a-ed43-750b-ad52-4a90a0d5b1ab" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_019d8679-589d-742f-9fe1-c7367563e24b" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019d867a-ed43-750b-ad52-4a90a0d5b1ab" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019d867a-ed43-750b-ad52-4a90a0d5b1ab_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019d867a-ed43-750b-ad52-4a90a0d5b1ab" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019d867a-ed43-750b-ad52-4a90a0d5b1ab_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019d867a-ed43-75f1-8eae-e94e534e0ced" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019d867a-ed43-750b-ad52-4a90a0d5b1ab" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019d867a-ed43-75f1-8eae-e94e534e0ced" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_ExscientiaGmbHMember_019d867a-ed43-7110-acce-893dd3bb0abe" xlink:href="rxrx-20260331.xsd#rxrx_ExscientiaGmbHMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019d867a-ed43-75f1-8eae-e94e534e0ced" xlink:to="loc_rxrx_ExscientiaGmbHMember_019d867a-ed43-7110-acce-893dd3bb0abe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_AssetAcquisitionEquityOwnershipPercentage_019d8679-589d-79e4-a1ec-fccdbd266e91" xlink:href="rxrx-20260331.xsd#rxrx_AssetAcquisitionEquityOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_019d8679-589d-7eae-abc4-aa3daaad7ff0" xlink:to="loc_rxrx_AssetAcquisitionEquityOwnershipPercentage_019d8679-589d-79e4-a1ec-fccdbd266e91" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionConsiderationTransferred_019d8679-589d-7340-95e5-1bcb54f768f9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetAcquisitionConsiderationTransferred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_019d8679-589d-7eae-abc4-aa3daaad7ff0" xlink:to="loc_us-gaap_AssetAcquisitionConsiderationTransferred_019d8679-589d-7340-95e5-1bcb54f768f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment_019d8679-589d-745c-8972-ca21b8f4a406" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_019d8679-589d-7eae-abc4-aa3daaad7ff0" xlink:to="loc_us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment_019d8679-589d-745c-8972-ca21b8f4a406" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_019d867a-ed43-7324-8ecd-3e15f1681c31" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_019d8679-589d-7eae-abc4-aa3daaad7ff0" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_019d867a-ed43-7324-8ecd-3e15f1681c31" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_019d867a-ed43-7318-8ec0-3100c9825ffd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_019d8679-589d-7eae-abc4-aa3daaad7ff0" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_019d867a-ed43-7318-8ec0-3100c9825ffd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_019d867a-ed43-7aa9-a1aa-e446d87187d6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_019d8679-589d-7eae-abc4-aa3daaad7ff0" xlink:to="loc_us-gaap_EquityMethodInvestments_019d867a-ed43-7aa9-a1aa-e446d87187d6" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.recursion.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="rxrx-20260331.xsd#LeasesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.recursion.com/role/LeasesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_019c9ac1-ae72-7cb5-a9fd-a00d78887274" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_019c9ac1-ae72-7f1a-9714-509ea48ed598" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_019c9ac1-ae72-7cb5-a9fd-a00d78887274" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_019c9ac1-ae72-7f1a-9714-509ea48ed598" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_019c9ac1-ae72-799f-9a71-1ed377f8ddff" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_019c9ac1-ae72-7f1a-9714-509ea48ed598" xlink:to="loc_srt_RangeAxis_019c9ac1-ae72-799f-9a71-1ed377f8ddff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_019c9ac1-ae72-799f-9a71-1ed377f8ddff_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_019c9ac1-ae72-799f-9a71-1ed377f8ddff" xlink:to="loc_srt_RangeMember_019c9ac1-ae72-799f-9a71-1ed377f8ddff_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_019c9ac1-ae72-7821-bfdb-b6e874a0d7c6" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_019c9ac1-ae72-799f-9a71-1ed377f8ddff" xlink:to="loc_srt_RangeMember_019c9ac1-ae72-7821-bfdb-b6e874a0d7c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_019c9ac1-ae72-7477-a219-8713f9dbae2e" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_019c9ac1-ae72-7821-bfdb-b6e874a0d7c6" xlink:to="loc_srt_MinimumMember_019c9ac1-ae72-7477-a219-8713f9dbae2e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_019c9ac1-ae72-722d-9af6-47e3b6ef4b29" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_019c9ac1-ae72-7821-bfdb-b6e874a0d7c6" xlink:to="loc_srt_MaximumMember_019c9ac1-ae72-722d-9af6-47e3b6ef4b29" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_019c9ac1-ae72-7820-ac61-87620038ae3b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_019c9ac1-ae72-7cb5-a9fd-a00d78887274" xlink:to="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_019c9ac1-ae72-7820-ac61-87620038ae3b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_019c9ac1-ae72-7661-a5c3-c6c0bf99cc25" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_019c9ac1-ae72-7cb5-a9fd-a00d78887274" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_019c9ac1-ae72-7661-a5c3-c6c0bf99cc25" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_IncreaseDecreaseInOperatingLeaseRightOfUseAssets_019c9ac1-ae72-73a1-a40d-8cb28d46058a" xlink:href="rxrx-20260331.xsd#rxrx_IncreaseDecreaseInOperatingLeaseRightOfUseAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_019c9ac1-ae72-7cb5-a9fd-a00d78887274" xlink:to="loc_rxrx_IncreaseDecreaseInOperatingLeaseRightOfUseAssets_019c9ac1-ae72-73a1-a40d-8cb28d46058a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_LesseeOperatingLeaseIncreaseDecreaseInOperatingLeaseLiabilityDueToLeaseModifications_019c9ac1-ae72-7093-8fcc-b1c0124190e1" xlink:href="rxrx-20260331.xsd#rxrx_LesseeOperatingLeaseIncreaseDecreaseInOperatingLeaseLiabilityDueToLeaseModifications"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_019c9ac1-ae72-7cb5-a9fd-a00d78887274" xlink:to="loc_rxrx_LesseeOperatingLeaseIncreaseDecreaseInOperatingLeaseLiabilityDueToLeaseModifications_019c9ac1-ae72-7093-8fcc-b1c0124190e1" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.recursion.com/role/GoodwillandIntangibleAssetsScheduleofIntangibleassetsDetails" xlink:type="simple" xlink:href="rxrx-20260331.xsd#GoodwillandIntangibleAssetsScheduleofIntangibleassetsDetails"/>
  <link:definitionLink xlink:role="http://www.recursion.com/role/GoodwillandIntangibleAssetsScheduleofIntangibleassetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_019c9ac1-ae72-7c1e-b6a2-2e097c8b8cb3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_019c9ac1-ae72-77c3-b764-88bd08a3141b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_019c9ac1-ae72-7c1e-b6a2-2e097c8b8cb3" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_019c9ac1-ae72-77c3-b764-88bd08a3141b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_019c9ac1-ae72-75be-be86-5e7d1e1e4574" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_019c9ac1-ae72-77c3-b764-88bd08a3141b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_019c9ac1-ae72-75be-be86-5e7d1e1e4574" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_019c9ac1-ae72-75be-be86-5e7d1e1e4574_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_019c9ac1-ae72-75be-be86-5e7d1e1e4574" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_019c9ac1-ae72-75be-be86-5e7d1e1e4574_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_019c9ac1-ae72-771c-849d-df69772b95fd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_019c9ac1-ae72-75be-be86-5e7d1e1e4574" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_019c9ac1-ae72-771c-849d-df69772b95fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_019c9ac1-ae72-7e44-951f-fdf22407bd65" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_019c9ac1-ae72-771c-849d-df69772b95fd" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_019c9ac1-ae72-7e44-951f-fdf22407bd65" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_019c9ac1-ae72-76de-9ce9-b7655b7b1aab" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_019c9ac1-ae72-771c-849d-df69772b95fd" xlink:to="loc_us-gaap_LicensingAgreementsMember_019c9ac1-ae72-76de-9ce9-b7655b7b1aab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_019c9ac1-ae72-7a26-8bb0-e66006b3a1a2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_019c9ac1-ae72-7c1e-b6a2-2e097c8b8cb3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_019c9ac1-ae72-7a26-8bb0-e66006b3a1a2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_019c9ac1-ae72-70d6-81da-82ab0dbb5d6f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_019c9ac1-ae72-7c1e-b6a2-2e097c8b8cb3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_019c9ac1-ae72-70d6-81da-82ab0dbb5d6f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_019c9ac1-ae72-7632-b713-be93a3b33e04" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_019c9ac1-ae72-7c1e-b6a2-2e097c8b8cb3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_019c9ac1-ae72-7632-b713-be93a3b33e04" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_019c9ac1-ae72-7d24-8753-4e522da78b74" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_019c9ac1-ae72-7c1e-b6a2-2e097c8b8cb3" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_019c9ac1-ae72-7d24-8753-4e522da78b74" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_019c9ac1-ae72-754e-acee-a6afc2396467" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_019c9ac1-ae72-7c1e-b6a2-2e097c8b8cb3" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_019c9ac1-ae72-754e-acee-a6afc2396467" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_019c9ac1-ae72-7125-b0ab-f6cdcb7ed940" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_019c9ac1-ae72-7c1e-b6a2-2e097c8b8cb3" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_019c9ac1-ae72-7125-b0ab-f6cdcb7ed940" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.recursion.com/role/CommonStockNarrativeDetails" xlink:type="simple" xlink:href="rxrx-20260331.xsd#CommonStockNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.recursion.com/role/CommonStockNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_019c9ac1-ae72-729a-a903-c7d056dcc028" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_019c9ac1-ae72-7082-be58-dcc153998c20" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_019c9ac1-ae72-729a-a903-c7d056dcc028" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_019c9ac1-ae72-7082-be58-dcc153998c20" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_019c9ac1-ae72-7d74-ac1a-67aee07f9541" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_019c9ac1-ae72-7082-be58-dcc153998c20" xlink:to="loc_us-gaap_StatementClassOfStockAxis_019c9ac1-ae72-7d74-ac1a-67aee07f9541" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_019c9ac1-ae72-7d74-ac1a-67aee07f9541_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_019c9ac1-ae72-7d74-ac1a-67aee07f9541" xlink:to="loc_us-gaap_ClassOfStockDomain_019c9ac1-ae72-7d74-ac1a-67aee07f9541_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_019c9ac1-ae72-7adc-a1a6-de3254ed0a1f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_019c9ac1-ae72-7d74-ac1a-67aee07f9541" xlink:to="loc_us-gaap_ClassOfStockDomain_019c9ac1-ae72-7adc-a1a6-de3254ed0a1f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_019c9ac1-ae72-7119-ba26-a6f1db2d4a17" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_019c9ac1-ae72-7adc-a1a6-de3254ed0a1f" xlink:to="loc_us-gaap_CommonClassAMember_019c9ac1-ae72-7119-ba26-a6f1db2d4a17" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_019c9ac1-ae72-7e60-9646-93052401ff22" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_019c9ac1-ae72-7adc-a1a6-de3254ed0a1f" xlink:to="loc_us-gaap_CommonClassBMember_019c9ac1-ae72-7e60-9646-93052401ff22" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_CommonStockVotePerShare_019c9ac1-ae72-7227-b530-0fcfeb0a0539" xlink:href="rxrx-20260331.xsd#rxrx_CommonStockVotePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_019c9ac1-ae72-729a-a903-c7d056dcc028" xlink:to="loc_rxrx_CommonStockVotePerShare_019c9ac1-ae72-7227-b530-0fcfeb0a0539" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsStock_019c9ac1-ae72-7351-827c-23a867c9ba64" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DividendsStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_019c9ac1-ae72-729a-a903-c7d056dcc028" xlink:to="loc_us-gaap_DividendsStock_019c9ac1-ae72-7351-827c-23a867c9ba64" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.recursion.com/role/CommonStockAtTheMarketOfferingNarrativeDetails" xlink:type="simple" xlink:href="rxrx-20260331.xsd#CommonStockAtTheMarketOfferingNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.recursion.com/role/CommonStockAtTheMarketOfferingNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_019c9ac1-ae72-777f-9676-4fa270e4385e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_019c9ac1-ae72-7962-9f25-d54dfb2d2b46" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_019c9ac1-ae72-777f-9676-4fa270e4385e" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_019c9ac1-ae72-7962-9f25-d54dfb2d2b46" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_019c9ac1-ae72-70e9-a120-944ae2f276dc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_019c9ac1-ae72-7962-9f25-d54dfb2d2b46" xlink:to="loc_us-gaap_StatementClassOfStockAxis_019c9ac1-ae72-70e9-a120-944ae2f276dc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_019c9ac1-ae72-70e9-a120-944ae2f276dc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_019c9ac1-ae72-70e9-a120-944ae2f276dc" xlink:to="loc_us-gaap_ClassOfStockDomain_019c9ac1-ae72-70e9-a120-944ae2f276dc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_019c9ac1-ae72-795b-a3ff-356d01edc0e7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_019c9ac1-ae72-70e9-a120-944ae2f276dc" xlink:to="loc_us-gaap_ClassOfStockDomain_019c9ac1-ae72-795b-a3ff-356d01edc0e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_019c9ac1-ae72-790b-a012-dbfd7f32c0a6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_019c9ac1-ae72-795b-a3ff-356d01edc0e7" xlink:to="loc_us-gaap_CommonClassAMember_019c9ac1-ae72-790b-a012-dbfd7f32c0a6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_019c9ac1-ae72-7e70-9dde-a4983e308d1d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_019c9ac1-ae72-7962-9f25-d54dfb2d2b46" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_019c9ac1-ae72-7e70-9dde-a4983e308d1d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019c9ac1-ae72-7e70-9dde-a4983e308d1d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_019c9ac1-ae72-7e70-9dde-a4983e308d1d" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019c9ac1-ae72-7e70-9dde-a4983e308d1d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019c9ac1-ae72-7d89-85f6-addcdb8f55aa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_019c9ac1-ae72-7e70-9dde-a4983e308d1d" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019c9ac1-ae72-7d89-85f6-addcdb8f55aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_AtTheMarketOfferingProgramTDCowenMember_019d86b0-3b06-7d77-ba44-bfc407063294" xlink:href="rxrx-20260331.xsd#rxrx_AtTheMarketOfferingProgramTDCowenMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019c9ac1-ae72-7d89-85f6-addcdb8f55aa" xlink:to="loc_rxrx_AtTheMarketOfferingProgramTDCowenMember_019d86b0-3b06-7d77-ba44-bfc407063294" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_SaleOfStockValueAuthorized_019c9ac1-ae72-7d56-a670-6763dc70dd41" xlink:href="rxrx-20260331.xsd#rxrx_SaleOfStockValueAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_019c9ac1-ae72-777f-9676-4fa270e4385e" xlink:to="loc_rxrx_SaleOfStockValueAuthorized_019c9ac1-ae72-7d56-a670-6763dc70dd41" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_SaleOfStockValueRemainingAuthorized_019c9ac1-ae72-79d4-9d48-d6bcab7c2e8f" xlink:href="rxrx-20260331.xsd#rxrx_SaleOfStockValueRemainingAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_019c9ac1-ae72-777f-9676-4fa270e4385e" xlink:to="loc_rxrx_SaleOfStockValueRemainingAuthorized_019c9ac1-ae72-79d4-9d48-d6bcab7c2e8f" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.recursion.com/role/CommonStockValenceAcquisitionExchangeableSharesNarrativeDetails" xlink:type="simple" xlink:href="rxrx-20260331.xsd#CommonStockValenceAcquisitionExchangeableSharesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.recursion.com/role/CommonStockValenceAcquisitionExchangeableSharesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_019c9ac1-ae72-7fcf-af74-2e672defefed" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_019c9ac1-ae72-7aff-9f32-987e50af866f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_019c9ac1-ae72-7fcf-af74-2e672defefed" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_019c9ac1-ae72-7aff-9f32-987e50af866f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_019c9ac1-ae72-736f-a0c2-e87d36d337bf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_019c9ac1-ae72-7aff-9f32-987e50af866f" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_019c9ac1-ae72-736f-a0c2-e87d36d337bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_019c9ac1-ae72-736f-a0c2-e87d36d337bf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_019c9ac1-ae72-736f-a0c2-e87d36d337bf" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_019c9ac1-ae72-736f-a0c2-e87d36d337bf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_019c9ac1-ae72-7fe1-86c0-3fd9c2ebc821" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_019c9ac1-ae72-736f-a0c2-e87d36d337bf" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_019c9ac1-ae72-7fe1-86c0-3fd9c2ebc821" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_ValenceDiscoveryIncMember_019c9ac1-ae72-7619-965e-862e0def20e1" xlink:href="rxrx-20260331.xsd#rxrx_ValenceDiscoveryIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_019c9ac1-ae72-7fe1-86c0-3fd9c2ebc821" xlink:to="loc_rxrx_ValenceDiscoveryIncMember_019c9ac1-ae72-7619-965e-862e0def20e1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_019c9ac1-ae72-7062-b353-850c8a0f547f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_019c9ac1-ae72-7aff-9f32-987e50af866f" xlink:to="loc_us-gaap_StatementClassOfStockAxis_019c9ac1-ae72-7062-b353-850c8a0f547f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_019c9ac1-ae72-7062-b353-850c8a0f547f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_019c9ac1-ae72-7062-b353-850c8a0f547f" xlink:to="loc_us-gaap_ClassOfStockDomain_019c9ac1-ae72-7062-b353-850c8a0f547f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_019c9ac1-ae72-7220-9d8e-cc466f750dc9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_019c9ac1-ae72-7062-b353-850c8a0f547f" xlink:to="loc_us-gaap_ClassOfStockDomain_019c9ac1-ae72-7220-9d8e-cc466f750dc9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_ExchangeableStockMember_019c9ac1-ae72-7485-8910-c0f903d04dac" xlink:href="rxrx-20260331.xsd#rxrx_ExchangeableStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_019c9ac1-ae72-7220-9d8e-cc466f750dc9" xlink:to="loc_rxrx_ExchangeableStockMember_019c9ac1-ae72-7485-8910-c0f903d04dac" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_BusinessAcquisitionContingentConsiderationEquityInterestsIssuableNumberOfShares_019c9ac1-ae73-724a-8ab0-b6e002ec5431" xlink:href="rxrx-20260331.xsd#rxrx_BusinessAcquisitionContingentConsiderationEquityInterestsIssuableNumberOfShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_019c9ac1-ae72-7fcf-af74-2e672defefed" xlink:to="loc_rxrx_BusinessAcquisitionContingentConsiderationEquityInterestsIssuableNumberOfShares_019c9ac1-ae73-724a-8ab0-b6e002ec5431" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_019c9ac1-ae73-7aa9-bed9-c9648dacd2e6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_019c9ac1-ae72-7fcf-af74-2e672defefed" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_019c9ac1-ae73-7aa9-bed9-c9648dacd2e6" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.recursion.com/role/CommonStockRegistrationRightsAgreementsNarrativeDetails" xlink:type="simple" xlink:href="rxrx-20260331.xsd#CommonStockRegistrationRightsAgreementsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.recursion.com/role/CommonStockRegistrationRightsAgreementsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_019c9ac1-ae73-72ca-84e8-e77d3b9da49e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_019c9ac1-ae73-7113-844f-eaab78e570c2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_019c9ac1-ae73-72ca-84e8-e77d3b9da49e" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_019c9ac1-ae73-7113-844f-eaab78e570c2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_019c9ac1-ae73-7905-8c4f-5feb35195507" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_019c9ac1-ae73-7113-844f-eaab78e570c2" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_019c9ac1-ae73-7905-8c4f-5feb35195507" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_019c9ac1-ae73-7905-8c4f-5feb35195507_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_019c9ac1-ae73-7905-8c4f-5feb35195507" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_019c9ac1-ae73-7905-8c4f-5feb35195507_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_019c9ac1-ae73-79e8-8ca1-9ffd741fe434" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_019c9ac1-ae73-7905-8c4f-5feb35195507" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_019c9ac1-ae73-79e8-8ca1-9ffd741fe434" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_ValenceDiscoveryIncMember_019c9ac1-ae73-7620-8452-bb48cf2e2907" xlink:href="rxrx-20260331.xsd#rxrx_ValenceDiscoveryIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_019c9ac1-ae73-79e8-8ca1-9ffd741fe434" xlink:to="loc_rxrx_ValenceDiscoveryIncMember_019c9ac1-ae73-7620-8452-bb48cf2e2907" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_RegistrationRightsAgreementTerm_019c9ac1-ae73-7e4a-9717-756992eacd15" xlink:href="rxrx-20260331.xsd#rxrx_RegistrationRightsAgreementTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_019c9ac1-ae73-72ca-84e8-e77d3b9da49e" xlink:to="loc_rxrx_RegistrationRightsAgreementTerm_019c9ac1-ae73-7e4a-9717-756992eacd15" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.recursion.com/role/CommonStockClassAandBCommonSharesAuthorizationNarrativeDetails" xlink:type="simple" xlink:href="rxrx-20260331.xsd#CommonStockClassAandBCommonSharesAuthorizationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.recursion.com/role/CommonStockClassAandBCommonSharesAuthorizationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_019c9ac1-ae73-74db-8a16-2963c47a3fb2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_019c9ac1-ae73-7a54-8148-25920773ad45" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_019c9ac1-ae73-74db-8a16-2963c47a3fb2" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_019c9ac1-ae73-7a54-8148-25920773ad45" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_019c9ac1-ae73-7447-b1c1-16db90a9559d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_019c9ac1-ae73-7a54-8148-25920773ad45" xlink:to="loc_us-gaap_StatementClassOfStockAxis_019c9ac1-ae73-7447-b1c1-16db90a9559d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_019c9ac1-ae73-7447-b1c1-16db90a9559d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_019c9ac1-ae73-7447-b1c1-16db90a9559d" xlink:to="loc_us-gaap_ClassOfStockDomain_019c9ac1-ae73-7447-b1c1-16db90a9559d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_019c9ac1-ae73-71a1-b68e-6603f2ec602d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_019c9ac1-ae73-7447-b1c1-16db90a9559d" xlink:to="loc_us-gaap_ClassOfStockDomain_019c9ac1-ae73-71a1-b68e-6603f2ec602d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_019c9ac1-ae73-74ec-b91e-9d5ca2f1f604" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_019c9ac1-ae73-71a1-b68e-6603f2ec602d" xlink:to="loc_us-gaap_CommonClassAMember_019c9ac1-ae73-74ec-b91e-9d5ca2f1f604" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_019c9ac1-ae73-7956-9d2b-02466df2dd24" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_019c9ac1-ae73-71a1-b68e-6603f2ec602d" xlink:to="loc_us-gaap_CommonClassBMember_019c9ac1-ae73-7956-9d2b-02466df2dd24" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_NumberOfClassesOfCommonStockAuthorized_019c9ac1-ae73-71ed-80f9-8a34d4f1c1ba" xlink:href="rxrx-20260331.xsd#rxrx_NumberOfClassesOfCommonStockAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_019c9ac1-ae73-74db-8a16-2963c47a3fb2" xlink:to="loc_rxrx_NumberOfClassesOfCommonStockAuthorized_019c9ac1-ae73-71ed-80f9-8a34d4f1c1ba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_CommonStockVotePerShare_019c9ac1-ae73-74f7-92c7-10dbf7f62c8c" xlink:href="rxrx-20260331.xsd#rxrx_CommonStockVotePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_019c9ac1-ae73-74db-8a16-2963c47a3fb2" xlink:to="loc_rxrx_CommonStockVotePerShare_019c9ac1-ae73-74f7-92c7-10dbf7f62c8c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_CommonStockConversionRatio_019c9ac1-ae73-7b31-a904-e0a82a2efce6" xlink:href="rxrx-20260331.xsd#rxrx_CommonStockConversionRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_019c9ac1-ae73-74db-8a16-2963c47a3fb2" xlink:to="loc_rxrx_CommonStockConversionRatio_019c9ac1-ae73-7b31-a904-e0a82a2efce6" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.recursion.com/role/CollaborativeDevelopmentContractsDetails" xlink:type="simple" xlink:href="rxrx-20260331.xsd#CollaborativeDevelopmentContractsDetails"/>
  <link:definitionLink xlink:role="http://www.recursion.com/role/CollaborativeDevelopmentContractsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_019d86b9-8d58-79dd-822a-33762a86a1da" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_019c9ac1-ae73-7a77-90b2-42b8ccf62711" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_019d86b9-8d58-79dd-822a-33762a86a1da" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_019c9ac1-ae73-7a77-90b2-42b8ccf62711" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_019d86b9-8d58-7a79-ad51-7557bfd139da" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_019c9ac1-ae73-7a77-90b2-42b8ccf62711" xlink:to="loc_srt_CounterpartyNameAxis_019d86b9-8d58-7a79-ad51-7557bfd139da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_019d86b9-8d58-7a79-ad51-7557bfd139da_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_019d86b9-8d58-7a79-ad51-7557bfd139da" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_019d86b9-8d58-7a79-ad51-7557bfd139da_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_019d86b9-8d58-7049-85de-7b4163c9f006" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_019d86b9-8d58-7a79-ad51-7557bfd139da" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_019d86b9-8d58-7049-85de-7b4163c9f006" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_SanofiMember_019d86b9-8d58-78dd-82e4-fa44ecd5f30b" xlink:href="rxrx-20260331.xsd#rxrx_SanofiMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_019d86b9-8d58-7049-85de-7b4163c9f006" xlink:to="loc_rxrx_SanofiMember_019d86b9-8d58-78dd-82e4-fa44ecd5f30b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_MerckKGaAMerckMember_019d86bc-1554-7bdd-9421-ec768252dd1d" xlink:href="rxrx-20260331.xsd#rxrx_MerckKGaAMerckMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_019d86b9-8d58-7049-85de-7b4163c9f006" xlink:to="loc_rxrx_MerckKGaAMerckMember_019d86bc-1554-7bdd-9421-ec768252dd1d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_RocheAndGenentechMember_019d86be-7eb6-77e0-b34d-759d850ac6d5" xlink:href="rxrx-20260331.xsd#rxrx_RocheAndGenentechMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_019d86b9-8d58-7049-85de-7b4163c9f006" xlink:to="loc_rxrx_RocheAndGenentechMember_019d86be-7eb6-77e0-b34d-759d850ac6d5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_019d86b9-8d58-75c0-bccf-aec46758ccaf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_019c9ac1-ae73-7a77-90b2-42b8ccf62711" xlink:to="loc_us-gaap_TypeOfArrangementAxis_019d86b9-8d58-75c0-bccf-aec46758ccaf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019d86b9-8d58-75c0-bccf-aec46758ccaf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_019d86b9-8d58-75c0-bccf-aec46758ccaf" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019d86b9-8d58-75c0-bccf-aec46758ccaf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019d86b9-8d58-75fd-8392-affed4e2bca2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_019d86b9-8d58-75c0-bccf-aec46758ccaf" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019d86b9-8d58-75fd-8392-affed4e2bca2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementMember_019d86b9-8d58-7704-bb65-99fa86c61be2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CollaborativeArrangementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019d86b9-8d58-75fd-8392-affed4e2bca2" xlink:to="loc_us-gaap_CollaborativeArrangementMember_019d86b9-8d58-7704-bb65-99fa86c61be2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_MilestoneTypeAxis_019d86ba-800f-7552-b720-3b705312c12f" xlink:href="rxrx-20260331.xsd#rxrx_MilestoneTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_019c9ac1-ae73-7a77-90b2-42b8ccf62711" xlink:to="loc_rxrx_MilestoneTypeAxis_019d86ba-800f-7552-b720-3b705312c12f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_MilestoneTypeDomain_019d86ba-800f-7552-b720-3b705312c12f_default" xlink:href="rxrx-20260331.xsd#rxrx_MilestoneTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_rxrx_MilestoneTypeAxis_019d86ba-800f-7552-b720-3b705312c12f" xlink:to="loc_rxrx_MilestoneTypeDomain_019d86ba-800f-7552-b720-3b705312c12f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_MilestoneTypeDomain_019d86ba-800f-76b1-8518-356b58476737" xlink:href="rxrx-20260331.xsd#rxrx_MilestoneTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_rxrx_MilestoneTypeAxis_019d86ba-800f-7552-b720-3b705312c12f" xlink:to="loc_rxrx_MilestoneTypeDomain_019d86ba-800f-76b1-8518-356b58476737" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_ResearchMilestonesMember_019d86ba-800f-7ec6-9446-d5d68f3efdf0" xlink:href="rxrx-20260331.xsd#rxrx_ResearchMilestonesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rxrx_MilestoneTypeDomain_019d86ba-800f-76b1-8518-356b58476737" xlink:to="loc_rxrx_ResearchMilestonesMember_019d86ba-800f-7ec6-9446-d5d68f3efdf0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_DevelopmentAndRegulatoryMilestonesMember_019d86ba-800f-7b72-be16-eef7b74737fa" xlink:href="rxrx-20260331.xsd#rxrx_DevelopmentAndRegulatoryMilestonesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rxrx_MilestoneTypeDomain_019d86ba-800f-76b1-8518-356b58476737" xlink:to="loc_rxrx_DevelopmentAndRegulatoryMilestonesMember_019d86ba-800f-7b72-be16-eef7b74737fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_DiscoveryDevelopmentAndSalesMilestonesMember_019d86bc-1554-78fe-b6e9-89ef35276d35" xlink:href="rxrx-20260331.xsd#rxrx_DiscoveryDevelopmentAndSalesMilestonesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rxrx_MilestoneTypeDomain_019d86ba-800f-76b1-8518-356b58476737" xlink:to="loc_rxrx_DiscoveryDevelopmentAndSalesMilestonesMember_019d86bc-1554-78fe-b6e9-89ef35276d35" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_RevenueRemainingPerformanceObligationAxis_019d86c2-74a2-7e02-8992-92a3035370f3" xlink:href="rxrx-20260331.xsd#rxrx_RevenueRemainingPerformanceObligationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_019c9ac1-ae73-7a77-90b2-42b8ccf62711" xlink:to="loc_rxrx_RevenueRemainingPerformanceObligationAxis_019d86c2-74a2-7e02-8992-92a3035370f3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_RevenueRemainingPerformanceObligationDomain_019d86c2-74a2-7e02-8992-92a3035370f3_default" xlink:href="rxrx-20260331.xsd#rxrx_RevenueRemainingPerformanceObligationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_rxrx_RevenueRemainingPerformanceObligationAxis_019d86c2-74a2-7e02-8992-92a3035370f3" xlink:to="loc_rxrx_RevenueRemainingPerformanceObligationDomain_019d86c2-74a2-7e02-8992-92a3035370f3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_RevenueRemainingPerformanceObligationDomain_019d86c2-74a2-7411-b611-ed16c7d1838d" xlink:href="rxrx-20260331.xsd#rxrx_RevenueRemainingPerformanceObligationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_rxrx_RevenueRemainingPerformanceObligationAxis_019d86c2-74a2-7e02-8992-92a3035370f3" xlink:to="loc_rxrx_RevenueRemainingPerformanceObligationDomain_019d86c2-74a2-7411-b611-ed16c7d1838d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_PhenomapsCreationMember_019d86c2-74a2-7f11-86dd-841767719e95" xlink:href="rxrx-20260331.xsd#rxrx_PhenomapsCreationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rxrx_RevenueRemainingPerformanceObligationDomain_019d86c2-74a2-7411-b611-ed16c7d1838d" xlink:to="loc_rxrx_PhenomapsCreationMember_019d86c2-74a2-7f11-86dd-841767719e95" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_PhenomapsRawImagesMember_019d86c2-74a2-7154-b0cc-e01c47cc2def" xlink:href="rxrx-20260331.xsd#rxrx_PhenomapsRawImagesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rxrx_RevenueRemainingPerformanceObligationDomain_019d86c2-74a2-7411-b611-ed16c7d1838d" xlink:to="loc_rxrx_PhenomapsRawImagesMember_019d86c2-74a2-7154-b0cc-e01c47cc2def" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_DevelopedAndCommercializedProgramsMember_019d86c2-74a2-75af-b7dc-8608b2ed44ea" xlink:href="rxrx-20260331.xsd#rxrx_DevelopedAndCommercializedProgramsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rxrx_RevenueRemainingPerformanceObligationDomain_019d86c2-74a2-7411-b611-ed16c7d1838d" xlink:to="loc_rxrx_DevelopedAndCommercializedProgramsMember_019d86c2-74a2-75af-b7dc-8608b2ed44ea" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_GastrointestinalCancerMember_019d86c3-5664-7793-b3b6-01bc6a41bfda" xlink:href="rxrx-20260331.xsd#rxrx_GastrointestinalCancerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rxrx_RevenueRemainingPerformanceObligationDomain_019d86c2-74a2-7411-b611-ed16c7d1838d" xlink:to="loc_rxrx_GastrointestinalCancerMember_019d86c3-5664-7793-b3b6-01bc6a41bfda" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_NeuroscienceMember_019d86c3-5664-759e-842d-b20d617cf885" xlink:href="rxrx-20260331.xsd#rxrx_NeuroscienceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rxrx_RevenueRemainingPerformanceObligationDomain_019d86c2-74a2-7411-b611-ed16c7d1838d" xlink:to="loc_rxrx_NeuroscienceMember_019d86c3-5664-759e-842d-b20d617cf885" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_ContractWithCustomerNumberOfNovelSmallMoleculeCandidates_019d86b9-8d58-70a1-859d-08d37b51970a" xlink:href="rxrx-20260331.xsd#rxrx_ContractWithCustomerNumberOfNovelSmallMoleculeCandidates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_019d86b9-8d58-79dd-822a-33762a86a1da" xlink:to="loc_rxrx_ContractWithCustomerNumberOfNovelSmallMoleculeCandidates_019d86b9-8d58-70a1-859d-08d37b51970a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_019d86ba-800f-7879-899d-3ee51d7a8d69" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_019d86b9-8d58-79dd-822a-33762a86a1da" xlink:to="loc_us-gaap_ContractWithCustomerLiability_019d86ba-800f-7879-899d-3ee51d7a8d69" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_019d86ba-800f-7bba-954a-3113deead32c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_019d86b9-8d58-79dd-822a-33762a86a1da" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_019d86ba-800f-7bba-954a-3113deead32c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_RevenuePerformanceObligationNumberOfObligations_019d86ba-ddbc-7d68-9fcf-c8f486ddb9b9" xlink:href="rxrx-20260331.xsd#rxrx_RevenuePerformanceObligationNumberOfObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_019d86b9-8d58-79dd-822a-33762a86a1da" xlink:to="loc_rxrx_RevenuePerformanceObligationNumberOfObligations_019d86ba-ddbc-7d68-9fcf-c8f486ddb9b9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_019d86bb-4d90-776b-a0a2-7923049b796c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_019d86b9-8d58-79dd-822a-33762a86a1da" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_019d86bb-4d90-776b-a0a2-7923049b796c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_RevenueRemainingPerformanceObligationVariableConsiderationAmount_019d86c2-74a2-710d-89fd-9d9cc5ef66bf" xlink:href="rxrx-20260331.xsd#rxrx_RevenueRemainingPerformanceObligationVariableConsiderationAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_019d86b9-8d58-79dd-822a-33762a86a1da" xlink:to="loc_rxrx_RevenueRemainingPerformanceObligationVariableConsiderationAmount_019d86c2-74a2-710d-89fd-9d9cc5ef66bf" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_ContractWithCustomerMaximumAcceptedProduct_019d86c2-74a2-726c-9fd6-32558fa1b9f3" xlink:href="rxrx-20260331.xsd#rxrx_ContractWithCustomerMaximumAcceptedProduct"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_019d86b9-8d58-79dd-822a-33762a86a1da" xlink:to="loc_rxrx_ContractWithCustomerMaximumAcceptedProduct_019d86c2-74a2-726c-9fd6-32558fa1b9f3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_RevenueRemainingPerformanceObligationNumberOfProjectsThatMayBeInitiated_019d86c2-74a2-7a21-9e79-6686f80d823f" xlink:href="rxrx-20260331.xsd#rxrx_RevenueRemainingPerformanceObligationNumberOfProjectsThatMayBeInitiated"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_019d86b9-8d58-79dd-822a-33762a86a1da" xlink:to="loc_rxrx_RevenueRemainingPerformanceObligationNumberOfProjectsThatMayBeInitiated_019d86c2-74a2-7a21-9e79-6686f80d823f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent_019d86c5-65c0-7042-856d-e1503fa14ebf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_019d86b9-8d58-79dd-822a-33762a86a1da" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetCurrent_019d86c5-65c0-7042-856d-e1503fa14ebf" xlink:type="arc" order="8"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.recursion.com/role/StockBasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="rxrx-20260331.xsd#StockBasedCompensationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.recursion.com/role/StockBasedCompensationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d9203-4db8-74fc-9809-04d30bffc129" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019c9ac1-ae73-78c3-ac04-c3f8072437bf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d9203-4db8-74fc-9809-04d30bffc129" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019c9ac1-ae73-78c3-ac04-c3f8072437bf" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_019d9203-4db8-7f05-9918-e7c485e34ac2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019c9ac1-ae73-78c3-ac04-c3f8072437bf" xlink:to="loc_us-gaap_PlanNameAxis_019d9203-4db8-7f05-9918-e7c485e34ac2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_019d9203-4db8-7f05-9918-e7c485e34ac2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_019d9203-4db8-7f05-9918-e7c485e34ac2" xlink:to="loc_us-gaap_PlanNameDomain_019d9203-4db8-7f05-9918-e7c485e34ac2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_019d9203-4db8-70bc-8214-ab5dff30d985" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_019d9203-4db8-7f05-9918-e7c485e34ac2" xlink:to="loc_us-gaap_PlanNameDomain_019d9203-4db8-70bc-8214-ab5dff30d985" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_A2021EquityIncentivePlanMember_019d9203-4db8-731f-933e-6d5662b6b6d5" xlink:href="rxrx-20260331.xsd#rxrx_A2021EquityIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_019d9203-4db8-70bc-8214-ab5dff30d985" xlink:to="loc_rxrx_A2021EquityIncentivePlanMember_019d9203-4db8-731f-933e-6d5662b6b6d5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_A2024InducementEquityIncentivePlanMember_019d9203-4db8-7587-b6ac-91cdce3ba2c7" xlink:href="rxrx-20260331.xsd#rxrx_A2024InducementEquityIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_019d9203-4db8-70bc-8214-ab5dff30d985" xlink:to="loc_rxrx_A2024InducementEquityIncentivePlanMember_019d9203-4db8-7587-b6ac-91cdce3ba2c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_019d9203-6c8c-74ca-9e08-aea2f33ded99" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019c9ac1-ae73-78c3-ac04-c3f8072437bf" xlink:to="loc_us-gaap_AwardTypeAxis_019d9203-6c8c-74ca-9e08-aea2f33ded99" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019d9203-6c8c-74ca-9e08-aea2f33ded99_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_019d9203-6c8c-74ca-9e08-aea2f33ded99" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019d9203-6c8c-74ca-9e08-aea2f33ded99_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019d9203-6c8c-7e81-929d-8804931a862a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_019d9203-6c8c-74ca-9e08-aea2f33ded99" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019d9203-6c8c-7e81-929d-8804931a862a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_019d9203-6c8c-7887-84a8-d3b9c91fcc28" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019d9203-6c8c-7e81-929d-8804931a862a" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_019d9203-6c8c-7887-84a8-d3b9c91fcc28" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_019d9203-4db8-7446-9d0d-05dc3a74df81" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d9203-4db8-74fc-9809-04d30bffc129" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_019d9203-4db8-7446-9d0d-05dc3a74df81" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_019d9203-6c8c-746b-b297-44526604f728" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d9203-4db8-74fc-9809-04d30bffc129" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_019d9203-6c8c-746b-b297-44526604f728" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_019d9203-908d-75b3-9f10-185be72a65d3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d9203-4db8-74fc-9809-04d30bffc129" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_019d9203-908d-75b3-9f10-185be72a65d3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_019d9203-908d-7f58-981f-3694e96120b5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d9203-4db8-74fc-9809-04d30bffc129" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_019d9203-908d-7f58-981f-3694e96120b5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_019d9203-908d-780b-b03f-fd738da9cc95" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d9203-4db8-74fc-9809-04d30bffc129" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_019d9203-908d-780b-b03f-fd738da9cc95" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.recursion.com/role/StockBasedCompensationScheduleofStockBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="rxrx-20260331.xsd#StockBasedCompensationScheduleofStockBasedCompensationExpenseDetails"/>
  <link:definitionLink xlink:role="http://www.recursion.com/role/StockBasedCompensationScheduleofStockBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_019c9ac1-ae73-7ac2-8b7d-4c31908e68da" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_019c9ac1-ae73-7af8-b735-670a1d75c0d3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_019c9ac1-ae73-7ac2-8b7d-4c31908e68da" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_019c9ac1-ae73-7af8-b735-670a1d75c0d3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_019c9ac1-ae73-7f03-ad66-8441efbaa0c2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_019c9ac1-ae73-7af8-b735-670a1d75c0d3" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_019c9ac1-ae73-7f03-ad66-8441efbaa0c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_019c9ac1-ae73-7f03-ad66-8441efbaa0c2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_019c9ac1-ae73-7f03-ad66-8441efbaa0c2" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_019c9ac1-ae73-7f03-ad66-8441efbaa0c2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_019c9ac1-ae73-7d58-a2ac-3178136e8c02" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_019c9ac1-ae73-7f03-ad66-8441efbaa0c2" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_019c9ac1-ae73-7d58-a2ac-3178136e8c02" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_019c9ac1-ae73-752e-8e52-c1b78027200b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_019c9ac1-ae73-7d58-a2ac-3178136e8c02" xlink:to="loc_us-gaap_CostOfSalesMember_019c9ac1-ae73-752e-8e52-c1b78027200b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_019c9ac1-ae73-78df-9f95-7daaeede72d5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_019c9ac1-ae73-7d58-a2ac-3178136e8c02" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_019c9ac1-ae73-78df-9f95-7daaeede72d5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_019c9ac1-ae73-7b03-967b-79f62b052025" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_019c9ac1-ae73-7d58-a2ac-3178136e8c02" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_019c9ac1-ae73-7b03-967b-79f62b052025" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_019c9ac1-ae73-7e6e-aa8f-e27d300de15f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_019c9ac1-ae73-7ac2-8b7d-4c31908e68da" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_019c9ac1-ae73-7e6e-aa8f-e27d300de15f" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.recursion.com/role/StockBasedCompensationScheduleofRSUActivityDetails" xlink:type="simple" xlink:href="rxrx-20260331.xsd#StockBasedCompensationScheduleofRSUActivityDetails"/>
  <link:definitionLink xlink:role="http://www.recursion.com/role/StockBasedCompensationScheduleofRSUActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019c9ac1-ae73-74db-b1f5-62691cd054dd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019c9ac1-ae73-73b6-bf16-22fa2b65562a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019c9ac1-ae73-74db-b1f5-62691cd054dd" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019c9ac1-ae73-73b6-bf16-22fa2b65562a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_019c9ac1-ae73-753c-a94f-0dc7c17b553a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019c9ac1-ae73-73b6-bf16-22fa2b65562a" xlink:to="loc_us-gaap_AwardTypeAxis_019c9ac1-ae73-753c-a94f-0dc7c17b553a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019c9ac1-ae73-753c-a94f-0dc7c17b553a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_019c9ac1-ae73-753c-a94f-0dc7c17b553a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019c9ac1-ae73-753c-a94f-0dc7c17b553a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019c9ac1-ae73-7789-a8a1-a8011e4574f6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_019c9ac1-ae73-753c-a94f-0dc7c17b553a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019c9ac1-ae73-7789-a8a1-a8011e4574f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_019c9ac1-ae73-7359-a9c1-69b7e986d25c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019c9ac1-ae73-7789-a8a1-a8011e4574f6" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_019c9ac1-ae73-7359-a9c1-69b7e986d25c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_019c9ac1-ae73-7d18-99ce-68c8be2df4fb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019c9ac1-ae73-74db-b1f5-62691cd054dd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_019c9ac1-ae73-7d18-99ce-68c8be2df4fb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_019c9ac1-ae73-769a-8ad6-dee1add873ad" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_019c9ac1-ae73-7d18-99ce-68c8be2df4fb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_019c9ac1-ae73-769a-8ad6-dee1add873ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_019c9ac1-ae73-7bb3-97b0-f0f2998b4018" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_019c9ac1-ae73-7d18-99ce-68c8be2df4fb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_019c9ac1-ae73-7bb3-97b0-f0f2998b4018" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_019c9ac1-ae73-70c0-a644-5d1f27d65849" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_019c9ac1-ae73-7d18-99ce-68c8be2df4fb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_019c9ac1-ae73-70c0-a644-5d1f27d65849" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_019c9ac1-ae73-7e30-a979-3ab5d30ea430" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_019c9ac1-ae73-7d18-99ce-68c8be2df4fb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_019c9ac1-ae73-7e30-a979-3ab5d30ea430" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_019c9ac1-ae73-7889-b1df-6eba03f885e8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_019c9ac1-ae73-7ee2-a911-cf1844ca7354" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019c9ac1-ae73-74db-b1f5-62691cd054dd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_019c9ac1-ae73-7ee2-a911-cf1844ca7354" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_019c9ac1-ae73-7330-9202-777a6c515f2c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_019c9ac1-ae73-7ee2-a911-cf1844ca7354" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_019c9ac1-ae73-7330-9202-777a6c515f2c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_019c9ac1-ae73-7413-9fef-64fafd30432b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_019c9ac1-ae73-7ee2-a911-cf1844ca7354" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_019c9ac1-ae73-7413-9fef-64fafd30432b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_019c9ac1-ae73-7e3b-a914-c486ab2b3795" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_019c9ac1-ae73-7ee2-a911-cf1844ca7354" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_019c9ac1-ae73-7e3b-a914-c486ab2b3795" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_019c9ac1-ae73-7efc-a440-32e0071484d9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_019c9ac1-ae73-7ee2-a911-cf1844ca7354" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_019c9ac1-ae73-7efc-a440-32e0071484d9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_019c9ac1-ae73-7628-be2a-23dfb7c7785e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.recursion.com/role/NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofNetLossPerShareDetails" xlink:type="simple" xlink:href="rxrx-20260331.xsd#NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofNetLossPerShareDetails"/>
  <link:definitionLink xlink:role="http://www.recursion.com/role/NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofNetLossPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_019c9ac1-ae73-7cf2-b5a1-962c2c12ca8b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_019c9ac1-ae73-74d0-974b-d000defc3833" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_019c9ac1-ae73-7cf2-b5a1-962c2c12ca8b" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_019c9ac1-ae73-74d0-974b-d000defc3833" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_019c9ac1-ae73-7a73-bb46-9b767fc3a717" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_019c9ac1-ae73-74d0-974b-d000defc3833" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_019c9ac1-ae73-7a73-bb46-9b767fc3a717" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_019c9ac1-ae73-7a73-bb46-9b767fc3a717_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_019c9ac1-ae73-7a73-bb46-9b767fc3a717" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_019c9ac1-ae73-7a73-bb46-9b767fc3a717_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_019c9ac1-ae73-79d2-b2e7-bd989cd2ff76" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_019c9ac1-ae73-7a73-bb46-9b767fc3a717" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_019c9ac1-ae73-79d2-b2e7-bd989cd2ff76" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember_019c9ac1-ae73-77c1-ae4e-65812e0930bb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_019c9ac1-ae73-79d2-b2e7-bd989cd2ff76" xlink:to="loc_us-gaap_StockCompensationPlanMember_019c9ac1-ae73-77c1-ae4e-65812e0930bb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_TempusAgreementMember_019c9ac1-ae73-782e-ab10-0259c2315720" xlink:href="rxrx-20260331.xsd#rxrx_TempusAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_019c9ac1-ae73-79d2-b2e7-bd989cd2ff76" xlink:to="loc_rxrx_TempusAgreementMember_019c9ac1-ae73-782e-ab10-0259c2315720" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_019c9ac1-ae73-766c-b050-481f37a2a43d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_019c9ac1-ae73-7cf2-b5a1-962c2c12ca8b" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_019c9ac1-ae73-766c-b050-481f37a2a43d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.recursion.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" xlink:type="simple" xlink:href="rxrx-20260331.xsd#FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"/>
  <link:definitionLink xlink:role="http://www.recursion.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_019c9ac1-ae73-795e-beb2-b4df2f31fe7f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_019c9ac1-ae73-76a7-99f9-33e750f60a9a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_019c9ac1-ae73-795e-beb2-b4df2f31fe7f" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_019c9ac1-ae73-76a7-99f9-33e750f60a9a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_019c9ac1-ae73-7f70-a559-9938946be5b7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_019c9ac1-ae73-76a7-99f9-33e750f60a9a" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_019c9ac1-ae73-7f70-a559-9938946be5b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019c9ac1-ae73-7f70-a559-9938946be5b7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_019c9ac1-ae73-7f70-a559-9938946be5b7" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019c9ac1-ae73-7f70-a559-9938946be5b7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019c9ac1-ae73-78d4-81bd-b47e0fad43b4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_019c9ac1-ae73-7f70-a559-9938946be5b7" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019c9ac1-ae73-78d4-81bd-b47e0fad43b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_019c9ac1-ae73-7b4f-b831-b04b9f856ebe" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019c9ac1-ae73-78d4-81bd-b47e0fad43b4" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_019c9ac1-ae73-7b4f-b831-b04b9f856ebe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_019c9ac1-ae73-727c-8909-f3e03667ce5b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019c9ac1-ae73-78d4-81bd-b47e0fad43b4" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_019c9ac1-ae73-727c-8909-f3e03667ce5b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_019c9ac1-ae73-732f-962e-42606715a6e1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019c9ac1-ae73-78d4-81bd-b47e0fad43b4" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_019c9ac1-ae73-732f-962e-42606715a6e1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_019c9ac1-ae73-7bd7-86c9-c3f53c49d0fc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_019c9ac1-ae73-76a7-99f9-33e750f60a9a" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_019c9ac1-ae73-7bd7-86c9-c3f53c49d0fc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_019c9ac1-ae73-7bd7-86c9-c3f53c49d0fc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_019c9ac1-ae73-7bd7-86c9-c3f53c49d0fc" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_019c9ac1-ae73-7bd7-86c9-c3f53c49d0fc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_019c9ac1-ae73-775a-b06f-00a2ccbe0930" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_019c9ac1-ae73-7bd7-86c9-c3f53c49d0fc" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_019c9ac1-ae73-775a-b06f-00a2ccbe0930" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashMember_019c9ac1-ae73-7a90-b692-2af8bb992c98" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_019c9ac1-ae73-775a-b06f-00a2ccbe0930" xlink:to="loc_us-gaap_CashMember_019c9ac1-ae73-7a90-b692-2af8bb992c98" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_019c9ac1-ae73-7fa1-869a-c7dfcd8de70c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_019c9ac1-ae73-775a-b06f-00a2ccbe0930" xlink:to="loc_us-gaap_MoneyMarketFundsMember_019c9ac1-ae73-7fa1-869a-c7dfcd8de70c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_019c9ac1-ae73-7986-aa8f-5ac3f9d3f63f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_019c9ac1-ae73-795e-beb2-b4df2f31fe7f" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_019c9ac1-ae73-7986-aa8f-5ac3f9d3f63f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_RestrictedCashAndCashEquivalentsFairValueDisclosure_019c9ac1-ae73-7507-bf96-85f5c742793c" xlink:href="rxrx-20260331.xsd#rxrx_RestrictedCashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_019c9ac1-ae73-795e-beb2-b4df2f31fe7f" xlink:to="loc_rxrx_RestrictedCashAndCashEquivalentsFairValueDisclosure_019c9ac1-ae73-7507-bf96-85f5c742793c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_019c9ac1-ae73-7b27-9332-f0937c75adcb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_019c9ac1-ae73-795e-beb2-b4df2f31fe7f" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_019c9ac1-ae73-7b27-9332-f0937c75adcb" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.recursion.com/role/FairValueMeasurementsScheduleofFinancialInstrumentsNotMeasuredatFairValueDetails" xlink:type="simple" xlink:href="rxrx-20260331.xsd#FairValueMeasurementsScheduleofFinancialInstrumentsNotMeasuredatFairValueDetails"/>
  <link:definitionLink xlink:role="http://www.recursion.com/role/FairValueMeasurementsScheduleofFinancialInstrumentsNotMeasuredatFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems_019c9ac1-ae73-7e6c-be9d-deff3aaf65bc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable_019c9ac1-ae73-75fe-a714-9bb0b50d86fe" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems_019c9ac1-ae73-7e6c-be9d-deff3aaf65bc" xlink:to="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable_019c9ac1-ae73-75fe-a714-9bb0b50d86fe" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_019c9ac1-ae73-7366-aba5-e731b293cc90" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable_019c9ac1-ae73-75fe-a714-9bb0b50d86fe" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_019c9ac1-ae73-7366-aba5-e731b293cc90" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_019c9ac1-ae73-7366-aba5-e731b293cc90_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_019c9ac1-ae73-7366-aba5-e731b293cc90" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_019c9ac1-ae73-7366-aba5-e731b293cc90_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_019c9ac1-ae73-7e56-b408-55de29728556" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_019c9ac1-ae73-7366-aba5-e731b293cc90" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_019c9ac1-ae73-7e56-b408-55de29728556" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_019c9ac1-ae73-7cba-8919-c89afd6faedd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_019c9ac1-ae73-7e56-b408-55de29728556" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_019c9ac1-ae73-7cba-8919-c89afd6faedd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember_019c9ac1-ae73-7d07-a3e6-44074b8438a5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_019c9ac1-ae73-7cba-8919-c89afd6faedd" xlink:to="loc_us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember_019c9ac1-ae73-7d07-a3e6-44074b8438a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_019c9ac1-ae73-715d-a73b-c9e7a625dd17" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_019c9ac1-ae73-7cba-8919-c89afd6faedd" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_019c9ac1-ae73-715d-a73b-c9e7a625dd17" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_019c9ac1-ae73-7e7d-a01f-c58b9c59d12f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable_019c9ac1-ae73-75fe-a714-9bb0b50d86fe" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_019c9ac1-ae73-7e7d-a01f-c58b9c59d12f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_019c9ac1-ae73-7e7d-a01f-c58b9c59d12f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_019c9ac1-ae73-7e7d-a01f-c58b9c59d12f" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_019c9ac1-ae73-7e7d-a01f-c58b9c59d12f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_019c9ac1-ae73-7693-98e2-c6117dc6f704" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_019c9ac1-ae73-7e7d-a01f-c58b9c59d12f" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_019c9ac1-ae73-7693-98e2-c6117dc6f704" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember_019c9ac1-ae73-7a40-8912-98ef2101ceea" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_019c9ac1-ae73-7693-98e2-c6117dc6f704" xlink:to="loc_us-gaap_NotesPayableOtherPayablesMember_019c9ac1-ae73-7a40-8912-98ef2101ceea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_019c9ac1-ae73-737e-a765-aa53ec96224a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems_019c9ac1-ae73-7e6c-be9d-deff3aaf65bc" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_019c9ac1-ae73-737e-a765-aa53ec96224a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_019c9ac1-ae73-7466-9358-dfd5d7c1f0f3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems_019c9ac1-ae73-7e6c-be9d-deff3aaf65bc" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_019c9ac1-ae73-7466-9358-dfd5d7c1f0f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_019c9ac1-ae73-77c6-8a59-2f7ab3b25a4a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems_019c9ac1-ae73-7e6c-be9d-deff3aaf65bc" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_019c9ac1-ae73-77c6-8a59-2f7ab3b25a4a" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.recursion.com/role/SegmentInformationScheduleofSegmentNetLossandReconciliationsofSegmentOperatingLosstoLossBeforeIncomeTaxBenefitDetails" xlink:type="simple" xlink:href="rxrx-20260331.xsd#SegmentInformationScheduleofSegmentNetLossandReconciliationsofSegmentOperatingLosstoLossBeforeIncomeTaxBenefitDetails"/>
  <link:definitionLink xlink:role="http://www.recursion.com/role/SegmentInformationScheduleofSegmentNetLossandReconciliationsofSegmentOperatingLosstoLossBeforeIncomeTaxBenefitDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_019c9ac1-ae73-7fa0-bedb-3225aa04049d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_019c9ac1-ae73-7faf-b3d1-0c9c35d691b9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_019c9ac1-ae73-7fa0-bedb-3225aa04049d" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_019c9ac1-ae73-7faf-b3d1-0c9c35d691b9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_019c9ac1-ae73-78f1-a5cb-c93e953fc0d5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_019c9ac1-ae73-7faf-b3d1-0c9c35d691b9" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_019c9ac1-ae73-78f1-a5cb-c93e953fc0d5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_019c9ac1-ae73-78f1-a5cb-c93e953fc0d5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_019c9ac1-ae73-78f1-a5cb-c93e953fc0d5" xlink:to="loc_us-gaap_SegmentDomain_019c9ac1-ae73-78f1-a5cb-c93e953fc0d5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_019c9ac1-ae73-781f-934c-7e6561c5885c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_019c9ac1-ae73-78f1-a5cb-c93e953fc0d5" xlink:to="loc_us-gaap_SegmentDomain_019c9ac1-ae73-781f-934c-7e6561c5885c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_ReportableSegmentMember_019c9ac1-ae73-7fe5-add9-463b159eae76" xlink:href="rxrx-20260331.xsd#rxrx_ReportableSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_019c9ac1-ae73-781f-934c-7e6561c5885c" xlink:to="loc_rxrx_ReportableSegmentMember_019c9ac1-ae73-7fe5-add9-463b159eae76" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019c9ac1-ae73-770f-b861-061f984a58ac" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_019c9ac1-ae73-7fa0-bedb-3225aa04049d" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019c9ac1-ae73-770f-b861-061f984a58ac" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_SignificantSegmentExpensesAbstract_019c9ac1-ae73-7183-8e15-8ddf886b45af" xlink:href="rxrx-20260331.xsd#rxrx_SignificantSegmentExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_019c9ac1-ae73-7fa0-bedb-3225aa04049d" xlink:to="loc_rxrx_SignificantSegmentExpensesAbstract_019c9ac1-ae73-7183-8e15-8ddf886b45af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LaborAndRelatedExpense_019c9ac1-ae73-7afa-90fa-0b81e7fd19c9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LaborAndRelatedExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rxrx_SignificantSegmentExpensesAbstract_019c9ac1-ae73-7183-8e15-8ddf886b45af" xlink:to="loc_us-gaap_LaborAndRelatedExpense_019c9ac1-ae73-7afa-90fa-0b81e7fd19c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_ConsumableExpense_019c9ac1-ae73-744c-83aa-96f88c63709b" xlink:href="rxrx-20260331.xsd#rxrx_ConsumableExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rxrx_SignificantSegmentExpensesAbstract_019c9ac1-ae73-7183-8e15-8ddf886b45af" xlink:to="loc_rxrx_ConsumableExpense_019c9ac1-ae73-744c-83aa-96f88c63709b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_PlatformFeeExpense_019c9ac1-ae73-7479-aa93-e97e5dc52a18" xlink:href="rxrx-20260331.xsd#rxrx_PlatformFeeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rxrx_SignificantSegmentExpensesAbstract_019c9ac1-ae73-7183-8e15-8ddf886b45af" xlink:to="loc_rxrx_PlatformFeeExpense_019c9ac1-ae73-7479-aa93-e97e5dc52a18" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_DiscoveryExpense_019c9ac1-ae73-73ff-a3c8-1f54fffb04fb" xlink:href="rxrx-20260331.xsd#rxrx_DiscoveryExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rxrx_SignificantSegmentExpensesAbstract_019c9ac1-ae73-7183-8e15-8ddf886b45af" xlink:to="loc_rxrx_DiscoveryExpense_019c9ac1-ae73-73ff-a3c8-1f54fffb04fb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_ClinicalDevelopmentExpense_019c9ac1-ae73-73fd-a47f-3cfd2b66fec5" xlink:href="rxrx-20260331.xsd#rxrx_ClinicalDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rxrx_SignificantSegmentExpensesAbstract_019c9ac1-ae73-7183-8e15-8ddf886b45af" xlink:to="loc_rxrx_ClinicalDevelopmentExpense_019c9ac1-ae73-73fd-a47f-3cfd2b66fec5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization_019c9ac1-ae73-70df-9f74-776385d45b7f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rxrx_SignificantSegmentExpensesAbstract_019c9ac1-ae73-7183-8e15-8ddf886b45af" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization_019c9ac1-ae73-70df-9f74-776385d45b7f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingOtherItemAmount_019c9ac1-ae73-70b9-a477-7e02e0f5ad96" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingOtherItemAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rxrx_SignificantSegmentExpensesAbstract_019c9ac1-ae73-7183-8e15-8ddf886b45af" xlink:to="loc_us-gaap_SegmentReportingOtherItemAmount_019c9ac1-ae73-70b9-a477-7e02e0f5ad96" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_019c9ac1-ae73-7e66-9fc8-8410bcd1acb9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rxrx_SignificantSegmentExpensesAbstract_019c9ac1-ae73-7183-8e15-8ddf886b45af" xlink:to="loc_us-gaap_OperatingIncomeLoss_019c9ac1-ae73-7e66-9fc8-8410bcd1acb9" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_019c9ac1-ae73-7fb0-9995-bf4aec15ea4d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rxrx_SignificantSegmentExpensesAbstract_019c9ac1-ae73-7183-8e15-8ddf886b45af" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_019c9ac1-ae73-7fb0-9995-bf4aec15ea4d" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_019c9ac1-ae73-7fc8-b300-6dcced5fb7e5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rxrx_SignificantSegmentExpensesAbstract_019c9ac1-ae73-7183-8e15-8ddf886b45af" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_019c9ac1-ae73-7fc8-b300-6dcced5fb7e5" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019c9ac1-ae73-72fd-b15d-c3f8489ce118" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rxrx_SignificantSegmentExpensesAbstract_019c9ac1-ae73-7183-8e15-8ddf886b45af" xlink:to="loc_us-gaap_NetIncomeLoss_019c9ac1-ae73-72fd-b15d-c3f8489ce118" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_SupplementalAssetInformationAbstract_019c9ac1-ae73-7888-9a4f-26a2e1f5ae9a" xlink:href="rxrx-20260331.xsd#rxrx_SupplementalAssetInformationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_019c9ac1-ae73-7fa0-bedb-3225aa04049d" xlink:to="loc_rxrx_SupplementalAssetInformationAbstract_019c9ac1-ae73-7888-9a4f-26a2e1f5ae9a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentExpenditureAdditionToLongLivedAssets_019c9ac1-ae73-73c9-b7f8-6ca3e6b62eba" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentExpenditureAdditionToLongLivedAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rxrx_SupplementalAssetInformationAbstract_019c9ac1-ae73-7888-9a4f-26a2e1f5ae9a" xlink:to="loc_us-gaap_SegmentExpenditureAdditionToLongLivedAssets_019c9ac1-ae73-73c9-b7f8-6ca3e6b62eba" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/IndividualsOnly" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#IndividualsOnly"/>
  <link:definitionLink xlink:role="http://xbrl.sec.gov/ecd/role/IndividualsOnly" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllIndividualsMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_NamandjeBumpusMember_019d8754-5c47-794b-abdb-f5c363ccdae7" xlink:href="rxrx-20260331.xsd#rxrx_NamandjeBumpusMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_rxrx_NamandjeBumpusMember_019d8754-5c47-794b-abdb-f5c363ccdae7" xlink:type="arc" order="2"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>rxrx-20260331_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019c9ac1-acf5-79ea-ae98-b958c721a179,g:9f615d00-f48b-491d-8614-00e244a2e814-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_rxrx_DiscoveryExpense_019c9ac1-af29-7d7a-a27d-3d47eee0b242_terseLabel_en-US" xlink:label="lab_rxrx_DiscoveryExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Discovery</link:label>
    <link:label id="lab_rxrx_DiscoveryExpense_label_en-US" xlink:label="lab_rxrx_DiscoveryExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Discovery Expense</link:label>
    <link:label id="lab_rxrx_DiscoveryExpense_documentation_en-US" xlink:label="lab_rxrx_DiscoveryExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Discovery Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_DiscoveryExpense" xlink:href="rxrx-20260331.xsd#rxrx_DiscoveryExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_DiscoveryExpense" xlink:to="lab_rxrx_DiscoveryExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_AccruedComputeLiabilitiesCurrent_019d8672-68e3-717e-a9cf-8cbe8eaab3e8_terseLabel_en-US" xlink:label="lab_rxrx_AccruedComputeLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued compute liabilities</link:label>
    <link:label id="lab_rxrx_AccruedComputeLiabilitiesCurrent_label_en-US" xlink:label="lab_rxrx_AccruedComputeLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Compute Liabilities, Current</link:label>
    <link:label id="lab_rxrx_AccruedComputeLiabilitiesCurrent_documentation_en-US" xlink:label="lab_rxrx_AccruedComputeLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accrued Compute Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_AccruedComputeLiabilitiesCurrent" xlink:href="rxrx-20260331.xsd#rxrx_AccruedComputeLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_AccruedComputeLiabilitiesCurrent" xlink:to="lab_rxrx_AccruedComputeLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_019c9ac1-afda-78c2-96b6-698f6a52f95f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_019c9ac1-afda-7345-a00c-ac5fe43dd1bd_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_LicenseAgreementIncreaseDecreaseAccruedLiabilities_019c9ac1-af29-7334-8508-224084e09fa2_terseLabel_en-US" xlink:label="lab_rxrx_LicenseAgreementIncreaseDecreaseAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses</link:label>
    <link:label id="lab_rxrx_LicenseAgreementIncreaseDecreaseAccruedLiabilities_label_en-US" xlink:label="lab_rxrx_LicenseAgreementIncreaseDecreaseAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">License Agreement, Increase (Decrease) Accrued Liabilities</link:label>
    <link:label id="lab_rxrx_LicenseAgreementIncreaseDecreaseAccruedLiabilities_documentation_en-US" xlink:label="lab_rxrx_LicenseAgreementIncreaseDecreaseAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">License Agreement, Increase (Decrease) Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_LicenseAgreementIncreaseDecreaseAccruedLiabilities" xlink:href="rxrx-20260331.xsd#rxrx_LicenseAgreementIncreaseDecreaseAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_LicenseAgreementIncreaseDecreaseAccruedLiabilities" xlink:to="lab_rxrx_LicenseAgreementIncreaseDecreaseAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashCurrent_019c9ac1-af29-7f5d-8b5f-71e3bc679304_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCashCurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Cash, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashCurrent" xlink:to="lab_us-gaap_RestrictedCashCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgPredtrmndFlag_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgPredtrmndFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing Predetermined</link:label>
    <link:label id="lab_ecd_AwardTmgPredtrmndFlag_label_en-US" xlink:label="lab_ecd_AwardTmgPredtrmndFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing Predetermined [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgPredtrmndFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgPredtrmndFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgPredtrmndFlag" xlink:to="lab_ecd_AwardTmgPredtrmndFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_BusinessAcquisitionContingentConsiderationEquityInterestsIssuableNumberOfShares_019c9ac1-af2a-71e9-93f1-29becd151d69_terseLabel_en-US" xlink:label="lab_rxrx_BusinessAcquisitionContingentConsiderationEquityInterestsIssuableNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity interest issued or issuable (in shares)</link:label>
    <link:label id="lab_rxrx_BusinessAcquisitionContingentConsiderationEquityInterestsIssuableNumberOfShares_label_en-US" xlink:label="lab_rxrx_BusinessAcquisitionContingentConsiderationEquityInterestsIssuableNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition , Contingent Consideration, Equity Interests Issuable, Number Of Shares</link:label>
    <link:label id="lab_rxrx_BusinessAcquisitionContingentConsiderationEquityInterestsIssuableNumberOfShares_documentation_en-US" xlink:label="lab_rxrx_BusinessAcquisitionContingentConsiderationEquityInterestsIssuableNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Business Acquisition , Contingent Consideration, Equity Interests Issuable, Number Of Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_BusinessAcquisitionContingentConsiderationEquityInterestsIssuableNumberOfShares" xlink:href="rxrx-20260331.xsd#rxrx_BusinessAcquisitionContingentConsiderationEquityInterestsIssuableNumberOfShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_BusinessAcquisitionContingentConsiderationEquityInterestsIssuableNumberOfShares" xlink:to="lab_rxrx_BusinessAcquisitionContingentConsiderationEquityInterestsIssuableNumberOfShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_019c9ac1-af2a-7e36-9596-83e93ae4f765_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Intangible assets, gross</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible Assets, Gross (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_019c9ac1-afda-756b-8e0d-8194091eeb71_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_019c9ac1-af2a-7b38-88d6-aea0572e457e_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional Paid-in-Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_PhenomapsRawImagesMember_019c9ac1-afda-73df-a252-3c08a8e54990_terseLabel_en-US" xlink:label="lab_rxrx_PhenomapsRawImagesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Phenomaps Raw Images</link:label>
    <link:label id="lab_rxrx_PhenomapsRawImagesMember_label_en-US" xlink:label="lab_rxrx_PhenomapsRawImagesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Phenomaps Raw Images [Member]</link:label>
    <link:label id="lab_rxrx_PhenomapsRawImagesMember_documentation_en-US" xlink:label="lab_rxrx_PhenomapsRawImagesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Phenomaps Raw Images</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_PhenomapsRawImagesMember" xlink:href="rxrx-20260331.xsd#rxrx_PhenomapsRawImagesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_PhenomapsRawImagesMember" xlink:to="lab_rxrx_PhenomapsRawImagesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TabularListTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_TabularListTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tabular List, Table</link:label>
    <link:label id="lab_ecd_TabularListTableTextBlock_label_en-US" xlink:label="lab_ecd_TabularListTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tabular List [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TabularListTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TabularListTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TabularListTableTextBlock" xlink:to="lab_ecd_TabularListTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_019c9ac1-af29-727c-ae3e-3caf21a709c2_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Recent Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_019c9ac1-afd9-73b7-8d7c-fd5c090de6a8_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Decrease in cash related to disposal of a business</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Divestiture of Businesses, Net of Cash Divested</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:to="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_019c9ac1-afda-7275-99a0-49df1ea1d095_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNetCurrent_019c9ac1-afda-7920-bac7-fcfa40fdddb4_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cost incurred</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNetCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Asset, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:to="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsStock_019c9ac1-afda-7ac4-bd16-de4412d369cc_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dividends declared</link:label>
    <link:label id="lab_us-gaap_DividendsStock_label_en-US" xlink:label="lab_us-gaap_DividendsStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dividends, Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsStock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DividendsStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsStock" xlink:to="lab_us-gaap_DividendsStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNonoperatingNet_019c9ac1-afda-7ad9-a003-d4179feaaac2_totalLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Interest income, net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNonoperatingNet_label_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Income (Expense), Nonoperating</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:to="lab_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockCompensationPlanMember_019c9ac1-afda-742a-9d68-bbb9fe746eaf_terseLabel_en-US" xlink:label="lab_us-gaap_StockCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock based compensation</link:label>
    <link:label id="lab_us-gaap_StockCompensationPlanMember_label_en-US" xlink:label="lab_us-gaap_StockCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockCompensationPlanMember" xlink:to="lab_us-gaap_StockCompensationPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_019c9ac1-af29-723e-a169-9f50be6108f2_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TradingArrByIndTable_terseLabel_en-US" xlink:label="lab_ecd_TradingArrByIndTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Arrangements, by Individual</link:label>
    <link:label id="lab_ecd_TradingArrByIndTable_label_en-US" xlink:label="lab_ecd_TradingArrByIndTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangements, by Individual [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrByIndTable" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TradingArrByIndTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="lab_ecd_TradingArrByIndTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_019c9ac1-af2a-7d46-ae10-1919d5f9e251_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:to="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_019c9ac1-afda-7792-b63b-1faee5b29f75_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net loss per share of class A, B and Exchangeable common stock, basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_019c9ac1-afda-7706-8e1a-c01f7c772e27_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net loss per share, basic (in dollars per shares)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToCompAxis_terseLabel_en-US" xlink:label="lab_ecd_AdjToCompAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation:</link:label>
    <link:label id="lab_ecd_AdjToCompAxis_label_en-US" xlink:label="lab_ecd_AdjToCompAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToCompAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToCompAxis" xlink:to="lab_ecd_AdjToCompAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NamedExecutiveOfficersFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Named Executive Officers, Footnote</link:label>
    <link:label id="lab_ecd_NamedExecutiveOfficersFnTextBlock_label_en-US" xlink:label="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Named Executive Officers, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NamedExecutiveOfficersFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:to="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_LicenseAgreementTerm_019c9ac1-afda-7a58-8d1c-82edeae04b3d_terseLabel_en-US" xlink:label="lab_rxrx_LicenseAgreementTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">License agreement, term</link:label>
    <link:label id="lab_rxrx_LicenseAgreementTerm_label_en-US" xlink:label="lab_rxrx_LicenseAgreementTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">License Agreement, Term</link:label>
    <link:label id="lab_rxrx_LicenseAgreementTerm_documentation_en-US" xlink:label="lab_rxrx_LicenseAgreementTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">License Agreement, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_LicenseAgreementTerm" xlink:href="rxrx-20260331.xsd#rxrx_LicenseAgreementTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_LicenseAgreementTerm" xlink:to="lab_rxrx_LicenseAgreementTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_019c9ac1-afda-779f-9767-3e2637f53fc8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock, Class of Stock [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_019c9ac1-afd9-7932-890f-3cff98ad0fc5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Segment Net Loss and Reconciliations of Segment Operating Loss to Loss Before Income Tax Benefit</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_019c9ac1-af29-7847-9c7a-d624252cee17_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Remaining performance obligation revenue</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue, Remaining Performance Obligation, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToCompAmt_terseLabel_en-US" xlink:label="lab_ecd_AdjToCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation, Amount</link:label>
    <link:label id="lab_ecd_AdjToCompAmt_label_en-US" xlink:label="lab_ecd_AdjToCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToCompAmt" xlink:to="lab_ecd_AdjToCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_CashPaidForAmountIncludedInTheMeasurementOfLeaseLiabilitiesAbstract_019c9ac1-afda-788c-8c2e-39821ffd48b3_terseLabel_en-US" xlink:label="lab_rxrx_CashPaidForAmountIncludedInTheMeasurementOfLeaseLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash paid for amount included in the measurement of lease liabilities:</link:label>
    <link:label id="lab_rxrx_CashPaidForAmountIncludedInTheMeasurementOfLeaseLiabilitiesAbstract_label_en-US" xlink:label="lab_rxrx_CashPaidForAmountIncludedInTheMeasurementOfLeaseLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Paid For Amount Included In The Measurement Of Lease Liabilities [Abstract]</link:label>
    <link:label id="lab_rxrx_CashPaidForAmountIncludedInTheMeasurementOfLeaseLiabilitiesAbstract_documentation_en-US" xlink:label="lab_rxrx_CashPaidForAmountIncludedInTheMeasurementOfLeaseLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Cash Paid For Amount Included In The Measurement Of Lease Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_CashPaidForAmountIncludedInTheMeasurementOfLeaseLiabilitiesAbstract" xlink:href="rxrx-20260331.xsd#rxrx_CashPaidForAmountIncludedInTheMeasurementOfLeaseLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_CashPaidForAmountIncludedInTheMeasurementOfLeaseLiabilitiesAbstract" xlink:to="lab_rxrx_CashPaidForAmountIncludedInTheMeasurementOfLeaseLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_019c9ac1-af2a-7f8b-a03a-a4aed5923940_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Other receivables and assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Other Operating Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_019c9ac1-af2a-7bf9-8bf2-afdad463f540_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee Stock Option</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMnpiDiscTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Disclosure</link:label>
    <link:label id="lab_ecd_AwardTmgMnpiDiscTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMnpiDiscTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:to="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_019c9ac1-afda-7621-a3e0-a5183a4a40c9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_019c9ac1-af2a-72bf-a7eb-3bc9def01c1c_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_019c9ac1-afda-79ca-9d66-4309763750a2_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_019c9ac1-afda-761f-b9d3-a9eba5714e27_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_019c9ac1-afda-721c-a690-3540fd810a4c_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_019c9ac1-afda-7ff6-b2cb-4ba8c7fdbc91_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive income (loss):</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTradingPoliciesProcLineItems_label_en-US" xlink:label="lab_ecd_InsiderTradingPoliciesProcLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTradingPoliciesProcLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="lab_ecd_InsiderTradingPoliciesProcLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_019c9ac1-af2a-7ae3-8081-25ffc4293dcc_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_SaleOfStockValueAuthorized_019c9ac1-afda-7f59-a13c-6c7269816936_terseLabel_en-US" xlink:label="lab_rxrx_SaleOfStockValueAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale of stock, value authorized</link:label>
    <link:label id="lab_rxrx_SaleOfStockValueAuthorized_label_en-US" xlink:label="lab_rxrx_SaleOfStockValueAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale Of Stock, Value, Authorized</link:label>
    <link:label id="lab_rxrx_SaleOfStockValueAuthorized_documentation_en-US" xlink:label="lab_rxrx_SaleOfStockValueAuthorized" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sale Of Stock, Value, Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_SaleOfStockValueAuthorized" xlink:href="rxrx-20260331.xsd#rxrx_SaleOfStockValueAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_SaleOfStockValueAuthorized" xlink:to="lab_rxrx_SaleOfStockValueAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_019c9ac1-afda-7cf7-a0bf-f0eb56f81805_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_019c9ac1-afda-7e56-9311-f66788ecc048_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock sales issuances, net of issuance costs (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_019c9ac1-afda-7e0c-a080-7db7e10ca93f_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_019c9ac1-af29-7ac2-a2e3-770b76b3505d_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities and stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_ConsumableExpense_019c9ac1-afda-746b-a562-41774384061f_terseLabel_en-US" xlink:label="lab_rxrx_ConsumableExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Consumables</link:label>
    <link:label id="lab_rxrx_ConsumableExpense_label_en-US" xlink:label="lab_rxrx_ConsumableExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consumable Expense</link:label>
    <link:label id="lab_rxrx_ConsumableExpense_documentation_en-US" xlink:label="lab_rxrx_ConsumableExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Consumable Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_ConsumableExpense" xlink:href="rxrx-20260331.xsd#rxrx_ConsumableExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_ConsumableExpense" xlink:to="lab_rxrx_ConsumableExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_019c9ac1-afda-7e84-a4b2-21274a71099b_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LicensingAgreementsMember_019c9ac1-afda-7be5-82bf-1ddfbf318147_terseLabel_en-US" xlink:label="lab_us-gaap_LicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Definite-lived licensed intangible assets</link:label>
    <link:label id="lab_us-gaap_LicensingAgreementsMember_label_en-US" xlink:label="lab_us-gaap_LicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Licensing Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LicensingAgreementsMember" xlink:to="lab_us-gaap_LicensingAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_MaterialsReceivedNotInvoiced_019c9ac1-af2a-71f8-85c1-93c0a40e52cb_terseLabel_en-US" xlink:label="lab_rxrx_MaterialsReceivedNotInvoiced" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Materials received not invoiced</link:label>
    <link:label id="lab_rxrx_MaterialsReceivedNotInvoiced_label_en-US" xlink:label="lab_rxrx_MaterialsReceivedNotInvoiced" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Materials Received Not Invoiced</link:label>
    <link:label id="lab_rxrx_MaterialsReceivedNotInvoiced_documentation_en-US" xlink:label="lab_rxrx_MaterialsReceivedNotInvoiced" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Materials Received Not Invoiced</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_MaterialsReceivedNotInvoiced" xlink:href="rxrx-20260331.xsd#rxrx_MaterialsReceivedNotInvoiced"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_MaterialsReceivedNotInvoiced" xlink:to="lab_rxrx_MaterialsReceivedNotInvoiced" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019c9ac1-afda-73ac-a391-6309d4452846_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liabilities and stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_019c9ac1-afda-7e8e-a261-c1f4ffe33db3_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents:</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_019c9ac1-afda-789d-b9a8-b4498e307a05_terseLabel_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Portion at Fair Value Measurement</link:label>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Portion at Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_019c9ac1-af2a-7c20-bd88-2a44ebd403e3_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_019c9ac1-afda-74ca-8044-cb7b106a1d36_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">General and Administrative Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentExpenditureAdditionToLongLivedAssets_019c9ac1-af2a-752a-8330-5b78cad640ca_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentExpenditureAdditionToLongLivedAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total expenditures for additions to long-lived assets</link:label>
    <link:label id="lab_us-gaap_SegmentExpenditureAdditionToLongLivedAssets_label_en-US" xlink:label="lab_us-gaap_SegmentExpenditureAdditionToLongLivedAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment, Expenditure, Addition to Long-Lived Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentExpenditureAdditionToLongLivedAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentExpenditureAdditionToLongLivedAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentExpenditureAdditionToLongLivedAssets" xlink:to="lab_us-gaap_SegmentExpenditureAdditionToLongLivedAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_019c9ac1-af2a-745e-ac37-084f4251148e_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net carrying amount</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoAvgTotalCompAmt_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
    <link:label id="lab_ecd_NonPeoNeoAvgTotalCompAmt_label_en-US" xlink:label="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonPeoNeoAvgTotalCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:to="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019c9ac1-af2a-78b0-8246-8797dcef2db1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_019c9ac1-afda-719d-9b81-da659dbf0197_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair market value of vested shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToNonPeoNeoCompFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote</link:label>
    <link:label id="lab_ecd_AdjToNonPeoNeoCompFnTextBlock_label_en-US" xlink:label="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:to="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PayVsPerformanceDisclosureLineItems_label_en-US" xlink:label="lab_ecd_PayVsPerformanceDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PayVsPerformanceDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="lab_ecd_PayVsPerformanceDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_AccruedDevelopmentCostsCurrent_019c9ac1-afda-716f-9ac4-d923069decf8_terseLabel_en-US" xlink:label="lab_rxrx_AccruedDevelopmentCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued development expenses</link:label>
    <link:label id="lab_rxrx_AccruedDevelopmentCostsCurrent_label_en-US" xlink:label="lab_rxrx_AccruedDevelopmentCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Development Costs, Current</link:label>
    <link:label id="lab_rxrx_AccruedDevelopmentCostsCurrent_documentation_en-US" xlink:label="lab_rxrx_AccruedDevelopmentCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accrued Development Costs, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_AccruedDevelopmentCostsCurrent" xlink:href="rxrx-20260331.xsd#rxrx_AccruedDevelopmentCostsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_AccruedDevelopmentCostsCurrent" xlink:to="lab_rxrx_AccruedDevelopmentCostsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_019c9ac1-afda-7889-baa0-3be2d7df4d6a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_019c9ac1-afda-75a3-a5ac-ce88a2564015_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Acquisitions</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonRule10b51ArrTrmntdFlag_terseLabel_en-US" xlink:label="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated</link:label>
    <link:label id="lab_ecd_NonRule10b51ArrTrmntdFlag_label_en-US" xlink:label="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonRule10b51ArrTrmntdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:to="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_019c9ac1-af2a-7ed8-a5b0-367e6981241d_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Loss before income tax benefit</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_019c9ac1-af29-77f4-8e51-f1db21761f9f_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_019c9ac1-af2a-747b-96ef-31292d89c9e2_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other liabilities, non-current</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_019c9ac1-af2a-7ecb-8f44-5d4992ce1980_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill impairment</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_019c9ac1-af29-71d1-8d9d-57f9df9c50c7_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Remaining operating lease term</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:to="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CoSelectedMeasureAmt_terseLabel_en-US" xlink:label="lab_ecd_CoSelectedMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Company Selected Measure Amount</link:label>
    <link:label id="lab_ecd_CoSelectedMeasureAmt_label_en-US" xlink:label="lab_ecd_CoSelectedMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Company Selected Measure Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CoSelectedMeasureAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CoSelectedMeasureAmt" xlink:to="lab_ecd_CoSelectedMeasureAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMnpiCnsdrdFlag_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Considered</link:label>
    <link:label id="lab_ecd_AwardTmgMnpiCnsdrdFlag_label_en-US" xlink:label="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Considered [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMnpiCnsdrdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:to="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_019c9ac1-afda-7d7c-959f-61c577cc91fc_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Comprehensive loss</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeNonoperating_019c9ac1-afda-7091-a66b-faf3a03fffba_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeNonoperating" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeNonoperating_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeNonoperating" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investment Income, Nonoperating</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNonoperating" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentIncomeNonoperating"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeNonoperating" xlink:to="lab_us-gaap_InvestmentIncomeNonoperating" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019c9ac1-afda-7f22-997c-310a0bacecd1_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MeasureName_terseLabel_en-US" xlink:label="lab_ecd_MeasureName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_MeasureName_label_en-US" xlink:label="lab_ecd_MeasureName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measure Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MeasureName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MeasureName" xlink:to="lab_ecd_MeasureName" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_LicenseAgreementAnnualPayments_019c9ac1-afda-790f-b93a-36026cc361fa_terseLabel_en-US" xlink:label="lab_rxrx_LicenseAgreementAnnualPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Annual payments</link:label>
    <link:label id="lab_rxrx_LicenseAgreementAnnualPayments_label_en-US" xlink:label="lab_rxrx_LicenseAgreementAnnualPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">License Agreement, Annual Payments</link:label>
    <link:label id="lab_rxrx_LicenseAgreementAnnualPayments_documentation_en-US" xlink:label="lab_rxrx_LicenseAgreementAnnualPayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">License Agreement, Annual Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_LicenseAgreementAnnualPayments" xlink:href="rxrx-20260331.xsd#rxrx_LicenseAgreementAnnualPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_LicenseAgreementAnnualPayments" xlink:to="lab_rxrx_LicenseAgreementAnnualPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_RevenueRemainingPerformanceObligationVariableConsiderationAmount_019c9ac1-af29-79ca-9379-003fb6e2ba55_terseLabel_en-US" xlink:label="lab_rxrx_RevenueRemainingPerformanceObligationVariableConsiderationAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research project, fees and milestones payments receivable for an option on a lead series</link:label>
    <link:label id="lab_rxrx_RevenueRemainingPerformanceObligationVariableConsiderationAmount_label_en-US" xlink:label="lab_rxrx_RevenueRemainingPerformanceObligationVariableConsiderationAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue, Remaining Performance Obligation, Variable Consideration Amount</link:label>
    <link:label id="lab_rxrx_RevenueRemainingPerformanceObligationVariableConsiderationAmount_documentation_en-US" xlink:label="lab_rxrx_RevenueRemainingPerformanceObligationVariableConsiderationAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Revenue, Remaining Performance Obligation, Variable Consideration Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_RevenueRemainingPerformanceObligationVariableConsiderationAmount" xlink:href="rxrx-20260331.xsd#rxrx_RevenueRemainingPerformanceObligationVariableConsiderationAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_RevenueRemainingPerformanceObligationVariableConsiderationAmount" xlink:to="lab_rxrx_RevenueRemainingPerformanceObligationVariableConsiderationAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_019c9ac1-afda-77cc-b98e-eba3424efcde_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Stock-Based Compensation Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_019c9ac1-af2a-7697-9c33-1e02d3d75b70_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_019c9ac1-afda-7f46-afc4-057826f2e681_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems" xlink:to="lab_us-gaap_ClassOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_019c9ac1-afda-7c78-b402-e837ceb0c16f_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_019c9ac1-af29-7e57-81e4-dd2d3f1355c3_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_IntangibleAssetsForeignCurrencyTranslationGainLoss_019ddec6-c270-766e-95d2-ff0d8bd2eb45_terseLabel_en-US" xlink:label="lab_rxrx_IntangibleAssetsForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intangible assets, foreign currency translation gain (loss)</link:label>
    <link:label id="lab_rxrx_IntangibleAssetsForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_rxrx_IntangibleAssetsForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible Assets, Foreign Currency Translation Gain (Loss)</link:label>
    <link:label id="lab_rxrx_IntangibleAssetsForeignCurrencyTranslationGainLoss_documentation_en-US" xlink:label="lab_rxrx_IntangibleAssetsForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Intangible Assets, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_IntangibleAssetsForeignCurrencyTranslationGainLoss" xlink:href="rxrx-20260331.xsd#rxrx_IntangibleAssetsForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_IntangibleAssetsForeignCurrencyTranslationGainLoss" xlink:to="lab_rxrx_IntangibleAssetsForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMethodTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing Method</link:label>
    <link:label id="lab_ecd_AwardTmgMethodTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing Method [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMethodTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMethodTextBlock" xlink:to="lab_ecd_AwardTmgMethodTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_ExscientiaGmbHMember_019c9ac1-afda-7695-9feb-b11e1ef5d4bd_terseLabel_en-US" xlink:label="lab_rxrx_ExscientiaGmbHMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exscientia GmbH</link:label>
    <link:label id="lab_rxrx_ExscientiaGmbHMember_label_en-US" xlink:label="lab_rxrx_ExscientiaGmbHMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Exscientia GmbH [Member]</link:label>
    <link:label id="lab_rxrx_ExscientiaGmbHMember_documentation_en-US" xlink:label="lab_rxrx_ExscientiaGmbHMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Exscientia GmbH</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_ExscientiaGmbHMember" xlink:href="rxrx-20260331.xsd#rxrx_ExscientiaGmbHMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_ExscientiaGmbHMember" xlink:to="lab_rxrx_ExscientiaGmbHMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_019c9ac1-afda-7b79-9c0d-2a93178edb01_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_019c9ac1-af2a-702b-a1aa-dccb274d719e_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unearned revenue, non-current</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_019c9ac1-afda-7e63-9f98-70ac56941b67_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_019c9ac1-afda-7b4c-bbc2-ee25209ad719_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_019c9ac1-afda-7ebd-b8b0-93b9fbda1a4b_terseLabel_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_label_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EquityMethodInvesteeNameDomain" xlink:to="lab_srt_EquityMethodInvesteeNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember_019c9ac1-af2a-70a9-afb4-1538cafb26e1_terseLabel_en-US" xlink:label="lab_us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Book values</link:label>
    <link:label id="lab_us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Portion at Other than Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_019c9ac1-afd9-748b-ae68-306566bda155_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_019c9ac1-af2a-784d-addc-43fa3083d235_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vested (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_A2024InducementEquityIncentivePlanMember_019c9ac1-af29-71e4-9c3e-b59ae6196d05_terseLabel_en-US" xlink:label="lab_rxrx_A2024InducementEquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2024 Inducement Equity Incentive Plan</link:label>
    <link:label id="lab_rxrx_A2024InducementEquityIncentivePlanMember_label_en-US" xlink:label="lab_rxrx_A2024InducementEquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">2024 Inducement Equity Incentive Plan [Member]</link:label>
    <link:label id="lab_rxrx_A2024InducementEquityIncentivePlanMember_documentation_en-US" xlink:label="lab_rxrx_A2024InducementEquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">2024 Inducement Equity Incentive Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_A2024InducementEquityIncentivePlanMember" xlink:href="rxrx-20260331.xsd#rxrx_A2024InducementEquityIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_A2024InducementEquityIncentivePlanMember" xlink:to="lab_rxrx_A2024InducementEquityIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_LicenseAgreementAggregatePayments_019c9ac1-afda-73e8-957a-b9cf01df793b_terseLabel_en-US" xlink:label="lab_rxrx_LicenseAgreementAggregatePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate amount payable in cash or equity</link:label>
    <link:label id="lab_rxrx_LicenseAgreementAggregatePayments_label_en-US" xlink:label="lab_rxrx_LicenseAgreementAggregatePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">License Agreement, Aggregate Payments</link:label>
    <link:label id="lab_rxrx_LicenseAgreementAggregatePayments_documentation_en-US" xlink:label="lab_rxrx_LicenseAgreementAggregatePayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">License Agreement, Aggregate Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_LicenseAgreementAggregatePayments" xlink:href="rxrx-20260331.xsd#rxrx_LicenseAgreementAggregatePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_LicenseAgreementAggregatePayments" xlink:to="lab_rxrx_LicenseAgreementAggregatePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_AccruedEarlyDiscoveryExpensesCurrent_019c9ac1-af2a-7cea-84c9-e690831abf4a_terseLabel_en-US" xlink:label="lab_rxrx_AccruedEarlyDiscoveryExpensesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued early discovery expenses</link:label>
    <link:label id="lab_rxrx_AccruedEarlyDiscoveryExpensesCurrent_label_en-US" xlink:label="lab_rxrx_AccruedEarlyDiscoveryExpensesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Early Discovery Expenses, Current</link:label>
    <link:label id="lab_rxrx_AccruedEarlyDiscoveryExpensesCurrent_documentation_en-US" xlink:label="lab_rxrx_AccruedEarlyDiscoveryExpensesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accrued Early Discovery Expenses, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_AccruedEarlyDiscoveryExpensesCurrent" xlink:href="rxrx-20260331.xsd#rxrx_AccruedEarlyDiscoveryExpensesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_AccruedEarlyDiscoveryExpensesCurrent" xlink:to="lab_rxrx_AccruedEarlyDiscoveryExpensesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_019c9ac1-afda-75f0-b835-e3388bda343b_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock option exercises and other (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_019c9ac1-afd9-7492-8ce5-0f44a927dccd_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_019c9ac1-af29-78c8-960f-810b6e1ecece_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flows from operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingOtherItemAmount_019c9ac1-afda-7886-92d2-5af846dba69c_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingOtherItemAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other segment items</link:label>
    <link:label id="lab_us-gaap_SegmentReportingOtherItemAmount_label_en-US" xlink:label="lab_us-gaap_SegmentReportingOtherItemAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting, Other Segment Item, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingOtherItemAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingOtherItemAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingOtherItemAmount" xlink:to="lab_us-gaap_SegmentReportingOtherItemAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_RevenueRemainingPerformanceObligationAxis_019c9ac1-af2a-7e9b-9782-36b04f889dd7_terseLabel_en-US" xlink:label="lab_rxrx_RevenueRemainingPerformanceObligationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue, Remaining Performance Obligation [Axis]</link:label>
    <link:label id="lab_rxrx_RevenueRemainingPerformanceObligationAxis_label_en-US" xlink:label="lab_rxrx_RevenueRemainingPerformanceObligationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue, Remaining Performance Obligation [Axis]</link:label>
    <link:label id="lab_rxrx_RevenueRemainingPerformanceObligationAxis_documentation_en-US" xlink:label="lab_rxrx_RevenueRemainingPerformanceObligationAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Revenue, Remaining Performance Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_RevenueRemainingPerformanceObligationAxis" xlink:href="rxrx-20260331.xsd#rxrx_RevenueRemainingPerformanceObligationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_RevenueRemainingPerformanceObligationAxis" xlink:to="lab_rxrx_RevenueRemainingPerformanceObligationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019c9ac1-afda-773b-9b71-6611d79519c2_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effect of exchange rate changes on cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
    <link:label id="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt_label_en-US" xlink:label="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:to="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_019c9ac1-af2a-70ab-98ad-d3d94a7cedbc_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Income Location, Balance [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_019c9ac1-af29-7415-b625-2cd4c700c72d_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">RSUs</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Other Measure</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Other Measure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_019c9ac1-afda-7276-8d11-657e2cab0f84_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireIntangibleAssets_019c9ac1-afda-7ed2-81ba-19e473e21297_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Purchase of an intangible asset</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_019c9ac1-af2a-7f83-bd02-8a595e7a393f_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year</link:label>
    <link:label id="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_label_en-US" xlink:label="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:to="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_019c9ac1-afda-74ab-96fa-85556ac6884e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestments_019c9ac1-af2a-70ff-8700-219ecd3a5882_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity method investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestments" xlink:to="lab_us-gaap_EquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_terseLabel_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted</link:label>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_label_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:to="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_019c9ac1-af29-7d71-b692-07d67de9b557_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Combination [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_019c9ac1-af2a-7888-8fc2-dce0c257bccb_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Indefinite-lived intangible assets</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Indefinite-Lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_RevenuePerformanceObligationNumberOfObligations_019c9ac1-afda-7ebc-a9c6-97b59b3a1d94_terseLabel_en-US" xlink:label="lab_rxrx_RevenuePerformanceObligationNumberOfObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of performance obligations under the agreement (in performance obligations)</link:label>
    <link:label id="lab_rxrx_RevenuePerformanceObligationNumberOfObligations_label_en-US" xlink:label="lab_rxrx_RevenuePerformanceObligationNumberOfObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue, Performance Obligation, Number Of Obligations</link:label>
    <link:label id="lab_rxrx_RevenuePerformanceObligationNumberOfObligations_documentation_en-US" xlink:label="lab_rxrx_RevenuePerformanceObligationNumberOfObligations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Revenue, Performance Obligation, Number Of Obligations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_RevenuePerformanceObligationNumberOfObligations" xlink:href="rxrx-20260331.xsd#rxrx_RevenuePerformanceObligationNumberOfObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_RevenuePerformanceObligationNumberOfObligations" xlink:to="lab_rxrx_RevenuePerformanceObligationNumberOfObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_019c9ac1-afda-722b-a5bf-e1f61d2f9064_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Common sock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_019c9ac1-afda-7a01-ac4b-7f77fe9f7f19_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_019c9ac1-afda-76ea-9ad3-b2eb47eed5c8_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_019c9ac1-af29-78c0-ac46-2abc5fe5b394_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_RestrictedCashAndCashEquivalentsFairValueDisclosure_019c9ac1-afda-75bd-8e5c-679ef8e6ac90_terseLabel_en-US" xlink:label="lab_rxrx_RestrictedCashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_rxrx_RestrictedCashAndCashEquivalentsFairValueDisclosure_label_en-US" xlink:label="lab_rxrx_RestrictedCashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Cash And Cash Equivalents, Fair Value Disclosure</link:label>
    <link:label id="lab_rxrx_RestrictedCashAndCashEquivalentsFairValueDisclosure_documentation_en-US" xlink:label="lab_rxrx_RestrictedCashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Restricted Cash And Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_RestrictedCashAndCashEquivalentsFairValueDisclosure" xlink:href="rxrx-20260331.xsd#rxrx_RestrictedCashAndCashEquivalentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_RestrictedCashAndCashEquivalentsFairValueDisclosure" xlink:to="lab_rxrx_RestrictedCashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationTable_019c9ac1-af29-7172-933f-dc5409b2815d_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Information [Table]</link:label>
    <link:label id="lab_dei_DocumentInformationTable_label_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentInformationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationTable" xlink:to="lab_dei_DocumentInformationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoMember_terseLabel_en-US" xlink:label="lab_ecd_PeoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO</link:label>
    <link:label id="lab_ecd_PeoMember_label_en-US" xlink:label="lab_ecd_PeoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoMember" xlink:to="lab_ecd_PeoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_019c9ac1-afda-7a92-b940-ef6eab5eab15_terseLabel_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Supplemental schedule of non-cash investing and financing activities</link:label>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_label_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Noncash Investing and Financing Items [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_019c9ac1-afda-7330-844e-193204f66c6e_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year</link:label>
    <link:label id="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_label_en-US" xlink:label="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:to="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_MerckKGaAMerckMember_019c9ac1-af2a-757e-898f-deb721ada7ee_terseLabel_en-US" xlink:label="lab_rxrx_MerckKGaAMerckMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Merck KGaA (Merck)</link:label>
    <link:label id="lab_rxrx_MerckKGaAMerckMember_label_en-US" xlink:label="lab_rxrx_MerckKGaAMerckMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Merck KGaA (Merck) [Member]</link:label>
    <link:label id="lab_rxrx_MerckKGaAMerckMember_documentation_en-US" xlink:label="lab_rxrx_MerckKGaAMerckMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Merck KGaA (Merck)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_MerckKGaAMerckMember" xlink:href="rxrx-20260331.xsd#rxrx_MerckKGaAMerckMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_MerckKGaAMerckMember" xlink:to="lab_rxrx_MerckKGaAMerckMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_019c9ac1-afda-7098-b8bc-a462a52c47f9_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_019c9ac1-af29-76c1-aa53-9ed01861702e_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDeterminationDate_terseLabel_en-US" xlink:label="lab_ecd_RestatementDeterminationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement Determination Date</link:label>
    <link:label id="lab_ecd_RestatementDeterminationDate_label_en-US" xlink:label="lab_ecd_RestatementDeterminationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement Determination Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDeterminationDate" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDeterminationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDeterminationDate" xlink:to="lab_ecd_RestatementDeterminationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019c9ac1-afda-709d-977d-3fe3bcf94d43_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Cash, cash equivalents and restricted cash, beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019c9ac1-afda-7462-89e4-27e089df6f44_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Cash, cash equivalents and restricted cash, end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_019c9ac1-afda-76a3-b7a9-b4506cf5f5a2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Income tax benefit</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_019d86f9-be02-7c71-a38b-6590102db32f_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Income tax benefit</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonClassBMember_019c9ac1-af29-7569-a888-ebd57bbb8da5_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonClassBMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Class B Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonClassBMember_019c9ac1-af29-77cb-a864-c14e5f9aa6aa_terseLabel_en-US" xlink:label="lab_us-gaap_CommonClassBMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class B</link:label>
    <link:label id="lab_us-gaap_CommonClassBMember_label_en-US" xlink:label="lab_us-gaap_CommonClassBMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Class B [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassBMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonClassBMember" xlink:to="lab_us-gaap_CommonClassBMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_019c9ac1-afd9-71fe-8d1f-07ecc465921b_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities_019c9ac1-afd9-79d8-ac5d-81ecf3618cf4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Repayment of long-term debt and finance lease liabilities</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Repayment of Long-Term Debt, Long-Term Lease Obligation, and Capital Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationLineItems_019c9ac1-afda-7863-8279-78d5a7a63a04_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:label id="lab_dei_DocumentInformationLineItems_label_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="lab_dei_DocumentInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_019c9ac1-afda-7074-b799-0b195368a24b_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_019c9ac1-afda-7d84-8784-5de246df6272_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PnsnAdjsSvcCstMember_terseLabel_en-US" xlink:label="lab_ecd_PnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pension Adjustments Service Cost</link:label>
    <link:label id="lab_ecd_PnsnAdjsSvcCstMember_label_en-US" xlink:label="lab_ecd_PnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pension Adjustments Service Cost [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PnsnAdjsSvcCstMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PnsnAdjsSvcCstMember" xlink:to="lab_ecd_PnsnAdjsSvcCstMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_019c9ac1-afda-7502-b8b2-07fc045761b4_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_019c9ac1-afda-730e-9b11-07c809c6927d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_SanofiMember_019c9ac1-af29-7ca3-9494-6e3fd5bf78a1_terseLabel_en-US" xlink:label="lab_rxrx_SanofiMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sanofi</link:label>
    <link:label id="lab_rxrx_SanofiMember_label_en-US" xlink:label="lab_rxrx_SanofiMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sanofi [Member]</link:label>
    <link:label id="lab_rxrx_SanofiMember_documentation_en-US" xlink:label="lab_rxrx_SanofiMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sanofi</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_SanofiMember" xlink:href="rxrx-20260331.xsd#rxrx_SanofiMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_SanofiMember" xlink:to="lab_rxrx_SanofiMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock_terseLabel_en-US" xlink:label="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement does not require Recovery</link:label>
    <link:label id="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock_label_en-US" xlink:label="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement Does Not Require Recovery [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:to="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_019c9ac1-afda-7319-98cb-c1ed05f66dae_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_019c9ac1-afda-7d44-ba0d-ad40b0f08050_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Combination [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_019c9ac1-afda-7e69-a7c3-f58f82f9a9bf_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_SupplementalBalanceSheetAndIncomeStatementInformationTextBlock_019c9ac1-afd9-788e-9b5d-b9e8a995e499_terseLabel_en-US" xlink:label="lab_rxrx_SupplementalBalanceSheetAndIncomeStatementInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Supplemental Financial Information</link:label>
    <link:label id="lab_rxrx_SupplementalBalanceSheetAndIncomeStatementInformationTextBlock_label_en-US" xlink:label="lab_rxrx_SupplementalBalanceSheetAndIncomeStatementInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Supplemental Balance Sheet And Income Statement Information [Text Block]</link:label>
    <link:label id="lab_rxrx_SupplementalBalanceSheetAndIncomeStatementInformationTextBlock_documentation_en-US" xlink:label="lab_rxrx_SupplementalBalanceSheetAndIncomeStatementInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Supplemental Balance Sheet And Income Statement Information</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_SupplementalBalanceSheetAndIncomeStatementInformationTextBlock" xlink:href="rxrx-20260331.xsd#rxrx_SupplementalBalanceSheetAndIncomeStatementInformationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_SupplementalBalanceSheetAndIncomeStatementInformationTextBlock" xlink:to="lab_rxrx_SupplementalBalanceSheetAndIncomeStatementInformationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesPayableOtherPayablesMember_019c9ac1-afda-7d8a-8d3c-adf0cb469e82_terseLabel_en-US" xlink:label="lab_us-gaap_NotesPayableOtherPayablesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Notes Payable</link:label>
    <link:label id="lab_us-gaap_NotesPayableOtherPayablesMember_label_en-US" xlink:label="lab_us-gaap_NotesPayableOtherPayablesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Notes Payable, Other Payables [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesPayableOtherPayablesMember" xlink:to="lab_us-gaap_NotesPayableOtherPayablesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_019c9ac1-afda-7d9b-a5db-1dc182d0be0e_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing, How MNPI Considered</link:label>
    <link:label id="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing, How MNPI Considered [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:to="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllTradingArrangementsMember_terseLabel_en-US" xlink:label="lab_ecd_AllTradingArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Trading Arrangements</link:label>
    <link:label id="lab_ecd_AllTradingArrangementsMember_label_en-US" xlink:label="lab_ecd_AllTradingArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Trading Arrangements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllTradingArrangementsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllTradingArrangementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllTradingArrangementsMember" xlink:to="lab_ecd_AllTradingArrangementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsAdjFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Footnote</link:label>
    <link:label id="lab_ecd_EqtyAwrdsAdjFnTextBlock_label_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsAdjFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:to="lab_ecd_EqtyAwrdsAdjFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock_terseLabel_en-US" xlink:label="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Vs Peer Group</link:label>
    <link:label id="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock_label_en-US" xlink:label="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Vs Peer Group [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:to="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_019c9ac1-afda-7619-ae63-6961fa61c4c8_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued expenses and other liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_019c9ac1-afda-7e06-a5ab-69e5603ed29b_totalLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Accrued expense and other liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_019c9ac1-afda-783b-93b3-c8e0459565f7_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_019c9ac1-afda-74cb-b9c9-3ba601c8bb86_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_019c9ac1-afda-7975-8adf-064023602d03_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flows from investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_019c9ac1-af2a-7685-ac8a-d53bb4dc6ba1_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PvpTable_terseLabel_en-US" xlink:label="lab_ecd_PvpTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure</link:label>
    <link:label id="lab_ecd_PvpTable_label_en-US" xlink:label="lab_ecd_PvpTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PvpTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PvpTable" xlink:to="lab_ecd_PvpTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_019c9ac1-af29-7874-9c46-894837668b08_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash used in operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Provided by (Used in) Operating Activity, Including Discontinued Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_019c9ac1-af2a-733c-aa0e-3374a2d5c390_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disposal Group, Disposed of by Sale, Not Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_label_en-US" xlink:label="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:to="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_019c9ac1-afda-7c10-8542-45b9a1d7f326_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cost of revenue</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_019c9ac1-afda-74ac-ab79-21b9d15d9947_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_019c9ac1-afda-727d-8f2a-ab0772cd2390_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Goodwill, beginning balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_019c9ac1-afda-7d5e-aa3a-dd5429314b7b_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Goodwill, ending balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote</link:label>
    <link:label id="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock_label_en-US" xlink:label="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:to="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_019c9ac1-afda-70cd-ac4a-ed68a6cc4a69_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Components of Lease Cost and Supplemental Cash Flow Information Related to Leases and Lease Term and Discount Rates</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoTotalCompAmt_terseLabel_en-US" xlink:label="lab_ecd_PeoTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO Total Compensation Amount</link:label>
    <link:label id="lab_ecd_PeoTotalCompAmt_label_en-US" xlink:label="lab_ecd_PeoTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Total Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoTotalCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoTotalCompAmt" xlink:to="lab_ecd_PeoTotalCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_019c9ac1-af29-7c5a-ae09-b62fc3f935a4_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_019c9ac1-af2a-7ecc-ae8e-13c1f58fe07a_terseLabel_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Money market funds</link:label>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_label_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Money Market Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MoneyMarketFundsMember" xlink:to="lab_us-gaap_MoneyMarketFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_SaleOfStockValueRemainingAuthorized_019c9ac1-afda-79ba-99ec-02b17e6cd47f_terseLabel_en-US" xlink:label="lab_rxrx_SaleOfStockValueRemainingAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale of stock, value remaining authorized</link:label>
    <link:label id="lab_rxrx_SaleOfStockValueRemainingAuthorized_label_en-US" xlink:label="lab_rxrx_SaleOfStockValueRemainingAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale Of Stock Value Remaining Authorized</link:label>
    <link:label id="lab_rxrx_SaleOfStockValueRemainingAuthorized_documentation_en-US" xlink:label="lab_rxrx_SaleOfStockValueRemainingAuthorized" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sale Of Stock Value Remaining Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_SaleOfStockValueRemainingAuthorized" xlink:href="rxrx-20260331.xsd#rxrx_SaleOfStockValueRemainingAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_SaleOfStockValueRemainingAuthorized" xlink:to="lab_rxrx_SaleOfStockValueRemainingAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TangibleAssetImpairmentCharges_019c9ac1-af2a-70ab-8d28-b172a2d690ee_terseLabel_en-US" xlink:label="lab_us-gaap_TangibleAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Asset impairment</link:label>
    <link:label id="lab_us-gaap_TangibleAssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_TangibleAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tangible Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TangibleAssetImpairmentCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TangibleAssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TangibleAssetImpairmentCharges" xlink:to="lab_us-gaap_TangibleAssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_019c9ac1-afda-7941-aeb5-c22b5a2d3268_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Numerator:</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_019c9ac1-af2a-7def-9275-173810a0f078_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_019c9ac1-af29-73fb-aee0-0175826092c1_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NatureOfOperations_019c9ac1-afda-7430-a869-0dfae23e3d58_terseLabel_en-US" xlink:label="lab_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Description of the Business</link:label>
    <link:label id="lab_us-gaap_NatureOfOperations_label_en-US" xlink:label="lab_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nature of Operations [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NatureOfOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NatureOfOperations" xlink:to="lab_us-gaap_NatureOfOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonRule10b51ArrAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted</link:label>
    <link:label id="lab_ecd_NonRule10b51ArrAdoptedFlag_label_en-US" xlink:label="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonRule10b51ArrAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:to="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_019d86e5-d731-7d47-961a-249276989aff_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_NeuroscienceMember_019c9ac1-afda-7b1f-8307-14c2cc4c0268_terseLabel_en-US" xlink:label="lab_rxrx_NeuroscienceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Neuroscience</link:label>
    <link:label id="lab_rxrx_NeuroscienceMember_label_en-US" xlink:label="lab_rxrx_NeuroscienceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Neuroscience [Member]</link:label>
    <link:label id="lab_rxrx_NeuroscienceMember_documentation_en-US" xlink:label="lab_rxrx_NeuroscienceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Neuroscience</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_NeuroscienceMember" xlink:href="rxrx-20260331.xsd#rxrx_NeuroscienceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_NeuroscienceMember" xlink:to="lab_rxrx_NeuroscienceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OtherPerfMeasureAmt_terseLabel_en-US" xlink:label="lab_ecd_OtherPerfMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Performance Measure, Amount</link:label>
    <link:label id="lab_ecd_OtherPerfMeasureAmt_label_en-US" xlink:label="lab_ecd_OtherPerfMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Performance Measure, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OtherPerfMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OtherPerfMeasureAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OtherPerfMeasureAmt" xlink:to="lab_ecd_OtherPerfMeasureAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_019c9ac1-af29-7638-ab8f-e98602b81b35_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_019c9ac1-afda-767b-8de7-f8c9dbaa522f_verboseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Financing cash flows from financing leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_label_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Principal Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:to="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_019c9ac1-afda-73a5-812e-6fdb2d409e08_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Security, Excluded EPS Calculation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_019c9ac1-afda-70f1-ad3e-dc113da0bbec_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_IndividualAxis_terseLabel_en-US" xlink:label="lab_ecd_IndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Individual:</link:label>
    <link:label id="lab_ecd_IndividualAxis_label_en-US" xlink:label="lab_ecd_IndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_IndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_IndividualAxis" xlink:to="lab_ecd_IndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_MilestoneTypeDomain_019c9ac1-afda-7468-b0b0-5676ee85ee30_terseLabel_en-US" xlink:label="lab_rxrx_MilestoneTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Milestone, Type [Domain]</link:label>
    <link:label id="lab_rxrx_MilestoneTypeDomain_label_en-US" xlink:label="lab_rxrx_MilestoneTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Milestone, Type [Domain]</link:label>
    <link:label id="lab_rxrx_MilestoneTypeDomain_documentation_en-US" xlink:label="lab_rxrx_MilestoneTypeDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Milestone, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_MilestoneTypeDomain" xlink:href="rxrx-20260331.xsd#rxrx_MilestoneTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_MilestoneTypeDomain" xlink:to="lab_rxrx_MilestoneTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeFinanceLeasesTextBlock_019c9ac1-afda-7dc6-8bee-62f63cb3ab34_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeFinanceLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Finance Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeFinanceLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeFinanceLeasesTextBlock" xlink:to="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_019c9ac1-af29-7c39-88e6-c59deedcd961_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_019c9ac1-af29-7df8-8ec1-d8fc13369abc_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_019c9ac1-afda-7a75-98b6-f4c6729b811c_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Provided by (Used in) Investing Activity, Including Discontinued Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember_terseLabel_en-US" xlink:label="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table</link:label>
    <link:label id="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember_label_en-US" xlink:label="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:to="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_019c9ac1-afda-7265-922c-9c0c6c1e8624_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Loss on disposal of a business</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (Loss) on Disposition of Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfBusiness" xlink:to="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_019c9ac1-afda-748c-a3d8-117a592f1105_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_019c9ac1-af29-7ec0-9600-62e2eb733000_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_ContractWithCustomerMaximumAcceptedProduct_019c9ac1-afda-7bb7-bd72-4d8932f6f78b_terseLabel_en-US" xlink:label="lab_rxrx_ContractWithCustomerMaximumAcceptedProduct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of eligible phenomaps</link:label>
    <link:label id="lab_rxrx_ContractWithCustomerMaximumAcceptedProduct_label_en-US" xlink:label="lab_rxrx_ContractWithCustomerMaximumAcceptedProduct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract With Customer, Maximum Accepted Product</link:label>
    <link:label id="lab_rxrx_ContractWithCustomerMaximumAcceptedProduct_documentation_en-US" xlink:label="lab_rxrx_ContractWithCustomerMaximumAcceptedProduct" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Contract With Customer, Maximum Accepted Product</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_ContractWithCustomerMaximumAcceptedProduct" xlink:href="rxrx-20260331.xsd#rxrx_ContractWithCustomerMaximumAcceptedProduct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_ContractWithCustomerMaximumAcceptedProduct" xlink:to="lab_rxrx_ContractWithCustomerMaximumAcceptedProduct" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_019c9ac1-af29-7054-8d1f-801cb0724f9b_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:to="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_019c9ac1-afda-7530-a707-71ac5e981dd3_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_019c9ac1-af29-7854-920c-0d9164493c2e_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_019c9ac1-afda-7352-a800-833365c8c414_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unvested stock options, unamortized stock-based compensation cost, weighted average period recognition</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_GastrointestinalCancerMember_019c9ac1-afda-70cf-903a-1b42b01247f8_terseLabel_en-US" xlink:label="lab_rxrx_GastrointestinalCancerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gastrointestinal Cancer</link:label>
    <link:label id="lab_rxrx_GastrointestinalCancerMember_label_en-US" xlink:label="lab_rxrx_GastrointestinalCancerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gastrointestinal Cancer [Member]</link:label>
    <link:label id="lab_rxrx_GastrointestinalCancerMember_documentation_en-US" xlink:label="lab_rxrx_GastrointestinalCancerMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Gastrointestinal Cancer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_GastrointestinalCancerMember" xlink:href="rxrx-20260331.xsd#rxrx_GastrointestinalCancerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_GastrointestinalCancerMember" xlink:to="lab_rxrx_GastrointestinalCancerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_RocheAndGenentechMember_019c9ac1-afda-7368-9e35-9e9f4e8b95ee_terseLabel_en-US" xlink:label="lab_rxrx_RocheAndGenentechMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Roche and Genentech</link:label>
    <link:label id="lab_rxrx_RocheAndGenentechMember_label_en-US" xlink:label="lab_rxrx_RocheAndGenentechMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Roche and Genentech [Member]</link:label>
    <link:label id="lab_rxrx_RocheAndGenentechMember_documentation_en-US" xlink:label="lab_rxrx_RocheAndGenentechMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Roche and Genentech</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_RocheAndGenentechMember" xlink:href="rxrx-20260331.xsd#rxrx_RocheAndGenentechMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_RocheAndGenentechMember" xlink:to="lab_rxrx_RocheAndGenentechMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_019c9ac1-afda-722e-91bf-37c7d73c4dc4_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_019c9ac1-afda-70d0-be7a-228984bb8d51_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_019c9ac1-af2a-7a1b-a885-91d07a10af17_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Notes payable and financing lease liabilities</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_019c9ac1-af2a-7d53-87e9-002b3abb8d2f_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Notes payable and financing lease liabilities, current</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt and Lease Obligation, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_LicenseAgreementAmountOfTimePriorToThePaymentDate_019c9ac1-afda-75df-a63d-a6939a69784a_terseLabel_en-US" xlink:label="lab_rxrx_LicenseAgreementAmountOfTimePriorToThePaymentDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business days prior to the payment date</link:label>
    <link:label id="lab_rxrx_LicenseAgreementAmountOfTimePriorToThePaymentDate_label_en-US" xlink:label="lab_rxrx_LicenseAgreementAmountOfTimePriorToThePaymentDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">License Agreement, Amount Of Time Prior To The Payment Date</link:label>
    <link:label id="lab_rxrx_LicenseAgreementAmountOfTimePriorToThePaymentDate_documentation_en-US" xlink:label="lab_rxrx_LicenseAgreementAmountOfTimePriorToThePaymentDate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">License Agreement, Amount Of Time Prior To The Payment Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_LicenseAgreementAmountOfTimePriorToThePaymentDate" xlink:href="rxrx-20260331.xsd#rxrx_LicenseAgreementAmountOfTimePriorToThePaymentDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_LicenseAgreementAmountOfTimePriorToThePaymentDate" xlink:to="lab_rxrx_LicenseAgreementAmountOfTimePriorToThePaymentDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019c9ac1-af2a-7cbc-bab3-c317cae428cb_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_019c9ac1-afda-7dd9-bd3d-e7e211210b7b_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortization expense</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_019c9ac1-afda-7153-8111-04dbaa5e190d_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_019c9ac1-afda-7bbf-98eb-9b60ca60ab4a_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_019c9ac1-af29-79e4-915e-e0b1cc0ef997_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other assets, non-current</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_SignificantSegmentExpensesAbstract_019c9ac1-afda-74e5-9885-633b1bb92791_terseLabel_en-US" xlink:label="lab_rxrx_SignificantSegmentExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Significant segment expenses</link:label>
    <link:label id="lab_rxrx_SignificantSegmentExpensesAbstract_label_en-US" xlink:label="lab_rxrx_SignificantSegmentExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Significant Segment Expenses [Abstract]</link:label>
    <link:label id="lab_rxrx_SignificantSegmentExpensesAbstract_documentation_en-US" xlink:label="lab_rxrx_SignificantSegmentExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Significant Segment Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_SignificantSegmentExpensesAbstract" xlink:href="rxrx-20260331.xsd#rxrx_SignificantSegmentExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_SignificantSegmentExpensesAbstract" xlink:to="lab_rxrx_SignificantSegmentExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_019c9ac1-af2a-7aee-a314-445e0ed59be9_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoName_terseLabel_en-US" xlink:label="lab_ecd_PeoName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO Name</link:label>
    <link:label id="lab_ecd_PeoName_label_en-US" xlink:label="lab_ecd_PeoName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoName" xlink:to="lab_ecd_PeoName" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_AtTheMarketOfferingProgramTDCowenMember_019d86b0-3b06-707b-b92b-8e74bc9176c0_terseLabel_en-US" xlink:label="lab_rxrx_AtTheMarketOfferingProgramTDCowenMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">TD Cowen Sales Agreement</link:label>
    <link:label id="lab_rxrx_AtTheMarketOfferingProgramTDCowenMember_label_en-US" xlink:label="lab_rxrx_AtTheMarketOfferingProgramTDCowenMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">At-The-Market Offering Program TD Cowen [Member]</link:label>
    <link:label id="lab_rxrx_AtTheMarketOfferingProgramTDCowenMember_documentation_en-US" xlink:label="lab_rxrx_AtTheMarketOfferingProgramTDCowenMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">At-The-Market Offering Program TD Cowen</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_AtTheMarketOfferingProgramTDCowenMember" xlink:href="rxrx-20260331.xsd#rxrx_AtTheMarketOfferingProgramTDCowenMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_AtTheMarketOfferingProgramTDCowenMember" xlink:to="lab_rxrx_AtTheMarketOfferingProgramTDCowenMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year</link:label>
    <link:label id="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_label_en-US" xlink:label="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:to="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_019c9ac1-afda-7d1e-8df1-a8109d8553d4_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingAggtErrCompAmt_terseLabel_en-US" xlink:label="lab_ecd_OutstandingAggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
    <link:label id="lab_ecd_OutstandingAggtErrCompAmt_label_en-US" xlink:label="lab_ecd_OutstandingAggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingAggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingAggtErrCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingAggtErrCompAmt" xlink:to="lab_ecd_OutstandingAggtErrCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_019c9ac1-afda-7393-8775-13a588f45672_verboseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Finance lease liability</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiability" xlink:to="lab_us-gaap_FinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrDuration_terseLabel_en-US" xlink:label="lab_ecd_TrdArrDuration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Arrangement Duration</link:label>
    <link:label id="lab_ecd_TrdArrDuration_label_en-US" xlink:label="lab_ecd_TrdArrDuration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Duration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrDuration" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrDuration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrDuration" xlink:to="lab_ecd_TrdArrDuration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_019c9ac1-af29-7843-9fc6-f72fed408226_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_REVenturesIMember_019c9ac1-afda-7114-b006-194c2317cc7a_terseLabel_en-US" xlink:label="lab_rxrx_REVenturesIMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">RE Ventures I</link:label>
    <link:label id="lab_rxrx_REVenturesIMember_label_en-US" xlink:label="lab_rxrx_REVenturesIMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">RE Ventures I [Member]</link:label>
    <link:label id="lab_rxrx_REVenturesIMember_documentation_en-US" xlink:label="lab_rxrx_REVenturesIMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">RE Ventures I</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_REVenturesIMember" xlink:href="rxrx-20260331.xsd#rxrx_REVenturesIMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_REVenturesIMember" xlink:to="lab_rxrx_REVenturesIMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_019c9ac1-afda-728c-af1d-5e3438d1f96d_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unearned revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_019c9ac1-afda-7e06-a56b-933e164eca70_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrantMember_019c9ac1-afda-7aeb-839a-71597c6b5800_terseLabel_en-US" xlink:label="lab_us-gaap_GrantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Grant revenue</link:label>
    <link:label id="lab_us-gaap_GrantMember_label_en-US" xlink:label="lab_us-gaap_GrantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Grant [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrantMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GrantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrantMember" xlink:to="lab_us-gaap_GrantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_LesseeOperatingLeaseIncreaseDecreaseInOperatingLeaseLiabilityDueToLeaseModifications_019c9ac1-afda-7f7e-801e-13d86537487f_terseLabel_en-US" xlink:label="lab_rxrx_LesseeOperatingLeaseIncreaseDecreaseInOperatingLeaseLiabilityDueToLeaseModifications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase (decrease) in operating lease liabilities</link:label>
    <link:label id="lab_rxrx_LesseeOperatingLeaseIncreaseDecreaseInOperatingLeaseLiabilityDueToLeaseModifications_label_en-US" xlink:label="lab_rxrx_LesseeOperatingLeaseIncreaseDecreaseInOperatingLeaseLiabilityDueToLeaseModifications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Increase (Decrease) In Operating Lease Liability Due To Lease Modifications</link:label>
    <link:label id="lab_rxrx_LesseeOperatingLeaseIncreaseDecreaseInOperatingLeaseLiabilityDueToLeaseModifications_documentation_en-US" xlink:label="lab_rxrx_LesseeOperatingLeaseIncreaseDecreaseInOperatingLeaseLiabilityDueToLeaseModifications" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Increase (Decrease) In Operating Lease Liability Due To Lease Modifications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_LesseeOperatingLeaseIncreaseDecreaseInOperatingLeaseLiabilityDueToLeaseModifications" xlink:href="rxrx-20260331.xsd#rxrx_LesseeOperatingLeaseIncreaseDecreaseInOperatingLeaseLiabilityDueToLeaseModifications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_LesseeOperatingLeaseIncreaseDecreaseInOperatingLeaseLiabilityDueToLeaseModifications" xlink:to="lab_rxrx_LesseeOperatingLeaseIncreaseDecreaseInOperatingLeaseLiabilityDueToLeaseModifications" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardExrcPrice_terseLabel_en-US" xlink:label="lab_ecd_AwardExrcPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise Price</link:label>
    <link:label id="lab_ecd_AwardExrcPrice_label_en-US" xlink:label="lab_ecd_AwardExrcPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardExrcPrice" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardExrcPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardExrcPrice" xlink:to="lab_ecd_AwardExrcPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_019c9ac1-af29-7ebe-a86d-aaa1661bd166_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_IncreaseDecreaseInAccruedDevelopmentExpense_019c9ac1-afda-79e9-9696-9961a5e7c881_terseLabel_en-US" xlink:label="lab_rxrx_IncreaseDecreaseInAccruedDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued development expense</link:label>
    <link:label id="lab_rxrx_IncreaseDecreaseInAccruedDevelopmentExpense_label_en-US" xlink:label="lab_rxrx_IncreaseDecreaseInAccruedDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) In Accrued Development Expense</link:label>
    <link:label id="lab_rxrx_IncreaseDecreaseInAccruedDevelopmentExpense_documentation_en-US" xlink:label="lab_rxrx_IncreaseDecreaseInAccruedDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase (Decrease) In Accrued Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_IncreaseDecreaseInAccruedDevelopmentExpense" xlink:href="rxrx-20260331.xsd#rxrx_IncreaseDecreaseInAccruedDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_IncreaseDecreaseInAccruedDevelopmentExpense" xlink:to="lab_rxrx_IncreaseDecreaseInAccruedDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_019c9ac1-afda-7884-a6dc-8b93dfc01d4a_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_019c9ac1-afda-732d-b248-59ead2b42462_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Additional402vDisclosureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_Additional402vDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional 402(v) Disclosure</link:label>
    <link:label id="lab_ecd_Additional402vDisclosureTextBlock_label_en-US" xlink:label="lab_ecd_Additional402vDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional 402(v) Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Additional402vDisclosureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Additional402vDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Additional402vDisclosureTextBlock" xlink:to="lab_ecd_Additional402vDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_019c9ac1-afda-7c8c-988a-41ad76fb6b8b_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrecognized compensation cost</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019c9ac1-af29-7b44-838d-54cef5c53a1a_terseLabel_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_label_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_019c9ac1-afd9-72a5-9f81-0d4577a68ec1_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-Based Compensation</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations_019db0b0-8b21-7b71-85b3-b9b984f6bd1c_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign income tax expense (benefit)</link:label>
    <link:label id="lab_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations_label_en-US" xlink:label="lab_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Foreign Income Tax Expense (Benefit), Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations" xlink:to="lab_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_019c9ac1-af29-7a66-8f1b-64552e027c62_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_UndrlygSecurityMktPriceChngPct_terseLabel_en-US" xlink:label="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Underlying Security Market Price Change</link:label>
    <link:label id="lab_ecd_UndrlygSecurityMktPriceChngPct_label_en-US" xlink:label="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Underlying Security Market Price Change, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_UndrlygSecurityMktPriceChngPct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:to="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_019c9ac1-afd9-7309-9c8c-422fbab2df42_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forfeited (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_019c9ac1-afda-70bc-8bd9-be2ea8c85841_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_019c9ac1-af2a-7e58-9f6d-e4fb0e987f2c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Combination [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_019c9ac1-afda-79c8-800d-3b5523a7b126_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gross carrying amount</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_019c9ac1-af2a-7c9a-b35f-f9cc10e097f4_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity, Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year</link:label>
    <link:label id="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_label_en-US" xlink:label="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:to="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_019c9ac1-afda-7eef-afae-769aac2c295b_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_019c9ac1-af2a-7c01-925e-b39d7c362f28_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_019c9ac1-afda-7386-9a17-a8d54acc8706_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_019c9ac1-af29-7844-aca2-ecb72a8fe5b2_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_label_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_019c9ac1-afda-71b2-b807-f9fadcc4f3d4_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease liabilities, non-current</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_019c9ac1-afda-708f-8d34-7c26388ee64e_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares issued in the period, upon conversion (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, Conversion of Convertible Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardGrantDateFairValue_terseLabel_en-US" xlink:label="lab_ecd_AwardGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value as of Grant Date</link:label>
    <link:label id="lab_ecd_AwardGrantDateFairValue_label_en-US" xlink:label="lab_ecd_AwardGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardGrantDateFairValue" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardGrantDateFairValue" xlink:to="lab_ecd_AwardGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_019c9ac1-af2a-764b-b6c4-3456092ce07d_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementMember_019c9ac1-af2a-78c2-a765-0ec53d7359d4_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementMember_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CollaborativeArrangementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementMember" xlink:to="lab_us-gaap_CollaborativeArrangementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock_terseLabel_en-US" xlink:label="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Price or TSR Estimation Method</link:label>
    <link:label id="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock_label_en-US" xlink:label="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Price or TSR Estimation Method [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:to="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LaborAndRelatedExpense_019c9ac1-afda-76ba-8096-2f76d45248b3_terseLabel_en-US" xlink:label="lab_us-gaap_LaborAndRelatedExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Salaries</link:label>
    <link:label id="lab_us-gaap_LaborAndRelatedExpense_label_en-US" xlink:label="lab_us-gaap_LaborAndRelatedExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Labor and Related Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LaborAndRelatedExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LaborAndRelatedExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LaborAndRelatedExpense" xlink:to="lab_us-gaap_LaborAndRelatedExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_ValenceDiscoveryIncMember_019c9ac1-af29-78f8-a3e8-41f62b61a669_terseLabel_en-US" xlink:label="lab_rxrx_ValenceDiscoveryIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Valence Discovery Inc</link:label>
    <link:label id="lab_rxrx_ValenceDiscoveryIncMember_label_en-US" xlink:label="lab_rxrx_ValenceDiscoveryIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Valence Discovery Inc [Member]</link:label>
    <link:label id="lab_rxrx_ValenceDiscoveryIncMember_documentation_en-US" xlink:label="lab_rxrx_ValenceDiscoveryIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Valence Discovery Inc</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_ValenceDiscoveryIncMember" xlink:href="rxrx-20260331.xsd#rxrx_ValenceDiscoveryIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_ValenceDiscoveryIncMember" xlink:to="lab_rxrx_ValenceDiscoveryIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_019c9ac1-afda-7408-a091-852bdb4c0d43_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireInvestments_019c9ac1-af2a-7c8b-8266-068e43f6cd69_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Purchases of investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpenses_019c9ac1-af2a-7e99-a96c-e2272213445c_totalLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total operating costs and expenses</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpenses" xlink:to="lab_us-gaap_CostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_019c9ac1-af2a-7970-be8d-89767e12faa7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_019c9ac1-afda-7348-9d1d-43aa2dd6f245_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_019c9ac1-afda-791d-86fc-a90d478fe030_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChangedPeerGroupFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changed Peer Group, Footnote</link:label>
    <link:label id="lab_ecd_ChangedPeerGroupFnTextBlock_label_en-US" xlink:label="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Changed Peer Group, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ChangedPeerGroupFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:to="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_PlatformFeeExpense_019c9ac1-afda-752a-8b3a-915a02bd1cad_terseLabel_en-US" xlink:label="lab_rxrx_PlatformFeeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Platform</link:label>
    <link:label id="lab_rxrx_PlatformFeeExpense_label_en-US" xlink:label="lab_rxrx_PlatformFeeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Platform Fee Expense</link:label>
    <link:label id="lab_rxrx_PlatformFeeExpense_documentation_en-US" xlink:label="lab_rxrx_PlatformFeeExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Platform Fee Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_PlatformFeeExpense" xlink:href="rxrx-20260331.xsd#rxrx_PlatformFeeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_PlatformFeeExpense" xlink:to="lab_rxrx_PlatformFeeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_019c9ac1-afda-76bb-8db6-6b122cd7e12f_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_019d86e5-d731-7c51-a7b6-659b72d8d67f_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of operating segments</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_CommonStockConversionRatio_019c9ac1-afda-7cfe-9821-28363e33e09c_terseLabel_en-US" xlink:label="lab_rxrx_CommonStockConversionRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, conversion ratio</link:label>
    <link:label id="lab_rxrx_CommonStockConversionRatio_label_en-US" xlink:label="lab_rxrx_CommonStockConversionRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Conversion Ratio</link:label>
    <link:label id="lab_rxrx_CommonStockConversionRatio_documentation_en-US" xlink:label="lab_rxrx_CommonStockConversionRatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Common Stock, Conversion Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_CommonStockConversionRatio" xlink:href="rxrx-20260331.xsd#rxrx_CommonStockConversionRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_CommonStockConversionRatio" xlink:to="lab_rxrx_CommonStockConversionRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToPeoCompFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AdjToPeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment To PEO Compensation, Footnote</link:label>
    <link:label id="lab_ecd_AdjToPeoCompFnTextBlock_label_en-US" xlink:label="lab_ecd_AdjToPeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment To PEO Compensation, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToPeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToPeoCompFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToPeoCompFnTextBlock" xlink:to="lab_ecd_AdjToPeoCompFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_019c9ac1-af29-769a-a311-d1387b2ed40c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Accrued Expenses and Other Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_019c9ac1-afda-72ed-b636-ceccc64a7afe_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrIndTitle_terseLabel_en-US" xlink:label="lab_ecd_TrdArrIndTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title</link:label>
    <link:label id="lab_ecd_TrdArrIndTitle_label_en-US" xlink:label="lab_ecd_TrdArrIndTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement, Individual Title</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndTitle" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrIndTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrIndTitle" xlink:to="lab_ecd_TrdArrIndTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeerGroupTotalShareholderRtnAmt_terseLabel_en-US" xlink:label="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
    <link:label id="lab_ecd_PeerGroupTotalShareholderRtnAmt_label_en-US" xlink:label="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeerGroupTotalShareholderRtnAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:to="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_SupplementalAssetInformationAbstract_019c9ac1-afda-709d-944e-96730b4cd508_terseLabel_en-US" xlink:label="lab_rxrx_SupplementalAssetInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Supplemental asset information</link:label>
    <link:label id="lab_rxrx_SupplementalAssetInformationAbstract_label_en-US" xlink:label="lab_rxrx_SupplementalAssetInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Supplemental Asset Information [Abstract]</link:label>
    <link:label id="lab_rxrx_SupplementalAssetInformationAbstract_documentation_en-US" xlink:label="lab_rxrx_SupplementalAssetInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Supplemental Asset Information</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_SupplementalAssetInformationAbstract" xlink:href="rxrx-20260331.xsd#rxrx_SupplementalAssetInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_SupplementalAssetInformationAbstract" xlink:to="lab_rxrx_SupplementalAssetInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_019c9ac1-afd9-7a0b-a926-43b45222a390_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_label_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfArrangementAxis" xlink:to="lab_us-gaap_TypeOfArrangementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_019c9ac1-afda-77eb-8ab7-93fcf5a97035_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_IncreaseDecreaseInLeaseLiability_019c9ac1-afda-782c-b297-32eb0defa9a3_terseLabel_en-US" xlink:label="lab_rxrx_IncreaseDecreaseInLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease liabilities</link:label>
    <link:label id="lab_rxrx_IncreaseDecreaseInLeaseLiability_label_en-US" xlink:label="lab_rxrx_IncreaseDecreaseInLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) In Lease Liability</link:label>
    <link:label id="lab_rxrx_IncreaseDecreaseInLeaseLiability_documentation_en-US" xlink:label="lab_rxrx_IncreaseDecreaseInLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase (Decrease) In Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_IncreaseDecreaseInLeaseLiability" xlink:href="rxrx-20260331.xsd#rxrx_IncreaseDecreaseInLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_IncreaseDecreaseInLeaseLiability" xlink:to="lab_rxrx_IncreaseDecreaseInLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDateAxis_terseLabel_en-US" xlink:label="lab_ecd_RestatementDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement Determination Date:</link:label>
    <link:label id="lab_ecd_RestatementDateAxis_label_en-US" xlink:label="lab_ecd_RestatementDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement Determination Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDateAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDateAxis" xlink:to="lab_ecd_RestatementDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_019c9ac1-afda-700b-a24b-3f02db5279be_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock option exercises and other</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoMember_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-PEO NEO</link:label>
    <link:label id="lab_ecd_NonPeoNeoMember_label_en-US" xlink:label="lab_ecd_NonPeoNeoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-PEO NEO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonPeoNeoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoMember" xlink:to="lab_ecd_NonPeoNeoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_019c9ac1-afda-7c96-b0cb-c276ff13f4fe_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_label_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:to="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrIndName_terseLabel_en-US" xlink:label="lab_ecd_TrdArrIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_TrdArrIndName_label_en-US" xlink:label="lab_ecd_TrdArrIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrIndName" xlink:to="lab_ecd_TrdArrIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019c9ac1-afda-75c5-85f5-6c9532f9af27_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsAdjsMember_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments</link:label>
    <link:label id="lab_ecd_EqtyAwrdsAdjsMember_label_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsAdjsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsAdjsMember" xlink:to="lab_ecd_EqtyAwrdsAdjsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_019c9ac1-afda-78ee-a575-110b37ec0a12_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PnsnBnftsAdjFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PnsnBnftsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pension Benefits Adjustments, Footnote</link:label>
    <link:label id="lab_ecd_PnsnBnftsAdjFnTextBlock_label_en-US" xlink:label="lab_ecd_PnsnBnftsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pension Benefits Adjustments, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PnsnBnftsAdjFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:to="lab_ecd_PnsnBnftsAdjFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingRecoveryCompAmt_terseLabel_en-US" xlink:label="lab_ecd_OutstandingRecoveryCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Amount</link:label>
    <link:label id="lab_ecd_OutstandingRecoveryCompAmt_label_en-US" xlink:label="lab_ecd_OutstandingRecoveryCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding Recovery Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingRecoveryCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingRecoveryCompAmt" xlink:to="lab_ecd_OutstandingRecoveryCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RecoveryOfErrCompDisclosureLineItems_label_en-US" xlink:label="lab_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Recovery of Erroneously Awarded Compensation Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RecoveryOfErrCompDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="lab_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_019c9ac1-afda-79f7-af3a-a4d55f6a5892_terseLabel_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair values</link:label>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Estimate of Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_019c9ac1-afda-7867-86c3-c499c8c634f1_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue recognized</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MnpiDiscTimedForCompValFlag_terseLabel_en-US" xlink:label="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value</link:label>
    <link:label id="lab_ecd_MnpiDiscTimedForCompValFlag_label_en-US" xlink:label="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MnpiDiscTimedForCompValFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:to="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscIndName_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscIndName_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardsCloseToMnpiDiscIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:to="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_019c9ac1-afda-713f-8629-11bbcccf7fb5_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_019c9ac1-afda-73cd-8e9c-735097c36573_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_019c9ac1-af2a-7a0c-a226-c0e6021b643d_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted cash, non-current</link:label>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Cash, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashNoncurrent" xlink:to="lab_us-gaap_RestrictedCashNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtErrCompNotYetDeterminedTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined</link:label>
    <link:label id="lab_ecd_AggtErrCompNotYetDeterminedTextBlock_label_en-US" xlink:label="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:to="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_019c9ac1-afda-76fe-a943-745443ca28fa_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_ExchangeableStockMember_019c9ac1-afda-78bf-9d1b-90ec8ccb20f9_terseLabel_en-US" xlink:label="lab_rxrx_ExchangeableStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exchangeable Stock</link:label>
    <link:label id="lab_rxrx_ExchangeableStockMember_label_en-US" xlink:label="lab_rxrx_ExchangeableStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Exchangeable Stock [Member]</link:label>
    <link:label id="lab_rxrx_ExchangeableStockMember_documentation_en-US" xlink:label="lab_rxrx_ExchangeableStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Exchangeable Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_ExchangeableStockMember" xlink:href="rxrx-20260331.xsd#rxrx_ExchangeableStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_ExchangeableStockMember" xlink:to="lab_rxrx_ExchangeableStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_ProceedsFromPaymentForShareBasedPaymentArrangement_019dd4fa-fb35-7f18-a09c-d886439f383a_terseLabel_en-US" xlink:label="lab_rxrx_ProceedsFromPaymentForShareBasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity incentive plans</link:label>
    <link:label id="lab_rxrx_ProceedsFromPaymentForShareBasedPaymentArrangement_label_en-US" xlink:label="lab_rxrx_ProceedsFromPaymentForShareBasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds From (Payment For) Share-Based Payment Arrangement</link:label>
    <link:label id="lab_rxrx_ProceedsFromPaymentForShareBasedPaymentArrangement_documentation_en-US" xlink:label="lab_rxrx_ProceedsFromPaymentForShareBasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Proceeds From (Payment For) Share-Based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_ProceedsFromPaymentForShareBasedPaymentArrangement" xlink:href="rxrx-20260331.xsd#rxrx_ProceedsFromPaymentForShareBasedPaymentArrangement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_ProceedsFromPaymentForShareBasedPaymentArrangement" xlink:to="lab_rxrx_ProceedsFromPaymentForShareBasedPaymentArrangement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_019c9ac1-afda-7870-8e3a-7fd9350538b4_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_AccruedLicenseFeeCurrent_019c9ac1-afda-71c5-aa54-21bf5f195ad1_terseLabel_en-US" xlink:label="lab_rxrx_AccruedLicenseFeeCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued license fees</link:label>
    <link:label id="lab_rxrx_AccruedLicenseFeeCurrent_label_en-US" xlink:label="lab_rxrx_AccruedLicenseFeeCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued License Fee, Current</link:label>
    <link:label id="lab_rxrx_AccruedLicenseFeeCurrent_documentation_en-US" xlink:label="lab_rxrx_AccruedLicenseFeeCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accrued License Fee, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_AccruedLicenseFeeCurrent" xlink:href="rxrx-20260331.xsd#rxrx_AccruedLicenseFeeCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_AccruedLicenseFeeCurrent" xlink:to="lab_rxrx_AccruedLicenseFeeCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_019c9ac1-af2a-7927-93c2-fda18b71750d_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_019c9ac1-afda-7b14-b462-cce73f035d61_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Notes payable and financing lease liabilities, non-current</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_019c9ac1-afda-76f7-9c65-a2ae58ba4c86_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Notes payable and financing lease liabilities, non-current</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt and Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_TempusAgreementMember_019c9ac1-afda-743b-84a7-1a40978135cd_terseLabel_en-US" xlink:label="lab_rxrx_TempusAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tempus agreement</link:label>
    <link:label id="lab_rxrx_TempusAgreementMember_label_en-US" xlink:label="lab_rxrx_TempusAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tempus Agreement [Member]</link:label>
    <link:label id="lab_rxrx_TempusAgreementMember_documentation_en-US" xlink:label="lab_rxrx_TempusAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Tempus Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_TempusAgreementMember" xlink:href="rxrx-20260331.xsd#rxrx_TempusAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_TempusAgreementMember" xlink:to="lab_rxrx_TempusAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_019c9ac1-af29-79ba-874e-e6da936a5cfc_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_019c9ac1-afda-7a96-8ad2-c1651a785a79_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Income Location, Balance [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_019c9ac1-afda-74f9-9479-c79d7b04db5c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtPnsnAdjsSvcCstMember_terseLabel_en-US" xlink:label="lab_ecd_AggtPnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Pension Adjustments Service Cost</link:label>
    <link:label id="lab_ecd_AggtPnsnAdjsSvcCstMember_label_en-US" xlink:label="lab_ecd_AggtPnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Pension Adjustments Service Cost [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtPnsnAdjsSvcCstMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:to="lab_ecd_AggtPnsnAdjsSvcCstMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019c9ac1-afda-7eef-9e1d-ab117b1acfe0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_019c9ac1-afda-75a4-8b8a-a1f621b58b83_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_019c9ac1-af2a-7627-be81-9c032619bb7c_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CoSelectedMeasureName_terseLabel_en-US" xlink:label="lab_ecd_CoSelectedMeasureName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Company Selected Measure Name</link:label>
    <link:label id="lab_ecd_CoSelectedMeasureName_label_en-US" xlink:label="lab_ecd_CoSelectedMeasureName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Company Selected Measure Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CoSelectedMeasureName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CoSelectedMeasureName" xlink:to="lab_ecd_CoSelectedMeasureName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_019c9ac1-af2a-78d6-a9bf-526653bca655_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:to="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrSecuritiesAggAvailAmt_terseLabel_en-US" xlink:label="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Available</link:label>
    <link:label id="lab_ecd_TrdArrSecuritiesAggAvailAmt_label_en-US" xlink:label="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement, Securities Aggregate Available Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrSecuritiesAggAvailAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:to="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_019c9ac1-afda-7e22-930e-485cc6d4e85c_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_019c9ac1-afda-7950-8071-e0f2b34009f9_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating cash flows from operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_terseLabel_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Appreciation Rights (SARs)</link:label>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_label_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Appreciation Rights (SARs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:to="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_DiscoveryDevelopmentAndSalesMilestonesMember_019c9ac1-afda-706c-840e-55c681b6ae45_terseLabel_en-US" xlink:label="lab_rxrx_DiscoveryDevelopmentAndSalesMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Discovery, Development And Sales Milestones</link:label>
    <link:label id="lab_rxrx_DiscoveryDevelopmentAndSalesMilestonesMember_label_en-US" xlink:label="lab_rxrx_DiscoveryDevelopmentAndSalesMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Discovery, Development And Sales Milestones [Member]</link:label>
    <link:label id="lab_rxrx_DiscoveryDevelopmentAndSalesMilestonesMember_documentation_en-US" xlink:label="lab_rxrx_DiscoveryDevelopmentAndSalesMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Discovery, Development And Sales Milestones</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_DiscoveryDevelopmentAndSalesMilestonesMember" xlink:href="rxrx-20260331.xsd#rxrx_DiscoveryDevelopmentAndSalesMilestonesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_DiscoveryDevelopmentAndSalesMilestonesMember" xlink:to="lab_rxrx_DiscoveryDevelopmentAndSalesMilestonesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllExecutiveCategoriesMember_terseLabel_en-US" xlink:label="lab_ecd_AllExecutiveCategoriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Executive Categories</link:label>
    <link:label id="lab_ecd_AllExecutiveCategoriesMember_label_en-US" xlink:label="lab_ecd_AllExecutiveCategoriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Executive Categories [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllExecutiveCategoriesMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllExecutiveCategoriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="lab_ecd_AllExecutiveCategoriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_MilestoneTypeAxis_019c9ac1-af2a-723c-8dc1-61a49b7d2548_terseLabel_en-US" xlink:label="lab_rxrx_MilestoneTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Milestone, Type [Axis]</link:label>
    <link:label id="lab_rxrx_MilestoneTypeAxis_label_en-US" xlink:label="lab_rxrx_MilestoneTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Milestone, Type [Axis]</link:label>
    <link:label id="lab_rxrx_MilestoneTypeAxis_documentation_en-US" xlink:label="lab_rxrx_MilestoneTypeAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Milestone, Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_MilestoneTypeAxis" xlink:href="rxrx-20260331.xsd#rxrx_MilestoneTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_MilestoneTypeAxis" xlink:to="lab_rxrx_MilestoneTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_019c9ac1-afda-7875-b7a1-8c59bf5eebe7_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, $0.00001 par value; 2,000,000,000 shares (Class A 1,989,032,117 and Class B 10,967,883) authorized as of March&#160;31, 2026 and December&#160;31, 2025; 530,628,653 shares (Class A 524,464,320, Class B 5,307,334 and Exchangeable 856,999) and 528,182,693 shares (Class A 521,831,046, Class B 5,547,334 and Exchangeable 804,313) issued and outstanding as of March&#160;31, 2026 and December&#160;31, 2025, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_019c9ac1-afda-7f60-aeeb-bdeec6462e80_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financing lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Right-of-Use Asset, after Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_019c9ac1-afda-716f-aa25-6cc48a5ddd68_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_019c9ac1-af29-7d42-a4aa-a2813a694f29_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_019c9ac1-af29-7db8-aa01-aba6daa37149_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average shares (Class A, B and Exchangeable) outstanding, diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_019c9ac1-af29-71df-90ff-cafaae906848_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average common shares outstanding, diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_019c9ac1-af2a-79ee-b7c3-6852807f04c3_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments and contingencies (Note&#160;7)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonGaapMeasureDescriptionTextBlock_terseLabel_en-US" xlink:label="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-GAAP Measure Description</link:label>
    <link:label id="lab_ecd_NonGaapMeasureDescriptionTextBlock_label_en-US" xlink:label="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-GAAP Measure Description [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonGaapMeasureDescriptionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:to="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_019c9ac1-af29-7473-bdf5-3a299f41f8fc_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Combination [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_019c9ac1-afda-7bd0-bec2-a68606a49517_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_AssetAcquisitionEquityOwnershipPercentage_019c9ac1-afda-76a5-873c-1b54eff8d39c_terseLabel_en-US" xlink:label="lab_rxrx_AssetAcquisitionEquityOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest acquired</link:label>
    <link:label id="lab_rxrx_AssetAcquisitionEquityOwnershipPercentage_label_en-US" xlink:label="lab_rxrx_AssetAcquisitionEquityOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset Acquisition, Equity Ownership, Percentage</link:label>
    <link:label id="lab_rxrx_AssetAcquisitionEquityOwnershipPercentage_documentation_en-US" xlink:label="lab_rxrx_AssetAcquisitionEquityOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Asset Acquisition, Equity Ownership, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_AssetAcquisitionEquityOwnershipPercentage" xlink:href="rxrx-20260331.xsd#rxrx_AssetAcquisitionEquityOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_AssetAcquisitionEquityOwnershipPercentage" xlink:to="lab_rxrx_AssetAcquisitionEquityOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_019c9ac1-afda-7143-9b65-dffc66961df4_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_019c9ac1-afda-759f-b5d4-7fbd6d962c7c_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity method investment ownership percentage</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Method Investment, Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock_019c9ac1-af2a-726a-94c9-655d27d0940c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Financial Instruments Not Measured at Fair Value</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Disclosure of Asset and Liability Not Measured at Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock" xlink:to="lab_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardUndrlygSecuritiesAmt_terseLabel_en-US" xlink:label="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Underlying Securities</link:label>
    <link:label id="lab_ecd_AwardUndrlygSecuritiesAmt_label_en-US" xlink:label="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Underlying Securities Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardUndrlygSecuritiesAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:to="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_CommonStockVotePerShare_019c9ac1-af2a-7c93-8d7c-443d5d1f409e_terseLabel_en-US" xlink:label="lab_rxrx_CommonStockVotePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vote per share of common stock (in votes)</link:label>
    <link:label id="lab_rxrx_CommonStockVotePerShare_label_en-US" xlink:label="lab_rxrx_CommonStockVotePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Vote Per Share</link:label>
    <link:label id="lab_rxrx_CommonStockVotePerShare_documentation_en-US" xlink:label="lab_rxrx_CommonStockVotePerShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Common Stock, Vote Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_CommonStockVotePerShare" xlink:href="rxrx-20260331.xsd#rxrx_CommonStockVotePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_CommonStockVotePerShare" xlink:to="lab_rxrx_CommonStockVotePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_019c9ac1-af29-7204-b529-f4953f4157b1_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_019c9ac1-afda-75cf-95c0-d30fbec3c519_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoActuallyPaidCompAmt_terseLabel_en-US" xlink:label="lab_ecd_PeoActuallyPaidCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
    <link:label id="lab_ecd_PeoActuallyPaidCompAmt_label_en-US" xlink:label="lab_ecd_PeoActuallyPaidCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoActuallyPaidCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoActuallyPaidCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoActuallyPaidCompAmt" xlink:to="lab_ecd_PeoActuallyPaidCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_019c9ac1-afda-759d-8b48-62a7faf8d934_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents [Domain]</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_019c9ac1-af2a-7e7d-8704-e108d61bdb5d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonClassAMember_019c9ac1-afda-7e92-b4cc-7088fd828358_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonClassAMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Class A Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonClassAMember_019c9ac1-afda-730c-8f6b-e6f56e3825da_terseLabel_en-US" xlink:label="lab_us-gaap_CommonClassAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class A</link:label>
    <link:label id="lab_us-gaap_CommonClassAMember_label_en-US" xlink:label="lab_us-gaap_CommonClassAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Class A [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonClassAMember" xlink:to="lab_us-gaap_CommonClassAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Table</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:to="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_AlphaBiotechnologyGmbHAlphaMember_019c9ac1-af2a-797d-954a-58e1d9af55ce_terseLabel_en-US" xlink:label="lab_rxrx_AlphaBiotechnologyGmbHAlphaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Alpha Biotechnology GmbH (Alpha)</link:label>
    <link:label id="lab_rxrx_AlphaBiotechnologyGmbHAlphaMember_label_en-US" xlink:label="lab_rxrx_AlphaBiotechnologyGmbHAlphaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Alpha Biotechnology GmbH (Alpha) [Member]</link:label>
    <link:label id="lab_rxrx_AlphaBiotechnologyGmbHAlphaMember_documentation_en-US" xlink:label="lab_rxrx_AlphaBiotechnologyGmbHAlphaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Alpha Biotechnology GmbH (Alpha)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_AlphaBiotechnologyGmbHAlphaMember" xlink:href="rxrx-20260331.xsd#rxrx_AlphaBiotechnologyGmbHAlphaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_AlphaBiotechnologyGmbHAlphaMember" xlink:to="lab_rxrx_AlphaBiotechnologyGmbHAlphaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_ResearchMilestonesMember_019c9ac1-afda-7f41-b22c-4ec0b8168a1e_terseLabel_en-US" xlink:label="lab_rxrx_ResearchMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research Milestones</link:label>
    <link:label id="lab_rxrx_ResearchMilestonesMember_label_en-US" xlink:label="lab_rxrx_ResearchMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research Milestones [Member]</link:label>
    <link:label id="lab_rxrx_ResearchMilestonesMember_documentation_en-US" xlink:label="lab_rxrx_ResearchMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Research Milestones</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_ResearchMilestonesMember" xlink:href="rxrx-20260331.xsd#rxrx_ResearchMilestonesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_ResearchMilestonesMember" xlink:to="lab_rxrx_ResearchMilestonesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_019c9ac1-afda-7b52-9a40-212de9d0c235_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_019c9ac1-af2a-7c3e-9b91-d8ea0c6756f1_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_019c9ac1-afda-7e88-b91b-c554f0075e35_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net Loss Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingRecoveryIndName_terseLabel_en-US" xlink:label="lab_ecd_OutstandingRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_OutstandingRecoveryIndName_label_en-US" xlink:label="lab_ecd_OutstandingRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding Recovery, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingRecoveryIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingRecoveryIndName" xlink:to="lab_ecd_OutstandingRecoveryIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_019c9ac1-af29-7800-92a2-f839683713f9_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_019c9ac1-afda-7e33-9bc0-98ee064be1e2_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetAcquisitionDomain_019c9ac1-afda-7fd2-befd-86a730724116_terseLabel_en-US" xlink:label="lab_us-gaap_AssetAcquisitionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Asset Acquisition [Domain]</link:label>
    <link:label id="lab_us-gaap_AssetAcquisitionDomain_label_en-US" xlink:label="lab_us-gaap_AssetAcquisitionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset Acquisition [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetAcquisitionDomain" xlink:to="lab_us-gaap_AssetAcquisitionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_019c9ac1-afda-7ccd-a797-6cb5ab8808a3_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from issuance of common shares, net of issuance costs</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Issuance of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019c9ac1-af29-702a-be60-be8830694fdf_netLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xml:lang="en-US">Total revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019c9ac1-af29-7870-b077-c1dcae47f01e_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllIndividualsMember_terseLabel_en-US" xlink:label="lab_ecd_AllIndividualsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Individuals</link:label>
    <link:label id="lab_ecd_AllIndividualsMember_label_en-US" xlink:label="lab_ecd_AllIndividualsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Individuals [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllIndividualsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="lab_ecd_AllIndividualsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_019c9ac1-afda-7e83-8046-c25e2c6a3f00_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_TempusLabsIncMember_019c9ac1-af29-7b4d-be18-35153e664381_terseLabel_en-US" xlink:label="lab_rxrx_TempusLabsIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tempus Labs, Inc</link:label>
    <link:label id="lab_rxrx_TempusLabsIncMember_label_en-US" xlink:label="lab_rxrx_TempusLabsIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tempus Labs, Inc [Member]</link:label>
    <link:label id="lab_rxrx_TempusLabsIncMember_documentation_en-US" xlink:label="lab_rxrx_TempusLabsIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Tempus Labs, Inc</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_TempusLabsIncMember" xlink:href="rxrx-20260331.xsd#rxrx_TempusLabsIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_TempusLabsIncMember" xlink:to="lab_rxrx_TempusLabsIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_PurchaseOfAnEquityInvestmentNonCash_019c9ac1-af29-75fa-969b-685a2c28c004_terseLabel_en-US" xlink:label="lab_rxrx_PurchaseOfAnEquityInvestmentNonCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Purchase of an equity investment</link:label>
    <link:label id="lab_rxrx_PurchaseOfAnEquityInvestmentNonCash_label_en-US" xlink:label="lab_rxrx_PurchaseOfAnEquityInvestmentNonCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Purchase Of An Equity Investment, Non-Cash</link:label>
    <link:label id="lab_rxrx_PurchaseOfAnEquityInvestmentNonCash_documentation_en-US" xlink:label="lab_rxrx_PurchaseOfAnEquityInvestmentNonCash" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Purchase Of An Equity Investment, Non-Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_PurchaseOfAnEquityInvestmentNonCash" xlink:href="rxrx-20260331.xsd#rxrx_PurchaseOfAnEquityInvestmentNonCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_PurchaseOfAnEquityInvestmentNonCash" xlink:to="lab_rxrx_PurchaseOfAnEquityInvestmentNonCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_019c9ac1-afda-7b06-9957-087dcca8ab97_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Purchases of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetAcquisitionConsiderationTransferred_019c9ac1-afda-79bb-93e5-fd1adb50aab6_terseLabel_en-US" xlink:label="lab_us-gaap_AssetAcquisitionConsiderationTransferred" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Asset acquisition, consideration transferred</link:label>
    <link:label id="lab_us-gaap_AssetAcquisitionConsiderationTransferred_label_en-US" xlink:label="lab_us-gaap_AssetAcquisitionConsiderationTransferred" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset Acquisition, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionConsiderationTransferred" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetAcquisitionConsiderationTransferred"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetAcquisitionConsiderationTransferred" xlink:to="lab_us-gaap_AssetAcquisitionConsiderationTransferred" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryIndName_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryIndName_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryIndName" xlink:to="lab_ecd_ForgoneRecoveryIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_019c9ac1-afda-7187-a846-80ae97a1061e_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_019c9ac1-afda-7d44-91fc-8ee7fba87804_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_terseLabel_en-US" xlink:label="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested</link:label>
    <link:label id="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_label_en-US" xlink:label="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:to="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_019c9ac1-af29-7bb8-896a-ee0663e7cfd2_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis" xlink:to="lab_us-gaap_DisposalGroupClassificationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_019c9ac1-af29-7a7a-84fc-3c608cb1599b_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss contingency accrual</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingency Accrual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:to="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherReceivablesNetCurrent_019c9ac1-af2a-752e-884d-13878e9ec64d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other receivables</link:label>
    <link:label id="lab_us-gaap_OtherReceivablesNetCurrent_label_en-US" xlink:label="lab_us-gaap_OtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Receivables, Net, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherReceivablesNetCurrent" xlink:to="lab_us-gaap_OtherReceivablesNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtErrCompAmt_terseLabel_en-US" xlink:label="lab_ecd_AggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
    <link:label id="lab_ecd_AggtErrCompAmt_label_en-US" xlink:label="lab_ecd_AggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtErrCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtErrCompAmt" xlink:to="lab_ecd_AggtErrCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_019c9ac1-af2a-7de1-81f4-c1c894984788_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Foreign currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill, Foreign Currency Translation, Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019c9ac1-afda-767b-9568-80a4425c3d09_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment_019c9ac1-afda-7090-abd5-214ca17fde48_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payments to acquire IPR&amp;D</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire in Process Research and Development</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment" xlink:to="lab_us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeerGroupIssuersFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Peer Group Issuers, Footnote</link:label>
    <link:label id="lab_ecd_PeerGroupIssuersFnTextBlock_label_en-US" xlink:label="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Peer Group Issuers, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeerGroupIssuersFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:to="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ErrCompAnalysisTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ErrCompAnalysisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Erroneous Compensation Analysis</link:label>
    <link:label id="lab_ecd_ErrCompAnalysisTextBlock_label_en-US" xlink:label="lab_ecd_ErrCompAnalysisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Erroneous Compensation Analysis [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompAnalysisTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ErrCompAnalysisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ErrCompAnalysisTextBlock" xlink:to="lab_ecd_ErrCompAnalysisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_IncreaseDecreaseInPrepaidDataAssets_019c9ac1-afda-71fc-bd67-e33c0f7a5e09_negatedLabel_en-US" xlink:label="lab_rxrx_IncreaseDecreaseInPrepaidDataAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Prepaid data assets</link:label>
    <link:label id="lab_rxrx_IncreaseDecreaseInPrepaidDataAssets_label_en-US" xlink:label="lab_rxrx_IncreaseDecreaseInPrepaidDataAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) In Prepaid Data Assets</link:label>
    <link:label id="lab_rxrx_IncreaseDecreaseInPrepaidDataAssets_documentation_en-US" xlink:label="lab_rxrx_IncreaseDecreaseInPrepaidDataAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase (Decrease) In Prepaid Data Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_IncreaseDecreaseInPrepaidDataAssets" xlink:href="rxrx-20260331.xsd#rxrx_IncreaseDecreaseInPrepaidDataAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_IncreaseDecreaseInPrepaidDataAssets" xlink:to="lab_rxrx_IncreaseDecreaseInPrepaidDataAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_019c9ac1-afda-7840-b06b-42f110852c2c_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_019c9ac1-afda-7bcb-aec9-81959d0ee847_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_019c9ac1-af2a-7c0e-a11d-27cf7e9bcfdf_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_019c9ac1-afda-76d6-a01f-f7672ea5161d_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Rule10b51ArrTrmntdFlag_terseLabel_en-US" xlink:label="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated</link:label>
    <link:label id="lab_ecd_Rule10b51ArrTrmntdFlag_label_en-US" xlink:label="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Rule10b51ArrTrmntdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:to="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_019c9ac1-af2a-7d15-adf6-d3b44b1b0ae3_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LicenseAndServiceMember_019c9ac1-afda-798a-a959-0657add30d46_terseLabel_en-US" xlink:label="lab_us-gaap_LicenseAndServiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating revenue</link:label>
    <link:label id="lab_us-gaap_LicenseAndServiceMember_label_en-US" xlink:label="lab_us-gaap_LicenseAndServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">License and Service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicenseAndServiceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LicenseAndServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LicenseAndServiceMember" xlink:to="lab_us-gaap_LicenseAndServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_019c9ac1-af2a-7905-a1db-1d5818028b79_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems_019c9ac1-afda-78a4-abe1-32e3614169de_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems" xlink:to="lab_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_019c9ac1-afda-7693-b3ad-331f81b0946a_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net loss per share of class A, B and Exchangeable common stock, diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_019c9ac1-afda-7618-b35b-79009391ddc9_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net loss per share, diluted (in dollars per shares)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities_019c9ac1-af29-7c6b-b889-bf84bb245936_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued expenses and other current liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Other Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOtherAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization_019c9ac1-af2a-7de9-8433-b8a4d16ba7d3_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cost, Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_IncreaseDecreaseInOperatingLeaseRightOfUseAssets_019c9ac1-afda-7872-b4c9-aa7b3efb8a4b_verboseLabel_en-US" xlink:label="lab_rxrx_IncreaseDecreaseInOperatingLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Increase (decrease) in operating lease right-of-use assets</link:label>
    <link:label id="lab_rxrx_IncreaseDecreaseInOperatingLeaseRightOfUseAssets_019c9ac1-afda-7465-a1d1-c2a3e57a1bad_terseLabel_en-US" xlink:label="lab_rxrx_IncreaseDecreaseInOperatingLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating leases</link:label>
    <link:label id="lab_rxrx_IncreaseDecreaseInOperatingLeaseRightOfUseAssets_label_en-US" xlink:label="lab_rxrx_IncreaseDecreaseInOperatingLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Operating Lease Right-Of-Use Assets</link:label>
    <link:label id="lab_rxrx_IncreaseDecreaseInOperatingLeaseRightOfUseAssets_documentation_en-US" xlink:label="lab_rxrx_IncreaseDecreaseInOperatingLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Operating Lease Right-Of-Use Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_IncreaseDecreaseInOperatingLeaseRightOfUseAssets" xlink:href="rxrx-20260331.xsd#rxrx_IncreaseDecreaseInOperatingLeaseRightOfUseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_IncreaseDecreaseInOperatingLeaseRightOfUseAssets" xlink:to="lab_rxrx_IncreaseDecreaseInOperatingLeaseRightOfUseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ErrCompRecoveryTable_terseLabel_en-US" xlink:label="lab_ecd_ErrCompRecoveryTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Erroneously Awarded Compensation Recovery</link:label>
    <link:label id="lab_ecd_ErrCompRecoveryTable_label_en-US" xlink:label="lab_ecd_ErrCompRecoveryTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Erroneously Awarded Compensation Recovery [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompRecoveryTable" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ErrCompRecoveryTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="lab_ecd_ErrCompRecoveryTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_019c9ac1-afda-7261-a986-d586c4482345_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_019c9ac1-afda-7fe3-af9f-0caeb90dbefc_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_019c9ac1-af2a-7006-9a21-b5ba1d64187c_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Per share data</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_019c9ac1-af2a-7005-9ecc-04572a85424c_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other income (loss), net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_019c9ac1-af2a-7942-b9f8-7cd9f64d44b0_verboseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Other non-operating income (loss), net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_NamandjeBumpusMember_label_en-US" xlink:label="lab_rxrx_NamandjeBumpusMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Namandj&#233; Bumpus [Member]</link:label>
    <link:label id="lab_rxrx_NamandjeBumpusMember_documentation_en-US" xlink:label="lab_rxrx_NamandjeBumpusMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Namandj&#233; Bumpus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_NamandjeBumpusMember" xlink:href="rxrx-20260331.xsd#rxrx_NamandjeBumpusMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_NamandjeBumpusMember" xlink:to="lab_rxrx_NamandjeBumpusMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_DevelopedAndCommercializedProgramsMember_019c9ac1-afd9-73a5-b4c6-d5f5f9986f79_terseLabel_en-US" xlink:label="lab_rxrx_DevelopedAndCommercializedProgramsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Developed and Commercialized Programs</link:label>
    <link:label id="lab_rxrx_DevelopedAndCommercializedProgramsMember_label_en-US" xlink:label="lab_rxrx_DevelopedAndCommercializedProgramsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Developed And Commercialized Programs [Member]</link:label>
    <link:label id="lab_rxrx_DevelopedAndCommercializedProgramsMember_documentation_en-US" xlink:label="lab_rxrx_DevelopedAndCommercializedProgramsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Developed And Commercialized Programs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_DevelopedAndCommercializedProgramsMember" xlink:href="rxrx-20260331.xsd#rxrx_DevelopedAndCommercializedProgramsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_DevelopedAndCommercializedProgramsMember" xlink:to="lab_rxrx_DevelopedAndCommercializedProgramsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_019c9ac1-af29-7453-90cb-d3a0e0c5f1ca_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Net Loss Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock_019c9ac1-af29-7f8f-b6da-f3ccda3fffcf_terseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Interest Income, Net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock_label_en-US" xlink:label="lab_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Income and Interest Expense Disclosure [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock" xlink:to="lab_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_019c9ac1-afda-711f-a761-a8961b1194f6_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unearned revenue</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_ReportableSegmentMember_019c9ac1-afda-77f2-854f-098d0c1a6be7_terseLabel_en-US" xlink:label="lab_rxrx_ReportableSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reportable Segment</link:label>
    <link:label id="lab_rxrx_ReportableSegmentMember_label_en-US" xlink:label="lab_rxrx_ReportableSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reportable Segment [Member]</link:label>
    <link:label id="lab_rxrx_ReportableSegmentMember_documentation_en-US" xlink:label="lab_rxrx_ReportableSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Reportable Segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_ReportableSegmentMember" xlink:href="rxrx-20260331.xsd#rxrx_ReportableSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_ReportableSegmentMember" xlink:to="lab_rxrx_ReportableSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_PhenomapsCreationMember_019c9ac1-af2a-73bc-b4e2-4880eabd3c42_terseLabel_en-US" xlink:label="lab_rxrx_PhenomapsCreationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Phenomaps Creation</link:label>
    <link:label id="lab_rxrx_PhenomapsCreationMember_label_en-US" xlink:label="lab_rxrx_PhenomapsCreationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Phenomaps Creation [Member]</link:label>
    <link:label id="lab_rxrx_PhenomapsCreationMember_documentation_en-US" xlink:label="lab_rxrx_PhenomapsCreationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Phenomaps Creation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_PhenomapsCreationMember" xlink:href="rxrx-20260331.xsd#rxrx_PhenomapsCreationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_PhenomapsCreationMember" xlink:to="lab_rxrx_PhenomapsCreationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_RegistrationRightsAgreementTerm_019c9ac1-af2a-780e-b422-4d0d2760c6fd_terseLabel_en-US" xlink:label="lab_rxrx_RegistrationRightsAgreementTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Registration rights agreement term</link:label>
    <link:label id="lab_rxrx_RegistrationRightsAgreementTerm_label_en-US" xlink:label="lab_rxrx_RegistrationRightsAgreementTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Registration Rights Agreement, Term</link:label>
    <link:label id="lab_rxrx_RegistrationRightsAgreementTerm_documentation_en-US" xlink:label="lab_rxrx_RegistrationRightsAgreementTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Registration Rights Agreement, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_RegistrationRightsAgreementTerm" xlink:href="rxrx-20260331.xsd#rxrx_RegistrationRightsAgreementTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_RegistrationRightsAgreementTerm" xlink:to="lab_rxrx_RegistrationRightsAgreementTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_019c9ac1-af2a-7665-ad03-f6f08a192583_terseLabel_en-US" xlink:label="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of RSU Activity</link:label>
    <link:label id="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nonvested Restricted Stock Shares Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:to="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_019c9ac1-afda-7537-89b6-8727cf7fec32_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgDiscLineItems_label_en-US" xlink:label="lab_ecd_AwardTmgDiscLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing Disclosures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgDiscLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgDiscLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="lab_ecd_AwardTmgDiscLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_019c9ac1-af29-753b-b190-fb5527aae1ec_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued compensation</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_019c9ac1-af2a-7bb3-8d90-7c80393dec88_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease, renewal term</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Renewal Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:to="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_019c9ac1-afda-7027-b0c8-f5fb6cff4ee4_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_019c9ac1-af29-73c3-8eac-0efccb9a0461_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_019c9ac1-af29-775e-8105-f503f451c0e9_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_019c9ac1-af29-7f40-a69d-af231efd3913_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_019c9ac1-af29-7f74-9b3c-c63bccb7f757_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xml:lang="en-US">Total segment loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrExpirationDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrExpirationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expiration Date</link:label>
    <link:label id="lab_ecd_TrdArrExpirationDate_label_en-US" xlink:label="lab_ecd_TrdArrExpirationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Expiration Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrExpirationDate" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrExpirationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrExpirationDate" xlink:to="lab_ecd_TrdArrExpirationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_019c9ac1-af2a-7dcb-a308-1bb5dad89c12_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued other expenses</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_019c9ac1-afda-7279-a252-c1455b5c4f7e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock options, vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_019c9ac1-afda-76ee-8a78-2df9269fa327_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_019c9ac1-af29-7614-8a11-5b5152b52013_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrAdoptionDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrAdoptionDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adoption Date</link:label>
    <link:label id="lab_ecd_TrdArrAdoptionDate_label_en-US" xlink:label="lab_ecd_TrdArrAdoptionDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Adoption Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrAdoptionDate" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrAdoptionDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrAdoptionDate" xlink:to="lab_ecd_TrdArrAdoptionDate" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_ClinicalDevelopmentExpense_019c9ac1-af29-7f29-b89f-49615a06ee6c_terseLabel_en-US" xlink:label="lab_rxrx_ClinicalDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Clinical development</link:label>
    <link:label id="lab_rxrx_ClinicalDevelopmentExpense_label_en-US" xlink:label="lab_rxrx_ClinicalDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Clinical Development Expense</link:label>
    <link:label id="lab_rxrx_ClinicalDevelopmentExpense_documentation_en-US" xlink:label="lab_rxrx_ClinicalDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Clinical Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_ClinicalDevelopmentExpense" xlink:href="rxrx-20260331.xsd#rxrx_ClinicalDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_ClinicalDevelopmentExpense" xlink:to="lab_rxrx_ClinicalDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Net Income</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Net Income [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_019c9ac1-af2a-7ccc-950f-5e8ae8a24a09_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTable_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTable_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardsCloseToMnpiDiscTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_019c9ac1-af29-747b-8cc0-0ef329a27dab_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Loss from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_019c9ac1-af29-7852-a0b6-b43e4d11d60f_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xml:lang="en-US">Loss from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_019c9ac1-af2a-7a31-9a90-7b70fdb94e53_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_019c9ac1-af2a-70b3-a2dd-57fd6c0bee93_negatedLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_DevelopmentAndRegulatoryMilestonesMember_019c9ac1-afda-7efa-9744-e7219e373d78_terseLabel_en-US" xlink:label="lab_rxrx_DevelopmentAndRegulatoryMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Development And Regulatory Milestones</link:label>
    <link:label id="lab_rxrx_DevelopmentAndRegulatoryMilestonesMember_label_en-US" xlink:label="lab_rxrx_DevelopmentAndRegulatoryMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Development And Regulatory Milestones [Member]</link:label>
    <link:label id="lab_rxrx_DevelopmentAndRegulatoryMilestonesMember_documentation_en-US" xlink:label="lab_rxrx_DevelopmentAndRegulatoryMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Development And Regulatory Milestones</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_DevelopmentAndRegulatoryMilestonesMember" xlink:href="rxrx-20260331.xsd#rxrx_DevelopmentAndRegulatoryMilestonesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_DevelopmentAndRegulatoryMilestonesMember" xlink:to="lab_rxrx_DevelopmentAndRegulatoryMilestonesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_terseLabel_en-US" xlink:label="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested</link:label>
    <link:label id="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_label_en-US" xlink:label="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:to="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ExecutiveCategoryAxis_terseLabel_en-US" xlink:label="lab_ecd_ExecutiveCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Executive Category:</link:label>
    <link:label id="lab_ecd_ExecutiveCategoryAxis_label_en-US" xlink:label="lab_ecd_ExecutiveCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Executive Category [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ExecutiveCategoryAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ExecutiveCategoryAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ExecutiveCategoryAxis" xlink:to="lab_ecd_ExecutiveCategoryAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_019c9ac1-af29-757a-9f35-b4eea98224f0_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impairment of indefinite-lived intangible assets</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impairment of Intangible Assets, Indefinite-Lived (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_019c9ac1-afda-7089-9b55-68f1d0594402_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_019c9ac1-afda-702b-9de0-872fe817244b_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_019c9ac1-af2a-72dd-91e7-ece1441a54e3_terseLabel_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Definite-lived technology intangible assets</link:label>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Technology-Based Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:to="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_019c9ac1-afda-744d-b8fc-3e1d89e103ec_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table</link:label>
    <link:label id="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember_label_en-US" xlink:label="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:to="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_LicenseAgreementTradingPeriodUsedForEquityValueDetermination_019c9ac1-afda-7cda-85e8-fc1bafaca689_terseLabel_en-US" xlink:label="lab_rxrx_LicenseAgreementTradingPeriodUsedForEquityValueDetermination" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading period used for equity value determination</link:label>
    <link:label id="lab_rxrx_LicenseAgreementTradingPeriodUsedForEquityValueDetermination_label_en-US" xlink:label="lab_rxrx_LicenseAgreementTradingPeriodUsedForEquityValueDetermination" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">License Agreement, Trading Period Used For Equity Value Determination</link:label>
    <link:label id="lab_rxrx_LicenseAgreementTradingPeriodUsedForEquityValueDetermination_documentation_en-US" xlink:label="lab_rxrx_LicenseAgreementTradingPeriodUsedForEquityValueDetermination" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">License Agreement, Trading Period Used For Equity Value Determination</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_LicenseAgreementTradingPeriodUsedForEquityValueDetermination" xlink:href="rxrx-20260331.xsd#rxrx_LicenseAgreementTradingPeriodUsedForEquityValueDetermination"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_LicenseAgreementTradingPeriodUsedForEquityValueDetermination" xlink:to="lab_rxrx_LicenseAgreementTradingPeriodUsedForEquityValueDetermination" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_019c9ac1-af2a-79d8-8730-d87603e87074_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average grant date fair value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_019c9ac1-afda-7215-bace-18a056ae434d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of shares available for grant (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_019c9ac1-af2a-7429-a848-56bb97dd07a1_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1_019c9ac1-af2a-7897-a9ed-b70c2f3d4b4f_terseLabel_en-US" xlink:label="lab_us-gaap_NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Purchase of an intangible asset</link:label>
    <link:label id="lab_us-gaap_NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1_label_en-US" xlink:label="lab_us-gaap_NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Noncash or Part Noncash Acquisition, Intangible Assets Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1" xlink:to="lab_us-gaap_NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_019dcd53-3d10-7817-9725-9cf6fb535498_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_019c9ac1-afda-711e-883a-f9c716b5da9b_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock_019c9ac1-afda-7a27-868e-28b1914ebf03_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Collaborative Development Contracts</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:to="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_019c9ac1-afda-798e-9c25-c426057ddf2d_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flows from financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashMember_019c9ac1-afda-713e-a0ca-95ef34919226_terseLabel_en-US" xlink:label="lab_us-gaap_CashMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash</link:label>
    <link:label id="lab_us-gaap_CashMember_label_en-US" xlink:label="lab_us-gaap_CashMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashMember" xlink:to="lab_us-gaap_CashMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Excluding Value Reported in Compensation Table</link:label>
    <link:label id="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember_label_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_019c9ac1-afda-775e-a64d-dcf3fdb69eb4_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Remaining unearned revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiability" xlink:to="lab_us-gaap_ContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_019c9ac1-afda-72f7-8249-60e49e2c9cb4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_019c9ac1-afda-717d-b0b2-306a869b5de1_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive securities excluded from computation of loss per share, amount (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_019c9ac1-afda-71e9-bee5-c56ee57b9d8b_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Denominator:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllAdjToCompMember_terseLabel_en-US" xlink:label="lab_ecd_AllAdjToCompMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Adjustments to Compensation</link:label>
    <link:label id="lab_ecd_AllAdjToCompMember_label_en-US" xlink:label="lab_ecd_AllAdjToCompMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Adjustments to Compensation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllAdjToCompMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="lab_ecd_AllAdjToCompMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_019c9ac1-afda-7bde-8f15-b7ae975fdd9c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_019c9ac1-af2a-7452-b0e0-027d63b9f5ec_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_RevenueRemainingPerformanceObligationNumberOfProjectsThatMayBeInitiated_019c9ac1-af2a-7ba0-984e-3aad799028a4_terseLabel_en-US" xlink:label="lab_rxrx_RevenueRemainingPerformanceObligationNumberOfProjectsThatMayBeInitiated" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of projects that may be initiated</link:label>
    <link:label id="lab_rxrx_RevenueRemainingPerformanceObligationNumberOfProjectsThatMayBeInitiated_label_en-US" xlink:label="lab_rxrx_RevenueRemainingPerformanceObligationNumberOfProjectsThatMayBeInitiated" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue, Remaining Performance Obligation, Number Of Projects That May Be Initiated</link:label>
    <link:label id="lab_rxrx_RevenueRemainingPerformanceObligationNumberOfProjectsThatMayBeInitiated_documentation_en-US" xlink:label="lab_rxrx_RevenueRemainingPerformanceObligationNumberOfProjectsThatMayBeInitiated" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Revenue, Remaining Performance Obligation, Number Of Projects That May Be Initiated</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_RevenueRemainingPerformanceObligationNumberOfProjectsThatMayBeInitiated" xlink:href="rxrx-20260331.xsd#rxrx_RevenueRemainingPerformanceObligationNumberOfProjectsThatMayBeInitiated"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_RevenueRemainingPerformanceObligationNumberOfProjectsThatMayBeInitiated" xlink:to="lab_rxrx_RevenueRemainingPerformanceObligationNumberOfProjectsThatMayBeInitiated" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_019c9ac1-afda-7d62-8b54-96eb99b383c0_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrTerminationDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrTerminationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Termination Date</link:label>
    <link:label id="lab_ecd_TrdArrTerminationDate_label_en-US" xlink:label="lab_ecd_TrdArrTerminationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Termination Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrTerminationDate" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrTerminationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrTerminationDate" xlink:to="lab_ecd_TrdArrTerminationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_019c9ac1-af2a-7fbd-8350-1845579598ce_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash provided by (used in) financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Provided by (Used in) Financing Activity, Including Discontinued Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Adopted</link:label>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag_label_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:to="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MeasureAxis_terseLabel_en-US" xlink:label="lab_ecd_MeasureAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measure:</link:label>
    <link:label id="lab_ecd_MeasureAxis_label_en-US" xlink:label="lab_ecd_MeasureAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measure [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MeasureAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MeasureAxis" xlink:to="lab_ecd_MeasureAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_019c9ac1-afda-77ae-af77-10f2f73f8ddf_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Basis of Presentation and Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_019c9ac1-afda-72e8-ad01-0e0b02af162d_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average shares (Class A, B and Exchangeable) outstanding, basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_019c9ac1-afda-7f58-8a81-66839cd55a32_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average common shares outstanding, basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_019c9ac1-af2a-7159-8b07-ac1b9219c2b9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_019c9ac1-afda-751a-a291-fe68e1d12bc2_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cost of revenue</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cost of Product and Service Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_019c9ac1-af29-7181-811b-3b591675b4bb_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain" xlink:to="lab_us-gaap_DisposalGroupClassificationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_019c9ac1-af2a-72ae-b71e-7ea4eaef12af_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Computation of Basic and Diluted Net Loss Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_NumberOfClassesOfCommonStockAuthorized_019c9ac1-af29-7106-b5cf-482dab53eae8_terseLabel_en-US" xlink:label="lab_rxrx_NumberOfClassesOfCommonStockAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of classes of common stock authorized</link:label>
    <link:label id="lab_rxrx_NumberOfClassesOfCommonStockAuthorized_label_en-US" xlink:label="lab_rxrx_NumberOfClassesOfCommonStockAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Classes Of Common Stock Authorized</link:label>
    <link:label id="lab_rxrx_NumberOfClassesOfCommonStockAuthorized_documentation_en-US" xlink:label="lab_rxrx_NumberOfClassesOfCommonStockAuthorized" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Classes Of Common Stock Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_NumberOfClassesOfCommonStockAuthorized" xlink:href="rxrx-20260331.xsd#rxrx_NumberOfClassesOfCommonStockAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_NumberOfClassesOfCommonStockAuthorized" xlink:to="lab_rxrx_NumberOfClassesOfCommonStockAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PvpTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PvpTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure, Table</link:label>
    <link:label id="lab_ecd_PvpTableTextBlock_label_en-US" xlink:label="lab_ecd_PvpTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pay vs Performance [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PvpTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PvpTableTextBlock" xlink:to="lab_ecd_PvpTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_019c9ac1-af29-7157-9d07-a664fea580ce_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Lease expense</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseExpense" xlink:to="lab_us-gaap_OperatingLeaseExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_019c9ac1-afda-778c-98a3-270404b5a919_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetAcquisitionAxis_019c9ac1-afd9-7947-b9d9-64222e342bad_terseLabel_en-US" xlink:label="lab_us-gaap_AssetAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Asset Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_AssetAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_AssetAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetAcquisitionAxis" xlink:to="lab_us-gaap_AssetAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_RevenueRemainingPerformanceObligationDomain_019c9ac1-afda-73d3-9abd-9d47c293b862_terseLabel_en-US" xlink:label="lab_rxrx_RevenueRemainingPerformanceObligationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue, Remaining Performance Obligation [Domain]</link:label>
    <link:label id="lab_rxrx_RevenueRemainingPerformanceObligationDomain_label_en-US" xlink:label="lab_rxrx_RevenueRemainingPerformanceObligationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue, Remaining Performance Obligation [Domain]</link:label>
    <link:label id="lab_rxrx_RevenueRemainingPerformanceObligationDomain_documentation_en-US" xlink:label="lab_rxrx_RevenueRemainingPerformanceObligationDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Revenue, Remaining Performance Obligation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_RevenueRemainingPerformanceObligationDomain" xlink:href="rxrx-20260331.xsd#rxrx_RevenueRemainingPerformanceObligationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_RevenueRemainingPerformanceObligationDomain" xlink:to="lab_rxrx_RevenueRemainingPerformanceObligationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable_019c9ac1-af2a-7cc5-aac3-453131d6ed48_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Disclosure of Asset and Liability Not Measured at Fair Value [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Disclosure of Asset and Liability Not Measured at Fair Value [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable" xlink:to="lab_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019c9ac1-afda-7d0d-b564-cce80a4f0f09_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_019c9ac1-afda-700e-a270-28e7d58c100a_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_019c9ac1-afda-78aa-aa8d-5c3217bca21b_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_019c9ac1-af29-7e8f-b04d-2ac5de3e7a83_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill and Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_RightOfUseAssetsObtainedInExchangeForLeaseLiabilitiesAbstract_019c9ac1-afda-70a5-bb31-5416e2f31942_terseLabel_en-US" xlink:label="lab_rxrx_RightOfUseAssetsObtainedInExchangeForLeaseLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Right-of-use assets additions, modifications and termination:</link:label>
    <link:label id="lab_rxrx_RightOfUseAssetsObtainedInExchangeForLeaseLiabilitiesAbstract_label_en-US" xlink:label="lab_rxrx_RightOfUseAssetsObtainedInExchangeForLeaseLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Right-Of-Use Assets Obtained In Exchange For Lease Liabilities [Abstract]</link:label>
    <link:label id="lab_rxrx_RightOfUseAssetsObtainedInExchangeForLeaseLiabilitiesAbstract_documentation_en-US" xlink:label="lab_rxrx_RightOfUseAssetsObtainedInExchangeForLeaseLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Right-Of-Use Assets Obtained In Exchange For Lease Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_RightOfUseAssetsObtainedInExchangeForLeaseLiabilitiesAbstract" xlink:href="rxrx-20260331.xsd#rxrx_RightOfUseAssetsObtainedInExchangeForLeaseLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_RightOfUseAssetsObtainedInExchangeForLeaseLiabilitiesAbstract" xlink:to="lab_rxrx_RightOfUseAssetsObtainedInExchangeForLeaseLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_019c9ac1-af2a-7b9b-85eb-52156074b703_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating cash flows from financing leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Interest Payment on Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:to="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseNonoperating_019c9ac1-afda-7e4b-869d-62312b00e967_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseNonoperating" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseNonoperating_label_en-US" xlink:label="lab_us-gaap_InterestExpenseNonoperating" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Expense, Nonoperating</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseNonoperating" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestExpenseNonoperating"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseNonoperating" xlink:to="lab_us-gaap_InterestExpenseNonoperating" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_019c9ac1-af2a-7b02-93ad-7bfe6dac71a6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Goodwill</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TradingArrAxis_terseLabel_en-US" xlink:label="lab_ecd_TradingArrAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Arrangement:</link:label>
    <link:label id="lab_ecd_TradingArrAxis_label_en-US" xlink:label="lab_ecd_TradingArrAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TradingArrAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TradingArrAxis" xlink:to="lab_ecd_TradingArrAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TotalShareholderRtnAmt_terseLabel_en-US" xlink:label="lab_ecd_TotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Amount</link:label>
    <link:label id="lab_ecd_TotalShareholderRtnAmt_label_en-US" xlink:label="lab_ecd_TotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TotalShareholderRtnAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TotalShareholderRtnAmt" xlink:to="lab_ecd_TotalShareholderRtnAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_ContractWithCustomerNumberOfNovelSmallMoleculeCandidates_019c9ac1-afda-7e45-82ce-cf2fb0f04a8c_terseLabel_en-US" xlink:label="lab_rxrx_ContractWithCustomerNumberOfNovelSmallMoleculeCandidates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum number of novel small molecule candidates</link:label>
    <link:label id="lab_rxrx_ContractWithCustomerNumberOfNovelSmallMoleculeCandidates_label_en-US" xlink:label="lab_rxrx_ContractWithCustomerNumberOfNovelSmallMoleculeCandidates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract With Customer, Number Of Novel Small Molecule Candidates</link:label>
    <link:label id="lab_rxrx_ContractWithCustomerNumberOfNovelSmallMoleculeCandidates_documentation_en-US" xlink:label="lab_rxrx_ContractWithCustomerNumberOfNovelSmallMoleculeCandidates" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Contract With Customer, Number Of Novel Small Molecule Candidates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_ContractWithCustomerNumberOfNovelSmallMoleculeCandidates" xlink:href="rxrx-20260331.xsd#rxrx_ContractWithCustomerNumberOfNovelSmallMoleculeCandidates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_ContractWithCustomerNumberOfNovelSmallMoleculeCandidates" xlink:to="lab_rxrx_ContractWithCustomerNumberOfNovelSmallMoleculeCandidates" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTradingArrLineItems_label_en-US" xlink:label="lab_ecd_InsiderTradingArrLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Arrangements [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingArrLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTradingArrLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="lab_ecd_InsiderTradingArrLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_019c9ac1-afda-730d-83ef-729ec17a8a48_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_019c9ac1-afda-7444-b594-2fe89f3756ed_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock units</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_019c9ac1-afda-7a00-833d-770e032b80b5_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAxis_019c9ac1-afda-729d-b69b-fd16af069b5e_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents [Axis]</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAxis_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis" xlink:to="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_019c9ac1-af29-7883-8a66-0c3852b02fc9_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_019c9ac1-af2a-785f-879c-a5eb97a7306d_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued property and equipment</link:label>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_label_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_A2021EquityIncentivePlanMember_019c9ac1-af29-733e-905d-d7efb0b2a3a0_terseLabel_en-US" xlink:label="lab_rxrx_A2021EquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2021 Equity Incentive Plan</link:label>
    <link:label id="lab_rxrx_A2021EquityIncentivePlanMember_label_en-US" xlink:label="lab_rxrx_A2021EquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">2021 Equity Incentive Plan [Member]</link:label>
    <link:label id="lab_rxrx_A2021EquityIncentivePlanMember_documentation_en-US" xlink:label="lab_rxrx_A2021EquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">2021 Equity Incentive Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_A2021EquityIncentivePlanMember" xlink:href="rxrx-20260331.xsd#rxrx_A2021EquityIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_A2021EquityIncentivePlanMember" xlink:to="lab_rxrx_A2021EquityIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PnsnAdjsPrrSvcCstMember_terseLabel_en-US" xlink:label="lab_ecd_PnsnAdjsPrrSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pension Adjustments Prior Service Cost</link:label>
    <link:label id="lab_ecd_PnsnAdjsPrrSvcCstMember_label_en-US" xlink:label="lab_ecd_PnsnAdjsPrrSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pension Adjustments Prior Service Cost [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PnsnAdjsPrrSvcCstMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:to="lab_ecd_PnsnAdjsPrrSvcCstMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_019c9ac1-af29-7675-b21c-03ce8efcddc6_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating costs and expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseCurrent_019c9ac1-afda-72c5-8621-b3cd1100a602_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepaid data assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepaid Expense, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseCurrent" xlink:to="lab_us-gaap_PrepaidExpenseCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MtrlTermsOfTrdArrTextBlock_terseLabel_en-US" xlink:label="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Material Terms of Trading Arrangement</link:label>
    <link:label id="lab_ecd_MtrlTermsOfTrdArrTextBlock_label_en-US" xlink:label="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Material Terms of Trading Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MtrlTermsOfTrdArrTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:to="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_FinanceLeasesAssetsPledgedAsCollateral_019c9ac1-afda-7d39-8d00-1d4807294754_terseLabel_en-US" xlink:label="lab_rxrx_FinanceLeasesAssetsPledgedAsCollateral" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finance leases, assets pledged as collateral</link:label>
    <link:label id="lab_rxrx_FinanceLeasesAssetsPledgedAsCollateral_label_en-US" xlink:label="lab_rxrx_FinanceLeasesAssetsPledgedAsCollateral" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Leases, Assets Pledged As Collateral</link:label>
    <link:label id="lab_rxrx_FinanceLeasesAssetsPledgedAsCollateral_documentation_en-US" xlink:label="lab_rxrx_FinanceLeasesAssetsPledgedAsCollateral" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Finance Leases, Assets Pledged As Collateral</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_FinanceLeasesAssetsPledgedAsCollateral" xlink:href="rxrx-20260331.xsd#rxrx_FinanceLeasesAssetsPledgedAsCollateral"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_FinanceLeasesAssetsPledgedAsCollateral" xlink:to="lab_rxrx_FinanceLeasesAssetsPledgedAsCollateral" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_019c9ac1-af2a-7c91-8e58-fcf29060c94b_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock sales issuances, net of issuance costs</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_019c9ac1-af2a-7fee-87e0-6dd69a1bd486_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_rxrx_SupplementalFinancialInformationAbstract_label_en-US" xlink:label="lab_rxrx_SupplementalFinancialInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Supplemental Financial Information [Abstract]</link:label>
    <link:label id="lab_rxrx_SupplementalFinancialInformationAbstract_documentation_en-US" xlink:label="lab_rxrx_SupplementalFinancialInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Supplemental Financial Information</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_SupplementalFinancialInformationAbstract" xlink:href="rxrx-20260331.xsd#rxrx_SupplementalFinancialInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rxrx_SupplementalFinancialInformationAbstract" xlink:to="lab_rxrx_SupplementalFinancialInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Rule10b51ArrAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted</link:label>
    <link:label id="lab_ecd_Rule10b51ArrAdoptedFlag_label_en-US" xlink:label="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Rule10b51ArrAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:to="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_019c9ac1-af29-79f9-b3e6-048fbcb714ef_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_019c9ac1-afda-7baf-a74e-286af0c950c0_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_019c9ac1-afda-7841-9500-26acba88c497_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common Stock (Class A, B and Exchangeable)</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_019c9ac1-afd9-77ce-a00b-fc35bc8dbba9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_019c9ac1-af29-784e-9460-d9f0c23fec32_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonNeosMember_terseLabel_en-US" xlink:label="lab_ecd_NonNeosMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-NEOs</link:label>
    <link:label id="lab_ecd_NonNeosMember_label_en-US" xlink:label="lab_ecd_NonNeosMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-NEOs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonNeosMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonNeosMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonNeosMember" xlink:to="lab_ecd_NonNeosMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019c9ac1-afda-708e-83ba-b805a5898e96_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net change in cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_019c9ac1-af29-739b-9b74-6284209468bd_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued professional fees</link:label>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Professional Fees, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:to="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>rxrx-20260331_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019c9ac1-acf5-79ea-ae98-b958c721a179,g:9f615d00-f48b-491d-8614-00e244a2e814-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.recursion.com/role/Cover" xlink:type="simple" xlink:href="rxrx-20260331.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_019c9ac1-adb4-7a00-b049-b99d5aa89bf2" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_019c9ac1-adb4-7207-b5f6-388f9e1e792e" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentInformationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019c9ac1-adb4-7a00-b049-b99d5aa89bf2" xlink:to="loc_dei_DocumentInformationTable_019c9ac1-adb4-7207-b5f6-388f9e1e792e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_019c9ac1-adb4-7f9b-bb9d-b89532cf4fba" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_019c9ac1-adb4-7207-b5f6-388f9e1e792e" xlink:to="loc_us-gaap_StatementClassOfStockAxis_019c9ac1-adb4-7f9b-bb9d-b89532cf4fba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_019c9ac1-adb4-76fa-8770-119ae2fb0f56" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_019c9ac1-adb4-7f9b-bb9d-b89532cf4fba" xlink:to="loc_us-gaap_ClassOfStockDomain_019c9ac1-adb4-76fa-8770-119ae2fb0f56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_019c9ac1-adb4-7c08-8c8d-15051495ba10" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_019c9ac1-adb4-76fa-8770-119ae2fb0f56" xlink:to="loc_us-gaap_CommonClassAMember_019c9ac1-adb4-7c08-8c8d-15051495ba10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_019c9ac1-adb4-7a22-b3ff-1377649fe90c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassBMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_019c9ac1-adb4-76fa-8770-119ae2fb0f56" xlink:to="loc_us-gaap_CommonClassBMember_019c9ac1-adb4-7a22-b3ff-1377649fe90c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_019c9ac1-adb4-7434-b5b3-e0528cb3afbf" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_019c9ac1-adb4-7207-b5f6-388f9e1e792e" xlink:to="loc_dei_DocumentInformationLineItems_019c9ac1-adb4-7434-b5b3-e0528cb3afbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_019c9ac1-adb4-7eea-b044-c3868fec5507" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019c9ac1-adb4-7434-b5b3-e0528cb3afbf" xlink:to="loc_dei_DocumentType_019c9ac1-adb4-7eea-b044-c3868fec5507" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_019c9ac1-adb4-776e-922f-a12c4228d1a8" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019c9ac1-adb4-7434-b5b3-e0528cb3afbf" xlink:to="loc_dei_DocumentQuarterlyReport_019c9ac1-adb4-776e-922f-a12c4228d1a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_019c9ac1-adb4-73c6-8686-5208b8a28d74" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019c9ac1-adb4-7434-b5b3-e0528cb3afbf" xlink:to="loc_dei_DocumentPeriodEndDate_019c9ac1-adb4-73c6-8686-5208b8a28d74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_019c9ac1-adb4-7aee-9532-fa656e676b84" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019c9ac1-adb4-7434-b5b3-e0528cb3afbf" xlink:to="loc_dei_DocumentTransitionReport_019c9ac1-adb4-7aee-9532-fa656e676b84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_019c9ac1-adb4-79f1-b135-5e77592e8faa" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019c9ac1-adb4-7434-b5b3-e0528cb3afbf" xlink:to="loc_dei_EntityFileNumber_019c9ac1-adb4-79f1-b135-5e77592e8faa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_019c9ac1-adb4-7510-8f2d-bf5c604386f2" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019c9ac1-adb4-7434-b5b3-e0528cb3afbf" xlink:to="loc_dei_EntityRegistrantName_019c9ac1-adb4-7510-8f2d-bf5c604386f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_019c9ac1-adb4-7f6e-9942-158ba99326f1" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019c9ac1-adb4-7434-b5b3-e0528cb3afbf" xlink:to="loc_dei_EntityIncorporationStateCountryCode_019c9ac1-adb4-7f6e-9942-158ba99326f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_019c9ac1-adb4-79c3-9c19-6798e033ed24" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019c9ac1-adb4-7434-b5b3-e0528cb3afbf" xlink:to="loc_dei_EntityTaxIdentificationNumber_019c9ac1-adb4-79c3-9c19-6798e033ed24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_019c9ac1-adb4-7d75-90c7-cd32d9a17aa1" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019c9ac1-adb4-7434-b5b3-e0528cb3afbf" xlink:to="loc_dei_EntityAddressAddressLine1_019c9ac1-adb4-7d75-90c7-cd32d9a17aa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_019c9ac1-adb4-7d28-a6fb-1ddff74834e9" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019c9ac1-adb4-7434-b5b3-e0528cb3afbf" xlink:to="loc_dei_EntityAddressCityOrTown_019c9ac1-adb4-7d28-a6fb-1ddff74834e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_019c9ac1-adb4-71a1-9432-dc879c0f9fd5" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019c9ac1-adb4-7434-b5b3-e0528cb3afbf" xlink:to="loc_dei_EntityAddressStateOrProvince_019c9ac1-adb4-71a1-9432-dc879c0f9fd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_019c9ac1-adb4-7c4e-b973-80b996e1432c" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019c9ac1-adb4-7434-b5b3-e0528cb3afbf" xlink:to="loc_dei_EntityAddressPostalZipCode_019c9ac1-adb4-7c4e-b973-80b996e1432c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_019c9ac1-adb4-718a-91d3-4cd0cd8f8786" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019c9ac1-adb4-7434-b5b3-e0528cb3afbf" xlink:to="loc_dei_CityAreaCode_019c9ac1-adb4-718a-91d3-4cd0cd8f8786" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_019c9ac1-adb4-71d6-9f6c-c0adcfa206e5" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019c9ac1-adb4-7434-b5b3-e0528cb3afbf" xlink:to="loc_dei_LocalPhoneNumber_019c9ac1-adb4-71d6-9f6c-c0adcfa206e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_019c9ac1-adb4-7619-93d0-1888d9a43650" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019c9ac1-adb4-7434-b5b3-e0528cb3afbf" xlink:to="loc_dei_Security12bTitle_019c9ac1-adb4-7619-93d0-1888d9a43650" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_019c9ac1-adb4-7ccf-b830-a48f9839eb80" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019c9ac1-adb4-7434-b5b3-e0528cb3afbf" xlink:to="loc_dei_TradingSymbol_019c9ac1-adb4-7ccf-b830-a48f9839eb80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_019c9ac1-adb4-7ff5-9803-4ca4efddd8cf" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019c9ac1-adb4-7434-b5b3-e0528cb3afbf" xlink:to="loc_dei_SecurityExchangeName_019c9ac1-adb4-7ff5-9803-4ca4efddd8cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_019c9ac1-adb4-7407-9a0a-ef39e5cbad60" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019c9ac1-adb4-7434-b5b3-e0528cb3afbf" xlink:to="loc_dei_EntityCurrentReportingStatus_019c9ac1-adb4-7407-9a0a-ef39e5cbad60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_019c9ac1-adb4-74c4-b211-661f23d88d60" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019c9ac1-adb4-7434-b5b3-e0528cb3afbf" xlink:to="loc_dei_EntityInteractiveDataCurrent_019c9ac1-adb4-74c4-b211-661f23d88d60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_019c9ac1-adb4-7a7d-9fe1-c33d10da02d1" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019c9ac1-adb4-7434-b5b3-e0528cb3afbf" xlink:to="loc_dei_EntityFilerCategory_019c9ac1-adb4-7a7d-9fe1-c33d10da02d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_019c9ac1-adb4-741c-98e1-3f393aa216a6" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019c9ac1-adb4-7434-b5b3-e0528cb3afbf" xlink:to="loc_dei_EntitySmallBusiness_019c9ac1-adb4-741c-98e1-3f393aa216a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_019c9ac1-adb4-7f77-8f72-159fb9e1d74e" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019c9ac1-adb4-7434-b5b3-e0528cb3afbf" xlink:to="loc_dei_EntityEmergingGrowthCompany_019c9ac1-adb4-7f77-8f72-159fb9e1d74e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_019c9ac1-adb4-7f10-927e-4f1f9dc427ca" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019c9ac1-adb4-7434-b5b3-e0528cb3afbf" xlink:to="loc_dei_EntityShellCompany_019c9ac1-adb4-7f10-927e-4f1f9dc427ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_019c9ac1-adb4-7579-ae31-eef58a3b4f57" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019c9ac1-adb4-7434-b5b3-e0528cb3afbf" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_019c9ac1-adb4-7579-ae31-eef58a3b4f57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_019c9ac1-adb4-7e33-94e0-060e654ff6b5" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019c9ac1-adb4-7434-b5b3-e0528cb3afbf" xlink:to="loc_dei_EntityCentralIndexKey_019c9ac1-adb4-7e33-94e0-060e654ff6b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_019c9ac1-adb4-707b-a536-8afc7cec11d0" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019c9ac1-adb4-7434-b5b3-e0528cb3afbf" xlink:to="loc_dei_AmendmentFlag_019c9ac1-adb4-707b-a536-8afc7cec11d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_019c9ac1-adb4-79c5-9faa-45a660b4f44d" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019c9ac1-adb4-7434-b5b3-e0528cb3afbf" xlink:to="loc_dei_DocumentFiscalYearFocus_019c9ac1-adb4-79c5-9faa-45a660b4f44d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_019c9ac1-adb4-76a7-b53f-3c7c6d02a12e" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019c9ac1-adb4-7434-b5b3-e0528cb3afbf" xlink:to="loc_dei_DocumentFiscalPeriodFocus_019c9ac1-adb4-76a7-b53f-3c7c6d02a12e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_019c9ac1-adb4-730e-a482-62cf712b2ce7" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019c9ac1-adb4-7434-b5b3-e0528cb3afbf" xlink:to="loc_dei_CurrentFiscalYearEndDate_019c9ac1-adb4-730e-a482-62cf712b2ce7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited" xlink:type="simple" xlink:href="rxrx-20260331.xsd#CondensedConsolidatedBalanceSheetsunaudited"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_019c9ac1-adb4-7423-bc44-7cdd40dede95" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_019c9ac1-adb4-7039-bec1-847f745ccd19" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_019c9ac1-adb4-7423-bc44-7cdd40dede95" xlink:to="loc_us-gaap_AssetsAbstract_019c9ac1-adb4-7039-bec1-847f745ccd19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_019c9ac1-adb4-769b-81b3-191511d06600" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_019c9ac1-adb4-7039-bec1-847f745ccd19" xlink:to="loc_us-gaap_AssetsCurrentAbstract_019c9ac1-adb4-769b-81b3-191511d06600" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019c9ac1-adb4-777a-a7c9-4a7654e5bc40" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_019c9ac1-adb4-769b-81b3-191511d06600" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019c9ac1-adb4-777a-a7c9-4a7654e5bc40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_019c9ac1-adb4-7003-949d-e80261ef51ee" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_019c9ac1-adb4-769b-81b3-191511d06600" xlink:to="loc_us-gaap_RestrictedCashCurrent_019c9ac1-adb4-7003-949d-e80261ef51ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_019c9ac1-adb4-7459-a535-ecc8a44489da" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_019c9ac1-adb4-769b-81b3-191511d06600" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_019c9ac1-adb4-7459-a535-ecc8a44489da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_019c9ac1-adb4-7aa9-b435-d52de805a903" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_019c9ac1-adb4-769b-81b3-191511d06600" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_019c9ac1-adb4-7aa9-b435-d52de805a903" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_019c9ac1-adb4-7f3b-abf7-4da496a5d7a9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_019c9ac1-adb4-769b-81b3-191511d06600" xlink:to="loc_us-gaap_OtherAssetsCurrent_019c9ac1-adb4-7f3b-abf7-4da496a5d7a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_019c9ac1-adb4-7e89-8587-90bc62cfda26" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_019c9ac1-adb4-769b-81b3-191511d06600" xlink:to="loc_us-gaap_AssetsCurrent_019c9ac1-adb4-7e89-8587-90bc62cfda26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_019c9ac1-adb4-789e-9dce-3083b5d3f717" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_019c9ac1-adb4-7039-bec1-847f745ccd19" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_019c9ac1-adb4-789e-9dce-3083b5d3f717" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_019c9ac1-adb4-7f0b-908d-a3bbb061fcf4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_019c9ac1-adb4-7039-bec1-847f745ccd19" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_019c9ac1-adb4-7f0b-908d-a3bbb061fcf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_019c9ac1-adb4-7f7f-92ff-e600be0b0130" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_019c9ac1-adb4-7039-bec1-847f745ccd19" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_019c9ac1-adb4-7f7f-92ff-e600be0b0130" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_019c9ac1-adb4-7532-b27b-15ed69a61654" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_019c9ac1-adb4-7039-bec1-847f745ccd19" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_019c9ac1-adb4-7532-b27b-15ed69a61654" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_019c9ac1-adb4-77d8-9a24-ded3f959aa2a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_019c9ac1-adb4-7039-bec1-847f745ccd19" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_019c9ac1-adb4-77d8-9a24-ded3f959aa2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_019c9ac1-adb4-73d9-98ba-d343a2bcc97e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_019c9ac1-adb4-7039-bec1-847f745ccd19" xlink:to="loc_us-gaap_Goodwill_019c9ac1-adb4-73d9-98ba-d343a2bcc97e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_019c9ac1-adb4-79ea-864a-3352a3935b4a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_019c9ac1-adb4-7039-bec1-847f745ccd19" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_019c9ac1-adb4-79ea-864a-3352a3935b4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_019c9ac1-adb4-70dc-bba8-a6adc44f7fc9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_019c9ac1-adb4-7039-bec1-847f745ccd19" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_019c9ac1-adb4-70dc-bba8-a6adc44f7fc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_019c9ac1-adb4-7bb3-8788-978249bdaa44" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Assets"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_019c9ac1-adb4-7039-bec1-847f745ccd19" xlink:to="loc_us-gaap_Assets_019c9ac1-adb4-7bb3-8788-978249bdaa44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019c9ac1-adb4-701a-8a35-9205ae825df5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_019c9ac1-adb4-7423-bc44-7cdd40dede95" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019c9ac1-adb4-701a-8a35-9205ae825df5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_019c9ac1-adb4-7645-9852-9b343289417a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019c9ac1-adb4-701a-8a35-9205ae825df5" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_019c9ac1-adb4-7645-9852-9b343289417a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_019c9ac1-adb4-73db-9947-833d14bb98c4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_019c9ac1-adb4-7645-9852-9b343289417a" xlink:to="loc_us-gaap_AccountsPayableCurrent_019c9ac1-adb4-73db-9947-833d14bb98c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_019c9ac1-adb4-761e-8b24-4fcd5d5b2204" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_019c9ac1-adb4-7645-9852-9b343289417a" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_019c9ac1-adb4-761e-8b24-4fcd5d5b2204" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_019c9ac1-adb4-7ed9-831f-0dd9b37e90bf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_019c9ac1-adb4-7645-9852-9b343289417a" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_019c9ac1-adb4-7ed9-831f-0dd9b37e90bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_019c9ac1-adb4-7a05-ba6e-5e1370b66a80" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_019c9ac1-adb4-7645-9852-9b343289417a" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_019c9ac1-adb4-7a05-ba6e-5e1370b66a80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_019c9ac1-adb4-7d96-81e8-3230e144b515" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_019c9ac1-adb4-7645-9852-9b343289417a" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_019c9ac1-adb4-7d96-81e8-3230e144b515" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_019c9ac1-adb4-7893-a7a1-9ef95110f7d9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_019c9ac1-adb4-7645-9852-9b343289417a" xlink:to="loc_us-gaap_LiabilitiesCurrent_019c9ac1-adb4-7893-a7a1-9ef95110f7d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_019c9ac1-adb4-716c-aeb1-a3616c81c15c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019c9ac1-adb4-701a-8a35-9205ae825df5" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_019c9ac1-adb4-716c-aeb1-a3616c81c15c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_019c9ac1-adb4-75e7-86ab-2d4358981537" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019c9ac1-adb4-701a-8a35-9205ae825df5" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_019c9ac1-adb4-75e7-86ab-2d4358981537" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_019c9ac1-adb4-7dfd-b5d4-f70f2d353b04" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019c9ac1-adb4-701a-8a35-9205ae825df5" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_019c9ac1-adb4-7dfd-b5d4-f70f2d353b04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_019c9ac1-adb4-7c7b-8ee4-a3a2bd9c9ab6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019c9ac1-adb4-701a-8a35-9205ae825df5" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_019c9ac1-adb4-7c7b-8ee4-a3a2bd9c9ab6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_019c9ac1-adb4-78ba-a5c4-f2a7228b1d70" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019c9ac1-adb4-701a-8a35-9205ae825df5" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_019c9ac1-adb4-78ba-a5c4-f2a7228b1d70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_019c9ac1-adb4-7d82-8150-35b46e16aaf1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019c9ac1-adb4-701a-8a35-9205ae825df5" xlink:to="loc_us-gaap_Liabilities_019c9ac1-adb4-7d82-8150-35b46e16aaf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_019c9ac1-adb4-752d-bea4-021e0e71e21e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019c9ac1-adb4-701a-8a35-9205ae825df5" xlink:to="loc_us-gaap_CommitmentsAndContingencies_019c9ac1-adb4-752d-bea4-021e0e71e21e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_019c9ac1-adb4-72df-9a32-873f879e993a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019c9ac1-adb4-701a-8a35-9205ae825df5" xlink:to="loc_us-gaap_StockholdersEquityAbstract_019c9ac1-adb4-72df-9a32-873f879e993a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_019c9ac1-adb4-72b5-95cc-948b6823b4dc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_019c9ac1-adb4-72df-9a32-873f879e993a" xlink:to="loc_us-gaap_CommonStockValue_019c9ac1-adb4-72b5-95cc-948b6823b4dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_019c9ac1-adb4-739d-8dd6-6ecba9db7630" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_019c9ac1-adb4-72df-9a32-873f879e993a" xlink:to="loc_us-gaap_AdditionalPaidInCapital_019c9ac1-adb4-739d-8dd6-6ecba9db7630" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_019c9ac1-adb4-7e18-8da4-e8a9de71909b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_019c9ac1-adb4-72df-9a32-873f879e993a" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_019c9ac1-adb4-7e18-8da4-e8a9de71909b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_019c9ac1-adb4-76b9-a056-6e83519a1aa3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_019c9ac1-adb4-72df-9a32-873f879e993a" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_019c9ac1-adb4-76b9-a056-6e83519a1aa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_019c9ac1-adb4-7be3-95d4-9429eee22419" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_019c9ac1-adb4-72df-9a32-873f879e993a" xlink:to="loc_us-gaap_StockholdersEquity_019c9ac1-adb4-7be3-95d4-9429eee22419" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_019c9ac1-adb4-70c9-91db-b2d5e7bc6ca4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019c9ac1-adb4-701a-8a35-9205ae825df5" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_019c9ac1-adb4-70c9-91db-b2d5e7bc6ca4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunauditedParenthetical" xlink:type="simple" xlink:href="rxrx-20260331.xsd#CondensedConsolidatedBalanceSheetsunauditedParenthetical"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunauditedParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_019c9ac1-adb4-779e-be76-306bdd1c7de2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_019c9ac1-adb4-7f72-8bb0-5e1901eab234" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_019c9ac1-adb4-779e-be76-306bdd1c7de2" xlink:to="loc_us-gaap_StatementTable_019c9ac1-adb4-7f72-8bb0-5e1901eab234" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_019c9ac1-adb4-7f98-b5ea-34ed70b806b1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_019c9ac1-adb4-7f72-8bb0-5e1901eab234" xlink:to="loc_us-gaap_StatementClassOfStockAxis_019c9ac1-adb4-7f98-b5ea-34ed70b806b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_019c9ac1-adb4-7907-951f-1d4b0dc1c314" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_019c9ac1-adb4-7f98-b5ea-34ed70b806b1" xlink:to="loc_us-gaap_ClassOfStockDomain_019c9ac1-adb4-7907-951f-1d4b0dc1c314" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_019c9ac1-adb4-7084-abe6-856623affe67" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_019c9ac1-adb4-7907-951f-1d4b0dc1c314" xlink:to="loc_us-gaap_CommonClassAMember_019c9ac1-adb4-7084-abe6-856623affe67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_019c9ac1-adb4-72ce-a01b-1aa7cf80ce94" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassBMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_019c9ac1-adb4-7907-951f-1d4b0dc1c314" xlink:to="loc_us-gaap_CommonClassBMember_019c9ac1-adb4-72ce-a01b-1aa7cf80ce94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_ExchangeableStockMember_019c9ac1-adb4-713e-a01f-f68aee158b6b" xlink:href="rxrx-20260331.xsd#rxrx_ExchangeableStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_019c9ac1-adb4-7907-951f-1d4b0dc1c314" xlink:to="loc_rxrx_ExchangeableStockMember_019c9ac1-adb4-713e-a01f-f68aee158b6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_019c9ac1-adb4-7bec-8072-2a991df753cb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_019c9ac1-adb4-7f72-8bb0-5e1901eab234" xlink:to="loc_us-gaap_StatementLineItems_019c9ac1-adb4-7bec-8072-2a991df753cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_019c9ac1-adb4-7e9b-9d49-070eafc448e1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019c9ac1-adb4-7bec-8072-2a991df753cb" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_019c9ac1-adb4-7e9b-9d49-070eafc448e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_019c9ac1-adb4-7fed-88da-f3cb3aa276c5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019c9ac1-adb4-7bec-8072-2a991df753cb" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_019c9ac1-adb4-7fed-88da-f3cb3aa276c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_019c9ac1-adb4-74dd-9600-c40b6bd294b5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019c9ac1-adb4-7bec-8072-2a991df753cb" xlink:to="loc_us-gaap_CommonStockSharesIssued_019c9ac1-adb4-74dd-9600-c40b6bd294b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_019c9ac1-adb4-7011-a3dd-751716ce262e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019c9ac1-adb4-7bec-8072-2a991df753cb" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_019c9ac1-adb4-7011-a3dd-751716ce262e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/CondensedConsolidatedStatementsofOperationsunaudited" xlink:type="simple" xlink:href="rxrx-20260331.xsd#CondensedConsolidatedStatementsofOperationsunaudited"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/CondensedConsolidatedStatementsofOperationsunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_019c9ac1-adb4-7c78-85ff-c67c04a81cba" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_019c9ac1-adb4-7c1b-8d9f-dd373d44db00" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_019c9ac1-adb4-7c78-85ff-c67c04a81cba" xlink:to="loc_us-gaap_StatementTable_019c9ac1-adb4-7c1b-8d9f-dd373d44db00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_019c9ac1-adb4-795e-a5fd-883c07890612" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_019c9ac1-adb4-7c1b-8d9f-dd373d44db00" xlink:to="loc_srt_ProductOrServiceAxis_019c9ac1-adb4-795e-a5fd-883c07890612" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_019c9ac1-adb4-7555-bef9-e7ead5c2cd5c" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_019c9ac1-adb4-795e-a5fd-883c07890612" xlink:to="loc_srt_ProductsAndServicesDomain_019c9ac1-adb4-7555-bef9-e7ead5c2cd5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicenseAndServiceMember_019c9ac1-adb4-7a04-901c-78dac51816b7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LicenseAndServiceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_019c9ac1-adb4-7555-bef9-e7ead5c2cd5c" xlink:to="loc_us-gaap_LicenseAndServiceMember_019c9ac1-adb4-7a04-901c-78dac51816b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrantMember_019c9ac1-adb4-734b-a567-1be763ed4d2f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GrantMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_019c9ac1-adb4-7555-bef9-e7ead5c2cd5c" xlink:to="loc_us-gaap_GrantMember_019c9ac1-adb4-734b-a567-1be763ed4d2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_019c9ac1-adb4-7590-a02c-e089fed6fc8b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_019c9ac1-adb4-7c1b-8d9f-dd373d44db00" xlink:to="loc_us-gaap_StatementLineItems_019c9ac1-adb4-7590-a02c-e089fed6fc8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_019c9ac1-adb4-7bc8-bb7f-6a096a016641" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019c9ac1-adb4-7590-a02c-e089fed6fc8b" xlink:to="loc_us-gaap_RevenuesAbstract_019c9ac1-adb4-7bc8-bb7f-6a096a016641" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019c9ac1-adb4-74fe-8613-d94e0045ef32" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_019c9ac1-adb4-7bc8-bb7f-6a096a016641" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019c9ac1-adb4-74fe-8613-d94e0045ef32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_019c9ac1-adb4-7f08-9370-44959c94bc83" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019c9ac1-adb4-7590-a02c-e089fed6fc8b" xlink:to="loc_us-gaap_OperatingExpensesAbstract_019c9ac1-adb4-7f08-9370-44959c94bc83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_019c9ac1-adb4-7736-aa9b-4ce0d45f79ae" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_019c9ac1-adb4-7f08-9370-44959c94bc83" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_019c9ac1-adb4-7736-aa9b-4ce0d45f79ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_019c9ac1-adb4-70f1-9dec-c73ec06c34b1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_019c9ac1-adb4-7f08-9370-44959c94bc83" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_019c9ac1-adb4-70f1-9dec-c73ec06c34b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_019c9ac1-adb4-7020-8e0a-36cdb572208c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_019c9ac1-adb4-7f08-9370-44959c94bc83" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_019c9ac1-adb4-7020-8e0a-36cdb572208c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_019c9ac1-adb4-73f6-a705-4d36ee56702a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_019c9ac1-adb4-7f08-9370-44959c94bc83" xlink:to="loc_us-gaap_CostsAndExpenses_019c9ac1-adb4-73f6-a705-4d36ee56702a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_019c9ac1-adb4-7a0a-8754-c57dc5cf4958" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019c9ac1-adb4-7590-a02c-e089fed6fc8b" xlink:to="loc_us-gaap_OperatingIncomeLoss_019c9ac1-adb4-7a0a-8754-c57dc5cf4958" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_019c9ac1-adb4-7c57-bfe0-3b5c66f193f5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019c9ac1-adb4-7590-a02c-e089fed6fc8b" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_019c9ac1-adb4-7c57-bfe0-3b5c66f193f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_019c9ac1-adb4-7c29-8dfd-e0d9fff33d67" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019c9ac1-adb4-7590-a02c-e089fed6fc8b" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_019c9ac1-adb4-7c29-8dfd-e0d9fff33d67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_019c9ac1-adb4-76cd-8c85-5510f82b443a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019c9ac1-adb4-7590-a02c-e089fed6fc8b" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_019c9ac1-adb4-76cd-8c85-5510f82b443a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019c9ac1-adb4-7504-a18a-5611bd004276" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019c9ac1-adb4-7590-a02c-e089fed6fc8b" xlink:to="loc_us-gaap_NetIncomeLoss_019c9ac1-adb4-7504-a18a-5611bd004276" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_019c9ac1-adb4-7391-a005-c83e4298cc1c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019c9ac1-adb4-7590-a02c-e089fed6fc8b" xlink:to="loc_us-gaap_EarningsPerShareAbstract_019c9ac1-adb4-7391-a005-c83e4298cc1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_019c9ac1-adb4-7e44-a0ca-2c9640a4b709" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_019c9ac1-adb4-7391-a005-c83e4298cc1c" xlink:to="loc_us-gaap_EarningsPerShareBasic_019c9ac1-adb4-7e44-a0ca-2c9640a4b709" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_019c9ac1-adb4-75e3-88e4-abf511a977a1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_019c9ac1-adb4-7391-a005-c83e4298cc1c" xlink:to="loc_us-gaap_EarningsPerShareDiluted_019c9ac1-adb4-75e3-88e4-abf511a977a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_019c9ac1-adb4-7677-9db5-b16f56788e27" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_019c9ac1-adb4-7391-a005-c83e4298cc1c" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_019c9ac1-adb4-7677-9db5-b16f56788e27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_019c9ac1-adb4-7630-8a40-07f5087b6491" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_019c9ac1-adb4-7391-a005-c83e4298cc1c" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_019c9ac1-adb4-7630-8a40-07f5087b6491" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/CondensedConsolidatedStatementsofComprehensiveLossunaudited" xlink:type="simple" xlink:href="rxrx-20260331.xsd#CondensedConsolidatedStatementsofComprehensiveLossunaudited"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/CondensedConsolidatedStatementsofComprehensiveLossunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_019c9ac1-adb4-742d-92b7-73ba8e8e6387" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019c9ac1-adb4-74c6-9069-6873942d6b6b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_019c9ac1-adb4-742d-92b7-73ba8e8e6387" xlink:to="loc_us-gaap_NetIncomeLoss_019c9ac1-adb4-74c6-9069-6873942d6b6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_019c9ac1-adb4-7348-92cb-b229263e3c41" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_019c9ac1-adb4-742d-92b7-73ba8e8e6387" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_019c9ac1-adb4-7348-92cb-b229263e3c41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_019c9ac1-adb4-7218-b3cf-ba6ff52e0fd6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_019c9ac1-adb4-7348-92cb-b229263e3c41" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_019c9ac1-adb4-7218-b3cf-ba6ff52e0fd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_019c9ac1-adb4-74b9-aa49-ce1b5ef6c6cc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_019c9ac1-adb4-7348-92cb-b229263e3c41" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_019c9ac1-adb4-74b9-aa49-ce1b5ef6c6cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_019c9ac1-adb4-7785-9f34-c7b4a3308404" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_019c9ac1-adb4-742d-92b7-73ba8e8e6387" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_019c9ac1-adb4-7785-9f34-c7b4a3308404" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/CondensedConsolidatedStatementsofStockholdersEquityunaudited" xlink:type="simple" xlink:href="rxrx-20260331.xsd#CondensedConsolidatedStatementsofStockholdersEquityunaudited"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/CondensedConsolidatedStatementsofStockholdersEquityunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_019c9ac1-adb4-79f9-a4a8-4bacd806261b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_019c9ac1-adb4-7c5d-af46-6be86834a669" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_019c9ac1-adb4-79f9-a4a8-4bacd806261b" xlink:to="loc_us-gaap_StatementTable_019c9ac1-adb4-7c5d-af46-6be86834a669" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_019c9ac1-adb4-79f5-a941-71b68935d95c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_019c9ac1-adb4-7c5d-af46-6be86834a669" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_019c9ac1-adb4-79f5-a941-71b68935d95c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_019c9ac1-adb4-7600-8bb2-f4fa1b9ddc5c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_019c9ac1-adb4-79f5-a941-71b68935d95c" xlink:to="loc_us-gaap_EquityComponentDomain_019c9ac1-adb4-7600-8bb2-f4fa1b9ddc5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_019c9ac1-adb4-7f84-b991-73746db0a1f0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_019c9ac1-adb4-7600-8bb2-f4fa1b9ddc5c" xlink:to="loc_us-gaap_CommonStockMember_019c9ac1-adb4-7f84-b991-73746db0a1f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_019c9ac1-adb4-7f4a-a50e-3c38f2d65f07" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_019c9ac1-adb4-7600-8bb2-f4fa1b9ddc5c" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_019c9ac1-adb4-7f4a-a50e-3c38f2d65f07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_019c9ac1-adb4-7b59-aa5c-70c5f83fbf7c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_019c9ac1-adb4-7600-8bb2-f4fa1b9ddc5c" xlink:to="loc_us-gaap_RetainedEarningsMember_019c9ac1-adb4-7b59-aa5c-70c5f83fbf7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_019c9ac1-adb4-7b31-b2b8-b223afb63b20" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_019c9ac1-adb4-7600-8bb2-f4fa1b9ddc5c" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_019c9ac1-adb4-7b31-b2b8-b223afb63b20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_019c9ac1-adb4-733f-b8e1-4a7da44d231e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_019c9ac1-adb4-7c5d-af46-6be86834a669" xlink:to="loc_us-gaap_StatementLineItems_019c9ac1-adb4-733f-b8e1-4a7da44d231e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019c9ac1-adb4-74b4-b632-ff7529637d97" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019c9ac1-adb4-733f-b8e1-4a7da44d231e" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019c9ac1-adb4-74b4-b632-ff7529637d97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_019c9ac1-adb4-7706-ab22-46c94dd7db37" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019c9ac1-adb4-74b4-b632-ff7529637d97" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_019c9ac1-adb4-7706-ab22-46c94dd7db37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_019c9ac1-adb4-73ec-a24d-fe0acf6a2a91" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019c9ac1-adb4-74b4-b632-ff7529637d97" xlink:to="loc_us-gaap_StockholdersEquity_019c9ac1-adb4-73ec-a24d-fe0acf6a2a91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019c9ac1-adb4-7d91-af45-350617a8ca72" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019c9ac1-adb4-74b4-b632-ff7529637d97" xlink:to="loc_us-gaap_NetIncomeLoss_019c9ac1-adb4-7d91-af45-350617a8ca72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_019c9ac1-adb4-79c9-9a2d-571c6378c401" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019c9ac1-adb4-74b4-b632-ff7529637d97" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_019c9ac1-adb4-79c9-9a2d-571c6378c401" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_019c9ac1-adb4-76fe-83ac-43a1747589dc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019c9ac1-adb4-74b4-b632-ff7529637d97" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_019c9ac1-adb4-76fe-83ac-43a1747589dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_019c9ac1-adb4-79cb-8ef7-b30a0bb9dbf2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019c9ac1-adb4-74b4-b632-ff7529637d97" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_019c9ac1-adb4-79cb-8ef7-b30a0bb9dbf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_019c9ac1-adb4-7af1-899d-92d270982691" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019c9ac1-adb4-74b4-b632-ff7529637d97" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_019c9ac1-adb4-7af1-899d-92d270982691" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_019d862f-75f6-76d0-b0c9-dd95433d73ea" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019c9ac1-adb4-74b4-b632-ff7529637d97" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_019d862f-75f6-76d0-b0c9-dd95433d73ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_019c9ac1-adb4-7826-b242-8d6149904f73" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019c9ac1-adb4-74b4-b632-ff7529637d97" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_019c9ac1-adb4-7826-b242-8d6149904f73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_019c9ac1-adb4-7e3d-a36a-82d0ea46b585" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019c9ac1-adb4-74b4-b632-ff7529637d97" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_019c9ac1-adb4-7e3d-a36a-82d0ea46b585" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_019c9ac1-adb4-7e7f-b5c5-f619dfc053ab" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019c9ac1-adb4-74b4-b632-ff7529637d97" xlink:to="loc_us-gaap_StockholdersEquity_019c9ac1-adb4-7e7f-b5c5-f619dfc053ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited" xlink:type="simple" xlink:href="rxrx-20260331.xsd#CondensedConsolidatedStatementsofCashFlowsunaudited"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_019c9ac1-adb4-7662-b5a6-7155da47c69c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_019c9ac1-adb4-7741-b838-bbcd21f0241f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_019c9ac1-adb4-7662-b5a6-7155da47c69c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_019c9ac1-adb4-7741-b838-bbcd21f0241f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019c9ac1-adb4-716a-9ffb-0d06f96a49df" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_019c9ac1-adb4-7741-b838-bbcd21f0241f" xlink:to="loc_us-gaap_NetIncomeLoss_019c9ac1-adb4-716a-9ffb-0d06f96a49df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_019c9ac1-adb4-7190-8023-fc8d04495603" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_019c9ac1-adb4-7741-b838-bbcd21f0241f" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_019c9ac1-adb4-7190-8023-fc8d04495603" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_019c9ac1-adb4-7c47-9cc1-4de0cf8bfa38" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_019c9ac1-adb4-7190-8023-fc8d04495603" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_019c9ac1-adb4-7c47-9cc1-4de0cf8bfa38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_019c9ac1-adb4-7d68-9c77-8538b3f4c877" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_019c9ac1-adb4-7190-8023-fc8d04495603" xlink:to="loc_us-gaap_ShareBasedCompensation_019c9ac1-adb4-7d68-9c77-8538b3f4c877" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TangibleAssetImpairmentCharges_019c9ac1-adb4-777e-a311-d8df6307858e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TangibleAssetImpairmentCharges"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_019c9ac1-adb4-7190-8023-fc8d04495603" xlink:to="loc_us-gaap_TangibleAssetImpairmentCharges_019c9ac1-adb4-777e-a311-d8df6307858e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_019c9ac1-adb4-7156-8189-c044cf009b1f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_019c9ac1-adb4-7190-8023-fc8d04495603" xlink:to="loc_us-gaap_OperatingLeaseExpense_019c9ac1-adb4-7156-8189-c044cf009b1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_019c9ac1-adb4-7d6b-8ce1-ef74ff664697" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_019c9ac1-adb4-7190-8023-fc8d04495603" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_019c9ac1-adb4-7d6b-8ce1-ef74ff664697" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_019dcd50-bfe4-7534-b7b9-b6273d2b0b26" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_019c9ac1-adb4-7190-8023-fc8d04495603" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_019dcd50-bfe4-7534-b7b9-b6273d2b0b26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_019c9ac1-adb4-7b39-b09e-6b516af0db7a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_019c9ac1-adb4-7190-8023-fc8d04495603" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_019c9ac1-adb4-7b39-b09e-6b516af0db7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_019c9ac1-adb4-736f-b0f5-b418d0c112c3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_019c9ac1-adb4-7190-8023-fc8d04495603" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_019c9ac1-adb4-736f-b0f5-b418d0c112c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_019c9ac1-adb4-7bad-a164-51282c55df64" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_019c9ac1-adb4-736f-b0f5-b418d0c112c3" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_019c9ac1-adb4-7bad-a164-51282c55df64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_IncreaseDecreaseInPrepaidDataAssets_019c9ac1-adb4-7a52-a00e-6ff785de5aeb" xlink:href="rxrx-20260331.xsd#rxrx_IncreaseDecreaseInPrepaidDataAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_019c9ac1-adb4-736f-b0f5-b418d0c112c3" xlink:to="loc_rxrx_IncreaseDecreaseInPrepaidDataAssets_019c9ac1-adb4-7a52-a00e-6ff785de5aeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_019c9ac1-adb4-7cb1-bc89-3f60c8140564" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_019c9ac1-adb4-736f-b0f5-b418d0c112c3" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_019c9ac1-adb4-7cb1-bc89-3f60c8140564" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_019c9ac1-adb4-7bbd-849f-7e5f01638f50" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_019c9ac1-adb4-736f-b0f5-b418d0c112c3" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_019c9ac1-adb4-7bbd-849f-7e5f01638f50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_IncreaseDecreaseInAccruedDevelopmentExpense_019c9ac1-adb4-7b0d-a1c4-97bf9ffb479a" xlink:href="rxrx-20260331.xsd#rxrx_IncreaseDecreaseInAccruedDevelopmentExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_019c9ac1-adb4-736f-b0f5-b418d0c112c3" xlink:to="loc_rxrx_IncreaseDecreaseInAccruedDevelopmentExpense_019c9ac1-adb4-7b0d-a1c4-97bf9ffb479a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities_019c9ac1-adb4-7895-84f9-e3c6c029944e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOtherAccruedLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_019c9ac1-adb4-736f-b0f5-b418d0c112c3" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities_019c9ac1-adb4-7895-84f9-e3c6c029944e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_IncreaseDecreaseInLeaseLiability_019c9ac1-adb4-79c1-a112-f8af9939d10e" xlink:href="rxrx-20260331.xsd#rxrx_IncreaseDecreaseInLeaseLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_019c9ac1-adb4-736f-b0f5-b418d0c112c3" xlink:to="loc_rxrx_IncreaseDecreaseInLeaseLiability_019c9ac1-adb4-79c1-a112-f8af9939d10e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019c9ac1-adb4-7f64-a456-348065ac2f29" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_019c9ac1-adb4-7741-b838-bbcd21f0241f" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019c9ac1-adb4-7f64-a456-348065ac2f29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_019c9ac1-adb4-757d-b196-9d7fe6770b92" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_019c9ac1-adb4-7662-b5a6-7155da47c69c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_019c9ac1-adb4-757d-b196-9d7fe6770b92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_019c9ac1-adb4-7403-9b9f-826ba38fc327" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_019c9ac1-adb4-757d-b196-9d7fe6770b92" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_019c9ac1-adb4-7403-9b9f-826ba38fc327" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_019db0a6-241a-7994-a8d1-3e3405a7eeab" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_019c9ac1-adb4-757d-b196-9d7fe6770b92" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_019db0a6-241a-7994-a8d1-3e3405a7eeab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_019c9ac1-adb4-7bed-bc0e-0327bf3bd9f1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_019c9ac1-adb4-757d-b196-9d7fe6770b92" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_019c9ac1-adb4-7bed-bc0e-0327bf3bd9f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments_019c9ac1-adb4-74f6-9e5e-73516616580e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_019c9ac1-adb4-757d-b196-9d7fe6770b92" xlink:to="loc_us-gaap_PaymentsToAcquireInvestments_019c9ac1-adb4-74f6-9e5e-73516616580e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019c9ac1-adb4-7655-bf79-bc3adc8c07c5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_019c9ac1-adb4-757d-b196-9d7fe6770b92" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019c9ac1-adb4-7655-bf79-bc3adc8c07c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_019c9ac1-adb4-7396-bf94-7a7fce39f491" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_019c9ac1-adb4-7662-b5a6-7155da47c69c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_019c9ac1-adb4-7396-bf94-7a7fce39f491" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_019c9ac1-adb4-72fe-aad7-66f1d4f34fd1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_019c9ac1-adb4-7396-bf94-7a7fce39f491" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_019c9ac1-adb4-72fe-aad7-66f1d4f34fd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_ProceedsFromPaymentForShareBasedPaymentArrangement_019c9ac1-adb4-75e0-ba52-500cbd210aec" xlink:href="rxrx-20260331.xsd#rxrx_ProceedsFromPaymentForShareBasedPaymentArrangement"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_019c9ac1-adb4-7396-bf94-7a7fce39f491" xlink:to="loc_rxrx_ProceedsFromPaymentForShareBasedPaymentArrangement_019c9ac1-adb4-75e0-ba52-500cbd210aec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities_019c9ac1-adb4-713f-8cf6-b769e9b77272" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_019c9ac1-adb4-7396-bf94-7a7fce39f491" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities_019c9ac1-adb4-713f-8cf6-b769e9b77272" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019c9ac1-adb4-731a-bfbe-43217697aef7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_019c9ac1-adb4-7396-bf94-7a7fce39f491" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019c9ac1-adb4-731a-bfbe-43217697aef7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019c9ac1-adb4-7a6e-81ee-c304f4a2f793" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_019c9ac1-adb4-7662-b5a6-7155da47c69c" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019c9ac1-adb4-7a6e-81ee-c304f4a2f793" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019c9ac1-adb4-7703-bbe5-16d415a39e15" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_019c9ac1-adb4-7662-b5a6-7155da47c69c" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019c9ac1-adb4-7703-bbe5-16d415a39e15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019c9ac1-adb4-7039-aae4-78d7a256d43b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_019c9ac1-adb4-7662-b5a6-7155da47c69c" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019c9ac1-adb4-7039-aae4-78d7a256d43b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019c9ac1-adb4-781d-b8fc-4058f7c67a28" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_019c9ac1-adb4-7662-b5a6-7155da47c69c" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019c9ac1-adb4-781d-b8fc-4058f7c67a28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_019c9ac1-adb4-7a4e-9d26-daf589e71e07" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_019c9ac1-adb4-7662-b5a6-7155da47c69c" xlink:to="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_019c9ac1-adb4-7a4e-9d26-daf589e71e07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1_019c9ac1-adb4-7b7e-a9ea-b6d44595a809" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_019c9ac1-adb4-7a4e-9d26-daf589e71e07" xlink:to="loc_us-gaap_NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1_019c9ac1-adb4-7b7e-a9ea-b6d44595a809" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_019c9ac1-adb4-726f-8770-24796b4d372a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_019c9ac1-adb4-7a4e-9d26-daf589e71e07" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_019c9ac1-adb4-726f-8770-24796b4d372a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_PurchaseOfAnEquityInvestmentNonCash_019c9ac1-adb4-7623-be3e-6db9bd3e3e19" xlink:href="rxrx-20260331.xsd#rxrx_PurchaseOfAnEquityInvestmentNonCash"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_019c9ac1-adb4-7a4e-9d26-daf589e71e07" xlink:to="loc_rxrx_PurchaseOfAnEquityInvestmentNonCash_019c9ac1-adb4-7623-be3e-6db9bd3e3e19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/DescriptionoftheBusiness" xlink:type="simple" xlink:href="rxrx-20260331.xsd#DescriptionoftheBusiness"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/DescriptionoftheBusiness" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_019c9ac1-adb4-7f00-bc7c-ce389e15548a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations_019c9ac1-adb4-79ba-aa7a-b4d4b4df4f3d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NatureOfOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_019c9ac1-adb4-7f00-bc7c-ce389e15548a" xlink:to="loc_us-gaap_NatureOfOperations_019c9ac1-adb4-79ba-aa7a-b4d4b4df4f3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/BasisofPresentation" xlink:type="simple" xlink:href="rxrx-20260331.xsd#BasisofPresentation"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/BasisofPresentation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_019c9ac1-adb4-75b3-a88c-63f773ad71de" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_019c9ac1-adb4-7966-83d5-e858f426e9ba" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019c9ac1-adb4-75b3-a88c-63f773ad71de" xlink:to="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_019c9ac1-adb4-7966-83d5-e858f426e9ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/SupplementalFinancialInformation" xlink:type="simple" xlink:href="rxrx-20260331.xsd#SupplementalFinancialInformation"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/SupplementalFinancialInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_SupplementalFinancialInformationAbstract_019c9ac1-ae72-7bf4-b3a7-36a1298bb8ae" xlink:href="rxrx-20260331.xsd#rxrx_SupplementalFinancialInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_SupplementalBalanceSheetAndIncomeStatementInformationTextBlock_019c9ac1-ae72-7f3d-97d9-7d2afad9d7ae" xlink:href="rxrx-20260331.xsd#rxrx_SupplementalBalanceSheetAndIncomeStatementInformationTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rxrx_SupplementalFinancialInformationAbstract_019c9ac1-ae72-7bf4-b3a7-36a1298bb8ae" xlink:to="loc_rxrx_SupplementalBalanceSheetAndIncomeStatementInformationTextBlock_019c9ac1-ae72-7f3d-97d9-7d2afad9d7ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/Acquisitions" xlink:type="simple" xlink:href="rxrx-20260331.xsd#Acquisitions"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/Acquisitions" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_019c9ac1-ae72-7140-bb9b-3f002e9c1bc3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_019c9ac1-ae72-7303-9aab-23269e0a685b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_019c9ac1-ae72-7140-bb9b-3f002e9c1bc3" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_019c9ac1-ae72-7303-9aab-23269e0a685b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/Leases" xlink:type="simple" xlink:href="rxrx-20260331.xsd#Leases"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_019c9ac1-ae72-7843-9654-47119b6cc6e5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_019c9ac1-ae72-7953-ad9b-24e876d6dbd7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_019c9ac1-ae72-7843-9654-47119b6cc6e5" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_019c9ac1-ae72-7953-ad9b-24e876d6dbd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeasesTextBlock_019c9ac1-ae72-73f6-acd8-25143107f65b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeFinanceLeasesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_019c9ac1-ae72-7843-9654-47119b6cc6e5" xlink:to="loc_us-gaap_LesseeFinanceLeasesTextBlock_019c9ac1-ae72-73f6-acd8-25143107f65b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/GoodwillandIntangibleAssets" xlink:type="simple" xlink:href="rxrx-20260331.xsd#GoodwillandIntangibleAssets"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/GoodwillandIntangibleAssets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_019c9ac1-ae72-7f25-9ce1-b88143a65486" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_019c9ac1-ae72-768e-b382-d3a6d63cf1d3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_019c9ac1-ae72-7f25-9ce1-b88143a65486" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_019c9ac1-ae72-768e-b382-d3a6d63cf1d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="rxrx-20260331.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_019c9ac1-ae72-7291-a8ba-ea8f043d8f9d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_019c9ac1-ae72-7aec-b558-bf283bb9e787" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_019c9ac1-ae72-7291-a8ba-ea8f043d8f9d" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_019c9ac1-ae72-7aec-b558-bf283bb9e787" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/CommonStock" xlink:type="simple" xlink:href="rxrx-20260331.xsd#CommonStock"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/CommonStock" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_019c9ac1-ae72-720b-b862-78c9230e63b1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_019c9ac1-ae72-738a-9ab3-f7aa7b757e7c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_019c9ac1-ae72-720b-b862-78c9230e63b1" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_019c9ac1-ae72-738a-9ab3-f7aa7b757e7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/CollaborativeDevelopmentContracts" xlink:type="simple" xlink:href="rxrx-20260331.xsd#CollaborativeDevelopmentContracts"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/CollaborativeDevelopmentContracts" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_019c9ac1-ae73-72e7-afeb-88be45add229" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_019c9ac1-ae73-789f-aba6-10daed6996ff" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_019c9ac1-ae73-72e7-afeb-88be45add229" xlink:to="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_019c9ac1-ae73-789f-aba6-10daed6996ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/StockBasedCompensation" xlink:type="simple" xlink:href="rxrx-20260331.xsd#StockBasedCompensation"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/StockBasedCompensation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019c9ac1-ae73-7efe-8fc5-0d992c5374d4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_019c9ac1-ae73-7b16-8120-bb30c93989d9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019c9ac1-ae73-7efe-8fc5-0d992c5374d4" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_019c9ac1-ae73-7b16-8120-bb30c93989d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/IncomeTaxes" xlink:type="simple" xlink:href="rxrx-20260331.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_019c9ac1-ae73-713c-9604-020263f37fb9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_019c9ac1-ae73-719f-9ac8-799629f783c3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_019c9ac1-ae73-713c-9604-020263f37fb9" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_019c9ac1-ae73-719f-9ac8-799629f783c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/NetLossPerShare" xlink:type="simple" xlink:href="rxrx-20260331.xsd#NetLossPerShare"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/NetLossPerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_019c9ac1-ae73-73f1-938b-cf45dda820a7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_019c9ac1-ae73-7819-ad09-32f3e12c2fdf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_019c9ac1-ae73-73f1-938b-cf45dda820a7" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_019c9ac1-ae73-7819-ad09-32f3e12c2fdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="rxrx-20260331.xsd#FairValueMeasurements"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_019c9ac1-ae73-7851-b3ec-a4d2e41a3814" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_019c9ac1-ae73-7817-9224-bc72f534ed48" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_019c9ac1-ae73-7851-b3ec-a4d2e41a3814" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_019c9ac1-ae73-7817-9224-bc72f534ed48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/SegmentInformation" xlink:type="simple" xlink:href="rxrx-20260331.xsd#SegmentInformation"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/SegmentInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_019c9ac1-ae73-74a0-86d4-ae1ff353bbbb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_019c9ac1-ae73-70dc-87c2-76e32c4c4816" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_019c9ac1-ae73-74a0-86d4-ae1ff353bbbb" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_019c9ac1-ae73-70dc-87c2-76e32c4c4816" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/BasisofPresentationPolicies" xlink:type="simple" xlink:href="rxrx-20260331.xsd#BasisofPresentationPolicies"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/BasisofPresentationPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_019c9ac1-adb4-7479-ae72-e01785c65491" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_019c9ac1-adb4-7c98-96fc-a981f5cc7a98" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019c9ac1-adb4-7479-ae72-e01785c65491" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_019c9ac1-adb4-7c98-96fc-a981f5cc7a98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_019c9ac1-adb4-7dde-a603-5d8fe10bf5ce" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019c9ac1-adb4-7479-ae72-e01785c65491" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_019c9ac1-adb4-7dde-a603-5d8fe10bf5ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/SupplementalFinancialInformationTables" xlink:type="simple" xlink:href="rxrx-20260331.xsd#SupplementalFinancialInformationTables"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/SupplementalFinancialInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_SupplementalFinancialInformationAbstract_019c9ac1-ae72-78b0-930a-8362f6426626" xlink:href="rxrx-20260331.xsd#rxrx_SupplementalFinancialInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_019c9ac1-ae72-7e95-873b-908a9aef2acb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rxrx_SupplementalFinancialInformationAbstract_019c9ac1-ae72-78b0-930a-8362f6426626" xlink:to="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_019c9ac1-ae72-7e95-873b-908a9aef2acb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock_019c9ac1-ae72-768e-98cc-c84a68fdb5f0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rxrx_SupplementalFinancialInformationAbstract_019c9ac1-ae72-78b0-930a-8362f6426626" xlink:to="loc_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock_019c9ac1-ae72-768e-98cc-c84a68fdb5f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/LeasesTables" xlink:type="simple" xlink:href="rxrx-20260331.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_019c9ac1-ae72-76ac-84ac-5d8cee46e0ba" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_019c9ac1-ae72-7d15-9bb7-e4638f67c2c2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_019c9ac1-ae72-76ac-84ac-5d8cee46e0ba" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_019c9ac1-ae72-7d15-9bb7-e4638f67c2c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/GoodwillandIntangibleAssetsTables" xlink:type="simple" xlink:href="rxrx-20260331.xsd#GoodwillandIntangibleAssetsTables"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/GoodwillandIntangibleAssetsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_019c9ac1-ae72-7102-8c74-88151f3b77f5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_019c9ac1-ae72-77f6-91b0-8c4eca79514a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_019c9ac1-ae72-7102-8c74-88151f3b77f5" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_019c9ac1-ae72-77f6-91b0-8c4eca79514a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_019c9ac1-ae72-7b11-a6ca-ee71c76019b7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_019c9ac1-ae72-7102-8c74-88151f3b77f5" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_019c9ac1-ae72-7b11-a6ca-ee71c76019b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_019c9ac1-ae72-74c9-938a-04f6611af920" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_019c9ac1-ae72-7102-8c74-88151f3b77f5" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_019c9ac1-ae72-74c9-938a-04f6611af920" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/StockBasedCompensationTables" xlink:type="simple" xlink:href="rxrx-20260331.xsd#StockBasedCompensationTables"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/StockBasedCompensationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019c9ac1-ae73-746d-b7b2-b101122457c4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_019c9ac1-ae73-7fe0-8c07-5b4082c757a8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019c9ac1-ae73-746d-b7b2-b101122457c4" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_019c9ac1-ae73-7fe0-8c07-5b4082c757a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_019c9ac1-ae73-758a-a917-64f6a30fe079" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019c9ac1-ae73-746d-b7b2-b101122457c4" xlink:to="loc_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_019c9ac1-ae73-758a-a917-64f6a30fe079" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/NetLossPerShareTables" xlink:type="simple" xlink:href="rxrx-20260331.xsd#NetLossPerShareTables"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/NetLossPerShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_019c9ac1-ae73-7b40-8408-2c4c6d01f4ee" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_019c9ac1-ae73-7ccd-bb4e-5ef451eda98e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_019c9ac1-ae73-7b40-8408-2c4c6d01f4ee" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_019c9ac1-ae73-7ccd-bb4e-5ef451eda98e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_019c9ac1-ae73-706f-bd36-dc1f3f957d02" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_019c9ac1-ae73-7b40-8408-2c4c6d01f4ee" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_019c9ac1-ae73-706f-bd36-dc1f3f957d02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="rxrx-20260331.xsd#FairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_019c9ac1-ae73-7239-9eed-c895380e90b6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_019c9ac1-ae73-7a93-b607-f521dc826528" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_019c9ac1-ae73-7239-9eed-c895380e90b6" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_019c9ac1-ae73-7a93-b607-f521dc826528" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock_019c9ac1-ae73-719c-92aa-3b413bf24c79" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_019c9ac1-ae73-7239-9eed-c895380e90b6" xlink:to="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock_019c9ac1-ae73-719c-92aa-3b413bf24c79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/SegmentInformationTables" xlink:type="simple" xlink:href="rxrx-20260331.xsd#SegmentInformationTables"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/SegmentInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_019c9ac1-ae73-7a2f-811b-f99627e489e7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_019c9ac1-ae73-7590-a123-7d27b046b56a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_019c9ac1-ae73-7a2f-811b-f99627e489e7" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_019c9ac1-ae73-7590-a123-7d27b046b56a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/DescriptionoftheBusinessDetails" xlink:type="simple" xlink:href="rxrx-20260331.xsd#DescriptionoftheBusinessDetails"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/DescriptionoftheBusinessDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_019c9ac1-adb4-7305-bb00-99c4a35d9bcb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_019c9ac1-adb4-74b8-b9f3-dd4782dcc4c3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_019c9ac1-adb4-7305-bb00-99c4a35d9bcb" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_019c9ac1-adb4-74b8-b9f3-dd4782dcc4c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/SupplementalFinancialInformationNarrativeDetails" xlink:type="simple" xlink:href="rxrx-20260331.xsd#SupplementalFinancialInformationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/SupplementalFinancialInformationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_SupplementalFinancialInformationAbstract_019c9ac1-ae72-7873-8b7b-d06ab5dff1d9" xlink:href="rxrx-20260331.xsd#rxrx_SupplementalFinancialInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_019c9ac1-ae72-7087-ab00-81db56fdbdfa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rxrx_SupplementalFinancialInformationAbstract_019c9ac1-ae72-7873-8b7b-d06ab5dff1d9" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_019c9ac1-ae72-7087-ab00-81db56fdbdfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_019c9ac1-ae72-7440-8461-cc4d20e94c3f" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_019c9ac1-ae72-7087-ab00-81db56fdbdfa" xlink:to="loc_srt_CounterpartyNameAxis_019c9ac1-ae72-7440-8461-cc4d20e94c3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_019c9ac1-ae72-743a-aa6e-b347f4d14ae5" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_019c9ac1-ae72-7440-8461-cc4d20e94c3f" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_019c9ac1-ae72-743a-aa6e-b347f4d14ae5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_TempusLabsIncMember_019c9ac1-ae72-706b-97ac-05992fa2107f" xlink:href="rxrx-20260331.xsd#rxrx_TempusLabsIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_019c9ac1-ae72-743a-aa6e-b347f4d14ae5" xlink:to="loc_rxrx_TempusLabsIncMember_019c9ac1-ae72-706b-97ac-05992fa2107f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_019c9ac1-ae72-7305-959d-ea4a56a76785" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_019c9ac1-ae72-7087-ab00-81db56fdbdfa" xlink:to="loc_srt_RangeAxis_019c9ac1-ae72-7305-959d-ea4a56a76785" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_019c9ac1-ae72-7ffe-b114-fcf51448781f" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_019c9ac1-ae72-7305-959d-ea4a56a76785" xlink:to="loc_srt_RangeMember_019c9ac1-ae72-7ffe-b114-fcf51448781f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_019c9ac1-ae72-7933-a972-b673730c02ee" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_019c9ac1-ae72-7ffe-b114-fcf51448781f" xlink:to="loc_srt_MinimumMember_019c9ac1-ae72-7933-a972-b673730c02ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_019c9ac1-ae72-7ebf-9b52-d19b60574333" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_019c9ac1-ae72-7ffe-b114-fcf51448781f" xlink:to="loc_srt_MaximumMember_019c9ac1-ae72-7ebf-9b52-d19b60574333" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_019c9ac1-ae72-7304-a243-fae2c193725f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_019c9ac1-ae72-7087-ab00-81db56fdbdfa" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_019c9ac1-ae72-7304-a243-fae2c193725f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_LicenseAgreementTerm_019c9ac1-ae72-71bc-bb95-97337792af6c" xlink:href="rxrx-20260331.xsd#rxrx_LicenseAgreementTerm"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_019c9ac1-ae72-7304-a243-fae2c193725f" xlink:to="loc_rxrx_LicenseAgreementTerm_019c9ac1-ae72-71bc-bb95-97337792af6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_LicenseAgreementAnnualPayments_019c9ac1-ae72-7c4d-9de3-6f60bad46fb6" xlink:href="rxrx-20260331.xsd#rxrx_LicenseAgreementAnnualPayments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_019c9ac1-ae72-7304-a243-fae2c193725f" xlink:to="loc_rxrx_LicenseAgreementAnnualPayments_019c9ac1-ae72-7c4d-9de3-6f60bad46fb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_LicenseAgreementAggregatePayments_019c9ac1-ae72-7fb4-b6cf-c75ab18c2392" xlink:href="rxrx-20260331.xsd#rxrx_LicenseAgreementAggregatePayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_019c9ac1-ae72-7304-a243-fae2c193725f" xlink:to="loc_rxrx_LicenseAgreementAggregatePayments_019c9ac1-ae72-7fb4-b6cf-c75ab18c2392" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_LicenseAgreementTradingPeriodUsedForEquityValueDetermination_019c9ac1-ae72-7503-95bd-37073ecfd4e6" xlink:href="rxrx-20260331.xsd#rxrx_LicenseAgreementTradingPeriodUsedForEquityValueDetermination"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_019c9ac1-ae72-7304-a243-fae2c193725f" xlink:to="loc_rxrx_LicenseAgreementTradingPeriodUsedForEquityValueDetermination_019c9ac1-ae72-7503-95bd-37073ecfd4e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_LicenseAgreementAmountOfTimePriorToThePaymentDate_019c9ac1-ae72-7874-a3a8-88737541d1d8" xlink:href="rxrx-20260331.xsd#rxrx_LicenseAgreementAmountOfTimePriorToThePaymentDate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_019c9ac1-ae72-7304-a243-fae2c193725f" xlink:to="loc_rxrx_LicenseAgreementAmountOfTimePriorToThePaymentDate_019c9ac1-ae72-7874-a3a8-88737541d1d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_LicenseAgreementIncreaseDecreaseAccruedLiabilities_019c9ac1-ae72-79a6-992a-6ea7827fc84b" xlink:href="rxrx-20260331.xsd#rxrx_LicenseAgreementIncreaseDecreaseAccruedLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_019c9ac1-ae72-7304-a243-fae2c193725f" xlink:to="loc_rxrx_LicenseAgreementIncreaseDecreaseAccruedLiabilities_019c9ac1-ae72-79a6-992a-6ea7827fc84b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/SupplementalFinancialInformationScheduleofAccruedExpensesandOtherLiabilitiesDetails" xlink:type="simple" xlink:href="rxrx-20260331.xsd#SupplementalFinancialInformationScheduleofAccruedExpensesandOtherLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/SupplementalFinancialInformationScheduleofAccruedExpensesandOtherLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_SupplementalFinancialInformationAbstract_019c9ac1-ae72-7a13-b492-9b0169e857f2" xlink:href="rxrx-20260331.xsd#rxrx_SupplementalFinancialInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_019c9ac1-ae72-7705-b56b-16a5b58b97e0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rxrx_SupplementalFinancialInformationAbstract_019c9ac1-ae72-7a13-b492-9b0169e857f2" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_019c9ac1-ae72-7705-b56b-16a5b58b97e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_AccruedComputeLiabilitiesCurrent_019d8672-68e3-77b7-abd5-a498e555ca5f" xlink:href="rxrx-20260331.xsd#rxrx_AccruedComputeLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rxrx_SupplementalFinancialInformationAbstract_019c9ac1-ae72-7a13-b492-9b0169e857f2" xlink:to="loc_rxrx_AccruedComputeLiabilitiesCurrent_019d8672-68e3-77b7-abd5-a498e555ca5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_AccruedDevelopmentCostsCurrent_019c9ac1-ae72-78c2-93da-7d5cfe6dccd9" xlink:href="rxrx-20260331.xsd#rxrx_AccruedDevelopmentCostsCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rxrx_SupplementalFinancialInformationAbstract_019c9ac1-ae72-7a13-b492-9b0169e857f2" xlink:to="loc_rxrx_AccruedDevelopmentCostsCurrent_019c9ac1-ae72-78c2-93da-7d5cfe6dccd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_AccruedEarlyDiscoveryExpensesCurrent_019c9ac1-ae72-7e62-8e86-17a68d3283ce" xlink:href="rxrx-20260331.xsd#rxrx_AccruedEarlyDiscoveryExpensesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rxrx_SupplementalFinancialInformationAbstract_019c9ac1-ae72-7a13-b492-9b0169e857f2" xlink:to="loc_rxrx_AccruedEarlyDiscoveryExpensesCurrent_019c9ac1-ae72-7e62-8e86-17a68d3283ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_019c9ac1-ae72-725a-adae-cb197eb0caf9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rxrx_SupplementalFinancialInformationAbstract_019c9ac1-ae72-7a13-b492-9b0169e857f2" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_019c9ac1-ae72-725a-adae-cb197eb0caf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_MaterialsReceivedNotInvoiced_019c9ac1-ae72-7a51-bbd4-e140db1a6855" xlink:href="rxrx-20260331.xsd#rxrx_MaterialsReceivedNotInvoiced"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rxrx_SupplementalFinancialInformationAbstract_019c9ac1-ae72-7a13-b492-9b0169e857f2" xlink:to="loc_rxrx_MaterialsReceivedNotInvoiced_019c9ac1-ae72-7a51-bbd4-e140db1a6855" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_AccruedLicenseFeeCurrent_019c9ac1-ae72-7eb3-8333-3b639b2464c7" xlink:href="rxrx-20260331.xsd#rxrx_AccruedLicenseFeeCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rxrx_SupplementalFinancialInformationAbstract_019c9ac1-ae72-7a13-b492-9b0169e857f2" xlink:to="loc_rxrx_AccruedLicenseFeeCurrent_019c9ac1-ae72-7eb3-8333-3b639b2464c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_019c9ac1-ae72-7a89-adba-c98879acd69e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rxrx_SupplementalFinancialInformationAbstract_019c9ac1-ae72-7a13-b492-9b0169e857f2" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_019c9ac1-ae72-7a89-adba-c98879acd69e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_019c9ac1-ae72-7c92-bb75-c30685de5e8a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rxrx_SupplementalFinancialInformationAbstract_019c9ac1-ae72-7a13-b492-9b0169e857f2" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_019c9ac1-ae72-7c92-bb75-c30685de5e8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/SupplementalFinancialInformationScheduleofInterestIncomeNetDetails" xlink:type="simple" xlink:href="rxrx-20260331.xsd#SupplementalFinancialInformationScheduleofInterestIncomeNetDetails"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/SupplementalFinancialInformationScheduleofInterestIncomeNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_SupplementalFinancialInformationAbstract_019c9ac1-ae72-7977-b3e2-7cbe152b9799" xlink:href="rxrx-20260331.xsd#rxrx_SupplementalFinancialInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNonoperating_019c9ac1-ae72-7d0f-9512-713efac590cf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentIncomeNonoperating"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rxrx_SupplementalFinancialInformationAbstract_019c9ac1-ae72-7977-b3e2-7cbe152b9799" xlink:to="loc_us-gaap_InvestmentIncomeNonoperating_019c9ac1-ae72-7d0f-9512-713efac590cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseNonoperating_019c9ac1-ae72-7f5a-b32f-a673481cc1de" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestExpenseNonoperating"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rxrx_SupplementalFinancialInformationAbstract_019c9ac1-ae72-7977-b3e2-7cbe152b9799" xlink:to="loc_us-gaap_InterestExpenseNonoperating_019c9ac1-ae72-7f5a-b32f-a673481cc1de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_019c9ac1-ae72-70ae-a63e-1f990935154e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rxrx_SupplementalFinancialInformationAbstract_019c9ac1-ae72-7977-b3e2-7cbe152b9799" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_019c9ac1-ae72-70ae-a63e-1f990935154e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/AcquisitionsNarrativeDetails" xlink:type="simple" xlink:href="rxrx-20260331.xsd#AcquisitionsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/AcquisitionsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_019d8679-589d-740b-ae09-5a1a20770a95" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_019d8679-589d-742f-9fe1-c7367563e24b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_019d8679-589d-740b-ae09-5a1a20770a95" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_019d8679-589d-742f-9fe1-c7367563e24b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis_019d8679-589d-7e85-ab52-061d916becc2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_019d8679-589d-742f-9fe1-c7367563e24b" xlink:to="loc_us-gaap_AssetAcquisitionAxis_019d8679-589d-7e85-ab52-061d916becc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_019d8679-589d-76e9-8662-5276f48b0d45" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionAxis_019d8679-589d-7e85-ab52-061d916becc2" xlink:to="loc_us-gaap_AssetAcquisitionDomain_019d8679-589d-76e9-8662-5276f48b0d45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_REVenturesIMember_019d8679-589d-7a27-bb5e-4cebc19c24a8" xlink:href="rxrx-20260331.xsd#rxrx_REVenturesIMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionDomain_019d8679-589d-76e9-8662-5276f48b0d45" xlink:to="loc_rxrx_REVenturesIMember_019d8679-589d-7a27-bb5e-4cebc19c24a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_019d867a-ed43-76cf-afd8-12081860ac4f" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_019d8679-589d-742f-9fe1-c7367563e24b" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_019d867a-ed43-76cf-afd8-12081860ac4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_019d867a-ed43-79f6-98c8-61c969bbfb19" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_019d867a-ed43-76cf-afd8-12081860ac4f" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_019d867a-ed43-79f6-98c8-61c969bbfb19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_AlphaBiotechnologyGmbHAlphaMember_019d867a-ed43-7191-bc9e-ad4dc2390b19" xlink:href="rxrx-20260331.xsd#rxrx_AlphaBiotechnologyGmbHAlphaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_019d867a-ed43-79f6-98c8-61c969bbfb19" xlink:to="loc_rxrx_AlphaBiotechnologyGmbHAlphaMember_019d867a-ed43-7191-bc9e-ad4dc2390b19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_019d867a-ed43-7b14-b9c3-d2c3c4f156d7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_019d8679-589d-742f-9fe1-c7367563e24b" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_019d867a-ed43-7b14-b9c3-d2c3c4f156d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_019d867a-ed43-76cd-a568-ede177bd89b5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_019d867a-ed43-7b14-b9c3-d2c3c4f156d7" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_019d867a-ed43-76cd-a568-ede177bd89b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_019d867a-ed43-717a-84c0-be28d3cc0035" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_019d867a-ed43-76cd-a568-ede177bd89b5" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_019d867a-ed43-717a-84c0-be28d3cc0035" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019d867a-ed43-750b-ad52-4a90a0d5b1ab" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_019d8679-589d-742f-9fe1-c7367563e24b" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019d867a-ed43-750b-ad52-4a90a0d5b1ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019d867a-ed43-75f1-8eae-e94e534e0ced" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_019d867a-ed43-750b-ad52-4a90a0d5b1ab" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019d867a-ed43-75f1-8eae-e94e534e0ced" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_ExscientiaGmbHMember_019d867a-ed43-7110-acce-893dd3bb0abe" xlink:href="rxrx-20260331.xsd#rxrx_ExscientiaGmbHMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_019d867a-ed43-75f1-8eae-e94e534e0ced" xlink:to="loc_rxrx_ExscientiaGmbHMember_019d867a-ed43-7110-acce-893dd3bb0abe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_019d8679-589d-7eae-abc4-aa3daaad7ff0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_019d8679-589d-742f-9fe1-c7367563e24b" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_019d8679-589d-7eae-abc4-aa3daaad7ff0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_AssetAcquisitionEquityOwnershipPercentage_019d8679-589d-79e4-a1ec-fccdbd266e91" xlink:href="rxrx-20260331.xsd#rxrx_AssetAcquisitionEquityOwnershipPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_019d8679-589d-7eae-abc4-aa3daaad7ff0" xlink:to="loc_rxrx_AssetAcquisitionEquityOwnershipPercentage_019d8679-589d-79e4-a1ec-fccdbd266e91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionConsiderationTransferred_019d8679-589d-7340-95e5-1bcb54f768f9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetAcquisitionConsiderationTransferred"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_019d8679-589d-7eae-abc4-aa3daaad7ff0" xlink:to="loc_us-gaap_AssetAcquisitionConsiderationTransferred_019d8679-589d-7340-95e5-1bcb54f768f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment_019d8679-589d-745c-8972-ca21b8f4a406" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_019d8679-589d-7eae-abc4-aa3daaad7ff0" xlink:to="loc_us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment_019d8679-589d-745c-8972-ca21b8f4a406" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_019d867a-ed43-7324-8ecd-3e15f1681c31" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_019d8679-589d-7eae-abc4-aa3daaad7ff0" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_019d867a-ed43-7324-8ecd-3e15f1681c31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_019d867a-ed43-7318-8ec0-3100c9825ffd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_019d8679-589d-7eae-abc4-aa3daaad7ff0" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_019d867a-ed43-7318-8ec0-3100c9825ffd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_019d867a-ed43-7aa9-a1aa-e446d87187d6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_019d8679-589d-7eae-abc4-aa3daaad7ff0" xlink:to="loc_us-gaap_EquityMethodInvestments_019d867a-ed43-7aa9-a1aa-e446d87187d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="rxrx-20260331.xsd#LeasesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/LeasesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_019c9ac1-ae72-7aa8-baf8-15476a8129b3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_019c9ac1-ae72-7f1a-9714-509ea48ed598" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_019c9ac1-ae72-7aa8-baf8-15476a8129b3" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_019c9ac1-ae72-7f1a-9714-509ea48ed598" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_019c9ac1-ae72-799f-9a71-1ed377f8ddff" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_019c9ac1-ae72-7f1a-9714-509ea48ed598" xlink:to="loc_srt_RangeAxis_019c9ac1-ae72-799f-9a71-1ed377f8ddff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_019c9ac1-ae72-7821-bfdb-b6e874a0d7c6" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_019c9ac1-ae72-799f-9a71-1ed377f8ddff" xlink:to="loc_srt_RangeMember_019c9ac1-ae72-7821-bfdb-b6e874a0d7c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_019c9ac1-ae72-7477-a219-8713f9dbae2e" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_019c9ac1-ae72-7821-bfdb-b6e874a0d7c6" xlink:to="loc_srt_MinimumMember_019c9ac1-ae72-7477-a219-8713f9dbae2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_019c9ac1-ae72-722d-9af6-47e3b6ef4b29" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_019c9ac1-ae72-7821-bfdb-b6e874a0d7c6" xlink:to="loc_srt_MaximumMember_019c9ac1-ae72-722d-9af6-47e3b6ef4b29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_019c9ac1-ae72-7cb5-a9fd-a00d78887274" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_019c9ac1-ae72-7f1a-9714-509ea48ed598" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_019c9ac1-ae72-7cb5-a9fd-a00d78887274" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_019c9ac1-ae72-7820-ac61-87620038ae3b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_019c9ac1-ae72-7cb5-a9fd-a00d78887274" xlink:to="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_019c9ac1-ae72-7820-ac61-87620038ae3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_019c9ac1-ae72-7661-a5c3-c6c0bf99cc25" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_019c9ac1-ae72-7cb5-a9fd-a00d78887274" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_019c9ac1-ae72-7661-a5c3-c6c0bf99cc25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_IncreaseDecreaseInOperatingLeaseRightOfUseAssets_019c9ac1-ae72-73a1-a40d-8cb28d46058a" xlink:href="rxrx-20260331.xsd#rxrx_IncreaseDecreaseInOperatingLeaseRightOfUseAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_019c9ac1-ae72-7cb5-a9fd-a00d78887274" xlink:to="loc_rxrx_IncreaseDecreaseInOperatingLeaseRightOfUseAssets_019c9ac1-ae72-73a1-a40d-8cb28d46058a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_LesseeOperatingLeaseIncreaseDecreaseInOperatingLeaseLiabilityDueToLeaseModifications_019c9ac1-ae72-7093-8fcc-b1c0124190e1" xlink:href="rxrx-20260331.xsd#rxrx_LesseeOperatingLeaseIncreaseDecreaseInOperatingLeaseLiabilityDueToLeaseModifications"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_019c9ac1-ae72-7cb5-a9fd-a00d78887274" xlink:to="loc_rxrx_LesseeOperatingLeaseIncreaseDecreaseInOperatingLeaseLiabilityDueToLeaseModifications_019c9ac1-ae72-7093-8fcc-b1c0124190e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/LeasesScheduleofSupplementalCashFlowInformationRelatedtoLeasesDetails" xlink:type="simple" xlink:href="rxrx-20260331.xsd#LeasesScheduleofSupplementalCashFlowInformationRelatedtoLeasesDetails"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/LeasesScheduleofSupplementalCashFlowInformationRelatedtoLeasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_019c9ac1-ae72-74d4-b767-265b57d52b79" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_CashPaidForAmountIncludedInTheMeasurementOfLeaseLiabilitiesAbstract_019c9ac1-ae72-7447-b49d-f3cf7a5bfc13" xlink:href="rxrx-20260331.xsd#rxrx_CashPaidForAmountIncludedInTheMeasurementOfLeaseLiabilitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_019c9ac1-ae72-74d4-b767-265b57d52b79" xlink:to="loc_rxrx_CashPaidForAmountIncludedInTheMeasurementOfLeaseLiabilitiesAbstract_019c9ac1-ae72-7447-b49d-f3cf7a5bfc13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_019c9ac1-ae72-713a-a135-e044106bee1d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rxrx_CashPaidForAmountIncludedInTheMeasurementOfLeaseLiabilitiesAbstract_019c9ac1-ae72-7447-b49d-f3cf7a5bfc13" xlink:to="loc_us-gaap_OperatingLeasePayments_019c9ac1-ae72-713a-a135-e044106bee1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_019c9ac1-ae72-74ec-9334-2f6b3da15c60" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rxrx_CashPaidForAmountIncludedInTheMeasurementOfLeaseLiabilitiesAbstract_019c9ac1-ae72-7447-b49d-f3cf7a5bfc13" xlink:to="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_019c9ac1-ae72-74ec-9334-2f6b3da15c60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_019c9ac1-ae72-72aa-8e8c-b368dc3a7efd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rxrx_CashPaidForAmountIncludedInTheMeasurementOfLeaseLiabilitiesAbstract_019c9ac1-ae72-7447-b49d-f3cf7a5bfc13" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_019c9ac1-ae72-72aa-8e8c-b368dc3a7efd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_RightOfUseAssetsObtainedInExchangeForLeaseLiabilitiesAbstract_019c9ac1-ae72-7373-a251-8119e0d68e2f" xlink:href="rxrx-20260331.xsd#rxrx_RightOfUseAssetsObtainedInExchangeForLeaseLiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_019c9ac1-ae72-74d4-b767-265b57d52b79" xlink:to="loc_rxrx_RightOfUseAssetsObtainedInExchangeForLeaseLiabilitiesAbstract_019c9ac1-ae72-7373-a251-8119e0d68e2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_IncreaseDecreaseInOperatingLeaseRightOfUseAssets_019c9ac1-ae72-71f7-a7f7-d2d8fe3944bc" xlink:href="rxrx-20260331.xsd#rxrx_IncreaseDecreaseInOperatingLeaseRightOfUseAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rxrx_RightOfUseAssetsObtainedInExchangeForLeaseLiabilitiesAbstract_019c9ac1-ae72-7373-a251-8119e0d68e2f" xlink:to="loc_rxrx_IncreaseDecreaseInOperatingLeaseRightOfUseAssets_019c9ac1-ae72-71f7-a7f7-d2d8fe3944bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/GoodwillandIntangibleAssetsScheduleofChangesintheCarryingAmountofGoodwillDetails" xlink:type="simple" xlink:href="rxrx-20260331.xsd#GoodwillandIntangibleAssetsScheduleofChangesintheCarryingAmountofGoodwillDetails"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/GoodwillandIntangibleAssetsScheduleofChangesintheCarryingAmountofGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_019c9ac1-ae72-7e0f-a7be-8a7f1f4d1b0e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_019c9ac1-ae72-7838-afaf-0c40dc53df81" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_019c9ac1-ae72-7e0f-a7be-8a7f1f4d1b0e" xlink:to="loc_us-gaap_GoodwillRollForward_019c9ac1-ae72-7838-afaf-0c40dc53df81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_019c9ac1-ae72-7d8a-8abd-f877f54aef46" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_019c9ac1-ae72-7838-afaf-0c40dc53df81" xlink:to="loc_us-gaap_Goodwill_019c9ac1-ae72-7d8a-8abd-f877f54aef46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_019c9ac1-ae72-7282-90f3-0a3221508bb5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_019c9ac1-ae72-7838-afaf-0c40dc53df81" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_019c9ac1-ae72-7282-90f3-0a3221508bb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_019c9ac1-ae72-77e8-bffc-116add1ded54" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_019c9ac1-ae72-7838-afaf-0c40dc53df81" xlink:to="loc_us-gaap_Goodwill_019c9ac1-ae72-77e8-bffc-116add1ded54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/GoodwillandIntangibleAssetsNarrativeDetails" xlink:type="simple" xlink:href="rxrx-20260331.xsd#GoodwillandIntangibleAssetsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/GoodwillandIntangibleAssetsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_019c9ac1-ae72-7b41-b38d-a09f844774f6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_019c9ac1-ae72-711a-9e89-416195268f6c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_019c9ac1-ae72-7b41-b38d-a09f844774f6" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_019c9ac1-ae72-711a-9e89-416195268f6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_019c9ac1-ae72-7a36-8644-55c7b74f0788" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_019c9ac1-ae72-7b41-b38d-a09f844774f6" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_019c9ac1-ae72-7a36-8644-55c7b74f0788" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_IntangibleAssetsForeignCurrencyTranslationGainLoss_019ddec6-c270-7bd8-b63c-84cbcde2139e" xlink:href="rxrx-20260331.xsd#rxrx_IntangibleAssetsForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_019c9ac1-ae72-7b41-b38d-a09f844774f6" xlink:to="loc_rxrx_IntangibleAssetsForeignCurrencyTranslationGainLoss_019ddec6-c270-7bd8-b63c-84cbcde2139e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_019c9ac1-ae72-7c07-8657-37f9fdd5b85d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_019c9ac1-ae72-7b41-b38d-a09f844774f6" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_019c9ac1-ae72-7c07-8657-37f9fdd5b85d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/GoodwillandIntangibleAssetsScheduleofIntangibleassetsDetails" xlink:type="simple" xlink:href="rxrx-20260331.xsd#GoodwillandIntangibleAssetsScheduleofIntangibleassetsDetails"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/GoodwillandIntangibleAssetsScheduleofIntangibleassetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_019c9ac1-ae72-7a55-b95e-77e3b15b55fb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_019c9ac1-ae72-77c3-b764-88bd08a3141b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_019c9ac1-ae72-7a55-b95e-77e3b15b55fb" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_019c9ac1-ae72-77c3-b764-88bd08a3141b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_019c9ac1-ae72-75be-be86-5e7d1e1e4574" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_019c9ac1-ae72-77c3-b764-88bd08a3141b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_019c9ac1-ae72-75be-be86-5e7d1e1e4574" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_019c9ac1-ae72-771c-849d-df69772b95fd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_019c9ac1-ae72-75be-be86-5e7d1e1e4574" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_019c9ac1-ae72-771c-849d-df69772b95fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_019c9ac1-ae72-7e44-951f-fdf22407bd65" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_019c9ac1-ae72-771c-849d-df69772b95fd" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_019c9ac1-ae72-7e44-951f-fdf22407bd65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_019c9ac1-ae72-76de-9ce9-b7655b7b1aab" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_019c9ac1-ae72-771c-849d-df69772b95fd" xlink:to="loc_us-gaap_LicensingAgreementsMember_019c9ac1-ae72-76de-9ce9-b7655b7b1aab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_019c9ac1-ae72-7c1e-b6a2-2e097c8b8cb3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_019c9ac1-ae72-77c3-b764-88bd08a3141b" xlink:to="loc_us-gaap_GoodwillLineItems_019c9ac1-ae72-7c1e-b6a2-2e097c8b8cb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_019c9ac1-ae72-7a26-8bb0-e66006b3a1a2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_019c9ac1-ae72-7c1e-b6a2-2e097c8b8cb3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_019c9ac1-ae72-7a26-8bb0-e66006b3a1a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_019c9ac1-ae72-70d6-81da-82ab0dbb5d6f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_019c9ac1-ae72-7c1e-b6a2-2e097c8b8cb3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_019c9ac1-ae72-70d6-81da-82ab0dbb5d6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_019c9ac1-ae72-7632-b713-be93a3b33e04" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_019c9ac1-ae72-7c1e-b6a2-2e097c8b8cb3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_019c9ac1-ae72-7632-b713-be93a3b33e04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_019c9ac1-ae72-7d24-8753-4e522da78b74" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_019c9ac1-ae72-7c1e-b6a2-2e097c8b8cb3" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_019c9ac1-ae72-7d24-8753-4e522da78b74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_019c9ac1-ae72-754e-acee-a6afc2396467" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_019c9ac1-ae72-7c1e-b6a2-2e097c8b8cb3" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_019c9ac1-ae72-754e-acee-a6afc2396467" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_019c9ac1-ae72-7125-b0ab-f6cdcb7ed940" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_019c9ac1-ae72-7c1e-b6a2-2e097c8b8cb3" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_019c9ac1-ae72-7125-b0ab-f6cdcb7ed940" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="rxrx-20260331.xsd#CommitmentsandContingenciesDetails"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/CommitmentsandContingenciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_019c9ac1-ae72-7a78-af3c-a1d1d344e3ab" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_019c9ac1-ae72-7e34-9bd6-ec627982c8ea" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_019c9ac1-ae72-7a78-af3c-a1d1d344e3ab" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_019c9ac1-ae72-7e34-9bd6-ec627982c8ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_FinanceLeasesAssetsPledgedAsCollateral_019c9ac1-ae72-7805-9722-47252d51a3dd" xlink:href="rxrx-20260331.xsd#rxrx_FinanceLeasesAssetsPledgedAsCollateral"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_019c9ac1-ae72-7a78-af3c-a1d1d344e3ab" xlink:to="loc_rxrx_FinanceLeasesAssetsPledgedAsCollateral_019c9ac1-ae72-7805-9722-47252d51a3dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_019c9ac1-ae72-73b4-99b5-52d26c494a42" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_019c9ac1-ae72-7a78-af3c-a1d1d344e3ab" xlink:to="loc_us-gaap_FinanceLeaseLiability_019c9ac1-ae72-73b4-99b5-52d26c494a42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/CommonStockNarrativeDetails" xlink:type="simple" xlink:href="rxrx-20260331.xsd#CommonStockNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/CommonStockNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_019c9ac1-ae72-72af-8568-a8ab55d773e3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_019c9ac1-ae72-7082-be58-dcc153998c20" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_019c9ac1-ae72-72af-8568-a8ab55d773e3" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_019c9ac1-ae72-7082-be58-dcc153998c20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_019c9ac1-ae72-7d74-ac1a-67aee07f9541" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_019c9ac1-ae72-7082-be58-dcc153998c20" xlink:to="loc_us-gaap_StatementClassOfStockAxis_019c9ac1-ae72-7d74-ac1a-67aee07f9541" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_019c9ac1-ae72-7adc-a1a6-de3254ed0a1f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_019c9ac1-ae72-7d74-ac1a-67aee07f9541" xlink:to="loc_us-gaap_ClassOfStockDomain_019c9ac1-ae72-7adc-a1a6-de3254ed0a1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_019c9ac1-ae72-7119-ba26-a6f1db2d4a17" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_019c9ac1-ae72-7adc-a1a6-de3254ed0a1f" xlink:to="loc_us-gaap_CommonClassAMember_019c9ac1-ae72-7119-ba26-a6f1db2d4a17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_019c9ac1-ae72-7e60-9646-93052401ff22" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassBMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_019c9ac1-ae72-7adc-a1a6-de3254ed0a1f" xlink:to="loc_us-gaap_CommonClassBMember_019c9ac1-ae72-7e60-9646-93052401ff22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_019c9ac1-ae72-729a-a903-c7d056dcc028" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_019c9ac1-ae72-7082-be58-dcc153998c20" xlink:to="loc_us-gaap_ClassOfStockLineItems_019c9ac1-ae72-729a-a903-c7d056dcc028" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_CommonStockVotePerShare_019c9ac1-ae72-7227-b530-0fcfeb0a0539" xlink:href="rxrx-20260331.xsd#rxrx_CommonStockVotePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_019c9ac1-ae72-729a-a903-c7d056dcc028" xlink:to="loc_rxrx_CommonStockVotePerShare_019c9ac1-ae72-7227-b530-0fcfeb0a0539" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsStock_019c9ac1-ae72-7351-827c-23a867c9ba64" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DividendsStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_019c9ac1-ae72-729a-a903-c7d056dcc028" xlink:to="loc_us-gaap_DividendsStock_019c9ac1-ae72-7351-827c-23a867c9ba64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/CommonStockAtTheMarketOfferingNarrativeDetails" xlink:type="simple" xlink:href="rxrx-20260331.xsd#CommonStockAtTheMarketOfferingNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/CommonStockAtTheMarketOfferingNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_019c9ac1-ae72-72f4-a216-dc39bca7b2b3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_019c9ac1-ae72-7962-9f25-d54dfb2d2b46" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_019c9ac1-ae72-72f4-a216-dc39bca7b2b3" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_019c9ac1-ae72-7962-9f25-d54dfb2d2b46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_019c9ac1-ae72-70e9-a120-944ae2f276dc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_019c9ac1-ae72-7962-9f25-d54dfb2d2b46" xlink:to="loc_us-gaap_StatementClassOfStockAxis_019c9ac1-ae72-70e9-a120-944ae2f276dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_019c9ac1-ae72-795b-a3ff-356d01edc0e7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_019c9ac1-ae72-70e9-a120-944ae2f276dc" xlink:to="loc_us-gaap_ClassOfStockDomain_019c9ac1-ae72-795b-a3ff-356d01edc0e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_019c9ac1-ae72-790b-a012-dbfd7f32c0a6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_019c9ac1-ae72-795b-a3ff-356d01edc0e7" xlink:to="loc_us-gaap_CommonClassAMember_019c9ac1-ae72-790b-a012-dbfd7f32c0a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_019c9ac1-ae72-7e70-9dde-a4983e308d1d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_019c9ac1-ae72-7962-9f25-d54dfb2d2b46" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_019c9ac1-ae72-7e70-9dde-a4983e308d1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019c9ac1-ae72-7d89-85f6-addcdb8f55aa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_019c9ac1-ae72-7e70-9dde-a4983e308d1d" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019c9ac1-ae72-7d89-85f6-addcdb8f55aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_AtTheMarketOfferingProgramTDCowenMember_019d86b0-3b06-7d77-ba44-bfc407063294" xlink:href="rxrx-20260331.xsd#rxrx_AtTheMarketOfferingProgramTDCowenMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019c9ac1-ae72-7d89-85f6-addcdb8f55aa" xlink:to="loc_rxrx_AtTheMarketOfferingProgramTDCowenMember_019d86b0-3b06-7d77-ba44-bfc407063294" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_019c9ac1-ae72-777f-9676-4fa270e4385e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_019c9ac1-ae72-7962-9f25-d54dfb2d2b46" xlink:to="loc_us-gaap_ClassOfStockLineItems_019c9ac1-ae72-777f-9676-4fa270e4385e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_SaleOfStockValueAuthorized_019c9ac1-ae72-7d56-a670-6763dc70dd41" xlink:href="rxrx-20260331.xsd#rxrx_SaleOfStockValueAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_019c9ac1-ae72-777f-9676-4fa270e4385e" xlink:to="loc_rxrx_SaleOfStockValueAuthorized_019c9ac1-ae72-7d56-a670-6763dc70dd41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_SaleOfStockValueRemainingAuthorized_019c9ac1-ae72-79d4-9d48-d6bcab7c2e8f" xlink:href="rxrx-20260331.xsd#rxrx_SaleOfStockValueRemainingAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_019c9ac1-ae72-777f-9676-4fa270e4385e" xlink:to="loc_rxrx_SaleOfStockValueRemainingAuthorized_019c9ac1-ae72-79d4-9d48-d6bcab7c2e8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/CommonStockValenceAcquisitionExchangeableSharesNarrativeDetails" xlink:type="simple" xlink:href="rxrx-20260331.xsd#CommonStockValenceAcquisitionExchangeableSharesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/CommonStockValenceAcquisitionExchangeableSharesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_019c9ac1-ae72-7b47-afc8-0bf6e4b8d12b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_019c9ac1-ae72-7aff-9f32-987e50af866f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_019c9ac1-ae72-7b47-afc8-0bf6e4b8d12b" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_019c9ac1-ae72-7aff-9f32-987e50af866f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_019c9ac1-ae72-736f-a0c2-e87d36d337bf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_019c9ac1-ae72-7aff-9f32-987e50af866f" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_019c9ac1-ae72-736f-a0c2-e87d36d337bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_019c9ac1-ae72-7fe1-86c0-3fd9c2ebc821" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_019c9ac1-ae72-736f-a0c2-e87d36d337bf" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_019c9ac1-ae72-7fe1-86c0-3fd9c2ebc821" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_ValenceDiscoveryIncMember_019c9ac1-ae72-7619-965e-862e0def20e1" xlink:href="rxrx-20260331.xsd#rxrx_ValenceDiscoveryIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_019c9ac1-ae72-7fe1-86c0-3fd9c2ebc821" xlink:to="loc_rxrx_ValenceDiscoveryIncMember_019c9ac1-ae72-7619-965e-862e0def20e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_019c9ac1-ae72-7062-b353-850c8a0f547f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_019c9ac1-ae72-7aff-9f32-987e50af866f" xlink:to="loc_us-gaap_StatementClassOfStockAxis_019c9ac1-ae72-7062-b353-850c8a0f547f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_019c9ac1-ae72-7220-9d8e-cc466f750dc9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_019c9ac1-ae72-7062-b353-850c8a0f547f" xlink:to="loc_us-gaap_ClassOfStockDomain_019c9ac1-ae72-7220-9d8e-cc466f750dc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_ExchangeableStockMember_019c9ac1-ae72-7485-8910-c0f903d04dac" xlink:href="rxrx-20260331.xsd#rxrx_ExchangeableStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_019c9ac1-ae72-7220-9d8e-cc466f750dc9" xlink:to="loc_rxrx_ExchangeableStockMember_019c9ac1-ae72-7485-8910-c0f903d04dac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_019c9ac1-ae72-7fcf-af74-2e672defefed" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_019c9ac1-ae72-7aff-9f32-987e50af866f" xlink:to="loc_us-gaap_ClassOfStockLineItems_019c9ac1-ae72-7fcf-af74-2e672defefed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_BusinessAcquisitionContingentConsiderationEquityInterestsIssuableNumberOfShares_019c9ac1-ae73-724a-8ab0-b6e002ec5431" xlink:href="rxrx-20260331.xsd#rxrx_BusinessAcquisitionContingentConsiderationEquityInterestsIssuableNumberOfShares"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_019c9ac1-ae72-7fcf-af74-2e672defefed" xlink:to="loc_rxrx_BusinessAcquisitionContingentConsiderationEquityInterestsIssuableNumberOfShares_019c9ac1-ae73-724a-8ab0-b6e002ec5431" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_019c9ac1-ae73-7aa9-bed9-c9648dacd2e6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_019c9ac1-ae72-7fcf-af74-2e672defefed" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_019c9ac1-ae73-7aa9-bed9-c9648dacd2e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/CommonStockRegistrationRightsAgreementsNarrativeDetails" xlink:type="simple" xlink:href="rxrx-20260331.xsd#CommonStockRegistrationRightsAgreementsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/CommonStockRegistrationRightsAgreementsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_019c9ac1-ae73-733c-bfc4-82ec5f1988a4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_019c9ac1-ae73-7113-844f-eaab78e570c2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_019c9ac1-ae73-733c-bfc4-82ec5f1988a4" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_019c9ac1-ae73-7113-844f-eaab78e570c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_019c9ac1-ae73-7905-8c4f-5feb35195507" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_019c9ac1-ae73-7113-844f-eaab78e570c2" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_019c9ac1-ae73-7905-8c4f-5feb35195507" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_019c9ac1-ae73-79e8-8ca1-9ffd741fe434" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_019c9ac1-ae73-7905-8c4f-5feb35195507" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_019c9ac1-ae73-79e8-8ca1-9ffd741fe434" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_ValenceDiscoveryIncMember_019c9ac1-ae73-7620-8452-bb48cf2e2907" xlink:href="rxrx-20260331.xsd#rxrx_ValenceDiscoveryIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_019c9ac1-ae73-79e8-8ca1-9ffd741fe434" xlink:to="loc_rxrx_ValenceDiscoveryIncMember_019c9ac1-ae73-7620-8452-bb48cf2e2907" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_019c9ac1-ae73-72ca-84e8-e77d3b9da49e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_019c9ac1-ae73-7113-844f-eaab78e570c2" xlink:to="loc_us-gaap_ClassOfStockLineItems_019c9ac1-ae73-72ca-84e8-e77d3b9da49e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_RegistrationRightsAgreementTerm_019c9ac1-ae73-7e4a-9717-756992eacd15" xlink:href="rxrx-20260331.xsd#rxrx_RegistrationRightsAgreementTerm"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_019c9ac1-ae73-72ca-84e8-e77d3b9da49e" xlink:to="loc_rxrx_RegistrationRightsAgreementTerm_019c9ac1-ae73-7e4a-9717-756992eacd15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/CommonStockClassAandBCommonSharesAuthorizationNarrativeDetails" xlink:type="simple" xlink:href="rxrx-20260331.xsd#CommonStockClassAandBCommonSharesAuthorizationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/CommonStockClassAandBCommonSharesAuthorizationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_019c9ac1-ae73-7ca0-8234-dbe2b7a5ea20" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_019c9ac1-ae73-7a54-8148-25920773ad45" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_019c9ac1-ae73-7ca0-8234-dbe2b7a5ea20" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_019c9ac1-ae73-7a54-8148-25920773ad45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_019c9ac1-ae73-7447-b1c1-16db90a9559d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_019c9ac1-ae73-7a54-8148-25920773ad45" xlink:to="loc_us-gaap_StatementClassOfStockAxis_019c9ac1-ae73-7447-b1c1-16db90a9559d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_019c9ac1-ae73-71a1-b68e-6603f2ec602d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_019c9ac1-ae73-7447-b1c1-16db90a9559d" xlink:to="loc_us-gaap_ClassOfStockDomain_019c9ac1-ae73-71a1-b68e-6603f2ec602d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_019c9ac1-ae73-74ec-b91e-9d5ca2f1f604" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_019c9ac1-ae73-71a1-b68e-6603f2ec602d" xlink:to="loc_us-gaap_CommonClassAMember_019c9ac1-ae73-74ec-b91e-9d5ca2f1f604" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_019c9ac1-ae73-7956-9d2b-02466df2dd24" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassBMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_019c9ac1-ae73-71a1-b68e-6603f2ec602d" xlink:to="loc_us-gaap_CommonClassBMember_019c9ac1-ae73-7956-9d2b-02466df2dd24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_019c9ac1-ae73-74db-8a16-2963c47a3fb2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_019c9ac1-ae73-7a54-8148-25920773ad45" xlink:to="loc_us-gaap_ClassOfStockLineItems_019c9ac1-ae73-74db-8a16-2963c47a3fb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_NumberOfClassesOfCommonStockAuthorized_019c9ac1-ae73-71ed-80f9-8a34d4f1c1ba" xlink:href="rxrx-20260331.xsd#rxrx_NumberOfClassesOfCommonStockAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_019c9ac1-ae73-74db-8a16-2963c47a3fb2" xlink:to="loc_rxrx_NumberOfClassesOfCommonStockAuthorized_019c9ac1-ae73-71ed-80f9-8a34d4f1c1ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_CommonStockVotePerShare_019c9ac1-ae73-74f7-92c7-10dbf7f62c8c" xlink:href="rxrx-20260331.xsd#rxrx_CommonStockVotePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_019c9ac1-ae73-74db-8a16-2963c47a3fb2" xlink:to="loc_rxrx_CommonStockVotePerShare_019c9ac1-ae73-74f7-92c7-10dbf7f62c8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_CommonStockConversionRatio_019c9ac1-ae73-7b31-a904-e0a82a2efce6" xlink:href="rxrx-20260331.xsd#rxrx_CommonStockConversionRatio"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_019c9ac1-ae73-74db-8a16-2963c47a3fb2" xlink:to="loc_rxrx_CommonStockConversionRatio_019c9ac1-ae73-7b31-a904-e0a82a2efce6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/CollaborativeDevelopmentContractsDetails" xlink:type="simple" xlink:href="rxrx-20260331.xsd#CollaborativeDevelopmentContractsDetails"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/CollaborativeDevelopmentContractsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_019c9ac1-ae73-7865-8875-5fb1b35cc1b2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_019c9ac1-ae73-7a77-90b2-42b8ccf62711" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_019c9ac1-ae73-7865-8875-5fb1b35cc1b2" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_019c9ac1-ae73-7a77-90b2-42b8ccf62711" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_019d86b9-8d58-7a79-ad51-7557bfd139da" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_019c9ac1-ae73-7a77-90b2-42b8ccf62711" xlink:to="loc_srt_CounterpartyNameAxis_019d86b9-8d58-7a79-ad51-7557bfd139da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_019d86b9-8d58-7049-85de-7b4163c9f006" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_019d86b9-8d58-7a79-ad51-7557bfd139da" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_019d86b9-8d58-7049-85de-7b4163c9f006" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_SanofiMember_019d86b9-8d58-78dd-82e4-fa44ecd5f30b" xlink:href="rxrx-20260331.xsd#rxrx_SanofiMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_019d86b9-8d58-7049-85de-7b4163c9f006" xlink:to="loc_rxrx_SanofiMember_019d86b9-8d58-78dd-82e4-fa44ecd5f30b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_MerckKGaAMerckMember_019d86bc-1554-7bdd-9421-ec768252dd1d" xlink:href="rxrx-20260331.xsd#rxrx_MerckKGaAMerckMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_019d86b9-8d58-7049-85de-7b4163c9f006" xlink:to="loc_rxrx_MerckKGaAMerckMember_019d86bc-1554-7bdd-9421-ec768252dd1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_RocheAndGenentechMember_019d86be-7eb6-77e0-b34d-759d850ac6d5" xlink:href="rxrx-20260331.xsd#rxrx_RocheAndGenentechMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_019d86b9-8d58-7049-85de-7b4163c9f006" xlink:to="loc_rxrx_RocheAndGenentechMember_019d86be-7eb6-77e0-b34d-759d850ac6d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_019d86b9-8d58-75c0-bccf-aec46758ccaf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_019c9ac1-ae73-7a77-90b2-42b8ccf62711" xlink:to="loc_us-gaap_TypeOfArrangementAxis_019d86b9-8d58-75c0-bccf-aec46758ccaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019d86b9-8d58-75fd-8392-affed4e2bca2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_019d86b9-8d58-75c0-bccf-aec46758ccaf" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019d86b9-8d58-75fd-8392-affed4e2bca2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementMember_019d86b9-8d58-7704-bb65-99fa86c61be2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CollaborativeArrangementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019d86b9-8d58-75fd-8392-affed4e2bca2" xlink:to="loc_us-gaap_CollaborativeArrangementMember_019d86b9-8d58-7704-bb65-99fa86c61be2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_MilestoneTypeAxis_019d86ba-800f-7552-b720-3b705312c12f" xlink:href="rxrx-20260331.xsd#rxrx_MilestoneTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_019c9ac1-ae73-7a77-90b2-42b8ccf62711" xlink:to="loc_rxrx_MilestoneTypeAxis_019d86ba-800f-7552-b720-3b705312c12f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_MilestoneTypeDomain_019d86ba-800f-76b1-8518-356b58476737" xlink:href="rxrx-20260331.xsd#rxrx_MilestoneTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rxrx_MilestoneTypeAxis_019d86ba-800f-7552-b720-3b705312c12f" xlink:to="loc_rxrx_MilestoneTypeDomain_019d86ba-800f-76b1-8518-356b58476737" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_ResearchMilestonesMember_019d86ba-800f-7ec6-9446-d5d68f3efdf0" xlink:href="rxrx-20260331.xsd#rxrx_ResearchMilestonesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rxrx_MilestoneTypeDomain_019d86ba-800f-76b1-8518-356b58476737" xlink:to="loc_rxrx_ResearchMilestonesMember_019d86ba-800f-7ec6-9446-d5d68f3efdf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_DevelopmentAndRegulatoryMilestonesMember_019d86ba-800f-7b72-be16-eef7b74737fa" xlink:href="rxrx-20260331.xsd#rxrx_DevelopmentAndRegulatoryMilestonesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rxrx_MilestoneTypeDomain_019d86ba-800f-76b1-8518-356b58476737" xlink:to="loc_rxrx_DevelopmentAndRegulatoryMilestonesMember_019d86ba-800f-7b72-be16-eef7b74737fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_DiscoveryDevelopmentAndSalesMilestonesMember_019d86bc-1554-78fe-b6e9-89ef35276d35" xlink:href="rxrx-20260331.xsd#rxrx_DiscoveryDevelopmentAndSalesMilestonesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rxrx_MilestoneTypeDomain_019d86ba-800f-76b1-8518-356b58476737" xlink:to="loc_rxrx_DiscoveryDevelopmentAndSalesMilestonesMember_019d86bc-1554-78fe-b6e9-89ef35276d35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_RevenueRemainingPerformanceObligationAxis_019d86c2-74a2-7e02-8992-92a3035370f3" xlink:href="rxrx-20260331.xsd#rxrx_RevenueRemainingPerformanceObligationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_019c9ac1-ae73-7a77-90b2-42b8ccf62711" xlink:to="loc_rxrx_RevenueRemainingPerformanceObligationAxis_019d86c2-74a2-7e02-8992-92a3035370f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_RevenueRemainingPerformanceObligationDomain_019d86c2-74a2-7411-b611-ed16c7d1838d" xlink:href="rxrx-20260331.xsd#rxrx_RevenueRemainingPerformanceObligationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rxrx_RevenueRemainingPerformanceObligationAxis_019d86c2-74a2-7e02-8992-92a3035370f3" xlink:to="loc_rxrx_RevenueRemainingPerformanceObligationDomain_019d86c2-74a2-7411-b611-ed16c7d1838d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_PhenomapsCreationMember_019d86c2-74a2-7f11-86dd-841767719e95" xlink:href="rxrx-20260331.xsd#rxrx_PhenomapsCreationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rxrx_RevenueRemainingPerformanceObligationDomain_019d86c2-74a2-7411-b611-ed16c7d1838d" xlink:to="loc_rxrx_PhenomapsCreationMember_019d86c2-74a2-7f11-86dd-841767719e95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_PhenomapsRawImagesMember_019d86c2-74a2-7154-b0cc-e01c47cc2def" xlink:href="rxrx-20260331.xsd#rxrx_PhenomapsRawImagesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rxrx_RevenueRemainingPerformanceObligationDomain_019d86c2-74a2-7411-b611-ed16c7d1838d" xlink:to="loc_rxrx_PhenomapsRawImagesMember_019d86c2-74a2-7154-b0cc-e01c47cc2def" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_DevelopedAndCommercializedProgramsMember_019d86c2-74a2-75af-b7dc-8608b2ed44ea" xlink:href="rxrx-20260331.xsd#rxrx_DevelopedAndCommercializedProgramsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rxrx_RevenueRemainingPerformanceObligationDomain_019d86c2-74a2-7411-b611-ed16c7d1838d" xlink:to="loc_rxrx_DevelopedAndCommercializedProgramsMember_019d86c2-74a2-75af-b7dc-8608b2ed44ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_GastrointestinalCancerMember_019d86c3-5664-7793-b3b6-01bc6a41bfda" xlink:href="rxrx-20260331.xsd#rxrx_GastrointestinalCancerMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rxrx_RevenueRemainingPerformanceObligationDomain_019d86c2-74a2-7411-b611-ed16c7d1838d" xlink:to="loc_rxrx_GastrointestinalCancerMember_019d86c3-5664-7793-b3b6-01bc6a41bfda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_NeuroscienceMember_019d86c3-5664-759e-842d-b20d617cf885" xlink:href="rxrx-20260331.xsd#rxrx_NeuroscienceMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rxrx_RevenueRemainingPerformanceObligationDomain_019d86c2-74a2-7411-b611-ed16c7d1838d" xlink:to="loc_rxrx_NeuroscienceMember_019d86c3-5664-759e-842d-b20d617cf885" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_019d86b9-8d58-79dd-822a-33762a86a1da" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_019c9ac1-ae73-7a77-90b2-42b8ccf62711" xlink:to="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_019d86b9-8d58-79dd-822a-33762a86a1da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_ContractWithCustomerNumberOfNovelSmallMoleculeCandidates_019d86b9-8d58-70a1-859d-08d37b51970a" xlink:href="rxrx-20260331.xsd#rxrx_ContractWithCustomerNumberOfNovelSmallMoleculeCandidates"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_019d86b9-8d58-79dd-822a-33762a86a1da" xlink:to="loc_rxrx_ContractWithCustomerNumberOfNovelSmallMoleculeCandidates_019d86b9-8d58-70a1-859d-08d37b51970a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_019d86ba-800f-7879-899d-3ee51d7a8d69" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_019d86b9-8d58-79dd-822a-33762a86a1da" xlink:to="loc_us-gaap_ContractWithCustomerLiability_019d86ba-800f-7879-899d-3ee51d7a8d69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_019d86ba-800f-7bba-954a-3113deead32c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_019d86b9-8d58-79dd-822a-33762a86a1da" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_019d86ba-800f-7bba-954a-3113deead32c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_RevenuePerformanceObligationNumberOfObligations_019d86ba-ddbc-7d68-9fcf-c8f486ddb9b9" xlink:href="rxrx-20260331.xsd#rxrx_RevenuePerformanceObligationNumberOfObligations"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_019d86b9-8d58-79dd-822a-33762a86a1da" xlink:to="loc_rxrx_RevenuePerformanceObligationNumberOfObligations_019d86ba-ddbc-7d68-9fcf-c8f486ddb9b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_019d86bb-4d90-776b-a0a2-7923049b796c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_019d86b9-8d58-79dd-822a-33762a86a1da" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_019d86bb-4d90-776b-a0a2-7923049b796c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_RevenueRemainingPerformanceObligationVariableConsiderationAmount_019d86c2-74a2-710d-89fd-9d9cc5ef66bf" xlink:href="rxrx-20260331.xsd#rxrx_RevenueRemainingPerformanceObligationVariableConsiderationAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_019d86b9-8d58-79dd-822a-33762a86a1da" xlink:to="loc_rxrx_RevenueRemainingPerformanceObligationVariableConsiderationAmount_019d86c2-74a2-710d-89fd-9d9cc5ef66bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_ContractWithCustomerMaximumAcceptedProduct_019d86c2-74a2-726c-9fd6-32558fa1b9f3" xlink:href="rxrx-20260331.xsd#rxrx_ContractWithCustomerMaximumAcceptedProduct"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_019d86b9-8d58-79dd-822a-33762a86a1da" xlink:to="loc_rxrx_ContractWithCustomerMaximumAcceptedProduct_019d86c2-74a2-726c-9fd6-32558fa1b9f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_RevenueRemainingPerformanceObligationNumberOfProjectsThatMayBeInitiated_019d86c2-74a2-7a21-9e79-6686f80d823f" xlink:href="rxrx-20260331.xsd#rxrx_RevenueRemainingPerformanceObligationNumberOfProjectsThatMayBeInitiated"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_019d86b9-8d58-79dd-822a-33762a86a1da" xlink:to="loc_rxrx_RevenueRemainingPerformanceObligationNumberOfProjectsThatMayBeInitiated_019d86c2-74a2-7a21-9e79-6686f80d823f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent_019d86c5-65c0-7042-856d-e1503fa14ebf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_019d86b9-8d58-79dd-822a-33762a86a1da" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetCurrent_019d86c5-65c0-7042-856d-e1503fa14ebf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/StockBasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="rxrx-20260331.xsd#StockBasedCompensationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/StockBasedCompensationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019c9ac1-ae73-7747-b5a4-5930d14f3d19" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019c9ac1-ae73-78c3-ac04-c3f8072437bf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019c9ac1-ae73-7747-b5a4-5930d14f3d19" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019c9ac1-ae73-78c3-ac04-c3f8072437bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_019d9203-4db8-7f05-9918-e7c485e34ac2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019c9ac1-ae73-78c3-ac04-c3f8072437bf" xlink:to="loc_us-gaap_PlanNameAxis_019d9203-4db8-7f05-9918-e7c485e34ac2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_019d9203-4db8-70bc-8214-ab5dff30d985" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_019d9203-4db8-7f05-9918-e7c485e34ac2" xlink:to="loc_us-gaap_PlanNameDomain_019d9203-4db8-70bc-8214-ab5dff30d985" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_A2021EquityIncentivePlanMember_019d9203-4db8-731f-933e-6d5662b6b6d5" xlink:href="rxrx-20260331.xsd#rxrx_A2021EquityIncentivePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_019d9203-4db8-70bc-8214-ab5dff30d985" xlink:to="loc_rxrx_A2021EquityIncentivePlanMember_019d9203-4db8-731f-933e-6d5662b6b6d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_A2024InducementEquityIncentivePlanMember_019d9203-4db8-7587-b6ac-91cdce3ba2c7" xlink:href="rxrx-20260331.xsd#rxrx_A2024InducementEquityIncentivePlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_019d9203-4db8-70bc-8214-ab5dff30d985" xlink:to="loc_rxrx_A2024InducementEquityIncentivePlanMember_019d9203-4db8-7587-b6ac-91cdce3ba2c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_019d9203-6c8c-74ca-9e08-aea2f33ded99" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019c9ac1-ae73-78c3-ac04-c3f8072437bf" xlink:to="loc_us-gaap_AwardTypeAxis_019d9203-6c8c-74ca-9e08-aea2f33ded99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019d9203-6c8c-7e81-929d-8804931a862a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_019d9203-6c8c-74ca-9e08-aea2f33ded99" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019d9203-6c8c-7e81-929d-8804931a862a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_019d9203-6c8c-7887-84a8-d3b9c91fcc28" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019d9203-6c8c-7e81-929d-8804931a862a" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_019d9203-6c8c-7887-84a8-d3b9c91fcc28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d9203-4db8-74fc-9809-04d30bffc129" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019c9ac1-ae73-78c3-ac04-c3f8072437bf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d9203-4db8-74fc-9809-04d30bffc129" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_019d9203-4db8-7446-9d0d-05dc3a74df81" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d9203-4db8-74fc-9809-04d30bffc129" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_019d9203-4db8-7446-9d0d-05dc3a74df81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_019d9203-6c8c-746b-b297-44526604f728" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d9203-4db8-74fc-9809-04d30bffc129" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_019d9203-6c8c-746b-b297-44526604f728" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_019d9203-908d-75b3-9f10-185be72a65d3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d9203-4db8-74fc-9809-04d30bffc129" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_019d9203-908d-75b3-9f10-185be72a65d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_019d9203-908d-7f58-981f-3694e96120b5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d9203-4db8-74fc-9809-04d30bffc129" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_019d9203-908d-7f58-981f-3694e96120b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_019d9203-908d-780b-b03f-fd738da9cc95" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d9203-4db8-74fc-9809-04d30bffc129" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_019d9203-908d-780b-b03f-fd738da9cc95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/StockBasedCompensationScheduleofStockBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="rxrx-20260331.xsd#StockBasedCompensationScheduleofStockBasedCompensationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/StockBasedCompensationScheduleofStockBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019c9ac1-ae73-77f2-a1ab-126537ad4560" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_019c9ac1-ae73-7af8-b735-670a1d75c0d3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019c9ac1-ae73-77f2-a1ab-126537ad4560" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_019c9ac1-ae73-7af8-b735-670a1d75c0d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_019c9ac1-ae73-7f03-ad66-8441efbaa0c2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_019c9ac1-ae73-7af8-b735-670a1d75c0d3" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_019c9ac1-ae73-7f03-ad66-8441efbaa0c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_019c9ac1-ae73-7d58-a2ac-3178136e8c02" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_019c9ac1-ae73-7f03-ad66-8441efbaa0c2" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_019c9ac1-ae73-7d58-a2ac-3178136e8c02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_019c9ac1-ae73-752e-8e52-c1b78027200b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_019c9ac1-ae73-7d58-a2ac-3178136e8c02" xlink:to="loc_us-gaap_CostOfSalesMember_019c9ac1-ae73-752e-8e52-c1b78027200b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_019c9ac1-ae73-78df-9f95-7daaeede72d5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_019c9ac1-ae73-7d58-a2ac-3178136e8c02" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_019c9ac1-ae73-78df-9f95-7daaeede72d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_019c9ac1-ae73-7b03-967b-79f62b052025" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_019c9ac1-ae73-7d58-a2ac-3178136e8c02" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_019c9ac1-ae73-7b03-967b-79f62b052025" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_019c9ac1-ae73-7ac2-8b7d-4c31908e68da" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_019c9ac1-ae73-7af8-b735-670a1d75c0d3" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_019c9ac1-ae73-7ac2-8b7d-4c31908e68da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_019c9ac1-ae73-7e6e-aa8f-e27d300de15f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_019c9ac1-ae73-7ac2-8b7d-4c31908e68da" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_019c9ac1-ae73-7e6e-aa8f-e27d300de15f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/StockBasedCompensationScheduleofRSUActivityDetails" xlink:type="simple" xlink:href="rxrx-20260331.xsd#StockBasedCompensationScheduleofRSUActivityDetails"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/StockBasedCompensationScheduleofRSUActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019c9ac1-ae73-759e-ba7a-7a06416a2616" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019c9ac1-ae73-73b6-bf16-22fa2b65562a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019c9ac1-ae73-759e-ba7a-7a06416a2616" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019c9ac1-ae73-73b6-bf16-22fa2b65562a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_019c9ac1-ae73-753c-a94f-0dc7c17b553a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019c9ac1-ae73-73b6-bf16-22fa2b65562a" xlink:to="loc_us-gaap_AwardTypeAxis_019c9ac1-ae73-753c-a94f-0dc7c17b553a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019c9ac1-ae73-7789-a8a1-a8011e4574f6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_019c9ac1-ae73-753c-a94f-0dc7c17b553a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019c9ac1-ae73-7789-a8a1-a8011e4574f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_019c9ac1-ae73-7359-a9c1-69b7e986d25c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019c9ac1-ae73-7789-a8a1-a8011e4574f6" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_019c9ac1-ae73-7359-a9c1-69b7e986d25c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019c9ac1-ae73-74db-b1f5-62691cd054dd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019c9ac1-ae73-73b6-bf16-22fa2b65562a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019c9ac1-ae73-74db-b1f5-62691cd054dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_019c9ac1-ae73-7d18-99ce-68c8be2df4fb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019c9ac1-ae73-74db-b1f5-62691cd054dd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_019c9ac1-ae73-7d18-99ce-68c8be2df4fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_019c9ac1-ae73-769a-8ad6-dee1add873ad" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_019c9ac1-ae73-7d18-99ce-68c8be2df4fb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_019c9ac1-ae73-769a-8ad6-dee1add873ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_019c9ac1-ae73-7bb3-97b0-f0f2998b4018" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_019c9ac1-ae73-7d18-99ce-68c8be2df4fb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_019c9ac1-ae73-7bb3-97b0-f0f2998b4018" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_019c9ac1-ae73-70c0-a644-5d1f27d65849" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_019c9ac1-ae73-7d18-99ce-68c8be2df4fb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_019c9ac1-ae73-70c0-a644-5d1f27d65849" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_019c9ac1-ae73-7e30-a979-3ab5d30ea430" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_019c9ac1-ae73-7d18-99ce-68c8be2df4fb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_019c9ac1-ae73-7e30-a979-3ab5d30ea430" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_019c9ac1-ae73-7889-b1df-6eba03f885e8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_019c9ac1-ae73-7d18-99ce-68c8be2df4fb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_019c9ac1-ae73-7889-b1df-6eba03f885e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_019c9ac1-ae73-7ee2-a911-cf1844ca7354" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019c9ac1-ae73-74db-b1f5-62691cd054dd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_019c9ac1-ae73-7ee2-a911-cf1844ca7354" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_019c9ac1-ae73-7330-9202-777a6c515f2c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_019c9ac1-ae73-7ee2-a911-cf1844ca7354" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_019c9ac1-ae73-7330-9202-777a6c515f2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_019c9ac1-ae73-7413-9fef-64fafd30432b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_019c9ac1-ae73-7ee2-a911-cf1844ca7354" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_019c9ac1-ae73-7413-9fef-64fafd30432b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_019c9ac1-ae73-7e3b-a914-c486ab2b3795" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_019c9ac1-ae73-7ee2-a911-cf1844ca7354" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_019c9ac1-ae73-7e3b-a914-c486ab2b3795" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_019c9ac1-ae73-7efc-a440-32e0071484d9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_019c9ac1-ae73-7ee2-a911-cf1844ca7354" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_019c9ac1-ae73-7efc-a440-32e0071484d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_019c9ac1-ae73-7628-be2a-23dfb7c7785e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_019c9ac1-ae73-7ee2-a911-cf1844ca7354" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_019c9ac1-ae73-7628-be2a-23dfb7c7785e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="rxrx-20260331.xsd#IncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/IncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_019c9ac1-ae73-7101-8175-49df0eb570b7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations_019db0b0-8b21-7489-a430-08a0e23239c5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_019c9ac1-ae73-7101-8175-49df0eb570b7" xlink:to="loc_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations_019db0b0-8b21-7489-a430-08a0e23239c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/NetLossPerShareScheduleofComputationofBasicandDilutedNetLossPerShareDetails" xlink:type="simple" xlink:href="rxrx-20260331.xsd#NetLossPerShareScheduleofComputationofBasicandDilutedNetLossPerShareDetails"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/NetLossPerShareScheduleofComputationofBasicandDilutedNetLossPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_019c9ac1-ae73-7f3a-905f-3cf580918171" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_019c9ac1-ae73-74af-8da0-c5d7867ce2d2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_019c9ac1-ae73-7f3a-905f-3cf580918171" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_019c9ac1-ae73-74af-8da0-c5d7867ce2d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019c9ac1-ae73-759f-9301-7aa70fb18f50" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_019c9ac1-ae73-74af-8da0-c5d7867ce2d2" xlink:to="loc_us-gaap_NetIncomeLoss_019c9ac1-ae73-759f-9301-7aa70fb18f50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_019c9ac1-ae73-7ccf-a078-cb87bdf336c2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_019c9ac1-ae73-7f3a-905f-3cf580918171" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_019c9ac1-ae73-7ccf-a078-cb87bdf336c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_019c9ac1-ae73-7a0c-be64-5cef2b007e83" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_019c9ac1-ae73-7ccf-a078-cb87bdf336c2" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_019c9ac1-ae73-7a0c-be64-5cef2b007e83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_019c9ac1-ae73-7e98-93ed-f72c942bda11" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_019c9ac1-ae73-7ccf-a078-cb87bdf336c2" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_019c9ac1-ae73-7e98-93ed-f72c942bda11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_019c9ac1-ae73-74e2-8e73-42b081f55ed9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_019c9ac1-ae73-7f3a-905f-3cf580918171" xlink:to="loc_us-gaap_EarningsPerShareBasic_019c9ac1-ae73-74e2-8e73-42b081f55ed9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_019c9ac1-ae73-7505-a8ad-1f36cfbff718" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_019c9ac1-ae73-7f3a-905f-3cf580918171" xlink:to="loc_us-gaap_EarningsPerShareDiluted_019c9ac1-ae73-7505-a8ad-1f36cfbff718" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofNetLossPerShareDetails" xlink:type="simple" xlink:href="rxrx-20260331.xsd#NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofNetLossPerShareDetails"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofNetLossPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_019c9ac1-ae73-729e-977b-e714b4cf7884" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_019c9ac1-ae73-74d0-974b-d000defc3833" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_019c9ac1-ae73-729e-977b-e714b4cf7884" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_019c9ac1-ae73-74d0-974b-d000defc3833" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_019c9ac1-ae73-7a73-bb46-9b767fc3a717" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_019c9ac1-ae73-74d0-974b-d000defc3833" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_019c9ac1-ae73-7a73-bb46-9b767fc3a717" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_019c9ac1-ae73-79d2-b2e7-bd989cd2ff76" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_019c9ac1-ae73-7a73-bb46-9b767fc3a717" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_019c9ac1-ae73-79d2-b2e7-bd989cd2ff76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember_019c9ac1-ae73-77c1-ae4e-65812e0930bb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_019c9ac1-ae73-79d2-b2e7-bd989cd2ff76" xlink:to="loc_us-gaap_StockCompensationPlanMember_019c9ac1-ae73-77c1-ae4e-65812e0930bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_TempusAgreementMember_019c9ac1-ae73-782e-ab10-0259c2315720" xlink:href="rxrx-20260331.xsd#rxrx_TempusAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_019c9ac1-ae73-79d2-b2e7-bd989cd2ff76" xlink:to="loc_rxrx_TempusAgreementMember_019c9ac1-ae73-782e-ab10-0259c2315720" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_019c9ac1-ae73-7cf2-b5a1-962c2c12ca8b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_019c9ac1-ae73-74d0-974b-d000defc3833" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_019c9ac1-ae73-7cf2-b5a1-962c2c12ca8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_019c9ac1-ae73-766c-b050-481f37a2a43d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_019c9ac1-ae73-7cf2-b5a1-962c2c12ca8b" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_019c9ac1-ae73-766c-b050-481f37a2a43d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" xlink:type="simple" xlink:href="rxrx-20260331.xsd#FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_019c9ac1-ae73-7a3d-95ca-e3dd1c8cce2a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_019c9ac1-ae73-76a7-99f9-33e750f60a9a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_019c9ac1-ae73-7a3d-95ca-e3dd1c8cce2a" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_019c9ac1-ae73-76a7-99f9-33e750f60a9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_019c9ac1-ae73-7f70-a559-9938946be5b7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_019c9ac1-ae73-76a7-99f9-33e750f60a9a" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_019c9ac1-ae73-7f70-a559-9938946be5b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019c9ac1-ae73-78d4-81bd-b47e0fad43b4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_019c9ac1-ae73-7f70-a559-9938946be5b7" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019c9ac1-ae73-78d4-81bd-b47e0fad43b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_019c9ac1-ae73-7b4f-b831-b04b9f856ebe" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019c9ac1-ae73-78d4-81bd-b47e0fad43b4" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_019c9ac1-ae73-7b4f-b831-b04b9f856ebe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_019c9ac1-ae73-727c-8909-f3e03667ce5b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019c9ac1-ae73-78d4-81bd-b47e0fad43b4" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_019c9ac1-ae73-727c-8909-f3e03667ce5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_019c9ac1-ae73-732f-962e-42606715a6e1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019c9ac1-ae73-78d4-81bd-b47e0fad43b4" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_019c9ac1-ae73-732f-962e-42606715a6e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_019c9ac1-ae73-7bd7-86c9-c3f53c49d0fc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_019c9ac1-ae73-76a7-99f9-33e750f60a9a" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_019c9ac1-ae73-7bd7-86c9-c3f53c49d0fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_019c9ac1-ae73-775a-b06f-00a2ccbe0930" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_019c9ac1-ae73-7bd7-86c9-c3f53c49d0fc" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_019c9ac1-ae73-775a-b06f-00a2ccbe0930" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashMember_019c9ac1-ae73-7a90-b692-2af8bb992c98" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_019c9ac1-ae73-775a-b06f-00a2ccbe0930" xlink:to="loc_us-gaap_CashMember_019c9ac1-ae73-7a90-b692-2af8bb992c98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_019c9ac1-ae73-7fa1-869a-c7dfcd8de70c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_019c9ac1-ae73-775a-b06f-00a2ccbe0930" xlink:to="loc_us-gaap_MoneyMarketFundsMember_019c9ac1-ae73-7fa1-869a-c7dfcd8de70c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_019c9ac1-ae73-795e-beb2-b4df2f31fe7f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_019c9ac1-ae73-76a7-99f9-33e750f60a9a" xlink:to="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_019c9ac1-ae73-795e-beb2-b4df2f31fe7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_019c9ac1-ae73-7986-aa8f-5ac3f9d3f63f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_019c9ac1-ae73-795e-beb2-b4df2f31fe7f" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_019c9ac1-ae73-7986-aa8f-5ac3f9d3f63f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_RestrictedCashAndCashEquivalentsFairValueDisclosure_019c9ac1-ae73-7507-bf96-85f5c742793c" xlink:href="rxrx-20260331.xsd#rxrx_RestrictedCashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_019c9ac1-ae73-795e-beb2-b4df2f31fe7f" xlink:to="loc_rxrx_RestrictedCashAndCashEquivalentsFairValueDisclosure_019c9ac1-ae73-7507-bf96-85f5c742793c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_019c9ac1-ae73-7b27-9332-f0937c75adcb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_019c9ac1-ae73-795e-beb2-b4df2f31fe7f" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_019c9ac1-ae73-7b27-9332-f0937c75adcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/FairValueMeasurementsScheduleofFinancialInstrumentsNotMeasuredatFairValueDetails" xlink:type="simple" xlink:href="rxrx-20260331.xsd#FairValueMeasurementsScheduleofFinancialInstrumentsNotMeasuredatFairValueDetails"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/FairValueMeasurementsScheduleofFinancialInstrumentsNotMeasuredatFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_019c9ac1-ae73-7a5d-b732-c667b815ffcf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable_019c9ac1-ae73-75fe-a714-9bb0b50d86fe" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_019c9ac1-ae73-7a5d-b732-c667b815ffcf" xlink:to="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable_019c9ac1-ae73-75fe-a714-9bb0b50d86fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_019c9ac1-ae73-7366-aba5-e731b293cc90" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable_019c9ac1-ae73-75fe-a714-9bb0b50d86fe" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_019c9ac1-ae73-7366-aba5-e731b293cc90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_019c9ac1-ae73-7e56-b408-55de29728556" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_019c9ac1-ae73-7366-aba5-e731b293cc90" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_019c9ac1-ae73-7e56-b408-55de29728556" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_019c9ac1-ae73-7cba-8919-c89afd6faedd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_019c9ac1-ae73-7e56-b408-55de29728556" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_019c9ac1-ae73-7cba-8919-c89afd6faedd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember_019c9ac1-ae73-7d07-a3e6-44074b8438a5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_019c9ac1-ae73-7cba-8919-c89afd6faedd" xlink:to="loc_us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember_019c9ac1-ae73-7d07-a3e6-44074b8438a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_019c9ac1-ae73-715d-a73b-c9e7a625dd17" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_019c9ac1-ae73-7cba-8919-c89afd6faedd" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_019c9ac1-ae73-715d-a73b-c9e7a625dd17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_019c9ac1-ae73-7e7d-a01f-c58b9c59d12f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable_019c9ac1-ae73-75fe-a714-9bb0b50d86fe" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_019c9ac1-ae73-7e7d-a01f-c58b9c59d12f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_019c9ac1-ae73-7693-98e2-c6117dc6f704" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_019c9ac1-ae73-7e7d-a01f-c58b9c59d12f" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_019c9ac1-ae73-7693-98e2-c6117dc6f704" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember_019c9ac1-ae73-7a40-8912-98ef2101ceea" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_019c9ac1-ae73-7693-98e2-c6117dc6f704" xlink:to="loc_us-gaap_NotesPayableOtherPayablesMember_019c9ac1-ae73-7a40-8912-98ef2101ceea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems_019c9ac1-ae73-7e6c-be9d-deff3aaf65bc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable_019c9ac1-ae73-75fe-a714-9bb0b50d86fe" xlink:to="loc_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems_019c9ac1-ae73-7e6c-be9d-deff3aaf65bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_019c9ac1-ae73-737e-a765-aa53ec96224a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems_019c9ac1-ae73-7e6c-be9d-deff3aaf65bc" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_019c9ac1-ae73-737e-a765-aa53ec96224a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_019c9ac1-ae73-7466-9358-dfd5d7c1f0f3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems_019c9ac1-ae73-7e6c-be9d-deff3aaf65bc" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_019c9ac1-ae73-7466-9358-dfd5d7c1f0f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_019c9ac1-ae73-77c6-8a59-2f7ab3b25a4a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems_019c9ac1-ae73-7e6c-be9d-deff3aaf65bc" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_019c9ac1-ae73-77c6-8a59-2f7ab3b25a4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/SegmentInformationNarrativeDetails" xlink:type="simple" xlink:href="rxrx-20260331.xsd#SegmentInformationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/SegmentInformationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_019d86e5-d731-7bed-a2e5-3ab3c0332d20" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_019d86e5-d731-7701-9836-8510b50fde83" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_019d86e5-d731-7bed-a2e5-3ab3c0332d20" xlink:to="loc_us-gaap_NumberOfReportableSegments_019d86e5-d731-7701-9836-8510b50fde83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_019d86e5-d731-7aa3-89e9-c3d728c3c625" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_019d86e5-d731-7bed-a2e5-3ab3c0332d20" xlink:to="loc_us-gaap_NumberOfOperatingSegments_019d86e5-d731-7aa3-89e9-c3d728c3c625" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.recursion.com/role/SegmentInformationScheduleofSegmentNetLossandReconciliationsofSegmentOperatingLosstoLossBeforeIncomeTaxBenefitDetails" xlink:type="simple" xlink:href="rxrx-20260331.xsd#SegmentInformationScheduleofSegmentNetLossandReconciliationsofSegmentOperatingLosstoLossBeforeIncomeTaxBenefitDetails"/>
  <link:presentationLink xlink:role="http://www.recursion.com/role/SegmentInformationScheduleofSegmentNetLossandReconciliationsofSegmentOperatingLosstoLossBeforeIncomeTaxBenefitDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_019c9ac1-ae73-7595-a01e-5331d333c053" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_019c9ac1-ae73-7faf-b3d1-0c9c35d691b9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_019c9ac1-ae73-7595-a01e-5331d333c053" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_019c9ac1-ae73-7faf-b3d1-0c9c35d691b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_019c9ac1-ae73-78f1-a5cb-c93e953fc0d5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_019c9ac1-ae73-7faf-b3d1-0c9c35d691b9" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_019c9ac1-ae73-78f1-a5cb-c93e953fc0d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_019c9ac1-ae73-781f-934c-7e6561c5885c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_019c9ac1-ae73-78f1-a5cb-c93e953fc0d5" xlink:to="loc_us-gaap_SegmentDomain_019c9ac1-ae73-781f-934c-7e6561c5885c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_ReportableSegmentMember_019c9ac1-ae73-7fe5-add9-463b159eae76" xlink:href="rxrx-20260331.xsd#rxrx_ReportableSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_019c9ac1-ae73-781f-934c-7e6561c5885c" xlink:to="loc_rxrx_ReportableSegmentMember_019c9ac1-ae73-7fe5-add9-463b159eae76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_019c9ac1-ae73-7fa0-bedb-3225aa04049d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_019c9ac1-ae73-7faf-b3d1-0c9c35d691b9" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_019c9ac1-ae73-7fa0-bedb-3225aa04049d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019c9ac1-ae73-770f-b861-061f984a58ac" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_019c9ac1-ae73-7fa0-bedb-3225aa04049d" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019c9ac1-ae73-770f-b861-061f984a58ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_SignificantSegmentExpensesAbstract_019c9ac1-ae73-7183-8e15-8ddf886b45af" xlink:href="rxrx-20260331.xsd#rxrx_SignificantSegmentExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_019c9ac1-ae73-7fa0-bedb-3225aa04049d" xlink:to="loc_rxrx_SignificantSegmentExpensesAbstract_019c9ac1-ae73-7183-8e15-8ddf886b45af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LaborAndRelatedExpense_019c9ac1-ae73-7afa-90fa-0b81e7fd19c9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LaborAndRelatedExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rxrx_SignificantSegmentExpensesAbstract_019c9ac1-ae73-7183-8e15-8ddf886b45af" xlink:to="loc_us-gaap_LaborAndRelatedExpense_019c9ac1-ae73-7afa-90fa-0b81e7fd19c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_ConsumableExpense_019c9ac1-ae73-744c-83aa-96f88c63709b" xlink:href="rxrx-20260331.xsd#rxrx_ConsumableExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rxrx_SignificantSegmentExpensesAbstract_019c9ac1-ae73-7183-8e15-8ddf886b45af" xlink:to="loc_rxrx_ConsumableExpense_019c9ac1-ae73-744c-83aa-96f88c63709b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_PlatformFeeExpense_019c9ac1-ae73-7479-aa93-e97e5dc52a18" xlink:href="rxrx-20260331.xsd#rxrx_PlatformFeeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rxrx_SignificantSegmentExpensesAbstract_019c9ac1-ae73-7183-8e15-8ddf886b45af" xlink:to="loc_rxrx_PlatformFeeExpense_019c9ac1-ae73-7479-aa93-e97e5dc52a18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_DiscoveryExpense_019c9ac1-ae73-73ff-a3c8-1f54fffb04fb" xlink:href="rxrx-20260331.xsd#rxrx_DiscoveryExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rxrx_SignificantSegmentExpensesAbstract_019c9ac1-ae73-7183-8e15-8ddf886b45af" xlink:to="loc_rxrx_DiscoveryExpense_019c9ac1-ae73-73ff-a3c8-1f54fffb04fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_ClinicalDevelopmentExpense_019c9ac1-ae73-73fd-a47f-3cfd2b66fec5" xlink:href="rxrx-20260331.xsd#rxrx_ClinicalDevelopmentExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rxrx_SignificantSegmentExpensesAbstract_019c9ac1-ae73-7183-8e15-8ddf886b45af" xlink:to="loc_rxrx_ClinicalDevelopmentExpense_019c9ac1-ae73-73fd-a47f-3cfd2b66fec5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization_019c9ac1-ae73-70df-9f74-776385d45b7f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rxrx_SignificantSegmentExpensesAbstract_019c9ac1-ae73-7183-8e15-8ddf886b45af" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization_019c9ac1-ae73-70df-9f74-776385d45b7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingOtherItemAmount_019c9ac1-ae73-70b9-a477-7e02e0f5ad96" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingOtherItemAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rxrx_SignificantSegmentExpensesAbstract_019c9ac1-ae73-7183-8e15-8ddf886b45af" xlink:to="loc_us-gaap_SegmentReportingOtherItemAmount_019c9ac1-ae73-70b9-a477-7e02e0f5ad96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_019c9ac1-ae73-7e66-9fc8-8410bcd1acb9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rxrx_SignificantSegmentExpensesAbstract_019c9ac1-ae73-7183-8e15-8ddf886b45af" xlink:to="loc_us-gaap_OperatingIncomeLoss_019c9ac1-ae73-7e66-9fc8-8410bcd1acb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_019c9ac1-ae73-7fb0-9995-bf4aec15ea4d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rxrx_SignificantSegmentExpensesAbstract_019c9ac1-ae73-7183-8e15-8ddf886b45af" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_019c9ac1-ae73-7fb0-9995-bf4aec15ea4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_019c9ac1-ae73-7fc8-b300-6dcced5fb7e5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rxrx_SignificantSegmentExpensesAbstract_019c9ac1-ae73-7183-8e15-8ddf886b45af" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_019c9ac1-ae73-7fc8-b300-6dcced5fb7e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019c9ac1-ae73-72fd-b15d-c3f8489ce118" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rxrx_SignificantSegmentExpensesAbstract_019c9ac1-ae73-7183-8e15-8ddf886b45af" xlink:to="loc_us-gaap_NetIncomeLoss_019c9ac1-ae73-72fd-b15d-c3f8489ce118" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_SupplementalAssetInformationAbstract_019c9ac1-ae73-7888-9a4f-26a2e1f5ae9a" xlink:href="rxrx-20260331.xsd#rxrx_SupplementalAssetInformationAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_019c9ac1-ae73-7fa0-bedb-3225aa04049d" xlink:to="loc_rxrx_SupplementalAssetInformationAbstract_019c9ac1-ae73-7888-9a4f-26a2e1f5ae9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentExpenditureAdditionToLongLivedAssets_019c9ac1-ae73-73c9-b7f8-6ca3e6b62eba" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentExpenditureAdditionToLongLivedAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rxrx_SupplementalAssetInformationAbstract_019c9ac1-ae73-7888-9a4f-26a2e1f5ae9a" xlink:to="loc_us-gaap_SegmentExpenditureAdditionToLongLivedAssets_019c9ac1-ae73-73c9-b7f8-6ca3e6b62eba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#AwardTimingDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgDiscLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgDiscLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMnpiDiscTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMethodTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMethodTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgPredtrmndFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgPredtrmndFlag"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgPredtrmndFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMnpiCnsdrdFlag"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MnpiDiscTimedForCompValFlag"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardsCloseToMnpiDiscTable"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="loc_us-gaap_AwardTypeAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_EmployeeStockOptionMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardsCloseToMnpiDiscIndName"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardUndrlygSecuritiesAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardExrcPrice" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardExrcPrice"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardExrcPrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardGrantDateFairValue" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardGrantDateFairValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardGrantDateFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_UndrlygSecurityMktPriceChngPct"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ErrCompDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RecoveryOfErrCompDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompRecoveryTable" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ErrCompRecoveryTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ErrCompRecoveryTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDateAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="loc_ecd_RestatementDateAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonNeosMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonNeosMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_ecd_NonNeosMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDeterminationDate" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDeterminationDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_RestatementDeterminationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtErrCompAmt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_AggtErrCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompAnalysisTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ErrCompAnalysisTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ErrCompAnalysisTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingAggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingAggtErrCompAmt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingAggtErrCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryIndName"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingRecoveryIndName"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingRecoveryCompAmt"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingRecoveryCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#PvpDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PayVsPerformanceDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PvpTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PvpTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ExecutiveCategoryAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ExecutiveCategoryAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_ExecutiveCategoryAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllExecutiveCategoriesMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllExecutiveCategoriesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ExecutiveCategoryAxis" xlink:to="loc_ecd_AllExecutiveCategoriesMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="loc_ecd_PeoMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonPeoNeoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="loc_ecd_NonPeoNeoMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToCompAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_AdjToCompAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllAdjToCompMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AdjToCompAxis" xlink:to="loc_ecd_AllAdjToCompMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtPnsnAdjsSvcCstMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PnsnAdjsSvcCstMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:to="loc_ecd_PnsnAdjsSvcCstMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PnsnAdjsPrrSvcCstMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:to="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsAdjsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_ecd_EqtyAwrdsAdjsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsMember" xlink:to="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsMember" xlink:to="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MeasureAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_MeasureAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PvpTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PvpTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CoSelectedMeasureName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CoSelectedMeasureName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NamedExecutiveOfficersFnTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeerGroupIssuersFnTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ChangedPeerGroupFnTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoTotalCompAmt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoTotalCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoActuallyPaidCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoActuallyPaidCompAmt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoActuallyPaidCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToPeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToPeoCompFnTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToPeoCompFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonPeoNeoAvgTotalCompAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TabularListTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TabularListTableTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TabularListTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TotalShareholderRtnAmt"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TotalShareholderRtnAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeerGroupTotalShareholderRtnAmt"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CoSelectedMeasureAmt"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CoSelectedMeasureAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OtherPerfMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OtherPerfMeasureAmt"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_OtherPerfMeasureAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToCompAmt"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoName"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MeasureName"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_MeasureName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonGaapMeasureDescriptionTextBlock"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Additional402vDisclosureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Additional402vDisclosureTextBlock"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_Additional402vDisclosureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PnsnBnftsAdjFnTextBlock"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsAdjFnTextBlock"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#InsiderTradingArrangements"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingArrLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTradingArrLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrByIndTable" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TradingArrByIndTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TradingArrByIndTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TradingArrAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="loc_ecd_TradingArrAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllTradingArrangementsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllTradingArrangementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrAxis" xlink:to="loc_ecd_AllTradingArrangementsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rxrx_NamandjeBumpusMember" xlink:href="rxrx-20260331.xsd#rxrx_NamandjeBumpusMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_rxrx_NamandjeBumpusMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MtrlTermsOfTrdArrTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrIndName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndTitle" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrIndTitle"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrIndTitle" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Rule10b51ArrAdoptedFlag"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonRule10b51ArrAdoptedFlag"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrAdoptionDate" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrAdoptionDate"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrAdoptionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Rule10b51ArrTrmntdFlag"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonRule10b51ArrTrmntdFlag"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrTerminationDate" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrTerminationDate"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrTerminationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrExpirationDate" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrExpirationDate"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrExpirationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrDuration" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrDuration"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrDuration" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrSecuritiesAggAvailAmt"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#InsiderTradingPoliciesProc"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTradingPoliciesProcLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>rxrx-20260331_g1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 rxrx-20260331_g1.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0(" 0$" 0$! @(" @(" @(" 0(" @(" @(" @+_
MVP!# 0$! 0$! 0$! 0$" 0$! @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @+_P  1" 5J"DP# 1$  A$! Q$!_\0
M'P !  $$ @,!              D#" H+! <"!08!_\0 D!    8" 0$# PD/
M"@P-# $E  (#! 4& 0<("1$2$PH4,148(2(Y<;&WP189,CA!5UA9=GB!EYC5
MUA<C0G)WJ;*VN-<:)%%6872"B9&6I[4H,S0U-C=28G6FL[38)2<Z0T=(9F>'
MB)6HPN?P)D93:'.AT415:8;&QT5)8X.3E*7%R-+4Z%1DDIG3986BP^'_Q  =
M 0$!  ,!  ,!             P($!0$&" D'_\0 =!$!   "!00(#P<." <.
M!00#  $" P0%,7$&!S)!$1=6E)7!T]0($A880E%55X&DL='2U? 5(71UA(6E
M(C4V-T948663H[.TY.430T5'<H*#DA0F1&1FM<()&2,E)S,X4F)C9W/#Q)&A
MHN+C)%/%X7:&IO_:  P# 0 "$0,1 #\ S^
M                                        !ZI+_7!3WU/@ >U
M
M                                        >J:?ZL7]Y7_E2@/:@
M                                                  #UCS_5+;WR
M?\I@![,
M
M
M
M                                          'JDO\ 7!3WU/@ >U
M
M                                           >J:?ZL7]Y7_E2@/:@
M                                                     #UCS_5+
M;WR?\I@![,
M
M
M
M                                             'JDO]<%/?4^ ![4
M
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M/A@T,^>+&(D4QL$*?NE]C "[<               'K'G^J6WOD_Y3 #V8
M
M
M
M
M                                /5)?ZX*>^I\ #VH
M
M                               #U33_ %8O[RO_ "I0'M0
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M16[RU4B&K*AV!V^12C[,S14PMAF;*R*G=]IW#G"+PWEC^Y/53Q2\'-98A?\
MY'FW-:C2F?9[?]=\4;"7H]C_ %#_ +[_ 'H"1GA-Y5WQ?Y";(JVJ^1^E;'Q6
ME+E,,J]";!^;R*V5JAK+23I-I'?-I/+UV ?4J-6<+)DR\,P?,FAC^(_=-&I5
M7*89713%.4IR&*8IBX,4Q<X,4Q38QG!BYQGL,7./1D!I;>5GTT7)+]WS<7QA
MV(!MB^DQ[F%P ^]$T'\7%? 2$@               ]8\_P!4MO?)_P I@![,
M
M
M
M
M                                   'JDO]<%/?4^ ![4
M
M                                  !ZII_JQ?WE?^5* ]J
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M2V]\G_*8 >S
M
M
M
M                                              !ZI+_7!3WU/@ >
MU
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MN 'WHF@_BXKX"0D               'K'G^J6WOD_P"4P ]F
M
M
M
M
M                       #U27^N"GOJ?  ]J
M
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M-^H5LK%(AXF=B?5BO2#MA)Y;R35PEE=FZ<ME?"[Z*RJ9BGR%XX
M     /6//]4MO?)_RF 'LP
M
M
M
M                                                         >J2
M_P!<%/?4^ ![4
M                                                         !ZI
MI_JQ?WE?^5* ]J
M        /6//]4MO?)_RF 'LP                 !TAN3DSQOXZ8KIN0?(
M'2.B2W#,MBI&W+M:AZP+:<P&(W,[BN9NT\Q]6\LO5J'\[\V\7S;U6;>-W/'2
M[X?/:EYB\1M^V9S2M$\I^..ZKDSB'=A=U+4N\-9;'LS6 8NV+%[..8&G6=XZ
M1AT7TG&HJN3)8135D$$SGP=9,I@N0
M
M
M
M                                           'JDO]<%/?4^ ![4
M
M                                          !ZII_JQ?WE?^5* ]J
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M08.I9RHL<I4R-TE3'R;'<QD!(#C.,XQG&<9QG';C./1G #]
M
M
M
M                                             'JDO]<%/?4^ ![4
M
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M6/AXVSUNS;6M$W"S$3 T1G89SS%>'D&;A)5Q%()G(MW2',?!RD#Y?D1Y*EU
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M8@]E'"CA2KGBY*-D8=J0WF\7ZB22*1"HO$2(!G
M
M
M
M                                     #U27^N"GOJ?  ]J
M
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M#>D+2[PTG7K0A$IOGAX9YE^4S&(<NT)=<Q%&R(9((#UCS_5+;WR?\I@![,
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M?OBJW1Y6\9\%L<J7<*LKDB:9SE#/,
M
M
M
M                           'JDO]<%/?4^ ![4
M
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M9XU&+U]6D6T-&F*X.F0CM5L=^Y.BF9R[<K%*<!GZ
M
M
M
M                                      #U27^N"GOJ?  ]J
M
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M=H\Y'K6J0BYB;8PRF*E:I!1FX6BX"853,LFFD<K ^"G[_87(2T>2S<OL\?\
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MF4O UQA9'#2>G'*RC8R3"L0*),G/CS=@4W> :VP!M<NIU[AAR)^\MK_\6ZJ
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M8GD;H#4.[6D4DX2A5-ET"M6V0@".\D,ZS7)>7CE7==44,FGWSLEVYS]SV<Y
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M6XYL@9;NYSVGR3)S=N<Y-G.<@.RP
M
M
M
M                         !ZI+_7!3WU/@ >U
M
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M,ZY'UTKA9B5+SE%:5RD4YE/-CY]H SUP'K'G^J6WOD_Y3 #V8
M
M
M
M
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M        'JFG^K%_>5_Y4H#VH
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M,&;K)*QIC&RICL-A7V.S./9";(
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MS4%9J]GDGESG:[,MIAM9I62BD6S(D)C!FZR2L:8QLJ8[#85]CLSCV0FR
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MK><H>R<-&B9E'SMI1;Y%QLE-1[9,G:X=Q[=VT1*<ACKE*<F3!($
M
M /5)?ZX*>^I\ #VH   ,5GRO7W-C2/W\6M?B%Y+@,#GA3Q.O'.3D_JGBMK>P
MU2JW7;;^Q1\'8+PM+MZO'*5JG6*ZOE956!B'SLI3QE;>))>"U5[5UD\'[A,G
M5($VV]/)4NIOJ2HR5OI;W0?(+U+:N7;BH:HO=F9WM9NT2,X7/'0^R*/ LY9;
MPTS82;-9%9\X/^LMVBBAB$.$%VEMY\DN#^\VVP-26V]Z)W=K.>>1$HCA![!3
M,=(Q+XS2=IMYJ<PVP22C_.FBS:2AI9HJW5,B=%VV,;'=*&TIZ._4QKG4_P")
M<5MI=A'UK<]#D$:!ORE1B;A**B+VV8(O6]AK*3M=5;YC9N-53?,"J*K':*^>
M1AW#E6/4<K!"CUE.'G1*V;SBMM]YS<^=O\>]_62BZ\5EM;U**)(0;2MQ< 6
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MM 3&(+HN447359)RV<I)KMW""A5D%T%BE416163-DJB)DS%,4Q<YP;!^W'L
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M>NT515162.=-5-8IR&,0V,@/9          #UCS_ %2V]\G_ "F 'LP
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M%WNX?L"';RI3W)6_?NS:3_C0J PMO)Z?=C>%/W3[2^(7:H#:Y@
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MRD=[!ZYJ3&0GYR/(H3)57#2-611SV854)WB@(OU?*<NC^G-^I1-\7Q9AG/\
MLF2T1M[$)[!NSMRW6J9)+^S_ *W^C^S[ "0/BOU2^GYS5G4:IQIY1ZZV'=73
M=X[94%WZOT/8<BUCFJSV2<Q%!V/"Q$Q,-VS-NLLY4:LEB((HF55,1/'> 7Y/
MWS*+9/).3>-(Z-CFCA_(2#]PBS8L&+-$[AX\>NW!RIM6J3<BAU%#F*0A"&,8
MQ<%SD!"IO+RB'I+Z)L4A4I+DTWV388IPLVD6VEJ9;]EPR"J'M<X0O$+$XK\L
M7*A3%QEC+.>S)/;]PO9G(>6DO*(.DIO&?@JG&<GD=>VBQ/D(Z.B]OT&_:\C<
M.W)NXD21O,M7<UN&3RH8I?$>3+<G:?'MP$UK9RW>MV[QFX0=LW:"3EJZ;*IK
MMG+9=,JJ#ANND;)5D3I&*8ARYR4Q3X,7.<9 <@  8IWE'_55YE].NW<8ZKQ5
MN]8I#7;E.VG*VR0F:#5+K)8?5B6I["&7B\VR/=MV?AHSC[)BF;J$5/W.^7)2
M]F0P#N0W)'>O*_:$UN?D5LVS[8V9/HM6S^T6AP@95&/8%4*PAX>,8-T&5=@4
M,J+9081[9LS1,Y4.DW(90YC!FQ^1P?[3_.;]TG2G\5[\ S/P !U3O3<=*X\Z
M:VGO78S[U.HNHJ#:=AVER7),KYAZI#NYATU8IJ&QAQ*."M<-VB.,]]=RY21)
M@QSEQD-1+'--T=4CJ H-SJ&=[AYD<A%%72Q,+OH^L9O=D,X>N,$]J=.H5NLF
M6/W<=A6\56^Z4I<)%*4-O)IK4U,T-J36>D]=1V(FB:GHE6UY4H_VF5$("HPK
M.#C<NE4R%\X?';LB*.%LX[ZRZRBQ^TYS9 8B7E37$WDKRVWOP HG&W26P]Q6
M-S5=\,5DZ;7G;V'AE7<WJLZ*UIM"Q4XNHQV4TE#&=RKQFU(4F<G6+@!'GK[R
M0SG)8J2E-WW?W'+75Q>-".V]&*YO=PQ'JJIX/B.L5FB*RDU:/B*&.17,<25;
M%[G>1<K8S[ 8Y7+WB5NK@_OZ\<;M_0+2#V+15F)W1X=[F5KD_#3+!&4@K/5I
MC+9+U6K[V-<(JHJ&2163/XC9TW;/$'#9(,Z3R2WF'L;=O&/>_&;8D_(V9MQ6
ML6NG.LI.9=JO9"+UOM=E<RM*(V<KK&.I!PTYKV649$-_J1O9TV2.2M&S9! ,
MM8       $'?E(?N+O,S_P W?^5;HP!J_M+ZNFMX;BU/I:MOXN+L6W]ET35T
M!)SAW2<+'35_M,74HM_+J,&JZZ<8B^EFZC@R*"RV$2'RDFJ?ND,&1%N_R4;J
M3:JHLY=Z99N/>]UX"->R;BB:UMUV:; E4&2/G"B%;B[MKV+8S4@9%-;PVI9)
M-RN<A46R+A94B9@QU-8[0V9HK8U8VAJFXV76VS*%-(S%9ME:?N8>?@9=D<Q,
MF262[,^&8GC(N6ZI3HN$5E6SE)1%11(P;7SBQRS>\Y>D7!\HYADSC[-L[B_M
M8MU:1J)FT82_TJ*O&O+\K%-3*',SB%KE4YQ9HB8YSI-G*)#'/DO?R&I! ;;7
MDAUA.GEP2CZE1>0O(6%BME%J-:<+ZSI<+8MCWF-1<PS19 UBB*5%O"5$RC?)
M542S"S ZZ2A%$2J$.4V0\>)/6UZ:O-6[Q>KM*<BXY/:<V0V8776Q:O;=9V&=
M7+DN,1M<=W"%:QEIG3=IC%CXR0>/S)HJ*E;>&F<^ E7771;(K.7"A$D&Z2BZ
MZRAL%3212(9110YL^P4I4\&SG/\ 4P A3V%Y1+T?=</G,6\Y=QEKDFV3X.AK
MS66X;RQ4R7/9_2UD@:"K$NL9-V]F2/S=OT7T/L@.J(/RGGI!RSH[=_NS8M91
M*IDA7\YHO:;AJH7&?]-(2MUV07\/^P9$I_\ > ):.,/-/BGS/K+VV\7M[4#<
MD3%9;EG&]7E#IV.MF>8,9GBT4^70;2]7,L4JG@^J#%MXWA'\+O=P_8%T(",;
MD_UDNFCP\L[FB[TY742)OC'*Z<C1Z5&V[;-HAG;<V"J1MFC=5UV9^8^4]L7)
M6\N9@J8F<'P7N9P8!:!6_*:NCY.R"K&0Y!7*H)$6RBC(V31.Y%&+K';V%63S
M6:9)+(HFS]5=%$Q?2<I2^R EIXV\O.,7,&K/[IQCWCKO=,!$*LF\\K2; W?R
ME9=22;A:-9VRNK>'(U-XX19O#H(R+1JHL1LJ=(ARD/G =B;<W+J?0=%F-G;L
MV12M4Z]@"%-+7&_6.+J\ T44*IENT]4)9TD1Q(KF3,1LU2R=RY4SA)!)10Q2
M9"$BZ>4X=(BI3:T,PW9?KVFW<E;+35+TML96$*;O=Q95)U986,4>MTS8-VJ-
MT52*8]E#*Q<ESD+TN)?6$Z<G-RVM]>\>N3%8L.R'34SIIKRUP-RUG;Y/*93'
M7:UV,V-78PMN?)(E.JJC#JOSIHD.L?&$R'.4),  !\];$5G-6LK9NDHNX7K\
MRB@@B0RJJRJL<X(DDDF3&<J*F.8N"EQCMR;/9@!JS>'_ )/1U.N7R/JTTTRE
MQZI/:H4ETY/JSVJTGJB2G=.A%THE;?VB1*8A3Y2<X@B1RGH\^+V@+\=U^25\
MW-9:HL6PJ1O#0VV[+5("3L4IKB*+=JO+S",2S6>N8RF3,W!F:3$P=-$V$$I#
M,2BJ;VF5R'[N#!C 4&^W/5MVJNR-=6:8IE\H\]&6BHVNOO58^;K\_"N4WL;*
MQSQ$V#(.4G2*1L?1%-[.#ER0QBY#<U\7=E3NY^,W';<-G8IQEFVQHK4>R[%&
MI(&:I1\[>Z!7[1+,4VQ\YRV32?RCA/!,YSDF"8+G/L .]@
M                                                      'JDO\
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MA:_7\*)R1T8Z/PV116676,V(JX4.H&V-X@_2F<7OO=M)_%K60%Q(
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MCA'PW[;766AXK3<*<_=QXL>>JF=6!#MQWB'V,X)G/M<%P&1"
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MY9EDKVSZ;:K2CU.$SV*9R^B7TP@U(B=22S'I^&=0)LO+$?I7>(/[OEO^+QR
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M=H&3<MT5B!G<^5*>Y*W[]V;2?\:%0&%MY/3[L;PI^Z?:7Q"[5 ;7,
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MKUELG-QK=MVQ;]:0<'=^V9)LB&>AT!UG.EMK7IK['U7G1_(:*Y :>W-$VI>
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MV.9-R8[J+-!FW123)CV"$2P7'H >V
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M%>[0]'LFPMM6"JVA],4NJ70CR$CJ:XEVS1!I;(EVBS/A\4I\J)$*J;N=SO\
M<[Q<ACG</O*I>9NO;S?+'S%DTN05*1U/8VVNM;4^@ZPUF9_N)>>JN:L]LUU@
MJZBZ@ZFC IVS#M1%O)',=9$A&"IS%41#U^OO*:.I]OOE3HVJMK-J+5&O+SO#
M6]1F*/1-4P,J@ZJEIOD)"OHMU8=B&FY+SS,2^53RZ:N69_$/E9,B/M2$"X7R
MQ?Z87A?^XSLC^.\2 ^_\C7SV7+J!9SV8QBL<;,YSGZG_ %5W=]7_ -OT /6]
M7;RF7>]0Y.RFG.G-?*E"ZNU$>3JUSVH[IE1V CMB_I.DTIE6JJ6J+>-VU%B%
MFBC)D\:$(:5<G>O2+.(XT:<!(CT".575_P"H-/RG(WE#N&#9\.ZB:<KL'#M]
M+ZQK$OO.^^:.(U5K7YF(JK=W'TVOO%BN)"2;+$PYE&:,.AEQX4QAB%W76BZY
M>ONEW%0VKJ!68C;W+&\P7S0P-(EGKEO2M=U==RLR87/9JT6X2>.DW;QJ^)&P
MS-9LZ>DCW"Z[V.;E;*/ PW#]:#KO\PK18%]/;5WG8LQ9//GM,XN:/CEHZHQK
MI195N5<E"H3R4*R_67&$W$J^=+'*B8IG)\$SV!]CH7RE#JQ\;-E,H_>5[;[Z
MK-5E%X:ZZ=W1KRHT^Q]YJMYK+1Y[G5J?&V&NVI R:A$SOU)!%LX)WG<6[*4Z
M.0RM>;G6"G;%T3U>I!P<LS.D765L.L*^JQL416[K(:VM,CL*%JVQJ%88B;CU
MF;J5:><.TD7"C4GG+-XTE&R::+IN<!K8ML[/N.[=I[*W-L220E]@;<OUPV9>
M95LP913:3N%[L,A:;+(-XN-12;QJ*TU*/%"(()I(HE.5),A"8Q@H2H\=NO;U
M->*^EJ!Q^TQN>JUW5^LHIQ"4Z%D-/:LL#R/C74I(S2S=:9FZJLZD#>?23HV#
MKJG/W3X+V]W!0&RZZ>^W[UR X,<2=W[/DFTQL7:_'[5U\NTLSC6,.UD[/9:G
M&RDP^0BHQ%)M')JOG"Q\(H)IHI]_NID(3&"X#7_^56^ZLR'WO&G/^4M@#8><
M0?I3.+WWNVD_BUK("XD          >L>?ZI;>^3_ )3 #V8      @[\I#]Q
M=YF?^;O_ "K=& -;CT]_I^.#_P!]]QJ^.>E -RD UX?E4_4/U1R5W#ISBCI"
MV1%ZK_&YS<[!M2W5MZTEJVYVI:21,*VIT5+LUCI/WE?A862+(G0,=$CVTG8G
M/YW'.4D@Z8\E.XWV3:G4D4WP@SR6E\7-77.?F)=5$ZB&+;M>OS6K:G7DE"^P
MC(NH6<O3TAC>U\WJKDOT1R +M?+%_IA>%_[C.R/X[Q(#[_R-;_9GU ?N8XV?
MYUW: [5ZS_D\6PN6>]=D<RNGW:->7>PWV<D5=T:*D;;%0;K]5*%1;Q=DDJ';
M7;K,46:?2#4RLS#S;N*RQE#N7"3Q0KSS)D&)IO'IB]0GC<TE)7='#GD!3J["
M)++R]Q)KN<LM#C$&Y3'67>WZHMW\*W1PF0YN^9]@N2$-G!LE*8P#VO"+J<\R
MN 5\KEKT1N2WMJC%2C9W/Z9L,_+S6GKM&D,4C^)GZ*[>&9HJ+,C+(IR#--M*
M,_&\5D\;JXQD!D/^5=7X^\];=*#D1 ,7[37FXM+[4OU=:.2X6/#GV# \>[PV
M8R#M(N$_5!2#F8TN,=F/%]2ELD*;!#=T.@/)'+C1Z]U%=KUVQ/(^/MU]XKW.
M#U\=XY217EW\3L365ML5;B43Y[7DHI78%Y)Y(3VQ6=2>*Y]H0P#8X (V.I]8
MH3873KZD-%UY;:[9+S3N*.[&EPJ];G(N;LE85=ZKLDTG#6*#CG2CF%D)"!:O
MLMD7*22KA,_?1(?'L@-1K57<5'VBMOIUMYY",I^'=S+3&<]KJ*;2+=:0;8["
MY^C9IK%]!OHP&[ABI2-G(N.FX:0:2L/,,&<K%2D>ND[824;(-TW;%^Q=H&,1
MTS6:K(J)*$SDIR*%,4V<9[0&I^Z^4W5+!U?.;S^FNVCV(0V)5H5VNR53<(EM
M5;U90:Y>FIE$S9P5TA=HNP(+D]*:S95,_=.0Q0&9AY*%%2\=TLGSR22<)LI_
MD[MV6KIUB&*FO$(U_7<$NJT,<N,';XGH6<)G.,FQXJ*I>WMQDN Q?O*<N'7K
M:.H_8=JUZ*\QUWRZKZ6YHE5!'PH]#8S99.O[?B4U.[C*TFK848^PNL^V[#;%
M3+C/[$H=!L>J-)-NAO+=-CU4??-DXY0M'+?'8X*T)QJ<^)MU[#).,%[//"[Z
MCTU3DP<N#,Y7*9D^[WC'"YKR7;ASZXWJ(-]VV**\^UYQ JY]FNE5T?&8.-I6
M7SZL:GC%L]W];>(N/FHL#4^,X[J^OB>DINS(21>63Q,Y\T73_G#X<*5O,+R0
MB4#83/EHTG"O=*O'>%%L%[J;ARQ,R[A<Y+DY8L^<8R4A^Z&,ETXNG;LOJ9;O
MG=!:BV=IS7%ZAZ!*["8DW%-VJ$9VF.A)>#BY2)JV:K3YA62GD$9Q-ZHWRDF;
MS%@Z<ER8C98Q F__ *$#Z@OV0?#?_&O=G\Q@"X3A]Y,=S+XJ<QN)>]M@<D.(
M)8+6/(C5.P'4#"W;::%NMT;0[?%VZ?K5.8SFI6*,S8',!#R1$VYG*9#%.;*Q
MR(E.? 7@>6(_2N\0?W?+?\7CD!#UY)3[I[>/O1-J?&/I8!LD0&'WY7'PU^;[
MCOIOFO5XKQ;#H2RXU=LUVV0[5E=6;,?I9JTI)..[G.6<1LI-NS;DQDOZYM%8
MYN]W?8#%(Z5?4PN738M_)2P5O$DY;[OXS;'UM#H,C%RC [A0BW$II/8#I#*A
M<N4XFU&>(*8QGM*TL[PV,=[L.0+?^GAQ.F^=/-;C]QF88?'9;,V"PQ>Y1ME3
M+F&UM E<6G9D_AQGV$WC>EP\X=ME0V"K/#H-^^4ZQ &XE@8*'J\'#5FNQK.%
MK]=B8Z"@X>/1*V81,/$LT8^,C6+=/L*W9H,6Z*21"^U(1(I<>Q@![8
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MOQ:^^,TC\9E8 ;%KRI3W)6_?NS:3_C0J PMO)Z?=C>%/W3[2^(7:H#:Y@
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M]C,N3&RJ;),9ZF:^A:\O7M+UBQ1ZB+IC-S*,JY5D-E2#1^BFLS*Z3BXTA_\
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M;8.W3D^<G<KO%%S^W4, DP
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M6NL83,#-)O$$I%E'EKVN8D[XS7&6;0K!%5<Y>ZB=8_M@V:H  UE_6GZG'/F
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M+*2RR*9"NIIXHW5=O5L$+XSIXLKG&,GR [B
M                                            >J2_UP4]]3X 'M0
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M+D?*MC$>2;R2,K!;#V\S343QEO'I1R<K7(M;!C>=9E9XYDR$09K+!G+@
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MY3R=%8A3D-VE-@!V>             ]8\_U2V]\G_*8 >S
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M8XBK)7:V5)2'U93)9F]02<,U&M534EE&KA(B[-_?'[93':GV8"?P
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M$T4DDRX*FF4I2X*7&.PN,=F/8 5@
M                                     !ZI+_7!3WU/@ >U
M
M                 6Y[^XB<7>5)*PGR2T#J;>&*6>4-4C;,I,';5:WF<PQ+
M,EAEY9FH>/3=>I<;YP5,Q2K98(Y/C.4B=@?#Z8Z?/![CG>&^R]#\4M$ZDV"T
MCI&(:W*@ZYKM<L3:,EDBHR;%&4CF1%46ZZ)2D5*4V.^3VINTH"\0   'JYF&
MBK%$2M?G8YG,0<Y&OH::B9)ND[CY2)DVJK*1CG[1<N2.F2[-==)5,^,E.18Q
M38R7("/CYT%TN?L!>*WXG*?^;0%_-2J57H56KM'I%>AJE3JA"1=:JM7KL<UB
M(&NU^%9HQT1"PT4Q2(C'Q;9BV01012(1---$I"%*7& 'T0        #U33_5
MB_O*_P#*E >U          &.5U>_)_\ YZQR2H_(7UV>=#9INCZWIG-1_4)Q
MM'$EBO7W95XQ8L3WZLE=\R\7.Q,M<M/,ENYZD>-YR?Q_"1"Y;HX=(C'25IN\
MJEZX/._\[GL],L7JC^I1C56*WBH14W&%989_JE63U8,XS-F/E7Q6OA^;=SPU
M._WBA,^ CBZI_3]QU,.)LMQ>-MK.E<R=ZI=U+><43]4;S<U0=NG/J;FL_-E
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M/<0YG/FF5?-L/'/@^)W/'5[._D+A@            'K'G^J6WOD_Y3 #V8
M                                         .H-V:#TIR2I.=;[]U91
MMPT+,NPGOF0V%7HZS5_U;BRN21TIB-DT5$ROT$W;K":G=[Y,.3XQGVV0%MM%
MZ7O3JUC<ZQL37O"GC;3KU2IR.LU1M=?U15(Z=K=AB'*3R*FX>00C\*,9-L\1
M35063R4Z2J13D,4Y<9 7X@
M
M
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M.(!\\KZZ'V$%J_(XY ?G$ ^>5]=#[""U?D<<@/SB ?/*^NA]A!:OR..0'YQ
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M.0'YQ /GE?70^P@M7Y''(#\X@'SROKH?806K\CCD!^<0#YY7UT/L(+5^1QR
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M)'-@.QOGE?70^P@M7Y''(#\X@'SROKH?806K\CCD!^<0#YY7UT/L(+5^1QR
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M.(!\\KZZ'V$%J_(XY ?G$ ^>5]=#[""U?D<<@/SB ?/*^NA]A!:OR..0'YQ
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M.0'YQ /GE?70^P@M7Y''(#\X@'SROKH?806K\CCD!^<0#YY7UT/L(+5^1QR
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M<0#YY7UT/L(+5^1QR _.(!\\KZZ'V$%J_(XY ?G$ ^>5]=#[""U?D<<@/SB
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M2K(KD43R8AL&R&;@
M
M
M         @"Z9GNP?7[^[G@-\3FW0$_H
M                          @[ZD?NG'0Q_=RY;?R?F("<0
M                                            $'?2I^G1ZV7W\58^
M*B+ 3B
M".3J^^Y<\^OO5MQ_Q/D@'>7!3Z2+AQ]ZMQZ^*.H +J0
M                                    !!WSP]VBZ"G]](_DI4\!.(
M                                   U=GE.'NP>_?N&T/\ $Y3P&T3
M
M
M                                                    0!=,SW8/
MK]_=SP&^)S;H"?T
M         0=]2/W3CH8_NY<MOY/S$!.(
M                           "#OI4_3H];+[^*L?%1%@)Q
M                                           !')U??<N>?7WJVX_X
MGR0#O+@I])%PX^]6X]?%'4 %U(
M                    @[YX>[1=!3^^D?R4J> G$
M                  :NSRG#W8/?OW#:'^)RG@-HF
M
M
M                                  @"Z9GNP?7[^[G@-\3FW0$_H
M                                                   @[ZD?NG'0
MQ_=RY;?R?F("<0
M         $'?2I^G1ZV7W\58^*B+ 3B
M                         ".3J^^Y<\^OO5MQ_P 3Y(!WEP4^DBX<?>K<
M>OBCJ "ZD
M   0=\\/=HN@I_?2/Y*5/ 3B
M -79Y3A[L'OW[AM#_$Y3P&T3
M
M
M                 0!=,SW8/K]_=SP&^)S;H"?T
M                                  0=]2/W3CH8_NY<MOY/S$!.(
M                                                    "#OI4_3H
M];+[^*L?%1%@)Q
M        !')U??<N>?7WJVX_XGR0#O+@I])%PX^]6X]?%'4 %U(
M                                             @[YX>[1=!3^^D?R
M4J> G$                                     :NSRG#W8/?OW#:'^)
MRG@-HF
M                                    /A[ELS6^NO4[&P=@TBB^J_G?
MJ3\V5K@JQB4\Q\W\^]3O5N00\]\'SQIXOA=_PO.D^_W>^3M#ZYF\:2+1J_8.
MFSY@^;(/&3UFNDY:/&CE(JS9TU<(F,1PV414(<AR&R0Y#E,7.<9 <H
M=?Q>U]6SEH=T>%V70)BZ,7$@U>U"+N5=D+0S<Q!U$Y5NZ@&DD=VW7:J(K%<$
M.C@R.4C84P3NY =@          #KZ-VQJR9M3JBQ&RJ!+7=DYD&;RG1MRKKZ
MU-'<3E3$JU<UYK)&=MW#7P5O."&1P='P3^)@O=, [!
M                                         ! %TS/=@^OW]W/ ;XG-
MN@)_0                                                     !!
MWU(_=..AC^[ERV_D_,0$X@
M                 (.^E3].CULOOXJQ\5$6 G$
M                                 $<G5]]RYY]?>K;C_B?) .\N"GTD
M7#C[U;CU\4=0 74@
M         "#OGA[M%T%/[Z1_)2IX"<0
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M3C)+:&OV$C&R/*+=[V/D&#RV1+=VQ?LG5X.D\9JMU%$U4E"'(H0YB'QG!C%
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M)98NG*.5TB$5RDL<G?[AC8 9TP                       ,=ORG#>&Z-
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M^,&VP&PT          &O*Z9__95W(7[ZWJ4_\]WH V&H
M          P[^1?5KYUZ_P#*':[P%JNV(=AQ<?;[XNT-U0%=:ZX?/U:ULW4V
MH[3<6?S:/:NI-$7<3=LG52+%?X50PY*FCDB:1"%#,0
M             ! %TS/=@^OW]W/ ;XG-N@)_0
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MRN^-;O"]?Y<]<3R ^OKN3\9MU_/H>X%A=Q:IO:A] VT,Y7?&MWA>O\N>N)Y
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M('=F/['ZJU[[<^]_U>%>I#)/<O9F\JMR3#;:SJW[9F4.Q\<VESEX>N9Y&_9
M[P_&M>_S\,X9'9(P][J5LW>56Y)C-G<SJ[$=C.9E#PS:7.5,W)GDAV?3!;NQ
M_P"5>^8_^%B>]D6ZC,C]RMF[RJW),(YV\ZT(?;/RAX9M+R_X2I^N:Y(]F/\
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MZ.2-E[PJO(.K0UVN1Z79KE+-_7G\[FGYJ<R,=O9RTY,^GL_V^-IY^KV=F?\
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M6>CC&6,.U&7WHW>][R$CGA[M%T%/[Z1_)2IX\8IQ
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M,3[RD/W:+F9_YN_\E+1@"0WH%]:WAGTUN*NUM,\CHC<;^X7/D%-[.AU]=T6
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MSWQKZRI,IUNG*Q4BE2-*U&0A:0LNQ=IG3:'.R>-.^1LY9LS$,1(+@.!-J\H
MX9=1#C=QGYL6S;VS..&YKK)5R<O%P78[^H,LW:TRR3#1>$WBNS>2U-FBNHE,
MQ8^0D8YPLFBJJM%K)]U8H9LH                " +IF>[!]?O[N> WQ.;=
M 3^@                                                     #'8
MZUOTV_2E_M_J"?R2'PZU@?7VQ?A=6_32/@V<_P"UIG#^(K6_4*PL6'V:?C@
M                 "B?Z+/X/@P"=)J45/J?A^0;#&.C+X5,>RWPQ2GNABIJ
M?4_#\@NQFNDP\RF*R71Q8*1_3CWOER,I;H8#P&Q+=#!&?2BI']./>^7(SDTH
M,7@+)3WPP4C^G'O?+D5DNCBP> S'@?T8]_Y,BTFC!'L_#QJ0R8O _HQ[_P F
M1L,(:<V'F4A>%\V/%!)XG^AS^#X<#.32@*(LQGT8O#/HS[Q_A&<E\<$5(7DT
MH"E]0_OX^'(K)?)AYD9]**D?Z'/X/AP-EBI_L/[KY 83W0Q45/J?A^0;!/=#
M%3%*/6C-='!3/Z,_ML?P<"A-='!3%I-&""D?TX][Y<BLE\<'D;Y<>*+P%6%)
MJ4C^G'O?+D5DNCBF\!F\C?+CQ14C^G'O?+D7ENA@]> ]:ZD?TX][Y<C88]GX
M.-X"LET<6$]\,%-3ZGX?D&:4-*;P*8O+=#!Y'3EP\ZD?T_AS\!1G)I03EOAB
M\!9XIY]!OP?PS"E'K1DTH*8W&*@;_2\^_G^"$G8^ ?@V&$]T,7'^H;]J;^#D
M>RWPQ24U/J?A^07>371P4QL(*?\ VO\ ]O\ W0RDTH/)KHX*8LPI-2EGZ OO
M_P#Q162Z.+"-TN''%X!/=#%6ATO;\+B']&/?^3(D[%#I>WX7%-Z3>^7X,C&?
M1B[%!=+[:G%4])O>^01=6@[##_:<0WU?VIOD$HZ$N/G=BKW0QAY8N,?T?@S\
M)1@[%7NAC#RQ<4_IQ[WRY$9]*+K4%\F+BF].??S\(Q=FAT?;\+B&]'^'^"8:
M[L4%\OMK<53ZGX?D&$]T,79H+_##R0<8_IQ[WRY$G5H-?MVG$/Z<_ML?PL"=
M)J=B@U^W:<93T&]_Y1-V*#7[=IQ%/J?A^02GOA@Z]#?#&/D<4_T6?P?!@8.S
M1=CX>-Q3^C/[7'\' GZ3KT-\,8^1QC>C/O9^ 2FNC@ZM!J\#BG]&/?\ DR(.
MS5[X80\D7$-Z?\/\(PQGT8NQ0W2XPXG%$79H=+V_"XA_1CW_ ),B=)J=:K:O
M;MN,I]3\/R";L5;5[=MQ#^@WOG^# C/I1=B@U>!QC^G/[;'\+ Q=>@O\,/)!
MQ3_0Y_!\.!KNO07R^VMQ#^G'O?+D'6H-?MVG%4])O>^0:[L478^'C<8_[+^Z
M^48SZ,78H-?MVG#4^I^'Y!%V:O?X?,XQ_3CWOER)TFIU:"Z7VU.*IZ<^^7X<
M";LT%TF#BG])??)\&!&?2B[%#?#&/D<13ZGX?D&$UT<'7H-*7V[-QC^G'O?+
MD0=FKW>#S.(?]E_=?*#L4-\,8^1QE/0;W_E&NZ]#I>WX7$4^I^'Y!A/=#%V*
M'2]OPN*;]C^UQ\HDZU6U>W;<93TF][Y!.DU.Q0:O XPFZ4FC !D
M                    -F)P>?.I3A9Q!DWROCO)#B[H!Z\6\--/QG3O4]3<
M.%,I($*1+!EE#9[I2E+CM["EQCV!]*LIY99,ILHI9?J99:]6X0PA6*38?G)E
MI++198Y64<D-B2CM.ORPPA6Z6$$;_/#W:+H*?WTC^2E3QQ'QI.(
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MWZ;?I2_V_P!03^20^'6L#Z^V+\+JWZ:1\&SG_:TSA_$5K?J%86+#[-/QP
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M[%#I>WX7%-^Q_:X^42=:K:O;MN,IZ3>]\@G2:G8H-7@<83=*31@ R
M                      &R[X'_ $CO#/[U+CO\4-/'TMRJ^R?*/X?7/UBD
M?G/EQ]FF5_QI:'ZW3(Z.>'NT704_OI'\E*GC@OBZ<0
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M,Y2,P\\;9\Y,&=GTW?<[N!/WEW%OXCJ* PG.E1_V4=R-^^,ZC7\8-M@-AH
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M;NEMIBK3%/LVXY:D/9$QU5-9LW$3;G9CE,M'98LWAHWOPV61 &T'
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MW[]PVA_B<IX#:)@
M
M
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M?Z@G\DA\.M8'U]L7X75OTTCX-G/^UIG#^(K6_4*PL6'V:?C@
M      "B?Z+/X/@P"=)J45/J?A^0;#&.C+X5,>RWPQ2GNABIJ?4_#\@NQFND
MP\RF*R71Q8*1_3CWOER,I;H8#P&Q+=#!&?2BI']./>^7(SDTH,7@+)3WPP4C
M^G'O?+D5DNCBP> S'@?T8]_Y,BTFC!'L_#QJ0R8O _HQ[_R9&PPAIS8>92%X
M7S8\4$GB?Z'/X/AP,Y-* HBS&?1B\,^C/O'^$9R7QP14A>32@*7U#^_CX<BL
ME\F'F1GTHJ1_H<_@^' V6*G^P_NOD!A/=#%14^I^'Y!L$]T,5,4H]:,UT<%,
M_HS^VQ_!P*$UT<%,6DT8(*1_3CWOER*R7QP>1OEQXHO 584FI2/Z<>]\N162
MZ.*;P&;R-\N/%%2/Z<>]\N1>6Z&#UX#UKJ1_3CWOER-ACV?@XW@*R71Q83WP
MP4U/J?A^09I0TIO IB\MT,'D=.7#SJ1_3^'/P%&<FE!.6^&+P%GBGGT&_!_#
M,*4>M&32@IC<8J!O]+S[^?X(2=CX!^#883W0Q<?ZAOVIOX.1[+?#%)34^I^'
MY!=Y-='!3&P@I_\ :_\ V_\ =#*32@\FNC@IBS"DU*6?H"^__P#%%9+HXL(W
M2X<<7@$]T,5:'2]OPN(?T8]_Y,B3L4.E[?A<4WI-[Y?@R,9]&+L4%TOMJ<53
MTF][Y!%U:#L,/]IQ#?5_:F^02CH2X^=V*O=#&'EBXQ_1^#/PE&#L5>Z&,/+%
MQ3^G'O?+D1GTHNM07R8N*;TY]_/PC%V:'1]OPN(;T?X?X)AKNQ07R^VMQ5/J
M?A^083W0Q=F@O\,/)!QC^G'O?+D2=6@U^W:<0_IS^VQ_"P)TFIV*#7[=IQE/
M0;W_ )1-V*#7[=IQ%/J?A^02GOA@Z]#?#&/D<4_T6?P?!@8.S1=CX>-Q3^C/
M[7'\' GZ3KT-\,8^1QC>C/O9^ 2FNC@ZM!J\#BG]&/?^3(@[-7OAA#R1<0WI
M_P /\(PQGT8NQ0W2XPXG%$79H=+V_"XA_1CW_DR)TFIUJMJ]NVXRGU/P_()N
MQ5M7MVW$/Z#>^?X,",^E%V*#5X'&/Z<_ML?PL#%UZ"_PP\D'%/\ 0Y_!\.!K
MNO07R^VMQ#^G'O?+D'6H-?MVG%4])O>^0:[L478^'C<8_P"R_NOE&,^C%V*#
M7[=IPU/J?A^01=FKW^'S.,?TX][Y<B=)J=6@NE]M3BJ>G/OE^' F[-!=)@XI
M_27WR?!@1GTHNQ0WPQCY'$4^I^'Y!A-='!UZ#2E]NS<8_IQ[WRY$'9J]W@\S
MB'_9?W7R@[%#?#&/D<93T&]_Y1KNO0Z7M^%Q%/J?A^083W0Q=BATO;\+BF_8
M_M<?*).M5M7MVW&4])O>^03I-3L4&KP.,)NE)HP 9
M          #9=\#_ *1WAG]ZEQW^*&GCZ6Y5?9/E'\/KGZQ2/SGRX^S3*_XT
MM#];ID='/#W:+H*?WTC^2E3QP7Q=.(
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MO7MZ@V%DJ%OK3]&3@I^$DDL+,W\>]0-G"B9B9[IBY[#I*$.DJ0BI#DP'VP
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M]-33S4DWU6Q+LQV9M+I8;/:AJAYYX>[1=!3^^D?R4J>-9I)Q
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MEU1K#;]7\3%9VMKRE;)KN%3IJJ8@KS6XVT1.%%$L]U13U/E&_;DOM<Y]DOL
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MLIMX2<8QDY(-DB*&;>K,(<S'"J]@4.H&=R
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M_&7N#^< >PZ(3._"[*[Q"R^9'6?]#IWN_I>W?6;\STP>#6>WMTAZ?_&7M_\
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M7A.D4S^"\:N&Y^YW5$3E[2CS;GSE;I/$ZAS5:&3]D2Z-4V/[2E]-VGQ0Z6'
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MTE#)"2BD]Z'8R0UZXQV;EAR'QY!WSP]VBZ"G]](_DI4\!.(
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M*:8T%I_5<LLT6RY:KRM U]7ZK)KMW!BXRX14?1:YRG[,=_!^]V%[>P!<*
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M?2I^G1ZV7W\58^*B+ 3B
M              ".3J^^Y<\^OO5MQ_Q/D@'>7!3Z2+AQ]ZMQZ^*.H +J0
M                                                  !!WSP]VBZ"
MG]](_DI4\!.(                                     U=GE.'NP>_?
MN&T/\3E/ ;1,      6G\]/I&>9_WI_(KXH+B Q.?(T?]9^HE_PEQ4_YKR*
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M+;K/&N5$5D8^P*7B4LL.5T9-;'A55@=4F2IE2*$UT#Y8%HBL0<+6J]P)O\/
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MR0\7&<*&>.-)TE5=10O>SW%#*&,;)<Y-DN3]W/LX 7I@
M                        ( NF9[L'U^_NYX#?$YMT!/Z
M                                         (.^I'[IQT,?W<N6W\GY
MB G$                                                       !
M!WTJ?IT>ME]_%6/BHBP$X@
M                CDZOON7//K[U;<?\3Y(!WEP4^DBX<?>K<>OBCJ "ZD
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MC5.LWT@BB5JXM=CE(&,;.DR'P=128GI5J11NP5*4)UO*^?<[="??I4CXC>0
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MRFB?U+[Q,9]DN#8QD!VL
M @"Z9GNP?7[^[G@-\3FW0$_H
M                  @[ZD?NG'0Q_=RY;?R?F("<0
M                                    $'?2I^G1ZV7W\58^*B+ 3B
M                                                    ".3J^^Y<
M\^OO5MQ_Q/D@'>7!3Z2+AQ]ZMQZ^*.H +J0
M                            !!WSP]VBZ"G]](_DI4\!.(
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MTJV+3=;CE.;L*R2\P^S-W^R2LBKE91%+/AG=F23[G8D0A?8 7'@
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MG",5LC8%ELNQ[3 ).DO 7S5C6N3<,ZH\,W,LD9Y&LVKXZ+Q9NHY.@J=+(2H
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M(Z.:-8^.CVK=BP8,6Z31DQ9-$B(-6;1J@0I&K1)!-,B:9"X(0A,%+C&, .6
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MP<+(&SGOG\SH#-)^7!I=,ZH;#X
M        0!=,SW8/K]_=SP&^)S;H"?T
M                         0=]2/W3CH8_NY<MOY/S$!.(
M                                           "#OI4_3H];+[^*L?%
M1%@)Q                                                      !
M')U??<N>?7WJVX_XGR0#O+@I])%PX^]6X]?%'4 %U(
M                                    @[YX>[1=!3^^D?R4J> G$
M                                  :NSRG#W8/?OW#:'^)RG@-HF
M                        #I66XV\=IW9C7=,YH/2TSN1D[BW[+;4KJRC2
M&S&C^#:(,(5ZUOCN#/*MWC-BU:HM5".\';HMB)HF(0A<8#NH
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M@G)6-\X21P8Q$DD6S9FV8,TD&+-L@D%V8
M               @"Z9GNP?7[^[G@-\3FW0$_H
M                                @[ZD?NG'0Q_=RY;?R?F("<0
M                                                  $'?2I^G1ZV
M7W\58^*B+ 3B
M      ".3J^^Y<\^OO5MQ_Q/D@'>7!3Z2+AQ]ZMQZ^*.H +J0
M                                          !!WSP]VBZ"G]](_DI4
M\!.(                                     U=GE.'NP>_?N&T/\3E/
M ;1,
M
M                                                        ! %T
MS/=@^OW]W/ ;XG-N@)_0
M             !!WU(_=..AC^[ERV_D_,0$X@
M                                (.^E3].CULOOXJQ\5$6 G$
M                                                $<G5]]RYY]?>
MK;C_ (GR0#O+@I])%PX^]6X]?%'4 %U(
M                          @[YX>[1=!3^^D?R4J> G$
M                        :NSRG#W8/?OW#:'^)RG@-HF
M
M
M                                        @"Z9GNP?7[^[G@-\3FW0
M$_H                                                      @[Z
MD?NG'0Q_=RY;?R?F("<0
M               $'?2I^G1ZV7W\58^*B+ 3B
M                               ".3J^^Y<\^OO5MQ_Q/D@'>7!3Z2+A
MQ]ZMQZ^*.H +J0
M       !!WSP]VBZ"G]](_DI4\!.(
M      U=GE.'NP>_?N&T/\3E/ ;1,
M
M
M                     ! %TS/=@^OW]W/ ;XG-N@)_0
M                                      !!WU(_=..AC^[ERV_D_,0$
MX@                                                       (.^
ME3].CULOOXJQ\5$6 G$
M             $<G5]]RYY]?>K;C_B?) .\N"GTD7#C[U;CU\4=0 74@
M                                                 "#OGA[M%T%/
M[Z1_)2IX"<0                                    !J[/*</=@]^_<
M-H?XG*> VB8
M
M
M   "Q7CKS)U]OKESSLXT5;74K6+=PXE=!0]_O<@:$\VV2YW!2K1980\:E'8R
MZ3;Q+>M/FO:]4.8Y71#(D1QWTBA?4
M                       +*N1/+*D:)Y'\*=%3NOGUKN?+2\[1I=#MC=6'
M09:\^8"B(W"T24@X>(J.S>>1:B+9)%F7'C'[<.54TBXSD+U0
M                                           65<8N65(Y%;HYFZVK
M6O7]1L7%?<D)IV[V9\I$K?J@R1JHWGH^99GCTBKE8MV+KS=--V8ZA/9[G=)G
ML 7J@                                                     "W
M[E7O&M<:.-6]^0-QK3^Y5;3NJKML&>J4;YAY[9HZM0+R1<P*)I0V&Q?.R(^
M8RV#ID(L8QB*=GAF#ZS16P8W;6D=.;5AH'YEH?9FJM>;!B:QXC=;YG(VYU*(
ML;&!\9J@DDKYFUDD6_>3223SYOWB)D+V%*':H
M                               LJWARRI&H>8G!GBW.Z]?62Y<P<\FO
MF#OK=2(*RUOGC]JZ)V)://TWB.7:GJQ%22+)+S,Y.PZ.?.>\GW< +U0
M                               &-#U)>OUQ:X#\M+QQIV/Q"M6W+G4X
M.CS4S>(U?7+5E(_-=4XJQ1S5#$\U5=K>;13]B@8ZN2^W1,1,GA$(8P9+P
M
M
M                                                 " +IF>[!]?O
M[N> WQ.;= 3^@
M      "#OJ1^Z<=#']W+EM_)^8@)Q
M                         0=]*GZ='K9??Q5CXJ(L!.(
M                                         (Y.K[[ESSZ^]6W'_$^2
M =Y<%/I(N''WJW'KXHZ@ NI
M                 $'?/#W:+H*?WTC^2E3P$X@
M               #5V>4X>[![]^X;0_Q.4\!M$P
M
M
M                               $ 73,]V#Z_?W<\!OB<VZ G]
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MSYX;P]^N_P#\0-H?H2,H9LLMXW6)XS4^</.N?S';MX<&VQZN>/SQ#AW]=_\
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M*?Y'-_?S5C':HR_[@>-5+G*\N1N4DVC9NS_;4'*O'/6IZ9N/8SR5_P C>_\
M^:H8;5.7G<*.^ZGSE>7(3*J;1LO9_MZMRSPSUK.F7CT\EL^Q_P")KD!_-5[
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M4=+1S1A-+&'2S0FE]Z:$98^_":$?>C"-V+G#QX
M   (.^>'NT704_OI'\E*G@)Q
M &KL\IP]V#W[]PVA_B<IX#:)@
M
M
M                 ( NF9[L'U^_NYX#?$YMT!/Z
M                                  ,=CK6_3;]*7^W^H)_)(?#K6!]?
M;%^%U;]-(^#9S_M:9P_B*UOU"L+%A]FGXX
M          ..,Y+XX(QOG]M<%$_T6?P?!@58371P45/J?A^0;"<UTF'F4Q62
MZ.+!2QZ3^\;X1:2^."<W9^!2/]#G\'PX%4U$;#">Z&*D?TX][Y<BLET<4G@*
MR:4&,^C%0-Z<^_GX19%XF]&?>S\ O+=# 4!L0OFQXH(SZ47@?T8]_P"3(I)?
M'!BXYO23W_EP*I3WPP>!_HL_@^# M)HP8*)OV?\ <C:3F[/P*)_H<_@^' V$
MU$9R7QP837R8^91_9_W7RBTM\,4YKXXO WHS[V?@%9-&#"-T_MJ@H#8DT8)1
MNEPXXJ1_3CWOER*R7QP8QOEQXHO _HS^UQ_!P*I3Z47'&PQ>!_1CW_DR*R71
MQ3I-2D,TU-3ZGX?D&P*8M)HP0FOCBH&].??S\(M1ZWCP-]7]J;Y!1*-\F$%$
M;#!0SZ"^]\N12CUM=X'^AS^#X<#8H];R:Z."F?Z+/X/@P-BCUO7B,Y;H8(37
MQQ<-3ZGX?D&RQFNC@IBL-.;#S(*)_HL_@^# O1ZQ2/Z<>\;X!:32@E"^?"*@
M?Z'/X/AP+/:+3A[:X.,KZ3>_CX3#7=J@NE]M3BG]/X<_ 42GOA@[-7N\'F<$
M_HQ[_P F1@[=!?+[:W$-Z?\ #_",(SZ47=J]W@\SAJ^C']S_  1&DU.U5[_#
MYG%4^I^'Y!-W*O?#"'DBX9_3G]MC^%@83:\?]EVJ"Z3!Q#^G'O&^ :\]T,7;
MJ^O&#AJ>DWO?().U5M7MVW$4].?P_P (HC/I1=R@U^W:<)3TF][Y!.?1B[5!
M?+[:W$/]$;\/P'$7:JVKV[;B']/X<_ 43I-3N5?^+<17]E^#Y!-VJ"^7VUN(
M?T8]_P"3(UW;J]\,(>2+A']&?VN/X.!.DU.W0:_;M.(KZ?PF^' F[E6U>W;<
M57T%]_'PE$9]*+M4%TOMJ<$_HQ[_ ,F1&DU.W5[_  ^9Q3^G'O?+D3=R@[#'
M_9<)3TY_#_"*(SZ47:J]W@\SB']./>^7(G/HQ=N@OE]M;B'_ &7]U\HB[=7O
MAA#R1<-3ZGX?D$Z34[5!=)@XI_HL_@^# C/HQ=NKZ\8.$?T8]_Y,B+M5;5[=
MMPS^C'[3Y,B=)J=VKW^'S.(?Z'/X/AP)NU5[H8P\L7$5]!??Q\)1KNY5KY,>
M)PU/3GWS? 881TY</.[57O\ #YG$4^I^'Y!)V:"^7VUN(IZ3>]\@E/?#!WJ#
M7[=IP3^G'O?+D1GNAB[-7O\ #YG&/]%G\'P8$G:HKO!!X@J    RS?)T.6&P
MK>KM;BC=;1(6.NT>G1^R]5-)9P9\[JT,WFV%7MU=C7SR2RLWK)7D[55V;%)L
M=LU6<O#X50,Y*DO_  '/%8%3J\*C;U6H9:&FK5)-0T\9?>A/-TDT]%/-"67I
M>GV))X1GC-TTT)8?4S=+TTOU8Z(/):H52%EY4U&JRU>L5VFC5JU&2'2PI9XR
M34M%21A"78C2]+)2PGGC-TT\LLD-B/2]-#*;'\-?68
M       0=\\/=HN@I_?2/Y*5/ 3B
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M5SB-M:3K$?+%EM<:\B'K@A(.X6!'+=9PJV/Y^54Z.5443D#-+
M
M                                                          0!
M=,SW8/K]_=SP&^)S;H"?T
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MT6?P?!@1GT8NW5]>,'"/Z,>_\F1%VJMJ]NVX9_1C]I\F1.DU.[5[_#YG$/\
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MS=2.T5%V"/E9NR.&Q^[DQK+>*W&*-<*$SW8VDL7K94Z$KD!E[@
M
M                                                          (
MNF9[L'U^_NYX#?$YMT!/Z
M               ,=CK6_3;]*7^W^H)_)(?#K6!]?;%^%U;]-(^#9S_M:9P_
MB*UOU"L+%A]FGXX                                    ..,Y+XX(Q
MOG]M<%$_T6?P?!@58371P45/J?A^0;"<UTF'F4Q62Z.+!2QZ3^\;X1:2^."<
MW9^!2/\ 0Y_!\.!5-1&PPGNABI']./>^7(K)='%)X"LFE!C/HQ4#>G/OY^$6
M1>)O1GWL_ +RW0P% ;$+YL>*",^E%X']&/?^3(I)?'!BXYO23W_EP*I3WPP>
M!_HL_@^# M)HP8*)OV?]R-I.;L_ HG^AS^#X<#8341G)?'!A-?)CYE']G_=?
M*+2WPQ3FOCB\#>C/O9^ 5DT8,(W3^VJ"@-B31@E&Z7#CBI']./>^7(K)?'!C
M&^7'BB\#^C/[7'\' JE/I1<<;#%X']&/?^3(K)='%.DU*0S34U/J?A^0; IB
MTFC!":^.*@;TY]_/PBU'K>/ WU?VIOD%$HWR8041L,%#/H+[WRY%*/6UW@?Z
M'/X/AP-BCUO)KHX*9_HL_@^# V*/6]>(SENA@A-?'%PU/J?A^0;+&:Z."F*P
MTYL/,@HG^BS^#X,"]'K%(_IQ[QO@%I-*"4+Y\(J!_H<_@^' L]HM.'MK@XRO
MI-[^/A,-=VJ"Z7VU.*?T_AS\!1*>^&#LU>[P>9P3^C'O_)D8.W07R^VMQ#>G
M_#_",(SZ47=J]W@\SAJ^C']S_!$:34[57O\ #YG%4^I^'Y!-W*O?#"'DBX9_
M3G]MC^%@83:\?]EVJ"Z3!Q#^G'O&^ :\]T,7;J^O&#AJ>DWO?().U5M7MVW$
M4].?P_PBB,^E%W*#7[=IPE/2;WOD$Y]&+M4%\OMK<0_T1OP_ <1=JK:O;MN(
M?T_AS\!1.DU.Y5_XMQ%?V7X/D$W:H+Y?;6XA_1CW_DR-=VZO?#"'DBX1_1G]
MKC^#@3I-3MT&OV[3B*^G\)OAP)NY5M7MVW%5]!??Q\)1&?2B[5!=+[:G!/Z,
M>_\ )D1I-3MU>_P^9Q3^G'O?+D3=R@[#'_9<)3TY_#_"*(SZ47:J]W@\SB']
M./>^7(G/HQ=N@OE]M;B'_9?W7RB+MU>^&$/)%PU/J?A^03I-3M4%TF#BG^BS
M^#X,",^C%VZOKQ@X1_1CW_DR(NU5M7MVW#/Z,?M/DR)TFIW:O?X?,XA_H<_@
M^' F[57NAC#RQ<17T%]_'PE&N[E6ODQXG#4].??-\!AA'3EP\[M5>_P^9Q%/
MJ?A^02=F@OE]M;B*>DWO?()3WPP=Z@U^W:<$_IQ[WRY$9[H8NS5[_#YG&/\
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M[!K&,VJ"),>P1-$I?J /H@
M
M                              $ 73,]V#Z_?W<\!OB<VZ G]
M                                               &.QUK?IM^E+_;
M_4$_DD/AUK ^OMB_"ZM^FD?!LY_VM,X?Q%:WZA6%BP^S3\<
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M?3Q;4^]2O'QO:,'\DSQ_8O4?C"C_ %>M/X/T0WV%V7\:4'ZI76;"/K4^FX
M                       @[YX>[1=!3^^D?R4J> G$
M                     :NSRG#W8/?OW#:'^)RG@-HF      +'>IU[FQU"
MOO'>67Q"WX!IT0&V>ZK'3(HW4\X:HZQ=%BX'=M$A"6_CWL5ZEDF:Q>/45J1Q
M7)AXBF9;YA9]NU;L99(N%,)939RA$%W<6U( U6-GK.V.-VX9:KV-E:-4[JTK
M?5&3]MA=Q"6VB7^DS)#)N6;YDM@[.493#%-9LZ;*]G>137;*9(8BI@V>/0QZ
MM\!U,N.Y8._/XR+Y:Z5BXR*W/6DL-V.+I&=A6$-N6L1R7=+ZBRBB94Y5!N0I
M(J:.JW\%!B\B3.0P@O*0_=HN9G_F[_R4M& +[>A'US>)?2_XN;2TEOW7G(NW
M6N[[]F]J14AJ"I:TGZ\WKTEKO6]2;LY!W=-N5]RC-8DJ?)'.FFT6;E060-AR
M8YU$T@FY_HO7IL?61YQ?BUT+_P!)<!-_T]NH#IKJ4:#<<BM%UO9E5I3:^V+7
M:L5MB&J\%:O5NLL8.0?N2LJA<IUIF+.WL#'P3^?>*8Q%,'13[I<G#77>4(<
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MKO#19QJ[72A52X48NDXF3<3$HB8J2R<E9U&#HI\Q3<Q0R&
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M!:1BHZ^5>*M3*-?+-C935>(-I1-)4R>>X8Z)LD]KV .S
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MPTW5Y)TV+((I.FIE4?%\1/#DACDQ@Y>T.P0
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M>[:K$UKB:LSQ8OZS'UJ4F6^8B>F5%.\1*/:R:L@L8F?!:'+V&R$O@
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MV9K:MKY[>S#AU>+344(.#:Y^H>2DF?[4!B]^1_\ T\_)G[U)_P#'!K !L-0
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M[                         $'?/#W:+H*?WTC^2E3P$X@
M                        #5V>4X>[![]^X;0_Q.4\!M$P
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MBX>+-%SD]H95F?)/:]@#!<\CW^G,Y2_>QMOC5I("6[ROGW.W0GWZ5(^(WD
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M%69ZA=E.D3*[",XO0C5?)2^(5&6=;^D'Z1#^DJ>30L9D^/0;)">R;N^U#.<
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MRN]S;O!%?Y ];MR ^L5N3\65U_,0>[]A=VJIOFA],VK\Y7>YMW@BO\@>MVY
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MXLKK^8@]W["[M53?-#Z9M7YRN]S;O!%?Y!^9X[<@<?\ <+W'Z?K8W;^KC_\
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M?C)R1-V_Z'S=_L]N?]JB^>GZG_TA%NK/)#7E;9N_ZIRC#:CSK_5?\F.4/O\
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ML&RNGA5X3PZ6>EGGZ7IZ:EEZ:,/?Z3I:*6^239T9IYY4MH^ OY8
M                (.^>'NT704_OI'\E*G@)Q
M              &KL\IP]V#W[]PVA_B<IX#:)@
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M<H^T<-\Q;AKW#E]J<G8;'L9 =F ->CY8+&S"7-CC%+KD6Q7WW%DD;&*&3/A
MTS%;:V$ZG")JYSW5%BL9FNY.7'MB8.EDWL'* NHU[Y)=%[(H%&V)6^IG<%Z[
M?J?6;I +I<<\+)K0MIA6,Y%JIJI\B^ZHF9@^;YP8OL&QV9+[ #Z9YY'6A()%
M1?\ 4AM+Y$BF%BI/.-!'*152E,0JA4UN1!L%/@BA\8SV=O8<V/J@+X>573VD
M.GMY.IRZXFUK:KS<*U4KLW?CW=S3BT=1Q$2>XZ==[%&)UM*T2^&J*$&SE$\J
M8?'\7)SJY(3O9( Z0\CV?5]3AMRFC&V4<VIGR::/YG!54\N,5^2U936]:RJA
MCVR:.9*+MOAGS[!\^)@OLD. R[@&O*\C_P#IY^3/WJ3_ ..#6 #8:@ "";K"
M]#3475/S5]DQ]]<Z0Y(4.N'J4+L-& 3M-:M]21>/I>.J-^KI7[-PLBUEY*1.
MPDFCLCAB68=85:R29FZ"(8Q#WH:]?_@<@^D>)FZ9BS5Z+57DO4OBUR9M-)\_
M;X-E951_KF]K5="<>&+[=1DDC)&55QW4<.3]SO!(1T+.NARZVORW9]/'G^FO
M:+S8#WBMTB_S]084/:-.V1K6%F)N<UOM2%C(V/;/$SQ-5L2!'*S!&9;3#--H
M_._\^\5B$=W6H/FE^4B:;MNQ5TU*(;9G!*WMR/#E;-&VOX67H<?8DE'"INZF
MUS-5VW*'4SV%)XQ^WZ'(#8L@,0+RPV8@4.)'$VON,H?-/)\C9R7B"Y4+AWF!
M@]9V%E8\HI9SWC-\2-BJOB&QCNER9(ILE[Y>T)D.B9$ST+T@>%3.QJJJR"VA
ME)9N9;Z/$#/3EEGJJEZ,?K9*O)0Y"?[PF/9S]$ Q2/(]_IS.4OWL;;XU:2 E
MN\KY]SMT)]^E2/B-Y  +H^F[$R\_Y.%3H*OF,2>FN$O)J)A#%+DQBR\D;<K.
M--@I38R8V'BR.>S&0$(7D<#^OI[>YSQCGP?FJ>:WTH_AL&53PXS7XZSWYO9C
M)(Y]LHCB2E*GXA\>P0WAE-[)R ,] !KRNF?_ -E7<A?OK>I3_P ]WH V&H
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MEM_)^8@)Q
M     0=]*GZ='K9??Q5CXJ(L!.(
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M\R[,XSXQG&5,J^W[P#NL
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M$&X$U^1W"NR;QV)J.WK,)T5_8%2E2Q(LZ)G5J\H1FHZ-V)Q>)U9;VY2>JAS
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MK*KB\65F10K:S[(M4D]M5_G&>7"1%C1)[1,224<5<OC(QC-FW/[*("^$
M   $'?4C]TXZ&/[N7+;^3\Q 3B
M                      @[Z5/TZ/6R^_BK'Q418"<0
M                                      1R=7WW+GGU]ZMN/^)\D [R
MX*?21<./O5N/7Q1U !=2
M              (.^>'NT704_OI'\E*G@)Q
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M:N,,]KEOKT':J])$PG(P-DB6$Y#/TR'*H1-[%R;=5!TGA0I#8P<AL8R3&?2
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M[.ST@/MP             ! %TS/=@^OW]W/ ;XG-N@)_0
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MY/S$!.(
M  "#OI4_3H];+[^*L?%1%@)Q
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MA%55SM&UL&)GE>*\2SG#B-K\,UB8-L8AO!6]0EGQ"$4?+=X)5P
M
M
M              $ 73,]V#Z_?W<\!OB<VZ G]
M      ?.Q]2JD5+O[!%UFO1L]*X7+)S;"%C6<O)E<+ING&'\DW;%6>84<HIJ
M'\0YN^=,IS=IBXR ^B                       !!WU(_=..AC^[ERV_D_
M,0$X@
M(.^E3].CULOOXJQ\5$6 G$
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M<F,5.#JS),TPDW14R6+S"5IF9+S5S@H#8@@
M
M
M" +IF>[!]?O[N> WQ.;= 3^@
M                 "#OJ1^Z<=#']W+EM_)^8@)Q
M                                    0=]*GZ='K9??Q5CXJ(L!.(
M                                                    (Y.K[[ES
MSZ^]6W'_ !/D@'>7!3Z2+AQ]ZMQZ^*.H +J0
M                             !!WSP]VBZ"G]](_DI4\!.(
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MH^#9-B)]U#&<A>$
M
M                                         ( NF9[L'U^_NYX#?$YM
MT!/Z                                                      (.
M^I'[IQT,?W<N6W\GYB G$
M                !!WTJ?IT>ME]_%6/BHBP$X@
M                                 CDZOON7//K[U;<?\3Y(!WEP4^DB
MX<?>K<>OBCJ "ZD
M         0=\\/=HN@I_?2/Y*5/ 3B
M       -79Y3A[L'OW[AM#_$Y3P&T3
M
M
M                       0!=,SW8/K]_=SP&^)S;H"?T
M                                        0=]2/W3CH8_NY<MOY/S$
M!.(                                                       "#
MOI4_3H];+[^*L?%1%@)Q
M              !')U??<N>?7WJVX_XGR0#O+@I])%PX^]6X]?%'4 %U(
M                                                   @[YX>[1=!
M3^^D?R4J> G$                                     :NSRG#W8/?O
MW#:'^)RG@-HF
M
M
M     @"Z9GNP?7[^[G@-\3FW0$_H
M                      @[ZD?NG'0Q_=RY;?R?F("<0
M                                        $'?2I^G1ZV7W\58^*B+
M3B                                                      ".3J
M^^Y<\^OO5MQ_Q/D@'>7!3Z2+AQ]ZMQZ^*.H +J0
M                                !!WSP]VBZ"G]](_DI4\!.(
M                               U=GE.'NP>_?N&T/\ $Y3P&T3
M
M
M                                                0!=,SW8/K]_=
MSP&^)S;H"?T
M     0=]2/W3CH8_NY<MOY/S$!.(
M                       "#OI4_3H];+[^*L?%1%@)Q
M                                       !')U??<N>?7WJVX_XGR0#
MO+@I])%PX^]6X]?%'4 %U(
M                @[YX>[1=!3^^D?R4J> G$
M              :W_P HKX=<J=O=5;=M[U?Q^VM?J9*TO2J$=9JI3I>9AGB\
M9JFK1T@BB^9-SD.JB^;+I*%[>\4R><9P V0
M
M
M                            " +IF>[!]?O[N> WQ.;= 3^@
M                                             "#OJ1^Z<=#']W+E
MM_)^8@)Q
M    0=]*GZ='K9??Q5CXJ(L!.(
M                    (Y.K[[ESSZ^]6W'_ !/D@'>7!3Z2+AQ]ZMQZ^*.H
M +J0                                                     !!W
MSP]VBZ"G]](_DI4\!.(                                     UV_E
M!O4'YC\?^J-NK6.G]XSU)HD/4-,O8VNLH.FR#9HZF-5U62DE4G$U6W*_ZZ^<
M+JF+E7)<&5SW2EQ[ #8D
M
M
M             ( NF9[L'U^_NYX#?$YMT!/Z
M                              (.^I'[IQT,?W<N6W\GYB G$
M                                                !!WTJ?IT>ME]
M_%6/BHBP$X@
M     CDZOON7//K[U;<?\3Y(!WEP4^DBX<?>K<>OBCJ "ZD
M                                         0=\\/=HN@I_?2/Y*5/
M3B                                     -79Y3A[L'OW[AM#_$Y3P&
MT3
M
M                                                       0!=,S
MW8/K]_=SP&^)S;H"?T
M            0=]2/W3CH8_NY<MOY/S$!.(
M                              "#OI4_3H];+[^*L?%1%@)Q
M                                              !')U??<N>?7WJV
MX_XGR0#O+@I])%PX^]6X]?%'4 %U(
M                       @[YX>[1=!3^^D?R4J> G$
M                     :NSRG#W8/?OW#:'^)RG@-HF
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M&KL]=:O-ZFBY)TK:XZPZY/*$O,0X:G9%3\^BS0LMAT0JN>YY@KZ>X O'
M                             <9T[:LFR[QZZ09M&R1UG+ITLFW;MT4\
M=Y15==4V"HIE+C.<F-G&,?5 =9UC>ND;O..:Q2]QZJM]E9K&;O*]5]AU&?G6
MBY"]\Z#F)B9=5P@M@OLY*9,IL8SV]@#M4
M                   0!=,SW8/K]_=SP&^)S;H"?T
M                                    0=]2/W3CH8_NY<MOY/S$!.(
M                                                      "#OI4_
M3H];+[^*L?%1%@)Q
M          !')U??<N>?7WJVX_XGR0#O+@I])%PX^]6X]?%'4 %U(
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MTS/=@^OW]W/ ;XG-N@)_0
M              ! 3U9[;\P//CHUWKU/]5_F*V#S=MN8OSOS#U2^9SC'ZL>I
M_GN6ZWF?C>9^'XO@J^'XG?\ #4[.X;;L^J?X=7JG4OX3^"_PRFHJ/I]CINE_
MA)X2=-TNS+TVQTVSTNS+TW_6@X.5%M=3>3.4>47^#?X;[@5"N5[^!Z?^"_AO
M\$J])3_P?\)TD_2=/TG2=/TD_2=-TW23=+L.Z_GLV/K!8_&IG^;8?TW:O_'G
MBW[0^F_7H1[VOTQ'U2?/9L?6"Q^-3/\ -L&U?^//%OV@Z]"/>U^F(^J3Y[-C
MZP6/QJ9_FV#:O_'GBW[0=>A'O:_3$?5)\]FQ]8+'XU,_S;!M7_CSQ;]H.O0C
MWM?IB/JD^>S8^L%C\:F?YM@VK_QYXM^T'7H1[VOTQ'U2?/9L?6"Q^-3/\VP;
M5_X\\6_:#KT(][7Z8CZI/GLV/K!8_&IG^;8-J_\ 'GBW[0=>A'O:_3$?5)\]
MFQ]8+'XU,_S;!M7_ (\\6_:#KT(][7Z8CZI/GLV/K!8_&IG^;8-J_P#'GBW[
M0=>A'O:_3$?5)\]FQ]8+'XU,_P VP;5_X\\6_:#KT(][7Z8CZI/GLV/K!8_&
MIG^;8-J_\>>+?M!UZ$>]K],1]4GSV;'U@L?C4S_-L&U?^//%OV@Z]"/>U^F(
M^J3Y[-CZP6/QJ9_FV#:O_'GBW[0=>A'O:_3$?5)\]FQ]8+'XU,_S;!M7_CSQ
M;]H.O0CWM?IB/JD^>S8^L%C\:F?YM@VK_P >>+?M!UZ$>]K],1]4GSV;'U@L
M?C4S_-L&U?\ CSQ;]H.O0CWM?IB/JD^>S8^L%C\:F?YM@VK_ ,>>+?M!UZ$>
M]K],1]4GSV;'U@L?C4S_ #;!M7_CSQ;]H.O0CWM?IB/JD^>S8^L%C\:F?YM@
MVK_QYXM^T'7H1[VOTQ'U2?/9L?6"Q^-3/\VP;5_X\\6_:#KT(][7Z8CZI/GL
MV/K!8_&IG^;8-J_\>>+?M!UZ$>]K],1]4GSV;'U@L?C4S_-L&U?^//%OV@Z]
M"/>U^F(^J3Y[-CZP6/QJ9_FV#:O_ !YXM^T'7H1[VOTQ'U2?/9L?6"Q^-3/\
MVP;5_P"//%OV@Z]"/>U^F(^J3Y[-CZP6/QJ9_FV#:O\ QYXM^T'7H1[VOTQ'
MU2?/9L?6"Q^-3/\ -L&U?^//%OV@Z]"/>U^F(^J3Y[-CZP6/QJ9_FV#:O_'G
MBW[0=>A'O:_3$?5+\^>S_P#B!_RJ?^TX#:P_'GBW[0\CT:.Q_-K],?NI3^>U
M_P#B _RJ_P#M-Q3:L_'OBO[0\CT:6Q?FU^F/W4?/:_\ Q ?Y5?\ VFXRAFJA
M&ZWO%?VECUZG_AM#AK]U*?SV[_WW[_*M_P"TV%)<T\(_=!L1^"?M+&/1K;'\
MVFS\\_NIXYZN'9GL];]^']5;/\VHSAFDC&.Q#*#Q3]I.O6_\-/IG]U/'Y[E_
M[[[_ )5__::C/:A_TA\4_:4^O9_\,_IK]TJ?SW7_ -]\_P K'_M-1GM/;/W1
M>)_M3R/1M['\V?TU^Z7YGJ[]GIX^9_&Q_P"TU&<N9OIONC\3_:F/7N1V=C:Q
M]_XZ_=+P^>\_^^]_Y6?_ &F@RVF?])/$_P!J8QZ-[8OS8_37[I>&>KYV9[/6
M]?Y6<_+K,5AF5V?NFV/D?[4QZ^#WMG:Q^F_W2\<]7[LQV^MY_P K79V_Y,QG
M#,GL_=-XE^UL(]'%&$82[5_O_'?[H>'SX#_WWC_*U_[3,9PS(0C=E1XE^UO)
MNCCZ6/VK_IO]T/#/6#[,]GK=_P#*WGY=8C.&8V$;LJ/$?VQYU\G_ (7_ $W^
MZ'CGK"=G_>[?Y6\_)K$9;1?^E/B/[8QCT<\(?S7[/SW^Z'AGK$=F>SUNWL^S
M_P!US^I_Y,12&8C9AL]57B/[8QZ^C_PN^F_W0L:XJ\O?6R;HYL[?_4]^;?UX
MF\8S<_S/?-9\S>-=>IM4;5CYF_5;YF7_ ,UW?\U\?SSS:+[O?\/S7/9XAJ0S
M"0C'8AE9[_P#]L8]?3'O6?3<?4Z]_/6-[,_2Z8_#MW/\UXIM ?Z6^(?MK&/1
MU['\UGTW'U.\?GQ__ON?^5W_ -I@,X=#]"-V5WB'[:QZ^V.SL;5<.'?W.I_/
MDO\ WW+_ "O?^TO&4.A\V;LKO$/VUCU]_P#X5_3G[G>)NLIW?^]Q[?\ RO\
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MUI\X]C/&K_+)_P"TK&<.ABV?NXV/FW]O>=?]_P"$WT]^YGY\^H_]]J_RR?\
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MOK8?\M7_ +24>QZ$38_G"^B8^LE:/_="_P"$_FAZ7_\ V#]R*6>N/V?]Z_\
M4[?]NO\ L]GUI1CUHT=6<'Z)_>3<H_\ = /X3^:7I?G[]RJ)NN9W>W_0O=O9
M_4W9_P"TC&'6DQ[X$."H>LFY)T>T)_YJ=CY]_<ZEGKH]F,Y]:Y_EM_\ :1CS
MK2O_ ! ^BOWDW).CJZ?^:WI?GO\ <ZB;KK=G_>M=O_ENS['L]GUH?ZHGUIO^
MGWT5^\FY)T;_ $_\V/2_/7[I4S==KL_[UG_+?_9[/K0_V!Y'H3MB&SU??17[
MR;LG1J=/_-KTOSS^ZE$W7?[,9_T*_H_\>'_M'QA'H4>UE]]%?O)N2=&3T_\
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MFEGDA_UIY/JMB3MS0GFV->Q#WTQ(_F+X>
M           "#OGA[M%T%/[Z1_)2IX"<0
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M]W/ ;XG-N@)_0
M      !CL=:WZ;?I2_V_U!/Y)#X=:P/K[8OPNK?II'P;.?\ :TSA_$5K?J%8
M6+#[-/QP                                  !2-Z">]\F 2GOA@XY_
M3CWOER-A@I'^AS^#X<"LET<4X?QGMVU$6DOC@E-='!3-]&7\'PY%7D^C%3&P
MBXXO+=#!C/HQ>!_1CW_DR*27QP14A5Y-='!1/]%G\'P8&P@\#>C/O9^ 6DT8
M"@+4>M*>^&"FI]3\/R#8H];!3%I-*"4]\,% WIS[^?A%Y-".$&"AGZO[4O\
M[$4AIS8>9*.A+CYU%3ZGX?D&S)HP8*8O)='%AKGPXE']A_=?(*R:4$9KHX**
MGU/P_(+,8W28P4S^C/[7'\' V$E WIS[^?A%9+HXO)KHX*2GU/P_(+T>M!3%
M'D;Y<>**@;TY]_/PC83CH2X^=X'^AS^#X<"LET<6"B-B2Z.*4]\,%(_IQ[WR
MY%I+XX)S71P> JPI-3CBTFC!-2-]7WL_PQ:CUI_QGMVE(_T.?P?#@;B:F;]C
M^UQ\HSDOC@Q[#P<3Q%);H8)37QQ<<;4M\,6,UT<'&-Z,^]GX!2&G-AYD8W2X
M<<5(_P!%G\'P8&Q)='%XI']'X,_"46DOC@UW'/Z<>\;X![2:FU07R^VMQ3^C
M'OF^$3=B@OE]M;BJ>C/O&^$PE'0EQ\[L4.C[?A<0_P!#G\'PX&#LT-\N$.)Q
M#^C'OF^$:[LU;5[=MQC>G_#_  C#&?1B[%!J\#AG^AS^#X<"+LT-TN,.)Q5/
MJ?A^03])V*O?#"'DBXIO3_A_A&$W:H;X8Q\CAG^AS^#X<"6J?'C=BAOAC'R.
M*I]3\/R",;_ZT/([%7N\'F<8_HQ[YOA$G9H-?MVG$/Z<_ML?PL#&?1B[%!K]
MNTXA_1CW_DR(NQ0:_;M.*?T_AS\!1A/=#%V*#7[=IQ3>G/OY^$2=B@U^W:<,
M_HQ[_P F1&?2B[-#=#"/E<8W[+_V_P#<#":Z.#L4-T,(^5Q#>G/OY^$0=JKW
M0QAY8N,,9]&+L5>Z&,/+%PS?LO\ V_\ <"+LU;5[=MQ3?5_;&^01GTHNS5[X
M80\D7$/Z<?M_ER,79H+I?;4XI_1CW_DR-=V:&^&,?(XBG_LL?^P&,^C%V*&^
M&,?(XI_3G]MC^%@1=BAOAC'R.(;ZOOY_@#&?1B[%#?#&/D<4_I_#GX"B+LT&
MOV[3B'].?VV/X6!&?2B[%!K]NTXA_1CW_DR,79H;H81\KBG]/X<_ 4:[KT&O
MV[0T?/8MZSDXQXZCI*.>-WT?(,7"S1ZQ>M%DG+1XT=MS%4:NDG)$SIJ$,4Y#
MDP8N2FP7(E2R24DDU'22PI:.DATL98PZ:6,L?J9H1EFTH1[*#L44LL\)I9I>
MFEF^IC+-=&'2Z,S99\<+T^VCQYT-LV3)W9+8NF-77Q^7!%,=U[;J/!6!T7NN
M'KA3'8XD%/8.X7/_ +I90W:<WT'MVIR6=;=LV?1_\W4:W3T,N%%33R0U0[7_
M %880?62U*O+5+3M&JR:-5IZ:CAA)232]J75+#5#!W4.8T@
M                       !!WSP]VBZ"G]](_DI4\!.(
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M4U3@%U6Z9Y%O!7JV6^5L^&3@Q<F;MCO*#5\+E+G'?,1'M[W< 9\0#7E=,_\
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MTS/=@^OW]W/ ;XG-N@)_0
M              !CL=:WZ;?I2_V_U!/Y)#X=:P/K[8OPNK?II'P;.?\ :TSA
M_$5K?J%86+#[-/QP                                  !2-Z">]\F
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MI_C&N_K-*^MN4'U^MOX96?TTZZ4?'G(
M        $'?/#W:+H*?WTC^2E3P$X@
M      #5V>4X>[![]^X;0_Q.4\!M$P     !8[U.O<V.H5]X[RR^(6_ -.B
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M9K<XT6CIXNH8M^:QS-WD&"_8HUC;%8"5[U+37316.SI_JB0JK*39K'#+T
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M@J4H3F^5^>Y\<??OR:G\26] $I709]R(X/?N837QC74!(3R4V;+:4XY[]W+
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M)$F4%5^0T%"L?UR8J[) J;:%V2VCVYE9:"0*1%RDBK*PJ1697L=#ADV@
M                                       @"Z9GNP?7[^[G@-\3FW0$
M_H               ,;_ *G7E#^MN ?)VB\8M<:DK7)NT2$=&K[4D8?=*%01
MU1-S<\6-B*C)(1VOYXCZS9BBFD'+55=FLT0>,O$)_3/>(&2   ,=WJO>4/\
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M@G\DA\.M8'U]L7X75OTTCX-G/^UIG#^(K6_4*PL6'V:?C@
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M0                                     (.^>'NT704_OI'\E*G@)Q
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MEZO$U=HN9[-2F4DVYIJTV.4<.).X3V6R*"1G\H\>/,HMDD<K>$D0A0^3Y?\
M!_B[STUY :IY8ZPQM:A5:YL]A0,%\VFPJ-EA;V$'/5QK+XE=;VV'>N.["V:=
M1\W6<J-3>>^(=$RJ2)TP[4T/HG5/&745&T1H^JXI&J=;Q2L)2ZKB:L5C]1HQ
M>0>RJK;U;MLL_DI+)G\@\4RH[>+J=JO9W^Y@I<!V;*Q4;.QLC"3<<PF(:78.
MXN6B91HWD(R5C)!NHTD(Z1CW:9TGK%=JLLDLBJ0Z:J:QB'*8ILX 0N[L\GAZ
M2.[YN3LTCQ:8:YL,N<QW;W3%TN^L8A(YLFSWH^B5Z>+6XOL,8V>QM#)8SV^W
MP;&"]@>JT7Y.?TFM$V>&N3/CJYVC8J^X*ZC5MUWBT;$@?.2?0+2-$>/D:].8
M+Z2IOXERD4W8<I,'Q@V F\8L646R:1T<T:Q\='M6[%@P8MTFC)BR:)$0:LVC
M5 A2-6B2":9$TR%P0A"8*7&,8 <L  6,\RNFWPJY^146PY3Z)K6PY2 )E*N7
M5J[F*?L2 ;Y,JIF/CKY3I%C*&A<K*J*'C5W*T:JKV*JM#JE*<H1H4GR8'I)T
M^U(69_JW:%];-7>'J%2NVXK8O5<'(;)T$5V]:-&/'[4AO#SX3AZL17")2."K
M)Y.0X3NZYUKK[3](KFM=54JKZZU_48Y*)K%-ID)'UVMP4>EDQRMHV)BVZ:+8
MN5#*'/G!.\HHL=53)U#F-D(R+ET*>E5>MQ2V_I7BLA"[<F+BEL%Q;M>[FY":
MI.RNZ+Q&23M%?A-7[9AXVJS&)5NF\\:,9LS9>Y.\-VN5%%3A+80N"X*7'>S@
MI<%[3&.<V<%]C&3'.;.3&]C';G.<FS]4!Y@
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M?1+*[[*\I_C&N_K-*^MN4'U^MOX96?TTZZ4?'G(
M                $'?/#W:+H*?WTC^2E3P$X@
M              #5V>4X>[![]^X;0_Q.4\!M$P
M
M
M                              $ 73,]V#Z_?W<\!OB<VZ G]
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MW2Q/L_M2>Q[ "*SR-!@AG/44D\YP9R3'$]@3'9CO)(*9Y(.%L]O^Y.HFC_\
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M*7^W^H)_)(?#K6!]?;%^%U;]-(^#9S_M:9P_B*UOU"L+%A]FGXX
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M^EF4!1>:?$RZ3LDNDUCH2I\C=/6*6?N5C=U%LRC8>Y++.G!S9["D(0QC9]&
M%V>,XSC&<9QG&<=N,X]&< /CK_L.@:HJ$WL+:5YI^M:%6FZ#FQWB_P!FA:=3
MZ^V=/&\>V<3=DL3YLRB6ZD@\9H$.NNF4ZSI)(N<G.3&0ZCU)S#XD;_LKNF:(
MY2\<]UW!A#N;$^JFH]W:SV19&-?9NV,>[G7<'3K,]=-H=)_*1B"CHZ14"+22
M"1SE.LF4P7' .N]H;=U1I&I.K_NC9VO=0T1D[8L'MUVA=*W0*DT?2:Y6L:R=
M62UR31FW=N')BIH)G6P=4^>X3!C>P ^%T]RMXN<AY*8AM \E-!;QF*ZQ0D[!
M%:>W'KO9DE!1KIQYJVD)AC2[$]5C&*CK'AIJKD(F=3VA39-[ #M^T6JL4J"D
M;1<K' U*M0Z&74M8K/+Q\#!1;8N<%,YD9:5<)-V+?&3>R=10A?[("..[]:#I
M5:]>98V#G=QY>.,+90-\QMT3V,@17&<E-A1WKQO*(IEP;'9DQCE+CL]G("YW
MCQS3XE<LT)!7C9R*U)N=>(2(O,1-%ND-+6*&;J^'A)W,U?#@LC$M3F4*4BKA
MJDF<_>(4V3E-C 7/ .N-J;?U1HVG2&P]T;+HFIJ'%&23D+CL>V05+K+5=?O>
M;M59JPOV[?SQ4Q#%11PIXJQ_:)D.;V %AE7ZS_2KM\\I6XCGAQU;2*1\)Y6L
MEW0I<(<Y\Y*7"%FN*#"-<>VQZ4W9\>S_ &< )*(J6BYZ+CIR#DF$U"RS%K)Q
M$O%/&\E%RD:^03<L9".?LU#I/F*S=1-1)5(YR*$4*<AC%-C(#V0
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M7F;;/4K+FTUQW5I4L]7$X]:31S%O%#&\WPG*,LD4P;)3^)G'I*8!=T
M            +8>9O*.J<*^,&X>4=XKMBMM7T[6D;#)UNJ>II9^8R^FHNO,&
M;%27>(-T<9DIAGE9113]:0(JH1)90I$3ACD-?*$>HS;*TIN'7?0RY"S&AFD>
MK._-8ZL.T5E)VL$2,Z3L</-L>.^&N8G#%-199=HVE6J).\8SG)"&/D)H^F!U
M2M"=4S3<[LK44?.4JXZ_E(NO[9U+;',>ZLE%EYEDX>PKU&0C%,I3]/DBQ\P6
M+D\)-3NC0+U-9FT<-ED"!)D
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M4UROV$AE%ZK3&?JA0-(QC[&2K926BHY]ZMWK*+DI<86?2+)@\3[Q7<%W3F(
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M8NQ0WPQCY'%/Z<_ML?PL"+L4-\,8^1Q#?5]_/\ 8SZ,78H;X8Q\CBG]/X<_
M41=F@U^W:<0_IS^VQ_"P(SZ478H-?MVG$/Z,>_\ )D8NS0W0PCY7%/Z?PY^
MHUW7H-?MVG&-]7]L;Y!C/HQ=FANAA'RME9Q:ILIKGC+QTU[.$6)-T31&HZ=+
MIKLW+!9.4J^OZ]"R!%F+PA562N';%;!DE2E43SCN'P4^,X'T(RAK5'7K?MRN
MT/\ S-=KE9I9/?A-]324T\\OU4NS+'ZF:^7ZF.I]9K8IY*U:UJ5JCC_P=8K%
M//+]5TWU,]+--#WY?>C[T;X8N^AR'/
M       $'?/#W:+H*?WTC^2E3P$X@
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MSK]S';'V=!0ZQ3%D]N7*$6S1H&2[5,$9IU_6;^0EW*ZIBMD4-A&6<')Y@<Y
M^ \CN^FAY?\ [@E/^,-N R!>O9TRN1/4_I'%G5>B9VD5:,I6UK99MEV:_3TC
M&PD! /ZLVCH^11AXB/=.K)*863>IMVZ*'L*N<86<-6ZBK@@6/:J\D#X50< U
M3W/R/Y*[#M>6":4@^H*NM]85CU0,F7#AU'P,Q2;,\13*KWO!(K*JE*7_ $W"
MGU QXNK7TT[YT*^2W'/</&3?EQ?UV\/;1;-*WE^6/BMIT"X:O=UO%B@+.M"L
MDHVR1ZD;=*_DC@K-LVE&[^0CWL21NCG+P-B+PJY#/N1/"?C=R;O*+&N2VT-
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M9,W?;+%P&8*
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M:28VK91$XE-O N6OG!'S9@]9M7Z"QVSANY06\W5#(SZ%_1M;]+?5MPM>T)N
MNG*3=+:';W^9K?C.JO0JA#*+/8K6]0DWS-%Q)%-).5'DR_\ ";I/W;9BBFWR
MA%MW+D)/>;?$+6/.WC%M3B]MK#EM5ME0J3=I8(U%NM-TRTQ#UO,U.YP6'..[
MZI1L^Q8K^'DQ".D2+,ES>;.5BY#!KUQP6\HHZ-U\OE8X=0<]M'4MMF,OEGVK
M6%(VYK"]JM4DVC*R/=7W#*DO0[9ZGE8HNW!8]@X4*S(U+)23)HF<!S'72YZ[
MW62WE1[-U!G%AT_JVIJF8XLNT&]+I\51:\^6:N)]KK#0]*40</[<\;M6I3/'
MC%JF\.P;)RDWW&R)"!GI\?-$ZYXQ:1U=Q]U)$FA-<ZCIL-2JJQ6.DL]58Q#8
MJ:TI,.DD4\2,^^?&=OI!UX9#.GT@X<G+@ZN0'<8       ,?SJ\5>0O/.CH\
MTB)69MY:X77G-5HQQ(J+(1[>0L'%Q2)9*OE&K=91-F5P\3,J9-)4Y2$-DB9\
M]A<[MEUFBJ5I6?7:66::CJM8H:2:672C+1SPGFZ79C"'3;$OO;,TN+XUEC8]
M9RAR0RJL"ITDE%7+<LVNU.AGI)II:.6EK-6I:&2:EC))//+)+//+&>:22>:$
MNSTLDT?>>U^=:\@OZ\--_P#I^Z?S>#^P[95A?>E;_)T/+OH-UG^<ON[8>^:_
MZK/G6O(+^O#3?_I^Z?S>!ME6%]Z5O\G0\N=9_G+[NV'OFO\ JL^=:\@OZ\--
M_P#I^Z?S>!ME6%]Z5O\ )T/+G6?YR^[MA[YK_JL^=:\@OZ\--_\ I^Z?S>!M
ME6%]Z5O\G0\N=9_G+[NV'OFO^JSYUKR"_KPTW_Z?NG\W@;95A?>E;_)T/+G6
M?YR^[MA[YK_JL^=:\@OZ\--_^G[I_-X&V587WI6_R=#RYUG^<ON[8>^:_P"J
MSYUKR"_KPTW_ .G[I_-X&V587WI6_P G0\N=9_G+[NV'OFO^JSYUKR"_KPTW
M_P"G[I_-X&V587WI6_R=#RYUG^<ON[8>^:_ZK/G6O(+^O#3?_I^Z?S>!ME6%
M]Z5O\G0\N=9_G+[NV'OFO^JSYUKR"_KPTW_Z?NG\W@;95A?>E;_)T/+G6?YR
M^[MA[YK_ *K/G6O(+^O#3?\ Z?NG\W@;95A?>E;_ "=#RYUG^<ON[8>^:_ZK
M/G6O(+^O#3?_ *?NG\W@;95A?>E;_)T/+G6?YR^[MA[YK_JL^=:\@OZ\--_^
MG[I_-X&V587WI6_R=#RYUG^<ON[8>^:_ZK/G6O(+^O#3?_I^Z?S>!ME6%]Z5
MO\G0\N=9_G+[NV'OFO\ JL^=:\@OZ\--_P#I^Z?S>!ME6%]Z5O\ )T/+G6?Y
MR^[MA[YK_JL^=:\@OZ\--_\ I^Z?S>!ME6%]Z5O\G0\N=9_G+[NV'OFO^JSY
MUKR"_KPTW_Z?NG\W@;95A?>E;_)T/+G6?YR^[MA[YK_JL^=:\@OZ\--_^G[I
M_-X&V587WI6_R=#RYUG^<ON[8>^:_P"JSYUKR"_KPTW_ .G[I_-X&V587WI6
M_P G0\N=9_G+[NV'OFO^JSYUKR"_KPTW_P"G[I_-X&V587WI6_R=#RYUG^<O
MN[8>^:_ZK/G6O(+^O#3?_I^Z?S>!ME6%]Z5O\G0\N=9_G+[NV'OFO^JSYUKR
M"_KPTW_Z?NG\W@;95A?>E;_)T/+G6?YR^[MA[YK_ *K/G6O(+^O#3?\ Z?NG
M\W@;95A?>E;_ "=#RYUG^<ON[8>^:_ZK/G6O(+^O#3?_ *?NG\W@;95A?>E;
M_)T/+G6?YR^[MA[YK_JL^=:\@OZ\--_^G[I_-X&V587WI6_R=#RYUG^<ON[8
M>^:_ZK/G6O(+^O#3?_I^Z?S>!ME6%]Z5O\G0\N=9_G+[NV'OFO\ JL^=:\@O
MZ\--_P#I^Z?S>!ME6%]Z5O\ )T/+G6?YR^[MA[YK_JLSTM>0.?\ W<-.8_\
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M0)YW(_=#DW"/PRT_4ZGGHZ<FLYSGYN=$^S_X3; _FQ%(=$OD)"&Q"R;7V/\
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MWK+M39_\FJ<]="CR5M"2^FH?[T_)/N3= /F,;MSC97&?V<>Q_P"YCM+V??\
M^LV)]<)D9&^R[3C_ &-5Y\WZ/)^N27TE%'^M/Z"@;R?[F1GT;+XS8]G^O+:?
MH_$R/(]$%D9'^3+4_(U7GK?H[*K$FE22;&,WHJ)O)^N96>W_ *Y?&7/;[/\
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M4L8]-/[VQTO2QT<B0?Q!_.P
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M.3J',J^D'#M9PY>/'"BKMZ\>+O':RSE954X=G
M                                  ( NF9[L'U^_NYX#?$YMT!/Z
M                          PXC]+GEMR]\H<M_+ODSI"<J7$34]_:V[7U
MCL,M4W\%?H[0D'7JIIJ(@XJ-L#IT5G+W*+C[.Y0>-$R*,223=V5%9<J(#,=
M                      !!WU(_=..AC^[ERV_D_,0$X@
M                                         (.^E3].CULOOXJQ\5$6
M G$                                                      $<G
M5]]RYY]?>K;C_B?) .\N"GTD7#C[U;CU\4=0 74@
M                                 "#OGA[M%T%/[Z1_)2IX"<0
M                               !J[/*</=@]^_<-H?XG*> VB8
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M@3@
M( NF9[L'U^_NYX#?$YMT!/Z
M                 (.^I'[IQT,?W<N6W\GYB G$
M                                   !!WTJ?IT>ME]_%6/BHBP$X@
M                                                    CDZOON7/
M/K[U;<?\3Y(!WEP4^DBX<?>K<>OBCJ "ZD
M                            0=\\/=HN@I_?2/Y*5/ 3B
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M@
M $ 73,]V#Z_?W<\!OB<VZ G]
M                  $'?4C]TXZ&/[N7+;^3\Q 3B
M                                     @[Z5/TZ/6R^_BK'Q418"<0
M                                                     1R=7WW+
MGGU]ZMN/^)\D [RX*?21<./O5N/7Q1U !=2
M                             (.^>'NT704_OI'\E*G@)Q
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M?L62K2LPRDXM..CRQRZ;PJK+#!$K8Z7A$[H7"@
M                                      ( NF9[L'U^_NYX#?$YMT!/
MZ                                                      (.^I'
M[IQT,?W<N6W\GYB G$
M             !!WTJ?IT>ME]_%6/BHBP$X@
M                              CDZOON7//K[U;<?\3Y(!WEP4^DBX<?
M>K<>OBCJ "ZD
M      0=\\/=HN@I_?2/Y*5/ 3B
M    -79Y3A[L'OW[AM#_ !.4\!M$P
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M+@
M                          $ 73,]V#Z_?W<\!OB<VZ G]
M                                           $'?4C]TXZ&/[N7+;^
M3\Q 3B
M  @[Z5/TZ/6R^_BK'Q418"<0
M                  1R=7WW+GGU]ZMN/^)\D [RX*?21<./O5N/7Q1U !=2
M                                                      (.^>'N
MT704_OI'\E*G@)Q                                     &KL\IP]V
M#W[]PVA_B<IX#:)@
M
M
M        ( NF9[L'U^_NYX#?$YMT!/Z
M                         (.^I'[IQT,?W<N6W\GYB G$
M                                           !!WTJ?IT>ME]_%6/B
MHBP$X@
MCDZOON7//K[U;<?\3Y(!WEP4^DBX<?>K<>OBCJ "ZD
M                                    0=\\/=HN@I_?2/Y*5/ 3B
M                                  -79Y3A[L'OW[AM#_$Y3P&T3
M
M
M                                                  0!=,SW8/K]
M_=SP&^)S;H"?T
M       0=]2/W3CH8_NY<MOY/S$!.(
M                         "#OI4_3H];+[^*L?%1%@)Q
M                                         !')U??<N>?7WJVX_P")
M\D [RX*?21<./O5N/7Q1U !=2
M                   (.^>'NT704_OI'\E*G@)Q
M                 &"1UR.EPOR:ZC>V]Q+<IM%ZI3L=5U.T;4^\/U$;&V0@
M-;UR",]=I&?HX(DNYCW!TNZ4V,I]TW>[V3%*&=N
M
M
M                                @"Z9GNP?7[^[G@-\3FW0$_H
M                                                 @[ZD?NG'0Q_
M=RY;?R?F("<0
M       $'?2I^G1ZV7W\58^*B+ 3B
M                       ".3J^^Y<\^OO5MQ_Q/D@'>7!3Z2+AQ]ZMQZ^*
M.H +J0                                                     !
M!WSP]VBZ"G]](_DI4\!.(                                     U=
MGE.'NP>_?N&T/\3E/ ;1,
M
M
M             ! %TS/=@^OW]W/ ;XG-N@)_0
M                              !!WU(_=..AC^[ERV_D_,0$X@
M                                                 (.^E3].CULO
MOXJQ\5$6 G$
M     $<G5]]RYY]?>K;C_B?) .\N"GTD7#C[U;CU\4=0 74@
M                                         "#OGA[M%T%/[Z1_)2IX
M"<0                                    !J[/*</=@]^_<-H?XG*>
MVB8
M
M                                                       " +IF
M>[!]?O[N> WQ.;= 3^@
M            "#OJ1^Z<=#']W+EM_)^8@)Q
M                               0=]*GZ='K9??Q5CXJ(L!.(
M                                               (Y.K[[ESSZ^]6
MW'_$^2 =Y<%/I(N''WJW'KXHZ@ NI
M                       $'?/#W:+H*?WTC^2E3P$X@
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MA
M
M    ! %TS/=@^OW]W/ ;XG-N@)_0
M                     !!WU(_=..AC^[ERV_D_,0$X@
M                                        (.^E3].CULOOXJQ\5$6
MG$                                                      $<G5
M]]RYY]?>K;C_ (GR0#O+@I])%PX^]6X]?%'4 %U(
M                                  @[YX>[1=!3^^D?R4J> G$
M                                :NSRG#W8/?OW#:'^)RG@-HF
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M7,V(UUUW >;&7_5$A_-,-L.^_P"9N?&RCW4O%#(P
M
M                                           ! %TS/=@^OW]W/ ;X
MG-N@)_0
M!!WU(_=..AC^[ERV_D_,0$X@
M                   (.^E3].CULOOXJQ\5$6 G$
M                                   $<G5]]RYY]?>K;C_B?) .\N"G
MTD7#C[U;CU\4=0 74@
M           "#OGA[M%T%/[Z1_)2IX"<0
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M>*-VR_C0CYHNW(HTRHJ$J(
M
M                         ( NF9[L'U^_NYX#?$YMT!/Z
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M#JU>H:Q/_P!62EDGC_\ "6:,7<8XS=
M                  0=\\/=HN@I_?2/Y*5/ 3B
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M[;UA1P0I^X9T2-EK=A')BY,4BZ_<,4ICXR&PP
M                !\/<MF:WUUZG8V#L&D47U7\[]2?FRM<%6,2GF/F_GWJ=
MZMR"'GO@^>-/%\+O^%YTGW^[WR=H?7,WC21:-7[!TV?,'S9!XR>LUTG+1XT<
MI%6;.FKA$QB.&RB*A#D.0V2'(<IBYSC(#XF+VOJV<M#NCPNRZ!,71BXD&KVH
M1=RKLA:&;F(.HG*MW4 TDCNVZ[51%8K@AT<&1RD;"F"=W(#L
M   >CL=FK=.AGMBMU@A*M7X_P//YZQRS"$AF/G3E!DU\\DY1PD@U\1XX;I)]
M\^.^HL0A>TYRXR'&JMRJ%ZBL3M(M5<N,)ERLSQ,U6<C+#%9=M^YEPUQ(Q#I9
M'S@GB)]\G?[Y._CMQCMP ^E
M                         $ 73,]V#Z_?W<\!OB<VZ G]
M                                          &.QUK?IM^E+_;_ %!/
MY)#X=:P/K[8OPNK?II'P;.?]K3.'\16M^H5A8L/LT_'
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MOY^$;$ET<6,^C%QAFB#9EOAB\FNC@XXI#3FP\R"B?Z+/X/@P+T>L4C>DGO\
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M4A]?UJM(2&*?K*+ET%#HS#UHXFIMY+/VN<-G+V5(T0.[:1;-ZY">H
M               8[?E.&\-T: Z<M>O&B-N;,TM=7/)C65?<7#5%ZL^O+0M
MOZ?L]V^ACV"I2C1V:+6=1L>HLW\;PE#LTC'(8Q"]@8U/#/B1Y0_SLX^U/DOH
MSJ#;U_4VN<A:8V$Q<N>/(&O6 [FH6.2JLOYS%(2CHK=/U6B7F$LY7SWT^Z?)
M2]O= >[W_K;RG#IG5)SR,O7)/?ESUI2S-7-HM[;D&3DK4*ND[>HL&Z]QU]LU
M])+'AS.%D2J/5819@W\8GG#EN<Y.\&3QT$>K+;>J'H#8B>X82"A^0/'R;JD!
ML5_5&BL;6KK7[NPG'%(O#6(564Q!S#M:I6QM(LD#G:$<0^';4K9!XFP9A/.
M          #!G\LO_P!=>G9_P?RN_P"<\<@&7YPF^DSXC_>QZ$^*JJ ,&?I4
M?]E'<C?OC.HU_&#;8#8:              ""ORE#W&;EK_PAQ[_E,:> 6Y^2
M@^Y9/?OG-N_Y@UV Z!W-P$ZS=CZT,-R/H^QMF->#+;ECH>^O:ZTY6NX>J&TS
M59/7:^PHHVGOFX3PM&JQ\/9DUHGU.,1]A8Y/!5(O[<,MX
M        &)%P8X"]9O6'5W2Y \@MC;,EN&!=K\FYYQ 3/*UU=JPO3[K4-L1^
MJV^=4'O#G"C5&>GJ:JW:F8%]33MDUNXCEIC) RW0
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MI?[?Z@G\DA\.M8'U]L7X75OTTCX-G/\ M:9P_B*UOU"L+%A]FGXX
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MV@/AW8/JUT2E^1>%H_\ L7]0R NM7"K_ /K,E$?5Q_10
M                              0=\\/=HN@I_?2/Y*5/ 3B
M                            -79Y3A[L'OW[AM#_ !.4\!M$P
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MWNT!WA UZ JT4T@JQ!P]<A&"?AL8:!C641%,DO3X;2/CD4T6Y.WZA"8P ]P
M .N;YJ'4^TBM2;-U?KO8Q&)3$9$OE*K5O(S*<W>.5J6P1KC#<N3>SG!.SMR
M\J'J/5&K$W2.L=8Z\UTB]*F1XE0Z76Z@F[(G[9,CE.OQS?#@I<^R7!\&[OU
M'8@"BLBBX250<))KH+)G2616(51%5%0N2*)*IGQG"B9BY-C.,XSC./2 Z$E^
M)W%BPO3R4_QIX_SDBHN9P=_,:;UU)O3KYSVY7,Z>ULZAELF]GO9-V_V0';-2
MI-,H,46"HE1K%+A"*&5)#5* BJY%$5/]&H6/AVB*)3YSZ<X)V@/J
M                8Q?E9WN7M6^^PU1_$;;@#H7H&=4KI]<9>F%I#3F^N5&L
M]8;-K=GW&[G*;97$RE+QS:P;9N$]#++E:0ZJ>4W$1(,UT\E4-[1<O>[#=XN
M]QUENOUT_P"P<)M\\=>-VT&_(G;.^]>SFK&Z-1KUF:4VEP=S;*0\_:K!;;)
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MM06LNM=N8@T4V=<M$@I$M9JO7R C"N%#0[.2BW2B;EH;/<1DH=]YM@K,S<A
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MOT=86 V:5<9*OLLSU+:P\>E$S&&[/N."I,6I#*(F-X!#=N $K0
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M@G\DA\.M8'U]L7X75OTTCX-G/^UIG#^(K6_4*PL6'V:?C@
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M^K71*7Y%X6C_ .Q?U#("ZU<*O_ZS)1'U<?T4
M                      $'?/#W:+H*?WTC^2E3P$X@
M                    #5V>4X>[![]^X;0_Q.4\!M$P
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M/7Y53<IZL]*64A8=9RG'[#Y":<IUJ*AC/A+P++YJ+\W2>YQ]"V^::CUT^/\
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M(H3)0'<P                          @"Z9GNP?7[^[G@-\3FW0$_H
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M:,7=HK+_ #:I+,DG62.O-@F#ZMO7$Z>&J>*N_-,4S>=3Y$[=W3IG9^JJQ4=
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MUS6K/*Q!#_0Q&;1 OFG:7/<,]AWWM,'P<YPRG0
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ML#Z^V+\+JWZ:1\&SG_:TSA_$5K?J%86+#[-/QP
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M(O"T?_8OZAD!=:N%7_\ 69*(^KC^B@
M                @[YX>[1=!3^^D?R4J> G$
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M*"T7,\5AZPS6R\F)(Q"I'F+189-PXDK=.F0(FF9]*/'CLR2":7C>&F0A0N"
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M#CZU4:C68YO%0%>@HI C9A&QD>U(4C=NFB3'HQWC9[QSF,<QC9#[$
M                   0!=,SW8/K]_=SP&^)S;H"?T
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M1?U#(&'U-K1AVZ'RTS)/'U??T4
M            $'?/#W:+H*?WTC^2E3P$X@
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M!DM  #7;>54^ZV<;?O6M&_R@M\@-B2
M                                                   ]3.12<["3
M$(LJH@C,14A%*KI8(91%.0:+,SJD*;'890I5LYQC/L=N &#;?_(XK:WDW#C4
MW.N >1>3^*P9; TE)Q$HRS@W:5%Q,UK83Q-\;'=+GQB,FWL^QA''9VY#N7CM
MY'SKBNW& LW*/ES.;3K#%V5[.ZRU?K<^O"SYDLY4(P=[+F+M)NTXM5;L*ZPU
MAV;PZ.3E;/6BQR+I!E_:DU+K?1&M:7I[4%/AZ#K/7<"SK--J$"BHE&0D,Q*;
MPD$SKJ*+/'1UC++.7+A59T[<N5G3I99RLHJ<.Q0
M                                  0!=,SW8/K]_=SP&^)S;H"?T
M                       0Z[9Z,.A-W]2BC=2K9>Q]G66[:Y?423J>GGA:
MH;5T9(:UKWF--63SF!]4_!:6XI;'A/+S/>E>WO&\V-X "8H
M             8['6M^FWZ4O]O\ 4$_DD/AUK ^OMB_"ZM^FD?!LY_VM,X?Q
M%:WZA6%BP^S3\<                            ''&<E\<$8WS^VN"B?Z
M+/X/@P*L)KHX**GU/P_(-A+L/#Q*8K)='%BH&].??S\(I+?#$>)O1GWL_ +M
M=0%Y;H8,9]&*FI]3\/R"DE\<$5,5%(_IQ[WRY&PE#0FQ\SP%*/6G-='!1/\
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M%Z1WN7W +[TS1W\0H4!(B  ,?/RGSW(3='[I&B_C/@ '6/DHWN5ROWRVW_\
M-%" 9+0  UVWE5/NMG&W[UK1O\H+?(#8D@
M
M                                                       " +IF
M>[!]?O[N> WQ.;= 3^@
M            "#OJ1^Z<=#']W+EM_)^8@)Q
M                               0=]*GZ='K9??Q5CXJ(L!.(
M                                               (Y.K[[ESSZ^]6
MW'_$^2 =Y<%/I(N''WJW'KXHZ@ NI
M                       $'?/#W:+H*?WTC^2E3P$X@
M                     #5V>4X>[![]^X;0_P 3E/ ;1,      6R\U*_.V
MSAORTJU6A96R6:S<9M\5^NUZ"CW<K-ST[,:MM4=$0L-%,$5%Y*6=2#EN@W;H
MD.LLLL1-,ACF+@!C)>2<<9.2/'&)YW%Y"\?=W:'/<)+C6:I)[EU5>M7J6@L
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M)[8H#+B
M
M                            0!=,SW8/K]_=SP&^)S;H"?T
M                                             0=]2/W3CH8_NY<M
MOY/S$!.(
M   "#OI4_3H];+[^*L?%1%@)Q
M                   !')U??<N>?7WJVX_XGR0#O+@I])%PX^]6X]?%'4 %
MU(                                                      @[YX
M>[1=!3^^D?R4J> G$                                     :NSRG#
MW8/?OW#:'^)RG@-HF
M
M
M          @"Z9GNP?7[^[G@-\3FW0$_H
M                           @[ZD?NG'0Q_=RY;?R?F("<0
M                                             $'?2I^G1ZV7W\58
M^*B+ 3B
M ".3J^^Y<\^OO5MQ_P 3Y(!WEP4^DBX<?>K<>OBCJ "ZD
M                                       0=\\/=HN@I_?2/Y*5/ 3B
M                                     -79Y3A[L'OW[AM#_$Y3P&T3
M
M
M                                                     0!=,SW8
M/K]_=SP&^)S;H"?T
M          0=]2/W3CH8_NY<MOY/S$!.(
M                            "#OI4_3H];+[^*L?%1%@)Q
M                                            !')U??<N>?7WJVX_
MXGR0#O+@I])%PX^]6X]?%'4 %U(
M                     @[YX>[1=!3^^D?R4J> G$
M                   :NSRG#W8/?OW#:'^)RG@-HF
M
M
M                                   @"Z9GNP?7[^[G@-\3FW0$_H
M                                                    @[ZD?NG'
M0Q_=RY;?R?F("<0
M          $'?2I^G1ZV7W\58^*B+ 3B
M                          ".3J^^Y<\^OO5MQ_Q/D@'>7!3Z2+AQ]ZMQ
MZ^*.H +J0
M  !!WSP]VBZ"G]](_DI4\!.(
M U=GE.'NP>_?N&T/\3E/ ;1,
M
M
M                ! %TS/=@^OW]W/ ;XG-N@)_0
M                                 !!WU(_=..AC^[ERV_D_,0$X@
M                                                    (.^E3].C
MULOOXJQ\5$6 G$
M        $<G5]]RYY]?>K;C_ (GR0#O+@I])%PX^]6X]?%'4 %U(
M                                              @[YX>[1=!3^^D?
MR4J> G$                                     8)77(MG20A^HWMME
MRQUEO2U;M+5=3J6.6H[^;;UP\>IK>N9KJ#1-EL*-3PJ2#PQPKG#;&<J9-VG/
MGV0&=J
M
M                                                           @
M"Z9GNP?7[^[G@-\3FW0$_H
M                @[ZD?NG'0Q_=RY;?R?F("<0
M                                  $'?2I^G1ZV7W\58^*B+ 3B
M                                                  ".3J^^Y<\^
MOO5MQ_Q/D@'>7!3Z2+AQ]ZMQZ^*.H +J0
M                          !!WSP]VBZ"G]](_DI4\!.(
M                         U=GE.'NP>_?N&T/\3E/ ;1,
M
M
M                                        ! %TS/=@^OW]W/ ;XG-N
M@)_0                                                     !!W
MU(_=..AC^[ERV_D_,0$X@
M                (.^E3].CULOOXJQ\5$6 G$
M                                $<G5]]RYY]?>K;C_ (GR0#O+@I])
M%PX^]6X]?%'4 %U(
M          @[YX>[1=!3^^D?R4J> G$
M        :NSRG#W8/?OW#:'^)RG@-HF
M
M
M                        @"Z9GNP?7[^[G@-\3FW0$_H
M                                         @[ZD?NG'0Q_=RY;?R?F
M("<0                                                       $
M'?2I^G1ZV7W\58^*B+ 3B
M               ".3J^^Y<\^OO5MQ_Q/D@'>7!3Z2+AQ]ZMQZ^*.H +J0
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M5!0]>L>)ZML(.1?J880=CE$#1YFU@8>$IYUWS&P?!DB=W'>"]L
M                 &/_ -5SR@#0O39O*&@ZGKN9Y(<G%V,+*2FNH.Q-JI5*
M(QL)?&AD;O;R1,HY1M+MBHU>,X5E%N7"S1X@NZ<1Z3MF=R$7-I\I;ZA''%]4
M[?S(Z3ELU1IV\2C="OS$LCMO5DJY8JI%<N6L5.[$I:T=8K(E'^(Y(R,E&G63
M(7O^;)G\<H937"WF7H[GMQ]I_)#C_..Y6D6G+N/?14R@U86RDVN*RB6=I-UB
M&CUP2(LS([AN91,BZR#AL];/F:[E@[:N5@NL
M                     0!=,SW8/K]_=SP&^)S;H"?T
M                                      0=]2/W3CH8_NY<MOY/S$!.
M(                                                       "#OI
M4_3H];+[^*L?%1%@)Q
M            !')U??<N>?7WJVX_XGR0#O+@I])%PX^]6X]?%'4 %U(
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M=/.M2U"OVYY(66Y0MI;S3>>F7,,1FV1BX=J9FJDJAW\F-DY3E/V>USCV0G)
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M<,;C'EDUG^:'QC< (/%2\Y[N69>1TAFPX:X5]D^)/.E?-C./-_9[GFA2]_\
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M\CYZ>UPS>D,DWE(ZN4FFU"PVZ-+DN/%9NK!#N(S*F,^W5I:F.[C!,&.&52
M                                           @"Z9GNP?7[^[G@-\3
MFW0$_H
M@[ZD?NG'0Q_=RY;?R?F("<0
M                  $'?2I^G1ZV7W\58^*B+ 3B
M                                  ".3J^^Y<\^OO5MQ_Q/D@'>7!3Z
M2+AQ]ZMQZ^*.H +J0
M          !!WSP]VBZ"G]](_DI4\!.(
M         U=GE.'NP>_?N&T/\3E/ ;1,      6.]3KW-CJ%?>.\LOB%OP#3
MH@,H^U^5J]1V5J:M8I^L.*.O7AHE*,:6Z*H>QIZR1!T44T4Y&*;VO:SR),\P
M5,N<%?1;UO\ 1=Y$WM>P((]3Z;Y9=2'DO*5W7-<NG(+D-MN>F[S<)0YTUW2R
M\M+(JV6^7BPO#),JO6TI28:X<OWBK9D@=^W;$R4ZK9$X;4'I3\!8CIM<+M<\
M:T9EA:+F@]F;WMNX1:3I",M&T;>=NI.NHM)X4JGJ*QC&,'#,%%$D%G#&L-G+
MANBY66)@->?Y2'[M%S,_\W?^2EHP!&%J#4O+&_0$C+:#UGR'NM7:RZD?+R6H
M*9LFQP#:?29,W*K&1>4R-6;HS!6#J/4,DJ8JQ472)S%[AR&,';/K;.I+]8+G
M!^*S?/YB ;//HQ0-^K'2]X;P.T(:WUZ^QFKW"%DA;['343;X]X:W695)&<CK
M"BF]:N,LU&IBE7(4_A'(;'M,E :EJ_RDI-WN[34YA7$U+VZR2DMA<YU%<2C^
M9>.Y#"RAO944\Z66[QL^V,;VP#:D^3ZUJO5CI <,D*ZB@FC,U.]V6671+V*/
M+#/;:OTA-K.E,]IEETWJBC;&39]HDQ32)V$3(7 3,@ #"$YK^5+<H.,7+KDG
MQUJ_&O0MBKNDMS[!UC"ST_*;")-3,=3;&^A&LE*$CIY)!-ZLDSPHH5),A"F4
M["E[ %L/]&%\OOL4>-W_ *6V?^DP#)HZ475B=<VN!&W>;G)F%UUH:O:;V9LB
MM6YW7'T\K58JDZ]H%"N[NRO5)QRY=&?=RV/D\H(Y.9;S-$C=(ZRN"&#!6ZF7
M/[>?6PYOU.IZYC9%CK)"U&UKQ:U+*2;.(:1D;,OT4'NP+T\=/"L(NT2R;-)_
M-/EUBM(>+C46>79VD:J\7#+2-PMXK]-;H9\VM'T/:&K+KN2\\3]PS6ZMBQEK
MK:TSLS9#C6L\V0C(9'#_ ,Z+3XPSM9A 1^"X,1)95VHCZI2+]58->=H9=NUW
MEIERY62;MF^U]=KN'#A0B2"""5OAU%55E5#8*FB5,IC&,;."E*3O& ;I"N7>
MEW'+S%1M]8M.8_"&7^*Y/Q,YECAUXV&IGF(QTKYKXF6[CP^_W>_X)^[V]W/8
M&OU\I7XF<H^0_508YT/QRWAN)!QQQU0S(^UIJR[7.+(Y:SEZP[(YEH&%7;,R
MHX61\8RJI"(X/C*IB%, A2L/1KZIU7K3FUR_!+D5ZCM&RCQSB+HCRP2Z+9''
M>54/6X!1U)9R4OMC8\T[Q2D,;..Z7)BA;1H[E/RQX:WI:7T7N;;FA[G7Y%>/
MF(JOV&:@$<O8YVH1Y!W&E/C98S2"3]-3"\?*L5T<+(Y*LW[^/:ALV.AQU.Y'
MJ=\1G%XV%'Q$-OS4%H+K?<K&!1*SAIYZ>+;R]7V)#1>%E/4>-F8M9R15MW^X
MC*UZ4(V(FSPV* F? :V+K9[LZG]?ZDG+^N:MVWST@]&QUO@T:M :_OG(.+U.
MQ@E=;4U9^G 1-;E$X=K$G>+2!UL-TRHG666.KWCG.;(8XT-*0KS8C27W.E>[
M/#.;&9UL,D-8FL1L2625=9--':62UP<LDUL1EC*&RL^8NBF5[Q5B=XQCE#:B
M=#;=O3_VEPAJM1Z?<7,4VC:J=DA-B:XOAF>=O5[8,TU))R=BV8Z9N%4K))3:
MB;APVF6AO4UVDQ.Q8),21:D5'!@=>4(\4+UQCZGO(6;GH5ZE1.1EMD]_ZQM)
MFV21=D8W]9.7NK)JX3[4_5*)OSJP,73<QO'PD1F\52(B_;'4#O'HY^4 7+I@
M:UM&@+SI@N]-(S=M>7JMH0]M1I5TH%CF6;%G82,7CN!?MK'7WOJ7'JX9+89J
M-G67#A)V?#@[<!T;UJNKS$=66]Z1GJ]HE_I2$TA WB$8YF+\A=IBV9O#^KOU
MG;U!E5XY"OIM35LI$TDU'QEO/#G.L3ND3*$B?D@+-Z?GMR,?I^)ZG-N(<ZS=
M=F?UKSU]N;3J\?W\=WV5/ CY+N^VQ['?]C/[$-B*
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M5+CM[0U^WD_?*G@QPVY?["L_/NL-XF1?U9O7M6;.N-#DKNPT[?V%A,I9#3$
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MO$6/A%IX").PB12X"8X
M  $ 73,]V#Z_?W<\!OB<VZ G]
M                   $'?4C]TXZ&/[N7+;^3\Q 3B
M                                      @[Z5/TZ/6R^_BK'Q418"<0
M                                                      1R=7WW
M+GGU]ZMN/^)\D [RX*?21<./O5N/7Q1U !=2
M                              (.^>'NT704_OI'\E*G@)Q
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M$F9=ZU-A-9NYEF>NU/&SC*:CIRW[,=XY#8#NOK\G+Q>Z^^G>2=B;/R5E=WQ
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M4XM*<PO+L'2:+ME).739R@BLF=(H7M@
M              @"Z9GNP?7[^[G@-\3FW0$_H                  ^-O\
ML37^IZA-;"VE>J=K6@UM!!S8[OL"S0E-J$ W<NV[!LXFK-8GS9E%H*/G;5 A
MUUB%.LY33+G)SEQD/E=0;^T1R$A92R:"W7J3>%=A)3U#FI_4&R*=LN%B)KS-
MN_\ 4B4E*7-/4&$IYBZ:K>;JJ$6\)RFIW.X<ILAV5+2\37XF3GIZ3CX2#A(]
M]+S,S+O6T;$Q$3&ME'DC)R<B\4(C'QS=FBLJLLJ<B:2:)U#G*0IC +,_GFG3
M=^V"\(?RK]#_ *>@'SS3IN_;!>$/Y5^A_P!/0'=^F^37&[D7\T>>/G(/2&]O
MF0]2<VW]1K:]#V?\R_J_ZI>H7S1?,3//O43SWU%F/-/.?"\Y]2G/@]_P%>X'
M=X   (\MS]6/IN<?K9(43;/,W1=:N<.[.PFZNRMR5MG("026,W6C;#&TQ&05
M@))-9,V%6[PJ*R6,=Y0A"YQD!WWQYYA<6.6,9(2W&OD!JC=3>(*0\VTH%SAY
MV:@"*J920/8:\@Z]4*^FHI["67C9$JGI3[V/9 7) /B=A;(UYJ6HR]_VK>Z=
MK2B0"1%YRYWZS0U0JL.BHJ5!)23L%@>MVC$IUU$R$\54O?.I@A>TV<8 1ULN
MMGTH']@+64.=NA"2)UTV^'+VR/(VOX455\(ICVV1C4HI-#!O9,J9Z5(A,]\Y
MRD]L DIJMKJUYKL/;Z39("X5.PLD9* M%6F(ZP5V<CE^W*#^'FHERLVDF)^P
MW<515.3/9[4P#Z$!:;R+YU\..)"K)GR3Y*:@T]+R;8KV-K=PN44TN$BP.=8F
M))A36RRLJ]BO$05)YRFS.AWR>'E3OYP7(?":"ZG73\Y0V9I2=$\N=)WZ[2.>
MR*I3>WM8*Y3)_;9,G!U2T%8R$XH4I39.5HW6,F7L,?!<9+G(7V@
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MF^R*T5^-R@?I '4'EQN,M;@ZN<B]VX<T??2R<X<LSG1ZZ+C-]D5HK\;E _2
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M7*";LZ*>6DDPZ:2,TNOMOK!JMH
M                $'?/#W:+H*?WTC^2E3P$X@
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M-LPS=RF,;!3&(8F3%+G)#=W)BYSCMR4V2&SCO8]&>S.<>Q[&<@/,
M                                  0!=,SW8/K]_=SP&^)S;H"?T
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M>_?N&T/\3E/ ;1,
M
M
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MWT?"N<QLO2]#VLR&>]DI'U<G=G1!%4NWV$S';VI3"G9]'X*?;]!CL#.^
M      &.QUK?IM^E+_;_ %!/Y)#X=:P/K[8OPNK?II'P;.?]K3.'\16M^H5A
M8L/LT_'                        !QC>C/O9^ 9R7QP1AHS>!0%6+Q/\
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ML9R=^ 53]7HUR ^*.Z
M       (.^>'NT704_OI'\E*G@)Q
M     &KL\IP]V#W[]PVA_B<IX#:)@
M
M
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M_P 6(W5NKC4@KXUS90D#'5^D)9B589'+K$TI6RN_$<M\%<X464<D.1;'B%#
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M  :Z/RNFM2$'U%]&74B/=CK)Q(I39HXSC/8K,U3;VY/5%'/^Z\-C+0)O3_\
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M[8OPNK?II'P;.?\ :TSA_$5K?J%86+#[-/QP
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MWWM^COBQJX_-++S[.,L_C:T?URF?=;)?[&<G?@%4_5Z-<@/BCN@
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M-9PNJ1$I,*+*GQD^0[R
M    8XWE-?+#D9Q X4Z7V!QHVW:].W.P\HZS39NQ5%5DC(R%7=:GV]-N(5=1
MZS6QYF>6@HE<Q2EP;)V!/9[,=F0D+Z.VW=E;ZZ:'$C;VX;A+7[9=XU])R5LN
M$X9 \M.OVUWM48B[?';(ID,MABQ9I]I2%[<(%[>]GM-D)+@
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M^+&KC\TLO/LXRS^-K1_7*9]ULE_L9R=^ 53]7HUR ^*.Z
M                                  (.^>'NT704_OI'\E*G@)Q
M                                &KL\IP]V#W[]PVA_B<IX#:)@
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M:'A>%W5.^&Q$X#_2*\+/O3..7Q/4T!=F
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M2&8]PI&-Y8V9@B:'A%<5J3:(?KB1,@,K3&<&QC.,XSC..W&<>SC.,^C.,^\
M@-ZXW6:D.E/7]&PFM*)2]I;CW%+V.55K%TD)EK$5[6M49HM'\^[)7W2+E*0>
MVB8B6T=DZF$54X>5]J<Z&.X$HG!K;VY-_P#$?0N\-^T2N:RVGMJA1^PIRB51
M675AZW$6MR[F:6SQZO+'=H2AZ.[KBT@@N;OMG[IRW[,82P4!=>
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M)(?#K6!]?;%^%U;]-(^#9S_M:9P_B*UOU"L+%A]FGXX
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M>6'_ #CC> RX^ _TBO"S[TSCE\3U- 79@
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M-,'3AR&\V1S[7 9@_E(_N,',7_X+QX_E3Z2 6N^2<>Y<3GWT^VOXI:N 2O\
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M4)QS6+C5M)6:.IMD8J%2?P%PNN6M$JLU'*G+G"<DUL%FCUFQNPW=61)GNY]
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M0ZKM.A7;65[B4)ZD[$J5CHUP@W>.UM,5BV0[R!GHMQC_ -XKQ;]VD;L^HM[
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MM'2*;ALZ;+IF27;N$%2Y(LB=,QBG(;&2FP?)<XSC(#7I>1__ $\_)G[U)_\
M'!K !(UY7%PG^;C26F^==1B?%L&E)5+3VVW39#O+K:OOLHHZH<U(K]S];8P^
MQW3I@GC&>W*VU>W)3%)VE"83H,\UO7M=-S2]JGY?$GM+3;7.@=NG77\9^O9=
M;Q\:V@+$_44-WW#J8U^\J,FY7,4I#OY)\F0QO .8!B+W,RW7E\H22KS516R<
M;*)<RU_QT#F=0Z7%GCH_6<6!\@X3-G+6-N=L6DLM%<E[R+K;K4IR8P3LP&QY
M111;(I-VZ23=!NDF@BB@F1)%%%(F")(HI$Q@J:928+@I<8["XQV8 5@
M            ! %TS/=@^OW]W/ ;XG-N@)_0
M !;4ZX<\5WW(-ORO?:!U8[Y)M,(>:[L<5*,6V(AEM5LTAL=*QJ(97*LG43>I
MR9\9[Y&F,(ES@N"@+E0                         !CL=:WZ;?I2_V_U!
M/Y)#X=:P/K[8OPNK?II'P;.?]K3.'\16M^H5A8L/LT_'
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MFA4:I[WR>C7'#XP[@
M      @[YX>[1=!3^^D?R4J> G$
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M+IU?VCRP_P"<<;P&7'P'^D5X6?>F<<OB>IH"[,
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M'6M^FWZ4O]O]03^20^'6L#Z^V+\+JWZ:1\&SG_:TSA_$5K?J%86+#[-/QP
M                      <8WHS[V?@&<E\<$8:,W@4!5B\3_0Y_!\.!>%\V
M/%!KJ(SDTH#Q/]#G\'PX%A1%9+HXITFIXG^AS^#X<#--1&PPGNAB\3_0Y_!\
M.!E)I03FOCBHBSQ^&]&?>S\ K)='%&?2BH"LFE GTHOPWHS[V?@%9;H8,5 7
MDT8)3WPP!DP<<;  A-?'%0-Z<^_GX1L/'X-@<;'I-[_R8&PUU 'DUT<'B;T?
MX?X)AL,/XOV[:G^P_NOD&4FE!*:Z."D;T&]XOPY%GG8>#B4A:31@BIJ?4_#\
M@R%,;#">Z&+P/Z,>_P#)D4H]:2D*"FI]3\/R"TFC!.DU*8R837QQ>!_1CW_D
MR-AAV?@XU(5DNCBPGOA@\#^C'O\ R9%9-*#!2%9;H8)TFIX&]!O>+\.1G)I0
M8]GX>-2%F*D;ZOO9_ABE'K3_ (SV[3P&XFHX^A-_<_" \1L,)[H8N/\ 4-^U
M-_!R/9;X8I*:GU/P_(+O)KHX*8V$%/\ [7_[?^Z&4FE!Y-='!3%F%)J4L_0%
M]_\ ^**R71Q81NEPXXJ>?1^$OPX".G+AYU:+5CYE'/I_ 7X,"3HT-\,8^1QS
M>G/OY^$>371P="AOAC'R.,;Z#/\ =?!@2GTHNA0WPQCY%$WI_P /\(PQ=&B[
M'P\:@?T_AS\!1C/HQ=&COEPXE!3ZGX?D$71HM6'F<8_IQ[WRY&,^C%T:&^7"
M'$HG]&/?^3(G/I1=&A[#V[3CG]&/?^3(Q="A[#V[2C]7'O9^$HG-V?@=*BT9
M/ H']&?VN/X.!-T:&^&,?(XX.C1=CX>-QQ&?2BZ%'K_HJ!O3GW\_",70HNQ\
M/&H&_8_M<?*)^DZ-#=#"/E4#>DWO8^$HFZ%'?+AQ*)_1CW_DR,9]&+HT6K#S
M.,;Z OX/@R,)KYL(<3I4&KP*1O1GWL_ )QOEQXHNA1ZW&/\ 0Y_!\.!A2:G0
MH]:^KAIP"W)RUOL"S3KMDIFI#91E;5M64AEVD,A7RJO$\DJBTD5).SS3ERR7
M:MTVF7!&ZN<K.NX@BJ8?S/+[.;8.0]FUB>:M4-H6Y'9DH:E)2PFGFI?>_P">
MA)LS4-')+-+//-/TL9H?4R;,\TK^B9(Y%6KE+7*&6%7I:K9?U,U)69I(RR=)
M]5_S6SL0I9YIH1A+"3INEC]5/]3"9FYPT5&U^(BX&(;Y:1,)&,(F+:>,NOYK
M'QC5)FR;^,Y4.HMDC9!(O?4.<YN[VG,;.<YS^>=8IZ6LT]/6:>?IZ:L3S3SS
M;$(=-//-&::.Q#8A#9FC=+"$(:H/MW145'0T5'0T4O2T=#+"66':EEAL2P]_
MW_>AVWM1-4                                                 0
M=\\/=HN@I_?2/Y*5/ 3B                                     -79
MY3A[L'OW[AM#_$Y3P&T3      '2/)?6LWN;CAR T]67<5'V/:^DMJZUK[^=
M6=MX1C.7JBSU7B7DRXCV+EPWB4GTHW.X.@V<+$1(<R2*I\%(8,#BF>2K=6[6
MZK]?7?*[BI0UY5-NC*+4S>G)BKJR230RAVR;]2#X[H9>)IF66RF53.<$RL?)
M>SO9 ??_ -#5];_[/;2/Y4O+G^8@!(OTZN@SSKU+*<JZ;SQY7UO96D.2O$C8
MG',S'5&ZMQ7^X5NP7JU4.0);6$;N35+"(8*-J_7[ DFY[':V%9(B/FQD5ECD
M"/;;GDE7,355W0M_"[E]KB>;QRRKV'D;ZYOVB=FP1\Y[6[2,F:!%V)K).BE]
MJ9WYU#E/Z2MD^WN8#UCOI%>4Z65JI0I[F5LM:H*%/'N',OSZVB[KKZ/<D\V6
M1?-VTLO(2$5AN8V,MW#,Y>Y[!$3?0@)/.EGY,70>*.R:9R3YC[)B-^;NI$VE
M::CKRH,W9M*U:U-#F6B[-,RMKBT9794\SD,(OF)UF<*T:O42*K,WYTD5B!DH
M\E]:S>YN.'(#3U9=Q4?8]KZ2VKK6OOYU9VWA&,Y>J+/5>)>3+B/8N7#>)2?2
MC<[@Z#9PL1$AS)(JGP4A@P1]?>2U=8'4JTHXU5R^XPZR<3:35":7U]O_ )/T
MQ>718G649)2BM<X]MC2":)W+G*15<G*GER?).[W\]X/NW7DLG5%VNX;,M_\
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MW&HXJL-63Z?08%BR5]CYFW89\%GX)"-\^$C]"&;2
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M/:/+Y>$T)!UYH7U/:LXQX<[\B\H\*R=L0R&.:NEK1R0X@<HN/M(D(&)N6[-
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M&6<$RL2$J<.SAF*SQ1,I?.9)9-GXSI?..^X<+JK'R8YS&R':0
M        ( NF9[L'U^_NYX#?$YMT!/Z
M                         (.^I'[IQT,?W<N6W\GYB G$
M                                           !!WTJ?IT>ME]_%6/B
MHBP$X@
MCDZOON7//K[U;<?\3Y(!WEP4^DBX<?>K<>OBCJ "ZD
M                                    0=\\/=HN@I_?2/Y*5/ 3B
M                                  -79Y3A[L'OW[AM#_$Y3P&T3
M
M                                            !C?=>3C5U7=MW#B]
MM7IAV78L1):F@]K,]CQ>N-WQ&J925/9I"@.Z\5[ V6V14=?(\J-?F.^U<Y==
MF>PA6RF5<8 0GQUF\L&L3-36K=GNEL14F43R\C5N&]8>%14*9$Q4]I2D6T.B
MICV#85)*X<$-[;"N/:@+]NCIY/;N?2_(B$Y[]16]MK=OB#F9>Y4[59;*MLB6
M9;%DL+()[*VWLY60<(62UM3.'SIDS8*R")7BS.36F#N&V6)0R^P&'_Y2/Q*Z
ME_/S;>AM(\8N.5INO'+5D(K<):YM[?KR$@;%MZZNUX9==^PG;>W=^8UVHL6Z
M3=<S4I\*7&8*0BB7A'.&3-PVXS5+AOQ:T9QBI.$5833NO82K+R2"&&^+%9"I
MFD;G;ET,8QX;R8N#Z=E%RXQC&%9<Y2XQCLQ@+F@
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M<=#']W+EM_)^8@)Q
M            0=]*GZ='K9??Q5CXJ(L!.(
M                            (Y.K[[ESSZ^]6W'_ !/D@'>7!3Z2+AQ]
MZMQZ^*.H +J0
M     !!WSP]VBZ"G]](_DI4\!.(
M    U=GE.'NP>_?N&T/\3E/ ;1,
M
M
M                   ! %TS/=@^OW]W/ ;XG-N@)_0
M                                    !!WU(_=..AC^[ERV_D_,0$X@
M                                                       (.^E3
M].CULOOXJQ\5$6 G$
M           $<G5]]RYY]?>K;C_B?) .\N"GTD7#C[U;CU\4=0 74@
M                                               "#OGA[M%T%/[Z
M1_)2IX"<0                                    !J[/*</=@]^_<-H
M?XG*> VB8
M
M
M " +IF>[!]?O[N> WQ.;= 3^@
M                  "#OJ1^Z<=#']W+EM_)^8@)Q
M                                     0=]*GZ='K9??Q5CXJ(L!.(
M                                                     (Y.K[[E
MSSZ^]6W'_$^2 =Y<%/I(N''WJW'KXHZ@ NI
M                             $'?/#W:+H*?WTC^2E3P$X@
M                           #5V>4X>[![]^X;0_Q.4\!M$P
M
M
M                                           $ 73,]V#Z_?W<\!OB
M<VZ G]
M$'?4C]TXZ&/[N7+;^3\Q 3B
M                   @[Z5/TZ/6R^_BK'Q418"<0
M                                   1R=7WW+GGU]ZMN/\ B?) .\N"
MGTD7#C[U;CU\4=0 74@
M            "#OGA[M%T%/[Z1_)2IX"<0
M          !@D]<CK#<F.(G4;VWHO6M'T5.5*M574\BQD;Q6;_)6-5>R:WKD
M\^([=P&SHQLHD1V_5*E@C-/)4REP<RAL9.8,[8
M
M
M                              ! %TS/=@^OW]W/ ;XG-N@)_0
M                                               !!WU(_=..AC^[
MERV_D_,0$X@
M      (.^E3].CULOOXJQ\5$6 G$
M                      $<G5]]RYY]?>K;C_B?) .\N"GTD7#C[U;CU\4=
M0 74@                                                     "#
MOGA[M%T%/[Z1_)2IX"<0                                    !J[/
M*</=@]^_<-H?XG*> VB8
M
M
M            " +IF>[!]?O[N> WQ.;= 3^@
M                             "#OJ1^Z<=#']W+EM_)^8@)Q
M                                                0=]*GZ='K9??
MQ5CXJ(L!.(
M    (Y.K[[ESSZ^]6W'_ !/D@'>7!3Z2+AQ]ZMQZ^*.H +J0
M                                         !!WSP]VBZ"G]](_DI4\
M!.(                                     U=GE.'NP>_?N&T/\3E/
M;1,
M
M                                                       ! %TS
M/=@^OW]W/ ;XG-N@)_0
M            !!WU(_=..AC^[ERV_D_,0$X@
M                               (.^E3].CULOOXJQ\5$6 G$
M                                               $<G5]]RYY]?>K
M;C_B?) .\N"GTD7#C[U;CU\4=0 74@
M                       "#OGA[M%T%/[Z1_)2IX"<0
M                     !J[/*</=@]^_<-H?XG*> VB8
M
M
M                                     " +IF>[!]?O[N> WQ.;= 3^
M@                                                     "#OJ1^
MZ<=#']W+EM_)^8@)Q
M             0=]*GZ='K9??Q5CXJ(L!.(
M                             (Y.K[[ESSZ^]6W'_$^2 =Y<%/I(N''W
MJW'KXHZ@ NI
M     $'?/#W:+H*?WTC^2E3P$X@
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MX/G'?5\$)40
M
M              0!=,SW8/K]_=SP&^)S;H"?T
M                               0=]2/W3CH8_NY<MOY/S$!.(
M                                                 "#OI4_3H];+
M[^*L?%1%@)Q
M     !')U??<N>?7WJVX_P")\D [RX*?21<./O5N/7Q1U !=2
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M_-O4;'L+^/\ K(3@
M
M                    @"Z9GNP?7[^[G@-\3FW0$_H
M                                     @[ZD?NG'0Q_=RY;?R?F("<0
M                                                       $'?2I
M^G1ZV7W\58^*B+ 3B
M           ".3J^^Y<\^OO5MQ_Q/D@'>7!3Z2+AQ]ZMQZ^*.H +J0
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MJVN$LJ,@6M[&IK20<*KQK%T[AYAJ_CC+NS1KMFD?+DS>19DP$Y@
M
M                                                      ( NF9[
ML'U^_NYX#?$YMT!/Z
M           (.^I'[IQT,?W<N6W\GYB G$
M                             !!WTJ?IT>ME]_%6/BHBP$X@
M                                              CDZOON7//K[U;<
M?\3Y(!WEP4^DBX<?>K<>OBCJ "ZD
M                      0=\\/=HN@I_?2/Y*5/ 3B
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M9VW<-?!6\X(9'!T?!/XF"]TP#L$
M                                                 0!=,SW8/K]_
M=SP&^)S;H"?T
M      0=]2/W3CH8_NY<MOY/S$!.(
M                        "#OI4_3H];+[^*L?%1%@)Q
M                                        !')U??<N>?7WJVX_XGR0
M#O+@I])%PX^]6X]?%'4 %U(
M                 @[YX>[1=!3^^D?R4J> G$
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M/JB;M%-R6BP;=[*%8F=EPY=.YN2D54FF'Q&#,)<
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MMD:(I\.Q9F43=3DEG*W@>*?"Q2G.;N%[ G#
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M.%7+.H;5JJ+%2>8,%%S&4+"OHN3@YJ.(JHJLC'V=J@X64<I+& 2/
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M9J'\)24M-"2BFC)+3T-)///0S3R1EI*62,9I)$1_#WVE
M        1R=7WW+GGU]ZMN/^)\D [RX*?21<./O5N/7Q1U !=2
M                                            (.^>'NT704_OI'\E
M*G@)Q                                     &KL\IP]V#W[]PVA_B<
MIX#:)@
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MR92//*0L2N9/T&48)&_8% 8^VH.M1UK^9VF-5\3^"-"V!;=HZ]IN&N\>1$;
M1NRMH7&7DYN:7:R\[<[I%XK>HZZ:-=,V*"KLOJDX7A_&;3#?O&;$"87HS1O6
M\U/RIVG-]5"7WBEQPC.,VP;2WDMEWC7UXID;?H>ZZV?,'3=]29Z0Q&RB5-)>
MSE0P=(GFY%\F3]H3NA%0_P"HSUDNN9RKOVI>GA>[%QMT=33/9N,1J]P_4B4J
M&OU9#U$@K;N/;-=(O.R%JDC=P_J3"JN445/&)'QRY&+F0.'8%_Z7'E.'%"%=
M;(UES<V!OY:)SF=D:?J?EMN2^2ZZC<Q7#M?.O=]0<.PN#K)O$SYJV2?NGA2>
M&1JLJ<J)@RA^B_R!Y2<EN!E#V1S*;2S7D"WNNSJ7<T[!K]'6%@-FE7&2K[+,
M]2VL/'I1,QANS[C@J3%J0RB)C> 0W;@!*T
M                         " +IF>[!]?O[N> WQ.;= 3^@         "P
M+J<<'2]17AMLWBEC8IM5NKP]I\S&W7-;Q;6\;*TFUQ-MCV[Z"]6&!G4>Y<Q*
M;=8R;I)1$CC*Q,*F)A(X89N-7>4.=!Y0[O7[Z:Y"\5JT<ZZC"N$F^06@F\$U
M.993$G1G:;:U:38E1\$SQW'I0+/Q3^&65>%*8Q@F(X->58<.=[9AZ;RWJTSQ
M,V&Z\W:J6S"CV_Z/E7I^ZB5;YHXN/++TOQG'MO#DHQ:/9I'_ *9G3X(90!D[
MT385"VE5(>^:RNU3V)2+"V*\@;A1[%$6NKS30V<EPYBIZ">+M9!'O>QWDE3E
M[<=GI ?8  #YJY7"KZ]J-HOMVG(ZL4VE5^8M=KL<NY*TBH&N5^/7E9J8D7)O
M809-HYHX54-GT$1R UQO0;9R/*+K^37(W7L%*16OXJW<O.1,RV;HE9(URE;1
MB]A5.KQ4F5)0Q&^/5S;%:;8;E.<V<HF[G:DD<Y V2V<8-C.,XQG&<=F<9]G&
M<9].,X]X!!5U&^F1T[M?]/[G!?:-PCXN5"[4SB7R'M=2M5;TG0(:>K5FK^I[
M9+0D]!R;"#(K%2K22:MUVZZ)B'151(<F<9+@!#YY&S_L!Y]_=?QV_P R[B 9
MK(   ->OY8)LR3E^9O&#4!G*YX2@\:7.P&C7*G:U;S6T]G7" F%$T^][1RI&
MZFKOB&[/9(BB7ZGL!GFZ#UK#:9T9IK45>:)1\#J_5>OM>P[)%(J*;:.IU4B:
M^T2*D7Z#.$8\G;]7M[<YSG/L@,93RO'4D19^">B-Q&1QFRZIY(L:RS<F(4WA
MU7:=#MGS1ML']*?B3M%HY_8]C/F?ML=O=S@+_P#R=+:;[8O1\XNO)]XLY?Z^
M1VEKAV\<GR?LB*1M*YMJR@GVYSDK=I2U*^U*7ZF&'M<=WLP Q2O)M$R<G>MC
MLC?]T1/*6>.U[R4Y'I.Y I73I&W;#N5?ITC)*J&-GNO,L]Q3A<J>S[=R;N^V
MSVE#8^ -;OS@8I</?*A:];Z:=:-BYOE[QDVB_(VSA!9RQWFWUV[V\T[Y/8,6
M0>6V_)FSG'LDDC=_!O;=H9$GE7VS)*C=+B/J4>Y611W+R7U1K^;11/W"NH6&
M@K]M?PW)<F_7&Y9W6L"?N_\ O4B6?V(#L7R7?6L+1^DAJZUQK-)O([DVINS8
M5A<E2*15_(P]]D=3-%55<>RMW(;6<6D7M]C'@Y+C'ISD)'>JSJ2(WATV^;NN
M9E'#A)]QNVA98LF2%4P2U:[K;S8M+<Y(;Z+P;A5(-7V,XS^L^US@W9D!B]>1
MO[-DC%YU:;=.EU89 VCMFP+/)_Z6923O&QJM;'14_P#WNZ:LZ63)L?L8<N,]
M[VO8&<.          ,=CK6_3;]*7^W^H)_)(?#K6!]?;%^%U;]-(^#9S_M:9
MP_B*UOU"L+%A]FGXX                             #B']&/?^3(K)='
M%KJ>?07WOER+27QP81TY</.XPV)+XX(S71P43_19_!\&!:COEPXF,]T,5(_H
MQ[_R9&Q+?#%)2%TYNS\#CC834U/J?A^06DT8):I\>-2-Z,^]GX!L2:,$9KY,
M?,H#9A?-CQ0>3=GX%(_IQ[WRY%I+HXI371P43^G'O&^ 7H]:,U\<5 _T.?P?
M#@;%'K83Z,5!3T&]_P"4;,MTN,>-%1-] 3W_ /V6!:2^.#".G+AYW'-Z<^_G
MX1>32@DI'].?VN/X6!L2:4&,^C%0/Z,>_P#)D;$FE!%1-Z,^]GX!9*>^&"@-
MA.:Z."B?Z+/X/@P+RW0P>J9_H<_@^' M)='%KJ(V)+HXHSZ45 WIS[^?A&Q)
M='%*-TF,%)3ZGX?D%I+XX)S7QQ4#>DGO_+@7DTH)SW0Q43>C/O9^ ;5'K2G[
M+PJ1OV/[7'RC8H]8XYO3_A_A&%:.^7#B:[CG^BS^#X,#8A=-AQP2GOA@HG].
M?VN/X6!LR:4&"B;]C^VQ\HV)-*"/9^'C419B          "0SI:3#^,YM:K9
MM%U$6]AC-BP\JF158A7+!#75HGTT%2)*%*LGB4@XU7!5,')WVQ3X)XA"')_#
M>B,JM#6,T>4M+2RPFI*C25"EHIMB$=B>:OU:AC-+LPCTL?X*FGEV9=B;I8S2
M]-TLTT(_:+H-:]6:GT0F1=7H*2-'16G0VK04TL)II>GHI;*KE9A+-"6,LL9?
MX:K4,^Q/",-F26;I>GEA-#+4'YHOVV                        1R=7WW
M+GGU]ZMN/^)\D [RX*?21<./O5N/7Q1U !=2
M                              (.^>'NT704_OI'\E*G@)Q
M                            &KL\IP]V#W[]PVA_B<IX#:)@
M
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M,7S,_<5UW_'F0 9^0#7E^3A>[E<H_P!S?E3\>-  2Z^5^>Y\<??OR:G\26]
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M@BZAYIG)-7;5ZR=HHNVCEFH@X2(H3)0'<P
M                         ( NF9[L'U^_NYX#?$YMT!/Z
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M75OTTCX-G/\ M:9P_B*UOU"L+%A]FGXX
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MA=-AQP2GOA@HG].?VN/X6!LR:4&"B;]C^VQ\HV)-*"/9^'C419B
M "_CI@_3RZ/_ /*7\4%_'\7Z(7[3^5_S?_K2I/LMT'__ $B\W?SO_J*TV70/
MS'?N$                        CDZOON7//K[U;<?\3Y(!WEP4^DBX<?>
MK<>OBCJ "ZD
M     0=\\/=HN@I_?2/Y*5/ 3B
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M'6>6Q&^7.(]XLTPXRWQQG4\#O^#WNYWS]WO]G?SV=H#U7]&9)?:XU/RO"_\
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M:8/@YSAE.@
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M=I925DM5Z>9S4#7+!X2A2G13=W2T;)*C@V.Q9JP;/$S'1<I& 960
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M_E?\W_ZTJ3[+=!__ -(O-W\[_P"HK39= _,=^X0
M  ".3J^^Y<\^OO5MQ_Q/D@'>7!3Z2+AQ]ZMQZ^*.H +J0
M                                      !!WSP]VBZ"G]](_DI4\!.(
M                                     U=GE.'NP>_?N&T/\3E/ ;1,
M      6G\]/I&>9_WI_(KXH+B PS_(_Z+2;K?.=Q;E3JM;2QU1X^FCRV:OQ,
M\5B9S,[<PZRSQ*LU?-3*8;M_$[G=[_@D[>WN%[H97?,/I.<%^:&JK7KO8''[
M5]8L4S$2+>L;;H%"JE4V=0IYRA_2%B@;/"Q:#AUX+Y-JLLP=G6CGY6O@O&RJ
M9O8#"P\E9V7L'5/4YV#H%"3<+4_96H=CPU[@VSA92#5LNJ95C,5JU%1PH4JC
MYH=.Q,&RYBFSAM;7).[CQ>T@3\>5J>Y@TO[[C57Q=[E 7(^3.^XY<:ONGW[\
M?6Q0$H',/AEHGG;J-OHSD;!S5FUD2[56]/H"$L<G5E9>2J+APXCX]_+PBB3Q
M*)5\[<$<%:KMES$/^M.43X*? ?=:.XT<?>-%4CJ1H#3&MM0UF+:%9MXZAU*'
M@%%D\>RHM*2+-KAU-R"JG:==T\6<.7"AC*KK*J&R?(8F'E>NO>+L5I3CML'$
M+2X?EW8=P'BH^2B&\?'WJVZ1:4FT*7-Q:2,_#6GH&/N".N4F3IX58[)Q*K-F
M)TR/'N,A+]Y.76M@5CI <4VNP49-HXE";2LU283"+I%^TU_8]N7B7J"V"._;
M'C7L:[Q)1YR_K1XV;9G1_6S$ 8T?EA7TXG%7[VF0^-&V@,T':G+/2/"/A5 <
MB>0%J1J]!I>K*/W4DO"<6"V6%U5&/J'2:;$J+)FG+9(ND3)-6Q3$(4I%'3I9
MLQ;.G*(8)]'I',[RH#GR_O5U<2^J>).I7Q63QPQ,J^J.B]:O7A73>BTPSM$K
M:W;TL+9FDJ]?*)?KBB/G[I%O#1T;%$#80\=N/&G^*>FZ+H31-,C:'K'7L0G$
MU^"CB9,HH;)C+2$S,OU>U::L3Y\HX=R#]R8[EXZ=*KK',<^0%DG4QZMO%KI=
MTN$E-SO9FW[/NS9TZUUI*AX8.;O9V;-0S9>P22L@Z2;5.EI/R^"I)/#]Y50B
MR4<UD'#== @8US#RR>5^:94TIT_X_-..OX:*,?R1<XLK1ME4V/.E7+G2>6L@
MMA'NY\#"+8N3^QYQC'L@) .//E3''ODSRHTAQJU[Q>W#'H;OV#KO6\7>;;;:
M;&'@IN[J14=(.9&KQ)'_ )S'Q\X^>(D.E(]]XW9D<^&V.MYLF&4P  +3^>GT
MC/,_[T_D5\4%Q 8?'D;/^S[GW]R'';_/6X@&=N PR/+'?]I7@_\ NH[A_BG3
M &0/T:O<K>!?WM>N?\U8 =!]8?I4;5ZGK+0T;KKEQ.<88S4I-JIVJ+C:Q8[/
M';()L0NNR1GJJU@]B0*9<19*7*E3PY(\[Y;.MX7F_=5PX# 'ZDG36D^EES/T
MYQXE=O,=U.;32=;;?):X^E.*&BR1L>R[E42P)H=U:)8SA1)2AJ+Y<X<DP?$D
M5+P2>"8ZH;:0!85U0>1,OQ/Z?'+??M;>GC+;1=-65*D2J9\)J1%]M_F]%H<N
M3)OHLM+A9H5Q@G[/S;N8-C)NT!B6^24<)]=;.LO(3F]M&L1MULVL+/7M7::<
M6-DC,-ZQ<).*5MFQ+JV3D4U"XN!(N0IK5B^+W7#-&8D^Z?O.RF(&6IU)^%.N
M>>7$'<NC+K3H:QV=]1;3):?G'K)J>:HVVV,(]<T6QUV643RM$K8L"$<B]*BH
MD5]'N7+!SD[9RJ3(8D'D?G(VPQ6Y.5G$&5?NC5JS:]B^0%;AW:QDVL):Z-9(
M'75U48M#]GAR4I%7:GX=8[,GRE1D/8+A(_:&>4Y<MV3==X\70:,VB"KETZ<J
MIH-VS=!,ZJ[APNJ?!442)%,8YS9P4I29,;/8 P(NJ#SIWGUT.8-7Z7?3Q<KR
M7'2"M7CWS8#59VWJNRW]5?H8G]LW:6:)F\WT/65CE/#H]A_5N2\V?HIOG[NN
M-&P6&\#.-L#Q \H^T[QEK-BE[="Z7Y 66DM;//(,VDI/*L--V95]*KLX],J3
M%-:0<.CHMRY4RW1.DB==P<F5U0V:X#I-7C9QU76477T%I59=90ZJRRNJZ,HH
MJHH?)U%%%#P.<J*&,8V3&SGMSGV<@/FKAI3B50*E:+W=-,:"K5/I5>FK9:[%
M*ZOH;:+@:W78YS+SDS(N#0'8@Q:QK-TNJ?\ 8D0-D!K[^(^ME.N;UOI/:,11
MF6N^+.K[7'[/D*_5X&/J<;5M$:IF&K76-)5;P3=%%K<+98$8W,GX:A7.%+#/
M/V9S)QQ2D#,/\H)]QXYL_<;KSX[-9@(A_)(=;:[N7"'D9(V^A4NU2#7E5(,F
M[ZR5:#G'B#,FH]7N"-$74FQ5.FUPLX7/A,IL$P=<^>[VFR E<ZMG3 X5<A.%
M7(^Q36C-7439NL=+[+V=K[;U'IM7I5RK5EH%2EKC&I25@AHM \Q473R'*WE(
M]Z99NJS>+J(^;/BMWB 8[GD=6Q+LEM[F7J@KV07UR^UOKW8;B..J92*C+M$V
M=]6V;UJ@<V<,Y!] S3Y-<R>"Y<IUYMA;O^:-^X&>B         LVY?=/WA]S
MQKL37>56CZMM0M;0DV]4GW:LO7[I423&6IY$M9NU6DF4I#MUEV$>JLW3=>:N
M%&".7#=;!,% 8_FQ?)"."D\Z?/-:\@N3NO,NUUEF\9-/];7Z%C"J'R8C1BF>
MBQ;Y1FF7)2E\YD'#C)2>W<'S[(#RU#Y(AP>J-BCIK;F]^0.XHN/<-W*U09*5
M#6L!-^"J4ZK"==P\2]E?4M5/!B'Q'24:[+]$F\)D!DTZ*X_Z4XR:XA=1<?\
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MOK.Q>>&2-1(CS3S;S/N><N?&\X[Z7@A(]J_7T+J76FN]5UMQ)O*[K*C5+7T
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MFB3'HQWC9[QSF,<QC9#[$
M            $ 73,]V#Z_?W<\!OB<VZ G]          'P.R=6:SW+5E:/M
MO7U,V=2UY.%F7%2O]9A[=6G,K7)5I.0,@Y@YYFNV<.F<PQ9N6YSI9RDLV(<O
M8; #[1JT:1[5JP8-6[)BR;HM&;)F@FV:-&K9,J+=JU;HD*1NW32(4I"$P4I"
MDQ@N,%Q[ <H   &+M:O)+.G);K19+9([HYL-I"SSTQ87S=AL?1:;!!Y-2#F2
M=(LDW/'!51-J59TH5/"BJI\$(7!U#F[<F#T7]"%=-CZ]W.+\96A?^C0 ^IHW
MDG'3IH%VI]]B-S<TW<M2;37[=%M978NC58US(5N7:3+)O(I,^.:"RK$[IDF5
M8J2Z*ADSF*15,_=.4,GLY<'*8N?08IBY_J]AL=F0&*WGR0OIL9SG.-V\X<8S
MG.>S&RM#=F/[&,FXTYSG\.0#^A"NFQ]>[G%^,K0O_1H 3D=/W@1I[IO\?DN-
M^CK'LFU4=&YV6]8EMJS%8G+8>7M)8TD@@=]4:?!L\QY"Q;;"),,,*%[3]]53
MMQV!B?\ E>^\96V;&X7<,:@5W*S!6%EW5.5F-(=Z]F9R[S*>K]4-VK)#M,>2
MPI [(223P4QU?5LA28Q^S#*JZ97#F*X&<'] \:6R#3%EI].;R^S9%IE-4DWM
MBW*'LNQ9##LGLOF9++)/&;%0^39)&Q3)'M[B)"X"[K9FL]?[FH%OU7M2HPE\
MUU?8-]6K?4+(R3D(6>A9!/PG+-XV4]'[$Z:A,D6061(LBHFLF0Y0Q7]Q^2&<
M,KC;)">T[R$WGIFOR3E9TG2))C5]GQ$'XRBARQU?E90L=)%B4B&3*D61>2;O
ML)G*KU8QNW 7P=/KR=#@OP,V+![L.YO/(?=-5=$D:=:]LJ0:=9HDP@?OL[!3
MJ' 1J+9O8D?8,@]DW$JLS6(1S'99."$4*$_0"./J&=*_B)U,JA"U_D;4IAO:
MZ@D[1H>W-?R;6M[.IJ#]1-9['1\P[C7C27@EEDRG/'2K%^R*H<SA!%%UGQ\!
M ,R\CMXTDGDG$AS%WFZJ^')3+1#*C4%A/*-,'+DR"5C74<MTG&4_$QA7,4<F
M#'QGP<EP8A@R.N"_3UXN=.G5CC57&2BJU]G-.VLG=KG8'_J_L/8LRR16;LY6
MZ68[=+STR"+AR5JS:H,XMCYXOEBQ;9<.,JA>V QNN;7DP_ WEEL>P[?H<]L+
MC!?+?)NYJV1^L4Z]+ZRG)N166=2<Z77\_']ZORCATK@ZI(F281QC=\_J=XZI
MULATIQW\DJX-:NNL7;]U[:W%R,80KU!\VH$@E ZWHLN=!;*I6ML0K97,M+1^
M<%3[46DO'8/W<E6\9$^40&4O7J_ U&!A*K586+KE9K41'0%=K\&Q:Q<+!0<.
MS1814/$1C),B,?&MF+=NB@@D0B222)"$*4I<8 >Y          &.QUK?IM^E
M+_;_ %!/Y)#X=:P/K[8OPNK?II'P;.?]K3.'\16M^H5A8L/LT_'
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MN>?7WJVX_P")\D [RX*?21<./O5N/7Q1U !=2
M                               (.^>'NT704_OI'\E*G@)Q
M                             &KL\IP]V#W[]PVA_B<IX#:)@     "T
M_GI](SS/^]/Y%?%!<0&O*\GSZJ_&CI>VGE',<CH?;$LTW)7]3QM3_4NJT!9E
M4'-'D;\YE\3))VX1/F:9T[3'>;Y2ROWS)K=_P^Z3OA+MSF\K<UW8=2VFA\$-
M-[8AMD6V%EJ^AN#=:-1JR&N?5-@HT^:>FU*HVJ>/9K,W\X,HR-(.H]LT=H)N
M%FT@F0S10/L/)7NF+MC4;R_]0;?%<GZ.[V/0W.L=$T^TQRT?.SE,L<S7+7:M
MMR#&03*YCX]ZM781C!'4P0[YJM*OLIF9.8URY"\/RM3W,&E_?<:J^+O<H"Y'
MR9WW'+C5]T^_?CZV* GK 05];W3O5:W!3]",>EW>+/3)>(E=E*;GQ5=J5754
ME*QC]A32T=,DK9I1GEX9)TUM'=\V<$,B9SVJ9+@Y#8#!WOVG]Z<(^8U%VSUS
M.*?(WD; 6:2(J9:U[Y),,[[F'6:.'ADMGQCJ?9[,3C&;YJL:LHV2&*;SE%M(
MN6S-8Z1@V:O%#?6C^37';4VZ^.$C&/M,W.HQJM(:1<>SATZTPBT_49:E/8!@
M;*-;EH5Y'N(MW')Y\-FXBCH)&,D0AS!@T>6%?3B<5?O:9#XT;: A>ZC_ %.-
MN]1S8^MGVQD[!2^->IV,32=4:M@W)'#>'B(6/A8VUVQTX<%39SVU9%B5LLY6
M4_662;EG'(FPT(99R&RUZ6<5PNBN#>C2\!2QQ^.;VND?PKTN6Y[=)6E3":-R
M>;463)A57:V)QNLC-E7QC*+EGALV(G'HLTB!(4 UIVNZD^Z[_7VMS#<\N]?:
M2C[UL"0>0;5[(1JK'C+H:1>QM,U_"JL5BJ0ZTRH:!1DW+95LKAY=I>5;G3=G
M(4P;#:G\6.-- U^TU53- :<KNMV4:VB$J5':XJ2=<68-&I6223^,/$F3E%,M
MB]U15SA99;)SG6.<YSFR& %OS4NLM'>55:WUEIR@U/5^NH'EQPL>P-&HL''U
MJIP:]GU;HVVSV(: BD4FT2W<V2<EG9T6Z2:)57Y^X0A<]TH;'@  6G\]/I&>
M9_WI_(KXH+B UBO2>XY]43D)/;L;=,W:-WUG+U>(HJ^WUZ;O=SI#,O&R[RT)
MTM*16;SC/YI/!=1]DRD7/B>:><JY+W/./;A-'\[8\JL^RJW?^7O)_IL B4ZK
MW%[JZ<?:GIN2ZEVW+_LNKV2PVQCJIM<.1+K=C:*GV$;"KV5=E'.+ \Q!.%8]
MQ%E,M@A/&PCW._['= ;#+HU>Y6\"_O:]<_YJP DP :[;RJGW6SC;]ZUHW^4%
MOD!L20$$/E*SERAT:^5":&#93>3'']L\R7/9@K8O(S5+LN3?[W+IJUQ_=@+-
MO)#6""'3>W6_+G!G#_FIL,BQL>DJ3/2/'LJ")O>,LN?_ .S@,J<!KA/)LL>I
MG6SV1'QF.XPSKSDU&F*D4Q4\1[:W0:S8O=Q]"GA9FS[.W_>_LNP!)WU^^J1M
MO=^W2=&_@''66R[.V!.,-?[_ )RIIK-IF?DYYNBYQHJKOCF3PQ@\1:_G=RE3
M*)LR,2*QCARFP1GBG"<?H]=*/6_2ZX\MZP3$3;>1.QVL7,[\VJU;Y-B5F4$S
MJLJ+4EW*)5FNO(51RY29E.5)1^Y5<RKE)%1RFT9AB8TK_LMQ[]]_?_B>L8#8
MC@ #$,\JPZC.=0:.J_ 364[AOL+D(R;W#=*\>X[KRNZ/B)4Q(>MKG1,4[5Q:
M+9%J%4[IO;1%0D6CE++>52-D)(?)^.G;ZP;@I6'UV@O4OD#R0Q$[>W%YVV\&
M7K[-ZP-G7&M'>3EPHCZAU=\95VW4QWF\W9YHF#93\/NAV!Y03[CQS9^XW7GQ
MV:S 8;?13Z[6L.E=Q]VIIF\:"OFV9+8&XG6SV,W4[77H!BP:.*34:IB)=-I=
MBJHHXPXK*BWBDSW.X]QCN=XANT.^><GE%W)_J<TI3@SPVXQ2>KL\B,EUM8",
M+>[V5N#8L9.KE3>T>K%BH&'95*%DHTKAI,F5))'7C7+I/+EDVRX.<,D/H!])
MFR],SCW<I_=1H=;DQR#?5R9V%'0CI.5CM<U*M,GF*AK-*8;J'0EIIL^G+ \F
M'C(WF*SN229ME'C:,;R#L)^@
M
M             ! %TS/=@^OW]W/ ;XG-N@)_0
M  !#KMGHPZ$W?U**-U*ME['V=9;MKE]1).IZ>>%JAM71DAK6O>8TU9/.8'U3
M\%I;BEL>$\O,]Z5[>\;S8W@ )B@                         !CL=:WZ;
M?I2_V_U!/Y)#X=:P/K[8OPNK?II'P;.?]K3.'\16M^H5A8L/LT_'
M                      <0_HQ[_P F162Z.+74\^@OO?+D6DOC@PCIRX>=
MQAL27QP1FNC@HG^BS^#X,"U'?+AQ,9[H8J1_1CW_ ),C8EOABDI"Z<W9^!QQ
ML)J:GU/P_(+2:,$M4^/&I&]&?>S\ V)-&",U\F/F4!LPOFQXH/)NS\"D?TX]
M[Y<BTET<4IKHX*)_3CWC? +T>M&:^.*@?Z'/X/AP-BCUL)]&*@IZ#>_\HV9;
MI<8\:*B;Z GO_P#LL"TE\<&$=.7#SN.;TY]_/PB\FE!)2/Z<_M<?PL#8DTH,
M9]&*@?T8]_Y,C8DTH(J)O1GWL_ +)3WPP4!L)S71P43_ $6?P?!@7ENA@]4S
M_0Y_!\.!:2Z.+741L271Q1GTHJ!O3GW\_"-B2Z.*4;I,8*2GU/P_(+27QP3F
MOCBH&])/?^7 O)I03GNABHF]&?>S\ VJ/6E/V7A4C?L?VN/E&Q1ZQQS>G_#_
M  C"M'?+AQ-=QS_19_!\&!L0NFPXX)3WPP43^G/[7'\+ V9-*#!1-^Q_;8^4
M;$FE!'L_#QJ(LQ          !?QTP?IY='_^4OXH+^/XOT0OVG\K_F__ %I4
MGV6Z#_\ Z1>;OYW_ -16FRZ!^8[]P@                       $<G5]]R
MYY]?>K;C_B?) .\N"GTD7#C[U;CU\4=0 74@
M                             "#OGA[M%T%/[Z1_)2IX"<0
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M2LD>W)A-J\=)OVB2+!^FT9!D.@
M
M               " +IF>[!]?O[N> WQ.;= 3^@
M                                #'8ZUOTV_2E_M_J"?R2'PZU@?7VQ
M?A=6_32/@V<_[6F</XBM;]0K"Q8?9I^.
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M,#8A=-AQP2GOA@HG].?VN/X6!LR:4&"B;]C^VQ\HV)-*"/9^'C419B
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MCJ "ZD
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MU-O$1$V:-<+,7<I7+'1;1,,G%9DBMTY!BB=\J\9H21&;SO.$#JJ!<,
M
M                                           @"Z9GNP?7[^[G@-\3
MFW0$_H
M@4ZJM6C[QU".B[2999ZVBKALWFG5I->.501D&\?8.-2<2]68JN6ZR:3PK=XH
M9(RB2I"G(7)TU"XR7.Q5*U2U*M56N44LLU)5:22EEA-L[$8T<T)X=-L1EFZ7
M9E^JZ6:$?^TY%NV/5LH;#MK)^NSST=3MVJ5FITTU'-"%++1UFAI*&>:BC/)/
M)">$D\8R1GDGEEFV-F2:'U*\+YUGQ^_KPW'_ (P4G^;T?.=LFW/O6J?W*?G#
MZU]:!FT[N6[OFH>K#YUGQ^_KPW'_ (P4G^;T-LFW/O6J?W*?G!UH&;3NY;N^
M:AZL/G6?'[^O#<?^,%)_F]#;)MS[UJG]RGYP=:!FT[N6[OFH>K#YUGQ^_KPW
M'_C!2?YO0VR;<^]:I_<I^<'6@9M.[EN[YJ'JP^=9\?OZ\-Q_XP4G^;T-LFW/
MO6J?W*?G!UH&;3NY;N^:AZL/G6?'[^O#<?\ C!2?YO0VR;<^]:I_<I^<'6@9
MM.[EN[YJ'JP^=9\?OZ\-Q_XP4G^;T-LFW/O6J?W*?G!UH&;3NY;N^:AZL/G6
M?'[^O#<?^,%)_F]#;)MS[UJG]RGYP=:!FT[N6[OFH>K#YUGQ^_KPW'_C!2?Y
MO0VR;<^]:I_<I^<'6@9M.[EN[YJ'JP^=9\?OZ\-Q_P",%)_F]#;)MS[UJG]R
MGYP=:!FT[N6[OFH>K#YUGQ^_KPW'_C!2?YO0VR;<^]:I_<I^<'6@9M.[EN[Y
MJ'JP^=9\?OZ\-Q_XP4G^;T-LFW/O6J?W*?G!UH&;3NY;N^:AZL/G6?'[^O#<
M?^,%)_F]#;)MS[UJG]RGYP=:!FT[N6[OFH>K#YUGQ^_KPW'_ (P4G^;T-LFW
M/O6J?W*?G!UH&;3NY;N^:AZL/G6?'[^O#<?^,%)_F]#;)MS[UJG]RGYP=:!F
MT[N6[OFH>K#YUGQ^_KPW'_C!2?YO0VR;<^]:I_<I^<'6@9M.[EN[YJ'JP^=9
M\?OZ\-Q_XP4G^;T-LFW/O6J?W*?G!UH&;3NY;N^:AZL/G6?'[^O#<?\ C!2?
MYO0VR;<^]:I_<I^<'6@9M.[EN[YJ'JP^=9\?OZ\-Q_XP4G^;T-LFW/O6J?W*
M?G!UH&;3NY;N^:AZL/G6?'[^O#<?^,%)_F]#;)MS[UJG]RGYP=:!FT[N6[OF
MH>K#YUGQ^_KPW'_C!2?YO0VR;<^]:I_<I^<'6@9M.[EN[YJ'JP^=9\?OZ\-Q
M_P",%)_F]#;)MS[UJG]RGYP=:!FT[N6[OFH>K#YUGQ^_KPW'_C!2?YO0VR;<
M^]:I_<I^<'6@9M.[EN[YJ'JPSTL^/N?3<-Q_XP4G^;T90SFVY"&Q"JU/^Y3<
MX8=9[FS[N6[OFS_5CQSTL>/N?3<=R=OW04G^;P9PSG6_"ZJ5.&Q_W=-R[SK/
M,V>SL^[EN[/PFS_5:G\ZMX]_UX[E_P 8:1_-X,]M'*#[SJ?Y.FYPQCT'6;+N
MY;T?E-G>JWCGI5<>LY[?FRW-_C#2/YNQG#.KE##_ ".I_DZ?G+SK.,V/=RW=
M\V?ZK>&>E5QYS[&;CN?_ !@I/\W0SAG8RCA_D52V?_+I^<L>LVS8]W;>WU9_
MJM^?.IN/']>6Y_\ &&D?S=#+;:RC^\JC^3I^<L8]!IFPC?;MO;ZL_P!5O#YU
M'QW_ *\]T?XQ4?\ FZ&>V]E+]XU'\E6.<O.LSS8:K=M[?5G^JGAGI0<>,^FZ
M;H_QAH_\W0SAGARFA_D%0_)5CG+'K,<U_=_*#?=G>JGYGI/<=<^FY[I_QBHW
M\W(SVY,I_O"H?DJQSIC'H+\UT?Y?M^'RJSO53Q^=.<=/Z]-U?XQT;^;@90SS
MY40]^%0J'Y.L\[>1Z"W-;'^7K?WU9WJIX?.F>.?]>FZ_\8Z+_-P,X9ZLJ8?R
M?9\/[*L\[8]97FL[OY0;[L_U4_,])CCGG&<?-INOV?\ PCHO\VXSV[<JNYUG
M?D:SSMY'H*LUD;[?R@WU9OJEX_.E>.7]>N[/\8Z)_-N,]O'*W[PL[\C6>=L>
MLHS5QA]?\H-]6;ZI4\])'CAGTW7=O^,E$_FW&4,^>5L+K/L[\C6>=L>LES5;
MH,H=]V;ZI>/SH_C?_7MN[_&2A_S;#.&?;*Z6ZS;-_(UGGAUDN:K=!E#ONS?5
M+P^=%\;OZ]MW_P",E#_FU&<,_.5\/Y-LW\C6N>,(]!%FICL_XP90^_\ YW9O
MJEXYZ1/&TWL_-MO#_&2A_+K49[?N6,+K.LV']C6N>/(]!#FHC]T&4.^[-]4O
M'/2'XV9QV9NV\/\ &6A?S:#*'1 990]_W-LR&Q_W-:YXQZQ_-/NARBWW9OJE
MX_.A>-?;V?-QO'M_J?-+0NWXM!GUP>6?<RR_R-;YZPZQW--L]-U0Y1;[LWU0
MCAX5\/\ 6G(_D%U#M37B<O,57N)7(V'U#KE[5). 8S4U6I"DL[(L^NSJ7K+Y
M"2G</G"A"JL&T:AA'L+EMD_M\Y]<-EIW+LO\A6^>D>@;S31^Z'*+?=F^J4C.
M>C_QISGM^;C>?^,M!_FR&<.B)RUA#8]R[*][_N*WSYAUC&:7=%E'ONS/5#QS
MT?>-&<=F;QO/_&:@_P V0RAT1N6\/>]RK*][_-ZYSYYUB^:3=%E'ORS?5#Q^
M<]\9_P"OC>G^,M _FQ&4.B0RXE][W*LK>]<Y\\CT"N:2,=GJBRCWW9GJAX?.
M=^,W]?.]?\9J!_-B*0Z)++F'\DV3^0KG/V,>@4S21^Z+*/?=F>IXO#/1UXS9
MSV_-UO7\%EH'\V0SAT2V74+K)LC\A7.?L>L1S1;H\I-^69ZG/G.G&7^OK>W^
M,VO_ .;$90Z)C+N'OPLFR-[USG[R/0(9HHPV(Y1Y2;\LSU.\/G.'&/\ KZWO
M_C/K_P#FP%.N=R^[DV1O>N<_8]8=FAW1Y2;\LOU.\/G-O&+^OK?'^,^OOYKQ
ME+T4&7\/>]Q['WO7>?O.L-S0;H\I=^69ZG>.>C7QASC&/F[WSV8_\*-?=O\
MA_4O&<.BBR_A_(]C[WKWK%CUA6:#=)E+ORR_4[P^<S\7_P"OK?/^-&OOYKQG
M#HI<X,+K'L?>]>]8L8] 3F?C]TF4N_++]3O'/1EXOYQV9OF^O\:->_S6C+KJ
M,X,/?]Q[&A\GKWK%YU@^9[8V.J3*78^&V9ZG>/SF/B]_7YOO_&C7G\UHSAT5
M><.'\C6+'Y-7?6+#K!,SNZ7*;?EE^IGA\Y@XN_U^;\_QHUY_-8/>NLSA]QK%
MWM7?6)U@F9W=+E-ORR_4Q\Y@XN_U^;\_QHUY_-8'769P^XUB[VKOK$ZP3,[N
MERFWY9?J8^<P<7?Z_-^?XT:\_FL#KK,X?<:Q=[5WUB=8)F=W2Y3;\LOU,?.8
M.+O]?F_/\:->?S6!UUF</N-8N]J[ZQ.L$S.[I<IM^67ZF/G,'%W^OS?G^-&O
M/YK ZZS.'W&L7>U=]8G6"9G=TN4V_++]3'SF#B[_ %^;\_QHUY_-8'769P^X
MUB[VKOK$ZP3,[NERFWY9?J8^<P<7?Z_-^?XT:\_FL#KK,X?<:Q=[5WUB=8)F
M=W2Y3;\LOU,?.8.+O]?F_/\ &C7G\U@==9G#[C6+O:N^L3K!,SNZ7*;?EE^I
MG/B^C=Q5CY%D^=V?=DZV:N$UUX>5MM02CY%,ALY,T>JPFOF;LC<_LX-ENZ05
M_P!PJ7(C6>BISCT]7IJ&BL^R*G24D(PEI*.K5J,\D?\ K20IJ]2T732]CT]%
M/#_K2Q;%2Z S,S5:W5ZQ6+8RAM&AH9Y9IJO35ZHRT--"'84D:O9E!3PDF[+^
M"IJ.?M3RI'-5:GU]I.EQE UG6&%5J\9WE",F13&</7JI$TW$K+/US&7EI=8J
M*6%7+A118^$$R=_N)D(7^#Y1Y2VYE;:U8MK*"T9[2M"L>]T\]TDD(QC+144D
M-B2CHI-F;I:.2$)(1C-'8V8S1F^UV1F162^;ZP*IDSDA8U'8ECU+ZJ6CH]F,
MU)230EA/34])-LTE/3S]++T]-2S3SS0EEA&/2RRRR]DCAOE8
M           ".3J^^Y<\^OO5MQ_Q/D@'>7!3Z2+AQ]ZMQZ^*.H +J0
M                                               !!WSP]VBZ"G]]
M(_DI4\!.(                                     U=GE.'NP>_?N&T
M/\3E/ ;1,
M
M
M ! %TS/=@^OW]W/ ;XG-N@)_0
M                  !!WU(_=..AC^[ERV_D_,0$X@
M                                     (.^E3].CULOOXJQ\5$6 G$
M                                                     $<G5]]R
MYY]?>K;C_B?) .\N"GTD7#C[U;CU\4=0 74@
M                             "#OGA[M%T%/[Z1_)2IX"<0
M                           !J[/*</=@]^_<-H?XG*> VB8
M
M
M                                           " +IF>[!]?O[N> WQ
M.;= 3^@
M"#OJ1^Z<=#']W+EM_)^8@)Q
M                   0=]*GZ='K9??Q5CXJ(L!.(
M                                   (Y.K[[ESSZ^]6W'_$^2 =Y<%/
MI(N''WJW'KXHZ@ NI
M           $'?/#W:+H*?WTC^2E3P$X@
M         #5V>4X>[![]^X;0_P 3E/ ;1,
M
M
M                          ! %TS/=@^OW]W/ ;XG-N@)_0
M                                           !!WU(_=..AC^[ERV_
MD_,0$X@
M  (.^E3].CULOOXJQ\5$6 G$
M                  $<G5]]RYY]?>K;C_B?) .\N"GTD7#C[U;CU\4=0 74
M@                                                     "#OGA[
MM%T%/[Z1_)2IX"<0                                    !J[/*</=
M@]^_<-H?XG*> VB8
M
M
M        " +IF>[!]?O[N> WQ.;= 3^@
M                         "#OJ1^Z<=#']W+EM_)^8@)Q
M                                            0=]*GZ='K9??Q5CX
MJ(L!.(
M(Y.K[[ESSZ^]6W'_ !/D@'>7!3Z2+AQ]ZMQZ^*.H +J0
M                                     !!WSP]VBZ"G]](_DI4\!.(
M                                    U=GE.'NP>_?N&T/\3E/ ;1,
M
M
M                                                   !&!Q X4[3
MX_<\NIYRBN4_0)/7_-2R<9)C5D/696Q/+A -M+T&\U6TDO\ 'RM59,HMPXD+
M-'GC\1TA*E5116,Y.U.4B:@2?@
M                   "./EMQ"V5OKF'TWN0=/G*-&TSA]LC>5OV7&622GV=
MGG(S9FKD*3 H45E%UEXTDGR,JB91V60>QB9&^2G15<*?K("1P
M                                            $<G"KB%LKCAR#ZAV
MU[Q.4:4KO+7D;#[>UPRJDE/OIF%K4?26=;6979M+UIBA&SN7S8YRI,',DAE'
M.#&<E/[3 2-@
M     "TWG;HFW\G^&G)SCM09&N1%UW3I6_:XJ\I<'DFPJS"<M,"[BX]U8'L-
M#R#MK$D<."96.W8NEBDQG)&ZIO:Y#L?C;KB<T[QUT'J.S.HI]9-6:6U9KBP/
M8)=XZ@WDY1Z- UF5=0SE^Q:KN(E1_%N#MSKMFRQT3D,H@B?)DRAW6
M                                               (Y.2W$+96Y.H+
MTS.5]8G*,PUWPR]>;^JA#3TE/M;I/>N*TG ZWI/S!1T?673&4\UG(MPK*^J,
MC%>"T.0[3SY;)FY0D;                                     8:?6&
M\G?YJ=0;GEL[E%IG9_%RLT"Z5S6D/%P^SKKMB&N#=S3:# U:34D(^JZ3FF22
M"DA%N#H93D%3&1.0RA4CYRF4,RP
M
M
M                   !"?T^MT[;OW5%ZUFK+ML>XVO7.E;EPO:ZDI4_//Y2
MN:X;W?5VSY>WMZ?%NUC)P;:1E(V/7=$0P0JIV2638]H7L";
M                                          1 \]]O[1HG4$Z/>NJ7
M?K55J+N+<G)6,VI58*9>1L+L",J>DVL[6XZU,VJA2S#%G,*'<HHK=Y,JQ^_W
M<Y[ $OP
M  (@.F[M_:.Q.575KI=\OUKN%6U%S&AZQK"$L<R\EV5$K4GKF,E7E=K!7JI\
MQ,'F2,98C1(Q4$CG-X*9.\;O!+^
M                     +#NJ%>;EK+IV<TMAZ\M$[2KU2N.6T;-4;;69)U#
MV"NS\/6'SV,EXB39*$59/D7**9R'(;!BY+Z>P!W%P\LT_=.(_%FXVR7?6"TV
MSCEI"S66>E%SNI*;GYW6=9E)F7DG1_9</G,BZ<K+'S[)U%C&SZ0%QX
M                                                B!YE;?VE3>K!
MT8=3U2_VJO:TW-\\4_59HL1,O658V)C77&VKV2B?-;$(*81FO4BP.G#QAXY3
M^;.%S*I]TYNT!+\                                     UW'E"'42
MYU<?NJ+N;5ND.6>]]4ZY@J;IIU$4JB;$L%<KD>YFM75F7EG+:+C79$DUW$F]
M<K+'[O>.HMDV<^CL#8C@
M
M
M            ( NF9[L'U^_NYX#?$YMT!/Z
M                             (.^I'[IQT,?W<N6W\GYB G$
M                                               !!WTJ?IT>ME]_
M%6/BHBP$X@
M    CDZOON7//K[U;<?\3Y(!WEP4^DBX<?>K<>OBCJ "ZD
M                                        0=\\/=HN@I_?2/Y*5/ 3
MB                                     -79Y3A[L'OW[AM#_$Y3P&T
M3
M
M                                                      0!=,SW
M8/K]_=SP&^)S;H"?T
M           0=]2/W3CH8_NY<MOY/S$!.(
M                             "#OI4_3H];+[^*L?%1%@)Q
M                                             !')U??<N>?7WJVX
M_P")\D [RX*?21<./O5N/7Q1U !=2
M                       (.^>'NT704_OI'\E*G@)Q
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M"&N&JKW5]B58LS'IMU9"(-8*A*/&A91!-XT,LW\;Q4BN4S'(7!R]H=F +/\
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MFVRW?S%T>$V36T;_ "&$DC+JF:4*4?-YE<I$2&,?)6)L$*3M-V +SP
M
M
M   ! %TS/=@^OW]W/ ;XG-N@)_0
M                    !!WU(_=..AC^[ERV_D_,0$X@
M                                       (.^E3].CULOOXJQ\5$6 G
M$                                                      $<G5]
M]RYY]?>K;C_B?) .\N"GTD7#C[U;CU\4=0 74@
M                               "#OGA[M%T%/[Z1_)2IX"<0
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M9,9 OSLT-L[B2:HR-CS:%V:A3R5;KSAXC$MHI?\ 6"2T)(R*Q'!_4\S,(G>
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MY,K/62/D*/;V:L@L<[ERS18&>'5>86=.0R9P
M
M                                            $ 73,]V#Z_?W<\!O
MB<VZ G]
M $'?4C]TXZ&/[N7+;^3\Q 3B
M                    @[Z5/TZ/6R^_BK'Q418"<0
M                                    1R=7WW+GGU]ZMN/^)\D [RX*
M?21<./O5N/7Q1U !=2
M            (.^>'NT704_OI'\E*G@)Q
M          &KL\IP]V#W[]PVA_B<IX#:)@     "QWJ=>YL=0K[QWEE\0M^
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MD;ERD$;ISPH!ULGBY*KZ%N*2!N]DK>0A);:$(NLCCM[$SK-[ W*K]4_F"/\
MN &<XO"0SJ583SF(BW$Y%-WK.*F5V#565C6DEEOF2:L)%1'*S-NXRT:>.1,Y
M2+>:I]_!NX7L#V1C8+C)C9P7!<9R8V<XQC&,8[<YSG/HQ_\ $ :I;R@'E9J_
ME]U-]RWW3CR/G-?T:'J6FXNYQ9R+,+W(:\8+,['9V+A,O<?1>;(\EF+!TF=5
M%]'0C1XBH9%=,I0R7?(_^.UKI7'7E+R5GXY9A ;WV#0:'0E'22R2DM$Z18W1
M2Q3\?WRX*XAU;)LEQ'%5+DW].4]ZCGNF1SW@S#@
M
M                                               $ 73,]V#Z_?W<
M\!OB<VZ G]
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MMN/^)\D [RX*?21<./O5N/7Q1U !=2
M                        (.^>'NT704_OI'\E*G@)Q
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M*V:I&66.95\\/DIU7+I<ZKEVY<+.7*JJZRBAP[(
M
M                                                0!=,SW8/K]_=
MSP&^)S;H"?T
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MR=7WW+GGU]ZMN/\ B?) .\N"GTD7#C[U;CU\4=0 74@
M                                    "#OGA[M%T%/[Z1_)2IX"<0
M                                  !J[/*</=@]^_<-H?XG*> VB8
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MSDB>7L5+L'ID4,N<HD"^,      0!=,SW8/K]_=SP&^)S;H"?T
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MZ>14S@^*<OJFW3C9N=N1]+T#8M;E)*HVI9D5P4SIBBR5P8ZR**CR-\0J@#-
MXT\CM2\M]&:YY$Z.LB=JUGL^ 2G:_(X(5!\T4(LLPF("<8X5/F+LD9--)"/D
M6AC&,V>QJR/>/@F#F"SGJI=4/3W2UT"UVML"*<WK8-VDGE:TUJ*,DTHB2O\
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M[HU"\DRS*M7?S3=TM V.O36&J&9RDRN(V6PR<*((.47$.\9N4"F02<.0E?
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MC^+]$+]I_*_YO_UI4GV6Z#__ *1>;OYW_P!16FRZ!^8[]P@
M          $<G5]]RYY]?>K;C_B?) .\N"GTD7#C[U;CU\4=0 74@
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MKYBPN^KM!:IH%O8LI1L9G),VEEJE3:/6S9PS44273(L4BR1\D4P8N<X 70
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M)C/=#%2/Z,>_\F1L2WPQ24A=.;L_ XXV$U-3ZGX?D%I-&"6J?'C4C>C/O9^
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M*.H +J0
M!!WSP]VBZ"G]](_DI4\!.(                                     U
M=GE.'NP>_?N&T/\ $Y3P&T3
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M;?I2_P!O]03^20^'6L#Z^V+\+JWZ:1\&SG_:TSA_$5K?J%86+#[-/QP
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MGGU]ZMN/^)\D [RX*?21<./O5N/7Q1U !=2
M                             (.^>'NT704_OI'\E*G@)Q
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M^->F\-C/1*F%BMS('PZ[I%3'(H4@72@
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MZU&-$4,S5@>R3ENDU8M$E7"F>TQ4NX0YBAC7>1H?ZT]1+_A'BG_S;D6 S=P
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MR XDP;E5EGSQ%1SJ*#J.V[<7)4^WP\1TFG.-G938_6CP[CO]A2F ; P
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MRN?D3$[/Y1\8N*E+?H6.8TA1K/:;=%07;(OV5[W?*UIM"U)\U;%,?U?)5Z+
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M^V+\+JWZ:1\&SG_:TSA_$5K?J%86+#[-/QP
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M8&Q"Z;#C@E/?#!1/Z<_M<?PL#9DTH,%$W[']MCY1L2:4$>S\/&HBS$
M    %_'3!^GET?\ ^4OXH+^/XOT0OVG\K_F__6E2?9;H/_\ I%YN_G?_ %%:
M;+H'YCOW"                        1R=7WW+GGU]ZMN/^)\D [RX*?21
M<./O5N/7Q1U !=2
M         (.^>'NT704_OI'\E*G@)Q
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M9MIL:3:T978CW%H<HJ$+,\B>0CQZ[L&88RV#841CZ#,W7STA3]]KBYQ./H'
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MIIH2W2^XEI2[,?\ JR]--++TT=<T)=*:#+D'YEOW
M     1R=7WW+GGU]ZMN/^)\D [RX*?21<./O5N/7Q1U !=2
M                                         (.^>'NT704_OI'\E*G@
M)Q                                     &KL\IP]V#W[]PVA_B<IX#
M:)@     "T_GI](SS/\ O3^17Q07$!K%.D_U->5O3<GMVRO%S25(W.\VW$46
M/N;6Y4[9%NQ -J:\M#F#<1Q->6J,.Q\X6LLH57+KQBJ^;I^#X>2*=\)I/Z*)
MZMOV"VD/Q,<E_P"=0!(STI>NKU".;W-O6?'/??%36.L=87&$V+)3ETK&M=VU
MR7BG-4H5@M$,FC+7.^/X]!)Q+1;-L<JS8QCE=9(D8BIB& =#^62_[7W ?[LN
M0W^9-0@.[NH]T[O7K] W@_M&AP>9'?/$SA5QXVE2RLFWC2MHUWG06OU=MT-'
MPRF4=**P,6SF6**93K+2%,09-\%R_4[0^T\EAZB/K@N+\WPLV+.X=;6XJ,V[
MK7QGSGOR%EX^2[XK:'20PH?)W!JK8G7J0KGVJ3:+FZZV3P;)%,X"(ZM?]EW.
M?OG;7_)RF &4GY03[CQS9^XW7GQV:S 0F^2F<FN-VDN%G(> W/R!TAJ*>D>3
M\A.1\+L_:]#H,L^A3ZHUJR),,XVUSS19S%Y>,7J.')"&1RHS42[_ 'TSXP%\
M761Z[7"/4O$W>&EM";KU[R-W[NG65PU?6HC4=AC]@4RFL[Y$/*C.W"XWVL.'
M,.Q6C8>4DG#2,([7?NW[9LBLT19'<.T0L?\ )!^)UZI^O^2_,.WP2\14MNFJ
M&J-//G7B(K66-HDK9I'9LZU;'+C"T"6Q.*O'-G1<F*J^KTLW]J9J;O!&/UC)
MJ&K7E+%)L5BEHR K\!N[@/-3L[-OVL7#0L-%Q6FWTI+2TF^630C8QLQ;K++K
MK'(DBDB=10Y2%SD!G*7;J<=.G7<$_L5LYR\4&4='-5G:R,?OK6MAF7*:":BI
MTHFM5RQ.Y*=>9*F;N-V31PX4SCNIIG-[ #7Y=5+D_(==?JC:GUWPYJDK,UO$
M-6^/>E7TU'/(:0MK<DY8+A<MJ6:-<HY7JU5;J34PX4PX*51I U+$@\1;.5'+
M1$-F31ZE%T&E4^B0F#XAJ55Z_4HC"N>U7$97(EG#L,*9]G]<\U9H]OL^G "%
M?RD[W&7EQ_;W'O\ E-Z< 6M>27^Y?6W[[/:_\0M0 ,G<
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M+S%CHDRE*V!._0,NI'(-ZK:GZR9\1K%TKDZB9$NQ'N]_OF*4P9FH
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M[8OPNK?II'P;.?\ :TSA_$5K?J%86+#[-/QP
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MP8&Q"Z;#C@E/?#!1/Z<_M<?PL#9DTH,%$W[']MCY1L2:4$>S\/&HBS$
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M-",E-)0T_P#!3TE>K,G32ST4\\DL:"AJU-)">62:EIJ62$8T$TLW8^H[]"P
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M 9.X
M
M                          @"Z9GNP?7[^[G@-\3FW0$_H
M                                           @[ZD?NG'0Q_=RY;?R
M?F("<0
M $'?2I^G1ZV7W\58^*B+ 3B
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M4W+0WF6;(6#C,2Y3>I?BE5\P;>PXP7P_:][(79@
M
M                                                           (
M NF9[L'U^_NYX#?$YMT!/Z
M                (.^I'[IQT,?W<N6W\GYB G$
M                                  !!WTJ?IT>ME]_%6/BHBP$X@
M                                                   CDZOON7//
MK[U;<?\ $^2 =Y<%/I(N''WJW'KXHZ@ NI
M                            $'?/#W:+H*?WTC^2E3P$X@
M                          #5V>4X>[![]^X;0_Q.4\!M$P
M
M
M                                          $ 73,]V#Z_?W<\!OB<
MVZ G]                                                      $
M'?4C]TXZ&/[N7+;^3\Q 3B
M                  @[Z5/TZ/6R^_BK'Q418"<0
M                                  1R=7WW+GGU]ZMN/^)\D [RX*?2
M1<./O5N/7Q1U !=2
M          (.^>'NT704_OI'\E*G@)Q
M        &KL\IP]V#W[]PVA_B<IX#:)@
M
M
M                        ( NF9[L'U^_NYX#?$YMT!/Z
M                                         (.^I'[IQT,?W<N6W\GY
MB G$                                                       !
M!WTJ?IT>ME]_%6/BHBP$X@
M                CDZOON7//K[U;<?\3Y(!WEP4^DBX<?>K<>OBCJ "ZD
M                                                    0=\\/=HN
M@I_?2/Y*5/ 3B                                     -79Y3A[L'O
MW[AM#_$Y3P&T3
M
M
M      0!=,SW8/K]_=SP&^)S;H"?T
M                       0=]2/W3CH8_NY<MOY/S$!.(
M                                         "#OI4_3H];+[^*L?%1%
M@)Q                                                      !')
MU??<N>?7WJVX_P")\D [RX*?21<./O5N/7Q1U !=2
M                                   (.^>'NT704_OI'\E*G@)Q
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MUEUYVW=/F-^>,<4I_P#5)_52U\C1/4WYH? 9?,;YCX/G7C>8ROG/?\#PF_\
MIP"^/U^'6B^T*?OI'%+]#P#U^'6B^T*?OI'%+]#P#U^'6B^T*?OI'%+]#P#U
M^'6B^T*?OI'%+]#P#U^'6B^T*?OI'%+]#P#U^'6B^T*?OI'%+]#P#U^'6B^T
M*?OI'%+]#P#U^'6B^T*?OI'%+]#P#U^'6B^T*?OI'%+]#P#U^'6B^T*?OI'%
M+]#P#U^'6B^T*?OI'%+]#P#U^'6B^T*?OI'%+]#P#U^'6B^T*?OI'%+]#P#U
M^'6B^T*?OI'%+]#P#U^'6B^T*?OI'%+]#P#U^'6B^T*?OI'%+]#P#U^'6B^T
M*?OI'%+]#P#U^'6B^T*?OI'%+]#P#U^'6B^T*?OI'%+]#P#U^'6B^T*?OI'%
M+]#P#U^'6B^T*?OI'%+]#P#U^'6B^T*?OI'%+]#P#U^'6B^T*?OI'%+]#P#U
M^'6B^T*?OI'%+]#P#U^'6B^T*?OI'%+]#P#U^'6B^T*?OI'%+]#P#U^'6B^T
M*?OI'%+]#P#U^'6B^T*?OI'%+]#P#U^'6B^T*?OI'%+]#P#U^'6B^T*?OI'%
M+]#P#U^'6B^T*?OI'%+]#P#U^'6B^T*?OI'%+]#P#U^'6B^T*?OI'%+]#P#U
M^'6B^T*?OI'%+]#P#U^'6B^T*?OI'%+]#P#U^'6B^T*?OI'%+]#P#U^'6B^T
M*?OI'%+]#P#U^'6B^T*?OI'%+]#P#U^'6B^T*?OI'%+]#P#U^'6B^T*?OI'%
M+]#P#U^'6B^T*?OI'%+]#P#U^'6B^T*?OI'%+]#P%CO%2Q]:+C)NGFSM_P"<
MN?-MZ\3>,9N;YGOGB_%*M_J=>IU4:UCYF_5;P7_S7=_S7Q_//-HON^)X7FN>
M[XA@OB]?AUHOM"G[Z1Q2_0\ ]?AUHOM"G[Z1Q2_0\ ]?AUHOM"G[Z1Q2_0\
M]?AUHOM"G[Z1Q2_0\ ]?AUHOM"G[Z1Q2_0\ ]?AUHOM"G[Z1Q2_0\ ]?AUHO
MM"G[Z1Q2_0\ ]?AUHOM"G[Z1Q2_0\ ]?AUHOM"G[Z1Q2_0\ ]?AUHOM"G[Z1
MQ2_0\ ]?AUHOM"G[Z1Q2_0\ ]?AUHOM"G[Z1Q2_0\ ]?AUHOM"G[Z1Q2_0\
M]?AUHOM"G[Z1Q2_0\ ]?AUHOM"G[Z1Q2_0\ ]?AUHOM"G[Z1Q2_0\ ]?AUHO
MM"G[Z1Q2_0\ ]?AUHOM"G[Z1Q2_0\ ]?AUHOM"G[Z1Q2_0\ ]?AUHOM"G[Z1
MQ2_0\ ]?AUHOM"G[Z1Q2_0\ ]?AUHOM"G[Z1Q2_0\ ]?AUHOM"G[Z1Q2_0\
M]?AUHOM"G[Z1Q2_0\ ]?AUHOM"G[Z1Q2_0\ ]?AUHOM"G[Z1Q2_0\ ]?AUHO
MM"G[Z1Q2_0\ ]?AUHOM"G[Z1Q2_0\ ]?AUHOM"G[Z1Q2_0\ ]?AUHOM"G[Z1
MQ2_0\ ]?AUHOM"G[Z1Q2_0\ ]?AUHOM"G[Z1Q2_0\ ]?AUHOM"G[Z1Q2_0\
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M>I?S$TZ'J7G/S4_JC0?GWG7J3YQW/4U'P?./"[RW<\4P;$T
M
M
M
M
M
M
M
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M>(Z-D9>/8OW_ (ZWFR'F3-RX*HZR=QCPR=PIN\?VA?;>U >_
M                                 4'+A!H@NZ=+HMFK9%1PY<N%"(H-
MT$2&567764-@J2!$RF,8QLE*4I,YSGL >LA;# 61LJ\KLY#SS1!?+99U"R;*
M4;HN,$35RW578KJ%36PFHF;),Y[W=4+GL[,X >Z
M                             'H&=IK$C*O(*/L<"^G(_"V7T,SEX]U*
MLL-E2HN,NXY!P99OA-91,A^^0O<.?!<]F38 >_              '#?OV$6S
M<2$F]:1S!HGE9T^?N46;-JD7/9E5PY<*%(BECZIC&QCV?2 X\3-0\^S+(P4M
M&34>=0Z*;^)?MI)F91+/=53*Z9K'(90IL]AL8-VE[?9 >T
M                ' D9..AV2\E+R#*+CFI2G=/Y)T@Q9-B'.1(IEW3E0J:)
M<J'(7&3&Q[)\8])@'A%2\5.,DI.$DX^9C5\JE0?Q3UM(,EC(J'16*D[:*G35
M,59-0INPWL&+DIO9P ]D                                       #
MU<M-0\ S-(SLM&0L>10B*C^6?MHUF517/=23,Z>+$(50QL=A<9-VF[/8 <A@
M_82C-O(1CUI(L':>%FKY@Y1>,W21L]F%6[ENH8BR6?J&*;./8](#F
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MW\2_;23,RB6>ZJF5TS6.0RA39[#8P;M+V^R ]H
M
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MMG39ZW1=LW"#QHY2(LW=-E4UV[A%0N#)JHK)&R59,Q<XS@Q<Y+G'H <D
M
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MN6V54$D)5G3I?:.M;7(V$[-RAX[2&Q3&+%W#SQ$_$70SDKC!U&V$L))]_"I
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MM99*6]4Z^[,JVAGBRSQGV^9NG)%_-N^H8ABE( O_
M
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MI2[8@Z=I-<F[ZC5-9XS(HI@O<(=RD4QL&.3M"\%A[FRR^\>;?$*0!9]T2?\
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M\=OO]A@%OO%UNLZZ.MI;-TS*KN-'\J$D4B8SDZBJDMM@I$R8_9&R?.,8Q_9
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M\I3(-UTEU2=_"1R&]N4+<.N9_K5QI_X0VU_S;7("=.K_ .QFN_\  41_F]N
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M;$M&R#M]'2,//."IE-*+-W;=J=%RKWW.<.54UU#X(CV!,@
M
M                                .BN2-4W)=M/6BMZ"ND7K[:;]> -7
MK5,N73./CT6EABWDTFLY90<DJB9>#;R"!.ZS4[3N2ESE,N<J$"%/:730ZA.Z
MY6!F]I[]TU=)6L(JH0#V5M5Z*K%I+N$W:I6OF>H4L8[SA!$^<YP8W>(7VWL
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MV.U7$0;5M0HNJI4MM =ALMC5PD;ZDJ,5S8-@ZV569E,+*&-XJIU3J'.8YS&
M0,/.FES0T!L*RR?$K;[)G4;*KAJBZ3MSZH6$D*=PHLT86J,58*LY11CXQBIN
MT%5E3^W73;MCK'1P%"\=(SE%LN"+<KYOZK7C=C^99H/OFRLMYDZZPJ"#&0,9
M)*V.JR\?R$MB24CRHM"1[1@V0(X[BRV3IX($S+74%C0XDM]!F?PF;:CQT1U
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MQ[&9>;)4FM6.RVV>K4>BYD6N9L\A-)P:B=;+ZGIN#)-8N+<IKK^#XSA$I#X
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MGXJ=79=@>AJ\AV>:T9KEB:<SM23[#M3I';&1S-%J_JZ8N43=F<Y)WC%SZ>\
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MC=R,KJU&<2"SAC&+3TG"G/@_?_I][3;!6Y&*BY Y<EPJ=J[6.J8F#'.;N$[
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MW=:.7M]H*QS',4V\41UZF0,"Q46541C$%GSXYUE#^,\56\54B1"(H(A?0
M
M
M                                ",[0W!V[:EYH[CY-RUSJTI6=D+;)
M6C*['-Y8DXPS=[=&V-F5\JY:E;_K#9FJFKE-0_>.<O<QW>W. DQ
M             $9\UP<NTIU!(WF"E<ZLE4&2T6LI5%&\MFR&S'ZO^8,Q2*E;
M>:Y[SXI5\9RKCL1/G'9W\=A@DP      $9_ 3@[=N(EBV],VVZ5:U([$1K2,
M8C7&\LBJQQ"/K$Z7,^S)MD\>W+,-\$PGD_LD/WLX]KW@DP
M
M
M                                             !%GR\X%[#Y8\@==
MW6P;!J[#2U)1@HU6DY1F_FA<QAI9.4NRC95)OELC+22::+4BWBE*1%@UR8G?
M2-WPE%;MT&J"+5LBDW;-D4F[=N@F1)!!!$I4TD44B8P5-$J92E*4N.PI2=F/
M0 K@
M
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MR?2$A5G<E)123B3BW40[\]B5BH/$SLW9<'*7!S%[IO9P;&0'<
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M\CH+E-JAMM>O5R6JT<YGIF!]29IPS=/2+PRB)%5\K,<^&9$_CER7'T6.S/:
MN.
M
M
M
M
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M>TK*SK%8CCD;^<N,*+NY&17364:0\.P;E,M*RRQ6ZV4T$2&/W$3JG[B*2JA
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MT5:HPCS,@R<)&EL+1\6JR:Y1;J=XZ)')RG[I2I'+G)RA?GT@/I.(W]T:]?\
M+QP"48
M
M
M
M
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MRMDOW,^.O\<]5@.R.E?](QIK^VME?&K=@$?G6\_V5\8O[2V5_G*@ )(NI?\
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MM"ND92-32<Q*JS<QHUP5/.2E.CDABXSV%-@!TYT@/I.(W]T:]?\ +QP"48
M
M
M
M
M
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MJW24)A%NH4B+/SM;*O818B!#>+@.Y.D!])Q&_NC7K_EXX!*,
M
M
M
M
M
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MY1M-3N<0DI8%XYD9>3:MU,Y;-$?#[G<1[B9CD,'<5MJL%>:K9:5:F&)6L6^
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M.YV$*7 #M(
M
M
M
M
M                                                     '23KCII
M1WMQ#?#K7L,MMUL9$R%X,K)>JA#H0?S-(FPB5[AL8Q8/^EL9RAG/<QC/T>,&
M =V@
M    +:MG</>,FY)UY:-D::I]CLTCX'JE8<-WD/.R9FS5%BV/)2T \:KR"B;-
MLV13,LH<Q$FQ"%S@A"EP'CK3ASQAU!,,;#KS2U+@K!&&,>-GEFCJ=FXY4Q>X
M9=A+V)T[<,W'<,<OB)J$/W3&QWNS.0%RX          Z2=<=-*.]N(;X=:]A
MEMNMC(F0O!E9+U4(="#^9I$V$2O<-C&+!_TMC.4,Y[F,9^CQ@P#NT
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
)        '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>rxrx-20260331_g2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 rxrx-20260331_g2.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0(" 0$" 0$! @(" @(" @(" 0(" @(" @(" @+_
MVP!# 0$! 0$! 0$! 0$" 0$! @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @+_P  1" 2V!]<# 1$  A$! Q$!_\0
M'P !  (#  ,! 0$           D*!P@+ P4&! (!_\0 @A    8" 0(# P,,
M"0P+"  G  (#! 4& 0<("1(*$1,4%2$6(E@7&!DC,3EXEZ>WUM<D,CA!0E=W
MMK@S2%%A<75VAXBTM<<:-#4V-SI)4F)REB5#68&)F+'()E-48W-T@I'!U=@G
M*$1%56=IDZBRT>A'9(2STM3P5F62E*&EPM/Q_\0 '@$!  (" @,!
M      8'!0@$"0$" PK_Q !O$0$  0,!! (&#P\."@@& 04  @$#! 4&!Q$2
M$R$(%!<B,3(5%D%"45)55V%QDY6TT]08(S8W5%9B<H&"A)2DTM4),S5&='61
MDJ&BL;*SQ!DD-$-3<X6CM<$E.$>#AL71\$5C9';"X43#\99EXO_:  P# 0 "
M$0,1 #\ O\
M
M
M
M
M
M
M
M
M
M
M
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MA.$XUI*$XUK&4:TE2O#@]H/HY0
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M8Y.+>I2WFX5R5*UI;R[%)2K#FX2Y+L)3L7N65;-V?++AL<,FL\
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MW[Z?7>VH]_\ 5OE9]>-RZ^E3R0_'?LW]*0\F=8]5<GW>[^>=V_?3Z[VU'O\
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M<M7(RMW80G&5(_;#D,Z
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M=J<(PI>R)UM5"V';\
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M(03*BC&U6N0U>8IIEQ@N"%:1+))/!/+'_-_\0GEG&Q\:-(8]B%B/I80I&/\
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M[6WBYDXQZ;&O<*SCAYW)&,.EK",JV;\(PMY,83E&%N<)6Z1I"-M5P
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M7M!8C>C&5:5G9N4E*%_&N<.KIL:]"Y8N<.,>>W6L:UCPK7+@YJ:
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M2WE8]*7;%^WQKCYF-.LJ6LK&G6,92MSY91K&M(SM783M7(QG"L6OXX2N0
M   >4I>[."EQDQC9QCL+C.<YR;XXQC&,@4I6M>%.NK_,XSYYQG&<&QDWGC./
M+.,X\L9QDN?_ ! 5I6E>%7C >4I3&-@N"F-G/EY%+C.<_#'GGRP7^V!2E92Y
M8QYI/$                     G.Z0/.V7UI?H7B[LN:5=ZRV#)>P:W?2;@
MQRT6^2:V3,X1JJ?SRC7)I^?"&$,9]-"4<HK)%3*[?*&G&Q^OSQ<BWI65<Y\7
M(ERVZU\-NY7P1^TG+O>7SL^%>KFJ[ NPH[(;-V6VBP=TFU>=*]LIM)=Z/2KE
MV7'R.U&[+O+$*RZZ8N?<ET?1]=+>7.U.$84O9$ZVJA;#M^
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ML@O6NU'^'&^/?Y]C:YT?1OO?_P!6KO\ \.0\K6N^IMS^;_ZGS+/9!>M=J/\
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M7I\U<:$97#A<KNV
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MHM:O0M1N8]R-R<.,*>+*]'AU5IU=36;L3+^RFVW9)[[];T_3K&=L[JUG4LS
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MG;M4APA64)1[8RKL.FN1N<)W)QGRXQC-V<!>H10KQ%,(NC7BVQ53GI0U4O\
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M'E;Y-?P;>?J6;>N8NC4NVXSIBV\:?)DYMOGC6D<F[?C+'MW8<)V;=F[2,_\
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M*QX]K9<Z\/3Y-FY/AYG'AUMG!E5K@
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MWM;7W8UXX\=G+\9^EYY:GI=;?\V%WA['%:X%LNX8
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M-C518JF8L^,'2EJ_2YA-3"3-9!N1?,M8#*D;1:*"V&RQ5R*O&?OKVT5_)O\
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M)&V4
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MW>_K&I_;6?Z+B!?J<7["[UOW5I/]EGMI^9'2D@.7FZ'>XWVZIBBN7=<@:\>
M9TEE/()E@DG*1'>)!:S-#=RA5L>9,I>1<D_;FQGX9;6MD[>LYLLV>=+'K*$8
M\(PI7Q?9YX__ *6[OP[#S3=]6W=[;?)VZO[/WKV+C8W:T,"WDQ_Q>DJ1GTE<
MJS+O^;P<G5P\-457-+I*P/$_0-FW7';OEKLYK\M6(W%>>41E!H.BV&=9PQU3
M22%J<F1.E[9A3&/1/W]G9\WS[L1+6]D+>D:?<SHYU;TK=84Y:VXT\:48^'GK
M_0U W[=AIIFYS=OJNWF-M]?UZ[IE[$M]K3T^%B,Z9.1#'X]+3,NUCR<_/XDN
M/+PZN/,D\Z'G[C.8_ENO/\WJ0)1L)^PUS_7W/Z(-LNP#^D9E_O\ :A\&P$.O
M/SEER?IO+_?U,I_('<55JL+=#L8>!K>P[1!1<4SQ$Q:A6\<UC))(K-+O44-Y
M)]OQ.;/[8QA#MH=7U6SK&?8LZA>LV;<^$:0NSI2E.$?!RR[UI!V1V^3>SH>^
MO>/H>B[R=;T?1\'/Z*QC8FI9>/9LPZ&U7EMPLW84A3FE6O><O?5K7VXN+!9+
M#;9=[8+5/3-EGY)3"LC.6"4?3,N_5*0J95'DE(K*+.E,)E*7&3GSGR(4N/FX
M$6N7;EZ<KEVY*[<EX92E*M:^W67?-2=1U34]9S;^I:OJ-_5M1RI<UW(R;UR_
M>NUX<.:=V[*<YRX=7-*5>%'HAZN OE[E_<.[6_!2O/YH907QF?L%E_N.?]C)
M^A_;GZ0&V'_V=J'_  6\H:"AWYX%S;HZ?N"]8_X2;*_GY.BY=C?H?QO]9=_M
M9.\OL(?^KKLG^Z]6_P")9+6K;W1&K.V=L[/VDXY#3L(XV5L*YW]:%1UQ'OTH
MA:XV.2L*D:D^4N267B2!Y$R6%<I)94PCWY(3N\BXW+V&M9>7E9==1E;[:NSN
M<.BI7EYYUEPYN?KX<?X56;:]@/I.V6V6U>U]S>9DZ?<VJU+/U*5B.F6KE+,L
M[*NY-;-)USH5G&W6[R1G6$>:D>/+'P(G^H9T](G@]%ZKDHO:4CL7.Q7]N8KH
MOZHVK>(K-9;UU=)9)1M///:L+>^E,&+DI.SV8N<9SYF\HCM'L];T*&+..77)
MKE2G3KAR<.3A]E+T6G'9+]C3A;@,38_*Q-K;NTWEHN9MN4;F'#%Z'M6&+6DJ
M2ADW^?G[8EQI6D>'#S>*T'P-_<8\8OY%Z)_H1L+4T#]A=+_U%O\ JT=M?8\?
M2,W3?O#IOP:"-+6G0BU!7;6RG-G[EMFS()F\(]4J475FE"9RN2+85]BEY1.Q
M2CI2-4QCL5*T.S7,0_VIRB;YPC&+L#AVKU+F5F3RK<:\>2D(VZ5^QE7FG+A]
MKRR^R:K;*_J>FQ&F:Q8U#:W;C,VLT^S.ERN'9Q8:;"]RUI7HKUZ.3EW:V9>"
M=+-<>Y6GBWH5ZVS'/_GAJWB5J";UWKR<@'6[).N+5&B4BLN&JAM>-\LBQ2-E
MG4(W.25EG&,3%/'LU<)*NG+9%%%'V8CE=OD]H=>Q-)P[F-C7*2SI1Y(0A_F^
MKASRX>+R4\6GFUX=7+S5I:O9']D-LEN:V)S]F=FM0QKNW>7C5PM/P,2</^C8
M2M]#'*R(6N]Q88D.^QK$^2=Z["$(0Z&-ZY:IVP$#-6ZP0M9K[!S,6&S3$=!0
MD:V+ZCR4F9EZBPCF+8N3?;'"SYPBF7&<_.,; INW;G>N6[5N/-.Y*E(T]-*L
MN6,?OJND;3=.S]:U+!TG3<>>=J6K7[6/8LPZYWK]^<;=NW'S:SG<G&,?LI=:
M_P#Z%U>UTKI;5>IFBB2Y=>T.LU9R[1+DB<A)1<4W;R\H4AL%[3.I4KQQGX8^
M<ZS\,?<QL%I^+3!P<7#I7_)[<(<?35I3KK]VO&OW7Z/=WFR=G838/8_8VS*E
MR.S>GXN'.=*<*7+MFS"-Z]U_Z:]SW:^S-EP<U-
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M*;-[)8'?8.S>!BX5N7+PK..-9A9YY?9W.3GGZ,Y5JR&.2DH
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M<ODK>MRIWD.24J8$9QYIUG++I&-(8UR=CL62[0
M                         ?@D&#*68/8N39MY"-DV;F/D8]Z@DY9OF+Q$
M[9VS=MERY(X;*MSJ$4(<N2G(?)3%R7.<#TG&,XRA*G-"756E?!6E?_?_ +ZG
M'R,;'S,?(Q<NS#*Q<JW.W<MSC2<+EN<:PG;G"7&,H3C*L94EU5I7A53"ZC'
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M*\8]L5K<N9&5PX1KR7[T[,9TI.%N$FB(PC7L
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M+V1'SF=DVI='T?C8MBL[5SY]>NV[,Y G;?X
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M&,8^YC&/[@F3=A_H
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M8/'DLV:5[Z=>'-=NSK65R]>GPISWKTYW9\._G5DD<M*0
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M#RH;1?4%?=<?XP^8Q[)/UMZ^_.@_I4^Q)=0C^(#\JVD?UC!Y4-HOJ"ONN/\
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M"<,:U<C&5)@L8P7&,8QC&,8\L8Q\,8QC[F,8_N"9-V'^@
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M.OM6W2$,?$\]&,[-JF1R5K">1=C5OX)"V-
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MH
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MM44A"H,<LI=OA$S58LHK@YO/!\93+G'[^,A:L
M                  06<Q_$4],WAS9'-&>[(LG(2_Q[IPRG*KQIBH#8*%;=
MM\J)*(3UUFK3$5U-T1TDJBX:-)=Y(-%43$<LDS=N#!&B3QAO$W,V=!3B9R'Q
M7,9QZ<J2?UJ>;/CS_;'KYILJ"?S?+./*3/\ V/[8#=/0OBB^E?N>6:0=KL^X
M>.TB]7(T;N=V:V3Q7U72G:4F#6'5EAL[>-9Y.;R]HD<LD2?MECI%^("Q<
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M734,JP8/7J95G#8ID\]IE,=_D?RSY_= ;8@
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M?#-FZ/Y9.7SPAGR^=Y8 2&@
M                                          ^+V/=6&MM>7S8LJB=Q
M%T&F6BZR3=(_IJKQ]5@WTZ\134[#>FH9NP4+C/:;RR;S[<_< <:;E/R;VUS#
MWUL?D1NNR/[)>]CV*0F'/M3QT[85V)5<K'@Z;6D72AO==3B8TS=E'-"=I$6S
M,A>TQS'SD+973D\+3I/DQQ4TUR1WWREON7F\M?5S9$%4M#M:4VB:A$VF.1DX
M^#F[;:8R:]_69L@L5&5119,"L)!%S'^:QVQG"@?MY5>#^MT' 25CX:<H&]ZF
M&2!EFVK][UUK5GTMA%,RJJ,9L^I*JL_>:IB^FW;O(%BU[SX]HDVZ7<<H3"^&
M3XR\@.)W!G=^J>2&I;KIO8"?-#9DPA6[O#K1CB5@?J0Z$KZ-D@'?SFUDJZ\Q
M7YQ!K*1ZSE@[/%+9;.5B$R8!DSG)XB;@;P-W?>..>QH#?]_VWKI6$;6V$UA0
M:TYB8EU8:S"VZ+15L-XOD&@\*:#GXQ0YF>'12'6REGYY#X*$>)O&%</,2GI%
MXJ\E<PO_ ,\#2.KBRGW?_G1BVY2_:_'_ &]_:_M@)%.%GB+NG#S4V%6]10MF
MV)H_:5RDVT%3JIOBK15=:6Z?>KIMH^#@;?4K+-P^)5TX5329MW[U@X>+JD:M
MDE7*B2)PG? 5NK[XICIHZZO-TU].P')]6<HELL5-F58W5E0<1RLM6)A["22C
M!POM!(ZS(SQBME(YTDCG)DN<D)G/;@,A\AO$I]-30FMM971G:+UM^X;5H-8V
M'&:@U;$5R8O-)A[=#LYJ(9;9?/;4A"T.P%:O4\.HO,H\E4,D[_83H'165#7_
M (]>*]Z>6W;Q"4?9U*WAQV+/R7N]M?;Q#U.QZUB<JF,1FM:)FH6AQ)P:*JQD
M2&7Q#+LVWJF5>.V[9-1P4+.<=)1TU'1\Q$/V<I$2K)K)1<G'.D7L?)1SY!-T
MR?L'C8YDWC-9JJFHDJF8Q#D4*<AC%SC("/'GIU6N%'3AC([/)+9YV]WGF!Y6
MKZ@HD8:X[5L<<18R'O)"N-G"*$##G63<$1?S3R,8.%6:R+=TJND=,H0.R?C#
M>)B4N=&'XE\B7T#A57!)*2G]:Q,N9#!OM2AH1I./42K&3^)B8D,X(;YN#G_;
M )4N!O7UZ>W/RW1.KJ/<K7J#<\\<C:OZKWG#1E4E[:^PGDZK&EV2%G).$L3_
M "<IL(,<22,LZ+YG1C38(IZ8;\\VN9NH> O'NT<E]Y-[B[UW4Y>K0LFWHD*Q
MG[*H]MT\QKL5['&R,PP141P_?HF6,=R3L2(<Q<'-VD,')XZC7)F)YC\Y>3G)
M>N8FB53:^TYJ:I2=D:H,)]&B1J36N49O,,6SYRFQD$ZC"PI%44W"Q$SD,0BA
ML8P8!-+TY>0GAYZ#QJU?JOEMQ2VYN+D[;';QGM2_O:FO+1&9VP6E\U@F%0E&
M6Y(X]?@65?6@T,*,F+1R=5%9RMZBZIC9"<WJ^4'H,<1GG$W4'-;CCO.>:4W2
MDI2N/\5I^V[(?1]2U;6+2LNK!S,DZW5%.9)YB>GGBB;AZH_=G(N<JKGM*F0!
MG7H'V7H]W.W\E9/I?Z<W=J^R0=;UFPVZZV_+6I^E+0DY)W)S4V\ E.[2L215
M$GT#-&<F(1H?R5;E[U2Y-@@65
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M<7E:^0/ORFPME8MVTON:>;J2RKV;@\I=['&<)(K9(NEG&"G"V^
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MS5>8SR\I,2#A27(RD$\./4?.\X5[BX75+@I@&V(
M                   "L9XA'K873IWQ5/XV\8E8='D[M6KJW27ODHSCIY#2
M^OE)-Q#P\JPK4JS793%TF9*,G",BOTUFK!M"+.7#)R9VS,0*&$-7^=G4YWD^
M)%-=[\P-Y2S962E'*[F?O<K$0I7!4_:7\E(.#,Z3447#A%%+U5&48V,LFV1*
MEW)I -A]E=#_ *L6IX!>S6W@[N1S$M4<.')J(A6=K2*"':8YUE8/5MBF7R:)
M$RF,J;+;R3*3S5[, -^?#@\F>4E?ZI_'#C3);JW*ST_9L;RB+QI"?N-H6I"C
MJG\?MM6:*;O*+-/#M8>686BNQ:Q3HMV[E)1AZ)S^F8Z9@Z80#'<]MW5%6=$9
M6?9VO*X]44]%-I/72MQ#HZN<]N$B-Y"23.93N^';C'F ^MAY^#L+7#Z FHF<
M99\O)W#R+.3:F[L>9<8<,ECD^/[WQ^/D ]N   #XR,V+K^:G758AKU39:RLL
M&R]KT99X1].-,$R<I\NHEH^.X;^1DU,9[T\>78;_ )N0'V8  ^+M^Q]>:]11
M<7Z^4RCMW)5#MW%PM$'6D%RI9QZID59E\@54I>\O=DN<^7?CN\@'FJ5^HE^:
MJOJ+=:E=6+?*>%WE2L</8VJ!EL&,EA=Q#O%B)&,4ALE[LX[NS/D ^N 4A_%Z
M<O-A5U3CCPMJ5E=P5(NE8F=X;9BHU9=JO;R-K"XJ6N(J7<(J%]JKK5]"W1V=
MD?!T5WQ&+E0AE6#8Q KS]*KHU[[ZK;O:S_6E]U]JRC:>-66-HMUZ).OU7\];
MB3#B)A*Y!0+%0\@LFQ@WRSQ5==HD@1=M@F5CK=J86-V7APN9U)Z9^^^%\+M+
MCI;-@;(Y<:JWE5+!BR;"@:SBD4BA3U7E6U@.\UNJO%V4\E+(G1:MTGS8R"&3
MG?$5^U@,7],OPW?/WB'SOXU\E-J6SC6\U]J.\N;+:&M.V'>)>RK,#UJ>BB)P
M\;(ZM9(.G>74DW^:HZ1)V=QN_P";VF"]2
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MG83L(4/BO&+_ +H7A?\ R,[(_GO$@/O_  :W^_/J _X,<;/]*[M 7KP
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M (2G[Y[>/P1-J?G'TL Z2(
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MAY6?NHN27\OFXOSAV(!UB^DQ]["X ?@B:#_-Q7P$A(
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M$6QA0I38P8N?G)X-_! =4@
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M]_X-;_?GU ?\&.-G^E=V@+UX
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M'("'KPE/WSV\?@B;4_./I8!TD0
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M[5 =7,
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MK['$THT3DHW+K#;U?9\/V_K=GK)=X7.0
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MQA&\]<JNR:N)A9G'R"J34BN5U$F#A4A#$15-@+_P
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MA9AL\342<-7*22[=5(Z2I"'+G& WH
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M>/\ 0FWP$EOBE/O2M^_EFTG_ #H5 4MO#T_?C>%/^$^TOS"[5 =7,
M
M
M
M
M
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M=S\A+5[G<SE?EJO**^X;IMB1C)#U(*<E$,8=,EBI^T^LE@BR:2A E=
M
M
M
M
M
M
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M93];Y5^EEO[&;T_8._UC^KV$"4,
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M%?)MP[C[(W?'QB0>>SG1,V\E.[UL!8-
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MOK(BS16>*1#V,:./94U5&2TD5H\.W"P8
M                     ^7N5VIFNJW*W/8-NK%$I\$CAS-6NY3\55ZW#MC*
M%2PXE)V;=(-8]#*BA"X.JJ0O<;!?/SSY (UYOK<])ZOS1H!_SLT4X?%<*-LK
MPDU*6:%RHD;L,8EDK<.[CC-\F_:JX=92.7YQ#F+\0&[&BN4/'#D]!+V3COO3
M5.ZH=F5 TDYUK>ZY;5H4SGNP@A/,(>05<5]V;TU/)%ZDW6^9GY@#/
M      #4[=_.[A;QKD%(7??*K06I["DGE8U5NNU*=#W Z1<%-E5*H+2WO-=/
MR,3XD:&Q\_'_ #L ,":^ZQO2YVA-H5VH<Y>/1YET_2C&3*R79O1,R$@X6*W;
M-8UQ>D8U*255<*)D2P@=3U3G*5/OSG'F$E"2J2Z2:R*B:R*R9%4E4CE42524
M+@Z:J2A,YPHF8N<9QG&<XSC/G@!Y
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MGLG7U\M64G"N:LI-_)&&<T^P.RHEQ&(N6KMH\6[F?O%)\=DW>A9N
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M&?K%IA(JQUR=C'!'4;-04XQ0DXB6CW*?S7+%S'NFZR*A?FG37*;'PR ]X
M       *P?BU/O8-+_"XU5^;O<H#9'PSOWG+C5_A/OW\_6Q0&!?%@0E\E>EO
M&/J@@\7KU<Y.ZFFMHG:HG42;4=:M[&@(YU(G*;R1C_JD3FOTO/./G.7+;'<7
M]\/X\*_N_CO:NF_ :/UY)UR.WOJR\[)FM]U(JC-G;)E]<;Q+25-V,NRQDJTQ
M JT%:GP:<A@IR)+4\S YRF03P<*['-M6L\N/$P4]IP\586%T7DOQG:2ESH96
M;B)5N&H4:+(;:V U?1A3I/&L$G59I1^^Q@^%EJD[<%,L4Y%% Z1X  YS'5A_
MXS_K3\)'IX?Z.T2 Z,X   (]K[TM.#NVN5\CS/W!I""V[NYW 5.NQJ^RE%;9
M1ZVUIS51I%/8;7<CYPZDSV&1/EX^:O7"*K4BK([4_?DX;REJ%3+7%J<6KUTM
M1<L5HQQ5BPD;BN+QKDADG$>M!X:^RJ,5$SF*=(R64SE-G!BYP YF6X=7ZQ9^
M)(J^N> #&-;4J)YQ<?7-68ZW[G=6JEB@G>N[-OCW$G#JG(SI<%;F.RU'K=O@
MC*.80CQLBFFP:DP4.GB  /QOW9&#%Z^.0QR,FCAV<A,EP8Y6R)EC$+DWPP;)
M2>6/,!5+TSXMGA==H_9LIMS3.T=,)TFH)SU0BF\M&[&L6UK&K*-8].D5EC%Q
M#!I#R7L[A1T=Y*OV; B+-0IW!5/3(<-)YSQDLF6UJ9K? =BM1T79DTBSG(AP
MUM;]B50N".5#Q^GUF<2[,GW9RA@KXA,G*7VA0N.\P6:.F7U3^.75'U3-WS2^
M9JJ76B.8R-VIJ"XG8XN%#?RZ+I6(?87CECH6"HR!H^2Q'2B'85QF-<(N6S-V
M@LU3#!75PZS%%Z33[0S&Y:.MFY%-[-=E.X\]9MT/525XFMEJ*BZ*]]ZQ+K+X
MSHUX;Y3[.ST_8#^??WE[0ULY.^)SZ?/'2N4A.%)<]\[4ME(J5PF]>:@5K\K"
MZV<VJOQD^:KWO9<K)-HPM@:%D%&SIK$$EG+5TS.B_;,3_# ;.])'K):\ZLIM
M[-Z3I2Z:?>:(3UNM,$M5F@[,VG$=E'O2<;F,<1#1N9NHW/0Y#URJI=N</4?3
M.;Y^,!JUU+/$G\5N!VR+'H?6U$FN4N\::[<1-ZBZW:H^E:VH-@:F])Y5[#L%
M:'E59"W-%OFO6$;%.TV:R*C)\]9OT5FR01@:S\8\V6M#-MN3@NXBJ6Y=%P^F
MM:[L3G;/$,#*$[EFE9M.OXYK8G14?4\DS2T80YNW[:3 "W5Q+Y<:&YO:1K7(
M'CE=FUVU[9#N&*BF43L)VL6-@FW4F*?<8)?/K5ZU,O:VN5VJOP.B[;O&RCAB
MZ:N5@_?RBY4Z'X9Z=L6^.1VP8K7.MZX9%JK*/\.'<A,S3Q-PI&5BKP;!%1W9
M+,[*U<Y;LFB2JQR-EECX(V;KK)A4&VEXQQHUM[]II?@ZM,T1H\53CIW9FY\5
M^TSC(JBF$73JL5B@R+6LN#I^GG*)965P3/G]M, RHP\8OH8]-@'TIPLVVVV
MX<R"=HK4=M"GOJC$-$"-,Q3N"NCBOMWE@6<**/L+H+P4;AK[*3L7=^MGT@MH
MZBVPQVWHS5^\F,0[AHS9VIZ5MAI NW"+I_%1]TI\9;V\0Y=HE*FX>(-Y(B)U
M"E*0YT3&+C!<X 5\.(7BA.&G(8VXI+<]0DN)]/U%0FEU-9+[>(NXO+N\>3[&
M"0IU*J-8KY).Q6H_MGM!&S%N[5]G:K+'(D@BJL0-;KCXPCB9&6ES'T?BIO\
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MK!;NUZ[GI^2>JE0:L:U&8G\*V5PHLHF0A6!7.3'4*3]MG& &ZX
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M'2:3/A5--3'F4JI"G+C/EC.,'+@V/N?O^60'D
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M&Y7!UW&%5U0VB  'X93_ '-D?_=%W_FZ@#GI>#]_=U<D_P $R2_/#JH!T.P
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M&TDM';\<J$_=M%B%L\S,62L[ V"XBG"GD4S6*1J-)06.7!RJ+6$R93X.V7(
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MAZCTK=(2OKM(+%YW#L/9VT4+FM!3AG6$4ZY1Y"6>82=%<M'4O#,V*Q3MGG<
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M^4.L\G24FY5MHY<+**K/#QOMBRAEG*@"=(
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MSPV434.0R6"9P;("N!XM3[V#2_PN-5?F[W* V1\,[]YRXU?X3[]_/UL4!/6
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M0F] '0T <]/Q@W[M;C!^"WC\[.P0'0D:?[4:_P#NNC_^3* _0
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M!REHU&6P7/P\E6VXM<N$#X_Z15D4S8_Z@"-SPA'WN+>GX;6P/S$\<P%JX
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M!9#[;DGJ>J4Q,!<9;D,1N@F;'D8B*1#8\_/R,4A<9QY_^(!Y@
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M8_55OM5Y+UW8$[ ?+77M&RRJ#'5NV*X[F,2FR+9#LG79-62#1]G1<G=&]O\
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MO3\-K8'YB>.8"U<
M                            H9<@N./(:3\5# ;?C=#;GD-2I\FN,TRI
MM%CJZ[NM=$AXG1^J64K*J79"#-&%C6KUB]1<+Y<^FBJS5(H<AR'Q@+YH
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M.2*B)3G*CF2]$ASD3+D!M&
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M-<&D&%CFX*7LC1/+:6N4I8HV%/(8CU74>U1K#0C9^[,NXRD%F<
M                                     'IY]-1:"FDDDU%558F13223
M*8ZBJAV:Q2$3(7&<F4R8Q<8QC'GG("B_X3[CKR"TURMY.S6W]%;DU3#2G'N,
MBHN7V3K&ZT:,D93&QZV[S&L7]G@VJ3Q_[*W65]%,YE?31.?M[2F, O<
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MH:+U==2)*H-[I6M?0*=Q8MG"*C9RVC;6[:JR$6V6;K*$73;N$R+$-VK%/CR
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MRHZUK<A8WC&-BW=@>P=+AV35W-*QD/$MU':B1ESH139$Y\IHI%(&5@
M
M
M
M
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M'JR+5/!I"6<*%PHZ>N3+/'BQS+N5UECF/D,I@
M
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MK?-@NH
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M6?$+L:0W+!TQE6;58*X60MN-H8A'EFQ[GCRO5DZ\1HIZBQ$&R?F10H730
M                                            5'NL)XB#D5PDY>6[
MA3QDXY:\M=XJC'7AS7_8CJX7<UDD]B5"!MS*(K.LJ2XAET7J*-@:M4SJ2S[+
ME<F389E+VD.$9TEUH/$G5F'?;GL7$JX1FJHQHXDI)><X+[.C-<QD6T3]I<RS
M^P*,T7[&%(CW=[Q66PV*4F<>MWER FKZ,OB':MU$KRSXT\A*)6]+\F'<$^E*
MA)565>&UEN-:%0,^FXFKQ4^X7D*A;48E-T]3BUW\J1VSBGCA%^11+#,!9G 5
M?.K!XE34/!V^V;CMQIH\1R)Y U%TM$7R<F9AU&Z=U=8VRIDWE7E7$,;#Z^6]
MHHF9*0CV#B/;1RRWL[B6]X-GD<B$/L'U?_$R[@B4=IZPXGW1UKU^0TK%FH?!
M^[S5/EHU?'JI9K\C-L9*0GHTJ9BX(JT?N#Y+^V6.;S, S[P_\5YM&H[-;:?Z
MF/'N.I[9M*-:_8MEZOK-MI]QUZ\.JFDJ_P!B:;MKYZO*-TBKE6>>ZEV#QNW1
M,9I#2"YR(&"Z[1[S4-ETVK;#U]9(>XT:[P$3::C:J^]1DH2PUV<9(R,1,13Y
MN?)';%PQ<(J)G+GRR4_]GX *YO7+ZZ^TNEYM#7.A=+Z*HNPKYL?5:.T$;YLB
M?L*]8@4'MNM%09P9:%5BL'<\Z]IJ[E<Z_OYF7!72:14#Y[CX"%)#K,>)8NK0
MVS:IP_NY:"Q2]N73J_!':DG2G3(Q,K9<8EI-F^D'#%-$O>HJVDNU)/YZQ\%-
M@P"13I.^)O6Y.;HJ/%KG'KBE:FV5?IT]4H>WJ&M+0&OY.XN53-H.C76F6V2?
M.JE./GZ96+5^C*.6SF2?MV:C"/*?U@%O8!1SYP^)3ZA_'_G;R)XGZ2T)QAOT
M/JW;EHU[1F\IK3>%JV'8(^!,;*2C]&I;P9)2DME!)513V..;D["9-A'&"Y,
MPS_LE7K=?0%TK_YK_+?]>(#?KI?=<#JF\ON<^C^._(OB#K'66FMAFV/BYWJN
M:'Y$TR8@"U74M\NL =K9;UM23BHTKFTUN%9J>U,EO63?G01]-RJBJ0+?
M                                               C_P"+?5#X/\T-
MO['T1QMW/G8VSM3QLS,W>$1H6R:\QCXJ M#&G2<@PLMJJ+*,GFI;!(L42&8O
M'/K$<E71]1#N5P$@   BRY<]:/IN\)[%(4;=G)"OJ[*BE,(2>L];Q4YL^YQ+
MON-A1A8VM,CW;2GR1"%[S-IAY'N.PY#%3-ZJ7>&D].\49TE;/.(1$KL/<%!:
MKN\-L6&X:7LZT(D4V?(KM?Y%J3#Q-KDV2XSG+/O+Y^9R8+@V2A.)HWD#I'DQ
M0(S:>@-ITC;NOY;.4VMIHL\QG8])VF0IUXR2*U4RK#32.%"X<,7B:#QL8W8N
M@F?YH#,("'??W7NZ47'2>D:G;^6-7MULBUW+5]!:?K]OV\5L\9*&0=L7%FH4
M"]A&C]-P4Z:B"THDL0Y#E,3&2'[0UYU]XG?I(WF;0A9/;>R=:^U/TH]K+;!T
M[<D810ZZQ4$72[^H-YCW;'Y.8N3+/"MR(D\SKY2)@QL!.Y0-AT+:]/@=A:PN
ME5V'1+2Q))5NY4F?B[/6)U@?)B%=Q$Y#.5FSY#O*H7)DU#=ITS$-Y&+G& ^R
M :E\J>=G$7A'7V-CY3;[H>H&TLBZ<041./74E<;(BSSDKM:KT.N,WLW9$$C]
MI%5&,>X(D=4A%#$,<F,A$*]\4MTEVDJG'(7K=,FS.IA,T\RTI9$XI$N3]N5E
M$9)PW?&3P7YV<$9'/Y?<(8WS0$_VOKU6=HT*D;,I3Y24IVQ*A6KW4Y)5F\CU
M)"LVZ&9S\"^5CY!%-=BHK%R#50R*Z::R63]BI"'+DN ^P
M
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M1?&"KR3B.CV[-=^L7^"JLHB90V/[*@#WP
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M<C=%!OA-$@=*T
M&"(GC#QZA-XVWDO':;U^CR!O#"&B[+N)>NL7VP7D7 0;.M1<6SLK]-5Q"QI(
M./8MU&[$[9%P5J0SDBQRX. SN YGFPZ[4:+XHJNUWC"QB(6M1O43TFVQ%UY)
M)*$BG\C.T-3?D4V9QQO38L4+ ^V4@LU1P0C8B*K8A$<)]A O1]7'EE+<)>G=
MR<Y!U=VFQOD!1T:IK9SE3!5V>PME3D7KVJ331+)<^U.(J3LR<OE+]J=*!5[\
ME)W9P%/[PM_3AJ7*';>UN='(2NQNQZ=I*S(5+6<1<"8L+.?W[*MX^WS]XGF<
M@90LL]K]=DH99MAZ18BDE>49$GD\BTU"AT(0%<CQ'731HG+?AAL/DA4*?",N
M2W%ZKR&S8^Y-&C=C.7+4509.Y79.O["_2\LS3-M5TY*9B"+E67;R$!AFP.W2
ME7Y5PTG\(MR_L>P]$;^X<W*87DB:"G:[L?4^'[Q5PY9T'9R\TVMM7CD3GSAK
M!QEVA4I A<?]_P!D+XQ\PI,8"TQ9N,/'JZ[KJ_(VY:<H%MWC2*NA3:5LRS5U
MC/6:G5YM,2<\@UJKF535)771968E%/;&::+S.'ZB1G&43=@#.X#F@>)/KM+I
M_63PMQ_91D1LF8I.B[;>6]>3;(*8WY*2DHO&23MHS^#>==U5'6KU<QB$5<J/
M_;%>]1R990.ETEZOI)^T>GE;"9/6RE@V$LJ]N/4RF4^<Y*GW=WEYYSGR^[Y@
M.=1JF3C8;Q9=@DI>0814<UYB;X.ZD))VW8LFQ3ZKV$D0Z[IR<J:)<J*)EQDQ
MB^9CXQ]TP#H90%YI5K66;U>XU:QKMRY.NA V")F%D2>?;WK)Q[Q0R9>[X>><
M8^/[X#ZH                                                  4O
M>H/)^*.VSLSDKJ[2NNI:H\8'FSMMUO6T]JR3XV5"V6?1A;3/QU$?'NLM>C62
M#?.Z.6)767:+14EZCDY52MS][<H:#^#_ ,Y-SKY*&-GSSGB;)YSG.<YSG.=P
MZKSG.<YR Z'0"L[XE3JD7/@UQXI^A-"V9Q5>07)I.>2/<H5Z=K9-8:CKYF;2
MR6."<(?;(FSS$D_0BHMZ7)56R+:8=LSHOV;5PB$171*\.9K/E'I.J<S.>3VX
MS55VKAS8M5:.@9R5J"M@J1G[A!O?-FVQ@9*64;S)D7#J+913IB<\>LTDUI);
M#[#-N$\VX?#2])'9U*?5JK:#G=)V([-9O#[!UEM/92UBAG&4E"H.#QE]M4W$
M312K&3,?#V.64.5/L*LGW9, IWPUEY5^&OZH;JE.+/(W?5RB]:EK;#QF7D/3
MN2O':Q.7B4;/8@7BQTHB\1W;8$6;CN6-#6.!>M$W;^)5<^\0Z;5*N-:V'3:E
ML"F2S6?IUZK,#<:G.L3&.RFJU9XMK-P,LT.;&,F:N8MZU63SG&/F+E 54^*W
MA..+-3?35RYF[-MO(2TS<M)R*-'H#R4U5K*#;OI%9V5NZE(YUFPVJ0PGZ?DY
M3>PJ!,+JIY8*Y*FN S7S4\,9TYM@:"O1.,6LIGCQN^N5*8E]?6B$V5LJW5^<
ML$+%.'437;W [)M<TBX@7KI$J#AVQPSDD<N2N?:7!43-5@B4\()RCV 3<O(O
MAM*6&2D-8R&JW'(*H5UUW.(^L7"MW&D46V.X@^2YS'^]HNZ0.72?GZ*IZNBJ
M4I%C*&6"VMU.><E>Z=W#+;?)N79-9NQ5Y@UK6KZF[4RFA;MJ6Q8T73(=SDBA
M#FB471EI*3](^%BQ,"_.AYK$(7(4<.EOTK-[==?<FTN;G-K<5Z0U$C?21]KM
MJ*2/RXW):DD"OY"A:W</&YH^ATF$BW$0W5<(,EFK!%ZVB(=AWIN5HP+4*OAH
M>CPK3EJL3C=9D)-5!0B=\2WINW-Q;.CI^GA^B5>^'B#+E^Z5)2)49]V.[+8V
M0$V&K]>0&HM::[U14\OS576-%J6O*UF4<D>2F:_2X!A6X;,D\213*Z?^[HUO
MZRA4R%.IW'P0F,^6 ^[
M                                              !!7UO>F5R>ZD]0
MT)7>-F^JSI);5\KLI]<T;59-A5Z-N36X,*:VA&A\T*(>9>%:+5V2R;#M')28
MDO-'SR93 "F5L_@5RWZ#.]M8<E.4?%_C9S#U<YMB+""L\S(W._:F6M2./?2K
M)1-TG#.*OL4\>B\6BG-FKTDP,XC5W4>TD5&"V4@Z)'!'FAJSG_Q@UMR>U'AT
MR@;NQ7:SM6DE2+35"N\*K[#;:1,JII)E</&$H50J3DJ::;UFLV?HD*BZ3* H
M$]!OV'/B!F'RQ\_E1\KN8V8?/P_WX_(S:7O;]O\ '_>_\JON?._L_#S =+<
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M2.7YIB*XSC[H#VX
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MF6>$M,>SD,(HN<L73R#?+IMWF&[A!3TCFP?L6(?M\C8SD/L@
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M6UF9UET'2*; +NP
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MFU/8:38RLU#)F>()O8]TV7)G!'L;+,7Y")$<X3(&Z0
M
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MYFZ*;XE<(RC%TF?S^/<GGS^(#:\
M                                   !AO>/(+2G&FEH['W[LRJ:EH*]
MC@:E\L;M(EAZXVG[,[,SA6<A++%]&+16<%-@SAR=)LB1,RCA9-,ICX#)=?L,
M!;(2+LM6G(BS5R<9MY.%GZ_),IF$F(YT0JK60BY6.640D&*B9BF3524.0Y<^
M939P B"Z^._M2:.Z7'*>-V=-0R$QN774UI_5]7?+ES+6V_V])-G&>XH\AO4=
M&B4\JS+A7&/2;(P)CJF[C)D4"$+P;M)M;#7?/+8SQH[2I%JN6@*97GAR&PR>
M6BAPNV)JW(-U,_ SEO%;#I>5<%_>?I=W[WD$<_B4M![,X:]4^A\ZM<-3QD1N
M)UK+<E$M249E:&@=[Z))5HF7AW29B^DM(8-4Z7/'(?)?:_E.X[2FRBX,4+Q_
M3]YUZ;ZA7&JA;^U+8(9T]E8.';[-HK.13<SNJMCFCD5++1;(Q/DKAFHVDO:O
M8G"J1$Y)A[/(-,J-G!#Y#;FVVZJT&LSMUO%C@J?3ZO%O)NRVFS2K&#K\!#QZ
M)W#Z4F)>2630CX])$IC**JG(0F,9SG(#F:\W=K6'KU]:2H:^TIB3D-3R%GJW
M'W5E@C8EWA:*T'29^5F[[N64:+M2J(L5#3%^LB?MB"+A%@Y81SA/"Z)29#I3
M3,[K;0NK74Y:;! :[U5JBFI'D[%9I9M$UZIT^J1B;8KJ5EY)8J;5FWCV:>,J
M*'\S9)C'Q/G&,A0XZEW5WY-=93<J'3IZ852O#G2EJDG$-/RT2@Y@+=OM@R72
M3E)ZXO79D<:TT"U*8JRJ$@HV,\;G(O8#(E62AVP65NCOT6]-=+S7I+++YA]G
M<L[M"HM=E[BRS.9C7V;GT7#K76J4WZ)5H6E).DT_:7AR(R$\X;$=ORH-R,(N
M.";@!5IYB^%XTUS Y/;JY-3G*[9M*E]T79[=9&JQ6O:K*QT$Z?-VJ*C%G(O)
MI)5VWQEOYE,=,IOG]N?N>>0UJ_V'+H7Z:^W?Q64W](@%:&"Z8M2E^LDOTOE-
MK6)"GI;KL.K<;8)7(P]D-'PE-E;6G*FKF9##7VQ0T>5 Q/:.S&#F4Q^U[ '0
M[Z4G2YIG2LT_L?4=+VM9]N,MC[)^J.\FK17HJN.HQUBKP=9+%-FD2\7(LW]&
M%*KE0Q\&[G.2=OD7S,$IP
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MFB34!.%0.DBE=-6V2<KDU&(+Y^:X>LXM.CO#^6>XA+"CC)2_ Q@O_P#&??\
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M(+;#2W&:$R;R*^S$P=(]HS@N,Y(1MW&-Y%[0NI@
M
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MA%XE%-XMNV,_9(K.Y%^U*JS<!<-
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M5U_1Z_O_ )$[$D'<[88]NV@WV:WLG6<5%K-V[E,RAECN_61\L913/DWS0M5
M "JI7NAKRPB>N4XZF3G8G'@^AUMZV?:)*FA:ME&V[B"FJ!+5AJR- *:G+#>]
MBRCY RA/?_HX0(8^%CJ>2.0M5@
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M<<QBY"Q*P2#@D9 5F#:&5Q4Z.U</I%=!B9V^<J.)!19X_<Y*V(V"5X
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MD>O_ &^02,1!XB@B$O
M                                                     K3]<_H,
MK=2F:KW(KCY<*KK[DU4ZJ6H3T5=22+:E;@K$8X4=UQK(SL2@X5JMLC?:I1%L
M]RP>(OV[QNR>F:HLT'*006,NDYXGC%?;:73W[MN+U='M&E?8DQSL<(TI"OLD
M2MF<:V81U\/*)UM%J5-,C+W?A,B2)$B-NPA"X"^[I:LV:EZ;U+3KJ_+*W&I:
MRH=9MDH1^YE2R-F@:M%1<\_))O4RK215I5JZ4PNL4JJW?ZARX.;. &3@
M
M                     !!]UK>C?6^JOK"F/*M;XC5_(_3V9GZG%WG6#Y]5
M[#7IQ,BTMKN[DBS9<LH5>69QKMK)H(/G$4LBY]%BY3?.4S!6%J?2#\3%IFLM
M]'ZGW7LBLZDC6RL9$QVN^;QJQKZ'CG2YCN6D!"+72/?P,<=11911)I&H%/ZR
MGS#'5/@P79NG3IO<_'SA+QUTSR(L);7NJ@43W-L*P%M,G=O>,VI-RS_!\VJ9
M3(YFC$8O6:655"_=0["9,F4ALANJ
M                              /5S4-%6*'EJ]/1[26@YZ,?PTS%/T2.
M&,E$RC59C(Q[UNIYE6:+,UEDU"&QVG(H8N?NY 4->27AH.?O&'D1,[JZ6&Z"
MEJSB1GY&B-XG;,OI'>.M(N8<+&-0C6Q600:6R%3CUDVA9 TNU5?HMC%D(Y(W
MVQ<-_ND5P)ZWFM.<%2Y =0W<E\M&IZQK^_UM2JWSE*^VXNM)V.#PRA31=0A[
M#*19"IR14U5EE%$#X,CZV/44Q@!;@
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MX
M
M
M
M
M                        #7RX\3.*VQ)X]HV!QGX_7JS*K+.5+%<=,ZYL
M\ZHX<*94774EYNMKN#K'4S@QS94[C&^)LYR S%6*G5J3#-*Y3:U7ZC7F.#88
MP-8AHZ AF6#^63%:Q<4W20;^?E\>PA?N /H0
M
M
M
M
M
M
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M7GN3G.7-.<I=]*O+QX4[WA2D@HB2#@
M
M
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MO<CU>H
M            -<Z+R_XE[2M471-9<HN.VQ+O.X?8A*91-V:UMUJF?=D<]F)+
MW57J_9G#N0]GB(Z0=+^DB?T6S%9<_:DD<^,[F[)[4Z;BW,[4=FM0T_#L\.>]
M>P\FU:AS2I"//<N6XPCQG*,*<9=<I4C3OJOI*Q?A&LKEF<8T\]6-:4_A;&#!
M/F
M                                            "J?XG#^LD_RDO]08
MOW<=X-J?:POZ<MLQV.O[</\ 9_\ ?DK'1&^]@\9/\='](3; @&]#Z.=<_!O@
M>.K/?%],;:+\$^ 8J5@0%68
M
M                                                         *17
MB4?W<^J?P3J+^>#>PVYW!_0?J7[YWO@N&N7=Y^P>7^ZY_P!C96Q.!/[ACA?^
M"=QT_,_3AK7MG]&&UG[YY_PJZJ[7/V:UC]U9']K-MB(TQ8
M                                                    .=AT)_OJ
M?%K^[N[^CCM\;][Z_I8[3>WA_P#$<5*M2_R*]][_ %XNB>-!$5
M
M                                !5/\3A_62?Y27^H,7[N.\&U/M87]
M.6V8['7]N'^S_P"_)6.B-][!XR?XZ/Z0FV! -Z'T<ZY^#? \=6>^+Z8VT7X)
M\ Q4K @*LP
M
M                                            4BO$H_NY]4_@G47\
M\&]AMSN#^@_4OWSO?!<-<N[S]@\O]US_ +&RMB<"?W#'"_\ !.XZ?F?IPUKV
MS^C#:S]\\_X5=5=KG[-:Q^ZLC^UFVQ$:8L
M                                        '.PZ$_WU/BU_=W=_1QV^
M-^]]?TL=IO;P_P#B.*E6I?Y%>^]_KQ=$\:"(J
M
M                   "J?XG#^LD_P I+_4&+]W'>#:GVL+^G+;,=CK^W#_9
M_P#?DK'1&^]@\9/\='](3; @&]#Z.=<_!O@>.K/?%],;:+\$^ 8J5@0%68
M
M
M                                *17B4?W<^J?P3J+^>#>PVYW!_0?J
M7[YWO@N&N7=Y^P>7^ZY_V-E;$X$_N&.%_P""=QT_,_3AK7MG]&&UG[YY_P *
MNJNUS]FM8_=61_:S;8B-,6
M                            #G8="?[ZGQ:_N[N_HX[?&_>^OZ6.TWMX
M?_$<5*M2_P BO?>_UXNB>-!$5
M
M       !5/\ $X?UDG^4E_J#%^[CO!M3[6%_3EMF.QU_;A_L_P#OR5CHC?>P
M>,G^.C^D)M@0#>A]'.N?@WP/'5GOB^F-M%^"? ,5*P("K,
M
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M^"=QT_,_3AK7MG]&&UG[YY_PJZJ[7/V:UC]U9']K-MB(TQ8
M                                                     .=AT)_O
MJ?%K^[N[^CCM\;][Z_I8[3>WA_\ $<5*M2_R*]][_7BZ)XT$14
M
M                                %4_Q.']9)_E)?Z@Q?NX[P;4^UA?T
MY;9CL=?VX?[/_OR5CHC?>P>,G^.C^D)M@0#>A]'.N?@WP/'5GOB^F-M%^"?
M,5*P("K,
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MWO6JU]HY42)'626)E$RF43^TE.8F3D(8H720
M                            %(KQ*/[N?5/X)U%_/!O8;<[@_H/U+]\[
MWP7#7+N\_8/+_=<_[&RMB<"?W#'"_P#!.XZ?F?IPUKVS^C#:S]\\_P"%757:
MY^S6L?NK(_M9ML1&F+
M                        !SL.A/\ ?4^+7]W=W]'';XW[WU_2QVF]O#_X
MCBI5J7^17OO?Z\71/&@B*@
M
M    JG^)P_K)/\I+_4&+]W'>#:GVL+^G+;,=CK^W#_9_]^2L=$;[V#QD_P =
M'](3; @&]#Z.=<_!O@>.K/?%],;:+\$^ 8J5@0%68
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MP4N,=I<8[< (?_"4_?/;Q^")M3\X^E@'21
M                           4BO$H_NY]4_@G47\\&]AMSN#^@_4OWSO?
M!<-<N[S]@\O]US_L;*V)P)_<,<+_ ,$[CI^9^G#6O;/Z,-K/WSS_ (5=5=KG
M[-:Q^ZLC^UFVQ$:8L
M                       '.PZ$_P!]3XM?W=W?T<=OC?O?7]+':;V\/_B.
M*E6I?Y%>^]_KQ=$\:"(J
M
M  "J?XG#^LD_RDO]08OW<=X-J?:POZ<MLQV.O[</]G_WY*QT1OO8/&3_ !T?
MTA-L" ;T/HYUS\&^!XZL]\7TQMHOP3X!BI6! 59@
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M)M3\X^E@'21
M    4BO$H_NY]4_@G47\\&]AMSN#^@_4OWSO?!<-<N[S]@\O]US_ +&RMB<"
M?W#'"_\ !.XZ?F?IPUKVS^C#:S]\\_X5=5=KG[-:Q^ZLC^UFVQ$:8L
M
M'.PZ$_WU/BU_=W=_1QV^-^]]?TL=IO;P_P#B.*E6I?Y%>^]_KQ=$\:"(J
M
M                                       "J?XG#^LD_P I+_4&+]W'
M>#:GVL+^G+;,=CK^W#_9_P#?DK'1&^]@\9/\='](3; @&]#Z.=<_!O@>.K/?
M%],;:+\$^ 8J5@0%68
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MFS66DV'W]FP?5IL/M'H%IQD?9?82>K[R]7VDGH^FL%D@
M                                    !2*\2C^[GU3^"=1?SP;V&W.X
M/Z#]2_?.]\%PUR[O/V#R_P!US_L;*V)P)_<,<+_P3N.GYGZ<-:]L_HPVL_?/
M/^%757:Y^S6L?NK(_M9ML1&F+
M                               !SL.A/]]3XM?W=W?T<=OC?O?7]+':
M;V\/_B.*E6I?Y%>^]_KQ=$\:"(J
M
M         "J?XG#^LD_RDO\ 4&+]W'>#:GVL+^G+;,=CK^W#_9_]^2L=$;[V
M#QD_QT?TA-L" ;T/HYUS\&^!XZL]\7TQMHOP3X!BI6! 59@
M
M
M                     I%>)1_=SZI_!.HOYX-[#;G<']!^I?OG>^"X:Y=W
MG[!Y?[KG_8V5L3@3^X8X7_@G<=/S/TX:U[9_1AM9^^>?\*NJNUS]FM8_=61_
M:S;8B-,6
M              #G8="?[ZGQ:_N[N_HX[?&_>^OZ6.TWMX?_ !'%2K4O\BO?
M>_UXNB>-!$5
M                                                     !5/\3A_
M62?Y27^H,7[N.\&U/M87].6V8['7]N'^S_[\E8Z(WWL'C)_CH_I";8$ WH?1
MSKGX-\#QU9[XOIC;1?@GP#%2L" JS
M
M
M   !2*\2C^[GU3^"=1?SP;V&W.X/Z#]2_?.]\%PUR[O/V#R_W7/^QLK8G G]
MPQPO_!.XZ?F?IPUKVS^C#:S]\\_X5=5=KG[-:Q^ZLC^UFVQ$:8L
M                                                         '.P
MZ$_WU/BU_=W=_1QV^-^]]?TL=IO;P_\ B.*E6I?Y%>^]_KQ=$\:"(J
M
M                                    "J?XG#^LD_RDO]08OW<=X-J?
M:POZ<MLQV.O[</\ 9_\ ?DK'1&^]@\9/\='](3; @&]#Z.=<_!O@>.K/?%],
M;:+\$^ 8J5@0%68
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M6$:)L*[95Y)BM*5.^P,<18_NEO)Q:#M-TTSG!$)*$?>S$(S.V(4)KP
M
M       !2*\2C^[GU3^"=1?SP;V&W.X/Z#]2_?.]\%PUR[O/V#R_W7/^QLK8
MG G]PQPO_!.XZ?F?IPUKVS^C#:S]\\_X5=5=KG[-:Q^ZLC^UFVQ$:8L
M
M '.PZ$_WU/BU_=W=_1QV^-^]]?TL=IO;P_\ B.*E6I?Y%>^]_KQ=$\:"(J
M
M                                        "J?XG#^LD_RDO]08OW<=
MX-J?:POZ<MLQV.O[</\ 9_\ ?DK'1&^]@\9/\='](3; @&]#Z.=<_!O@>.K/
M?%],;:+\$^ 8J5@0%68
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M]\\_X5=5=KG[-:Q^ZLC^UFVQ$:8L
M                                  '.PZ$_WU/BU_=W=_1QV^-^]]?T
ML=IO;P_^(XJ5:E_D5[[W^O%T3QH(BH
M
M            *I_B</ZR3_*2_P!08OW<=X-J?:POZ<MLQV.O[</]G_WY*QT1
MOO8/&3_'1_2$VP(!O0^CG7/P;X'CJSWQ?3&VB_!/@&*E8$!5F
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MX\64<.W/"GBTLX76SW*+*GTA1\G44-_"4R;SSG.?CG/QR WC
M                          %(KQ*/[N?5/X)U%_/!O8;<[@_H/U+]\[WP
M7#7+N\_8/+_=<_[&RMB<"?W#'"_\$[CI^9^G#6O;/Z,-K/WSS_A5U5VN?LUK
M'[JR/[6;;$1IBP
M                    <[#H3_?4^+7]W=W]'';XW[WU_2QVF]O#_P"(XJ5:
ME_D5[[W^O%T3QH(BH
M                                                           *
MI_B</ZR3_*2_U!B_=QW@VI]K"_IRVS'8Z_MP_P!G_P!^2L=$;[V#QD_QT?TA
M-L" ;T/HYUS\&^!XZL]\7TQMHOP3X!BI6! 59@
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M^#_X(/&K\S%* 5<_&1?\%W!#_#[>_P#-W60"S!TO/O:?3W_ EXL?F/HX#>H
M                                     4BO$H_NY]4_@G47\\&]AMSN
M#^@_4OWSO?!<-<N[S]@\O]US_L;*V)P)_<,<+_P3N.GYGZ<-:]L_HPVL_?//
M^%757:Y^S6L?NK(_M9ML1&F+
M                              !SL.A/]]3XM?W=W?T<=OC?O?7]+':;
MV\/_ (CBI5J7^17OO?Z\71/&@B*@
M
M          JG^)P_K)/\I+_4&+]W'>#:GVL+^G+;,=CK^W#_ &?_ 'Y*QT1O
MO8/&3_'1_2$VP(!O0^CG7/P;X'CJSWQ?3&VB_!/@&*E8$!5F
M                                                U%YR\,-7<_\
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M-6M%1:Q6U+GJV;J>8ZV-$64DX68U+3,&\.^(BCCT#8?E3+DYLG25^;Y!.H
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M)W'3\S].&M>V?T8;6?OGG_"KJKM<_9K6/W5D?VLVV(C3%@
M                                                    YV'0G^^I
M\6O[N[OZ..WQOWOK^ECM-[>'_P 1Q4JU+_(KWWO]>+HGC01%0
M
M                               53_$X?UDG^4E_J#%^[CO!M3[6%_3E
MMF.QU_;A_L_^_)6.B-][!XR?XZ/Z0FV! -Z'T<ZY^#? \=6>^+Z8VT7X)\ Q
M4K @*LP
M                             0(]:_HQ67JTR''!_7=^P>DOJ$,]KM':
M4UKY_>/E)]4A?7:R"C8[&V1GNW#3Y#K8/@Q5O6]Y$SC)/2SWA,_I37JNI--Z
MDU2O*ISJVL=94+7JTVDT-'I3"M+JL56U)5-@9RMEBFX-&Y6PCE57*6%NS*I^
MWNR&3P         !3 Y<>$NE=V;RV[NW6'-6/@S[>V7?MFOZ=?-+N718&3O=
MIE+6[C6=LKVPBYD&*3N6623,>*15*1$IC&4,;/D'P.H/!TIEGXB6Y"<WUI6"
M0?ME9^J:GU$9A,3$<F<N7#2.V%<;LX)"NCHD["+*5U]@G?Y^GGR[3!;UXM<5
M=$<,=,5C07'.AL=?:UJQG;IM&-W#V1DI:9DCE6E[)9)V4<*N[!8GBQ$\KNG*
MIS]B239'"+1NW;HAL0
M            *17B4?W<^J?P3J+^>#>PVYW!_0?J7[YWO@N&N7=Y^P>7^ZY_
MV-E;$X$_N&.%_P""=QT_,_3AK7MG]&&UG[YY_P *NJNUS]FM8_=61_:S;8B-
M,6
M        #G8="?[ZGQ:_N[N_HX[?&_>^OZ6.TWMX?_$<5*M2_P BO?>_UXNB
M>-!$5
M                                               !5/\ $X?UDG^4
ME_J#%^[CO!M3[6%_3EMF.QU_;A_L_P#OR5CHC?>P>,G^.C^D)M@0#>A]'.N?
M@WP/'5GOB^F-M%^"? ,5*P("K,
M                                            'Q-RV3KK7+/$AL*_
M4NB,.S)_;KE:8*KL_3+GYRGM,V^0)A/&2Y\\]WE\ 'KJ'N'4FTR+*ZQVEKG8
MZ;=/*KA2AW>LV\B"13D2,HL:OR;C":>%%"8SG/ECN/C'W<@,C@ #Y.W7JDZ_
MC"S5\N55I4.=7T"RUNL$16XPRW893T</YEXBD93TRF-V]_=VESG[@#Y>C;ST
MEL]V9AK7<6K-A/BIJJF94;852MKLJ2'EZZAF\!+N#E3)\.[/EY%_A>0#*@
M^6M5XI5%89E+M;ZO3HS&#9S(VJP1->8EP3XG-EY+O$4\8Q^_\[X /1T;;^IM
MGIF6UKM#7>PTB8/E16C7:M6Q)/!,^1\F/ 23C!<8S]WSS\ &10
M                                                   !2*\2C^[G
MU3^"=1?SP;V&W.X/Z#]2_?.]\%PUR[O/V#R_W7/^QLK8G G]PQPO_!.XZ?F?
MIPUKVS^C#:S]\\_X5=5=KG[-:Q^ZLC^UFVQ$:8L
M                                             '.PZ$_WU/BU_=W=
M_1QV^-^]]?TL=IO;P_\ B.*E6I?Y%>^]_KQ=$\:"(J
M
M                        "J?XG#^LD_RDO]08OW<=X-J?:POZ<MLQV.O[
M</\ 9_\ ?DK'1&^]@\9/\='](3; @&]#Z.=<_!O@>.K/?%],;:+\$^ 8J5@0
M%68
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M23;VV8FK5K"\3KF7FDI5--?U'K>21<DR8A2';O4C)8]$Q '5,
M                                              4BO$H_NY]4_@G4
M7\\&]AMSN#^@_4OWSO?!<-<N[S]@\O\ =<_[&RMB<"?W#'"_\$[CI^9^G#6O
M;/Z,-K/WSS_A5U5VN?LUK'[JR/[6;;$1IBP
M                                         <[#H3_?4^+7]W=W]'';
MXW[WU_2QVF]O#_XCBI5J7^17OO?Z\71/&@B*@
M
M                   JG^)P_K)/\I+_ %!B_=QW@VI]K"_IRVS'8Z_MP_V?
M_?DK'1&^]@\9/\='](3; @&]#Z.=<_!O@>.K/?%],;:+\$^ 8J5@0%68
M
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M;;S&,8QC'+Z_8QC&/+&,8T]9/+&,8Q_^OF Z)
M                                  "D5XE']W/JG\$ZB_G@WL-N=P?T
M'ZE^^=[X+AKEW>?L'E_NN?\ 8V5L3@3^X8X7_@G<=/S/TX:U[9_1AM9^^>?\
M*NJNUS]FM8_=61_:S;8B-,6
M                             #G8="?[ZGQ:_N[N_HX[?&_>^OZ6.TWM
MX?\ Q'%2K4O\BO?>_P!>+HGC01%0
M
M          53_$X?UDG^4E_J#%^[CO!M3[6%_3EMF.QU_;A_L_\ OR5CHC?>
MP>,G^.C^D)M@0#>A]'.N?@WP/'5GOB^F-M%^"? ,5*P("K,
M
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M.Y)W\F8.S%DVKJ'13(BW]&:*EE,Y>[N;F-YYP;R*$I(
M                                      *17B4?W<^J?P3J+^>#>PVY
MW!_0?J7[YWO@N&N7=Y^P>7^ZY_V-E;$X$_N&.%_X)W'3\S].&M>V?T8;6?OG
MG_"KJKM<_9K6/W5D?VLVV(C3%@
M                                YV'0G^^I\6O[N[OZ..WQOWOK^ECM
M-[>'_P 1Q4JU+_(KWWO]>+HGC01%0
M
M           53_$X?UDG^4E_J#%^[CO!M3[6%_3EMF.QU_;A_L_^_)6.B-][
M!XR?XZ/Z0FV! -Z'T<ZY^#? \=6>^+Z8VT7X)\ Q4K @*LP
M
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M)]%T:J052CWLCE!)KE^[90#%NDX>Y:MVZ?JG+D_8@0GGVE+C ?;@
M                                               I%>)1_=SZI_!.
MHOYX-[#;G<']!^I?OG>^"X:Y=WG[!Y?[KG_8V5L3@3^X8X7_ ()W'3\S].&M
M>V?T8;6?OGG_  JZJ[7/V:UC]U9']K-MB(TQ8
M                                           .=AT)_OJ?%K^[N[^C
MCM\;][Z_I8[3>WA_\1Q4JU+_ "*]][_7BZ)XT$14
M
M                      %4_P 3A_62?Y27^H,7[N.\&U/M87].6V8['7]N
M'^S_ ._)6.B-][!XR?XZ/Z0FV! -Z'T<ZY^#? \=6>^+Z8VT7X)\ Q4K @*L
MP
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M#*0[QPEZ.(?V<AE/6(B58I5<!(B
M                        I%>)1_=SZI_!.HOYX-[#;G<']!^I?OG>^"X:
MY=WG[!Y?[KG_ &-E;$X$_N&.%_X)W'3\S].&M>V?T8;6?OGG_"KJKM<_9K6/
MW5D?VLVV(C3%@
M                   YV'0G^^I\6O[N[OZ..WQOWOK^ECM-[>'_ ,1Q4JU+
M_(KWWO\ 7BZ)XT$14
M                                                           %
M4_Q.']9)_E)?Z@Q?NX[P;4^UA?TY;9CL=?VX?[/_ +\E8Z(WWL'C)_CH_I";
M8$ WH?1SKGX-\#QU9[XOIC;1?@GP#%2L" JS
M
M &$>0G'#1G*W5\WICD3K&K[8UI8#)K/JS:F1ETFT@@DX09S<)(ME$GE;L3=-
MTYPUDH]PU?MO:3^@X3[S>80,2GA2NE8_G32[0G)"$C\F*;Y+1>X(]:"+C!^[
M)"N)JD/)/)<E^;GSD<Y\ON9*;X@)Z^.N@-:\6=)ZZX^:>C)"'UGJN!Q7*C&R
MDL^GI%M'8>.I ^'LO)JG7?.#O'SI0QSF_P"_=I,%)@I2AFH
M                                                   !2*\2C^[G
MU3^"=1?SP;V&W.X/Z#]2_?.]\%PUR[O/V#R_W7/^QLK8G G]PQPO_!.XZ?F?
MIPUKVS^C#:S]\\_X5=5=KG[-:Q^ZLC^UFVQ$:8L
M                                             '.PZ$_WU/BU_=W=
M_1QV^-^]]?TL=IO;P_\ B.*E6I?Y%>^]_KQ=$\:"(J
M
M                        "J?XG#^LD_RDO]08OW<=X-J?:POZ<MLQV.O[
M</\ 9_\ ?DK'1&^]@\9/\='](3; @&]#Z.=<_!O@>.K/?%],;:+\$^ 8J5@0
M%68
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M:/C;/[1:AI.'<G=Q\3H>65VL:SKTF/:N2XUA"$:]].O#A&G>\/;;MB*HX
M
M I%>)1_=SZI_!.HOYX-[#;G<']!^I?OG>^"X:Y=WG[!Y?[KG_8V5L3@3^X8X
M7_@G<=/S/TX:U[9_1AM9^^>?\*NJNUS]FM8_=61_:S;8B-,6
M                                                      #G8="?
M[ZGQ:_N[N_HX[?&_>^OZ6.TWMX?_ !'%2K4O\BO?>_UXNB>-!$5
M
M                                 !5/\3A_62?Y27^H,7[N.\&U/M87
M].6V8['7]N'^S_[\E8Z(WWL'C)_CH_I";8$ WH?1SKGX-\#QU9[XOIC;1?@G
MP#%2L" JS
M                                   !5(\3M]SA'_<Y*?\ IT -B-PG
M[:_P#^^+TW+?ME_ _P"]I6^B#]Z]XQ?XZ?Z0NV17>]?Z/]?_  7X%C(+O*^C
M;6OP;X)82N"NT%
M                  4BO$H_NY]4_@G47\\&]AMSN#^@_4OWSO?!<-<N[S]@
M\O\ =<_[&RMB<"?W#'"_\$[CI^9^G#6O;/Z,-K/WSS_A5U5VN?LUK'[JR/[6
M;;$1IBP
M             <[#H3_?4^+7]W=W]'';XW[WU_2QVF]O#_XCBI5J7^17OO?Z
M\71/&@B*@
M                                                   JG^)P_K)/
M\I+_ %!B_=QW@VI]K"_IRVS'8Z_MP_V?_?DK'1&^]@\9/\='](3; @&]#Z.=
M<_!O@>.K/?%],;:+\$^ 8J5@0%68
M                                                      *I'B=O
MN<(_[G)3_P!.@!L1N$_;7^ ?WQ>FY;]LOX'_ 'M*WT0?O7O&+_'3_2%VR*[W
MK_1_K_X+\"QD%WE?1MK7X-\$L)7!7:"@
M                                   *17B4?W<^J?P3J+^>#>PVYW!_
M0?J7[YWO@N&N7=Y^P>7^ZY_V-E;$X$_N&.%_X)W'3\S].&M>V?T8;6?OGG_"
MKJKM<_9K6/W5D?VLVV(C3%@
M                             YV'0G^^I\6O[N[OZ..WQOWOK^ECM-[>
M'_Q'%2K4O\BO?>_UXNB>-!$5
M
M      !5/\3A_62?Y27^H,7[N.\&U/M87].6V8['7]N'^S_[\E8Z(WWL'C)_
MCH_I";8$ WH?1SKGX-\#QU9[XOIC;1?@GP#%2L" JS
M
M        !5(\3M]SA'_<Y*?^G0 V(W"?MK_ /[XO3<M^V7\#_O:5OH@_>O>,
M7^.G^D+MD5WO7^C_ %_\%^!8R"[ROHVUK\&^"6$K@KM!0
M                                                %(KQ*/[N?5/X
M)U%_/!O8;<[@_H/U+]\[WP7#7+N\_8/+_=<_[&RMB<"?W#'"_P#!.XZ?F?IP
MUKVS^C#:S]\\_P"%757:Y^S6L?NK(_M9ML1&F+
M                                            !SL.A/\ ?4^+7]W=
MW]'';XW[WU_2QVF]O#_XCBI5J7^17OO?Z\71/&@B*@
M
M                        JG^)P_K)/\I+_4&+]W'>#:GVL+^G+;,=CK^W
M#_9_]^2L=$;[V#QD_P ='](3; @&]#Z.=<_!O@>.K/?%],;:+\$^ 8J5@0%6
M8
M                           *I'B=ON<(_P"YR4_].@!L1N$_;7^ ?WQ>
MFY;]LOX'_>TK?1!^]>\8O\=/](7;(KO>O]'^O_@OP+&07>5]&VM?@WP2PE<%
M=H*
M       I%>)1_=SZI_!.HOYX-[#;G<']!^I?OG>^"X:Y=WG[!Y?[KG_8V5L3
M@3^X8X7_ ()W'3\S].&M>V?T8;6?OGG_  JZJ[7/V:UC]U9']K-MB(TQ8
M
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M<.Y;N69RMW82MW(^&,J5C6GWM:.%<MW+,I6[MN5NY'PTE2M*T]NE>M[,>KT
M&.+%M_4M07PSMNT-=5=WD_IE;6*[5N$<>I^\GA*3DDC94_M>7G_:',L:;J.3
M3FQL"]D1]&%J<_Z(U<VQIFIY-.;&TZ_D1IYL+,YT_FQJ^RB)N'GV"$I RT;.
M1CG&<MY*(?-9%@XQY>?FB\9JG35QY9+^U-D<6Y:N69RMWK<K=R/AC*-8U_BU
M<6Y:NV9UMWK<K5R/AC*-8RI]R5*5>U'J]
M                      !5(\3M]SA'_<Y*?^G0 V(W"?MK_ /[XO3<M^V7
M\#_O:5OH@_>O>,7^.G^D+MD5WO7^C_7_ ,%^!8R"[ROHVUK\&^"6$K@KM!0
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M?LUK'[JR/[6;;$1IBP
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M%K^[N[^CCM\;][Z_I8[3>WA_\1Q4JU+_ "*]][_7BZ)XT$14
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M-3DK7PRY+D)PI*O-6L*1K6O-Q2-"(*_
M             !5/\3A_62?Y27^H,7[N.\&U/M87].6V8['7]N'^S_[\E8Z(
MWWL'C)_CH_I";8$ WH?1SKGX-\#QU9[XOIC;1?@GP#%2L" JS
M          '.9Y93_)?D[S$WIKQK*[HWO-16[MKPU/H3%S<=AN(F#@+S.1L>
MPK=5:&=8BXEI'HMTRE;-TT42$^=V_$PW3V=LZ%H6S6DYLK6)I%NYBXT[EZL;
M5GFG.S"5:SN5Y>:LI<TNN7-)O#LW9T'0-E]'S96\31[-S%QIW;THVK,93G9A
M*LIW*\.-9RYI=]6LI?R,7;8X-<O]&5/-[VUQVVG2*:F9$KNSRM8>'A(PSI3T
MV_OJ08^LG"&46R4A/;,H^9SE(7YYBX-S]-VKV;U?([4T[6K&5E4\$(SISUY?
M#R4ER\_W.+(Z;M=LSK&3VGINN8V5E5\6W&['GKP\/)&7+*?WG,^_X6=0GD3P
MEO$'+Z]N<U*ZV+,-G-TT[-2+EY1;7%'4*2420BW)E$Z[8#M>[V>49%1<I+(H
M^L9RTPHU5XNU&QNB[4XEZWF8L+>=6E:6LF$8QO6I>=ZX^/#CQYH3YJ2IS<.$
MN$H\+:K8K1-K,2]:S<2%O.Y*TMY4(QI>M2\[WT>6LX<WC6Y\U*QYN7A7A*/1
M(H-U@ME42E[&JK@[JKW^IUVZUQTJ0I3NH&U0S.=AW!R$,;!3'CWS<V<8,;&.
M[RQG.!I=EXE[!R\K"R8\N1AW9VIT]"=N582_EC5I%FXE[ S,O!R(\F1AW9V9
MT]"=J<H3I_#2O\"EWU@>J3M7=.Y[]QWTS>)FF:"UI-2=(F3U21=Q#_;%GA'/
MN^S2-AE&"Q%'E10FVSQM&L4U/8W2+/$DY*X.X;D9[/;M=@=/TO2\/6M3Q89>
ML9T(W(=+&,J8T)QYH1A2752Y*%:5G/AS1E+DCR\M>.U&[+=[IVE:5AZYJ>+#
M*UK/A2]#I*4G3&MSCS6Z0C7O8W)0K2LY\.>-9<E.'++C%UI[A%RTY!46;V;I
MK0]^V%18%P\9O[%",&QFCA\P316?,85%VZ27LT@B5PCZJ$<DZ6)D_D8A<_ 3
M[4MJMG='R[6!J>K6</*O4C6,)R[ZD9>+6?+&484ER][6=:46%JFUFS6BYEC
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M_E=$OI,FR?IT<43',8V?J<K8\SYSG/D6TV I,9SG^P4I<8_N#3+>']&FT/\
MKZ?V<&D6\BG#;C:/A_I__P"G!(F(8A(
M             *I'B=ON<(_[G)3_ -.@!L1N$_;7^ ?WQ>FY;]LOX'_>TK?1
M!^]>\8O\=/\ 2%VR*[WK_1_K_P""_ L9!=Y7T;:U^#?!+"5P5V@H
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MYY_PJZJ[7/V:UC]U9']K-MB(TQ8
M         (FNMOLO86ING3N6YZONMJUY;V\WK&+:VJF3DC6["SCYS8M<BI9L
MQFHE=)RQ*XC7;E!7*2A#&27.3)NTV19^YO3L#5-O])Q-2P[6H8LH9,ZVKT(W
M+=90Q[DX5E"5)1KRRI25.-/#1S-.MPN9=J,XTG'KZJ^THJZNXH<RN6JLA<]8
MZ6W5NI-PZ6+)WU&#L$U$.I!(W8Y;N[U,^3-W*E-^V1,\,XQ^V,3M+D;K:EM1
MLCLK2WB:EK&'H\HT[W'YX0G2GG:QLP[^,?9Y."2SOX]BO+.Y2W['_P"F*]IZ
M<W7QRNJ54V[KV^ZAO+)-O+,(ZUPLK6)8S?)_-I,0[APFG[8S]9,V$W350Z7>
MCG&%>\ABER>F:OH^T&'+*TK.L:OA3XPK*U.%R''S83I'FY:^C"<:5Y?.O>%R
MW=AS0E2Y'V.M:-Z"O5(W1L[:^.&G(J[2VRTYZKS,SI>\6AVI*76.DZ=&&F)N
MCS,\Z-EQ98E6K,I=^T</#KO&BD*JAE99LX1(SUJWX;M='TW3/+?L_APT_H+L
M(9EFU3ELRC>ER0O1A3O;<Z790A.D.6$XSC+A&5)5GAM3PK<(=LVH\M:UZZ>9
MU^;_ !EBGFQRFK'#'C-M'D-9VA97Y%0R:59KN5<H*6J[SKM"%I]=PJ0N3HMG
M$X]9Y=K$*<[9BBY==A\-S%%!;&[,Y.V&T>F:!C2Z.F9/Y[<_T=F%)3O7/;C"
MDN2GGIUC#SS$X]BN1>A:IY[^2/5Q<XOD?RMY'<T=EKW+=%[LU_GYF6,G6JBU
M5?&K%:]XNS)Q]:H-,;*'0B693.4T$4T$SNW)OGN5G3M5597L#V?V7V?V/TZ&
M)H^!:P<>S#YY>KR]+<Y8]]=OWJ]<Y=7&5:RY(^+&,84I2DLM6+6-#EMQC",?
M-_YUD]GO3@URYXQU2NWW?&AK[K*HV=V@PAK#.LVAF'O1P@X>-8F25C'B^:_-
M*-V;Q1-F_P -G1R,U3$1R4A^WYZ)MILKM'E9&#HFN8^I9>/&M9PA*7-R1K&-
M9QYJ4YX4E6E)3AS0ZX]?&KQ;R<>]*4;5VDI13*]$GJO[7UUNV@\3=]WF8O>E
MMJRT?1]?2MMD74Q-:MO4HK[%46$5,OE#KJ4N3EEF<8JP6.=NP6>-7C,S1%-\
MD[J+?'NPTO4-%SMJ-#PX8.L:7"5[(A:C&$,FS#OKM9PCPITUJ'&[2<>^G&,X
M3YY2A6' U+"A<MSOVH<MRWUUX>>IYOW5U2Y.G#&H6MZS6.W=LZW..FSA//:H
M@X0C'2J"R>?WE"JE*;&?[)1I]B1C<R\6$X\T)7(4K3T:5E3BC\>N5*>BY?\
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MN-D4A>IS2A7V/,]GE=  :,(P .=AT)_OJ?%K^[N[^CCM\;][Z_I8[3>WA_\
M$<5*M2_R*]][_7BZ)XT$14                                     8
MKUUI'4.I'ENDM9ZTIE'D[[89*U766K5?CHR5M5AEGSB1?RE@E&Z.'$LX.]=N
M#X]90Y4LJF*D4A?@.9F:IJ&HQQ[>;F7<JWBPC"U&<ZRC;A&G+2,(^"G53S*<
M:^;5D=0UK5]6ABV]2U&]G6L*W&U9A<G*4+5N%*1C"$*UY84I&E*=5.OPU8RY
MIW_6^L>)_(.W[:-&JT-GJFZ1\Q&2F&YT+$O.P;R#B:JW0=?,=2,I,2#!@V2S
M\#N)!/&<EQYFQSMF<3-S=H-(Q]/X]M2OVY1E3SG).DZSZNNE(1I6<J^A1D]C
M<#4=2VJT'$TKFCG3RK,H3AS<;<83C.=VM8]=(VH4E.5?0I5S.T$%W2Z+9LBJ
MX<N%4T&[=!,ZRZZZQRII(HI)ER918RABE*4N,Y,8_E@;JUK2-)2E+A&CL;E*
M,8RE*7+"'?5K7P1HO^<C&-FXT]&*TU"1,LRMVON%-.U),Y*XSE=C.2-"KFL)
MO#=TEGYIT7<H\PB9//S?2)V9^!<C4W1ZV-;WDV<F'?X^9J5S(C]E"-Z=^'\-
M*4X^VT2V>GC;2;X,7+M?/,74-9O94.]\:$;]S)AQI[,84X\5".G5]2VVZJU5
M)3*2MFL<'7TE"XQDR:DS)M8XBF,&QY=V#+ES\1M;DWZ8^/D7Z_YF$Y_Q8RE_
MR;S9F13$P\K*KWT<>U.[_$A67_XNI)7ZQ U:L0=,@(MI'5BN04=68:';I$PR
M8P,1'HQ<?&)-\E[<-4V#=%+!?+M[2>7D-&+]^[?OW<F[<K.]>G*<I>;*=:UE
M67M\W&O%UFY&5?R\F]F7[E;F5D3E<G.OC5G.7/*5:^C6M>+F><MZ!&:IY4<D
M=:0C9-G!4/>NUJI -4RX(FW@(.\SD?!I)D+^T*6)19XP7^#]P;K;/YD\_0M%
MS;LN:YE8EB<Z_9SM0E/^=S.QO93/N:ILQL[J-Z7->SL'%NSKZ:<[,)3_ )]9
M+OW1$NCZX]-G0V))4[AW4W6Q:9ZZBAE#G90NQ;.I#)?._:$0A'D:V(7[F$V9
M?+R+Y8&LF\[&AC;9ZIR=4<BEF[]V=F'-_#*E9?=:8;Z,.&)O$UWHX\L<JF/>
MX?93Q[?/_#.,I>W5(E7]):AJNQ+CMRNZTID1M'8!F>+GL%G7XY.XV%./8-(Q
MHVD+!E#+DS,C%@S)Z!52HF] IC$RIYF$.O:IJ&1A8^GWLVY<P<+CT=FLY=%#
MC*LJUC#Q>/&LNOAQ\SBK_(UK5LK Q-*R=1O7M-P.;H<>LY=#;XRK*M8V^/+Q
MYI5[[AQ[[P\'UMRM%7I%2LUQNTM&P50JT#+S]HF9=0B47%0$2Q7>RSY^HK\T
MK-)BBN8_GC/F4GEY9S\!Q\:Q?R<FQCXUN5R_D3C"$8^&LZUY8TC]E6O_ *N)
MB8V3FY6/B85J5_,RIPA:A#QYSG*D84I[-95ZO,<O#8TO7K!L*^3]2BL054G+
ME:)>LP>$DD,0]>DYM\]A8K""!LD1]GC5FJ/83/87T?+'S1O%AV[UC$Q;61<Z
M3(M6H4G/TTXPC&5?OJ\TG9;I]G(Q\#!L95SILJS9MPNS\;GN4A2DY\:]??2C
M*3H'](?6\_JOIS\8JQ9FKAC,2%4G[R=FYSG"S:-V7>K5L. P9(WQ;G-7K1%'
M.GG&#$55/@Y2G[L#4K>#FVL_;'7+]F7-;C<C;X^C*S:A9G_/A)H;O8U&QJ>\
M+:3)Q94N6;=V%GFCYLL:S;L3^V^>6Y]?FT;MP^G-35_8-FVQ!ZTHL3M"Y$9)
M6O8;"J0K:[6%&/CVD4R;RUG29X>/&Z<>Q:(E3.MDF"-B%[?FB+W=1S[N)9T^
M[F7;F#C<>CLRG.MJ'&595Y8<>6G&5:U\"&WM7U6_@8VEWM1O7--P^/18\KLZ
MV;?-*LZUA;K7DI6LI5EQY>/6A6VQXA;BCK*W7Z@(:?Y"6"V4&U6>FO.^(UQ#
M5U_,5>9>0CQ5I+%V.Z<IQ:CIBL9)4\?A;TSDR=N0YLD+9>!NAU_-Q\7*KJ.'
M9L9<(7:=]>E.,9QI.G&/0QCS<)=]3GX>RN+2MP>U.I8F#G3U; Q\7.M6KT>_
MR)W(PN0I.G-#M>$>>E*]<>DX<?/>!5$WC>MF<_.6>QMDT75$P^O&Y+3[WBM9
MZ^BY&VR+%HU81L(P;E+%QI59)5./CF9GS[+=NFHX.LY5(B4_EB^]+Q<'9/0,
M3"RM0I#%TZ'+6]>E2W&M92E.7C2X4[ZLN2'-+A3EIWS:/1<'3=A=E=/T[.U2
M%O"T>UR3R;\XVHRK*LIUKUUY8\TI5Y(<TJQCPI'FX+R_2SXBV#A=P_IFJKJ9
MM]4:>F)K8^QFC%=L[9Q-JM:<>@6 0=M3&3?'CZ_#P+)==-11%9RP75;J&;F2
M&KNW>T%K:3:+(S\;CVE:C&S9K+JE*%OF[_A7P4G.4YTIU5I25.:G'F:4[S=J
M\?;':W,U3"I6N!8A#&QY2I*E9VK7-+GE2O?1YYSG.D:TI6D91I6G'BD9$10
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MVV@_UW_].VTYWD_1SM%^Z/\ ^G!(F(:A(
M               *I'B=ON<(_P"YR4_].@!L1N$_;7^ ?WQ>FY;]LOX'_>TK
M?1!^]>\8O\=/](7;(KO>O]'^O_@OP+&07>5]&VM?@WP2PE<%=H*
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M-K/WSS_A5U5VN?LUK'[JR/[6;;$1IBP
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M6YTM:PCX(TY84Y(QI&D*<*4Q'D52Y*4[^165RO?5Y:?_ -V^_"SQ&NM-R7R
MUCR@UDUT?(VF4:0T'LRMV!6=UPC(O\X19-[BSEVZ3VGL5'F2)8?E6DFR9GB9
MWOL+5-9V2#[8=C[J.D8-[4MF]2KK4,:%9W,:Y#DR.6/AK9K"LH7JTIU\G+;E
M7AWG/.48.-D:3<MPE.S/I>7S.'77VO169,9QG'GCXXR-=F( '.PZ$_WU/BU_
M=W=_1QV^-^]]?TL=IO;P_P#B.*E6I?Y%>^]_KQ=$\:"(J
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M'S>;P>PH/>=NZQK=C:+;3R4G*]65J[T'1TY._G9L\.?GYO/<WB^PM?#7UKH
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MX5=5=KG[-:Q^ZLC^UFVQ$:8L
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MO3GS7JPE3JE"/"$.;P5G"=:5K&L9)O16:F@
M                 53_ !.']9)_E)?Z@Q?NX[P;4^UA?TY;9CL=?VX?[/\
M[\E8Z(WWL'C)_CH_I";8$ WH?1SKGX-\#QU9[XOIC;1?@GP#%2L" JS
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M^>?\*NJNUS]FM8_=61_:S;8B-,6
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MXV.Q\3*OPU;4I2M6YSCQNXO#C2%94YO\3IU=7HN)+2,>D95I<GWM/31_-_\
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MU_=W=_1QV^-^]]?TL=IO;P_^(XJ5:E_D5[[W^O%T3QH(BH
M                     #Q+HIN$56ZQ<'173.BJ3.<XP=-0N2'+G.,XSCS*
M;./AG]\>:5K2M*T\-"E:TK27@E1%5]A$Z7_T8_RT<A/UL"=]TW;?U;_)L/Y.
MM#NS[ROKD_(\#Y*?81.E_P#1C_+1R$_6P'=-VW]6_P FP_DYW9]Y7UR?D>!\
ME/L(G2_^C'^6CD)^M@.Z;MOZM_DV'\G.[/O*^N3\CP/DK>3CUQKTIQ5U^;5F
MA*7\@Z&:<DK+F"Q8[7:/.;ETV:,B]S*7.=D7OFHFP9X]/VCTB>C\PA?,WG%M
M7UK4]?R^W]5RJY>5R1AS\EN'>1X\M.6U"$?-KYG%"-H-H]9VHSZ:GKN;V]G\
MD;?/T=JWWD./+'DLPMPZN:O7R\>OKK5Z7D3Q&XX\L(%I7N0.IJUL5K&^KF'D
MGQ'L59X+U\?;R05O@'C24AT5#=AE46[M-%8R),K)GR0GE]-'V@UG0+LKVD:A
M/#E<\:-.%83^WMSI*$O8K6/&GF5??9_:O:'97(ED:#JES3Y7/'C'EG:GP\'/
M9G2=J=:>96L)5CU\M:(U5?#]=/)1]EV2%V^W;Y/@WNM+9SG+'&,9-Y)X47B#
MN>SXE^ZX[OF%^=]WSFM-[>U\8\O28\I5\]T%./\ 6Y?Y%C4W\[?TAR5O8E9>
MG[6IS?R3X?S4@?&C@OQ6XAMG9=!:?@*9+R38C.6MSE:3LUVE6I<E.HU=6ZS/
MG;Y%@HL0JIV;=9!EZA"F*W+VD[8CK6U&N[0RCY+:C/(M6Z\8V^]A:C7TU+<*
M1AS>9S5I67LH%M'MMM/M9*/D[JUW,LVZ\86J<MJS"5?/1LVJ0AS4\'/*-9\.
MKF;;C HLC)NW1VZ<>QKI;M@W+CI[XM]ZL\]<K7+?5;WK'8E++:)5U.3DD6/B
M-FH-6/KR;YTKZ+9!%NEZO8BDFF4I,33&WB[8X>-CXN-K/1XV-"%J$>U\6O+"
M%*0A'FE8K*O"-*4XRK65?-K58V%O<WA:?B8N!B;0]%BX-J%FU#M3!ER6K4*0
MA'C/&E*7",:4YI2E*O#OJUJ^;^PB=+_Z,?Y:.0GZV!R.Z;MOZM_DV'\G<KNS
M[ROKD_(\#Y*?81.E_P#1C_+1R$_6P'=-VW]6_P FP_DYW9]Y7UR?D>!\E;<<
M9N&G&WAW&6N'XY:WQKJ.O+^,D;4W^5]\MWO5]#-W;6,6RO>;1**,O20?.BX(
MW.B0_K>:A3&QC.(YK>T>M;13Q[FL9G;MS$C6D*]':M<M)<M9=5J$./'EIXW%
M$]I-K]HMK;F+>VAU#R0N8E)1M5Z&Q9Y:3K2LN%+%JW&O&L:>&E?L6(M[=+S@
MAR-FI&S[*X]5+-OEW;J1E+=2W4YKJ?E91ZJ=P[EIMW192/)8Y15914ZJ\BD[
M44.?)CF,;RR,EI6W&U6CVHV,+5[O:UNE(TMW:0O0C&/@C"EV,^2D?,C"L>#*
MZ)O+VWV>LV\73=H+G:MFE(PLWJ0R(0A'JC"%+T9RMPIYVENL(Q\QIVOX?+I\
M*N3+IL]T-DC&,;#-#99#-B8R;&<$(9S75%NW!?,N/-4QL%_?\_B)%3>WM=2'
M+S8TJ^FZ#K_K\O\ (ET=_.WU(\M98<I>FEC=?\V[2/\ (V\XX]+C@]Q9FVUM
MUAI.(<WAGZ9F5XOLC+7ZQQJZ)N]-Y!&LSM=I6'^/,V,N8MHS7,4^2'4,3YHC
M^L[=;3Z[9E8SM2E'$GX;5JD;,)>Q/DC&4Z>Q.4J>A1%-H=YFVFT]J6-J6L3C
M@SZJV;$86+5:>EGT5(SNQ^QNSG3V$@XB2!@
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M>ZSG7L.[:P\[M:EF]*U.EJ[R8.-"?1W)4Y)\DHUC+EE7EE2M*]:8D5RJH
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MH7NV,W,ES79\L8<TN$8\>6$8PIWM*=5*49*'#<(
M                     %4CQ.WW.$?]SDI_Z= #8C<)^VO\ _OB]-RW[9?P
M/^]I6^B#]Z]XQ?XZ?Z0NV17>]?Z/]?\ P7X%C(+O*^C;6OP;X)82N"NT%
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M'[&$8T]A#M0U34-5O=L:CF3RKWF5G7JI3TL(^"$?L8TC3CYC-0QCA
M              "D5XE']W/JG\$ZB_G@WL-N=P?T'ZE^^=[X+AKEW>?L'E_N
MN?\ 8V5L3@3^X8X7_@G<=/S/TX:U[9_1AM9^^>?\*NJNUS]FM8_=61_:S;8B
M-,6                                          #6_DWQ)X^<QZ3":
MZY'Z^^J-3:]:FMUAX?-JNM1RRLS.)F8-O)XD:)9(MVMVQD_*I>BJN=N;VKOR
MCE1-(Y,]LYM5K^R.9>S]GL_R/S,BW6S.?1V;O&U6<)RCRWK=V%._A"O&D>/5
MXW"M7TLW[N/*L[4N64J</!2O]:C1_P"P3]*OZ+/Y;^1OZWA-N[9O.^N;\BT_
MY(Y7DEF_Z;^;#\T^P3]*OZ+/Y;^1OZW@[MF\[ZYOR+3_ )(>26;_ *;^;#\U
M^^*Z'G2ZA)2-FHSC!AM)1#]G*1[C.Z.0SCT'T>X2=M%LH.MM'36[7"*1NQ0A
MR&[>TY3%SG&?C>WS[RKUJ[9N;2\UN]&L94[3P*<U)4Y:]<<3FZX^AUO%=1S*
MTX5O?S8?FI816+A(]^3_ $MN#W+R<=6_<.DHH]^=X(5UL.E2<M1+>_RGCM*M
M-O:R[00M#K"7DF565;/52)D(1(Y"D)VSG9O>7MILI9CB:1K$^T(^#'O1A?LT
MI]A&[&5;=/-X6I0CQ\/AJY-G,R;%.6W<XP]++OJ?<X^#[C3Z!\/)TW(>21?O
MZKMBT-4EBJJ0D]M681C'!"J&/ENLI66L<\PCDOS<]CLA^TO[?S[LYEE_?WO"
MNVY0AE8N-*7GX8T)2C[-.EK<A_##@Y%=5RZTZI4C][_Z\4MFE=#:;XZ4AGKG
M1VN*KK*ELE#+EA:M&ILRO'ARE(K)S#XV3N9Z74333*H\>K.':F$RX.MG!2^5
M6ZQK>K[09LM0UO4+NI9D^KGNRYN%/2PCXL(>A"%*1IZ5P9W;EZ7/<G6<J^B^
MHV+KZH[9H-UU?L"(Q/T7856G:5<8++Z3B\3%9L\:YAIJ.]Y0KQL[C\KQ[MRG
MZS5PBNEW]Z*R:F"G+QM/S\K2\[#U+ O=!G:?=A>LSX1ER7;4J3A+A.,H2X2I
M27+.,HR\V-:/6$I0G&4*\LH5XT\'5P1B?8)^E7]%G\M_(W];PLKNV;SOKF_(
MM/\ DCF^26;_ *;^;#\T^P3]*OZ+/Y;^1OZW@[MF\[ZYOR+3_DAY)9O^F_FP
M_-/L$_2K^BS^6_D;^MX.[9O.^N;\BT_Y(>26;_IOYL/S4D.G-.ZWX_ZRJ.G=
M1UO%2UQ16"T75:YB6G)WW6P<OG<FLC[WLLH\?/NY\^=*9.Y=+'^VY+W=F"XQ
M76KZMJ&NZCE:MJN1VWJ.=*DKMSDA#GK2E(^);C"$>]C2G>QC3[M7#G.=V<KD
MY<TY>%B/DSPCXL<Q(QE&<BM-U?83B)0,VA+&K[Q@;K!MCJG7,TA[O6GK.58Q
M^71O5.T*[]C64Q@RR"HRVSFV>TVR5V5S0-6NX,;E>:=OO9V9U\'-.S<I.U67
M#O>?DYZ1KWM:/>SD7\>O&U=K&O\ )_!X$:N/#L].+$A[9[FW+EMZN3YB<[2<
M>[\E\_/T?4Q"^U>G^]Y^T]__ $^[XBQ>[]O Z/EZ;#YO3]K4YOZ_)_-<WR5R
M^'#FC_%2>\:N'O&OB!5W52X[:GKFN6$D8BLU(L\OYBTV)5/.<I'L5PL+QW*3
M2:9CJ901<.SH-O6.5LDB0V2BM=HMK-HMK,F.5K^JW=0N6_$C+EA:M_ZNS:C"
MU#CYZL84K+SU:N%>OWK]>:[<YOZ/N4\'@;,"/OD .=AT)_OJ?%K^[N[^CCM\
M;][Z_I8[3>WA_P#$<5*M2_R*]][_ %XNB>-!$5
M
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MM%9!51(_%S<##U/$O8.?CPRL7(CRSA./-&7YM8^-&5.65*\)1E&4>9PM1TW
MU;"R-.U/%AF8.5'A.U.G&DH_TTE277"<>6<)1I6-8RC2KH6=-CF6CSEXL57<
M#Z/:0]\B920U]M2'CBK%BV>P:XTC7;YY#X7QW)Q,C"S$%*(H]ROL>)S+ SAR
M=H=PKIWMMLU7977\C3HRE<Q;L8WK$J^-6S.LJ4I+[*$XSA6O>\W)S\(\W!HE
MO!V2KL9M-E:5"Y6]@W(QOXTY>/*Q<K*D8SX>?MSA.W6O"G/R4GRQY^6F_(BJ
M%
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MLN'&G@G&O"L)Q\WA.-:2]CP5ZZ59_&(8L
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M7FU&R>HX^1G:M8K3,Q;]V[>GR4KSVJ3G6=>:G7QC'F[Z<9?95C2BPL*200
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MV>LPM7,W CT?1]<[?F<//2AZ'+YL?%X>+R^"MMX:P(2
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M&GRW*=7F5\RK<<1-\
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MGR@[D>P'UO\ Y7F_*7^?9N>I]])O\B_'S]4X=RW83U"_*LSY0]>Y+N_^M_\
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MD4X[_JD#N/;NOK<_+,_Y2\5V0V>]3_\ ?7Z?_P!4^SD=4C][E!\/[>E.._\
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MOJE_2A_(GQV_5('<;W;_ %N?EF?\J*[-:)YF'_O+WY[Q_9R^J;]*+\B7'?\
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M,.XQNU^MO\LS_E3U\@-)^I/]Y=_/?Y]G0ZIWTH_R)<=/U1AW&-VOUM_EF?\
M*CR TGZD_P!Y=_//LZ'5.^E'^1+CI^J,.XQNU^MO\LS_ )4\5T'2*?\ \7A]
M_=_//LZ'5.^E'^1+CI^J,.XQNU^MO\LS_E3QY Z5]2_SKWYY]G0ZIWTH_P B
M7'3]48=QC=K];?Y9G_*GI+0M*I7AVMQ^_N?GGV=#JG?2C_(EQT_5&'<8W:_6
MW^69_P J>/(/2_J7^?<_//LZ'5.^E'^1+CI^J,.XQNU^MO\ +,_Y4>0>E_4O
M\^Y^>\7V=/JH?2CQ^)+CK^J,>W<7W:?6Y^69WRM\_(73?J/^?=_//LZ?50^E
M'C\27'7]48=Q?=I];GY9G?*SR%TWZC_GW?SW^?9T^JA]*3\B7'3]40=Q?=I]
M;GY9G?*WBNC:9]2\/O[GYY]G3ZJ'TI/R)<=/U1#W[BN[3ZVZ_CF?\J>/(73/
MJ;^?<_/?YGKI]5#']=)^1'CI_P# U$'<5W:?6W7\<S_E3TKHVF\:_P"+\/OY
M_GO]^SI]5#Z4GY$N.GZHAY[BV[/ZVORS4/E3QY#:=_H/Y\_SW\&ZZG51QG]U
M)G\2/'/'_IU!\0[BV[/ZVORS4/E3Q71].I__ !^/W\_ST65QMEEV#:[)>;M-
MR-FM]NFY.QV:PR[D[J3FYV8=K/I.2?.#Y\U'"SM90YL_-+\_R+@I?+ LO$QL
M? Q<?!P[,<?%Q84MVK4*<L80A'EI&E/0C2+EQL6H1C&,>6,7S9DRXS]S_P#K
MG(Y//+T2MJ%*<>%:L_\ &_E'OOB-?EMG<=MBR.MKJYA'U<>R;2+K\^RDH.1.
MV7<QLK7[;%/XV6;^TM&BR>'+17*"[9)PCE)9(ARX+:'9O1-JL&.FZ_I]-0PX
MSI<C&LIPE&<>/+*$[4X782Y92C7EG'FI*L9<:2Y7QO8N/D1Z.[;YH^W7_P#&
MK>_[.KU4OI2_D1XY_JB$([BV[/ZVORS4/E3B^16!PX]K^'[.?YQ]G5ZJ7TI?
MR(\<_P!40]NXKNT^M?\ +-1^5O'D7I_U/7^//_U/LZO52Q_72_D1XY_JB#N*
M[M/K7_+-1^5O7R+P?J?^?/\ .?S]G7ZJ?TI/R(\=?U/CV[BF[+ZVORO4?E;U
M\B\'_15_AG^<_P -UUNJGC^NE\O['_QD>.>?/\D =Q3=E];7Y7J/RMXKIF#P
MX]%_+/\ .6 N@KSYY:<T;;R4C.2VV/JDL:!7-9OJBA\A=:T[W2[L,G=&\PKA
M6@TV*.^]9&)C\=KDRQ4_9O-,I,G/DU$[[]A=EMC\79V[L[I?D?<SKF3&[7IL
MF]SQA&S*'Z_>N\O+SU\7EX\W?>=8G4\6QCQLRLV^7GX\>N5?0]&4FJ?67ZH?
M.CBAS9GM1:"WEFAZ]::ZU_.MJ]G6>GK5Z<K-L':\HZS+737\B^-A51-//89S
ME,G;Y)D)C(D^Z+=ML3M1L=9U77-%[?U">1D0K/MG+M=Y"5*1IR6;]J'>^FX<
M?1?; PL:_CQN7;?/*M:^>K3^BJP)<=S[*BNF+:N0K"R>AN".X'SFYV5PS#P*
MN$=DL^/KJ\-[)[@6BC1:F2VE,KKV,S(S#/EZ!FN6_P!I%$XFD:==WD8V@7,;
MFTFYK<,.5GGG_DTL^-F5OI.?I?UJO+S\_/YO/S=;%QMPKF4M5I\[Z7EX?8\_
M#V_ @=Z)W4UYO\N>8\IJOD-NW&P:$WTQ=[:C _4VU'4^RP1$[36<<_\ >E(H
M,:]-Z;65?E]++C*)_:/,Z9LD(8MW;XMW&QNRNR5O4]!T?M#.EF6;7/VQEW.\
MG"]*5.2]?NPZZPIU\./57A5D]0P\>Q8Z2U;Y9<U*>-6OH^C5F?KP=0GE_P ,
MMM:&K'&O;OU.(.Z:ZLL[96/R!UA<?>4JPLJ;!HZ]IOM+E%F>",S&)V-U$DC?
MMCDR?R,,1N1V"V4VNTK7,G:'2?)&_A9%N%JO;&39Y82M\U8\+%ZU2O7U\94E
M5\],Q<?(MW)7K?-6-?35IYGL5I_[]A+UTR-S[*Y"\$^/.Y-OV7-OV3>:[8G]
MILF8: @/>;MA?+7"M%?<]6BV3!CV1L8Q2[6[5$N?1[S8,H8YS51O'TC3= VV
MU[2-*Q^U-.P[EN-NWSSGR4E8M3KW]V<YR[Z4J]<Y>'T' S+<+.3>M6H\L8^#
MP^A3T>M65Z8_5OZA'(7G9QYTUN#D#FWZVO%CL;&TUSZE.D8#WHU84*V331+W
MO5M:LG[+LDHUBKW-G2)C>CV&R9(QR&V.WC[K-@]!V)U[5])T#M74,.W;E:N]
MM9D^24LBU"7>7<F<)=[*5.^A+^%F,W Q;6/>NPM\LH^+WTO1IZ:J7KKP<S>2
MO#+4NAK-QLV1]3><NFQ;)!65[\CZ#<,247'UI.0:-?9K[5I1%EV/#&/ZC<B2
MIOVISF)\T53N2V0V=VOU37,;:/3_ "0LX=BU.W'IK]GEG*[RUKQL7;4I=7G9
M2K'^5P--Q[.1.[2]'GY:1\]*GF^Q6+,_1.Y0[VY<\.9/:W(:\_5!OK?<UVJ2
M,]\F:?4^VOQ$%3'D<PQ%T>OQK(WINI:0-ZN6^5C^T]IU3X(3!<-OCV:T793:
MVWIF@X?:.%+#LW>3I+UWOYSO1E+FO3NSZZ0CU<W+U=5'SU"Q;LY'1VH\L>6E
M?-KZ/H]?_H@>N'5OZA$7U.[3QY8<@<H:>CN>,UIAE4/J4Z25RCK1GR#=4A"M
M_*!?6II13!:PF1K[8=Z9^;R];+LSG[<+OQ-U>P5S=QBZ]/0.;5KFAPRY7NV\
MS_*:X%+TKO)VST7Z[WW)R<GG>3AWK)QP<6N'&[6'"Y6WS<>,O&Y.;TW+X5@/
MK+\DMU<4>$TYMW05U^06PV>Q=?P3:PYKM3M7IQ,W(.D91K[IND!(L3^JFFGC
MO,VRH3!?-,Y,BB-T6SVC[3[8V=*US#[?T^>/D3K#I+MKOX1IRRY[,[<^]]#F
MY?18O3[5N_D<EV/-'EEZ:G]'7_R:J=!7FYR?YHU+DI)\EMF_5(?:_L6LX^HK
M_(O7U.]TM+#&W1Q,)93H%4BB/LK+1+#/<Y*L9/V?.$C$P<^#2??AL;LULAE;
M.V]G=-\CK>=;R97:=-D7N>MNMFD/\HNW.7ASR\7AS<W7YCD:GC6,>5FEF')S
M<W-UUKZ'HUKP1D]6#JP<_P#C/S_WYI+26_/D7K&E?4L^3-9^I9I:Q^[/E'I;
M7-MFLYFK=KE_(/,K6">EG'[(=K>G[9Z*/8B1)(EC[K]U^PFT6PFAZSK.A]N:
MEF=L]+=[9S+7-T69D6H=Y:R(0IPA"$>]A'CR\:\95E)RL+"Q+V);NW;?/*?'
MS9>FE'SLEDCG!N;96H.GSN;>&NK)\G=I5/3#"VP%HQ#P$MEA/+$A<JR'N6=B
MW4<Z\_;''VI=HJC\_P L)_ OEKWL9H^G:MMYI&C:AC]L:;E9DK4[?/.'-#O^
M$>>$XW(^"G72=)?9,3C6X7,JW:G3FMREPJADZ%/46YD\R>0^WJ+R0W%]4:JU
M?3*ML@HSZGVK*A[#8"WBJ1&'^'M#H\6Y=9]VR3U/TEEE4/MW?Z7>4A\6[OLV
M V1V1T#2<W9[2?(_*RLSHIS[8R;W&WT-V?+RW[UV-.^I&O&,:5[WP\&0U/$Q
M\>U;E:M\E92X>&5?,KZ,JOG.N;U)N:?#OEIKW6?''<_U.J/.\=:C>Y6$^IUJ
M>W>U6J3V5MROO97,E>J)*.T>^)K$(CZ";@C8OL'>1$JJJQU/ON6W>;'[6[*Z
MCJ.T.C^2&;9U"[9A/I\NUPMQQL2<8<MB];A7A.Y.7&5.;A+AQX4IR^=-P\:_
M8E.[#FE&=:>&M.]Y8^A5-_QWW-LJ\]-[6^_+59/>FV9_BFCLF7M>8> 8^U74
MVNW$X::Q!1T6C&M\^]$RJ^SI,R-/AV>S^G\P4WK^D:=A;P]0T/%Q^BTJSJG:
MT+7/.7"SVQ2')SRG6Y7O:\.:L^?S>/%C[MNW#+E:I'YW&?#A['%78Z0G51YZ
M<H^=FM--;UWOF]:VL-<V3(3%<^ICINL^UNX"ASTS$J^^*=KN/?M_2D6;57M2
M=$*?L[%<'2,8AK]WK;LMB-FMB=3U?1-$[3U#'N8T87>V<RYRQG?A"?>7K\X2
MYHRE'OH=[YWK93/PL:SC2NV[?+*G#S9>C]E5<:&IC!
M                                                   "*_JF]-^&
MY_ZHARUV1C*KO;67O-YK*TRF%B0LHTE2MC3%%MJK-%17$"\58LE6[HJ2RT:\
M:X613.@X?MW4ZV"VUN[(ZA<Z:W+(TG/I&F1;CX\91YN2[:X\*<\>:M*QYJ1G
M&O+7OHPK&R-VV\"[L/J=ZM^$LO1=1Y:9-N/+SQK#FY+UOFX4YX<TJ2AS1C<A
M7A*O&D*QHR[\XQ;]XO6=.I;[U3;]:2SI>20AUY^--\G[+B(RS+*.*A:F)EHR
MW,VYI"/PLO&NW:2>7Z.%3X,<I3;4Z1KND:[8[8TG4+>;;CR\W)+OX<>/+TMJ
M7"=J4N$N6,Z1K+A5N9HFTFA;28W;6AZE:U&W3EYZ0EW]OGX\L;EN7"Y;E+A+
MEC=A2M>6O+X&Q/#7II<I^:LW KT&ARM8U3)NE,RF\+E&/(G7;"+8OW4;+N(!
M^Y*F:^2R#YBZ:^P0_M*A'A/2>JL$,.'3?#;2[;:#LO:O4R\N.1J%N/5BVI1K
M>E*5(UISQIQZ&,J5C7GN<.KOH1G7EC+!;6[PMFMD+-ZF=G0R-4MT[S#LRC._
M*4HTE",Z4K6EF$J5I/GN\L>3KA2=>6%;[W%_CCKWB;HZA:'UDV7Q6Z1&J)+2
M;[)33%GGW[A:0L-JG%4\>2DH_F'#I<Q"^2+9,Z3-L5)HW013U*U[6LS:'5<K
M5LZ7&_E2\6GBPA3JA"'L0C2E/1KUREQE*M6D>T>OYVU&LYVMZC+_ !G,EXM/
M$MPI2D86X?8PA2E./AE+C.7&<I5KL&,4P@
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M.UFT%S:76\K4Y1K;LRX0LPKX868<:PI+[*M:RG/AU<\Y<.INL(LCH
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MKZ-(4I'C3V)2YJT]BM$D0@C
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MZ/+3VZ_^^+I@CKL1$
M                                                          53
M_$X?UDG^4E_J#%^[CO!M3[6%_3EMF.QU_;A_L_\ OR5CHC?>P>,G^.C^D)M@
M0#>A]'.N?@WP/'5GOB^F-M%^"? ,5*P("K,
M
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M<*>Q3J9+'#<0
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M6M[<9VJ6+F+BV>T<6YU3X5XW)Q]+S<(TI&7FTC&LJ^#FX<8UGF%.(2
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MWL?!'S*-WQ#G'
M                                                      %4_P 3
MA_62?Y27^H,7[N.\&U/M87].6V8['7]N'^S_ ._)6.B-][!XR?XZ/Z0FV! -
MZ'T<ZY^#? \=6>^+Z8VT7X)\ Q4K @*LP
M                                                           <
M^WK???0N3G_5TQ_1ZU0-S-U'T :!^%?#<EM=NU^@G1?PGX7?=!(:9M40
M
M                                              <\?_EUO_*T?^N&
M-ZO^QG_PQ_Y4M#]KWX#_ '=T.!HJJ\
M
M                                     !5/\3A_62?Y27^H,7[N.\&U
M/M87].6V8['7]N'^S_[\E8Z(WWL'C)_CH_I";8$ WH?1SKGX-\#QU9[XOIC;
M1?@GP#%2L" JS
M                                       !S[>M]]]"Y.?]73']'K5
MW,W4?0!H'X5\-R6UV[7Z"=%_"?A=]T$AIFU1
M
M                          !SQ_\ EUO_ "M'_KAC>K_L9_\ #'_E2T/V
MO?@/]W=#@:*JO
M
M                     53_ !.']9)_E)?Z@Q?NX[P;4^UA?TY;9CL=?VX?
M[/\ [\E8Z(WWL'C)_CH_I";8$ WH?1SKGX-\#QU9[XOIC;1?@GP#%2L" JS
M
M                         !S[>M]]]"Y.?]73']'K5 W,W4?0!H'X5\-R
M6UV[7Z"=%_"?A=]T$AIFU1
M
M            !SQ_^76_\K1_ZX8WJ_[&?_#'_E2T/VO?@/\ =W0X&BJKP
M
M
M    %4_Q.']9)_E)?Z@Q?NX[P;4^UA?TY;9CL=?VX?[/_OR5CHC?>P>,G^.C
M^D)M@0#>A]'.N?@WP/'5GOB^F-M%^"? ,5*P("K,
M
M      '/MZWWWT+DY_U=,?T>M4#<S=1] &@?A7PW);7;M?H)T7\)^%WW02&F
M;5$
M                                                     '/'_P"7
M6_\ *T?^N&-ZO^QG_P ,?^5+0_:]^ _W=T.!HJJ\
M
M                                               !5/\ $X?UDG^4
ME_J#%^[CO!M3[6%_3EMF.QU_;A_L_P#OR5CHC?>P>,G^.C^D)M@0#>A]'.N?
M@WP/'5GOB^F-M%^"? ,5*P("K,
M                                                    '/MZWWWT
M+DY_U=,?T>M4#<S=1] &@?A7PW);7;M?H)T7\)^%WW02&F;5$
M
M                                       '/'_Y=;_RM'_KAC>K_L9_
M\,?^5+0_:]^ _P!W=#@:*JO
M
M                               53_$X?UDG^4E_J#%^[CO!M3[6%_3E
MMF.QU_;A_L_^_)6.B-][!XR?XZ/Z0FV! -Z'T<ZY^#? \=6>^+Z8VT7X)\ Q
M4K @*LP
M                                 <^WK???0N3G_5TQ_1ZU0-S-U'T
M:!^%?#<EM=NU^@G1?PGX7?=!(:9M40
M
M                    <\?_ )=;_P K1_ZX8WJ_[&?_  Q_Y4M#]KWX#_=W
M0X&BJKP
M
M              %4_P 3A_62?Y27^H,7[N.\&U/M87].6V8['7]N'^S_ ._)
M6.B-][!XR?XZ/Z0FV! -Z'T<ZY^#? \=6>^+Z8VT7X)\ Q4K @*LP
M
M                   <^WK???0N3G_5TQ_1ZU0-S-U'T :!^%?#<EM=NU^@
MG1?PGX7?=!(:9M40
M
M      <\?_EUO_*T?^N&-ZO^QG_PQ_Y4M#]KWX#_ '=T.!HJJ\
M
M                                                         !5/
M\3A_62?Y27^H,7[N.\&U/M87].6V8['7]N'^S_[\E8Z(WWL'C)_CH_I";8$
MWH?1SKGX-\#QU9[XOIC;1?@GP#%2L" JS
M                                                           !
MS[>M]]]"Y.?]73']'K5 W,W4?0!H'X5\-R6UV[7Z"=%_"?A=]T$AIFU1
M
M                                              !SQ_\ EUO_ "M'
M_KAC>K_L9_\ #'_E2T/VO?@/]W=#@:*JO
M
M                                         53_ !.']9)_E)?Z@Q?N
MX[P;4^UA?TY;9CL=?VX?[/\ [\E8Z(WWL'C)_CH_I";8$ WH?1SKGX-\#QU9
M[XOIC;1?@GP#%2L" JS
M                                             !S[>M]]]"Y.?]73
M']'K5 W,W4?0!H'X5\-R6UV[7Z"=%_"?A=]T$AIFU1
M
M                                !SQ_^76_\K1_ZX8WJ_[&?_#'_E2T
M/VO?@/\ =W0X&BJKP
M
M                        %4_Q.']9)_E)?Z@Q?NX[P;4^UA?TY;9CL=?V
MX?[/_OR5CHC?>P>,G^.C^D)M@0#>A]'.N?@WP/'5GOB^F-M%^"? ,5*P("K,
M
M                          '/MZWWWT+DY_U=,?T>M4#<S=1] &@?A7PW
M);7;M?H)T7\)^%WW02&F;5$
M
M             '/'_P"76_\ *T?^N&-ZO^QG_P ,?^5+0_:]^ _W=T.!HJJ\
M
M
M       !5/\ $X?UDG^4E_J#%^[CO!M3[6%_3EMF.QU_;A_L_P#OR5CHC?>P
M>,G^.C^D)M@0#>A]'.N?@WP/'5GOB^F-M%^"? ,5*P("K,
M
M            '/MZWWWT+DY_U=,?T>M4#<S=1] &@?A7PW);7;M?H)T7\)^%
MWW02&F;5$
M                                                           '
M/'_Y=;_RM'_KAC>K_L9_\,?^5+0_:]^ _P!W=#@:*JO
M
M                                                   53_$X?UDG
M^4E_J#%^[CO!M3[6%_3EMF.QU_;A_L_^_)6.B-][!XR?XZ/Z0FV! -Z'T<ZY
M^#? \=6>^+Z8VT7X)\ Q4K @*LP
M                                                     <^WK???
M0N3G_5TQ_1ZU0-S-U'T :!^%?#<EM=NU^@G1?PGX7?=!(:9M40
M
M                                        <\?_ )=;_P K1_ZX8WJ_
M[&?_  Q_Y4M#]KWX#_=W0X&BJKP
M
M                                  %4_P 3A_62?Y27^H,7[N.\&U/M
M87].6V8['7]N'^S_ ._)6.B-][!XR?XZ/Z0FV! -Z'T<ZY^#? \=6>^+Z8VT
M7X)\ Q4K @*LP
M                                       <^WK???0N3G_5TQ_1ZU0-
MS-U'T :!^%?#<EM=NU^@G1?PGX7?=!(:9M40
M
M                          <\?_EUO_*T?^N&-ZO^QG_PQ_Y4M#]KWX#_
M '=T.!HJJ\
M
M                 !5/\3A_62?Y27^H,7[N.\&U/M87].6V8['7]N'^S_[\
ME8Z(WWL'C)_CH_I";8$ WH?1SKGX-\#QU9[XOIC;1?@GP#%2L" JS
M
M                   !S[>M]]]"Y.?]73']'K5 W,W4?0!H'X5\-R6UV[7Z
M"=%_"?A=]T$AIFU1
M
M      !SQ_\ EUO_ "M'_KAC>K_L9_\ #'_E2T/VO?@/]W=#@:*JO
M
M
M 53_ !.']9)_E)?Z@Q?NX[P;4^UA?TY;9CL=?VX?[/\ [\E8Z(WWL'C)_CH_
MI";8$ WH?1SKGX-\#QU9[XOIC;1?@GP#%2L" JS
M
M     !S[>M]]]"Y.?]73']'K5 W,W4?0!H'X5\-R6UV[7Z"=%_"?A=]T$AIF
MU1
M                                                    !SQ_^76_
M\K1_ZX8WJ_[&?_#'_E2T/VO?@/\ =W0X&BJKP
M
M                                            %4_Q.']9)_E)?Z@Q
M?NX[P;4^UA?TY;9CL=?VX?[/_OR5CHC?>P>,G^.C^D)M@0#>A]'.N?@WP/'5
MGOB^F-M%^"? ,5*P("K,
M                                              '/MZWWWT+DY_U=
M,?T>M4#<S=1] &@?A7PW);7;M?H)T7\)^%WW02&F;5$
M
M                                 '/'_P"76_\ *T?^N&-ZO^QG_P ,
M?^5+0_:]^ _W=T.!HJJ\
M
M                           !5/\ $X?UDG^4E_J#%^[CO!M3[6%_3EMF
M.QU_;A_L_P#OR5CHC?>P>,G^.C^D)M@0#>A]'.N?@WP/'5GOB^F-M%^"? ,5
M*P("K,
M                                '/MZWWWT+DY_U=,?T>M4#<S=1] &
M@?A7PW);7;M?H)T7\)^%WW02&F;5$
M
M                   '/'_Y=;_RM'_KAC>K_L9_\,?^5+0_:]^ _P!W=#@:
M*JO
M
M           53_$X?UDG^4E_J#%^[CO!M3[6%_3EMF.QU_;A_L_^_)6.B-][
M!XR?XZ/Z0FV! -Z'T<ZY^#? \=6>^+Z8VT7X)\ Q4K @*LP
M
M             <^WK???0N3G_5TQ_1ZU0-S-U'T :!^%?#<EM=NU^@G1?PGX
M7?=!(:9M40
M
M<\?_ )=;_P K1_ZX8WJ_[&?_  Q_Y4M#]KWX#_=W0X&BJKP
M
M                                                      %4_P 3
MA_62?Y27^H,7[N.\&U/M87].6V8['7]N'^S_ ._)6.B-][!XR?XZ/Z0FV! -
MZ'T<ZY^#? \=6>^+Z8VT7X)\ Q4K @*LP
M                                                           <
M^WK???0N3G_5TQ_1ZU0-S-U'T :!^%?#<EM=NU^@G1?PGX7?=!(:9M40
M
M                                              <\?_EUO_*T?^N&
M-ZO^QG_PQ_Y4M#]KWX#_ '=T.!HJJ\
M
M                                     !5/\3A_62?Y27^H,7[N.\&U
M/M87].6V8['7]N'^S_[\E8Z(WWL'C)_CH_I";8$ WH?1SKGX-\#QU9[XOIC;
M1?@GP#%2L" JS
M                                       !S[>M]]]"Y.?]73']'K5
MW,W4?0!H'X5\-R6UV[7Z"=%_"?A=]T$AIFU1
M
M                          !SQ_\ EUO_ "M'_KAC>K_L9_\ #'_E2T/V
MO?@/]W=#@:*JO
M
M                     53_ !.']9)_E)?Z@Q?NX[P;4^UA?TY;9CL=?VX?
M[/\ [\E8Z(WWL'C)_CH_I";8$ WH?1SKGX-\#QU9[XOIC;1?@GP#%2L" JS
M
M                         !S[>M]]]"Y.?]73']'K5 W,W4?0!H'X5\-R
M6UV[7Z"=%_"?A=]T$AIFU1
M
M            !SQ_^76_\K1_ZX8WJ_[&?_#'_E2T/VO?@/\ =W0X&BJKP
M
M
M    %4_Q.']9)_E)?Z@Q?NX[P;4^UA?TY;9CL=?VX?[/_OR5CHC?>P>,G^.C
M^D)M@0#>A]'.N?@WP/'5GOB^F-M%^"? ,5*P("K,
M
M      '/MZWWWT+DY_U=,?T>M4#<S=1] &@?A7PW);7;M?H)T7\)^%WW02&F
M;5$
M                                                     '/'_P"7
M6_\ *T?^N&-ZO^QG_P ,?^5+0_:]^ _W=T.!HJJ\
M
M                                               !5/\ $X?UDG^4
ME_J#%^[CO!M3[6%_3EMF.QU_;A_L_P#OR5CHC?>P>,G^.C^D)M@0#>A]'.N?
M@WP/'5GOB^F-M%^"? ,5*P("K,
M                                                    '/MZWWWT
M+DY_U=,?T>M4#<S=1] &@?A7PW);7;M?H)T7\)^%WW02&F;5$
M
M                                       '/'_Y=;_RM'_KAC>K_L9_
M\,?^5+0_:]^ _P!W=#@:*JO
M
M                               53_$X?UDG^4E_J#%^[CO!M3[6%_3E
MMF.QU_;A_L_^_)6.B-][!XR?XZ/Z0FV! -Z'T<ZY^#? \=6>^+Z8VT7X)\ Q
M4K @*LP
M                                 <^WK???0N3G_5TQ_1ZU0-S-U'T
M:!^%?#<EM=NU^@G1?PGX7?=!(:9M40
M
M                    <\?_ )=;_P K1_ZX8WJ_[&?_  Q_Y4M#]KWX#_=W
M0X&BJKP
M
M              '\&3(?R[R%-Y>?EW8P;R\_N^7G@!_I2E)CM*7!2X^YC&,8
MQ\?[&,?< ?T
M                                      "/7>/2OX(\C]I6C=&Y]('N
M&R;E[E^4ECQLW;]>Q(XKM>BJI#>4/5[\R8-,HP,%%H?:&J?J>S955[UCJ*'F
M6D[P]K]#T^QI6E:MVK@XO/T<.U\:?+SSE=GWURS.=:5G.4N^K7AQX4[WA1*]
M,VYVHT?!LZ=IVI]KX6/S<D.AQY<O/.4Y=].W*<N,YRKWTJ^'A3JZDA0AJ*
M
M                                                 CL^Q1\"/J\?
M7,?4,5^K9]5SZN?RR^JAN+M^JE\L/E_\IOD[]4#W5V_*S]E^Q>P^[O+]C^R>
MS?:1.^Z;MOY"^5WR:_Z'[5[3Z'M;$_R;H>@Z+I.@Z7]:[WGZ3I//<W-ULIY-
MZEVMVIVS_B_)T7+R0\3EY.7CR<?%ZN;CQ]E(F((Q8
M
M
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MNSA:K-")LWI
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MZ*/LMO4(_C__ "4Z1_5R'EOVB^KZ^Y8_Q9\V=V2?KD5]YM!_11]EMZA'\?\
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M;0;U)[&;99'"D-/S;L)VLF?I,#,I2$,B?I;-RUC9,^OH[,XQK))H)2VL
M
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M/NFSV_P?[?\ : I2M>/"G@>(  >7!#'\^TN3=N,F-Y8SGR+C[IL]O\'^W_:
MI2M>/"G@>(                    !9_P"COSSEMBM2\5=NS2TG:Z[#KOM1
M663<96D)^M1#?U)*DOW"QLG>RD9'I*.F*ALG.I&MG**F2%CTO6L[8W7[F32N
MDY<^>];CS69U\:4(^-"OHRA3OJ</.<?2NV7L(NR)S=I[/<@VUU"N5K&F6)7-
M%RKT^:[DXMF/-<P+LZ]].]BVZ=+CUKQE7%A<A+ECC0YY^183L;
M                                                          1D
M]3+G.3B!JQI#TM9FXW?LI%^QI"+@B3M*J1#;&$9:]R3)3S*M[.==-&.16+E)
MR]/WG(NW9NT<Q7:?7O(?$C&SWV=E<8P^PIYMV5/L?!&GFR]&D9-4>RL[(&.Y
M/9"S@Z#<A/;W:JER&!&48W*8=F'"-[4+MNO&DNCK*D,:$Z<EV_7FE&Y;L7H5
MJOZ%T%O#FSN=S6JH=[9;9/.G-FOE^M3Y\Y80C-V[\Y*TVZ;5*JLJ8[I;&"$P
M55R[7.5)!(^?/RJK3\#.US-E:LUK<NW>_NW)RKRQIYZ<Z_\ NLI>*ZA]W6[C
M;_?WMU<TK1YSU;6-2G/+U'4LRY.=K'A.?SW,SK]>><JRG+JC'GO7KDN2$95Y
MN6SYH#H_<2=0Q3%6]UU;>5V*DF:1L%Z.Y1KN'787UR1%&CWF&3>.R;'F4D@:
M3<%SC/[*\LY*+1T_8[2,2W&N1:[>O>;*?@^Y"E>7E^VYY?9.V7=OV$^YK8K#
MQY;0Z77>#KT8TZ7)U&LJ8W/P[ZF/IUN=,>-OT*9/;=VG^FX5X-J9O@IPTL$:
M>*?\8-(H-5$\I&5A-=URLR>"&[L9R69KC%H\3/\ .SY'*N4^//S\_,9>YH.B
MW8\DM+L4C]C;C"O\,*4K_*M[/['S<;J>)/#R-TV@6[,J<../I>+B7?N7\6W9
MO1K[-+O'V4/7,WHIP[.#F-A<0W4L60C$%W[[2]@D5I?$DU1*911*@V-^;+HD
MD1,OVMA)*N3.S'-A)^FH5)LM#=:V(A&W+)T>4J2CWU;-9<U:_P"KG7KYO8GQ
MYO3>=:3;\^P/P;&GYVTNY:Y>ID8D97+F@Y-R5_IH1[Z5--RKE>FZ2D?%QLN=
MZ5ZO-R9,)\EJ=<ATU<L7+EB^;.&;QFX6:NVCI%1LY:N6RADUVSE!0N#H."+8
M.4Y#8QDN2Y*;!<E%;5I6%91E'DE%U@7K-W'NW+%^W6U?M5E"<)QK&<)QKRUA
M.,N%8RC6G+6DN^C+JJ_(/9\@                               'G255
M;JHKMU5$5T5"*HK)',FJDJF8ITU4E"&QE-0IBER4V,]Q39\RCQ2M:5XT\#WM
MW)VYQN6Y5MSMUC*E8RX5I6G724:TZZ2I7P5ZO!3KXK8'27Z@,KR!@W&@=Q3)
MY';M)B,R%4M,@O\ L_8E-8Y2;N22:RA_-]<(SO1]=7^K/V)\.U"G<-G[E6V=
MDMH9:C;II^;<Y\RS3C"<O#=A'TWHSAYOIJ=]X:5J[B^PU[)'+WDZ?=W<;<9W
M;6VF@V>DP\RY+YYJF#;Y:3I>E+]<SL3C'I)^/DX\J7IQE<LY-V<V(G#?(
M
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MU+9+:W3)Z5K.ERY9PEUPG"5.,+UFY'O+UB['O[=V%:QE'TLJ2I3%P^"*
M   \I2]V<%+C)C&SC'87&<YSDWQQC&,9 I2M:\*==7^9QGSSC.,X-C)O/&<>
M6<9QY8SC)<_^("M*TKPJ\8#RE+W9P4N,F,;.,=A<9SG.3?'&,8QD"E*UKPIU
MU?YG&?/.,XS@V,F\\9QY9QG'EC.,ES_X@*TK2O"KQ@
M FNZ4?4&F]+7>!X[[8GEGNF+O*)151DY5R8^-86Z5<]C'V9TX4\FM+D)!<J3
MQ V<(,W+HDBGE F7_M$UV2VBGAW[>G9=SGP<B7+"4O\ -3KX/O)5\-/!&O7U
M=]26^/8==DIG[":_IF[+;+4)7]A=>O4LX-R]/F\B,R]/A:Y9RKWF!DW)<EZW
M7O+%Z=,F/1Q[9Z6V4+;=QX
M       HE<]MROM[<MMV7A=V=U%-KG)TZI%R<YD&]1I+A2M066J1O@W3<MHT
MSY4A?A[3*KG^<8YC&H7:#-KGZOG7ZRYH0G*$/M(=Y'^'EYO;K5^>OLBMN;^\
M'?-MYK]R]*[A6<V]A8?7WL<+ E7%Q^2/G*7(V^V)QI_G;UR7AK5;?Z?6@(OC
MGQ4U93V[!)M9K# ,+_L%WE/!'3ZYW!BUE)!)X?!<>I[ R.PBT<]N/M$(EG..
M\QS&MW9[3X:;I.+8I'EN7(TN7*^C.<>,OXM.$/:B[G.QMW;X>['<_LAHEK'C
M:U34L:WJ6I3X=_<S\VW"]<C<KYO:T*V\2W_\O'AYO&LMUAG5\/RNG39DV<O'
MCE!HS:(*N7;MRJFW;M6[=,RB[APNH;!$42)%,8YS9P7!29,;."X'BM:1I64J
M\(T?&[=M6;5V]>NQLVK,93G.<HQA"%(\92E*O>QC&-.:M9=5*==5?WDKU MV
M\I-R1/%KIV+/SJM)INZM&YHKM00?%A)!NJZ<QLJNW42@]9M'!4?;I)4AS363
ME8LTE&BY$I:O-3VASM5S::5LYS=5>_O4\WEKWW+7SMN/AE+S_@CWM>_ZX=Z?
M9([>;W-N</=%V,T[LIV;\)YFN6>J,^U[D93G:O2C*%C2;,Z1[8RIQK7.ZL>S
M"=FY2&9K/UI..\G2Y?2&^Y=6%?W+8-71HFY)FM1"L'!3NQZ?$1IVEH9QCARN
MHT]X1)WZ!4CK',1O5&^/VV3Y&+VUTZ=F>#J$^$KU^'1WI0IRTK<A&/?TCU^-
M'C3QO!"*J>SMW9Y>A9NP.\7-E8R=<VDQ(Z?KF1B698^-D:IA6;=89<+,IW)0
M[9LUN6J1E.O+:P[7GN*"L0=U\@"4_I#\?6V[N6D1/6"*0E*5IN%>W^<;R#5-
MU&O9PV?<U-BG*:A#$,MF:?&D2$.7R.2L+%S_ &,R?9#3J9VK6[ER'-8PXRNU
MX^"5?%A3^&O-]Y5MUV%F[:SM[OEP]1U+"CEZ#L/CSU+(A<A&=J[?_6,&S.,H
MUI*O3S[9I25.$HXLZ56PKSH#4=_I-OHTMK^H-HVXUJ<K#YRQJ\&U?M&LY&N8
MU9VP<I,BG;/DBN,J(J$,4Z:J9#D,4Q<&%MY&GX=_'O69V(1C>A*%>6$>/73E
MZNKPT\Z[C=H-W&QFT>@ZUH&9L[A6L77,7(Q+L[>)8A<A#(M3M2G;G&W24+L*
M3YH3C6DH3C&4:TE%0FV/0YW5VP+MK>SHX0L-$M4[4IA/!3$3-(0$DO%N%4,&
M_JC511OE1(^/FG36(<IC8-@PH')L7,7(NXUWKN8\Y0E[<:\'YU=J=G=1V1VD
MU[9?5H=%J>SN9DX=^GG>EQKL[4JQ]&$ZPXPEUTE"M)1[V29GI1]..H<@8N0W
M_OJ&>2VN(Z9S$Z\IYG2S&,N\K$K*%GIJ>,W[5GE99OBHM$D$E2$>/&SQ)R;+
M=J=!S--DMF[.HPEJ&?:K+%C+EMP\6,ZQ\:4O-K"E>KAQ[Z7-S=[3EKO/V'G8
MP:)O(P\C>1O%P9YFR^+D=#I>%6<K=K/O6:U[8R,GDY9SQ;-SELPMPN1C>OPO
M0O<;=F5J[,[N[G)PTX12+/5DNJSA9ULT:N%-<ZFID>LK7(]TBBNR4EV,9EFP
MA/6:+(JHME%B.5$%"+$0RD=(YYIG:YHVA5CBRY;=R-/UJS"G>Q\SC2G"-./I
M>/-PZ^'6WHV^[(#<;N#RK&R.=*&!GPA"5=,T;!MUEC6IQC*W6_"UT./C\\)4
MG"W.=+LK=8SC;Y)1E76GDI=N$'-'ASR"VKKF+UU=+SK[6MAL;=\ZK3>O;4H\
MRS9'<,'+TJK5O*(,<ND_+!\*+1;PZ&2%4<E(;&,=J=_0M;T?4,O%C;O7\>U6
M?'DY;T*\.]X^"?#^-"OV7!56]/7]P6_;<AO(VNV8Q=,UW:#9O2LG*C=GBQQM
M8T^_"W65N=SFA;RXVY3IR\U)3Q+]8UCQN\M>$?'2CZ<=0Y Q<AO_ 'U#/);7
M$=,YB=>4\SI9C&7>5B5E"STU/&;]JSRLLWQ46B2"2I"/'C9XDY-ENU.@YCFR
M6S=G482U#/M5EBQERVX>+&=8^-*7FUA2O5PX]]+FYN]IRUUL[#SL8-$WD8>1
MO(WBX,\S9?%R.ATO"K.5NUGWK-:]L9&3R<LYXMFYRV86X7(QO7X7H7N-NS*U
M=F=W=SDX:<(I%GJR759PLZV:-7"FN=34R/65KD>Z1179*2[&,RS80GK-%D54
M6RBQ'*B"A%B(92.D<\TSM<T;0JQQ9<MNY&GZU9A3O8^9QI3A&G'TO'FX=?#K
M;T;?=D!N-W!Y5C9'.E# SX0A*NF:-@VZRQK4XQE;K?A:Z''Q^>$J3A;G.EV5
MNL9QM\DHRKK3R4NW"#FCPYY!;5US%ZZNEYU]K6PV-N^=5IO7MJ4>99LCN&#E
MZ55JWE$&.72?E@^%%HMX=#)"J.2D-C&.U._H6MZ/J&7BQMWK^/:K/CR<MZ%>
M'>\?!/A_&A7[+@JK>GK^X+?MN0WD;7;,8NF:[M!LWI63E1NSQ8XVL:??A;K*
MW.YS0MY<;<ITY>:DIXE^L:QXW>6O#[+I$T.CS?!K7$E-4VJR\BO9-D%</Y2N
MQ#]ZL5&\32*6%73MH=17!4DTRE\S9[<$*7'PP/KL?CV+FA8LIV83ESW.NL8R
MKX\O-Y6<["W9[9_/['[9?+S]#P\S)N96J<UR]C6;DZ\NHWZ1XSG"59<M(TC3
MC7JI3@_9>^HATY=<7>XZ\M4:P:V:B6FPTZQMFVDEGK=M.UF6=0LNW0>(064W
M*1)!BX*50F<D/@A3X-Y&QG/M?VBV<QKU['O1I&[8G*$OG''OH2Y:^=]&C[[0
M]DSV,6R^OZYLSJ^+;M:ML[F9.%E0AH,IPAD8EZ>/>C&<<>L9QC=A*,9QZI4[
MZ/&E4.?5,Y4\6N1\1IAIQT;)INZE)7AQ:SIT%6E_L>9:U5.(3RJJR0S(8RK&
MR&>W'?Z?9YF\N\O=#-JM6TO4X8,=-ZY693Y_G?)XW)R^93CXM6D'9=[W]T6]
M+!V%M;L;=(WM&O:A/,E33JX'>7X8=+/7*W;Z3KMW.KKY/8XK W!K7.O7_#SC
M4^?T2F/7CS3E&<NWCNL0KERZ<+0K51==PX69&.LL<YC&,8QLF,;.<YR+"T''
MQY:-I<I6(2E*S#KY(^E]IV2=C]LSLWD[D=UF1D;/X-_(O:%ITYSGB6)SG.6/
M"4I3E*W6LJRKUUE6O-7S6+-*<RNGGR:NK?4U1A:BK;9LCTL56KOJ*/B6]B,Q
M0.Z>,X]R]AU6;EYAH@LIANHL190B)S)I*=ANWBX.M;.:I>CAV;<*WI\W+"=F
ME./+XU*<:</;HB.P>_'L:=Z^NV]C=%PL*6M9U)]#BY^BV[,<GHX5G.%N=RS.
MQ.=(1E*EN4Z3G&,N2,N6K0_J7<(-&: E-1<K=;U=E1ZO#;EH49MVB0,9ZM47
M@W4NI+YM43!X/E*(.0\7[ XCVR16;O$FV,FBW527,[P&T^A8&GRPM6QK-+%F
MW>MTO6XT[SEYN//2/F>#A*,>J7&G53ON;7?LJ]P6[W=QE[%;XMEM)AL_I.#K
MFFV=:T[&LTKARQYWY7NW+./QY+$H]#VM<QK,(V+T;UJL(6YPN=/N?KWJ$=.G
M9]YI^N:C'1[JT7BQP]5KK5UI1=DV<34X^0CHQNN\<0>$VJ9W3A$N5#YP0F#^
M9LXQ@9O&VBV;RLFSCV8TK?R)TA'YQPZY5Y8]?*O79KLE>QDVMVAT79;1<6U>
MU;:#+LX>-">@RMPGD9%R-NU&4ZV.6%)3K2E92ZH^-+O6WN]K+QMXWZYDMI[4
MIM2B:=%/HJ->.X[7<;-N\/)IZE'L4DF$?%'4.4SA<O<;R\BX\\YSY#,9]W3-
M-QI9679A&S&L8]5N,O&KPCPC&G_)=6\+5MUVZ[9C*VOVOT/#P]#P[EFU.=K3
M;5^?/?N4MVXTMV[,IUXSEUU\%*(!NIAS/X;\@] 0-(T"V2+=F6TJ_8WAR:S6
MJ&<5UC6[@P>^4JM&H^IYO96+QZ.#9,?]OV^1.[%?;3ZWHNHZ?;L:?'C>C=I+
M]:Y.]C"<9=?"GFRIU.N/LJM^FX_>5NXT_0-W%N,=>Q]7QLJ<J:5+"_Q:UBYU
MJY\^E:AQ^>7K/><>^\/#O4[^BJ;JJ'XO:<M$[1*7[)%:$UW/S+Y2H0KQSELR
MU[#R,@[.4L>91TX]-)<^?+N.?/W/,V1/<"SB0TO#NW,>%8QQ[4I5Y*5\%N-:
M^8[#MW^A['X6Z78?5M1V?P.AP]G=-R<B<L*Q.?);TVS<N3K\[E.<N6-9>;*5
M?LFE?V47IC_^TC;\1#S_ .$8PWEJV8]+_N/_ -*(^:X[%'_0Q_\ \>G\G09\
M]MU:1Y!\LJI=]$MTBT+-=H-?<)?)7-336F6,]**27?#JM4LJ%RU?,RY4,3Y_
M9V_.P00+:#-P=1U>S?P8_..6U'Q.3KC*7'J]CFHZ_.R*V]V!WD[Y-%U_=[;I
M39VN-IN-.G:?:=)7[>3>K=XV90AQ[RY;CSUCWU.]\ZMN;52T5IK75OVE=:!4
M6]3I$,XGIU>/HT'(/4V+;M*IELR388,NMG*A,8+C.//N^.<?$6]E]H86->RK
M^/"EG'CS2Y81E7E]KE=S>U\=WVQ&S.M;7:_LYAV]'T"Q/)R96M/Q[ER-N'#C
MR0I;XSKU^!I[JG?O33YHR"VMH*M:IL%GD&[HS>DWW5,979^2;I(F4<+5US+0
M9$W[]-!-93MCGAWR)&QW'8F1/U"X;$U#9G6Y5Q[=NS.]+SERS2%9?:\T>NOV
MM>:/A4EL?O'[%??KDW-E\#2]'U+5LF$^7 U+1[6-DW8TCS3KBSO6*1N78TXS
MY<:]+(A2%;O+&,>=$UU1>F15./E:-R"X_MG['6:,DQC;_0W;YY*EI*TLY1CX
MBP0,I)N%73BO.)1=NU7;N55EFKN0;G154:K9291+:G9>QIUJFHZ?&L<6M:1N
MVZUX\G'JC*-9=?+*M>%:5E*M)5CR]7@TW[+7L4-'W;:57>3NWLW,?96W=MVM
M2T^=R=ZFGRO3C;LY.-=NRG>EC7;TH6;MJ[.<[-ZY;E"<K,Y0L0[:@V7.Z;VG
MK_:M85,E.4"V0EH9%*J=(COW4]2<.8UP8O[9B[9%<-7!,_ [=XJ3)38,8HAF
M%E7,++Q\NU^N8\XSI][+Q?:K3O9?8M(=B=J]1V&VNV<VPTF58:ALWF8^7"G-
MPY^AN4K.S/["]#GLW*==)6YRC+JDZ"L#-1]D@X:Q1*V'$7/Q,=-1CGR[?782
MK)%^R6P7/[7N;N$S>7_2&PUN<+MN%R'7&Y&DJ?:UZZ/TEZ=GXVJ8&#J>'<Z3
M#U*S:OV9>FMWH4N0E]]"5*O<#Z.:
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M&'C3A;Z.M:QCD5R;L>%;TDBHDC9IXCG(B0ZBAR)D3(8QSF-@I2E+CN,<YC?
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M7L3,MPO6IT\6=NY"DX3I[$HRI*G\KV(^CD@
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MYO&Z"SQ]SB_1UN?Z?N2;K>VN/;'E=T3I./AY_(S%Y^/'K\;BV!&16,
M
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M8 9%8X
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MNX']3\N7Y;D=8C=ZK=O:+/C;]#D[0TJ=>'_>2N_=XIFQ-6\P
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M]&&PFG1U;<UL;I4[E;,=4V8T[&K.E.-81O:59M2G2/5S5CS\W#CUUI[:'?[
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M2\#!TS#M]'AZ;9M6+,?2V[,*6X1^]A&E'N!]'-
M                                            !0WYPZ??:,Y6[OU\
MY:G:QZ%YF;#6,F(8J:U0M[@UGK)T5<E[7'IQ,HU;JF)\TKAFLEY8.3)<4'KN
M'+ U;.QZQY8\\I0^TGW\/Y*\/MJ2?G@W_;$Y&[_?#M]LY=LRLX]O4+V3B>A+
M"S9=M8E:5\$N%F]"U.M.]Z6W.E>6L:QC:RZ8?)6)Y%\5J0BM()+WW5$3%ZTV
M!&'4*=\1>!8X8UNP+)YS@RK:5KS-HOZ_;A([Q%^@0QLMC^5K[+:G#4M)L4K/
MFR,6,;5RGF][3A"7W\:<W'T>:/F.X3L3]ZF#O.W0;/PEDTN;1;'6;.E:E:K7
MY[26/;Z/%R94\:4,S&A"YS\.6M^F3:CS2LR:%\R>D7;+'MEM>N(<JQH-=VR^
M7KFX*AF87KD%5HV84*^FK!&-V2I,RE)<J,TS/(!,BF4WGH>Q('9J>E&X#6=C
M[UW,A?T>5,>&7+EO0XUC2$:]<I1X>-;KPZ[?@YN7EIR^)KMOQ["[6M3VSM[0
M[ELRWL[IFV5R6-K>%T\L3&P[5^O/D9-J-NM.FP+TH4K>TV,9\F1T?:]N5F?)
MBRR\3N).K.(.M6U#UTQ]KE'N&SN[7F1;HEL=XG$DC$R_D54\Y]DC4C*+%8L$
MSY09I*F[<J+JN7+B6Z1I&)H^+''QH\95[Z<Z^-.7HR]CTL?!'[;C6NY&YS<U
MLAN4V6M[.;,8W39>1RSS]0NQCVUGY$8_KEVM./):AQE''QHRZ.Q"LJ1Y[D[M
MV[M*,NMQ5 ZV?)6(VANNJZ.J4DC(0>CFTMFUNVBI5&J^Q;'ECB3BN]/.2K&B
M8F-CT#YP;S1>2<BU4*4Z!A4FV^IPRLZS@69<T,'FY_\ 63X<:?>4I2/VTJT\
MZZ=>SUWJ86UNW>D; :-E4RM/V A>[<G"7&$M4RZ0Z6SQIQC*N'9M6[59<W&&
M1>R;,XQE;DA&$*:$LM:+U3,;QW%K744%ZA9#8%PA:W[4D3U,QK!Z[3Q+S*A/
MCW-V,25\\5^!OM;,_P ,_M1R,'$GGYN+B6_&OSI#VHU\:7WM.:OWJ8;OMD,W
M>!MOLKL7IU)1RMI<ZQB\](\W16YSCTU^M/2V+-+EZ?V%NJ\-NW=>HN$^B6-O
MMS258Z]I*%2H-=K]69LY"963[&\)"0T,R?R#1%?+>+9J+*8.X2[6L6L<O><A
M2'O3/SL/0\"-^[&M,?'Y+<8PI2M?2QI2E91\6/77K\%*^T[^]O=O-B]P^[W'
MUO6K%['V:T&.%IV-C8<(7+\H\(8^/8L0N7;,)=%9A*<N:[#ELV9RCQE2E*Z6
MZHZO_#_8^Q*;K6LU[:=;F=@V>%J<7)3E-J,1 IR\T])'1)99[&75PH@@=\Z3
M2PIA!3L,X[C8P3N-C"8FV.C9.39Q;5N[;N9$XPI*4(4CS2KRTXUI.7GO843L
M=V:^Y+:C:70]E=*TW5]+SMI,JQAV;N1@X=G&I>R)TMV>FG:S[DXPE=G2'-T<
M^64^OA'FD^ ZW6A_J@\<*_N.*985G]'V4JLFJF3N6/1+NJPA)HN<$QW*^A8D
M:HOC.?,J*!7BOS2Y.8<?;C [8TV&;"/&Y@SZ_M+G"E?X*\E?8CS([V?&[SRR
M[K]-VXP[/2:EL!E4E=K&G?2T[/E;Q\CP4XUZ/)CAW>OO86^FKU4K*K)?2/Y2
MUO=W&JL:M=/T&VRM$P\?29B%7<)8=R=.8)^RTVRQC?/D96-+$IMX]QY=QD'<
M5G*O81RV]3D['ZM;SM,M8DJ\,G3XQA*/IH4\2=/8X=[7T)4^RBE/88[W-+V^
MW5:3LC>R(V=JMWN/:P+UB4X\]W!MQY,'*LQ\:MFEFD,:YX:V[UGO^6-RSS:2
M\KNB7=[KMBRW[CG>-?Q56NLX]L#^E; <V.$4JDE+./:I%O!2D' RI9:%,^6=
M+))JI,U&B)R-B>T^GA3.#U;8>_?R[F3IV1:A9O5E*L+G-3DK7QN$J1GQIS<U
M?.\*=[WRA-\/8$Z]KVV6K;1[L=H--P])UZ_<R;F!J4\FQ7#NWI\]V./>L8V9
M&]CUNRG.$)PLSLPE2S3IN6DJXYW/TG*)Q=X3;NVQL:T*;&W5"Q55<P#N$5E(
M2ETM1W=JS%/TXMF9=-:U.EF4B_2.YD4R(^FL3T8YNNG[0?CYNR./I6AYV5DW
MNV,ZW&'+*G&,(=_"->6/AGU5KUU^Y&,NM&=N.PXV>W2;A=OML=I]6KM1MY@V
M<.>-/'K>Q\# K//Q+-VEF'-&>9.=NY<A6[E0C#A*G)C6KE.EK)!TC^4M;W=Q
MJK&K73]!MLK1,/'TF8A5W"6'<G3F"?LM-LL8WSY&5C2Q*;>/<>7<9!W%9RKV
M$<MO4DFQ^K6\[3+6)*O#)T^,82CZ:%/$G3V.'>U]"5/LHMH>PQWN:7M]NJTG
M9&]D1L[5;O<>U@7K$IQY[N#;CR8.59CXU;-+-(8USPUMWK/?\L;EGFTEY7=$
MN[W7;%EOW'.\:_BJM=9Q[8']*V YL<(I5)*6<>U2+>"E(.!E2RT*9\LZ6235
M29J-$3D;$]I]/"F<'JVP]^_EW,G3LBU"S>K*587.:G)6OC<)4C/C3FYJ^=X4
M[WOE";X>P)U[7MLM6VCW8[0:;AZ3KU^YDW,#4IY-BN'=O3Y[L<>]8QLR-['K
M=E.<(3A9G9A*EFG3<M)5QSN?I.43B[PFW=MC8UH4V-NJ%BJJY@'<(K*0E+I:
MCN[5F*?IQ;,RZ:UJ=+,I%^D=S(ID1]-8GHQS==/V@_'S=D<?2M#SLK)O=L9U
MN,.65.,80[^$:\L?#/JK7KK]R,9=:,[<=AQL]NDW"[?;8[3ZM7:C;S!LX<\:
M>/6]CX&!6>?B6;M+,.:,\R<[=RY"MW*A&'"5.3&M7*=+63SHZ?N"]8_X2;*_
MGY.B3[&_0_C?ZR[_ &LFV'80_P#5UV3_ '7JW_$LE'=O?HK[\VIN_<>T(;:F
MH(^(V/M38-\BH^36N?O-C'V^V2]@9,Y K6JJ)8?)-9!(BOIJ')WD-V*&QVF$
M=SMB-0R\[,R895F-O*O7;M*2Y^-*3G65*5[RO7WW_)K-O#[!+>+M?M]MOM;@
M[8:)C86U&L:EJ-FW>EG]+;M9N9>R;<+G)ASASPA=C2?)*4>:->$I1ZT9_,W@
M!LOA.PH$A?[C1;6EL)W8V486GJ3YU&*M:1AEW1GY9J%:8RFH6:1]/*>3F[D3
M=V"_-$8UK9_*T..//(OPOTR.>,>3CPCR<OAYHT]%JMOS[&_:O<-C[-Y.T>N:
M?K%O::>5"S3!KD\UNN+''E/I.V,>SU2[8C2/+6OBUI+SJV?P-_<8\8OY%Z)_
MH1L+=T#]A=+_ -1;_JT=R?8\?2,W3?O#IOP:"K3,]6_GQ((NV!=UM8U-;*R)
MEHS7&L6[S")S&+G"+L]0.=NI@OGY*)Y(H7./,IRY^<*JN;8;02I*/;W+]K;M
M<?ZCJ,S^S-[(O*A>QH[>0Q8RXQYK.EZ5"?#P=[/M*LH5]F'+.GF51\6^XVN_
MV.6N%WL4S;;3/.C/9BP6"1=2TM(N5.TOJ.GKQ0YU.U,F"$+Y^1"$P0A2D+@N
M([>O7<B[.]?NUOW[G7*M9<92^^:UZUKFL;2:KF:WM!JF1K&KZA.L\C)R;L[U
MZ[/T9SG6LJ\*<M(QX\L8TI&-*4I2C/W!_P#=C<7OY>=5_P \X<9+1/V9TK]T
M6?[2*QMP?T\-T?\ ]QZ1\-LK0767_<)7K_#/6_\ .MD+2VS_ &!R/M[7]>CM
MH[./_J^;0_N[2_AMI38%,NCQ?@U! N+1P]U=6&JR+9W8^--)@6R[C!_9V[B7
MU=&QZ"R^$\9-E$BK@AC=N,Y\BY\L>8OW#MUNZ-BVJ=[*YC0C_#:I3^A^BS8K
M3[FK[D]DM)LW(V[VJ;*X&/"<N;EC*]I%FU&4N7KY:2GQKPZ^"O?]@8Y(?QQ:
M3_\ J]\_0\5WY0=4^K<?_>?F.M;_  =V]#Z]M _C:C\B:;V#BW<.(/-WC_J:
M[V"LV::6V%I6UDDJH>4-&98S.PFK5NW-F8C&JI71%8M?)\83,3R.3M.;/G@N
M%N:5>T?7-/Q+]R%RYTF//C#CPX5N^S2GI5'ZGNBUS<KO]W;[&Z_J6+J>=<U+
M0<RES#K>K9Z/(U*$(QKTUJS/GI*S+F[WAPK'A7P\+87-K1=HY+\8-GZ2I4G
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M+<;5N/W(0H]Z/HR
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MK=W5<B,NJ49:C.M['C*E>N,X8?:T)QEWT9QE&7#P) 1(FR
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MT7%O0Y;N-BWH\MS/NPKWT+V5;KT6/2O"5,6=R<N:.3#DGY%A.QL
M                                                          !#
M?U;."LIR.HD=N?5L0:1W!JZ)<M'\"R1[Y&_4!-9:16B&*9<9RYL$8\6>NX]
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M.&@XUZ/"Y"S>A6%[5)QKUPZ:S*5G#C+A65BY>O\ +6%W'FL."QG9>
M
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MPZJ.\J,:0I&,8TC&-.%*4\%*/*#W
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MV$+M)H1-F](
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M-Z4I2%*4I<%*7&"E*7&,%P7&/+&,8Q]PN,"=-^:4I&E*4IPI1_0/(
M
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MN3E*<Y2G*LJ_7CD,T
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M4U$D91@RD4DE>WU4TWK9-R1-3L-G'J8*IC&?+/EY_<SD![$
M         :=<^^8M8X!\2ML<M;C3Y^_5O4^*+[QJ=9>Q\?-R^;ULJFZT989/
M)7[0B5"0N31RKD_W46:A28R?)0$''$GQ16@.6O);2W&JN\7=PU&<W3?(>AQ5
MFFK;2GT5"O9DQR(/Y!HQSA9PU(8GSRIY[_+]KY_< 6C
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M+(IJ)(RC!E(I)*]OJIIO6R;DB:G8;./4P53&,^6?+S^YG(#V(
M           TZY]\Q:QP#XE;8Y:W&GS]^K>I\47WC4ZR]CX^;E\WK95-UHRP
MR>2OVA$J$A<FCE7)_NHLU"DQD^2@(..)/BBM <M>2VEN-5=XN[AJ,YNF^0]#
MBK--6VE/HJ%>S)CD0?R#1CG"SAJ0Q/GE3SW^7[7S^X M&
M
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M #G<Z&_X<M,_RKZ[_G?#@.UR
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MI*T0J#.U.&\'%RCUPA&/'CENSC7#E=%-%(Y\!4WZ+_WU;@;^$71O\Y6 ==<
M
M       !QT>IU]\GZA7X<7++\_5^ 2<\#_#C\HN?_%77O*[6.\M!4ZK;'=75
MI#UB^*[#1L#-2D7FQ41\:26K]+?-DRK25;=+)>DHKGV=9+OP4_<0H1E\_>G?
MR2Z;.Y&FEN2$17"2LU )6JFW"CS:MBHMZK9W2T>M*UN3>QS)XGZ$HU=-G#61
M8,'J*J.#G;>S.&R[@+0?A*>=^X)[8VT^ M[M$C:-4P.I9C=.G6DTX]L7UY)P
M-VJ<!;JE77"I<K(UN53OB<EAED_LC-U N5VB2*LB\,L%Z0QL%QDQLX*4N,Y,
M;.<8QC&,9SG.<YS\"X__ %^ "&SD3U^NE3QILTC2;;R>B;S<HARHSE8+3%:M
M&UT(YRC@Q7#9U;*G%+0";U)<ITEFWO;+E%8IDUD2&(?L#%NK?$J=(S9TZSKR
M_("Q:S>R*J;=DZVEJR^UV#.X54*F1-Y98R'?Q\*CY&[C+OW+5L0I,]ZQ3?-
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MG:G#>#BY1ZX0C'CQRW9QKARNBFBD<^ J;]%_[ZMP-_"+HW^<K .NN
M
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MS<92T3],D(5@M3Y)_BCTF;;5J%6KYH_#1NJZ.]:HD(W<1K3L*3 0*[JT_?\
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ML7H;_ARTS_*OKO\ G?#@.UR
M         ..CU.OOD_4*_#BY9?GZOP"S;TB?$/<'> G3RTMQCW#1N2EEV9KJ
M1VHZFC:VHNO9>MN4[IMF[7F(]V2UGVS#J+9+#V*/(OZK='L7(H0GJ$*54X0:
M]9WJJ..JOR&J.Q8?6RNK-8:JIKBCZYKDM)MYFW/V\E+K3,Y9+:_9)E;-Y)VY
M,S(FR:^HW9H1J1/:72AUESA8&\)!P6V96)_<_/J^5Z3K-&N&N5=&:44EF66Q
MKZUD[E VC8EQAR..U3W"PD:#6HQL\(0R#UR_E&Z2G='KER&??%9=1S8>BZ%K
M'@SINSR%0F]]U:4V#N^>A'JD=/&U"C+NJQ6Z0R?-5,+-8BP6")M7O;*>4CN&
M=4Q&G.LQD7[<X53.DOTJMG]5C>MCUI4K@QU=KG6U<9VS;&UI*!=V=.ML99^:
M,KD!!UYL^9EFK?*NF\H=HW</F"&&=>DG9W.3M$FSD-O.L1T"]A]+BATW>-6W
M"COW1UFL[6C3TTO2%J-;=?V^392<A"(3<0UL$LUDJR^:Q#PB,F1TVRF^[&2S
M,F5FJSD-D?"\=1K86DN74#P@N5FD)70/)/,^UJ4#*/5%X[7.Z(R&D+)"S==*
MY6SB+9S[6)D(B0:-R%*\D)&)='[3-53*!,?XI;J;;'XS:WUOPNT1:Y"E7SD+
M6IJY[;MT"^/'V:'TN@_=5>,JT,\;^2\46RV!G8DGCQ!1%8K&GN6!3'2DG'8%
M-+IN]-_?'4WWY]1'2IX6 9P4+\KME;(M>79:KKVG)R+.,-(O",D3K3$XY>/$
MT8V+;]J[U8BASJ-F39Z^:A84WGX/CD!4->O+#H/EM0=V; CV!W9]=7#6#_3+
M>;602455C:Y<\;"L;8THJ8I4FN))O%LSG/C+EZS3[CD"77H4\?MX\:.CMRTU
MER"U-L#3=^:[(Y32'R5V+5Y:JRKR(SI>DQ+>?B499JGB:K;B0AY1-I),S.&#
MSV(YVKE=,O> YN0"SU7?"H]3*]:G7VY-W;CU%; FX5>W-M46+8]GE;Y+NG+5
M:3Q%2UMBZ:\KZ%J>J&*5(V9IPP,L]+EY*-2>JHD%:1)6R46TIK-UY6KW"FSY
M%4'+5=Q&3==LE>D>]-=NY0,56.EFDHS*8AR&*JBLVQDN2FQW .O[Q*Y8-;UT
MV-%\S=O2Z12K\1ZKN[<<ZW;-VJ!)6N:R1L>U)1LR3RFDW;EEHBQ*II8R0A"$
MP3YN,? .61SOYO[TZD7)^S[MVO-O7+BRSR\)K"@J2IODMJVD.9'T:S1JRBZ4
M(VC6J+8S7+YWVHGD7IUY)Z?*SA4X"T=KCPN'"Q?2<<3;'49;,N0\A747,B^H
MUBT^OJ&K6EVR]4\4G79EX:7N4.Q?J%1,[Q,PRLBFV,N1M'96PBB%1*;2VCPL
MY26!C3KXWBMN<9=TST-![%U],)O8W%OUA;7D4E9*O+-S93DH)P\B3*HY-@R;
MEJY])9(R:IT\AUV."?)!3E[PYXW\EW<<QAI7<>IJI;[%#Q:JR\9$VQPQ*SM\
M7&JK_;#1[>T-)9%#U,Y4])$F#YR?NR VR 1>=9'B)MKG3T]=T\9-'FJQ-E7^
M8U,Z@CW297@*Z1"H[<I-PFE'\JVCW9V^2PD'(&)@J"AE3DPF4O<? "K+6?"6
M06OJRSLG+_J/:KU&NLV-AU'5JCL_DTW>X)C)_8]A;.V'7\R#=,^2^>#03<Y\
M'^ZE_""#;J?=-W37 ]_2Y#1W/GCCS0JMQDI*(?QFL[72<;2U](,FQ7K<]QHE
M4V!8<)UUPC[0FA*E=(D,Y;9;K-&^3H>L$P_A&.3M^KO+'<G$Y[999QJ79&G+
M#M6(J"JN7,1%[5H]BH\9F?CVZI<^Z7#VC2TT@^41,0KS,)&D<E6,T;&1"1/Q
MB/[EWB#_ "^6_P#-XY 4SN!?!_D1U"-Z9XY\;"U\EMDZE)6:UR%NM>*G4H6@
MP4W749.8LCE%%=U*1:$])5G/L;!C(O#K'1619GPW.HB&\/4KZ#_+KICZJJN[
M]I6S4.SM8V*UL:+)3VJIFTN'E0M4I&OY.);6&'M]3BU?=+U.+E$VKUIERF59
MGZ+PC-1RS(Y#(WAIN0]QTIU5]*TB)G7+&B<B(N\ZGV/!X-E1C.(DHUFM]&74
M;&\R)R;38%=K_HN<%]9)L_>H$.5)XX*<+@_B.>HI:N"7"5O4=32[^N[SY32T
MUK"DVJ*?*1TM1:=%QK5[M"[P;QLL1=K8D8N6AXN/<-S)K,7=P2DD5B+,4B*A
MSJ.'?$;>//KD=3>.FD&#6;V/L!U*2#N9LLBX9U^NPD6V6EK/=+G.X;KJ,X=H
MT35464*DNY<N%D6;1NY?NVS=8)S>HGX::^=/SAAL3E[*<LZCL_&K3T7%LUZP
MU+,U/UB7O8]1UJS-7K8XO4A[S,A*7!BX4*YC67<@U5[,^IV$,$8/1?\ OJW
MW\(NC?YRL ZZX
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M2@7=G3K;&6?FC*Y 0=>;/F99JWRKIO*':-W#Y@AAG7I)V=SD[1)LY#;SK$=
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M #E8!UUP
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MIW][7ZA7X#W+#\PU^ <BG0W_  Y:9_E7UW_.^' =KD
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M>7N97]WCO_2LT: Y]O1?^^K<#?PBZ-_G*P#KK@
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MV]%_[ZMP-_"+HW^<K .NN
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MND$D7JSS55QKU<O5,B959V9Q*J1-5V!!OBTV06?>H=X:+]@6<*G.9SE4^39
M9JWAUR.K9R_C$]4S7)*\MXFSEQ"FH^B:C :VEK2=WCTUHU9_K.!:SLXBZ3[D
MU6/MRC19,QTS-C$.?!PO->&^T]MG2'2\U[3-SZVO.JKFXV=M>Q_)38M8F:?:
M"PD[8$W4/*.8&P,T';5JZ;XRJ@95(GJI&*H3N(;!LA/( C:ZN/#BQ\\NGSR%
MXV49:-;[%M$'7[-K9:65*V8KWC7EM@;W"PSAX<V"1Z<MFON(<SI3[6U+/9<'
MQDB60'*5C77(O@]R(A9K$==]!<C=#W:-GHYK9:\K"VNFVN#<)OF"KVOV6/,F
M\9J%P7)D73=PRD&;DQ%".6;C)3A,AMCJT]:KJ::$W-KN/7?OM#TC6-FM?(^4
MTMK*(HM>QK:KP+Z8M7U2]BKF-F/C74*U>>K"M9%G[[)W,$8U]A7V4X0]\.\9
M-RXXLE*7)C9Y&Z0P4I<9SG.<[,K.,8QC #J=];$IC=*'G=@N,FS]0*RY\L8S
MG.,%=1QC9^'[V"X-G/\ < <O/I]%R;GKPB*7&<YSR\XUXQC&,YSG.=S4O&,8
MQC[N?B [#NR\9-KB_E+C.3&I-JP4OEG.<YS!/L8QC&/W_/(#B3 .MER\X21/
M4%Z52?&9X=I'6RPZ&UE8M63L@8Z+:N;;I]0AIJC/WRY$S&;Q*\HW]VR1RIG4
MQ&3;["9,J9( Y7VT=4[^X?[J?439E7OVB]X:LL;5\DW=^\JM:J[-P[[+J%M%
M8FV*Q#+-?:FJ+N+F(UPHV<D(B\8.E$C)*9"21_S\ZTW4!T]M'57U<>0&Y-,:
MVU7<[QN].L1->JM=B]3TZJS5CMZ^W;Y4:_%J34&K78F5QEA.23DTRH3#)NV?
M.U$4#A&%H7&3;STP4N,FR;;&NL%+C&<YSG-PA\%QC&/NF_\ M@.UP
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MII?//_-^<8N $VGC$<9^M<XA&[<]N-_6W&3>6?+!C:[=Y+C.<8_;9[#>7_5
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M%76R;/P_L%*?.0'76
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MU@
M                                  'H['6:W<(=Y7K;7H.TU^13]*0@
M['%,)N'?)?=]-Y&2;=5!TG_:.0V &$83B%Q-K4NA8:YQ>X[0$ZV6(NWFX32F
MM8J7;KIJ&53<(R3&LIK)+%5,8V#%/@Q3&R;S\P&Q.,8+C&,8QC&,>6,8^&,8
MQ]S&, /] ?C?Q["4:+Q\FR:2+!R3*3ED_:HNVCA//W4UFSA,Q%D_[1BYP Q+
M%\=./D',*6.%T3IN'L"I\*JSL7K"DQ\RJI@W<5123:09%S*=WQ\\G\_,!F8
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MK: J4#%UN%;JK9+E51"*AFJ*"*ANTO=DJ>,F\OB ^G
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MI?/[@#VP
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MD;,8Y@BFBT;XSG/D1,A2E\_N /;
M
M
M
M
M
M
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MV43*NH9=K HK*8/CX*+'*7/9V@)$P
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ME3RQGRQY^0#VX
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MBXR<I<J>6,^6//R >W
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MHY<+=J*DNPBV!S]J.'GM"B*)PL7@
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MW:BI+L(M@<_:CAY[0HBB<+%X
M                                                "'?K^6V7I?1^
MYN3$(JZ1>/*%3*DL=H?*:N8B_;=UW1)]-0Q<XS[*>!LDD1<OW#(G4+GX9 <I
M^CPK"RW6H5V5?>ZXN?M%?A9*2R8I?=S"5EF;%X^[CX-@N$6[A53SR4Q?F?.Q
MD!U]>;'(VJ],K@7L#>]1U,TN%+XTTO7<%5M10]A1H+!6OK6VF:N@H*/GB5V4
M) L6#&<:*$P6.<X,G&^A@A._"A JZ?[,P9?^#G=?^=JE_P#$U -T^G=XF]IS
MXYD:8XDDX5.=4GV^[N30M_-R)2O!*^:I:ZN%_P"\U7QH^(S*%<?)3V3RQ(H>
MC[?Z_P!L]+T50U'\7!SLO-/::7X!T">>P$'L6HYWCO+$>Y5:KVJLEL\I6=94
MYXLCDN5('Y15&W23YJ8V2KN(F)4.4I6_VP*_/1LXQ=-3>E[V5<.I;R9KNGM=
MZ];5QK2-6/KH>A2>V)Z?/+J23]_8V[4[IK4XAG%HE60CE6KUR\GFQ_;FR#91
M%\&?>M)Q7Z.FL*!KK;'3"Y(U&S6-U=T:5L30T+LZ:V>0E?D(*>F6&QH)]9LN
M9.+29R4*G'R*3F0<MEOE#'G;$:*HN/; V3\)ERGN^O\ F]=N*JLZ<^K>0.L[
M-:"UAT8ZB#;:6KVS>;BK!#X,IVL72M(+;FS["9?V:DV996R;W>AV!FOQB_[H
M7A?_ ",[(_GO$@(;.CST@[7U9]A[6@([<]?TG2=*15-E+Q/O*M(W>T/S7MQ9
MF\ QJM80E(UHZ^V5"4P[7=RS3V;"S<Z+=]DZA$PR;UGNB58>D]]1ZVQ&Z2[S
MU9N)[9*^UFGE(-1;'4+A6V[&1-!S$>A8I1K),7L._,X9/$7**ASQ3Y%9BB5%
M%P[#<?PD.V[%4^H5M'4R,K(EIVW.-UJ>RD DNIB+=6_7EOILO5K \;8-VJ/&
M4#*WIH@?..XA+.X+C]N ^I\5QSLO&R^7$9P9KT\]CM1<=:_4;/=ZZS<K(M+9
MN._UIK;VDM-D3[22#>(U_9*VA&IG[_97,W+G[N]?R2#5GHS\2^CQLV@7/<'4
MYY1T^LV%*Y.JE0>/4CLN3UH7W!&Q<6^>7ZV2E?*C*R17LA)*M(UNR?LD&Y(1
MTHY,\.Y1(R#7_K.<;NFCH_8^J[1TS>0]>VSKG8L3:T;UK:*O+K83C4MBJRM?
MQ&O&UBD$?;#UV<8SCC+=O(.'CM%U6WY\.SMED6[0)\O!_P#*>[S#?D_PZL4Z
M>3I50BZ]O36,.[.=5Q6W$Q-*539C6-544SE.$=/W5)=>S$*5%%\L\<E+ZS]P
M8X13^*E^^OV#^0/3/^:3X#X?HW=!^P]5>A;"W)+\A8?26L->7];6JS2-H[V_
M7R?M#6N5VTNLI,',Y$1\+ XB[1&X3=Y>OG!UT5DLQR:>".#AJUU>^E=:^E+O
MZI:JD=E-=PT?9-%)?-?[ 1JZ],?.4&TL\@[!7)^N*3$BDQG(^0:H'R=L_<HN
M6<JS<_L=959FV"P/X0F_3%MK_/\ XQ3<S,'H\O7]97J$C$7&/9:_*61I?J%?
M9:+063.DA*2$6G12*'R0V#XJK?O*;!.T!!3UP>FYJSI=\K->:#U'>K_L&MW'
MCW5MOO9G8QJZ:;:S<[L?:M,<QC7-9A6"'NDC&@1JI,'1RMZSQ?N4,3TR$#;'
MH3]%O1/55H7(:V[AVKMK7;O3]NHE=@VNM34XC>3;VJ&L$D^<2V;16Y QETU(
MEN5+".4BE*<_>4^<X[0M>-./6K/#J=+/F??=(W>];,<,7;K9=;>;7Q6G2R&V
M+TPHNF->1YFM7@6*3JN)VI2LN721TS*JIG<E]9(GD8@<WZD&6Y/\F:N;?^ZT
MJF?=NVXM3;V_=C.G$J2O(7&QH*7+8ME744P>04;-WCYX8F3I$4.B5+U42&[R
M!;SO73X\+I*:-EJ!0N;]/JNWB5IRUK6]Y;D),3L[\JT6?=&2]IIQVY*Y(0ZD
MDFGE^T8PT>J=LLLFS<,UO171"G'I7<FP^.&Y->[OU)8SU[8^IKE$W&GSS/*B
MC=.5@GI5TTG*&3D]X0;M$JS=XU5QA)XR>+-ER&26.0P7^_$;=3&VZLZ<G'.L
MZ5GW51M74(KK>9=V.#>.FLI%Z094NHVR]QL))-5"G8N95QL&DQ:BO?W*Q4A*
M($+DROJHA2@Z;? /9G4GY4U#C-K>5:55-_%S%QV#L"1CG$O&:ZUS6_8TYRU/
M(IJY24E'!I*3A8U@UPL@1S)V%D@LY:-U%'2(7*[EX/GAV[H"\=K_ )1<E(#:
M6&1\-;9<$-86VAFDNTIL*.J%#4N%D,,<F+Y>F2Q^H3!_,RJO:4H#9_P\O3'Y
M2],UWSBI'(Z!K2<1>;MI[ZE5]J-L@K#7MDP=-C=E)2\_&1C9[[WK+<AK)#DR
MWG(Z-<F46/A%)9)+*Q@I0=<O[[5SH_EF6_FO7 $D/2E\-W,]13C%7^5MVY2Q
MFGJ3>9.X15(JE6UJZV!:5LTVT35-E)"TO9:U0C2"+[]@WAV[9IB2]=HHFJHY
M9K9,B0(;>I'P3N?3BY;;!XM7&UQ]^^2K6OV&IWZ+B74 TN=,MD2C+04T:"=O
M')X60+ZCIF^:8=/$T'\4Y2;O'2.$G*H7>_"/[;L5TZ?6V=93\I(2C33?)&PL
MJ<D\746;0-0O-+I]I^3\60YLX;,\7(]TD#$+\/:+(L?^& M4
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MSG]\!O,
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M5W;YV47.XDIZVL*?&0]GGG[A3.3+.GT]&R#I0^?B8[S.?WP&\P
M
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MU%"VW:#?!S9_L^BBB7_W@!-#X/#]RIRY_"#K/YN(P!<%
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M)V^LT-XO,Q;.0<-4DY5%-O+1RJ;MIE=FY1>)*MG*R9L& <<T!VZ:3_O,J/\
M@Q ?Z*: .-YSG13;\V>8C=$F$T4.4W()%(A?N)II;:MQ$R8_Z."E+@!U*>BM
M]ZDX'_@^5'_[)X E!
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M?^#Y4?\ [)X E!
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MI<]92\W%-Z#&LUY.)C+K"LEY*-(\P=(RZ)#I%5(9/O[RF+@+4@
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MR;R.3&0$C(
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M$V>F72 E*O:ZY*H^U&<1<_7IMJ@[B))/U"^H@X1353R;R.3&0$C(
M
M
M
M
M
M
M
M
M
M
M
M
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M/RP%FP
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M74!&V(K8[R_EM&-I$V<97UL/*9$>Z<LOJ=D[>W+CU_>N?/T?1^VA.N
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M\!=-
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MQ44RB=A.UBQL$VZDQ3[C!+Y]:O6IE[6URNU5^!T7;=XV4<,735RL%/SQE_\
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M/.2J(F3,4Q3%SG!L&\\ /.
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M6CFFP4NR@9.5/>=@U>@MS(2L@U72:D;N+,DY/W)'[R,S)E[3'P; 1+4OQ.G
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M[4 I0^,H_P!Y' #_  JY'_Z(TL LJ])C[V%P _!$T'^;BO@)"0
M
M <?;0G#RS\O)_GQFC^VO+IQNT5LGDS"5YDGA4UIC:%NG7<%>HG*14S**.DM>
MVZU2+1)'!E7+R!0:D+^R %[/PP_/;ZZ;@P3CW=9KVW;O#I:(U\;#MQZDA-Z5
MEDGBVI)C&%#8RHG&M(^8K9B)E-A!M3XY58_J/B=P:(^*MY>V>ZRO'3I:Z/\
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M<APZ1("&7Q"7WG3FO_@KK'\^VK0$9G@__P!P7R-_"[G/S-:> 6S0
M
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M4\BJDY:,KAK32ENG*,[D6Z3MFSO4BPQ"4=R[9JF['J*=JEH8YD#9[5NST\_
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M^NF=/0[SY,<_L_F<YS]QS!-$
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M(
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M#]I>[R :3^(2^\Z<U_\ !76/Y]M6@(S/!_\ [@OD;^%W.?F:T\ MF@
M
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MQGO[>S^$ K:^&NX:=,OG=6>0>H^6VFH#9G(:CV**O](+([#VQ39>1T]*Q4=
M2J<5&T2^13.49Q%Q9IG=JF0.Z1-=VF%%#(G1*F%I?_8Z_1J^A;$?CHY'_KA
M9SXO]*GIG\*MWL]@<:-%UC5N]%:38VK!=+:^T[-8UJ(^>P\?9GC:JWC9$DDO
M#XD%X1NN]*RSZ"SQ%'UTSKX*<*3TM<8G@MXI*S; W Z2J]4)S4N]CF)V3+YQ
MT13^4U;G,Q%F>K+^6$8=M#[A8NW"^/,K9%LH<O<9'M =)L!Z.1LM<AY2O0<O
M/PD7-6UX]CJK#R,JQ8REFD(R)>3TDQKT>Y<%5FGC>#C9!ZNDV(J=%HP6<J8*
MBD<Y0YZGB59)/7W6SXYWNQ9+'P$=JGC)=COG'GA#W%7-R[ ))/39)YY]%-:!
MDBF\L=W[&S_T0'1!161<HI.&ZJ3A!PDFNBL@H15%9%4F#I+(JDSDJB9B9+DI
ML9\C8SYX <^_QA$U#/>67%.&92T8[EX/0ECS-135^T<24/B4OCIS&FE&*2V5
M8_#ALDHHAZI2>L0ACI=Q2FR OR:Z_P"#ZB?X&UC_ $(Q <_WI4?\:.Y&_A&=
M1K^<&VP'V/C#M:3T?R@XD;A5:K9K%OT)9-:LGV"J&;XGM<[#EK1*-#YP7L16
MS'[2ASEQG/FH4A_+'DF8!.)Q Z,W0SY;\9=*<BM?<2ZO8:_M*@0-A6=1VZ>1
MV21]DRS39W"N/4<[@QEG+1=J:S$<\0-C!D7,:HG_  <9R&R7^QU^C5]"V(_'
M1R/_ %P@)%.)''CC/Q?TO%:FXD5J!JFEXRP6Q]%Q-:N$]>HI.Q.9YXVN';8[
M)8I5TX>)V)C(-W*)WA_97+)1MV(F2,F4-F0
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MW6%(L]5BY%++5U)R&EI^U(V*%;96Q@Q99*+V(X=F:^7J&;PSM8V/)H?M#H"
M.<9K.PPG-3Q4[.]:T=YLE.;<M7]G86*)1.O&/:]QIUVH@>PI.4RY+F#=N=7I
M^SN<YP1P22;Y)GS<)E,$VGB_/O?''W\,FI_F2WH E*Z#/WHC@]_)A-?G&NH#
M5_Q0?WHG;?\ *CHW\X<6 _+X73[T?K+^5O=_\]G "P^  .9EU VNR^MYUU+M
MH72$_#IQD5-37'[65FL"D@O3ZQ0- PMFE+O;G[J):KJ&K[VZ,;])LU$4LY7^
M4[)L3O54)DX;X)>%8ZDB"2:*//C5:*2*9$4DDK7OE-))),O8FFDF2OXPFF4I
M2XQC&/+& $975)Z$_+_I]:.AN36Y]WT3?584O$!K.57JK_8$K/U).?8V"2A)
M.47ND.@5.LFE(]1GYIK&['T\VQZ7V\QRA>5Z%/+O',KIF\>;Q*RGO38&LX0V
M@]I**+>T/?ECJ9NQ@V,C)K9SYJR<K15:9-KFS@OFK93_  ^'GD('O&4?[R.
M'^%7(_\ T1I8!95Z3'WL+@!^")H/\W%? 2$@
M                                               Y[/A2OOJ/+?\
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MG./X034>(2^\Z<U_\%=8_GVU: C,\'_^X+Y&_A=SGYFM/ +9H
M
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M%EKW;&K>*=V"OE*IZKB(:KN&CPR),DB':Z*)2A:=Z+O2:KG2LX_3M9F;!#;
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ML0J,*XG(MD[=-VS6W-VIE5VC8RJC(ZA42$,4H"0<
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MI/Z2XRP"<<Y^:\Q:24-TPMEBAU4_)-=F5O)$53.8GL>295[@MY=*WB->N"7
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MF5X93:\&I5ZXSB=8Q19;44P\MTF9#V5-+UUUURJ8)D[]90V>_(6KP
M
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M+['WM$<.CY.<.@"
M
M
M
M
M                         *WW7DWQU:..]PXO;"Z;-5VO<:<P@]K%WK!:
M_P!,,MV5YVX]X4%2GEN-=+6))_'HX9I63*+MC[(HD3VC]E)%,;N"$Z.Z_OB!
M;(S4U]7N!D'(WM0F4BRD)PTY-25W1]0IDR+DKI+TLP]KPM\<9/%F1^9VF1,
MS-TENC)SGY!\W*]U/>J,2=@)2"NK7;$+2]F)MFNX=D[/K*;-OKZ7LM*9L4T=
M946!>1D:X91[@C%X4U5CF#6';Q!BKX"\8
M
M
M
M
M
M
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M+L@EV8;694E"%0NVQ[YKU.)S .-?RAI!5LI1EG>5O;&Y52R)4?3)Z1E3A8#
M08==WJ#\JNGAH73&Q>*-)I]UM=[V\O2K.VN-%M5[9,:\E3)Z<2<-&-5L4<HQ
M=&DH]N7U55%"9)YDP3!C=P#;_I1\FMR<QN 6@.2'(&O0=5V[LA#92EN@JW79
MJIPK+-5W#L*CP1F5?L,H]>1_K5FLPRZGJN5?55='62[$5")D"1
M                                      %;CQ#_ %?I/I\Z:AM"Z"GR
MQW+3?,,O(1$\V(W<.-.:K(^<1<GL/"+I-0AK-)2#*1BX IDS%25824D8Q5(U
MLB[#,O0MU/U#B:+2Y+]0CDSM+9-HWC5X>3UAHRW+168[6M DO99J,MEK30AT
M5R[%EVOLJA&6%"$B(U;T7A#R3MRVC GB
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MK,RCKTDRE]H<23QPJ?M*4O>MGM+C'P 9_
M                                                  4F=Z=0[FM6
M_$M0?$>"Y&7^-XV..1'':I+:?;+Q>*BI7+7IO6,Y8HD[<\;E;+=W,3$HX5SZ
MW?ZCP^<9Q\.T+LP  U%Y[;IV)QSX9<E]ZZCB(R>V9JG45ONM(AYJ(DI^*D+#
M"QYW$>WD86'?-G4DURICS,DBND<^"?M\ (E.@5U..9/4=;<JU>6] HU'SIU?
M2*>OSTK75SH.)7%_2VT:U%DLVVT26);+?Y%UO*/L_H^A[>KZWJ^LCZ86)0
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M;AH'3EHLLT\]/VN7GY_7==E9F4=>DF4OM#B2>.%3]I2E[UL]I<8^ #/X
M
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M3_.\P%8KJ8>*#I'&[;%AXX\)-5P?(_:%4G%ZE:-D6B0F<ZHC;JU=JQCJI5&
MJBB,GLY\A+%]F<.6TA&,_:$<HL%I+!_62".]YXD3K6:;BV^Q^0'3]HD+J:36
M;JH3UCXY<F]30:B"JA2%0@[[8[XY8=JGF8I#+(O3=^<=OG@IB9"U/TG.I17N
MJ;QAE.0\'JR9T^\K&T)W45JILM8V-M;$M%>J-&N#M_7["SCF1I*!4C[Y%D3.
MX8LW!5FS@AT.PJ:JH5;+GXHGJ4[-V==]?\3>$6I[!BLV"8ABQC:C[SWW<$6\
M?*NXQN^<9H-H@TDE%3-?,O?&Y)Y]Q<%-V@/4?[)DZN7&BQ5YSS/X&TV&I,H^
M*52,M&FM]\<+;-($*8R[2L6R[STE'HN,)_/\SP3_ +>SXX[?VH7!.GSSWTGU
M'>.%<Y%:3<NV;)V^=UJ\T::5:GM.M+[$I-5Y>GV,K,V4U%BM'T>\9N4_M3V/
ME6CLA4\JG12"J-XR_P#W5Z=G][^5W^<\<@%OSA-^XSXC_@QZ$_-55 &S@#\,
MF[,PC9!\4F%#,F3MV5,V<EPH9L@HM@AC8Q\TN<D\O/\ M@*/&C_&!39XS:<C
MR+XQ5<K^*IZ*^GJUIZ7L#=6W7Y:401S&W6QV^0=HU:HI1)G2ZSQLT?//51(D
M@R<=YO3#6ZW^)RZQ$4U;[G/Q.T]3=&/W3<T+(6#0N]5**_8/EDRQR"NS7NPF
MB,H^6*8I2+M5FR:QUNY)IC&<$P$GT'XMSBZ7B(TV99=.6U3EQ[U>U=SQM@7S
MHE2<O&;%N[;["QMF0AS-XK6[KV@J6$,MGE@;O45FGNURS2+,+!&+9?$[=85D
MS1W8EQ)TW6=#NETC14E.:'WPYH3Q@^531CDW&T%MC-$9"0/W%*FNV7;(JJK%
M-AIVY*F M*]&_JYT?JM:7M4]FHI:PWGJ%[ P^X-=-Y3$K#?^Q$T>+5^[TEZL
M;#I:H22L3-)%0=D]JCW<4NS65=IX;/W@?>]8;J'6?ID\03<CZ?K6!VG87FSJ
MCK6/KUEGI"OPS)2U1EFD??CQ:+8K+R!$,UW!/92&;95]L[O:4^SR.%66%\1'
MUW-S,$;1I3@)2[#3U$O;FDMKWB=RBV+&NH\V38(LM86.QG39TW^']50(W+GM
M ;/<+?%77-QNJ&T7U)./%6TH:7LS&K2VU*"VNM(::P>O3IM$7.S-5['D)5^W
MA2.ED5'[]O+(J,&W>M[J<D*;L"Z*@NBY11<MEDG#=PDFL@NBH15%=%4A5$5D
M5DS9*HD9,Q3%,7.<&P;SQ\ %,RV^*LL>D.:?(W1N]^.E9<:8TEL_D#K*%FM7
MO)IULZS2^LK59JK04WA;+8$HJ/1D9"%8^]'.$S8:).5EFS98Q"-SAHQ>?%&]
M5F\8F=H:9XHZEINCH=VJH1^\U/M_9T?',296/AO;]H(6J-CG#@J29N]5LQB2
M_:39],OD8!/)T4^OM =3*RS''[=.OX#3_)V$K;RVPR-1>R3C7&UJ[$G;EL"]
M3:SSA=]6+)'E=H++1#E[)978D6?MGQR-GC=J%CT
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M)QKC:U=B3MRV!>IM9YPN^K%DCRNT%EHAR]DLKL2+/VSXY&SQNU"QZ
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MVZ39,[DZ)#!6DW7XL[I^ZJ?*5'0>G=U[RCX0F&#"<C8>O:CUXNU:_:&J5?\
ME,Z4F$V944\=I5Z\S*0G9@A<_$I K=]9#K>T+JO:PUQ2VW#!#3-MU5L+-E@-
MROMN,K]9#U:3K\U&6#7AXI#4<0:/AY&24K\DIDLLL3#BGH?L<_<8Y NS^'TL
MDM;>COPFE)IQER\:T_8M:14SYYR6)I>[]FT^ ;_$V?ZC!P,<EC_W#\/(!5@Z
M5'_&CN1OX1G4:_G!ML!9@\2A]YFY:_WPX]_TF-/ -<_"@_>LGOX3FW?] :[
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M7]ER_;N2-5E"NT")NDD5DPZ-UKJ%5O56GZ-<Z[#6BFVJ$D*W9*O.Q[63@IR
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M<J[#7&1BF:TK4]7Z]EUJ>6LU>172.M&MY"V1EE=2IVYT2O\ V:.0<$.6-0.
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MWH\K,;MNCPS%D4J+&KKM;%L*.;-44TD6T;(I,TDNQ''<'2>
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M_%QTW"3#%U&2\-+LFTE%RD:^1,V>1\C'O$CHOF*S=15-5)4AR*$4,0Y<ESG
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MJXU0B(Z HV]'E9C=MT>&8LBE18U==K8MA1S9JBFDBVC9%)FDEV(X[@Z3P
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M[-?>;2V*Q?MS9;J5=P6JW)[$KY4])ZC)1Y2'RL\22R'29
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MOVYLMU*NX+5;D]B5\J>D]1DH\I#Y6>))9#I,@
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M1-:PBOFM'UHTHQC57CUX<[Z57AV[@Y&#<B,<W"<
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M
M                                      I<;PZ9G.>T^)$A.:,!Q]L$
MCQA;<A>/=S<;:3LE"2ATZS3M.ZUK]DE,Q+BV$E/3:S$'*-S)X8^L<[//I)GP
M8AC!='          &JO./7.T]O<..3NK='R"\5N'8.C]CU'6<BVL*M2<L[K.
MUB0CZ\NC9T%DSP2A9)9OY.RJ$RC^W[\>7F I+5F"\77QH(E4H%;D+;8Z-[8]
MH[GICC?R82<M\_,06+9[NZLKU1'RR3)3KN"*HEQVJE2[3$P'ZVG1<ZZG5-VY
M3YWJ:[3E=7:WKB!E4K#L"V:QM3N&CG2Y<R+76NBM*SA8J'M3O[45=>02@BG1
M:$RNY<^S-FAPO0<=M":XXN:.U=QZU'%*PVN=1T^*IM7:.5BN7ZS2-2\W,K+N
MRI$P^G7\@J\?/W'83VAY)+K=A>_RP&:                  !7:\05T@GG4
M9TC#[=T;"MG/+S1$8Y0IL?ETQC"[<URX>*R,SJU[(R+A%!K,-WSAW)5]=PJ1
M!-XY?,%3)$ESO&@9$Z%]EZEE3T:GQAZB'&^X4-?2=8B(S3>\YBT:^G$[I1(W
M+6&C=>7!I6K@^>9N$.Q]E*QD_0RC(Q3/L?G1D67M,P$\(
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M1!90C%1RZ*BBU:E56*QCXYFPPNOAMZQPW2
M !2XZ<O3,YSZ8Z^>\>6FSN/M@J?'>S;?YJ6."V:[LE">Q<G"[-L%\<T5^A&1
M5L7D2IR#>8C3IE.SP=+#K[>1'R/VA='
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M:HLYK8-]GUBN[3<I9H@LH1BHY=%11:M2JK%8Q\<S8877PV]8X;I
M                   I<=.7IF<Y],=?/>/+39W'VP5/CO9MO\U+'!;-=V2A
M/8N3A=FV"^.:*_0C(JV+R)4Y!O,1ITRG9X.EAU]O(CY'[0NC@
M
M
M
M
M
M
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M#"QC&6>PK]L=0AEHI^[<!;(
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ML5"H8>Q]:O<Q#PB&8.BP,9&MS(1K=NEWHLTSJ>CWK9.IDQS!,2
M
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MRBA$7&#ME5B&"WN
M                                     *LG7)Z_EDX(;$;\0>(E8K=T
MY,.8:%E;[=+0S5L=>U06UI%<UBK1-18NDSV;9CR)<,9'";PWL#!G*QICM)55
M\J@Q")<^R_%ZH5#/(12/W;FKEC\V4T#]3WB8>P^ZL-O?!D#:!)7_ )1%4]E^
M9[)BO^V^?['[/7^8 EVZ&?7WG>?=Z><2N6%9K5*Y.Q\%+S='MU6:JU^L;<:5
M9+"MGK[VJ2#Q52M[*91J;N141:'.P?LHV262;166!6[H-G_$,<_.2'3NXBZE
MVYQBL%=K=WM_(ZOZYFGUDJ<1;V:M5?ZSVE9W31".FDSI-W1I:K0Y\+%+WE(@
M<F,]IS^85YJYX@WK"\VZ!KGC_P %=$OYO?\ !U;VC>>[*3JZ)OTW)S+R3DB-
M)6)K3Z%5JFH*>1BHS;9=3"3P[QTU[T5H\QO05#"E@ZQ'B"NFKM.DGYN-+5-U
M6PR#J3+KS>^J=;QM8V#&,E$D; QJFT=<5=JY92#=)XW,7$?*KHL%G+19U'+M
ME/07"_-Q(Y,4'F1QJTWR=UD94M-W'2F%I9,'"Q'#VORF%7$5::E)+)IE(O+0
MUJCIJ*=G3+Z9W,,ME/S)DN<A%3UI.MS0>EG6J]0:968G;/*O8\(M8*?0)9\X
M:U*CU,KM:-0OVRE(QPF]6BW,HTD$(R,:*-W$HI#ONYZP1;>LH%=K6O+GQ7_,
M.O,=]Z(A;K&ZNFF_RCJ1(?4G%K7]/E(?)S%1<U)INF%)+7B%5[3904RXE2N2
M?/154)Y9 ;V]*+K/=3JY]0O7'3CZA^G(6,MFP6NPG*UGL^MI'3>UZMFFZIO6
MRF+Y2"BDT(2UUF0^1/LS=9K&,RG+)'>(R#E)(C?(2+]<;K:1G2YJ]0UIJNKP
M&Q^4^UX1_8JW#6A=P>FZTI39XK$HWR[QL8^;O9H[Z8;R#6'C4%VI'1X20<.7
MR";-)L_"OI2MV>+8Y'TUER,ULCM=OKV>9)V2KM&=*XG:\;OX!]CU(YU7-:WJ
M+9S=FAE6N$U&BQV#\[INLFY(LX(L18X;[]'[Q#F\=I\DX?@AU):A'5;<%ELC
MG7U*VH6J8UC.M]HM#.$$-:[CU\JFW:Q-@D91 T?'NHQI']DHLSC7,4;VLS]N
M$H?B4/O,W+7^^''O^DQIX!KGX4'[UD]_"<V[_H#78#+O7&ZVD9TN:O4-::KJ
M\!L?E/M>$?V*MPUH7<'INM*4V>*Q*-\N\;&/F[V:.^F&\@UAXU!=J1T>$D'#
ME\@FS2;/PKZ4K=GBV.1]-9<C-;([7;Z]GF2=DJ[1G2N)VO&[^ ?8]2.=5S6M
MZBV<W9H95KA-1HL=@_.Z;K)N2+."+$6.&^_1^\0YO':?).'X(=26H1U6W!9;
M(YU]2MJ%JF-8SK?:+0SA!#6NX]?*IMVL38)&40-'Q[J,:1_9*+,XUS%&]K,_
M;A:CY+<BM8<2]#[0Y&;FF30>N-355[:+"X0*@K(O\HF2:Q-?@FKAPD1_9)2;
M=1L;&MC*I%</I5NCE0F#]Y0HG6;K:];KJA[IMM5Z9^N;/K/7E;*FNE4=7TRA
MV^>B81RNHUBI7:VYMEP)X^$FGBQ7!DD6BL(U[4#HIIO#-%GBH?IVEU)O$X]/
M#7=FD>4U!EWU-D$(Y@SV[L?2^K[] ZU?.9R/;M%B[&TB8D(WDI!TL6/11M"T
MB1;WEV,$2KE1.0+,?0(YP\@.H#P;FMZ<DYR!L.PV&^K]0$)"NUB+J;#Y.0%9
MH,K&('BHA,B)G)75BDNY7M[SE.3!OVF $-FG>MCSWT'UG3\!N=]TH4SIH^[I
MG26)>.UK6Z0_20OJ?J<?MC)RL:D0Z,3)>^J"NZ*X4,BC'V==98WJMBF 73 %
M07KC];/EKQGYNZFX1< I.K+;#]Q59KLAM(TJ!O,G.;1W!+1J>L]<QS6=3.6-
MD$:^M"O?-+!?:?JA-B'-^Q\8P%L'6,?>XG6VOHO:,_&VO9D;2*JQV):(:,2A
M8BR7II!,&]MGHJ'0+@D3&NY].0<(-B8P5!)P1(OP( ^Y 1;=9_E1N#A7TX.0
M')+0TK$0FU-?.M1H5F4G8)C98QJ2W[LUW29O+B&DRF0>&/7[%*)D]0N?3.L5
M4OSR% 8=Z"7-K?G/O@HXWOR/FX&P;%1W;L*C%D:[68RJ,,P%>BZB\C$C1<0F
M1'+@JTT^[E<%P8^#EP;XE 1+]>;K2<U.G?SWU;IG15IJ,;I^2T3K39UN@977
MM9LTW*2$SLW9T%9",IN93RJS]>OU.-11(4Y")*DRJ7.#'.8!I9;NK;U_^I?+
MV*Z=.;C]?]/<=HIX_8PCG7NNZA:5Y4D<90CAO/;KVW7_ &">MI#9\UV-;)'&
M;=Z*)VRQ\>TKAZ[A#XACJ'<7.7L#QDZJJ#N;ILE:ZW0K\]V1K>N:IVMHPT\X
M;H1M[65J%9C$;14TF\HS>R!7[-XN\C28>1<AC..QX%_<!1CZC'B.>6NUN3DM
MP\Z35;*O[NN$CKF*VG7Z+'[=V?N&WQ3ETPE7&JZQ)1TC$QM%PLU?9:O%8Z1=
MO6C/$N1S&MC>C@,90/([Q:O&MHTVO>=6[6V]16F??4O1;9J#2>TBR#+YQE4Y
M>NZ:;I76 :D3PH90C-S'&1(3O5["% 8R\'[GSYS<E\Y^[GBB^SG_ ,>W]8 +
M)WB%^?/([IW</=5[AXQS]>K=YMO)2L:TF7UDJD3;V:M4D]7[;M+QJA'3*9TF
MSHTQ4(4V%\%[RD1.3&<%4. W;Z4?(G9W+/IZ\8N1&Y9&,E=G;.ILW,6Z2AHA
MG 1CM^PO%I@4%6L.P+A%B7W?%,\&*GC!3'*8_E\X! /U=?$BW31V\9WAGT[J
M; ;&W!6K'B@WK;4S"/+TQ8[&,\1C7&N=2T2)6QBW6UG,']WO';W#EL221<1K
M:*>'3P[P&C_U:_%_5BOK[ED:KMJ7K94#.W564TQQ&F)L[0A?:/0)J"OU;Y4-
ME,%,7'DVC$W>>PQ#9SG!L )S.@5U8.1/4NKG):I\FM<4FE[)XP/]30TC.4Z,
ML%86M+C89MI-7S>S4F>>NLUNQ1[K6ABN/9UTT5E94Y"L&/L^"*!$_P P^HAX
MAC9?-SDWH+@?K>XM]6:>W#==>U>ST#C/4YN&7@Z_)'9QCBR;0W)796&+-+M"
ME4SE-TS*IDV3H($(7MP&M.QN3OBQN'=7?[QW5'[#D-8UI#-@N!Y;6O%;:E9C
MH)E^SI![;6NIH=Y+4^NIMRJY=NR+19&B/GD[EO@G=@+(O1%ZQ<;U5=57IG=Z
MA#:YY'Z97A?JDU:K8E34BPURS^W$K=XI9YATY<L&:KR*E6CV-<.WB[!9FBH9
MVLB]1[ KK>*GV'U!9#8$SK?8%*58].>#VWIZ;T=>/DK7&R,QN5;04]F9C/E:
MV<&DY!4B\QMS'LSA,B.,1OS?/T$<Y#"G /DIXCVE<0=*5?AAHZ0M?&.'A)U#
M4U@)J#6-@))0ZMRLCF64),SCM-W(%)9EIQ+!UBX-Y(X+CN(4IC!:;TQR0ZB5
M,Z.')7DGS(K3;7?-'5&G>4VP8./EJ;6HAJP/KRG62?UI*2%3A%E6#IOZL:W.
M=,V>URFCY+$\CY\PUX\.=U*^5?4?U[RCL'*.S5:RRFJ[EK*'J"U9I<)32-6%
MHA+<]EDGB,(B0KXQG$,SR0Q\=Q/(Y2Y[3 ,C]<;K:1G2YJ]0UIJNKP&Q^4^U
MX1_8JW#6A=P>FZTI39XK$HWR[QL8^;O9H[Z8;R#6'C4%VI'1X20<.7R";-)L
M_"OI2MV>+8Y'TUER,ULCM=OKV>9)V2KM&=*XG:\;OX!]CU(YU7-:WJ+9S=FA
ME6N$U&BQV#\[INLFY(LX(L18X;[]'[Q#F\=I\DX?@AU):A'5;<%ELCG7U*VH
M6J8UC.M]HM#.$$-:[CU\JFW:Q-@D91 T?'NHQI']DHLSC7,4;VLS]N%F?GAM
MJYZ$X4<MMWZY=LF%_P!1<<=R['I3Z18(2K!G:J;K^>L$"Z>QCLN4I%JG)L&I
MSHJ8,10I,D.4Q<Y+D*-&BO%%]26R4"W:CC]6UWD/RLV7:82(TE+5W6^,MJE%
MFC'Y)II'ZJUZP*]V9<'+TS91@F=5-LS]C.HX1D4C&: /2;HYV^*1XKU]3D7O
M=UNFC:URLQ4EI"RZ#T')T"#;2STJ,>QLT/"Z_7S1T5'BR#4BCPL>[]5=%OEQ
MZZI,'"V3T3>JNVZI_&NP7"U5Z!I.^].V&-I^YJE65WJM?<FFHY60J5_K;:14
M57BJ[-)Q\^DFR7<NEFKRL/T?:%D2H+*!,R YRW51I\AT?.O/K3ECJQ@O4=6[
M$N--Y),X^OMS(1KB M$L[J')G7J";<N"=LDHG>%E&B1,8:,]A,2(D)V(FP'1
M<CG[&68,92,=MW\;),VTA'OFBI%VKUD[13<-';99,V2K-U&ZB9R&+G.#%/@V
M/N@/V@                                        /1M*U76$Y+V9C
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MBF?./5(2(9GRU;.WDJ%FOPP7WH73/\I.]/SG3H"P:
M
M              C'ZJO4VU+TP.-\GMBY98V;:=J+(U_1.I/;?0DMAW5%LF?*
M[W")O6CZ+%>U,W4Y(8Q@J""R+1$QY!^P07"IETZ^F3MOJ&0G*#K!=23VZ[L;
M+KC;UTTE2;:SR1KLVTQ='GD8B_/X%P7TXW3==]A;,ZM$$)AL_4AT5.PL-'HI
M3 ?:>#@_X8.<W\FVE/YT7X!9KZX?)Z>XD],#E)L^G2:D/?INJ1>J*-(MS'3>
MQ\]MNPQ="=S$8X3-C+66C:S-6"3:J^?VMQ"IFQYFP4I@K:^$>X*4^V2&Z>?]
MZC(J>D]?69;0>E6D@R2>&J]J4KE?MVR;NV]J1SAI.8K-KJ<7'N4#842;3<VD
M?RPL0!>P 0B=?W@I3^:73PW','BXM';W&JIV??FI[:JQ2/+M<4*$=6"^4A)\
MFCEP>)L%-C))K[)A0C8\LVAWS@I\QR?:$+G@^N3L[,5/E7Q!GY-5W#TQ[4M[
M:U8JF.J>-0M*CJF[/:(J*'S[/&^\8O7KA% GD3#F5?K]OJ.#F,%T+%:KF+'F
MX>X(3Y6YAB5PUHS%,?E%FO)/5I)."S-Y0]IS#%D'#AP5KZOH866.K@G>;)@'
MO '-.\24^KNV>M"SHVB4T'.S6M*X^:NM*];1,XD9'>,E(O',"GD[%/N?6!"K
MVC6[#R)E51(\41H;.%FYD4@Z5B13E22(HIE90B9"G6R4I/54*7&#*9(3'D7N
M-YY\L?#'GY8 <W>)VKK?2/BFKUM3;UWK>N-<5#EYO!Y:+K<)5M"UR!:O=<7J
M):.)24=F*FS14DI!B@3)\X[E')"?=-@!>0IG54Z:VP9AM7ZGSLXK2,V_<(M(
M^+<[LH<,\DWCA0J+=E%H3DTVS*/5%#%*1%OZJA\F^:3(#?E)5-=--9%0BJ*I
M"*I*I'PHFJFIC!TU$U"9S@Z9BF+G&<9SC.,^>/@ \@
M
M    YQ?1!KL)SCZ_6U-\;(27M_R3G>1W*R%)-+G=I$L!-@1];H+I9-UW&,G#
M.MB0[F-2+DF&;B!8&2QA)L5,!T= '.*ZQ];A>#WB&-6;IUDBXJ:=KOW&KD],
M-()8[8JDW,WCW)LGTD6?D?T9UW4+$XDD#9.5XK9WQ3X,BY](H3;>+\^]\<??
MPR:G^9+>@"23P_5+I]4Z2G$*0J]5KM=?W*F3UFN#^#A8V*>VJQJWNV,%)ZQN
MV+<BDY,98LF2'M+DRBWH,T4<'])(A"AJEXJ>DPMGZ5$Q8Y)BW<2>N-]:@M%>
M>*$S[0P>RKN:HKTS=0OQ\E8FW/B')GYF?,ILX[TR&*'W?A@Y=_)=(72[)XOE
M5O7]D;TB(I//W&S!;9\]/*(%_M9E)R24_NN0%7'8]1C^HAXH&Q:JW BI9Z/G
ME[8]?3%;=+F-'OM=<6*W,86J1D5BYPWA9"+U.\(^22P0RWOMXH0Y%U\K .DJ
MBBDV12;MTDT$$$R(((($*DBB@D4I$TDDR%P5-,J92X*7&,8+@OE@!\?.:VUY
M9K?2M@V*ATZ>OFMEYIQKRZS%:AI*VT1:RPKVN6-2H6)XR.[K9G]?DI!D]]C6
M1]J:/%$%N],^2@.>#L&NPO/3Q3\AKS9J2]MHT=RO>5![6Y1<ZT8YJ_%6@OGK
MJJ9:N>XB===OM4R.'C9/!".22KS/P5<G5,'1SQC&,8QC&,8QCRQC'[P#GP^+
M<TY!ZGYH<9.25#36JEYW#K*5)8YR#=&CW[NXZ/L4"VKMP(X;&*LVL2-?M%;9
ME=%/@V$:PQPGV'0,<X3Z==F_&VQX?;:&TC%R4^R=<\.+^8IDS)&*:X[IT18L
ME,EDN,IYQ[RSYESC'E]P!\5X4'[UD]_"<V[_ * UV KU[!KL+ST\4_(:\V:D
MO;:-'<KWE0>UN47.M&.:OQ5H+YZZJF6KGN(G77;[5,CAXV3P0CDDJ\S\%7)U
M3!T<\8QC&,8QC&,8\L8Q^\ Y\/BW-.0>I^:'&3DE0TUJI>=PZRE26.<@W1H]
M^[N.C[% MJ[<".&QBK-K$C7[16V9713X-A&L,<)]AT#'.&W_ (I+DI9;MT].
MG-'1[UVQ@.2[]GO&SM4<KL_>2E;U)4Y2%CY B?;A1B1YMQPYRV5P8GM,:V6[
M/4;$,0)U^@MQZI?'KI7\46]4AV[&6W#KV(W[?98OIG?66V[89MK&G(22Z9<>
MJ9K5UJW%MR^7VEG MTC=RA#G.'PWB0?O+W,S_J\>OZ5>C0&IWA,OO7EG_"OV
MQ_,?4@"-OQ<O#)S#SV@>H+0V*[-9V9OH7;\C%X4;+M)J+]Y6S3UM55:>1TW9
MV:=PC%WI\D]/W-!MBG[CHX*%B_@7U*:'O/I3TWGIL^>0;EUKIBRR'(E9$R&'
M;#8&EH=TTV-A-G@Q<(O)9U#EE(MGC.5%&]LCTB=YU2]P5-/#_:=NG4MZMV\.
MHKNZ.]YPVH;+/[O?E<>H[B2;HVA(S##4E2CS."E[HNO0+>P/V'9GS8GH<,3)
M"D5( Z&8  @K\2A]YFY:_P!\./?])C3P#7/PH/WK)[^$YMW_ $!KL!!!XH-@
MQE>L;QDBY-HWD(V3X]<>6$@P>(D<-'K%YO[<[=VT=(*ER59NHW44(<AL9+DA
MS8,7R, Z$E<K==IT##U6HP$+5JO7X]K$5^MUR*8P<!!Q3!(J#*,AX>,;I-XV
M/11(4B2**9$DR$P4A,%P H'^,+I,+&\J.)>P6C%NA.V_0UJJ\T]2+@BSYE1K
M\M(0I7/E\%3)&O4H4I\X[^P^"&-V$(7 6B^IKOJYZFZ+G(+=$)+NV%YD.*-8
MB$+"S<+,Y*/F]PL*EKUU.QSQ V%&<L@M>'#ELL0Q3HN$4E"&P8N,@((_!\<;
MZ7F@\J.6\C#H/K\I>(?C_5)IRDBH>NUJ*KD)?[DUB3Y3[VZTF^LE/]K/W&[D
MJXV(3LQE;"@77 '/*\'_ /NY^3/X*3_\\&L $O\ XOG[W;H3\-*D?F-Y  -O
MNEMLJ2TQX>75VX8?),2^I^('(7947E4O>EB1HLAMZT,3*$\L]R7M46GYX\L^
M> %=#PDN@*SM_F)R0Y,7UHI:K=H/7]>)4).96]O6CKSO.6MC.5N1U7'<JYL6
M:Q4;4S(X,H;R3L[PY\'6.DJF'0G ?$P>MM=UBWW/8%;HE.K][V.C76^PKG"5
MF&BK5>D:@E*(U0EPL#%FFZLA8Q"<F2,/;%5O9"2K@B'854^#!6BY^^*6XL\6
M=@6O3G';6<UROO\ 39%Y 6*V,;8RHNFXRQ,7"C.0C8FW%AY5[=EV;I%8BYV,
M<C&K&+@K.76QDYT@CQ6\0+UMMZ1+Q#2?2@C+15+"R<LU,8XT\LMO,'T/)MU$
M%D5I&KV2+:.FZC-8Q3G,EZ)R'SYD[<^0#5[PAK^59]0?DC7CX7C6+KB-:7\E
M#&*LD1.5@]VZ98L?61<FRH19JC-2R1<*9,<OMA\',8W< F7\7M][>T;^&[KO
M\P_) !)%T ?O/O"/_ 2[?G@V* V7ZIGWL_J"_@6\G/S,W(!6O\&__P $?.G^
M4;2/\V=A (S=@UV%YZ>*?D->;-27MM&CN5[RH/:W*+G6C'-7XJT%\]=53+5S
MW$3KKM]JF1P\;)X(1R25>9^"KDZI@Z.>,8QC&,8QC&,>6,8_> <^'Q;FG(/4
M_-#C)R2H::U4O.X=92I+'.0;HT>_=W'1]B@6U=N!'#8Q5FUB1K]HK;,KHI\&
MPC6&.$^PZ!CG"V;S@OYMK]%KD]M$Q3%-LKIP;+OQBF(9(Q37'CO)V+)3)9+C
M*><9D?B7.,>7W %?/P=%+I[BB\T[\YJM<<7J+NFJ:S%W):%C5K3&5R2@+<_D
MH&/GU&^73&&<OF;-9PV25(BNJR1.J0YD4\E"VURUI,+LGBQR3U]8V+>2@KKH
M;;E7E63HN3(KLINA3T>L4WE\4S8*OW%.7.#D.0IR9*<N,X"EEX."7?H[>YS0
M*:^2Q4EK?2DP\;?'M5?PEGOS*-7SYY^!DV]@E"X^'_RR8!?1 4O/&.4J-=ZD
MX/;&RB7$Q ;&W%2DW!.TIU(VW5FESJR*O[ZI2.J2W,GYY\D_65\OZIGS"T'T
M][,O<^!/".W.,F,YL_$;C?/NC'S@QLNI;3M-?.L&/@V<&-APNIC.<9SC/W<&
MS@!N                                           *A_-CPJD3REW]
MR!Y(U3FC(4FV[LV5>MIITRP:0;6"NQ4K<9AY.8KY[%&[,9N2QZ;IT9++S#%9
M7!/MGLAS8[#!&#P*Y[<I>@WS9^QN\P:_K)_QY>WN C+18*=3JO$R<1'WDB:5
M3WQ6+_!0D6_OE;61>QKB41LY'\DBP8.6;?$=(M%&QPGM\5(PD7G2BGW#(RF&
MT5OW3+^7P0N3%-'*.IZ+3*KDO]33][247GSS_"+C'\(!\5X3.9A)'I?VF/BT
M2(R-?Y6[4C;)DIL>HZE75)U/--79R?=*7W#*0Z.,_<S[!GX_#.,!9V 8 Y83
M$-7N+/)6P6---6O0>@-R3$\BMY>BK#1FNK&]E$U?/']3,Q07P;^UD!11\'U"
M2B_-CD]8TCFQ"Q7%HT)()X+YD-*6#;.O7\0<QOX)BM:S.8QC]_O-_P T!T+0
M$"?6UZU.O>F?K!UKK7#V#N_,K8<&O]3^CF50D&&L8M^DH@CM793-,QO9XU%3
M)C1$6KV+3;M'M[2QR+QRF$(GAU^DKM3<VYF/5AYI(S\@DXL,KLC0D;=U73BV
M[7V5.O'3USR!M97Y?5^3K9Z\>.H$ZODM*RATIE+TX]BQ4E0LN]9#G9;>G9P/
MV9R'UY7&%CV.:3KVNM?%F,E-!0%LO3AQ'L+=-LS%SF68Q:"#IV5CCMP\7;(M
ME3I(**JD"H1T)[#TZ:1L^R=1[J2<S]8S/*NQ7&SS>MJ%L5_/S5AIUA=RKY.P
M;IOI\P:R3S83]\9[F!2*<Z,4R6+*E[G[IA[H"1?Q#_4ZX#\J>G%/ZEX]<G]<
M[6V.\W!JR=;5*L*32LHK$0KZ46E7^,/8=%,K=!-1/)\Y4+^WQC'GG(#(GAT.
MHYP?TST^-$<:-H\D-?4G>\MMS8D-'ZSFE9=*PNY2_;/?%IS-+T8HZ'J/S2L?
MA'.5NW]DX[S$\C=H6Y@
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MAZX^.X6+$UIY$TJV,7D:W4RQ-*-F3MF5%0[PST.@2
M
M   .;!Q%V.QZ,_B"=GP7(9H2A:JF-A[<U9-V9WE9.*A=/;IF$[AJ79!%44<E
M6J^/1UZ[?F\OV&S4>^H7#EB=$H='0]ZI*=+-LA2XU8FO"US-P-?36")+2RU+
M$?[VS:36C+OV$M=]U_LGVWU_9O9_MWJ^G\X!SC^2FPFG64\0UK-IQ^99O&I8
M7:FH:)&61OZQXN5TGH>51L^UMD'662*5O75RHWIW&]^">V(O(U''[+>$3R$[
MGB_/O?''W\,FI_F2WH E*Z#/WHC@]_)A-?G&NH#5_P 4']Z)VW_*CHW\X<6
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M[_I,:> :Y^%!^]9/?PG-N_Z UV @K\3I]^<XK_R"\</Z0NXP'0T 4)O&._\
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M2^SL4_+'[P"OMX.+_@8YQ?RGZ<_FI=0%NC>'_ KM_P#DNV!_-.6 4;?!R_\
M#OS8_DDU5_/&R@+\8"CGXQC<<0LOPDX]1[Q!Q8FJ>U]Q6:,*;.7C")DCU6D4
M1WE(N?ZB]?1NPTRYS_#@\X+Y_.[0N \0=?/]2\2^+VJI5BI&2FL^.VD]?R4:
ML7!%8]_3=:UFN/&*I<>>"J).(U1,V,?<R3(#8L
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M[S@V@TVFXWA7MSV2QQRD'?<1%2+(:CV@H>HE6KY(4^56^#0+'+DOM&,K?/\
MG$\R]H7>0
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MF5%(F/5<-J[(.$4_2;+*IATC@
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M(]_IE"0<
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MB8L_86\Y;IKT4DNY)N98K9BQ;,HQG[2OEHR14<N3K!O(
M
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M:2\M!L%DY)[9YJQNI%--N5$Z<?%%R=4[;Y@6%P
M                  $$/6[XM]3?FWJ^)XR\+)W2]!T=;XG+O?5HNNQ+)5[]
M>EL23@C36#)E$4=^G&Z^]D;,WDDL1V9Q,*O"1JJ3:/:.TY<,I]%_I457I=<:
ML5>9/ V?DCM-2/L>_=A0V%G$>XDF:;G$!K^IO7C1%=2DP3=X\(@HJDBH_?R#
M^2410(Y09- F+
M  >)9%)PDJ@NDFN@NF=%9%8A5$545"Y(JDJD?&<*)F*8V#%SCRSCX9^ "F1S
M@\)?$;#VU9MJ<(-]UW34-:IB3LIM.;+@)=6L4N:D'ZDAEEK^YTQ-1U$U$BRQ
MB,X]S%.5H]) A"/W*?81$,Y=(/P^/)'@'S)@>6.\^1VK=B'KU(NM22JU):WN
M<D9(]L@C0J"Z]FN$?'99MVI3=^"8:K]Y28(7T_NE"V4
M
M                                \2R*3A)5!=)-=!=,Z*R*Q"J(JHJ%
MR15)5(^,X43,4QL&+G'EG'PS\ %,CG!X2^(V'MJS;4X0;[KNFH:U3$G93:<V
M7 2ZM8I<U(/U)#++7]SIB:CJ)J)%EC$9Q[F*<K1Z2!"$?N4^PB(9RZ0?A\>2
M/ /F3 \L=Y\CM6[$/7J1=:DE5J2UO<Y(R1[9!&A4%U[-<(^.RS;M2F[\$PU7
M[RDP0OI_=*%LH
M
M
M
M
M
M
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MK-%;!=>TOKA07#B7A<*HNI!ZP/"R;:7@ETD4_2D0Z!X
M
M
M
M
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MBIM;!LRPL:'74Y-HP<.<Q1+"\>Y.=FS;F7#HP@
M
M
M
M
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M!RN^9G0>8#HV
M
M
M
M
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MT3AU"RD*0I2$QVE(7!2EQ]S!2X\L8QC^Y_Z ']
M
M
M
M
M                                                   (T>H+TE^&
M?4N:UI?DI4[;FZ4F(?P-)V70+K*56X5:(E'A7[]BS:+E>0DL@H^335QB4AW_
M *9R9]'T\'4P<();#X/#BLYE$EJIRYY PD+A7&5H^Q5?7-HE%$._&3II3$;'
MQ"2*V4^[&#Y8GP4WSNS.,=N0DFX*>'7Z>_!C84)N.+BK]OK;=7>-I6H6W>LO
M7YV+HTXTR51M.TVEUFLQ<:TF47!$EFCR12E'S!RB1RP=-EB$.4)X@&O_ "6X
ML\?>86KI337)/5M8VQKN47(]S"V)!<CF)E4$5V[:>K,[&KH2%4L2+=TZ32D(
MUTU>)IN54BK>DJH0X5F-H^$#X<V.?=26I^2N_P#6,.Z5];%<L4=2=EM8_N4R
M91M&2/N^%=%983[2IX=JO'!?NJN%@%6K67'WC%P0ZSA..//V+-L#C!IK>]KI
M-TD;/'3<0RFJB_@Y9336RK5 UYYE=2LF=2VOIV58I*.FRT<HY;G(_:&,FN'2
M%B^H)TT-<52D5ZJ<ON'-?J2IH"G:[J.O]QZF68E2<F:QL!7ZE4*9.*&18D]9
MHDFBT:E1;$.3OPD3[@? =2OI3<>.J=5]5U/D%<-S4^/U#/6:PUIQIRQ4BO/G
MKRTQ\7&R*,XI=M>6%-TU*C$M3(X02;'*?)\G4/C)2E"(_P#V(5TV/X[N<7XR
MM"__ !- !_L0KIL?QW<XOQE:%_\ B: $O?37Z67'WI:TG9E#X_6_<5PB=JVF
M'MUB=;BL%)L$DTD82)4AFC>&5I6O:\BV89:JJ&4*L@X4,IGS*H4OS &I/.+P
M['3VYR;,M>[;,VVYJ'<5YE#SMUNNIKXD1"X39T$6N9&=JVPH2>C6ILH-T,'+
M$H17JY1[SF,<QSG"-1AX.[BXG8/:93E[OUY5^_.?<["I:[C9_L\R^1/E(X:.
MVW?V=^.[W3_#QGR^;Y9">#I]=)CA?TTXF8+QSH<FZOMFCR1-LW-L>4;6S:UB
MB"+HNL0JDXWC63.OP)G;5HLLPAH^,9N5F3=P[07<((J$"2P
M
M
M
M
M
M         0X=33HB<0>IY(Q5\V3\K-7;R@(AG78[<FM'+!*8E*VP<.G+*O7.
MNS+5>/M4:@J^>9;K93;2;?U"HI2.&A/9C!$#JCPAFFM?;*J=[G>:FSK-'5"V
MPEI8P43J2JU=ZY/ RS669,G4X]M\J3)3*-2$5.1B3N*<W80F0%PT
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
6                          ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>May 01, 2026</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-40323<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">RECURSION PHARMACEUTICALS, INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">46-4099738<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">41 S Rio Grande Street<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Salt Lake City,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">UT<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">84101<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">385<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">269 - 0203<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Class A Common Stock, par value $0.00001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">RXRX<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001601830<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">524,677,865<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,227,334<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 654,473<span></span>
</td>
<td class="nump">$ 743,294<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashCurrent', window );">Restricted cash</a></td>
<td class="nump">5,511<span></span>
</td>
<td class="nump">4,594<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Other receivables</a></td>
<td class="nump">13,585<span></span>
</td>
<td class="nump">24,649<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid data assets</a></td>
<td class="nump">11,742<span></span>
</td>
<td class="nump">11,742<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">24,246<span></span>
</td>
<td class="nump">28,566<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">709,557<span></span>
</td>
<td class="nump">812,845<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash, non-current</a></td>
<td class="nump">5,196<span></span>
</td>
<td class="nump">6,033<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">95,811<span></span>
</td>
<td class="nump">103,931<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">42,816<span></span>
</td>
<td class="nump">45,339<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Financing lease right-of-use assets</a></td>
<td class="nump">18,694<span></span>
</td>
<td class="nump">20,210<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">294,073<span></span>
</td>
<td class="nump">309,903<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">160,170<span></span>
</td>
<td class="nump">162,158<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred tax assets</a></td>
<td class="nump">957<span></span>
</td>
<td class="nump">957<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets, non-current</a></td>
<td class="nump">12,248<span></span>
</td>
<td class="nump">12,754<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">1,339,522<span></span>
</td>
<td class="nump">1,474,130<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">20,348<span></span>
</td>
<td class="nump">18,118<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses and other liabilities</a></td>
<td class="nump">54,205<span></span>
</td>
<td class="nump">70,230<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Unearned revenue</a></td>
<td class="nump">32,794<span></span>
</td>
<td class="nump">37,605<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities</a></td>
<td class="nump">13,087<span></span>
</td>
<td class="nump">12,663<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Notes payable and financing lease liabilities</a></td>
<td class="nump">9,265<span></span>
</td>
<td class="nump">9,091<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">129,699<span></span>
</td>
<td class="nump">147,707<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityNoncurrent', window );">Unearned revenue, non-current</a></td>
<td class="nump">114,723<span></span>
</td>
<td class="nump">114,012<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities, non-current</a></td>
<td class="nump">42,842<span></span>
</td>
<td class="nump">46,647<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Notes payable and financing lease liabilities, non-current</a></td>
<td class="nump">7,181<span></span>
</td>
<td class="nump">9,564<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred tax liabilities</a></td>
<td class="nump">18,283<span></span>
</td>
<td class="nump">23,255<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other liabilities, non-current</a></td>
<td class="nump">2,025<span></span>
</td>
<td class="nump">2,080<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">314,753<span></span>
</td>
<td class="nump">343,265<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note&#160;7)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.00001 par value; 2,000,000,000 shares (Class A 1,989,032,117 and Class B 10,967,883) authorized as of March&#160;31, 2026 and December&#160;31, 2025; 530,628,653 shares (Class A 524,464,320, Class B 5,307,334 and Exchangeable 856,999) and 528,182,693 shares (Class A 521,831,046, Class B 5,547,334 and Exchangeable 804,313) issued and outstanding as of March&#160;31, 2026 and December&#160;31, 2025, respectively</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">3,191,608<span></span>
</td>
<td class="nump">3,170,145<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(2,193,506)<span></span>
</td>
<td class="num">(2,076,002)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income (loss)</a></td>
<td class="nump">26,662<span></span>
</td>
<td class="nump">36,717<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">1,024,769<span></span>
</td>
<td class="nump">1,130,865<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="nump">$ 1,339,522<span></span>
</td>
<td class="nump">$ 1,474,130<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 815<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480870/815-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 64<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481620/480-10-55-64<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-14<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-11<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 19: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 35: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (01)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-41<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 740<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478064/805-740-55-13<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 39<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-39<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482598/350-20-45-1<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 64<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481620/480-10-55-64<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 18: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 31: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-14<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-5<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482955/340-10-05-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483032/340-10-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -SubTopic 210<br> -Topic 954<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477220/954-210-45-5<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 16: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (unaudited) (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.00001<span></span>
</td>
<td class="nump">$ 0.00001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">2,000,000,000<span></span>
</td>
<td class="nump">2,000,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">530,628,653<span></span>
</td>
<td class="nump">528,182,693<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common sock, shares outstanding (in shares)</a></td>
<td class="nump">530,628,653<span></span>
</td>
<td class="nump">528,182,693<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">1,989,032,117<span></span>
</td>
<td class="nump">1,989,032,117<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">524,464,320<span></span>
</td>
<td class="nump">521,831,046<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common sock, shares outstanding (in shares)</a></td>
<td class="nump">524,464,320<span></span>
</td>
<td class="nump">521,831,046<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">10,967,883<span></span>
</td>
<td class="nump">10,967,883<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">5,307,334<span></span>
</td>
<td class="nump">5,547,334<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common sock, shares outstanding (in shares)</a></td>
<td class="nump">5,307,334<span></span>
</td>
<td class="nump">5,547,334<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=rxrx_ExchangeableStockMember', window );">Exchangeable Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">856,999<span></span>
</td>
<td class="nump">804,313<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common sock, shares outstanding (in shares)</a></td>
<td class="nump">856,999<span></span>
</td>
<td class="nump">804,313<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=rxrx_ExchangeableStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=rxrx_ExchangeableStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Operations (unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 6,472<span></span>
</td>
<td class="nump">$ 14,745<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating costs and expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of revenue</a></td>
<td class="nump">12,490<span></span>
</td>
<td class="nump">21,829<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">87,896<span></span>
</td>
<td class="nump">129,634<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">34,591<span></span>
</td>
<td class="nump">54,650<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total operating costs and expenses</a></td>
<td class="nump">134,977<span></span>
</td>
<td class="nump">206,113<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(128,505)<span></span>
</td>
<td class="num">(191,368)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Other income (loss), net</a></td>
<td class="nump">6,397<span></span>
</td>
<td class="num">(11,277)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before income tax benefit</a></td>
<td class="num">(122,108)<span></span>
</td>
<td class="num">(202,645)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit</a></td>
<td class="nump">4,604<span></span>
</td>
<td class="nump">158<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (117,504)<span></span>
</td>
<td class="num">$ (202,487)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Per share data</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per share of class A, B and Exchangeable common stock, basic (in dollars per share)</a></td>
<td class="num">$ (0.22)<span></span>
</td>
<td class="num">$ (0.50)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per share of class A, B and Exchangeable common stock, diluted (in dollars per share)</a></td>
<td class="num">$ (0.22)<span></span>
</td>
<td class="num">$ (0.50)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average shares (Class A, B and Exchangeable) outstanding, basic (in shares)</a></td>
<td class="nump">529,303,984<span></span>
</td>
<td class="nump">402,771,972<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average shares (Class A, B and Exchangeable) outstanding, diluted (in shares)</a></td>
<td class="nump">529,303,984<span></span>
</td>
<td class="nump">402,771,972<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_LicenseAndServiceMember', window );">Operating revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 6,301<span></span>
</td>
<td class="nump">$ 14,818<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_GrantMember', window );">Grant revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 171<span></span>
</td>
<td class="num">$ (73)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 16: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-18<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479532/912-730-25-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-7<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_LicenseAndServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_LicenseAndServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_GrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_GrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Comprehensive Loss (unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (117,504)<span></span>
</td>
<td class="num">$ (202,487)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income (loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Currency translation adjustments</a></td>
<td class="num">(10,055)<span></span>
</td>
<td class="nump">21,782<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="num">(10,055)<span></span>
</td>
<td class="nump">21,782<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
<td class="num">$ (127,559)<span></span>
</td>
<td class="num">$ (180,705)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Stockholders&#8217; Equity (unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock (Class A, B and Exchangeable)</div></th>
<th class="th"><div>Additional Paid-in-Capital</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
<th class="th"><div>Accumulated other comprehensive income (loss)</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">396,802,394<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2024</a></td>
<td class="nump">$ 1,034,782<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">$ 2,473,698<span></span>
</td>
<td class="num">$ (1,431,283)<span></span>
</td>
<td class="num">$ (7,637)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(202,487)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(202,487)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="nump">21,782<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,782<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Stock option exercises and other (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,108,659<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Stock option exercises and other</a></td>
<td class="nump">2,788<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,712<span></span>
</td>
<td class="nump">76<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">36,058<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,058<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Common stock sales issuances, net of issuance costs (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,499,680<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Common stock sales issuances, net of issuance costs</a></td>
<td class="nump">41,024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41,024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Mar. 31, 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">406,410,733<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 31, 2025</a></td>
<td class="nump">$ 933,947<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">2,553,492<span></span>
</td>
<td class="num">(1,633,694)<span></span>
</td>
<td class="nump">14,145<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2025</a></td>
<td class="nump">528,182,693<span></span>
</td>
<td class="nump">528,182,693<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2025</a></td>
<td class="nump">$ 1,130,865<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">3,170,145<span></span>
</td>
<td class="num">(2,076,002)<span></span>
</td>
<td class="nump">36,717<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(117,504)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(117,504)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="num">(10,055)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10,055)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Stock option exercises and other (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,613,410<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Stock option exercises and other</a></td>
<td class="num">(752)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(752)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">$ 22,215<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,215<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Mar. 31, 2026</a></td>
<td class="nump">530,628,653<span></span>
</td>
<td class="nump">530,796,103<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 31, 2026</a></td>
<td class="nump">$ 1,024,769<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">$ 3,191,608<span></span>
</td>
<td class="num">$ (2,193,506)<span></span>
</td>
<td class="nump">$ 26,662<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 16: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows (unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (117,504)<span></span>
</td>
<td class="num">$ (202,487)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">19,673<span></span>
</td>
<td class="nump">19,331<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">22,215<span></span>
</td>
<td class="nump">36,058<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TangibleAssetImpairmentCharges', window );">Asset impairment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">5,956<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Lease expense</a></td>
<td class="nump">5,243<span></span>
</td>
<td class="nump">6,130<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Loss on disposal of a business</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,502<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income taxes</a></td>
<td class="num">(4,597)<span></span>
</td>
<td class="num">(419)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other, net</a></td>
<td class="nump">1,674<span></span>
</td>
<td class="nump">4,824<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other receivables and assets</a></td>
<td class="nump">14,746<span></span>
</td>
<td class="nump">4,839<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_IncreaseDecreaseInPrepaidDataAssets', window );">Prepaid data assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">27,131<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Unearned revenue</a></td>
<td class="num">(2,248)<span></span>
</td>
<td class="num">(9,762)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">2,070<span></span>
</td>
<td class="nump">3,692<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_IncreaseDecreaseInAccruedDevelopmentExpense', window );">Accrued development expense</a></td>
<td class="nump">730<span></span>
</td>
<td class="nump">599<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities', window );">Accrued expenses and other current liabilities</a></td>
<td class="num">(18,451)<span></span>
</td>
<td class="num">(26,591)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_IncreaseDecreaseInLeaseLiability', window );">Lease liabilities</a></td>
<td class="num">(4,652)<span></span>
</td>
<td class="num">(5,760)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(81,101)<span></span>
</td>
<td class="num">(131,957)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(258)<span></span>
</td>
<td class="num">(1,832)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Purchase of an intangible asset</a></td>
<td class="num">(80)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested', window );">Decrease in cash related to disposal of a business</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(4,438)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInvestments', window );">Purchases of investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(338)<span></span>
</td>
<td class="num">(7,270)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common shares, net of issuance costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">41,024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_ProceedsFromPaymentForShareBasedPaymentArrangement', window );">Equity incentive plans</a></td>
<td class="num">(1,262)<span></span>
</td>
<td class="nump">1,550<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities', window );">Repayment of long-term debt and finance lease liabilities</a></td>
<td class="num">(2,208)<span></span>
</td>
<td class="num">(2,047)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by (used in) financing activities</a></td>
<td class="num">(3,470)<span></span>
</td>
<td class="nump">40,527<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate changes on cash, cash equivalents and restricted cash</a></td>
<td class="num">(3,832)<span></span>
</td>
<td class="nump">4,833<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net change in cash, cash equivalents and restricted cash</a></td>
<td class="num">(88,741)<span></span>
</td>
<td class="num">(93,867)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash, beginning of period</a></td>
<td class="nump">753,921<span></span>
</td>
<td class="nump">603,024<span></span>
</td>
<td class="nump">$ 603,024<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash, end of period</a></td>
<td class="nump">665,180<span></span>
</td>
<td class="nump">509,157<span></span>
</td>
<td class="nump">$ 753,921<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Supplemental schedule of non-cash investing and financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1', window );">Purchase of an intangible asset</a></td>
<td class="nump">1,915<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Accrued property and equipment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,146<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_PurchaseOfAnEquityInvestmentNonCash', window );">Purchase of an equity investment</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 4,438<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_IncreaseDecreaseInAccruedDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Accrued Development Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_IncreaseDecreaseInAccruedDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_IncreaseDecreaseInLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Lease Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_IncreaseDecreaseInLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_IncreaseDecreaseInPrepaidDataAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Prepaid Data Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_IncreaseDecreaseInPrepaidDataAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_ProceedsFromPaymentForShareBasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds From (Payment For) Share-Based Payment Arrangement</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_ProceedsFromPaymentForShareBasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_PurchaseOfAnEquityInvestmentNonCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Purchase Of An Equity Investment, Non-Cash</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_PurchaseOfAnEquityInvestmentNonCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; including effect from exchange rate change and including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477401/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-12<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate change on cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; held in foreign currency; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 230<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477401/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 912<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478345/912-310-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in other expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activity, including, but not limited to, discontinued operation. Financing activity includes, but is not limited to, obtaining resource from owner and providing return on, and return of, their investment; borrowing money and repaying amount borrowed, or settling obligation; and obtaining and paying for other resource obtained from creditor on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activity, including, but not limited to, discontinued operation. Investing activity includes, but is not limited to, making and collecting loan, acquiring and disposing of debt and equity instruments, property, plant, and equipment, and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activity, including, but not limited to, discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of intangibles that an Entity acquires in a noncash (or part noncash) acquisition. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of all investments (debt, security, other) during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the cash inflow during the period from the sale of a component of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for debt, mandatory redeemable security, and principal payment for finance lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TangibleAssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The charge against earnings resulting from the aggregate write down of tangible assets from their carrying value to their fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TangibleAssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of the Business<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">Description of the Business</a></td>
<td class="text">Description of the Business <div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Recursion Pharmaceuticals, Inc. (Recursion, the Company, we or our) is a clinical stage TechBio company decoding biology and chemistry to industrialize drug discovery. The Recursion Operating System (Recursion OS), a platform built across diverse technologies, enables the Company to map and navigate trillions of biological and chemical relationships within the Recursion Data Universe, one of the world&#8217;s largest proprietary biological and chemical datasets. The Company integrates physical and digital components as iterative loops of atoms and bits scaling wet lab biology and chemistry data organized into virtuous cycles with computational tools to rapidly translate </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in silico </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">hypotheses into validated insights and novel chemistry.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2026, the Company had an accumulated deficit of $2.2 billion. The Company expects to incur substantial operating losses in future periods and will require additional capital to advance its drug candidates. The Company does not expect to generate significant revenue until the Company successfully completes significant drug development milestones or in collaboration&#160;with third parties, which the Company expects will take a number of years. In order to commercialize its drug candidates, the Company or its partners need to complete clinical development and comply with comprehensive regulatory requirements. The Company is subject to a number of risks and uncertainties similar to those of other companies of the same size within the biotechnology industry, such as the uncertainty of clinical trial outcomes, uncertainty of additional funding and a history of operating losses. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has funded its operations to date primarily through the issuance of Class A common stock (see Note 8, &#8220;Common Stock&#8221; for additional details). Additionally, the Company has received payments from its strategic partnerships (see Note 9, &#8220;Collaborative Development Contracts&#8221; for additional details). Recursion will likely be required to raise additional capital. As of March&#160;31, 2026, the Company did not have any unconditional outstanding commitments for additional funding. If the Company is unable to access additional funds when needed, it may not be able to continue the development of its products or the Company could be required to delay, scale back or abandon some or all of its development programs and other operations. The Company&#8217;s ability to access capital when needed is not assured and, if not achieved on a timely basis, could materially harm its business, financial condition and results of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Recursion believes that the Company&#8217;s existing cash and cash equivalents will be sufficient to fund the Company&#8217;s operating expenses and capital expenditures for at least the next 12 months from the issuance date of these financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482836/275-10-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482836/275-10-55-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock', window );">Basis of Presentation</a></td>
<td class="text">Basis of Presentation<div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited interim condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (SEC). Accordingly, certain information and footnote disclosures normally included in annual financial statements prepared in accordance with generally accepted accounting principles in the United States (U.S. GAAP) have been condensed or omitted. These unaudited interim condensed consolidated financial statements should be read in conjunction with the Company&#8217;s audited consolidated financial statements and notes for the year ended December&#160;31, 2025. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is management&#8217;s opinion that these condensed consolidated financial statements include all normal and recurring adjustments necessary for a fair statement of the financial position, results of operations and cash flows for the periods presented. Revenue and net loss for any interim period are not necessarily indicative of future or annual results.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Pronouncements </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2025, the FASB issued ASU No. 2025-10, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Government Grants (Topic 832). </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The new standard adds guidance to ASC 832 on the recognition, measurement and presentation of government grants. This standard will be effective for Recursion starting the annual period of 2029 and for interim reporting periods within that annual </span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">reporting period. Early adoption is permitted. The amendments can be applied on a prospective, modified prospective or retrospective basis. Recursion is currently assessing the impact of adopting this guidance on its consolidated financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2025, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2025-07, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives and Hedging (Topic 350) and Revenue from Contracts with Customers (Topic 606).</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The new standard refines the scope of the guidance on derivatives in Topic 815 and clarifies the guidance on shared-based payments from a customer in ASC 606. This standard will be effective for Recursion starting the annual period of 2027 and for interim reporting periods within that annual reporting period. Early adoption is permitted. Recursion is currently assessing the impact of adopting this guidance on its consolidated financial statements. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2025, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2025-06, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounting for internal-use software costs (Topic 350)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The new standard amends specific aspects of the accounting for internal-use software costs including the criteria for capitalizing software costs. It also amends the related disclosure requirements. This standard will be effective for Recursion starting the annual period ending 2028 and for interim reporting periods within that annual reporting period. Early adoption is permitted. The amendments can be applied on a prospective, modified prospective or retrospective basis. Recursion is currently assessing the impact of adopting this guidance on its consolidated financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2024, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2024-03, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disaggregation of Income Statement Expenses (Topic 220)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The standard requires new disclosures in the notes to the financial statements about certain caption expenses presented on the face of the Income Statement including information on: purchases of inventory; employee compensation; depreciation and intangible asset amortization. Recursion must also disclose a qualitative description of the amounts remaining in expense captions that are not separately disaggregated. This standard will be effective for Recursion starting the annual period of 2027. Early adoption is permitted. The amendments can be applied on a prospective or retrospective basis. Recursion is currently assessing the impact of adopting this guidance on its consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Financial Information<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_SupplementalFinancialInformationAbstract', window );"><strong>Supplemental Financial Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_SupplementalBalanceSheetAndIncomeStatementInformationTextBlock', window );">Supplemental Financial Information</a></td>
<td class="text">Supplemental Financial Information <div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Tempus agreement</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2023, Recursion entered into a five-year agreement (the Tempus Agreement) with Tempus AI, Inc. (Tempus) to purchase access to their records of patient-centric multimodal oncology data and use rights for therapeutic development purposes. This data will be used to improve the training of Recursion&#8217;s artificial intelligence and machine learning models and is expected to accelerate Recursion&#8217;s drug discovery process. Recursion is making annual payments, ranging between $22.0&#160;million and $42.0&#160;million, up to $160.0&#160;million in aggregate, to Tempus in cash or equity at the Company&#8217;s option. The equity value is determined by using the <span style="-sec-ix-hidden:f-283">seven</span>-trading day period dollar volume-weighted average price (VWAP) for Recursion Class A common stock ending on the day immediately preceding the date that is <span style="-sec-ix-hidden:f-284">five</span> business days prior to the payment date.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Recursion is expensing the record purchases based on a contractually agreed price as &#8220;Research and Development&#8221; expenses in the Condensed Consolidated Statements of Operations as the records are downloaded. To the extent that the Recursion payments to Tempus are greater than or less than the records purchased amount, Recursion records the applicable amount to &#8220;Prepaid data assets&#8221; or &#8220;Accrued data liability&#8221; on the Condensed Consolidated Balance Sheet, respectively. Recursion did not purchase any records for the three months ended March 31, 2026. For the three months ended March 31, 2025, record purchases were $27.1 million. </span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accrued Expenses and Other Liabilities</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.660%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.521%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,566&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,771&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compute liabilities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,535&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,278&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued development expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,214&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,693&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued early discovery expenses</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,535&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,581&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional fees</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,875&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,232&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Materials received not invoiced</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,010&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">703&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued license fees</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,915&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued other expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,555&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,972&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expense and other liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,205&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,230&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Income, Net</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.461%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,963&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,558&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(350)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(508)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,613&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,050&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March 31, 2026 and 2025, interest income primarily related to earnings on cash and cash equivalents in money market funds. Interest expense primarily related to the Company&#8217;s supercomputer financing lease. Interest income, net was included in &#8220;Other income (loss), net&#8221; on the Condensed Consolidated Statements of Operations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_SupplementalBalanceSheetAndIncomeStatementInformationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Supplemental Balance Sheet And Income Statement Information</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_SupplementalBalanceSheetAndIncomeStatementInformationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_SupplementalFinancialInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Supplemental Financial Information</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_SupplementalFinancialInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Acquisitions</a></td>
<td class="text">Acquisitions<div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">RE Ventures I</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2025, Recursion acquired Rallybio&#8217;s interest in the joint venture, RE Ventures I, such that Recursion now owns 100% of the interest in RE Ventures I for total consideration of $20.2 million. Recursion determined that this transaction met the criteria for as an asset acquisition since the lead asset, ENPP1 (Rec-102), an inhibitor program for the treatment of hypophosphatasia (HPP), represented substantially all of the fair value of the gross assets acquired. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to closing, in August 2025, Recursion issued additional consideration as part of a required milestone payment. As a result, Recursion recorded an additional expense of $2.4 million </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the agreement, Rallybio is eligible to receive additional milestone payments under certain conditions. Milestone payment obligations that are incurred prior to regulatory approval of the compound will be expensed as acquired IPR&amp;D when recognized.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sale of Exscientia GmbH</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2025, Recursion completed the sale of its Austrian operations (Exscientia GmbH) to Alpha Biotechnology GmbH (Alpha). As part of the sale, Recursion obtained a 49% equity interest in Alpha. For the year ended December 31, 2025, Recursion recorded a loss on the disposal of Exscientia GmbH of $4.5 million, which was classified as &#8220;Other income (loss), net&#8221; on the Condensed Consolidated Statement of Operations. Recursion also </span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">recorded a $4.4 million investment on the Condensed Consolidated Balance Sheet within &#8220;Other assets, non-current&#8221; related to its 49% equity interest in Alpha, which was determined to be an equity method investment.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 38<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-38<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 46<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-46<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 43<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-43<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 45<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-45<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 29<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-29<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 29<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-29<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-5<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-3<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-4<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-4<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479326/805-40-45-1<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/805-30/tableOfContent<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/805-20/tableOfContent<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-5<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/805-10/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases <div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has entered into various long-term real estate operating leases primarily related to office, research and development and operating activities and an equipment financing lease related to the supercomputer. The Company&#8217;s leases have remaining terms from under one year to seven years and some of those leases include options that provide Recursion with the ability to extend the lease term, generally for five years. The options are included in the lease term when it is reasonably certain that the option will be exercised. </span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three months ended March 31, 2025,</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Recursion entered into operating lease modifications and terminations resulting in a decrease to the right-of-use asset and lease liability of $10.1&#160;million. The modifications had no impact to the Condensed Consolidated Statements of Operations.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to leases were:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.028%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.837%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amount included in the measurement of lease liabilities: </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,316&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,265&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from financing leases</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash flows from financing leases</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,178&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,019&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets additions, modifications and termination:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,084)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeFinanceLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases <div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has entered into various long-term real estate operating leases primarily related to office, research and development and operating activities and an equipment financing lease related to the supercomputer. The Company&#8217;s leases have remaining terms from under one year to seven years and some of those leases include options that provide Recursion with the ability to extend the lease term, generally for five years. The options are included in the lease term when it is reasonably certain that the option will be exercised. </span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three months ended March 31, 2025,</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Recursion entered into operating lease modifications and terminations resulting in a decrease to the right-of-use asset and lease liability of $10.1&#160;million. The modifications had no impact to the Condensed Consolidated Statements of Operations.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to leases were:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.028%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.837%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amount included in the measurement of lease liabilities: </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,316&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,265&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from financing leases</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash flows from financing leases</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,178&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,019&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets additions, modifications and termination:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,084)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeFinanceLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/842-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeFinanceLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/842-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">Goodwill and Intangible Assets</a></td>
<td class="text">Goodwill and Intangible Assets <div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes in the carrying amount of goodwill: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:82.964%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.836%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2025</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162,158&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,988)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2026</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160,170&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No goodwill impairment was recorded during the three months ended March 31, 2026 and 2025.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible Assets, Net</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes intangible assets:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:21.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.888%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2025</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross carrying amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net carrying amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross carrying amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net carrying amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Definite-lived technology intangible assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233,086&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(79,725)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153,361&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236,497&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(69,156)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167,341&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Definite-lived licensed intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,072&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,908)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,164&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,158&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,619)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,539&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite-lived intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135,548&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135,548&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138,023&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138,023&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">381,706&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87,633)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294,073&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">385,678&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75,775)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309,903&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense was $12.7 million and $11.7 million during the three months ended March 31, 2026 and 2025, respectively. Amortization expense was included in &#8220;Research and Development&#8221; in the Condensed Consolidated Statements of Operations. Intangible assets, net decreased by $5.2 million during the three months ended March 31, 2026 due to foreign currency translation adjustments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No indefinite-lived intangible asset impairment charges were recorded during the three months ended March 31, 2026 and 2025.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/350-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/350-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">Commitments and Contingencies<div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contract Obligations</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, the Company enters into contracts with clinical research organizations, drug manufacturers and other vendors&#160;for preclinical and clinical research studies, research and development supplies and other services and products for operating purposes. These contracts generally provide for termination on notice and are cancellable contracts.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Indemnification</span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has agreed to indemnify its officers and directors for certain events or occurrences, while the officer or director is or was serving at the Company&#8217;s request in such capacity. The Company purchases directors and officers liability insurance coverage that provides for reimbursement to the Company for covered obligations and this is intended to limit the Company&#8217;s exposure and enable it to recover a portion of any amount it pays under its indemnification obligations. The Company had no liabilities recorded for these agreements as of March&#160;31, 2026 and December&#160;31, 2025, as no amounts were probable. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employee Agreements </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has signed employment agreements with certain key employees pursuant to which, if their employment is terminated following a change of control of the Company, the employees are entitled to receive certain benefits, including accelerated vesting of equity incentives. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Legal Matters</span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may, from time to time, be involved in various legal proceedings arising in the normal course of business. An unfavorable resolution of any such matter could materially affect the Company&#8217;s future financial position, results of operations or cash flows. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2021, the Company entered into a lease agreement for laboratory and office space (the Industry Lease) with Industry Office SLC, LLC (the landlord). In March 2023, the Company sent a letter to the landlord detailing numerous construction delays and irregularities, deficiencies and deviations from applicable structural drawings and/or non-conforming conditions with applicable building codes (collectively, the Claims). On June&#160;23, 2023, the </span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">landlord filed a lawsuit against the Company (Industry Office SLC, LLC v. Recursion Pharmaceuticals, Inc., Case No. 230904627) amended in October 2023, in the Third District Court for Salt Lake County, State of Utah (the Court), alleging anticipatory repudiation, breach of contract and breach of the implied covenant of good faith and fair dealing and seeks monetary damages and attorney&#8217;s fees. As of March&#160;31, 2026, the Company had no liability recorded for these events as an unfavorable outcome was not probable. In September 2023, the Company filed claims in the Court against the landlord alleging, among other things, breach of contract and fraudulent misrepresentation (the Counterclaims). In October 2023, the landlord filed an answer and denied the Company&#8217;s allegations asserted in the Counterclaims. The Company and the landlord are currently engaged in discovery. The Company is unable to estimate the possible amount or range of damages associated with the Counterclaims.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pledged Assets</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2026, assets pledged as collateral against finance leases totaled $15.2 million. Assets pledged as collateral are Lab Equipment reported in &#8220;Property and Equipment, net&#8221; on the Condensed Consolidated Balance Sheet. As of March&#160;31, 2026, the liabilities associated with collateral pledged were solely comprised of a finance lease and had a carrying value of $16.2 million. The collateral pledged under the lease agreement may only be operated by the Company within the continental United States and must maintain a good title. The assets cannot be sold, disposed of or repledged by the Company.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 405<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/405-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/450/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478522/954-440-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Common Stock<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Common Stock</a></td>
<td class="text">Common Stock <div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each share of Class A common stock entitles the holder to one vote per share and each share of Class B common stock entitles the holder to 10 votes per share on all matters submitted to a vote of the Company&#8217;s stockholders. Common stockholders are entitled to receive dividends, as may be declared by the Company&#8217;s Board of Directors. As of March&#160;31, 2026 and December&#160;31, 2025, no dividends had been declared. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">At-The-Market Offerings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In </span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February 2026</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company entered into a Sales Agreement (the TD Cowen Sales Agreement) with TD Securities (USA), LLC (the TD Cowen Sales Agent), to provide for the offering, issuance and sale of up to an aggregate amount of $300 million of its Class A common stock from time to time in at-the-market offerings (the TD Cowen ATM Offering). The TD Cowen ATM Offering was made under a prospectus supplement dated February&#160;24, 2026 and related prospectus filed with the Securities and Exchange Commission pursuant to the Company&#8217;s automatically effective shelf registration statement on Form S-3 (Registration No. 333-284878). </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March 31, 2026, the Company sold no</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">shares. As of&#160;March&#160;31, 2026, an amount of $300.0 million remained available for future sales under the Sales Agreement.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to </span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February 2026, Recursion had entered into sales agreements with Citigroup Capital Markets Inc. and Jefferies LLC. See Note 8, &#8220;Common Stock,&#8221; in the Company&#8217;s Annual Report on Form 10-K for the year ended </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2025</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Valence Acquisition Exchangeable Shares</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In </span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">May 2023</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, in connection with the acquisition of Valence Discovery Inc. (Valence), the Company entered into an agreement to issue up to 5.9&#160;million shares of Class A common stock (the Exchangeable Shares), that may be issued upon exchange of exchangeable shares of a subsidiary of Recursion. The Exchangeable Shares are substantially the economic equivalent of the Class A shares and classified as common stock within the Company&#8217;s stockholders&#8217; equity. The Company&#8217;s calculation of weighted-average shares outstanding includes the exchangeable shares. As of March&#160;31, 2026, 4.9&#160;million Exchangeable Shares have been redeemed for Class A shares.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Registration Rights Agreements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Tempus agreement</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In </span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">November 2023</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, in connection with the Tempus Agreement, the Company filed a registration statement for resale of the shares of Class A common stock issued or issuable under the Tempus Agreement. A new registration </span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">statement (333-284878) was filed in February 2025 and a prospectus supplement covering all shares that have been issued under the Tempus Agreement and remained held by Tempus was filed in May 2025 and in November 2025, a prospectus supplement was filed to register shares issued to Tempus in payment for the 2025 annual fee.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After registration of any shares issued to Tempus under the Tempus Agreement, the Company has agreed to use commercially reasonable efforts to keep such registration statement effective until such date that all shares issued to Tempus covered by such registration statement have been sold. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Acquisitions</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2024, in connection with the acquisition of Exscientia plc (Exscientia), the Company filed a Registration Agreement providing for the resale of the shares of Class A common stock issued for Recursion stock options and RSUs. A registration statement on Form S-8 (File No. 333-283347) was filed to register the shares for resale by the holders. The registration statement must remain effective as long as such Recursion stock options and RSUs remain outstanding.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2023, in connection with the acquisition of Valence, the Company filed a Registration Agreement providing for the resale of the shares of Class A common stock and Exchange Shares issued or issuable in such transaction. A registration statement on Form S-3ASR (File No. 333-272281) was filed to register the shares for resale by the holders. The registration statement must remain effective for a period of not less than three years. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Class A and B Common Shares Authorization</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2021, the Company&#8217;s Board of Directors authorized two classes of common stock, Class A and Class B. The rights of the holders of Class A and B common stock are identical, except with respect to voting and conversion. Each share of Class A common stock is entitled to one vote per share. Each share of Class B common stock is entitled to 10 votes per share and is convertible at any time into one share of Class A common stock.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480237/815-40-50-6<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/505/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-16<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Collaborative Development Contracts<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementDisclosureTextBlock', window );">Collaborative Development Contracts</a></td>
<td class="text">Collaborative Development Contracts <div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sanofi</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Description</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In </span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">January 2022</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company and Sanofi entered into a collaboration agreement to develop an AI-driven pipeline of precision-engineered medicines. The research is focused on up to 15 novel small molecule candidates across oncology and immunology and utilizes the Company&#8217;s AI platform. The Company is leading small molecule drug design and lead optimization activities with Sanofi assuming responsibility for preclinical and clinical development, manufacturing and commercialization.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Pricing</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company received a $100.0 million non-refundable upfront payment. The Company has received multiple milestone payments related to this agreement totaling approximately $34.0 million. These related to the advancement of several of the discovery programs within the collaboration and the addition of an existing Company program into the collaboration. Recursion is eligible for additional milestone payments based on performance progress of the collaboration and tiered royalties ranging from high-single-digits to mid-teens. Recursion could earn a maximum of $555.0 million from all research milestones and $1.8 billion from all development and regulatory milestones.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Accounting</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Recursion has determined that it has at least eight performance obligations related to the small molecule projects. These performance obligations are for performing research and development services for Sanofi to design small molecules and perform lead optimization activities. The performance obligations also include potential licenses related to the intellectual property. The Company concluded that licenses within the contract are not distinct from the research and development services as they are interrelated due to the fact that the research and development services significantly impact the potential licenses. Any additional services are considered customer options and will be considered as separate contracts for accounting purposes.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has determined the transaction price to be $154.5 million, for the initial performance obligations, comprised of the upfront payment, several milestones that have been achieved and estimated additional target exercises. Recursion has fully constrained the amounts of remaining variable consideration to be received from potential milestones considering the stage of development and the risks associated with the remaining development required to achieve each milestone. Recursion will re-evaluate the transaction price each reporting period. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue over time based on costs incurred relative to total expected costs to perform the research and development services. Recursion was unable to estimate the completion date of the performance obligations due to the current stage of work.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Merck KGaA (Merck)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Description</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In </span><span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">September 2023</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company and Merck entered into a collaboration agreement to discover novel small molecule drug candidates across oncology, neuroinflammation and immunology. The collaboration utilizes the Company&#8217;s AI platform and the Company is performing drug design and discovery while Merck will be assuming responsibility for the preclinical and clinical development.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Pricing</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company received a $20.1 million non-refundable upfront payment. Recursion is eligible for additional milestone payments based on performance progress of the collaboration and tiered royalties from the mid-single-digits to low-double-digits. The Company could earn a maximum of $73.0 million for discovery, development and sales milestones per project.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Accounting</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Recursion has determined that it has three performance obligations related to the small molecule projects and the transaction price to be $20.1 million. Recursion has fully constrained the amounts of remaining variable consideration to be received from potential milestones. Recursion will re-evaluate the transaction price each reporting period. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue over time based on costs incurred relative to total expected costs to perform the research and development services. Recursion was unable to estimate the completion date of the performance obligations due to the current stage of work.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Roche and Genentech</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Description</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2021, Recursion entered into a collaboration and license agreement with Roche and Genentech (collectively referred to as Roche). Recursion is constructing, using the Company&#8217;s imaging technology and proprietary machine-learning algorithms, unique maps of the inferred relationships amongst perturbation phenotypes in a given cellular context with the goal to discover and develop therapeutic small molecule programs in a gastrointestinal cancer indication and in key areas of neuroscience. Roche and Recursion will collaborate to select certain novel inferences with respect to small molecules or targets generated from the Phenomaps for further validation and optimization as collaboration programs. Roche and Recursion may also combine sequencing datasets from Roche with Recursion&#8217;s Phenomaps and collaborate to generate new algorithms to produce multi-modal maps from which additional collaboration programs may be initiated. For every collaboration program that successfully identifies potential therapeutic small molecules or validates a target, Roche will have an option to obtain an exclusive license to develop and commercialize such potential therapeutic small molecules or to exploit such target in the applicable exclusive field.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Pricing</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In January 2022, Recursion received a $150.0 million non-refundable upfront payment from the Company&#8217;s collaboration with Roche. In September 2024, Recursion received a $30.0 million milestone payment ( &#8220;acceptance fee 1&#8221;), which was an acceptance fee related to the first accepted neuroscience Phenomap. In October 2025, Recursion received another $30.0 million milestone payment (&#8220;acceptance fee 2&#8221;), which was an acceptance fee related to the second accepted neuroscience Phenomap. Recursion is eligible for additional milestone payments based on performance progress of the collaboration. Each of the Phenomaps requested by Roche and created by Recursion may be subject to either an initiation fee, acceptance fee or both. Such fees could exceed $250.0 million for 16 accepted Phenomaps. In addition, for a period of time after Roche&#8217;s acceptance of certain Phenomaps, </span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Roche will have the option to obtain, subject to payment of an exercise fee, rights to use outside the collaboration the raw images generated in the course of creating those Phenomaps. If Roche exercises its external use option for all 12 eligible Phenomaps, Roche&#8217;s associated exercise fee payments to Recursion could exceed $250.0 million. Under the collaboration, Roche may initiate up to 40 programs, each of which, if successfully developed and commercialized, could yield more than $300.0&#160;million in development, commercialization and net revenue milestones for Recursion, as well as tiered royalties on net revenue.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Accounting</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Recursion has determined that it has three performance obligations, one related to gastrointestinal cancer and two in neuroscience. These performance obligations are for performing research and development services for Roche to identify targets and medicines. The performance obligations also include potential licenses related to the intellectual property. The Company concluded that licenses within the contract are not distinct from the research and development services as they are interrelated due to the fact that the research and development services significantly impact the potential licenses. Any additional services are considered customer options and will be considered as separate contracts for accounting purposes.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company has determined the transaction price to be $210.0 million, comprised of the upfront payment and the acceptance fees. The consideration did not include the $30.0 million variable consideration for the first acceptance fee until the map was accepted, which was during the third quarter of 2024. As a result of Roche&#8217;s acceptance of the neuroscience Phenomap, Recursion is now recognizing the acceptance fee as part of the transaction price over the completion period of one of the neuroscience performance obligations. The consideration did not include the $30.0 million variable consideration for the second acceptance fee until the map was accepted, which was during the fourth quarter of 2025. As a result of Roche&#8217;s acceptance of the neuroscience Phenomap, Recursion is now recognizing the acceptance fees as part of the transaction price over the completion period of one of the neuroscience performance obligations. Recursion has fully constrained the remaining amounts of variable consideration to be received from potential milestones considering the stage of development and the risks associated with the remaining development required to achieve each milestone. Recursion will re-evaluate the transaction price each reporting period.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue over time based on costs incurred relative to total expected costs to perform the research and development services. Recursion has estimated the completion of the performance obligations by 2028.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Additional Revenue Disclosures</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Of the revenue recognized during the three months ended March 31, 2026 and 2025, $4.4 million and $14.7 million was included in the unearned revenue balance as of December&#160;31, 2025 and December&#160;31, 2024, respectively. Revenue recognized was from the upfront and variable consideration payments received from the related contracts, which decreased the aggregate unearned revenue recognized. As of March&#160;31, 2026, the Company had $5.2 million of costs incurred to fulfill a contract on its Condensed Consolidated Balance Sheet within &#8220;Other Current Assets.&#8221;</span></div>Unearned revenue was classified as short-term and long-term on the Condensed Consolidated Balance Sheets based on the Company&#8217;s estimate of revenue that will be recognized during the next twelve months.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 808<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479402/808-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 808<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479402/808-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 808<br> -Publisher FASB<br> -URI https://asc.fasb.org/808/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock-Based Compensation</a></td>
<td class="text">Stock-Based Compensation <div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2021, the Board of Directors and the stockholders of the Company adopted the 2021 Equity Incentive Plan (the 2021 Plan). The Company may grant stock options, restricted stock units (RSUs), stock appreciation rights, restricted stock awards and other forms of stock-based compensation. As of March&#160;31, 2026, 27.1&#160;million shares of Class A common stock were available for grant in the 2021 plan. In November 2024, the Board of Directors and the stockholders of the Company adopted the 2024 Inducement Equity Incentive Plan (the 2024 Plan) as part of the Exscientia acquisition. As of March&#160;31, 2026, 11.3&#160;million shares of Class A common stock were available for grant in the 2024 plan.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the classification of stock-based compensation expense for employees and non-employees within the Condensed Consolidated Statements of Operations: </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:76.677%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.012%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">900&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,950&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,876&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,800&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,219&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,839&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,995&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,589&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">RSUs</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity awards granted to employees primarily consist of RSUs and generally vest over four years. The weighted-average grant-date fair value of RSUs generally is determined based on the number of units granted and the quoted price of Recursion&#8217;s common stock on the date of grant.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes Recursion&#8217;s RSU activity during the three months ended March 31, 2026: </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.784%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stock units</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-average grant date fair value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding as of December 31, 2025</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,489,925&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.55&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,154,778&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.98&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,703,740)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,375,565)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding as of March 31, 2026</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,565,398&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.99&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair market value of RSUs vested was $18.1 million during the three months ended March 31, 2026. As of March&#160;31, 2026, $159.1 million of unrecognized compensation cost related to RSUs is expected to be recognized as expense over approximately the next three years.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/718/tableOfContent<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income Taxes <div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company did not incur a significant amount of U.S. income tax expense during the three months ended March 31, 2026 and 2025. The Company has historically incurred operating losses and continues to maintain a full valuation allowance against most of its U.S. net deferred tax assets. Foreign income tax benefits were $5.5 million</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for the three months ended March 31, 2026 and the Company did not incur a significant amount for 2025. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s U.S. net operating loss (&#8220;NOL&#8221;) and tax credit carryforwards are subject to review and adjustment by the Internal Revenue Service (&#8220;IRS&#8221;) and may be subject to annual limitations under Section 382 of the Internal Revenue Code, as amended and similar state provisions in the event of certain ownership changes. These ownership changes may limit the amount of NOLs and other tax attributes that can be utilized annually to offset future taxable income. In general, an ownership change, as defined by Section 382, occurs when the ownership of certain shareholders or public groups increases by more than 50% over a rolling three-year period. As of March&#160;31, 2026, the Company completed a Section 382 study covering the period through January&#160;31, 2025 and concluded that a deemed ownership change occurred on September&#160;25, 2017. As a result, the Company&#8217;s ability to utilize its NOLs and other tax attributes may be subject to annual limitations. The Company will continue to monitor ownership changes that could result in additional limitations on the utilization of its tax attributes. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company files income tax returns in the United States (federal and various state jurisdictions), Canada and the United Kingdom and is subject to examination by taxing authorities in these jurisdictions. The Company is not currently under examination by any taxing authority. For U.S. federal income tax purposes, tax years beginning with 2016 remain open for examination.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 740<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477617/942-740-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 740<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478822/944-740-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12C<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12B<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477891/740-270-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-13<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/740/tableOfContent<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-14<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-21<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Loss Per Share</a></td>
<td class="text">Net Loss Per Share<span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March 31, 2026 and 2025, Recursion calculated net loss per share of Class A, Class B and the Exchangeable common stock. Basic net loss per share is computed using the weighted-average number of shares outstanding during the period. Diluted net loss per share is computed using the weighted-average number of shares and the effect of potentially dilutive securities outstanding during the period. Potentially dilutive securities consist of stock options and other contingently issuable shares. For periods presented in which the Company reports a net loss, all potentially dilutive shares are anti-dilutive and as such are excluded from the calculation. For the three months ended March 31, 2026 and 2025, the Company reported a net loss and therefore basic and diluted loss per share were the same.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The rights, including the liquidation and dividend rights, of the holders of the Company&#8217;s Class A, Class B and the Exchangeable common stock are identical, except with respect to voting. As a result, the undistributed earnings for each period are allocated based on the contractual participation rights of the Class A, Class B and the Exchangeable common stock as if the earnings for the period had been distributed. As the liquidation and dividend rights are identical, the undistributed earnings are allocated on a proportionate basis and the resulting amount per share for Class A, Class B and the Exchangeable common stock was the same during the three months ended March 31, 2026 and 2025.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables set forth the computation of basic and diluted net loss per share of Class A, Class B and Exchangeable common stock:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.058%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands, except share and per share amounts)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(117,504)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(202,487)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">529,303,984&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">402,771,972&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per share, basic and diluted</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.22)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.50)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company excluded the following potential common shares from the computation of diluted net loss per share for the periods indicated because including them would have had an anti-dilutive effect: </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.057%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.205%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Stock based compensation</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,504,219&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,896,288&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tempus agreement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,369,128&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,504,219&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,265,416&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/260/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text">Fair Value Measurements<div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value hierarchy consists of the following three levels:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1 &#8212; Valuations based on unadjusted quoted prices in active markets for identical assets that the company has the ability to access;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2 &#8212; Valuations based on quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active and model-based valuations in which all significant inputs are observable in the market; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3 &#8212; Valuations using significant inputs that are unobservable in the market and include the use of judgment by the company's management about the assumptions market participants would use in pricing the asset or liability.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is required to maintain a cash balance in a collateralized account to secure the Company&#8217;s credit cards. Additionally, the Company holds restricted cash related to an outstanding letter of credit issued by J.P. Morgan, which was obtained to secure certain Company obligations relating to tenant improvements. Recursion also holds restricted cash as required by a lease agreement. The Company also holds restricted cash as required by several grant agreements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the Company&#8217;s assets and liabilities that are measured at fair value on a recurring basis:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.514%"><tr><td style="width:1.0%"></td><td style="width:43.727%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.741%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.543%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.744%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.745%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2026</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basis of fair value measurement</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,442&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,442&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">609,031&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">609,031&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,707&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,707&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">665,180&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">665,180&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.098%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.297%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.452%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2025</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basis of fair value measurement</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,627&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,627&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">670,667&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">670,667&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,627&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,627&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">753,921&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">753,921&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the financial instruments that are recognized at fair value on the Condensed Consolidated Balance Sheet, the Company has certain financial instruments that are recognized at amortized cost or some basis other than fair value. The carrying amount of these instruments are considered to be representative of their approximate fair values. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the Company&#8217;s financial instruments that are not measured at fair value: </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.531%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.992%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.448%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Book values</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair values</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2025</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes payable and financing lease liabilities, current</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,265&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,091&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,265&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,091&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes payable and financing lease liabilities, non-current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,181&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,564&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,181&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,564&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,446&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,655&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,446&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,655&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 107<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-107<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 940<br> -SubTopic 820<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478119/940-820-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Information</a></td>
<td class="text">Segment Information<div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Segment loss</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Recursion operates as a single operating segment that is managed on a consolidated basis. The Company&#8217;s chief operating decision maker (CODM) is its Chief Executive Officer. The CODM uses segment net loss to evaluate the performance of its segment, analyze financial trends, compare the budget to the actual operating results and make resource allocation decisions. Segment net loss represents the Company&#8217;s consolidated net loss. All corporate costs, global function support costs, overhead costs and other shared costs are included within this segment. Other segment items primarily include general and administrative expenses including facilities, information technology, professional fees (including auditing, tax and legal) and insurance.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents Recursion&#8217;s segment revenue, significant segment expenses, and segment net loss: </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.484%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:112%">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,472&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">14,745&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Significant segment expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Salaries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,298&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">83,554&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Consumables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,146&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">54,677&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Platform</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,614&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">8,765&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Discovery</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,332&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">6,287&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Clinical development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,569&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">10,564&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,673&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">19,331&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Other segment items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,345&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">22,935&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Loss from operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,505&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191,368&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Other non-operating income (loss), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,397&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,277)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Income tax benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,604&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">158&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Total segment loss</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">117,504&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">202,487&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Supplemental asset information</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Total expenditures for additions to long-lived assets</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">2,978&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-15<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 34<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-34<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/280/tableOfContent<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Arrangements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2026 </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrByIndTable', window );"><strong>Trading Arrangements, by Individual</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrAdoptedFlag', window );">Non-Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrTrmntdFlag', window );">Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrTrmntdFlag', window );">Non-Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=rxrx_NamandjeBumpusMember', window );">Namandj&#233; Bumpus [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrByIndTable', window );"><strong>Trading Arrangements, by Individual</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MtrlTermsOfTrdArrTextBlock', window );">Material Terms of Trading Arrangement</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 3, 2026, Namandj&#233; Bumpus, a member of our Board of Directors, adopted a Rule 10b5-1 trading arrangement that is intended to satisfy the affirmative defense of Rule 10b5-1(c) for the potential sale of up to 12,735 shares of the Company&#8217;s Class A common stock until June&#160;2, 2027</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrIndName', window );">Name</a></td>
<td class="text">Namandj&#233; Bumpus<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrIndTitle', window );">Title</a></td>
<td class="text">a member of our Board of Directors<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrAdoptedFlag', window );">Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrAdoptionDate', window );">Adoption Date</a></td>
<td class="text">March 3, 2026<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrExpirationDate', window );">Expiration Date</a></td>
<td class="text">June&#160;2, 2027<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrDuration', window );">Arrangement Duration</a></td>
<td class="text">456 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrSecuritiesAggAvailAmt', window );">Aggregate Available</a></td>
<td class="nump">12,735<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_MtrlTermsOfTrdArrTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_MtrlTermsOfTrdArrTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TradingArrByIndTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TradingArrByIndTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TrdArrAdoptionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TrdArrAdoptionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TrdArrDuration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph C<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TrdArrDuration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TrdArrExpirationDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph C<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TrdArrExpirationDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TrdArrIndName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TrdArrIndName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TrdArrIndTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TrdArrIndTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TrdArrSecuritiesAggAvailAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph D<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TrdArrSecuritiesAggAvailAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_IndividualAxis=rxrx_NamandjeBumpusMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_IndividualAxis=rxrx_NamandjeBumpusMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited interim condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (SEC). Accordingly, certain information and footnote disclosures normally included in annual financial statements prepared in accordance with generally accepted accounting principles in the United States (U.S. GAAP) have been condensed or omitted. These unaudited interim condensed consolidated financial statements should be read in conjunction with the Company&#8217;s audited consolidated financial statements and notes for the year ended December&#160;31, 2025. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is management&#8217;s opinion that these condensed consolidated financial statements include all normal and recurring adjustments necessary for a fair statement of the financial position, results of operations and cash flows for the periods presented. Revenue and net loss for any interim period are not necessarily indicative of future or annual results.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Pronouncements </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2025, the FASB issued ASU No. 2025-10, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Government Grants (Topic 832). </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The new standard adds guidance to ASC 832 on the recognition, measurement and presentation of government grants. This standard will be effective for Recursion starting the annual period of 2029 and for interim reporting periods within that annual </span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">reporting period. Early adoption is permitted. The amendments can be applied on a prospective, modified prospective or retrospective basis. Recursion is currently assessing the impact of adopting this guidance on its consolidated financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2025, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2025-07, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives and Hedging (Topic 350) and Revenue from Contracts with Customers (Topic 606).</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The new standard refines the scope of the guidance on derivatives in Topic 815 and clarifies the guidance on shared-based payments from a customer in ASC 606. This standard will be effective for Recursion starting the annual period of 2027 and for interim reporting periods within that annual reporting period. Early adoption is permitted. Recursion is currently assessing the impact of adopting this guidance on its consolidated financial statements. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2025, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2025-06, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounting for internal-use software costs (Topic 350)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The new standard amends specific aspects of the accounting for internal-use software costs including the criteria for capitalizing software costs. It also amends the related disclosure requirements. This standard will be effective for Recursion starting the annual period ending 2028 and for interim reporting periods within that annual reporting period. Early adoption is permitted. The amendments can be applied on a prospective, modified prospective or retrospective basis. Recursion is currently assessing the impact of adopting this guidance on its consolidated financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2024, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2024-03, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disaggregation of Income Statement Expenses (Topic 220)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The standard requires new disclosures in the notes to the financial statements about certain caption expenses presented on the face of the Income Statement including information on: purchases of inventory; employee compensation; depreciation and intangible asset amortization. Recursion must also disclose a qualitative description of the amounts remaining in expense captions that are not separately disaggregated. This standard will be effective for Recursion starting the annual period of 2027. Early adoption is permitted. The amendments can be applied on a prospective or retrospective basis. Recursion is currently assessing the impact of adopting this guidance on its consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Financial Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_SupplementalFinancialInformationAbstract', window );"><strong>Supplemental Financial Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock', window );">Schedule of Accrued Expenses and Other Liabilities</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accrued Expenses and Other Liabilities</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.660%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.521%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,566&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,771&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compute liabilities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,535&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,278&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued development expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,214&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,693&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued early discovery expenses</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,535&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,581&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional fees</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,875&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,232&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Materials received not invoiced</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,010&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">703&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued license fees</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,915&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued other expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,555&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,972&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expense and other liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,205&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,230&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock', window );">Schedule of Interest Income, Net</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Income, Net</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.461%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,963&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,558&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(350)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(508)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,613&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,050&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_SupplementalFinancialInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Supplemental Financial Information</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_SupplementalFinancialInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of interest income and expense, including, but not limited to, interest income and expense from investments, loans, and securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Schedule of Components of Lease Cost and Supplemental Cash Flow Information Related to Leases and Lease Term and Discount Rates</a></td>
<td class="text"><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to leases were:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.028%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.837%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amount included in the measurement of lease liabilities: </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,316&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,265&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from financing leases</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash flows from financing leases</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,178&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,019&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets additions, modifications and termination:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,084)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule of Goodwill</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes in the carrying amount of goodwill: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:82.964%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.836%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2025</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162,158&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,988)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2026</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160,170&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Finite-Lived Intangible Assets</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes intangible assets:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:21.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.888%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2025</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross carrying amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net carrying amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross carrying amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net carrying amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Definite-lived technology intangible assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233,086&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(79,725)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153,361&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236,497&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(69,156)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167,341&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Definite-lived licensed intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,072&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,908)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,164&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,158&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,619)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,539&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite-lived intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135,548&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135,548&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138,023&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138,023&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">381,706&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87,633)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294,073&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">385,678&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75,775)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309,903&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Indefinite-Lived Intangible Assets</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes intangible assets:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:21.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.888%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2025</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross carrying amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net carrying amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross carrying amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net carrying amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Definite-lived technology intangible assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233,086&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(79,725)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153,361&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236,497&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(69,156)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167,341&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Definite-lived licensed intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,072&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,908)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,164&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,158&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,619)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,539&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite-lived intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135,548&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135,548&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138,023&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138,023&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">381,706&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87,633)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294,073&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">385,678&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75,775)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309,903&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -SubTopic 30<br> -Topic 350<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1A<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -SubTopic 30<br> -Topic 350<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Schedule of Stock-Based Compensation Expense</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the classification of stock-based compensation expense for employees and non-employees within the Condensed Consolidated Statements of Operations: </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:76.677%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.012%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">900&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,950&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,876&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,800&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,219&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,839&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,995&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,589&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock', window );">Schedule of RSU Activity</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes Recursion&#8217;s RSU activity during the three months ended March 31, 2026: </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.784%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stock units</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-average grant date fair value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding as of December 31, 2025</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,489,925&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.55&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,154,778&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.98&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,703,740)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,375,565)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding as of March 31, 2026</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,565,398&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.99&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested restricted stock shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Subparagraph (c)<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Computation of Basic and Diluted Net Loss Per Share</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables set forth the computation of basic and diluted net loss per share of Class A, Class B and Exchangeable common stock:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.058%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands, except share and per share amounts)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(117,504)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(202,487)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">529,303,984&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">402,771,972&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per share, basic and diluted</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.22)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.50)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Antidilutive Securities Excluded from Computation of Net Loss Per Share</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company excluded the following potential common shares from the computation of diluted net loss per share for the periods indicated because including them would have had an anti-dilutive effect: </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.057%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.205%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Stock based compensation</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,504,219&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,896,288&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tempus agreement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,369,128&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,504,219&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,265,416&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the Company&#8217;s assets and liabilities that are measured at fair value on a recurring basis:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.514%"><tr><td style="width:1.0%"></td><td style="width:43.727%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.741%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.543%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.744%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.745%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2026</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basis of fair value measurement</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,442&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,442&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">609,031&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">609,031&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,707&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,707&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">665,180&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">665,180&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.098%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.297%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.452%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2025</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basis of fair value measurement</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,627&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,627&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">670,667&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">670,667&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,627&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,627&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">753,921&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">753,921&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock', window );">Schedule of Financial Instruments Not Measured at Fair Value</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the Company&#8217;s financial instruments that are not measured at fair value: </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.531%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.992%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.448%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Book values</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair values</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2025</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes payable and financing lease liabilities, current</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,265&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,091&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,265&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,091&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes payable and financing lease liabilities, non-current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,181&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,564&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,181&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,564&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,446&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,655&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,446&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,655&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information about fair value of asset and liability not measured at fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of Segment Net Loss and Reconciliations of Segment Operating Loss to Loss Before Income Tax Benefit</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents Recursion&#8217;s segment revenue, significant segment expenses, and segment net loss: </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.484%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:112%">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,472&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">14,745&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Significant segment expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Salaries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,298&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">83,554&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Consumables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,146&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">54,677&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Platform</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,614&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">8,765&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Discovery</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,332&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">6,287&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Clinical development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,569&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">10,564&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,673&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">19,331&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Other segment items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,345&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">22,935&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Loss from operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,505&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191,368&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Other non-operating income (loss), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,397&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,277)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Income tax benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,604&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">158&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Total segment loss</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">117,504&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">202,487&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Supplemental asset information</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Total expenditures for additions to long-lived assets</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">2,978&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Description of the Business (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="nump">$ 2,193,506<span></span>
</td>
<td class="nump">$ 2,076,002<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Financial Information - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 30, 2023</div></th>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_LicenseAgreementIncreaseDecreaseAccruedLiabilities', window );">Prepaid expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 27,100,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=rxrx_TempusLabsIncMember', window );">Tempus Labs, Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_LicenseAgreementTerm', window );">License agreement, term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_LicenseAgreementTradingPeriodUsedForEquityValueDetermination', window );">Trading period used for equity value determination</a></td>
<td class="text">7 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_LicenseAgreementAmountOfTimePriorToThePaymentDate', window );">Business days prior to the payment date</a></td>
<td class="text">5 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=rxrx_TempusLabsIncMember', window );">Tempus Labs, Inc | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_LicenseAgreementAnnualPayments', window );">Annual payments</a></td>
<td class="nump">$ 22,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=rxrx_TempusLabsIncMember', window );">Tempus Labs, Inc | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_LicenseAgreementAnnualPayments', window );">Annual payments</a></td>
<td class="nump">42,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_LicenseAgreementAggregatePayments', window );">Aggregate amount payable in cash or equity</a></td>
<td class="nump">$ 160,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_LicenseAgreementAggregatePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>License Agreement, Aggregate Payments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_LicenseAgreementAggregatePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_LicenseAgreementAmountOfTimePriorToThePaymentDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>License Agreement, Amount Of Time Prior To The Payment Date</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_LicenseAgreementAmountOfTimePriorToThePaymentDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_LicenseAgreementAnnualPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>License Agreement, Annual Payments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_LicenseAgreementAnnualPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_LicenseAgreementIncreaseDecreaseAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>License Agreement, Increase (Decrease) Accrued Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_LicenseAgreementIncreaseDecreaseAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_LicenseAgreementTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>License Agreement, Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_LicenseAgreementTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_LicenseAgreementTradingPeriodUsedForEquityValueDetermination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>License Agreement, Trading Period Used For Equity Value Determination</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_LicenseAgreementTradingPeriodUsedForEquityValueDetermination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=rxrx_TempusLabsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=rxrx_TempusLabsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Supplemental Financial Information - Schedule of Accrued Expenses and Other Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_SupplementalFinancialInformationAbstract', window );"><strong>Supplemental Financial Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued compensation</a></td>
<td class="nump">$ 14,566<span></span>
</td>
<td class="nump">$ 31,771<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_AccruedComputeLiabilitiesCurrent', window );">Accrued compute liabilities</a></td>
<td class="nump">7,535<span></span>
</td>
<td class="nump">8,278<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_AccruedDevelopmentCostsCurrent', window );">Accrued development expenses</a></td>
<td class="nump">4,214<span></span>
</td>
<td class="nump">2,693<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_AccruedEarlyDiscoveryExpensesCurrent', window );">Accrued early discovery expenses</a></td>
<td class="nump">7,535<span></span>
</td>
<td class="nump">4,581<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Accrued professional fees</a></td>
<td class="nump">1,875<span></span>
</td>
<td class="nump">1,232<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_MaterialsReceivedNotInvoiced', window );">Materials received not invoiced</a></td>
<td class="nump">1,010<span></span>
</td>
<td class="nump">703<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_AccruedLicenseFeeCurrent', window );">Accrued license fees</a></td>
<td class="nump">4,915<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Accrued other expenses</a></td>
<td class="nump">12,555<span></span>
</td>
<td class="nump">17,972<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expense and other liabilities</a></td>
<td class="nump">$ 54,205<span></span>
</td>
<td class="nump">$ 70,230<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_AccruedComputeLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Compute Liabilities, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_AccruedComputeLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_AccruedDevelopmentCostsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Development Costs, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_AccruedDevelopmentCostsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_AccruedEarlyDiscoveryExpensesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Early Discovery Expenses, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_AccruedEarlyDiscoveryExpensesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_AccruedLicenseFeeCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued License Fee, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_AccruedLicenseFeeCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_MaterialsReceivedNotInvoiced">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Materials Received Not Invoiced</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_MaterialsReceivedNotInvoiced</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_SupplementalFinancialInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Supplemental Financial Information</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_SupplementalFinancialInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Financial Information - Schedule of Interest Income, Net (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_SupplementalFinancialInformationAbstract', window );"><strong>Supplemental Financial Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeNonoperating', window );">Interest income</a></td>
<td class="nump">$ 5,963<span></span>
</td>
<td class="nump">$ 5,558<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseNonoperating', window );">Interest expense</a></td>
<td class="num">(350)<span></span>
</td>
<td class="num">(508)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNonoperatingNet', window );">Interest income, net</a></td>
<td class="nump">$ 5,613<span></span>
</td>
<td class="nump">$ 5,050<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_SupplementalFinancialInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Supplemental Financial Information</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_SupplementalFinancialInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseNonoperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense classified as nonoperating.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseNonoperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNonoperatingNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest income (expense) classified as nonoperating.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNonoperatingNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeNonoperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income from investments (for example, dividends) not considered a component of the entity's core operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeNonoperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2025</div></th>
<th class="th"><div>Jul. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Combination [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Loss on disposal of a business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 4,502<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember', window );">Disposal Group, Disposed of by Sale, Not Discontinued Operations | Exscientia GmbH</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Combination [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Loss on disposal of a business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rxrx_AlphaBiotechnologyGmbHAlphaMember', window );">Alpha Biotechnology GmbH (Alpha)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Combination [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity method investment ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity method investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,400<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionAxis=rxrx_REVenturesIMember', window );">RE Ventures I</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Combination [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_AssetAcquisitionEquityOwnershipPercentage', window );">Interest acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionConsiderationTransferred', window );">Asset acquisition, consideration transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment', window );">Payments to acquire IPR&amp;D</a></td>
<td class="nump">$ 2,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_AssetAcquisitionEquityOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Asset Acquisition, Equity Ownership, Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_AssetAcquisitionEquityOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionConsiderationTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred in asset acquisition. Includes, but is not limited to, cash, liability incurred by acquirer, and equity interest issued by acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479908/805-50-55-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480060/805-50-25-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480027/805-50-30-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480027/805-50-30-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionConsiderationTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-47<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-5<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-3<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-4A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-4<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-4A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-4A<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-4<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 37: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481664/323-10-45-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflows from the purchase of net carrying value allocated to in-process research and development costs and materials acquired in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=rxrx_ExscientiaGmbHMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=rxrx_ExscientiaGmbHMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rxrx_AlphaBiotechnologyGmbHAlphaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rxrx_AlphaBiotechnologyGmbHAlphaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionAxis=rxrx_REVenturesIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionAxis=rxrx_REVenturesIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Operating lease, renewal term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_IncreaseDecreaseInOperatingLeaseRightOfUseAssets', window );">Increase (decrease) in operating lease right-of-use assets</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (10,084)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_LesseeOperatingLeaseIncreaseDecreaseInOperatingLeaseLiabilityDueToLeaseModifications', window );">Increase (decrease) in operating lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (10,100)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm', window );">Remaining operating lease term</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm', window );">Remaining operating lease term</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_IncreaseDecreaseInOperatingLeaseRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) in Operating Lease Right-Of-Use Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_IncreaseDecreaseInOperatingLeaseRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_LesseeOperatingLeaseIncreaseDecreaseInOperatingLeaseLiabilityDueToLeaseModifications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Increase (Decrease) In Operating Lease Liability Due To Lease Modifications</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_LesseeOperatingLeaseIncreaseDecreaseInOperatingLeaseLiabilityDueToLeaseModifications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRemainingLeaseTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Schedule of Supplemental Cash Flow Information Related to Leases (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_CashPaidForAmountIncludedInTheMeasurementOfLeaseLiabilitiesAbstract', window );"><strong>Cash paid for amount included in the measurement of lease liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating cash flows from operating leases</a></td>
<td class="nump">$ 4,316<span></span>
</td>
<td class="nump">$ 5,265<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestPaymentOnLiability', window );">Operating cash flows from financing leases</a></td>
<td class="nump">336<span></span>
</td>
<td class="nump">495<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeasePrincipalPayments', window );">Financing cash flows from financing leases</a></td>
<td class="nump">2,178<span></span>
</td>
<td class="nump">2,019<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_RightOfUseAssetsObtainedInExchangeForLeaseLiabilitiesAbstract', window );"><strong>Right-of-use assets additions, modifications and termination:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_IncreaseDecreaseInOperatingLeaseRightOfUseAssets', window );">Operating leases</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (10,084)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_CashPaidForAmountIncludedInTheMeasurementOfLeaseLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash Paid For Amount Included In The Measurement Of Lease Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_CashPaidForAmountIncludedInTheMeasurementOfLeaseLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_IncreaseDecreaseInOperatingLeaseRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) in Operating Lease Right-Of-Use Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_IncreaseDecreaseInOperatingLeaseRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_RightOfUseAssetsObtainedInExchangeForLeaseLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Right-Of-Use Assets Obtained In Exchange For Lease Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_RightOfUseAssetsObtainedInExchangeForLeaseLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestPaymentOnLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest paid on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestPaymentOnLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeasePrincipalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for principal payment on finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeasePrincipalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets - Schedule of Changes in the Carrying Amount of Goodwill (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2026 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, beginning balance</a></td>
<td class="nump">$ 162,158<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation adjustments</a></td>
<td class="num">(1,988)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, ending balance</a></td>
<td class="nump">$ 160,170<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-41<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 740<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478064/805-740-55-13<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 39<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-39<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482598/350-20-45-1<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) asset representing future economic benefit from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense</a></td>
<td class="nump">12,700,000<span></span>
</td>
<td class="nump">11,700,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_IntangibleAssetsForeignCurrencyTranslationGainLoss', window );">Intangible assets, foreign currency translation gain (loss)</a></td>
<td class="num">(5,200,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill', window );">Impairment of indefinite-lived intangible assets</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_IntangibleAssetsForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Intangible Assets, Foreign Currency Translation Gain (Loss)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_IntangibleAssetsForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-18<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-11<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-24<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-12<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -SubTopic 30<br> -Topic 350<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss from asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482598/350-20-45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-3<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Goodwill and Intangible Assets - Schedule of Intangible assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">$ (87,633)<span></span>
</td>
<td class="num">$ (75,775)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-lived intangible assets</a></td>
<td class="nump">135,548<span></span>
</td>
<td class="nump">138,023<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible assets, gross</a></td>
<td class="nump">381,706<span></span>
</td>
<td class="nump">385,678<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">294,073<span></span>
</td>
<td class="nump">309,903<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember', window );">Definite-lived technology intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross carrying amount</a></td>
<td class="nump">233,086<span></span>
</td>
<td class="nump">236,497<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(79,725)<span></span>
</td>
<td class="num">(69,156)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net carrying amount</a></td>
<td class="nump">153,361<span></span>
</td>
<td class="nump">167,341<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember', window );">Definite-lived licensed intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross carrying amount</a></td>
<td class="nump">13,072<span></span>
</td>
<td class="nump">11,158<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(7,908)<span></span>
</td>
<td class="num">(6,619)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net carrying amount</a></td>
<td class="nump">$ 5,164<span></span>
</td>
<td class="nump">$ 4,539<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -SubTopic 30<br> -Topic 350<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480265/350-10-S45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -SubTopic 30<br> -Topic 350<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480265/350-10-S45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 928<br> -SubTopic 340<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478859/928-340-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -SubTopic 30<br> -Topic 350<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480265/350-10-S45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of intangible assets, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsGrossExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualAtCarryingValue', window );">Loss contingency accrual</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_FinanceLeasesAssetsPledgedAsCollateral', window );">Finance leases, assets pledged as collateral</a></td>
<td class="nump">15,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Finance lease liability</a></td>
<td class="nump">$ 16,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_FinanceLeasesAssetsPledgedAsCollateral">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finance Leases, Assets Pledged As Collateral</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_FinanceLeasesAssetsPledgedAsCollateral</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Common Stock - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2026 </div>
<div>USD ($) </div>
<div>vote</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsStock', window );">Dividends declared | $</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_CommonStockVotePerShare', window );">Vote per share of common stock (in votes)</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_CommonStockVotePerShare', window );">Vote per share of common stock (in votes)</a></td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_CommonStockVotePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common Stock, Vote Per Share</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_CommonStockVotePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483014/272-10-45-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482987/272-10-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid stock dividends declared for classes of stock, for example, but not limited to, common and preferred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -SubTopic 405<br> -Topic 942<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477787/942-405-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Common Stock - At-The-Market Offering (Narrative) (Details) - TD Cowen Sales Agreement - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Feb. 28, 2026</div></th>
<th class="th"><div>Mar. 31, 2026</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_SaleOfStockValueRemainingAuthorized', window );">Sale of stock, value remaining authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_SaleOfStockValueAuthorized', window );">Sale of stock, value authorized</a></td>
<td class="nump">$ 300.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_SaleOfStockValueAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sale Of Stock, Value, Authorized</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_SaleOfStockValueAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_SaleOfStockValueRemainingAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sale Of Stock Value Remaining Authorized</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_SaleOfStockValueRemainingAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483014/272-10-45-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482987/272-10-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=rxrx_AtTheMarketOfferingProgramTDCowenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=rxrx_AtTheMarketOfferingProgramTDCowenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Common Stock - Valence Acquisition Exchangeable Shares (Narrative) (Details) - Exchangeable Stock - shares<br> shares in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>May 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2026</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Shares issued in the period, upon conversion (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rxrx_ValenceDiscoveryIncMember', window );">Valence Discovery Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_BusinessAcquisitionContingentConsiderationEquityInterestsIssuableNumberOfShares', window );">Equity interest issued or issuable (in shares)</a></td>
<td class="nump">5.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_BusinessAcquisitionContingentConsiderationEquityInterestsIssuableNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Acquisition , Contingent Consideration, Equity Interests Issuable, Number Of Shares</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_BusinessAcquisitionContingentConsiderationEquityInterestsIssuableNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483014/272-10-45-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482987/272-10-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=rxrx_ExchangeableStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=rxrx_ExchangeableStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rxrx_ValenceDiscoveryIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rxrx_ValenceDiscoveryIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Common Stock - Registration Rights Agreements (Narrative) (Details)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
</tr>
<tr><th class="th"><div>May 31, 2023</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rxrx_ValenceDiscoveryIncMember', window );">Valence Discovery Inc</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_RegistrationRightsAgreementTerm', window );">Registration rights agreement term</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_RegistrationRightsAgreementTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Registration Rights Agreement, Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_RegistrationRightsAgreementTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483014/272-10-45-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482987/272-10-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rxrx_ValenceDiscoveryIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rxrx_ValenceDiscoveryIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Common Stock - Class A and B Common Shares Authorization (Narrative) (Details)<br></strong></div></th>
<th class="th">
<div>Mar. 31, 2026 </div>
<div>vote</div>
</th>
<th class="th">
<div>Apr. 30, 2021 </div>
<div>class</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_NumberOfClassesOfCommonStockAuthorized', window );">Number of classes of common stock authorized | class</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_CommonStockVotePerShare', window );">Vote per share of common stock (in votes)</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_CommonStockConversionRatio', window );">Common stock, conversion ratio</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_CommonStockVotePerShare', window );">Vote per share of common stock (in votes)</a></td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_CommonStockConversionRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common Stock, Conversion Ratio</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_CommonStockConversionRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_CommonStockVotePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common Stock, Vote Per Share</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_CommonStockVotePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_NumberOfClassesOfCommonStockAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Classes Of Common Stock Authorized</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_NumberOfClassesOfCommonStockAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483014/272-10-45-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482987/272-10-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Collaborative Development Contracts (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="4">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">51 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Oct. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2023 </div>
<div>USD ($) </div>
<div>performance_obligation</div>
</th>
<th class="th">
<div>Jan. 31, 2022 </div>
<div>USD ($) </div>
<div>phenomap </div>
<div>performance_obligation </div>
<div>candidate </div>
<div>program</div>
</th>
<th class="th">
<div>Mar. 31, 2026 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2026 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Revenue recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.4<span></span>
</td>
<td class="nump">$ 14.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNetCurrent', window );">Cost incurred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=rxrx_SanofiMember', window );">Sanofi | Collaborative Arrangement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_ContractWithCustomerNumberOfNovelSmallMoleculeCandidates', window );">Maximum number of novel small molecule candidates | candidate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Remaining unearned revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Revenue recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_RevenuePerformanceObligationNumberOfObligations', window );">Number of performance obligations under the agreement (in performance obligations) | performance_obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligation revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 154.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=rxrx_SanofiMember', window );">Sanofi | Collaborative Arrangement | Research Milestones</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Remaining unearned revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">555.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=rxrx_SanofiMember', window );">Sanofi | Collaborative Arrangement | Development And Regulatory Milestones</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Remaining unearned revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,800.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=rxrx_MerckKGaAMerckMember', window );">Merck KGaA (Merck) | Collaborative Arrangement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Remaining unearned revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_RevenuePerformanceObligationNumberOfObligations', window );">Number of performance obligations under the agreement (in performance obligations) | performance_obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligation revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=rxrx_MerckKGaAMerckMember', window );">Merck KGaA (Merck) | Collaborative Arrangement | Discovery, Development And Sales Milestones</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Remaining unearned revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 73.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=rxrx_RocheAndGenentechMember', window );">Roche and Genentech | Collaborative Arrangement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Remaining unearned revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Revenue recognized</a></td>
<td class="nump">$ 30.0<span></span>
</td>
<td class="nump">$ 30.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_RevenuePerformanceObligationNumberOfObligations', window );">Number of performance obligations under the agreement (in performance obligations) | performance_obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligation revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 210.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=rxrx_RocheAndGenentechMember', window );">Roche and Genentech | Collaborative Arrangement | Phenomaps Creation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_RevenueRemainingPerformanceObligationVariableConsiderationAmount', window );">Research project, fees and milestones payments receivable for an option on a lead series</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_ContractWithCustomerMaximumAcceptedProduct', window );">Number of eligible phenomaps | phenomap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=rxrx_RocheAndGenentechMember', window );">Roche and Genentech | Collaborative Arrangement | Phenomaps Raw Images</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_RevenueRemainingPerformanceObligationVariableConsiderationAmount', window );">Research project, fees and milestones payments receivable for an option on a lead series</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_ContractWithCustomerMaximumAcceptedProduct', window );">Number of eligible phenomaps | phenomap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=rxrx_RocheAndGenentechMember', window );">Roche and Genentech | Collaborative Arrangement | Developed and Commercialized Programs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_RevenueRemainingPerformanceObligationVariableConsiderationAmount', window );">Research project, fees and milestones payments receivable for an option on a lead series</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_RevenueRemainingPerformanceObligationNumberOfProjectsThatMayBeInitiated', window );">Number of projects that may be initiated | program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=rxrx_RocheAndGenentechMember', window );">Roche and Genentech | Collaborative Arrangement | Gastrointestinal Cancer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_RevenuePerformanceObligationNumberOfObligations', window );">Number of performance obligations under the agreement (in performance obligations) | performance_obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=rxrx_RocheAndGenentechMember', window );">Roche and Genentech | Collaborative Arrangement | Neuroscience</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_RevenuePerformanceObligationNumberOfObligations', window );">Number of performance obligations under the agreement (in performance obligations) | performance_obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_ContractWithCustomerMaximumAcceptedProduct">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contract With Customer, Maximum Accepted Product</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_ContractWithCustomerMaximumAcceptedProduct</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_ContractWithCustomerNumberOfNovelSmallMoleculeCandidates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contract With Customer, Number Of Novel Small Molecule Candidates</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_ContractWithCustomerNumberOfNovelSmallMoleculeCandidates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_RevenuePerformanceObligationNumberOfObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue, Performance Obligation, Number Of Obligations</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_RevenuePerformanceObligationNumberOfObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_RevenueRemainingPerformanceObligationNumberOfProjectsThatMayBeInitiated">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue, Remaining Performance Obligation, Number Of Projects That May Be Initiated</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_RevenueRemainingPerformanceObligationNumberOfProjectsThatMayBeInitiated</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_RevenueRemainingPerformanceObligationVariableConsiderationAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue, Remaining Performance Obligation, Variable Consideration Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_RevenueRemainingPerformanceObligationVariableConsiderationAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 808<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479402/808-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=rxrx_SanofiMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=rxrx_SanofiMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_MilestoneTypeAxis=rxrx_ResearchMilestonesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_MilestoneTypeAxis=rxrx_ResearchMilestonesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_MilestoneTypeAxis=rxrx_DevelopmentAndRegulatoryMilestonesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_MilestoneTypeAxis=rxrx_DevelopmentAndRegulatoryMilestonesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=rxrx_MerckKGaAMerckMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=rxrx_MerckKGaAMerckMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_MilestoneTypeAxis=rxrx_DiscoveryDevelopmentAndSalesMilestonesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_MilestoneTypeAxis=rxrx_DiscoveryDevelopmentAndSalesMilestonesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=rxrx_RocheAndGenentechMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=rxrx_RocheAndGenentechMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_RevenueRemainingPerformanceObligationAxis=rxrx_PhenomapsCreationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_RevenueRemainingPerformanceObligationAxis=rxrx_PhenomapsCreationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_RevenueRemainingPerformanceObligationAxis=rxrx_PhenomapsRawImagesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_RevenueRemainingPerformanceObligationAxis=rxrx_PhenomapsRawImagesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_RevenueRemainingPerformanceObligationAxis=rxrx_DevelopedAndCommercializedProgramsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_RevenueRemainingPerformanceObligationAxis=rxrx_DevelopedAndCommercializedProgramsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_RevenueRemainingPerformanceObligationAxis=rxrx_GastrointestinalCancerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_RevenueRemainingPerformanceObligationAxis=rxrx_GastrointestinalCancerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_RevenueRemainingPerformanceObligationAxis=rxrx_NeuroscienceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_RevenueRemainingPerformanceObligationAxis=rxrx_NeuroscienceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Narrative (Details)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2026 </div>
<div>USD ($) </div>
<div>shares</div>
</th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Stock options, vesting period</a></td>
<td class="text">4 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Fair market value of vested shares | $</a></td>
<td class="nump">$ 18.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions', window );">Unrecognized compensation cost | $</a></td>
<td class="nump">$ 159.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unvested stock options, unamortized stock-based compensation cost, weighted average period recognition</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=rxrx_A2021EquityIncentivePlanMember', window );">2021 Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of shares available for grant (in shares) | shares</a></td>
<td class="nump">27.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=rxrx_A2024InducementEquityIncentivePlanMember', window );">2024 Inducement Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of shares available for grant (in shares) | shares</a></td>
<td class="nump">11.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=rxrx_A2021EquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=rxrx_A2021EquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=rxrx_A2024InducementEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=rxrx_A2024InducementEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Schedule of Stock-Based Compensation Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total</a></td>
<td class="nump">$ 21,995<span></span>
</td>
<td class="nump">$ 35,589<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total</a></td>
<td class="nump">900<span></span>
</td>
<td class="nump">2,950<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total</a></td>
<td class="nump">11,876<span></span>
</td>
<td class="nump">17,800<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total</a></td>
<td class="nump">$ 9,219<span></span>
</td>
<td class="nump">$ 14,839<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479983/718-10-S45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Schedule of RSU Activity (Details) - RSUs<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2026 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward', window );"><strong>Stock units</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Beginning balance (in shares) | shares</a></td>
<td class="nump">27,489,925<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares) | shares</a></td>
<td class="nump">6,154,778<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares) | shares</a></td>
<td class="num">(2,703,740)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares) | shares</a></td>
<td class="num">(2,375,565)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Ending balance (in shares) | shares</a></td>
<td class="nump">28,565,398<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted-average grant date fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Beginning balance (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 6.55<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share) | $ / shares</a></td>
<td class="nump">3.98<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (in dollars per share) | $ / shares</a></td>
<td class="nump">6.69<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (in dollars per share) | $ / shares</a></td>
<td class="nump">6.46<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Ending balance (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 5.99<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations', window );">Foreign income tax expense (benefit)</a></td>
<td class="num">$ (5.5)<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current and deferred foreign income tax expense (benefit) attributable to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10B<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share - Schedule of Computation of Basic and Diluted Net Loss Per Share (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract', window );"><strong>Numerator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (117,504)<span></span>
</td>
<td class="num">$ (202,487)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average common shares outstanding, basic (in shares)</a></td>
<td class="nump">529,303,984<span></span>
</td>
<td class="nump">402,771,972<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average common shares outstanding, diluted (in shares)</a></td>
<td class="nump">529,303,984<span></span>
</td>
<td class="nump">402,771,972<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per share, basic (in dollars per shares)</a></td>
<td class="num">$ (0.22)<span></span>
</td>
<td class="num">$ (0.50)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per share, diluted (in dollars per shares)</a></td>
<td class="num">$ (0.22)<span></span>
</td>
<td class="num">$ (0.50)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share - Schedule of Antidilutive Securities Excluded from Computation of Net Loss Per Share (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of loss per share, amount (in shares)</a></td>
<td class="nump">5,504,219<span></span>
</td>
<td class="nump">17,265,416<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember', window );">Stock based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of loss per share, amount (in shares)</a></td>
<td class="nump">5,504,219<span></span>
</td>
<td class="nump">11,896,288<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=rxrx_TempusAgreementMember', window );">Tempus agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of loss per share, amount (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">5,369,128<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=rxrx_TempusAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=rxrx_TempusAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_RestrictedCashAndCashEquivalentsFairValueDisclosure', window );">Restricted cash</a></td>
<td class="nump">$ 10,707<span></span>
</td>
<td class="nump">$ 10,627<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">665,180<span></span>
</td>
<td class="nump">753,921<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_CashMember', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents:</a></td>
<td class="nump">45,442<span></span>
</td>
<td class="nump">72,627<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember', window );">Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents:</a></td>
<td class="nump">609,031<span></span>
</td>
<td class="nump">670,667<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_RestrictedCashAndCashEquivalentsFairValueDisclosure', window );">Restricted cash</a></td>
<td class="nump">10,707<span></span>
</td>
<td class="nump">10,627<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">665,180<span></span>
</td>
<td class="nump">753,921<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents:</a></td>
<td class="nump">45,442<span></span>
</td>
<td class="nump">72,627<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents:</a></td>
<td class="nump">609,031<span></span>
</td>
<td class="nump">670,667<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_RestrictedCashAndCashEquivalentsFairValueDisclosure', window );">Restricted cash</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents:</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents:</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_RestrictedCashAndCashEquivalentsFairValueDisclosure', window );">Restricted cash</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents:</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents:</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_RestrictedCashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Restricted Cash And Cash Equivalents, Fair Value Disclosure</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_RestrictedCashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-10<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -SubTopic 10<br> -Topic 825<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482881/825-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-11<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-10<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482881/825-10-55-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_CashMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_CashMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Schedule of Financial Instruments Not Measured at Fair Value (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems', window );"><strong>Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Notes payable and financing lease liabilities, current</a></td>
<td class="nump">$ 9,265<span></span>
</td>
<td class="nump">$ 9,091<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Notes payable and financing lease liabilities, non-current</a></td>
<td class="nump">7,181<span></span>
</td>
<td class="nump">9,564<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember', window );">Book values</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems', window );"><strong>Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="nump">16,446<span></span>
</td>
<td class="nump">18,655<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember', window );">Book values | Notes Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems', window );"><strong>Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Notes payable and financing lease liabilities, current</a></td>
<td class="nump">9,265<span></span>
</td>
<td class="nump">9,091<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Notes payable and financing lease liabilities, non-current</a></td>
<td class="nump">7,181<span></span>
</td>
<td class="nump">9,564<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Fair values</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems', window );"><strong>Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="nump">16,446<span></span>
</td>
<td class="nump">18,655<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Fair values | Notes Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems', window );"><strong>Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Notes payable and financing lease liabilities, current</a></td>
<td class="nump">9,265<span></span>
</td>
<td class="nump">9,091<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Notes payable and financing lease liabilities, non-current</a></td>
<td class="nump">$ 7,181<span></span>
</td>
<td class="nump">$ 9,564<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2026 </div>
<div>segment</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments</a></td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments</a></td>
<td class="nump">1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information - Schedule of Segment Net Loss and Reconciliations of Segment Operating Loss to Loss Before Income Tax Benefit (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 6,472<span></span>
</td>
<td class="nump">$ 14,745<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_SignificantSegmentExpensesAbstract', window );"><strong>Significant segment expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="nump">128,505<span></span>
</td>
<td class="nump">191,368<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Other non-operating income (loss), net</a></td>
<td class="nump">6,397<span></span>
</td>
<td class="num">(11,277)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit</a></td>
<td class="nump">4,604<span></span>
</td>
<td class="nump">158<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Total segment loss</a></td>
<td class="nump">117,504<span></span>
</td>
<td class="nump">202,487<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=rxrx_ReportableSegmentMember', window );">Reportable Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">6,472<span></span>
</td>
<td class="nump">14,745<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_SignificantSegmentExpensesAbstract', window );"><strong>Significant segment expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LaborAndRelatedExpense', window );">Salaries</a></td>
<td class="nump">74,298<span></span>
</td>
<td class="nump">83,554<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_ConsumableExpense', window );">Consumables</a></td>
<td class="nump">7,146<span></span>
</td>
<td class="nump">54,677<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_PlatformFeeExpense', window );">Platform</a></td>
<td class="nump">7,614<span></span>
</td>
<td class="nump">8,765<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_DiscoveryExpense', window );">Discovery</a></td>
<td class="nump">6,332<span></span>
</td>
<td class="nump">6,287<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_ClinicalDevelopmentExpense', window );">Clinical development</a></td>
<td class="nump">6,569<span></span>
</td>
<td class="nump">10,564<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">19,673<span></span>
</td>
<td class="nump">19,331<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingOtherItemAmount', window );">Other segment items</a></td>
<td class="nump">13,345<span></span>
</td>
<td class="nump">22,935<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="nump">128,505<span></span>
</td>
<td class="nump">191,368<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Other non-operating income (loss), net</a></td>
<td class="nump">6,397<span></span>
</td>
<td class="num">(11,277)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit</a></td>
<td class="nump">4,604<span></span>
</td>
<td class="nump">158<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Total segment loss</a></td>
<td class="nump">117,504<span></span>
</td>
<td class="nump">202,487<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rxrx_SupplementalAssetInformationAbstract', window );"><strong>Supplemental asset information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentExpenditureAdditionToLongLivedAssets', window );">Total expenditures for additions to long-lived assets</a></td>
<td class="nump">$ 258<span></span>
</td>
<td class="nump">$ 2,978<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_ClinicalDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Clinical Development Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_ClinicalDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_ConsumableExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Consumable Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_ConsumableExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_DiscoveryExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Discovery Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_DiscoveryExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_PlatformFeeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Platform Fee Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_PlatformFeeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_SignificantSegmentExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Significant Segment Expenses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_SignificantSegmentExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rxrx_SupplementalAssetInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Supplemental Asset Information</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rxrx_SupplementalAssetInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rxrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for allocation of cost of tangible and intangible assets over their useful lives directly used in production of good and rendering of service.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LaborAndRelatedExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(14)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LaborAndRelatedExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-7<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentExpenditureAdditionToLongLivedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenditure for addition to long-lived assets included in determination of segment assets by chief operating decision maker (CODM) or otherwise regularly provided to CODM. Excludes expenditure for addition to financial instrument, long-term customer relationship of financial institution, mortgage and other servicing rights, deferred policy acquisition cost, and deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentExpenditureAdditionToLongLivedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingOtherItemAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other expense (income) and loss (gain) calculated as difference between segment revenue and separately disclosed expense category to arrive at segment profit (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingOtherItemAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=rxrx_ReportableSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=rxrx_ReportableSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.26.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>130</ContextCount>
  <ElementCount>250</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>50</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>11</UnitCount>
  <MyReports>
    <Report instance="rxrx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="rxrx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>9952151 - Statement - Condensed Consolidated Balance Sheets (unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited</Role>
      <ShortName>Condensed Consolidated Balance Sheets (unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="rxrx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>9952152 - Statement - Condensed Consolidated Balance Sheets (unaudited) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunauditedParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheets (unaudited) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="rxrx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>9952153 - Statement - Condensed Consolidated Statements of Operations (unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/CondensedConsolidatedStatementsofOperationsunaudited</Role>
      <ShortName>Condensed Consolidated Statements of Operations (unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="rxrx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>9952154 - Statement - Condensed Consolidated Statements of Comprehensive Loss (unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/CondensedConsolidatedStatementsofComprehensiveLossunaudited</Role>
      <ShortName>Condensed Consolidated Statements of Comprehensive Loss (unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="rxrx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>9952155 - Statement - Condensed Consolidated Statements of Stockholders??? Equity (unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/CondensedConsolidatedStatementsofStockholdersEquityunaudited</Role>
      <ShortName>Condensed Consolidated Statements of Stockholders??? Equity (unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="rxrx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>9952156 - Statement - Condensed Consolidated Statements of Cash Flows (unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows (unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="rxrx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>9952157 - Disclosure - Description of the Business</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/DescriptionoftheBusiness</Role>
      <ShortName>Description of the Business</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="rxrx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>9952158 - Disclosure - Basis of Presentation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/BasisofPresentation</Role>
      <ShortName>Basis of Presentation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="rxrx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>9952159 - Disclosure - Supplemental Financial Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/SupplementalFinancialInformation</Role>
      <ShortName>Supplemental Financial Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="rxrx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>9952160 - Disclosure - Acquisitions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/Acquisitions</Role>
      <ShortName>Acquisitions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="rxrx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>9952161 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="rxrx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>9952162 - Disclosure - Goodwill and Intangible Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/GoodwillandIntangibleAssets</Role>
      <ShortName>Goodwill and Intangible Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="rxrx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>9952163 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="rxrx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>9952164 - Disclosure - Common Stock</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/CommonStock</Role>
      <ShortName>Common Stock</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="rxrx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>9952165 - Disclosure - Collaborative Development Contracts</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/CollaborativeDevelopmentContracts</Role>
      <ShortName>Collaborative Development Contracts</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="rxrx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>9952166 - Disclosure - Stock-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/StockBasedCompensation</Role>
      <ShortName>Stock-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="rxrx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>9952167 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="rxrx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>9952168 - Disclosure - Net Loss Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/NetLossPerShare</Role>
      <ShortName>Net Loss Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="rxrx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>9952169 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="rxrx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>9952170 - Disclosure - Segment Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/SegmentInformation</Role>
      <ShortName>Segment Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="rxrx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>995445 - Disclosure - Insider Trading Arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements</Role>
      <ShortName>Insider Trading Arrangements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="rxrx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>9955511 - Disclosure - Basis of Presentation (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/BasisofPresentationPolicies</Role>
      <ShortName>Basis of Presentation (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="rxrx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>9955512 - Disclosure - Supplemental Financial Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/SupplementalFinancialInformationTables</Role>
      <ShortName>Supplemental Financial Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.recursion.com/role/SupplementalFinancialInformation</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="rxrx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>9955513 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.recursion.com/role/Leases</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="rxrx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>9955514 - Disclosure - Goodwill and Intangible Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/GoodwillandIntangibleAssetsTables</Role>
      <ShortName>Goodwill and Intangible Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.recursion.com/role/GoodwillandIntangibleAssets</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="rxrx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>9955515 - Disclosure - Stock-Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/StockBasedCompensationTables</Role>
      <ShortName>Stock-Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.recursion.com/role/StockBasedCompensation</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="rxrx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>9955516 - Disclosure - Net Loss Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/NetLossPerShareTables</Role>
      <ShortName>Net Loss Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.recursion.com/role/NetLossPerShare</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="rxrx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>9955517 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.recursion.com/role/FairValueMeasurements</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="rxrx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>9955518 - Disclosure - Segment Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/SegmentInformationTables</Role>
      <ShortName>Segment Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.recursion.com/role/SegmentInformation</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="rxrx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>9955519 - Disclosure - Description of the Business (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/DescriptionoftheBusinessDetails</Role>
      <ShortName>Description of the Business (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.recursion.com/role/DescriptionoftheBusiness</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="rxrx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>9955520 - Disclosure - Supplemental Financial Information - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/SupplementalFinancialInformationNarrativeDetails</Role>
      <ShortName>Supplemental Financial Information - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="rxrx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>9955521 - Disclosure - Supplemental Financial Information - Schedule of Accrued Expenses and Other Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/SupplementalFinancialInformationScheduleofAccruedExpensesandOtherLiabilitiesDetails</Role>
      <ShortName>Supplemental Financial Information - Schedule of Accrued Expenses and Other Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="rxrx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>9955522 - Disclosure - Supplemental Financial Information - Schedule of Interest Income, Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/SupplementalFinancialInformationScheduleofInterestIncomeNetDetails</Role>
      <ShortName>Supplemental Financial Information - Schedule of Interest Income, Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="rxrx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>9955523 - Disclosure - Acquisitions - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/AcquisitionsNarrativeDetails</Role>
      <ShortName>Acquisitions - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="rxrx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>9955524 - Disclosure - Leases - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/LeasesNarrativeDetails</Role>
      <ShortName>Leases - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="rxrx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>9955525 - Disclosure - Leases - Schedule of Supplemental Cash Flow Information Related to Leases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/LeasesScheduleofSupplementalCashFlowInformationRelatedtoLeasesDetails</Role>
      <ShortName>Leases - Schedule of Supplemental Cash Flow Information Related to Leases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="rxrx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>9955526 - Disclosure - Goodwill and Intangible Assets - Schedule of Changes in the Carrying Amount of Goodwill (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/GoodwillandIntangibleAssetsScheduleofChangesintheCarryingAmountofGoodwillDetails</Role>
      <ShortName>Goodwill and Intangible Assets - Schedule of Changes in the Carrying Amount of Goodwill (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="rxrx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>9955527 - Disclosure - Goodwill and Intangible Assets - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/GoodwillandIntangibleAssetsNarrativeDetails</Role>
      <ShortName>Goodwill and Intangible Assets - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="rxrx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>9955528 - Disclosure - Goodwill and Intangible Assets - Schedule of Intangible assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/GoodwillandIntangibleAssetsScheduleofIntangibleassetsDetails</Role>
      <ShortName>Goodwill and Intangible Assets - Schedule of Intangible assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="rxrx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>9955529 - Disclosure - Commitments and Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/CommitmentsandContingenciesDetails</Role>
      <ShortName>Commitments and Contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.recursion.com/role/CommitmentsandContingencies</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="rxrx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>9955530 - Disclosure - Common Stock - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/CommonStockNarrativeDetails</Role>
      <ShortName>Common Stock - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="rxrx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>9955531 - Disclosure - Common Stock - At-The-Market Offering (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/CommonStockAtTheMarketOfferingNarrativeDetails</Role>
      <ShortName>Common Stock - At-The-Market Offering (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="rxrx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>9955532 - Disclosure - Common Stock - Valence Acquisition Exchangeable Shares (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/CommonStockValenceAcquisitionExchangeableSharesNarrativeDetails</Role>
      <ShortName>Common Stock - Valence Acquisition Exchangeable Shares (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="rxrx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>9955533 - Disclosure - Common Stock - Registration Rights Agreements (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/CommonStockRegistrationRightsAgreementsNarrativeDetails</Role>
      <ShortName>Common Stock - Registration Rights Agreements (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="rxrx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>9955534 - Disclosure - Common Stock - Class A and B Common Shares Authorization (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/CommonStockClassAandBCommonSharesAuthorizationNarrativeDetails</Role>
      <ShortName>Common Stock - Class A and B Common Shares Authorization (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="rxrx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>9955535 - Disclosure - Collaborative Development Contracts (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/CollaborativeDevelopmentContractsDetails</Role>
      <ShortName>Collaborative Development Contracts (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.recursion.com/role/CollaborativeDevelopmentContracts</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="rxrx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>9955536 - Disclosure - Stock-Based Compensation - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/StockBasedCompensationNarrativeDetails</Role>
      <ShortName>Stock-Based Compensation - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="rxrx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>9955537 - Disclosure - Stock-Based Compensation - Schedule of Stock-Based Compensation Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/StockBasedCompensationScheduleofStockBasedCompensationExpenseDetails</Role>
      <ShortName>Stock-Based Compensation - Schedule of Stock-Based Compensation Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="rxrx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>9955538 - Disclosure - Stock-Based Compensation - Schedule of RSU Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/StockBasedCompensationScheduleofRSUActivityDetails</Role>
      <ShortName>Stock-Based Compensation - Schedule of RSU Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="rxrx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>9955539 - Disclosure - Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/IncomeTaxesDetails</Role>
      <ShortName>Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.recursion.com/role/IncomeTaxes</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="rxrx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>9955540 - Disclosure - Net Loss Per Share - Schedule of Computation of Basic and Diluted Net Loss Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/NetLossPerShareScheduleofComputationofBasicandDilutedNetLossPerShareDetails</Role>
      <ShortName>Net Loss Per Share - Schedule of Computation of Basic and Diluted Net Loss Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="rxrx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>9955541 - Disclosure - Net Loss Per Share - Schedule of Antidilutive Securities Excluded from Computation of Net Loss Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofNetLossPerShareDetails</Role>
      <ShortName>Net Loss Per Share - Schedule of Antidilutive Securities Excluded from Computation of Net Loss Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="rxrx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>9955542 - Disclosure - Fair Value Measurements - Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails</Role>
      <ShortName>Fair Value Measurements - Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="rxrx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>9955543 - Disclosure - Fair Value Measurements - Schedule of Financial Instruments Not Measured at Fair Value (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/FairValueMeasurementsScheduleofFinancialInstrumentsNotMeasuredatFairValueDetails</Role>
      <ShortName>Fair Value Measurements - Schedule of Financial Instruments Not Measured at Fair Value (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="rxrx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>9955544 - Disclosure - Segment Information - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/SegmentInformationNarrativeDetails</Role>
      <ShortName>Segment Information - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="rxrx-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>9955545 - Disclosure - Segment Information - Schedule of Segment Net Loss and Reconciliations of Segment Operating Loss to Loss Before Income Tax Benefit (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.recursion.com/role/SegmentInformationScheduleofSegmentNetLossandReconciliationsofSegmentOperatingLosstoLossBeforeIncomeTaxBenefitDetails</Role>
      <ShortName>Segment Information - Schedule of Segment Net Loss and Reconciliations of Segment Operating Loss to Loss Before Income Tax Benefit (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" isDefinitelyFs="true" isUsgaap="true" original="rxrx-20260331.htm">rxrx-20260331.htm</File>
    <File>rxrx-20260331.xsd</File>
    <File>rxrx-20260331_cal.xml</File>
    <File>rxrx-20260331_def.xml</File>
    <File>rxrx-20260331_lab.xml</File>
    <File>rxrx-20260331_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>rxrx-20260331_g1.jpg</File>
    <File>rxrx-20260331_g2.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="444">http://fasb.org/us-gaap/2025</BaseTaxonomy>
    <BaseTaxonomy items="30">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
    <BaseTaxonomy items="11">http://xbrl.sec.gov/ecd/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>76
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "rxrx-20260331.htm": {
   "nsprefix": "rxrx",
   "nsuri": "http://www.recursion.com/20260331",
   "dts": {
    "inline": {
     "local": [
      "rxrx-20260331.htm"
     ]
    },
    "schema": {
     "local": [
      "rxrx-20260331.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/2023/calculation-1.1.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "rxrx-20260331_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "rxrx-20260331_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "rxrx-20260331_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "rxrx-20260331_pre.xml"
     ]
    }
   },
   "keyStandard": 211,
   "keyCustom": 39,
   "axisStandard": 23,
   "axisCustom": 2,
   "memberStandard": 27,
   "memberCustom": 23,
   "hidden": {
    "total": 10,
    "http://xbrl.sec.gov/dei/2025": 5,
    "http://fasb.org/us-gaap/2025": 2,
    "http://www.recursion.com/20260331": 2,
    "http://xbrl.sec.gov/ecd/2025": 1
   },
   "contextCount": 130,
   "entityCount": 1,
   "segmentCount": 50,
   "elementCount": 515,
   "unitCount": 11,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2025": 444,
    "http://xbrl.sec.gov/dei/2025": 30,
    "http://xbrl.sec.gov/ecd/2025": 11
   },
   "report": {
    "R1": {
     "role": "http://www.recursion.com/role/Cover",
     "longName": "0000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited",
     "longName": "9952151 - Statement - Condensed Consolidated Balance Sheets (unaudited)",
     "shortName": "Condensed Consolidated Balance Sheets (unaudited)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunauditedParenthetical",
     "longName": "9952152 - Statement - Condensed Consolidated Balance Sheets (unaudited) (Parenthetical)",
     "shortName": "Condensed Consolidated Balance Sheets (unaudited) (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "us-gaap:CommonStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "us-gaap:CommonStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R4": {
     "role": "http://www.recursion.com/role/CondensedConsolidatedStatementsofOperationsunaudited",
     "longName": "9952153 - Statement - Condensed Consolidated Statements of Operations (unaudited)",
     "shortName": "Condensed Consolidated Statements of Operations (unaudited)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "unique": true
     }
    },
    "R5": {
     "role": "http://www.recursion.com/role/CondensedConsolidatedStatementsofComprehensiveLossunaudited",
     "longName": "9952154 - Statement - Condensed Consolidated Statements of Comprehensive Loss (unaudited)",
     "shortName": "Condensed Consolidated Statements of Comprehensive Loss (unaudited)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "unique": true
     }
    },
    "R6": {
     "role": "http://www.recursion.com/role/CondensedConsolidatedStatementsofStockholdersEquityunaudited",
     "longName": "9952155 - Statement - Condensed Consolidated Statements of Stockholders\u2019 Equity (unaudited)",
     "shortName": "Condensed Consolidated Statements of Stockholders\u2019 Equity (unaudited)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "c-29",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-29",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R7": {
     "role": "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited",
     "longName": "9952156 - Statement - Condensed Consolidated Statements of Cash Flows (unaudited)",
     "shortName": "Condensed Consolidated Statements of Cash Flows (unaudited)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "7",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "unique": true
     }
    },
    "R8": {
     "role": "http://www.recursion.com/role/DescriptionoftheBusiness",
     "longName": "9952157 - Disclosure - Description of the Business",
     "shortName": "Description of the Business",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "8",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NatureOfOperations",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NatureOfOperations",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R9": {
     "role": "http://www.recursion.com/role/BasisofPresentation",
     "longName": "9952158 - Disclosure - Basis of Presentation",
     "shortName": "Basis of Presentation",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://www.recursion.com/role/SupplementalFinancialInformation",
     "longName": "9952159 - Disclosure - Supplemental Financial Information",
     "shortName": "Supplemental Financial Information",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "rxrx:SupplementalBalanceSheetAndIncomeStatementInformationTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "rxrx:SupplementalBalanceSheetAndIncomeStatementInformationTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://www.recursion.com/role/Acquisitions",
     "longName": "9952160 - Disclosure - Acquisitions",
     "shortName": "Acquisitions",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://www.recursion.com/role/Leases",
     "longName": "9952161 - Disclosure - Leases",
     "shortName": "Leases",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://www.recursion.com/role/GoodwillandIntangibleAssets",
     "longName": "9952162 - Disclosure - Goodwill and Intangible Assets",
     "shortName": "Goodwill and Intangible Assets",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://www.recursion.com/role/CommitmentsandContingencies",
     "longName": "9952163 - Disclosure - Commitments and Contingencies",
     "shortName": "Commitments and Contingencies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://www.recursion.com/role/CommonStock",
     "longName": "9952164 - Disclosure - Common Stock",
     "shortName": "Common Stock",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://www.recursion.com/role/CollaborativeDevelopmentContracts",
     "longName": "9952165 - Disclosure - Collaborative Development Contracts",
     "shortName": "Collaborative Development Contracts",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://www.recursion.com/role/StockBasedCompensation",
     "longName": "9952166 - Disclosure - Stock-Based Compensation",
     "shortName": "Stock-Based Compensation",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://www.recursion.com/role/IncomeTaxes",
     "longName": "9952167 - Disclosure - Income Taxes",
     "shortName": "Income Taxes",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://www.recursion.com/role/NetLossPerShare",
     "longName": "9952168 - Disclosure - Net Loss Per Share",
     "shortName": "Net Loss Per Share",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://www.recursion.com/role/FairValueMeasurements",
     "longName": "9952169 - Disclosure - Fair Value Measurements",
     "shortName": "Fair Value Measurements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://www.recursion.com/role/SegmentInformation",
     "longName": "9952170 - Disclosure - Segment Information",
     "shortName": "Segment Information",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
     "longName": "995445 - Disclosure - Insider Trading Arrangements",
     "shortName": "Insider Trading Arrangements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "22",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ecd:NonRule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ecd:NonRule10b51ArrTrmntdFlag",
       "ecd:Rule10b51ArrTrmntdFlag",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ecd:NonRule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ecd:NonRule10b51ArrTrmntdFlag",
       "ecd:Rule10b51ArrTrmntdFlag",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://www.recursion.com/role/BasisofPresentationPolicies",
     "longName": "9955511 - Disclosure - Basis of Presentation (Policies)",
     "shortName": "Basis of Presentation (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "23",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://www.recursion.com/role/SupplementalFinancialInformationTables",
     "longName": "9955512 - Disclosure - Supplemental Financial Information (Tables)",
     "shortName": "Supplemental Financial Information (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "24",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://www.recursion.com/role/LeasesTables",
     "longName": "9955513 - Disclosure - Leases (Tables)",
     "shortName": "Leases (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "25",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://www.recursion.com/role/GoodwillandIntangibleAssetsTables",
     "longName": "9955514 - Disclosure - Goodwill and Intangible Assets (Tables)",
     "shortName": "Goodwill and Intangible Assets (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "26",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://www.recursion.com/role/StockBasedCompensationTables",
     "longName": "9955515 - Disclosure - Stock-Based Compensation (Tables)",
     "shortName": "Stock-Based Compensation (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "27",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://www.recursion.com/role/NetLossPerShareTables",
     "longName": "9955516 - Disclosure - Net Loss Per Share (Tables)",
     "shortName": "Net Loss Per Share (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "28",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://www.recursion.com/role/FairValueMeasurementsTables",
     "longName": "9955517 - Disclosure - Fair Value Measurements (Tables)",
     "shortName": "Fair Value Measurements (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "29",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://www.recursion.com/role/SegmentInformationTables",
     "longName": "9955518 - Disclosure - Segment Information (Tables)",
     "shortName": "Segment Information (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "30",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://www.recursion.com/role/DescriptionoftheBusinessDetails",
     "longName": "9955519 - Disclosure - Description of the Business (Details)",
     "shortName": "Description of the Business (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "31",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:RetainedEarningsAccumulatedDeficit",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R32": {
     "role": "http://www.recursion.com/role/SupplementalFinancialInformationNarrativeDetails",
     "longName": "9955520 - Disclosure - Supplemental Financial Information - Narrative (Details)",
     "shortName": "Supplemental Financial Information - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "32",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "rxrx:LicenseAgreementIncreaseDecreaseAccruedLiabilities",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "rxrx:LicenseAgreementIncreaseDecreaseAccruedLiabilities",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://www.recursion.com/role/SupplementalFinancialInformationScheduleofAccruedExpensesandOtherLiabilitiesDetails",
     "longName": "9955521 - Disclosure - Supplemental Financial Information - Schedule of Accrued Expenses and Other Liabilities (Details)",
     "shortName": "Supplemental Financial Information - Schedule of Accrued Expenses and Other Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "33",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://www.recursion.com/role/SupplementalFinancialInformationScheduleofInterestIncomeNetDetails",
     "longName": "9955522 - Disclosure - Supplemental Financial Information - Schedule of Interest Income, Net (Details)",
     "shortName": "Supplemental Financial Information - Schedule of Interest Income, Net (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "34",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:InvestmentIncomeNonoperating",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:InvestmentIncomeNonoperating",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://www.recursion.com/role/AcquisitionsNarrativeDetails",
     "longName": "9955523 - Disclosure - Acquisitions - Narrative (Details)",
     "shortName": "Acquisitions - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "35",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:GainLossOnSaleOfBusiness",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-50",
      "name": "us-gaap:GainLossOnSaleOfBusiness",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "unique": true
     }
    },
    "R36": {
     "role": "http://www.recursion.com/role/LeasesNarrativeDetails",
     "longName": "9955524 - Disclosure - Leases - Narrative (Details)",
     "shortName": "Leases - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "36",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:LesseeOperatingLeaseRenewalTerm",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:LesseeOperatingLeaseRenewalTerm",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://www.recursion.com/role/LeasesScheduleofSupplementalCashFlowInformationRelatedtoLeasesDetails",
     "longName": "9955525 - Disclosure - Leases - Schedule of Supplemental Cash Flow Information Related to Leases (Details)",
     "shortName": "Leases - Schedule of Supplemental Cash Flow Information Related to Leases (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "37",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OperatingLeasePayments",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OperatingLeasePayments",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R38": {
     "role": "http://www.recursion.com/role/GoodwillandIntangibleAssetsScheduleofChangesintheCarryingAmountofGoodwillDetails",
     "longName": "9955526 - Disclosure - Goodwill and Intangible Assets - Schedule of Changes in the Carrying Amount of Goodwill (Details)",
     "shortName": "Goodwill and Intangible Assets - Schedule of Changes in the Carrying Amount of Goodwill (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "38",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:Goodwill",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:GoodwillForeignCurrencyTranslationGainLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "unique": true
     }
    },
    "R39": {
     "role": "http://www.recursion.com/role/GoodwillandIntangibleAssetsNarrativeDetails",
     "longName": "9955527 - Disclosure - Goodwill and Intangible Assets - Narrative (Details)",
     "shortName": "Goodwill and Intangible Assets - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "39",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:GoodwillImpairmentLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "us-gaap:GoodwillImpairmentLoss",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:GoodwillImpairmentLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "us-gaap:GoodwillImpairmentLoss",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R40": {
     "role": "http://www.recursion.com/role/GoodwillandIntangibleAssetsScheduleofIntangibleassetsDetails",
     "longName": "9955528 - Disclosure - Goodwill and Intangible Assets - Schedule of Intangible assets (Details)",
     "shortName": "Goodwill and Intangible Assets - Schedule of Intangible assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "40",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R41": {
     "role": "http://www.recursion.com/role/CommitmentsandContingenciesDetails",
     "longName": "9955529 - Disclosure - Commitments and Contingencies (Details)",
     "shortName": "Commitments and Contingencies (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "41",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:LossContingencyAccrualAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:LossContingencyAccrualAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R42": {
     "role": "http://www.recursion.com/role/CommonStockNarrativeDetails",
     "longName": "9955530 - Disclosure - Common Stock - Narrative (Details)",
     "shortName": "Common Stock - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "42",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DividendsStock",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "us-gaap:DividendsStock",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DividendsStock",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "us-gaap:DividendsStock",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R43": {
     "role": "http://www.recursion.com/role/CommonStockAtTheMarketOfferingNarrativeDetails",
     "longName": "9955531 - Disclosure - Common Stock - At-The-Market Offering (Narrative) (Details)",
     "shortName": "Common Stock - At-The-Market Offering (Narrative) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "43",
     "firstAnchor": {
      "contextRef": "c-60",
      "name": "rxrx:SaleOfStockValueRemainingAuthorized",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-60",
      "name": "rxrx:SaleOfStockValueRemainingAuthorized",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R44": {
     "role": "http://www.recursion.com/role/CommonStockValenceAcquisitionExchangeableSharesNarrativeDetails",
     "longName": "9955532 - Disclosure - Common Stock - Valence Acquisition Exchangeable Shares (Narrative) (Details)",
     "shortName": "Common Stock - Valence Acquisition Exchangeable Shares (Narrative) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "44",
     "firstAnchor": {
      "contextRef": "c-62",
      "name": "us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-62",
      "name": "us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R45": {
     "role": "http://www.recursion.com/role/CommonStockRegistrationRightsAgreementsNarrativeDetails",
     "longName": "9955533 - Disclosure - Common Stock - Registration Rights Agreements (Narrative) (Details)",
     "shortName": "Common Stock - Registration Rights Agreements (Narrative) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "45",
     "firstAnchor": {
      "contextRef": "c-63",
      "name": "rxrx:RegistrationRightsAgreementTerm",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-63",
      "name": "rxrx:RegistrationRightsAgreementTerm",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R46": {
     "role": "http://www.recursion.com/role/CommonStockClassAandBCommonSharesAuthorizationNarrativeDetails",
     "longName": "9955534 - Disclosure - Common Stock - Class A and B Common Shares Authorization (Narrative) (Details)",
     "shortName": "Common Stock - Class A and B Common Shares Authorization (Narrative) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "46",
     "firstAnchor": {
      "contextRef": "c-64",
      "name": "rxrx:NumberOfClassesOfCommonStockAuthorized",
      "unitRef": "class",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-64",
      "name": "rxrx:NumberOfClassesOfCommonStockAuthorized",
      "unitRef": "class",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R47": {
     "role": "http://www.recursion.com/role/CollaborativeDevelopmentContractsDetails",
     "longName": "9955535 - Disclosure - Collaborative Development Contracts (Details)",
     "shortName": "Collaborative Development Contracts (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "47",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ContractWithCustomerLiabilityRevenueRecognized",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ContractWithCustomerLiabilityRevenueRecognized",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R48": {
     "role": "http://www.recursion.com/role/StockBasedCompensationNarrativeDetails",
     "longName": "9955536 - Disclosure - Stock-Based Compensation - Narrative (Details)",
     "shortName": "Stock-Based Compensation - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "48",
     "firstAnchor": {
      "contextRef": "c-90",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-90",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R49": {
     "role": "http://www.recursion.com/role/StockBasedCompensationScheduleofStockBasedCompensationExpenseDetails",
     "longName": "9955537 - Disclosure - Stock-Based Compensation - Schedule of Stock-Based Compensation Expense (Details)",
     "shortName": "Stock-Based Compensation - Schedule of Stock-Based Compensation Expense (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "49",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R50": {
     "role": "http://www.recursion.com/role/StockBasedCompensationScheduleofRSUActivityDetails",
     "longName": "9955538 - Disclosure - Stock-Based Compensation - Schedule of RSU Activity (Details)",
     "shortName": "Stock-Based Compensation - Schedule of RSU Activity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "50",
     "firstAnchor": {
      "contextRef": "c-91",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-91",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R51": {
     "role": "http://www.recursion.com/role/IncomeTaxesDetails",
     "longName": "9955539 - Disclosure - Income Taxes (Details)",
     "shortName": "Income Taxes (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "51",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ForeignIncomeTaxExpenseBenefitContinuingOperations",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ForeignIncomeTaxExpenseBenefitContinuingOperations",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R52": {
     "role": "http://www.recursion.com/role/NetLossPerShareScheduleofComputationofBasicandDilutedNetLossPerShareDetails",
     "longName": "9955540 - Disclosure - Net Loss Per Share - Schedule of Computation of Basic and Diluted Net Loss Per Share (Details)",
     "shortName": "Net Loss Per Share - Schedule of Computation of Basic and Diluted Net Loss Per Share (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "52",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R53": {
     "role": "http://www.recursion.com/role/NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofNetLossPerShareDetails",
     "longName": "9955541 - Disclosure - Net Loss Per Share - Schedule of Antidilutive Securities Excluded from Computation of Net Loss Per Share (Details)",
     "shortName": "Net Loss Per Share - Schedule of Antidilutive Securities Excluded from Computation of Net Loss Per Share (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "53",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R54": {
     "role": "http://www.recursion.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails",
     "longName": "9955542 - Disclosure - Fair Value Measurements - Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)",
     "shortName": "Fair Value Measurements - Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "54",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "rxrx:RestrictedCashAndCashEquivalentsFairValueDisclosure",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "rxrx:RestrictedCashAndCashEquivalentsFairValueDisclosure",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R55": {
     "role": "http://www.recursion.com/role/FairValueMeasurementsScheduleofFinancialInstrumentsNotMeasuredatFairValueDetails",
     "longName": "9955543 - Disclosure - Fair Value Measurements - Schedule of Financial Instruments Not Measured at Fair Value (Details)",
     "shortName": "Fair Value Measurements - Schedule of Financial Instruments Not Measured at Fair Value (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "55",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-123",
      "name": "us-gaap:LiabilitiesFairValueDisclosure",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "unique": true
     }
    },
    "R56": {
     "role": "http://www.recursion.com/role/SegmentInformationNarrativeDetails",
     "longName": "9955544 - Disclosure - Segment Information - Narrative (Details)",
     "shortName": "Segment Information - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "56",
     "firstAnchor": null,
     "uniqueAnchor": null
    },
    "R57": {
     "role": "http://www.recursion.com/role/SegmentInformationScheduleofSegmentNetLossandReconciliationsofSegmentOperatingLosstoLossBeforeIncomeTaxBenefitDetails",
     "longName": "9955545 - Disclosure - Segment Information - Schedule of Segment Net Loss and Reconciliations of Segment Operating Loss to Loss Before Income Tax Benefit (Details)",
     "shortName": "Segment Information - Schedule of Segment Net Loss and Reconciliations of Segment Operating Loss to Loss Before Income Tax Benefit (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "57",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-127",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rxrx-20260331.htm",
      "unique": true
     }
    }
   },
   "tag": {
    "rxrx_A2021EquityIncentivePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.recursion.com/20260331",
     "localname": "A2021EquityIncentivePlanMember",
     "presentation": [
      "http://www.recursion.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2021 Equity Incentive Plan",
        "label": "2021 Equity Incentive Plan [Member]",
        "documentation": "2021 Equity Incentive Plan"
       }
      }
     },
     "auth_ref": []
    },
    "rxrx_A2024InducementEquityIncentivePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.recursion.com/20260331",
     "localname": "A2024InducementEquityIncentivePlanMember",
     "presentation": [
      "http://www.recursion.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2024 Inducement Equity Incentive Plan",
        "label": "2024 Inducement Equity Incentive Plan [Member]",
        "documentation": "2024 Inducement Equity Incentive Plan"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccountsPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable",
        "label": "Accounts Payable, Current",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r38",
      "r786"
     ]
    },
    "rxrx_AccruedComputeLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.recursion.com/20260331",
     "localname": "AccruedComputeLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/SupplementalFinancialInformationScheduleofAccruedExpensesandOtherLiabilitiesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/SupplementalFinancialInformationScheduleofAccruedExpensesandOtherLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued compute liabilities",
        "label": "Accrued Compute Liabilities, Current",
        "documentation": "Accrued Compute Liabilities, Current"
       }
      }
     },
     "auth_ref": []
    },
    "rxrx_AccruedDevelopmentCostsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.recursion.com/20260331",
     "localname": "AccruedDevelopmentCostsCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/SupplementalFinancialInformationScheduleofAccruedExpensesandOtherLiabilitiesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/SupplementalFinancialInformationScheduleofAccruedExpensesandOtherLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued development expenses",
        "label": "Accrued Development Costs, Current",
        "documentation": "Accrued Development Costs, Current"
       }
      }
     },
     "auth_ref": []
    },
    "rxrx_AccruedEarlyDiscoveryExpensesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.recursion.com/20260331",
     "localname": "AccruedEarlyDiscoveryExpensesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/SupplementalFinancialInformationScheduleofAccruedExpensesandOtherLiabilitiesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/SupplementalFinancialInformationScheduleofAccruedExpensesandOtherLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued early discovery expenses",
        "label": "Accrued Early Discovery Expenses, Current",
        "documentation": "Accrued Early Discovery Expenses, Current"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.recursion.com/role/SupplementalFinancialInformationScheduleofAccruedExpensesandOtherLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited",
      "http://www.recursion.com/role/SupplementalFinancialInformationScheduleofAccruedExpensesandOtherLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued expenses and other liabilities",
        "totalLabel": "Accrued expense and other liabilities",
        "label": "Accrued Liabilities, Current",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r40"
     ]
    },
    "rxrx_AccruedLicenseFeeCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.recursion.com/20260331",
     "localname": "AccruedLicenseFeeCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/SupplementalFinancialInformationScheduleofAccruedExpensesandOtherLiabilitiesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/SupplementalFinancialInformationScheduleofAccruedExpensesandOtherLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued license fees",
        "label": "Accrued License Fee, Current",
        "documentation": "Accrued License Fee, Current"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccruedProfessionalFeesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccruedProfessionalFeesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/SupplementalFinancialInformationScheduleofAccruedExpensesandOtherLiabilitiesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/SupplementalFinancialInformationScheduleofAccruedExpensesandOtherLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued professional fees",
        "label": "Accrued Professional Fees, Current",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r40"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated other comprehensive income (loss)",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r15",
      "r53",
      "r109",
      "r555",
      "r592",
      "r593",
      "r1070"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofStockholdersEquityunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated other comprehensive income (loss)",
        "label": "AOCI Attributable to Parent [Member]",
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r9",
      "r15",
      "r465",
      "r468",
      "r526",
      "r588",
      "r589",
      "r910",
      "r911",
      "r912",
      "r968",
      "r969",
      "r970",
      "r971"
     ]
    },
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional 402(v) Disclosure",
        "label": "Additional 402(v) Disclosure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r842"
     ]
    },
    "us-gaap_AdditionalPaidInCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdditionalPaidInCapital",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional paid-in capital",
        "label": "Additional Paid in Capital",
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock."
       }
      }
     },
     "auth_ref": [
      "r48",
      "r786",
      "r1122"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofStockholdersEquityunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional Paid-in-Capital",
        "label": "Additional Paid-in Capital [Member]",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r604",
      "r968",
      "r969",
      "r970",
      "r971",
      "r1071",
      "r1124"
     ]
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Compensation, Amount",
        "label": "Adjustment to Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r855"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Compensation:",
        "label": "Adjustment to Compensation [Axis]"
       }
      }
     },
     "auth_ref": [
      "r855"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote",
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r855"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment To PEO Compensation, Footnote",
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r855"
     ]
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "crdr": "credit",
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofStockholdersEquityunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r321"
     ]
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:",
        "label": "Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtChngPnsnValInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table",
        "label": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]"
       }
      }
     },
     "auth_ref": [
      "r888"
     ]
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Erroneous Compensation Amount",
        "label": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r814",
      "r824",
      "r834",
      "r866"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined",
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r817",
      "r827",
      "r837",
      "r869"
     ]
    },
    "ecd_AggtPnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtPnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Pension Adjustments Service Cost",
        "label": "Aggregate Pension Adjustments Service Cost [Member]"
       }
      }
     },
     "auth_ref": [
      "r889"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Adjustments to Compensation",
        "label": "All Adjustments to Compensation [Member]"
       }
      }
     },
     "auth_ref": [
      "r855"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Executive Categories",
        "label": "All Executive Categories [Member]"
       }
      }
     },
     "auth_ref": [
      "r862"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Individuals",
        "label": "All Individuals [Member]"
       }
      }
     },
     "auth_ref": [
      "r818",
      "r828",
      "r838",
      "r862",
      "r870",
      "r874",
      "r882"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Trading Arrangements",
        "label": "All Trading Arrangements [Member]"
       }
      }
     },
     "auth_ref": [
      "r880"
     ]
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AllocatedShareBasedCompensationExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.recursion.com/role/StockBasedCompensationScheduleofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total",
        "label": "Share-Based Payment Arrangement, Expense",
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized."
       }
      }
     },
     "auth_ref": [
      "r351",
      "r357",
      "r358"
     ]
    },
    "rxrx_AlphaBiotechnologyGmbHAlphaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.recursion.com/20260331",
     "localname": "AlphaBiotechnologyGmbHAlphaMember",
     "presentation": [
      "http://www.recursion.com/role/AcquisitionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Alpha Biotechnology GmbH (Alpha)",
        "label": "Alpha Biotechnology GmbH (Alpha) [Member]",
        "documentation": "Alpha Biotechnology GmbH (Alpha)"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AmortizationOfIntangibleAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.recursion.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortization expense",
        "label": "Amortization of Intangible Assets",
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r123",
      "r230",
      "r237",
      "r691",
      "r697",
      "r698",
      "r700",
      "r702"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "presentation": [
      "http://www.recursion.com/role/NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive securities excluded from computation of loss per share, amount (in shares)",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r160"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "presentation": [
      "http://www.recursion.com/role/NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities [Axis]",
        "label": "Antidilutive Securities [Axis]",
        "documentation": "Information by type of antidilutive security."
       }
      }
     },
     "auth_ref": [
      "r160"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "presentation": [
      "http://www.recursion.com/role/NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r160"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AntidilutiveSecuritiesNameDomain",
     "presentation": [
      "http://www.recursion.com/role/NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities, Name [Domain]",
        "label": "Antidilutive Securities, Name [Domain]",
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r160"
     ]
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "presentation": [
      "http://www.recursion.com/role/CollaborativeDevelopmentContractsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r453"
     ]
    },
    "us-gaap_AssetAcquisitionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetAcquisitionAxis",
     "presentation": [
      "http://www.recursion.com/role/AcquisitionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Asset Acquisition [Axis]",
        "label": "Asset Acquisition [Axis]",
        "documentation": "Information by asset acquisition."
       }
      }
     },
     "auth_ref": [
      "r227",
      "r231",
      "r232",
      "r233",
      "r234",
      "r235",
      "r596",
      "r1062"
     ]
    },
    "us-gaap_AssetAcquisitionConsiderationTransferred": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetAcquisitionConsiderationTransferred",
     "crdr": "credit",
     "presentation": [
      "http://www.recursion.com/role/AcquisitionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Asset acquisition, consideration transferred",
        "label": "Asset Acquisition, Consideration Transferred",
        "documentation": "Amount of consideration transferred in asset acquisition. Includes, but is not limited to, cash, liability incurred by acquirer, and equity interest issued by acquirer."
       }
      }
     },
     "auth_ref": [
      "r773",
      "r1063",
      "r1064",
      "r1065"
     ]
    },
    "us-gaap_AssetAcquisitionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetAcquisitionDomain",
     "presentation": [
      "http://www.recursion.com/role/AcquisitionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Asset Acquisition [Domain]",
        "label": "Asset Acquisition [Domain]",
        "documentation": "Asset acquisition."
       }
      }
     },
     "auth_ref": [
      "r227",
      "r231",
      "r232",
      "r233",
      "r234",
      "r235",
      "r596",
      "r1062"
     ]
    },
    "rxrx_AssetAcquisitionEquityOwnershipPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.recursion.com/20260331",
     "localname": "AssetAcquisitionEquityOwnershipPercentage",
     "presentation": [
      "http://www.recursion.com/role/AcquisitionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest acquired",
        "label": "Asset Acquisition, Equity Ownership, Percentage",
        "documentation": "Asset Acquisition, Equity Ownership, Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total assets",
        "label": "Assets",
        "documentation": "Amount of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r76",
      "r84",
      "r105",
      "r127",
      "r128",
      "r129",
      "r164",
      "r174",
      "r192",
      "r196",
      "r208",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r454",
      "r457",
      "r502",
      "r544",
      "r545",
      "r550",
      "r639",
      "r713",
      "r714",
      "r722",
      "r786",
      "r792",
      "r793",
      "r805",
      "r1016",
      "r1017",
      "r1082"
     ]
    },
    "us-gaap_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Assets",
        "label": "Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current assets",
        "label": "Assets, Current",
        "documentation": "Amount of asset recognized for present right to economic benefit, classified as current."
       }
      }
     },
     "auth_ref": [
      "r99",
      "r112",
      "r127",
      "r128",
      "r129",
      "r208",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r454",
      "r457",
      "r502",
      "r786",
      "r1016",
      "r1017",
      "r1082"
     ]
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current assets",
        "label": "Assets, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetsFairValueDisclosure",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.recursion.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total",
        "label": "Assets, Fair Value Disclosure",
        "documentation": "Fair value portion of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r479",
      "r480",
      "r778"
     ]
    },
    "rxrx_AtTheMarketOfferingProgramTDCowenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.recursion.com/20260331",
     "localname": "AtTheMarketOfferingProgramTDCowenMember",
     "presentation": [
      "http://www.recursion.com/role/CommonStockAtTheMarketOfferingNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "TD Cowen Sales Agreement",
        "label": "At-The-Market Offering Program TD Cowen [Member]",
        "documentation": "At-The-Market Offering Program TD Cowen"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise Price",
        "label": "Award Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r877"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value as of Grant Date",
        "label": "Award Grant Date Fair Value"
       }
      }
     },
     "auth_ref": [
      "r878"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgDiscLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r873"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing, How MNPI Considered",
        "label": "Award Timing, How MNPI Considered [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r873"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing Method",
        "label": "Award Timing Method [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r873"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing MNPI Considered",
        "label": "Award Timing MNPI Considered [Flag]"
       }
      }
     },
     "auth_ref": [
      "r873"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing MNPI Disclosure",
        "label": "Award Timing MNPI Disclosure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r873"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing Predetermined",
        "label": "Award Timing Predetermined [Flag]"
       }
      }
     },
     "auth_ref": [
      "r873"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://www.recursion.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.recursion.com/role/StockBasedCompensationScheduleofRSUActivityDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Type [Axis]",
        "label": "Award Type [Axis]",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underlying Securities",
        "label": "Award Underlying Securities Amount"
       }
      }
     },
     "auth_ref": [
      "r876"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r875"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Awards Close in Time to MNPI Disclosures",
        "label": "Awards Close in Time to MNPI Disclosures [Table]"
       }
      }
     },
     "auth_ref": [
      "r874"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Awards Close in Time to MNPI Disclosures, Table",
        "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r874"
     ]
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "presentation": [
      "http://www.recursion.com/role/BasisofPresentationPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basis of Presentation",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
       }
      }
     },
     "auth_ref": [
      "r962"
     ]
    },
    "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://www.recursion.com/role/BasisofPresentation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basis of Presentation",
        "label": "Basis of Presentation and Significant Accounting Policies [Text Block]",
        "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r961"
     ]
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BusinessAcquisitionAcquireeDomain",
     "presentation": [
      "http://www.recursion.com/role/CommonStockRegistrationRightsAgreementsNarrativeDetails",
      "http://www.recursion.com/role/CommonStockValenceAcquisitionExchangeableSharesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Combination [Domain]",
        "label": "Business Combination [Domain]",
        "documentation": "Business combination or series of individually immaterial business combinations."
       }
      }
     },
     "auth_ref": [
      "r227",
      "r231",
      "r232",
      "r233",
      "r234",
      "r235",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r445",
      "r446",
      "r447",
      "r596",
      "r731",
      "r732",
      "r1057",
      "r1059",
      "r1060"
     ]
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BusinessAcquisitionAxis",
     "presentation": [
      "http://www.recursion.com/role/CommonStockRegistrationRightsAgreementsNarrativeDetails",
      "http://www.recursion.com/role/CommonStockValenceAcquisitionExchangeableSharesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Combination [Axis]",
        "label": "Business Combination [Axis]",
        "documentation": "Information by business combination or series of individually immaterial business combinations."
       }
      }
     },
     "auth_ref": [
      "r227",
      "r231",
      "r232",
      "r233",
      "r234",
      "r235",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r445",
      "r446",
      "r447",
      "r596",
      "r731",
      "r732",
      "r1057",
      "r1059",
      "r1060"
     ]
    },
    "rxrx_BusinessAcquisitionContingentConsiderationEquityInterestsIssuableNumberOfShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.recursion.com/20260331",
     "localname": "BusinessAcquisitionContingentConsiderationEquityInterestsIssuableNumberOfShares",
     "presentation": [
      "http://www.recursion.com/role/CommonStockValenceAcquisitionExchangeableSharesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity interest issued or issuable (in shares)",
        "label": "Business Acquisition , Contingent Consideration, Equity Interests Issuable, Number Of Shares",
        "documentation": "Business Acquisition , Contingent Consideration, Equity Interests Issuable, Number Of Shares"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BusinessAcquisitionLineItems",
     "presentation": [
      "http://www.recursion.com/role/AcquisitionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Combination [Line Items]",
        "label": "Business Combination [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r227",
      "r387",
      "r388",
      "r389",
      "r390",
      "r396",
      "r397",
      "r398",
      "r399",
      "r405",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r441",
      "r442",
      "r443",
      "r447",
      "r736",
      "r745",
      "r1057",
      "r1059",
      "r1060"
     ]
    },
    "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BusinessCombinationAndAssetAcquisitionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BusinessCombinationDisclosureTextBlock",
     "presentation": [
      "http://www.recursion.com/role/Acquisitions"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Acquisitions",
        "label": "Business Combination [Text Block]",
        "documentation": "The entire disclosure for business combination."
       }
      }
     },
     "auth_ref": [
      "r386",
      "r387",
      "r391",
      "r400",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r411",
      "r412",
      "r418",
      "r421",
      "r422",
      "r428",
      "r429",
      "r430",
      "r438",
      "r442",
      "r443",
      "r444",
      "r446",
      "r448",
      "r736",
      "r737",
      "r738",
      "r739",
      "r742",
      "r743",
      "r744"
     ]
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "crdr": "credit",
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued property and equipment",
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r21",
      "r22"
     ]
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents",
        "label": "Cash and Cash Equivalent",
        "documentation": "Amount of cash and cash equivalent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r101",
      "r692"
     ]
    },
    "us-gaap_CashAndCashEquivalentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashAndCashEquivalentsAxis",
     "presentation": [
      "http://www.recursion.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and Cash Equivalents [Axis]",
        "label": "Cash and Cash Equivalents [Axis]",
        "documentation": "Information by type of cash and cash equivalent balance."
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails": {
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents:",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r498",
      "r499",
      "r500",
      "r1072",
      "r1073"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Cash, cash equivalents and restricted cash, beginning of period",
        "periodEndLabel": "Cash, cash equivalents and restricted cash, end of period",
        "label": "Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation",
        "documentation": "Amount of cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r65",
      "r126"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net change in cash, cash equivalents and restricted cash",
        "label": "Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation",
        "documentation": "Amount of increase (decrease) in cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; including effect from exchange rate change and including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r65"
     ]
    },
    "us-gaap_CashMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashMember",
     "presentation": [
      "http://www.recursion.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash",
        "label": "Cash [Member]",
        "documentation": "Currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits."
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "rxrx_CashPaidForAmountIncludedInTheMeasurementOfLeaseLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.recursion.com/20260331",
     "localname": "CashPaidForAmountIncludedInTheMeasurementOfLeaseLiabilitiesAbstract",
     "presentation": [
      "http://www.recursion.com/role/LeasesScheduleofSupplementalCashFlowInformationRelatedtoLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash paid for amount included in the measurement of lease liabilities:",
        "label": "Cash Paid For Amount Included In The Measurement Of Lease Liabilities [Abstract]",
        "documentation": "Cash Paid For Amount Included In The Measurement Of Lease Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changed Peer Group, Footnote",
        "label": "Changed Peer Group, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r853"
     ]
    },
    "ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year",
        "label": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r850"
     ]
    },
    "ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested",
        "label": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]"
       }
      }
     },
     "auth_ref": [
      "r848"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://www.recursion.com/role/CommonStockAtTheMarketOfferingNarrativeDetails",
      "http://www.recursion.com/role/CommonStockClassAandBCommonSharesAuthorizationNarrativeDetails",
      "http://www.recursion.com/role/CommonStockNarrativeDetails",
      "http://www.recursion.com/role/CommonStockValenceAcquisitionExchangeableSharesNarrativeDetails",
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunauditedParenthetical",
      "http://www.recursion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Stock [Domain]",
        "label": "Class of Stock [Domain]",
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "auth_ref": [
      "r92",
      "r106",
      "r107",
      "r108",
      "r127",
      "r129",
      "r154",
      "r155",
      "r157",
      "r159",
      "r166",
      "r167",
      "r208",
      "r258",
      "r260",
      "r261",
      "r262",
      "r265",
      "r266",
      "r272",
      "r273",
      "r275",
      "r276",
      "r278",
      "r280",
      "r283",
      "r284",
      "r287",
      "r290",
      "r297",
      "r502",
      "r598",
      "r599",
      "r600",
      "r601",
      "r604",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r627",
      "r647",
      "r665",
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r892",
      "r964",
      "r965",
      "r972"
     ]
    },
    "us-gaap_ClassOfStockLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfStockLineItems",
     "presentation": [
      "http://www.recursion.com/role/CommonStockAtTheMarketOfferingNarrativeDetails",
      "http://www.recursion.com/role/CommonStockClassAandBCommonSharesAuthorizationNarrativeDetails",
      "http://www.recursion.com/role/CommonStockNarrativeDetails",
      "http://www.recursion.com/role/CommonStockRegistrationRightsAgreementsNarrativeDetails",
      "http://www.recursion.com/role/CommonStockValenceAcquisitionExchangeableSharesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Stock [Line Items]",
        "label": "Class of Stock [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r106",
      "r107",
      "r108",
      "r166",
      "r275",
      "r283",
      "r284",
      "r285",
      "r287",
      "r290",
      "r295",
      "r297",
      "r463",
      "r598",
      "r599",
      "r600",
      "r601",
      "r723",
      "r892",
      "r963",
      "r964"
     ]
    },
    "rxrx_ClinicalDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.recursion.com/20260331",
     "localname": "ClinicalDevelopmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/SegmentInformationScheduleofSegmentNetLossandReconciliationsofSegmentOperatingLosstoLossBeforeIncomeTaxBenefitDetails": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/SegmentInformationScheduleofSegmentNetLossandReconciliationsofSegmentOperatingLosstoLossBeforeIncomeTaxBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Clinical development",
        "label": "Clinical Development Expense",
        "documentation": "Clinical Development Expense"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company Selected Measure Amount",
        "label": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r854"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company Selected Measure Name",
        "label": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r854"
     ]
    },
    "us-gaap_CollaborativeArrangementDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CollaborativeArrangementDisclosureTextBlock",
     "presentation": [
      "http://www.recursion.com/role/CollaborativeDevelopmentContracts"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaborative Development Contracts",
        "label": "Collaborative Arrangement Disclosure [Text Block]",
        "documentation": "The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants."
       }
      }
     },
     "auth_ref": [
      "r91",
      "r451",
      "r452"
     ]
    },
    "us-gaap_CollaborativeArrangementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CollaborativeArrangementMember",
     "presentation": [
      "http://www.recursion.com/role/CollaborativeDevelopmentContractsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaborative Arrangement",
        "label": "Collaborative Arrangement [Member]",
        "documentation": "Contractual arrangement that involves two or more parties that both: (i) actively participate in a joint operating activity and (ii) are exposed to significant risks and rewards that depend on the commercial success of the joint operating activity."
       }
      }
     },
     "auth_ref": [
      "r453"
     ]
    },
    "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems",
     "presentation": [
      "http://www.recursion.com/role/CollaborativeDevelopmentContractsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r453"
     ]
    },
    "us-gaap_CommitmentsAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommitmentsAndContingencies",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and contingencies (Note\u00a07)",
        "label": "Commitments and Contingencies",
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r44",
      "r77",
      "r553",
      "r626"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "presentation": [
      "http://www.recursion.com/role/CommitmentsandContingencies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and Contingencies",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "documentation": "The entire disclosure for commitments and contingencies."
       }
      }
     },
     "auth_ref": [
      "r70",
      "r251",
      "r252",
      "r685",
      "r1008",
      "r1013"
     ]
    },
    "us-gaap_CommonClassAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonClassAMember",
     "presentation": [
      "http://www.recursion.com/role/CommonStockAtTheMarketOfferingNarrativeDetails",
      "http://www.recursion.com/role/CommonStockClassAandBCommonSharesAuthorizationNarrativeDetails",
      "http://www.recursion.com/role/CommonStockNarrativeDetails",
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunauditedParenthetical",
      "http://www.recursion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Class A Common Stock",
        "terseLabel": "Class A",
        "label": "Common Class A [Member]",
        "documentation": "Classification of common stock representing ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r1124"
     ]
    },
    "us-gaap_CommonClassBMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonClassBMember",
     "presentation": [
      "http://www.recursion.com/role/CommonStockClassAandBCommonSharesAuthorizationNarrativeDetails",
      "http://www.recursion.com/role/CommonStockNarrativeDetails",
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunauditedParenthetical",
      "http://www.recursion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Class B Common Stock",
        "terseLabel": "Class B",
        "label": "Common Class B [Member]",
        "documentation": "Classification of common stock that has different rights than Common Class A, representing ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r1124"
     ]
    },
    "rxrx_CommonStockConversionRatio": {
     "xbrltype": "pureItemType",
     "nsuri": "http://www.recursion.com/20260331",
     "localname": "CommonStockConversionRatio",
     "presentation": [
      "http://www.recursion.com/role/CommonStockClassAandBCommonSharesAuthorizationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, conversion ratio",
        "label": "Common Stock, Conversion Ratio",
        "documentation": "Common Stock, Conversion Ratio"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockMember",
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofStockholdersEquityunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common Stock (Class A, B and Exchangeable)",
        "label": "Common Stock [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r795",
      "r796",
      "r797",
      "r799",
      "r800",
      "r801",
      "r802",
      "r968",
      "r969",
      "r971",
      "r1071",
      "r1121",
      "r1124"
     ]
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunauditedParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, par value (in dollars per share)",
        "label": "Common Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r47"
     ]
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunauditedParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares authorized (in shares)",
        "label": "Common Stock, Shares Authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r47",
      "r627"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunauditedParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares issued (in shares)",
        "label": "Common Stock, Shares, Issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r47"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunauditedParenthetical",
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofStockholdersEquityunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Common sock, shares outstanding (in shares)",
        "periodStartLabel": "Beginning balance (in shares)",
        "periodEndLabel": "Ending balance (in shares)",
        "label": "Common Stock, Shares, Outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r47",
      "r627",
      "r645",
      "r1124",
      "r1125"
     ]
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, $0.00001 par value; 2,000,000,000 shares (Class A 1,989,032,117 and Class B 10,967,883) authorized as of March\u00a031, 2026 and December\u00a031, 2025; 530,628,653 shares (Class A 524,464,320, Class B 5,307,334 and Exchangeable 856,999) and 528,182,693 shares (Class A 521,831,046, Class B 5,547,334 and Exchangeable 804,313) issued and outstanding as of March\u00a031, 2026 and December\u00a031, 2025, respectively",
        "label": "Common Stock, Value, Issued",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r47",
      "r273",
      "r279",
      "r554",
      "r786"
     ]
    },
    "rxrx_CommonStockVotePerShare": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.recursion.com/20260331",
     "localname": "CommonStockVotePerShare",
     "presentation": [
      "http://www.recursion.com/role/CommonStockClassAandBCommonSharesAuthorizationNarrativeDetails",
      "http://www.recursion.com/role/CommonStockNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vote per share of common stock (in votes)",
        "label": "Common Stock, Vote Per Share",
        "documentation": "Common Stock, Vote Per Share"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Company Selected Measure",
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r859"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Net Income",
        "label": "Compensation Actually Paid vs. Net Income [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r858"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Other Measure",
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r860"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return",
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r857"
     ]
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ComprehensiveIncomeNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofComprehensiveLossunaudited": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofComprehensiveLossunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Comprehensive loss",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r115",
      "r117",
      "r121",
      "r542",
      "r562",
      "r563"
     ]
    },
    "rxrx_ConsumableExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.recursion.com/20260331",
     "localname": "ConsumableExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/SegmentInformationScheduleofSegmentNetLossandReconciliationsofSegmentOperatingLosstoLossBeforeIncomeTaxBenefitDetails": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/SegmentInformationScheduleofSegmentNetLossandReconciliationsofSegmentOperatingLosstoLossBeforeIncomeTaxBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consumables",
        "label": "Consumable Expense",
        "documentation": "Consumable Expense"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ContractWithCustomerAssetNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ContractWithCustomerAssetNetCurrent",
     "crdr": "debit",
     "presentation": [
      "http://www.recursion.com/role/CollaborativeDevelopmentContractsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cost incurred",
        "label": "Contract with Customer, Asset, after Allowance for Credit Loss, Current",
        "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current."
       }
      }
     },
     "auth_ref": [
      "r299",
      "r301",
      "r302",
      "r306"
     ]
    },
    "us-gaap_ContractWithCustomerLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ContractWithCustomerLiability",
     "crdr": "credit",
     "presentation": [
      "http://www.recursion.com/role/CollaborativeDevelopmentContractsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Remaining unearned revenue",
        "label": "Contract with Customer, Liability",
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable."
       }
      }
     },
     "auth_ref": [
      "r299",
      "r300",
      "r302",
      "r306"
     ]
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ContractWithCustomerLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unearned revenue",
        "label": "Contract with Customer, Liability, Current",
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current."
       }
      }
     },
     "auth_ref": [
      "r299",
      "r300",
      "r302",
      "r306"
     ]
    },
    "us-gaap_ContractWithCustomerLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ContractWithCustomerLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unearned revenue, non-current",
        "label": "Contract with Customer, Liability, Noncurrent",
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r299",
      "r300",
      "r302",
      "r306"
     ]
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "crdr": "credit",
     "presentation": [
      "http://www.recursion.com/role/CollaborativeDevelopmentContractsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue recognized",
        "label": "Contract with Customer, Liability, Revenue Recognized",
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due."
       }
      }
     },
     "auth_ref": [
      "r307"
     ]
    },
    "rxrx_ContractWithCustomerMaximumAcceptedProduct": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.recursion.com/20260331",
     "localname": "ContractWithCustomerMaximumAcceptedProduct",
     "presentation": [
      "http://www.recursion.com/role/CollaborativeDevelopmentContractsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of eligible phenomaps",
        "label": "Contract With Customer, Maximum Accepted Product",
        "documentation": "Contract With Customer, Maximum Accepted Product"
       }
      }
     },
     "auth_ref": []
    },
    "rxrx_ContractWithCustomerNumberOfNovelSmallMoleculeCandidates": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.recursion.com/20260331",
     "localname": "ContractWithCustomerNumberOfNovelSmallMoleculeCandidates",
     "presentation": [
      "http://www.recursion.com/role/CollaborativeDevelopmentContractsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum number of novel small molecule candidates",
        "label": "Contract With Customer, Number Of Novel Small Molecule Candidates",
        "documentation": "Contract With Customer, Number Of Novel Small Molecule Candidates"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CostOfGoodsAndServicesSold",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofOperationsunaudited": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofOperationsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cost of revenue",
        "label": "Cost of Product and Service Sold",
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities."
       }
      }
     },
     "auth_ref": [
      "r55",
      "r56",
      "r536",
      "r698",
      "r703",
      "r775",
      "r953"
     ]
    },
    "us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CostOfGoodsAndServicesSoldDepreciationAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/SegmentInformationScheduleofSegmentNetLossandReconciliationsofSegmentOperatingLosstoLossBeforeIncomeTaxBenefitDetails": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/SegmentInformationScheduleofSegmentNetLossandReconciliationsofSegmentOperatingLosstoLossBeforeIncomeTaxBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation and amortization",
        "label": "Cost, Depreciation and Amortization",
        "documentation": "Amount of expense for allocation of cost of tangible and intangible assets over their useful lives directly used in production of good and rendering of service."
       }
      }
     },
     "auth_ref": [
      "r913"
     ]
    },
    "us-gaap_CostOfSalesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CostOfSalesMember",
     "presentation": [
      "http://www.recursion.com/role/StockBasedCompensationScheduleofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cost of revenue",
        "label": "Cost of Sales [Member]",
        "documentation": "Primary financial statement caption encompassing cost of sales."
       }
      }
     },
     "auth_ref": [
      "r776"
     ]
    },
    "us-gaap_CostsAndExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CostsAndExpenses",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofOperationsunaudited": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofOperationsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total operating costs and expenses",
        "label": "Costs and Expenses",
        "documentation": "Total costs of sales and operating expenses for the period."
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "srt_CounterpartyNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "CounterpartyNameAxis",
     "presentation": [
      "http://www.recursion.com/role/CollaborativeDevelopmentContractsDetails",
      "http://www.recursion.com/role/SupplementalFinancialInformationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Counterparty Name [Axis]",
        "label": "Counterparty Name [Axis]"
       }
      }
     },
     "auth_ref": [
      "r127",
      "r133",
      "r134",
      "r267",
      "r285",
      "r527",
      "r533",
      "r549",
      "r694",
      "r695",
      "r696",
      "r901",
      "r902",
      "r903",
      "r904",
      "r905",
      "r906",
      "r907",
      "r908",
      "r909",
      "r1066",
      "r1067",
      "r1068",
      "r1069"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current Fiscal Year End Date",
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredIncomeTaxAssetsNet",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax assets",
        "label": "Deferred Income Tax Assets, Net",
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r363",
      "r364"
     ]
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 15.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred income taxes",
        "label": "Deferred Income Tax Expense (Benefit)",
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r89",
      "r963",
      "r967"
     ]
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax liabilities",
        "label": "Deferred Income Tax Liabilities, Net",
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r363",
      "r364",
      "r551"
     ]
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DepreciationDepletionAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation and amortization",
        "label": "Depreciation, Depletion and Amortization",
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r124",
      "r164",
      "r179",
      "r196",
      "r697",
      "r713",
      "r714"
     ]
    },
    "rxrx_DevelopedAndCommercializedProgramsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.recursion.com/20260331",
     "localname": "DevelopedAndCommercializedProgramsMember",
     "presentation": [
      "http://www.recursion.com/role/CollaborativeDevelopmentContractsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Developed and Commercialized Programs",
        "label": "Developed And Commercialized Programs [Member]",
        "documentation": "Developed And Commercialized Programs"
       }
      }
     },
     "auth_ref": []
    },
    "rxrx_DevelopmentAndRegulatoryMilestonesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.recursion.com/20260331",
     "localname": "DevelopmentAndRegulatoryMilestonesMember",
     "presentation": [
      "http://www.recursion.com/role/CollaborativeDevelopmentContractsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Development And Regulatory Milestones",
        "label": "Development And Regulatory Milestones [Member]",
        "documentation": "Development And Regulatory Milestones"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "presentation": [
      "http://www.recursion.com/role/StockBasedCompensation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-Based Compensation",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "documentation": "The entire disclosure for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r319",
      "r323",
      "r352",
      "r353",
      "r355",
      "r734"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "rxrx_DiscoveryDevelopmentAndSalesMilestonesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.recursion.com/20260331",
     "localname": "DiscoveryDevelopmentAndSalesMilestonesMember",
     "presentation": [
      "http://www.recursion.com/role/CollaborativeDevelopmentContractsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Discovery, Development And Sales Milestones",
        "label": "Discovery, Development And Sales Milestones [Member]",
        "documentation": "Discovery, Development And Sales Milestones"
       }
      }
     },
     "auth_ref": []
    },
    "rxrx_DiscoveryExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.recursion.com/20260331",
     "localname": "DiscoveryExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/SegmentInformationScheduleofSegmentNetLossandReconciliationsofSegmentOperatingLosstoLossBeforeIncomeTaxBenefitDetails": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/SegmentInformationScheduleofSegmentNetLossandReconciliationsofSegmentOperatingLosstoLossBeforeIncomeTaxBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Discovery",
        "label": "Discovery Expense",
        "documentation": "Discovery Expense"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisposalGroupClassificationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DisposalGroupClassificationAxis",
     "presentation": [
      "http://www.recursion.com/role/AcquisitionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disposal Group Classification [Axis]",
        "label": "Disposal Group Classification [Axis]",
        "documentation": "Information by disposal group classification."
       }
      }
     },
     "auth_ref": [
      "r97"
     ]
    },
    "us-gaap_DisposalGroupClassificationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DisposalGroupClassificationDomain",
     "presentation": [
      "http://www.recursion.com/role/AcquisitionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disposal Group Classification [Domain]",
        "label": "Disposal Group Classification [Domain]",
        "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember",
     "presentation": [
      "http://www.recursion.com/role/AcquisitionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disposal Group, Disposed of by Sale, Not Discontinued Operations",
        "label": "Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]",
        "documentation": "Disposal group that has been sold. Excludes disposals classified as discontinued operations."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r11"
     ]
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "presentation": [
      "http://www.recursion.com/role/AcquisitionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disposal Group Name [Domain]",
        "label": "Disposal Group Name [Domain]",
        "documentation": "Name of disposal group."
       }
      }
     },
     "auth_ref": [
      "r245",
      "r246",
      "r731",
      "r732"
     ]
    },
    "us-gaap_DividendsStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DividendsStock",
     "crdr": "debit",
     "presentation": [
      "http://www.recursion.com/role/CommonStockNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividends declared",
        "label": "Dividends, Stock",
        "documentation": "Amount of paid and unpaid stock dividends declared for classes of stock, for example, but not limited to, common and preferred."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r74"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Period Focus",
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Year Focus",
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Information [Line Items]",
        "label": "Document Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentInformationTable",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Information [Table]",
        "label": "Document Information [Table]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Quarterly Report",
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r809"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Transition Report",
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r841"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year",
        "label": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r852"
     ]
    },
    "us-gaap_EarningsPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EarningsPerShareAbstract",
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofOperationsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Per share data",
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofOperationsunaudited",
      "http://www.recursion.com/role/NetLossPerShareScheduleofComputationofBasicandDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Net loss per share of class A, B and Exchangeable common stock, basic (in dollars per share)",
        "terseLabel": "Net loss per share, basic (in dollars per shares)",
        "label": "Earnings Per Share, Basic",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r95",
      "r122",
      "r140",
      "r141",
      "r142",
      "r143",
      "r144",
      "r145",
      "r146",
      "r147",
      "r152",
      "r154",
      "r157",
      "r158",
      "r159",
      "r163",
      "r271",
      "r356",
      "r384",
      "r450",
      "r476",
      "r477",
      "r543",
      "r564",
      "r704"
     ]
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofOperationsunaudited",
      "http://www.recursion.com/role/NetLossPerShareScheduleofComputationofBasicandDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Net loss per share of class A, B and Exchangeable common stock, diluted (in dollars per share)",
        "terseLabel": "Net loss per share, diluted (in dollars per shares)",
        "label": "Earnings Per Share, Diluted",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r95",
      "r122",
      "r140",
      "r141",
      "r142",
      "r143",
      "r144",
      "r145",
      "r146",
      "r147",
      "r154",
      "r157",
      "r158",
      "r159",
      "r163",
      "r271",
      "r356",
      "r384",
      "r450",
      "r476",
      "r477",
      "r543",
      "r564",
      "r704"
     ]
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EarningsPerShareTextBlock",
     "presentation": [
      "http://www.recursion.com/role/NetLossPerShare"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net Loss Per Share",
        "label": "Earnings Per Share [Text Block]",
        "documentation": "The entire disclosure for earnings per share."
       }
      }
     },
     "auth_ref": [
      "r151",
      "r160",
      "r161",
      "r162"
     ]
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effect of exchange rate changes on cash, cash equivalents and restricted cash",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation",
        "documentation": "Amount of increase (decrease) from effect of exchange rate change on cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; held in foreign currency; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate."
       }
      }
     },
     "auth_ref": [
      "r506"
     ]
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/SupplementalFinancialInformationScheduleofAccruedExpensesandOtherLiabilitiesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/SupplementalFinancialInformationScheduleofAccruedExpensesandOtherLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued compensation",
        "label": "Employee-related Liabilities, Current",
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r40"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
     "presentation": [
      "http://www.recursion.com/role/StockBasedCompensationScheduleofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r1049"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "presentation": [
      "http://www.recursion.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unvested stock options, unamortized stock-based compensation cost, weighted average period recognition",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r354"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions",
     "crdr": "debit",
     "presentation": [
      "http://www.recursion.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrecognized compensation cost",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount",
        "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options."
       }
      }
     },
     "auth_ref": [
      "r1050"
     ]
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee Stock Option",
        "label": "Share-Based Payment Arrangement, Option [Member]",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": [
      "r1023",
      "r1024",
      "r1025",
      "r1026",
      "r1027",
      "r1028",
      "r1029",
      "r1030",
      "r1031",
      "r1032",
      "r1033",
      "r1034",
      "r1035",
      "r1036",
      "r1037",
      "r1038",
      "r1039",
      "r1040",
      "r1041",
      "r1042",
      "r1043",
      "r1044",
      "r1045",
      "r1046",
      "r1047",
      "r1048"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r807"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Common Stock, Shares Outstanding",
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Current Reporting Status",
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r807"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Filer Category",
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r807"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Interactive Data Current",
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r891"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r807"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Shell Company",
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r807"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Small Business",
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r807"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r807"
     ]
    },
    "ecd_EqtyAwrdsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Awards Adjustments, Footnote",
        "label": "Equity Awards Adjustments, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r846"
     ]
    },
    "ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Awards Adjustments, Excluding Value Reported in Compensation Table",
        "label": "Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]"
       }
      }
     },
     "auth_ref": [
      "r887"
     ]
    },
    "ecd_EqtyAwrdsAdjsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsAdjsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Awards Adjustments",
        "label": "Equity Awards Adjustments [Member]"
       }
      }
     },
     "auth_ref": [
      "r887"
     ]
    },
    "ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table",
        "label": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]"
       }
      }
     },
     "auth_ref": [
      "r887"
     ]
    },
    "us-gaap_EquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofStockholdersEquityunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Component [Domain]",
        "label": "Equity Component [Domain]",
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r93",
      "r94",
      "r95",
      "r118",
      "r119",
      "r120",
      "r135",
      "r136",
      "r137",
      "r139",
      "r146",
      "r148",
      "r150",
      "r165",
      "r209",
      "r210",
      "r242",
      "r270",
      "r298",
      "r356",
      "r373",
      "r374",
      "r381",
      "r382",
      "r383",
      "r385",
      "r449",
      "r450",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r475",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r515",
      "r526",
      "r561",
      "r588",
      "r589",
      "r590",
      "r604",
      "r665"
     ]
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "EquityMethodInvesteeNameDomain",
     "presentation": [
      "http://www.recursion.com/role/AcquisitionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment, Name [Domain]",
        "label": "Investment, Name [Domain]"
       }
      }
     },
     "auth_ref": [
      "r205",
      "r206",
      "r207",
      "r380",
      "r502",
      "r894",
      "r895",
      "r896",
      "r1052",
      "r1053",
      "r1054",
      "r1055"
     ]
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "presentation": [
      "http://www.recursion.com/role/AcquisitionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity method investment ownership percentage",
        "label": "Equity Method Investment, Ownership Percentage",
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting."
       }
      }
     },
     "auth_ref": [
      "r205",
      "r502"
     ]
    },
    "us-gaap_EquityMethodInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EquityMethodInvestments",
     "crdr": "debit",
     "presentation": [
      "http://www.recursion.com/role/AcquisitionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity method investments",
        "label": "Equity Method Investments",
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized."
       }
      }
     },
     "auth_ref": [
      "r164",
      "r184",
      "r196",
      "r204",
      "r899",
      "r981"
     ]
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Valuation Assumption Difference, Footnote",
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r856"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Erroneous Compensation Analysis",
        "label": "Erroneous Compensation Analysis [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r814",
      "r824",
      "r834",
      "r866"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Erroneously Awarded Compensation Recovery",
        "label": "Erroneously Awarded Compensation Recovery [Table]"
       }
      }
     },
     "auth_ref": [
      "r811",
      "r821",
      "r831",
      "r863"
     ]
    },
    "us-gaap_EstimateOfFairValueFairValueDisclosureMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EstimateOfFairValueFairValueDisclosureMember",
     "presentation": [
      "http://www.recursion.com/role/FairValueMeasurementsScheduleofFinancialInstrumentsNotMeasuredatFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair values",
        "label": "Estimate of Fair Value Measurement [Member]",
        "documentation": "Measured as an estimate of fair value."
       }
      }
     },
     "auth_ref": [
      "r268",
      "r498",
      "r499",
      "r501",
      "r689",
      "r720",
      "r721"
     ]
    },
    "rxrx_ExchangeableStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.recursion.com/20260331",
     "localname": "ExchangeableStockMember",
     "presentation": [
      "http://www.recursion.com/role/CommonStockValenceAcquisitionExchangeableSharesNarrativeDetails",
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunauditedParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exchangeable Stock",
        "label": "Exchangeable Stock [Member]",
        "documentation": "Exchangeable Stock"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Executive Category:",
        "label": "Executive Category [Axis]"
       }
      }
     },
     "auth_ref": [
      "r862"
     ]
    },
    "rxrx_ExscientiaGmbHMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.recursion.com/20260331",
     "localname": "ExscientiaGmbHMember",
     "presentation": [
      "http://www.recursion.com/role/AcquisitionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exscientia GmbH",
        "label": "Exscientia GmbH [Member]",
        "documentation": "Exscientia GmbH"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems",
     "presentation": [
      "http://www.recursion.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
        "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r498",
      "r499",
      "r500",
      "r689",
      "r785",
      "r1076"
     ]
    },
    "us-gaap_FairValueByBalanceSheetGroupingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueByBalanceSheetGroupingTable",
     "presentation": [
      "http://www.recursion.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]",
        "label": "Fair Value, by Balance Sheet Grouping [Table]",
        "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities."
       }
      }
     },
     "auth_ref": [
      "r498",
      "r500",
      "r689",
      "r785",
      "r1075",
      "r1076"
     ]
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "presentation": [
      "http://www.recursion.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient."
       }
      }
     },
     "auth_ref": [
      "r268",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r478",
      "r480",
      "r481",
      "r482",
      "r483",
      "r489",
      "r490",
      "r492",
      "r498",
      "r528",
      "r529",
      "r530",
      "r689",
      "r720",
      "r721",
      "r726",
      "r727",
      "r728",
      "r729",
      "r730",
      "r778",
      "r781",
      "r785"
     ]
    },
    "us-gaap_FairValueByMeasurementBasisAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueByMeasurementBasisAxis",
     "presentation": [
      "http://www.recursion.com/role/FairValueMeasurementsScheduleofFinancialInstrumentsNotMeasuredatFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement Basis [Axis]",
        "label": "Measurement Basis [Axis]",
        "documentation": "Information by measurement basis."
       }
      }
     },
     "auth_ref": [
      "r268",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r689",
      "r720",
      "r721",
      "r1076"
     ]
    },
    "us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems",
     "presentation": [
      "http://www.recursion.com/role/FairValueMeasurementsScheduleofFinancialInstrumentsNotMeasuredatFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]",
        "label": "Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r489"
     ]
    },
    "us-gaap_FairValueDisclosureItemAmountsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueDisclosureItemAmountsDomain",
     "presentation": [
      "http://www.recursion.com/role/FairValueMeasurementsScheduleofFinancialInstrumentsNotMeasuredatFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Measurement [Domain]",
        "label": "Fair Value Measurement [Domain]",
        "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value."
       }
      }
     },
     "auth_ref": [
      "r268",
      "r720",
      "r721"
     ]
    },
    "us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable",
     "presentation": [
      "http://www.recursion.com/role/FairValueMeasurementsScheduleofFinancialInstrumentsNotMeasuredatFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Disclosure of Asset and Liability Not Measured at Fair Value [Table]",
        "label": "Fair Value Disclosure of Asset and Liability Not Measured at Fair Value [Table]",
        "documentation": "Disclosure of information about fair value of asset and liability not measured at fair value."
       }
      }
     },
     "auth_ref": [
      "r489"
     ]
    },
    "us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock",
     "presentation": [
      "http://www.recursion.com/role/FairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Financial Instruments Not Measured at Fair Value",
        "label": "Fair Value Disclosure of Asset and Liability Not Measured at Fair Value [Table Text Block]",
        "documentation": "Tabular disclosure of information about fair value of asset and liability not measured at fair value."
       }
      }
     },
     "auth_ref": [
      "r489"
     ]
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueDisclosuresAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueDisclosuresTextBlock",
     "presentation": [
      "http://www.recursion.com/role/FairValueMeasurements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Measurements",
        "label": "Fair Value Disclosures [Text Block]",
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information."
       }
      }
     },
     "auth_ref": [
      "r481",
      "r485",
      "r487",
      "r488",
      "r489",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r539",
      "r778",
      "r782"
     ]
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueInputsLevel1Member",
     "presentation": [
      "http://www.recursion.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 1",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date."
       }
      }
     },
     "auth_ref": [
      "r268",
      "r309",
      "r314",
      "r315",
      "r480",
      "r490",
      "r498",
      "r528",
      "r689",
      "r726",
      "r727",
      "r728",
      "r729",
      "r730",
      "r778",
      "r785"
     ]
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueInputsLevel2Member",
     "presentation": [
      "http://www.recursion.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 2",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets."
       }
      }
     },
     "auth_ref": [
      "r268",
      "r309",
      "r314",
      "r315",
      "r317",
      "r480",
      "r481",
      "r490",
      "r498",
      "r529",
      "r689",
      "r720",
      "r721",
      "r726",
      "r727",
      "r728",
      "r729",
      "r730",
      "r778",
      "r785"
     ]
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueInputsLevel3Member",
     "presentation": [
      "http://www.recursion.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 3",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r268",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r480",
      "r481",
      "r482",
      "r483",
      "r490",
      "r498",
      "r530",
      "r689",
      "r720",
      "r721",
      "r726",
      "r727",
      "r728",
      "r729",
      "r730",
      "r778",
      "r781",
      "r785"
     ]
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "presentation": [
      "http://www.recursion.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value."
       }
      }
     },
     "auth_ref": [
      "r268",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r478",
      "r480",
      "r481",
      "r482",
      "r483",
      "r489",
      "r490",
      "r492",
      "r498",
      "r528",
      "r529",
      "r530",
      "r689",
      "r720",
      "r721",
      "r726",
      "r727",
      "r728",
      "r729",
      "r730",
      "r778",
      "r781",
      "r785"
     ]
    },
    "us-gaap_FinanceLeaseInterestPaymentOnLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FinanceLeaseInterestPaymentOnLiability",
     "crdr": "credit",
     "presentation": [
      "http://www.recursion.com/role/LeasesScheduleofSupplementalCashFlowInformationRelatedtoLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating cash flows from financing leases",
        "label": "Finance Lease, Interest Payment on Liability",
        "documentation": "Amount of interest paid on finance lease liability."
       }
      }
     },
     "auth_ref": [
      "r519",
      "r522"
     ]
    },
    "us-gaap_FinanceLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FinanceLeaseLiability",
     "crdr": "credit",
     "presentation": [
      "http://www.recursion.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Finance lease liability",
        "label": "Finance Lease, Liability",
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease."
       }
      }
     },
     "auth_ref": [
      "r517",
      "r523"
     ]
    },
    "us-gaap_FinanceLeasePrincipalPayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FinanceLeasePrincipalPayments",
     "crdr": "credit",
     "presentation": [
      "http://www.recursion.com/role/LeasesScheduleofSupplementalCashFlowInformationRelatedtoLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Financing cash flows from financing leases",
        "label": "Finance Lease, Principal Payments",
        "documentation": "Amount of cash outflow for principal payment on finance lease."
       }
      }
     },
     "auth_ref": [
      "r518",
      "r522"
     ]
    },
    "us-gaap_FinanceLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FinanceLeaseRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financing lease right-of-use assets",
        "label": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization",
        "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease."
       }
      }
     },
     "auth_ref": [
      "r516"
     ]
    },
    "rxrx_FinanceLeasesAssetsPledgedAsCollateral": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.recursion.com/20260331",
     "localname": "FinanceLeasesAssetsPledgedAsCollateral",
     "crdr": "debit",
     "presentation": [
      "http://www.recursion.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finance leases, assets pledged as collateral",
        "label": "Finance Leases, Assets Pledged As Collateral",
        "documentation": "Finance Leases, Assets Pledged As Collateral"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/GoodwillandIntangibleAssetsScheduleofIntangibleassetsDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/GoodwillandIntangibleAssetsScheduleofIntangibleassetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Accumulated Amortization",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r103",
      "r213",
      "r236",
      "r691"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "presentation": [
      "http://www.recursion.com/role/GoodwillandIntangibleAssetsScheduleofIntangibleassetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "documentation": "Information by major type or class of finite-lived intangible assets."
       }
      }
     },
     "auth_ref": [
      "r229",
      "r231",
      "r232",
      "r233",
      "r235",
      "r236",
      "r239",
      "r240",
      "r537",
      "r538",
      "r596",
      "r688",
      "r691",
      "r746",
      "r747",
      "r748",
      "r749",
      "r750",
      "r751",
      "r752",
      "r753",
      "r754",
      "r755",
      "r756",
      "r757",
      "r758",
      "r759",
      "r760",
      "r761",
      "r762",
      "r763",
      "r764",
      "r765",
      "r766",
      "r767",
      "r768",
      "r769",
      "r770",
      "r771",
      "r772"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FiniteLivedIntangibleAssetsGross",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/GoodwillandIntangibleAssetsScheduleofIntangibleassetsDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/GoodwillandIntangibleAssetsScheduleofIntangibleassetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gross carrying amount",
        "label": "Finite-Lived Intangible Assets, Gross",
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r213",
      "r236",
      "r538",
      "r691"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "presentation": [
      "http://www.recursion.com/role/GoodwillandIntangibleAssetsScheduleofIntangibleassetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company."
       }
      }
     },
     "auth_ref": [
      "r229",
      "r231",
      "r232",
      "r233",
      "r235",
      "r236",
      "r239",
      "r240",
      "r596",
      "r688",
      "r691",
      "r746",
      "r747",
      "r748",
      "r749",
      "r750",
      "r751",
      "r752",
      "r753",
      "r754",
      "r755",
      "r756",
      "r757",
      "r758",
      "r759",
      "r760",
      "r761",
      "r762",
      "r763",
      "r764",
      "r765",
      "r766",
      "r767",
      "r768",
      "r769",
      "r770",
      "r771",
      "r772"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FiniteLivedIntangibleAssetsNet",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/GoodwillandIntangibleAssetsScheduleofIntangibleassetsDetails_1": {
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.recursion.com/role/GoodwillandIntangibleAssetsScheduleofIntangibleassetsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.recursion.com/role/GoodwillandIntangibleAssetsScheduleofIntangibleassetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net carrying amount",
        "label": "Finite-Lived Intangible Assets, Net",
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r537",
      "r1003"
     ]
    },
    "us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ForeignIncomeTaxExpenseBenefitContinuingOperations",
     "crdr": "debit",
     "presentation": [
      "http://www.recursion.com/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign income tax expense (benefit)",
        "label": "Foreign Income Tax Expense (Benefit), Continuing Operations",
        "documentation": "Amount of current and deferred foreign income tax expense (benefit) attributable to income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r127",
      "r130",
      "r366"
     ]
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount",
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r818",
      "r828",
      "r838",
      "r870"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount",
        "label": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r818",
      "r828",
      "r838",
      "r870"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount",
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r818",
      "r828",
      "r838",
      "r870"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery, Explanation of Impracticability",
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r818",
      "r828",
      "r838",
      "r870"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Forgone Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r818",
      "r828",
      "r838",
      "r870"
     ]
    },
    "ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year",
        "label": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r851"
     ]
    },
    "us-gaap_GainLossOnSaleOfBusiness": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "GainLossOnSaleOfBusiness",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/AcquisitionsNarrativeDetails",
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Loss on disposal of a business",
        "label": "Gain (Loss) on Disposition of Business",
        "documentation": "Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant."
       }
      }
     },
     "auth_ref": [
      "r456",
      "r959"
     ]
    },
    "rxrx_GastrointestinalCancerMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.recursion.com/20260331",
     "localname": "GastrointestinalCancerMember",
     "presentation": [
      "http://www.recursion.com/role/CollaborativeDevelopmentContractsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gastrointestinal Cancer",
        "label": "Gastrointestinal Cancer [Member]",
        "documentation": "Gastrointestinal Cancer"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "GeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofOperationsunaudited": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofOperationsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "General and administrative",
        "label": "General and Administrative Expense",
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line."
       }
      }
     },
     "auth_ref": [
      "r58",
      "r649"
     ]
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "GeneralAndAdministrativeExpenseMember",
     "presentation": [
      "http://www.recursion.com/role/StockBasedCompensationScheduleofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "General and administrative",
        "label": "General and Administrative Expense [Member]",
        "documentation": "Primary financial statement caption encompassing general and administrative expense."
       }
      }
     },
     "auth_ref": [
      "r58"
     ]
    },
    "us-gaap_Goodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "Goodwill",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited",
      "http://www.recursion.com/role/GoodwillandIntangibleAssetsScheduleofChangesintheCarryingAmountofGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill",
        "periodStartLabel": "Goodwill, beginning balance",
        "periodEndLabel": "Goodwill, ending balance",
        "label": "Goodwill",
        "documentation": "Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r102",
      "r214",
      "r540",
      "r714",
      "r719",
      "r736",
      "r740",
      "r741",
      "r774",
      "r779",
      "r786",
      "r985",
      "r992",
      "r1061"
     ]
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "presentation": [
      "http://www.recursion.com/role/GoodwillandIntangibleAssets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill and Intangible Assets",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "documentation": "The entire disclosure for goodwill and intangible assets."
       }
      }
     },
     "auth_ref": [
      "r983",
      "r995"
     ]
    },
    "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "GoodwillForeignCurrencyTranslationGainLoss",
     "crdr": "credit",
     "presentation": [
      "http://www.recursion.com/role/GoodwillandIntangibleAssetsScheduleofChangesintheCarryingAmountofGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Foreign currency translation adjustments",
        "label": "Goodwill, Foreign Currency Translation, Gain (Loss)",
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) asset representing future economic benefit from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r222",
      "r447"
     ]
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "GoodwillImpairmentLoss",
     "crdr": "debit",
     "presentation": [
      "http://www.recursion.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill impairment",
        "label": "Goodwill, Impairment Loss",
        "documentation": "Amount of impairment loss from asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r215",
      "r221",
      "r226",
      "r228",
      "r447",
      "r719",
      "r779"
     ]
    },
    "us-gaap_GoodwillLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "GoodwillLineItems",
     "presentation": [
      "http://www.recursion.com/role/GoodwillandIntangibleAssetsScheduleofIntangibleassetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill [Line Items]",
        "label": "Goodwill [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r719"
     ]
    },
    "us-gaap_GoodwillRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "GoodwillRollForward",
     "presentation": [
      "http://www.recursion.com/role/GoodwillandIntangibleAssetsScheduleofChangesintheCarryingAmountofGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill [Roll Forward]",
        "label": "Goodwill [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "GrantMember",
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofOperationsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Grant revenue",
        "label": "Grant [Member]",
        "documentation": "Award of money not required to be repaid."
       }
      }
     },
     "auth_ref": [
      "r1019",
      "r1020"
     ]
    },
    "us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill",
     "crdr": "debit",
     "presentation": [
      "http://www.recursion.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impairment of indefinite-lived intangible assets",
        "label": "Impairment of Intangible Assets, Indefinite-Lived (Excluding Goodwill)",
        "documentation": "Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value."
       }
      }
     },
     "auth_ref": [
      "r230",
      "r959",
      "r1004",
      "r1007"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofOperationsunaudited": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofOperationsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Loss before income tax benefit",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r54",
      "r79",
      "r83",
      "r544",
      "r546",
      "r559",
      "r699",
      "r701",
      "r703",
      "r708",
      "r713",
      "r975",
      "r977",
      "r978",
      "r979",
      "r980"
     ]
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "presentation": [
      "http://www.recursion.com/role/AcquisitionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disposal Group Name [Axis]",
        "label": "Disposal Group Name [Axis]",
        "documentation": "Information by name of disposal group."
       }
      }
     },
     "auth_ref": [
      "r245",
      "r246",
      "r731",
      "r732"
     ]
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeStatementLocationAxis",
     "presentation": [
      "http://www.recursion.com/role/StockBasedCompensationScheduleofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement Location [Axis]",
        "label": "Statement of Income Location, Balance [Axis]",
        "documentation": "Information by location in statement of income where disaggregated amount is reported."
       }
      }
     },
     "auth_ref": [
      "r243",
      "r247",
      "r248",
      "r459",
      "r460",
      "r461",
      "r462",
      "r484",
      "r486",
      "r491",
      "r503",
      "r504",
      "r505",
      "r585",
      "r587",
      "r650",
      "r688",
      "r689",
      "r736",
      "r741",
      "r776",
      "r777",
      "r780",
      "r785",
      "r1056",
      "r1058",
      "r1092"
     ]
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeStatementLocationDomain",
     "presentation": [
      "http://www.recursion.com/role/StockBasedCompensationScheduleofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement Location [Domain]",
        "label": "Statement of Income Location, Balance [Domain]",
        "documentation": "Location in statement of income where disaggregated amount is reported."
       }
      }
     },
     "auth_ref": [
      "r247",
      "r248",
      "r459",
      "r460",
      "r461",
      "r462",
      "r484",
      "r486",
      "r491",
      "r503",
      "r504",
      "r505",
      "r585",
      "r587",
      "r650",
      "r688",
      "r689",
      "r736",
      "r741",
      "r776",
      "r777",
      "r780",
      "r785",
      "r1056",
      "r1058",
      "r1092"
     ]
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxDisclosureTextBlock",
     "presentation": [
      "http://www.recursion.com/role/IncomeTaxes"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Taxes",
        "label": "Income Tax Disclosure [Text Block]",
        "documentation": "The entire disclosure for income tax."
       }
      }
     },
     "auth_ref": [
      "r127",
      "r131",
      "r362",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r375",
      "r377",
      "r378",
      "r379",
      "r548",
      "r595",
      "r603",
      "r735"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofOperationsunaudited": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      },
      "http://www.recursion.com/role/SegmentInformationScheduleofSegmentNetLossandReconciliationsofSegmentOperatingLosstoLossBeforeIncomeTaxBenefitDetails": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofOperationsunaudited",
      "http://www.recursion.com/role/SegmentInformationScheduleofSegmentNetLossandReconciliationsofSegmentOperatingLosstoLossBeforeIncomeTaxBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Income tax benefit",
        "negatedLabel": "Income tax benefit",
        "label": "Income Tax Expense (Benefit)",
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r85",
      "r90",
      "r127",
      "r149",
      "r150",
      "r164",
      "r182",
      "r196",
      "r365",
      "r367",
      "r376",
      "r565",
      "r699",
      "r701",
      "r703",
      "r735"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInAccountsPayable",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable",
        "label": "Increase (Decrease) in Accounts Payable",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "rxrx_IncreaseDecreaseInAccruedDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.recursion.com/20260331",
     "localname": "IncreaseDecreaseInAccruedDevelopmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued development expense",
        "label": "Increase (Decrease) In Accrued Development Expense",
        "documentation": "Increase (Decrease) In Accrued Development Expense"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInContractWithCustomerLiability",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unearned revenue",
        "label": "Increase (Decrease) in Contract with Customer, Liability",
        "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable."
       }
      }
     },
     "auth_ref": [
      "r535",
      "r958"
     ]
    },
    "rxrx_IncreaseDecreaseInLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.recursion.com/20260331",
     "localname": "IncreaseDecreaseInLeaseLiability",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease liabilities",
        "label": "Increase (Decrease) In Lease Liability",
        "documentation": "Increase (Decrease) In Lease Liability"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes in operating assets and liabilities:",
        "label": "Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "rxrx_IncreaseDecreaseInOperatingLeaseRightOfUseAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.recursion.com/20260331",
     "localname": "IncreaseDecreaseInOperatingLeaseRightOfUseAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.recursion.com/role/LeasesNarrativeDetails",
      "http://www.recursion.com/role/LeasesScheduleofSupplementalCashFlowInformationRelatedtoLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Increase (decrease) in operating lease right-of-use assets",
        "terseLabel": "Operating leases",
        "label": "Increase (Decrease) in Operating Lease Right-Of-Use Assets",
        "documentation": "Increase (Decrease) in Operating Lease Right-Of-Use Assets"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOtherAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInOtherAccruedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued expenses and other current liabilities",
        "label": "Increase (Decrease) in Other Accrued Liabilities",
        "documentation": "The increase (decrease) during the reporting period in other expenses incurred but not yet paid."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInOtherOperatingAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Other receivables and assets",
        "label": "Increase (Decrease) in Other Operating Assets",
        "documentation": "Amount of increase (decrease) in operating assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "rxrx_IncreaseDecreaseInPrepaidDataAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.recursion.com/20260331",
     "localname": "IncreaseDecreaseInPrepaidDataAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Prepaid data assets",
        "label": "Increase (Decrease) In Prepaid Data Assets",
        "documentation": "Increase (Decrease) In Prepaid Data Assets"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofStockholdersEquityunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/GoodwillandIntangibleAssetsScheduleofIntangibleassetsDetails": {
       "parentTag": "us-gaap_IntangibleAssetsGrossExcludingGoodwill",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.recursion.com/role/GoodwillandIntangibleAssetsScheduleofIntangibleassetsDetails_1": {
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/GoodwillandIntangibleAssetsScheduleofIntangibleassetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Indefinite-lived intangible assets",
        "label": "Indefinite-Lived Intangible Assets (Excluding Goodwill)",
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit."
       }
      }
     },
     "auth_ref": [
      "r213",
      "r238",
      "r691"
     ]
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Individual:",
        "label": "Individual [Axis]"
       }
      }
     },
     "auth_ref": [
      "r818",
      "r828",
      "r838",
      "r862",
      "r870",
      "r874",
      "r882"
     ]
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r880"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r810",
      "r886"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insider Trading Policies and Procedures Adopted",
        "label": "Insider Trading Policies and Procedures Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r810",
      "r886"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insider Trading Policies and Procedures Not Adopted",
        "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r810",
      "r886"
     ]
    },
    "rxrx_IntangibleAssetsForeignCurrencyTranslationGainLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.recursion.com/20260331",
     "localname": "IntangibleAssetsForeignCurrencyTranslationGainLoss",
     "crdr": "credit",
     "presentation": [
      "http://www.recursion.com/role/GoodwillandIntangibleAssetsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangible assets, foreign currency translation gain (loss)",
        "label": "Intangible Assets, Foreign Currency Translation Gain (Loss)",
        "documentation": "Intangible Assets, Foreign Currency Translation Gain (Loss)"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IntangibleAssetsGrossExcludingGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IntangibleAssetsGrossExcludingGoodwill",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/GoodwillandIntangibleAssetsScheduleofIntangibleassetsDetails": {
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/GoodwillandIntangibleAssetsScheduleofIntangibleassetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Intangible assets, gross",
        "label": "Intangible Assets, Gross (Excluding Goodwill)",
        "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill."
       }
      }
     },
     "auth_ref": [
      "r102"
     ]
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 7.0
      },
      "http://www.recursion.com/role/GoodwillandIntangibleAssetsScheduleofIntangibleassetsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.recursion.com/role/GoodwillandIntangibleAssetsScheduleofIntangibleassetsDetails_1": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited",
      "http://www.recursion.com/role/GoodwillandIntangibleAssetsScheduleofIntangibleassetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangible assets, net",
        "totalLabel": "Intangible assets, net",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges."
       }
      }
     },
     "auth_ref": [
      "r229",
      "r1003",
      "r1004"
     ]
    },
    "us-gaap_InterestExpenseNonoperating": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InterestExpenseNonoperating",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/SupplementalFinancialInformationScheduleofInterestIncomeNetDetails": {
       "parentTag": "us-gaap_InterestIncomeExpenseNonoperatingNet",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/SupplementalFinancialInformationScheduleofInterestIncomeNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Interest expense",
        "label": "Interest Expense, Nonoperating",
        "documentation": "Amount of interest expense classified as nonoperating."
       }
      }
     },
     "auth_ref": [
      "r178",
      "r699",
      "r703",
      "r915"
     ]
    },
    "us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InterestIncomeAndInterestExpenseDisclosureTableTextBlock",
     "presentation": [
      "http://www.recursion.com/role/SupplementalFinancialInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Interest Income, Net",
        "label": "Interest Income and Interest Expense Disclosure [Table Text Block]",
        "documentation": "Tabular disclosure of interest income and expense, including, but not limited to, interest income and expense from investments, loans, and securities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InterestIncomeExpenseNonoperatingNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InterestIncomeExpenseNonoperatingNet",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/SupplementalFinancialInformationScheduleofInterestIncomeNetDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.recursion.com/role/SupplementalFinancialInformationScheduleofInterestIncomeNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Interest income, net",
        "label": "Interest Income (Expense), Nonoperating",
        "documentation": "Amount of interest income (expense) classified as nonoperating."
       }
      }
     },
     "auth_ref": [
      "r713",
      "r775",
      "r915",
      "r977"
     ]
    },
    "us-gaap_InvestmentIncomeNonoperating": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InvestmentIncomeNonoperating",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/SupplementalFinancialInformationScheduleofInterestIncomeNetDetails": {
       "parentTag": "us-gaap_InterestIncomeExpenseNonoperatingNet",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/SupplementalFinancialInformationScheduleofInterestIncomeNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest income",
        "label": "Investment Income, Nonoperating",
        "documentation": "The aggregate amount of income from investments (for example, dividends) not considered a component of the entity's core operations."
       }
      }
     },
     "auth_ref": [
      "r59"
     ]
    },
    "us-gaap_LaborAndRelatedExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LaborAndRelatedExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/SegmentInformationScheduleofSegmentNetLossandReconciliationsofSegmentOperatingLosstoLossBeforeIncomeTaxBenefitDetails": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/SegmentInformationScheduleofSegmentNetLossandReconciliationsofSegmentOperatingLosstoLossBeforeIncomeTaxBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Salaries",
        "label": "Labor and Related Expense",
        "documentation": "Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit."
       }
      }
     },
     "auth_ref": [
      "r541",
      "r701",
      "r914"
     ]
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LeaseCostTableTextBlock",
     "presentation": [
      "http://www.recursion.com/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Components of Lease Cost and Supplemental Cash Flow Information Related to Leases and Lease Term and Discount Rates",
        "label": "Lease, Cost [Table Text Block]",
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income."
       }
      }
     },
     "auth_ref": [
      "r1081"
     ]
    },
    "us-gaap_LeasesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LeasesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeFinanceLeasesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeFinanceLeasesTextBlock",
     "presentation": [
      "http://www.recursion.com/role/Leases"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leases",
        "label": "Lessee, Finance Leases [Text Block]",
        "documentation": "The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability."
       }
      }
     },
     "auth_ref": [
      "r514"
     ]
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeLeaseDescriptionLineItems",
     "presentation": [
      "http://www.recursion.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lessee, Lease, Description [Line Items]",
        "label": "Lessee, Lease, Description [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r521",
      "r525"
     ]
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeLeaseDescriptionTable",
     "presentation": [
      "http://www.recursion.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lessee, Lease, Description [Table]",
        "label": "Lessee, Lease, Description [Table]",
        "documentation": "Disclosure of information about lessee's leases."
       }
      }
     },
     "auth_ref": [
      "r521",
      "r525"
     ]
    },
    "rxrx_LesseeOperatingLeaseIncreaseDecreaseInOperatingLeaseLiabilityDueToLeaseModifications": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.recursion.com/20260331",
     "localname": "LesseeOperatingLeaseIncreaseDecreaseInOperatingLeaseLiabilityDueToLeaseModifications",
     "crdr": "debit",
     "presentation": [
      "http://www.recursion.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase (decrease) in operating lease liabilities",
        "label": "Lessee, Operating Lease, Increase (Decrease) In Operating Lease Liability Due To Lease Modifications",
        "documentation": "Lessee, Operating Lease, Increase (Decrease) In Operating Lease Liability Due To Lease Modifications"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeOperatingLeaseRemainingLeaseTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseRemainingLeaseTerm",
     "presentation": [
      "http://www.recursion.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Remaining operating lease term",
        "label": "Lessee, Operating Lease, Remaining Lease Term",
        "documentation": "Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r525",
      "r1079"
     ]
    },
    "us-gaap_LesseeOperatingLeaseRenewalTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseRenewalTerm",
     "presentation": [
      "http://www.recursion.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease, renewal term",
        "label": "Lessee, Operating Lease, Renewal Term",
        "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r1080"
     ]
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeasesTextBlock",
     "presentation": [
      "http://www.recursion.com/role/Leases"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leases",
        "label": "Lessee, Operating Leases [Text Block]",
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r514"
     ]
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities",
        "label": "Liabilities",
        "documentation": "Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r39",
      "r40",
      "r41",
      "r42",
      "r43",
      "r44",
      "r45",
      "r127",
      "r128",
      "r129",
      "r208",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r455",
      "r457",
      "r458",
      "r502",
      "r625",
      "r707",
      "r722",
      "r805",
      "r1016",
      "r1082",
      "r1083"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities and stockholders\u2019 equity",
        "label": "Liabilities and Equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r52",
      "r78",
      "r557",
      "r786",
      "r792",
      "r793",
      "r963",
      "r966",
      "r982",
      "r1077"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liabilities and stockholders\u2019 equity",
        "label": "Liabilities and Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current liabilities",
        "label": "Liabilities, Current",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r41",
      "r100",
      "r127",
      "r128",
      "r129",
      "r208",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r455",
      "r457",
      "r458",
      "r502",
      "r786",
      "r1016",
      "r1082",
      "r1083"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current liabilities",
        "label": "Liabilities, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesFairValueDisclosure",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/FairValueMeasurementsScheduleofFinancialInstrumentsNotMeasuredatFairValueDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.recursion.com/role/FairValueMeasurementsScheduleofFinancialInstrumentsNotMeasuredatFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities",
        "label": "Liabilities, Fair Value Disclosure",
        "documentation": "Fair value of financial and nonfinancial obligations."
       }
      }
     },
     "auth_ref": [
      "r480",
      "r1072"
     ]
    },
    "rxrx_LicenseAgreementAggregatePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.recursion.com/20260331",
     "localname": "LicenseAgreementAggregatePayments",
     "crdr": "credit",
     "presentation": [
      "http://www.recursion.com/role/SupplementalFinancialInformationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate amount payable in cash or equity",
        "label": "License Agreement, Aggregate Payments",
        "documentation": "License Agreement, Aggregate Payments"
       }
      }
     },
     "auth_ref": []
    },
    "rxrx_LicenseAgreementAmountOfTimePriorToThePaymentDate": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.recursion.com/20260331",
     "localname": "LicenseAgreementAmountOfTimePriorToThePaymentDate",
     "presentation": [
      "http://www.recursion.com/role/SupplementalFinancialInformationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business days prior to the payment date",
        "label": "License Agreement, Amount Of Time Prior To The Payment Date",
        "documentation": "License Agreement, Amount Of Time Prior To The Payment Date"
       }
      }
     },
     "auth_ref": []
    },
    "rxrx_LicenseAgreementAnnualPayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.recursion.com/20260331",
     "localname": "LicenseAgreementAnnualPayments",
     "crdr": "credit",
     "presentation": [
      "http://www.recursion.com/role/SupplementalFinancialInformationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Annual payments",
        "label": "License Agreement, Annual Payments",
        "documentation": "License Agreement, Annual Payments"
       }
      }
     },
     "auth_ref": []
    },
    "rxrx_LicenseAgreementIncreaseDecreaseAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.recursion.com/20260331",
     "localname": "LicenseAgreementIncreaseDecreaseAccruedLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://www.recursion.com/role/SupplementalFinancialInformationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid expenses",
        "label": "License Agreement, Increase (Decrease) Accrued Liabilities",
        "documentation": "License Agreement, Increase (Decrease) Accrued Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "rxrx_LicenseAgreementTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.recursion.com/20260331",
     "localname": "LicenseAgreementTerm",
     "presentation": [
      "http://www.recursion.com/role/SupplementalFinancialInformationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "License agreement, term",
        "label": "License Agreement, Term",
        "documentation": "License Agreement, Term"
       }
      }
     },
     "auth_ref": []
    },
    "rxrx_LicenseAgreementTradingPeriodUsedForEquityValueDetermination": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.recursion.com/20260331",
     "localname": "LicenseAgreementTradingPeriodUsedForEquityValueDetermination",
     "presentation": [
      "http://www.recursion.com/role/SupplementalFinancialInformationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading period used for equity value determination",
        "label": "License Agreement, Trading Period Used For Equity Value Determination",
        "documentation": "License Agreement, Trading Period Used For Equity Value Determination"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LicenseAndServiceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LicenseAndServiceMember",
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofOperationsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating revenue",
        "label": "License and Service [Member]",
        "documentation": "Right to use intangible asset and performance of related service. Intangible asset includes, but is not limited to, patent, copyright, technology, manufacturing process, software or trademark."
       }
      }
     },
     "auth_ref": [
      "r1019",
      "r1020"
     ]
    },
    "us-gaap_LicensingAgreementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LicensingAgreementsMember",
     "presentation": [
      "http://www.recursion.com/role/GoodwillandIntangibleAssetsScheduleofIntangibleassetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Definite-lived licensed intangible assets",
        "label": "Licensing Agreements [Member]",
        "documentation": "Rights, generally of limited duration, under a license arrangement (for example, to sell or otherwise utilize specified products or processes in a specified territory)."
       }
      }
     },
     "auth_ref": [
      "r361",
      "r758",
      "r996",
      "r997",
      "r998",
      "r999",
      "r1000",
      "r1001",
      "r1003",
      "r1004",
      "r1005",
      "r1006",
      "r1051"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LongTermDebtAndCapitalLeaseObligations",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/FairValueMeasurementsScheduleofFinancialInstrumentsNotMeasuredatFairValueDetails": {
       "parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited",
      "http://www.recursion.com/role/FairValueMeasurementsScheduleofFinancialInstrumentsNotMeasuredatFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Notes payable and financing lease liabilities, non-current",
        "terseLabel": "Notes payable and financing lease liabilities, non-current",
        "label": "Long-Term Debt and Lease Obligation",
        "documentation": "Amount of long-term debt and lease obligation, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r552"
     ]
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LongTermDebtAndCapitalLeaseObligationsCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/FairValueMeasurementsScheduleofFinancialInstrumentsNotMeasuredatFairValueDetails": {
       "parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited",
      "http://www.recursion.com/role/FairValueMeasurementsScheduleofFinancialInstrumentsNotMeasuredatFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Notes payable and financing lease liabilities",
        "terseLabel": "Notes payable and financing lease liabilities, current",
        "label": "Long-Term Debt and Lease Obligation, Current",
        "documentation": "Amount of long-term debt and lease obligation, classified as current."
       }
      }
     },
     "auth_ref": [
      "r40"
     ]
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LongtermDebtTypeAxis",
     "presentation": [
      "http://www.recursion.com/role/FairValueMeasurementsScheduleofFinancialInstrumentsNotMeasuredatFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term Debt, Type [Axis]",
        "label": "Long-Term Debt, Type [Axis]",
        "documentation": "Information by type of long-term debt."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r1009",
      "r1010",
      "r1011"
     ]
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LongtermDebtTypeDomain",
     "presentation": [
      "http://www.recursion.com/role/FairValueMeasurementsScheduleofFinancialInstrumentsNotMeasuredatFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term Debt, Type [Domain]",
        "label": "Long-Term Debt, Type [Domain]",
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r27",
      "r1009",
      "r1010",
      "r1011"
     ]
    },
    "us-gaap_LossContingencyAccrualAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LossContingencyAccrualAtCarryingValue",
     "crdr": "credit",
     "presentation": [
      "http://www.recursion.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loss contingency accrual",
        "label": "Loss Contingency Accrual",
        "documentation": "Amount of loss contingency liability."
       }
      }
     },
     "auth_ref": [
      "r253",
      "r893"
     ]
    },
    "rxrx_MaterialsReceivedNotInvoiced": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.recursion.com/20260331",
     "localname": "MaterialsReceivedNotInvoiced",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/SupplementalFinancialInformationScheduleofAccruedExpensesandOtherLiabilitiesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/SupplementalFinancialInformationScheduleofAccruedExpensesandOtherLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Materials received not invoiced",
        "label": "Materials Received Not Invoiced",
        "documentation": "Materials Received Not Invoiced"
       }
      }
     },
     "auth_ref": []
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "MaximumMember",
     "presentation": [
      "http://www.recursion.com/role/LeasesNarrativeDetails",
      "http://www.recursion.com/role/SupplementalFinancialInformationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum",
        "label": "Maximum [Member]"
       }
      }
     },
     "auth_ref": [
      "r169",
      "r254",
      "r255",
      "r256",
      "r257",
      "r318",
      "r347",
      "r348",
      "r349",
      "r359",
      "r483",
      "r534",
      "r584",
      "r586",
      "r594",
      "r617",
      "r618",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674",
      "r681",
      "r682",
      "r683",
      "r684",
      "r686",
      "r687",
      "r718",
      "r723",
      "r733",
      "r736",
      "r742",
      "r745",
      "r781",
      "r782",
      "r783",
      "r784",
      "r788",
      "r1018",
      "r1084",
      "r1085",
      "r1086",
      "r1087",
      "r1088",
      "r1089"
     ]
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measure:",
        "label": "Measure [Axis]"
       }
      }
     },
     "auth_ref": [
      "r854"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Measure Name"
       }
      }
     },
     "auth_ref": [
      "r854"
     ]
    },
    "rxrx_MerckKGaAMerckMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.recursion.com/20260331",
     "localname": "MerckKGaAMerckMember",
     "presentation": [
      "http://www.recursion.com/role/CollaborativeDevelopmentContractsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Merck KGaA (Merck)",
        "label": "Merck KGaA (Merck) [Member]",
        "documentation": "Merck KGaA (Merck)"
       }
      }
     },
     "auth_ref": []
    },
    "rxrx_MilestoneTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.recursion.com/20260331",
     "localname": "MilestoneTypeAxis",
     "presentation": [
      "http://www.recursion.com/role/CollaborativeDevelopmentContractsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Milestone, Type [Axis]",
        "label": "Milestone, Type [Axis]",
        "documentation": "Milestone, Type"
       }
      }
     },
     "auth_ref": []
    },
    "rxrx_MilestoneTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.recursion.com/20260331",
     "localname": "MilestoneTypeDomain",
     "presentation": [
      "http://www.recursion.com/role/CollaborativeDevelopmentContractsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Milestone, Type [Domain]",
        "label": "Milestone, Type [Domain]",
        "documentation": "Milestone, Type [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "MinimumMember",
     "presentation": [
      "http://www.recursion.com/role/LeasesNarrativeDetails",
      "http://www.recursion.com/role/SupplementalFinancialInformationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Minimum",
        "label": "Minimum [Member]"
       }
      }
     },
     "auth_ref": [
      "r169",
      "r254",
      "r255",
      "r256",
      "r257",
      "r318",
      "r347",
      "r348",
      "r349",
      "r359",
      "r483",
      "r534",
      "r584",
      "r586",
      "r594",
      "r617",
      "r618",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674",
      "r681",
      "r682",
      "r683",
      "r684",
      "r686",
      "r687",
      "r718",
      "r723",
      "r733",
      "r736",
      "r742",
      "r745",
      "r781",
      "r782",
      "r783",
      "r788",
      "r1018",
      "r1084",
      "r1085",
      "r1086",
      "r1087",
      "r1088",
      "r1089"
     ]
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "MNPI Disclosure Timed for Compensation Value",
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]"
       }
      }
     },
     "auth_ref": [
      "r873"
     ]
    },
    "us-gaap_MoneyMarketFundsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MoneyMarketFundsMember",
     "presentation": [
      "http://www.recursion.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Money market funds",
        "label": "Money Market Funds [Member]",
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities."
       }
      }
     },
     "auth_ref": [
      "r1021",
      "r1022"
     ]
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Material Terms of Trading Arrangement",
        "label": "Material Terms of Trading Arrangement [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r881"
     ]
    },
    "rxrx_NamandjeBumpusMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.recursion.com/20260331",
     "localname": "NamandjeBumpusMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Namandj\u00e9 Bumpus [Member]",
        "documentation": "Namandj\u00e9 Bumpus"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Named Executive Officers, Footnote",
        "label": "Named Executive Officers, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r855"
     ]
    },
    "us-gaap_NatureOfOperations": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NatureOfOperations",
     "presentation": [
      "http://www.recursion.com/role/DescriptionoftheBusiness"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Description of the Business",
        "label": "Nature of Operations [Text Block]",
        "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward."
       }
      }
     },
     "auth_ref": [
      "r87",
      "r168",
      "r705",
      "r706"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by (used in) financing activities",
        "label": "Cash Provided by (Used in) Financing Activity, Including Discontinued Operation",
        "documentation": "Amount of cash inflow (outflow) from financing activity, including, but not limited to, discontinued operation. Financing activity includes, but is not limited to, obtaining resource from owner and providing return on, and return of, their investment; borrowing money and repaying amount borrowed, or settling obligation; and obtaining and paying for other resource obtained from creditor on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from financing activities",
        "label": "Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in investing activities",
        "label": "Cash Provided by (Used in) Investing Activity, Including Discontinued Operation",
        "documentation": "Amount of cash inflow (outflow) from investing activity, including, but not limited to, discontinued operation. Investing activity includes, but is not limited to, making and collecting loan, acquiring and disposing of debt and equity instruments, property, plant, and equipment, and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from investing activities",
        "label": "Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in operating activities",
        "label": "Cash Provided by (Used in) Operating Activity, Including Discontinued Operation",
        "documentation": "Amount of cash inflow (outflow) from operating activity, including, but not limited to, discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity."
       }
      }
     },
     "auth_ref": [
      "r65",
      "r66",
      "r67"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from operating activities",
        "label": "Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofComprehensiveLossunaudited": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofOperationsunaudited": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.recursion.com/role/SegmentInformationScheduleofSegmentNetLossandReconciliationsofSegmentOperatingLosstoLossBeforeIncomeTaxBenefitDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited",
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofComprehensiveLossunaudited",
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofOperationsunaudited",
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofStockholdersEquityunaudited",
      "http://www.recursion.com/role/NetLossPerShareScheduleofComputationofBasicandDilutedNetLossPerShareDetails",
      "http://www.recursion.com/role/SegmentInformationScheduleofSegmentNetLossandReconciliationsofSegmentOperatingLosstoLossBeforeIncomeTaxBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net loss",
        "terseLabel": "Net loss",
        "verboseLabel": "Net loss",
        "negatedTotalLabel": "Total segment loss",
        "label": "Net Income (Loss) Attributable to Parent",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r57",
      "r67",
      "r80",
      "r95",
      "r98",
      "r113",
      "r116",
      "r120",
      "r127",
      "r128",
      "r129",
      "r132",
      "r138",
      "r142",
      "r143",
      "r144",
      "r145",
      "r146",
      "r149",
      "r150",
      "r156",
      "r208",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r271",
      "r274",
      "r277",
      "r281",
      "r356",
      "r384",
      "r450",
      "r477",
      "r502",
      "r560",
      "r646",
      "r663",
      "r664",
      "r699",
      "r701",
      "r703",
      "r803",
      "r1016"
     ]
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetIncomeLossAvailableToCommonStockholdersDilutedAbstract",
     "presentation": [
      "http://www.recursion.com/role/NetLossPerShareScheduleofComputationofBasicandDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Numerator:",
        "label": "Net Income (Loss) Available to Common Stockholders, Diluted [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "rxrx_NeuroscienceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.recursion.com/20260331",
     "localname": "NeuroscienceMember",
     "presentation": [
      "http://www.recursion.com/role/CollaborativeDevelopmentContractsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Neuroscience",
        "label": "Neuroscience [Member]",
        "documentation": "Neuroscience"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://www.recursion.com/role/BasisofPresentationPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Recent Accounting Pronouncements",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-GAAP Measure Description",
        "label": "Non-GAAP Measure Description [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r854"
     ]
    },
    "ecd_NonNeosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonNeosMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-NEOs",
        "label": "Non-NEOs [Member]"
       }
      }
     },
     "auth_ref": [
      "r818",
      "r828",
      "r838",
      "r862",
      "r870"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount",
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r845"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO Average Total Compensation Amount",
        "label": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r844"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO",
        "label": "Non-PEO NEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r862"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted",
        "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r881"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated",
        "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r881"
     ]
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Supplemental schedule of non-cash investing and financing activities",
        "label": "Noncash Investing and Financing Items [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1",
     "crdr": "debit",
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Purchase of an intangible asset",
        "label": "Noncash or Part Noncash Acquisition, Intangible Assets Acquired",
        "documentation": "The amount of intangibles that an Entity acquires in a noncash (or part noncash) acquisition. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r21",
      "r22"
     ]
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofOperationsunaudited": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.recursion.com/role/SegmentInformationScheduleofSegmentNetLossandReconciliationsofSegmentOperatingLosstoLossBeforeIncomeTaxBenefitDetails": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofOperationsunaudited",
      "http://www.recursion.com/role/SegmentInformationScheduleofSegmentNetLossandReconciliationsofSegmentOperatingLosstoLossBeforeIncomeTaxBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other income (loss), net",
        "verboseLabel": "Other non-operating income (loss), net",
        "label": "Nonoperating Income (Expense)",
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)."
       }
      }
     },
     "auth_ref": [
      "r59"
     ]
    },
    "us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NonvestedRestrictedStockSharesActivityTableTextBlock",
     "presentation": [
      "http://www.recursion.com/role/StockBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of RSU Activity",
        "label": "Nonvested Restricted Stock Shares Activity [Table Text Block]",
        "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock shares."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "us-gaap_NotesPayableOtherPayablesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NotesPayableOtherPayablesMember",
     "presentation": [
      "http://www.recursion.com/role/FairValueMeasurementsScheduleofFinancialInstrumentsNotMeasuredatFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Notes Payable",
        "label": "Notes Payable, Other Payables [Member]",
        "documentation": "A written promise to pay a note to a third party."
       }
      }
     },
     "auth_ref": []
    },
    "rxrx_NumberOfClassesOfCommonStockAuthorized": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.recursion.com/20260331",
     "localname": "NumberOfClassesOfCommonStockAuthorized",
     "presentation": [
      "http://www.recursion.com/role/CommonStockClassAandBCommonSharesAuthorizationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of classes of common stock authorized",
        "label": "Number Of Classes Of Common Stock Authorized",
        "documentation": "Number Of Classes Of Common Stock Authorized"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NumberOfOperatingSegments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NumberOfOperatingSegments",
     "presentation": [
      "http://www.recursion.com/role/SegmentInformationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of operating segments",
        "label": "Number of Operating Segments",
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues."
       }
      }
     },
     "auth_ref": [
      "r714",
      "r976"
     ]
    },
    "us-gaap_NumberOfReportableSegments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NumberOfReportableSegments",
     "presentation": [
      "http://www.recursion.com/role/SegmentInformationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of reportable segments",
        "label": "Number of Reportable Segments",
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements."
       }
      }
     },
     "auth_ref": [
      "r709",
      "r717",
      "r976"
     ]
    },
    "us-gaap_OperatingExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingExpensesAbstract",
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofOperationsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating costs and expenses",
        "label": "Operating Expenses [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/SegmentInformationScheduleofSegmentNetLossandReconciliationsofSegmentOperatingLosstoLossBeforeIncomeTaxBenefitDetails": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofOperationsunaudited": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofOperationsunaudited",
      "http://www.recursion.com/role/SegmentInformationScheduleofSegmentNetLossandReconciliationsofSegmentOperatingLosstoLossBeforeIncomeTaxBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Loss from operations",
        "negatedTotalLabel": "Loss from operations",
        "label": "Operating Income (Loss)",
        "documentation": "The net result for the period of deducting operating expenses from operating revenues."
       }
      }
     },
     "auth_ref": [
      "r83",
      "r699",
      "r703",
      "r708",
      "r975",
      "r977",
      "r978",
      "r979",
      "r980"
     ]
    },
    "us-gaap_OperatingLeaseExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Lease expense",
        "label": "Operating Lease, Expense",
        "documentation": "Amount of operating lease expense. Excludes sublease income."
       }
      }
     },
     "auth_ref": [
      "r1078"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease liabilities",
        "label": "Operating Lease, Liability, Current",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r517"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease liabilities, non-current",
        "label": "Operating Lease, Liability, Noncurrent",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r517"
     ]
    },
    "us-gaap_OperatingLeasePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeasePayments",
     "crdr": "credit",
     "presentation": [
      "http://www.recursion.com/role/LeasesScheduleofSupplementalCashFlowInformationRelatedtoLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating cash flows from operating leases",
        "label": "Operating Lease, Payments",
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use."
       }
      }
     },
     "auth_ref": [
      "r520",
      "r522"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease right-of-use assets",
        "label": "Operating Lease, Right-of-Use Asset",
        "documentation": "Amount of lessee's right to use underlying asset under operating lease."
       }
      }
     },
     "auth_ref": [
      "r516"
     ]
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherAccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/SupplementalFinancialInformationScheduleofAccruedExpensesandOtherLiabilitiesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/SupplementalFinancialInformationScheduleofAccruedExpensesandOtherLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued other expenses",
        "label": "Other Accrued Liabilities, Current",
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r40"
     ]
    },
    "us-gaap_OtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other current assets",
        "label": "Other Assets, Current",
        "documentation": "Amount of current assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r111",
      "r786"
     ]
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherAssetsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other assets, non-current",
        "label": "Other Assets, Noncurrent",
        "documentation": "Amount of noncurrent assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r104"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofComprehensiveLossunaudited": {
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofComprehensiveLossunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Currency translation adjustments",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent",
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r9",
      "r75"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofComprehensiveLossunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other comprehensive income (loss):",
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofComprehensiveLossunaudited": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofComprehensiveLossunaudited",
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofStockholdersEquityunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Other comprehensive income (loss)",
        "terseLabel": "Other comprehensive income (loss)",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r9",
      "r75",
      "r114",
      "r117",
      "r146"
     ]
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherLiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other liabilities, non-current",
        "label": "Other Liabilities, Noncurrent",
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r43"
     ]
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherNoncashIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Other, net",
        "label": "Other Noncash Income (Expense)",
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other."
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Performance Measure, Amount",
        "label": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r854"
     ]
    },
    "us-gaap_OtherReceivablesNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherReceivablesNetCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other receivables",
        "label": "Other Receivables, Net, Current",
        "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount",
        "label": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r816",
      "r826",
      "r836",
      "r868"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Amount",
        "label": "Outstanding Recovery Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r819",
      "r829",
      "r839",
      "r871"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Outstanding Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r819",
      "r829",
      "r839",
      "r871"
     ]
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r843"
     ]
    },
    "us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PaymentsToAcquireInProcessResearchAndDevelopment",
     "crdr": "credit",
     "presentation": [
      "http://www.recursion.com/role/AcquisitionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payments to acquire IPR&amp;D",
        "label": "Payments to Acquire in Process Research and Development",
        "documentation": "The cash outflows from the purchase of net carrying value allocated to in-process research and development costs and materials acquired in a business combination."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    },
    "us-gaap_PaymentsToAcquireIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PaymentsToAcquireIntangibleAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Purchase of an intangible asset",
        "label": "Payments to Acquire Intangible Assets",
        "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill."
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "us-gaap_PaymentsToAcquireInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PaymentsToAcquireInvestments",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Purchases of investments",
        "label": "Payments to Acquire Investments",
        "documentation": "The cash outflow associated with the purchase of all investments (debt, security, other) during the period."
       }
      }
     },
     "auth_ref": [
      "r61"
     ]
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Purchases of property and equipment",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets."
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Peer Group Issuers, Footnote",
        "label": "Peer Group Issuers, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r853"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Peer Group Total Shareholder Return Amount",
        "label": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r853"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Actually Paid Compensation Amount",
        "label": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r845"
     ]
    },
    "ecd_PeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO",
        "label": "PEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r862"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Name",
        "label": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r855"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Total Compensation Amount",
        "label": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r844"
     ]
    },
    "rxrx_PhenomapsCreationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.recursion.com/20260331",
     "localname": "PhenomapsCreationMember",
     "presentation": [
      "http://www.recursion.com/role/CollaborativeDevelopmentContractsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Phenomaps Creation",
        "label": "Phenomaps Creation [Member]",
        "documentation": "Phenomaps Creation"
       }
      }
     },
     "auth_ref": []
    },
    "rxrx_PhenomapsRawImagesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.recursion.com/20260331",
     "localname": "PhenomapsRawImagesMember",
     "presentation": [
      "http://www.recursion.com/role/CollaborativeDevelopmentContractsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Phenomaps Raw Images",
        "label": "Phenomaps Raw Images [Member]",
        "documentation": "Phenomaps Raw Images"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PlanNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PlanNameAxis",
     "presentation": [
      "http://www.recursion.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plan Name [Axis]",
        "label": "Plan Name [Axis]",
        "documentation": "Information by plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1023",
      "r1024",
      "r1025",
      "r1026",
      "r1027",
      "r1028",
      "r1029",
      "r1030",
      "r1031",
      "r1032",
      "r1033",
      "r1034",
      "r1035",
      "r1036",
      "r1037",
      "r1038",
      "r1039",
      "r1040",
      "r1041",
      "r1042",
      "r1043",
      "r1044",
      "r1045",
      "r1046",
      "r1047",
      "r1048"
     ]
    },
    "us-gaap_PlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PlanNameDomain",
     "presentation": [
      "http://www.recursion.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plan Name [Domain]",
        "label": "Plan Name [Domain]",
        "documentation": "Plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1023",
      "r1024",
      "r1025",
      "r1026",
      "r1027",
      "r1028",
      "r1029",
      "r1030",
      "r1031",
      "r1032",
      "r1033",
      "r1034",
      "r1035",
      "r1036",
      "r1037",
      "r1038",
      "r1039",
      "r1040",
      "r1041",
      "r1042",
      "r1043",
      "r1044",
      "r1045",
      "r1046",
      "r1047",
      "r1048"
     ]
    },
    "rxrx_PlatformFeeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.recursion.com/20260331",
     "localname": "PlatformFeeExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/SegmentInformationScheduleofSegmentNetLossandReconciliationsofSegmentOperatingLosstoLossBeforeIncomeTaxBenefitDetails": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/SegmentInformationScheduleofSegmentNetLossandReconciliationsofSegmentOperatingLosstoLossBeforeIncomeTaxBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Platform",
        "label": "Platform Fee Expense",
        "documentation": "Platform Fee Expense"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PnsnAdjsPrrSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PnsnAdjsPrrSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension Adjustments Prior Service Cost",
        "label": "Pension Adjustments Prior Service Cost [Member]"
       }
      }
     },
     "auth_ref": [
      "r846"
     ]
    },
    "ecd_PnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension Adjustments Service Cost",
        "label": "Pension Adjustments Service Cost [Member]"
       }
      }
     },
     "auth_ref": [
      "r890"
     ]
    },
    "ecd_PnsnBnftsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PnsnBnftsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension Benefits Adjustments, Footnote",
        "label": "Pension Benefits Adjustments, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r845"
     ]
    },
    "us-gaap_PortionAtFairValueFairValueDisclosureMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PortionAtFairValueFairValueDisclosureMember",
     "presentation": [
      "http://www.recursion.com/role/FairValueMeasurementsScheduleofFinancialInstrumentsNotMeasuredatFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Portion at Fair Value Measurement",
        "label": "Portion at Fair Value Measurement [Member]",
        "documentation": "Measured at fair value for financial reporting purposes."
       }
      }
     },
     "auth_ref": [
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r689",
      "r1076"
     ]
    },
    "us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PortionAtOtherThanFairValueFairValueDisclosureMember",
     "presentation": [
      "http://www.recursion.com/role/FairValueMeasurementsScheduleofFinancialInstrumentsNotMeasuredatFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Book values",
        "label": "Portion at Other than Fair Value Measurement [Member]",
        "documentation": "Not measured at fair value."
       }
      }
     },
     "auth_ref": [
      "r497"
     ]
    },
    "us-gaap_PrepaidExpenseCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PrepaidExpenseCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid data assets",
        "label": "Prepaid Expense, Current",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r110",
      "r211",
      "r212",
      "r693"
     ]
    },
    "us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromDivestitureOfBusinessesNetOfCashDivested",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Decrease in cash related to disposal of a business",
        "label": "Proceeds from Divestiture of Businesses, Net of Cash Divested",
        "documentation": "This element represents the cash inflow during the period from the sale of a component of the entity."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from issuance of common shares, net of issuance costs",
        "label": "Proceeds from Issuance of Common Stock",
        "documentation": "The cash inflow from the additional capital contribution to the entity."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "rxrx_ProceedsFromPaymentForShareBasedPaymentArrangement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.recursion.com/20260331",
     "localname": "ProceedsFromPaymentForShareBasedPaymentArrangement",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity incentive plans",
        "label": "Proceeds From (Payment For) Share-Based Payment Arrangement",
        "documentation": "Proceeds From (Payment For) Share-Based Payment Arrangement"
       }
      }
     },
     "auth_ref": []
    },
    "srt_ProductOrServiceAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "ProductOrServiceAxis",
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofOperationsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product and Service [Axis]",
        "label": "Product and Service [Axis]"
       }
      }
     },
     "auth_ref": [
      "r199",
      "r536",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r690",
      "r698",
      "r701",
      "r703",
      "r724",
      "r725",
      "r787",
      "r788",
      "r789",
      "r791",
      "r794",
      "r897",
      "r916",
      "r917",
      "r918",
      "r919",
      "r920",
      "r921",
      "r922",
      "r923",
      "r924",
      "r925",
      "r926",
      "r927",
      "r928",
      "r929",
      "r930",
      "r931",
      "r932",
      "r933",
      "r934",
      "r935",
      "r936",
      "r937",
      "r938",
      "r939",
      "r940",
      "r941",
      "r942",
      "r943",
      "r944",
      "r945",
      "r946",
      "r947",
      "r948",
      "r949",
      "r950",
      "r951",
      "r952",
      "r954",
      "r955",
      "r956",
      "r957",
      "r1014",
      "r1015",
      "r1091",
      "r1093",
      "r1094",
      "r1095",
      "r1096",
      "r1097",
      "r1098",
      "r1099",
      "r1100",
      "r1101",
      "r1102",
      "r1103",
      "r1104",
      "r1105",
      "r1106",
      "r1107",
      "r1108",
      "r1109",
      "r1110",
      "r1111",
      "r1112",
      "r1113",
      "r1114",
      "r1115",
      "r1116",
      "r1117",
      "r1118",
      "r1119",
      "r1120"
     ]
    },
    "srt_ProductsAndServicesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "ProductsAndServicesDomain",
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofOperationsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product and Service [Domain]",
        "label": "Product and Service [Domain]"
       }
      }
     },
     "auth_ref": [
      "r199",
      "r536",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r690",
      "r698",
      "r701",
      "r703",
      "r724",
      "r725",
      "r787",
      "r788",
      "r789",
      "r791",
      "r794",
      "r897",
      "r916",
      "r917",
      "r918",
      "r919",
      "r920",
      "r921",
      "r922",
      "r923",
      "r924",
      "r925",
      "r926",
      "r927",
      "r928",
      "r929",
      "r930",
      "r931",
      "r932",
      "r933",
      "r934",
      "r935",
      "r936",
      "r937",
      "r938",
      "r939",
      "r940",
      "r941",
      "r942",
      "r943",
      "r944",
      "r945",
      "r946",
      "r947",
      "r948",
      "r949",
      "r950",
      "r951",
      "r952",
      "r954",
      "r955",
      "r956",
      "r957",
      "r1014",
      "r1015",
      "r1091",
      "r1093",
      "r1094",
      "r1095",
      "r1096",
      "r1097",
      "r1098",
      "r1099",
      "r1100",
      "r1101",
      "r1102",
      "r1103",
      "r1104",
      "r1105",
      "r1106",
      "r1107",
      "r1108",
      "r1109",
      "r1110",
      "r1111",
      "r1112",
      "r1113",
      "r1114",
      "r1115",
      "r1116",
      "r1117",
      "r1118",
      "r1119",
      "r1120"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentLineItems",
     "presentation": [
      "http://www.recursion.com/role/SupplementalFinancialInformationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment [Line Items]",
        "label": "Property, Plant and Equipment [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r524"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentNet",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property and equipment, net",
        "label": "Property, Plant and Equipment, Net",
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r524",
      "r547",
      "r558",
      "r786"
     ]
    },
    "rxrx_PurchaseOfAnEquityInvestmentNonCash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.recursion.com/20260331",
     "localname": "PurchaseOfAnEquityInvestmentNonCash",
     "crdr": "credit",
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Purchase of an equity investment",
        "label": "Purchase Of An Equity Investment, Non-Cash",
        "documentation": "Purchase Of An Equity Investment, Non-Cash"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pay vs Performance Disclosure",
        "label": "Pay vs Performance Disclosure [Table]"
       }
      }
     },
     "auth_ref": [
      "r843"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pay vs Performance Disclosure, Table",
        "label": "Pay vs Performance [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r843"
     ]
    },
    "rxrx_REVenturesIMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.recursion.com/20260331",
     "localname": "REVenturesIMember",
     "presentation": [
      "http://www.recursion.com/role/AcquisitionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "RE Ventures I",
        "label": "RE Ventures I [Member]",
        "documentation": "RE Ventures I"
       }
      }
     },
     "auth_ref": []
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "RangeAxis",
     "presentation": [
      "http://www.recursion.com/role/LeasesNarrativeDetails",
      "http://www.recursion.com/role/SupplementalFinancialInformationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement [Axis]",
        "label": "Statistical Measurement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r169",
      "r254",
      "r255",
      "r256",
      "r257",
      "r308",
      "r318",
      "r347",
      "r348",
      "r349",
      "r355",
      "r359",
      "r483",
      "r531",
      "r532",
      "r534",
      "r584",
      "r586",
      "r594",
      "r617",
      "r618",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674",
      "r681",
      "r682",
      "r683",
      "r684",
      "r686",
      "r687",
      "r718",
      "r723",
      "r733",
      "r736",
      "r742",
      "r745",
      "r781",
      "r782",
      "r783",
      "r784",
      "r788",
      "r797",
      "r1012",
      "r1018",
      "r1074",
      "r1085",
      "r1086",
      "r1087",
      "r1088",
      "r1089"
     ]
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "RangeMember",
     "presentation": [
      "http://www.recursion.com/role/LeasesNarrativeDetails",
      "http://www.recursion.com/role/SupplementalFinancialInformationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement [Domain]",
        "label": "Statistical Measurement [Domain]"
       }
      }
     },
     "auth_ref": [
      "r169",
      "r254",
      "r255",
      "r256",
      "r257",
      "r308",
      "r318",
      "r347",
      "r348",
      "r349",
      "r355",
      "r359",
      "r483",
      "r531",
      "r532",
      "r534",
      "r584",
      "r586",
      "r594",
      "r617",
      "r618",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674",
      "r681",
      "r682",
      "r683",
      "r684",
      "r686",
      "r687",
      "r718",
      "r723",
      "r733",
      "r736",
      "r742",
      "r745",
      "r781",
      "r782",
      "r783",
      "r784",
      "r788",
      "r797",
      "r1012",
      "r1018",
      "r1074",
      "r1085",
      "r1086",
      "r1087",
      "r1088",
      "r1089"
     ]
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r811",
      "r821",
      "r831",
      "r863"
     ]
    },
    "rxrx_RegistrationRightsAgreementTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.recursion.com/20260331",
     "localname": "RegistrationRightsAgreementTerm",
     "presentation": [
      "http://www.recursion.com/role/CommonStockRegistrationRightsAgreementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Registration rights agreement term",
        "label": "Registration Rights Agreement, Term",
        "documentation": "Registration Rights Agreement, Term"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RepaymentsOfLongTermDebtAndCapitalSecurities",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Repayment of long-term debt and finance lease liabilities",
        "label": "Repayment of Long-Term Debt, Long-Term Lease Obligation, and Capital Security",
        "documentation": "Amount of cash outflow for debt, mandatory redeemable security, and principal payment for finance lease obligation."
       }
      }
     },
     "auth_ref": [
      "r63",
      "r64"
     ]
    },
    "rxrx_ReportableSegmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.recursion.com/20260331",
     "localname": "ReportableSegmentMember",
     "presentation": [
      "http://www.recursion.com/role/SegmentInformationScheduleofSegmentNetLossandReconciliationsofSegmentOperatingLosstoLossBeforeIncomeTaxBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reportable Segment",
        "label": "Reportable Segment [Member]",
        "documentation": "Reportable Segment"
       }
      }
     },
     "auth_ref": []
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "presentation": [
      "http://www.recursion.com/role/CollaborativeDevelopmentContractsDetails",
      "http://www.recursion.com/role/SupplementalFinancialInformationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Counterparty Name [Domain]",
        "label": "Counterparty Name [Domain]"
       }
      }
     },
     "auth_ref": [
      "r127",
      "r133",
      "r134",
      "r267",
      "r285",
      "r527",
      "r533",
      "r549",
      "r694",
      "r695",
      "r696",
      "r901",
      "r902",
      "r903",
      "r904",
      "r905",
      "r906",
      "r907",
      "r908",
      "r909",
      "r1066",
      "r1067",
      "r1068",
      "r1069"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ResearchAndDevelopmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofOperationsunaudited": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofOperationsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development",
        "label": "Research and Development Expense",
        "documentation": "Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity."
       }
      }
     },
     "auth_ref": [
      "r360",
      "r688",
      "r699",
      "r700",
      "r713",
      "r1090"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ResearchAndDevelopmentExpenseMember",
     "presentation": [
      "http://www.recursion.com/role/StockBasedCompensationScheduleofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development",
        "label": "Research and Development Expense [Member]",
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included."
       }
      }
     },
     "auth_ref": []
    },
    "rxrx_ResearchMilestonesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.recursion.com/20260331",
     "localname": "ResearchMilestonesMember",
     "presentation": [
      "http://www.recursion.com/role/CollaborativeDevelopmentContractsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research Milestones",
        "label": "Research Milestones [Member]",
        "documentation": "Research Milestones"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement Determination Date:",
        "label": "Restatement Determination Date [Axis]"
       }
      }
     },
     "auth_ref": [
      "r812",
      "r822",
      "r832",
      "r864"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement Determination Date",
        "label": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r813",
      "r823",
      "r833",
      "r865"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement does not require Recovery",
        "label": "Restatement Does Not Require Recovery [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r820",
      "r830",
      "r840",
      "r872"
     ]
    },
    "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember",
     "presentation": [
      "http://www.recursion.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and Cash Equivalents [Domain]",
        "label": "Cash and Cash Equivalents [Domain]",
        "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "rxrx_RestrictedCashAndCashEquivalentsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.recursion.com/20260331",
     "localname": "RestrictedCashAndCashEquivalentsFairValueDisclosure",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails": {
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted cash",
        "label": "Restricted Cash And Cash Equivalents, Fair Value Disclosure",
        "documentation": "Restricted Cash And Cash Equivalents, Fair Value Disclosure"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RestrictedCashCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RestrictedCashCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted cash",
        "label": "Restricted Cash, Current",
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits."
       }
      }
     },
     "auth_ref": [
      "r898",
      "r960"
     ]
    },
    "us-gaap_RestrictedCashNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RestrictedCashNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted cash, non-current",
        "label": "Restricted Cash, Noncurrent",
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits."
       }
      }
     },
     "auth_ref": [
      "r86",
      "r900",
      "r960"
     ]
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RestrictedStockUnitsRSUMember",
     "presentation": [
      "http://www.recursion.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.recursion.com/role/StockBasedCompensationScheduleofRSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "RSUs",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met."
       }
      }
     },
     "auth_ref": [
      "r1023",
      "r1024",
      "r1025",
      "r1026",
      "r1027",
      "r1028",
      "r1029",
      "r1030",
      "r1031",
      "r1032",
      "r1033",
      "r1034",
      "r1035",
      "r1036",
      "r1037",
      "r1038",
      "r1039",
      "r1040",
      "r1041",
      "r1042",
      "r1043",
      "r1044",
      "r1045",
      "r1046",
      "r1047",
      "r1048"
     ]
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited",
      "http://www.recursion.com/role/DescriptionoftheBusinessDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated deficit",
        "negatedLabel": "Accumulated deficit",
        "label": "Retained Earnings (Accumulated Deficit)",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r49",
      "r74",
      "r556",
      "r591",
      "r593",
      "r602",
      "r628",
      "r786"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofStockholdersEquityunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Deficit",
        "label": "Retained Earnings [Member]",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r93",
      "r94",
      "r95",
      "r135",
      "r136",
      "r137",
      "r139",
      "r146",
      "r148",
      "r150",
      "r209",
      "r210",
      "r242",
      "r270",
      "r356",
      "r373",
      "r374",
      "r381",
      "r382",
      "r383",
      "r385",
      "r449",
      "r450",
      "r464",
      "r466",
      "r467",
      "r469",
      "r475",
      "r513",
      "r515",
      "r588",
      "r590",
      "r604",
      "r1124"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofOperationsunaudited": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.recursion.com/role/SegmentInformationScheduleofSegmentNetLossandReconciliationsofSegmentOperatingLosstoLossBeforeIncomeTaxBenefitDetails": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofOperationsunaudited",
      "http://www.recursion.com/role/SegmentInformationScheduleofSegmentNetLossandReconciliationsofSegmentOperatingLosstoLossBeforeIncomeTaxBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "netLabel": "Total revenue",
        "verboseLabel": "Revenue",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise."
       }
      }
     },
     "auth_ref": [
      "r81",
      "r82",
      "r164",
      "r175",
      "r176",
      "r190",
      "r196",
      "r199",
      "r201",
      "r202",
      "r303",
      "r304",
      "r305",
      "r536",
      "r699",
      "r703"
     ]
    },
    "rxrx_RevenuePerformanceObligationNumberOfObligations": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.recursion.com/20260331",
     "localname": "RevenuePerformanceObligationNumberOfObligations",
     "presentation": [
      "http://www.recursion.com/role/CollaborativeDevelopmentContractsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of performance obligations under the agreement (in performance obligations)",
        "label": "Revenue, Performance Obligation, Number Of Obligations",
        "documentation": "Revenue, Performance Obligation, Number Of Obligations"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevenueRemainingPerformanceObligation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RevenueRemainingPerformanceObligation",
     "crdr": "credit",
     "presentation": [
      "http://www.recursion.com/role/CollaborativeDevelopmentContractsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Remaining performance obligation revenue",
        "label": "Revenue, Remaining Performance Obligation, Amount",
        "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue."
       }
      }
     },
     "auth_ref": [
      "r88"
     ]
    },
    "rxrx_RevenueRemainingPerformanceObligationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.recursion.com/20260331",
     "localname": "RevenueRemainingPerformanceObligationAxis",
     "presentation": [
      "http://www.recursion.com/role/CollaborativeDevelopmentContractsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue, Remaining Performance Obligation [Axis]",
        "label": "Revenue, Remaining Performance Obligation [Axis]",
        "documentation": "Revenue, Remaining Performance Obligation"
       }
      }
     },
     "auth_ref": []
    },
    "rxrx_RevenueRemainingPerformanceObligationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.recursion.com/20260331",
     "localname": "RevenueRemainingPerformanceObligationDomain",
     "presentation": [
      "http://www.recursion.com/role/CollaborativeDevelopmentContractsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue, Remaining Performance Obligation [Domain]",
        "label": "Revenue, Remaining Performance Obligation [Domain]",
        "documentation": "Revenue, Remaining Performance Obligation [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "rxrx_RevenueRemainingPerformanceObligationNumberOfProjectsThatMayBeInitiated": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.recursion.com/20260331",
     "localname": "RevenueRemainingPerformanceObligationNumberOfProjectsThatMayBeInitiated",
     "presentation": [
      "http://www.recursion.com/role/CollaborativeDevelopmentContractsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of projects that may be initiated",
        "label": "Revenue, Remaining Performance Obligation, Number Of Projects That May Be Initiated",
        "documentation": "Revenue, Remaining Performance Obligation, Number Of Projects That May Be Initiated"
       }
      }
     },
     "auth_ref": []
    },
    "rxrx_RevenueRemainingPerformanceObligationVariableConsiderationAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.recursion.com/20260331",
     "localname": "RevenueRemainingPerformanceObligationVariableConsiderationAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.recursion.com/role/CollaborativeDevelopmentContractsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research project, fees and milestones payments receivable for an option on a lead series",
        "label": "Revenue, Remaining Performance Obligation, Variable Consideration Amount",
        "documentation": "Revenue, Remaining Performance Obligation, Variable Consideration Amount"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevenuesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RevenuesAbstract",
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofOperationsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue",
        "label": "Revenues [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "rxrx_RightOfUseAssetsObtainedInExchangeForLeaseLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.recursion.com/20260331",
     "localname": "RightOfUseAssetsObtainedInExchangeForLeaseLiabilitiesAbstract",
     "presentation": [
      "http://www.recursion.com/role/LeasesScheduleofSupplementalCashFlowInformationRelatedtoLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Right-of-use assets additions, modifications and termination:",
        "label": "Right-Of-Use Assets Obtained In Exchange For Lease Liabilities [Abstract]",
        "documentation": "Right-Of-Use Assets Obtained In Exchange For Lease Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "rxrx_RocheAndGenentechMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.recursion.com/20260331",
     "localname": "RocheAndGenentechMember",
     "presentation": [
      "http://www.recursion.com/role/CollaborativeDevelopmentContractsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Roche and Genentech",
        "label": "Roche and Genentech [Member]",
        "documentation": "Roche and Genentech"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 10b5-1 Arrangement Adopted",
        "label": "Rule 10b5-1 Arrangement Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r881"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 10b5-1 Arrangement Terminated",
        "label": "Rule 10b5-1 Arrangement Terminated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r881"
     ]
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SaleOfStockNameOfTransactionDomain",
     "presentation": [
      "http://www.recursion.com/role/CommonStockAtTheMarketOfferingNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of Stock [Domain]",
        "label": "Sale of Stock [Domain]",
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement."
       }
      }
     },
     "auth_ref": []
    },
    "rxrx_SaleOfStockValueAuthorized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.recursion.com/20260331",
     "localname": "SaleOfStockValueAuthorized",
     "crdr": "credit",
     "presentation": [
      "http://www.recursion.com/role/CommonStockAtTheMarketOfferingNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of stock, value authorized",
        "label": "Sale Of Stock, Value, Authorized",
        "documentation": "Sale Of Stock, Value, Authorized"
       }
      }
     },
     "auth_ref": []
    },
    "rxrx_SaleOfStockValueRemainingAuthorized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.recursion.com/20260331",
     "localname": "SaleOfStockValueRemainingAuthorized",
     "crdr": "credit",
     "presentation": [
      "http://www.recursion.com/role/CommonStockAtTheMarketOfferingNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of stock, value remaining authorized",
        "label": "Sale Of Stock Value Remaining Authorized",
        "documentation": "Sale Of Stock Value Remaining Authorized"
       }
      }
     },
     "auth_ref": []
    },
    "rxrx_SanofiMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.recursion.com/20260331",
     "localname": "SanofiMember",
     "presentation": [
      "http://www.recursion.com/role/CollaborativeDevelopmentContractsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sanofi",
        "label": "Sanofi [Member]",
        "documentation": "Sanofi"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
     "presentation": [
      "http://www.recursion.com/role/SupplementalFinancialInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Accrued Expenses and Other Liabilities",
        "label": "Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]",
        "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "presentation": [
      "http://www.recursion.com/role/NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "label": "Antidilutive Security, Excluded EPS Calculation [Table]",
        "documentation": "Disclosure of information about security that could potentially dilute basic earnings per share (EPS) in future that was not included in calculation of diluted EPS."
       }
      }
     },
     "auth_ref": [
      "r160"
     ]
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "presentation": [
      "http://www.recursion.com/role/NetLossPerShareTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Net Loss Per Share",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities."
       }
      }
     },
     "auth_ref": [
      "r23"
     ]
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "presentation": [
      "http://www.recursion.com/role/AcquisitionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Combination [Table]",
        "label": "Business Combination [Table]",
        "documentation": "Disclosure of information about business combination. Includes, but is not limited to, recognized asset and liability."
       }
      }
     },
     "auth_ref": [
      "r227",
      "r387",
      "r388",
      "r389",
      "r390",
      "r396",
      "r397",
      "r398",
      "r399",
      "r405",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r441",
      "r442",
      "r443",
      "r447",
      "r736",
      "r745",
      "r1057",
      "r1059",
      "r1060"
     ]
    },
    "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable",
     "presentation": [
      "http://www.recursion.com/role/CollaborativeDevelopmentContractsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]",
        "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r453"
     ]
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "presentation": [
      "http://www.recursion.com/role/NetLossPerShareTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Computation of Basic and Diluted Net Loss Per Share",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r973"
     ]
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
     "presentation": [
      "http://www.recursion.com/role/StockBasedCompensationScheduleofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements."
       }
      }
     },
     "auth_ref": [
      "r36"
     ]
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "presentation": [
      "http://www.recursion.com/role/StockBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Stock-Based Compensation Expense",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement."
       }
      }
     },
     "auth_ref": [
      "r36"
     ]
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "presentation": [
      "http://www.recursion.com/role/AcquisitionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment, Name [Axis]",
        "label": "Investment, Name [Axis]"
       }
      }
     },
     "auth_ref": [
      "r205",
      "r206",
      "r207",
      "r380",
      "r502",
      "r894",
      "r895",
      "r896",
      "r1052",
      "r1053",
      "r1054",
      "r1055"
     ]
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "presentation": [
      "http://www.recursion.com/role/FairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)."
       }
      }
     },
     "auth_ref": [
      "r1072",
      "r1073"
     ]
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "presentation": [
      "http://www.recursion.com/role/GoodwillandIntangibleAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Finite-Lived Intangible Assets",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment."
       }
      }
     },
     "auth_ref": [
      "r691",
      "r1002"
     ]
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfGoodwillTable",
     "presentation": [
      "http://www.recursion.com/role/GoodwillandIntangibleAssetsScheduleofIntangibleassetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill [Table]",
        "label": "Goodwill [Table]",
        "documentation": "Disclosure of information about goodwill, including, but not limited to, change from acquisition, sale, impairment, and other reason."
       }
      }
     },
     "auth_ref": [
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r719"
     ]
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfGoodwillTextBlock",
     "presentation": [
      "http://www.recursion.com/role/GoodwillandIntangibleAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Goodwill",
        "label": "Schedule of Goodwill [Table Text Block]",
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule."
       }
      }
     },
     "auth_ref": [
      "r719",
      "r984",
      "r985",
      "r986",
      "r987",
      "r988",
      "r989",
      "r990",
      "r991",
      "r992",
      "r993",
      "r994"
     ]
    },
    "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
     "presentation": [
      "http://www.recursion.com/role/GoodwillandIntangibleAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Indefinite-Lived Intangible Assets",
        "label": "Schedule of Indefinite-Lived Intangible Assets [Table Text Block]",
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment."
       }
      }
     },
     "auth_ref": [
      "r691",
      "r1004"
     ]
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "presentation": [
      "http://www.recursion.com/role/SupplementalFinancialInformationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment [Table]",
        "label": "Property, Plant and Equipment [Table]",
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r524"
     ]
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "presentation": [
      "http://www.recursion.com/role/SegmentInformationScheduleofSegmentNetLossandReconciliationsofSegmentOperatingLosstoLossBeforeIncomeTaxBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "documentation": "Disclosure of information about profit (loss) and total assets by reportable segment."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r25",
      "r26"
     ]
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "presentation": [
      "http://www.recursion.com/role/SegmentInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Segment Net Loss and Reconciliations of Segment Operating Loss to Loss Before Income Tax Benefit",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r25",
      "r26"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "presentation": [
      "http://www.recursion.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.recursion.com/role/StockBasedCompensationScheduleofRSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "documentation": "Disclosure of information about share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r320",
      "r322",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r355"
     ]
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfStockByClassTable",
     "presentation": [
      "http://www.recursion.com/role/CommonStockAtTheMarketOfferingNarrativeDetails",
      "http://www.recursion.com/role/CommonStockClassAandBCommonSharesAuthorizationNarrativeDetails",
      "http://www.recursion.com/role/CommonStockNarrativeDetails",
      "http://www.recursion.com/role/CommonStockRegistrationRightsAgreementsNarrativeDetails",
      "http://www.recursion.com/role/CommonStockValenceAcquisitionExchangeableSharesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Stock by Class [Table]",
        "label": "Stock, Class of Stock [Table]",
        "documentation": "Disclosure of information about stock by class. Includes, but is not limited to, common, convertible, and preferred stocks."
       }
      }
     },
     "auth_ref": [
      "r28",
      "r29",
      "r30",
      "r31",
      "r32",
      "r33",
      "r72",
      "r73",
      "r74",
      "r106",
      "r107",
      "r108",
      "r166",
      "r283",
      "r284",
      "r285",
      "r287",
      "r290",
      "r295",
      "r297",
      "r463",
      "r598",
      "r599",
      "r600",
      "r601",
      "r723",
      "r892",
      "r963",
      "r964"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r806"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r808"
     ]
    },
    "us-gaap_SegmentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SegmentDomain",
     "presentation": [
      "http://www.recursion.com/role/SegmentInformationScheduleofSegmentNetLossandReconciliationsofSegmentOperatingLosstoLossBeforeIncomeTaxBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segments [Domain]",
        "label": "Segments [Domain]",
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity."
       }
      }
     },
     "auth_ref": [
      "r81",
      "r82",
      "r83",
      "r84",
      "r164",
      "r171",
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r179",
      "r180",
      "r181",
      "r182",
      "r183",
      "r184",
      "r185",
      "r187",
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r196",
      "r197",
      "r198",
      "r202",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r241",
      "r249",
      "r250",
      "r440",
      "r443",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r710",
      "r713",
      "r714",
      "r719",
      "r790",
      "r1091",
      "r1093",
      "r1094",
      "r1095",
      "r1096",
      "r1097",
      "r1098",
      "r1099",
      "r1100",
      "r1101",
      "r1102",
      "r1103",
      "r1104",
      "r1105",
      "r1106",
      "r1107",
      "r1108",
      "r1109",
      "r1110",
      "r1111",
      "r1112",
      "r1113",
      "r1114",
      "r1115",
      "r1116",
      "r1117",
      "r1118",
      "r1119",
      "r1120"
     ]
    },
    "us-gaap_SegmentExpenditureAdditionToLongLivedAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SegmentExpenditureAdditionToLongLivedAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.recursion.com/role/SegmentInformationScheduleofSegmentNetLossandReconciliationsofSegmentOperatingLosstoLossBeforeIncomeTaxBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total expenditures for additions to long-lived assets",
        "label": "Segment, Expenditure, Addition to Long-Lived Assets",
        "documentation": "Amount of expenditure for addition to long-lived assets included in determination of segment assets by chief operating decision maker (CODM) or otherwise regularly provided to CODM. Excludes expenditure for addition to financial instrument, long-term customer relationship of financial institution, mortgage and other servicing rights, deferred policy acquisition cost, and deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r164",
      "r185",
      "r196",
      "r713",
      "r714"
     ]
    },
    "us-gaap_SegmentReportingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SegmentReportingAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SegmentReportingDisclosureTextBlock",
     "presentation": [
      "http://www.recursion.com/role/SegmentInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Information",
        "label": "Segment Reporting Disclosure [Text Block]",
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments."
       }
      }
     },
     "auth_ref": [
      "r84",
      "r164",
      "r170",
      "r171",
      "r172",
      "r173",
      "r174",
      "r186",
      "r188",
      "r189",
      "r194",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r202",
      "r709",
      "r711",
      "r712",
      "r713",
      "r715",
      "r716",
      "r717"
     ]
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SegmentReportingInformationLineItems",
     "presentation": [
      "http://www.recursion.com/role/SegmentInformationScheduleofSegmentNetLossandReconciliationsofSegmentOperatingLosstoLossBeforeIncomeTaxBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Reporting Information [Line Items]",
        "label": "Segment Reporting Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingOtherItemAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SegmentReportingOtherItemAmount",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/SegmentInformationScheduleofSegmentNetLossandReconciliationsofSegmentOperatingLosstoLossBeforeIncomeTaxBenefitDetails": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/SegmentInformationScheduleofSegmentNetLossandReconciliationsofSegmentOperatingLosstoLossBeforeIncomeTaxBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other segment items",
        "label": "Segment Reporting, Other Segment Item, Amount",
        "documentation": "Amount of other expense (income) and loss (gain) calculated as difference between segment revenue and separately disclosed expense category to arrive at segment profit (loss)."
       }
      }
     },
     "auth_ref": [
      "r164",
      "r188",
      "r189",
      "r196",
      "r713"
     ]
    },
    "us-gaap_ShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "documentation": "Amount of noncash expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "presentation": [
      "http://www.recursion.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock options, vesting period",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition."
       }
      }
     },
     "auth_ref": [
      "r734"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "presentation": [
      "http://www.recursion.com/role/StockBasedCompensationScheduleofRSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Forfeited (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r340"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.recursion.com/role/StockBasedCompensationScheduleofRSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forfeited (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event."
       }
      }
     },
     "auth_ref": [
      "r340"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "presentation": [
      "http://www.recursion.com/role/StockBasedCompensationScheduleofRSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
       }
      }
     },
     "auth_ref": [
      "r338"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.recursion.com/role/StockBasedCompensationScheduleofRSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
       }
      }
     },
     "auth_ref": [
      "r338"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "presentation": [
      "http://www.recursion.com/role/StockBasedCompensationScheduleofRSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning balance (in shares)",
        "periodEndLabel": "Ending balance (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r335",
      "r336"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.recursion.com/role/StockBasedCompensationScheduleofRSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning balance (in dollars per share)",
        "periodEndLabel": "Ending balance (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options."
       }
      }
     },
     "auth_ref": [
      "r335",
      "r336"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "presentation": [
      "http://www.recursion.com/role/StockBasedCompensationScheduleofRSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average grant date fair value",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "presentation": [
      "http://www.recursion.com/role/StockBasedCompensationScheduleofRSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Vested (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r339"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
     "crdr": "debit",
     "presentation": [
      "http://www.recursion.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair market value of vested shares",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value",
        "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash."
       }
      }
     },
     "auth_ref": [
      "r342"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.recursion.com/role/StockBasedCompensationScheduleofRSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vested (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement."
       }
      }
     },
     "auth_ref": [
      "r339"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "presentation": [
      "http://www.recursion.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.recursion.com/role/StockBasedCompensationScheduleofRSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r320",
      "r322",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r355"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward",
     "presentation": [
      "http://www.recursion.com/role/StockBasedCompensationScheduleofRSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock units",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "presentation": [
      "http://www.recursion.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of shares available for grant (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant",
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable."
       }
      }
     },
     "auth_ref": [
      "r34"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://www.recursion.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.recursion.com/role/StockBasedCompensationScheduleofRSUActivityDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Type [Domain]",
        "label": "Award Type [Domain]",
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350"
     ]
    },
    "rxrx_SignificantSegmentExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.recursion.com/20260331",
     "localname": "SignificantSegmentExpensesAbstract",
     "presentation": [
      "http://www.recursion.com/role/SegmentInformationScheduleofSegmentNetLossandReconciliationsofSegmentOperatingLosstoLossBeforeIncomeTaxBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Significant segment expenses",
        "label": "Significant Segment Expenses [Abstract]",
        "documentation": "Significant Segment Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementBusinessSegmentsAxis",
     "presentation": [
      "http://www.recursion.com/role/SegmentInformationScheduleofSegmentNetLossandReconciliationsofSegmentOperatingLosstoLossBeforeIncomeTaxBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segments [Axis]",
        "label": "Segments [Axis]",
        "documentation": "Information by business segments."
       }
      }
     },
     "auth_ref": [
      "r81",
      "r82",
      "r83",
      "r84",
      "r96",
      "r164",
      "r171",
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r179",
      "r180",
      "r181",
      "r182",
      "r183",
      "r184",
      "r185",
      "r187",
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r196",
      "r197",
      "r198",
      "r202",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r241",
      "r244",
      "r249",
      "r250",
      "r440",
      "r443",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r710",
      "r713",
      "r714",
      "r719",
      "r790",
      "r1091",
      "r1093",
      "r1094",
      "r1095",
      "r1096",
      "r1097",
      "r1098",
      "r1099",
      "r1100",
      "r1101",
      "r1102",
      "r1103",
      "r1104",
      "r1105",
      "r1106",
      "r1107",
      "r1108",
      "r1109",
      "r1110",
      "r1111",
      "r1112",
      "r1113",
      "r1114",
      "r1115",
      "r1116",
      "r1117",
      "r1118",
      "r1119",
      "r1120"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://www.recursion.com/role/CommonStockAtTheMarketOfferingNarrativeDetails",
      "http://www.recursion.com/role/CommonStockClassAandBCommonSharesAuthorizationNarrativeDetails",
      "http://www.recursion.com/role/CommonStockNarrativeDetails",
      "http://www.recursion.com/role/CommonStockValenceAcquisitionExchangeableSharesNarrativeDetails",
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunauditedParenthetical",
      "http://www.recursion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Stock [Axis]",
        "label": "Class of Stock [Axis]",
        "documentation": "Information by the different classes of stock of the entity."
       }
      }
     },
     "auth_ref": [
      "r92",
      "r106",
      "r107",
      "r108",
      "r127",
      "r129",
      "r154",
      "r155",
      "r157",
      "r159",
      "r166",
      "r167",
      "r208",
      "r258",
      "r260",
      "r261",
      "r262",
      "r265",
      "r266",
      "r272",
      "r273",
      "r275",
      "r276",
      "r278",
      "r280",
      "r283",
      "r284",
      "r287",
      "r290",
      "r297",
      "r502",
      "r598",
      "r599",
      "r600",
      "r601",
      "r604",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r627",
      "r647",
      "r665",
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r892",
      "r964",
      "r965",
      "r972"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofStockholdersEquityunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Components [Axis]",
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r47",
      "r50",
      "r51",
      "r93",
      "r94",
      "r95",
      "r118",
      "r119",
      "r120",
      "r135",
      "r136",
      "r137",
      "r139",
      "r146",
      "r148",
      "r150",
      "r165",
      "r209",
      "r210",
      "r242",
      "r270",
      "r298",
      "r356",
      "r373",
      "r374",
      "r381",
      "r382",
      "r383",
      "r385",
      "r449",
      "r450",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r475",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r515",
      "r526",
      "r561",
      "r588",
      "r589",
      "r590",
      "r604",
      "r665"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementLineItems",
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunauditedParenthetical",
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofOperationsunaudited",
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofStockholdersEquityunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Line Items]",
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r135",
      "r136",
      "r137",
      "r165",
      "r272",
      "r273",
      "r275",
      "r278",
      "r515",
      "r536",
      "r597",
      "r605",
      "r616",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r627",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r638",
      "r640",
      "r641",
      "r642",
      "r643",
      "r644",
      "r648",
      "r649",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r665",
      "r701",
      "r703",
      "r798",
      "r1123"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementOfStockholdersEquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementTable",
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunauditedParenthetical",
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofOperationsunaudited",
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofStockholdersEquityunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Table]",
        "label": "Statement [Table]",
        "documentation": "Presentation of information about comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity."
       }
      }
     },
     "auth_ref": [
      "r135",
      "r136",
      "r137",
      "r165",
      "r203",
      "r272",
      "r273",
      "r275",
      "r278",
      "r515",
      "r536",
      "r597",
      "r605",
      "r616",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r627",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r638",
      "r640",
      "r641",
      "r642",
      "r643",
      "r644",
      "r648",
      "r649",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r665",
      "r701",
      "r703",
      "r798",
      "r1123"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Price or TSR Estimation Method",
        "label": "Stock Price or TSR Estimation Method [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r815",
      "r825",
      "r835",
      "r867"
     ]
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockAppreciationRightsSARSMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Appreciation Rights (SARs)",
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period."
       }
      }
     },
     "auth_ref": [
      "r1023",
      "r1024",
      "r1025",
      "r1026",
      "r1027",
      "r1028",
      "r1029",
      "r1030",
      "r1031",
      "r1032",
      "r1033",
      "r1034",
      "r1035",
      "r1036",
      "r1037",
      "r1038",
      "r1039",
      "r1040",
      "r1041",
      "r1042",
      "r1043",
      "r1044",
      "r1045",
      "r1046",
      "r1047",
      "r1048"
     ]
    },
    "us-gaap_StockCompensationPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockCompensationPlanMember",
     "presentation": [
      "http://www.recursion.com/role/NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock based compensation",
        "label": "Share-Based Payment Arrangement [Member]",
        "documentation": "Share-based payment arrangement in which award of equity shares are granted. Arrangement includes, but is not limited to, grantor incurring liability for product and service based on price of its shares."
       }
      }
     },
     "auth_ref": [
      "r974"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
     "presentation": [
      "http://www.recursion.com/role/CommonStockValenceAcquisitionExchangeableSharesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares issued in the period, upon conversion (in shares)",
        "label": "Stock Issued During Period, Shares, Conversion of Convertible Securities",
        "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r30",
      "r47",
      "r50",
      "r74",
      "r269"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofStockholdersEquityunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock sales issuances, net of issuance costs (in shares)",
        "label": "Stock Issued During Period, Shares, New Issues",
        "documentation": "Number of new stock issued during the period."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r46",
      "r47",
      "r74",
      "r598",
      "r665",
      "r676"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofStockholdersEquityunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock option exercises and other (in shares)",
        "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture",
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP)."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r46",
      "r47",
      "r74"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "crdr": "credit",
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofStockholdersEquityunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock sales issuances, net of issuance costs",
        "label": "Stock Issued During Period, Value, New Issues",
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r46",
      "r47",
      "r74",
      "r604",
      "r665",
      "r676",
      "r804"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "crdr": "credit",
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofStockholdersEquityunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock option exercises and other",
        "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture",
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)."
       }
      }
     },
     "auth_ref": [
      "r35",
      "r46",
      "r47",
      "r74"
     ]
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited",
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofStockholdersEquityunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total stockholders\u2019 equity",
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Ending balance",
        "label": "Equity, Attributable to Parent",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r47",
      "r50",
      "r51",
      "r68",
      "r629",
      "r645",
      "r666",
      "r667",
      "r786",
      "r805",
      "r963",
      "r965",
      "r966",
      "r982",
      "r1077",
      "r1124"
     ]
    },
    "us-gaap_StockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockholdersEquityAbstract",
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stockholders\u2019 equity",
        "label": "Equity, Attributable to Parent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "presentation": [
      "http://www.recursion.com/role/CommonStock"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common Stock",
        "label": "Equity [Text Block]",
        "documentation": "The entire disclosure for equity."
       }
      }
     },
     "auth_ref": [
      "r71",
      "r282",
      "r284",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r296",
      "r298",
      "r463",
      "r474",
      "r668",
      "r669",
      "r680"
     ]
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsidiarySaleOfStockAxis",
     "presentation": [
      "http://www.recursion.com/role/CommonStockAtTheMarketOfferingNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of Stock [Axis]",
        "label": "Sale of Stock [Axis]",
        "documentation": "Information by type of sale of the entity's stock."
       }
      }
     },
     "auth_ref": []
    },
    "rxrx_SupplementalAssetInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.recursion.com/20260331",
     "localname": "SupplementalAssetInformationAbstract",
     "presentation": [
      "http://www.recursion.com/role/SegmentInformationScheduleofSegmentNetLossandReconciliationsofSegmentOperatingLosstoLossBeforeIncomeTaxBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Supplemental asset information",
        "label": "Supplemental Asset Information [Abstract]",
        "documentation": "Supplemental Asset Information"
       }
      }
     },
     "auth_ref": []
    },
    "rxrx_SupplementalBalanceSheetAndIncomeStatementInformationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.recursion.com/20260331",
     "localname": "SupplementalBalanceSheetAndIncomeStatementInformationTextBlock",
     "presentation": [
      "http://www.recursion.com/role/SupplementalFinancialInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Supplemental Financial Information",
        "label": "Supplemental Balance Sheet And Income Statement Information [Text Block]",
        "documentation": "Supplemental Balance Sheet And Income Statement Information"
       }
      }
     },
     "auth_ref": []
    },
    "rxrx_SupplementalFinancialInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.recursion.com/20260331",
     "localname": "SupplementalFinancialInformationAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Financial Information [Abstract]",
        "documentation": "Supplemental Financial Information"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tabular List, Table",
        "label": "Tabular List [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r861"
     ]
    },
    "us-gaap_TangibleAssetImpairmentCharges": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TangibleAssetImpairmentCharges",
     "crdr": "debit",
     "calculation": {
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Asset impairment",
        "label": "Tangible Asset Impairment Charges",
        "documentation": "The charge against earnings resulting from the aggregate write down of tangible assets from their carrying value to their fair value."
       }
      }
     },
     "auth_ref": [
      "r37",
      "r69"
     ]
    },
    "us-gaap_TechnologyBasedIntangibleAssetsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TechnologyBasedIntangibleAssetsMember",
     "presentation": [
      "http://www.recursion.com/role/GoodwillandIntangibleAssetsScheduleofIntangibleassetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Definite-lived technology intangible assets",
        "label": "Technology-Based Intangible Assets [Member]",
        "documentation": "Technology-based intangible assets, including, but not limited to, patented technology, unpatented technology, and developed technology rights."
       }
      }
     },
     "auth_ref": [
      "r767",
      "r996",
      "r997",
      "r998",
      "r999",
      "r1001",
      "r1003",
      "r1005",
      "r1006"
     ]
    },
    "rxrx_TempusAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.recursion.com/20260331",
     "localname": "TempusAgreementMember",
     "presentation": [
      "http://www.recursion.com/role/NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tempus agreement",
        "label": "Tempus Agreement [Member]",
        "documentation": "Tempus Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "rxrx_TempusLabsIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.recursion.com/20260331",
     "localname": "TempusLabsIncMember",
     "presentation": [
      "http://www.recursion.com/role/SupplementalFinancialInformationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tempus Labs, Inc",
        "label": "Tempus Labs, Inc [Member]",
        "documentation": "Tempus Labs, Inc"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Shareholder Return Amount",
        "label": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r853"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Shareholder Return Vs Peer Group",
        "label": "Total Shareholder Return Vs Peer Group [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r860"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Arrangement:",
        "label": "Trading Arrangement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r880"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Arrangements, by Individual",
        "label": "Trading Arrangements, by Individual [Table]"
       }
      }
     },
     "auth_ref": [
      "r882"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.recursion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adoption Date",
        "label": "Trading Arrangement Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r883"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Arrangement Duration",
        "label": "Trading Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r884"
     ]
    },
    "ecd_TrdArrExpirationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrExpirationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expiration Date",
        "label": "Trading Arrangement Expiration Date"
       }
      }
     },
     "auth_ref": [
      "r884"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Trading Arrangement, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r882"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title",
        "label": "Trading Arrangement, Individual Title"
       }
      }
     },
     "auth_ref": [
      "r882"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Available",
        "label": "Trading Arrangement, Securities Aggregate Available Amount"
       }
      }
     },
     "auth_ref": [
      "r885"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Termination Date",
        "label": "Trading Arrangement Termination Date"
       }
      }
     },
     "auth_ref": [
      "r883"
     ]
    },
    "us-gaap_TypeOfArrangementAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TypeOfArrangementAxis",
     "presentation": [
      "http://www.recursion.com/role/CollaborativeDevelopmentContractsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r453"
     ]
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underlying Security Market Price Change",
        "label": "Underlying Security Market Price Change, Percent"
       }
      }
     },
     "auth_ref": [
      "r879"
     ]
    },
    "rxrx_ValenceDiscoveryIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.recursion.com/20260331",
     "localname": "ValenceDiscoveryIncMember",
     "presentation": [
      "http://www.recursion.com/role/CommonStockRegistrationRightsAgreementsNarrativeDetails",
      "http://www.recursion.com/role/CommonStockValenceAcquisitionExchangeableSharesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Valence Discovery Inc",
        "label": "Valence Discovery Inc [Member]",
        "documentation": "Valence Discovery Inc"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year",
        "label": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r849"
     ]
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofOperationsunaudited",
      "http://www.recursion.com/role/NetLossPerShareScheduleofComputationofBasicandDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Weighted-average shares (Class A, B and Exchangeable) outstanding, diluted (in shares)",
        "terseLabel": "Weighted average common shares outstanding, diluted (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r153",
      "r159"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "presentation": [
      "http://www.recursion.com/role/NetLossPerShareScheduleofComputationofBasicandDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Denominator:",
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "presentation": [
      "http://www.recursion.com/role/CondensedConsolidatedStatementsofOperationsunaudited",
      "http://www.recursion.com/role/NetLossPerShareScheduleofComputationofBasicandDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Weighted-average shares (Class A, B and Exchangeable) outstanding, basic (in shares)",
        "terseLabel": "Weighted average common shares outstanding, basic (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r152",
      "r159"
     ]
    },
    "ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested",
        "label": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]"
       }
      }
     },
     "auth_ref": [
      "r847"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "SubTopic": "405",
   "Topic": "942",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477787/942-405-45-2"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-20"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482130/360-10-45-5"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(3)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Subparagraph": "(c)",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14A"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-5"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "12",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-3"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-4"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-5"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "30",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-5"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481142/505-10-45-2"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-10"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-4"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-5"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-8"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-1"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-11"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(2)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480418/310-10-S99-2"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-2"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/440/tableOfContent"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/505/tableOfContent"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-6"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-7"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-19"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r85": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2"
  },
  "r86": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "SubTopic": "210",
   "Topic": "954",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477220/954-210-45-5"
  },
  "r87": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r88": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "606",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-13"
  },
  "r89": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r90": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h))",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r91": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "808",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/808/tableOfContent"
  },
  "r92": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r93": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r94": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "9",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-9"
  },
  "r95": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "9",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-9"
  },
  "r96": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-1"
  },
  "r97": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5C",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5C"
  },
  "r98": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r99": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r100": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-5"
  },
  "r101": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r102": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r103": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r104": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r105": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r106": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r107": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r108": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-1"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/260/tableOfContent"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-10"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-16"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-3"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-7"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-3"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-15"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-1"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-1"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-3"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-2"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-9"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/280/tableOfContent"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-15"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26A"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26B"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26C"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "34",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-34"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-42"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481664/323-10-45-1"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482955/340-10-05-5"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483032/340-10-45-1"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480265/350-10-S45-1"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482598/350-20-45-1"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482598/350-20-45-2"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1A"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-2"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-4"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-6"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-1"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-2"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3A"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3A",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3A"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4.d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-1"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481538/470-20-65-4"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(f)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481538/470-20-65-4"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-1"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-2"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-3"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-1"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-2"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-3"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(01)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3A",
   "Subparagraph": "(24)(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-3A"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-16"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-1"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-2"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-3"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-11"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-4"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-7"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-8"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-8"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/718/tableOfContent"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-1D"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-2"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-3"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "17",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480336/718-10-65-17"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479983/718-10-S45-1"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.F)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "720",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483359/720-20-50-1"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482916/730-10-50-1"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483041/730-20-50-1"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/740/tableOfContent"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-4"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-6"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10B"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12B"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12C"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-14"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-17"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-21"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.5.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 11.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-2"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "270",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477891/740-270-50-1"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482603/740-30-50-2"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478758/740-323-25-1"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/805-10/tableOfContent"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-3"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-4"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-5"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-7"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/805-20/tableOfContent"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-2"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-3"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-4"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-4A"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-4A"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-4A"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-5"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-5"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/805-30/tableOfContent"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-2"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-3"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-4"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-4"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-4"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479326/805-40-45-1"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "808",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479402/808-10-50-1"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "808",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479402/808-10-50-1"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "808",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479402/808-10-50-1"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1B"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4F"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8A"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-6"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482736/825-10-45-2"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-10"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-11"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-11"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-30"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-32"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482804/825-20-50-1"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "230",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-17"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/842-20/tableOfContent"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "12A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479165/842-20-35-12A"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-5"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-5"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-5"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-9"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482546/910-10-50-6"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "912",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478345/912-310-45-11"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479941/924-10-S99-1"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483154/926-20-50-5"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "928",
   "SubTopic": "340",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478859/928-340-50-1"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "940",
   "SubTopic": "820",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478119/940-820-50-1"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(14)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478671/942-235-S50-1"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478451/942-360-50-1"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "740",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477617/942-740-50-1"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(1)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column J))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column K))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4E"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-9"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.W.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479583/944-40-S99-1"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "740",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478822/944-740-50-1"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "805",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478072/944-805-50-1"
  },
  "r597": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r598": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r599": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r600": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r601": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r602": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-11"
  },
  "r603": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-13"
  },
  "r604": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r605": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-6"
  },
  "r606": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-2"
  },
  "r607": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-27"
  },
  "r608": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r609": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r610": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r611": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r612": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r613": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r614": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r615": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r616": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4"
  },
  "r617": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r618": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r619": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r620": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r621": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r622": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r623": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r624": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r625": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r626": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r627": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r628": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r629": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r630": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r631": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r632": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r633": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r634": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r635": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r636": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r637": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r638": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r639": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r640": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r641": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r642": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r643": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r644": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r645": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r646": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7"
  },
  "r647": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478297/946-220-50-3"
  },
  "r648": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r649": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r650": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r651": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r652": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r653": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r654": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r655": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r656": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r657": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r658": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r659": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r660": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r661": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r662": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r663": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r664": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r665": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r666": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r667": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r668": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r669": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r670": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r671": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r672": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r673": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r674": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r675": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-1"
  },
  "r676": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r677": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r678": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r679": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r680": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-6"
  },
  "r681": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478322/948-310-S50-2"
  },
  "r682": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column A)(Footnote 3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r683": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r684": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r685": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478522/954-440-50-1"
  },
  "r686": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "976",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477332/976-310-50-1"
  },
  "r687": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "978",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479230/978-310-50-1"
  },
  "r688": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2"
  },
  "r689": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "SubTopic": "10",
   "Topic": "825",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482881/825-10-55-10"
  },
  "r690": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(a)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r691": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "40",
   "SubTopic": "30",
   "Topic": "350",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482640/350-30-55-40"
  },
  "r692": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r693": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r694": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-16"
  },
  "r695": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-21"
  },
  "r696": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-22"
  },
  "r697": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-12"
  },
  "r698": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-11"
  },
  "r699": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-14"
  },
  "r700": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-18"
  },
  "r701": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-21"
  },
  "r702": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-24"
  },
  "r703": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-4"
  },
  "r704": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52"
  },
  "r705": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482836/275-10-55-2"
  },
  "r706": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482836/275-10-55-4"
  },
  "r707": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r708": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r709": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r710": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r711": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r712": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r713": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "48",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-48"
  },
  "r714": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "49",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-49"
  },
  "r715": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r716": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r717": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r718": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481933/310-10-55-12A"
  },
  "r719": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482548/350-20-55-24"
  },
  "r720": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69B"
  },
  "r721": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69C"
  },
  "r722": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "64",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481620/480-10-55-64"
  },
  "r723": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r724": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r725": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r726": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r727": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r728": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r729": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r730": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-17"
  },
  "r731": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-11"
  },
  "r732": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-6"
  },
  "r733": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480547/715-80-55-8"
  },
  "r734": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r735": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "231",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-231"
  },
  "r736": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-8"
  },
  "r737": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-29"
  },
  "r738": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-29"
  },
  "r739": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "38",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-38"
  },
  "r740": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "39",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-39"
  },
  "r741": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-41"
  },
  "r742": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "43",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-43"
  },
  "r743": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "45",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-45"
  },
  "r744": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "46",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-46"
  },
  "r745": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-47"
  },
  "r746": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-14"
  },
  "r747": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-14"
  },
  "r748": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-14"
  },
  "r749": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-14"
  },
  "r750": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-14"
  },
  "r751": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-20"
  },
  "r752": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-20"
  },
  "r753": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-20"
  },
  "r754": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-20"
  },
  "r755": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-29"
  },
  "r756": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-29"
  },
  "r757": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31"
  },
  "r758": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "31",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31"
  },
  "r759": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "31",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31"
  },
  "r760": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "31",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31"
  },
  "r761": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "31",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31"
  },
  "r762": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "31",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31"
  },
  "r763": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "31",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31"
  },
  "r764": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "31",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31"
  },
  "r765": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "31",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31"
  },
  "r766": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "31",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31"
  },
  "r767": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "38",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-38"
  },
  "r768": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "38",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-38"
  },
  "r769": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "38",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-38"
  },
  "r770": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "38",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-38"
  },
  "r771": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "38",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-38"
  },
  "r772": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "38",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-38"
  },
  "r773": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479908/805-50-55-1"
  },
  "r774": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "740",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478064/805-740-55-13"
  },
  "r775": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A"
  },
  "r776": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "182",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480401/815-10-55-182"
  },
  "r777": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "184",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480401/815-10-55-184"
  },
  "r778": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r779": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r780": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "102",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-102"
  },
  "r781": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "103",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-103"
  },
  "r782": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r783": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r784": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r785": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482881/825-10-55-12"
  },
  "r786": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481372/852-10-55-10"
  },
  "r787": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479401/944-30-55-2"
  },
  "r788": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-29F"
  },
  "r789": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r790": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r791": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9E"
  },
  "r792": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "605",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477548/944-605-55-11"
  },
  "r793": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "605",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477548/944-605-55-14"
  },
  "r794": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480078/944-80-55-18"
  },
  "r795": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r796": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r797": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1"
  },
  "r798": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r799": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r800": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r801": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r802": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r803": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10"
  },
  "r804": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-11"
  },
  "r805": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12"
  },
  "r806": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r807": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r808": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r809": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r810": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r811": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r812": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r813": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r814": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r815": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r816": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r817": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r818": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r819": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r820": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r821": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r822": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r823": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r824": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r825": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r826": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r827": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r828": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r829": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r830": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r831": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r832": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r833": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r834": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r835": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r836": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r837": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r838": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r839": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r840": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r841": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r842": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r843": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r844": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r845": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r846": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r847": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "i"
  },
  "r848": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r849": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iii"
  },
  "r850": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iv"
  },
  "r851": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "v"
  },
  "r852": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "vi"
  },
  "r853": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r854": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r855": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r856": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r857": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r858": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r859": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r860": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r861": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r862": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r863": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r864": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r865": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r866": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r867": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r868": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r869": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r870": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r871": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r872": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r873": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r874": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r875": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r876": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r877": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r878": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r879": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r880": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r881": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r882": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r883": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r884": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r885": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r886": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r887": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Number": "229",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1"
  },
  "r888": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "A",
   "Number": "229"
  },
  "r889": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Number": "229"
  },
  "r890": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "i",
   "Number": "229"
  },
  "r891": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r892": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-3"
  },
  "r893": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-10"
  },
  "r894": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-2"
  },
  "r895": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-2"
  },
  "r896": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-2"
  },
  "r897": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "SubTopic": "40",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r898": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r899": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r900": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r901": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r902": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r903": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r904": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r905": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r906": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r907": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r908": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-10"
  },
  "r909": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-12"
  },
  "r910": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r911": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r912": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r913": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r914": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r915": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r916": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r917": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r918": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r919": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r920": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r921": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r922": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r923": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r924": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r925": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r926": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(k)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r927": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r928": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(m)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r929": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r930": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r931": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r932": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r933": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r934": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r935": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r936": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r937": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r938": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(k)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r939": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r940": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(m)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r941": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r942": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(o)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r943": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(p)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r944": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(q)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r945": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(r)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r946": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(s)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r947": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(t)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r948": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(u)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r949": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-30"
  },
  "r950": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-31"
  },
  "r951": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-32"
  },
  "r952": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "33",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-33"
  },
  "r953": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r954": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r955": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r956": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r957": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r958": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r959": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r960": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r961": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-1"
  },
  "r962": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r963": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-1"
  },
  "r964": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r965": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r966": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r967": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r968": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r969": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r970": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r971": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r972": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "55",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-55"
  },
  "r973": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r974": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r975": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r976": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-18"
  },
  "r977": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r978": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r979": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r980": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r981": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r982": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r983": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/350-20/tableOfContent"
  },
  "r984": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r985": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r986": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r987": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r988": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r989": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r990": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r991": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r992": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r993": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1A"
  },
  "r994": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-2"
  },
  "r995": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/350-30/tableOfContent"
  },
  "r996": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-1"
  },
  "r997": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r998": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r999": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r1000": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r1001": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r1002": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1003": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1004": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1005": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1006": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1007": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3"
  },
  "r1008": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/405-30/tableOfContent"
  },
  "r1009": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r1010": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r1011": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r1012": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "410",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481931/410-30-50-10"
  },
  "r1013": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/450/tableOfContent"
  },
  "r1014": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r1015": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r1016": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r1017": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r1018": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r1019": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r1020": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r1021": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1022": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r1023": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1024": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1025": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1026": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1027": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1028": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1029": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1030": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1031": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1032": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1033": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1034": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1035": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1036": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1037": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1038": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1039": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1040": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1041": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1042": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1043": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1044": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1045": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1046": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1047": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1048": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1049": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1050": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1051": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "730",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483041/730-20-50-1"
  },
  "r1052": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A"
  },
  "r1053": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A"
  },
  "r1054": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A"
  },
  "r1055": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A"
  },
  "r1056": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r1057": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r1058": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-3"
  },
  "r1059": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r1060": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r1061": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-4"
  },
  "r1062": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "15",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480123/805-50-15-3"
  },
  "r1063": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480060/805-50-25-1"
  },
  "r1064": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480027/805-50-30-1"
  },
  "r1065": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480027/805-50-30-2"
  },
  "r1066": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-7A"
  },
  "r1067": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8"
  },
  "r1068": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8"
  },
  "r1069": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8"
  },
  "r1070": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r1071": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r1072": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1073": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1074": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1075": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-11"
  },
  "r1076": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-13"
  },
  "r1077": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r1078": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-4"
  },
  "r1079": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3"
  },
  "r1080": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3"
  },
  "r1081": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r1082": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r1083": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r1084": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1085": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1086": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1087": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1088": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1089": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1090": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "912",
   "SubTopic": "730",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479532/912-730-25-1"
  },
  "r1091": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479432/944-30-50-2B"
  },
  "r1092": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r1093": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r1094": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r1095": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4C"
  },
  "r1096": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4D"
  },
  "r1097": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4G",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4G"
  },
  "r1098": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1099": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1100": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1101": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1102": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1103": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1104": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1105": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1106": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1107": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1108": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1109": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1110": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1111": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1112": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1113": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1114": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1115": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1116": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1117": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1118": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1119": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1120": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1121": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r1122": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r1123": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3"
  },
  "r1124": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r1125": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>77
<FILENAME>0001601830-26-000078-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001601830-26-000078-xbrl.zip
M4$L#!!0    ( ! TIER3"1>!00<  !L=   4    97AH:6)I=#,Q,2UQ,#$R
M-BYH=&W=6=MRVS@2?=^OP-JU&;N*DB7;\DBRDZILDJU*;>UN)C-5\S@%$DT1
M:Y#@ *!DS=?O:9"ZV)(3>2X9;_P@B\*M+Z=/=Q,W12C-JYN"I'KUEYN_]GKB
MK<V:DJH@,D<RD!*-U]5,_*C(WXI>KYOUQM9+IV=%$.>#\ROQHW6W>B[;\:"#
MH5>K?6[.VN>;LWC(36K5\M6-TG.AU<LC?3&9I(K49'(Y&%^.QN-TE&=7Z=4H
MHXD\'XV'/PV/L!33VS4^+ V]/"IUU2N(SY]>7=3A>J%5**;#P>!O1_?F!;H+
M/6GTK)I&:3&:VRI "H==VZ\[FS^R:#6<66/=]'@0_ZYYI)?+4IOE])O73DOS
M3>)EY7N>G,[;8:]_(0@'.>/CHA7\6ZPVNJ*5(L-SEO[=7:%3'<3%L#^\+^&G
MY,Q@:')?5- WY(+.=2:#MI6PN?C@=)7I6AKQ[HZR)N@YB?_DF$'N$%/_"2I\
M:)QO)$X+5GQL#'DQO)"]X>6)/!6R4F(X4MT3U L%B>^AE]-!8^:[NZR0U8S$
MZRSP\'!R<9D(Z84$Z 'H'94_A;P_1NG+O4J_3\2_Y7]E$/^$_(G(HAN74$^&
M%\>C\?6S%7S8%^*]*"1@Y6BN:0%N"H7VXKM&.D#'+,5'JJV#.RKQ#^M*,1ST
MOF/??&2W>8;IAT*Z4F8$=&;2^$2\K[(^U)X\7[7/^^+OTD-7B%\NQ6UE%X;4
MC))6>=>JK"PP65FP-C:4N@)^EZ*I@FL(8H+'(Z7#%E*4>&*Q1"X9ND[84L<0
MB/-V)E24D??2+7E**6\I1L)Z3X_?%(3!D2;F@RY4,NW _YA683DD4>3$HM!9
M(7S#'YOU"W+4;<(*E-H;) K..0L="BCH:\JB@+QO#=&L@IIS+%,B76Z;X7E[
M\N(3GB21ZPJV8K-O;)-$&K(8=EOCNLJ![I9W0;FF =VP_;<,D<!WFB.BAOG8
M\XP(8S:N[:SJ'QP-]"C-&R<\HS&8 ']:&#T>YZ,\F?2%R(U=^)6S'<VT#XZI
M5/*/K=R0,MGRF5\)LR/M\W;;95_\<$_'%\?C\^&WU[YS3,>@#%C;IKNH_7LA
M'44[PVXZ-<3V$ 3GID;[@J?SM!+!R@'+STK[S%C?8!V'L;.F-7CM;$8*/WMQ
M OLJ@L-:(][+0ELI;'1"6RF,G]I'S3FV:AW-^PL.HRW_M_Y@60X^*+]W4(Z#
M6,^'J, ,9NZG9YB5CVNIF!-ZAO(PO;BJ_ZBJ;#\&N 9X2QYU"LP1">SSODJ8
M6S/9^,.7,,FE!+MW)[6T:1N'#1!$<^UC:&(657$?SMJ;H-XF!D=&1D=VO+EQ
M1M*1!@]J!#AD\=9H%8M]WZ1>*RV=9@5TR^Z1JBK>J?',N!'W/M)S#&3K"0*%
M6!@EHD8VUEEC)/,/U(I";)@;*]H\L)V^\"TEG@B*P'I2^RGA<V!XUA!*'T+H
MX&#<0=+A87PPH #"N5:,$^EM)9FOI ?&.'\S>*13*T<"6EJFVNBPY 2P[UB&
M=?1Y=.>Z1=B7XUI:O.L4JAM7 TX^)JPLLTY% 6(E,*,*><@ 51BAFN'*4U#E
MM,B)[0>8Z2O$3G8JWLVE:6*,LF$ISY&^T6)5*,YVT_ Z11W .>WC_LP<H8*%
MX O?YO_4-N%Q"0YA1;F>35S<Y)\OZT2Z*ILB^JFU!.2)GN8#OBYO*S!%:\A=
MAW!=WZ7B.++7ZT_@!TX@-D-_Q&;?8NL]NY;6!_S.C3KV\FB@Q,]MZR5.'EF2
M S^(W >S.\%11U)L2;A;J9JU7*>M5(7TZ]3&,1_Q1BJ28;1'1U1+-!ZW9+K^
MY,'\Y#>;Z'&,/9<"=?1K"]382ZL5TI)-F''4;WM[$W'LKR?DK9WB8RV:1 $2
MK//K5!%_P)8ENM% ] E.2RV2$8\K#?GB)B? !"C$,T7A/Y=!*R#3SXV&^!&T
M397%-N;T_[D.?8T^CM-Y?/F&@[E*SS3!]AV9K^O!!<E;9N<VG49^CH5 ;/I7
M/=V3/-J5;FUGLR?^I,)"3^OP>]3[7?F )7 ALGS2I@B/_.";LD3]^0M%93K:
MV]O]?J7TCT+Q-5@^=PB)!!:G&,7P67P]TCDW:4E25W-KYL1,6<E9]Y;'=8%/
M96WLDC"Z*&P;[?(>=.#JWR6-])_(C2'6EYTU4[B?7 ]&-;+V-%U]N08SU48N
MI[J*1HJ+K@&-F:YZJ0W!EM,1+#IG>D-ZZ=XCQU?*[7!W+7 U[H_&$[X9") F
MJ-7!W:5!/UX:G 6U.S89]R>#QX<'_>%Z["SNW>X/#7PMJY='%T</(#4]K^_$
M$$)OO?AFE#U4HM1*&?I2L(LJOCB^A,_CY]8+XK7S#M"Q<V2P-2P#SXC85HJ5
MP,_?!-OOQ=\4FO+=FPQQ4J^O.6@]V*75TZ=8Z]>:X\L5%]$F;\$W,5N*?\GE
MB^/AU>#Z*HF7?@]NI]8JG\5 ?6):W;[,0P,8WT%.VW<8<WKT>J]C@<%FB4P!
MNB;L+GE4B'N?[>7D6;P4_1]02P,$%     @ $#2F7"IU/[P[!P  %QT  !0
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M;F^5MJ$US@V7U)?_H_>YKD/%6Q>Z1.76;M?E41#WGNUM=!QNP7\ 4$L#!!0
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M6E.*,TL48SHSL$4$YY2''6+\&5H>5TEQVL,\XH*ZR^.''.:"'2$"Z'MGF^6
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M\%-K_X+I+@S\ !8 VB\O,%JY,95[=3>^'^;'$AB@+5V1VUI7;J^)7!Q?)A4
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M8+*3N$G<7*G<MZ_J3)K2QMHT;1U+^*WJM%TK- E.$YQV"NJLN:6S?0G\A=4
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M#=DN'09@%CX&"XUM^K?+R_N/*?C-H8YA.[!LX VFP?VB./+'<[.#F-R1<_X
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MB3VT0QAKYGMCWY@FW0BPOP2A!<&>3N8S;S;Q@AG,S0C@[==_?WAXA4T&DAZ
M033$SG:AS9MM.(X\Q9%A^Z(]BVR'[(/4$:TD8I*O<B_>1U@;R'?&^V(@@P;A
MJU*WY6B,3047[['H=HE*5\A+Z[-T"B<W,WS>+D\V:K20,(#:07&033\:REU
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M6//8.Q(WQN6CI9P80.AVL*_[<&5.U7'"E')VQV-VFSO(YLWI1-N4NAL9IKS
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MB+:V;HX[00.KBL^"&3,1P->9-Y25!V2[> <IRTC!\)S>?/.-!8Q&Q<'>,1C
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M^ LY@F+3 ZAS$ZTC%&68OL.4'-=[@TU!_HI8$**>'41P>X"A&Z8=SHGLXR7
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MN'BGIO--1M('-@3AYL]10F@Y1A%W@(#0@+,QTC*(Y!*H_]BKRH/G$^5)@07
M?U_C6*!C1T$(7W_"IU]Q[A9_^)7__O'3O:I\^G3/'W%@)%BT]0I=GL); I-K
M92<7$-N$2=%Q"GU+/@KB'?B3@W3CHG6.I 4<#]X9<>W 8@[J0CAG&_3/<>0
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M#=QTRD&/ I[QQ8^96T.2,$4HH)UB^>3)9U;Z<>X5B7T%*1(@:^RGB M3NF-
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M6\8]+7 ]\4KRJ'?V9,]*X&1,GV_X14I1/*V<6;F2HFE(W]ET%J44MI<G(+^
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MSY<#*DI1U=+$9<WE<+[V#0DAHI>VJG&\HNPR95.NTBF/IGVE;V%[6_O]_<\
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M?N+C!_//YI!<,0XB'XG+BZ5ATM@4:/TX-@=")I^.&!GFEW. 0T.( K!)R #
M3"QZ&;I^Q()RIFR3E/&]N>%P&#S$7D8/&V;@3^"VW" <E,-N+)@*CR!,;>LF
M9 Q1"Y/9<H GD$U8=#HU@$ZB:?$\XW[)MZEW==OI=-;=)@XQY*3P8./-#8KC
M[7>SY1/]W18P2!: Y<:-Y19)RG!Q^FF\6AZ\0Y E0@])%G0APN/.-#&-_=3R
M(YT]'2 $%H$ $O*%0?B?%)\+J=X[7*V<I2[L_R:0H,4T-<$C'Y*A$M!HJ;&E
M8*2+^@@&5[>T\&4Z3'.;--+J I]=4+& +_W)$+Y8<.55HZ '@K0G_KW0K5:
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MP/=<!8HMP5:BZH$2.VBN2N@]S&G@5X5.Y=>:^E\V]7?*H?Y4VBBFC-Y8'MF
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M$+_UX[?'S%L137N8&=]PW8@ZXTWM4+1P(=Q3&(I35ZNO2SSDI=?=>Q:C=JQ
M4T2]^(X AG(,A*3%S&%0BY[L@,850)KX;)CN-^\]N\P/)O9,,2>H?0>RZ^+2
M%S1_FBKO*1$S?]C=-'XWL<HP].UA%"(;1I!^(#)<>A3:#M?@:.&HK'DPP@CX
M*C!H].+BTU0DP)DK@52+BA,5FVDOSHHV +@T+T&9IS=.53P3:QV4YPGCBT\>
M3FT ^<)B4&M?F8&5"$H$&I4SZAU!?32HMT[2%;C3_)M0/17? \Y),@[8R0WJ
M:;(#TK;]-$1_']R6S,$'863AMT]),RC1T K>Y47CB?(/ [;1G^<T)UGH)6G
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M'0R6546IB\B7*\R6Q3"48*UYW$?;K3IVQXD(#KD\#?WJMMG0M^!^A0%*JEB
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M5E%HBQ@Q-T'(#);C+3U]&7.BIR_#6^!H"@VG?&8&#C;E>")E@V7RE^=,Z00
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MBJP+E2MUBEMV,KZ0U6X/+E"X3O&L]Z6F@A=1U2WU9'LK4756E=FG'^!R<^3
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MVM@9!$NK1KXWE:5:GKM7]':/M,@+8:58WP/_6KQ17V4EW$?7]*8,][WP+4+
M"[VO=II5S0W<6>=\<62SQ'\/2#8(VS#0U%9W[[2G@Y/-16NE"#.=%,3:=*#*
M-5;XO5*QV*]65(LJJE\\U\M>D%V=63Q*,]C;;7].&NH)3O_Z,%RR-#IH-X%7
M:JJ>DUBS5!5X:!JX4)<F/Q^J/A\REXWLW?C>"_-CKB!\OIG?C9^"WM_R'2U,
M]MK5;5OM-O=VY=<>RX,9Z$4I8/F0,6#3*4L'/(GS\0SJ<?,K;SB6=9"'=K.E
M-'DQ]8;%UGOFMWQ;/O^%A;L;@&T,2&D]M;,_?R]Z#XNQA?H:O-!KL+6>O]<U
M:!,RA-K>/SGKL->@E-+:95?-(K[FOE6;%1GZ[%U&*VIUH]G,8:@N(#98$+ P
MC?>U4[7NPL)/7BV=A7^MJD*7S]^X0D?%TY8=1CX+D!LI.&F*H2 .GN.YXQO'
M?F(6/\ ]&YB\,$26+59]@79^;ACV?4)F=X+ OGO8%ND3$M<=T5:>P.N P"O-
MX"MR6P\/@7Y^EV$OV)7SNPP'RTG8[C(45 TQ/T$=],[BKM3HY8=&+^^7@5[>
MUVOT\@M!+S^XQD]DA^E5BMY0/A-H-+*Z&$06JY(B0O2E)/ [!&0.[  7\2$&
M98;E<'9(O_DF\);A)U^7,GMR%J4Q_$_IBUH%)+SGEO:VNLC*FO4>B'>L@NHM
M[>TT3A[ ^C9HQ3:BEEM98C)2Q(3 V@G*MQD3%'R58* _3 R0K2:+2#P%JO+1
M-1O*=?P#-8W/K2K/3%4B&-U7O,CG,-/XO9_0)WR>RCY#Z'(;\;RG9/SZ<R68
M>)%C*4-\R$"0:IS9GQ*\&Z&W:<3()6QKL+;P)F LA/Z5H((G5^4QA ^FA-A,
M6V":?+:X1R[U#C=F,V;X/$]#H9NIJ0K>1[WY)F\<^DI[$R]O$9Y<3BT#4YYL
M=;!Y0O#Q5<(:_JL\IG"5P)@3A#F#H5P$;^?9GPA>_P&T*45KWOQ.1B[^9 Z[
M(Q"!WS&338?,1U!@!:%7E6O\!?TK,](K<;0) :K*S$ M)W(,GR#1$T!S.E8@
MDADS"50>B604H=:7(9UX%4A@.:2K*L,H@%L1! K!JK/QG'9BYL UX]#NPS_A
M%:# T(#3>(=IJ>*-R6M4N5ED[S\;OG7C>-X/ O]/SI#C_[M/GO,$T[6#'_Q5
M0+*@U!FVB_CMV$( AC%]>\CP*Y!EM+.(/(_#75%/BKNA%X6X__2J3^)5"=U=
M*1)V_O]%L)4,MW'YW/Y?0_D?+Y(7R6=/-LAB?)D5-ZS(F\$WF+GR 31ASY<O
MRCM7 1U/1Q1$PX#]%>'^+4XHR,Q(38':;YZ_RKTK:=Z%70JF^$-$LQOQ2?*-
M-VF5IA$%C.8D>A%(L@%BLNS1"!8+I,:0Z<([*04VG'CP"(QGF_:,;BA?<\#6
M''9#^1=#_P[HWG!5@9P<T9(87X1;C;/PE5D$7YCP)M"7L74QO&;.OQ8_Q;_7
MD!2J\T Y<DZ;-RQR'49M$_Z*;.Q:,)PKCO%\('G<WRB>\M6#PTCH72=1$9G]
MT05F1.0<MYX(Y-U%8<"I_!E)R/60I\2$G.* 2=>*3)L(SDCM^ W(',>9SQ1N
MT"%+?69#L-B8<CT)PUGP^M=?;;_A2S'? !'UZRM5>7Q_#Z^%58P#E1HA!)+$
M\6^B>B1>N&\,IPHJ@\,7!J.;1B N$-Y5?M/,"2R+.<0?GYF#SF^PGFE-4V;9
M!CT[=+PQW614$R*L:(5IDL@@)A0:/]C$<RPF]I ZG/"I&,10\5>FU%#H$5'S
ME=XWN-,,9O>16KF \1K8:#C0YN. &6G%\ =T!5?,U90ZC,7@1ELX]V'JX%*#
M4>\6L&<\GZ'V!%(6GO5!*B7'QE6LY!6"1FPTE>$7+&;'8HV2%0FNOV+F^%5F
M]LE1Q,MP;!K><S?03"/=ORC#O%2%5 CDTW#%AM@JQB2P7/C0]Z+QA!^(I#W8
M>J!Y8/VH*0#3YRTRQ*>80RMZN^#0H:=RUN@30SRT[7$9O&Y;=T;GZD1V\=<G
MO)OL^?C&ZX$$PX41T&DZ<9$I:PHT U@$\L?OS)R\M;V8ZY% ,)2I'4@E"[U'
M%E.&MH>MDH@M@JYKD@H(VJ3O@;Z.$3LNE"8&_&E83]@1R4(6!$P%C&EX RB?
M7(<$W<R6W(?YV' )!AG[QI0S36%S@-Q!]N4"DY[8,Q0FSTSH9)R-PF\X$[/\
M:$Q:+H'0T!@IE!,T6PAKBPN 9#?B,A'E<1Z@M7K]]5&:6_(9G-F3C98+V&TW
MH7<#_Z,J=Q]O7-YMRC1F<;=0SJ#I7$DS=F$ZCM@V@EZ!<8Q <FR:##\+-5X,
M3F8*"K<]]2PC\RP8O\9)J8BWW.+F(:Q?GD8P!3I0IIX#VXKMD^8N:B2VZ,H$
M/V0NN@ZMF.S21\-;C0EO1MR-B^P\'X4^9K1PL0\DX08.;T<VG3GLIQ*8-NE&
M*,%(])IHL?(S  D*A$6N!TU_ X8.'*\/5BT+Z7_)6Q#RB$;R([0W8'UD.#Q/
M/)K"LT%]OQJ'9FH%W6/;BI_^ <5/01;X+U M@5]\?<8#?;!G#'^B_#%#I\YR
M%\-U,0U["C:>;W)LEAMLS--LM;3_'6N-/V?C*\5PPO^^8H;OHG+]OS/YIFOM
M%?\^&Y9I-7NSG[OT[^KTV[.?/!9FWV@48EJ<?';4%F4B;1$PVO&QEQ)G&JR.
M,]4AH\L(&:W,HCJLYOK!>((EXZ0?C1$+N2+Q\+OR#D0OB8=O[^]O-+W=4:Z_
MO?W<&KQZO4_WU4V+/-#]>0"68 /A4XP@6>:,QR?0@\: \2G7#[^_(IV#JS)R
MY2HI="$I<.@X\0.LS+\Q'2,(%-H4D-J@R*!75"IDJ 4F&AFZ;<E]LMSU,='3
M)C!A!R>M,/)QQ[H#Z8GH+>&>3:YA&3/XV# GI"< \V2D1IFH@/K*4^2@WA+K
M:##2#ZY2@+WKV**'*JB<."K.\]V7._S*L/V54K_*YQO3:*R"TP&F-<E842;=
M/M&38<<L"K*@(T3KBQ:&*OPO=:N%I87/-O:>#4BC4HQ .$:L"/8/Z @&!;ZK
MPJ#P*&_(FGO0_#3H_3:B.MBCN3A*?GR!(!A4_Q9-!JEI2B\<-MU-F0(IA5.2
M4\6/,9\7O2>Z3RX@;K3GCCU<\L,$7>':K[KR[N[OGS[>P50CBR)^SP4Y4B(N
M*;OF!A.^7K>ZLT7,C7ZLA)R8NBEBV'V39].?9$9O,CNGM1N4;Q[?P6?AC@7#
MT6&<0 W31_20@#D8H^,93F$T1;?RM?O?6O=5?4C'.:0OP/R\@-V@-"0^%7H_
MP88D(7'][M/WX!5W90P9<Q5OB+YN+C>00ZJQAWQJ_+2G$5S0^(1Q5'B4.UOG
M+.0C@"Z*79SKTSW.Z7ZGH_G3\U'.@ [Z_=O=>[R+(,E^0_5$T="CKJ-P"T(*
MB( 6\-O'&Y^WS%&P9UTH'L#T@Q!CF^3[<#%$:G ">/($[=3'>IQC?5A04^,\
MG$3E8-@O'MU!E.RI\DMN,<Q_%:W;>.A>,&+V9#@1';ET_M1G>=RSM.8NO,BD
M<H\@X('[U'$*G5!A[E@DF=0'=)P#>H>"C*&7E!M)F"8E5%"R'$+F3]&UQC/3
M>.X9YC9Q_53G@A --3A+"K8:LSG>/Y@FCV].*,&E;$?8$A5@ 2"9];'/BQ+-
M84,=8Q:PU_(?;\ R J-A_MIV:8/HH9U\@ZU&I]E')Y(H\!(O%OZE!I# K\N?
MM_N-03/_JV9#R_U\CZ%RZ\^Z:^K/FGK7,IG,TN>$DLW1%U_YG*QRORNC,?JZ
MD@QQ5TJTQL@9^!VTMQ!9SXUHJ:?<63 K(._WJ"<HUZA>9+%N-M7W;=S&-5NU
MJ0CQ].=0/I>B<WB0\9E%6VFG?O76$/^S!47O#YUQT+W*I]EXKWA UYV3#KQ3
M#6QVH\Z:KO+W2FLJUUV]T?G;\>YP!O6TM9F"IK9E.>RHMTT82C?Z-D1S ;21
MOPL#Y;K3;;1JTE@FC=:+)@P->$9#WXDN\FL<7P;1M&\ZVY/-VHVZ0)H".=0$
MG3Z'IK*UJWM5IAXS#Q%CO[8;@<;\V4,%.IK&D=1VOP]7Z//[W[5?]?U"J8>/
MJ-%<,7O.50S'\3"=R#85/G?%=B?VT,:,WB%#XSB)=%(U#,Z$DLLMYGI3(_0B
MS&5SYIAQ$2C7'^X>7F%8%?.K0I%59[$1)?Z"04IE#Y9O@YV!F6]W#_>$A-90
MWAH!SRF.4]5LL*MAV@%/B?I\]_ [^K0FS\8<+' KDE:\BX/<X"LP@PJN""6_
M!6IR*#[V[PAX895POV#D(A5FA:N$ 5->AR+*8!PJO))9@I3LQV<O@[:82W"L
M^-3)_#<G\:.1NX5G\#S1?GNC&_@_TW--!DPP2;W#>"+&"2DSD_+57:7=^AN<
MN!69DCR(.)5A!(S4Q3RY?S'V V0*QG71C2K\/QUX3'ZI=U+UDD RTEQ6* 5'
MY29(N_DWI(HXQRX;)1:)I+P#B:L\SNPQ<Z:TKQ13#J*9:*M %4V9F#!%BR.>
MN@&CC&R'0MAPLW)BOS5-;4%3(@$&XY<8_<#Z!3@7.L8LTZ.0"'V.@11@7<)H
MH%B_]D;G@1=5?-R2<15,,.@T^AF"4+$2C/\.GNXW.V_:\FD\8!ZCH8)'60('
M3 =K)4)DS*;+;.2"O_I&,!'%=:;/B$G>/_R^JJRA"O(E3DC&H"'<5$'5'][=
MI9S>Q'51+4&6GT["\=G8YK?(<ZDH%G,!>.Z$*FU_):(\2X)>,I,2/25@6/,)
M[W5&>!*82]E0WL<>6HR;_?'P_M-7RM3@)9S)_86)68K6_S_XI;B=,+$AR C*
M_DDEEL1%I'A03N!)-_)^F1F'55P^8&Z3(IPH"KK":==(1G9:8!1^>GRG):*_
M\@H,S!GO$2;(R+QJ5<FN(95W%8C$JX5\JT6^FYMXQ9!U\_ <Z2U48R72L;#"
M2;F;^;:CBKIYW&5!4L1N++G3^/7[+Y_^Y[>_?Y<9+XD@XU2.DTIG4*3+8WE>
MNHFU<$Z4I(-=/]Y_NG]596X@"0PW@]JHT55,Y\+S"@NL38.]I?*Z*<.J,SN8
M\OH)C*O 6D48%!Z:1"A)\9K?./:(I32X1%8GB1"H4#*'A3(C8IZD/_!J0:KT
MR](.[#WE77'Y'',GU&6S-"/EL\R#22? X.0G#%5DRE53IL3PL#:3!06/[(5E
M1>O-.BOZTK.B#TM!WPG8('U55>7^R^/-#%FYCW !^:FBQ+,9EG_YG&^34/AI
M8Y$NW'Z]*=)(X[*GY730I)I*I'PFB<!9&R$7(R3))?6-F6W!.Y-:H16FL3<+
M@=?].UV4%"^H**,YYAE]$#@B6*XLD6?B\CHU*:(3*&;$YV,);E""M0LRI,IJ
MUWNIH48S4/BI' ZD11!Z6-LE9,8R!3U3<=&-1\5%LN3G=<%EUH;AEJFM6<?=
MEA9V3Z_ 1@YZ3?WT&]FFG)1O;(PN.<^?YUEG^M_U;KVQ.VVL!+@$KB[LAN&O
M^H(/++W5VM_U7LT,=F4&F7HH97GO>198*HML:?^1U&LWW<X'T.NUX  >/K9^
MAVO8[KQ1_JXUV[UO'#2.3JBI*]?OOSP\:'! '[^\NXD--;2B,=U=N&/>T-G<
MB&##V/O5]6[&5/[/;5 .8T>'*KQ4^&E]E*4=95?K*=?W[W[OP4'Q B"YWT&F
M(!$THZ'MKKA.-3O;YPA:G2[<IL]WG[YK&PXAG=1:'T*Y"F;L8-WG#/2\,ZB,
MH7-'Y9GD;N,@)SS<RRLSA>,>_ZW\TFDVT0AR1'0NMH<X.N)LY'N(<6+,!1*F
M.;%9JE)IQXAK$> %/1=X04"WK )>T/OZCL +O6X"O*!G@!<J<[B?F8&[,(J<
M=79LSL$7M5E/$Z>2_H6 .Y*ISCBUFM@/05@L#N-EP0*X)<:G#7WFCM$Q)!P9
M*5R>QVIX*%8!#690;29LBN$WN+*/ANN-; $9*]?R)RA688YG)LZ)H& ZXE>N
M\*]QEY@1H]%B7,9FO@!O2A$5,0O<2!>NC*+I<?EV$A.)IQ%'$XRQ8;M8 #<Q
M' ?.@Z8C:K"!U]B($\CS.0@QSS7IC_,Y'I&-HJ9.A(L(@8,H3H-.*>4YY!#&
MPF5(]==89N[@QMQPU*"I,2/*E>DNB0L4QOWF 5G0COW&7.2>YH0['I.HK2AJ
M>C((UACGM?DH">.0WJS&,QY&MA-B8E *23KO]82GQ/-QL,:1/:%'%\-]-R;W
M0_,5\>'PUN+\.$)2FH(,Y0N+?)RM,5,$(I2$&# XCBUY)C78READ<8POF.S4
M<",$G8W(5?SPB%E(/K7Z<6E4@P?L!)RS\MD&/CEV;"/O;0DH@0;R<5CD95,Y
MKGA=(V6V.@2^3=O%M6R)]#F;8/:6;0:D:. R243G['6"9^%[,]]FQ.Z(LDS?
MGH7)( 1G"1MN<<BO&X[Y1>>0#O<!P3JXV(1XEK$21)Y7@)3 \[D,F4N&@!>X
M"-P_90;2-?*'1MQN"3< @:3Y^L+Y+ >,:=],PSI$1R$ZK0[1U2&Z?;3*M(:D
M</N!!:^5=\#59-A>!+N 04CD=5[)PRTB>SH#AE@%V;TBYR9RJ#V ^2.-,/@@
MUO7ZV ;JU2T)W V D8H=JW6R,M8769BH;&74NN$\@_1X]U&: DN8CW-U*?F#
MI\&A2G"38#'FPBH*2,/8SR?Q#TEFLI%(_.7CT6>28C $NQY+,P4FQ/%[N):D
MRG_@9Q*B1[Y 0$.B_L,3?2H18LTG06H2($V2.S]4OB\([L\>J'K!*6CQ+>EF
M!(%-Z)9 ="YBR.0 ::44C[3$3ZB+*R\R[RIUGB,;:8STBU@!IE.4 )NJP'P2
M5,RS!#D(^92V1IDP9Z8,?=L:\]+P6*F&WXY!D8/I/R,BRK, 9 \8D_E>CC'D
M*.<)B"?9(4)SK;/'#P"4\O,!*$3% GY&%L6(&4)G=I4O]$_EK>W%X*S F A%
M.$XR!TIS37OFB//G.*H\\XSX8>;^4',2D$O<=9#11H5U0V,@R#GG<0XL#RAF
MCFFJ:(/!<%PG1P4Z:]O&K\R\(X)_ +&AH>VPFV4E6!74GO*IBX3C'Z[W["YH
MS+ G+F@IE%9(RO(BJ\VR6&4RGWD<#U=)\6RRX\$,]6W1JA;V$)%J['\+C!G\
M@6/,9<[+"$4X?Y2*9^2%_Z] ^:?M4Y^.>YA10XG_7WT7=KL+'S[S=@QH'A!&
M,&[_Q_M/WY1_>?Z/8.+->,.0^#RX.*!C>>2 Q.)^+!I\J3/D-)XV\20K1_Z7
M);A</HT?"HZ9]9I]]WG# $H1)Q->5>![#DLES%;,N!=='5PK(RK$E<)&#R',
M G6N0-&ZBB-:VRPN0;0X@%$=+AF2VRB^#Y/YB-?#@$U1&P#FRD\^2;^AO.57
M/+Y'PC\BX $%3*,:)[IB<C%I]T&(GC)WK$HSV(X3SE./X<'"90DBO'-8IV6$
MY@1VW?>9&=](+,^RR2''%;BX?Q'V+!8WVIR+"T\%,Y3MG+['/KOQ(S>="TOJ
MW4WR(PZS[MM!S&9$F8*\ZPA'1 H((_V+]P6B-UD(4P*&XFQ7#6J5F-P.3'J@
MG:J7@6C,A>XGV*_EQGS5<T(^VN@1/V3OA55IP'K[^)HI[STRRIQ2JL<8-H5]
MXKAZLH8D3#?8>XTU ?^(7.J2U2;W&W61L:C:<CSVV5CHY*U.H\U[R\IX6# Q
M?!;WP[LG&-H["><6A!Y8D@;U08E\<\)K$1'!%'Y__,/YI=OH-$]@-\!)\'VB
M@T$]3[A<*2YA,F;1!OZB:]U&6T8:C[\]P W1X05LF$H14Z!ZQ]LK$MJB[;+I
M!;Q=WB]:J]&5^](X >' ]7ADLY#W"XSO2'R0AO) OFDPK; KT"RD<-R(;2+S
M ^WA+ZUFHWDZ,N(>"M[&">3E4/@"4]YZJD'ZP(9^A$H/=N;+--]4.*P9Z4SX
M\:.!8,-WP(9X'1X-] ^&F?+(TCY]NN?Z/+61X@V5X$ARG[H'+HC^N)ER;\RP
M<X+RV?!_H%*$W4!5D:Z-[4;BEI$>O0?U&^2)=+)4XF-P#R4,15WP4GS2F(*:
M%I[H[#O-TQX^]C>$[<P3!'3LQ]\2I*]3,-,T10>>8YU@Z8-!8W!"6A"ZP5JA
M=X(KTAYHC=X)MR5I66I([M10'L"(C Q>94QN%N"!PM6WQ,FH)AQ3.63IO>M)
MIN.S*3?XC"?#=BB,DFH(BTPK>&'7,"VHR<E/CK(XA2M.VY*XPZ+79$IV45E4
M*C,$7NH;/($!>^^<1$_ZI=5+V+RL,H\E4+(\VQV!CD]N,TP7(VVJG3S9. 'Y
M+\C^;I93;B/%O[\#=<R,? $5_L?CW2O2 J[ABWOOV7!?E2[)0:=*R=7U4N[N
M1(P-5!G,?4#K3/2T[I[BPL7,*$C!MY, 3!C?JF.ETZM$<"I_=4G+5^P[1PKD
MLVBXYQMVP-G'*$K,;V&,\XZC]%=BB\LD1!DU1J\G'F&F;W<V&JCF1AOA5_:8
M)I-IG^L;0>A'E'\#SV&5N2!=RJ9)-P7$8)*#[1 BWN$%/: \\FA8H(D+= M8
MI$"9H#:#ED?X^KP6WB6D K0; UY_^B3 EPB4V.?=XO&B484Y/H+/)AE%HJTT
MHYQ&,B#$<%)FW1O!!%:!T"+8&OH)/I5MY[$8T^=E]O0]L67XXY=NM]/0XSMK
MT+7,N20I)"?B_)&/%;BI$\2J31(D0^9@:B]/JZ3?2JB3I8D]PUNQ36P0Q:&(
MF#3@P91WAH =,$L3.[K$.6?A,\,N[#+OK+I7@GO:;,(YXK)(7 CX"'<2&*P]
M=LD5G-E4Q-#"@_T*NX%*(?^;X_W_HFF]1B<Y.=BT7^"D4A]9D2_]M>$$N(BL
M<>;XUW3(BCQ?>IY;F1B80H<S7)VY9-0Y%*&*!NQF-(VX5L#!NKCN]8L.5#5<
M]$94[V36+.\9<Q&M[/V-7(2BD<5C7A1*SS[=83OD:A)1:U)CA@1-.#+_2G>@
MCUM]TRUPF6CWA!PR\W#LL!2Q%*&FYE^4='2#UUW+;+R$QXCX':X;EQ1S(LE,
M4D7FRA_P,#"E"-%3["E&C;C+7^4MO%,A4%A0FH;E8()?\6[7E-,JXO>D6BS<
M\KC+-_MI!Z(]U@K>H=+<Q5[@YXC_@6ZY89AL69 N/E 7:A)\;VXX\)14;FEM
MU#0\5H6Y+(YY76PB.+;)7#@F;]%]$]LJO,GLU)@3^6 G["'/+5DZ7RDBL8DM
MFC/2.R9^'P4*9WT&1DX_CG ?7WR.HI[=@3I'L<Y1+$9!&&:(W(UW\GG">%J;
MCS@CR)B&V,Z-!0%)23"4>5 G%44"QB+8#_%<(2N($PRIX33B\3O =<'.0FVL
MVGK\Q$#'/>\]0_P-@V'<*!0E&4;2&?G>< V":L0$>QO^Y1-$*"/])C1^4NN4
M$-M6?;\+7JU6-7G ^1TP80PE9+[K$%M%3=RU,J41Z- )1<Z- 6P:9I4W:X^+
MT'BF.!,@!)1Q:!!@2"^MC#(TC?&Y%'8<1S;!8S1HY;0!"/ UY2@GF5RS^,T@
M#_[N/7/).:;"Y;06+<O1N#41:PA6+-_D]XL[G1;\BZIWO"#$X#("CY,[\/C
MEF TI( D61J+)3FIG8A1.^,MX11MXK(3-QJA_\&246Q1[TJ$73/PF$ IX8W:
M)Q3IS*@*F5W+/3>N(GF@_[ICA@"VI"\A1LPWYA!ZZ[J'O<BQQ'V52A0V@AF[
MMGRO";8<4 ^G!U[6 <R/<!D%J""N$VD8=1@W2/PEE*IAB3'Y5.R AO=I?O&I
MXR_83P/U'WLJ3=[$=[)J\G)0Y%APK_X4"A3FEXQC>AX:F+HE1L%*-J),PC +
MC<QA\X'BLR)C%KD1+\<LBEZV94I&^RI'5UG5-N=82>HQ]U[.U#B$(RA_&A4V
MC+ZGDQ\4T9DHFL*QP2 !L:%<$5B\-O2X78\T]%%R]:Y(VZ-NLZ%U>J6T/>HW
MVDV]E)&T9J/?[U=L4MU&MY/_Q$)3I\52ZS;O@94%VO>]9_YO_2I1[$_6U&:P
M59^6:Q(R7@1#6)AE]Y/@K>&&H*T$5DF0!<[/;VUUTCX &]<I6,1JI])EK/">
MQ&Q>ZXP%XM7T/.+-\K2J-7O8;@O2$9+-G3#.=HT%NGV<YQI_N?0%_FV'#C?5
M:IFVG73YQCVJI1SG=BWZSF. PHWU3).QT2BW-5'OM >?WW4GJ>OT\TF@R$J;
M2@4(/'^=2YRJT+K2ZZ'62Z=?4%=M-37NQ]IG:9(XMU[BKS555)@JM+;:U_HU
M6=1DD34>^VI'ZRU9B$>@B%AHZL6$9BYU5&4W.T?>RB.NK9C"NZIA^]FH/[\1
MO/\*U6<KVLU9<95I5^L551K6'.DA>,&9[>=UK[4]+ZBW<MU6ZNWVZ4FS.'.K
MX$ZZOT[W8^-":)VQ0^.[QXO2=V?LA?:@RO>JJ[9[^FXF0;'>RP=4#<__%, R
MZ[4[]3&<6E[W5;V(R*Y/H'SKJ5N5[3^U7;48[\L-5F^KCFQR>K^8YTORV5=/
MITE\]1R@06)I(=[7-I&;30LO? )5??[BW1;W'N^"]Y(<%[K:'C1/;R!>T);J
MFMK7!_66EJG<#-16:U![A$K:S?:1G6NG5@@O-\_@FRRQ7D!5WL<U<RYDW.^I
M_4'W9$'92]Q231^HW591?W&]I^NYK:;V6OTZ2ES2=K;T.DI\&>;6;QR/.P>7
MXR587JVVVAG44>,RM[335KN=VI@ME=WJ3;79J4VOTJ17@1RG%VEZG7UPW-O%
MG?PB0E0:B+Q!KU<':T_MH&QV54UKU>=P:F'0TU2M59FP[8L\@E:G*MM_:DE=
M1\VK%#4_8S7H$X* <LS\Y<8J+U+QN=;TOMII5H;5O$A.KPTTM=4M[H>MSZ"\
ME%E=[7=KO?/4Q]"JUA&<6O&Y7 ?[5X&<C8AH*H(2OP2_>E=M#8KZ&&JGY7K1
MJ:EZ[\B.R\O=3JVG=GMU358YF_F?XQ#;?KYXWS,974,VXKW78PC,(7/9R-XK
M'>C\]1TPOW15:]:J_VGCB+K:;=<F\"D3YIIJIU6'7TY]#.VB&0JU^;6M4E(-
ML^OCDOQ5KD4$>#6:Z 4IN&VUVZR ?GM!.ZIUBH)/U?NYGD+;[:*9X[4%=A14
MC 1D7K&\"-'&2<2=L6GV130#VU'>[[4AEX0&5\I^5/ "76M:3^TTV[N:1OO>
MF$,@$M:T^T)H%\WZ=K\X<%]-NS7MGMH=TE8'_?U"H:<@WQV<)>63<D6.L+T?
M -=QC^^TCI9?J0M/V0V*^INFHPL30?EOY8L7*E-F8'>T4>2<MIT2C?,:&P?:
MYGH57L_!\2]U*NN;RY]UTRG3F\X\E]KL)J@JE]ITJM7H:(.*]7<J<R1-R_^F
M>,^I9G=]<ZX-'H2U.;IGU;+H)3=EVG2Z)]"?%X59Z1W#+J1[3]UFZH"]B0[?
MN7O+'E0+8OI%;L+?\C;A$MI5K4(3JMM5Y0UP\3!2=;NJ,^U 4[>KJJFB;E=5
MD\5VP9JZ757=KJJNDZK;5=7MJLKF!76[JKI=5=5VLD[,V[!!:YM9U5DB=99(
M.6V^ZARGFGI/Z G8MSU:3;XU^9[08[%'6[DZ.^_4'I*=L0WKS+R7FIFW=KI+
M<2K%#I0QP<B'S%+""9#4> )?YG=%48RQS]B4$M* CNPG>(: Z@AWGHUM4S$<
MQS9<DP4-Y5],,7RFP*_MT,'1/1C89/"4\F3 6I J3<\-;$N@W"E&H)A 8(;M
M*K!D%H2>RP(:Q# G-LS#:BB8-A?:4UQ#DA.' WMCUZ918$DN'(AEPX>A,X=W
M^#YS^ (]6&/Z>=,()GQ6LS!H+)V-/!6QB6U,@)MY ;WG-0T*JTGRWOZ6#;V+
M2]A,'C&&<.6B</4C!XK6;TD>>FLA7)_Z[TD,<#DSQNQFZ#/CQXTQ@BF^-IQG
M8QX@ T^M!';X)KUMBRM>N:[1*+NN[_84B. +>U:^>5/#A17NLCC.RBP@$TYK
MKX%U,A]_!=,QJC -9>*ST7]?_8=MCEIMQEI#UFL:[7:K/3 ,H]<::<..->JP
M9O]_>V!ZT^T! KZ'%^)]_+^_&K=YAU<E[O/!\_GU6Y.VIV!RE$H_@UT"(@L0
MCR6^YY@1"_P@OLDSWX9!@:O9GJ4\ _^PX$?PG9'[M. 2_Y9LZYMGXGOX(SA<
M$($8#0)DXO@FAQ%#03XAV-+,]_X$KJ+,)C!TH% J6W86RTRDPGG9LF'C8N)*
MY4AGJV3I3//).DWZ'-.D>XUF?WUR<X&1!NL3KO-QF_5<W&;?>UXT2RXYT?:L
M<J1?<A;X5L1[(?G$=<[TI:<+USG3N^9,O]#8H[F^X7CM!J_=X#LW:3^]+[PF
MWYI\22_0U+X^J,FW)M^S)-_K@=IJ%>B >7K*K8.0J=-KGTG\N))!R JX3N^S
M.C(/N04<4@*=U_?H4G?G__D??5WKO0E$U\W00U_WDVTQ!=[[9)LL4$:>KUA^
M-%8L.S ].(4Y#/I79*,_GN(8Z%R"'TTQ *AX0S@=WKU*>;;#B3(S_-!E?C"Q
M9XH9!7!F\ <%] )RH:,SUYDC^KH3P6NG!AA>L'HQ(U7.0YEXD1_(5\&KAW/R
M_[+IS/'FC 4B:CGSF6D;TH$/BX$GPCEO)PJ3IH!FH\*QVH+1$I-\1!B1,)<.
M?)>8"2>#Y1!K-GBB*L\3&^:2&H;B*!-[1&%FH),9Q:F>/?^'8I@^PNSC:6$$
MV(N"E123"@6+6(L@5Q&!"6 ^!DS 2@5J3GR:!6,OW])!]G>I('MU27('R)H5
MB00"SOE2@S3M1J?=*BFTTFF7%>XI:Z3R@C2=1J^W/G!4!VDN(X11!VGJ(,VE
MK+$.TM1!FE,"V\ (QT6U6:_$U7 WIX6[.3(Y/#A&B"9;#7%S'J@5;4W5.D5K
M@FLPDTLGBVY?[75V1.^NR>)BR>):[ZF=0?%H30URLR)ZTJQ!;O)7NQ_(S9&5
MGG<RXO$RT&W40>$FBS4JR]H4CJ;:;Q=-X:BW=+VD4@?- H*JWLVUNZD5Z)]5
MQE:>CZ Z*^O\'C["M^_3L?Q<:!;;O@UV!.>H]=656]K9L<5UO:6Y6]HZ'9#L
M)6XGY2GI;TZPI^<CL<[*M'H,/?.',C0"D<O#W(!R@%Z$I04ZK%94@M6*[ 8)
MUF_6QFNY3BRUW^_4EE9I'M;:TKH 2^N/WY5O_VE,9V_>*:'Q4S%]9MGA2S"[
MKC6UUSVR6_MR]=EK7=7[6KV;Y>QF1S]=-Y=+W,]KO7CUSPL15F=E9'T-)\Q_
M"195IRC6=*VLKLT240>=;KVC97)4V-+FD6,M%[R;15)57J0Q=>$(,)LJS&I(
MF!J4(&\C^CVU/R@JV4Z/3%"3;TV^/' P4+NM';.Z:_JMZ??4>EM;4WNM_GD@
MB]2@,$O'U]+/X^AJ4)A\)(=--7V!8I@F'&)(H"^&$L">VB/87_ADYOD25041
M'[RXIX1\EEH_Q' A&U5T OL()VQ.G1YLUXQ\'SL];)ZC@+(A@':"*Y$/(X")
M0!;!B1EF:#_9H4V([8@N@_14$'I"GHL@QQL4**\[;7D];=>"J;V^T?I4W'V\
MD\1\&+T;ZP#'>O&;S#YH[48'UQUC!XGCHJ/C!,*(6&:B>/#-\N[7&[SU!@.]
M)Q!,P%OA0@8"B&=JS!6'&5;J$.C.P,VU; N.(5"3.Y!<S01LB?"1?L)?;LJZ
MKH]KG^-"%FJ*O-S,H0@.:KM/+ @%]!'\9.9[5F2&0;WK^^YZEJR#:#9S;)(W
M@8?88" H")D,<:6FAAN-0%!$/N%5D<A@B#WE3PV31:1;P$F-,<R/\$;JRF.C
M-R/ZF#SR$'^&8@CFD'Q(\ZJ/>+<C!I$2>*[+G!O9VDDJ!6GV%AB.X=OXV9"Y
M;&3CJ0T]-PH$2%R J8<WRZF'=(()GAQSQ\:8*Q4K=9E1Y)J$7%:?Z#Z7=O%F
M)LHE,DK+'B.\&AS$R#>"T(_HNKZI-WR7#?<P)"RZI!$Y&X[CF9F[E.C3H*$;
M2/R1$Z[%=4LT[?0]#"=>P.A2 8>U'?%]&J)158PIFA7_%HW@7+QM0>0C+N ;
M_//%MV9KUZW93C:-@[5FVYM1:0S_4R:U:?J)&!6\>(5D$#B@HE<C2%J+MG@E
M$TK2,8,,$]KDBH '4/OCCRK7W]Z]OW\E6[S]X=K(&7^'D2QO6F7<V(SO)>5B
M651Y;=^Z04A>;)#IACYP;O@NQOK-=\G\,0/F#'P%.$B,K"N?#E(#$]8O,7D4
MVR/XM0LO=[((KS R;SWJ.&"SVE-;=.A<<.5X!"H*WXJOT8AM*'<NS,UZ(MS8
MF3'G/4E1PHP]SPKPH7@I\,R0*5' Q_(1?%"XB$81'7B&*H06OT*J*;/(#R+T
M@A%@KEQ[!&LS?!\! /D#2$8.[+D]LKGT!%$W,^R4:(W<T':PX> D9\H&S8I/
MM,JT]IAR"Q9#?HUAGL,,IFRB@PSGF<<(!/BU(L&G).XPL .&8- Q>C0<2[S%
MJ:ZO 5QJYMJ\Z:L\XL0G$G>^G<#%MY'ITJJX9@(4#2?B!)Z<<Y#[BN]@,$0!
MW3W?(D(Q<<[6&R4&CR@ZZ^79Q!-=<",D2R%M29%EP$7?N')8&G7(YIY[X@Z7
MA^LPNMG;O %'.]E="WLCNTC#TN$IAVG$)!S?!#D+2R)H9R@I)J0@QMH&KJ#\
MHO<:&G9)=J2]NLVZ.P2W#H_3&.[*5VT]8+<@,<0J: :+N56^'4;C; _&_1L7
M1'3X=Q:(-YM:6J,+Z/U"(E'EB'X+5.YQ:GE&=GD7CL1=MTO=>J2Z76J-Q'T1
M*]P:B5O3:R3NLUYCC<2=<2N]Q$VHVZ5NGRR_60VLT^7K?,U<$*.VVAGL6%I;
MIQO7Y'OJJM"VVNW4#8!K\CU/\KW6FVJS4[=0/=ML^0*(/W6V?/4\K/^*]>-U
M*K3,8$K%2W_;J' G2>Q)], ;Q9EK;U(!;)F0%B>SK<UAV^[EZ;#6FN0<VZ4F
MG3P"Q<R)"]L]GJL821NQ(.#YCR,F @<&S#=.> R-GZKBL''Z!Z;GSSS*":>(
MJX%I$IBK&6*,*I/[PS?U B-.,D-)!I,V1F[4E2&F;-]623E(1;]T&[TX1K20
MPC5AAL4K/(!2(YZ[*),=YLSP\= 59";\T#W%0_>]/86IPLD$!CT1Q^I3 3%\
M.#?#]O^W]ZS=:2-9_A4=3^^LO8LQXDTRG7.(XTPSG;;=QIG>KT(J0!TAT9*P
MS?SZO?=6E53" @N;A\#ZD!/;B%+5K?M^7CT%)J;.VH9FF'_-;)YXI2"X/9D:
MML_3U<>&/XH.48D.08$ZQY![<O#48\^Q\+N^]T#1]^"PYL!2:Q:MYP+Q,NW4
M\8+@K*1=LZ.: \MS#>WD&5T6'F_4J=EL;BA6I.NKXS+95ZHV-K.G5KE:V\QT
M6URI442=BJC3$9RPB#H54:?W$' IHDY;BCH=W&#8'D*=@>G*%;M7NCC>GW_R
M #V0C5*G^<IAD7GPD!<X=A XUFB\<E9*@6,%CF4Z:KWRRGE1>0N6'' XY)7C
MI8XRYO'VAM-YU0F7)!1E0O5#:T);:ZPQ#J%HZ+L2EHW*&EWA"EBN@J6^MCI5
MP',UG:\QI^-=-IO.MVQZ_1"$ YO:T6J_LC-L,04EG?#U9JFVSMBN IPKY5*K
MI.LYF-/S-H:6$V"Z%Y.-F!4[*GW@+']3^0IK\/V4[(/T.,8N '44SJ!-PB.'
MA 4LO[.NJV*SM+119V6!O>\*>T]UO51MK3]IM$#= G7WKQXV6^L:,/M'WSTK
M6SFYO%1U=$EF_X83[-)S56%#VL_:M1=J$V9@!ZCAS-E 9NV6&N_)=/)==]X[
M^90M@7W%OK8$D3V 0DVG7Y:YO+H;E-)1"Y.A\6N:YV+3]JD78!^\H9H-_\_)
MX!?>*1^>_3?\T35X9GNBU5[V'D^O:\GT7AJI-A;,OH6.G+;U\\G+?3X[K9.B
M^^JA=U_=#MJE)PQ^L_^:V98=SGE[/F-*C:SO6  T;[)@URVA%;Z:D4MDHPM
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MC7 1RI^LF2\;*;^H+=+WT^ZQNPP72GCHL8&HC\.G9I,9UZ$L-@0X4,WB3U7
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MLZ^4K#N&'!UD: _$(25DXV1P;XJ*KGIOON?"SR9/;<IE81E/295Y?3%2?C9
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M2<4;%N\$S&U%)7DI&=U5H!+K?CSDB\O)#L(854XH 1BL%]I;M(#@6H%*LXK
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M'#].79<!67'B,^CWY[\3)A,C=;T0F:E8YN]_:U>K<#8<.TL_ZQ\)JP /IU[
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M:[KC)$TO<WD;)^WNMPXMP3:WLN@EJ;S<KS^0DFS)>J'D)(VZ\G[8QA(! GQ
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M65GC6CR:H/4 !?43X3QFH&;'$D:_ET./C<,-724^I0:#YOB:2D*7^Z!:+)J
M]-4$?&P[DT<"3%?EIES8O%&Z#.C=Z92.;?.RN'T3M(F<!;A]_;+%Z11C)48]
M'6]'-9-J?K8"?1.T_4Q1!ZXC?F3OZY>/XY01Y1J6TS1!JPL(!#?+APZ4ZY+7
ML@D:Q"\,^IVIR5& 3RJTHS@KO,"'FG<]I9YWSCUP @\0 9>Y5)54#U9G^$S9
M=/4L,W+NN3X]5F%QI7@(:O-IBN;EC[6O5# M9:H$%"YOV8;B$8P;NWJ88^?G
M])Y-@VG?<6"FC!]V Z=X<.JP^#E,)+9N%/M/<)2\F5!U3A\.X50?7M-?=GB<
MI53A_^(CU=_:W.K%I5&]\X'=PA6:I&7MQ$+5A(>%EG'[U$>+-#=6TK$:?1.T
M#4\_S$N^58Y*9!HW08\!Z S)P<FAMR7H:!'_T6-_J]<[E%R\#6!^-K=DEJ[
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M>"I]@SH (*'":'BY*-,R!$%C20 7" N>HV5!B-"[W5^[_.0]"Q@]%6T>)$#
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MUU.?QHXOF[],7QRJ$XL*7&I]\_?/\V@:I0>]G.JJ^A ^SPO[SXMODYIX@C+
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M :TH @(9+A5A3G5+T#Y$,9H G6A=QE:BVW2FM\"'\(>>8FJI(6@"-5"CID9
M1^[5U)^X3><HF]2/I1*I'ED:@T&@02.C7#I/?+ZJT+5QTW$T8:NPAZW];\Y$
M#Y("HZ)Q+HB@W!FH4<A=I5D#<00WI3\Y[>7>!TAV@/3O"^>60M33CWKBWLY>
MZIO)7$];P%$--(,>$$MDP(ZS '/'/[8".@<5R"?Q0?(VYW%^WMT[Z,VH#%-
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MGX[8']OQI#E,BRJ%HE[</IEPJAR:+E(J3O,\F]Y=!DVT]Q@&5"NHH6,&96_
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M%XN4IGNCR_EMZH%S'P=8EZD6"FC'$!","1,<(JK;^A '6-/D^-VC%K>-??S
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M2!U^CL&[1>FK_:40+-"40D"PAU @*JE[/N'Q?6;^XS4^S==X,.U]GC'#O67
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M+S!+.+'617WKM/PW/7V\%W87 T]6[=Z"V#>O_N[C](_1E?^W/_Q_4$L#!!0
M   ( ! TIER>REM?E)H& )S=!P 4    <GAR>"TR,#(V,#,S,5]G,2YJ<&?L
MO 50'%VWL#N$X)+@3H('#^Z0X$Y@<'<='&9P$BRX#:[!8?#!&22XNWL(%MPA
M6+CO.77E.Z?J/_><>]_Z3OWW_D]U5W?OWGOUZNZU=JU>>U<_+S[_ +Q6E%60
M!2#]!1L2&P#PO *0^M>C_SM>O/AK_=?M_\[_M??B7X3\8]5_K/:?YOD[  \=
MQ1Y3&1D)#_ "#PD9#^FY%_ &@ 1 >OD"&0GP?X*!C(Z)]1+M!0KJOU2(?PT
MH/YU161DC%>8V#C82 R %\@O_SJ'AHZ!AT^ 2<A%1$I#*^1:V]1%3,8M^%%'
M5P_L]24U;6Z>A$[2#5(&;VQ>(*=7US;S"(I(2"EI>,?#R\<OH&'N65Q7O\C
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MX;.N^XI38-*;(7^B5Z-\\=+ZUQ_R+\ZBCK^LYDO\:8B*Z6U]E3[\:GHU7'B
MZ+04+3YD>8",E-;M]<V5JE73B/Z^XRGXK6PZ?UKAEKP\%ED2C3Q[](H16C[F
M=@NN5O<:58E1_-*D1U/V@)Y9$#W'>^IIVY):4;Y ?S"3.</IP#PLG3]V0[=N
M,[Z4_ S(%'SRION\Z###I **%7-!CA"6<UYPU5BZ'U"<A4$BQQE^E)RCF<6
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MC\&$H_'UQRQE]HZ/P64V+&QNR=P""L WC /N9$AO!<=YHFW(^EVSP%N"5S8
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M.A&>#&B?/.GPSR7Y(^1W]- B&/.X@7^YZTTJXW><S]\ 7,L7Z4):@P$T+E+
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M:&H-^.7W"HHR6Q='R;(D&C[]F-G>9]\*?K*J!O&VQUBK]]A[L$\8/2[P^IO
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M_)(?%NGK[RK@CZR. F&S$1TPZOM<)\MR=46E,9'4!N#UDP6J#+ZRRRUJ6;&
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M^U/\Z;OFGB3;\Y ]N7Z"Z_^#NV3_RP=LE#4W%KV[R*3;7ZWU0_RL_38NF,O
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MD=I]8W;N3$'()RV;<I#[GVJR"IF\89@\K83V;%HOY\5&1CI.1OO]9ORA6<F
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M$?XHA'/ALAF4)*>1LNRR3DIA[VZR[!O[#RW0Z>K;&;.U8N1XAVO7=K3^Z6
M;V*%WJY1^ ^I6JGXBPY2/B5J4LZE])Y(@_]OBUR$-?_>C-R*>(#::B1ASJ]^
MSYQI3FAK^Z+^[73+?H:J%J-4Q_6A37-7\-CM*QC=+(/C_IF&8/76I4VBTE<1
M1@G1R:"A+'I.4X_?%G-AIJ>4B>)/MGHY-LT4NKI:B.[.<X5JS-Z5RC%)/G0Q
M<[ R$V(%>)Q4R3$NUL++Q3W2PQ4E?Y'4S=M'HG]-:FM\V&VOJ.[?KQRE\9DH
M8'#XRRFMBYM;%8?#J6<4V#X2;V5+E%?G>Y9DZQ00>1D2W9-'FGHV^@@PM=
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M<E=YO_-<0WOO^WMHY'_^'>PR_E!2+W@S9>].#TP#VE5:AQ?$VHN:-0%M39O
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M/@+2O^';_>O+$[R[4FEWWYS"ZXY' /L*V5.3),W0\HVP1T#P%46WZ.Y[838
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M4N$_Z01J4E;%VV#*/NC/_;V=-/'ZLBGWE/10<'M]^E;GWLQAL]WPS\[".XG
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MW1G4 B9IA_.OJ-KGKC2_ADBUOL71O*MFB1;<RR!JE#NJI.\_5#H<;HCWJ4"
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M@8[-/\K9;.7A<6QVKO1G[QUF;%,=<X+6C: +#WLL9[ 1QI_<LOKI,\ ?\UA
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M6U>2>>O!<(Y[A0\F7A(:\PV0*HY1JW6[MH:UA:ZOKX)/LY3+BZQWP:: AT[
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MF>]G-B;GF@7%?23 %D"X;S LTX*LW]D]\\#/U)H;C+:8BX91V$P.AL3Z+Q;
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MY$JW!B>^A^_=4B97SJ#*=I0P>+U2H[W'^)3,8Y6=CY-3=JB!FUJ^+8&GRI#
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M*8P$9+#XX]/R<E/;D'>G'PV<<T>TBIKB].%R"*NTK "H/>T:V]\HC*OP\6O
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M<C(DO>&/H328H&OH(1D"'AA'??1OA:W8HP8E]8 IA2I2^W+GM8=K8A4OG=1
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MJV3.0"X@?K(0?@V(GQ\YN*<B88GS25NGEHTI,ENU@1=/'R<RX?F?(:&OC?Y
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MW:<UB8X3%CKI W^HSZ:A^UOF9]$]Z2+XU]%MB4?><R9T*C75<01:K[SDQ=H
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M%/2YSR:S^_WU98;_(K^B38MXE0])[X<+ZJ-+]2B5O%O^<N2T<?U1WRZC_:\
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M>NXRCL30"2<Y,=&Q;Q+YE7GIO.[T0O^T1I%TOW_[ 9,0W*#\U^6RQ(W+H$F
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M?/SIEFBI1(^T#A-W*R3[;NN;(M+W[T4P'B-7@!HX6F#19*+HTK\=\%H@120
M!AT-X)@"SO.J;G4Y;44-U5K]1K[TC?'4+OWVC1ONAK-40&[=IW*GZ;UH.NG]
MA;Z=^LZ]9,=40VJ/X^7ZI<A!AM)F7JDQGE%R@S 2%5"<K?GVE<:2VA/7 <U)
MUSM*(Y(P7]X-H&%TO$IMLBVDAI4;Q/4BD)A?,MSS;%63CC!"W>#ZVNAX5O1W
M14*]'(?ILAB?BF6D(LWKDQ1(E>J0&4.]DF5=DHG('&>K_CC0#BT1;]CZT88M
MKQ\T9IJRTOEW\]UR7YH"T89X,W-E+N^B'\[I#%DA KQ3WRLX=Q-U!+4)7Z8&
MVJ)X(J/]?/69TWCYEE/;%W< G_@3NKG:BK:5;+KY(<"3B1<_$6YS"3!1LZ_J
M7YK%OJ+&Z1B:+CX/:=&1OG=J?!_]"H9QX9\"Y,< L0+E"4Y+Z3:NH?3F![C\
MX;A>;ML>$I &3B?-=%&A)(O3W9^C_[V*6(J 7YQE+YS:22$"*VB &JQQ)==C
M J:$QDTG17RAKIL6E8D5%P[,Y$NJS@:Q*;KLY#WE<,TMK"YWA"<'T'XLK8I]
M.]7]U4%*U'3TF#_@<J0>:6UMQ-AA@13^?%/-R.R!>@9R(.B&%H?;<UVFFY.'
M/Z8\ XO&$F%Q4U\(Y-KEZT9;:7?*EKVR1$?+*9S]WL>]K0YL-;P,O*6@:F73
MP?2$$Z6!Y^&6_\1^PG#DRT7V#')FRJMXH5*R$^DY^K%(5&A1H/+T0ESE>3P_
MZ98>-^T";R]!\#)+$_24Q22!E:L-KKI-H@.CQGA3 */IJ!%2/T=I/=!B=L&V
M(8^;>X)RVJM(P[Z)S.X;TT0+)&?+*\G4D,+Z]F]^&-M\&LGU@+?MR[1TL"=W
M\^>/!!I;-*5/2QA"JD>[?R0;[+)+^OF%R,(AY]MDUX'2T9&E70,R#@FS\13M
M];F_BX\1YB#%E^V27YC\R3S3:K?+,E;FCD]VCEJ1-[(8.4\$BX^]<[R46;TS
M3NM1H'*F^P*2ZV6FG<EQ'GO[;R)H<;>\'G.44G))K-^9(7"BU]F]A51\!IFA
MC]]\")T_2LJ9O ^C>V5B=/!K*?\5R9QM5V%)2J+]PMS+_">4PEZB]_5"J**=
M/%*XC_SU>!K(3)BK=^<3H%+MAQ^G3R. )VIGC\):4RPR*2#3XAZH3%$U)P6)
MD*4,,MV7#3]*>+2TX@]#R3V 'I5ORK.?6('I.Q@WKP!CEZ(DCXK04/Z6=F%1
M/\?RW)+Z5?-?+ZL?2T0;K-%IVXM)*#[$7O!)-[U;4E]YTAOHCAT#OP_ML+@"
M(-WU.DX1Y 'R]@ Z4H#3U\TJ5!'3>4Z%7.YV#+Y"(86?PA[TNB]3CUJR!"=%
MZC4B]K%<_W[2RE#'1#I0/JX;)T%)4 5[OP?KVPWGNRN54XNX=$=1K@G;]*??
M%;4?SK.)"+&K,+EN5(GZ<]-MF.[HQ'UBOV?ZMNE&N&$*8_G&CL_Z3[.>?/^_
MS'A@\-'RN8''6?2PR/:Q&!8'_R>YGW#[#7<&?KWA?E4RM[HAK<MY)(UQ.5;/
M5HUJ@WY?2^VA.;&"&X*;HKC4!#+HVDIF-NW+1%NB#-L71AQ!4:6U$C+9-N&<
M)'8!T.Q"@;3L)GCKI70?8*2/J*V3XSYJ ,.X[3J0'4L+N*N/_]IB#J%*C3O5
M3)(&Y:MO18DF5Q@5FW 8Z=.4\/C%%:H.BE5-@R=FB"[@?#R"*>:^5*.X1/,7
MZT.B[Y M)4_7^C\9[(4,%*YR4)515+ ,+ @9B$E5.%!0 '4LY]L3E5P8GX78
M1[N#%Q[%5:I7)56Q3CX>\+Q+^MC[";GOB%-(,7HID1&(Z)SGW1#SBAU_Q@?W
MDPH>$/+:?F2X=2M7#^3YW)I#![)5/SE&BJ\ :])VUQO]B'G"0L&<RUE>:\?_
M-WA)[Z/[^_^H!__[/W$'[35>+%PL$"!< ;0TT7''GN7DE0T"/S86"^-WP=B+
M"N'P/8J*TU!+JR[<^-ZW_]57X0J@F/U]]^VC_(G<?TYU9JP9: *XK9&N85R:
M'H+_.J,SBYY6"4]3-U#+B[K]KX,]&C6/9T]N6IGD?!1>5_S7\9\2Q.%EU#<C
MKIVP>\H'*PLG$!ZVT>Z0;W;2Y&N]G7@;8R#U_\'>5P;%%6UK$B,A6 CNP1V"
M.R00'!IIW-W=G01W:1JWX.[NP=W=71J'X#I <N?=]V;F3<W45$W-U#V_NNC-
MV6NMT^?L;W]KK>\0S5PZCON*J[]])ME8,/@!IER]?$=-IHX_(]L?H/@?[5@V
M( 6_0=)GW.Y821%T6[LE8J<+?9<+VY/Y0FP'?ZFK+4*)+A*1X6G.O^--2X%W
M?A<:GSXG;VO_=8"L#B,W4'I7T"3=,^X.\ZZ*U^L'W^/GV(KXSU__P50VL7$]
MT93HW_/?2XC^F[FLWP?6+6+P_L''-E3SORU^L:OVU\$VO*&6SB-4T/9JJ\N*
M9WP*\.C6BRDUD_6'N+I*JE<WI,\O2?@^I2WE>SH[T\_$ZC;T[^4=7-?PE[R^
M6J+<ACV9;^AK.KXL09PN?M]^B"P]0FPI:75)#0H[@[\!>KPE>HHX1>X9+V(W
M[<F3N=-?)>^G'J"J[[?U2,%XS_RKEDBN&.\7#8\'J, G:[W-8Q#8&EZZI 96
M<*@O^;3SIN,]0/5$D&D_4YE9IPE+="T1P=?T]N1_:+.,Q8MNPIUA>PR/BE7L
MG?OQI4]@6Y*NP3VY ]_/)QV=O.E'!BOD+=/Y"W!:&T&!SRPUX6.H)W\VB:L"
MG6T.MU8PZIDX>!YG8DV_Y6WY/&5/3A<SIQ+X'/8G5\J_>OCB";-U/<>3>&?8
MY'R?S>]TZWSZ'NTUA)D3!>NN'L"0[.7R $6>4/JU>*YBE>+)WR?">RJU":.K
M>_4/E0Z'&T_;U=:YFC*2,KMVR89\FN2,O1+L&DK?B'E1?@3S& L[0V9''. U
M_>%MW =[XXNV=TZ$J]AC]_@K&#H\P6J!V)F=. #RH/)G9H__>=CC#_POE_?,
MF"X$/A&9_AY?&W_?_F$/GY@]#X"'6=B*IO;NL,:*'PB!XMZ/UVOEUY3=]I.?
M_L\1^;0K]>16GK/$H:N7VG3:GBN7.?T#E-[=5.\S40S=;#[F^QR1H'*%YK9-
MJ[!GRA,0"<S_:MLTFRC'S7[1=[0L,?.S3OS1 ['#R.5?P=?2]N06OO0G;(%/
MR0(XTCHVCE,LF1M[\S_4IS\GLTL#GL&'1^1VO[OQ5MOW4@>?*#C[Y^(#5"_S
M@O,S7_D<R:>[X"]WO51Z5\0C3:9<F#]7M48!86T\@1DUMB=_#)L6JZ@$!E3W
M?_]94G;XXP%*^!#N_HR6\U9JK&MT/N^&K)?7;XI7,</=9J-K)DOAULC0O5H\
M-/2?M"G7/"_K_L_4-,-N9;^LE)1NPNT_[C,D#G:IQ7A7#UW>E-7#"KKNTN]H
M2XP*2E36IQ<O(^;,AB=6COK6<$\ILDN'BE-#V>.;%2ITO&5FA>^\!^ Y\'_+
MS)V25Y#? F DF.@S@!:J.2#LT/  C_5'V0M2Z#,@A;U3U>ICW9_7S#P\UV3!
M<N)LU %N\:2+!<W_*$=25X90SN+IL5-O-[DUGKG*(VF.K@M$LSJ=79,0E9MH
MD5KK)7_8S^JU"]X4#GZ%U/SOB<@#GG!N-QX[.GP6A("S[/MB#=8$D(*9ZX2.
MBWOF8J9SMDC:6)/!'7]G0JG3A<TFW:#KX1#2X77F\E6I*SZJ5#3^=O\#U)7*
M ]3ULL<U+50/,.-"VM7NR^I<D^B:I('01M9(M0E0IMRCL[?EMWQP08]S>1 I
MQ6>\UHU2E&2+3?Q"IVR73F#SPB?-XPVRT\%Z*\E8!8#\F(FD^G%;E/T,[-
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M)Y?=F($[Y^E>-7\5DK,8&(URWG684GM*]H* &]4Y]'3"!]+<*6'>%>'J..P
MKY"OF8]MH+H/'_)M//H;BZJ)#;KF_!"^9:S6;P%\=OTS0<.R$#@(,L@QH%8)
MW5NIC !.7:9+81'+NIQOXM*BTZ4\:<3@^P*J6;K93"7I!DN6GX%BOOI/=P.M
M@H-@?C72&"MS_>(PC,!CD;3YC3,1!>[-=ICY;7IQ@]*ZCU;%ZB*QN5T:S$ND
M1J"W#.X4PKTC31>)V.F8M.=<?"OU&S:@\[7J\O(*:)*DC^P_D$?J<_&NAA.[
M&<:Q[(H99E\9*T9J'GSU0=0UN8EQ3[)SMX=L.,BBOB\,>%5O[CG=)P9D5]7I
M'Y%=9I1==+.Z5MPVANU;KZ:W0^CMM1($!60:SJFR+#5-H[-8RI?L+5,4)Z+A
M2<N5>^I,^"&%))Q?++*91@!2^>'N SA#B2+PI%VS/WW2)C8Y4ADRL'&Q;/W5
MES=C9"B<%*<\IR"\'2<0A]-=^&DF<92\2#<$7)9'1L^@[6#]BK"9TL0/'2!\
MQ%!>4]E.-(>;'E#=5?^^"Q%KP0'TWICS&^;/<^)T-(E G1HFG4ZF*P6G@PN5
M]E81#O9 P<U]V,?5TGGKV"@,C;D+SLFL(D\970\"36N,M7-8LAZ@.%G_2IE)
M3NAL/&6)9))8#S"#YI69+FM&O!*/B"58J@8:Q"F E&MV4UG9:4/*TXR#5%G>
MLK!!8E>9&3M'P$D)*C/G/;*?PX+Y^48KRR%&1MJ)M9)O.. &8XS;#_%Q]Z"*
MQR)SHO-VM'*J>(Y'STQ\##1D6$/RQ?GI' 'L&1O%J,91[\=-[ F)U&@5V2Y$
M%D$2T$&T^: (/_]FS[1:<W^ME%'@?<]-Q -4_90TXAK/X(N28>B&ZI1SU?:;
M78Q;?M87'/>RU1]I&P(A^^B5=J<6^8RJTM,:>1U9]"BRRB)FTF0:H$*-#!W1
M.)M(+'H#U%J'&E9;[Z#O[LN=AZP$"+B<ZR=V0:L;*;X<4P&NGO.SO\7,[[DZ
MV3*^9)?O#8^_/^^9W,^85(XD )8IZ7[0(M#6^7CUKKI4P%)AJYU 5]K4OH\J
M>N7728!SV['S6]\$1']5UWGG&SOSIJ],83E*QP6F(ZQU!Q63T]'FUXLG0WJ%
M/)8M27$WBLTR\>T;-KR$0.-NV@44&5,# LLFL>)'+\P@DU5=TU;)Z=/L"J7H
M\Q/3E1$<#!+,TE12=H6.F^)Y[KTB;#,S54GSL5E!E9]Y2W+'"?C>L!,\;M,&
MU&YVV0J/X;-_F3*]**9+6CI7=NX[+(!<'9MT'3V1:7T[(8_#.+LDFVRR#J]V
MQ:&2/?Z_6C*^:BCL!IGC.8E&J0-,21D"AC%-F[ .'8)(.WJFG(HI409,OE4W
M>TDP61OI(:FHS;V+DVFY.8C%K1X)G_ZE?QXFBY>$D$YQ4N#4W''%M[3T16!L
M5>N"&4M[C)U,WW&2AY"]D(%6R\AV"?-F,J<HL"!2.CZ[!P^UUM\5Y?/528[C
M7<4I&1O;QCA?\ #.!'6I+-8.\J5ANC>5RY3P0+<RU8 I!D4OD(@$"$ U/+GH
M=<#($HN<U2I%L.SU\U/398/O2\*6FX-W(LH\TTMMAQ7B1)8SDT@ 3%V8V>F:
M]]1%8T#>!;FV,6?D;_,P=!@Q3.=U-GZ+Y0!PR= &$OC'@&W&M7^,F[@<3_FX
MTH+Y'7^9]"5,[BJ3K_<7\ PMUL.LFU&6 Z>LO8$MY=]*#%8_)2:H)GD'U1L=
MC=@E,!%%>;&&XAW[ #B/5/BM6*QN6#\Z_PZ+<E.QC/9I:91T,&0684$W,DS!
MR*2/*]1Q^ER'"<3@$<Z%<]6<Z89[Y9ITKVYBGM#([\!2LC$^9\8.XYX]?:H7
M.F3>YE\3XE:U[7 Y$5M27Z?&A5;_WBYM7QRGP<Z3L&-U  "1Q7+J\VYCN%<\
M6X6$=8@B[RI=,1=>[*?03'38*!T7;<C.V^>_#K T)>[I#Q$U<@P,<L5HW% 5
M[V8@D"%H^,BNV,,J2T]RHK$/V4,H5<F[#$+NR+0?GO>J)L%*V[ OL+:7*"W8
M%.X0(A'@8I/^V$#I!'Q-( FROX!=W'L1@\AZ/6KEE1U#76F Y<2*:%<P>5Z4
MKU>F>- -S<N,&A]?3"MO'$U8Q"S<;D,=K.2N+Z]!MR83J8#I^"T,YYN_ QO"
M4;4U728=Q=E6O@JVK26KDXD>T03'[E["8$#MU\_ZJ2@,VSW,M<*%.UCM=PX=
M(JV&U '=YE?OK+=*/L-5C->L:)UX,46Y9'K9JN] -Y2N551^'G<H,X>895&.
MH=RPK$5G<$?03P"5RJV0S>UUP'U">D&LOB&';7H14&9O_QVK\9^^U #Z<Z-4
M0_IIG=G)YE2'C>6*1+]QHWR8/O/N%+2:@U]M[2_6I+:/DQ[2F$NOX .7<QV;
M<O [Z3GOL33X7G)[I#.([5OE7JFCWP=_X:P/7I2W5@U<]\"_O$E^10&X4W,P
MSQN+K=8!QY;<]AD8J"\;"91NOIK<ZYI(*V/:Q-G(3B[_G<)RY+J!\  5^*6?
M>:ZJ *O6]:[/7ER)56FN*W12HEP^1(54+Y'=>D4')60N*U"??=!U.8/"6L<
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MI'6NM6K+,V]*CI\HW*@\G_J9]>N&5T05K]1!KZ ZDL._M.17;QG%QUH9!=O
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MK/*T\V*F2%9KZRZ5?JU/9E-0ZOS>E+]/%E$A1[+12?$$N%(X8WU;A(5@CC@
M6015U X, WH!G\17AW_,FPNXG+KU6:R^YYLPCU_U>E6DI7W&7:[:(H_7HE D
MGU]/]G&O\#K9;G;4-ZI:)"O/G]L\(H$PX%T "L&D%*GX:]8SPFV?#H0<%SZ?
M*H>[!ZCP*&R\^M3[[/#^T[MRU:D5]:^N(V(SKJM*E6.RBNC*DD-9R<CM KTP
ME\0$KGCW##:OVY+RC)DX&1T:4+'C2LN#U]X>]2?+#&G5\P35INAPITB]YCZ=
MWP[HP(M187B JK1]\SB%_0U"9UIV\6;< :QZ;0D_HP_ G:'+#XD&XIS65,>@
MY(8R7LLQB"[9VG.\?#'@!>89RXT1NF>RD],09UNG67("RH[X[Z$8*XVQ&*.Z
M?"2>(<M,MMGTKW8ST/[=1FQ,+!3O5!UWP;4Q%+*%>]KP(6)?HSC5CK9BRKFH
M:E5BPT%).D_Y^L7\Z'YB/X=/UA>A*<+Y/C;=@3JJ'EQO8VC5[>JO1'DZ<4PR
MI)9\WL#C!ZBG2W6Y,F32+$WYN%4)+TLHNK)=8,TU;LR;*=(P[@3=3.S_.*M]
MURV<!.A4PCC?4=*%Q1'(FI+[B,3+KK02J(-#IQ(_C[T6(\5->R-@K1SM(B%^
M\CJY2%Q F K&,DUYKLRYQ:<N1O.++Y/N*$T&3B2)'"NU&G'M'*_^?N[XEY60
M>'4A/S1ZO;[,6H?N-Q17EOS:,)1%=7Q]OH_[D.W-27LRDRUVR?9.U#/T.M44
MZ".)A;UN]<'6$S5G=75F_?*)X=*Y<ODM=>$9O8PJEL;:T;"*JJ ;1D66P 1]
MY>+90<>P])GLEQ'I.JOQ;9UE\A([N8S'N/F)WD<0"6G5X6L3&<-9EUJ_,QK&
M@ASEM(+[SHV$/MC9S?K\;^,$N(,-(6&&"^.C$27[ (C@O@JAW:!-QL)'W5PP
MX6'8'>)E2A>"B]IU@/3AK0]XP:$O"](H)K<O/V!](\\4LUALBEC8+<CW;<>>
MH;NK6J;OD^(J#4M=3GC 5>\0'!!CA4$3BD,L@LMVC*MX;(H;MGE[) %97D.)
ML+=#.5)Z#7 =O% =$1P9# ZV#*H1R;*6P*K5/TO;KC6MUR8'^0Q":2_HGW#7
M_+R?7.7+[H._4<VFA.B!"GHGM]&4LD+ <OP1\2P9<4)9J<CB/>'9\I^W!F%F
M71-G!K^HR[O&J,?R5-\:CBN:^R(/%@ZS7#5]*:L>P[50TOM$I)\.RJ^.+S.)
MPQ =(+$!T-97T7^@1CC6AP/L]P57B+_N/FH.4%[SG#>8Y)(;MV%5@:X?W]^G
MV2W'1A-%4%\_K=IMC+\C=<K%6K FB?2*-IX@C.=Y;6.*5"8<OB'-EZ3C;6='
MM<W8!LA$*]M/L([>IVLJQ1ND%3(U;N-'$DM_-RXZ2M'4F3?013TZ7L["1@F_
M1.AXI?K)2S]?N* C03_WS0^KN1[R%82B1@%5!_WEN?G@0"_[A=]FCE<%:%49
M$M2^UJ8LU=IU!C*C(^YDMHNOV!47[T7F+>U&&/P3B9&#D][4 -M#S7BWY!-*
MS*?-OF^V56:GV1E'.M=F!>825&,IIF>:,%.:V4AW=?./KZX5A":T,K;WW'9
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MG_=AY>SA<6XUT2T@QA>6=PO /]H<,UXCMO9-C3))%U]IW\F:GKX%\!<X:Y:
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M_#TL9X< 'A^T7I7;EV%EX#7K#F=O_P%54^)K^,(G:DMQH\EY)"JOQD?<[A;
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M-"X:>2X3D[V[AI5HLJ7!^:C[L<+*[)+V+.0%1<._$0F"MO=.Q;K4U<[53]S
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M1XVR#*BEM8'V2)-ON74;7"H(YL2"P^1'IQBW+YW8?2X-WUV9X.M",>R76.=
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MT2+8+2$M&<SI37@XSM[2D1QAZV98&;1/O^RN%9^C>%Y4^]K)9_#9F(N.36T
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MMYA2<OS+]U=QL''?[I*#S_/P)S""K53@A]+MU8%!M=<!Y@O4%OABP/H)_DL
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MQD)S8V1&FP 8=Q\?6P!,(!:R_PY<G !U:^W2859<T2%U6B4_ZW8U*PHNWN0
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M7YW_FNO'\F1\KH@$>2<3&P\?1I#[:FV"$X!)\6]Z1F8'2KA>VYA]OBJMM<D
M[S\;J6!TX.;E'^Y=Y/"P'0D+[G60I6TE'D$#<2A-SEK@7OLA\U8Q57QHD8['
M>@)&EOK]3TWX/];^"^+^?P5Q0B/8C5@*&RP# D.Z3BO,2G4E/3F/8;L/N@M8
M?WR'>;&RREZ-1#^CAS4;S8#//J4[8$YOO<:PTZW*4_<*+P,)*>=T7[WAT'<Q
M""5B[1X"\;NJ&:ZG##81L03N1ZNY6:#*#V2IEALFF:O;S\V/6D!5TG.'!NU+
M^J](T+6#3-4E8&^(2P9!@Q*40^:(?^W@M' <,?VGA,?P?>K-DN!]?$.X=S#T
M&/,7L/OJ6B<<0K0)[<G?@C66-S #(;42%UNP*Y$)2%+2L(#B*=/AL:?J?SW_
MK^?_]?S_B^>>Q@G3XNT9YB>.D'G2GFLTTN;7Q>E<:I"$'-M^WF4[FAI02IZE
M[M7Q#6"?;+,L>!_G=JNZ?NNJ7_;TS.LFL:T*F\D8&*U@=E[-Q,2R69_2V4<U
M@GNC57_IZEN"(R3X-\-[XK<I[E2Y[PF0>SC> !;Q>J]129M?L99SJ0G>*SI\
M4Z.38N&INW\^7_O^8@?2PA!W@<<Z>4D'<P@IN:[3"'<A]0WH:+HJO^ <6T%V
M_6J#2AI7=0-X7NZTIGIJUE.X(Q:@Y.(49Z?V<Z9B *'+^6HOZ-6U$V01H__Z
MV4L+AW"M]GV_ L8#((Y+L,^]B*=Q)N@YR_I4PSZ*,?P[IEY,0$G@*%? " ^B
MFZB@F0:$3,Y< C^3SPU :_?L2ZG@>V\-#<,,FZ1ZT]B%8,T=,)?-D4-1#ZD@
M/Y=/@]8-X$Y$K$9]N<+&W2BK.\[N/&"F?2"\/:<_GJAY+O\&</5NDBR)XJU1
M-P/,P1?&(6!]F ]AF:KP09XBS7>^VL<@N7:Z 73"!ZZ?OK30B0 V[T<G</.N
ML;VL^;%G6+1QNN+Z8V^3-*X1#CJ)6!,_-=VJV<%UZ@7%\F\F]VCO> :4 [6O
MSA<U>2[V(-#KM(OGK),E3'Q?20X55M'  V*1D6+Z/'9'B(Z.%(]N $M4B8/\
M<1O^A2<>-2OZ"1WUBHWF<5Q,&TC)9ER$&D#W)O2>L:SC-17+G.N)#XI2O6D?
M]7>!_<\S#?G#%M"&E[<L"QT=(7T;[DN;J3VR._4!Y1[:OYCBF9JM"O#/@9,)
MB3"&;-O+RH]S#HRV#H-&U$XZHAH"!0+.#>CUM3I+IZ:>7P-.TOHP5J\LT_I4
MCX=6R)P@(E,"^8@EZ4=GV3*VN0% 9[(N,(#>)G9?B8HA;=F:RZM:HGH5#J2H
MY76:^^<P=]:+ _"^1YF@4'N-W"JF'9Q+;I6)=\,.M:8A>3M!19!MV,E;]6A'
MMJ__2MM"YX_>SC!/R_1NX+!+YYA"I-;,-;[Y117LL/U,[WCY!D =HW%$8%@*
MMW$"HI]_7)5VW3A$P:R92][.1"R:W2%0G%LG6/96SNU6#JW/F)3+8*>O_WQ9
M.([$(>KKS.J XUA.O""_S_<Y;7,X$V?[&O.I2>V2I5T[+?'ZJI:E[JD+Z;/R
M.O6K\Z58^HM#A'%Y!1?/6"?!/!HQ^UT^O. QK4B&N7:OO 3E6KMAZ'?GHQUW
M1#?]:V]/7D;T:5IV%A!GVF7$.0(Q+^LO:">/30X[SU2.5Q$#T@ ?/7<K+;?C
MXH"%0WAYM]@>H!Y<@E=RK$8*>H[?+B@#^5*NXBR"_PB%#[KT3?<'35QMKVI%
M",-W4QJ5YW)T$O@SO@MJ!Q_8E4.$D#7$5P6X#/KZN\UW' _S^Y,N$=XHHN&9
MYWQUT(=S[0KI[)N\?D3:S'(^$#C! BMWXN/=NB"K@!PI56R,K;B&[\60QHW
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MK4KN(Y[D 98<5 ?S("R>DT9S=>&90!SOOI[O(>PPDMSBN<IX-H55U&8VM<[
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M>&)"Y^N]354R'7.=[R,-,A3S$_V7ZL:8BW0:Q\^:6GTF,F"?_Z:?(+;0L_D
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M*"-['ZIJO;-,9OH^/.<-D858!"_HZG'60B8<,QFA*,_OXI7(M:?""/0I($
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M'ER%DZK-GJ,.7;3G<+)W3^'VXYWHE97):HOT:35<2V:8%9732M-E/(NAS=L
MP]0I)IT.0U,(&K^RN^&8R^.R?GJ0Y];5=2IGUN":G@[GV=;%;EVRAI3> '@:
M[.-HKE0: #U7 &1R 25J^89AL$33'HH2Z(R(Z:<-C1J76<>8UM@O+>*)BQ^%
MV?G)5(W1]67]8KG1+8TUL\DJ"16VOC$]7#Q?,8/"II\4.Q"OA!? AAXO$7Z4
MW.2*FS$.IO$S34_(X37*RQJT+%30RRWU"DI)TN\/C4T-*RGA3>UZK-J*7NU
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MDL6HVG3P_ ZUNH6/O5G1>9'1*;@G=(MZ\GAY8HV:\ /.Z:2KS[K3&Q'3TLI
M1K/\7AQ4_MC,F2EVKTQ1(IHD@=Q*B7ZS>($WY.W0SBZA*X"&(*M;D.W"5\>I
MOA=TG([.VLQ?1-K&-8.MLHH(_ID2K>,Q+])+'U?GBW%]I_:<CDZ0UR%#J[ ,
M>76)F_NC"%RPUV^3UJR<5"]J&F(0/-Q>SBX[;CL*;%0]C./UX$1)*0H2*](T
MDMV43B\45W2^VG+&:HWXFL)H4<&QMI(^46V=VZ *!#;5BF8QJ]6-9JL/39J0
MC[,$!6 >1?711,/'8Q0X).;WT\M?B"AB*A+Z8=0_>3D'.?)UT[(SWV4KVN6%
MG_8T3A+5192U;M+Y=G69O"#[W2G383'K+I3V3V6TQ:)A@N6,2MO 6\MT9N3O
M67N *UW2D]'-O &M1M7B<=X%CJ8L@45@7)-[=0&6YI)Y_Z$!HH)$,S;1YD?0
M9ASV/B;-:;EY-X.!2:LI^)2 E/E?U\<RM:WU=_9O%F)AZ^5U- EZU;>3T\YS
M':V_(P)HT%M 5;8M@JRJ1;Z00=TSR8OK?W(NN9:YF<.1NRYNJEH__YN<5?&]
M"W%Q'O+Y;?8Z5,1&+!I,X0S899N"C3:^FE++W^V=O)Z3/\;+RF.B[2_W_.GN
M<1L7X/L$ _77PB1YD$#HOV 1#=R@)ORSB@.4/H</V$@=S!!B&G*!V'^QR[24
MAZTAX382=Q%APC]Y=Q&Q"\E#Z@)%(@/I%=5-ZAFYV3VZ)NA?E++,Y_L<A^]D
M3T2BV*DWW"-]9 %5*>E\Z> Q-:'!_J6-4VXW_]53 QD\2H*L]O#_G-9A:ZA-
M C%-(\;&T*[=->&K+(%8;;O2SO] <I?K$"IECF6RR<@\%H1H0R0R[J$JN02C
MJ=Z"R%7$-1%//?5F("O8DIP]OMBB[<]1[\):CSKLC(E)ET= +5HPOPU5/1?M
M8^[E_ILN.;>U/[*,AYWM(S";P?CNY^!V64N^[G\S-"C#V]@1F[!&FZ^:,C24
M*.MM=(]UEG^&3"L7=XO169MCW,_/I3G@^2A9IV-+J0_(9$GW19\*M8;6-5NY
MAZS'E]W?#U'Y?.H]R+F-;5,$_@"',;]DN1DZN"\E/&3I<1XTXP0_EB7P;[AO
MJ@7]OOG.'-X"C&9^UDL3"C\4:=X=WX6Q]<V-7Q;S'K(#O \@%LS_ B?WWJ?U
M7\I)-.U'RGKB-2@_U&4$APD.KE_\&VN3/D*]-SEXX[R7YD2\C<X%/G'^FV)X
M6'4.>'W301NQ>*W8(_SHV9VHPST$A*PYM<TFX!_KU?L,1.=CW>$^7?&8-WDL
M!6%FCNV.[Q]<0)4>,2W.-+RHWM.VL?^%\9YY4#_@8>7O03F/>1624[V[#</T
M+];FH5IU/^Y]TB3X,6 GOY>]U_RQ7A;R !ZW'=J [0I(!XV8.S^@4D@?MR*D
M2JT>K[T/%U/OD^>U!^6[O57-"Y8EV[&_ZPN<O_1]'5;;!W=5[F<I\C!0<M+#
M'!X3+G?;W#F7X\KI3J%[#3!3-@QV'C0"/::3J,V#]Y\1O\\% )Z^]Z8ZWER:
M276+6UYV%\5825R^PLV]UA>[;#*[)DDGV&'J.Q_Q.9'<!F*>Y/V=^[\?[O_]
M7E9$!#U-;.%B=C614#>."/8=FS"2:H=!JZG 3A\.2ZMWA"?D0+Z/:PH)!2F@
MH"&>8SE^DW4!BS\7?5ZW@."/[3F7J$,(C1>(G%L (O8+FWNX2>#Y*>H'CP)_
MAIG*MCIF^XYV0^1P[![>Z;UU 1(;$VMW7L_W+-M;XRNGYL0YO$Y%+717$7R@
MV4 ACX&=/E2O/&%CF)5Z=P>$5,&3!5W&3[/?,9\EVJ+B1&I0AVC.%;]"@2R:
MN^S@K6,["16NU8%%U,QL=+U>7GD_8RR^;YSW:R_RW%".^<R=S0RS-(T1N5BD
M]OR=0KEPN*6A/Z^C=,C:/-9$6+PX[],\W!B.X]:+M#IN]W"+=043:Y"N<]6>
MR^*Q]Q:2J69^1*&[G>6-;AJ_\G'Y2.]9Q5C7_(M\7:O+,Y_EW+>\-T@FMP &
MGUN TBW@%B#Y 6.#3?#"D.0R]19PJ?"U1RGS3#;4H65IMID#9+ON8C0_7&.9
MH6/_L:NJE<TLM+#K,BQXGFD4T?:\.!9AMWX+*+Y8<&Z5JYOGTK&A/L_[R9V0
MN^[@3<%12=P_&3--=Q$>+Z-,\2=K6,(P48/.?D<6,E.47*;-Z$M2IO/B.=E6
M.BBYOH_BIP%O-PEY<PVI $(O9*XMJG RF4=%5-ESMD2IDB_8.J>&C&+*H<>?
M.)=*A#_M599+L(OG7/ZB4@(WE]:J4O?F"E9=+&;CL;#L+[4CAZ,MT;RBO8F+
MV-%!7I4#TFS*M-<:LF?NS_<%J02*W05\D42(6-U>'5)G.P[P]RB4[R0WM83I
MQ!2F&L)7Y?W\ D.@,M@Y^.,<-X:!E0;C(U;#K6%T2U8C.J.N#962EG\> /;!
MB&P=TMJ"\3<YKQ; Y9 L*S<M7);+,Y??LIU5,TV$JT;$*36L,R+Y14S8%3TT
M1@/$AWQTWT.87&JB"GC Y:TA:"UW<Z:GS4'^70?)MN28H[^AI[295'.S'/X]
MZ,E$FI:9(R]CB=NT@W/1E[JU7#/C=WX0T4,__"YIE<A[S6M5+]HO2 '7KOY[
MHF[,I"9<XQG.?I247^ IY1J3G?>F<3M5AX\<-;7=] *0IR@<WU&XO6/2@*S@
M #/J(%)>H5 _33]=DS,B)# PU!Q",]4]@:9$)@V:K1#!CA)AC6./^9Q)*JFX
M#'A?4QCQ.=31HLHT1+#8A,\;&%LR_P?<QV-"H/;64L?00O&Y8P!)?I7-F';5
M@$M'#V]XHS?_OO/P04/^,R;O3XEW%^;WMX"Q^QTV$OKTOSMFK$:;&J/+1*SG
M/V&A7+.)\!0S[[KY,)<!E!.NMND:8JZI$$:3M1'W=GHP+(&8,Q_IL%%WX273
M8'^ W(GWIGL93YX%HU&V ;=!#D%5,L\XI5/]I.9FQBX.4"<**+.<5]##SS13
MY!9'@ KOC!)B[[7!<EJSHJ8SXE '/D%K-#H2.>GZL5"?:KE;K(\HX;D%Z&@;
M[&'5>UQ;208.7KM@)8F2(>GV-I\FTVM>K+\.XPOQZ*P[/J5A:F]<&/18?=W_
M/^IZA?0D1?GT%E )UH-Z@#;A>=*9?U.:16O-7FWC5(3V[:=\[FGK'+48BJ1V
M;]Y,9JCB2"*I:!3:41/9.?6,K$1/[M.L9S@YLH&AA1FP_IUV[PO_,&<9_-,T
M7C79L?YWR<!F0WLFCG*/:-7 MXFB!%=HLB*;"&ZN"]R/YR=0 W!R%!T5:1?-
MIJ3(0+JXI,$;$Q\?ZS0OP,K$$?R*QY.4[&8D4R(&6XLB/[@PK?MS=V*X_9?:
MP8]"Q?U'P?7"YE<^^<H)=+-:%*"4Q-C8XNI) F%]Y<1\$?2DX)I:57.4KJEW
MH(;991%NKZA@#V?4+WB_7.6N-Y?D>,QU!/;X%.8YB#JQU.UZ*QD927M84$SS
M\H"R7)=!QQKBU2*P_@DESRT^6"+-A8]#BEOX]D!X#J1H#G7P?+6N*H'XTOC0
M';QGX>")HC[,%= U3>_8K(#_ O.W--$V';:4L^Q(B/%B:U2_KP_[<329UW[8
M@J###Y92HII.A/DA*$G>J8 $EU-&"MRN2*G>ID4T?J/R^8 5;#GF30B_DO@Q
M49"M,I/^ISO/]R@ZQ3)/W".1\M7'^@]OZ<VW0*UT:N2:A\0#/3P4-N3SVG3L
M2#,9R%,+ZMAUNJ/^F@6Z?8$;'(DY[W=YGPE6L44O$C;NU?52D=6^=[*AKH-T
M%N.IZA==I\,KD]F>&SK<)%M9*-5H1)7S!HLT! ''IVCBK?6&&."X8:AUFD M
M6OTE'<1^H.R!*'9";,9P/<_G4*Q5Y<)T5T'_2JBQ[PI/U.[Q?*M,3/)$D8A*
M4/C<>N-W*5PNZJJ>"OCN2\*E$@$7NX'NA/(YC16JIMGI4"FFK.V#_7EA77U\
M?8?9>"%GG9D?I2D^8;Q^KSY#&\)$ZF%#CI08*;]Q<<N :&R*OXL;Q$#J^"HT
M[[:*^)WJIU=LZWZHY5<%UBBQC3)+CN/@L*D.A\(9/*@2QWH4!I&%"4KK4/@F
M;^0O/7?1%,IKDIGC9E*$%;9>1"G,$E]1TEU6/%6+2;;<'<-6BBMBV0D_TCBR
MU-&'J&;J.$MF_:F1$0E5-&1(C(@-&1X_*9)LYE;=3),L@Y ;>68Y5Y@7Y#Q7
M[CXWZR706MD@C\%M"D!)#]%=<T?8P;M?9F3H;FKQI.E,\2S-:C<-6PV'96^=
MO8KM0WENWOYZIVEMY,,QBS6.S?O?-_Y=Z-&),)<Z)D^H"4"@])D<&+>86HKX
M@Q8EC994@G)6\>^]>!"CYN1KSN3F/2J)8O?BI34*#BM='5^*?#JG*.,2HAH=
M2F2'6.G\UZLTGM3$]0-_6U>QKSVEY.TQ-/BJ^US,.L=+:*=/L'<R.E$5WS+A
MA\^4M!D[:5%QZFNQ],5%?,?;C%QADOU'[N-G03*>/8?B99QJV6]EW&J:20UM
M=3JQG?:JJGL-IL/,,^NU1SR*[GIJ>AU=O60MYE*5NI\X:?*%L_,I>"1CO\U
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M2$1N64#B70GLS4JL=EG I0K98UV-NHN,3YX$7S%:T"R]*=#I&/?J_YR!1S5
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ME$B*'EB.-XVI789%A>30U+&B_(PN>HN>>L3/C6%;:C&O:^??REYQ&5^3--$
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M@+GJXXN :9P$NG+CUP'G/?)WUAJBN\Y 7LOAT1(XM;*ZB0C:1;?,V+9<T9M
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MA!^3])]*B K-[(_?YD1%,H69,X'MB9&(YS&8=(?'K^ /:AX]>6FDB],;RFV
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M I#6 (SG1[![M98<U^X]B]I*-RS#AE^ +J^/XGE*#ZOKF-"8>N)J4NS.VC9
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MD0L 1R8:]76/6UT^*]G:7:0;Z2;#>E^+ITN%>7&J0VPW-Y[/62470.QS,Q]
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MB<;UAD[9VR<Q$;+V336X.>^G98X7U1N:"?+HV'EKF\;0_%B52NRQCW=<N[-
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M"\@/R&=%RI]UJM]#>,^*1)_'KGEW+XT2S,%R6H&'HZ#MHX6%>$LGE?OL"33
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MW.K5GKY:('6UNBI"Z>X&J#PT*>7?C?$\TC9VV!!#/ Z![4RYO&TPY\0^4LM
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MD:&]BY:"A@%>68?4MPI.[Y>5HR6*DO!T8>=P?'[="/5$$UCW)L-/- #3RW+
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MJNTQ/^CV/>I5Z&/689R)#5QZ0I62ZX#/8G)S92O8E)N1$4XJUY!O9GRV(==
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MXI9B%S2"=0!I?>0AJM0U$A!E*'*4 3NLZ!-_VV:?_HS26Z;EI_C;QK\*,2M
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M/9XN5_JQ_[FSC]J *=,=R)JYI7!YI)#C]@$@?S7DL^U]6NNSRK#RZK=2P<2
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M0>UQO=0FT6Z5)/5&0(CR,K;SWL@B_EU:=))_5NUF+W??1F2<^*!2Y/?HP]"
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M#O?>F2[<5J('#/?THND*YBUTT&_@#F"RZ*.WVYPD2@T=\M%+>C.?9?>MT;,
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M5:^'3HMJAVBT F$!A%J2V1Y4L<7Q#C0V 3PG4?$(0"@U<YCM7OF6W,S1[@/
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M'QP*]L="48VH4W&(.>^OOT-K)[' *LB)-LOC'L@=E/U'F+VE[FVD%84Q.0\
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M/Y^E(""_;\AQ0-L0AVX@YWUBC#[0H>'B<HB8'=7<R+#PR]QMUJJ@B'4YGV.
M@OF/():9 =25]11J_B<0'JHB*WVET(@0E0)R[.9JV&T1H\EPFFW<6>'Y+2'O
MYJ^)Y/9.MP/Y3=^2X4')+#-*SI(8T15EZ^?KI1#T$V,T8+77]R[0<F,,]HFC
M")F@WQV^UFGM1"V2[G#RUP:[:(>: &OOQ)++P<)36E_6$('@R3-$KOX16W)E
M*1[%M;X' &*#PD*-?K#EL:^6,Z.P@FOM+P:#P4462WDFRV(>2[693P5<9E_"
MQ!K&'/ID129/./@@V 2KC=LQH!MLNDM7%H2MM_0]]JZ5L2$1;:7:-EJ]U)L+
M'BUJW([P E6.##4&3'&>11I*G!MES843Y+.L%0(3%\@%3"(U;JEJU(TV&N>H
MF'2L'/0QT91!$'B6*9G4Q@7#VEBB@7&\C@"%[=FD7(,0QF%KF;P.18NA./,5
M3VC9\&G.&YO[^:-&M1RVKE#-W,-=?"H:KGE0$ +>UM&)Z$XJBQFA3M>"U%M3
M.?O\K;+QPB*L\*@A58,WTP4E-,Q;Y,J_0F]@G4[7'Z?\17@]WR_W]/D411!V
M/LW_+X@'2[%<D89X>?E'2=6,%S67'6$<FBR_@D-(B!:%VSHZ2(&T5^(EDXJ<
M1C9';+2&HRKK)"A1E![G.'PU.L;!.6; LUF@<5)XD49&=A+0(8N!X##5*MZ8
M.4"NG*FYDKVNA2..4\"$VDZ$MOAU"GF,:I_= '1\TR0[R<QT/:=XHL#4,"F.
M58K_N(?^I ]O(TIJP[=1@#Y:8M']<XI%-]-.N]P#8.LF[\1%J&PO5L]S2^LV
M!8WQ&F72&]*R/^V^T;I="=,\1KH^'/.^]MJZ782;4<-9C&WM&3Z& >_M;AKU
M#I(> (5#_]D4OI'&9S>U!P"52%^*R57?_EY B\5]D:!CZ?O64A2N!T#>?MK
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MS2'M&CG'CQ2OW?A;QT99%VI<NX]V&QY3K?4.G+U,Q%#'9@' &H878L,-T?G
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M^M3\[G'VR&8_2^V"Z?5H%GK2''SC V)NGB"6BEP"7HWNI"@"ZI*&"B+&EX_
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M7W=N>)SAO[(KF_\11L%+)"KF-FD+C:+09M''M?W'CMY+-7AWPPNB6LL3OXV
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M,;8!:%-ZR!2:N&@<X<EIL'&!*2[_B;.'P$RFS$(6P&,>UOM!]I![RBS5V?4
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M*>X9%>GXD!B^]#X:J?3PPKU]&K/8T-!(MOCXF(#J(7H.T_")F[P $N3B\"G
M:J*Z[FR9:O$,7IGA?V/O+8/BVJ)]7[*S0Q(D;%P:"1+<W4EP=PWN;HUK)\$2
MW G00'!W;30XC7O3.#3N[G))]C[V[KGGG7IUJMZ7NZKZPZH:/>888\X>L^>/
M?R^:]$MDU K5U])C4Q)CO:RV"@H*UE.\GMZ=;B5#%2OS.C_=:R/P7:+V$*<Q
M(];*[C?$)6Q"T9^C4"2]5VT>U:.AMF5?84N8K,[?7F!E1H])>?-E&4W4DJ$"
MW]5PSH,/AA/3XNKT92W/#_N,5,4K=WQ4=;[V?^^D\U]] "PW)EI)@CJFWCAY
MKWK>GY]-9(3O*&U67/ZQ<,#DZ*/FC0R_KCD,,7:J%0.3-J2+^/EQ;B+XXZ[W
MA'[6^X3I+DXN?OZ_0?S?(/XG@] (TX5?<?'\.+4GAE]V5308C&QBC.@9D@FW
MSCH>9\C<70GM^"\>O'/Y%<@L7_7A-V.GEHQALO2&,F$_OYI-A&C"]9'/Y'G;
M//_&1?X9P7YV*NE5(@8J_&[E>C<, 8,M*3QP6AMFB!7N@AK<AO:5MH3FY+CU
MC^U(\:NOVW<CGRP0\@^<=&09SPL'LPYP7;PG;C"X)X:B?'U>!C,^.'DC&L[/
MKR9$(E"D-MN3U+PDYE$.SO/7AFI.39=(VU?"1, B0LYWGC=WVU$]$62GRY>%
MX.SY>Q]OM1.+6:_*PRBCH^Z,80P]$*EP&[_I<;;4W16)_#KUYN[<>$:<5UV9
M[>V:-C&;I4O(9IE8Y".282G+U7CV@]^;//94E]K]7>VUB%H7PR6*GRMA D\#
M ?7<;QZL'7O2 *=; X6^>?/[(&]-/IY46XNF5H7/G7@>?/_!Y+)0+W]^'>0U
M_=NDK553Z:@[;=@P'2+,[P=R+4<H1ER?\2?T^PUK7::9QG'#AAQ]2S)64@7
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M>6U*^5,Q=EN;:"6H1TZGL-*MBT, >7H^R8J+.->J&UGB5D,Y<]<3AEF5/#@
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M]9V^C.*=-I]R('^/_.<0P$.VD%GC!K#LOM#;TV!/SWYL<D(H-5RRW.E>.K[
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MJ-&YVYCM>SBYS!PEENA@? )F@5XXOBEXL7>ORA3 -S+%[?->TC !@=:]I*A
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MJ\>1)3@*,K',%E9[Z<WX0PXNU<A'P/CD(9I[)]E\H+ZA+H2,:\,J.QZ'M+2
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M'NG_E8:N)(#%<I[[!%$>MFZ]A#UN?MU:_=V"%0(R&#KVYM##]NJH-^]>W%H
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M_) %.:')ZU9J>Y;GU;D!KPT:P=ARX&.CRYM9,YZ9P6D>-N*>)<PW/E_0R[U
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M;(2>.GY;G\QX;B+\F?6(R6HT!FE0&H.)V4,6Q5(?#7BQHG^-L"TR3%]HBJV
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MXQUC=91TR=5F"^1X'*IV9)$(]C%U<"X\T:G2)R7ABJE6E4N-?B.WG!/98]_
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MS*FS25S<0C, *SK&/JI>N&AVAF^!37*?6J23CR\0"KHJ6:X>Y^9]7.)@%CX
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M=Z&"=>%156_GFTN$-V4N/U5S@A)W-; @U2>=7[EV#8/5997JNEX!UJ>;9J>
M$<1L/]*G8'3(D;-*29+)JP9]6GN\K3B@3F&OJ]!QJG@#%.54_%R1IU^B?(CN
M!,1KK!TU3B+ .IDRU?]Q4D/6IPVQ1VZ%$8J4/1C"/9'4//8%N;6$<*7J;?&7
M5-&\N;Z=[VJ+_!)7VR31;56JL91J)5BG&62PH=<WO81,^XU@.DL@"*F3L\]1
M&M]TG#+G,FE7[NO<R92;*KNA<LSLG>9TD,2N:U(C>L%$?3]VSR5\Z.42,,4T
MH:*FE.\D:)./*O3#J7#T83(T8OT* ^)%VHOKWB*7K)S-(W8ZYP*@'<^KH9[H
MSPEUC8.+=R;348N%/9/FC/L:+O9.O6C)U\B##2"Y#\$N^3%[U,@9XR&]ERO>
M<IX^>T[]/9J5RE=Q[\LQB@(*AI%6_.[+3@975\&+.Q7[D^;DM!,A[('9-\%E
M)1C"+T@NVM/)YK[#TJX=1<FU\II:@BH/B\KJ79'ZJ/KHH]*;Y1'5Y,E#HQ8I
M/QM(YP>/,<RLU](S)XMGXQ]9KF*M ^PAO>8=MK';"&C.@FIX'.:'=HHL8/H1
M^M)*S)S.U)K"_ HH*W:K@QVRO.J /N,6ZVOF%L1T4:]#+(/:#>OF ">Q=H)X
MP:^^V#L')/6GWAM--RK,LSCG;S;-Y(]-IB1.CMHP7E$89VH5N+^@' _"Y372
M#?%&T2LAB XGX.SV+.]'YG^C@&S0OGKK<0P-/)_[2\)V6$2573,_*FNWNU2&
MIFK3[*RZ<'!FMKW":VG8#&V:P@5$PAAZC^(:'JP!WN3J<PY9@)5M<>!;=>K<
MI6_/:USXL?B+G <<GR#4]QW,Y)0'[?S3>0Z+<Y5V'"]WOW./[PTDT9G4AYJ%
MH]+>*"FU]>.C)V?:D21(*=0 $ZKL+E9WJDT&ZX<6.#Y>D]#- :3ZZ>MS *6*
M/9%P^L9\H9B54+QSJ%GA@LVYEU,-DX%7RFI64Y1]_6J6/!J+ML=6=,R'X?$R
M*7-4;'D!3 >6L!QR;27S!,29%?$(BLKO#54N.V&1=LD[PL(6<&MY>\OW<"QY
MAVFOFN.GN6B44&Y<U(T/QZBJB/!E+5!C/ZK^2!B^MG=.T:&$96:3KF4H*;W
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M[N?MSZ8HV+<D3Q".QV_J?_4@@?\)TN-3,82]??M,\?7A30L M0@7(+*$_60
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M,(!LG*/D_-,!:]=[K+$8C5C!ILPW"K]:^8D,#1R8=E)C3O7Q?!<HO?:\T[/
M&]:09I>FTX5]&E'-J%<ASXQ7I_7TTC3G..W2!#(1_+"0U.(#"NSMYQO+&6[#
M([J@TQAUJS\1YK_A,L1BZ:*>:Q85>9;\DUV.OX'M"03=2P<7;/MGY^YS5+<!
M)4&LX(3$6UT*M.SAL(\S,XU;OZX@TYY]%2]2%"KF*.;7"Q5+_QQN"A,H"D\Z
MC*TL9A25%JCXHH,5SD4@WU4QXS<%,>E^#"?=D9 ?DG3_TL8T_+B-)ZG?5X_
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MG&4\=6BBRW=S)UD 5'HIJD75\D78YG::S0FJ*;&Q6<['9[7J<3&G+D2UNBX
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MR+@C(?4Y+D(L>\C+>OP+$BCBGMYWAG:A:KM=7I/-+*A_BMV^G''T@N6F8N^
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M!NK/YKW*$OD'(^7187W->&*PYOSYZHW4#@[O.:GC'Y![DF\+JYW_SOH*OF'
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MJN>L>NKIJOZI-7R5E2CBKCM>B>_\R#+?L?BA"F[;N#.04DZ&@)G[ZZ[;=,;
M ^KX$M9R69J1?7TGZ/ #;;AM=B"-K>6 IDER'2EA_K7*P JJW6'2%HW]:X<F
M+S<J_.P>VXI5GF^+%DT;.B(2K-$^V5>M$0C6'<V4JQ2V-6\3[O3L]F6)4%4\
MV69U*9:ZKL9)=^M4&8!9I)]&[D-$"\SO5>2U#A:69'E"1"M$E/<QU;%"J@(K
MU#ZHY^"CHN*,,^G#F+)8AAI""BK3\T=D%Z.)-?^_G3TTP7&K%ZX+L?)EC1-$
MPLK+3;K1M('AV_MX3L.J2M: ACPG-Y68SKZE@^'5HM=GT*HR,:A*))UT6\^(
M.?D]TOQ94>4-8[HJ!:\W[.2G]DZXBS$] R/\@H&NXP3)!63(<T]3BD73-JQ8
MV$Y)((S6(DXA 78#C.TG(_3-'_P1!U)WRLNB&U'Y-\P<PTPJ&@_ LH@C9#8(
M'OOU%\.S;9M%7=R#&696M>+90.!6MWZR7-KF]=R7"F,HP_[QS.RZACT-N5H-
M$P94#Q^0%C-(8K!\S 2F5(1?-]\WI:VW?K8LEX!VB^?9.#5^\N; #1P2GURM
MZ&R%;CA?_?FRU;Q)\M,58"Q^3NK(#T7OG$R^3UINKWGS0ISN4XN853:U!OOR
ML.OV?I.94KR2 *X/KZ5_(NJH/CZW)#A.YBCU>T^7?.<=()VWF'S#NGCF0;>_
M](#;L3=N.IU3X9RQ3-N@\2$B+D<;6TQCBL&G2:EX@6(R3J/J3'8EU+1HZ7W'
MXB/[+M.48'H+.&2;6&TO63TEU0.1(7]4OEW=(H$PLP&OHTGV4:[5!I#/I<H$
M,)^D3HG(J!XM*L=GY0DWR%+HJFXWQEWC-DPV2!.O_DP.Z'8O7>"0"/B,$1+8
M^[D)[GU2AZ)(WC%&0^]'I43BJ5=!]2"'B9*,-)C-WJ<Y3_"OOAP3(3],*%DC
MX4F9;?F )8%E]0#=.*H+R:(R7QO,2+I!6++!+8KA5>$ ?QO8P4(XN<5\.;==
MH*#VR*(7[&Z";\<O-QDM88GX7-B4_RT)6A=KHECE*2+=_=N5&G*88J5/8<M.
MQP7*7B9LKW@W8A17JTRU10:;W:KN$O ,U3IKMU52IE;DYR(NHN@\[27\(_FF
M-W$OEP;X!$8Q+/?1^(#6+P/;"Q-9&.,.D?H^WQ%K!RML6_D%BIM'MS*ULE/C
MI.)Z$F^DI$I<F6,[;(Y5GD!B7K%,5"#66%H4<PF\4\PB1GW 93VAW\W;EPE(
MP=SX<>":CKLEXX1()HO2S*A5H&1V5]?W8Z5,BX'!#K+0Z>2"^YQ.D54'KA"=
MNQ:BS5F1-):HB1LLOU/T6K)TPOB@#2L^$O1XOQ:DNG \.\^3QYD&G)%OA /X
MK;YIV^L>="Z3!#!.'7G84H+]%]"<\9Y-X,\Q1Y.X#%U0VXJ,L"&4B@IKK,E0
MKZP]&S><Q!.7C)?3C%IYG0@UEZ;@FBR* BDZH[Z0Z^2J?<12-4T6BA\L7$10
MK]_+SO>DB"(,2#@A=]@@\8U,W;O:(G1,F,,GK>]*J>D)C'?PGF^)#U)OG6R6
M5[,D[<EM-&" 4[QVB_,!I$ABPU,D,F:M9SJC,T2"$[R)0W'5+U6C]K-U5)KI
M=52TU<'51QZ41/+J556"4QJ*WRAHNXPG:*K+S7I:Y0MKV<8Q1I-+EW/\"?*U
MJ*^)VVQ[A5-TD'D2;7E3+A[+]DQPS<!CJXNELQ&6#XJC'0555P@6> >\H!GG
M4/:B";<FE?[]L&U9>#]T*_+LE/RX3C@N;I"Z@!]K$)%2A2JVC!,Q*X=UY[BV
ML\H"5\O@H6N$1>%!^<:X>CGBL!5OOL%/\NON0/[J\,4!=GJU- [Y$0KUI*)B
MA<9G7QW"QI,?UMFIT.;GZ#()O[3R1+.:]@R'*@=C:EI/OI38S6<'-5M-)RIC
M&6FA^RQ8O6BW)?O%-Q8!C\N#?F6QF)_B*J@O_%NR=RJ0G6!*U[VKGE1L:G6E
M9YW?',(.E[?F&,5_CBQ;Q(0XX,3-8_4YRS6#5"78/)>QJ1QM!,\D0D"2P'SL
MDPF \)$UL^/.>GG@"J:E4EU=?5:_\#+M7%KY/+\HR,FA1CIW=GH@#GP[3W^?
M23YTQRL>5A"%W[QZ$M?S0T,\3J.S3<:AW5^9D+]'UB(BKVKMCE-TSMYI:*F0
MS;.^4-C"JD,W-K&[K;=&Y*,6C;3F]]@+>QY6T-V.%YM<K 6!K_,3?L-9_6W!
MI%;8H\^J$[W"]7:S?WMMH_*@H$:- >'0\?(<1U)WJVZ!3)^8!*X$=U\/.*$"
MFX1OIY,[M A9Z&W-G9 V]Z8+URTZ<5Y#8_D9^!IH=55^7#SC8)T] 0Z=PD#Z
M&5X:2>E,F$+)URO9/67-1\Q[-KKA I*X)7G(6EE&<YUM:@B:I(I8<M_D9\5[
ML!F+7S*IF[(#%FOQ2_94>%DAY*)8/I':2S'<1&E4"7,_Q[O7?]O)@%_!#YB6
M\'U/Z,0#:^6M<4S.#>G@IC8M%XZ/=UW$UV 26 FXO_M20!EFG@^9K2] QJ_Q
MG7\G7A5D^I,;5O$(6^IMSJ:AEJ"H@<0;4WS'.VWX28=L5M'5!H6S%R@6[G:@
MDAFYM4#^7441[@M4A2JI;:P]T:OF538B;PT];"*?_?:TZ\975.GP/.\.GXF/
M@CR7=PCBR-O)M"'R>>57S9*]-P4\VYKK*<%:=4C[Y\M."Z.6$,432IQ<]1WY
M>0XKGKN%:J9,7HFJ+!=OQ1U8-]%178)])(WN)^!]\:IY2V+Y(=P<2JJ.A]@@
MK3^A5AU=Y#8S335#]&&Z"V5IM.E=$Z/<[HK/>@PZ92Q$AFDU-S]H8<E@;[1'
M!ZF%=B[/RLI&.#:H2:6*6Z?:/8QR?\<T4;*B))[&Y*Q:XTI ,OG<.0I;GHC3
MI7V5)NQKT['$ 2[_/,3K)C^+7%U8YJB5H:8V7*8F2YN(A5'N02R]&-+7%Y-M
MHD:OX$0?6J)/2BB3'U(IE+2<],J/L? G;-SR1.-0&6?8?,H<3TAJK78.>H7U
M0HG]/C>@T"C.<;N^Y'JA;T1YF3$K-.>;^H_N7TH0O:UZ>61/>/\:0NQ9$%E2
M::=)%8/IO[>,P$U'\#SUK8-0([<05XEFP69C=<6 5L#!MH'5YD.8VCMQS#A_
M S[CY=GD&,-W6Q\'$_-6Y:689$8HIV\W%-/X>SMK6K[=F*].&Z3IES^P=(XP
MQ$V5<*WC]$;YVQ"CH!#B+8MB:G"\WS7J'&CD&4@C5X#=M@O?X!IA3C,A3.[U
M+D1$<H^\XVII&F\!16]E2L&:\WUU<%2Z49^>"BMAT*EG8_?=<5N\K#T\7-KT
MH+GGD8_SVJ;AC+:B'$[S4]0MZ/N^+%X<M,GQ\[RI;DF.K1C#*DS)^06***??
M\BY=#U*F0;\<*;G&[9 >14+4 R+:AROTX0\E,0RWL1P'-O#H9/GP*9]KL:TX
M(J^-"G 0K.QNU3U&\<ZF*H'U*YLI(ZJX[/;'\_8!K ?Q5LGVNAW+FN::=O7^
M'U9A(CZG.L:Y7HLP /,S8>X/'/TVMSJS*BZAO95/BWL<!RVZ16W<=WGB1"?P
M[W7 A.VE=%J\5J+]"M=*J!36XO29[-8+,J5(&'>=NSF8'$.L+C3AEAB])"$@
MC,9^I.7^L+2->@H."<N-UB@Q#]8T#Z)>>^BA?^,%_-?_$TU4;FQ,VHC*H%\I
M!?G\Z5-O6TI::I+[ @<E*2E#<47NEA&Y3J$(<",5+&J4J &(80.)[!/TD,A&
MXRTWS3D)+7EI.'/T3O')!M4,G/J$C$UJ<4Q28:54#9WL3:]P^D>OJ%T1%?H"
M]W;[I.N RN%VF=QJT]J\/#!Q,;(!KK(N,4>7J>>9)\DF9QIRKT"PS&UQ<LI>
MQ_A=Z[UCT)JKPN4Q33O%1R4Q'_%1K)=K>;UH]&;14<,F23[D)Z1JGI'9&6Y1
MW:9QP"^3HY?FQ#WRN40E!IZX>#0<(0:]0'T_W!"<#VL5[':'?8&*>ZU_+^?H
M,,-/A=(V-:L5>E<GW]9?TL]Z80&G%]@-Y^3MC)KS)-M-7+TY$E&9Z3JO)C Y
MA';LA?I#QA0*49^OX#D[<>7#F;DOY(G.++K@R%I-8F&#LBQ:GF6B0W52N3?&
M;#D$[:S-MH:^9BHO^S4[;  S)MT;8_BY37LE^F!Q0:D7*(H;<1LB>@MOT0OC
ML[K)!NO]7-V.0@M",\ZW\I'YXPPRDW&%O+52 S.&*W):Q)\:HF)X:+;\4&_C
MNZB0EAI%1>%12Z8NOFI9]-]LM1-S4W0M#SJZ?6Z0D),R?V"/.Y2UK)BC">LL
ML9G6XGS/H %9+K97 "OF]\H,I[!8I@D:@ND)?=.YD0*79#;9;1*TC<<]XXHX
M+W!D)TO-7=9%[CJ(Z/1B4T.M:ZYT!G.K_!J\L/DTJ+=&M%WL:\S.]<RA7UGG
M:SGX.+4>D!#_X!=WT"63/I"M,)Y4AH&G;2[61JTM,9.?GO4:A53;QCI+TF/5
M6BNQ]2H':C+R<#"$]C6X-XT(65IZ2U1 I^V;L#?E[V\&B*W*X0I!+.^*FOBF
MW:0Y4W?@FA-G9<UDX=?!.QDCZG4@RYMWU^C3@")_6MN04:J#>*W1@E$ PJ@T
MTMD7V[KF%DN&D**9LC+*DH5AXF@V@#3#6]N\T@LPPT_+_A_-8=SXE,E&F)6=
M_%HX@RS7@4;+LG?!4:]O6?L8Y4G]J6;,"46IC]PP7J":G*L]6/;HB*6_9Q_E
MR_H+A L-\A-=W=-L%K Y:K7$=1]O;B$2\' [>E8[9=<>/YLY6-A;83J-.]/U
MP7$WT.!,' X/UZKJ$P.KDV:D,;2VKYK"9;1[W,CT6^SSU"?R(B.&[,A4#A%"
M#C@W]RR(4.P&U)(]Z>=2%<[<W54;R<"F^##.M/:Z+&A*'?BPA)ZS"0./!,!\
MQAQZM/<[KL,#UJ/;(ZHQUD\524;@KWW _LU]%-N=4>AYAGH3U:H37?Z%Z<E%
MM-XG)1HFIV ;M%X+/;T\>]U)&O+SIMOQ4>V2M-)GN<P/3WJ6FV_._O6D_S>Q
MYAM_(90CTAM^'\=3?WRG[5GWR1I=N[5E0MB&A"(YH::E*!!1W1,\HP2][@PN
M313'V&/GD[_D?B1&AC$KC A$7T;4_?LQ- W;][19"":J2537'Q@H9NSN>OB]
MH@(F2.K-O:+WWT"E]<(PM*_/33MH3@*A^OTC.:#>I]RN?[>1\WI\)-/?.+5$
MYN"GO'F600IL^OJ;LGG&F?,HV/%Q3O]1K]Y*_IIXV=/_'[XIV5^,-WBDJZ,[
MEX$R'!4 V/<FCC:D^9L4["5P]8Z%1KR,@N3S7^JZ&=N7=,H\9A!<1203]#WS
MR6,R/B*O("Q>]*]:8:&O(A+]+4)'&8=# S_H^%$.!/BQXN_1<VO/"I)"]!!$
MP8L&8Y)YZ7D(=F'DS&2>92P7?%V2%2<6LCGV?D]$IA]P(XQ-O(]_G?^,+%Z]
MBJCT-Q^=S5^Y,E?Z93Y5O$#9/(T-R%+_KE<^?2=(*<'[:]L+U L4AJIT3MB[
M948".\!?-J>XG#;?_K@Y9"@G4WZ-J<.72BSP%DA,%OFWF?K+(Y&_(9WV"HCC
MK'[./&Y#A)//PQ;Z?09I2*O@SV?40,8(;. ?0.SISMIO@&L3F\M@$)K?'RHM
M8P16*=\(\Q_8:_@?H+EG@W"(R#^HTIV)7V_,>3BG.?QI(9PF#/Z@>C/Q_8V5
MT4Y%[F9!Z#S1'"K?3_\@4U/_(D8AL&)A5:=G#>NL>Z)C.;-/F'\1\;\*_X&Q
MKU8]E0LH"DK^)8I^MY%L/?2D0'>D/DE$ID#_&^8W;O4W^!1G]9->QZFA/ON%
M/C*5E+^:K\0?>NF;C=_(V=]\5N)=AUL! D0:=AX,]UFX7@$%*T:JP]UE4*G1
ME,B<2HZ6CGYG:R6V^[K<I/UY,\_27EH;7@BF#.GNMXL$VI(-=H70F^95M$&"
MJ"K[!4ANM94Y<NH^$ _/U&=DNJB.@R(O.ZHUIUSB292<?V\K!271<$9A@9O3
M5''V\%XN$9CWC0'#D29WK\XXULWGR#PR+N;F)Z[!*%&Z252S,FT]E[_AF>K^
M$F$*LQSD[0EDM)<]WM@3=0".6G?F.';4((2R 'PT2=(L'35<_"27,%*A9GGO
MZM.E;%9$;=(L%^J6F[*7GRBE Q C+.RYX2A1CVU4+9DI;-\^8+-7DG["W0H8
M:WL?,3[[3KS^G4":>=VG?Z,/_AS_EY*@8"7/Z:+OHT(U=9_ZD/:LC22F[U<P
M+E0E(:XLQ:EMU?0;).LX% NE/8%"*I,<BH?1'0G.9_<,$XQRGE!=L1U;T;=J
M$)SB4UZF*W,T7>OYZ2!/=Y!G=.B9!WJ,[02G6FODMUA6^T(?9MJ3R8X7*$VZ
MBPT891@E+W[W<+O!(CF0O+TI7'T(5[#C"C;P0(L#%]QN@<!S-/23*XS-0MR"
ML@2;.L8(:)A*78*+H:C6H5RNQ6<^Q6-2*JX$QYCH"?BVR4;4XK< F"'L4)JV
M4T%X&[&E'[M3.5NN*A[[UKN3?Z*8?D4@XX!+ILA%=MTYJ>?X@<21 &'3*RAQ
M26",(*56*<FB<7E2R,S5238LP8&7&'Y%]&%SX]V,Q@;60(ND:?ZA]@:52#)3
MA@M_&YQ_$C/=@=W4HI43PNJX#C&/U=;5<GS*BI3N8;.R[HVFY:((T+^"Z7-4
MIJ5G'G'^09O!T5:^]@Z=R8 (?:9GY?@!W4?LI^9[0W/=)/[7W!7%- U DP7G
M5E)IF.O%#*,U24OI:I:Q #IG;O4V-B\L.L8,#O^H$;O W5)P3Z@;]LD2(^'G
M30\ORL>"AVV-1U7 5\..(9L\]'ABC\#3VZH:J!F4"=:2GH+<S>>+S)(]O.<=
M/>?.L9]I68).,044.@R85UG[<N_9G+R>#<-WMI.%DO)//059:4*!-^=*@6(+
M9(.HLY,<P7/>$J<S@\+%/&H-SU>%UV'\WTAPOR$+D1>G/(\K^@WFBYS@'!3&
M[2U]">#T&^YX0/]HU _Q%C7+4#/;-[X;XRQ,#RFI"$>\?]V#N4&11NT'L2!#
M9< [(U_JF,,5$'4>3>*5Q)8EX."A(Q>.@W7^"C4KNN6RD#GH]'Y\:J+8B,Q\
M2;1 P'RL=<,0Q)'>V,A*7B2E_806<UI[?@TD;)]8K;YN]:U<2=8VD2M0WF?N
M(Y\1*-/T*_]H&2FH83V"S% *5$:%V-QKO#=/EG[R@^KU&)@N$!UU',_1U&:7
MF)C2!1PD5E54R^\E'%$5/@B\EDW&@%2+#29ONH=B"W1$$82 CX(5L%]M3J[H
M2%Q:3U#&J=%QSJIZW;WQ'06Y#.+,6F@S;$GLXT_Z&7=7P5V]BWDGXZ'D#-4K
MWB_UN1>R7UM7,4,:\[B!S'AL];5D"]YRBQ<)9+$W1W6"QAR1L3]0UR"-/=\/
M7K*WQ2?\9/%U?\2/1V] /V]E?X\*YZ>WD"W0E)"CFQF5KPK/',-(59'E =YM
ML9!]VB'<&1/8KM6^PCRZ K=YWL@0]>7>VCQE@Z*%=-G-I2(G3W(Q \+\?J'>
M09TETL[?@Q^D>&KNP=^^;U.4T87!.-B?55K[=7>GUXT-GW*Y9Z"_[7""BL:C
MP'$/Z:JJ.+A1JWXW:M]*E^_;Z//%IZ_DJ84Z/$Q?3EE3V/H#B_B 7]9['X!Q
M"52>1<V]%> *O#,^(&&>XXHH5CDJLU<L[5P0I%H;JAN];[FVS:;*;56\LW'(
MLI5)>&$HT&.>AEB-RMGQ,Z9T_9P,Q,8< ._L1>R7:3,&K&1M^U>']-^DR[_J
M_8M&3TN$O-'/X?3]I!+6_0(EG-EQNJ:+/1R%@;=/QLWV_1]Y]?8;J@9C),V$
MN6OFWS%O4A$?D:H)I^4?]:5D]IF[(I*6=)0X\-)D9?0''<5X#^YE]O=?^@7N
M,OOQ;R0-ZT!$Y;>;XWZ 5<1?4S$"2R@2]K.>3RMI#W>W8EV0M3D"2W?9D\<D
M?"0GJ-]$^'4;\5L?/_W*KMMVZX7,0\&FN]]Q:,HCX<7^LM1-TH/\0R0T97%(
M\PNF'@4_] '^)H6R"VD_-U2*TI02\DOYHS,F3#MX9*6 E.AZ!/^(,0X<9V]D
M=I)?M:*G:L/A^UM$59;ZHQ)FPNXO;5;@VPIS$W:Z:?)+@5U[$[&3&-.*W;==
M^P3^4G&"&_S-\J\:4B(% E:7'C_PB77!'0<R"DYQ'LD^$D09M>'D_LVG^9<X
M@@?JOQ5\T'M>?<B*2U'X [K7^$:91__TRNL%ZIGZM]Q#;=+F6B_(%/_)U/4U
M,JW!;?HW-UU<(/.'GO]KN8@_VHK@3R.)@W0(".'Q?X9[1C*W^0LN>^*@94HQ
M_E%?HNCN/EV/9(@Z>(R0KM[O/O(_1W\H_@:UF_X6-F\%"G[>O='!8U!W2P/>
MVYUX-OYERM_9!J&%/.'\DK@AHWG88D&5UT=<.W^:A]F1V@/%>B)J&M*:&9#M
MX.P-*Q4F)O_:]PGWJ5S0WY?S'PV(_$?;V76;3(1EB5?<T\+\(=+_*MQ,C(+G
MVPY\T/;,]@;E"#M^C(K_M +RF+N5HMQ57&4DD*+Z&R93[!\)V/:UW7^MK]-B
MNY- +AZFXG5,*^X-^!2N]\YN_=>ERWH%QW9./;EPE,P=J:^*\"<S?03?I>;\
MNLLR!9&>XP3HO([N>==[RP79JB\.-^B?.6I\M/.]9OI]JM+2;]\"KMS9^U!"
M>;__[PST_Y?"GZ"11^GI'.=H'^W6Q0+#8WBY9%MKKPGO!X81DX+BQ65FZ9C'
M$9<* <#N*/K(N2X0J25.D /1O,V7HY#8@ -;CX(;@JL"V3*Z[F:YK!S-(JPR
M&@67QK5#S,(=.$M"7[NBJIAV37I<'B(6L/F(I(1;:@7^*)F"Y3B,G!(=Q_8'
M_=5^Q@\.]?W#VV%M:K83',/@VR!CE45/"=Z(1/#45+9$R\5.DU;T$0FBBOXF
MV8PH>K<Z.*&_F=5X-+E1\J9842)([1PVON7X//GF.7BCMVR\ZCX*8#&O9G_>
M'>K%:YLSMBJ3FZI%.;>(C]F-@-%<>E"F:H.*!U(]QE)</YR+.9A_G?@JN4)1
M4V8'IXG[Y$BG%UV++NKR!0J+S,FZG/U#182#$1PTH5XN15*\?LQ@J2R-%ET[
MZJ GY@B&AC@Y-Q8D6.'':EXBCQO<1-\B&J2BR=G$TLHJ.)LYLJ[UOJ >=_X#
M=<3$ERIJI]XS9@%$;:F+"%7O)^7F, E:,3/N_HE(,[^W9PXN Y@[Q-2W62VN
M#U4-^$BEI@^J*66Z_5YR3#:D9<;LW7$>8 G*F@.,^?R*X&FVP428#MY!+X S
MD,1$AZ3IQSFH@"-KP7U6V$Z,-5H!>SAZX8)=X"RPV[$&L8,.U?9M<,=>F;(X
M7'(:P*GJFP?FD?I*K+.+L D;7M]RX3@RO6T$XLHR($K3O9%\J@(G&??649[F
MW1/HTEY-YCPU;TR% G3(S1I++6^5!K6FS.X,GAWO[QJKG<:*0HL5^\Q5_$VL
M73-2%AK[#0M-=>"74!%QBFL6;6PP>.[P%;R7(X^5G70, =KFS&;\M#)MY,4X
MGOE=8^&#'U@OH&09<4-5U:A<6MD2,'[X+B^E@HH8_P.$7F_+,493N3SYKKF3
MO%&(F"^2,,O*1W.'(]G]:3!%U-A$_#!TTVZ*.:5KWEJ60]1Z:0MCJ$!?V0=?
MLN#+T\3&D_X1<S@0:K@4"J9)D"Z_E@1V2D],1R+*F:>_.Q1@',D:?DW'JKRX
M")K&<'@^Z (RO+:1?X$B>)('MN CFUT'A_5(53A6-$E>(K4UPYH&>/J>9J.0
M4FW@#8HUB<KXY)/F<)JF-=XW")HB&C^6:85K8\O2,NATY88QN&V)-0#Q(%3/
M23JEF,2F\OTMLGP>E-8A\Y#\+/"1E-L;Z4OQ'\@O4.=FN\?JCE831B")OOJY
MNH@'KJ6"7H_M"(=:1G9$6L.+2PKNDI*DS"H><9*S0V(HYL1S14/ S+)RW75+
M+76<DY]-6*K?UWF_0&9ES7G513SO'C*B0$1M(U%02*&&R@@O<\8&6>HU_U<.
M+JB9I^D\1Q?.N [I[!E,.=D!@H"UWBKFQ32(2/4 >/) ZH.3]'/B=A05 ?D&
MUS4J+WOSTU+TLB]?AAJ#XN&J[+*\@6%4J)0)$_O#'>#:Y%Z3TD3EV)2@(FVM
M#6(YN<OVE#%Z)7]#B=!\;G8T[NP=Z6D0_N4(FZD0W+R2(Q KWA'>J?"P ]32
M!&LWO$!):[$O*L,O9QX3O5^M?D7V)%3.'(?\]D)LBW&/TM+B46TUJKH:<HPI
MKE?DE(6S';)37S.B+4$__48ZRG"_D03A,!6*&?J<T[PBS=+:9?DTI@H?17(<
M$U!N?0WO,B.YG,R8(NDEBJAZI6+O/6J80>MUDD.->/+CG]X-6#53OU>_)_W4
M/H5^1RY : %]<!1VVE2_E^N)S_T"92'S\U'4PCM+7;WR@>W1]O_?:]I%[(ZV
M9GXUH3CKP#$=7E/ -#C[.^!@?[L ]L T!8_(4J.@/R'[P';YZHNH2N>$.J9D
M_&,UL4W]&?^9_OGXUR@O9[$1&@R&_/PSA,'W.]J)>5$7PO?GO?:B;D?Z$TA5
M*\L?\Y4;VY>XFRXHPPX(/M0[64\[!<X"@6=OU,JS6PY8?"+0;P\$IDOG$Y&L
MHZUKZO@S\5J2Y<=GIL6Z@@>4X[;/OP))6>3XQ?S5*1H[^FOK2E@@L7=%15>"
M*'TL&+U_LOIK+F'DS,1&?_^K2FI2/LJ!E)+Z V8AV+Y_!O^(0,),_PB)W\8/
MW$D@RM\BF" I1(QO1DTX5))%:S:?6]<?N7'[\V#X,X,B)#1"8]HJ6C-_ABH>
MR-^.6D_^L*;,B<KBO!%\AX):V>F1%19UA?0 \($EF[<)I*'YDP_C^:]<D^8^
MRS_/OD#5/^\:4<;]KA< 2U^R2%KPDY[/"U3H;]488)V(S%6T,WXK?;I&5L!(
MY&1:"]Q6'"TXQ5[[ ?K'X?G;3)NSXK!_C":R<)OOHS=Z,&\*?JF0/V>(K&2>
MOD"]Z\+^8P45$D_>.IQB  7"=?!XM[I"/O]QX/[Q>)[3/%89Q5AW>\:SVK1)
MNK-]Q/A?H$"D#GNBXUF'_,URW']:*%P'GJAKL2;GRN[$Y"=UVG*F[T3V..C'
M=Q\Q'XNHM3797X5Q('T;_CFB<[>N2W:_I.^NXL%SJ&\K]\W%Z:_"?T29S=SS
M+#%U9N[NV#(BV98"9^[*M0!:2!/&;SOLKPK[8X&)EJ"P_JH1T]HMR\>4N\H@
M]+S/)3]R;<2\#A]?V[5IN_Z^M%W47]V-D9(.SV\N]D=U4>[^NM-,1KM\\E!"
M5SV\(V^K2J*&Z5L>N 8%(\J(9VDRG:KU#DVHO%\I/^E&V$.O1^[^[^B)__Y?
M#O%(QSXPVLC80:+Q VM&:,4@Q6P9T_,*J!<AO+JHE\M8(?RFH28?_6$C$C49
MU,9E^]:"&SX#21U^4L0*2-D'(#O"'1#W>Q=S6,MUGL,'9>^57=80%8%*Z KH
M$F_?9I:Y1;>S)<KY<%K%?Z'+G92KP$U8L59-IE35ZAE8/G?]'/L5"O'S/>@.
MP,Z 7VW9!.NKV5G?A_"DZ\-NY@5Q=: C*9BNJK5/%3^=@J]E5,S-'Z+1PU5-
MBB'/!; V&0,AL3HIP8W*]+R$!GSYWR2L C-AF#3RJ2-U8KD%WEAOJ  ,E=Q&
M]&)6/(R0\-><=T9D2>(\<J^+KZ^38%?M2@8F-_FL!T)F"/I_/F%N%-&QR6H<
M1F;YV$]CI>2$4)6IQYN%4@Y&5ZZ;_919RU<D5M9O];_>:%X^)F 5V&P;3)TD
ML-N$^5G&&AI3M1]!5>NL_,9S76XVP(M3-%M>DS1YZ$/'AM%,F,HEP)Z+E/&]
M>E_:K:1A5&Q:EA\_]$#*_EGM#,BFQ-6WES]N'9.R1";KT]A26D,96MADN9AY
M?X[VZHA,!WN<=1L:2P,E)@M5!^]RES/L8L-YX7VZ>:(5P<DS_%Z2A),:":)_
M*.R'6@2(5^OQ.1(%8[U9 $B+?]+99%CE\/3B"/&UG;OUG40+_X[7"+3,(=XC
M!/.F-ED99_H@L01#)TQK>3O-U:RN?(K#'G'C!>J&4L>!6G7(R&"]^G1;%/PV
MHT4]XJNA$O2F=>(^97W07?9<HF8\<GNB9%7WT40_DEK0X+22CF.*>P'7U1N^
MW;Y:>_N"U9.DB$A+8&7@(:(63Z^;A(HWA?2!E\WD]@G$6NPP2-Z$O/[-XOG0
M$9*%K*^E'\.'+SF6*<=7&"-":_OJ$_#<DG"P&5]6Z-XXA](VB\!(/@+G 8N9
M$6GN2QP)XY:EBWKBYE[Q0!,8__S*""H;96H$D697Y]$,;HT637NT2/AE]C3&
M(E2:C]D#F;@"PBU?_^W# XS88C_OBDG[]%,N<8[ =-&YE=>A\CP2+)M:I:QB
M&![^36>F8''2FD1-\8"]:MLDP2]$NX?&UC+=ES]CR-F0G"FG;GE>ZR _"(WC
M^F>#M%Z=SH:>9+\6(WK@I_/)BD6=(\7@9D_GOGQAAD!ZC8(%)>SZ=]CUK1F3
MAN0-_R&-M[%.6-M HDQM[B6"IIC9D3H0OWS**Y7LZFHR10<NB^W1? OEY@2*
MG^32!*J#V@!7ZQEIU[POAG9+ TG*OC/\M/>AO5<"&^@CDCWF+@MFS?R9%C,%
MA8*-G"VE3L5G3LG"T@EVM>;4C9*.AR&@=UL%YFZFEK=!'6?+<#2_@K\*&(W#
MG>)-6=+9]X?P\T*>15>O=*MJ3(^H#"N5#I!))X(2TRI/&&IU4F+=4_NFY;*/
MOZRMX],</;3AOP:^A=2-"'-\^4\;F("&0B[<XPK$(9$MDTZ;?!9NTN XIM#-
MP>L5O@/#R'KXM1/2'[:/.<RH;Y\8?3DB:T_Y M5(.QWQ9F7R%8*-'0Z8*Q5V
M/T0Y="B'CR5"I+]QR-&_&WS4G-X#/O*P"X]CU?K/ O_G=O"K0T/+!/3N< ]<
M1#*0JZC[>',I!>C&XTX>(=\&A?LXL1X\N<1T!>50%8Z-0V/WZZ7WEY8%X_3R
MX_0*Y$-Y?\V-I?XN0QDJF9V!"-1G"U:>I(D$$FQW((0#ZVEQYD<\>!U SCOS
MKY2AW@"NNF\HN2<?0MJ>/W[Z&AA%MKC'N26XRC*Z7IWVVIJGV[[+ZM2_(.%J
M\SI<KJ%\:,8>[YLZN=58F'I)&!OXN-5%MHHS(=3RKCJ,7:G^2X(\E60G+5E\
M9;7Y^TV:@??<O2=T+U"1%RH)]'=&O:U5GUL_+(5(R.SFT>$C1]#O)C$%/[TK
MR2N&EZM<EK=9-EL?)F0\_F@2>M/<@_!V?W"+G&IDF)FSRQME+[U(M>P8)#Y5
MD:CUH&Y_N!@@W2]BZV4C_%V1DC)XN:6SK\9R:WYSUO4LIR<'$"Y,EVP9<._&
MU<IVO 2]SIYPUI2EI\IY0KUUD,B;3JN8KR%M,2 J63K);R6=:5GDJ7KMEV-8
M+26176![.%V#QFX(L._P3.-%&$#?QZWC<;/-:+;?V.K)H_(XXH>HS%X6;1U,
M6VB.C<D \X\YW>)*;KA<SD9CKCC:!AB$&<<MLRW,I7+\Z)7HHST301U]*]X7
M^&&+V*"6Q<7YN3'.U#M:=V2Z*XX9C-?5%0IP%,0>#:1M37G=VV9IZ4W"S")T
M8(;M08L",9$BM_ZA[XY4\4B3;7>#UHP6*\)[[N '[['U@&_E0CTJ?H8FH&M9
M9D<SC-K^):#8UL"DDH+2M"LWQL+[ @&R#%GZ2,0Z^- .8GY:SX)RP=UC:@MD
MK@NIQ#K\)38C,3H=0)U<[==O#4+:A9A8DMT3"W- 8O6<E1\+2;.+8KUIW;(7
M)ENA75=I=1I.[ZG%?)2]OZ>*#T!M)1+=SG>EL[L(?5.(20V=GBZAP:&RJ=4H
M-^_*LYI_P(B6)_J8.[6A_V4NKO6F C7,8/[1O[Z!=:G&%!^1*P2B>8+&U97-
M-:UJK_$N@J'4/$YF"+-*(Z6'"14OQ-(Y?@%COLM%J8Z"@ER5DG5.U# JW /J
MX_M]E:+Z"A%&,+/GU?2EDW%-;]=B0L1\V2IMRE#1Q=YA;VS_B14F%>5X4_^,
M4?"WXK4%OD9)0!8V'2[U?!/$LOI=P,8\7[GNJYIIY-)IV<_]<&4UKL ,3M4A
M-;-HV^[JK3;[5.[T@)7=,ZS:=KYKQ+L2V"@^@I\RHJ[) Q3O@G>A>]*WIGB+
MIE>+Y2XJ&",;L@ZMOM7KS4U'J.09[+0?WX'DP!)Y,3^;1T@/1#*4U'>LG:JP
MS+OIL'&/O*,1A]PS3P_3+M?J/]QV3QO+'*FYQRHU;4L^2X#4CU(E$Z(:QX;V
M?E:E0<0:JSY7?;FS!U*1>W:U=6;6DW_\<C2>6HI1(";-<?DSBOWR>,RD(NTP
MT9E&O?A1V:Y.-7U1-H?,?"8@<[H4+5RI4F6+]$.)"7=JN\P1^)UX.%J,E,C3
M6"-1#9&B<^$V!-^8RZIS 6MRR'DMMES\\"C$QR_B:[277FAF1+J1Z.RTJ5D1
MMCU*'A59-L#];#QYLPQ5P]_9^O%Q1!/FTXK<CGQ8XNN&#W,/[G#N,Q>;LI6+
MWB]0VM&?@F65OLNC]:+KC&V'15F&YZACE9.O<"CGZ@1$#!_:]W1&R+SV^'\'
ML/^95_W/O.I_YE7_1\ZK& 0S,B5&69\OGT4]%;0_Z9]M6KY @8^]GOKL%A^O
M&KZ:6+^>;IRD<@[XR<1,Z913+\-!+X[5"$TEY-UCA.K9N]T%6"14U676H#?L
M;Y$RPQ*7F+NVS38:@?KBOYF,'I[1NEQ<OJ*:(;L?61EY586UXGI.:\:>M\(Y
MGYQCK#!'FHJP[26A5$^F.T_?7<:9L'4A),@!#>1"H-]JE]<EN? *H/4,F51)
MM8HLHT%A4IJK.AK4G;\RB;9_UP\6PGMXKYP+"&(-D-Y!+:&OL4@SP=7)&A&)
M_'0OX.Y%QC?Z,'F'>?;9[E40) ;\/-IX<T,"L;F867^5-IU0H=GT64K%FGV.
MU\C KFAN6(V^BI[JB]$\W?PZ:UQPG'6)RQ'2,I,;.X ;:?XP#@;A6?%$Q(KI
M^Y5#AK?M<2)Q"=WT 0&!Z@O4E(KJ;51V+W/M@/BL^0.9WJ<:<3B 5'K>I;9G
M+E >F>^Y#.S>#T:O\TG,XA.0IQ(XTCY>P\"/*!+P(#K>.$KVHJNB7$G;2:KM
M%>WN';0XZ&X<R1K:E[S2_ QCHY-VIW*9;B"ZGL2H^LJM59K'>I^H4).E((N3
M?])0T8+MJ0*N/B?ORG^@BV86_50%OX>]QF.:P2E9=2>(S^I<13B>#5VKUWR5
M0KTH7F0:\>W]U>6WL2<:G3/]MIBY9OMGV?U%IS*CD2D/67=3D(6HDR0I,VQ*
MA  57+R]7N[CSLC'C=9M4U==;">Y6TN1-<$)NL[15M9(/?2I,6SC?WM70F.@
MT%TLW6Z<K(( M[$K7TEM(E84TS/#"!#7F1 :]"$F^*DQC@,$X82=73[!55+*
M9#NK6@RL$=_-V.#)4]!Y7YT!-U,*FT'\89\;QU@DLDB%C92[=FM7X]6FZ"2.
MN,Q/V!N*RA(+RCZ 2OC-6?4LRRCJYS[Q**KN\Y2F[%F[]_1JI>4KDA/U^,@F
MUVD1B5:$[% '.KES.EH<B^X=F;76BO2;7,W,Y7?HFK-X39 W5:$?*KJ#-+!R
ME9\+AC@41?$%S(%&8E&XY?.Z/4H"4"(H:N6-39QY7:YE#L0:'">;5^6(X+&F
MO(#Q+]^+IG<";1<XYL'T16![USIK0DX]>H.%[SEWK]FX1TRW"T3/.M]LN!_?
M"<VX"MG@U<MQ-<I2@OE&6'P(NYX5I"=651)M=OKD2&RL/#O/%0TCF$*2Q083
M>)\7/#&2.]7A4G>79P^TKYBJN<9XA;ZN2MHG\,#H#G6B44IJ$-J OZ^-A,;N
MC^M*,>R<.3O+J+(&*40^'CX;='1=5S/&BJ[3^VW<+SDQS2TSN Z7U4=6SRJG
M)W*[KE0V96VR'VT><"4P*[F_0!EHS8 LW1^ZL=A\=0$:Y-HXS]@!9]J;C8(.
M7.\0VMTT%NUW2MD)64/3Y$*;[*OGH< 121I)J66INJJ';5XD 18I ]^44^0Z
MO 'O?[5 ,T0)$=6RW0MC42)G1=UW,@4TD+^3$+L4/8WL<>8,"I5.E%&K_3Q[
MM?)CXB&[\2WI9O]]*S2^6VV3$9L?P\#:;K5S3T%F<H7_?K/<9-G7EC;+.Y7Q
MLA-JLY6D)F&"T&I>9KRL6@Y"\UOSRZ'8LLK&C4(\[S;31<*"3I(XFA4!!\QE
MC90D,>X#[9CQSL&KS'CI*5@QJP;:"I[; N&[<-NKYD45;VSM0R^J)B"=/:P&
M@>2,YLHQ,G 3]*F'I6RQ)5(<Y=>4/XIVLONB[F=Z?NE\7.MH&36^A[8L9]48
MAQ-/O6>^7-T+E%1\F6:VYK!PZ[&[HL(A$0DHW[HKU_O<A!$9\ 6&@5_K\7LY
MX#0Q9487QRXG?*'+4+WD%(-&3!4_VP/KC,G$R[E(;*&ED]'_<UR@#D$]?9!_
M..I#3MEVKUI3HD?#ITBW"FJ'"@YPJ)K1$?+K28N%_M?ZDWNI/JB-XC+YM?II
M&S J^.&1O:*41M?YQ\7-B6\8O8.#KC]"DR)'>=E<H:A0J@[0#>@Z1I'57M)9
M$#Q7V1G*#:-:%1DY5U64WS];GI4FNN',Z$^2&^(T6JJAYB<;17%YI\S;*H1E
MTB:F\A[[E^7?\FJ/F\F?O4"YFCVI59XL[I[.LD_G+- M!?+5&.GCYE-<H69&
M7FA. UAL'!)A>DHJDSJFK1;>ATV$E69R-9#TPA&20"*Q/VZ^?=L[5;L\TU*B
MN#AI7E\IWZ62U#<[<AVU,$ADO8+%KXW.'X91K7ZRT1QKV)'\ B6._/TQ;A^]
MN.YI)[;%03K2X1+)'Q-0UEGOU_:I !CDHRVD,U3@Z\V(I2.246Q8[<@:U\S[
MT2#N!4H$%7\J=<#+I8 SW3^L5:!FV,7S4"HO:_FUAXE.Z@+5/IK:M1),8'31
M :&7N&>OU&V.FT'Q5+5;K.7\8"^$#$:)7BYLYY6!7$LN(_C1"%2QT.C?P;/$
M6)WIN518WV:*= 6I=S#E)HV<!,JV+E"FL<BNAR\TL8AKLJ@MD#K<BG>P0#-Y
MI^L(7^HIM?%#3EK)<],4DP>*E.>:SB%K6+-E%0PXX&@/W416H!&-Q!5N'ZL#
M,?GBO<:%&L6H ?*$:W^AON^6\$-5FLK#TNW58_9-,%+@5V:H?=DM@>;)U)&.
MGI5,3>/F-F<*I;%C7WYP^? 1^A4<W0,-M+"$\E5D6TX;D,)3L:5*Q5R#KY_#
M<FL#&.-/@T4E>O&UBDI7"5OCF:5_]DB[8RW=&EM#OLU:66N5#>9^8[&QAB!&
MW*PJ?^4(70Z7\DS,2@>7K R7[@B5^Y%L+?E58KM<>=8]4Y$>T<;-2JR2'/70
MEG*QI8X;\!3!8F8V(5RCC[]".KFJ.B[7/7P3MS$JUNJ)_JXD=J<*UHS/<(K'
MHSA*M>S51+N:D(:S,*ZL;YTS*:O9/B&KIKT_KI9%$OE\@IA!%\\6IE+!A&8S
M*$)V\")[JW_DI"ORRY/R+"E)J)7' />!;_.L5^4E,7SA];!!SZ1_#!XQCAM<
M38E5<JU3PHX5O]/79N(1 E21*4DG!15?3]WGCZ'<AR3"1ZEWVBTE2J.BV?VG
M@[(S#&]\,%7F*5*K+1UG^+.ZSY+Z>?W+&RY,,+:+JG2*F F>NDL"9D6%T\_Z
M[+.CC5RFY>,]9@.T&>>6OH]ICJ37F5R)1)@;; $:&S(^)[-WW8G\I >=W98W
M2#IEBC7&AKC6(7J2IEF('V0^D7]G6,QV49F\4AWSP#JP*IRN'?DYE?JN5JL'
M+_]>]O(SG>J[FJU=YVWN)-N2.,T^M[+D!(GBP-%TY?2T!EH3>2A*1GMK4C "
MLV&E)%N0;T5/G^SP8!^CV!"I_KIFZ;.4Y$6\@U^]L3_' 6W1<$8G*IF)0"\4
M$&4"4GY">I_F,/ S:V_)=<:IC0T =#8Z!AHE/XURWBY;83QU8Y4/3FFW#UE;
MHX$FIM&:K=:BVVSVBX=#_&JNL^),H=Z%[$].WT@Z%L[$-TIK0Q_E-'/H4R(4
M72ZQI=@6)-K )10-:I9CB>)R,\BE3 ]N2]S.F>]M[#!Z+ON+!H?=T MCW[93
M^Y2/K(2Z-+#5O]V?3-&O'E$5LD[N810[U.2A?Z\CED_>VQ7>1.V?!])IZB^M
M1JBF"@TY6\N;7Z*6(18_H1Z)F8(VZK&+BN'9)A8Y%_JQ_&RJA&F&2[4 -A,,
M^;*OJMJ.%W VY2-:A\8.ZDFI=#^7A-W\4H4:2S99]V6-*BRIN1H8D2:W64]B
M,3:>0/-$G%V7,?OM:XK*!#,Z2PVM\G"& (NB*BVFX<:L$UZ*A1$9ICR2L LB
MP-GD53!1VWG[9G]>G7+YQ/J3V_,S_1*?<5K>P7SR[K#K/L601]?P/ =_=N?9
M05V>V0?U\UI]G&FCS)MI296<_KG#+$M58IJ+4JS:Z,C6PQ%J,YZZALKB#'VR
MHWM\C\GOAAI<+&%UW6][U8S)74;#QUEOL,X(LGW>#.A7N,Q1&[U 30P6>9?N
MA_6N6]\3H#<1UH$%W.7FIR=BRRC)J6_(@?,#Z/2&BZ0A!;0V&ZOD+88A"S6#
MX:1;;_%SMU+C^@BCIJ +.8GN;79='F9]AEJ[3)AD7PEES0*LKT_ C%2FS;W3
MQ:4>B7"4N@?&^_1G%_&*!AV-'@=EZ]3SF%WO:ST+D$M:0#7#19W>T  3,SMY
ME<.0H*GFDUA.G$VTYQ12+#K*EHQ@@Y3D+X8R19*(<W,T0_8TX2[VK_=O6;?X
M3\I"!B+DNZU-;!>(0MP6%TUTS?(!*5M:"6UQ.8L<%,6466BM]:I6:BSR6"'T
M<9.BVDD@I+0ZZY!SD%H!\SMHTN.<9=%+/9D5@::5YH)I[GK[ZIYB"UD;+1:<
M6LO4XL-T"1($@I+,F:QU!</AKF0:<9P+9X:8WH_B3&H&/6L&I(,# @>R_2:3
MU\]DMDJUG*4?]+AH^Q5<K]K=H$IID:12XY,63VJ+NC7HSSC*4[: .828<Z+O
M?-XROD!9"STWF=S)PY\P[.BN0P0NCSR$+!>M\NK:RPY3I#A,>33QD9;\;*LN
M6V,^-[5Y4%5D<"6Q6#&3)'-:Q;CO!K>;X4V%\4FP;/Q7!&I6BGW^*3W1R^&-
M@[*#)B] J@L=O69^S<P5F"1,M;^IO'_*[WW50..3.1$%C,P2=VR<712GP3P!
M\(W]E3.]+@PI?4O.<<U2@I>@S3KG6SJ >^?;"[_2>-@HK9MH^,[O4T6-&A%M
M#YIIHK&CZ.9[Y:H\S.,Z 0I!ITHGUYM,!_D^<:?EYRM.Q_0.)W*S-93#=0M:
M%O<K_;DYQOYY697+?50(Q-+S&/@E.]7N=QLA_I23:+@@YWGL\N"PZY@R"7"W
M/]-'G' GT?,, ]>SNIW;P1]')MHKS0:9ICX2S98E&Q9O(NLBFSYZFZHY[B.I
MYM'W2AO(D+&II-+>H"15TM6YBH8ZP)5MD&.AZYU'N0_M@GH/Y51.B6B%)9IT
MFD/@X+S>MCERJ'W9 J"BJ3H['NR]2Z!4Z#V.$;=3,A*0]$LD;,WODXX2L6[R
MR"EV(>78SIC'DU8[>,<#D^D -C"B/I]IQ%6S06M1WM_KD=AV6P\NG!TZ-"^*
M1Y,EVU+-NVZ@M->&U;(/&WBW2O!Q/_6 >I/QVU0E@8_ 9+88MCU+8D.>(67<
MO'<!#338@TC"F+\S)F(K(MF/,BA #;.((]B[(88%FD[&!*:7]?>F/EZ[- ^N
M$=;=$=83J*\K#<O&N3R V4M+RIILI>N$C26E:VX5"VQ)N(0JS",+9>,P\8OC
M?CW'L+A<H@5*4BUQPWU]3$!0_'4!#\[QFVQ;"QMKV1>H;B^$%LXCM,;2NHR%
M+/%#F@$*10TG_0,[K'K&;3/+L_USB'- UN[Q09C$A\;FH\PF^U4PCO3;5TYK
M_V%6]6\HL'?2/5@Q8'.'&L(8N>)#/(8\W_7#J>96=])90)48K>.4$H]S(]]P
M%W<@C"+;D*$V:;9;/T):XMP/E/#))>^Q);=O<66[A!2%-5;.]H#I_D(D_K*B
MIA$L Q,D_,HK R7:>/A^.#AY9O-I8BX5UK*U.ME?#Y7M-T;HVG1VRSMPH+S6
MAZO4&DS+HYQ<@.W\I-$DBW2]K5]>/Y;(7E(/-U)XW)R ]*\)^BO"9K)<>1DO
M,.6]\4E'.3=/$LC6Q)XE&F^?*(KDPY&P2X+SU18NUS0A#W=K=2C!/$_^B(P#
M/O='E.8-B*SW6SNQSOBNJ#2%2;R9W67V:"/7B"*VA);>[UO0[,XKM = UGF)
MA -.YN FJ_3<E)Y1@SPNA-57OGKQ<*;-]CN%L_ \'OM*V^;#*)HAG],,Q %(
MB@L$L4W,WS[CEI)J;V&5FF.DA/N58S#9E=#L(+@$R^/\8-7?$/#+/3.)6G")
M7-AK0RTP&_;2S.JB-P1\'BHHM.NKCZZ41*7?;$P"Q5_LP1;T.JSSQFK(['!S
M(5^\(N2-R@V2E;VSC&D]DL/>77S;:S0P6D ?4VN3-&]V!PM/79+,?>,8I)B?
MEJ BBFBDPWN61I,Q<I]_G%C)^Q#9PKZ>B49F2,8U"5E6R0,ER83(MF=/KF>;
M[,1(ZN&^H>?P>3,!Z*,LJ(XAXE4/?H%:./V$_1'ZI[- Y<QB:"9#1=U*>][A
M/<&YH9AU8B7=^WJ\TFK30A7%[H"WOJ# "A;14.$"4%Y:]&9'?QH^3M^['9-Q
ME-P-N$U+JUN:')0/H-AF.I<JM/./8LH%I$FT\69P\4 LFQ69UL+TY!AF#\E8
M%Q:#3?*V L5B!0O;J05V@U;I0C6</%S=XJF?0+KX0NI->QL8 3QDDFH&@SE0
MB_6^!+D0=NLA-I1 ^-OL<T%? N:MQ01[OK@-L>^+DS'#P1W?\J<5H]C'P]W=
MU&AZV9H@F'#&9ZX\ \1($I=E#SLGMUZ/7WX(8']V;-T[Z7D :*V$KE/&9^L"
MI\ZRK8NFE2H7UQ*. +7F1RESX)O:Z6H51 !AZ-&0@4F#Y682S2>][_]Z2!"=
M>6:>.)YH?.KO_7S(@[K*OGAY57ECJSZQ1?F;"!Z9I0D&E]E,T2%@$1MG_B_H
M4<C,?TQCQ,TV+C(DW!;XUZ7_[!1[?=IFZ?I]5A&W/^_5/[O-Z*E#^QWMY$"
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MMGBY_?56*Q 1\"I?:7+4>"N(&L.K?@\)WL [8R!@4 8C$OWX]3>YKNA2/QU
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M"^G<[3]9/'3G?-[NEGN/ML63<0M-DP IFIZF/1"X)6OER9\4H8C]Z4?4>"=
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M(O:?D:F_MUP\U*!H.":..^*N2G7W0"/+2XN<S LC<SVQG0=O-B[:<Z=*69E
MB!BZE]VKS9$?L.NV!>*(WPWH_Y%;H=-HKI,%%,2PJ!&C.CT<Q@1+[U,G6_M8
MV4D8@+$ZM7-()S>\/:TU[?3"!AE-A@O^))QZNW2&\?+I?1]MVD=,\-<B>5E)
M86EIIE/%"46J.K>Z <ZXN3DP5N@0V;.#V^VF6<M'"EO'L9.'T6*_E&/+75N!
MNC/52DE!W8;85]HD/R\>7!8/ZIX 6%Q->U[N;^(?ANZ/+)/YMERGV[1^N\<-
MO3&<9>YL$S[!T0T("U.Z85T:'9GQ-OW?_O_;_W]$_VZII<?M3L'XHXS=)T"J
MH/5O$S CB^A6N3%B/C"[_'3 ';9;Y9$MJ2W0K2@H G*."FQ<S9O,3A4TOR6.
MLV9_0TWIGU#WT&&9;$H:KG?I-A:FT7D%:51,N7\FN?O%Y>"@)?8$7?LQ!&WP
M.XB:\%!BX/[!,EFQTE2P^J[AEOO7#IH$''5PR%(PW7'N[LN,\-318^T3H)B9
MQ;%6E)^?6Z$?QBA0A]I*P[&,XI_N3VQVAE*27LS#ZCP_WR28M7J KG4GE'V/
MCIO"DT9&>'<IN+J+UZD=IC?C>V5_;A\WA/OH)<G:V=9U\DHK( 3=WCVNH_\D
M8I:EQR&\_7KPRA[E?M',]259%L'0F\JK>Y'I)T".Z._A3O$K8JBM7QO*N8(E
ME,QC49A[[KY[+2 GH[O?TF+EL>IQ[UW7.>T=1>W.)$7>FP#(U2..[B[JQ:CE
M(+RK/S;/+L"H*"NGO?=P],'S =CR!#!ZUW8GF'V7?]=3NS-(0?FGQPEXEZ5'
M$.?F?#J%3&+NL2HB9?3M#NULX'TV'#$69V712U[X*/;'B%=!$!=T$;8\.IXL
M7#8U/"6;VCQ:TRP8N_0$T-B][;K&IF>Q=<$7NK<3)JIT#<MTTS[_A^G9E&+J
M]=$3H.K-U.VJS<BH*9FSZ-BPPT?;:C^'EA&56'%2_QQ@3&5G9,V#7JY#[M*O
M_H>Y-N%3_S+ACZ?,#0HB5VCZ5_J[3#1[!:/M0L=_,RMTR+V']3M:;!P='D&%
M#WQ+GP!E\P^FD8-@OU4HUOS 7==(6?NV4*O=O>'TZG@R3]E4W91MFM>Y@]"J
MY1^0;+NLN7<$9<N^?(.(D ;+K4H(/2I>+WMFM,>*"P6XF\^.)[.63;E.N:9E
MC5ILCQ;-/0$J=DH/GP!OAGC+6W*'MTQK2++G;O1],PIXQ!4"<NIJ4M*%N>8Z
MJU1YE!\M306SRVAK[K)LJL:<K5T_IA?WKPX@B*M<DW'<U"V/2<_9STQWV@BF
MX1+PCT/WIG-+75MG:H]?;U\6#!T[F *_;>W&:-X,8K8./3J<[?VQ@WG#Q89)
M I?3X7\(<L-*R</+2W&/].'.G4LA;<-=.<IQW>PY_Q6[^VE3GXYQOK)XWS*I
MI2N+WAD"Q;3(, H$LX?$5NI-9LFPQ::;)78&L76VZN$'A879NQHKFI1TR'M(
M3EOF?1.LA0W2F#I<N7/OTC62$"L>$&A\Y7^N'@F?]2 NX>%BR]@DSK[/M F$
M^_>@];+/UT5Q^X#GYY\  E5GA8(>P+?$'6$OM58J5'E48FPV@<W+A/?Z-H&/
M!(]KN1,[JMS*730>E+\')3.+2"-)OV&L'OI-F_@T* K*M%3,9]^>/RA6C!0^
M(.&EL&M71PE!!3S&=N5H]NKVO@1[D*<\ <2ULBJ4;[8SYF[/GP )F;*WR,PL
MIF?ZQ*>&*]?N>2-S%_/G'SU_SMV4]EW8I+6FN%H2'4+AYX$;FRJ/7R(&4Y=F
MH$*/LH?WK6.[X9*YL[EOX%W;SQ$0#=HR V2XX7#GJ*G[9>#6IHI?/9M][IEZ
M2R"POF7#U4W/353L^ FP5X8S70J"FPXO^? 8WO!,I3T!=M\:6OE-'6OVVPMY
M004)@&^KK_(R,+[=J__Y35++\J".6(G#/ZM] )KW!%CW4'I)/<1MO8GHIVX4
MTK=VA0(]!=\N_P[X5B.HD^M0N+3:[^CI<?D$V%I4?@)H'K^ZS?PZL?.&<[R+
MZCY@8C>\/Q>12ZSAU!E>_:#S^V:79/WV8O?$OO@)(/+2? C3FA(C=2NK?_!(
MR"MCF2 3"[O_*.1</@S>P'3!OXO)D;6\?"$8>[L )QMCM7P"7#.SBCU:Y=6@
M;,7&+OC=Q.I??5* CLP97$'PR<IPSZ80&5Y'A\L/73><4\(_*&K/A2Q"V:Y.
M)?N/A/RR]9\ GS3E:QIIQ_%)1V\K)'>S75,.UA_EN5[M 9IT9RROR/]PUU&M
MBS4W\:N^6XJ>"^.ST9;!B]]/ !IPT#F ;Z5.N.5-/K."C_O_DQ:FX-Y25A[M
M=H=]Z*HETU<&([BDE&VT03J/6;\%>T(09%*7E\%0LX%Z0OC2]P.EXM@!F$&'
M00;$;N#3/BF+4*0.&(\Z#2 ,1-7-3RA\3$R0_4/C?9HD6#]QO10$<K'H2^OE
MYL4,6978E9%B*U[31F.(AB84/(90)00N*&B^;-E]-DA7U!#)Z><OZS(S9R)C
M@RS,$-]E$CX8Q"-P)%*5S;)5,:8L8>8UW1-!-X=09B-P23MU>\S:C>3 6YJ?
ML;)'%P+[*E+;GITG<DX>!F)HYN_[.*[9ZE/%*Q^.U@A8E9@E8T_(4OV.BI?'
M3'8<=P@C#9?E$&Q@@,3:3EN5"W346G6%EJL7MUJIE[D)"DMS6>3<4U,S<U+E
M@MEE%<6D!<[&A@7BDN.3I:#65)\"W_@7_.NC $E:S567W6Q#G\;-1]H! ((%
MS9]*C_=NNOGB1%+IF?O[?_>1PGM$%ND1P4=%1'X@-8/7?UMT]JRL#N9T972%
M6.(.N\XH^KQ \^\.\A\:$@8KDZ3BLAU8,32]E91;_H)2;;7Q@0)^E*NM'\SX
MT(13::B6+;,N-,GE4+HP8EYJFTV*22(@WJD@GI$K+M;5^OZB<_\T%HWW"LH\
MW+1_;[G$)Q1-5F%.T1@/+5:JL+>%EP?[KR"9"<M]#[_-'=:H)&N*]^H^9;?M
MH"=NME(SY'T-YAK9F/+]RL'!EV!C&UWPYBN6W*!M68<%@BAXZ@D@J\I:QAZC
MTHUQP;%Z.#KU[#(@[Y.%)3X)1&+'KZ8PE&DUE>O"J'K731,:T9<=MFG"PXJB
M7AL6V /+[\D<>>07^?C&P*!JE,_8FB_:4;&I4N$TQ9N1:=&POCH!6UGG.!TM
M3;G:GKZ9Z@DP:YX0YP:)XJ"E$2_K+P.Y5.HWAGMU_S)US_?QNI%X$+=B\\O-
MW,'OG:Z>+11O5-IL>D7MB5GD:Q;B$^^82VO=VJLZLU*3_[-3OGLZYB1-C*KU
M%64]]AD!1@83Z6*,OJ9/GIO3#I=GQ+)2$2)=5@8V(,I3"UK@B&GD"L4. M'E
M\]O/%S:>KKA2>U34GVG*E!$>3?9I4/'_JN(.2Z,(LR,&R-,3\VL.+3$%T5MY
M?WL-ZX-!6\4/W3+L@CTSJ[\;G92&RF]2@\LCPAG2HL3B1#-"!_[2R+C:\GT
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M5N!SMBFU-N'U3%.84+^^8W6MM LH,P]4C\C"_JWK%8"IN$'6L?13B@SC!MM
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M@3;H[:C$DY-V!^C__ LRY5SL3]E$:IXCZ94'A41G(C6P/F[:TPB^9I'E6ZP
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M[JGHW(ASQ04RY^Y&;'V$1F21K>C$3["]6KI;<;,O4IFR6R?M0PVD1D<Z-D?
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M=N/-7Q9E*EC5*;2>3D--E<=T"[*;]E,U;]W6IAR4-H4I00S$Z*N[9SS&=K+
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M[SWRL7?95R]I4_P9YJF_P'C2ZQ&L'YNWT:5II>ZJ%EML<O9Z9'B4LB19.<V
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ML^Q$9.>_V&'%?IQ7F7U,?RB;Z3$Y.WWLV.3E5W@L*[I[44UPVH9(=V9L[9E
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M[EPL;.KN;;TY@KN&@=FD<-X^=J! -,'JF2QBJ$D+N3'[C8VS,<_T*LZ8:*&
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MM8=O7(RW?J$]K#L/4C\6\3%1^W' 0^_YT./%.<LH/%,$+AS@7\&?U%71/P7
M)KG(ME$JNFIDPP49 HYE0M253=+8>JYIA&L-S0WO*VY5[DW0S._64:>D,?-K
MRW*!.QL478CAF0CX9%<^K7FW1)@,DEE)B0LRHCP3.)7P[=LI,3VNBO9Q\UB/
M2,2"LNKRU\.OG%=2WCC P/%I@/[[2W_IF#8Y^<X:=IHZ3/6H]#E"3YTP&T)R
MF.5/EK U'3R=9V% :/7@F/(]082$>B.[X*'2@1CFH0 8$G/+.1N!"J( !DS)
M@8JX%<FNYG']N9G/2/D9TS79U$.XU$TL TX1&_W'L8,+M?T1U0FOCE7?5KT>
MKFK.KZ@@?1B]&A=QI)Y[=8I/O6X[>Z$^RIP$L63=9RIU7Q.O#+W93Q(:;0@5
M]]OQ?LU4X+/33PA8;Q4[U$^?D+^_J$: 6KX09)3/;<X(1-JF9_SH)-B391BK
M[1XS:I-WOK>BT2<6HP^JN-V9J7)*:EM .I!2_7[Q/S5,V5=(\GJXG[I'?EX;
M30G@?SXK$^"M2FB-GLHR4KCO! &JT)U+)=)-,XOP!)A\'>LP&*L'H;XA'GS-
M9.)CK[D*:D-)TO+@+*O-"*@H '5&/;H4C);!NU1MN%IFP=NY_(8L(UUZS&2D
MQ&I7?3=;!ZCO-/3^0N"&OK$QJ>(L7E1K+NL#V;3S(]JFO8TRJ'A:#7>(%6VX
M-*V1313@YXJ.&==)<HW<Q5U#J''2@QK# DDJ("'+)3Y"0<+65ZE-3;^ZTM$$
M9@XERF,A,!T0XB:.DT P'3@!)%G71I#2"8H')Z"UIO#E^I=OFPLRDDB9)4YB
MMY#>%DKQF6OPMS3$6K"7S:3H3?8E/-2!O54U\-J\(0 %L.V3<Q^?:VS8A9**
MANTMN%!<E*/S>VA&YIUI0].8<2DDZWAV2MF[\@ALR(5M.<=658=H>&(#>(A@
M!96^^0JES39/- U[S=^N*2"9D<\%* C;:$#3%NZ;3CU-\?*O!C&GIKKNK&.<
M-GR:RQ'_V) *U2F+#12/U\,'PS'&$9UJQ#G=X:8V>,_#@"!2J&6H)57,.U)!
MCU=GVU7.Z\OCK*3F4-"PE^V>P%!;@U96$\\2Y^GKD9BJB18W:0TF<I[UP+*N
M=YUI>3GEQQS,3.9A+-,[3 X]Z/VCFR)4GZX(*WEU#:=KZBH$!BSY#>9@RJ4S
MYS3PIJ^;[3-*;D.+TM55+7X/4F7T^,/7\$6^T>VU'DOL\5.;I0:2]*7U,8B_
M\#/MRWS"AB?/'=<7;(=ZYYS &)KM6Z)J--WG[6_4_8 +#YM!H!2K)'^R#EF[
MKBX:(%K0!?M2HKKK9;K:C._:]FJP9?+X6!EG5I]+&\[N-H-\*HI*V^2[^:/_
M3ZK"USLK_IA3L2)$[0^]F/47\@$E(.>(<G9V;45E*_[02%,;+BNK>DW:U#R;
MHAF,^Y=Q7(JQ.",JJA0C*F3)^P_2>_]3]^NVYSU.[7@VNE(K\O;,5E=[SJY&
M !93KAXV>TQ0W-CHD*ASL/KIM(.S2._-PG61)'ZBV<<KS^7X,.:ECYM]G.\/
ML*(%1V86WE\2%E])UY>>\7??G_-!C3??GN>Y!-*E^7&U1)D7B1>3=(R8?_,(
M#17OY!*((OA@G-X^SN\F3XU#]2CU<_>+HB#]2&U'RE)\:C_^/=WC12?EZ7(]
M>_^8Z@7K&R8Q$YR"91==F?Y21DO6:G*BL*^X*8Z;?"IOC?/CI2P>.47.$W&V
M_'W88YXN[OIX0,V!-$570%^+4NUH]B8L=71##MJ]P2*M68X_9&N2Z)]B9#;&
M]_2\-DQC@#;N57?[*,(I_+/?$NU6\FW>IG#)1FT//5R]QZE?&895%5$L7,_2
M#7DE1U>:6*A23DP>AN>KK=V)80'$7$3UKD&AM0O+_<[_)Q4P>!=5#5GXB+NP
M\':\OR BX#9C< %LACVNF29\<0VIWE[U!6OO%N JO@L%5)?"W-V2(6%0)0FC
M;QIW9K_'7%3T6L!V(:&UT=*1VMZ.]&O=C=DB]UE:0LT*KRDV*_]=W>($41B\
M!Q1JRCEMW)WBG?_6T^&+I^?, 5!4]L]/HGB/1D4!AS<S[X[,^LN*#-^F5PV'
M):@TF5)*B/T';;_3<>\0EZ[K.#;KT4N'6.F]<](K&"DN_6"QVG'(5[#XP]5Z
MXGZ4U_JJ<,*&R7.Q=+LQQP]R\OE2[L()^=V^XV&V?B6N_8KYK[_7Z)^_48!A
M!UI"9-;S#EWCFHV:_O83BBCZ/'?OP[B G^"T6;9;7PEW?J<V:PD#(:ZL+C=%
M=^, LU&-C':*++!KPGR_'9X2PPMSHQ(7ZZ)3S+@:BC.IXES\MX$\@:?6J>J,
M'LR]ON#MJ);*GK2PTWQ!DY,L WQ8J1WN A#BNE-)XI-/M839):KRMD/GQ81&
MMX2_OWS-;:'46DQNXY&B8TE&O8[1N9J$M[<IOS85'6'\?,[ \GH]V\3'KMRR
MHMM0$S41LM:9G*:L=_%NXUK.:PU'Z8AF].7/W9^A&J7<LZMC<3"SK#<Y;_%K
MM--@GJ95C/@4"R&;^^S$4+NPOAYS.[.%DCAG58$@)K+@/+GE@)=:_-SGTQM)
MRA1N^\)LA][V/1YU#XM+4=ZS;"9:ZC UH79I&?759)U0T+WH%(Q.FS=*1;CK
M$OD\S8.)W%297X9*-!T0J)E%Q5X.$49=R"/Q,V-F):#E!TF^$^9!8C0:XZ'0
MP0E'7$M;(X,/DUKCME610V\4E>=6<#^A7K.'^ES+>!I\OZZ(%%R<31?C919=
M/]RL^,$T-2??::J99\S]U2R2*BM.QKM1XCF'N1RK:W)24;T 05&R5]&=*+G!
M<1S51R N@[BB 59]<]F.9^^!6&$M1=/:0D>#SZ@M2FTP<*D,Y+X#&Y,U9,/W
M@H8;)-6]>27!_I*Y7'%>O7' ;8#)GK1A_JTH*]F5S (H^UL^C\AW3-Y^=,88
MA&G:<6IB#$N"-1A?I2R^=.&'LTQR#(_GDWT.3R%XUN,K!\K^CK'4G".=";VQ
M<0;'6>.1=XNO 8ZC6VG3=>C23W8_$6@W=RD4I.4_I&>K2:&+IDZ&]::W:_I^
MVV3D=0U67%(]U%CB5?^>(0HN5/NH"II*5]4K&9Q8/0)MTEK%,@WO/_>6-Y'C
M*I^FIA"T"9Y[4:=ZZHXQ<ZPB-<,7LOBV$RN4/N')I("5A'#*I![K6@8B*-S-
M\HK1FI["7=8N(BJ:V7F!.&QKXNYDA:[RW80I7K\,6>'/R;<W @6(]ZX^=2>P
M*_4*>[DW[G$=UJ_?E9@&)IF5.U:?X^]R^/43D\F\^S+KA+LC3Q0DWN/26/J.
M:E.1YG3R;HP,PUB0<7.8\NHN>YGO68^ 0,@N")JPLIF]24*/[Y"C^^W-1%<W
MTQ%&:D UKJEEW*0%\+5VIR2#H-VY?R%(#PXN,EZ9<KV;@!; #BM/+CZ<G%K.
M\7[QF5$>EJZT&/5/JK06V%E@-+J3L566%J-/UI=E"P=]H2(\?EHBW[N*L]OE
MG/KDY$L<MD*%\YY!3K/*5%KRY,YUK/MZ8N4^DPK2X>"^<>8G0RUK:^(YXKDA
MOSA^.K=S.U(JPZ!;MLK#5&D@+>=]ZY^G[_\O-C<Y#U-5NB[H]@P=0"W?191-
ME3L5H+P/$W3=*>E91MMMBU0L6/![)965*J+=:6;FNSQIL!9R>ANT(CECGQ<4
M!WMA8/F.,)TWWCQPKEQO&_#=ZD*_IC6 &QJQ)=PF7=G?7GX^S,"ZDK[[R/,+
M3>#RH&MA):N^IS('F#A3IL2.F<N=>%R\+_5TY^03J)PBH@TB),,F.Z1N5Z+M
M3M+P,J6;YRN(K.!!FA3:"[7-)(Y:.'K]D<=ZXD6*"C!= 21Q_./XWJX\Y=PN
MFFFZ0FFG^E!#KD;#BI"!02W4)(9@:*[!Y]A\G[@)'/SISG O:DJD:*AF&RZ?
M\4:S-*7FH=@XXF1PQ]:^\HV>&9>& O]"/?!KK:UT=[9$16K]Z2-J[9(XEV#?
M!Z95%O18'+=9%57IPJ[Y.IGCO]""?L8Z[ZRK(;%#P=<%"[PS#7,Q9RWHQI,;
M-"7 _&3\=KF=4):$]L@:AJ(3GBZFSX#W:XK4=>RL9^8-ZPJ1-?36DY["#QAG
M;R.?JE%R*86Q=!@_=(S$%S;>CXF3IZ%>UR%" "RJ2ZD7A9_Y?V/9*DE2$Q(:
MG7I?-SOWD'%HSV@A+T.C=C(G/$Z&2N87FJG1!"&XPF"080C!?'8)JT@N9:1.
M/.2,-*P%A;[@=YNA#J0[QX(+*].S:DL?(-F.35[S)^3Y=\T6%]57VK:I3G8Y
MCMMM$M?5])\H>W)UT"L2N:9YIK$&-"U,'H0:4RE%M\;?JR3T>)P\?Q(D).H2
M8*)DFZH?GX)*JK$> 9*8*J.4TU,8 YMG=:XG[^92TI-OVV6ZFQ"'KVU#>!BJ
MG0BZ0C?Z/R1]?RESW7@E%:>GLQBG)[@,@Y4>DJ]I?I/)K+)'H50G=5KL[H]5
MJH%UN2I,1\F-38LDS0X+A++I.SJ 6$6.C$\TRY$RT]2B,Y.5_5QKCP"L4[U(
M%F;\0N2!W_#4[+P<?+3X972,,A<)8D!K[S!G<4*?5]DX!E["_K0ZB>_%"NM^
MCE%_7%ZE^H'TA*KDH %3E?5>>DMYQL>.PPC1$SDHT\32$(]S+69D"W=@D3DX
MCCEX!L3ID/.43[Q+ &&GQ!@MW1F=\//?YPK1ODOYM>VURB\T^_-']]+803K?
MKV^,;]G*KZTH,9"^LV.\OC@Z2T4:!"S"0R)D_WF*3";V9ZEH_-CMU2G5X:S6
MBX$8*_;(E]2%;!00(I"TEX/$_RP97??'&@;",SLTYF]--^P#&1E?%/)8+#LB
M.JRMO14[3UY(YSZJ4XPBB?FW?ADA7$;A4WU1R>]!'5?5J_Y]32(/8^YX+UKU
MPJ2='67^0/Y]%?'SQ<B>A,U:Z)?[(!'_E>_3N9,=WD1%C-L\;2<1R79)1,<Y
M.?99]&V_T&J^_WMI[L@_6W=0G5A]H*7^6Y,-8WD&CDP)IB=G)DM7G$":43\F
MNC.+Q>'O+']TXGA0E38E^1CWCL#W2?L7=[M ;+7A,[Y;2JS'>7_T0OFSVK7%
M:.B7%KZ+TY\1(6R1C!([''ZQ_];DQ) ,]X]^)?;20K_0DA[^%LEW&/@W;&#1
M>;Z(V8H*S[ZO350\2'F/S,G#M_.6^OG($AN9/(3L;W7#0:([56M^JDLO\11W
MA@\<;UDPD[FRVC\N5=_!A)6KZ>)Q]F\%K:D&_X<K)#P>>[*S,?(+[4KV,JLM
M:O7N59O5;>55VYV5BG?BML@OM#P#NWO(+S1E'5#CDTV!BZ?_85C_=>H)8$N:
METT>3C1A C<,OL+46*MB)U+5-89>=WC S<N'WSGB\QE6?>B'JY>-DT[W**0*
M6&[0ZC9\Z \N2Q[E"S6"9J:'C9D<>/R$G,C_:,MZP^[.U1OS-/8CE56!:($H
MG=ZKD.AOA_%?&3W?J2S7(SC"/="<D>MK$/(K@E$LD6@/7-DC<WP+]@P-;3M]
M78F9_;W(]5&[\+@BNBE+GJY@AQ6"B*<-<PF $HGB!+G41_1&SO&^\G9IQ^S3
M_5T_L0,X8F.B2*4D^B2/#<5K?"GN8M?!0WOT$45FRKFU:70I(4S)H6!RSK1
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M-/26TVW, 166!,H-+,=DZH0*=0R-5:R;6X01&N;]UBP:4;F+ '#FGJ+)AH[
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M>5 ^+#$IA "XQJVV[@7+G"CZ.*RS]IJ?CG&6[GZ%IS*U#+15O^$'9E$05W&
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M*AGLM2C;1EN;D.T3SZVQP"PM(<]^9Y ZS4XOF'G5.?6B!V(9V>ZQ-W<N/Z1
M&-V6RAL@/2V5B ,X@;0,W6R1U"0M(#Y.?5Y@XIVD \&W\-)]ZD_!5=QA<5&:
M(CN*5,K"G@YZ26_]V^*8FV"2V(VQ)Y0%R"G/;YN0<Z"0BW7_EBJ#Y ENY!$M
MY_$\FQ[J$]U1T:N+U09.,\9, HPWFT"I":K/TUA_)&O_H/KI2X?&8_:)87T=
MWJE>GV3MV3CN%FUT:*K=M4'#.=7AJ,/I:[4DEX0R?CI#K*@:'&:BU(?2#9]>
M7]U^(BLS)3!)HN#PZW33W[!0H9 &3NJ+GX$0J? >@4&6R>GQ:H 3O@385GW
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MB7/LC7JS'.@+H[6#0$4UL%%(CQJ6F*Q +5);7+C+?H.LGN]'RQ)SVQ4&TQ<
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MAQLJV25_01^HZ)PMZ;2(\S3)O<=MJ[6[;6BXF.+Z[HGT*5L]TOC3EW6Y3G7
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M<F<9JBE,WGV-I*%XD$/SS%F*E_"P52N1MOTN %9<KE@B[%_LJ/P6ULGBX*/
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M!L'??V+9^K.HB= Q7.3E#K"BV&7WA5 Z;J)>]'T9<J;N/2)<%?>-A>7D:,/
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MAH1+CX OL>00\=')XD?M'UW)B'A_W6+*YO)%5"EPOC&JE6G79J24^S@PV ;
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MCH (#_8*NU60HU"3K0_]NC%E42$6_W"^C$3 66^6-6?8)SGK WYA"TE:S9_
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M\]@6P*]WL[;Z/7,OJC:*.C3(BI-(O^N*<?@K!"G'I\T]?MJ]*+YAJS5GI4Z
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MUS1>-[3[/+^S\>7?FW8H<JI^NWY;Z>;S!/$ELSBMW=W=_8BCIOKM/%]JH9\
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M<8D=$?%)_7R1MRPNNM+^5G89\XJ?1>?W["D?APV')ZN\B&36TAQQOATE]@&
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MUS*;=(Q2/D[0F=Z'LKM\3L4+?*SAB87Z''6]+28.0"O%:@%J$?K5'R-@<<A
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M_GXOP:>(I/!T\Z \YG3?+KLRBZ$\QL6Z&//E_&&E](_[.:$JYLO=_+P+X%:
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M"A B3T"<8<U@.(8BN9>@6<_"@+$T%"=OX<$V>], 5S:1#(D&JVK) ,AWN;A
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M/(\'-VU[%U9R)RVZ*PQ)A@R0[<@X>HKVAT[0^GH&D(]*>)J ZKYM.=$: ;6
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MI9.^Z%>F_F6H,X;0^J>"L6-(UX>4$]+QOKGFG!;XFT)KGKV$YO&A/*Q:52%
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M8$* [T+]=/0B+<6$N*/CUA;90I/6"6E>W#OT>KMW9H'-<HH!1\;[,)_G^;R
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M_H*&H8\]((ORU6/=%Y?Q0C]X6'7?:8DN]_1G3E,<7;MF0<?N5@&\^]X6>3W
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MB$G"$EF?=>=S9]N96!B+*J:<#D7W-4L]2K&T7:^@&@W^( 4,N$29'\\M] W
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MQ]<O,&V:-NL*V5^.*1'W2I/)7&WI,T(I\8\*N98E(!E_'O-JQ(CI;28M8.)
M&PUQ\SXE4T%A<XO$*@HH4>R6NIV<>)"ARMAXINA9X&@Y"W]"6ANV^Q8!!9O9
MG_RES'79,[S4A\CI'_^DP0;5^UI:U)6Z'8IG%DD"I0=O-%[&J'+-L8QGE:5*
M\HU(')848;)9=@N6W/A$_YY= :F@#Z.<FR5R)?-ZF@-%<B:Z:]\'Z._D(!8Y
M(,.%;+XY:964J66O(89+ DGW/3\QQP$ 1">>R:=RK_!+&L>E2=];RFO355YB
M_-RT()"-*#)77C:;1VK[JTOSJ+7H'W#<=Z^<OB'&;1$6,OG$E0JZP%&W[ XM
MX)$$_BH*N=2H9.$;[%G[(BFK?6$GD9?NF>WZ<'M,&/9@?(4IH[U#F]^:?$(E
MJ82D" -;GKJHN@2B8,(\CW]Z^JP3&@I+;*]#)E7X.XN RL'IOE85"\MF^0&E
M)US;OIT)01%LP6SZMCI]^ZR>(!;MIOQ7OQA5O9^;J:(U*CMXO4UQ'L(#FQZ<
MFF4 "7^)*FKEC4>6\HT9["S4Q/UB1]$BE QLN;7*^5Z5TZ9=Y+M#/-G059.=
M&F^'X[7JO7Y8+)YM<L,\5XDGE</HQ9MDB@%R#MGBHY"L2B8SEA;U#G6!E?;E
M;#4ZFDW"H,DD+J#OQGLV7^QXK"P4OMP2A=D)DDF+K'A8A2:YN9R1.:>7LLE+
M_O(]H4A@#S4A""5S6*[7\P/';,:<M2D_=5FOIL9R,4C3P"E9('?5Q:<_.\-F
MK4,%"\*@I3I:"RU3NC[9%]60I5H.(0.88.VO=5:'N<WUT(\^7[\>?P*8M,T\
M ;!=Z_ZTM&.<''33&2S^4EEOI^PY3>UDF:*>_]A[K.C.LLPU)J0T_K8GOZ75
M8^^'GLEOVQ&@0K@*R=>/[0E0>;TMNK>9P L=Q,62E'2%1-Z:*OSFV%;UH(6Z
M.[EN;$AW^) <>  ';7=J36ZFNODRZGC%\=Z;B$ -F5R@PU&K7EHEKC*:YW>'
MC8>=JFLVK<>+S"X7)^6,[TP^: PHVE:-0Z5@)'^W2:?5)7?[ G56I@NX@XG)
M:7F_?$A93[_WFVP5S7G5W*,_NS/_O751:&2/B=Q\-G7Q(,.CL7XQQ:<C6C J
M)18NX 3<EVI7"#=_/+_?YS,)GE3ID9S?/?%WD[W05*7!$X)ZN58:=Y<Z8R,J
MAT?$4RZ9F7GB1N_*"HD]U&ED25M/NLND(@#)^2K'-4K]QRW=R]2"NYP2LU!B
M/)8;:8%CW29CSJ2OUITW8S(AZAS<K!QGDD(I'DO]ZLP%+[%K]IG,%NDU"7B%
M]"TS)042.HQV6>D]+1:DVXR8-@4&WZ].B,P!=<>+2F92[=L3W[BHY^"2"C)]
M;^+U=0FB?W=</JF%MAOK]@YHMW 3Z5@Y&IQ-S]!P<OK!,N67%9Z8-A8C7?VQ
M0RPW8#*-1R+Z75#)4#/ZYH,E+R<7^]7$MA!8V6%%H=398KS%1$JV'5E)%#AZ
MI1N8"&E3X=>5%L),3>FEZV]TL"G<4)K3-R>TX0FGEY93\ZF8%IQUN#=D%'[(
M!CF9+A-]ZEO^[E\]U%+W_:MZG:$M^J0I."(>ZQ_F#"!RG:.%4,>E -/-A1AA
M))ZL4.FXR2K#21WTSZ+:^E7M5N"SWAQ]6ZB@"-LZ-?=KLQR/7FC5>Y"'M4/R
M)7.F?,G8O$/!,KTA>\FJ@ P (^[96U8K+XD*=Y9KNQ=_73V/$#]6CU?WXXZ,
M942+"L,XO/G%DF.-N18E_349+O?PR=VFW%\VV\6N#@7PU(5>^=0ZHX4<NYW6
M<CSJU]E^$0G'>,RS_?9"&%/T-ILH:J1Q>'+/>!+S[KG.2YBQP?JJX:)N[@2(
M\U2\J4.5X1R#RY]$*2(C2I<W: TK37AIM ;"0GEBOF3IKMC,0F4Y^IQ&F5YO
M)XM206)(AV* 5%_!0/Q?Z>3]OUPZ24D6[S!7Y?WX\_ $4$""T(++&Q9JO3T*
M^(_T9BX+Z0Z-:DS9B,GH1N$;NW3WU,W?G)$Z9VF_SZPPE7^!_WD+_/IVV]#)
M56,J*'M1ZX1XHOQ8O_(W)G@S7<&+ :DY?C%"S'%A/-.D:>C8-D(HO_LOZ*1K
M0M<VO_.(^<QF;"\P.^<H6:#!PC1FRJ9,(4D-=HQ?5A0-4R(#$/3MNJ1TP),)
M%88M(;C=M'7&&G)VVNCW&:"I1].\A4 B,(MW( []H.%9XIO:3F9HB-?YD8R@
M8,:\;'W!-AVT_\7&]Y!+,QNA(&@<7 3YJ;+O25RQ,X"/6.YF#EB-;LVQU'7M
M%#3/Q,,_E<48+$)I9T37C_*[P-)L=I:&^ALE",2-!8IRHD<S)[P:],7Q/;2P
MM];SF-K)O=9,3%;4OZMU-RSZ8JZJ.TN0P.8VQI7U7="V-!];TGUV$/JHLEKK
MO3<:W@4L$C;T^2%P,;$^:2;3DT>89$O+'+!-=?:*I=GK^AB3/Z(K^9]JI1Y-
MG-1Y'94*Q3->((RT[[=Q[^3>05XO;M7$5TA'X;)9[:%4^?N6J&[T)YZA)6?U
MGU;Q[_>D%[*[!LP6?%>$JUK4WOSBCQN\[=I$L%\4U^Y[4XP0'&)\DJ*73OVR
ML?;V^@G 2_U,Y[/"ACZ^SG+;>9GS7'<0R\6S^U8[VVW&DW%2#H+CN:HC_M,:
M@J+,&_5U:Z":7)."+OE+M]S4&.RJ^+2<7*SZ@_RD636_^L@V]YS342W;-9L<
M8TLE_8(/0\W5,/$U'*9%54X)2ZB%7Z @E[NT*4=1AH&QWA<Y?[[##T=(,2._
M9*U0#X5SV05G://A0R8_'O$S:)M@0/-\3VV.N.OV6^ZQ*'X\YG@R04J.;(YT
M9GA$(QBIOI8=A3]XG/78[%G^^&;%\M+5Z_FR=H=,^Q+?P?H?UN\\J??X$]1S
MEPGZL[(*;'U54W3 ;,F&E>5V"X^*YE\C:=,N@R2JEB)N(*8L4E&?_6>-G[:3
MM8/\B0J,%[*JM/)G<,_;ZSL=VLD;2+'JKCDC NK$M2&I:H;%PW%Y,88-['*M
M8K.CRKG_0'X#L%W6:'B:7V]XN#P<=XGLI!LT!S3QOE_GX4N/L]$>\(CP(H6M
MA+3/W)S.HA4TQTGCI'MQW5U/,C&H_C:A8LA_WS\GA/\N'R/+R*G&"A<2(37(
MX4FU;1720.HI-\Y59C]S2;=O5,)2PF/PT0S#&9F]# ^PH.Q_]TB'-JY90B1*
M-+K$$T[$C>BIM[QT;&74[<F-3 DQRPR+'B''5!I*B?5H4<U2S1=HM;%CE\#[
MC'".DC1=[*IK18MS^X.Y:YK'2+_M"!?DP)BV@HB!JIK!$T.E%O9;F*PD&M,"
M,;SY;1J=ZI6HM'C.<":K=DUGGY__;+<4.G=>6XRVCXE53"[\A#-*&R'JWNX9
M?.P*-H]N9WVV5@6!B>2;B.;C_&IX I3C5E*G#/OKX[1NWLSGK07KSYB2(<\$
MR%1,CA>S#HEONP+951/^#DJM%G=]73J3\BDAR.5R\2,Y:A?[HILRB'A.I4ER
M[FYST;/1=-"\EMO2LL!E$)&R'.I6G1IUHJ'!+G8I0IL>F!/Y)E='1'F4NN?3
MEC!:H#Q)EZL6&Q*^*U8S(_LR;CFJ]FPNB&.?:Z]8QE)V..$/Z&V7<Y;QB_-S
MO[<[N7A^58K5ZX$.VP&L?4./N1PE7G+OUO28ILN;R_TM5<>2!ILDQZ.@A@E4
M+1R?Y/^()#.SZ]2NLY_NTNP@)D,N2^F#MT"@^G+]D7%UDF@>/AJ-*9E#N\6-
MSJ;;P<=6C+YC\%6GT]E::<SYVZ-G3X#W+CAH,Y&9N<@UZ[B,?T_P R*I46/+
MUP2", ;&T8-A4ED[FS*PU.,>ON:M=V.7I3)VO5+))+&0CW.8&1V;;3&SH1+'
M5EBVE&=E49(9JC-5Q-%+41^, U&GH@#BXT7LY"]&W2@_&SI1G?[-.ZH!!F]O
M,%"@53%ABX,NL?U&UBZX&8S$6$GU>CQA D?6D=N<\FT"XZO6+_888 $53%"T
M\F:OQ(/:(P1]^03  C[R'_Z09BS9GU:K?3QH83U?ML6$ &(>F[^K#KX\^USU
MU]Q5F[R]3Z:4.,FRG4;P[_1G JW)Y)*-E(WVU>2_NU_Q@ =C5Z7(1S0YP?8$
M!::+)4,@U@QKAJ%KJVGI=G\->IK,EJ&,MOY3L_B88K-&<\&@YU675]:$U_C@
M9<#5^?;7N#\#.@:,_ES4_@9X&\6^S3.ZH6Y)_;.F^-_@7]_I>QJG?.Y4^E86
M$L'FW6U"$R8R5+XLHOT$F'WW6?5%\HY;UHXM7CS^MRXEDQP^ 79U)6L1S]1?
MSK5 2J8]>CNJHL-839LJO?E18[<>'9F<ZEILE\\[Z^VDA<V19^.(P57Q[52;
M?N$+RLC&E4+K4K[!=;U^0T7;/ULD'+AVS$$Q(T%EOR[7,%ZMF;<BTU?>>AO)
M'7-7RGY719STCRHKS5:?"R8M*?T=TQ#J7W!0:M<>%KF,P4[M<0'17*( 3!<Q
MXYH< L4SE%T[FGE.Z%+=CJ49,-6SMCCTZKLW$\P_S9F9^&PS&"+YU8&@+K-4
MYDGXLUUVJF?)\$U@T_&*ZZ=C4^.9#$?->>8L#86\%<$M$8VXZ_ A+22QM%I$
M:FN7Q8V$Y\GGP:.S#NZ.EY7Y!TMZV?PW4N$\EZ%6RQ7Y3/#B';NM>:M#&QOF
MJN/'^G"$H=1L8M*1&/IDJ/%SEV7^V$A=_;S<$Z#YA&#*@WRAC\<<3:LU[&(0
M1*[2,3L"-)XW&Q0S:V'(<%1IWB?RBY8RCW5-NL"*<W.?'_<.4[\/)E_^G(3_
M)JC:K/B^9&<(@?*@) (,N6?0'N]%WI?\E-F?_IR^_HT?+D@MMD'8P']FQV0^
M1TD(P]Z#]03ORB[1S_)3-3O)L3749]L+>^CN+Z>*75EALIS'0'-WMO<*92-T
MM[FK!C6=17A!$]&#E2VWB04&P6O^.-FR@KU.!KN7WK8QOQXC'U=:.]>'E9,)
M/U7,M*+718 NRVY"FGU9Y@:D^[%C=@^:_0(*N/*PAUOT3^_GD@T)MBLBIDAB
M+[@TCAED=&*%C>@GX!E'H,Y,:/RPQII0MW#H7I!*V=\)PVWJ/H1B/Z+-\8C3
MCHKCS]QH/SW,P!4)(A=E+TZ^LD=H/1XP@M(D1;8T:Q:(_5\3C'UI=TW75L$Q
M\#D,*:YQ]1(F;O2*29JF(D%PF?=/$LH0^@A"VWIG72/KH2%_.3YD)F69%BUU
MME6:9G6IMN<W D\$L__\1<U0_MO"+Q7%GB_>##M[(P7#9$0V0J1F5&(ZWBVC
M,(IC&KFO]+S_FS ]8]OOP==G2X$@V(45)AWXNA9-9*C"0/XBB-[5]J(?1XBC
MA0Q(H:LR2FIG!LO]&BF.5'?QQW8!8>!VJ&FXXL,D,JW0KIV!>=5.1PE)QGQV
M-%!I27$@AY@_H6PQ_;6,8#*G\CQZ#O+)AU0?2-,!8X!/"L"MT>V',X8&YS$:
MCS"3H_NPU#$))NKGPWCEXR>5YC8.R-3+LND4C_-\>]N$U?93FLZD)T!88Y>6
M,D[>X>U5EN?E*:G,9=,W/ 3&JVZ#=HV& ]SC4Y'#S$OMUL22.<K I4]W?YRE
MFS"KBT>[0^N>H8D#QM=4-(52SN?EAZMU%4OB5'>2S$ 8%VG2L7<_KS)8EZD,
MK6K@M((: T57NYR)'! O'O[MZI$7J?JW;GM 9<2O\4WD"B5")5TU#DLFYG.'
MQ<M?ER#/%Z9^"]6&>ZUYOO83W/-MQO +5U+[ )29(.A]HO[2K/MSIDK;;[\*
ME]L\E(Q<Y"AE=WE?_6/3_>K[7%?.X]S,QL6*)-:?:Y,[I9N"O[RUTOR<]-(Q
M9733_$5AS>Y/@+>MWRC^>,RH74B$+ONU-$^3HYSC(AL*%U9NN%1I^;)B9&4#
M4OCWF<"V::T)13-&_2Q'+!-#_O"/LF\J]C$$5[4/ S(I_*6</5%^O'[^! 0V
M22GA!I^-WF^(UBN()@EF7+2U2PIZ,8%9I%5]2$>[)XO5FC#Y?OVO[ XK=LM9
M2^]4VP)4(R%VVH.2A@5%;5O/0)-=7)0H9[Y\ 2H,=0%?9[2KL])QG1N> @.,
M=H(5=_J&(9V^S\_$-&8,58Y"E*Q7<@-7A!V.D75)0C^F9D3$_T)*49OJ.4OD
M?&=;% V^>+8N$^3X*Q60=(9R</2. G%E#$[4RL'K/Z =$75TMT-[Y_M$1&7E
MK7TW?+RB5M]3_*:[-K\3Q/=WB=>]2JUW7#YKJC'5#BS-\3@4O\HF?XL9H!*X
M>RV,4-%H?Z<X-1=?><YJG""Q)'+I']$[6 %&?S,P9KNI(B)UN'K0]DR??Q=F
MK-"B;(>O?9?OZI$7BLD+$]%,6_(G7:ESNJ;!P0'5.]K5F+[E]^:G.$PK8?0;
MZ4KV&TPHQ(_-(6Z/MF<H]TC-A?!ETNH<J^[SMXF8+)*UJWQY^6:YIIQA.[5F
M%ZJQNC@SZTV,(_==52,GXE-\>ED&1Z3Z2%T"@^Z6S7X3IL+5G\.'ZG;_6G=R
MS@G$K6F(40<4/E*C882YS#/#IP//\MB?^R*B))A,>1$UY#' Z_/UIKMG&*_F
M"&_H4QUY1\ALL[ZX?>@GTH)W#"QCC/:Z8BH*U.,+O&JBRHCX9)?,</64-A:^
M@J"9=?[/EL*5L_Q!^V5[;;/0)97W;EU!,"4^OP8O'Q3K2G\CI$:=HHW'RUVP
M7C#1>RFYZ-+B; X#)$4C?%)C$^1^+GV&&M+XH3J\RMG@GKQF'MDDU^1,103H
MO@S23_5;I^E]PQ+"-ERS=B<(N#^%!_6.*WXO\D3 JTZY)#3-F^-&>Y,##>/T
MO]D2*7XGLQ^YMY/2:2,E)3S=7!HYBB-N7$&]P*'>5DQV'7*3=@XQT8-PC:LS
M>!G<XMC&<([E'B9RVP$Y,Q]TXW1YTEU6_]P$SX5C79%38'A]X+\XLCZ-.,>[
M5],-]IL$I+GY7[Q[ E &H%P7WS#SN G4&D]7'+/)ZW],S!^('R_DZ=#$M>$R
MX*^VHX4POMDQ=KB":.<3(ETPE3U%RIQ6*TJ((=3I2YW8=7[>F=X>"5L6]4*U
M!C+XU.^9,T:LFP:'-Q<#['=UBGU6@@QL%2SI.AH(Y;GK,G(_P#R?0Y8Y6C5;
MC;CY,ME-3NZ]EK*'B R8QD]=4 ESAN>.10D0K37V7U[-KFMWM(<]7S#'?.5V
M-7(2ERW>4EG*>+]N$!XOB>1BCJTE[(^;?47$1;-L5SQ>J+&6P<^TO2PBC;>N
M-*=O5E;DW*K4Q/V_Q[R1D*D%W\TA"G[+N89-- \3.,H>/.[;]A<'[>3_[= Z
MD7CO;8CD-]3!(2G&A<F':#I<#+D[[0;V%2WTLP!5&DETV(/7VA.@MGI;,[FX
M$\=Q4A_1JZHA8 O[2ND@=4[$7A^Z:,=B0(_L^VSMZ^VN0UE%#6Z+9 8./QJ+
M@5+\U7T@.X/7R\GK1-0#V/+D$_(L[FN^O]4ZT8S*$H,M 6V 0_6TL]Y7!Y2L
M=2/)@A9N*W]""[E^F/O2Z@@_VHL\L;9#PN'+-5LF]*2[I3J>>)X[RL'__39<
MYQC$_Y43Y*<?+-L\%OG+[#[T"> MH[1^\T.<Y_)T;5ZFU6GCC1W&;8A]P!/
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M,:7=DRR/U[NLMK*-WIT=';%:PG?%,<3I3.-DA5%B)W_&N5EF+:PJ"RD:5J*
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M-OU9Z*RD5V7Y;LONGSJGZ@S^8O#L$!-+?%U"+5JJ/\2B=%5:BADOB?!86M$
MIGU'G%#)(J6#.$=4QPR)<!_.<LR&F0>]SAYL?9#GR21?Q&4"V97_PRYW[,9
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M_@OHE;\Z<?O;#'4GIJS"N5'2B<L\(P 6:CR/3N#N^$;,WB' Z*A6[)B@J7[
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MG>IBN\V\!6!]V*=FK8..<=.D$KD3(L?:X6!&W7B>SH=RA;5)YO/$D3;H9;8
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M(9N6HDI!2A/HY,IN5YW75!R%*^[$Z#W7ZEC.2E%&;D,7&*V6!D?HM7(.%O:
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M]!(.GQ*#+?NLA=Q!:^B(Y4ADL_M9K5/GR)+:R [NYJC5!N)TJ$Q[,-,[*H?
M(VW-*B!E*_RIA4NF1NP6RPMCRC%(H8<0UY5D@"J7M</\=RMG>VZH8]/::)]#
M "6@R,U,!*);NM10K-MF]K7&0@_J&E33IK-4VN)2_6[9S"N(J+$U.@O0G5)5
M06VJX @TOG@V:K*Q-#(B[E- :EHX$YE-T)]DK+NZQYC1PY>%-7UQIQAY5Y7L
M;!]Q;QJF,]O^VC<*RDMSA1&Z\RUTFJ)I04'5K584@%#->5%P'C^"M(4/;^R)
MO*T.-&ILF3ECER?]I_F+(7UMXQ<JUFR)95FM')'I@M38/.Y9U-B'0WBO.V'#
M:Z%7QH<;G2HJAX71R;0=.NFV=;-&M'8>*U*$U;5)ET")=/[ZG /PI]1[+*E[
M+3?5J QQA^R,X#*&J8;!\LP4,E/JO<R /H^&VOG,^63D% $B)."C?:V!<K.4
M=/DSC'F+W4!E7"/U<?M*(TN)3:/O\\N.F<ZFJVTQ%B>'1I6WQ#,7]GW2:2S;
MD11CT-ZQ%"T4Q]I;/6.;+)Z0%^7OW1!P8?7:F#7CV>?5A^OCRD8C5F$M'PM,
MB4TLJX;9RCA=N.6B. UQNWWT3=;B,K*J-,P*,"*6.&X8/978L0. ">WYB^R4
M EM)NZ1EIL,J@Y.EDL'MJFGV\078C-PF+-@3!S8N&[\;OPE\;6;[/%7V=_T:
ML\0L0+4,,[0:SABS#N8E3Z?0(V6H<Z;FFJWQZ@($4JI/11<[!Q()//V+Q;B^
M\6XC359FD#\B(OI3,,5\RT $7VR<]4RH?#V0*Z-8;[%1G3BI4%T@*82=3V>U
MY<EDT@K7;N"7IB/0;)$LE\),&Q5LUE1SC+OGD3D&G.#**>HLHSQ/%FMMMTGU
MO1B*R9 <WW'G61-,W 0E3AA6F;]C<6R:%ZW@AKCGPUE6M^>;$Z(3P-5U,-IZ
MF"R1]764KDTS[7I6J!A4UX;R'\6#\20:@*> LHY3^S- &E"M,C#GG]842H],
MR</5;0MSQ=+4!1$K'9\$]U^' U+A-;QQ)OM'7TK*M7^;V^E&%*-M0 LN)(3?
M(F21)=YXD@%''MF^RBR@HC-S<7U[3F_^9'TIMV=539ID,*F5^8:CVEJVT)K#
M5T^LHG5RQU+6WNYK<UY4<=6^&-5C^5;/3EP@=/0#$YO)_>M,(+'SMS_NUQ8^
M>G;/@NDK;D>5W #DCZ4*XCT? 3Z/4>JAP1;>ATJU_-7T4[/B@.LIHVRTMAA?
MOB(#2M>22URVB!7WHU+RN<D4A)_G+U:@TM!#J$^?7^NX!\)RWE^T;B]5LO6*
MV"AML$[GVNWI/FR.JL&0WD3<I>2RTB^M8A-G2L:XE7;8J# C00:I4 =T:-:P
MI1?ZT<]^&A6KEJ 9>Z8<C'6+_] +D3@W[V57KY95T1BD&IT\NVKQ%1,_BFEG
MHF9EDO_5UZ96-Z:KA:(DS05L,0O4A<F%H,J]>ROWLH$MKBI!.4$.I9GJ9&/$
M/LIE_EP/*0:^1I<:&5&) KIHVS%C-P^ &JT/DM]L\X39\W4*]#TY?ZE05^//
MAAG/Q])*ZS)M&?D_==JBJ3E9QT/*V8*=[JE7RHJQ<8ATH0N,P (#*#N$W>U9
MP]?_:B'DOQPP1)6X@Z*_._[I@44O=[,I)0F#CT"=13GA[H<_8XS.C(8MSC9D
M;^Y,*5&4$QX4$Y,;V$\PW_^7(G!7V+M=PS,3/;<*;!W* V/'F%;]BJQZO>,O
MZL#.:#+N.!9NK+/R\U> L7I;70$439]R+8[9ZK_IH1.?#I>PFB%Y[2Q^H:JS
MBB0*X]^P3_FT[P41TR5OL9M7G<\&N8T-N@WR1F2$2,,&!OWKQ9Y 5_^?L.+*
M<[1"!9TM83>>U58I2Y7PR/@.2F->?1S8NT=P I"(<QG('_WR@1N^]7JG%6Z_
M>Q:,=?SS__3O_C?^&_^-_VW0_UWX'U!+ P04    "  0-*9<8&Q5<8.]!0#.
MFP8 %    ')X<G@M,C R-C S,S%?9S(N:G!G[+EW4!O[NBW(3D[8V&";;+$Q
M!DRP,#G#,9B<3$X"MA$@0 0C0&0X>]L8&Q R08C,)ALDP$(((81@FR!RC@($
MQ@211,X8&-]3[]UYY[[WYMZ:/Z9FILZJZNKNZJ^Z5Z_O]Z7NR\G++RQW#'4-
M=%E^^ [)'R196"ZG6;3_<?:?X<<?OV__V/\W_)]'/_[;3?Y'T__1[+^,R[]8
MV*_]7'=UXJ<?V%E^9/_A)_8?+MM8!%A^8/GQ)Y:?OM^2Y;_A^HVKUUA_^N7*
MSS_^F\$?=UA8KGPG\]-//]V\?I/U&HOH=_N??[GRP]5KUSENL-^]=U^0\Z$=
M%S>/D+1R*+J,.#[Q2$;IF99M2%V]K+[YRX!@>-R[6D('KYR\@J**@84K+%U8
MV_[W]QFX3A%+*W!@T!_)G\<F11\_U[&&>*5^K!E:T7-[@Q\>W;9Q3TDK*&D9
MV?G. ?"=W/<W^.G?*7ZG=/67:S]?_T[KQO?K_NP_L/SPTP\__WCE]FVV&]>N
M_/ +RX\__!O)J^P<=P6OW>-Z*"USG_.9EKF%M>W+@%14[<@HMY""HI6-*^SW
M/]ZD%0^/79>5UPT*3DXI*,35X-MX'LEI6P;&%A$^"ROIO7[;/K2M W:#M\P_
M;]U)=_]Z.<5R\SN5']E_8F?19&G^B^5?^!?^%[BVLHRT<!)N'9:P#XQ5T)US
M*@?)CA,FF-. QTGF+7T/Z(S$^#:,K+50:5!*"] %JV-AK>#<6U;+*5_)5&!#
MF";5,G,&9,8DONQ+P)PBD\^FNIOBV$ZPV0<;Q9-/NK3"K3=5S>N(@@:MAE0R
M=Y!T6EB!VK<\^PZVNV4W6OC1, B/[BO<D%%)20C\DL76SXNIV$_IBWQ9+M&=
M<>SO,OZIMVA<1Y)[4@_XA&.U,=U\_.[Q8S=GQ>>,367'4N=ASH;>J7-_H,7*
MKE"<_R#1T/)D=T'S"]9K0Z5GVJ_OR9EO\!F]H-;F4-8D-Z+75[SMB4WR7B,-
M71XA8SD_CY5R>(.9, I8*PY^&>V^N]-29FUJ"7M$THC<>Z.H2_5.U]"(D>8<
M?\BNN?E;/7?%ND,'0,/(/8(P=VY]J^_$OV*C1-D_PJM(_-0IQ"I6,^%F!C4?
M)C5PL !;7[7LNMT1W7<N!HC,'%>W[CJ*:,[;WYQKRG=B?CRZ9+$YL?\GJ]LB
MP4AK6-3L%B-W^FADG4( 7+*LS4EH-/HY18F'"1YOT9I+!!?[<6M59F3ZMSUR
M]&E42%W1W+GC$F0"T5-=8O9(\\&9XGZQVK\_+,1_SJSJ<#3BD@43B3W=(07O
MER_&+31[7*3%I:IT5) TMD+V^IEGJP>S4\B8 W]4OK,BL FE]N%;R,;<\(==
MB-V!K2A]\R*,WARE09XVW[JHW,6O4Y<FALM2!)+.LT\M ,;K@(K%,\K<@"IQ
MJVPBPEO]DF6LR28J=*;AU&I7>V<.'V.HW94+'@/EAY!/&/#S_=,M7[WF4V+W
M0#4?VL4P3S]:]=!_53],%AN.2=T\BE'[ESS_DN?_07G<*C3-DWP' <6[0LEG
MO%9= E=DH6V%JK>R%D\HJY*SN[/:#TI%\V13W.*D\C/9M"/GC_"U6<MJI()R
M)_1T3PER[[A$Y:K;YL6AWS>I+UO:5GU+U>_SPU5RA,T44I(*;N8=UNZ-SHN'
M@L5M*Z4;7ZQ'W')/093LUE3RF<%VK.SKID:+!7BK=-*D+?4/IS"Q,\IQ>IK!
MMKT@%2,*R*V75U%L]%&/_O0[)Y2D=YT7)!M3&J<H.M?:A(UJL'&!\BK&!%+R
M[52J3(&Q30]$QN/@!U[7H-SLI*E&]S'>Y9?]MGX+'2-S.-B^<LD$TF/47<5L
MPQ@+VG<+&N5/Y7GG!3<I_NH.!BA^0*0BP]_SRT1_WK,V3:5ZUYG+EE9X2+-I
M?VF7QN6P7N$2A+'G"!M,HY2&K:IY;5![7N*AGAL1=V7OOFBC#OS53<Q_G7G-
M"1_>NP ?F[9$B++6;6H1WLPKC:>\67"@FE<*&VY_.7R]LO1?*4/2&@QZ0RNR
M5MDDM<XW^4 <Z_PJO[9!&A4A<OY\5-7.\W';#??E4EOQ&TLB?9V%;\5%7TR*
MBU44*-EG3F;!U6H"I2SZ,DXU>"<&$R-E4%$W!,F!1+(HV3>G=RJW=MQWI4%#
MP%;ME!'.]')HH:IG[#DU1T<2%@G>,OF2[LJP%EF41$CG9CWY#YJ@("MUJM$9
MB[FW5MP_YXU$$C:N_]SI_R@O17JN\I:38*I"1/:#ZY9?VC[';S=Y_%H9_*2A
MCR*F;8SG=]2 !R9"8$T#3T);\B8DSXFVCH,;%].^8%'1J\$-)KD?AL%BNCRD
M=*:'MZT7 V(DRVBA+IC=*G?L1:E@^"Y<Y;'\&\M.F5/5;F&:Y&P@KB:0@_()
M:ZV0T868\1%]8!79];/1>2*[&M<OQV" EGR@\WB5;59XZ?,H#"%N5PN78",/
M['0Z69M82D91$.$S2\M@;WNE5V?3H8$X;XTQ0;W^?PHOO>I_#^7)V?^/Q_*_
M4MV_Y/G_BSS$NO?+1]*"N>S3&B^V2M*-)Y6O/R$  _L"<\*^L77[O>P6YSK3
M-5.Z&-R[Y6__IK[#JG-^8S:G.<6ZDK_1Y'RK^<<-?_O9Y2'3%Y<L)EB(6^MF
MZ\.#3J,IE(3NN2>P3@TU44U[2I?\-236C"(W2[)/C%(Y'&J2L?AM9\]Z6>Q3
MI*OHK$_RAC=&J4LZD:)7WWWS(I_(FZ>VP-_9H3"0/:8/.J/IY@@?#2ZXZ"(0
M] %(Z8$"5$B RV]GA_A[T4XQ1-F1\/IC"T"*+V2GLI67(1F^;IQHW[]1;FCS
M3:D;*AR 1_%"4:.13@>WT!QB!)EK=NL6;@:Q=06_?HDS5SI[)&UC^<0XQB!&
MI\50LF_@SRH'DN/U?.&:_3Y;5AO<-'>(,BG2TXB2([P*,5M!1QF>H#"UN>/^
M$2^)[?C]J5OQ8Q$>Z6'@U(3P-&)V+,RJTLL?V"XLWIK]A@1LL<1%I%OCX9$U
M\[A6$?Q?_U,!8A_J Q0W&,45V]0P;O@@FL@6]9!*:/5TG9HY?U%LEBIY@.?^
M>QN/"CWC5>$WH&:[^.(*'TJFF:<DU''*YP%O[@.O:>4\]PK;SRLVBPTG0D<$
M5!3;@SU[Q76:P2?'E#?[F!EXD:^?5NI;% +^= 7\>$\K[$0-G\0O:GK_C3)P
ML5\F<1Y<B#8RW&1>5,V,3/GG1F0=MUK8HJ2W9YLK7V;J8>/MI#\E@1R$1\(D
MB["BVR\Z&_W>#\S B,:4XB?!F83365#)T*(>VUR!7UK9WA(UYK/=R&0PNHZ>
MY7@XM7Y$UO:LW/#(5CG*F+)^YU IQ C#2UD<NI6UMMHY$Z[;5J4OC.FOM7SK
M65J(-:W(*5TT@$6>,*[Y(1+')",C+UR?8)\_C)GY_$K:>IR0I!:9WGT$;3ZM
MX,O>G;.F&<)F#T=TK?<;-LMOQ'#R2",T%EWR_RG*U4[^>WBJK_XK%?PK4_Y+
MGO^7R--E%5W$/_VGNL&BGM"A7'F*QDV/B??/X7SR77L1P_:4I<:WJL9F:I!'
M76PNFC+\;T]:MR!>\KUA@=H69"DBVDB L6,8Q-9%/]^@'[M\GGU;GMWC<E=C
M/UC),,]7^($6CSK3BU'>8K5-M:IV (<6C!_R]@CS&2VY.RCD+7W]B/<EE.MK
MR(,2'KN6)C,)MJSU@6Q)T6O5&?5!Z/#ZK@PY/\N/!NG)Q#MD<;LQG^$!15L3
M-C^SYK@HN[,@;-.XG-\%(T+C4S HQXDU4L6DDHVY-GQG_*E0("&TIT*^MS6G
MBMZ!+&MV75H)-*H&]'WL#LJ?S+0CK72N?E06D;TSO)%MT-9-5?,7Y!,%'' H
MN9V_7J[(%4T<\RF$F%CUNO+'?8X'@Y4X;P*U%H64#%.)X@'%Y<YRE1++PU;;
M0Y.'(AXB!>\1^;^C_#6ORMPA>QQD4IF8NC)>4R[?F5CH]9: 2N'K5$)BD8,A
M:OXS\^I0]_\\\X2.OGA_I_NQZX<W0%.P@)*@O@6XERJ-V!9[!8(H]T<S/JA#
M[:@R:24]^L?>OP-\@G-?3Z2,\ [$]Q;X<]HMV2(SI^^J[][+*"OG7E'R-TWT
MPVG8JA@89Q-.*](5;SRT?)A8>'6K/:K*%RM=)NDD(MU%!I0[5X.$I#XA\\_\
M[P[O#4W87*@J[Y]G]?;33 87%IA7, EBCLU8MP#2[QX!"SRM-WJ% ?0<B8ZW
MQ@QC!T/U11EF3]8'6?ABG.2)L)J'C6\14>%Y<>:HROW']CQ%.AG4O9:,^$+K
MNP8)6@P1X*VWO0:)WX89QP]_B; <.U#-(<*JW0VC82EHJ=GIN(AO[)<LV57,
MB'#'Y=GT(@G>I@FHJGEFJD.W$ASHLA*5%V?:6BP]O[%OM[/7.)"5MG!55(B[
M7%&Q(VI'@.\/]V#W)7F1SYX=UT]"W-T%R-4HC=DY)-QL2D-V^$"_(R_<[SEX
MM<2#<7L!AK./*)GM%Y'#[QU!:NV.&Y4QX8>(<JVYV[JVH@C]W3-YS"_8E,HQ
M\_NI*A(/ T4*O>]T56259^.>CQI?V)MH9912 W)"[K7&.M@BO!R")=;3&7XP
M(DP^MM/&"B4!N%_B-9]8/E_BY7)+8\GYAZ6U_\UX>\XB(\P7P*1X'/#<"L%7
M[T/>"5Q].&84N7\=D>-&ZO86Y3Z7P29%1"9J?VE3#IB*=&N6B]KP6/K:DRT@
MOJG6U (K._!.6^$+J,L6"^=1E29DI0_,$IR];6\KBO(-;@^/=5K@JO.^$[3)
M 8O;O$=\C7$X+S=*2:S8_3T9'OO$VL*GY)!7/=&TI;HX\%X&_#SUWN!+/]<4
M=RE8=*KB<D<X-92I-7^WMQ9![,$]IHV!IVUBAG63$=T1\@AEL-(E"Z=S1):S
M1,B1*HU!.&6S$4%2L#%/LFZN&P6/8AT)$$LJ\G7>$MF*B,SVN[?=D=)O$K$Z
M?K"Z39206V?&&DZ-KCQX7;61#)\*SOW]D:"HJTTW$Z"H8:R=UBY]H\CV/= Z
M^17=583L/F3^RXB!*W\L?F=7<HE&C $L^MN33;T--?POODW95J'6, 1*SI03
MJX^<NJ*7 L0*CUT)KVP =73A@9ZF@.N6O6FB?E98H&,.&#;6V4V?U I "1VV
M?NC_^W_]<S@+BU!9N92<02M=.$X>E25%/-2J7F\8R_ZC\$NRG@_]KID3O=:N
M5*(TP+/1_4V*LJE.?A?>Q"K-E_D 5UDZ7E[TVW#=)4N/3#V5KG[;!-8,9I,[
M7'((RW'HHADTV_D9_=;@*_Z*5$<V=ZR?LA+5[U8($P+0!G*$QY1>4E\MQGK9
M#8@PWYG*$(:WRTO?#9%3,\\^I4U5#$B&J%I.C#NB^CN9"Z4X]C6R>"I1(HC4
M75AFQN9\=T!3/<3/^=$?W"H]=TK+7SV5#6Z<?3LQ(.5<"5$>Z._HRUF_9&GH
MIFQ$,$RR&^F;,UL3_D4%JQQYF"KH71(Z/Q^EW,_YI#LH71?NN[8W@,X+VI\
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M*;:EL3(J"YG;0/ICGZ\&S_\<3PP_F+_[-R1@M*;A,?$A0Y"B$&?4W8R'^T-
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M.2P(!ZH+YRA??1!4Y 'SU&FTD&X?_KKRL1%JH6OPXVDEV#Q! ]3U<6:5) C
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M8/>?S]#77JU#Z@5>*)7P5!<^R,4F,1H[;-UVDWNSXC[:3)=#L@7O"WYRG3>
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M%63=W+)&5M GH^O?[<C%0O3*FBL46%^U.*%X%N2]U&!@;H'Q$+,J<[(268/
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M':&@9_3$/X;:@4,DC%O=^CZC+Y79WJ(#K:+;AEFVAUA9K9]9Y>=U/ KI+\@
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MA^JR!@Z)R."=>NL)_W0GETV_>_1,WR]E"M6-)=.O8TRR[Q[8-MOD4(-3V+@
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MI;UU5_?>/&V6J.)MTF9MK$I2@FQ3@K8IHV23BS>]XBFE[OC.NDLF:*S"T/%
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M!1_ V\'FW!TK=2E2\KOM_1.1+D5<PE_]IB=] 8]VMOUX4?E#13S[HE4Z7+
MAS*W;"X'^NUT0)(@$GU".S[1C#LJS"I<^[KM::=25R-2]_/0YG,6M#JZK8:J
M.[=I*R(I:[!^;#!H.2!T'S_I0<=1;YDKKNS9:D#"^?_<)\1K3Z.V(F"R E[_
M0"OW;'GFYD%"G$'4#)O(CCNRJ*0YUK.FCC-:44E3GJIN6+RXX4@1[YG*2K_P
MR^.IZNDZ2YKO[&KBNC-4<+\M$%&=N2P%$*.;CTI/<%=2LKR;M(? NA)W  5"
MGR)%FC<0R(W!JFD.!'5H6P NX4&^2Q1]%&O6K3]H$ .W8Y>*M".E9)?%]T:V
M[)TH!H3.P)+*]C4XGT\#2C_/T<QI#5-R*'>C:''G_+EU-ZZ)8NUI94".A%7'
M:M&?U8/^"M34G1][1NV-*%L9"E=\!D)'GCD"2)PE;5BQ.MF+1M_Z(,C#T,.Z
M>6959AX$)WZT3YMGNV[F:/ L)-/Z "'QYMOS02L+;D&E!V8D#<W<$Q\ .K@3
M"YFL=.RSWO=V71V2950;V7TESL_[FM&CA;#! =<<,1W YP2X;*""AB:]DM([
MF"AD,(<1Z_NO'X(0"&8*ZWK.V8C*/LI W\O4#M!W+^=_.WW/)3D-Q;M;Y[<^
M7OD\4UGYTMGXGMSB"[*)/=H7:J,H<CQ8H^>M&.CNU<J>-@H/TY,)N\Y%V8YI
MW_"PSX"GB@84TJM'->LP5!A1MTI-] 1!EJX OQPFG7<-DF*YAH]+$]->\RK:
M51KMKG1ED_.SD:T1:.1[1]S3H^\=/@ I^#9OA^X/+9L/3HJ-E?_N]JF:M.$J
M]BNWXI+W^(8Q/+GJPNS)V>3N#C6^$BF;92YD3=GV$#2F>^TXV%SC5I,EC-(]
MMI=FD>U.00DB-T+ULVQ+1GMRBSAFN@[ JN%#QG[-9"\<K]JS8 53Z%A0T_G'
M<=K&+Y4\Y;N)+59W1$Q[TKV>2/Y,;?2C+,*Z0U<[L@/6QE?AJ\6HL8I?QY-R
M_\:^TT"DU4*?43%O8/6?LV1&/<!AC[S%\OGUE1VNOJ<LO@RAEKV];LAF;C@^
M(/&"!ZIPKUXN2)Y>.K$14([<4E+;"I<T@M: S!6A%[ZETCY-R!C>-/KJM^V9
M1J=PQ9^@:J=I>9Z-'I$K5A/;),2<<YZE=1K>LL:+RTP&3EM9!B2 !E5(<+^Y
M5- -_+3+M=!O5SMN^B';*QA"AH594D9I4070J]\:'F@^-&WJ35$<M+%RCX<7
M?//,]KHF')T9,7?<[P%D_SL(-;^&)^3JOC\>Z,X][B2U[V^> AQB<QQ+&XLK
M*8TG89C;(W7D,T3%6,UH@;+][+T)4%1.'9_QL49KOJH3+$75/K&Z,2.6>1JY
MM+44$AN+:EOX+AK5UNI8.?&/JQVQX3]5<IY#CU7FY;G?#F9+$F/&#7AWX4_7
MU[8=[,3^ZT9-OPHZ?5UFE[':F^H4B/:D>'<_V_$VWXWKNEXXLARTM;P<6OW>
M]V+$M\MK?F1=30BYM-[&5ZS^2H>;]2[6<_*LUARY(S U/K0F7V?D<K8]'=SJ
M8&8)]1PM/-/)6"VO^,]45G@%Z?P&2^*#N"<3' \EC%4 8JV^M;GRP\Y&<MV&
MO&I&R51G\>R'PS_->L+S>N'@-G6%=N.(K(%:#4EG),''*BVJ5'D<WCYV<,DT
M^",@]Y()*Y[2%9LV$:8C_4H$'79 -R(@)\A]Z285XLJM>13V)W4.:8)BGK8Q
M9WN+]I;PCB..WJ39/RK/A6FNR;,+$Z_9MJ.!4RK1:9HRG[M^+(W%AC9V;&#V
M&(@0&^![0I#]<JRK$^4$YMYPB-/0LB/Z8AYJN)I?4T)2-HZ/P[VPH]B6A1"W
ML,<*[W 0S=P14KPFF\7YZU_GE5UT)_;",KH+NQ6V/XG5WZ3FZ7[@UN)_K8*+
M/UR8;\;U!VWD*(_[&:-W5,F*-MB;7B-&C4-VP;+V;S8OF4)SS672LQG#2L/P
MC-*W1V'1/AV=+JOW6;"C(]WE,&?URJ4#A)+2$RJ?/R\[JWHG'P_X3#*=QB"?
M8V?!3C6U?73/DL:I*2'4A$B3;!TPY)Q%/CT)N>[%&I=2CAL<Z8<5Q:@KV)+_
MWG;!-;/Y-(^3U)B!3[_UR<?C4Z#OOMMR:MZVBOXC&,(,39>UXN;LMO\+!9$+
MEA/GHH*<!ZB[D6NB>^=U7'CH5/,XG4#V@]/-P<TX2]('X"&)?D:##SDMFW4F
M*VT3/BXS'I9RWGDC@677T9H+][D U!8/CP1*CB2<O^LX_11/)(4KG13'&YR[
M7C*U[%]<+?]+O!*V35\)_^7>?US)]!>W^:E6Y7E[?"6["R^T^#!Q/FE[R_5*
M7P#_\PR*0$M7IL(E4W'.+GR6GVBR,'?)=,EDR7S)=*C66<#M=_I5^E?Z+4#K
MU$06>V%N >\G*[ 1&//JY_V/-YN %MX>9H8JH@_+("M;RD6>GN4"[]W#EJ^+
MUE<4%ZG%R9Y'>]*W8$';>%E[2AU7?Q7/V6_OF=!M0WR,3>7@/IMBA-OBR<QD
M.<GBOHX,#J>>=S92>O0AES645S8PRV(1WY/0<GJC885=UW$^>US-W+]IA8?R
MFM"*-'.R>!M4FZ<O(!;AZ:/:P\9?$6@_/%3^X&NLR9,ZS^"UV8"6QP7IWYR^
M?AT:+B\1S^I/J.CYA%3>.X;/T5_,F__]#E;O=!5#]O:*=.""4F!?!D;2U0]P
M8:51S0*B!Y!6GHUIGC.5R(V;D%^1/L.(?VG-PX2[NED<+E+;6<-VXNTG+TBC
M!\YF6E8I#/:HA;:F8AJ:;#',FO-='3>_.C=16 [(&XLZ#&O9K&;3]Q);6?_W
MXACK(N8#!?$8:^/>\NOOL<U%P0>C]+S1CWBPF@@+4 OK[V4T'*&GGIDH_N-4
M;/3".#X6D40*.PE/HJZ]).-(;!^6@4!S5L*?TF8-?6M(+YY\:G=FSH8F+T-^
M@Y4OMF'J?9SHP>CW:TF OJ%,TU0U(G:49NGG(1W--=S(4M@642@\^ 13\*WM
ME:RN(LVQ_&V(A?E50YQ'.F1%LL>("&<UFD,6/EQVG+99#ELYK[M-!519RE3<
MBGKX:73\6;C6; 4N;JRULN?Y]Y_'.W.MV1!V!5XKJ88$+V5R@IMZ375.8HO>
MO$9>]YP@E]XCNC8F3?,8-.!=:[F#9ZSE^92Y/](?4*A]_K2K*::XLANC)]5U
M#\J<WJ,J$1TR%>*Q^^;I[C(TV?($\:EHZO#F9ML[/;^!O7'(CO>&&Q]#YN(.
M-ZVU:D,N!H<?G=_>;4[Q1_OB6><KPY[U]N6T,)IYWUL2%(HT62/("5Y1#;^9
M@T!;-@JN()<H?HQWFCHUCS&14XNO\J#YJ1:%9@W>QH2E1EX5$>(LQM-371R$
M3+XO! ]&)2?N]5,47M='R&(^0#^;P=5\+!(TIWGFQAE(U;W3P#"EDR+<U4PD
M+7TFX(%JK]^Q3Q?X^JW&"E;E@EC_Z?.MT/WO';"H9C CPO(4_4/BNON7_W6_
M0N1A[OB=PR0I:L  6C;49?DJ9U!RR(MAV\0&[0:08ZON/9-+)NLH.Q/@BNTE
M4V&*I:O:,C49[/L3E%)C+ )+@Z^/AYSZZ#UKY6_> :J>X\J*"*:O!X@:!U2Z
M$$XA/:/]=K3#M)=18)*?/0;\0'%4J5#5C-*>?\KYD5$IJ'&_U8OE[YF 7TB_
MG.?(SM1M]_Z:[+ &JY%W^1(;WI'K!OM/ XCW,X/3RQ#Y$E[M-$^U3'/19Q"(
MH:*@7>*PM[<2$A_.G^87FR,^XVA%3(R8H8,9"KZ73'_;'C]3,,T?F-MNR.=V
MG!XE,&RAG#.PYD!I,VRCK]/R\GSO ((\E<3G#9Q?35"1J1TJ7![UOS9V7*S=
M]V XU!4RY5"W]\?9I^O=GL*W2U,G4?F^F=!HJ\"58X*LY>=VR!8G69NG(FQL
M._Z5/#/7M$9$(!KA6:S:VG.<?? =5KJ8%KW^"V3HJ^1A#NQ\W>6"V(F2%/&7
M?V\\0#%JV(DAVMV1RY)%#*MEHZ(V.)U[6\7FT9Q!'5Z"1S_!KT_6WCU,+>6G
M3:/0'AZO PIYP_($DR*E#)K!H4U3?>9W+)]_9<ZJ6$LL$LMT;I=)U5MO9GQO
MNNWR@#\!/ &B5(Q*Q?_JR4CY/1X_?X%6]>"=_1?]"-B<[>LQH"U7']'G8T:6
M8UD)7O27.*FEJ<XE5=D,#KS#=[;,C?TUI+CH%?/M=?T \Q88KQS%:'?K%<OY
MQ+K-GA3(,"TH5'A?#FX:2'J%_Z)M )*+Z\_.@8.Y:)5>&BN@>ZN-]D;/&T9=
M_3KKF",:QGWQ!=OZMRBG'%:U.75HU9]UI G:YZUB]$Q,A*KG\/)VM#X^[3S@
ME8B7M$V9>#^F7H( :ZAQ7ER:'QI(K)Y,4I(/HME:)0F;5MK6N=>'2C%D@C)6
MRY87ETA2%Y8.6P8#TY(?H#R='^,6%5-)2L*:8A*EB>^U@;_T-&^IZ]V'EW+T
M%T!@$MX;2.DKF1\^9".@*6^3W!TX\V$"GE,M5@7!.(A%@H!19"-\BZ.O*"T*
M5E'VS?J72/=Z7U:"KGWLS<_PX=D;8]9DSYY7GE^_4=^GVJHZ=/M3MP/XW;!!
MIBLUC2"E\)V%1P)>S\<$#"^P%<156(GH.'Q\D;&/BHB6C7L;PJ/!W; 39-\L
M)\JYZ+_V G%69*C'BX8Q6PT,KF_9_RS;#UZ#Y+:,=YRO6W6^F"%>,KW=[R]^
MA(Q![X[F_@##C^.]\)L^CUV^HZ+R7<,J>IO(9X(G\2C>G;C%$TGQN8*99^KX
M1=30'W4YU+O$-H+B8<V\UY]?H0CQ:TH^7%0[G"9!_\Y8^O-@=LTXPC$DAL;1
M.XRV[L/6K&/]R#LX_RDIQ^6-%LNP2Z9WSJ*N#5"G#QVQL DLM84>;#H>X>E$
MZA";+T&:5]<)YRX6E^,+,R*-L8(^E$%+5]0</&I9;!QSO'XZ/#3*%W85;4BO
M]%1PB44O*&6GH0DMWT+\=/[^UBQW6T 15PI].MNJO)+MBX8V6C:'/_Q6E?>^
MJJW2KI 7Y331*/TW:"@W:*]ZQ'"F(U7**C5ZQ]APH@,%_I'CO199M15=7QCG
M:$M7S':8Y44/8TMI\],$)3_0BODG;&*E0Y)^S^/@169;"'U<L2(L1M3_L/ A
M3$)$I=O[&#<!LPU^J[#5&#;C> 3\UH/DY(Q)2 &"/A2C))H].!KKM:G[SB-*
M+P@NB)1W.R2$A*'X6^H0(,M[))12\&TF2NU<"4RUA N&999M/ U:-C)2]^Y/
MRK<?@JNT*P1X7C)%<X3IQ'?J@<>F*]!J%HF>N;Z;MA)D/#K[@T/(1VPVL P]
MT<<&IV:$S9M6:L.\1L:[ZU,#1;A5978OF0R,5W?:)'H7($&&M8LY-NG-?6@4
M\+Z8\-"HL-@VLBSN9556I!5>NBCZVBU?A-XUZP]/8==-9E%:UUPT_1:>"/'+
M!J9*6A%S5) C/</+ +YN'"7@[SXZX[K:X'G;%.X3=7'<*A'>[F3?9E,%.20P
M>'8\&,,E?.I"F?&8#;,3^[F#A,6R<P&5:L-)Q;2W?:A"-6:K<J=MV;!SOU>P
MN(20)[&5_0T]AC;%!FU6-V2\!+BY.:JOY T^UI=@-Q96'1V3>A;-C[+OP666
M@YS3"I4J1$GPZF[Y8AOQ6S.]%?+>?'SA!="#R9>41*>C[XKB=B33*3J@)*-T
MW7':CT:1ECV<)36 95UX4UK"I0@N/ +9/E/YRT:-":)1E%FC1L0O"V'G_]?!
MJ\C_3O#J\/^CX%79ZO_4[.[^'\WN]^S_<[/;^SAS/.L*K+!D?CFVK?QIK<O,
M7^#^_W@9@M3?@-X8#KT(_W"U9H1EKL2V/U\6E@DQ)Q=R_@)A4-G8FE6\8N1X
M?TT)Q\]445=VXEK&)1,2U\7:,Z(4ZQ0>[;<7MGDQ.M^1DI9&^OX%F\V_&V64
M66SH7"V[<]S.@W!65]"UDV\S^K*K]6\BUCEL)Q>G4H>W%0P"1+X 77O[:=;+
MH8?7RE# !^)A!FMV,P&.:<5[>8WL;W\S=B(R1^D5!ZNJ3'6(AR:J@/WE=Y$<
MOR*WSEG^O8!U*\]O'2%OXB+3L#.'6VT@FG$L2D/SD:"JQXH.?X:Q"1Z3(:*E
M]4%*O5VU9?_)?LG:MES>A5.=ULCFOW-\16@*HX='6I]8&FE73O1 %Y=,/OS7
MONC4::F !D\"I(\.98L'>'MMJKHIK'U\U[#U]+L602:[#QZ5./4KI&89U(SO
M6.A$BI!W5="G0 Z=YB2[*=\M3H;$)GL-$:MYKTR*D(-4UO^*ESHLX\TDK\P3
MDCH[EM>CI/9"._CUOXZNUP#=?1PB&+X])1C ;]\.>YBH@G0\@G<<@EW]I20>
M&;,TN]#?3&G(@8JSK&X-$.R%^$WP7=9E8B"+E9SD(8D-$V%+&*?*?O'CARW'
M+?? ,'\ O-:E51PKM)B#%)ONI( 6%$0LIA0TO!0OD-6;2H=^^F+.,Q#9 .>N
M*'I$X"J"W A?D^)U'H=&6*PG5?^G$T ][\$Y_;1LOW@%NKJ;?WH5=IH>/SMX
MPD\N+KLV&\\(*[EDNMI>\D_)0M'5D3;5N!\=P(O[OG5K*^NM84KK\=SGH 6Z
MQXYT?=)%+4[DM.XW&W[PP%0'A.C5T!%H-",[7<>L6YGH=&LMWI&--XCO_&EB
MK:**^*W,2DW+E5S D]<K)KEL0X8@$\&%K >X@9:YCG<8& P*<]&S/?6A;0>N
M5P( D=/.*JTGOX(NV!R:._YS8D;TRYVBQXZL>FP<*59;CDXBW55!U3EH"5IU
MJP+:<$:5#>XWO?/$RUZ_(',9S_^'R,F[D(,//PX U5DI)$LU=C6V\];D]:XJ
M1=22N$+NX=2X@Q"WN3JC1G('^<Q]I8S&<%_C',UO_Z2FCYX^>.I.4 D=K+6N
M,&N!!*XL,BP/'(.(TK,3B2VW33.&OI'(.%/JIU6_5KU5'IDHOJEWDMYB1IQ*
MQ\>G[L[>COI)=Y22O\?\;RV5D\=4:$L^=\$TPHFGN43T7_GM@E-B%J&>.<*0
MUL>S=K-(ZH,&(U5+!1-@@V63FL*PSGGED/!QMTQ*O7)8G>6JK<<>JJ\]4O0&
M&1G79[,*;XFMD^@<K"*+GQ05WBL'/U)@09%31VHF: 28>)+7(RY?:<@T=+T.
MD&[F0B+"WH2@G:.A%2E1;%N^_5K'B]41T,_"A_/M\/^$XIYLI5B_RDG&OZOB
M!BCA'_<*@A#:2BI"(#CPP<-=VE2W41N$^-!"G_B>&G:L43+3( ]7RYN=$978
MT,^ZFW3<6<NSM[BT9]5;40C@=6Z?0E83^8DLC4X%L_#S?")*AVN;0EVV8S;_
M\@VNM3YKM*##4_/><2?([0/K*=>W8Y$HFL -G9*TK=Q*\K^N*/C7:T^#:3S#
M]KX3][Z_S$2E;*KGY.='I=Q8E4S)CFWH'H4_S@^"_X;8/PJQ_N&U3AA_]8E6
M,4OY@_&:5B!_9W69GY+9Z#1&@E?$M+\H#%GMBLEP'U9=BSH_[J/@@O;!*G-P
M('\CS/&2Z83=#C/>YF2SZ9G\I#64SHK^S1CW5SX,&.KV*@5(/[7DODJ7J[1L
M#RI^IQE<<R9S)%/O&"?Y+# H<,-U+SHPB=_4T:JV*ZP=?.1:2IGW12 29C4R
M9LFRR ':?'%*DLHX7!1"+WR6MD6)WZ@+IM2A%9UY)K__K]'<OPR+/D==O4A:
MO38DYIN>:.QMJ$Q^. ,RZ/5%.T7WW_&U6&? &AXT8J-W.^_UQ0P0%9.]_GS\
M[6DIH]H\]QH:.K^+ADD5\,<#9#/L2C1]("<\G2DE_GB_.0___=AH&X/EZ?D4
MS(Q(S=^C29%/5PG!@UA^68UK7KZ.J:( &;2QU:*1F:CS^AIAZ "A+?Z!V\RO
MW:6VK3KA8.Y;:=8GTM@?N]T9IGKXBFM[Q]J#RTF<Z>;"YSF#$+E_YZD]9ON&
M!H9N!:-9^*76)+=<:X8 <5E;Z^<M^-Z#L1U@?Z+RMO3?ETP>4OFP3V[^7F#,
MC<4M+H\*TUN'&^//AOO@5-6-L[U+IF/E_9RMM%OXM=G#M$*+U(9E[BS0,.&V
M#\#;]I_2[2JU&J?-4;(X8/8EBP/*#<A:^LT&CJK5M^^&R$B1J/UENKCDD<6L
MB%R6-[64X6+'[T$*U;:E\6MV-?B.5BZK@IS5K20TUR73D[9SCAFP$G7VM*&0
M,7YPYA<6/!Z*$EX12JM<UKX_A'5'ES7*@$;GY]!1/%,)7GVY 9#Y!)!9+H7^
M8>(D&O#*+_9?-0JAH4B?$F>_=;3' J=:17H.78X8F52^;VGI/31[R--J)VQA
M57CTX<T#3@EU==_;T1$MS2?BMF>C^F,H\.I09U2UM'NSB&=X.-HQ;- W'<8B
MHCN^B+^ATPE?<^4[W,"G[KCB !=4XC0:$9MLF3,@O="0[,XP,]TRF!U8K74U
MT(JC7O/-D_7)A*N&[9*SH8HC#YXKL'Y*DC'0%LGFF/T*4;D/]^NS@K?H:81"
MHRJ-HA2JC#,S,Y(RXJ6ESF2"@MS$8?[.<#?_WT-04Z%"""USN]$'S:D0&\]$
MBCO8O2G2L(G$<0YUH-A-9NY?CRP/%<LR_:ML,/&!WHYO;,YW./;>@[\[QI[H
M5DD^/M?.NTCV=_GQK>?L$T()4T +]6TA]L$46?F5;DV,$@"<YW6(I-E=6,&&
M./I*?$OA#_)MC3N>LD+1;F&*6(&,*+@WSQD>+IA9:!0:LRJ3X+L4;)4A8A@%
M%\P>O%%ZS[-(EK6Z\INKHLNU_+_1WZS^DE2Z1;M-;?XJW,?'A686$INJ:3K(
M*<OZYC^"-CAD=^[_K7,D7'R"9EZN6[PX/Q]U@(B-"DJM<-#+210"M$U;[@"[
M-;SY!M9GHW4P3BHE/HZH-&;3*710PUXP),"IO_];0]B!0+0P=6LJK45[I(T0
M6K-E<-35$U!D$8S-(/&G*%W]M8]K0F0=.U3I6(7J6F;6/PWWYI@Q%N5W_! W
MC^.5V)$J75R^73K!%F(V^^V#&/@A5<MMF]<*,%$O7STU@?ZO_L^-[DD!R-R6
M^:-[=3>&7&BB"Z$325';Z.C8CS@L97X=@R]L(M.O6Y,DI>_P7]?O^3+91#MM
MKA C]:(ARLT[@#5LHB>F2\PY 04AKB"$1O!/KP"G[Q2ABM"0'7"/ >;Y1.A<
M/PH5VGBCTS\+J3H\%3A=KFMA:#T$X=C@26:_OBTPY#^7?*$&JMO727<&\1L;
MVY[N *M86X).%7&/?1?088Q9^T&T?V .W=AHO)2[(;525+OQ'8\7!T'#)D>(
MJS^#8SK+7O#C*3G)N7H)L9JPE<5UBW.5,/W9Z$NO/>,"EY)?ZW3^&E'^3\X*
MD/R'OZ!'O@-)%[H<>J-@@[-M@*=,Z_?WM^EPHEA=MM!?BW2?:_3;3?6*F@/=
MW-OO*5" <1G)49?->&+DPPS;.Q;]=6*X$21>>$<'2^'7#DR4=0#086CZ *^T
M&QRE[.FF_WAXSQLR-1S3XH \M2R3TJM'M(U#5Y_?,8DK&?[U6L%MYM109=!4
M*#QFWKK_W8O&.^NY-#8<6TV:H%G#;8; I(^!B/ ;%;GBI^75&$-=*PM<'NNP
M'T](-%9F[Q?^NF!G':LLM#)"Y3B&9%2DH:Y!%S<W!K2?/E03EO"W4K,@CM26
MZWE^V9I(VU84''>9V(\F0X82:U]-1QRA+)_A$Y0IQU.%N6XJ>F';H^_PQN7A
MBLN+H+HCTYL-KGJ-YO<LJ<342NQLWLPUU?7^3D>I?D[Y<2U67HF89_$9SQ5F
M-$W(S!Y+7X;*\5N96(F4V>/[::K5X^/LWN;:[8T)OV)3<?.:P :_WV^H[&J/
MN3U2-A,6[B,K(]E?TF%JRZ&:5FBYFN,W!X77./]R*JL08S3K1W)G0:-4S3!_
M4["-)P%!U].YJQV\3S5+_]/@BDE;_3Q^!V#"[^%2\R!XROM]BUZS]_I:5M9-
MC/C@'_ER^ [3QC\=3,K<?\SK_5CUH,UGE*\!W>;1_JNZK3VYDVV&0S8)I691
MXVA8X2(BPL*57CX5)N5O%WH:V8A[4+U>X%_95&!6DL3,!=IYLK\7L/+[47?.
M2,6*_&P#O7!O>[SJF20Y%6EO"Y\3NJLA<Y(DM_3G5)(K_<F:D#R4LA]IQ<=Y
M?T#KDU.]+<VV43Y-]9O<;))%Y5_P@ALKA)A/!;530FRF>MMN.)FFH+'MN7[\
MLL3_P=Z;1K.]OW^_?KN[<ZNS>6BK*(JBYFEOB@JBYID2H82H(&;=NZ8JJ1HB
M1;"5F$.)B"#L4B&)H4)BIDJD0LQ##=73WW^M<Y__??_OL]9]/SAGG776OAY]
MGWS7NC[7NH;WZ_/Y#B*O#]HTJ/:8SVS6EI]LQ/;Z7B-65SZTO-ZPP8O,4L&+
MHB<XWCX!O"2-F7DO7<EI?742X5Z%\R+"-SV*(7&AV1 Q6^!$]+F6[0M=^1;0
MV.(; M7C^RD40C_EW]B&W-FXH>#VEIH?FX)X!JI-BV:]6PG.LI!8GZ/W=)W^
MMGW-+62A_WT3\-Z%JH!VHC"LEY2><7>XBB1_"YZ]+4>[:YD\1B/-+VKS3>3'
MOLH_[/F[;\(BW!=>(G%U*DIXA.$97S&.5_ SGJ8X4;L'$UL L#J(=W@&4<:A
MI'39_N)DM&+9WN6(N19\3A&.HW'^QJ'CC#_BYL["AUVCB0_JNO9O4Q,@/H6O
M(V5NYENWO9')TFD=F;QIE$TU5KBX .7U ?9_/8#"U427U5:]7=":@6:E:(PC
MX $;*Z<9V2XXFGCC>"+0P6N1%>Y!R)>KUVI/*>/DFY9R!)[5E[EO6NI+'1O_
MO/46*LL_,O=!@B\<F8:KZYQNIMHE^O5W.C.&7*+]+CJ]4VM4^#3E3'"A/0K$
MF9J0/> 7 44WCQ^,<"9=];RI7?>F3<PWEUH3OMM2O<+?>85'SM,$^E\.?OCX
M=U^2/1CM!-P3LN:.&=B5W]'F&%LC(IZ?JUZY/"/V]TK2FEK7"0A\WF0\9@7K
M3PAT'@F[IR.,"H3GW-%Z9"BU4PD46<_6G <,YRFGBRE!F4,5VZ^G^2M)2-SN
M:3YY5*J41.S>D_#>,36@^!>QVUKG5&2;7HU;?)+&7!$4>ZW[(&4ZZ1OE,#U+
M6+.M6OM6?MRBO;VQ_/*>9@2M"034J2\%?28"(NH1_#/,K]-)PF&-6DF,0'=Z
M0!*N4:C.:%)092+F*6#M=Q^F;NU]7-4D 6BF%MA%2M2@B_S[.14(?RP@S /H
M[RM^F_6M6J:D8&5XI65>^NXR@HQ8C;YA5RQ_#E#P]&'054V@^J6,E!U^JL"'
M&]0[.^? 2O'=N_G7?._YO2_,NA<)#GV#B-*>OD/4L$QW,%782^<]C+>.EE4S
MK$\VG&Z2@G]5WHT[9M!LNQ/F,<O!([!HH.,^C.3D6!9G*5\;,<YN=8F14 "$
MD&TP<G<*-(CJ9([)N0=&]LN]\I+ 1L,/CI_>8B?@^*NM^GP-H_EFI=89R6\+
MC&B2O(RN,--$&RE@WL?'[=YZ%W.E^CEY@8A+EOCGC^N]=IH'TR1_MG'Q0DMR
M*08PU!B;>C@Z#?VS.7#ZZ\'J9N-%?OM.,@6QXMH/ I(I>&>.8%8I=(R4=?X]
MUO/N@,ZG\@>2@C8DI&SEXDP4U0:RLJ\Q&E@J40J79&Q'+T+*6/E,X$J#@E#K
MT[EKWJ^%*Z8-1%504C*]L/Q3%'-95XIQ9*YU K%$+JL&+,[7R*XNEV_LK4<U
MN3BA4J($-8C.9;&T\%MW!_@]=5KI"7,:&VG%&LS,TA)W9WK;""AXP]C)\I&I
MTLMIH5?N=C]55G-_\6\961G_WF@&C2GC/Q(C=I8)IV6$\*8M@+OODM7._-19
MWF,?3"1.625!KZ^:Y=PG0O$U;=<QTF+*56[O-37&7,+K(W-S+W=W=3&V)PD*
MTP6WH-/-/D[H52!L3L#@,@*LR?R930"JFYG=CMQ"CXBBZ^T9I);)S0<% \-*
MHF9 *;SM1*.+Z MS;I.1ZN$+DR[#@1K64M83!IT:Y9=?ST>]&Y.=H&8&"52K
M+%MX&LF\Y\^G.$-\!.OD+]8T8[^ILY-P'OTP:Q-/F*$BEJ&M3PFGVT3%?YLQ
MCJ]=%F2NR_CR7W(<WFR ,H5J+U+HC+28?)0OY0P0MI 8Z2D(=%N!V/UF9+!D
M%5K+!RM*LX-*;C!;?1>@*=BQ)SN2"LK^IYY#E[_YO<V5"KZ8$=II+0OX.W-C
M[9ICLLRPG;((L:='@-\XI6H)WHA0ZY\V$YN>A'L*T1VP9*LZQ1>--<1*C\"9
MIB_AI)98B1#M>OI.('ME%U7I=Z!V,O_;N!8SW^M[_OOZ,P/3R^HP3]C4G,+N
M>[3?W7V.DEC$#YXA0\V!$-V/1VS-K<$BR?'O4S]X$)Y=F^I>^G3/8Q7+UX;:
M:/AIAZZ*@$#]#;N.?<@9?4ZD^1>$1/#C^6]OMMQT2[69B)GQZTP4W6..YK]O
MXPWU(F4!>^[8P^*6C-4U#9FW2(JFAI(+,2*?8BOJ,8[]/:_3Y:SKY6+H7VM#
M&]GL(H2"WWH=KZC%KRL-GPBZ?W';![ZL^ARCGO]&PAA$VM'Q0O[VVB%-F_/.
MP&T8;/X\Z>*]#<(@8-/^6HTVQ]X^7%&RV2F8H7^S5B=SOF1BI\[#J\0_(:3M
MZQ5J6U(!=E$(+D-%8"N(WN_2"H@/]RT>HA[U##P*'5&XF&I(T;VZJPAQ'ZG'
M0'=J38?+"<!*PX3*>;H5Y[!-]W2 &T/]6FW <^1T2)2+4D;9LE"0'WA^\&GH
MI%VAGK'B[W%]K N];@09%_2<;.=C(J_N2HEL,*3@E^A2]1O>#BW+^2CAOP(N
M.-?"'&_6Z=M%V]SA?9%"!)Z<"+%IN&AOUY!LOO2>8N>83'62H14.(>I#0-N5
MP&/Y%4BX!+M$+R?TT)U(6^WI^FPOK%ZQRP=]+K7:BA-:I/FUY.A(TK(0%9%*
MN6>8RFE+Z1JS(S!/F4Y\0C&B,P01*0?88!F)6[^NM(IY4R-7\D#.KWG:D;ML
M@HI.& 89 695A-B70'_->_&"Y/CM++;@4(8VNG3C2W_&(^[$S5=O(Z].!%8E
ME?N_%8J1%'%R2&,K5+JREM/\Q)5%HE</:ZU9'(S,K!\;K YFBFV'YD(/P^%K
M7U9B]SLC]PESGV9&M&3H\'JNTW(!6F.J5!'HH!GD03QCT%0SF3"?P7MPD R>
MX*]*(I;??X L6_-,P?ZNK'!IHC2MZZ/3S;"16R$K*\/*[>\X;-&7[U(8^GYG
M E["]717JG>#:[KR=HU 9WK&LXG/XX>C'!O3?=3"[2:XQ4--($,R%^OA3L&E
M>HDA)H=+99P<ZG*N++*)6CL&U[-9#,#ZUW]5J:X 2YG.AXZ_%[5+>-C(A8[M
MI.7:6 U'K1@ZMND^L\[7@Z)4 FIJ8S9!=XEI(%^I >,/7T"37=T]W82#&9U;
MYV*YFA'?9\]O/Z\_5$^N;Y7!14O^.?MD9>:4P@TB;+UF'N'#%\G:#=?49'\=
ML*N^]1H ^-]YZ7-8+R18J+4O\)9T74$M_?;R&>)*%'V$I>+]!M[$S7Z(*+UN
MJB*W&7D8(EJ]>;F<\BAT.D.2_^F?QM?<AK@01^4>9)0V\_#09ANW&YL2(7>D
M)V1E#/]MU<-\-NEO\$K_\IO.T?=@5ZR<<C"GIR]-4LB "S*UQ#=X.H_W8B1D
MR:J)7SO# R;?Y? !!J;GC<>=^8+QZ8[<V""=5U^K7BR3S0TI#3;G>V@?'^%M
M*,.J-IT0U= I-I1U\F65B=6-<R!K!WD?OT@T+FT#M@'>;<#X?6%F;K?I.)F0
MLMVN<EKLQU>K VJ?^/,I-UD&-'G<SD2 9"=(/MN2_=#O^6_JSG:&SFFK8ZGV
M=2Y(::A-0@L[-8T4DDM(>5T#*TN7Y=B],U4=Z&=R2T8^UGG>+Q1SK%285I4[
M'2D3/>JN^F'X,5N]A&_LK4R(WK#::C9!V!G[BFFU[H:GC>ZNHWC%P7<=)A+<
MDE=+=G[;X'Z>]].>'3\<Q=TCW]]T 2020Z>TB)OOI;65\/IJK#Z7A@26PM;5
M$="'F[/@PS\*UW9GJZ\3&@]BC[\>H+B7(O9B9\T8^Q(K!<<>E_3]5[:.+V=$
M!H\?N^L2W8/,AMSFOP/%J>/B^1[U/?A6$(VTFI\LEMR+\, <ND/I7W]VVMEG
MNU8[E%IBS=3#1TR-.F,DY!Y7TGG>-R"I?LE+NJVPT-W![Z*HEMQ>Q(>&4/[,
M9P_I6AH[[Z;>C'\ M11.TYM8$$"](]5=F! 1%ELJT9->+S,ZF9 W37K.^+6G
M-1%9NAKON^;81Q(TI 3:\\U_VN"PN_].6#->.=IIS760.&-?<"PY-OJB32U:
M]]6R9V[3I,]"#1QR(3[7C[*4#-'/S,Z,*LYYMK'<<TJ)Z4A6GQZ(@^JDOJ:C
M3MY@+!,4IXEQWRFN1%@;'1O-8=IM#^#P@2XVHWASKJ_S(*G*_P!)F>[M[=!T
M)46M+)-MT"PR/KOZ!P]&>W0@_4+(>#?5U,#4Q,*@M_WEVY<Q=&LI>_G)I*M6
MF>8B&9-G!=C<Z[=KQ/Y:NFYKY#U@=,U*1"17 6!SZ7)!(%4E 2.<@7H %MMM
M1.I<Q<10C/8^TJ@??LKXOZG$^*)X&'_-#$[3N=6'6_F3"B>(9ZV?$<_251+F
MG %7,9)"=%OPI*\D43BVKI>A*/R#!^[*P9V$.CDS</XS*W;[RHWPA'B#WBYS
MRWOC<]8Q0PU+<P_[QW!>LN[#;\IZE'?+*ST(VNI;:S,X1:%K)%@]BO>P/:WZ
M[FC[L@6^@+-F^+1QJD#XJ7I&':3%V%?:(C6WQE]08Y0H+?QF*<"=4E"YZ9H@
MS1L!R$!+:.R0D4\V/OZ6N]A!!5K8%DO(A;D;K?GWPZ^\LUIG'.Q.CUW^5'_A
M<H_7O9+;)0%GB\7Z$@8S;$R5KXE_^'MQDA%F=A]1[9QCU K_9IV-6&[$R"SY
M"3GDI)XVGYG9V0ZX8"%G,@/]M.3L_JM,D+BPL/-(C2,.^F M<!P'D>+C=NK!
M+R,DQ)6S/?F!!>WPI>4>H)A.Q%PX<+K%S82WH.59\8@;#<G0 ^*RJD ";#5S
M4*ZAKY2:N88J%NP$L&9GO]$>K5UP*S1^R(J^O8W1'(!ELS4'7,&:U#:(# "_
MB 7/VKN%+:^OG.3/.2IB!J_,?6W[8Q+9;'R1'M#Y+R2GL_3$J5[4KZ:M OQ!
MV4_[E;,Q"O?S[G!E=-H_]SHR\.:.9(&#Q&7X_.<TJ$-.X4@DT>_HO(0O89"$
MS2;C$G&3/<S0M@L1=+Z-X@KO4:$1B2]D1LI4P5OC; [FUKFP\/;3?XV[(F:C
M,W[!3;BD>\^"7L*JT$8YL^J2IS)+U8,=C"_Z%O:^^J9G5KA9$G_4%[/VI\F@
MG-6(BM\CUJ);+T*',H!/WXC8_,$C(8QW^32C-N7\6F^4VU[=Z%B/E136C!SG
M#UZ2#=LR[O;]1'?O\^P9]U3Z^+LPOQ&K0WH'':T1I7A3C06]$A^:?_\/<-3[
M2IX/#9(?KD+))R=90BKF&!FS-*D4;8"E8K/FKFJ@#9]2DEYQU'3S-PEA)*L<
M+P9U?OY+_SAW:PT"5JJ9"]C=V"E0/"'V(+'MJ;^@*AE_YEL]WBM<VN<*1JOR
MD4&!V]J?7]4<),)G%GZKV<V9'U<?^R)257X%3.BG_%Y:>7'*;BC>B=UPN_U2
M)KNMXO,/'A5Q[<]66]21L L3UIJ1*)B$I7((%G3DKM/12^;:;ZLC"'PEZ?C#
MH"HNWSV(J?& .]QH*@I0$#-4[[3] (43"-YU3_9817157<TVL0^,16*MT-I&
M/IE_N7.OCV 83TQ^]2K-"ULR'HM[=S)B[0S+580R1R45NBUN[8_U]W\LK4S)
M#><O7=]V\.75T1&9:BA7/Z7MJ[8<N*LE"-\U# AS0Q(J[&_TEN57+#[Y*5M#
M0JU)YA!FBW-780RR2%U:AQ@1C!4\OTQFC=++,\5??\\_L-:,,U\6JUHX),T.
MFK82ULI'H_UU?_ PVNWWHU$2FJ?K_W*U:^+=FR*TM.+S%3A$V/A>ZL/SJ OV
M$CF0YI?Y!6XMM#N?$[6,E7VHOK> YB@-LHG8+J9B81*)1ACL&N5&4J;0\XS/
M\P!JO9=J/WM-SF][.<^8OG;>=4)4:KM8\PO;?W_?<3A;<O L<,#8B ;+EA2@
M7LW6(#?. PGL$MB)&,@9L%S>*)P['>ENM[GYZK>A)@LJYD)-?G;^3<[#C6?7
M+#Y9;;[$^QMB,Z/*);RI(.%?%8.P!8;Z?-<)J?G18K-B.N^)&B:(F+US]ME?
M]E>.-]53&B*4Z;L.06'8W&$PG(!!E/L3Q^!RL-!27WA3<-TDP24S[9:@)0H!
M.D/&SPG4[V3V@YJ!ID[<X2UX_KWA+)VW]8XL#R#03$<)8-B2F9/UK#IY0"6-
M7U"K2N1[J8+.\8DY.'=R5!*^0W$GAK0C?67L[0[]:>V9JE6<EC)B!=B_A5F>
M4>.?BV/_^Z?SW*/4X?60:5(4C@B/D0$>P&H*_X@ _2W(79.)5)?XE5-]JY>T
M>EQ[<*L[EANX.C.F\)?[;T2?I^S[KXM'WPNV;,B:5'A?#PCM2QG2S%12-M]]
M'8!WL[9G^;<@]IV1FN"S/X6OLSU:#B@2 5OGL-:?.:+V6DEI)*W5#&3;]V(*
M7?D>36CQW@X)$#%,1LOY1VSA[N4Z%^0Z8P.I(\5R88F1<F*BYF<T -P\ORG$
M@E3+GT%VHY.3L"&Y"\S0.0PLOU%AYZ54=;OC@/N]&;&KP:>^UE0G\KXKDP53
M!F+0BQ3<E*9]F+R)T$@@B,-?XY2.3J1TZL:)55"5@*'R[#5%GP?+4<;]0==<
MQ[E2W;YWO3YSQK^]_93-<AIXC /=GFYFAF#!6F01L"P3OQRK/XJ@U6$L[^B+
M'JIOE\)T<IFZ=I2]Z(Y"VE[0K&7M[DCT#Y[J&&PZ_!1[2MM-HQ%>R!S7EKFK
MTF9]1?[/J$;7K&3KW["TFZ7.<$T'C70K6(-O8D/.&3" H7>\V@G?4%:!;58*
M@1?=*%^/1"7'!Y/%+_'ZCR:K*VY+")L0M(.:E+J21@-?5^/MU^4T'<LP%8L^
M]+Y:6"@29YX_Z@<ER)P)V7S&7DA6%W/6:SJ1C497&70S.6UI,SM5*W(/2HK_
MN@E?_9"4F)P>X/Y1@&QDXFACH)GG_>W*G:Q;9SR2SEGM$JHX<$]A>[S<+G<2
M(2- WIFP?K M\W,R9?AL<U?7/(P_=-.W$>Q 7A1F:1U1$Q,0"+&N]^JO"#.8
MSE=K\(2.2 !W[R?X"=E\L%0Z,H>E9JE=!TY$9V@S@XFOO/L2R%,=E)O>_>SX
M-Q3=]R)E"M']['1%Q9>6=@R%X<1^L]OL2?=6Q673Y5Q2_[(__$#4+'+2L,(9
MJP&;8>+EAN:6(GVSG&&'8I!3:/;C12M#$8[(XD_:]>Y1ZB_<>MNC_Y%,P;'1
M"\^0VQ@9@'4VL5JAA=DNQ #%O8G5DRK!?(GT;;G)ERIG3P[&R"IS^[)&S^G]
M1O'UIKY_9@ZNML8Y&71FF(=7^9[*EK&Y;453!*W !Z82YJO9DRRL/F5.\9+'
M/L7FP^<-_?2O %+1[@VXZN*7Q<]K*.CVP1R]3T[W]+EM.>%,9"]L7RYJJG+&
M,-.Z[%=?,3\FC%8*>@1R+7C=G<G]7Z"'?WV[(Z"<\V17P2(_\LRX&A2T )KY
M*RLGZ&W;0VX!#CX.6W@M+#O%N6(@0I3IC<GNIH2@+YF25=**94,,W.PP,3<P
MS_=^\+27BTL(BZN(2_ K]"G7P[ #T[00A/3Y'+90)YQ]-CBM6(-:CY1D.#LD
MVG9RE/Y.-;FBICUYTD?UJ/8%$5!+$NLUN+>"3%;H*\EZ7#,0'9+3@'AI]ZP;
M',*Z3;E:95A 5;0RR)FP*&HM66!R*YA1L9R]K.VB(^+A@W5C]ZC"03'WU%;I
M:%'50%J@GC&F],MTW_0 ,<KZ;RI&4LMS(&9X4UTV-@85&#Y=ISEZ!!%[0!2T
MWU:^%;028<1P@ 0#E9*:B=V538W#*KO&OVMGTH3=;EVKS+I78!P<RK@]I+%S
MW68:VNL=W>OZ -9UVI$:&RI?0Z.#1"!#W#Z!'6OT%"YYPH'^/:&%)/]T 'H>
M=R) 73\5Y*/:I\7-Z1Q#G=?8(@XM/C&V6R[C?5BI01UT T^@2H8V.+@0(=4B
MG47;*,HSZVZAK*5J;LN+]:7/5,.)G6[2]@LI2DQ?!JK$Q+Q1L[XH.==UH?UY
MNW0.?/CWUG/4R&L]*$Q!)=.C+VW^B/U$2]J7'\2L3!5)^U[:/]Y*+Q<:ZZ-O
MU4YC8GD#]0;"\K[3VO">6,;H)<2.  &QW0UC$6K(#UFOGQTH1<FK2EJD9:?V
MZJ,M9UY=+E.Z]!7#GVY;2KG (B+BY^,+"%J!;X%O[<M14>V*0C##M6J%'SRK
ML"C=T-]WUW"'81,*HI/1YS'LP%JLK,,[),UZ>!WDH4Q0\+9IPM#FK2]WK2T!
MG:<)SEMRSWM7S;D#M@'\VOQ0QV#I6R]$T==%HOR5JT?>\=95.4:-F#)L+CA]
M_DZT,N+%H:05J[B=G*,-%W_G,I_JC'MH&II>;NL'K##0R[F^)7/$^0:6T6J9
M2=K9'8P^- OQVQVTXM84WDC2TZVRGU&X4:@#2D_QS6M[LSV<71[%C3X<A5JV
M0\8^5_]Q*K1Z,R33]J7  5[Q37XGQC'YT=>'#K*'[H?_.LGWHKJ*]5"B^$MY
M)I1R3<,)?,$VZQ8L['7,T4J^1"[$=F3%!5,ME'BH%OCMEO"HS*-#6TR$D3X]
MO(XD>L*BFQXJSPH\E5KZF5R/2TFIX6B,,4%.@#!$M9JRI_\41!-@EW9+R-X.
M&Q&,=/0[W*,'%9I2VL(E)&]SPS>O7AIUFF>O%<JC%&9TX&PIJV&,Z]V0BN(^
M$)JM- #R'N^= UBC?\K!/.ME+&3>WAWQ." M+:T/G=;6EL("@X'A"M-$32"+
MEH4$_U386+!V%A(B,V"7C7%FXNOX9S^IJWT>64!:V@<&(K$V!=K7^J7KUM1>
M^4D."B<;I>M40C(1]3=#S^TO7J%.'Z.:9,8G.46M&>GYN2G]YN:TMR1I1;'7
M(<GJO%4ASY":Q$@,-3-@9CJPJ<=$65BB2:B6.ORX1C(N#UJ,2C3;P0\.,?<@
M[GCZMNN>IN:2 C!R<W/+CJ.H+>$5>#8TP$7Y,'2LZ=30UX^$ I*SK_SPQ2_Y
MS:%+9SYZKUQ"*Z"CH$6ZCU]FL\R3(RK7K7,-%V9R!34U;9:4&Z0SX ]8\W!8
M062LHB# ;F[6K'H%K5L\@<!,K!Q&%3*X?'%TCCV6W*>L*M*7-KF!.PM\AA,>
M5X<"<TJTL]">IC!K&W2EF)]9>M-H/@K*L4-K,%H-GRQCQ*HR!]L?3@7<"%VX
M_K!,UNF-L=#O5Q\]P2BEIMVS05$,^6F]7;/BZBJ\MK4*=GW^9N2% L]^[CI6
MLWTY%^<2TI0O#./V9TQPS7PDH^JQ Y_Z*1\QU)YN[-@8\<S4'+#V.)/# 5>K
MJ^U'!KURYNNB7.S<E1RZD)5SUUU:XG)$ROL T=8I(RT31>'\TVH7\HB:*NS7
M7X[N:Z+"^KVV-17\'<H%(V>B>M()M*Y7X*J@M5CG&<F^BV916M-'9MDLM$2%
MMW/:O'L5.?;"W."Y_?HB@5'Z@5![5;DC1[9RQ,KH.C59*XDR4#R(%B!K(C:4
M&H)TV)J# P*U8N>8A2?-9*@_>4S!SZ$67^<&<?X&<6Y0:YMJ#;>NF2-C)X1/
MN]W=L<V)W92:?U)=?O.=I))UWXO[]#.9AB=ETEP]O=#M (%V=V,1=,Q4GZ9U
M,]%!J5)1.#,L69W0V;AX6&G<'S@P$1!((ZB90/#R;Y$<,D';4%WZ*DI.G(\
M\EJ0"$G4:CTPJZ[,J9F:9+':99ZZ7+JC?GX,]5 9Z%@<@4[[_8O4A_?PM>#K
M2R)MT "1,67_A87!0NW4];\7W4954S\M$"O=T6!VY+*8WJPBKTQ.90=I!Q*!
MNJ\J_W4Y?$/!)N?9Z^(,?Q5$5+7@MDJRCMPB.0;D8?85PO(?AY0[.KI4\4%.
MVC/X6FKG W:(N7>U+T P=*>65<=^8RU3FOIIHZY,D:7J>(%4$:)Z!FX:@8_B
MYF>0?!9J9M)3-0!66#VFU1JR"57#.1 K1]1\;6D"9M1X#N!PJ-2,<'&I$9:I
ML0TAKF\.?BT;[&QOA0;+ AKK;*OZB]S5%=J1.F^.PE=FZ1D9F[Z..P[2TZO'
M4='3';%ZK9-6:\?83=Q_!RYB_XU;M/\SMGP<Z4]_C^_C-&&C8XA#]Y;50BD0
M2>4A38="NWS&-:=Y.Y^;LS?GC*OOO9*RTZD<*WYSZ[5K_DD184U!#8*6:T#*
M_,QZ2"<L,<*!O%;B;'?A4U.)']S#JK .YV)8A&LA]0*O4O_NZ^VB9"LP,]&2
M4=VT<,A9JE+V_"#-R1J)$G-H[%C5)3;%#N_83N2+^_B<OD3JV?FMS6G5G?6Q
MJ/Z0-JU_%R-R2)C0G:&-;D?K!GF9=+0.2P>U Z$^'O+*F[6LT)B(T"ST?L2W
MJ39ZG:*8XU8TT)T>2)[@(N^W$0*3*O'N)ML%=0LYQ:B"3Z%3!8J&DPZUH6Z*
M1I#2!=9_*,]'Z^3XSZE_*'_GCUN+=>/%1SNM8@FURZNE?*C@T\9C>T+96INO
M+P<P/F8.X?=SOLK<+O$)&-8B2]EI"I89"HS=.N=NA/A)3Z)B"H&3?"QWJ*,K
M6J)G&$9O+!?;Z\S["=1[R0V.Z@_ZLR?[?7U")U%R48X'\,J"1"\'C(!!.,17
MZ'LS@.4)O9*]+!9%OHR =#Z(.9DS"&X!4IP5U 1IX!PPK 55[P0N&AB@$CO]
M_G*X:KT)O?%LOZ<T#[QF9YC?^+:G"'I.CQ\ZW0%S"'+%+J-T5 L@,@Z3V:V<
MDJA:;-5R2Y)]'9;C)-2.+5*('M<,K_7V=B\Z9U/(7:87T#)9" ER2 T1!(A,
MCS28$):VH[3D,;5YMVJE[@CD*1WASTWJ/LZ*YO.].)VG.7FPDAKFJD0KP]I1
MI?5L=H0O'[M[R]1O]U I'[/+4S-T()GEYYA3K'/4PF15.;&=C/'IF@GL&TI'
M48.+145 .]RH/8G%U5:1/L>EN0X5F6B_'94'PO?GSFX"\!B(  V5EP&VK!-&
M>0 *'\5I[P8M/5K<5ZF)JLY:W7NNJ[@ZVU[DQJWX*1;M]UU&QB+-**W>]PK\
MAWO[U\"U%CAG/9]?/A#@O_;=:3W]Z_8H2/J&Y!.KLZ=\%?]>DLWMC?&=3]M/
M1_8[V)#..K=6>A"A"Q!38X=:9F9YL2.S#9\:7QD4'G4P<,H=6;VF_33,0E'O
M*OZYL+3+2,,]=[Q>I0O)9]&<.Y7H-V\0G WYC!67KMLSGF.<!4A4J[53F14#
MHN]PIH\5X:_\K3GO)5XH65MH;9<$Z%O]TA:> *OE]5YGN0\J;$4>!?@L?K&V
M_=C7FDJ/B)+#)8N)\4*=;/+C+^'RPYH.12^T1M]JTJJE3H[(G5NPL1@)N>\7
MU41LD7$O4UUVD_<<U ,,YF<5NK9I,--;0VCM#J2'W!G8\S<#DY5%$G^QPP*0
M0WKZT23)@'&9CHW/,+D:_TV,GYN-E%7=#QZ]-7:I0SBC7><EE<%="51=MEXG
M1^U6WQV=Q,"6 >_Q24-@ J52-: >..%SPSQ%3M$KY[FZU#O3R ._BF-3:E6!
M\IXP05 _X_D+#77H#$DA>A0<Q8J98%JC-JK^Y$2U5V/!9MI.(YNJKDMT)>1*
M_JCB=#;H"YF@0 W!RBS:I/HU@[H*4OK<2LE%C@&KLAF\K/S^C/<7QMBO*G\7
M-11\2+?MWIYQ*KAM-(P I^W5U"HWM.<_$&DVD7_WE*@UX!HPD:R@HQGETNXM
M\8-'<[2O_*C$29[;#=7W(\SBQPZDD#X1>:>NS^DZ6-?(?9J;MR<%IV%F!F6W
M08Y?YK_YZJD42>:'0SO7\I8]&*IV0I78KQNFAK9+CZT87P46<--?>WK^>OBH
M)#&F'F6)5+MNU\G>LNI<KFC(51I1"XGX,C_QL0>/\-(5S5=* UD:9!RVBUMX
MJ)'V7#IT<\=)PJ#=:)/QV*+.,M[4O^8GR&2\T :+X*_3B(5TI:U:MA=,9JZM
M3M6PM:C6-44!FA>^_0\$=<)\O_^C_YI28T)A.[SU46K-;7;]LIE-=G_F[Q.3
M3597U=Y8W>FKH["Y??"Z7H,BR5O#\(?9;N]."EB$F^"Q3VAB=E_77-:XEO3!
M\5W)SW7KW_R,!,=/$&-5XH3_A<*IUQJ>=_^ A#764'JJQ97O9_N=QR,D]9B4
M1(CO[>RT:@$F?\G9:1STE:.3G'8X0AC\U(G,U 7A=]HVY=Y5G:\35+HD13%7
M%%>\<IMA*6W.L#Q;PQ@.*6C-YKM=*?K05@9AZHK/Q2S"!E2Z:=VH"2JR/-79
MC+Z^ 1;;M0HUJUIR\6W!-A#_K'"DCNLVC,>\ JBF5?OOY']"J;;N0@W:I,\.
M)ZS,$&2<25#; B+PZG*A@O+.@,^,E%8]-4^GNM(^Y<ZHMKI+4[K-55)"9T2D
M5VEKZ$B-Z )FS2UB]+2%(7HFS<7K":;OT'RRQ7HJT+])SLGD WQ4T6.RTU4C
M-KO8P_\*7+PEG7&BAQ"/*%U[[KOFWH<3Z*($RO*QAI]QV-2_T2ODD:-)E!*4
M>BV[M<_,*OW7^%C4ZB_1'9-Q-=8SPTM[AR4<CT;=^>F]6$6'A?2&\/T8G>_5
MN,%O!D:L'M_]B%U6)$G1*#Q]1^.YG'=<8%R/&).;KK#7 A6)$K^M&H?B1K::
M%<__X(GM&C<9E6I9Q 5?D7#\0A*RJ\$U(B&(@@:A'LS+PLVHR$BWT@>A7^NF
MYT]1/KF;?KCVZ.L\,Q5FZ'OR-2<Z'#")Q,IV@V0BH--SC-TWZ6)Z'\L]H%<A
M\)T?/+;7Q%;Y[+-:+A:10,K;X$N2>$>7=,.>ZB+^7ZZ1A'%;S%6P:]HMY_!O
M*)#[N?7QE5TY;)+/9&!^9OUXC3(ON%RZ3+3F&&!MRDERZNJI$Q'H<0()S(9K
M[C=O*F@#7*\[.-1.=<!9AWN2,!9U"X!?JW9R&-8:8. #+=T9*O@"B-YN937'
M03I<XO81"[:SC*L3!(:@A)C6=<?9:QY:.DJ#OOPRDF<E157/WSZX[75KR_11
MKB,!*F!J;'H?9A)P!U34^/C5^ZCX4BNK&UF:URT>/H-Y$V7,=0S""'<'KF9#
MC5V'LJ,GZ+;K .26)/_L-46YTW+\^B=D%WGC+O:ZXZ+Z6/[<_":,X&2K_X*D
M:>>"]*.!:XE^=P'9V1!3*U0@.F<A<+=#PK8MZ/MX2%7?#2(88M]?'5WOL$ =
MFKAZ\;S$124=G&^BZ98QK3SQFKI7_\O*:*!!O@AMHA 3-[4R.]@1U=?V%+A#
M);MJKQXHUY2X'V+5F.'5I(OOAF&A@7_-&)-JEP31!6H*/O45WO/N"VBH(:8^
M6@I>3H%=1FO.R1H_2YL?%;*+[[GRBV_>#QX9357KA#0L(Y*?5*TZ9IQBTN6P
M/!G^Q-#@XWU#T9<-::\0[Z42HI6OZ1E9W.DU?W[Z1'Z0'>->IQK6WXF/._F3
MXM1KZ=GEF%(_=^=[HBK1T:-#[Y4>8,4C6PTQ?A&7,6W_YRY7\S")X--?\]:%
M<&9_S.!!6@S5*L%-"[X_65XGJA&Q,9\XK0U?"A/1@B]U)EN%*SC8[FL- "O3
M0.AQI=?@B^BWX_<_,_%(L(Q9H?5O:^ZM&?!(P6O(E51Z-EN3:H-F:P9GLV4W
M:C"RHWEX5*Q3V&A=%_IG+LH0):M*)KN625P\YW) IK+Y\OI>]5559DJ1E-ZS
MB79?LG?ZH)7YO*2AH PBBU^W*S^]BA.1D::$/\\,-.G#4#=_\)P6\UBL$<V?
MV=UNTA<:X.U;.^\XU'@4]2Q)M<!02N-]^=A\*+Y>_&(,7Z%N!F75*'!7ZM7X
M),[7S?.UU\*Z#4&PY_YI30O.#<._D7-.N0'"J^)WPX^4TO7HV9$4AJI.[R;+
MUY441*>&S1V)*6[J15N1"A:YV-?TB?YV!GY%\/D19'^4C7 ^4"6S,7FT%:(F
M*>>DB&346(NB_+Y^S?QXUU#DOPARS]*$2\<33L@Q$A^=NIBA<"8+?E]A]NY0
M'E@&X.KYP'3".C+VPV!]M?_;^C2EG?-,;L\'@:DZ>=V*+=CP-S[H8%!1M(L,
MPO>\+R&]9BE"8*-4?M[P,:56M<*D&U%]C:A]'R'# !A<YZS%7/J]@2C<OG?[
MI&\C08S2WG.99:>1*M\.!5R4? 3]4ILF-*B;<6,]!J7+,CF]_W9_]I?T0ON2
M"A]Z!JVO-4,H,JL (OYE@W5LK.Y/*&X+;,:+Q-9-QCH\K0<Y ]1@6PT*\W3;
MY47$J\'B4M+;KO2&;:T?/*%0T<?9[[1PD!6L?]K<A-P#Y"][3\LP"M6_:$C<
MN#-<!U#KVKDLUQ-A(OMYT9+7;F5S3;UH@ R%2DK^1/UFDG3RNU:-X+G/BRRD
M9K/2I";!):C^$XW0( RJ6L&2#-[7&CV8-E$YA:J&Y+]#<D _.9\ILK50LT_4
M9-&Z$$][/?X[NJ']7W1C\9_HAD";(@KVZB)^^8)]'][.(C&F:\;#[6@Y@VW.
M-UV;O>I%<&X?'TYQN$PGZ5]EZ$I9:C::YWZV%;*RQAY>WD1JJF;!G[_A'FT
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M.F%$+_[K! %^X<$]G6BOW9MD95FMSKPK?</2?Z?<R3UC<'3?.AU/<K#!G9G
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MWA:O'^B/OA2>"MA$(&8]X@XY.T[(G(KJ)GC9%1KE&-Y$T-2ENT>JSE@-<T;
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M(N;SCM\41GIFVX]CO!-(I6,ZSA-76EN22;A7)DY1O\(OK W):.35GB,-=-H
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MCY.3.P<KL1S0/,:\S95CE_N'$5ERDKLJ]5*M['9@\I>HXN?_*DI?_F&\K=;
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M-4%#\5T*I")"_.PS39[HKLNP_/+!R%AP<7NR+:?^7;',M#8X49+,ZLK?V/G
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M'3WT/%QJT>)U8H#BE:UTSK2QW42%1H:".KJ3W\2"W<XW=TZ'3+EO-<(_I7+
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M:%KO:QCMF&"I6^.+%6=E(T">$&P&W0HFLW-)E, =V"BA6B_D9^$)EJ"W/Q]
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M(77<<4CU5K0WY7?K0$>7MPE1$@S$(N8UTI-SCGQ$V[&#\(BT0X[8H0J=Y!U
MVV?S@I_]S?-&247Z;WU79_--?'-_54R?*!KLM3VO%51KUE^67%IZHY5%[%M.
M3#9N9<))=0N)'$2]3/0Q8RWFF_?:93 G(,TC$5$9S-GMS4R4.JL.<U>$[Y3,
M$Z91J@%+$'3(I,\I_AYQ?A.12ZUJON>>O*1..J5@-]R4&09<+XMY0)L,^H$M
MQ&AKC@8=LN$[J"YZ8OIV<<%L\R((?I^N;7X9I&>+*FQZ7H^MG^1?7=L[F4 ,
M3ABI$+H,S2-8NEO)K3-%>?]_?W7[[Z I:?'^8PQWIT,C'/W;39K<J""W^_8I
ML\=B)$N9L'ZDN8@7*$FO+#^81IE%3MIF-SG"3C7DA DV(OFI# 1\U/I[ #C,
M$E@-=>HE/$Z0C]'U'HP5!5C\PT!8Y)@QZ!5IC%]/=M/3W_X0D$_<NYZQSFPC
M*7+NQSNCNAMLU2A!G#"M<]]UET42[/^H6*[<=.!SZ\@8*MF_9J)04B).SG-T
MJ+9/D?E1+1^60I(+%37JH;KK'['VHG?+(KS:FZ\=;)%NU=9_W,Y"4WV>_-3J
M1C7-E,#'["WBD>7.DBLF-J D)!MO/?_J8RO:1WU;/6N[>'>K/W9Z+F%EP/2V
MA@MFS1\TB3A?D:C@ =XZX@@B"]S*9O^8/OB&4A,/"1:P*$^MY/8^%@CF$-XI
M**(*LH463+VM.>)OVKIO\=W[)U<&.]0EH?)5)AGZ^\>VS/@-\"-7\.F6C*X\
MG>E4U"I/=JH*D6A0?3H'J2U4%Q5_2S I!@]K64YWJER*$2]<T7^9W3NV*.17
M-W5?[3N%)IX]>%!KU9)O4V=-0U5.FI8/]66,B+EM3TI>)X3%JJ^@&)LU>5=0
MP]-BU@H^K;.I>#,5?F0_.OD7C&,_H9D<=+A\J(-9B?SMD=9FXI5&FT823C,]
MUJ2Z)%K/4VR2HG2&OEMMO1)J'3K%S+D7*SOA=U^<BQ)OG$]5D9\7S[$[E-U,
M1#5-NV@-5,Z!.6\X:8.R4*GU&H8L,0= 0VG_?"]_?V(6=E.QGCFX7V+JOM)
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MV]:2G6 G%W,HQQ7.<\FF\.!**R*E\3.6M2(TK4)418U8V&/:L-;,">Z-G1F
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MAO;DNIX:058/EJ5.S!/Q\2!BZ@7KC^1:O4,(]V.,*J.2>4E4YZ2X"LG,2F]
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M;ZM,.2>D<$9I(.6O"@/+Z+Z+M0$SCD6^(JX7NS(<H+K^9TSUWNYV$GG^-O8
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M\L24A<F5O<SS8>\VA9OX["+'S\R-_J%A/3<\#<^'?3 9-#"9'*Z6BJ[<VF"
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M;,+R15=Y$K"%IW_1M/)Z1.>+T ZMD%[9I68'&_DNKW^;S4"!0R]8V&F#R^$
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MTLYV\VJD15-TY83FSBS< MT"+>E5]*-EN'$LD*V0+DV(M(_2>ZV+/S<;9F7
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MU>I29B5@L_!RM.R8BK.T1O,;G85PM+/E*Q;%S%VA?C3GT#_LB_H[9X(*)^+
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M[G@G?LH8^<4GY_N5H4(?@J>\K!:&LVI7)_PB-<JFJT$O,/_U6AY;T[A=R<:
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M4S[7J,BLEHMAS<?<3[A[UZ-'U?6M9D[X[GD>G5'YQYQ[@_/V)\]=,AD">SK
MF-B-1_(?LM[8 \%?O26.EB&G!F)__MB:DLXXD#[;;[[%T9&M&(P$'TZM ,IZ
M'UKLN71N=F=1/Q4ARC/9_'S\C:9@8_7, ^R7NG(=AQS+J@U,?^"#W>K!& D:
M29TLURVBK1P2QONTS440IY3 ;$F=\*921]7WCG?BB!2U98(8SV(3ZURQ,@VI
M0*1A0V!T0>J$=6Z3;0'.12[ZB8L%B?L^8:1FZ4>ZNY6A'-8#[A<#5%=2E2NI
M,7X*+NR5PJ$HRT7&[VK0PH(KB$EWHD[BT@=F/=W%[<RDKT@ T0!>$D:O]'$*
M?"W@B4?U'\??38\^GS:JTM9<Q8HO'K+NI6-_([8(:M#&CI:95EO[\"K[0+E9
MEK=XP+FFT8HGRTLN)CH:'()53D+-^A _7>8.ZXWLYP'"'/EE3S?^LWV)\2\&
M(D#K5GH<OZOF2I'*6\H+,#%W7B<@["-G;\+2/B#%\71J()OU;<\HI+0V.@=B
M\AQ!HF3+2WW?!P-.7[\Z-7CR%@.#831-TO[>^6=./[W"6E9\-:HV/[GG-7S2
MI%\#^I"EVKEMJ4 &J!_ZY<1^(4?O-[9LN>,7VQO?K[9>#MHLO#HCL5,VD=@B
M>MU&Z*IE7'6&7V/9[. G-A5)LG3!V?!'ONS=.: %H!J]S_4PNK\'LV@&J!!'
M%O@^*_3E>Q^]#'_F, ,X[4J=T'5TR)_DRXY37K9F7XA.Y 3R5PC.B&@UN_9O
MV4M K;QX@NSNO@C@X'AOK/FU:KO-P!5*7'9CS-:@"-"HP91Q8)?+2C_T/#'L
MPPHY&80$;U$A;M95MS@?3X6IAD VN6] *7!J(3M@R_N T3=3ADS3Z3C;\41S
M)LZ1^ZO'R3"%/$%K_P=RU:Y2X?1?T$ -\#_DSPECT!2H3HX,IGHBGHP?+K-\
M=4L36L&3 @J7JZ]A2G'>5<Y%U*%9#>E8Z$%]&K*B1G4[XB-Y,.LY88=9/OP=
M\#X%8>V3,O^R?3LB'T5S*ZM=P$/>(=;,4*L;)I'(]5S*P!!"8J<*C9HZBEX?
M7WJE]%@(5. [Q4F8IR?A>PFSHG]5[:^SQKRL4D(=>N0Q7">6KC8[5E^4(%*H
MFG2S:T.4Z+IVGM0=Z.6JH"B=MDH?<_E>\Z:S0]\K!C>ACETS.;D$JA(*^:6;
M",P<NF;B!/RP=?_)FQ(7+R^T6%IA&@Q\&7507&LD#2ZD'TW\+O7MWS#1_UM8
MU&N_ V>RDDL$%MHNC>9NYHE2,@B^9TN=462M.?GA.WA2]T@FA,%<[%+525,-
MQMORN9; I6"NJ!" RC.6'AE9_7Q&Q^NAB&8<"EOU;<M->L9E>3FY04&UTGI+
M*LINDFGP,).*#DNB'#V.CD41N^M3I!G/R?G BS7>+QZ<+T9 )2D-V6..&3'T
MI@HC*Y[%)?T,LZ20Z/IVFT-.(QGG:?H/1CB#K._/_JCLGA+S49"+OD#]?'"0
MC,F#JY\[Y]87,!W=(/<,3I)3P"#>#]?PNMH;H?)]#6B;E?^-HSA*M6^$+:B9
M83PU1QMS2#Y1]!W)\"&1<)W8J.=F_#;(MJ^<5(&J[!?9=<W/(UXP.WQ4HSU]
M8*&SOPFHQG0MWZE^K"KEJF9Q.N0U]M,]05#@TX^%P2H)APE."(=7]-2<(<BO
MDFTZ0J'W?2^ P<ZU[+5:[-X^G75G_37R</C^; >4;:!)S>&9Q>&>.89=LR[&
MJW.A:6!RU7B>__XXP,87X49LA5K,L!PU>,&EED)>84K2;TSK4+O$<9Q;KTT>
MG96?F8K(;[46E<WT)DU=!!'!+^4=V*D8BTJG5QJ)Y=;-JGXM;9^N^F[@&2P4
MK4 =!"^4%:,=;\HEL_5W3SD=X ,FWG8OJ%L(DMKBU Y//QSYL7Q9(TD'(2JJ
M,*.8\]/ RC:;K#HA63&U"O0,:YBSHV$'X[(#U<D7SOW\*\_U2M0&Z8,/V#W@
M9HVHGNGK794:N:*%-XEB7=K%W_K1G.^@Q,.UF6P1%/JE0C&.P11W/?:%,KZY
MHA>73\S,21[-=4<\JFN-JMU^[B^2@KK*E0MMUA)J6(Q-]BLBZAKZ>\6E$P?D
MT34N'D:S>A=@+D/!++94V#BS-F'PSU1.!X-B[KFD0;X\DXM9^P)E]I' G>_X
MU==XD4^+]B\#,@&#9&K;HW3S:DVY9[Z80<Y9X&WTT$IRP/E7C_7.]I-'.X(]
M;#-S[H8!,M%R.;^6UZ,\D"J;)"";J+0/.2OGW@'1A8^VW*RK7(I6V,OONSWX
MKT"S1=/0^5H.$=AN3X@\U@\&68[:HXJ\KWKQ##9\T5;61?_SU!NI]Z)??#Z5
M"/&*W7< &\ZPWAC<=-P,JLRW*JP)5'9\_@T8W"BN7WFEW:./T[-;^6EZ[B!*
M4"]DL*K MJ^"*V@T@:)(0^M 6S_"[8E1U0?Q>'VC5282.=DR^?.@:J8M,<DV
MH8T*\^_EM1%(6:L'#HQ?_R;4?.BEN>5]^%&F;>%*"MOH>E/[P!;MFE9&;["\
MIH+EJ'=.WVVEOKILXVAJS'@6R>[I\87P^.4W0IOW"Q[XVMJA7R#WDJH@;<<8
ME8&GV8I5??.0GY5X6?OX^=^_+'U9B@(- -Q#9GCXK:P'+B?<XTE'SI7.<MX9
MP-U7K\QZ,HO&892/SF@=.$^L'5&MP?)<(>D>@=GDUYDXS3EO_6">-@=7A(Z\
M# .BSLB-0E[#SK9;=M9'XRIG8/Y1C&<A<\PZBYKE>H<T]2]&I56ASA4>NW)4
M\0P['5?&EX_,Q"[TX$I-854.DLXZ^"'!]!ETEY3@E= 6<&-% $FC\T/B-?I4
M+RE\-K8AYTO!_.O$$:T;FLN.V0I5%34QOO$0W8 5:.'[G<'NCCBA_4 CWGK>
M3^2(@X=ND.CL2HP>]Y,RQZEQL[[N/M[:,Z[M)"?)!B\^JVGFC$OKP.*7FUM5
MUF.77)D59;,QEJGGX[B9MCLLSYRYYW&+_M1(*K>COU<)'JF9-*MR&X^3#'AU
M21,\,KZ]X3%C4,9\%0\N5^#34]:;D+4Z_8[--^%WL&(N0U#KF7D3-CJTYHMO
M@[H04.X53O7.&G)P#)GK$QK4&.L ]B#*7@/S7:YU'U10XNZO%>(,##A;SI[,
M$EU2$ES/:S(R4_*W0-8&J[/>Q8-;T%R>Y9^_HFR=3_('H34DG,+S2Z$XT&(8
M70W:3T/7EP+[^^R]II;;30QIQ957;<$AY#F]1 %$#W<5""8B54/BU.TB^X4T
M"9G)KJ+L"!:NJ?^I#PSPV/)JH2%>U\.H0S]A%0U(KJMBKT18U<%2F^2'U5:G
MMLV;/G#,[-S%J],LWS?1/6G[6EQ)_"P<J!(NE'0CRZZ<'LZ3G]!*B)! KKVH
M:)VRPN0@,$\70+B"4(VH[#/AFYH\<87V-95MFMKM^_<%[DD\!.VG<<;HFND=
M-XW.A]$6J15WJQA5>B&>[9W'>Q[^9F0NM"EFWJ%ATUL:; *OV0"U]KI5Y"ZS
M=C Q?!G;1&FV[/9_TU&([+0_/OM\#X#.QE7ROZ0I(*8R5>Z9?MVV_$CISAK)
M>=7[T=E*K;H"S+745E<,%;CFBIO!]]PB"UMH-SL7.JJ2/ R#<7FN%^QX%J<!
M%<#J8V,MV_E7X_'%ONPL/]8F=K+$@+VA8SK%L:0PF+ \UJWZ:VR5J?\@D10,
MK-$2\)!UP+KJH$-'8-Q;EY?T^<=MD? C\A7,'=/G5&)SIB;BG%?S;GB42B(W
MW'/.?2<)KOJ% HE<L._?!9H)[#()VK3S;_-1#>OO:B)"*Q6NB6><:LC-E)GR
M&'*')J;F-A+4D8-4L^!^O&<GR4'CVMTXBQ'EBR&*+VY>\2K.#Z;JK#(?K U/
M?)A?*QZX>Z*H4%:9M:M&ZN6'9Z,A?[1<."M7:_J@&U$FS@^[4[TI4<$T^YV<
MO?1-]Z%G8S:L:(2FJ:%E>DCEV'FPQ(&3GY3;CLB5A8MK_]<QRN?!_W'+-^MS
M,E?=\J.7RAO;1;A\1&'*[IO7OA((=9EPF5>D0^<T'M/YL(TP*L)$4EQ_1AY5
M-W@U?9W5J3JEL)4H; Z(I;'KI='UM4MU5$!M!3B;B(Q@V#7RNGA%8?OM9"8E
M$-BK_)MAM:OF6)*HJ]D=EFZFE('KU59S+477#NQ-]:#):I]U=#(3)<X5<<1^
MXQ6J\CYT\/$OAC5OM']/$@6>FE%S[R"JZ@AU =@M82-;VU9"Y:D704>%/*.O
M,[+-G/A8)8*-44B]>6;/:1M;9I*; 8?\2Y' ? 6W9/7%9^*?]CYO:5;-'#Q:
M_VRB6U*0@R*C-!"-ZR8+2="@](W$Q$3$@+*X_>3W=<\U( WDVITB!#@2]UAC
M=DV-M'E6-&-679A;#_<U>9&$'C$$O![I:+[F1VIF[93]\O;UW1>]>.BT$)V#
M($467<A 02IF'T+TW,W +L&M\8E>:PB6?BG4HO*KHU88K#@2EA^9]H8/L6>U
M3>?Q3>S->S,'_894%X/F^0K')AZ-UE< '&1H FNN"WQXL%UK.*UM<S_+:OOA
MNU3I?[1E8/+"@X=O"QHGQG:JJF9:#XT+!K SQ9W0U_4W%4G;-C)+=M.A]9.#
MVG2T1]QPH43\RU91L(&1%T)>&1ZK 519?3P9H23\_A=C0GVB4X5BZ7+")Y,U
M:U]TPCUKW_6P_9\;V+.\*=R)VQ2Q0M-;H<&HP)"I1CM2LP\P!]&=.%@HW*M1
MW;+T:,]V9M@JR#5\A0%Z^5IS*@H!-TW1'VI,]QK[T64[WT-/!'K=+IHQF0S7
M*!N;\)5L'@=Z55$O-NC'?LY**>6T*'OS$$*U 7"J^9R8JMT^G.!ZR)VL6\PJ
M 1]G0B>:$'X=;]8$;/Z<N4I8FBN9+V\,SI[Q8JPS:I?J1IMHVG"#P]R2DSD(
M"-\$-*CWJ9.@W@C0$5JE:NUJ?D6QKB5AE/@+I:4$4OXI=2[3X+H0#C#-ORYS
MA$K8FLG.MG ..A*G12I,@C&W!E48SFE6+.0S8W=C\*T^PZ>%7;: [F>O#AI4
MFM&--("BK^R)XW8'"^5C^ ,E8GT#XNSE\SG<%:LOZV0S*88S6A#P>>O++*L]
M'BU2W:VFD&V$D/"L 8_M\8H+/;< ; ;&-OV#D%E(OS;8^5[>SL;Y4$<4#064
MO60]N!-5/^9XWG-8DHJ[4U;U3.A2M_?-;*:%/>>T2']%L<]YVU$*>V1 @'W(
MD@G'FGG65YE^$4]B4,>WXTS3&9ZW9JURI2)>@R]W$D836V[2,.7&]7&2?P;!
MXBR(81>\83.I;]CQK>C+5V&X>2#/U2VI&M?*50<2$ZOFX)V6L8\=^:?QHAZY
MN?EEAS_*=1*LV&R"EM<T?(?-#M9ZN9N&6[S4;8^!>_B.QIW%)VK%H6T0$S)!
M$#_-A%(>@7TRZ(T#N[32K6'-.]Z)\(P^>AB)ZX'+3)V?Y\)JIFIFUO*J0:'0
M:^$9Q>63TL*XT9AAB/+3KO@\1V]"J@RI<.40A-NK-0,<?B/4<[/&B'#+]<R4
M@J=S'+?V< E.#>,*#6&C^"0@)D[V.?=!F[L;],?!O4]@I$$G[=O1M-,49@8]
MN[78XT; >_6PZH5X2H2Q8X>V[N@ET#.&K*B:TR@9IIB(K)[Y3J&_6<=TSJ3+
M6?+G-,;EB$UO2+=LU?]5^F3JL]-_ VC_71_,3=:1ICF'FEI3*>L E_*)1!.#
MD>.2!4$G??50LY@6H>9WQ8TA]OY3^;0VF\;<H,3AKR?4R>F)EXJ3++H8["EU
MMZ2C@<'B*X8PW61_\VV[=]?NF6"NMQ67_,+B-\7&<[&25RAF8H\L@:C.?@DX
M+UF4NVVU\CN!B/DUQ?H$[: E)3$F5\4,RKK<WQ;HU9PY'X\1K--^K[H&!V:E
M^GG<,]SJKRL.Q!S%B3:NYR%Y>AP:*AD.';9U=C_B2UO5OK 13[DLNF]A65X,
M3NXJCIQ:V=))$_[:OA!P\%NY^8M!]ZOK G7J?W;\6^*;1Q/&DW'QOL1Y\@ZH
MRD2BSM[R:>Y ZN173:EM$#EDGLV4KFY[+5T7>/X70[RIJ>GVK9CAI]N'/]\*
M#\O54=;'"#UFAE"EX(3:E<I&Y><,WU%3?-QSGO2L+(_#7Q5.9N4%[*1\+R?\
M(]0H]MC5J'?%0B_QXO\PT'H[YK#_O*@4"\!4S$I0-%)0%78CZU;(*>?[Y:SF
MC(D;66<2JL$M-PL.CKU>5*Q 8,5,B@MN9L9W?<2Y3:N^%>KOD.SO@-16HUK+
MOQHN>&&K:]O0NS0HMWN*PUJ4A=_O<1 R<[_6F>2/)<@S(1JF3) M_,S_S!%#
MSZ""\(.4I_M?C-1,:?^#*K7#C/7JYFXMJR_7M$-M3C]L$TXA]2)B8\,I<14S
MN]M4*3OU)B68(PY4783BZ MI'QRU[\4WS3Z^+=] 'R8ZR8Y(F9SD$7UI#%9X
MG%8K0DXNCC#[.K.KZZ[UR;QCRM\QNLE,67IZUFIMNX;5M(_WFF^R/Q'$3PG$
MHWU$3(3@RH5CF&$< !@!6!+<')<2GF:+N!UFX2&^0]6!$"% I=V[8H;F":D?
MA,[_9OH^Y13K_AGLYXFQ%>(<M3VP&3GC79SI7.+G#<W,:/XVV%G98W"JS2^T
M:S:]5/5S?>JTG[**F%_A_9^3![N);@QMU130F[O9&;C*L[2'2:#;0H:8<ZYU
MF+L+K&)B:-'XO. .NZPN;&"C3.R.5:Q"[ +3>6,!8-9MT[L7O0/4.IV&EIJM
M%-IIKWV8RXV*?^ TGC6$^)$U>RT8'V>S4M=Y;C<DC^FYN[_GKZA:YDMT_E'-
M661;KQ)9_SXB@70[6HV;]BNN\EI'N!0'ECE/U_(_U-!F_D"X^A?#!;QI/-'V
MI^POQAEO$MU?C/"?[ST:,9Y,G@TPGM)5(2*D)I<N<@^Q77YUI;E\;.XL=9;2
M^.7K[Q>P>5$P.ODG+>WG)Y!Y$'?1DJM?6$7)Z(K4;)2_CQ/ ])?_L(<0J20[
MP^^SN.Y-_8>N5U0*UT<B:.<=:U"C)6UW[9FY%+Q5W:C&=IZ1YV"E236]T'E>
M4"EO3FN/'4?&>F""[Q/U]?W:M5;'M<7Z7%7FFC2XI%&C0-92, 9XHLQ5NITH
MKL]G$]&]8US,A[NA^0WNDMT$WY4S;!.W.>8E4+J]77# [(0K7IU]/LCKA=B&
M,-X \),$'R<&UFY^[#P8:9Y045$,S,0PD&HS<#0X<_#PL#"('":'NZY3K23+
M8ZYS)<A4T\#%@IP#/=W)I NJ*7<9&QJ[@A>U4T#3SNW&C#\\'T/]8^RSD7^<
M4E]@RVEPJL]MFU0\ZL4E<7,RDWB_J//P<MTQY$J:]=;PN#NH'!C9"YNG#I_B
MKW.T>?%84Y?CQ.T\T]\ >'VBJZ QR!YD1)C*QT[2.4Y$%:JG I!DFKXFAWEK
MTF!*.ZS0F15ME?K6I'3,ZBZT[!8=_.&%&&V^4!TE;9"/3-1T<Q XL[S1E= 6
MC"JI7K0AT"%9V[MX,DV;5B/T9\CBT 2T7K:P6,PK0'NC@K0+J1^LB^]A:QDE
MUWR[P9/IG>Z\B2G)F(E];!A^<@$0B']X^Q^$X!71 E4E)EUQ9W% A6=((2@7
MV2;5>-QZ\37'>*AA_E4BDU&"U^Y=WL-0% Z;P9O@&-,PP;:;3CNEZ<I<NB>$
M4F]B4S(Y3,"5\[K)TY?*TADJ$W\Q8MT:M[@Z,LZ%/\I\J!R-%UA*N#2M.66T
M*:;L+F^4=)"=E$ .6EF#UZ1?B)SK^0T>:ZO[$>;6!;A2.F[0>4^N=3;$S?S%
M>&AJ_7/V)_<M'?.FP)WT#<_Q^MY?#(_ UK6:B[K1ILE=[*%L]>._& VW?S$Z
MS).DO;?_8B"&,+,^64@!'Q!'H)VXD=B-)&DMR=X+1-=HTZJY[BAYQ\-#5_#I
M7PS[R\N_& -/(]8)&V?V]PE9S!C,V4A$B@_J$_YX]X#6U]"0'O('.C)H!9WW
M]J447>>SO%*<BL..>5VUJ]:I"9Z;?L.5)J?YK"POQ"Q.1P^L217/PP]?7$)/
M[]I2:,XJ-*.,DS[+BN5,/5A:^R&9^(DN0<B:E/>D3B=TV!.X1]=ATU"D"1%;
MUG9'8[T08KG:>'5AXXY)9Q2K+<&2TU"N(@0NWW^?\RUQ?H\4+:<5,?Q:1(P(
MH]B%YS>WGU7:[_&=$B9;4?>JZP!5]Q-'TIN6%U2HXS:L?BIR0*MC\8R3L'XI
MUM 0ZTXQ?@BUB-*Z#X#T]B99T#WP5OG.I:C\K%&87%1=;5U8!>)H: 5!Z.[7
MRY_**Q62^*R),;7YI80B*\-<H^0A22TXA6K^=P^^A,NR6).WKJU]%^:6,.8-
MC74;TQ,_%AUGLM7&C);CHESQY7F_XH8H7P'G^07VR(^L:!965/<2+4-%WGQ2
MK*^)$1(-PE8J_L9S_)^LQ\]^CGQLJ95^R#_[O?:>^JJ=KJL-E?@QR#IM/QR(
M\</K6<9?C,AU#6^7Z_"0>4-_Y^4_15/&5<T974+U'T?9WR L8W7VAXI/4Q8)
M"-SWM\ W2:(G:LW?/#Z7H]\Z"$7M\E=3S)#5Z'P.1RW0%TRKU^%$4.#<G&L3
M16?FRR2TZ3$N-RGSORIBQTE0^9\-JF??=+H&A"H93(\TB)V9TFM58)27C4(%
MPPQOHV"\^="OI'YR)N0\N.;:LV1Q'+##M[+6?7*7/"_5R'E(SEZL_Y#T35X,
M8+@5E^8Y,(C=OK8N>L.L_]C"<!WVK<71$-#\S_QKS\/3B9.7OL<?>6KZ2481
MI%$\YYR3)=4B.Z@AZ#;,_0M8[WA"I0VMQ1T9X!2@K!>\0:= W.VX'3UO:M\8
MD9*H[?CQ>+W$E64J:,A\_LY'0436H^3;&8\O:,OZ[:97R%-*:964(Q>[\?SJ
M-S9VX"4O]'J5.#KX#FA2/L!OF*-<?MK!(^N[^Y0"^^ \[KA%Y,2R.T9LS?TA
M8]-_K8T'U$@&(/Z5TU1]=-CAYJGU$$6UY%7YI1#PT>'RI_G*SG.?GYJEWB;,
MMS%%(INSC&&:C/7K.95*!OHK?/=AJI;<[NV:2ZS<WE2XOXZ6C.>-WO@)SI7O
MQ,AGC+YCS&(ZV)YLR,)>'_%</>J?W0"CM?=O$C5F];* 9B,W*S,_EU,X39AJ
M,ZH3OSA) K%&WLTZS5[]M+HG=@#TQBU!"9.*$D-G1; GL@7F-&,\:94/Y-<;
MPI&PFS;GDG&:LHKE?]8(W$S=10< ?YW6,'+K14><QQ+,[KD?%5?_'4X"]28_
MUL&_(87_IFZJW*0L_^V"-?]!_U,.@CRI^1JQ,L=?)KC?)JJ)K6L%K"(Q\Z8R
M4\2@R(Y17>)9SI3IGA&N#+:=HW*YL3?=F%.P*!X3KJ2P"1UUK]-76JBWK7BO
MRIEJ.8JA*7)JR"AP>LN$0+#OMM1[3IJMJHWEV(19) C?.B/,K<G;>73A3&A<
ME3/%$<\P"C^F(V/!EY-I?'6"%.OEXYP=A]5SL9O\MVF^CVK%M"XO&E@6] X"
M;+*^-OB@6:TO4! 0VP!,+4%XWE8O6[=Z3<HF*7"IREG0!"PZ(>52WF_.&Y<#
M(TT]Q":LO1?TW$S<B;%M]":U\ZOYQ=90;C::ZOI+'=0"&K>#:(-!'#FZMAYX
MUHLI@5L[@PX_OEP^[R;8&!,3/M]/H'1/,0[+[A#D/B2W=%0= []^-SLUH:MW
M@N971AY3;].>&6.-#;LCL<\G(C(;-;3%>%[3GV=AW&1V^4+,A"%'@3_6A9OQ
MW2I^U#B.+IX 6$,AT[4X\0/RF8)XP=S<@KO@%"PU2I:ZP0E]]3HY,I ,B\4^
M81^6P7I3!SSCK"7CN(#&"]1-WGE:EC_+ZJ@XO<P67RGD*16P(K/+5,AD-/=#
M: $OOF\T[7(BIVCE<NS]C]DA IF#*JY#$Z_SC;0?DDX5;,>P>_BH6,U(KN_E
M02TBRF(UW%W4PN?'\)<!R0S5=I]-,,,2*8D4[M-/O[_N?13[K62:8=>70SW+
M)2C%.K]'I5KY@N?$OI2$/D.*7[U)F 5:XP-Z#I-EL0%SGHS]C."2:40H@*VP
M?%Q;PM4"TR3\#H*+DA8RBCY#5Q@FUB77M];JM$]65@%ZEW*3B:Q!"?*!&C-&
M%75!?3UO:Z9M,P:-/,V4JLX?XA-_4A!3%VQ7"=?]X>-NN=[F^3#8+6>4/'OA
MI4 DW/15-T+$G8;U!293OLIB)K(-2%#]U7(XDYA)(+$@5.?LY<VS'%Y$<"#$
M*7<T4.I@^7F[?.)C7D-E2^JB)TXC+2T!^"^&)#8K*']$5&Z)WA:IT"/BCP+?
M9;<XE9&:S6M8#Y$COGMRS%<VB_>J>_M"=[/1X?T:DKK<QSEI3#X3DX9S*13*
M>\Y1+I&FC&S],W:7M[]8<Z4C\*O_1=2>A/V*>UM?0NE@?QSP4,>1D1K4$8M5
M=#%PPF (WW9X$*@3"+6CYZH)H*C7=]6UF*#.9AE*$&#;M)YEC_LT[/GP$K/V
M-<^H?E9$G0'KFZ:DT-SJ87YD2'JLATPY6H9'7]3F53PXWY8]"<A,()LF90-P
M??JV]?;L1+F@U126(VRG+DO/U^(YA\Z=O_8>3>-'KSQV,"T-^$5)A%W34#)+
MH/@W3:UFH-$O8LO:HI$D.#(_G6><H$(;$HT" [$SA<95QD^19CXPJI<YQFRN
M;6#(:K"GP$^!U',3@K045_/UP#3O,]_G[K?)];1CF]5Z]W1B#;VZ W+.K,:C
M,&UN904;>WN:LWQE_<BT< \DXH";/ECOP'V0_L+<\4YCN[YXA.>E5OM'S77/
M@\X\4TB>RXFJ19C'C3X!3>=X?EV"^MAI^>)>K+PJ-]E0WQUG& 20>%,-=BV7
MTU .KQL2'(G)>G6'W]*X4EY/.7:"/K<**ID]/'=A.6[,%$11B/U^+@%G=;W7
M 9LI6T_%Q2F_3A_A*!N2L7HS 7N&K!;V:@BO-C=6">N<24^*G[L@@S?1>=H$
M 9C7R:*F/)!W1FVGN\GV;3JE"%)\OL!:UI,(ADTR D-%$4V\?!UK,5VUB2,G
M/!1(PQCZBO(,"(F"*";5&!5ERBV4>]P7@IVB#O7-E,'%\YD^-P[;'&P?!:S3
M!_ON!OA)1 Y!\QM)(!MA#AHQN*5>-8%'4;ERG^#O>A4""^Z5DV#F&0T=^-;U
M4L) _12W"KBB_#4N0&!@G^'F&0,P,1Q*IO_C;-I%W:-]H;!V=(_.#C9Q@HL
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M[M ')XMM9*4Z^SG&$GD*[.P-.[E(3<Y>C>+/VCN]J5Q0F=<2#YGWS-RP?!T
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M+WD_R1O2>5 @O=9NP2,N\0G^@1DU-N!Q&7G.&4'MTPGV@V)R?A4=OP\A2\Y
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M;HQL#'B9ZT-N$EZQN'?WPD8#6J7Y:L%.0V*?&O_32KL-Y=FR?!6 DT^;)QW
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M2@[?XAF8DPB;N3T5EB3/3V*\Q\1T)T6PJ5W2>3S>L0$%F:;)Q&,I41.>HBH
M00W'_FX>\R)>'D>7-3=B\Y3!N1;[D]D."6>J<O^E\@CB2^H3HBURFK'T.=1J
M:H3Y")0_H$+VII%V^A0[T=9>"8<(&6S2EMVS=5I &WPY5?Y2E^+'X:((B(YU
MITP;H!/U_WC[+.>BM#0>2OD4Z4C=<$IO0J:)>;OCZ557'Z\UYZ[>[*BW-^+=
M!XV<3A'0"B]IU>9$&&YW)$6FX"3N,AVS;"7T.@TS?Y9T]WI:/</#[\#K4@^H
MGIZ53ABH/YE<COMX=E=+HJZ0]2 B[0'_.DU3G/VF!M&@BE9Y#*4+W:\0MBNL
MY\(\M]LH)CM9XZU]>UQ=\8<YM<T5@Q036H HY\E\;%U",K>H@(%R^V'*2&N7
MW5!(ZC \B?;!X1W%G(?+/IML TFTKD<>'[>/G>.'MG<-5&RD<U:##J ?T ,9
M$]51\S0U<6^[C8NU[H/C+3^NOTV@%7J;$_'DPR;A<N]JHQ:)P55&-AA/BZZG
M+#)T=&I0G2P]RI1S!ZE^EW(9H(R.::+MPK"G"^A.E?V.\CYPI1:5-7]6F_8#
M:?*T)B^"NP2*W7S2_;C>(: OH'C^VJ'&J&02M-G/LB<3H=-4G9:4/\/C_%%)
M$&[/]SM8MW*2*2 O(%?ML'@ SO?:V.<>TTG=YH7F1LAG]-1;=Y+W^&)<U$?G
MHA\N-<F3)VF6H%>^C:Z:KX*%-W6Q_?E4#?IU8Q!G=!3C=%R1Q2LBL6-P]8Z_
MBKDVYTRCV5;!387+'/3*8E/]7$WT%!=5!JANT4;",M4-A:=.&!J3E/H$;5Y$
MN)RPL"4H=MV9>/7OJ^4_U4!_XQJMNYH7(]@=DK$V]?K%@&@/9V>%0&C8U(ZL
MTN3P^PS3 3EJ&7ZZQ6?3/HN$]4*2<\6:B G.1S9DU#>M!/K)I2KFOI:5=>R!
MXI=>[HO@Z>?SIWY)WH17J)>/4&&((KT>2N>H\DG0VTF."NY7<ESY[W)ZM374
M/\F+1DL!,T65@'0I/",CM'"Z*<W;YUU.M,<I 97X:1BU16?3>"0D^8>QE/,'
MFC8"#.PAJZ+&WJ/IS"%[\OLPC';T872?A%,PT(+N':?[A "JTN\\AO(;% Z)
MUL,C67I<.#_-)W=>6?A;5%LF6Z)SV3Q>3-N[^FMN$P:\*SQ4\S74FK'U76T?
M+4:85HUQ>VT&ZC&%!548A$15 #[9?&,Q[E5]Q$[R??DS2R8\?G+03*4>',T)
M6U+\QNF^__6)W]VLGF@KQ<Z#X1+@XP"G.@M]?".FJLP9&?4R57" ]XR-=((7
MD%BK $1J1)[U*WS]ME!N$W#41S^PDL<M(?O:DVOEMD\4_VU&QS7G7F8>R$G&
MM8841WSV^]Q9)I@WNY<E.PC';*]?A[QM)P!^>QKX_1E^K?7[HN;\A2E"74"V
M?14M&?QZ<]-WCBE*[4PL32F\15OLO4V.?%>'7F&199/'QJ6BI\^:@R'Y*BU5
M._GM$ZS<S$:+-]Z5Q8'%T-IRP8S,\MN/+>0)D2^41EMVNS[<.DF9CZA0VZ'!
M*98("7$Y,VR,O"9>E+5^QU <J'R\J+DKBMTC22\52L-)2U5MH &X0RV'AM2?
M!+R!]HF\6C,>*@!<RH_FS)1^!VT9V,ZCY:MPXIPP@)^DY^H<VA@I\FYS>3Q5
M9)=FX^3KD5]:R#N;SR(W"+O*%B%CF[HJM$#_5,*)D)!22H#WL*O@)3\N.V<
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MU#[:,N>IL#$>.@P637ZZ2\>>UR!TDBQ*YCFA4+00[Q[FWVL#XRAVNI3]9CW
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MK%3OP91Z--1JG/9"OWDN[P4]:G9;\BXR*9G^JA"4)+MRF\0;6(W01"S-\?V
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M7O@^#R.TW:K$W%S0<EE<R%>61VO9 KL2')\B>!:GZFQDHI;$ON4.3\;O&%>
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M0ZXO<RQWS,U ,GRI)MJ*HI-I 9MA$OJU\.*$]8O9HZ'>MF0_D;W'E7H8?.W
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M0>I35&L3>%Q76AH\O8_J7B\G]GX6]T.$^QI;Z?3NGHOO,GY<P#;%I5I]?H;
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ML]LSSIMG=-;M>3\LSJ!&S9_O=DSM_F@M$G3WL"Q0NWK5HX+SEZ;HU$KE^#W
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M_W'(M"2'ZI"I$HOW,I83#X^6XO4KK#.F'>>V/!J&P?@^(K_KU<;L.T]2M3'
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M\ UC:&<YYT;%[XP0,S$ECY %K.,=)V$9GG[Q!5%9/A,B.''%XLJ5+G"RSAM
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MOIF,-7A[&,W5^5<^R)-8^];#IPZ=-:K&$,%QKL=Y^S-_)35EA:N0\1@H11$
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M9?K= E5WPNL?LH2&(9D4CD8!@Q%\K$MS>LJ'+*M^@LQPDYA9X68.G;%))#.
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M0GG. \-XBOX3P]E2U:C>VVHG?_NO @CLHAQO]<X *Q!5,#'[WAE.RQ2%O_6
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MFG0E;23O_5ODZ(M1361T3(I"I]?7$,BL&Q??V;]CY!9,\$+04EP =)]8%GA
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MV+MWM[CE Y6,N\"O"1T*4N(@M>+EH3RB=K3TP^%,9<Z+6=D,U?C9MEAG#\"
M\P>3K1E;>I_&B-Z"\H\UKA7#YF1<,V)K^^D,>^=,0\*67(IC&*^.G#MH<#%-
MT[JWM*LX*7S$4&K)2G;%BDY[[44=9RSMD7SE,4%A*84TL3QZ<PV!T#C).[?5
M<,BR%U8#0[;5/@AYWHL-5(ENFSED,3D/;)UJV[7B&3OCHUHZDMDAY_]N9F9V
M_=:)W"D&+GNN]B!%NWNQ\DP"GDV!5O'$GM]7.,XW:;50&,>F$"JD6N8P#N8
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M?$HI(#2'/X#WV']Y4\8>Z=XF4M2E^]%?CV(*'*M)AHP/FJL,+!OV4N:-+MF
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M20?[=],:@Z8@(0?U$FWXW-$EVU!EW%+9ABI*(+SXE>I<BRHR\.2FL)^$J9?
M1\"TN:Q5.EA+CI>N*Q*3O2/CA**-*, %K+?+?E- ?9=5T'OQZ+/?S7+E[)K=
M1/D/N1E-8V[UBK<,H7+/*'='H+9#Y^+JW%W)$)46/]G;\&LL7.TY12<S)^[$
M&N'4O2EL^GT$(]$!,WF"5XEI]%:M(_W*F84)J*O2+]DBXPY()3'EN;0I[C1X
MB_\IYRIS#ZO7,ZFH*EOQKG-69'ET/!469P@MH&!MEIXW/\GB-?S#/H.+^*(_
ME?OSP ]L7DY&5IQESL9HC@=A9B?NL"]-DPF8_#? MR6J=<HO;)BI@HT*1SOY
M*ESHK5,W8![JDQ\;A*[A!]3!/5P5KI#;J0^-].7+)W3 #DQ(G5_%OQW!\EP;
M"Q;]CNL#8LZJ[U!W!7<5+"+S4TQ-1';TMP1$0M*#PK.:^O#1)FZ%$WSJW AG
M)&0?0?FQ3/_@*WMOWEE^4?B/=I^%7W[ZP]Y ?=3?WAT39IQ)+:_1)F< 6_@-
M<%<B T)98XPX9B&P&16E0$*!]C52;G.E__.>3]>(0[?;^N_?SI1H44F=L(03
M>?%W@?J]%I^;!K0>:W9>LKD;&VFY/-N'+3F?B+5-#[>TZ<!$IUEUAQ[L1M:G
M:S;HN/>JMZH6O!VRJ6:/N4 "VK8MA>/+VT:;9C=AA7N7;)W=4<M#718D?S"'
M_NBTZGE22-@QM6S>-[\PS_+?-,B=H+5UO-FS1P0RF%H7]!>%RS#UT7OI'Y\]
M1-SQ''J>[DXDXH_^;@FC@S5B\R+SJ#MZ 5\<5K3QMR!Z6LL!K()]RRITP@&F
M&]#Y\2('D(-!!=A&S^2M/T">#UI=V2V?8J[IWZX4Y1W>>*@BP\)8MX[\):O"
M^SETY\E20ZCGW4:!?RC)G,=\3SH'^JJJ[D24AZ=E:!BH _JGW!:UJN1--V[
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M^E$Y&E'N@W=68%MSB-K]$'@DF9>4).2B_+^SBO?J_YE5N!PEUWYO5W)Y6".
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MJ')8R;%M_B5 KAP>+T\KD$SW*1O1_82 )3*U"A\2[UK/1![M;KJOD3F*/0Z
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MCM;L6 <X:AH]I\G[6>K6*[D&[5*BTL51\#:N-]*I3APN/-9>I *XY2D]!]L
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MGR&G1"V;V<2S!5$7S,&1>87;BR=P2,,IQCO -<@*F52^.ADE5K/%(-8?K33
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MZ4+38VG\S3Z3Q9$@[[S(U=MYU7"E)@7#W=O0?56B' $[;IW&%D>1_TN(517
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MBZ=\-,H4[\RQ'^=_=(AZG_6&M<PG;^(U[!%I7U?DE\C+/ 83G$"0)4IMW$"
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M\;*+^1N#*^YK)_;W7S,FRDZ/Z9PE,N'EY+>_$QIZ;.J1N,J$VM+0,)D: -*
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MS&T-L-5$7LV4%JPB:_3!!EGYE:J+@V6[NC8U1E2F11*;5HQ<KXQ9]'@KVQ/
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MOQ?)W"ND7W_UQI?*#O]Z!W2A0]ZDT4LNXE8=O67;>(GOO4_[3KM3W=BBY X
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MEI8:OKRXU7#9*B]IQ'+H@)J36?.3,;=U[,P&INUVWXF"<8K!HNTI=Z+ 2U1
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MH&98C?R$EFUMTVJ\A!X9.&OG(\FE4C&1P1GEE%68XUXIN.Y^\4'ZV2.OKL8
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MH1)Z]=D(#RJ5^/(H$ MNDBEBL,VF*2$Z#"+PRN@X[;&D]70S6]1IY1(VTUU
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MFUI=8!7DVVJ Z*U18]6TT\[1#0[_OJ[GW:+,^(:B[U)W+ND'ZYS =>#6B'"
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MZ]*M&ZL)_;#(U#X GLYG"U*P[<G&B=P9ZFATOTF6>K$6[%76 7_$)E!^CI7
M@:\EK5O?'+@&R2EWO/%_--0:VC,N\*W>.6N%Z#HN:Q;DH7TJYDWQB:\ &Q4.
M>S*406(S(.YKDC"MSO:3K;''SV384P-%GJ7[):Z(C/Z!$??;DP8;;B*$&'^<
M@^',-XE%#[F($4 3L+MRUZ)KF^C3*IT16_^6@MN]CKMN?P ?_+([J'/!%AYT
M&C(6M-,R</7\1O1R?<^^OR/'2-G]*CI70[%X98N_M12,,'#D(='].L=YWNBG
MTP2Q'X!,IYO#&"G@YDL%;FRS]1L2U]:UUW078MH)V._^<^+^YN21;.UDHO3#
M+7?_Q&7UT2M8QV<M38'WS?V;]/TZ2DF]TA'6$OC%'44+)5IIYT^;I"U"$T]
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M.J6WK(R%;-4Y@3NX3HNUAC1#Y@VE*'MHU7[1 4%;V@E7F@IU2.A7)T<QYX(
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MF#:VSZ@OFSF5_0ZDV4,XQMR"@,>24ZN'11LSP?HHY$@@#BOI!24QV^D.T\3
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M7X\95-Y*)1&BQ#8M&"[A,D0LL38YML^GM<2Z6M(>-K87E<5[1Y&/WC,XKV'
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MM,,G>CLPU::RXW1N>NSU:!Y0N+%7?TM7.FHG'"6P3#-GB!&E/5S@0H.@T7(
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M24%UURC7**Y]R1<I$,3K&!6TE8-1W'#U]:(@UM=KA@1(]OT9G3?Q\OQH!GM
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MQF5$G?0-8[W)]7(\(DZ&?9HC?I,A0.?,NQ)5BF%RV=2W&\YO\OG$1?3.4N3
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M/=![N59QH&0W86Q0.PD:Y7W\>F16.$]+JEAI]@H=53USL<-96M\Y#1ZI7#0
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M/EL?'I;DC^R*1,E9Y4PN7 !ZZ?]H5+-JQF4O^"'B*8L;'^JSFLN5 ##IY3*
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M$*ZL<![\K_Y#"00?UKRWX]F;XLM%?3@''N9=ETX%569*XDM;&KDZ/'[IJ_V
M4 ^A+:Q4-4X_>1&6J?E3-:^OTK29B#=R*_Z?<ONG4-+F]J<'_J]X (6-,;]=
MK*WSC(I=%';WQ,R(0K5CS> <5Q+<*FFD6DB_^;W#0:$:=\[+1(V+5["=ENV!
MZDW2E?]+UT%.Q)6B34Y="O?T,M&+*\=%27-E-^3E<W73&S]O%(N #I3*NX6J
MEZ+^.WBX%EGG54:I=%=*QL<?PA/T45& :.S5Z"Q[C"$S]:B!(^4+-0.N6G7)
M#_:IN;FS'O/ZZ0K&29:\=2))WFM:E\E%QX:21;U26 +7_]FS@E/B$M*-VWJ0
MK9V\VS7D@(?PX)!?N'NJ0.]9,F2D=K47@F,K>S%1I-;S#LG['1I/+H\V<Y]@
MGY%$B[J2EVX^FMH3D.3L@V>3CB?-@_9XA'\#%:27J=[.RX^LWP\N78Z:_RBQ
MR!4DQ51VUB(EE.1*<BA)N]<&<2WV_,3[:_-S<'8:USCN6[96QM8JU>P;>)T6
M1BL_-%Z$Y<Y>-O=6Q%0KRDU&5D/5;2_N5)]9Q@SG8&ZD.KO,$BX]7B=%BTJ+
M?./K]W"M_J?@O3%36[W_%R5]*6'G#Q #E+SS!EZN?9N(JZ%S$PL5W>&(D=KL
M)<6\"(A_8\ H,8FEH^7QV5WHZX*">QVCHBEQTS#TGDQ7A$&R9IRYP=B'V7I(
M8BD@@$5R,8NP)T[=T$$? 35,8I#*JQHG^37L6@!CJ@GO (E VDU6;9LU8]7G
M?8_Z*)SR3/8U&G \D"1!MI%5,U#0X9:I%>/L8:^VW;KDI,>KY>!<<JW^+?:3
MI%^B#^?_K^2/3<)@8TM#3- ?=0_7WDB-"N-#@Y[>.FF>2@<7EIEVYM,=*.AB
M?U*1&Q^CIO);80'" R?2:+,'J+\X8W5Q)6\NT-7P.]9\I.,<P(N5+MU'48K;
M'5><F11BTKU>6I&$D82/6$@JS:KPZ$99^9B5&M_#+D5=37@EOOP(,,-L[JG!
M'=X)=7-_H"J -63\Q1JT>VRX:OIE+[B7&>Y40&YTR;7OB:J *;P%G3XS)1WA
MM0\Z*A$%#]L'R4WD07#B(S8JP*WYS<:(SNP KZF]P,%+S#&I*(V M!,E-+U7
M+7:=R(R.6>OUH./TE#_21&"*GZ7/$TL!D+--W2#5\O'>>"OFL=T690V(9V^$
M+QA'##J,1&9QY;14VCT8W<C7Q)O-<UD=+6M.^<N2R$Q;1W()B(VJ+HWJX*<O
M3IHCBL_AZXN_NTE_H)'3?K@6S/^@-N1+ $6417S63-))3'9MYI.N-BV,*7^"
MYU5PO6Z5/2\MV/JHUKWWUOH53A5/#(,7T .4L$HK3M^PS$W 9;4\1Y[?3YL]
MS3Q/JW&%=-6>L<3UR-4[LX2B)^?3ZL3AH$#1@Y=V.U+7W#HQE>WL<)?7$R$-
MUVMUI]U[Q1DUU;8'-Y%A DH-[+59@"MS"1['J=&'!B^D!B:(W(<3(1J4=]'.
M*.@1@88XU/[2ROCFF??R6XQ]8:J!E&/#9S.Y-Q&+@D8;HB]OGB_O=/(RPNF)
M05(]^-0-M]5NS0E+D]O@%SY.L<]7Y:!X#I5(@\=JF6[FE7>P"XSCV!Q\3N5I
MF"[/;,7K([MQKI^#PJ>._G*>C)L(XB>?Z2Y5 W0^_#'I#>1IHOF+M?!$G,8(
M4WR8D]5"M_$7BPV!R4AU;'88B:]@F^& G/3 I3C0AO""-JBHR<=JM<SF;IB^
M0;1G*,/V#:*L$JFNBWV(M[W;-6@H+'2MU'>D:81ZK[T/^(52'E.9L5?I%PV.
M=*%QK-89C+&;B&;[]3N=7!L\AG0C+]'K.3OMQ9(^UATCG!;^*BYO'GUO/_-S
M<3'1HZ9&^2_6OV>*;1*\SVXK#]PT1^&GST[+2S\X7@K'3/F.9,[-#$M6"Y(D
M@F]HJFP("3G7Z?<KBPLH#I<W.GQ;2-/=:\$ZZ<TNNHD9$_!:5AXB&]DU-''Y
M<.Q"&2KT)Y D%;PK"1Z(EU-;3^BP&85E&YW'@QT,S7*+/[7/&,(,MNGQ&HJ+
M-R?2W4RXMFG-* =TJ@M'JAWJ&J(5VI6$I0;')Q6X1D.V;4CD[27>P/9=IMK-
MW>LW .@5L2&(IJ?1UH9OYUYXPFP#K&Q=KT=I_R'2R0!8O7],H#>![0.T2'0V
MOS6&];@E;3ZD__@8>]>#J.4VJ 5-B;3WD#=7<G'_L4-53V;&-ZGM*X]D'5N\
MG*DO_UT?Z:KGR;"R"X2%+E724V9:-H_+41#7IB2]QJZX!P=(U\5-AE6<&49E
MS/OZ3KP2JYTI$+H<G# ,^/:TB,2Q #E0 =\I,[)L&K1\^^E ]Z 6,&3>7W\A
M6430:AR[3'F7Z.MGX.0 XM=_\$"S5^EFQ.3:OH7H15ZRM2J516MR!'D- T!R
M5%)VYI;R\105\R;,FE)8EI^Q2%AWR"(Y#CN.BIN)(JZR*50S-D91]?MA@,6#
MMVAVO,9ZLWD40G>^1,-YE.OU.D2-X?;GVO-(+@L-,0?813*/J\='!9[Q$Q4/
MFB4=3ME9/)$0Y:^3TPV<B/#)C!UKQWT_O6Y2EK<!;C5@5D;3[P$ZC^E3T,PW
M<_-NR=7O=OJC+9CB"QHB)6>%&BR=HHQ:9\[+31LJ^UR[P <!-K;]#_^.J[.I
M[00=@/TDZJ*1V8F3.G$"M =)COK]+:?QG%8\)#8*IN9'9D<#<0 7\:2ET$H9
M>;V2\\"H!3]CTG]L=16[50=_(K0 WM<#<GJE8%@\9,K.MCPY!BPIA#=GECDD
M@E-Y,MM37[EL,](>N&6<&Q6]F$"J?,Z3-DDI,D.2#275Y'L[NKWC ,@L*$J;
M1!TP9?1\K\T%=0VOJS1E:9TQY2F23\:V<;:>]4L9_,:CNRC<$XLE\W**!2-T
MW$XOMR2AY3W0[*\OU#3!HD%>-=;L[T;*9LLTMX6>S8@[,9(PY&YC?\74701,
M0#B$BAPU9['N;(Y&TI2"]P*$\5BRV+<6.RV1KC.HT$1Y-16MXGK7FR0I-"7&
M^V8HU_KSN!G#PQ !ZMXD(JAB="7*JU&P 7MO,L.T9E1'VC&]AT?^P$",BP B
M7\S4VQ6#80LI@D$P V4UN#6LR,B3WT5;<QII4O$KC&(*&GBI)+U2LOMI 40#
MN$^];O(4P846N78CA8_,(0A]@WL[HC[0 ^F<XHPZJ5W'_@ 376)PM[QBO-I\
MR)=J]/C\E"1W!:^XDXV^^>["ON'T=H67BFQ><A>Y\E9 \(1F? KPV2@J%&<:
MDY/QDJ4@'"<MXGM2-)LT.3M-?RX)+Z<P_EKB3*M 8SV9&0H <O^^58EYO*AO
MP)Y'R>$$HU\^^%0<.&1.F8VN=3(#:Z[33:I^E]:,P/6&Q]\D:/6\F;J*(W2=
M;C/Y TC%\X1;J"/N0VO",=?G:V2QFY09P)&H6F?WOUC"+-[Q H41678)Z9\L
M$T%R<';\I*_64C$0F>,'8&,D9W]KXJ>2_6ABS\VF??[97?SB[$X4G?Z7HF%
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MT2>C)=T#^9^]S:=6M5PYXQT,]I66J]51QV7W\,\S)'6 L]G9^><U9(IA)UM
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MSBVB1\5!>8X=<\F2HD7"]D:6M!E[_#\OB-'<.8AJ\R,",MP#M08HD,]H\WZ
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M-NU?IN;N*0A3;Y ].2*_,4+C(PY>WKY /ZM96:56]P-Y0D%>(J4VCY(0DF9
M?!?_%;RQ8Z4(WB$4&/@(=XF'0!\^Q1#M$\D2I_Q4K!:B>UE(.FBU"3DE\%-5
M9Y(E;;?1$G%/W#SMR_,X8'WT*XK<AJT/C^C3UT1[_A?2E%T.Y*!OO>XH;38@
M1+.H&"2F)LX='BWD&A69TW(@3H9R.^['J;IN#[YR#OTC7,&0L?0.:_$PT6@[
M.^1'>.0D)!% ,B?U<1&Q(S\EH)H4N5@IJ5WOSF%Y8XF]7A<,0GMLS%^]T\_N
MRN[X)+:,-E-R$W6E"PKR6M*S0TRR '\,R,%BVPHKTRPD,9K9T@+X2Y/%IH4;
MVXPY/ID.IR-O3)I!Q+02A(.JBN]1RB- Y=KO$9$6AQI&1EIKOM?]_=,O.7;.
M8T*N'(C8>!(=HB!<D @F^T0AVLU.MYQ_>-5CS&Q6%,RN[N)DU:7:76GHCK_<
M0E3+]#5FL;1V3'CBIU:5.XC]+I^"5<"XH'#YQ<V,V>1([<.,*XG/ZI^[9=J@
M/X(.GS-YMQ]K(U[=;\<1?&8C,<\!E^.9G[R_W\YM^E.^O8RF-2086O&\&[L=
MNC%>_(LU:HO%(X/U)$^3)4;;MP5<*OY=^]ZK59<_$_YM;?B662.A^>PO5FXR
M97/?Y4]/D4=H@AZE%DHOTMV6LNNVWBV\2\]VQ)>RDX&0W:%-^(=D9-*)9U(F
MO#XZ,59+'DA#G+,1+ -$Z>[;G#9QZ0UG.:)=*4"[<@:V2CL"(T:Z_N&@,+FO
M=ZBJ7LN$"CI]KWO&CY&.!?TZMM@9_7!-<910CN7HT/ S_T!:\V,!-/_&6XW/
M +X??.Y/<BB8]_<13KYYN<Z+N?0/,!B+'_VHDT0M3WSA@)/]@(1'OV3N3E;I
MM4Q8?%*;Z?$5YQ;;!91@_F/[K\SO3XH"'5,">P*P?2/V2YBL08"DF.18SY#M
M&\JK?K:-Y$L"8PZK)4$0HJ(\J2*CYT/4Q_6!*$>K%U)_L<CHSR/6E]^*W?3B
M\>[N2[:G5N1%\Y* ! 6A_"T^UJ6D!PV3[D!2$5,0<6QD2:*G6]YZ+C U*XSI
M8)KQWTAHY>CE5)^/K^@>N),-URL1[3< 31V2;,Q!$AL:$[""'3PV^OS#,G(8
M(EGST^[G ]UYP<_+;QX#_TA+_9Y8R-C!]-UKD7A7ER"NMQ1B)I DH.8,1S4K
M, YH24Z;!V9ADBM*3#8@8>(IL8-\+]2H,DO_9K 4E/3C#44D.&O!('2GK>.Z
MIO&X4,6=Q)FW/*'4(6L=H1_P:;S,!6;K7Z-L.&MP7T8Z4P^=HEIC63493O)&
MOK6R3UW8&G]TW<IF[G\Z>FUP$+\I4_SHQ1*[9H=X[^=UBCB&<0JW+]MVCYN#
M.4=B PH\(5E1)<A$:X9ZT78H1A*[Q_XT\D&6#[WH85J$>7HJ(8!V(D5 ]0;5
MUS#,RS8&;8@API7R/*JXG$"J9M>\DJ&[\!K,?$?"]!!ZX$NMBB/']=X$4.Y4
M<?R0&*?DD78FU\G40.\>[R=;@M<VOND2HMJ$U6_Z.)B>?&Z53Q]A*+M5.54R
ME*D%M_G9SR5FW3XQ )^;R!IL'A&[SH>8C*H!*J9F5P ;R=;8]"=##83O^NL5
MZ"_0::\T?D^_?=FQA)[[BQ4>A_XS<G+\](V[W(,HP.>X<K5IDT;SWPL^R3.7
M[%BSW^/O@I=M;6+B?TM08VVE3]$\"!_1O<5&9W?LP-X\*?B!A2>S2Z+F5MM,
M-N)/PQ;5GM!T(IEP<=U8SF*]P,O/7N$$L\"9):80UT.SI(!3AF)LV<1QXWGN
M?Y)Y'KOOSS3Y=V1+.!EPLHH^"9J\ T !Y)JX[=&-F,HI@T.CIE&TED@UIT")
M:Z#/Q\P,IQ _:UF?9Q-8'@TGU'*:;F]AWI$;-U!WB/Y6T?56JP4K=:EN]DQE
M%LX4#;;%U[C@BIK$,FJ%\9U-/2'*4@5)7#+-=87(G(AWN3KU=@%-QEJ7A]5U
MJ/F+0U1ESSR$W# =N\62&UMX3#0&PS@N$@08U),&C(DZP# *\N2<9.KK'#HD
MJ&<#N\S7&ORNM\3VE; '^BGQMJ,QGEQ1DPNQ(H-%'3O>36WE34F0N"#:F)8I
M\E@NL=+!&2\>.&^9PU,]?J>NZ795@B$!2$/H+KPQ9FM.P1H8\V3ED?7?3J)B
M$0;9M"S9'G^,582SZF2<$7[7I7#+Y.O77"2_S^]G:"O_T##]Q9(@^TCW_*?'
MT+;H7RQ*XV3SNX81<W321\'EF+<J("KG/*93:8XKW$D>__:)XOS!PJ_#TWP#
M:HW*9JO,ZW3!4Q0$JT<3JD+J2XJZ#4TH=F^BMW:&Z67TS3MZHS+,#G@7U;XN
M79DMXJHQ+/HC(:+4GN\KA7,+2&A#<$N<1ZA3A0<5$3QK/E!AB1(VAKX6\.OE
M-GA*?,*B./J1YT)E]X!A92O'RK/@QV3)D9R1 ^UB=G89OAF;D1L&FNO%RQ,Z
M"M'"B9PQA9"<4$:5G(S>GZ]@O2 ^/O0.5V]$^' #C8S,R("Q;AFLB%MOM[$^
M*>%[P_"T4QW9]6V]L2*?0+85Z: J\CU/Z8EBN&O6$(L[E^M,S7^BH;2G-_^G
M.&$T=T]^LT5+WY2FIMOG>#ZM&1&@+:CX!",>XKFD*J'INQ^PMX--/6F,>OXA
M+J:/G"O&8__WDE/QC#+<,%0KZPL??%*[:BY^W"5KLE0ULULBXI'/AFGA%AN)
MX 'XEGB4^!M*\_EHJ273<#A:ZBS&Y\9OJ_^9=^!_^]'^9<]Z4&XZL)ID C8/
M+UJ>:BB.9YX]*--G33P'\<+$V37\7GBT">DNO_A5>VH ;:??D%I?:OATYT@Q
M1R* Y>D2FQ2?$?^)G_ ^I5@=RE:GE>16E1#$P$Q_\W2A+KASS_I5-DI-5 ]
M_*^_HXC4:3,%@#%?MO)7BY82_F1O;3&(%92TF4;XC#<(C5D7@MD4]:RO^/;K
MNW(;$7$JA>%#4":M6N$ZOCBAA>2*.OB'8E-$#X<)0<XY2X.Y$KZAP[F@#B/L
MUMV9BYB-$QEEM?/'/:^:/8GF6F& >6@C?_F1>?Q_B^ 3$&>PM9X ]YSO>>]O
M7UTXV3/W7P;83T5:!9&K@354)O+>+QRI3XEVGO,$INX>1;1HBHO"#(/GGUV&
M#K^CHUFS*MIDGE'K>6O-2<(U4)EBE0,N9E#J[VM_+\J37^,_*\=VDC0R!91/
M54<QA>J\8%/7L7PMOG5=?E7\ENWFI@_-8>]B\&GQ'*9^#K++&DA,!04-(7G?
ME#E5%279%=3M]J<X GFBBV*N6'8=*R<Y*9QK<4C^8F&6H^!)001F>Q!/[FC<
M0TZY;<F(NC?\E1MMEEHH>,%\F0Z?VZ9W[7EDY-9A?/R<4)QK]0+;.W!^F&:.
MA/]\UYDKRO_ O.IPA+>&7W!J4'ZXVX88 [3_G,W;UA97.;63/%R;M<!#KJ@Y
M+WR1:CO7VW7-R$+TB./>I@76&_3DYZ$9V*FBE2.U+;W9=ZP#(-(TO:/."JCA
MN8J^A-;K0H>-=7[<E[[/,6\O+5(^5!GRM#0D&M#SW2&F;'GSWN>_+I,L1ZD^
MWT$GX'?+@T=G>>)8.?B6]@$4KZ6D/1"#Q9T]#:D8K/J@06K6(FNZ]O0 B+W$
M,IB=B':,00B1XG7*TB^BGB& 1J;TRV;,H@0)H2O8&ZC6B)!U'YS*R^=O#.;I
MQL)OI@7JW/&HR7>_-7Q'V'1%?E7I"A5"/@TP:@.N9!7M\L$I^$P2F8JH]S=P
M.W+6E2.TY%*%)SAC/#)F.%_*KK$)H"UM^YO_D;TM\;LOC!20(\&*)IDD:7D1
M3<++87)4TG1MW#E=XVQER42ZO6'MC*U728!-CT!MW9GSJJ*DR<$3,=-)_SVR
M HP(B:L2+(6)T?PMSE\LS6"R4]FOK>+,;=NZB_,M@."%F*+);8IU8Q#7.4Y=
M_4SV4].=J4<[<2AG60MWV9ZIH@K]ZI>_SI\!:4)I4P?#<;4NF.K=SF+I)&\\
M2[XIZ>]PW:?'WC6&Z#I8[:64-DJF5AL8%4#.;R<MY3\,3WW=3T[; 5B,L9IP
MY@N1\771]N)@?(7?+N05FB_3<_[%RG;G>3'Z/_2/WBZ_*#O\N6'[>Y;BYA<4
M:UOD'^2&VAY]=P\YUFE\"/2\_M]3O4'M=T?<;Y]+W]VSU%,2U)^$[8/7VH$G
MDEK-/DQI=5_&2(RI&>,(4E;IS0[F'W>":A%:@GX!NM$.]VP062IUFMF)5'&M
M_<MTNA5P>WZ;8/.37B 5C/27OX>^R<(,)X";&78A_03;OW5_@_6'87^9&^^<
M$P58*#SA,M[)H4M <0SO^U^L2Q+=[XY7SVQ:/R)U=(#B*\Y9%6:<=4@:HW[G
M&R2JO5I-22JW4&YNS4N<:P^TRIPB ,U;/LQDABN@B?0\,W.M)@3?2CUK]'>^
M/SQ\^O!LP?A/G]8[;7!Q2Y0YR16S9(SV^MU9^5>5F"W*@9'3=#N:^N;1@]@Y
M'=LAAM:\=YY<@3<IQNQ)[B[4?4I* -=;V?=GH4:"%@.%;*X'>QCG5[KS !6$
M YT"OD5"*&.,)6D)^IV'^[+(IK3A'^64!F&""O=IMX"_6$ #:B,+C9@<M45-
MU#YFR8DWJO?.PQJ1ZO,,LI#74YTJS5X^H)02,3A*K,8X_G\3O_Q?GA=2[<J?
M49M5#V0Y^G^Z[?]7<'W4"?LA997;A<[$@OG:4(HW7C)HVE[*"_UQ430I+GE)
MDO[V5E:Q@?SD:PISD4!O5!'MG9AHMKT(,<\T(ZG-#]S*"U)H8]%Y]F8#9U*I
M*[K@I^F-@5W+0.@PTN@A%-[SHS:Y$[[S3RTPPN.EUN@>S/Q.'YGF_W_\/*9X
MLB6-S6LPUIU&W?8JI1\<G),=%1H9Y;R:*?&9M@PZL![^0.2N?'IC>_738*VS
MXR_6T\"=!ZWZ^#/;3U@Q&DJSLYYS)](2BT@)Z7MC(^53Z;PY+PL0@T+2W$22
MYU:"C^0$ '@<A,O ZH]<.=1! _?T&1H[@PJ$"%\H7L]RW'R_)#XAF%65'ZP#
MLU*Q4^^\&#L5.$H #K'OTS=^&&BU@GOI:+'J"'PO(.T<2":=Z<?W>^"2WB$8
M: ]V.XNB-IZ:\0GBUI$F-V*KL[+6-W<_'%+GG >7KV=Q."+J6&E(U)BVUZ0'
M)+*Y 3@*\Y6RH7^Q+JY6*]?SY3"(W5R<U:Z[J ^W^"O[,;A[XBZ&DVZ5V]X[
MDT,Y?KF504P6?G=%:Y<Q:SG<5]@)U%LK.EOX>8W'K0L">4B#/21<S1%WN,$]
M4>C-;&C#A)'YYI"+BR44X&]UQF/3A/LL,?ER1-H:=%GKVOY2Y>D[U;>@*K";
M^;MCR?2L>0<7'%87ZT-Z89<1(.P"H8,-=,257KV'')!QG9%/;K^U3["E.*HH
M'Y=,<E^DG'[JKF<F(1_.ITYH^ON?; A!!WX.#_PW5N\/?E*_7XVX.\G1^T-[
M?7'/=/4=-] K;_R2[YUGTV957<4;-UYKG[(\DX)":E&]^1T?!"28 ,Q.0CO%
M8W58O!@8*8B7S";H4;4B2%@JXA83YAS(*-6,23@.C%O1R_N)PKFS1+Q9ED")
M:+PODEW\H%]+H3ZC]893[$.XS\=XL$%%JY!ND,*TQ<90$HNNI6E.@<]93B3A
M+H=[:9:U0)P'S3/&ER96*/%AQQL*2CZAG*VWKD^9+DPW]42VQI7*PP=6Z6>_
MS8P;30LLA33. U(0[@?<Y)*O#NNK'6?"143,G!:4^\"Y/VQQ$?&F%O42FUW.
M+R_J0N6YMU;,=XZZVI4_B$:P^+3A9"-]V*KG$U/\<Q__B0:SFGW5U\\F^1C=
M)O%#6F!FI%]=0]DPJ]Z+:VJ%FOY+19%K2%++ATX'F6+].!FWHK+/?"DURKN+
MK.9U)QW>OQQBU7/=4Z;[W!MV]W0!9OE&,7915%DUTO\^ 5NE$0LT3&C3HF1&
M+J/ Z.AYQ%WRI-K=6N_;,V>%+S='_Y4!-&UA=[CE$_W%>BZ-?0.!8,W^I,_J
M>[@JZV@=S]_D_K)U]W\A*XYC[D_P/P3C>"^/QN4_^O7KA50'KNART#^ ZNOX
M7)P6\N@R[TU;;*#/0#N[@RC^NO;T!VHFL*6\0.=ICMS0(O*C(;>(J"J;)K]#
MHI-Y\92R'&=(@(1[&9=TWOA:*Z_/Q%6I 99O11&@,(M PV$H._L96XF55WO9
MCT_\!KDYQ?6X5*2'K$A@X8&-ZSC]V ',4)%CCK&6X:'+(1$O[W<E)H;"P<&^
M3(IW0H^[5\3 $@S"6Q;UQ4SMV&TEURL'F#B7L9J"I>3=PP$>\_<3+-YV+5U<
M5<E"E5DV2EM?&D>!RVV+/_-_(J,_9^QRX  ]TP745H/7;=VB3/*#O0@Y!7+6
MJ,3;M0^>>*=3W=<B51UO+*^2^_'#-/,%HZU.-8!KAMO;FU4,RLHRKM&*ZB!A
M>31=F_]!9U2V384H4.Y_W:(1*A!CD=+2C^]LO+G0!V6()$XK_7K!9X3F_[P#
M65-35QE+C@RHN%[,NALIJ37L<'9LTJ[ZW6"</)-Z6E9\0<5QFG #6E6QDE#_
M\C^ GB("KD!.R3.GLW@[)SR%AN8CU=7PX466=@LD[Z>9?9$&F6RW-,NWM1_W
M+NS:%"_)E!)/B<E#N4=&)13W +:T!G%4E'MD6,A%F1*3'Y.[DT:!:LK4J5Q(
M;&WH^S>:G+5A50;,-')=\G6:;*.E4_66(OUE\5(W1+0?GW_U4MI!5OKGN\6I
MR2Z5ZA7/K91F+0)$QJS)52)N;T\[D>&&OO4J>2)7&U[G:GW#5AG676(@"BO7
MI.^M=B-=C)JJ!++\A)_)%X?!P4*G0 >9EL1D[PT0GM#0_%)M87]E14PX>ZYN
M]&&3D_6D8Y:X1&^,9)+/)9GEC>UKP=[N+LNA^<O"E!G18-.]MH@1;NLE[#]+
M+MZY25L&PB5I7!_3]+:\HW=?+>;=!^NKK0]04XX1.6:+VISA\!P/%J1\FPGB
MN$ZN;>;^B2]SHN,$'*\,P-45FOEN6.HU&;H/ ZRFW;<$=_1MDLL.F48&K@BO
M.FGM\*:N9=OB?S!^RCG>228F]QD'0>_>%'MOXXW1XF[L7ENH2FD["#986H&2
M&>OW!]4G1"V--T4TL-6Y)MV6Q*CYD??/SEK(5P"KLM@53$3T5E3E:%G/H/'X
ME^8R8H]:FRO*V>VF8!%PVMVIWS;>ZBE_%'A+.6F^A=6PJO$S&U0.RSA;,T).
ML47/+7-\6D#$G#LLEI49%L&14E@+IB*^)AVT5ZGI1G.'NX<TTUT]I149]6@]
M-0+;6*C@1PP!['R&/?B4*4&CKE8Z8IR/G-UBT);MX.7OO:\K>TF[+^H(!M&\
M)A!2,[F.D*C065WDS3)*6P3IO^!/Y+5'8BPL!>[=$VW\Q3.+RL>G%OO$,AOR
MBJ-5:[82^3O"H?I=<!NRHE4F8YFV.*7,SONF)S $[^N0='2]O5O#GUR1T0_5
MN]?8]D]9<J@B-5.H^)2GH=Y$K$L /G?WYVMV^;B8UV(MD^;QK5\FYSN \[ZC
M19?H^)GHK4^&52<!XUVJCD$:.M:9$JD^6M58O4H&X=Y%LD(C8;)%Y,BGYLJY
M8[2\"0WY@.8PJ/@L*B@?1?<S)&GR4EB<R%Z25A<NKMZ@T*RA4>9=G>F2'>D[
M@*K,213:&O/,<H"[ZS2X(VQQ9%'7_K>KQTM_L>SC5C19:> EFOT;/(N>5TP'
MMV0!4G*!EPIM'=JZOJ,3*4 RCV018,\<,$XN%=[;;A'Q:K L+#[G[LC<<;%Z
M2,.FT^S&A?\9\;Q>[USC\X$90$_Q@Q:JFJEJ96$ZJ[*X*W%[&FC!;#>C;"M_
M%8T:O)N$?:]3>_;]EN)\=]%44.RKYR^:U0FH4Y,D_^LJ2>N<M**L1O0T4?6,
MG5$[9"0YO8E+%[=PA.R"34M!AYGYAZZ)Z  M[>:'R!>HB\9M#-&4N?&O#4X#
M0U[S_A% Y'G#?=40_<VB*L:T)A%QZHG;_=UJ,H""+-/NDF]6113,5.G0/J.M
MV-)]@7R,)),):V<RNI>.8/@H7C.=7&SQX8K%\96!H$^.6>VG)TF7FX(R,'-H
MYKS_\CPIFGF(7/%^<?;2T6KI(P_=M&0)AO$VXI@_+N?CI$\;$*_N@FUD6A3L
ME.XX4TVDY]?H>2!:X[6_LL8*%A:??9&$9H=5FK!&\'Q@@O6O**0#+1+)Y(+]
MK4Z"[[H>L$]&8VAD+0K>!DWJ<?IR\[1A_QDN>;\W2Y.:UI.4X++_0<#%I(%;
M/&U=(.>-XV<]H;6G V]T,EXW55*$WV^]\5$_XF\VK>.FC@\RRA?,G_'DKH,3
M>H)C$0)L,ZI_L72;IHI,D85+%)?D6[Z9&>*V;'^Q&N4/B^BHUB*^4HC$Q3ZP
MTK_#X!9>^7!L;@!>I1<QB(2/;@(@$XJI\0J>&+4-1W6J$JN#_0E3I)>.RMF+
M3*;R8G?""';OQR.F=+=B#H<I<YOCA=[5D+[7EW#?T,:X"2D-QL)Y!;G<[O(Y
MUL=TUM-&3.6+9[UI[H@AJH7N8BWO_=AQY\X0K/-<'PE'%[YR6J.I6Z7W<Q=
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MHB!P?\[F$C)XPWIX+8[R] #R:>H.UQKGV:1I0)3XY(I.'=@@5GK,J?*3G+I
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M=GV>.F;H]4.H5&A8FN;"<>IE;KB#[@Y?O>J/L?=;.)^R1_2DFJF.&#;<=PM
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MP-^+(H\!FQJBO*9Q($AG]HV)3,R%BRV3?+8TM!;&-KN7!%R]?$%@_,\MK6[
MB;/.0?6'X#T+W[+K1$&?91]]G9NN6,AE /@8<H:CQ^[FE\4&7 A#2?:W$./D
MX\LOW$#.L0G_/7N^!/=0"]^.\GJ"\P^&I_-;[?+RYHE?V_(1K<F>;;U^V6V7
M$I7<H "^,3-G2I6EO 1WI)J\N+3WZ78__'7^..<^C52W#XDTA$HDI1M<FH8%
M1C9*Y6WDL#=FHTR]&OIUEO;'%Z=H6F*]T$51#]D&2COZOG^$<#@MR6T;ZA'4
MTN1V%6=(]*;_68UIE=3<Z>)5=2T6XHF^7)QI^5JF_+'( *0 [A55:>TL-S$L
MZ>W2GBBQ ?.](S2TTRHVZAAB!SBHZ0QF_Y/9SAH9UKD8S'VD,$JI,9R9?$@=
MRRXU[-5VM)-NE)LQSFP-$:.HYO^9ZIPQFM*@ZY=PVZJR)F/ =A#Z9;4ON8">
M1F7</;9^P+DL95RJ 7&F<GUC:"]1V@9'"&=W4JED=!+*(X4JK\D:78>1\RFQ
M@Z46*V.CX]0,B@'N'!WN0]R'_V1*:#^IB$Q$;A=L1P'7IJ@GUC&M-,, ?;O0
M@Q5 3A\3HUTF<3[I9V<=BC7^]$9"N[SNZU)#15&Q\9%A3@3.[GKDMT]'A:1R
MZS'R=JD[_6";9+8R?3U;X;]HM"U/S36BEX9L7%!8@RQ)GZ/5Z@CYN'S#A'%^
MQ,>(2U9\4/F'3Q*Z_AXN9"C:95+=E5MKZ\Z="[.8W@6.ASMO&5T]CW0!,%Q/
M;,J#S"E]J JR%6T[%!R>4].;S79XSJ3WWN3@TWF0X7@OH%YD ]+2TGF"6V1D
M;U,UVS*P,'&*M)8Q:DBVJ4]-\8@O->RQ?C_NGC+(,D4EZ"K-&3/^I5;$E*8Z
M7[HC=SR!;G #'5Z,1/C0Y($;4B'U#E&4/NX2C0H;W,N"YFQ>G:]V+8EM<BFJ
MP;O5'_M=K8T*):OMTQH&B"O!^*2UZT5M(?U^+ZB\%0,<WH)1JGSSU#W*C#<9
M UXVG%-834/ LN?X?0%LLM%K1'%U[]"+''\SWYA[KX][7"$1QEK;2YY^)Q/^
MX[#I9G5U6'>(YNEK'\51>+&PB@4&4]AKI9PT/(8USAT^X*X^$\NY"(]IF\+0
M=Y-P-'1>,91O=!O-%\2K[1 UZJ^XV U"+6N;>K4_(0Z9(>;DEG:R.85JVI;<
MO_@;N0OXC?8E(NYS.*'RM:FQ#L7<AHKIKQ">C'NZO_=#5%6L^_R8?)F'UFZQ
MZ^!16:TDC>J5YJ=!#G=\^%B19H<-?"FU4^%@[R.?XFF!JL.[VK2J-*H!OO?_
M[^Q-[Y7K?$ 4F\!U80.2^A!\LWUA1+A7OK61:ZZB;LY,1R,LR:/#.469Z*AR
M').U4PXW+-4:X"<W>J[H^_N>WDQ0?E!GZ2J/^J.W" ?XJ6.=$?'.8"T-:L.F
MTECK)?1VKHF$'!'&!ND- LM&?L@@=:*D,4I9S7LG97,F4[5[O+OEU$#4>5RQ
M;=^G+4)T1R1F S,[TST4IT\GG[YC,I4<F%J^8&.0Z:@Y[*)TKX3-IY=%Y\KL
M;9;1KRD.P%2%V6Q6;)E/A?[!!_[N$CY5$I?)I'XT%/RJPOZC&]#^^[EB+]]\
M-'55T<FD-92U]<J2>89W1DDB4O/TE/T53\I'_VF^[=?'S8NYOJ-V?RJ[VD:;
M.;AF:>->J9REF,*[F^B;NO.*<DVZ.F&668..Y4S >IS/D@S7C,O6I^-J\G[L
MG?_<B>$''&^H'$W[]5W7EI7-ZCN]V5$64@TJQ\O0L]EAI]\+#Q,*3(_+LZ9?
MWV'#4$Y/))<TVRH)?6>E"D2W[_I]HWU,/+0!M,>C^<7=2[*/Z+C>,0Y/KPW0
M%D5TIZ!BY2Z\JTI>*]>.L3"00057EK5,F331'\/8=^]OM(#YD5BUG_5]>YU1
MN,W/CV-8.TW*"/4P4P>WQ&C4-HBEI@T;RF=C)IM!;\US:LN7I3\B5;Y.K'/V
M'F=Q\>60VF0U)AOXB?VXD*2D9-9$"Z;:YI03&MF*>,@T4^Y2E>Q]UP1^R\=)
MIJ2]E.5&,V]+'FM+/\ FY=?I_]PDQ_S/]7O M8=6#:F!55>INT"DD?CZ95-$
MU$:[/U[>T@V*=!2;<\0"ZI2O2,*65SNHTQ7 6LS'=XF=;UN?H<?HZ$$-O"?"
M7'AV[>-U^8MF<Z?WQ_%)[%GWRV9?YF/24)+#@632UX-2FAGPT,'^RE\TG2AA
M"=J1:D\Q&7"52Q(;LY?%M[F5R=%<<?)>F:JMDE3_"589(S,41#\2.^#+_S35
M_S- 68P*^C-4L1SEGCYM,UFT>^X.9MF!#%$+<].&U ':)+ 4(QC[O! )=YI$
MKLV'&-<1^=<](@V\MAP4EBT0G<M*/JQ,R<D+_R+U63JBI/5.:(:4L-;'9S7?
MK #\K@;$)L;'M5>0OVCILEJKP;9-%OVHOI#&1XF0K'^,N\AO[O(/UH\."#K-
M0;6:G>*TZ#PB\NTZ.5#3&J<1B%5#;4'?;=7["QV. +9T!^==;=FBF8%'UE6F
M5"?B#'3G0^&0(;[9&07/LVWN,D2>18,>V"<@A 'ZL&]_DUKQSL6F5N=/\YJN
MC\K;Q!S@D8BGO4,+X%>C\H;F>W=+B0JI++V<SFW<$^SI+HS.G;]HZ)[*][U_
MT3!U;Q,.NMG$NIB?15CX+U45$I@LP&I%.M4.;_S(*J?;C(&,O\ZIA<YE[:XH
MY[1YR\)JY*,YRNL62PMS$[BTO QQPJKX3Z;/J[UZG"S-1O@U&!UQ''+EC736
M.JW?K[,D3!G)3]3%H>>U@);<4>G7I-A7;@QI1#16;E"52Q\0N>:B#S5;1%D:
M)O:[P;6G<F(W8OLJ1<X<:_K+.5CE466%+; O&SG(E?XTGGI 1RQA+X:<\P?!
MH$L4UC8LCI?UEC^XS"KFF I%P9HE2Q,HNR4>!)O"Z.M> ZZI$L57# P4K.M#
MQ<GGW04-LNTUW_3 !I<'PR%38E?4=\5TSHU=7?;]$V(I=#<L)*W/DIJT+'P:
M'IKV7>:*7+X1>BVKGX =$([4P&L=]0+0B]Y>UJY9+['.&VPXM>A#U-&8_J3-
M +@AK]:V^<2>6J3U>+7\.!<V87&OP%HZ%]X*LY*4>13PRAD18)MD](D> RC2
MBXPI]!LYMZ7D<SO<X-I7'_^BI$U_-'GW'-N.:V<\<-2UD+ZZW<BZR7W1F)3;
MFR-^%'F):[ZC;EQ%34/P:3!SC'F:>?9'7WKMZO;*;I!0)H-0D[AQ7V^!57YJ
MW7P^1\S:1?=OS)4;AGP]H=ICKKSU''+=#A6Y..JPJR[G)F>%YE!.V43*\_G'
M(4"/=R'CUF^ZI8PB:ETDB2%#?I#26D2UI?Y,^QH7SM8KH;H=^$3Y>HU*J)S&
M2_G1KGA[VE769E$XG]QMLY0S0=2V^N,4LO7/;[?S!Z#]3XJ#K4^/,+60U]/=
M?[[ S?C/_S\?(4G);CM]:Q3!M>3<KLU^MB!-Q]*R7EL<=OB;T":>RYA4,*%I
MJ,/6#YD0J_1<+TI*BI6)4CW\,L,2R.NPNW36?)L3,.RDFN:H;=G?]B17LAD.
M:2KOTJ$V!18A#HK-J>I*]*N,:SO;C%[O;#$7<.IA*)+$_A!"?3PLSQT4!&T7
M/7AG:KH0)JGA^MBD[ EA&-\(?\+:Q[D]&UUXZ'M^66L*R$MRGK<X=:*WD!9)
M3?9LM)R7FVN)(;G+M'REU*D!^&<JZ!_ X!C>MP^4.1MY:7E?&TZ%*8^?/TI+
M=^O'537< UZ ODV,O/>M#!^+R8,LQRIWFFQ<I>\.]-M_>;M:X;]RM?GI)E_J
M1>>F9Q'PJ.3L*)\IQA<%-BR54L0^#JZ@;>-W;ZQZ>S@T'G <VEW<H3Y60FMK
M;)UPW,;VQ9@7_9/_SDWS7CWY?7=5A^QW-K$F!#Y2QZ:;KB6!'>.*!=#B\ZK%
MP7_6:%0H'[B7D"S7U\*Q*=A@:O]0)$PW_4A+]MT04W]T8]NKK2]N3>"BK3>;
M4J&Z<24CVFZHR((SLSP92(FP+2Z:XWY-2'$6!,#$$F;FU29PE8G[]1Z_\P7)
MNNV]1H>HWF)8,E7JW$+CVUPM4[$E.UUK%K.L54N*U,UNH75F%VZZT@DK&K*;
M1Z)BJQOL0N )L>;3)1$&]2'3=.W];-\;T8VGI-RO#8[:/LX_2DCDND'QU;Q3
MZ/[<Q9=\#+)#S#+N/Z$JDF=ZZ -)89D8O]-?*=_LGRA.J^8_W2UWV<H:./!U
M!2O+G*CD.W^%P%MS!9&EX3/3JW.ZTORYV6KLS3<G-Z)+&G2JTHQ5_%4>853[
M+\HRSFI[0QXR)U?J\@$=SR&+2.]8W^=XAOR NF,2R)XBE3765L_M"<+K+YI9
M05ORZI5Q@F/*B--&+(MCXP6*(ZIN"S_:LM*'%!#P<D2UNE(\MWS<X,23XVH]
MI?8DIP)L-Z@FZASNA+)V(,X:<B(6S)T0"'BO=[K!?2F8Y4=*%[_3^-,4B4[V
M$.^;Z =N[01P#<ZDZ335GYV$)W;&KGD]< :OKSY&;A+M+;[6HZAK9*)F(*24
M_3%M:@T=MBPU[K6;)=CUH%C92'Q)_O%2?!@ZTI8@W'N@BW+JE;4O#%*>=\H)
M4T31C_'?C^@ _,]RG"&P%U6$/R+5XY&CY 2$O28_B##X?P4?S.8A,V>"SWR+
M'P%_T4;;;[Y@L_A&W%^-G>4C)98#HN(];H[7]Q'C2B,MV4%6U3*(5:AVVO*C
M\\)%];M%MGSFF00^]0AATH& "1E5H"VZ^D\1ES):>F\?S@?_B[@4R@PY?CU;
MQV-'Y'"7$@5=WBO+]E,>DBPB8C#>]P[9F*!-HED,=M\!H'O6'U/15R]OO"[H
MUP6]+_*W"E6/'3%&D,10&E:1VE8!K,OKX<01@2%+(W"^LDR,(5F[(6B*=OV<
MNG<P8RA5=@AL5Q&EAO>+0NH&?!&BRW%R!J*H6\NLA;P4]]+5 KI16#BBL$SM
MKE]7<MRX0'#3!X!&?L+Q*AL!.)]M 0,-_WB(H7N9[:II'A\P50?FP(ER3,9W
M7CZKX#( 5.,;=$E:.E9LUE1,19HU;0NZIIV':4X,R.HD\CWG02"MY!JR1TFL
M;S)_T7@?HGTCA4U% "+?.FAKS[AN; J0(L8!>LUSHK-:N9$F>/V,WFZ)G+F?
MW?6LS>,$NZ4AP#T1X$2Y2MJWKU@F2(R64V?5WXT=/GHA/3[:P8/),*%2 ;,.
M&D.#"T,'7<MOV<$SR0%.X*JB#66MDZIV]D[OTSC9E&))/_&,WRS>_XSUOO,?
M'KG16=8K]_$/%^[<#<XV(3U.TX5::"_%X;K/HH9J-]ALLSSW)C$<>F(A=K="
M@^UQ#: <=O*UL5[Y!H[:[8J5H$]6PJ]FVE>(RO2O#\(0_OXN\B:22G!*!KY.
MW3FMU>SX>X/5@=)=8OHK2@^:J2U^AGBYITVI3U2[O!5H]VS;$F5NF$HZO\U+
M2KD"+:/"\S]KZ;^N%$KXDJI^C*Q)M$YGG-II61\CRK"N(!B <>/N)F(G;A.5
M\QJX -T_5T($2J*8_%BF8A>=?*:I-2K\5!K,=O:J6BLC:_#KV6"*S_9L=%KA
M(%V\W(?&VAG/Z0(X6\ENXX>D0EYX$IZ/9I_.#2V\IZ3!/7%:MVG"H3NC*:J2
M"U3V0TMA.:*8 'D+8HG^02_=QY?W66 <)]"'<&R/.P#XDN%FY,2>?&&_7AV6
M4U?_HO%>K76+=@7J"HM TN36LJD4<! D7)Y3DMUWKY;T9;F\A]$(H:^ES&\Q
M4@$"0QT7')\XCI36"[@2Y1=![@*&#*V(D]5]Q55V%/E"1WX]9?^7H"1-P+*'
MP4;QZO1J$00<OF37N"(E7G["O!LG2C^DO]7W3-OS.7?4_E*5-I1:T>'=LM.
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M<I7IB5.IMHYO]>F"V]41\[@/=X;#9<,SK1V(X%O35X'W@$DOC8HQS\"3V5J
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M<3+18_![PU8&QVRVQF,QB)?BTI6*<5ZA9]D=3JF8Z"QRML%VY]<,+XGWBR\
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M57:">3=+-U98K7D3+[4,])=\F4R%??T,*2\TP%P>\^B7@M8+:3PZ=8(@-LZ
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ME*S=L3=?S[SF7PPU;>P#HN&ZDS?\1T,*!R%TM5^^XIUJ%# X#Q%]3==4PW3
M#R]:>Q%^P*&17>W"M"Y+L^?3NZ&9MKG2"7GD*VVQ/$M!OSLO_BHOAV6S!0$F
M#Q-FP!@%_,E%1@ 1([0Y\B!BXLV;D)\X%:Y)M:[UF_QJ\H^4+H_53IA=!3\:
MQFLR/.GA9-3%I:>UC6D-V2I#J):GLP+]DXPS "4\7O"&N=0"4R+Q;,I56(GE
M7<X;++V7VH.D%+KIBV?;0]81L>F2HEM8GW/TR1@R(,"%83M#PRT8V+GT G@<
MAS;D_CTB(DOAR>#?P234XWP0K'=<?GFZ3VJT((Q3*%IG<XNIR6RK@(>HK8_I
MKA\=Z)DNG]1],5_?V:RJ)Y :W%/2&N?U\[36MO!WJCS! ^.[78I_=;7X9_),
M5A T PM<ILX)A3O!XF99I2VJM7#M@BH1,KJ0'5IFBX2X,)HV!GBRUU?WU\ZT
M'S[%" ./AQ<IR7\PW,RNIE[X^K<X#U+P7I[.\*.B05.[**2T 2USK%&-.'.]
MV9XM]#J21!F6MG@"[!^<LGE(P*>#U(R?K>C52?V!1.1Z1S\K_R0@W-,!AJ/D
MM[UP(]O=*^=WZ#,:$9(+G84S/'Y ;56SV@$T+PV%U+ (DR"05F["5^R$ZN;;
M3M<O167?!+::"]()?[BWQ"4WU,!:CZ13\<T"N)%+&+-QL9#B=.1^9H&G$XK=
M8A9W-&)-K<(LKH*,\2$0LL#X\_!=LN2(B78"O/H;"2Y9PBP35VB>-Y-/)E;6
M9#E3SK4PT4_$'/#-ZC,=9"1M$N#C*$YWCKHQP^(S2+& [36L$Y@/"I0]+[N-
M\/Z+87=ZZ]D;4#0[NQ)M[L^/59F#^)$Z2A7:(', ;L!6@07G>V/;36/L)6$\
M35WAJ#BK4I\14=\@45[H7$P09K/P%#6+4=.4J)/X#E]@@&K&#Y8&UMGPBEIY
MAJ0=#6OQ?EQQ3O 6].YQ;,6U1AAD[9'WC/C.%D3Y7-P2%AM[/R]VU.<)7O(6
MNJC?#[_%XG.:Y0;9<< )J3W)LKOBAR2OW^6R&U&I)(@Z>1D[&C@;3?/YTU%E
M'G98L/+JUEG?@F0N'%KS;;ZYY+]DJ@%&5&Z+9M90TN0)(I"8T=A.%DPM2L'#
MIX0XZ]EY*%$7+V3[3CM=?HV-'^NL>W8-$GT O?2\P)S*_T'-Z*@!L#_IBX#I
M8HY6U^3. Q,MNWLS^_%ZSHZ5W:!+Z0Z[/?]JF?\S>?JY->Q2?>T::!NMMI@9
MDH92;<(!O&!U?'ZBA6)N& BJRC>!U=&X0UD(TEV6ATP4NC^C1S>>7T9)F(MS
MN6.4#*JQ$3JE]J;6NXI_^L.*(,^HC%_BTSIMB:AEFL"EMJ_BY4G0&.M0-4()
MK4P'^NIP!X/%172E$T&!4^]A+V#<'K_90$4MGPSR11GF5Z\$7OR@O7G;/]9"
M5F' "\HA(37*-6BSB30CX Y,Q.FT7GG Y0DD5-)CJF7(<TXJ%G/\5NP?1+1*
M_G'BC:0ZZGT+Y9) &2LKT9[!5*7I#+JRCKIY8&"B#PFJ"!M_H^>W4/VP^O/)
M)#$&%B\C?F&KB$98=LMF@J.H7!Y73;JG6XDMOK'%>1J2R_\9H33O<J/FQ&F'
MZ;7?GS?)/ZB:X%6@#ORI$P6!)GU]SN;C Q?G2Y?L:',J*8L3_)<$8PA>_B0'
M5V:OO<A\@BFN"/PFL9R:&N;T%^KV<<4GBG:PY=@#;T39!S4V+W:&NUBZ]@2_
MGF, K#FE;0K2WFJ;5[]=&\O5Z>CE1X[YVK1@Y9-//%$4-_:P.2W([Y9%B)8;
M,LX+T_Z#KDBK-D%B0K7KOM)5?*RWCG\'G2TSPU;GAV8P%DF\"^[&EC J',#]
M1EGRPKD%M!;_FY^IL7%])3'U47X27;35LH@F.TPV.))UU[*R:QP22/6J)81A
M-KKDYBK2[&[W2G1)ZQ6CVX7IO#48M/ -S@/3*<CM"I0$ FNN@T/='![:^^5G
MDH7 &U?PA%:%^]J]@4,%0B>KWNG]NQFUE#CP 7'Q<\BM3&,;%G,GQ(7"2(CO
M7ZWK?R9A!C_((0*ST[K^5J+\PTQSO;8Z* (DS$17/8MD:HQ0_AKPG9B%UAS^
M:4V0/SZD>PXD^SZ\RR6G2 )/T.^"_-,"CCN(+6-^)->NX=C=4:J:8BS4)KN_
MO>&(S4 4/ZF(ON- BW$.SZ',8H:. ]9H68;*'A__B_$-Q] C6:AZU\Y-=*I=
M:5UCO\TIMYP]0:LL9?";*9WU0[%I:[2G8KE&R4M!DXRYE"-BA HYF*A/+7$+
MLEA,DI]  R_&#;GTV""?#\WB]<@?/$KX>2:,62H+J]$W)N)\L]T!05XC(+,I
MY1U""F0A<9&NKB+>447.A0<RE-."X8O0X/>"^27\L5_&JTZ]K\'SE*3JK+7;
M;L=1>I%"%II=>V7..Y:&ESY!PR0E,+#V'S#2^J*'+*(%FKZ^@QV:V$@O8" 9
MX6M]:^LT'OC6H=PI$F3#C#N$/IBP1FVXE5O[AFHF<$ES+Q2_UWH)*5D("R@Z
M0NQ:X''N#-K)[4P(,DHJW>9Z!'O8]J'X/2K/>IW4!#^,X+[PT\'7Z]VW6B@[
MHHHTBC/+EW'W?E@D.,Z-&&#LZ7<]=M$72(AS&(V*0>6;DW59OFM8T]\[JCG1
M[5R:V7"5'&)6#XEIF^-Q#9ARQP4<OJYP=*J7&43&CW0P)B=$QGYWM [3^;)]
MZ$EO[9'!Q+3.>HR/^^DJ<[\!?ZHNEN.#Y2+)$JG#$1*\[P?[[F=:7\B9%1)E
M_:@YX>>'[+$#&,;*?(U(,T(,+V<@WN=^, I/C;<F"/T]RQ_;(=ORU6K;7?O1
MQX:IPWY+B&W51M>MU^)E+=_Y9 @ PDNGIB;#Z"J6:):M,/^RGEG6AE_J<.T7
M1#)#_UT'KWB9N]QK7U"5VF[[Q'J'6+I::&P5:+^A34J*YX47#FTM=,/D\[KI
M8E&4C]=K=0!/@ESP9^QLSB@,%)OP^7RT2'U(C;;';.LN*1POGVZ.:(SV:Z:,
M53E-V7:ZSUA4^"2;:%9/^8CYRZB-'8*0\X?*+]+UL6'< 237:;I=(9FA20V.
MMZO%)Y6EK]RD>_A7A3+6R]R4](V[RT&UE=MI.TRMVBU]=02F85+8S@JW$;<T
MK^>:7(%[57*%S0OX[<?K\0> !58:R?GKE*YF9;E/J+=6(&R%8 G'RXX Q9?^
MYS B-@KBFQX/2?H)RS>^R_.+0'UOKT%-8P$4J)I9OK&CP$K?!RV?%[T)WALA
M;6'435FLJP/6<;RGD5'?$DS9WWGS#N(V.@X<@DT*N.(RXD@D!0U:R>D1% XN
M=RO&LI@2/^X\?J/\]:^N'/\\L"?W<:<,0WP5,^92-PN5EV"%=)_O7].;_V*K
M3=8-UJ%26S/L,AG+V_)\R1(0FPC0,U$G_XM1Y&0Q>7GJRN$0H/LVL#=BW!Q/
MIQ21_:5'8DW/W/*.T%!OD99 LNNCD)62S& ?3012I8U83#OG!?_XX3CG4ER"
M'8Z'ZZWWJ:FQA)U <QGZ=LG5/;K0F@AUP&Z8%9FOS#.L82L,*)RSX72LH%-S
MD$JQ/)=FE!TERY-E(>?3#A*4\/AF\Q>#MKEN<,78>@_ .RRJJ[U$<JSF)#K*
M&OYB:)L.]%S+;M&K3IBD%8]0$8\5)01@Q)X'&-#!DM695A+@[]; T?EKS];&
M8GQG4HHW*_]BS'$<)U_5Z-7(JKOI:C]N<9F3RLC==1).@HW%IHI#K=L=#%O+
M@K^!RL".UU%Z[PX$E 4NT"Q+SZ)(;+P7]_CE245<EB49X9%_!,UYYD8:OLQG
MF[LRT[FR5A6;:Q?D%R%D&;9:AAYRHS+6IHC82^@!KQTU"K3@F9UK8WX%I3\8
M%X_SJZXIBL#AZDZ0FFK"VV2)=('<>!,5<)Y\WF2I&E0RL>LE_C'63U?F/<!@
M3.FLKQ9PD[#7&;AQ]>HJHU?'L9A%(^)BIXJ5\\RQEF&<T6T^A0#%R\3)JA3S
M3KYFQ">'7O7/L()JV%\,]&=]/O&88T<_KGKVOQCX7[#NWE7"* ?=!;H^ZGSX
MBQ'^XWG'Y?R>^>!*2GU6NN3&59>C'I5;11$%RL2UN9P ]CQ1GE@N^7,&?XAF
M<I7-4*-Q"KS$'*?V#0%7^@53,/OHDU*1]=-#%_0.W6C#\1*W;4N).^&VZD63
M;F51)XT4&[[%5Z*6^*PR*(/\[ES1R.M?W0B\(*VR).]Q4[)!P1Y>8@_AYN:L
MP$5S0>\N ]#=18YS=:E-,_)Q@NL&?XLZ)&;)'>V^T882[QWPZ;1/D? 0\G5)
M6_,'"*0'G(V'TNW?06)I '7.4$^9N;$*DS"JW=8^IL3H#3!WU<_T)<U(EAX2
M,4Y8<CJ_P]&+Y4\102__CPYY_[_BR1MR@!"5(U;I9A3HPNR^?'9IY.GG+#=A
M)QM9%KRTI(IJAST$T]5X&]>LQYV&-4ZG9\J!.=^4[8-$7E(,"3XRZOTSN,CG
M#!M#*#SKV#T#)C1&KMK8HZ/=+;6O4*%_D/@3P9MB-CRSL>13R@5DF G2V#11
M7L]$!=%]T>/Y5X?^7_P7_[=@_47^-U!+ P04    "  0-*9<9CES-G3*   :
MD@@ %0   ')X<G@M,C R-C S,S%?;&%B+GAM;-2]>W/C.)(O^O]^"MS9B'.Z
M(XQIOL3'G-T]X7)5]3J.N^RH<O>>N1TW.D 2M#DCDQZ2<I7GTU\ )"5*HD@D
M!-"U,3%=LDT@,W]4)A) /O[M?W][6J,76M5Y6?S[G^P_6W]"M$C*-"\>_OU/
MO]Y_Q.&?_O=__,N__-O_@_'_???Y!KTOD\T3+1IT55'2T!1]S9M'U#Q2]%]E
M]??\A:"[-6FRLGK"^#_$L*OR^;7*'QX;Y%B.WS_6_[7ZBV5'2402&Y,D6^$@
MH@03&H4XCE9A$C@VL8/HXN$O4>;;J]2R<.:%,?8B.\6A;WO8LJCC><2A(?N!
M3[K.B[__A?\G)C5%3+RB%C_^^Y\>F^;Y+S_]]/7KUS]_BZOUG\OJX2?'LMR?
M^J?_U#W^[>CYKZYXVHZBZ"?QU^VC=3[V()O6_NG__G+S)7FD3P3G1=V0(N$$
MZOPOM?CE39F01J ^RQ<Z^03_"?>/8?XK;#O8M?_\K4[_]!__@E +1U6NZ6>:
M(?[OKY^O3Y*,?N)/_%30!_YN[VB5E^F7AE3-#8GIFG$O9FM>G^F__ZG.GY[7
MM/_=8T6S\6G75;4W*^<RXES:/N?R7T\1^^D,]C7QVQSSJH$Y(>XG73Q.8?I)
M&[OWS$)0\PP/R)S-<ON%^E"D2WUWMZ3.9MT\Q[J^%F5#U@M\+79D!BRO^2]N
MV*>.#)]HPI@*.IWI'K!*OS6T2&EK+?>F1GGZ[W]BG_ZHOE7?_GB?UTG)%LK7
M#]^>:5'3/W;K5N9$.$@#MFXY08K=U LHI5;L>,X?S?8+_0<M\*]?>MJ"P,3L
M?P+(U)S0S8K6Y:9*VE6-4>0K>LO$?VS)_=M/.W:@ *S-BK56DPAUI,Z1+.V<
M'+$^FY-PCXP!2<MD;\XU=SC*ZE"2,IF6I-5>_@CF#ISEMM[%OXX/^ND(Z\NJ
M9X-4R0PLW1,_)25SEIX;O/<=R*KR28+?II1X/2TBC-R?4%FEM&*N[PCK^U^3
MRR2I-C2]*I^>-PV]R4F<K_,FI_75IJK8:^06(0W]P,%^2%T<V '%)$HR'"8Q
M#2DAL4M#:8LP1\VPA>C(HZ2EC]8[!@":-0N9A W1"03,IO08=*31@/8%ZJCK
M! -@=G2"HF:&S@('9IEDA9VT5+.3+&>Y9.79LV32@V"6;5/C!T*>__B8%SF?
M]H6FU^RK4#SD\9I>UC5M:D9Y\[19<T?L\JFLFOR?[1=TX "E! =AXN#(CWWL
M1V'FDY631:OLCR/'_N3W6IT3J2^[W'YF^@O?$T=#ZG(6X R<IVVD8=B4#&?+
M"Q;,H!TWJ&7G H&AE+87YZ.QVZS4# X!14;J6.#1S<YP<58_T753][_A]F8E
M;,T9#"QB@,X'J+=*&F:"F:JZ:O[XS.:GO]"GF%:']L?U5IA85H))LLJHYZ:I
M':<R[M;!O(8=JR]\G:V;/"%K] LE]::BXCSU]_?E$\F+_T_.G!QB,6TCSI 0
MIOC*PDDK^ E1IK26#1EH+/MIIZV'LRVB@B=$Z/7JU)\5=BPW><(W/9</%17O
MX;I(*O96Z'O:_MOY% -GXO!4PW4]'*ZL$#N.9X4>M:*,R)]JP.D;5KZ[BCZ3
M/$6TW0U"MC(*6$IL;LPB!%/>CA>T9>8"]>R@'WJ&?D2]XW^CM"-4@!&P+3(+
MI]I&R0"LL.V3.BB3&RJ%:9?;8JG+O+?I.F,:M6W89UHW59XPA^F*U(^#@Z6A
M4<Y6*0[C588#F[IQX@>1:WDR1GF2BF'3NZ.)$D84MFL:AT5N8W2VL# K.I"3
MT]-X%B(ED*;MRSB-17<HDV(>;D*F'X;I(DW2/RZ_DBJ]?WI@#D/:5$]%^G%-
M'F14[.1@T^>UG":ZSY_RX@%QPI1-PGZ@J9RFG19Z6LNTR L\ECTI*OJ=4]:P
MRYB5:D3-:IK\^:%\^8F-[30L27>*=7K&191J5J!>H>8?5-B'O-O4[/74]67R
MCTU>Y]Q]NBJ+AKT_IJ7L4YVSB817]8$]T+Q>%^R-,HVNK^MZ0^(U_;3A6Z';
M[,LCJ0XV*82O@A&.W,S&3A0S_NV5G?J1]"9%,W.&];SE >4=$RAG3+ O?EF)
M3YP=]$->H%KP\B/ ,=?]CB0V/V^(/,SB](RB :>(K>Q;9M$>MQ>H>TM;AE'/
M\05J>4:W&6JY?L-7!-A8O>&K4MMUO<DK@^W+#&$ZN6G337.Y'9TAM/:V>Z9H
MJ.T%#T_3?Z[*NO[P+5EO>'3NSV69?LW7Z\/%D+H^CE:1CT.71BZA7A;XJS^:
M;035['Y)CBQHF3L1)3:AOH-+(])=&CUP/F#;1DD$Y?:1^G&!+4(C]VB"!?3#
ME@G4<W%ZX0?O-F%B:]I^2A)==#\* ^)P@PH<#;,8*<W_^,#L5//Z,>^-T.'U
MV,J/<4BM%(=VY%F136D<V#).\MCDIIU<00YQ>MWB*Z?WHSA,:_>YTL%T&""8
MM*).23"Q367#6DUD'W8*.#K9(FHV)4:O3)//J"VREVDJUGFROB-Y>EU<D>><
MK5;'5\Q\;8W=$(=AZF-"B;4*'.JM @HY>)VD9OJ$:$L;<>(X+W!''K:H3B,F
MMY9JPP%X<G0$ >HHH]];VAK.CD R:EHOIVDMNDQ*B7VX.LH-4CAYNGND1?E$
MGNO/Y.OU$WF@]8G@D33#Q%DYV$VLD(1TY461)7V$=(J*Z=OLGBQB=%%+&'"<
M<!(;B:,;'1+#='=,V'FM!4@-. W1(;W:L0;HE<..(^:$FCQ7.#EXN0.".?[W
M=OJS#\.OC.Y)O%F3ZB:OFWM^%G!/OS7O&'=_E[TV.CF!83/2T46<\ 42I.7O
MC$Y+/7]OI$5@F!49RHI^%U01)XL$74TW1[-R*=T>G9YUL1ND6<&&MTCS#ZMY
M[#<\\**^C.NF(HEL$,#^((,Q5((.^KVGI-&?'!=!DP-Y,/FB'N.X8(<NXHFG
MU+Y#G^C7RR0I-^)L]ZXJ"_8Q$1$^]5VYSI/7]K\[8W80@>,$"=L#NI2YB^P7
M-@FL*)$*BU1EP'AP3L*O1'8LH7V>8#M$,+IR.FP2,YB6,TY.8W6!6C[0[]V_
M6M>7<\'09"_ Y!>U**K@'-H<Y7G4K!*CD%":UA^90._S%UHW>;.IZ&W6WTO1
M^A-M;C,>XM3^G:9[&UD>L!T'.$R9><K256)%5DI](I5T>@X3AJU3'VV)\D+$
M#J**MKE#38G2O'XN:[)&988(BCL>8?9*"7<YFV4:3> >NN,&<95! WXX>CN.
M+A#CB?^*<X5ZMO39KG- T62_E%A8U(:= ]*A'3MK+M7+Z_U(Z>NBLZ3U'7GE
MVX'#$S@G6.$H(A;VHC2S*;%3*UI!#-<L1=/GZQTU]-R2@UY5S^$E9W"TH@"S
M+F-9#<QB;W&YF\%%X6I:4E9MM])S]!:^D)84__@N6G:@FN[SF!F^2?NOO'F\
MVM1-^40K<>O-C,Q(2@/7_LBQ<$R2 &=)1CPK2],T!J4T2- TK/]7)0_'+!).
M3#+H&@*8G/IKA@%F 'KB;4W GOQ%&ZYR@4C&4$67ZW7YE=?"0UE9\2J":=Z@
MF[+6635" 0U-)D*&XJ)& @#!H9F #%4S%,S7R%-:I/67YN"0A=L$DG@X3FT?
MI]3S;"=U_2A)(#9A?WK3FY2>&$IILB9@&W" A9RZJTL(T^PMG0LD*.E3T7$)
M-&GCP>2+*MZX8(<Z=N(IY8!1$8[*UG>FJUW%JT]E43Z+J-7B@2GND9*E$:^:
MX.+4LX,HHX00?I()"A>=)0I2/:5@T2X90O!P@0HJ69<)A)RL ZX7#Z@/WD'1
MDN>QH8*!']F>?L"#UO!0:7'U!8?.DUPZ-%0:A)' 4/FQ:G9!V!9>.(I-+<(-
M[MAW9CP.QG,(CE(_Q'$<,VL0>#XE&63-G:!E> $6E!&O@]Q6K>L9@%F"*:SD
M#( F!&!Z+Q(.\#LA/-O$B:(KEU7%RXBT!5BTA[=)B*E)WZ<H+:KF$B(?:K?,
M$#6E[D/&;_*"7C?TZ:ATB^-23&P_PE&VLF+JVU:8@>XHCR@85N">'OJ=4T2"
MI&1DUVE0Y'3V+%%AF@J3$JR6)R71I(S'\R^J@B?%.U2\TP\J1'95A"=I,'OZ
M[O6Z2$4TBW10U\A8T_%<+<FA_6?[MICG-J9\N[&1C?@^*?NT4ND0&Z93$A)W
MP5ZZ(KPFQ%,+[AJ;<+FXK@EQ]D*ZIIY3K#M*\NHWLM[0=Z^#@G',D<GKRV_Y
M4:I_ZO'D"]O"=F1'Z2J+J+.2RF*2I&=8-8<U\01-]#NG"ESEYC"36_,T(@'3
M5C (\.J?<J+I*O4Y0VW9NIYRHA\5\90<IJ;D'TA5,+M1W]%*;%3XO,GAUC.(
M'!S[;HSMC%"ZBITH"U9_O- J+F65>Y0.Y(L\I :(!FO0FB?BLAU[6WB#QTXD
M:\*K#UR@=X@4*?KP+7GD:Y.(.&;;TZ>R0#7?'%SP+6N>B*H=:;E>DVHPD60!
M#QC.EH]#:A.<6'86)$'@4"> F-"S458PG,<83^(F6_ED&C@Y.WHV'##KV9-#
MC%Y;C^)"6-%$G_F<E$B3T1RGL:BIG!3ST$!./ZQ08"S]VWW)#P;$BBU;6&PX
MR'0X2_JW3=V(1;HIT? (XR^ BF)[4LYO&Y0%A.G0:=FTN2(GI5&K'+8WTW(5
MP\8$V*L4-OH 7!L^D2>:?OA&DTV3O]#;+,L3]HW]6(!SJ&8G,KU.<?IHRP#J
M.;A '\NR*<H&D%HU#\J\0FG% Z9D\U"P/;GNU"MI>974<'[VQ5136M"ANLH/
MTE!L_)Y63T>WS:L0AZF=X-"A*274\F)7JD;_20J&];DOWDQVQ9MYL<DS"EX+
M6*855XNP,&4=*5)]KT'.,TIW0^755IQ[4N[S*F\/90+5UA8#WZYZ]I#OR?K8
M>P\J7E8GCS3=K)EU$G=G[UZO^$;Z?BQD/(@R' 5^@%WJ^&Z0K=PL >6Z3- R
M?5G=4>8G!=W%]2L2U&</JL&HR6UC-6$!,SM?VA.05O M%-J.Z@&RZ;JKGJ"T
M[%WUO,A'=]420\[6:?K [<1G^LS; 14/UP5O%2YL]KO7[H^C6;<\MRUR'1Q&
M5H;=),NBD*16EH!21!3Y6-(6M*1% A8/BA9GAY\I?^GY.A?\U</G;OLHH?9I
MMIL5_[ZC3!S:!X'=DV_L-P7-<F!8G.I[ UL<4V\#:(U&7L26)S1@2MPM]D^8
MJ"*A"2+]1@W$Q5L9/!6H)HRATG2J[3]>:+&AGRGOEL5SCFDEB#$$;N-U_G#4
M>)$'^H1>@*,D(#CU'<]9.0FE-NA 7XJJ82.X)<X/\7OJJ-R21U7+)+1OB R>
M<N9*.THPX]21OT [I 8<H!T+%[REXD9OPQ& Y-H:D,C07+@A"0"&XP8ED,'G
MW"<\-?#KA"?C[:1/GKC/?EVG187<*<"DU':EH$L=3PESYHW"TT+!\J?8'[]/
M>%(->A?G$CR1G5>2_%A6+?K,$UYO4MZA]/Z1#B(<;C-15VC0P&M;6.JPO7&8
MX#!Q*':CT+&S+/7"V)4^NM3 D&$-%;4>1'-$GI=)!),\H49PR?.XFT>*G@:A
M.\Q)7HMT[T%K>,FK06WO2.(<=6'D859#@,ZY0XR]SE"@GD'V 3$6]QJIWF9(
M<#EL$RA3;<P,_(#CW85?@]IIL);7H>GL6"-@DT?-.N@L=S*M$96]@VR=\^HJ
MF'+++&ZU/>!IVP8<QL-F88R)Y1),/$+35>2XD6?]<=3D7J%LR!AU*0V,6@T\
MXD%:"P5EMM]+:/["CU;:0["V#<BY155&,97;_VF$2&=YE1:MW3G@Y31.&HJL
M3(EMK-+**-$W+K<R!<1\S97)T8KG[%UD&DV'&Y"C+@99A,,X<X1CFWJ^FZT\
MJ5KGTV1,GY+S.PE\=GKG.$*2!]9GRPT\CYY.ZA0IW:(>7I<UK/'<>5)27<?*
MXT26/36>%/3H4'CZ:<7@^*?G=?E*J?B"WS[S&;M\8TA,]JE)#&ME3[>[N6TI
M V.O3\HOIY5:1->LF"T;!K*N9X75%9Y]DLZR(=ISXAZ%:<\.4.\%_4OQG+_/
MZP0<E'IR M.'KL-&R;]\NKM&G/JZY'L9>%?H8_$ESEYU2 X\B)T0VD# Z:R$
M9W6*/IYU\6[1)P4;ZQA]^N%S T?N*EX0I7GE]1.:RR+E#3B?Q=7K6&28[[!/
M+K4P6=FAR_;&GI5(=82&$C:LP3WQ"R3(MYED/0/G1HK-0"KI$QL "J;PYV%T
M1DB&G,#:8S!FR+Y1T(4<&*>C+"3'*S;Y*YH\S=<BZOT+33:5.+AKNV_2E%=%
MYO[\ICTMOLV.<KU>QR<82U!WX@R3@,;8C9,HI9EE)S:H:*%!7DV[&P/":$=9
M*<7=Y!N3,VS?R7L .C]JKP#>V] \.+HZ(QKD=-F^BN8A/^K*N #),RK:/99K
M-J)N6[$?%91.1"$['WNN%06^&ZPL JIK>4P"9#[A52SO^9"V)D!']G_\:^C8
MP?]"5)!7J&,WB9!O9SB.4A>3B,9D%=@>KP/ %N&\3+\TI&J6P.F0G#1:[^A#
M7H@HN)BL>125;G@<.\'$CRSLKG@]\M"VB)=T\'PHTN7 Z8G)G\D5J4Y<)/<!
M9TD*6^7:^2_09=-4><SL#X^_;DIT1_26#S\MD\[*AOL$EB]H."K@:!W#\2?5
M++BX_>++1T4?:5&S!:)-5N#I"Z(7R3WY=B>^_X<W9Z<"M++,Q[&3Q-B+29@$
M6<H<<%!IJ/-9,NQ@MU>]R9##KN0Q^H$71_E1,OQ*XSN0,P[+(@LS)BVH>\QM
MBR=S_G[<=D/B:30F&COJ0T>36=+ T*)F3!^ AV9/X\SP>X=K1I ]V17=$ZWF
MF/?,>SG=2)8WE9S%9,R*(([Z HT]>7%()[I2I9N*[T]O=-9"!8JM=$(O,_]B
M9_4 88>G]I!AB@=O:_&6:#I^<][%+1R>H1'JXM *;>RLLBSQG,A-88T_Y,@:
M7JW%?@YXZB4'E^0!EG808+H_>TFN/6H%)K&N R8YHLN>%8& .#KV@8U62,_X
M0K99YJ+HY.6F>2RK_)\'[4RY4[^*,+'=!/M)X/A1:/N1ZTMG79RF8SI8C;19
MQ%V%QQ=.')$M=4"8_@14TV9 (P! O>>RWW:U'"Z0H,OVZIJ%!Z0>Z %!+:-
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M:9+$3N"E@1V!HK DZ1I6O5\+2JJ"IJCJ(R:5*P3+ BFGH ;@@:ENSP#ZRCA
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M24W3OB M\'#_/"+FOLJ")G['B:*.*KJL*GYI(CZ;.)+7@X4F/_%,9A;U)_4
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MW6V[1.,1UXYP%"8Q3FR:6JO,]U-"(:?AT^0,GX.W==24XPMFH)+S\?4! +,
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M0[V<>5JIX2UOE/.E8?ZHZ,7UF?*NVSR 8=,\EE7^3YH>)1[$!$<13;#EQ'9
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MN:G)DS8O8K!]D+RE49K<L+9W/*&>*9[6MV6+^U&'C,G?LJAA.7_38AQ&F(T
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MI-SP+82,/+HV"Y.TEMT6R(A]M &0&J2FPB(09MS/)S3&H1N)\@Q1D/CQ*K1
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M 1YO^G TLQUZ]$5F,4@B [CE4XV0W'W?-%**[OL@HD[>_ DMM-X=($2ND]M
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M/1D+19T>?DP?./5'&&.(<8:.K $")R)8"010%,,$#*3 $=(Q41* @5Q<183
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M,@]5U=4U,;9FIOFP!T)#"T=.'&/?"((T":S =@-86Y1+(I!?8*G.)UVCU'Y
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MYYO>S-,2:=X/]/EE7[+?_?(FBP<RS9@_'3D).Y>8 ;9=T[6IYSEV()1I-D9
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M'F^R+SR0?YOR"M(D>V3GR5^SU[)BI\KJ[>K/(BE_+K(JN<GNBN(?!3"!2IJ
M9IWZ!R4%YKLTYC^AZR<.)J^"[%TUY6D74FW;A_[,?.**UL62=\4V+Q!_MT0/
M3X1M9P5%_;)G'EWYM0X'BAX5EWV/>8]SE4\!,P&K?@7%N6:+X91RAN6IKN8O
M+P:F[U(O7TS.Z_ZT+5_RDNQ^+O+]2]UM>INRG8J?C,_]B#K/)@IP$'H$\\):
MSZ9^G"9"I;6"]#1;PXXZJLFC4_H@/T,4/S'?72$J,,.T"!"PBR\HIB*G?X[:
MJL< 0='/#P:BK\DFOY8E3TQG.PC-XK>K."[V9'=579.BX)._ZXWIW 00G^#
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MH*1_$:*Z7:,V)'C@ ?68$,OEDL=3T/]1C!+0KUD.$-Q5 4BLR@41(;FN:P$
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MB=RF7[89R?@4SKN\W-9YJ5%9CPT1;@8POY0^?3]0YSU>#_11QP#ZK6-!:7L
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M0:3F5+Z<1<WG$S/@JW\4F.$^^1Y'_M#GD^]Q??H]#K,!&9=-=<JF[2>C,,-
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MH9:8F(K.<3/$5CW!B0E^?G83? L>+7THDJNB>#AVEZ['>@H&3 =?UJR8/6J
M(:;CHL['21=+"5/$KME[OVY26&A0F'12,*E(Z?"*JP5+)P7JQTNG']1=NGA^
MG$NC! >V:V S<%S7#]TPB)D.YA79B>V4XJ1!RGE@0/S0UC6L>.G7W>V[NKLU
M*Q>55RSJTWC%E8KO49ZH>,,&$/Y!RQ''-G*)%>";^DU6LL4+9N7N\MTV9HLQ
M>O%5DK^P0T =H!3<X&<7TKS9M_2/ U!:+NHL5LX*3?9U/]Z&(W%?8!ZA>;]
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M;X'.&<T?H59G& ;!LIV1EV%6H2RJWZ]Y7SM:O)"B>N.5 $-%>!%),?$=BJV
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M__D?W=^P_XF8$?D__^/_!U!+ P04    "  0-*9<T%^EW.-I  "GM 4 %0
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MI Y66&\1<L,NO2^6ZP>&RPFJGB[+0JH<?JV65L_^P^O%K_$G+4$HR^(53&M
MF>8<1AM'J1L$AXZ%^P'C<D*K.>1;%$36]3P[F> Z59B2 $A$.7<0:Y2IDTQK
MZ7XPN9RX:AX93YW#L8[J/4.]J^H+^O2^A ''-@B$#;9^F)_:M7(_F%Q.,#6+
MA+.AY%_^W!)K9/'O YJ(12]JOO0N?K&L9Y5+[>)>Z5GJ@Q9O<7ZUO)OK.U?%
MG[[DI6^KL?X?GZLAV8D,#6Q;UFI*\S'\6LWCJE6T+?6ZUJZK&Q;%!!A+TUNP
M<Q1&(KS:=QL8U/-I#UU#^XE<+9=1OEU<0J* B8X8D%0$09FU#NU+9#Z%RY<4
M%-*>*!<2MCN+#!!W 5V*UM0_6-<N)K@R0*)HI9%"++GPT5'+W:AH)R'30F>(
M9G>"9(B8"\#*:[V\N9J[])^W_WE7?=>SR,SR:O5:+Q;WU?SZKWIVUSJ0A=!
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ME--\EFYZ2G!YLX GF] + -#'R(E.M0OOO5[ZSVG:S,?PEZ5OQ-5.'0Q X1"
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MT]M/"I.CG^+M9: *L@+I_+TR]/+FUUG]Q]@],MK+G*LWQ@$&\U>N/*W85:3
M.8YPTM$#0XPY387E:K1D_!WT9'B029_Y:5%_KZ+D7MW_)<K_W?RI<?>5757?
MX[6GNV^\H @82=*L)NLP"A!3E'NXXO%4%I+&,!1!.]YQQE17 ;[:WI<J%!T
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M;VVY"T=&8&-:@(]VT9E:X06X!X.87?>H;:>AV-E=ZB6Z*=:UJ-MCN @PQC.
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MGS56B>.(AWK?8C:- Y (&1!2HPWA:9JT/'+E7_[#?'N%#1F_NG_XR^Y DX)
M(TS2F"]A(.6&\?%R,XXB]3(*(O=BJ/MP'D]IQ5JKKJG8;_Q*5[.L<[P?/W+<
M<=X["2^T;VE3240@ \9 ")2R5!/FE,E>+E%$W]+/23-S[QYO]U?6WMW>-9'_
M-SY4MFI7=!D)C H$.$>%Q,Y:FKWKU6&J?JXNI8<QMVT?,^OM>%.HUCM^[J_3
MFA.6QWW0B\=.R2=;QZ/7.$_)W'[6)BV>BX>K-,( ![DVS(6 MEMT%E,\]VE1
M?_.+U?VG61I!/7>I_7G33[OQJ[<Y@U( G7:A1"XZ"\$9%\9S\_;3=HE%<?N
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M$N5P2S:6G-!.G*:L;76?(+F)%?Y[-:]N[VYW$ZX( 5K%KPP7)(K"0MPOH>Z
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M&J>-A8\&P5%550 4=[]L[C'KC_XGP31ZL]8!XE'T;+E$EJ#,&.Q-W+21E]'
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M]G(S+GH&X'YE]9L!N%=R4X^"VS?#C@H!XM5>@>C;D*"<T1[_8\P W*^ROC,
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M RXG*[$#%$=)]&0DQ%.[JMV7E5ZLLN(A2L)7U_/UY#E[WU37SAJ=/%8,M6Y
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M7A=Z%CFZ<K?5O$H>;$K(W<N426$$+@P0*G!L($L@R0RS7H1-^WXR'M#R:Z4
MJ.5Q45\$WUZXJ18#:80#U!*DH/1<9F\!FYF%4K*U2[D\3(F0 C;( V>;[R8[
M8GC;7'GN@=8R (^%(Q ZCUCN8MY^E$WK24X*GNT2A/R:O-B8_.<O?[FR\?"J
M5O<C1N!WK'*>>/LA]HJ,KJ=6\48+'6$-.45<8XYX9IM12G0]<WYQFK9@ N(
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MMN9&=23\OO^%76,,AI>M<FYSIFHV=B4^LS5/6P()AW,P^ #.3/;7KX3OF(N
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M:70S,3$M<3 Q,C8N:'1M4$L! A0#%     @ $#2F7"IU/[P[!P  %QT  !0
M             ( !<P<  &5X:&EB:70S,3(M<3 Q,C8N:'1M4$L! A0#%
M  @ $#2F7%EYK#D1!   # \  !0              ( !X X  &5X:&EB:70S
M,C$M<3 Q,C8N:'1M4$L! A0#%     @ $#2F7!T0_N^9]P  /; + !$
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M2P$"% ,4    "  0-*9<9CES-G3*   :D@@ %0              @ $QR T
M<GAR>"TR,#(V,#,S,5]L86(N>&UL4$L! A0#%     @ $#2F7-!?I=SC:0
MI[0% !4              ( !V)(. ')X<G@M,C R-C S,S%?<')E+GAM;%!+
4!08     "P + -0"  #N_ X    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>rxrx-20260331_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:rxrx="http://www.recursion.com/20260331"
  xmlns:srt="http://fasb.org/srt/2025"
  xmlns:us-gaap="http://fasb.org/us-gaap/2025"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="rxrx-20260331.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-05-01</instant>
        </period>
    </context>
    <context id="c-3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-05-01</instant>
        </period>
    </context>
    <context id="c-4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">rxrx:ExchangeableStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">rxrx:ExchangeableStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-38">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-39">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-40">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-41">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-42">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxrx:TempusLabsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-11-01</startDate>
            <endDate>2023-11-30</endDate>
        </period>
    </context>
    <context id="c-44">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxrx:TempusLabsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-30</instant>
        </period>
    </context>
    <context id="c-45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxrx:TempusLabsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-30</instant>
        </period>
    </context>
    <context id="c-46">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">rxrx:REVenturesIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-07-31</instant>
        </period>
    </context>
    <context id="c-47">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">rxrx:REVenturesIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-07-31</endDate>
        </period>
    </context>
    <context id="c-48">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">rxrx:REVenturesIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-08-01</startDate>
            <endDate>2025-08-31</endDate>
        </period>
    </context>
    <context id="c-49">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rxrx:AlphaBiotechnologyGmbHAlphaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-50">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">rxrx:ExscientiaGmbHMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-51">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rxrx:AlphaBiotechnologyGmbHAlphaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-53">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-54">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-55">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-57">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-58">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-59">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">rxrx:AtTheMarketOfferingProgramTDCowenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-02-01</startDate>
            <endDate>2026-02-28</endDate>
        </period>
    </context>
    <context id="c-60">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">rxrx:AtTheMarketOfferingProgramTDCowenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-61">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rxrx:ValenceDiscoveryIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">rxrx:ExchangeableStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2023-05-31</endDate>
        </period>
    </context>
    <context id="c-62">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">rxrx:ExchangeableStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-63">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rxrx:ValenceDiscoveryIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2023-05-31</endDate>
        </period>
    </context>
    <context id="c-64">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
        </entity>
        <period>
            <instant>2021-04-30</instant>
        </period>
    </context>
    <context id="c-65">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxrx:SanofiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="c-66">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxrx:SanofiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="c-67">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxrx:SanofiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-68">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxrx:SanofiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rxrx:MilestoneTypeAxis">rxrx:ResearchMilestonesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="c-69">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxrx:SanofiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rxrx:MilestoneTypeAxis">rxrx:DevelopmentAndRegulatoryMilestonesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="c-70">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxrx:MerckKGaAMerckMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-71">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxrx:MerckKGaAMerckMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rxrx:MilestoneTypeAxis">rxrx:DiscoveryDevelopmentAndSalesMilestonesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-72">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxrx:MerckKGaAMerckMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-09-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-73">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxrx:RocheAndGenentechMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="c-74">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxrx:RocheAndGenentechMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-75">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxrx:RocheAndGenentechMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-10-01</startDate>
            <endDate>2025-10-31</endDate>
        </period>
    </context>
    <context id="c-76">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxrx:RocheAndGenentechMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rxrx:RevenueRemainingPerformanceObligationAxis">rxrx:PhenomapsCreationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="c-77">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxrx:RocheAndGenentechMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rxrx:RevenueRemainingPerformanceObligationAxis">rxrx:PhenomapsRawImagesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="c-78">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxrx:RocheAndGenentechMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rxrx:RevenueRemainingPerformanceObligationAxis">rxrx:DevelopedAndCommercializedProgramsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="c-79">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxrx:RocheAndGenentechMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="c-80">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxrx:RocheAndGenentechMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rxrx:RevenueRemainingPerformanceObligationAxis">rxrx:GastrointestinalCancerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="c-81">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rxrx:RocheAndGenentechMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rxrx:RevenueRemainingPerformanceObligationAxis">rxrx:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="c-82">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rxrx:A2021EquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-83">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rxrx:A2024InducementEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-84">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-85">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-86">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-87">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-88">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-89">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-90">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-91">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-92">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-93">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-94">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-95">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">rxrx:TempusAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-96">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">rxrx:TempusAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-97">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-98">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-99">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-100">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-103">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-107">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-110">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-111">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-114">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-115">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-116">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-118">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:PortionAtOtherThanFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:PortionAtOtherThanFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-122">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-123">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:PortionAtOtherThanFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-124">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:PortionAtOtherThanFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-125">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-126">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rxrx:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-128">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rxrx:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">rxrx:NamandjeBumpusMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601830</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">rxrx:NamandjeBumpusMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="vote">
        <measure>rxrx:vote</measure>
    </unit>
    <unit id="class">
        <measure>rxrx:class</measure>
    </unit>
    <unit id="candidate">
        <measure>rxrx:candidate</measure>
    </unit>
    <unit id="performance_obligation">
        <measure>rxrx:performance_obligation</measure>
    </unit>
    <unit id="phenomap">
        <measure>rxrx:phenomap</measure>
    </unit>
    <unit id="program">
        <measure>rxrx:program</measure>
    </unit>
    <unit id="segment">
        <measure>rxrx:segment</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-26">0001601830</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="c-1" id="f-27">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus contextRef="c-1" id="f-28">2026</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus contextRef="c-1" id="f-29">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:CurrentFiscalYearEndDate contextRef="c-1" id="f-30">--12-31</dei:CurrentFiscalYearEndDate>
    <rxrx:LicenseAgreementTradingPeriodUsedForEquityValueDetermination contextRef="c-43" id="f-283">P7D</rxrx:LicenseAgreementTradingPeriodUsedForEquityValueDetermination>
    <rxrx:LicenseAgreementAmountOfTimePriorToThePaymentDate contextRef="c-43" id="f-284">P5D</rxrx:LicenseAgreementAmountOfTimePriorToThePaymentDate>
    <us-gaap:NumberOfReportableSegments
      contextRef="c-1"
      decimals="INF"
      id="f-547"
      unitRef="segment">1</us-gaap:NumberOfReportableSegments>
    <us-gaap:NumberOfOperatingSegments
      contextRef="c-1"
      decimals="INF"
      id="f-548"
      unitRef="segment">1</us-gaap:NumberOfOperatingSegments>
    <ecd:TrdArrDuration contextRef="c-129" id="f-559">P456D</ecd:TrdArrDuration>
    <dei:DocumentType contextRef="c-1" id="f-1">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport contextRef="c-1" id="f-2">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-3">2026-03-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport contextRef="c-1" id="f-4">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">001-40323</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="c-1" id="f-6">RECURSION PHARMACEUTICALS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-7">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-8">46-4099738</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-9">41 S Rio Grande Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-10">Salt Lake City,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-11">UT</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-12">84101</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-13">385</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-14">269 - 0203</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="c-1" id="f-15">Class A Common Stock, par value $0.00001</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-16">RXRX</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-17">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus contextRef="c-1" id="f-18">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="c-1" id="f-19">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="c-1" id="f-20">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="c-1" id="f-21">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-22">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany contextRef="c-1" id="f-23">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding contextRef="c-2" decimals="INF" id="f-24" unitRef="shares">524677865</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityCommonStockSharesOutstanding contextRef="c-3" decimals="INF" id="f-25" unitRef="shares">5227334</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-4" decimals="-3" id="f-31" unitRef="usd">654473000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-5" decimals="-3" id="f-32" unitRef="usd">743294000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashCurrent contextRef="c-4" decimals="-3" id="f-33" unitRef="usd">5511000</us-gaap:RestrictedCashCurrent>
    <us-gaap:RestrictedCashCurrent contextRef="c-5" decimals="-3" id="f-34" unitRef="usd">4594000</us-gaap:RestrictedCashCurrent>
    <us-gaap:OtherReceivablesNetCurrent contextRef="c-4" decimals="-3" id="f-35" unitRef="usd">13585000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent contextRef="c-5" decimals="-3" id="f-36" unitRef="usd">24649000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:PrepaidExpenseCurrent contextRef="c-4" decimals="-3" id="f-37" unitRef="usd">11742000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent contextRef="c-5" decimals="-3" id="f-38" unitRef="usd">11742000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:OtherAssetsCurrent contextRef="c-4" decimals="-3" id="f-39" unitRef="usd">24246000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent contextRef="c-5" decimals="-3" id="f-40" unitRef="usd">28566000</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-4" decimals="-3" id="f-41" unitRef="usd">709557000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-5" decimals="-3" id="f-42" unitRef="usd">812845000</us-gaap:AssetsCurrent>
    <us-gaap:RestrictedCashNoncurrent contextRef="c-4" decimals="-3" id="f-43" unitRef="usd">5196000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent contextRef="c-5" decimals="-3" id="f-44" unitRef="usd">6033000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-4" decimals="-3" id="f-45" unitRef="usd">95811000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-5" decimals="-3" id="f-46" unitRef="usd">103931000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-4" decimals="-3" id="f-47" unitRef="usd">42816000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-5" decimals="-3" id="f-48" unitRef="usd">45339000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset contextRef="c-4" decimals="-3" id="f-49" unitRef="usd">18694000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset contextRef="c-5" decimals="-3" id="f-50" unitRef="usd">20210000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c-4" decimals="-3" id="f-51" unitRef="usd">294073000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c-5" decimals="-3" id="f-52" unitRef="usd">309903000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:Goodwill contextRef="c-4" decimals="-3" id="f-53" unitRef="usd">160170000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c-5" decimals="-3" id="f-54" unitRef="usd">162158000</us-gaap:Goodwill>
    <us-gaap:DeferredIncomeTaxAssetsNet contextRef="c-4" decimals="-3" id="f-55" unitRef="usd">957000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet contextRef="c-5" decimals="-3" id="f-56" unitRef="usd">957000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-4" decimals="-3" id="f-57" unitRef="usd">12248000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-5" decimals="-3" id="f-58" unitRef="usd">12754000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets contextRef="c-4" decimals="-3" id="f-59" unitRef="usd">1339522000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-5" decimals="-3" id="f-60" unitRef="usd">1474130000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent contextRef="c-4" decimals="-3" id="f-61" unitRef="usd">20348000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="c-5" decimals="-3" id="f-62" unitRef="usd">18118000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-63" unitRef="usd">54205000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c-5" decimals="-3" id="f-64" unitRef="usd">70230000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="c-4" decimals="-3" id="f-65" unitRef="usd">32794000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="c-5" decimals="-3" id="f-66" unitRef="usd">37605000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-4" decimals="-3" id="f-67" unitRef="usd">13087000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-5" decimals="-3" id="f-68" unitRef="usd">12663000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent contextRef="c-4" decimals="-3" id="f-69" unitRef="usd">9265000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent contextRef="c-5" decimals="-3" id="f-70" unitRef="usd">9091000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-71" unitRef="usd">129699000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-5" decimals="-3" id="f-72" unitRef="usd">147707000</us-gaap:LiabilitiesCurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent contextRef="c-4" decimals="-3" id="f-73" unitRef="usd">114723000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent contextRef="c-5" decimals="-3" id="f-74" unitRef="usd">114012000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-4" decimals="-3" id="f-75" unitRef="usd">42842000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-5" decimals="-3" id="f-76" unitRef="usd">46647000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations contextRef="c-4" decimals="-3" id="f-77" unitRef="usd">7181000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations contextRef="c-5" decimals="-3" id="f-78" unitRef="usd">9564000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet contextRef="c-4" decimals="-3" id="f-79" unitRef="usd">18283000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet contextRef="c-5" decimals="-3" id="f-80" unitRef="usd">23255000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c-4" decimals="-3" id="f-81" unitRef="usd">2025000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c-5" decimals="-3" id="f-82" unitRef="usd">2080000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities contextRef="c-4" decimals="-3" id="f-83" unitRef="usd">314753000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c-5" decimals="-3" id="f-84" unitRef="usd">343265000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies contextRef="c-4" id="f-85" unitRef="usd" xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies contextRef="c-5" id="f-86" unitRef="usd" xsi:nil="true"/>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-5"
      decimals="INF"
      id="f-87"
      unitRef="usdPerShare">0.00001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-4"
      decimals="INF"
      id="f-88"
      unitRef="usdPerShare">0.00001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-4" decimals="INF" id="f-89" unitRef="shares">2000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-5" decimals="INF" id="f-90" unitRef="shares">2000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-6" decimals="INF" id="f-91" unitRef="shares">1989032117</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-7" decimals="INF" id="f-92" unitRef="shares">1989032117</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-8" decimals="INF" id="f-93" unitRef="shares">10967883</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-9" decimals="INF" id="f-94" unitRef="shares">10967883</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-4" decimals="INF" id="f-95" unitRef="shares">530628653</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued contextRef="c-4" decimals="INF" id="f-96" unitRef="shares">530628653</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-6" decimals="INF" id="f-97" unitRef="shares">524464320</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued contextRef="c-6" decimals="INF" id="f-98" unitRef="shares">524464320</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-9" decimals="INF" id="f-99" unitRef="shares">5307334</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued contextRef="c-9" decimals="INF" id="f-100" unitRef="shares">5307334</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c-10"
      decimals="INF"
      id="f-101"
      unitRef="shares">856999</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="c-10"
      decimals="INF"
      id="f-102"
      unitRef="shares">856999</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="c-5" decimals="INF" id="f-103" unitRef="shares">528182693</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-5" decimals="INF" id="f-104" unitRef="shares">528182693</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-7" decimals="INF" id="f-105" unitRef="shares">521831046</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued contextRef="c-7" decimals="INF" id="f-106" unitRef="shares">521831046</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="c-8" decimals="INF" id="f-107" unitRef="shares">5547334</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-8" decimals="INF" id="f-108" unitRef="shares">5547334</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c-11"
      decimals="INF"
      id="f-109"
      unitRef="shares">804313</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="c-11"
      decimals="INF"
      id="f-110"
      unitRef="shares">804313</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue contextRef="c-4" decimals="-3" id="f-111" unitRef="usd">5000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="c-5" decimals="-3" id="f-112" unitRef="usd">5000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital contextRef="c-4" decimals="-3" id="f-113" unitRef="usd">3191608000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="c-5" decimals="-3" id="f-114" unitRef="usd">3170145000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-4" decimals="-3" id="f-115" unitRef="usd">-2193506000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-5" decimals="-3" id="f-116" unitRef="usd">-2076002000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-4" decimals="-3" id="f-117" unitRef="usd">26662000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-5" decimals="-3" id="f-118" unitRef="usd">36717000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity contextRef="c-4" decimals="-3" id="f-119" unitRef="usd">1024769000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-5" decimals="-3" id="f-120" unitRef="usd">1130865000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-4" decimals="-3" id="f-121" unitRef="usd">1339522000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-5" decimals="-3" id="f-122" unitRef="usd">1474130000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-12" decimals="-3" id="f-123" unitRef="usd">6301000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-13" decimals="-3" id="f-124" unitRef="usd">14818000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-14" decimals="-3" id="f-125" unitRef="usd">171000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-15" decimals="-3" id="f-126" unitRef="usd">-73000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-1" decimals="-3" id="f-127" unitRef="usd">6472000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-16" decimals="-3" id="f-128" unitRef="usd">14745000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-1" decimals="-3" id="f-129" unitRef="usd">12490000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-16" decimals="-3" id="f-130" unitRef="usd">21829000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-1" decimals="-3" id="f-131" unitRef="usd">87896000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-16" decimals="-3" id="f-132" unitRef="usd">129634000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-1" decimals="-3" id="f-133" unitRef="usd">34591000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-16" decimals="-3" id="f-134" unitRef="usd">54650000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:CostsAndExpenses contextRef="c-1" decimals="-3" id="f-135" unitRef="usd">134977000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="c-16" decimals="-3" id="f-136" unitRef="usd">206113000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss contextRef="c-1" decimals="-3" id="f-137" unitRef="usd">-128505000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-16" decimals="-3" id="f-138" unitRef="usd">-191368000</us-gaap:OperatingIncomeLoss>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-1" decimals="-3" id="f-139" unitRef="usd">6397000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-16" decimals="-3" id="f-140" unitRef="usd">-11277000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-1" decimals="-3" id="f-141" unitRef="usd">-122108000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-16" decimals="-3" id="f-142" unitRef="usd">-202645000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-143" unitRef="usd">-4604000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-16" decimals="-3" id="f-144" unitRef="usd">-158000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-145" unitRef="usd">-117504000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-16" decimals="-3" id="f-146" unitRef="usd">-202487000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-1"
      decimals="2"
      id="f-147"
      unitRef="usdPerShare">-0.22</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-1"
      decimals="2"
      id="f-148"
      unitRef="usdPerShare">-0.22</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-16"
      decimals="2"
      id="f-149"
      unitRef="usdPerShare">-0.50</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-16"
      decimals="2"
      id="f-150"
      unitRef="usdPerShare">-0.50</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="0" id="f-151" unitRef="shares">529303984</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-1" decimals="0" id="f-152" unitRef="shares">529303984</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-16" decimals="0" id="f-153" unitRef="shares">402771972</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-16" decimals="0" id="f-154" unitRef="shares">402771972</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-155" unitRef="usd">-117504000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-16" decimals="-3" id="f-156" unitRef="usd">-202487000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-1" decimals="-3" id="f-157" unitRef="usd">-10055000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-16" decimals="-3" id="f-158" unitRef="usd">21782000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-1" decimals="-3" id="f-159" unitRef="usd">-10055000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-16" decimals="-3" id="f-160" unitRef="usd">21782000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-1" decimals="-3" id="f-161" unitRef="usd">-127559000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-16" decimals="-3" id="f-162" unitRef="usd">-180705000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c-17"
      decimals="INF"
      id="f-163"
      unitRef="shares">528182693</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-17" decimals="-3" id="f-164" unitRef="usd">5000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-18" decimals="-3" id="f-165" unitRef="usd">3170145000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-19" decimals="-3" id="f-166" unitRef="usd">-2076002000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-20" decimals="-3" id="f-167" unitRef="usd">36717000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-5" decimals="-3" id="f-168" unitRef="usd">1130865000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss contextRef="c-21" decimals="-3" id="f-169" unitRef="usd">-117504000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-170" unitRef="usd">-117504000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-22" decimals="-3" id="f-171" unitRef="usd">-10055000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-1" decimals="-3" id="f-172" unitRef="usd">-10055000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="c-23"
      decimals="INF"
      id="f-173"
      unitRef="shares">2613410</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-24" decimals="-3" id="f-174" unitRef="usd">-752000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-1" decimals="-3" id="f-175" unitRef="usd">-752000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-24" decimals="-3" id="f-176" unitRef="usd">22215000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-1" decimals="-3" id="f-177" unitRef="usd">22215000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c-25"
      decimals="INF"
      id="f-178"
      unitRef="shares">530796103</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-25" decimals="-3" id="f-179" unitRef="usd">5000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-26" decimals="-3" id="f-180" unitRef="usd">3191608000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-27" decimals="-3" id="f-181" unitRef="usd">-2193506000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-28" decimals="-3" id="f-182" unitRef="usd">26662000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-4" decimals="-3" id="f-183" unitRef="usd">1024769000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c-29"
      decimals="INF"
      id="f-184"
      unitRef="shares">396802394</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-29" decimals="-3" id="f-185" unitRef="usd">4000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-30" decimals="-3" id="f-186" unitRef="usd">2473698000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-31" decimals="-3" id="f-187" unitRef="usd">-1431283000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-32" decimals="-3" id="f-188" unitRef="usd">-7637000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-33" decimals="-3" id="f-189" unitRef="usd">1034782000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss contextRef="c-34" decimals="-3" id="f-190" unitRef="usd">-202487000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-16" decimals="-3" id="f-191" unitRef="usd">-202487000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-35" decimals="-3" id="f-192" unitRef="usd">21782000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-16" decimals="-3" id="f-193" unitRef="usd">21782000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="c-36"
      decimals="INF"
      id="f-194"
      unitRef="shares">4108659</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-37" decimals="-3" id="f-195" unitRef="usd">2712000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-34" decimals="-3" id="f-196" unitRef="usd">76000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-16" decimals="-3" id="f-197" unitRef="usd">2788000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-37" decimals="-3" id="f-198" unitRef="usd">36058000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-16" decimals="-3" id="f-199" unitRef="usd">36058000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c-36"
      decimals="INF"
      id="f-200"
      unitRef="shares">5499680</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-37" decimals="-3" id="f-201" unitRef="usd">41024000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-16" decimals="-3" id="f-202" unitRef="usd">41024000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c-38"
      decimals="INF"
      id="f-203"
      unitRef="shares">406410733</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-38" decimals="-3" id="f-204" unitRef="usd">4000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-39" decimals="-3" id="f-205" unitRef="usd">2553492000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-40" decimals="-3" id="f-206" unitRef="usd">-1633694000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-41" decimals="-3" id="f-207" unitRef="usd">14145000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-42" decimals="-3" id="f-208" unitRef="usd">933947000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-209" unitRef="usd">-117504000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-16" decimals="-3" id="f-210" unitRef="usd">-202487000</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-1" decimals="-3" id="f-211" unitRef="usd">19673000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-16" decimals="-3" id="f-212" unitRef="usd">19331000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:ShareBasedCompensation contextRef="c-1" decimals="-3" id="f-213" unitRef="usd">22215000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-16" decimals="-3" id="f-214" unitRef="usd">36058000</us-gaap:ShareBasedCompensation>
    <us-gaap:TangibleAssetImpairmentCharges contextRef="c-1" decimals="-3" id="f-215" unitRef="usd">0</us-gaap:TangibleAssetImpairmentCharges>
    <us-gaap:TangibleAssetImpairmentCharges contextRef="c-16" decimals="-3" id="f-216" unitRef="usd">5956000</us-gaap:TangibleAssetImpairmentCharges>
    <us-gaap:OperatingLeaseExpense contextRef="c-1" decimals="-3" id="f-217" unitRef="usd">5243000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense contextRef="c-16" decimals="-3" id="f-218" unitRef="usd">6130000</us-gaap:OperatingLeaseExpense>
    <us-gaap:GainLossOnSaleOfBusiness contextRef="c-1" decimals="-3" id="f-219" unitRef="usd">0</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness contextRef="c-16" decimals="-3" id="f-220" unitRef="usd">-4502000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-221" unitRef="usd">-4597000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-16" decimals="-3" id="f-222" unitRef="usd">-419000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:OtherNoncashIncomeExpense contextRef="c-1" decimals="-3" id="f-223" unitRef="usd">-1674000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense contextRef="c-16" decimals="-3" id="f-224" unitRef="usd">-4824000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets contextRef="c-1" decimals="-3" id="f-225" unitRef="usd">-14746000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets contextRef="c-16" decimals="-3" id="f-226" unitRef="usd">-4839000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <rxrx:IncreaseDecreaseInPrepaidDataAssets contextRef="c-1" decimals="-3" id="f-227" unitRef="usd">0</rxrx:IncreaseDecreaseInPrepaidDataAssets>
    <rxrx:IncreaseDecreaseInPrepaidDataAssets contextRef="c-16" decimals="-3" id="f-228" unitRef="usd">-27131000</rxrx:IncreaseDecreaseInPrepaidDataAssets>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability contextRef="c-1" decimals="-3" id="f-229" unitRef="usd">-2248000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability contextRef="c-16" decimals="-3" id="f-230" unitRef="usd">-9762000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="c-1" decimals="-3" id="f-231" unitRef="usd">2070000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="c-16" decimals="-3" id="f-232" unitRef="usd">3692000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <rxrx:IncreaseDecreaseInAccruedDevelopmentExpense contextRef="c-1" decimals="-3" id="f-233" unitRef="usd">730000</rxrx:IncreaseDecreaseInAccruedDevelopmentExpense>
    <rxrx:IncreaseDecreaseInAccruedDevelopmentExpense contextRef="c-16" decimals="-3" id="f-234" unitRef="usd">599000</rxrx:IncreaseDecreaseInAccruedDevelopmentExpense>
    <us-gaap:IncreaseDecreaseInOtherAccruedLiabilities contextRef="c-1" decimals="-3" id="f-235" unitRef="usd">-18451000</us-gaap:IncreaseDecreaseInOtherAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherAccruedLiabilities contextRef="c-16" decimals="-3" id="f-236" unitRef="usd">-26591000</us-gaap:IncreaseDecreaseInOtherAccruedLiabilities>
    <rxrx:IncreaseDecreaseInLeaseLiability contextRef="c-1" decimals="-3" id="f-237" unitRef="usd">-4652000</rxrx:IncreaseDecreaseInLeaseLiability>
    <rxrx:IncreaseDecreaseInLeaseLiability contextRef="c-16" decimals="-3" id="f-238" unitRef="usd">-5760000</rxrx:IncreaseDecreaseInLeaseLiability>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-1" decimals="-3" id="f-239" unitRef="usd">-81101000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-16" decimals="-3" id="f-240" unitRef="usd">-131957000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c-1" decimals="-3" id="f-241" unitRef="usd">258000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c-16" decimals="-3" id="f-242" unitRef="usd">1832000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireIntangibleAssets contextRef="c-1" decimals="-3" id="f-243" unitRef="usd">80000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireIntangibleAssets contextRef="c-16" decimals="-3" id="f-244" unitRef="usd">0</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested contextRef="c-1" decimals="-3" id="f-245" unitRef="usd">0</us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested>
    <us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested contextRef="c-16" decimals="-3" id="f-246" unitRef="usd">-4438000</us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested>
    <us-gaap:PaymentsToAcquireInvestments contextRef="c-1" decimals="-3" id="f-247" unitRef="usd">0</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:PaymentsToAcquireInvestments contextRef="c-16" decimals="-3" id="f-248" unitRef="usd">1000000</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-1" decimals="-3" id="f-249" unitRef="usd">-338000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-16" decimals="-3" id="f-250" unitRef="usd">-7270000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c-1" decimals="-3" id="f-251" unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c-16" decimals="-3" id="f-252" unitRef="usd">41024000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <rxrx:ProceedsFromPaymentForShareBasedPaymentArrangement contextRef="c-1" decimals="-3" id="f-253" unitRef="usd">-1262000</rxrx:ProceedsFromPaymentForShareBasedPaymentArrangement>
    <rxrx:ProceedsFromPaymentForShareBasedPaymentArrangement contextRef="c-16" decimals="-3" id="f-254" unitRef="usd">1550000</rxrx:ProceedsFromPaymentForShareBasedPaymentArrangement>
    <us-gaap:RepaymentsOfLongTermDebtAndCapitalSecurities contextRef="c-1" decimals="-3" id="f-255" unitRef="usd">2208000</us-gaap:RepaymentsOfLongTermDebtAndCapitalSecurities>
    <us-gaap:RepaymentsOfLongTermDebtAndCapitalSecurities contextRef="c-16" decimals="-3" id="f-256" unitRef="usd">2047000</us-gaap:RepaymentsOfLongTermDebtAndCapitalSecurities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-1" decimals="-3" id="f-257" unitRef="usd">-3470000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-16" decimals="-3" id="f-258" unitRef="usd">40527000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-1" decimals="-3" id="f-259" unitRef="usd">-3832000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-16" decimals="-3" id="f-260" unitRef="usd">4833000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-1" decimals="-3" id="f-261" unitRef="usd">-88741000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-16" decimals="-3" id="f-262" unitRef="usd">-93867000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-5" decimals="-3" id="f-263" unitRef="usd">753921000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-33" decimals="-3" id="f-264" unitRef="usd">603024000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-4" decimals="-3" id="f-265" unitRef="usd">665180000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-42" decimals="-3" id="f-266" unitRef="usd">509157000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1 contextRef="c-1" decimals="-3" id="f-267" unitRef="usd">1915000</us-gaap:NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1>
    <us-gaap:NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1 contextRef="c-16" decimals="-3" id="f-268" unitRef="usd">0</us-gaap:NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid contextRef="c-1" decimals="-3" id="f-269" unitRef="usd">0</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid contextRef="c-16" decimals="-3" id="f-270" unitRef="usd">1146000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <rxrx:PurchaseOfAnEquityInvestmentNonCash contextRef="c-1" decimals="-3" id="f-271" unitRef="usd">0</rxrx:PurchaseOfAnEquityInvestmentNonCash>
    <rxrx:PurchaseOfAnEquityInvestmentNonCash contextRef="c-16" decimals="-3" id="f-272" unitRef="usd">4438000</rxrx:PurchaseOfAnEquityInvestmentNonCash>
    <us-gaap:NatureOfOperations contextRef="c-1" id="f-273">Description of the Business &lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Recursion Pharmaceuticals, Inc. (Recursion, the Company, we or our) is a clinical stage TechBio company decoding biology and chemistry to industrialize drug discovery. The Recursion Operating System (Recursion OS), a platform built across diverse technologies, enables the Company to map and navigate trillions of biological and chemical relationships within the Recursion Data Universe, one of the world&#x2019;s largest proprietary biological and chemical datasets. The Company integrates physical and digital components as iterative loops of atoms and bits scaling wet lab biology and chemistry data organized into virtuous cycles with computational tools to rapidly translate &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;in silico &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;hypotheses into validated insights and novel chemistry.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2026, the Company had an accumulated deficit of $2.2 billion. The Company expects to incur substantial operating losses in future periods and will require additional capital to advance its drug candidates. The Company does not expect to generate significant revenue until the Company successfully completes significant drug development milestones or in collaboration&#160;with third parties, which the Company expects will take a number of years. In order to commercialize its drug candidates, the Company or its partners need to complete clinical development and comply with comprehensive regulatory requirements. The Company is subject to a number of risks and uncertainties similar to those of other companies of the same size within the biotechnology industry, such as the uncertainty of clinical trial outcomes, uncertainty of additional funding and a history of operating losses. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has funded its operations to date primarily through the issuance of Class A common stock (see Note 8, &#x201c;Common Stock&#x201d; for additional details). Additionally, the Company has received payments from its strategic partnerships (see Note 9, &#x201c;Collaborative Development Contracts&#x201d; for additional details). Recursion will likely be required to raise additional capital. As of March&#160;31, 2026, the Company did not have any unconditional outstanding commitments for additional funding. If the Company is unable to access additional funds when needed, it may not be able to continue the development of its products or the Company could be required to delay, scale back or abandon some or all of its development programs and other operations. The Company&#x2019;s ability to access capital when needed is not assured and, if not achieved on a timely basis, could materially harm its business, financial condition and results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Recursion believes that the Company&#x2019;s existing cash and cash equivalents will be sufficient to fund the Company&#x2019;s operating expenses and capital expenditures for at least the next 12 months from the issuance date of these financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:NatureOfOperations>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-4" decimals="-8" id="f-274" unitRef="usd">-2200000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock contextRef="c-1" id="f-275">Basis of Presentation&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unaudited interim condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (SEC). Accordingly, certain information and footnote disclosures normally included in annual financial statements prepared in accordance with generally accepted accounting principles in the United States (U.S. GAAP) have been condensed or omitted. These unaudited interim condensed consolidated financial statements should be read in conjunction with the Company&#x2019;s audited consolidated financial statements and notes for the year ended December&#160;31, 2025. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;It is management&#x2019;s opinion that these condensed consolidated financial statements include all normal and recurring adjustments necessary for a fair statement of the financial position, results of operations and cash flows for the periods presented. Revenue and net loss for any interim period are not necessarily indicative of future or annual results.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recent Accounting Pronouncements &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2025, the FASB issued ASU No. 2025-10, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Government Grants (Topic 832). &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The new standard adds guidance to ASC 832 on the recognition, measurement and presentation of government grants. This standard will be effective for Recursion starting the annual period of 2029 and for interim reporting periods within that annual &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;reporting period. Early adoption is permitted. The amendments can be applied on a prospective, modified prospective or retrospective basis. Recursion is currently assessing the impact of adopting this guidance on its consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In September 2025, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2025-07, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Derivatives and Hedging (Topic 350) and Revenue from Contracts with Customers (Topic 606).&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The new standard refines the scope of the guidance on derivatives in Topic 815 and clarifies the guidance on shared-based payments from a customer in ASC 606. This standard will be effective for Recursion starting the annual period of 2027 and for interim reporting periods within that annual reporting period. Early adoption is permitted. Recursion is currently assessing the impact of adopting this guidance on its consolidated financial statements. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In September 2025, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2025-06, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accounting for internal-use software costs (Topic 350)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The new standard amends specific aspects of the accounting for internal-use software costs including the criteria for capitalizing software costs. It also amends the related disclosure requirements. This standard will be effective for Recursion starting the annual period ending 2028 and for interim reporting periods within that annual reporting period. Early adoption is permitted. The amendments can be applied on a prospective, modified prospective or retrospective basis. Recursion is currently assessing the impact of adopting this guidance on its consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2024, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2024-03, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Disaggregation of Income Statement Expenses (Topic 220)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The standard requires new disclosures in the notes to the financial statements about certain caption expenses presented on the face of the Income Statement including information on: purchases of inventory; employee compensation; depreciation and intangible asset amortization. Recursion must also disclose a qualitative description of the amounts remaining in expense captions that are not separately disaggregated. This standard will be effective for Recursion starting the annual period of 2027. Early adoption is permitted. The amendments can be applied on a prospective or retrospective basis. Recursion is currently assessing the impact of adopting this guidance on its consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="c-1" id="f-276">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unaudited interim condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (SEC). Accordingly, certain information and footnote disclosures normally included in annual financial statements prepared in accordance with generally accepted accounting principles in the United States (U.S. GAAP) have been condensed or omitted. These unaudited interim condensed consolidated financial statements should be read in conjunction with the Company&#x2019;s audited consolidated financial statements and notes for the year ended December&#160;31, 2025. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;It is management&#x2019;s opinion that these condensed consolidated financial statements include all normal and recurring adjustments necessary for a fair statement of the financial position, results of operations and cash flows for the periods presented. Revenue and net loss for any interim period are not necessarily indicative of future or annual results.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="c-1" id="f-277">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recent Accounting Pronouncements &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2025, the FASB issued ASU No. 2025-10, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Government Grants (Topic 832). &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The new standard adds guidance to ASC 832 on the recognition, measurement and presentation of government grants. This standard will be effective for Recursion starting the annual period of 2029 and for interim reporting periods within that annual &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;reporting period. Early adoption is permitted. The amendments can be applied on a prospective, modified prospective or retrospective basis. Recursion is currently assessing the impact of adopting this guidance on its consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In September 2025, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2025-07, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Derivatives and Hedging (Topic 350) and Revenue from Contracts with Customers (Topic 606).&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The new standard refines the scope of the guidance on derivatives in Topic 815 and clarifies the guidance on shared-based payments from a customer in ASC 606. This standard will be effective for Recursion starting the annual period of 2027 and for interim reporting periods within that annual reporting period. Early adoption is permitted. Recursion is currently assessing the impact of adopting this guidance on its consolidated financial statements. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In September 2025, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2025-06, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accounting for internal-use software costs (Topic 350)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The new standard amends specific aspects of the accounting for internal-use software costs including the criteria for capitalizing software costs. It also amends the related disclosure requirements. This standard will be effective for Recursion starting the annual period ending 2028 and for interim reporting periods within that annual reporting period. Early adoption is permitted. The amendments can be applied on a prospective, modified prospective or retrospective basis. Recursion is currently assessing the impact of adopting this guidance on its consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2024, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2024-03, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Disaggregation of Income Statement Expenses (Topic 220)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The standard requires new disclosures in the notes to the financial statements about certain caption expenses presented on the face of the Income Statement including information on: purchases of inventory; employee compensation; depreciation and intangible asset amortization. Recursion must also disclose a qualitative description of the amounts remaining in expense captions that are not separately disaggregated. This standard will be effective for Recursion starting the annual period of 2027. Early adoption is permitted. The amendments can be applied on a prospective or retrospective basis. Recursion is currently assessing the impact of adopting this guidance on its consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <rxrx:SupplementalBalanceSheetAndIncomeStatementInformationTextBlock contextRef="c-1" id="f-278">Supplemental Financial Information &lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Tempus agreement&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2023, Recursion entered into a five-year agreement (the Tempus Agreement) with Tempus AI, Inc. (Tempus) to purchase access to their records of patient-centric multimodal oncology data and use rights for therapeutic development purposes. This data will be used to improve the training of Recursion&#x2019;s artificial intelligence and machine learning models and is expected to accelerate Recursion&#x2019;s drug discovery process. Recursion is making annual payments, ranging between $22.0&#160;million and $42.0&#160;million, up to $160.0&#160;million in aggregate, to Tempus in cash or equity at the Company&#x2019;s option. The equity value is determined by using the &lt;span style="-sec-ix-hidden:f-283"&gt;seven&lt;/span&gt;-trading day period dollar volume-weighted average price (VWAP) for Recursion Class A common stock ending on the day immediately preceding the date that is &lt;span style="-sec-ix-hidden:f-284"&gt;five&lt;/span&gt; business days prior to the payment date.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Recursion is expensing the record purchases based on a contractually agreed price as &#x201c;Research and Development&#x201d; expenses in the Condensed Consolidated Statements of Operations as the records are downloaded. To the extent that the Recursion payments to Tempus are greater than or less than the records purchased amount, Recursion records the applicable amount to &#x201c;Prepaid data assets&#x201d; or &#x201c;Accrued data liability&#x201d; on the Condensed Consolidated Balance Sheet, respectively. Recursion did not purchase any records for the three months ended March 31, 2026. For the three months ended March 31, 2025, record purchases were $27.1 million. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accrued Expenses and Other Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:69.660%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.521%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued compensation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued compute liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued development expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued early discovery expenses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued professional fees&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Materials received not invoiced&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,010&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued license fees&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued other expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,555&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expense and other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Interest Income, Net&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.461%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(350)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(508)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended March 31, 2026 and 2025, interest income primarily related to earnings on cash and cash equivalents in money market funds. Interest expense primarily related to the Company&#x2019;s supercomputer financing lease. Interest income, net was included in &#x201c;Other income (loss), net&#x201d; on the Condensed Consolidated Statements of Operations.&lt;/span&gt;&lt;/div&gt;</rxrx:SupplementalBalanceSheetAndIncomeStatementInformationTextBlock>
    <rxrx:LicenseAgreementTerm contextRef="c-43" id="f-279">P5Y</rxrx:LicenseAgreementTerm>
    <rxrx:LicenseAgreementAnnualPayments contextRef="c-44" decimals="-5" id="f-280" unitRef="usd">22000000.0</rxrx:LicenseAgreementAnnualPayments>
    <rxrx:LicenseAgreementAnnualPayments contextRef="c-45" decimals="-5" id="f-281" unitRef="usd">42000000.0</rxrx:LicenseAgreementAnnualPayments>
    <rxrx:LicenseAgreementAggregatePayments contextRef="c-45" decimals="-5" id="f-282" unitRef="usd">160000000.0</rxrx:LicenseAgreementAggregatePayments>
    <rxrx:LicenseAgreementIncreaseDecreaseAccruedLiabilities contextRef="c-1" decimals="INF" id="f-285" unitRef="usd">0</rxrx:LicenseAgreementIncreaseDecreaseAccruedLiabilities>
    <rxrx:LicenseAgreementIncreaseDecreaseAccruedLiabilities contextRef="c-16" decimals="-5" id="f-286" unitRef="usd">27100000</rxrx:LicenseAgreementIncreaseDecreaseAccruedLiabilities>
    <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock contextRef="c-1" id="f-287">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accrued Expenses and Other Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:69.660%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.521%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued compensation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued compute liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued development expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued early discovery expenses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued professional fees&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Materials received not invoiced&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,010&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued license fees&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued other expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,555&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expense and other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-288" unitRef="usd">14566000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c-5" decimals="-3" id="f-289" unitRef="usd">31771000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <rxrx:AccruedComputeLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-290" unitRef="usd">7535000</rxrx:AccruedComputeLiabilitiesCurrent>
    <rxrx:AccruedComputeLiabilitiesCurrent contextRef="c-5" decimals="-3" id="f-291" unitRef="usd">8278000</rxrx:AccruedComputeLiabilitiesCurrent>
    <rxrx:AccruedDevelopmentCostsCurrent contextRef="c-4" decimals="-3" id="f-292" unitRef="usd">4214000</rxrx:AccruedDevelopmentCostsCurrent>
    <rxrx:AccruedDevelopmentCostsCurrent contextRef="c-5" decimals="-3" id="f-293" unitRef="usd">2693000</rxrx:AccruedDevelopmentCostsCurrent>
    <rxrx:AccruedEarlyDiscoveryExpensesCurrent contextRef="c-4" decimals="-3" id="f-294" unitRef="usd">7535000</rxrx:AccruedEarlyDiscoveryExpensesCurrent>
    <rxrx:AccruedEarlyDiscoveryExpensesCurrent contextRef="c-5" decimals="-3" id="f-295" unitRef="usd">4581000</rxrx:AccruedEarlyDiscoveryExpensesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent contextRef="c-4" decimals="-3" id="f-296" unitRef="usd">1875000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent contextRef="c-5" decimals="-3" id="f-297" unitRef="usd">1232000</us-gaap:AccruedProfessionalFeesCurrent>
    <rxrx:MaterialsReceivedNotInvoiced contextRef="c-4" decimals="-3" id="f-298" unitRef="usd">1010000</rxrx:MaterialsReceivedNotInvoiced>
    <rxrx:MaterialsReceivedNotInvoiced contextRef="c-5" decimals="-3" id="f-299" unitRef="usd">703000</rxrx:MaterialsReceivedNotInvoiced>
    <rxrx:AccruedLicenseFeeCurrent contextRef="c-4" decimals="-3" id="f-300" unitRef="usd">4915000</rxrx:AccruedLicenseFeeCurrent>
    <rxrx:AccruedLicenseFeeCurrent contextRef="c-5" decimals="-3" id="f-301" unitRef="usd">3000000</rxrx:AccruedLicenseFeeCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-302" unitRef="usd">12555000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="c-5" decimals="-3" id="f-303" unitRef="usd">17972000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-304" unitRef="usd">54205000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c-5" decimals="-3" id="f-305" unitRef="usd">70230000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock contextRef="c-1" id="f-306">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Interest Income, Net&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.461%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(350)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(508)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock>
    <us-gaap:InvestmentIncomeNonoperating contextRef="c-1" decimals="-3" id="f-307" unitRef="usd">5963000</us-gaap:InvestmentIncomeNonoperating>
    <us-gaap:InvestmentIncomeNonoperating contextRef="c-16" decimals="-3" id="f-308" unitRef="usd">5558000</us-gaap:InvestmentIncomeNonoperating>
    <us-gaap:InterestExpenseNonoperating contextRef="c-1" decimals="-3" id="f-309" unitRef="usd">350000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating contextRef="c-16" decimals="-3" id="f-310" unitRef="usd">508000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestIncomeExpenseNonoperatingNet contextRef="c-1" decimals="-3" id="f-311" unitRef="usd">5613000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet contextRef="c-16" decimals="-3" id="f-312" unitRef="usd">5050000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:BusinessCombinationDisclosureTextBlock contextRef="c-1" id="f-313">Acquisitions&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;RE Ventures I&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2025, Recursion acquired Rallybio&#x2019;s interest in the joint venture, RE Ventures I, such that Recursion now owns 100% of the interest in RE Ventures I for total consideration of $20.2 million. Recursion determined that this transaction met the criteria for as an asset acquisition since the lead asset, ENPP1 (Rec-102), an inhibitor program for the treatment of hypophosphatasia (HPP), represented substantially all of the fair value of the gross assets acquired. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Subsequent to closing, in August 2025, Recursion issued additional consideration as part of a required milestone payment. As a result, Recursion recorded an additional expense of $2.4 million &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As part of the agreement, Rallybio is eligible to receive additional milestone payments under certain conditions. Milestone payment obligations that are incurred prior to regulatory approval of the compound will be expensed as acquired IPR&amp;amp;D when recognized.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Sale of Exscientia GmbH&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2025, Recursion completed the sale of its Austrian operations (Exscientia GmbH) to Alpha Biotechnology GmbH (Alpha). As part of the sale, Recursion obtained a 49% equity interest in Alpha. For the year ended December 31, 2025, Recursion recorded a loss on the disposal of Exscientia GmbH of $4.5 million, which was classified as &#x201c;Other income (loss), net&#x201d; on the Condensed Consolidated Statement of Operations. Recursion also &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;recorded a $4.4 million investment on the Condensed Consolidated Balance Sheet within &#x201c;Other assets, non-current&#x201d; related to its 49% equity interest in Alpha, which was determined to be an equity method investment.&lt;/span&gt;&lt;/div&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
    <rxrx:AssetAcquisitionEquityOwnershipPercentage contextRef="c-46" decimals="2" id="f-314" unitRef="number">1</rxrx:AssetAcquisitionEquityOwnershipPercentage>
    <us-gaap:AssetAcquisitionConsiderationTransferred contextRef="c-47" decimals="-5" id="f-315" unitRef="usd">20200000</us-gaap:AssetAcquisitionConsiderationTransferred>
    <us-gaap:PaymentsToAcquireInProcessResearchAndDevelopment contextRef="c-48" decimals="-5" id="f-316" unitRef="usd">2400000</us-gaap:PaymentsToAcquireInProcessResearchAndDevelopment>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="c-49" decimals="2" id="f-317" unitRef="number">0.49</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:GainLossOnSaleOfBusiness contextRef="c-50" decimals="-5" id="f-318" unitRef="usd">-4500000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:EquityMethodInvestments contextRef="c-51" decimals="-5" id="f-319" unitRef="usd">4400000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="c-49" decimals="2" id="f-320" unitRef="number">0.49</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:LesseeOperatingLeasesTextBlock contextRef="c-1" id="f-322">Leases &lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has entered into various long-term real estate operating leases primarily related to office, research and development and operating activities and an equipment financing lease related to the supercomputer. The Company&#x2019;s leases have remaining terms from under one year to seven years and some of those leases include options that provide Recursion with the ability to extend the lease term, generally for five years. The options are included in the lease term when it is reasonably certain that the option will be exercised. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;three months ended March 31, 2025,&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Recursion entered into operating lease modifications and terminations resulting in a decrease to the right-of-use asset and lease liability of $10.1&#160;million. The modifications had no impact to the Condensed Consolidated Statements of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental cash flow information related to leases were:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:67.028%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.835%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.837%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three months ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for amount included in the measurement of lease liabilities: &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from financing leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing cash flows from financing leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets additions, modifications and termination:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,084)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LesseeFinanceLeasesTextBlock contextRef="c-1" id="f-321">Leases &lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has entered into various long-term real estate operating leases primarily related to office, research and development and operating activities and an equipment financing lease related to the supercomputer. The Company&#x2019;s leases have remaining terms from under one year to seven years and some of those leases include options that provide Recursion with the ability to extend the lease term, generally for five years. The options are included in the lease term when it is reasonably certain that the option will be exercised. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;three months ended March 31, 2025,&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Recursion entered into operating lease modifications and terminations resulting in a decrease to the right-of-use asset and lease liability of $10.1&#160;million. The modifications had no impact to the Condensed Consolidated Statements of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental cash flow information related to leases were:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:67.028%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.835%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.837%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three months ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for amount included in the measurement of lease liabilities: &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from financing leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing cash flows from financing leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets additions, modifications and termination:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,084)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeFinanceLeasesTextBlock>
    <us-gaap:LesseeOperatingLeaseRemainingLeaseTerm contextRef="c-52" id="f-323">P1Y</us-gaap:LesseeOperatingLeaseRemainingLeaseTerm>
    <us-gaap:LesseeOperatingLeaseRemainingLeaseTerm contextRef="c-53" id="f-324">P7Y</us-gaap:LesseeOperatingLeaseRemainingLeaseTerm>
    <us-gaap:LesseeOperatingLeaseRenewalTerm contextRef="c-4" id="f-325">P5Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <rxrx:IncreaseDecreaseInOperatingLeaseRightOfUseAssets contextRef="c-16" decimals="-5" id="f-326" unitRef="usd">-10100000</rxrx:IncreaseDecreaseInOperatingLeaseRightOfUseAssets>
    <rxrx:LesseeOperatingLeaseIncreaseDecreaseInOperatingLeaseLiabilityDueToLeaseModifications contextRef="c-16" decimals="-5" id="f-327" unitRef="usd">-10100000</rxrx:LesseeOperatingLeaseIncreaseDecreaseInOperatingLeaseLiabilityDueToLeaseModifications>
    <us-gaap:LeaseCostTableTextBlock contextRef="c-1" id="f-328">&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental cash flow information related to leases were:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:67.028%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.835%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.837%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three months ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for amount included in the measurement of lease liabilities: &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from financing leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing cash flows from financing leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets additions, modifications and termination:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,084)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeasePayments contextRef="c-1" decimals="-3" id="f-329" unitRef="usd">4316000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments contextRef="c-16" decimals="-3" id="f-330" unitRef="usd">5265000</us-gaap:OperatingLeasePayments>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability contextRef="c-1" decimals="-3" id="f-331" unitRef="usd">336000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability contextRef="c-16" decimals="-3" id="f-332" unitRef="usd">495000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeasePrincipalPayments contextRef="c-1" decimals="-3" id="f-333" unitRef="usd">2178000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments contextRef="c-16" decimals="-3" id="f-334" unitRef="usd">2019000</us-gaap:FinanceLeasePrincipalPayments>
    <rxrx:IncreaseDecreaseInOperatingLeaseRightOfUseAssets contextRef="c-1" decimals="-3" id="f-335" unitRef="usd">0</rxrx:IncreaseDecreaseInOperatingLeaseRightOfUseAssets>
    <rxrx:IncreaseDecreaseInOperatingLeaseRightOfUseAssets contextRef="c-16" decimals="-3" id="f-336" unitRef="usd">-10084000</rxrx:IncreaseDecreaseInOperatingLeaseRightOfUseAssets>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock contextRef="c-1" id="f-337">Goodwill and Intangible Assets &lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the changes in the carrying amount of goodwill: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:82.964%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.836%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,988)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of March 31, 2026&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;No goodwill impairment was recorded during the three months ended March 31, 2026 and 2025.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Intangible Assets, Net&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes intangible assets:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:21.268%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.888%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.326%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.408%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.350%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.622%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross carrying amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net carrying amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross carrying amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net carrying amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Definite-lived technology intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;233,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(79,725)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;236,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(69,156)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167,341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Definite-lived licensed intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,908)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,619)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Indefinite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;381,706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(87,633)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;294,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;385,678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(75,775)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;309,903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization expense was $12.7 million and $11.7 million during the three months ended March 31, 2026 and 2025, respectively. Amortization expense was included in &#x201c;Research and Development&#x201d; in the Condensed Consolidated Statements of Operations. Intangible assets, net decreased by $5.2 million during the three months ended March 31, 2026 due to foreign currency translation adjustments.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;No indefinite-lived intangible asset impairment charges were recorded during the three months ended March 31, 2026 and 2025.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfGoodwillTextBlock contextRef="c-1" id="f-338">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the changes in the carrying amount of goodwill: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:82.964%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.836%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,988)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of March 31, 2026&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill contextRef="c-5" decimals="-3" id="f-339" unitRef="usd">162158000</us-gaap:Goodwill>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss contextRef="c-1" decimals="-3" id="f-340" unitRef="usd">1988000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:Goodwill contextRef="c-4" decimals="-3" id="f-341" unitRef="usd">160170000</us-gaap:Goodwill>
    <us-gaap:GoodwillImpairmentLoss contextRef="c-16" decimals="INF" id="f-342" unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss contextRef="c-1" decimals="INF" id="f-343" unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock contextRef="c-1" id="f-345">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes intangible assets:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:21.268%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.888%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.326%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.408%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.350%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.622%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross carrying amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net carrying amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross carrying amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net carrying amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Definite-lived technology intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;233,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(79,725)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;236,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(69,156)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167,341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Definite-lived licensed intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,908)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,619)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Indefinite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;381,706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(87,633)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;294,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;385,678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(75,775)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;309,903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock contextRef="c-1" id="f-344">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes intangible assets:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:21.268%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.888%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.326%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.408%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.350%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.622%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross carrying amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net carrying amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross carrying amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net carrying amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Definite-lived technology intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;233,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(79,725)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;236,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(69,156)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167,341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Definite-lived licensed intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,908)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,619)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Indefinite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;381,706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(87,633)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;294,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;385,678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(75,775)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;309,903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-54" decimals="-3" id="f-346" unitRef="usd">233086000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-54" decimals="-3" id="f-347" unitRef="usd">79725000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-54" decimals="-3" id="f-348" unitRef="usd">153361000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-55" decimals="-3" id="f-349" unitRef="usd">236497000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-55" decimals="-3" id="f-350" unitRef="usd">69156000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-55" decimals="-3" id="f-351" unitRef="usd">167341000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-56" decimals="-3" id="f-352" unitRef="usd">13072000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-56" decimals="-3" id="f-353" unitRef="usd">7908000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-56" decimals="-3" id="f-354" unitRef="usd">5164000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-57" decimals="-3" id="f-355" unitRef="usd">11158000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-57" decimals="-3" id="f-356" unitRef="usd">6619000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-57" decimals="-3" id="f-357" unitRef="usd">4539000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill contextRef="c-4" decimals="-3" id="f-358" unitRef="usd">135548000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill contextRef="c-4" decimals="-3" id="f-359" unitRef="usd">135548000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill contextRef="c-5" decimals="-3" id="f-360" unitRef="usd">138023000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill contextRef="c-5" decimals="-3" id="f-361" unitRef="usd">138023000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill contextRef="c-4" decimals="-3" id="f-362" unitRef="usd">381706000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-4" decimals="-3" id="f-363" unitRef="usd">87633000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c-4" decimals="-3" id="f-364" unitRef="usd">294073000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill contextRef="c-5" decimals="-3" id="f-365" unitRef="usd">385678000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-5" decimals="-3" id="f-366" unitRef="usd">75775000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c-5" decimals="-3" id="f-367" unitRef="usd">309903000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-1" decimals="-5" id="f-368" unitRef="usd">12700000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-16" decimals="-5" id="f-369" unitRef="usd">11700000</us-gaap:AmortizationOfIntangibleAssets>
    <rxrx:IntangibleAssetsForeignCurrencyTranslationGainLoss contextRef="c-1" decimals="-5" id="f-370" unitRef="usd">-5200000</rxrx:IntangibleAssetsForeignCurrencyTranslationGainLoss>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill contextRef="c-1" decimals="INF" id="f-371" unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill contextRef="c-16" decimals="INF" id="f-372" unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="c-1" id="f-373">Commitments and Contingencies&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Contract Obligations&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the normal course of business, the Company enters into contracts with clinical research organizations, drug manufacturers and other vendors&#160;for preclinical and clinical research studies, research and development supplies and other services and products for operating purposes. These contracts generally provide for termination on notice and are cancellable contracts.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Indemnification&lt;/span&gt;&lt;span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has agreed to indemnify its officers and directors for certain events or occurrences, while the officer or director is or was serving at the Company&#x2019;s request in such capacity. The Company purchases directors and officers liability insurance coverage that provides for reimbursement to the Company for covered obligations and this is intended to limit the Company&#x2019;s exposure and enable it to recover a portion of any amount it pays under its indemnification obligations. The Company had no liabilities recorded for these agreements as of March&#160;31, 2026 and December&#160;31, 2025, as no amounts were probable. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Employee Agreements &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has signed employment agreements with certain key employees pursuant to which, if their employment is terminated following a change of control of the Company, the employees are entitled to receive certain benefits, including accelerated vesting of equity incentives. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Legal Matters&lt;/span&gt;&lt;span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company may, from time to time, be involved in various legal proceedings arising in the normal course of business. An unfavorable resolution of any such matter could materially affect the Company&#x2019;s future financial position, results of operations or cash flows. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2021, the Company entered into a lease agreement for laboratory and office space (the Industry Lease) with Industry Office SLC, LLC (the landlord). In March 2023, the Company sent a letter to the landlord detailing numerous construction delays and irregularities, deficiencies and deviations from applicable structural drawings and/or non-conforming conditions with applicable building codes (collectively, the Claims). On June&#160;23, 2023, the &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;landlord filed a lawsuit against the Company (Industry Office SLC, LLC v. Recursion Pharmaceuticals, Inc., Case No. 230904627) amended in October 2023, in the Third District Court for Salt Lake County, State of Utah (the Court), alleging anticipatory repudiation, breach of contract and breach of the implied covenant of good faith and fair dealing and seeks monetary damages and attorney&#x2019;s fees. As of March&#160;31, 2026, the Company had no liability recorded for these events as an unfavorable outcome was not probable. In September 2023, the Company filed claims in the Court against the landlord alleging, among other things, breach of contract and fraudulent misrepresentation (the Counterclaims). In October 2023, the landlord filed an answer and denied the Company&#x2019;s allegations asserted in the Counterclaims. The Company and the landlord are currently engaged in discovery. The Company is unable to estimate the possible amount or range of damages associated with the Counterclaims.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Pledged Assets&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2026, assets pledged as collateral against finance leases totaled $15.2 million. Assets pledged as collateral are Lab Equipment reported in &#x201c;Property and Equipment, net&#x201d; on the Condensed Consolidated Balance Sheet. As of March&#160;31, 2026, the liabilities associated with collateral pledged were solely comprised of a finance lease and had a carrying value of $16.2 million. The collateral pledged under the lease agreement may only be operated by the Company within the continental United States and must maintain a good title. The assets cannot be sold, disposed of or repledged by the Company.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LossContingencyAccrualAtCarryingValue contextRef="c-4" decimals="INF" id="f-374" unitRef="usd">0</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:LossContingencyAccrualAtCarryingValue contextRef="c-5" decimals="INF" id="f-375" unitRef="usd">0</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:LossContingencyAccrualAtCarryingValue contextRef="c-4" decimals="INF" id="f-376" unitRef="usd">0</us-gaap:LossContingencyAccrualAtCarryingValue>
    <rxrx:FinanceLeasesAssetsPledgedAsCollateral contextRef="c-4" decimals="-5" id="f-377" unitRef="usd">15200000</rxrx:FinanceLeasesAssetsPledgedAsCollateral>
    <us-gaap:FinanceLeaseLiability contextRef="c-4" decimals="-5" id="f-378" unitRef="usd">16200000</us-gaap:FinanceLeaseLiability>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="c-1" id="f-379">Common Stock &lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Each share of Class A common stock entitles the holder to one vote per share and each share of Class B common stock entitles the holder to 10 votes per share on all matters submitted to a vote of the Company&#x2019;s stockholders. Common stockholders are entitled to receive dividends, as may be declared by the Company&#x2019;s Board of Directors. As of March&#160;31, 2026 and December&#160;31, 2025, no dividends had been declared. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;At-The-Market Offerings&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In &lt;/span&gt;&lt;span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;February 2026&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, the Company entered into a Sales Agreement (the TD Cowen Sales Agreement) with TD Securities (USA), LLC (the TD Cowen Sales Agent), to provide for the offering, issuance and sale of up to an aggregate amount of $300 million of its Class A common stock from time to time in at-the-market offerings (the TD Cowen ATM Offering). The TD Cowen ATM Offering was made under a prospectus supplement dated February&#160;24, 2026 and related prospectus filed with the Securities and Exchange Commission pursuant to the Company&#x2019;s automatically effective shelf registration statement on Form S-3 (Registration No. 333-284878). &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended March 31, 2026, the Company sold no&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;shares. As of&#160;March&#160;31, 2026, an amount of $300.0 million remained available for future sales under the Sales Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to &lt;/span&gt;&lt;span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;February 2026, Recursion had entered into sales agreements with Citigroup Capital Markets Inc. and Jefferies LLC. See Note 8, &#x201c;Common Stock,&#x201d; in the Company&#x2019;s Annual Report on Form 10-K for the year ended &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;December&#160;31, 2025&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Valence Acquisition Exchangeable Shares&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In &lt;/span&gt;&lt;span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;May 2023&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, in connection with the acquisition of Valence Discovery Inc. (Valence), the Company entered into an agreement to issue up to 5.9&#160;million shares of Class A common stock (the Exchangeable Shares), that may be issued upon exchange of exchangeable shares of a subsidiary of Recursion. The Exchangeable Shares are substantially the economic equivalent of the Class A shares and classified as common stock within the Company&#x2019;s stockholders&#x2019; equity. The Company&#x2019;s calculation of weighted-average shares outstanding includes the exchangeable shares. As of March&#160;31, 2026, 4.9&#160;million Exchangeable Shares have been redeemed for Class A shares.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Registration Rights Agreements&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Tempus agreement&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In &lt;/span&gt;&lt;span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;November 2023&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, in connection with the Tempus Agreement, the Company filed a registration statement for resale of the shares of Class A common stock issued or issuable under the Tempus Agreement. A new registration &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;statement (333-284878) was filed in February 2025 and a prospectus supplement covering all shares that have been issued under the Tempus Agreement and remained held by Tempus was filed in May 2025 and in November 2025, a prospectus supplement was filed to register shares issued to Tempus in payment for the 2025 annual fee.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;After registration of any shares issued to Tempus under the Tempus Agreement, the Company has agreed to use commercially reasonable efforts to keep such registration statement effective until such date that all shares issued to Tempus covered by such registration statement have been sold. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Acquisitions&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2024, in connection with the acquisition of Exscientia plc (Exscientia), the Company filed a Registration Agreement providing for the resale of the shares of Class A common stock issued for Recursion stock options and RSUs. A registration statement on Form S-8 (File No. 333-283347) was filed to register the shares for resale by the holders. The registration statement must remain effective as long as such Recursion stock options and RSUs remain outstanding.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2023, in connection with the acquisition of Valence, the Company filed a Registration Agreement providing for the resale of the shares of Class A common stock and Exchange Shares issued or issuable in such transaction. A registration statement on Form S-3ASR (File No. 333-272281) was filed to register the shares for resale by the holders. The registration statement must remain effective for a period of not less than three years. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Class A and B Common Shares Authorization&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In April 2021, the Company&#x2019;s Board of Directors authorized two classes of common stock, Class A and Class B. The rights of the holders of Class A and B common stock are identical, except with respect to voting and conversion. Each share of Class A common stock is entitled to one vote per share. Each share of Class B common stock is entitled to 10 votes per share and is convertible at any time into one share of Class A common stock.&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <rxrx:CommonStockVotePerShare contextRef="c-6" decimals="INF" id="f-380" unitRef="vote">1</rxrx:CommonStockVotePerShare>
    <rxrx:CommonStockVotePerShare contextRef="c-9" decimals="INF" id="f-381" unitRef="vote">10</rxrx:CommonStockVotePerShare>
    <us-gaap:DividendsStock contextRef="c-58" decimals="INF" id="f-382" unitRef="usd">0</us-gaap:DividendsStock>
    <us-gaap:DividendsStock contextRef="c-1" decimals="INF" id="f-383" unitRef="usd">0</us-gaap:DividendsStock>
    <rxrx:SaleOfStockValueAuthorized contextRef="c-59" decimals="-6" id="f-384" unitRef="usd">300000000</rxrx:SaleOfStockValueAuthorized>
    <rxrx:SaleOfStockValueRemainingAuthorized contextRef="c-60" decimals="-5" id="f-385" unitRef="usd">300000000.0</rxrx:SaleOfStockValueRemainingAuthorized>
    <rxrx:BusinessAcquisitionContingentConsiderationEquityInterestsIssuableNumberOfShares contextRef="c-61" decimals="-5" id="f-386" unitRef="shares">5900000</rxrx:BusinessAcquisitionContingentConsiderationEquityInterestsIssuableNumberOfShares>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities contextRef="c-62" decimals="-5" id="f-387" unitRef="shares">4900000</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <rxrx:RegistrationRightsAgreementTerm contextRef="c-63" id="f-388">P3Y</rxrx:RegistrationRightsAgreementTerm>
    <rxrx:NumberOfClassesOfCommonStockAuthorized contextRef="c-64" decimals="INF" id="f-389" unitRef="class">2</rxrx:NumberOfClassesOfCommonStockAuthorized>
    <rxrx:CommonStockVotePerShare contextRef="c-6" decimals="INF" id="f-390" unitRef="vote">1</rxrx:CommonStockVotePerShare>
    <rxrx:CommonStockVotePerShare contextRef="c-9" decimals="INF" id="f-391" unitRef="vote">10</rxrx:CommonStockVotePerShare>
    <rxrx:CommonStockConversionRatio contextRef="c-6" decimals="INF" id="f-392" unitRef="number">1</rxrx:CommonStockConversionRatio>
    <us-gaap:CollaborativeArrangementDisclosureTextBlock contextRef="c-1" id="f-393">Collaborative Development Contracts &lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Sanofi&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Description&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In &lt;/span&gt;&lt;span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;January 2022&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, the Company and Sanofi entered into a collaboration agreement to develop an AI-driven pipeline of precision-engineered medicines. The research is focused on up to 15 novel small molecule candidates across oncology and immunology and utilizes the Company&#x2019;s AI platform. The Company is leading small molecule drug design and lead optimization activities with Sanofi assuming responsibility for preclinical and clinical development, manufacturing and commercialization.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Pricing&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company received a $100.0 million non-refundable upfront payment. The Company has received multiple milestone payments related to this agreement totaling approximately $34.0 million. These related to the advancement of several of the discovery programs within the collaboration and the addition of an existing Company program into the collaboration. Recursion is eligible for additional milestone payments based on performance progress of the collaboration and tiered royalties ranging from high-single-digits to mid-teens. Recursion could earn a maximum of $555.0 million from all research milestones and $1.8 billion from all development and regulatory milestones.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Accounting&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Recursion has determined that it has at least eight performance obligations related to the small molecule projects. These performance obligations are for performing research and development services for Sanofi to design small molecules and perform lead optimization activities. The performance obligations also include potential licenses related to the intellectual property. The Company concluded that licenses within the contract are not distinct from the research and development services as they are interrelated due to the fact that the research and development services significantly impact the potential licenses. Any additional services are considered customer options and will be considered as separate contracts for accounting purposes.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has determined the transaction price to be $154.5 million, for the initial performance obligations, comprised of the upfront payment, several milestones that have been achieved and estimated additional target exercises. Recursion has fully constrained the amounts of remaining variable consideration to be received from potential milestones considering the stage of development and the risks associated with the remaining development required to achieve each milestone. Recursion will re-evaluate the transaction price each reporting period. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes revenue over time based on costs incurred relative to total expected costs to perform the research and development services. Recursion was unable to estimate the completion date of the performance obligations due to the current stage of work.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Merck KGaA (Merck)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Description&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In &lt;/span&gt;&lt;span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;September 2023&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, the Company and Merck entered into a collaboration agreement to discover novel small molecule drug candidates across oncology, neuroinflammation and immunology. The collaboration utilizes the Company&#x2019;s AI platform and the Company is performing drug design and discovery while Merck will be assuming responsibility for the preclinical and clinical development.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Pricing&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company received a $20.1 million non-refundable upfront payment. Recursion is eligible for additional milestone payments based on performance progress of the collaboration and tiered royalties from the mid-single-digits to low-double-digits. The Company could earn a maximum of $73.0 million for discovery, development and sales milestones per project.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Accounting&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Recursion has determined that it has three performance obligations related to the small molecule projects and the transaction price to be $20.1 million. Recursion has fully constrained the amounts of remaining variable consideration to be received from potential milestones. Recursion will re-evaluate the transaction price each reporting period. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes revenue over time based on costs incurred relative to total expected costs to perform the research and development services. Recursion was unable to estimate the completion date of the performance obligations due to the current stage of work.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Roche and Genentech&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Description&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2021, Recursion entered into a collaboration and license agreement with Roche and Genentech (collectively referred to as Roche). Recursion is constructing, using the Company&#x2019;s imaging technology and proprietary machine-learning algorithms, unique maps of the inferred relationships amongst perturbation phenotypes in a given cellular context with the goal to discover and develop therapeutic small molecule programs in a gastrointestinal cancer indication and in key areas of neuroscience. Roche and Recursion will collaborate to select certain novel inferences with respect to small molecules or targets generated from the Phenomaps for further validation and optimization as collaboration programs. Roche and Recursion may also combine sequencing datasets from Roche with Recursion&#x2019;s Phenomaps and collaborate to generate new algorithms to produce multi-modal maps from which additional collaboration programs may be initiated. For every collaboration program that successfully identifies potential therapeutic small molecules or validates a target, Roche will have an option to obtain an exclusive license to develop and commercialize such potential therapeutic small molecules or to exploit such target in the applicable exclusive field.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Pricing&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In January 2022, Recursion received a $150.0 million non-refundable upfront payment from the Company&#x2019;s collaboration with Roche. In September 2024, Recursion received a $30.0 million milestone payment ( &#x201c;acceptance fee 1&#x201d;), which was an acceptance fee related to the first accepted neuroscience Phenomap. In October 2025, Recursion received another $30.0 million milestone payment (&#x201c;acceptance fee 2&#x201d;), which was an acceptance fee related to the second accepted neuroscience Phenomap. Recursion is eligible for additional milestone payments based on performance progress of the collaboration. Each of the Phenomaps requested by Roche and created by Recursion may be subject to either an initiation fee, acceptance fee or both. Such fees could exceed $250.0 million for 16 accepted Phenomaps. In addition, for a period of time after Roche&#x2019;s acceptance of certain Phenomaps, &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Roche will have the option to obtain, subject to payment of an exercise fee, rights to use outside the collaboration the raw images generated in the course of creating those Phenomaps. If Roche exercises its external use option for all 12 eligible Phenomaps, Roche&#x2019;s associated exercise fee payments to Recursion could exceed $250.0 million. Under the collaboration, Roche may initiate up to 40 programs, each of which, if successfully developed and commercialized, could yield more than $300.0&#160;million in development, commercialization and net revenue milestones for Recursion, as well as tiered royalties on net revenue.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Accounting&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Recursion has determined that it has three performance obligations, one related to gastrointestinal cancer and two in neuroscience. These performance obligations are for performing research and development services for Roche to identify targets and medicines. The performance obligations also include potential licenses related to the intellectual property. The Company concluded that licenses within the contract are not distinct from the research and development services as they are interrelated due to the fact that the research and development services significantly impact the potential licenses. Any additional services are considered customer options and will be considered as separate contracts for accounting purposes.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company has determined the transaction price to be $210.0 million, comprised of the upfront payment and the acceptance fees. The consideration did not include the $30.0 million variable consideration for the first acceptance fee until the map was accepted, which was during the third quarter of 2024. As a result of Roche&#x2019;s acceptance of the neuroscience Phenomap, Recursion is now recognizing the acceptance fee as part of the transaction price over the completion period of one of the neuroscience performance obligations. The consideration did not include the $30.0 million variable consideration for the second acceptance fee until the map was accepted, which was during the fourth quarter of 2025. As a result of Roche&#x2019;s acceptance of the neuroscience Phenomap, Recursion is now recognizing the acceptance fees as part of the transaction price over the completion period of one of the neuroscience performance obligations. Recursion has fully constrained the remaining amounts of variable consideration to be received from potential milestones considering the stage of development and the risks associated with the remaining development required to achieve each milestone. Recursion will re-evaluate the transaction price each reporting period.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes revenue over time based on costs incurred relative to total expected costs to perform the research and development services. Recursion has estimated the completion of the performance obligations by 2028.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Additional Revenue Disclosures&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Of the revenue recognized during the three months ended March 31, 2026 and 2025, $4.4 million and $14.7 million was included in the unearned revenue balance as of December&#160;31, 2025 and December&#160;31, 2024, respectively. Revenue recognized was from the upfront and variable consideration payments received from the related contracts, which decreased the aggregate unearned revenue recognized. As of March&#160;31, 2026, the Company had $5.2 million of costs incurred to fulfill a contract on its Condensed Consolidated Balance Sheet within &#x201c;Other Current Assets.&#x201d;&lt;/span&gt;&lt;/div&gt;Unearned revenue was classified as short-term and long-term on the Condensed Consolidated Balance Sheets based on the Company&#x2019;s estimate of revenue that will be recognized during the next twelve months.</us-gaap:CollaborativeArrangementDisclosureTextBlock>
    <rxrx:ContractWithCustomerNumberOfNovelSmallMoleculeCandidates
      contextRef="c-65"
      decimals="INF"
      id="f-394"
      unitRef="candidate">15</rxrx:ContractWithCustomerNumberOfNovelSmallMoleculeCandidates>
    <us-gaap:ContractWithCustomerLiability contextRef="c-66" decimals="-5" id="f-395" unitRef="usd">100000000.0</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized contextRef="c-67" decimals="-5" id="f-396" unitRef="usd">34000000.0</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiability contextRef="c-68" decimals="-5" id="f-397" unitRef="usd">555000000.0</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability contextRef="c-69" decimals="-8" id="f-398" unitRef="usd">1800000000</us-gaap:ContractWithCustomerLiability>
    <rxrx:RevenuePerformanceObligationNumberOfObligations
      contextRef="c-65"
      decimals="INF"
      id="f-399"
      unitRef="performance_obligation">8</rxrx:RevenuePerformanceObligationNumberOfObligations>
    <us-gaap:RevenueRemainingPerformanceObligation contextRef="c-66" decimals="-5" id="f-400" unitRef="usd">154500000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:ContractWithCustomerLiability contextRef="c-70" decimals="-5" id="f-401" unitRef="usd">20100000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability contextRef="c-71" decimals="-5" id="f-402" unitRef="usd">73000000.0</us-gaap:ContractWithCustomerLiability>
    <rxrx:RevenuePerformanceObligationNumberOfObligations
      contextRef="c-72"
      decimals="INF"
      id="f-403"
      unitRef="performance_obligation">3</rxrx:RevenuePerformanceObligationNumberOfObligations>
    <us-gaap:RevenueRemainingPerformanceObligation contextRef="c-70" decimals="-5" id="f-404" unitRef="usd">20100000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:ContractWithCustomerLiability contextRef="c-73" decimals="-5" id="f-405" unitRef="usd">150000000.0</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized contextRef="c-74" decimals="-5" id="f-406" unitRef="usd">30000000.0</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized contextRef="c-75" decimals="-5" id="f-407" unitRef="usd">30000000.0</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <rxrx:RevenueRemainingPerformanceObligationVariableConsiderationAmount contextRef="c-76" decimals="-5" id="f-408" unitRef="usd">250000000.0</rxrx:RevenueRemainingPerformanceObligationVariableConsiderationAmount>
    <rxrx:ContractWithCustomerMaximumAcceptedProduct
      contextRef="c-76"
      decimals="INF"
      id="f-409"
      unitRef="phenomap">16</rxrx:ContractWithCustomerMaximumAcceptedProduct>
    <rxrx:ContractWithCustomerMaximumAcceptedProduct
      contextRef="c-77"
      decimals="INF"
      id="f-410"
      unitRef="phenomap">12</rxrx:ContractWithCustomerMaximumAcceptedProduct>
    <rxrx:RevenueRemainingPerformanceObligationVariableConsiderationAmount contextRef="c-77" decimals="-5" id="f-411" unitRef="usd">250000000.0</rxrx:RevenueRemainingPerformanceObligationVariableConsiderationAmount>
    <rxrx:RevenueRemainingPerformanceObligationNumberOfProjectsThatMayBeInitiated
      contextRef="c-78"
      decimals="INF"
      id="f-412"
      unitRef="program">40</rxrx:RevenueRemainingPerformanceObligationNumberOfProjectsThatMayBeInitiated>
    <rxrx:RevenueRemainingPerformanceObligationVariableConsiderationAmount contextRef="c-78" decimals="-5" id="f-413" unitRef="usd">300000000.0</rxrx:RevenueRemainingPerformanceObligationVariableConsiderationAmount>
    <rxrx:RevenuePerformanceObligationNumberOfObligations
      contextRef="c-79"
      decimals="INF"
      id="f-414"
      unitRef="performance_obligation">3</rxrx:RevenuePerformanceObligationNumberOfObligations>
    <rxrx:RevenuePerformanceObligationNumberOfObligations
      contextRef="c-80"
      decimals="INF"
      id="f-415"
      unitRef="performance_obligation">1</rxrx:RevenuePerformanceObligationNumberOfObligations>
    <rxrx:RevenuePerformanceObligationNumberOfObligations
      contextRef="c-81"
      decimals="INF"
      id="f-416"
      unitRef="performance_obligation">2</rxrx:RevenuePerformanceObligationNumberOfObligations>
    <us-gaap:RevenueRemainingPerformanceObligation contextRef="c-73" decimals="-5" id="f-417" unitRef="usd">210000000.0</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized contextRef="c-74" decimals="-5" id="f-418" unitRef="usd">30000000.0</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized contextRef="c-74" decimals="-5" id="f-419" unitRef="usd">30000000.0</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized contextRef="c-1" decimals="-5" id="f-420" unitRef="usd">4400000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized contextRef="c-16" decimals="-5" id="f-421" unitRef="usd">14700000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerAssetNetCurrent contextRef="c-4" decimals="-5" id="f-422" unitRef="usd">5200000</us-gaap:ContractWithCustomerAssetNetCurrent>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="c-1" id="f-423">Stock-Based Compensation &lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In April 2021, the Board of Directors and the stockholders of the Company adopted the 2021 Equity Incentive Plan (the 2021 Plan). The Company may grant stock options, restricted stock units (RSUs), stock appreciation rights, restricted stock awards and other forms of stock-based compensation. As of March&#160;31, 2026, 27.1&#160;million shares of Class A common stock were available for grant in the 2021 plan. In November 2024, the Board of Directors and the stockholders of the Company adopted the 2024 Inducement Equity Incentive Plan (the 2024 Plan) as part of the Exscientia acquisition. As of March&#160;31, 2026, 11.3&#160;million shares of Class A common stock were available for grant in the 2024 plan.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the classification of stock-based compensation expense for employees and non-employees within the Condensed Consolidated Statements of Operations: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:76.677%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.011%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.012%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three months ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,876&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;RSUs&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Equity awards granted to employees primarily consist of RSUs and generally vest over four years. The weighted-average grant-date fair value of RSUs generally is determined based on the number of units granted and the quoted price of Recursion&#x2019;s common stock on the date of grant.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes Recursion&#x2019;s RSU activity during the three months ended March 31, 2026: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:63.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.835%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.784%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-average grant date fair value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding as of December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,489,925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,154,778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,703,740)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,375,565)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding as of March 31, 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,565,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair market value of RSUs vested was $18.1 million during the three months ended March 31, 2026. As of March&#160;31, 2026, $159.1 million of unrecognized compensation cost related to RSUs is expected to be recognized as expense over approximately the next three years.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant contextRef="c-82" decimals="-5" id="f-424" unitRef="shares">27100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant contextRef="c-83" decimals="-5" id="f-425" unitRef="shares">11300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock contextRef="c-1" id="f-426">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the classification of stock-based compensation expense for employees and non-employees within the Condensed Consolidated Statements of Operations: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:76.677%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.011%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.012%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three months ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,876&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-84" decimals="-3" id="f-427" unitRef="usd">900000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-85" decimals="-3" id="f-428" unitRef="usd">2950000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-86" decimals="-3" id="f-429" unitRef="usd">11876000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-87" decimals="-3" id="f-430" unitRef="usd">17800000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-88" decimals="-3" id="f-431" unitRef="usd">9219000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-89" decimals="-3" id="f-432" unitRef="usd">14839000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-1" decimals="-3" id="f-433" unitRef="usd">21995000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-16" decimals="-3" id="f-434" unitRef="usd">35589000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-90" id="f-435">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock contextRef="c-1" id="f-436">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes Recursion&#x2019;s RSU activity during the three months ended March 31, 2026: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:63.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.835%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.784%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-average grant date fair value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding as of December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,489,925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,154,778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,703,740)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,375,565)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding as of March 31, 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,565,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-91"
      decimals="INF"
      id="f-437"
      unitRef="shares">27489925</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-91"
      decimals="2"
      id="f-438"
      unitRef="usdPerShare">6.55</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-90"
      decimals="INF"
      id="f-439"
      unitRef="shares">6154778</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-90"
      decimals="2"
      id="f-440"
      unitRef="usdPerShare">3.98</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="c-90"
      decimals="INF"
      id="f-441"
      unitRef="shares">2703740</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-90"
      decimals="2"
      id="f-442"
      unitRef="usdPerShare">6.69</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="c-90"
      decimals="INF"
      id="f-443"
      unitRef="shares">2375565</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="c-90"
      decimals="2"
      id="f-444"
      unitRef="usdPerShare">6.46</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-92"
      decimals="INF"
      id="f-445"
      unitRef="shares">28565398</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-92"
      decimals="2"
      id="f-446"
      unitRef="usdPerShare">5.99</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue contextRef="c-90" decimals="-5" id="f-447" unitRef="usd">18100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions contextRef="c-92" decimals="-5" id="f-448" unitRef="usd">159100000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="c-90" id="f-449">P3Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="c-1" id="f-450">Income Taxes &lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company did not incur a significant amount of U.S. income tax expense during the three months ended March 31, 2026 and 2025. The Company has historically incurred operating losses and continues to maintain a full valuation allowance against most of its U.S. net deferred tax assets. Foreign income tax benefits were $5.5 million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;for the three months ended March 31, 2026 and the Company did not incur a significant amount for 2025. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s U.S. net operating loss (&#x201c;NOL&#x201d;) and tax credit carryforwards are subject to review and adjustment by the Internal Revenue Service (&#x201c;IRS&#x201d;) and may be subject to annual limitations under Section 382 of the Internal Revenue Code, as amended and similar state provisions in the event of certain ownership changes. These ownership changes may limit the amount of NOLs and other tax attributes that can be utilized annually to offset future taxable income. In general, an ownership change, as defined by Section 382, occurs when the ownership of certain shareholders or public groups increases by more than 50% over a rolling three-year period. As of March&#160;31, 2026, the Company completed a Section 382 study covering the period through January&#160;31, 2025 and concluded that a deemed ownership change occurred on September&#160;25, 2017. As a result, the Company&#x2019;s ability to utilize its NOLs and other tax attributes may be subject to annual limitations. The Company will continue to monitor ownership changes that could result in additional limitations on the utilization of its tax attributes. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company files income tax returns in the United States (federal and various state jurisdictions), Canada and the United Kingdom and is subject to examination by taxing authorities in these jurisdictions. The Company is not currently under examination by any taxing authority. For U.S. federal income tax purposes, tax years beginning with 2016 remain open for examination.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ForeignIncomeTaxExpenseBenefitContinuingOperations contextRef="c-1" decimals="-5" id="f-451" unitRef="usd">-5500000</us-gaap:ForeignIncomeTaxExpenseBenefitContinuingOperations>
    <us-gaap:ForeignIncomeTaxExpenseBenefitContinuingOperations contextRef="c-16" decimals="-5" id="f-452" unitRef="usd">0</us-gaap:ForeignIncomeTaxExpenseBenefitContinuingOperations>
    <us-gaap:EarningsPerShareTextBlock contextRef="c-1" id="f-453">Net Loss Per Share&lt;span style="color:#1e1e1e;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended March 31, 2026 and 2025, Recursion calculated net loss per share of Class A, Class B and the Exchangeable common stock. Basic net loss per share is computed using the weighted-average number of shares outstanding during the period. Diluted net loss per share is computed using the weighted-average number of shares and the effect of potentially dilutive securities outstanding during the period. Potentially dilutive securities consist of stock options and other contingently issuable shares. For periods presented in which the Company reports a net loss, all potentially dilutive shares are anti-dilutive and as such are excluded from the calculation. For the three months ended March 31, 2026 and 2025, the Company reported a net loss and therefore basic and diluted loss per share were the same.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The rights, including the liquidation and dividend rights, of the holders of the Company&#x2019;s Class A, Class B and the Exchangeable common stock are identical, except with respect to voting. As a result, the undistributed earnings for each period are allocated based on the contractual participation rights of the Class A, Class B and the Exchangeable common stock as if the earnings for the period had been distributed. As the liquidation and dividend rights are identical, the undistributed earnings are allocated on a proportionate basis and the resulting amount per share for Class A, Class B and the Exchangeable common stock was the same during the three months ended March 31, 2026 and 2025.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables set forth the computation of basic and diluted net loss per share of Class A, Class B and Exchangeable common stock:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.438%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.204%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.058%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands, except share and per share amounts)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(117,504)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(202,487)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;529,303,984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;402,771,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss per share, basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.50)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company excluded the following potential common shares from the computation of diluted net loss per share for the periods indicated because including them would have had an anti-dilutive effect: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.438%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.057%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.205%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Stock based compensation&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,504,219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,896,288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tempus agreement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,369,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,504,219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,265,416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="c-1" id="f-454">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables set forth the computation of basic and diluted net loss per share of Class A, Class B and Exchangeable common stock:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.438%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.204%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.058%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands, except share and per share amounts)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(117,504)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(202,487)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;529,303,984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;402,771,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss per share, basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.50)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-455" unitRef="usd">-117504000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-16" decimals="-3" id="f-456" unitRef="usd">-202487000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-1" decimals="0" id="f-457" unitRef="shares">529303984</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="0" id="f-458" unitRef="shares">529303984</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-16" decimals="0" id="f-459" unitRef="shares">402771972</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-16" decimals="0" id="f-460" unitRef="shares">402771972</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-1"
      decimals="2"
      id="f-461"
      unitRef="usdPerShare">-0.22</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-1"
      decimals="2"
      id="f-462"
      unitRef="usdPerShare">-0.22</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-16"
      decimals="2"
      id="f-463"
      unitRef="usdPerShare">-0.50</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-16"
      decimals="2"
      id="f-464"
      unitRef="usdPerShare">-0.50</us-gaap:EarningsPerShareBasic>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock contextRef="c-1" id="f-465">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company excluded the following potential common shares from the computation of diluted net loss per share for the periods indicated because including them would have had an anti-dilutive effect: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.438%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.057%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.205%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Stock based compensation&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,504,219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,896,288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tempus agreement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,369,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,504,219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,265,416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-93" decimals="0" id="f-466" unitRef="shares">5504219</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-94" decimals="0" id="f-467" unitRef="shares">11896288</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-95" decimals="0" id="f-468" unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-96" decimals="0" id="f-469" unitRef="shares">5369128</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-1" decimals="0" id="f-470" unitRef="shares">5504219</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-16" decimals="0" id="f-471" unitRef="shares">17265416</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:FairValueDisclosuresTextBlock contextRef="c-1" id="f-472">Fair Value Measurements&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value hierarchy consists of the following three levels:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 1 &#x2014; Valuations based on unadjusted quoted prices in active markets for identical assets that the company has the ability to access;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 2 &#x2014; Valuations based on quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active and model-based valuations in which all significant inputs are observable in the market; and&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 3 &#x2014; Valuations using significant inputs that are unobservable in the market and include the use of judgment by the company's management about the assumptions market participants would use in pricing the asset or liability.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is required to maintain a cash balance in a collateralized account to secure the Company&#x2019;s credit cards. Additionally, the Company holds restricted cash related to an outstanding letter of credit issued by J.P. Morgan, which was obtained to secure certain Company obligations relating to tenant improvements. Recursion also holds restricted cash as required by a lease agreement. The Company also holds restricted cash as required by several grant agreements.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize the Company&#x2019;s assets and liabilities that are measured at fair value on a recurring basis:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.514%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:43.727%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.741%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.543%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.744%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.745%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basis of fair value measurement&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;609,031&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;609,031&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;665,180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;665,180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:45.098%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.297%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.204%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.449%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.452%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basis of fair value measurement&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;670,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;670,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;753,921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;753,921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to the financial instruments that are recognized at fair value on the Condensed Consolidated Balance Sheet, the Company has certain financial instruments that are recognized at amortized cost or some basis other than fair value. The carrying amount of these instruments are considered to be representative of their approximate fair values. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize the Company&#x2019;s financial instruments that are not measured at fair value: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:26.531%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.443%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.443%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.992%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.443%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.448%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Book values&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair values&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Notes payable and financing lease liabilities, current&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Notes payable and financing lease liabilities, non-current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock contextRef="c-1" id="f-473">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize the Company&#x2019;s assets and liabilities that are measured at fair value on a recurring basis:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.514%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:43.727%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.741%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.543%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.744%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.745%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basis of fair value measurement&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;609,031&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;609,031&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;665,180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;665,180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:45.098%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.297%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.204%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.449%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.452%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basis of fair value measurement&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;670,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;670,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;753,921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;753,921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-97" decimals="-3" id="f-474" unitRef="usd">45442000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-98" decimals="-3" id="f-475" unitRef="usd">45442000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-99" decimals="-3" id="f-476" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-100" decimals="-3" id="f-477" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-101" decimals="-3" id="f-478" unitRef="usd">609031000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-102" decimals="-3" id="f-479" unitRef="usd">609031000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-103" decimals="-3" id="f-480" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-104" decimals="-3" id="f-481" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <rxrx:RestrictedCashAndCashEquivalentsFairValueDisclosure contextRef="c-4" decimals="-3" id="f-482" unitRef="usd">10707000</rxrx:RestrictedCashAndCashEquivalentsFairValueDisclosure>
    <rxrx:RestrictedCashAndCashEquivalentsFairValueDisclosure contextRef="c-105" decimals="-3" id="f-483" unitRef="usd">10707000</rxrx:RestrictedCashAndCashEquivalentsFairValueDisclosure>
    <rxrx:RestrictedCashAndCashEquivalentsFairValueDisclosure contextRef="c-106" decimals="-3" id="f-484" unitRef="usd">0</rxrx:RestrictedCashAndCashEquivalentsFairValueDisclosure>
    <rxrx:RestrictedCashAndCashEquivalentsFairValueDisclosure contextRef="c-107" decimals="-3" id="f-485" unitRef="usd">0</rxrx:RestrictedCashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-4" decimals="-3" id="f-486" unitRef="usd">665180000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-105" decimals="-3" id="f-487" unitRef="usd">665180000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-106" decimals="-3" id="f-488" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-107" decimals="-3" id="f-489" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-108" decimals="-3" id="f-490" unitRef="usd">72627000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-109" decimals="-3" id="f-491" unitRef="usd">72627000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-110" decimals="-3" id="f-492" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-111" decimals="-3" id="f-493" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-112" decimals="-3" id="f-494" unitRef="usd">670667000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-113" decimals="-3" id="f-495" unitRef="usd">670667000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-114" decimals="-3" id="f-496" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-115" decimals="-3" id="f-497" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <rxrx:RestrictedCashAndCashEquivalentsFairValueDisclosure contextRef="c-5" decimals="-3" id="f-498" unitRef="usd">10627000</rxrx:RestrictedCashAndCashEquivalentsFairValueDisclosure>
    <rxrx:RestrictedCashAndCashEquivalentsFairValueDisclosure contextRef="c-116" decimals="-3" id="f-499" unitRef="usd">10627000</rxrx:RestrictedCashAndCashEquivalentsFairValueDisclosure>
    <rxrx:RestrictedCashAndCashEquivalentsFairValueDisclosure contextRef="c-117" decimals="-3" id="f-500" unitRef="usd">0</rxrx:RestrictedCashAndCashEquivalentsFairValueDisclosure>
    <rxrx:RestrictedCashAndCashEquivalentsFairValueDisclosure contextRef="c-118" decimals="-3" id="f-501" unitRef="usd">0</rxrx:RestrictedCashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-5" decimals="-3" id="f-502" unitRef="usd">753921000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-116" decimals="-3" id="f-503" unitRef="usd">753921000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-117" decimals="-3" id="f-504" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-118" decimals="-3" id="f-505" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock contextRef="c-1" id="f-506">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize the Company&#x2019;s financial instruments that are not measured at fair value: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:26.531%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.443%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.443%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.992%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.443%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.448%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Book values&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair values&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Notes payable and financing lease liabilities, current&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Notes payable and financing lease liabilities, non-current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent contextRef="c-119" decimals="-3" id="f-507" unitRef="usd">9265000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent contextRef="c-120" decimals="-3" id="f-508" unitRef="usd">9091000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent contextRef="c-121" decimals="-3" id="f-509" unitRef="usd">9265000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent contextRef="c-122" decimals="-3" id="f-510" unitRef="usd">9091000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations contextRef="c-119" decimals="-3" id="f-511" unitRef="usd">7181000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations contextRef="c-120" decimals="-3" id="f-512" unitRef="usd">9564000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations contextRef="c-121" decimals="-3" id="f-513" unitRef="usd">7181000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations contextRef="c-122" decimals="-3" id="f-514" unitRef="usd">9564000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-123" decimals="-3" id="f-515" unitRef="usd">16446000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-124" decimals="-3" id="f-516" unitRef="usd">18655000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-125" decimals="-3" id="f-517" unitRef="usd">16446000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-126" decimals="-3" id="f-518" unitRef="usd">18655000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="c-1" id="f-519">Segment Information&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Segment loss&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Recursion operates as a single operating segment that is managed on a consolidated basis. The Company&#x2019;s chief operating decision maker (CODM) is its Chief Executive Officer. The CODM uses segment net loss to evaluate the performance of its segment, analyze financial trends, compare the budget to the actual operating results and make resource allocation decisions. Segment net loss represents the Company&#x2019;s consolidated net loss. All corporate costs, global function support costs, overhead costs and other shared costs are included within this segment. Other segment items primarily include general and administrative expenses including facilities, information technology, professional fees (including auditing, tax and legal) and insurance.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents Recursion&#x2019;s segment revenue, significant segment expenses, and segment net loss: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:74.484%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three months ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:112%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;14,745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;Significant segment expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Salaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;83,554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Consumables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;54,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Platform&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;8,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Discovery&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;6,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Clinical development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,569&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;10,564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;19,331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Other segment items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;22,935&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Loss from operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128,505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;191,368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Other non-operating income (loss), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,277)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Income tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;Total segment loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;117,504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;202,487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;Supplemental asset information&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Total expenditures for additions to long-lived assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;2,978&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock contextRef="c-1" id="f-520">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents Recursion&#x2019;s segment revenue, significant segment expenses, and segment net loss: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:74.484%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three months ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:112%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;14,745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;Significant segment expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Salaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;83,554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Consumables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;54,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Platform&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;8,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Discovery&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;6,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Clinical development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,569&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;10,564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;19,331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Other segment items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;22,935&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Loss from operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128,505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;191,368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Other non-operating income (loss), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,277)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Income tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;Total segment loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;117,504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;202,487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;Supplemental asset information&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Total expenditures for additions to long-lived assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;2,978&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-127" decimals="-3" id="f-521" unitRef="usd">6472000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-128" decimals="-3" id="f-522" unitRef="usd">14745000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:LaborAndRelatedExpense contextRef="c-127" decimals="-3" id="f-523" unitRef="usd">74298000</us-gaap:LaborAndRelatedExpense>
    <us-gaap:LaborAndRelatedExpense contextRef="c-128" decimals="-3" id="f-524" unitRef="usd">83554000</us-gaap:LaborAndRelatedExpense>
    <rxrx:ConsumableExpense contextRef="c-127" decimals="-3" id="f-525" unitRef="usd">7146000</rxrx:ConsumableExpense>
    <rxrx:ConsumableExpense contextRef="c-128" decimals="-3" id="f-526" unitRef="usd">54677000</rxrx:ConsumableExpense>
    <rxrx:PlatformFeeExpense contextRef="c-127" decimals="-3" id="f-527" unitRef="usd">7614000</rxrx:PlatformFeeExpense>
    <rxrx:PlatformFeeExpense contextRef="c-128" decimals="-3" id="f-528" unitRef="usd">8765000</rxrx:PlatformFeeExpense>
    <rxrx:DiscoveryExpense contextRef="c-127" decimals="-3" id="f-529" unitRef="usd">6332000</rxrx:DiscoveryExpense>
    <rxrx:DiscoveryExpense contextRef="c-128" decimals="-3" id="f-530" unitRef="usd">6287000</rxrx:DiscoveryExpense>
    <rxrx:ClinicalDevelopmentExpense contextRef="c-127" decimals="-3" id="f-531" unitRef="usd">6569000</rxrx:ClinicalDevelopmentExpense>
    <rxrx:ClinicalDevelopmentExpense contextRef="c-128" decimals="-3" id="f-532" unitRef="usd">10564000</rxrx:ClinicalDevelopmentExpense>
    <us-gaap:CostOfGoodsAndServicesSoldDepreciationAndAmortization contextRef="c-127" decimals="-3" id="f-533" unitRef="usd">19673000</us-gaap:CostOfGoodsAndServicesSoldDepreciationAndAmortization>
    <us-gaap:CostOfGoodsAndServicesSoldDepreciationAndAmortization contextRef="c-128" decimals="-3" id="f-534" unitRef="usd">19331000</us-gaap:CostOfGoodsAndServicesSoldDepreciationAndAmortization>
    <us-gaap:SegmentReportingOtherItemAmount contextRef="c-127" decimals="-3" id="f-535" unitRef="usd">13345000</us-gaap:SegmentReportingOtherItemAmount>
    <us-gaap:SegmentReportingOtherItemAmount contextRef="c-128" decimals="-3" id="f-536" unitRef="usd">22935000</us-gaap:SegmentReportingOtherItemAmount>
    <us-gaap:OperatingIncomeLoss contextRef="c-127" decimals="-3" id="f-537" unitRef="usd">-128505000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-128" decimals="-3" id="f-538" unitRef="usd">-191368000</us-gaap:OperatingIncomeLoss>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-127" decimals="-3" id="f-539" unitRef="usd">6397000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-128" decimals="-3" id="f-540" unitRef="usd">-11277000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-127" decimals="-3" id="f-541" unitRef="usd">-4604000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-128" decimals="-3" id="f-542" unitRef="usd">-158000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss contextRef="c-127" decimals="-3" id="f-543" unitRef="usd">-117504000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-128" decimals="-3" id="f-544" unitRef="usd">-202487000</us-gaap:NetIncomeLoss>
    <us-gaap:SegmentExpenditureAdditionToLongLivedAssets contextRef="c-127" decimals="-3" id="f-545" unitRef="usd">258000</us-gaap:SegmentExpenditureAdditionToLongLivedAssets>
    <us-gaap:SegmentExpenditureAdditionToLongLivedAssets contextRef="c-128" decimals="-3" id="f-546" unitRef="usd">2978000</us-gaap:SegmentExpenditureAdditionToLongLivedAssets>
    <ecd:Rule10b51ArrTrmntdFlag contextRef="c-1" id="f-549">false</ecd:Rule10b51ArrTrmntdFlag>
    <ecd:NonRule10b51ArrTrmntdFlag contextRef="c-1" id="f-550">false</ecd:NonRule10b51ArrTrmntdFlag>
    <ecd:NonRule10b51ArrAdoptedFlag contextRef="c-1" id="f-551">false</ecd:NonRule10b51ArrAdoptedFlag>
    <ecd:MtrlTermsOfTrdArrTextBlock contextRef="c-129" id="f-552">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 3, 2026, Namandj&#xe9; Bumpus, a member of our Board of Directors, adopted a Rule 10b5-1 trading arrangement that is intended to satisfy the affirmative defense of Rule 10b5-1(c) for the potential sale of up to 12,735 shares of the Company&#x2019;s Class A common stock until June&#160;2, 2027&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;</ecd:MtrlTermsOfTrdArrTextBlock>
    <ecd:TrdArrAdoptionDate contextRef="c-129" id="f-553">March 3, 2026</ecd:TrdArrAdoptionDate>
    <ecd:TrdArrIndName contextRef="c-129" id="f-554">Namandj&#xe9; Bumpus</ecd:TrdArrIndName>
    <ecd:TrdArrIndTitle contextRef="c-129" id="f-555">a member of our Board of Directors</ecd:TrdArrIndTitle>
    <ecd:Rule10b51ArrAdoptedFlag contextRef="c-129" id="f-556">true</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:TrdArrSecuritiesAggAvailAmt
      contextRef="c-130"
      decimals="INF"
      id="f-557"
      unitRef="shares">12735</ecd:TrdArrSecuritiesAggAvailAmt>
    <ecd:TrdArrExpirationDate contextRef="c-129" id="f-558">June&#160;2, 2027</ecd:TrdArrExpirationDate>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
